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PL 1.1
EFFECT OF POST-OPERATIVE MORBIDITY ON DISEASE-
SPECIFIC SURVIVAL AFTER HEPATIC RESECTION FOR COLO-
RECTAL METASTASIS (CRM)
Are, Chandrakanth; Gonen, Mithat; D’Angelica, Michael; DeMatteo,
Ronald; Fong, Yuman; Blumgart, Leslie; Jarnagin, William
Memorial Sloan Kettering Cancer Centre, New York, USA
Background. The importance of post-operative complications in determin-
ing cancer-specific survival is controversial and ill-defined.
Aim. This study analyzes the influence of surgical morbidity on long-term
survival after resection of hepatic CRM.
Methods. Demographic, disease-specific and operative data were recorded
for consecutive patients submitted to resection of hepatic CRM. A clinical
risk score (CRS) was used to stratify patients according to disease extent.
Complications were graded for severity; cancer-specific survival was com-
pared for patients with (COMP) and without (NO COMP) non-fatal
complications.
Results. Of the 1106 patients submitted to resection (199103), 26 (2.4%)
died perioperatively; 454 of the remaining 1080 (42%) had at least 1
complication, 194 of which were severe (17.9%, grade 3 or 4). COMP
patients had more co-morbidities, more extensive operations and more
advanced disease (higher CRS) compared to NO COMP (Table); however, at
a median follow-up of 26.5 months, disease-specific survival was no different
between the two groups (p/0.1). Operative morbidity in the entire cohort
(42%) was similar to that of patients who survived at least 3 (38.9%) or 5
(40.7%) years. Further sub-group and multivariate analyses identified no
adverse impact of operative morbidity on survival.
Conclusion. Post-operative complications after hepatic resection of hepatic
CRM do not adversely affect cancer-specific survival.
VARIABLE
NO COMP
(n/626)
COMP
(n/454) p
Age 60.79/0.5 61.39/0.6 0.44
Gender (%male) 51.1% 61.7% 0.001
]/1 Co-morbidity 41.9% 50.3% 0.006
Segments resected 3.219/0.06 3.679/0.07 B/0.0001
Bilateral resection 37.7% 47.4% 0.001
Transfused 36.2% 56.4% B/0.0001
(/) Resection margin 9.3% 12.9% 0.21
Post-resection
chemotherapy
67.6% 70.9% 0.27
Node /ve 18tumour 60.4% 59.4% 0.73
Tumour size /5 cm 33.1% 39.8% 0.025
CEA /200 10.9% 10.5% 0.85
/1 tumour 47.4% 55.5% 0.01
Disease free intreval
B/12 months
43.2% 48.1% 0.11
Clinical Risk Score (CRS) 1.889/0.05 2.129/0.06 0.004
All patients (median
survival)
48.5 months 43.8 months 0.1
PL 1.2
SYNBIOTIC TREATMENT TO PREVENT POSTOPERATIVE
INFECTIOUS COMPLICATIONS IN BILIARY CANCER SUR-
GERY: A RANDOMIZED TRIAL
Nagino, Masato; Sugawara, Gen; Nishio, Hideki; Ebata, Tomoki; Nimura,
Yuji
Nagoya University Graduate School of Medicine, Nagoya, Japan
Background. Use of synbiotics has been reported to benefit human health,
but clinical value in surgical patients remains unclear.
Objective. To investigate the effect of perioperative oral administration of
synbiotics upon intestinal barrier function, immune responses, systemic
inflammatory responses, microflora, and surgical outcome in patients under-
going high-risk hepatobiliary resection.
Methods. Patients with biliary cancer involving the hepatic hilus (n/101)
were randomized before hepatectomy, into a group receiving postoperative
enteral feeding with synbiotics (group A); or another receiving preoperative
plus postoperative synbiotics (group B). Lactulose-mannitol (L/M) ratio,
serum diamine oxidase (DAO) activity, natural killer (NK) cell activity,
interleukin-6 (IL-6), fecal microflora, and fecal organic acid concentrations
were determined before and after hepatectomy. Postoperative infectious
complications were recorded.
Results. Of 101 patients, 81 completed the trial. Pre- and postoperative
changes in L/M ratio and DAO activity were similar between groups.
Preoperatively in group B, NK activity and lymphocyte counts increased,
while IL-6 decreased significantly (PB/0.05). Postoperative serum IL-6,
white blood cell counts, and C-reactive protein in group B were significantly
lower than in group A (PB/0.05). During the preoperative period, numbers
of Bifidobacterium colonies cultured from and total organic acid concentra-
tions measured in feces increased significantly in group B (PB/0.05).
Incidence of postoperative infectious complications was 30.0% (12/40) in
group A and 12.1% (5/41) in group B (PB/0.05).
Conclusions. Preoperative oral administration of synbiotics can enhance
immune responses, attenuate systemic postoperative inflammatory responses,
and improve intestinal microbial environment. These beneficial effects likely
reduce postoperative infectious complications after hepatobiliary resection
for biliary cancer.
PL 1.3
APPLICATION OF FIBRIN GLUE SEALANT AFTER HEPATECT-
OMY (DOES NOT SEEM JUSTIFIED). RESULTS OF A RANDO-
MIZED STUDY IN 300 PATIENTS
Figueras, Joan1; Miro, Monica2; Llado, Laura2; Ramos, Emilio2; Torras,
Jaume2; Fabregat, Joan2; Serrano, Teresa3
1Trueta Hospital, Surgery, Girona, Spain; 2Bellvitge Hospital, Surgery,
Barcelona, Spain; 3Bellvitge Hospital, Pathology, Barcelona, Spain
Objective. To evaluate the efficacy, amount of hemorrhage, biliary leakage,
complications, and postoperative evolution after fibrin glue sealant applica-
tion in patients undergoing liver resection.
Background. Fibrin sealants have become popular in improving periopera-
tive hemostasis and reducing biliary leakage after liver surgery. However, the
trials about its use in liver surgery are small and of poor methodological
quality.
Patients and methods. Tree hundred patients undergoing hepatic resection
were randomly assigned to fibrin glue application (FG) or Control (C).
Characteristics and debit of drainage and postoperative complications were
evaluated. The amount of blood loss, measurements of hematological
parameters liver test, morbidity particularly biliary fistula and postoperative
evolution were also recorded.
Results. Postoperatively no differences were observed in the amount of
transfusion (0.159/0.66 vs. 0.179/0.63 PRCU; p/0.7234) or the patients
that required transfusion (18% vs. 12%; p/0.2), respectively for FG or C
group. There were no differences on postoperative morbidity between groups
(23% vs. 23%; p/1). Incidence of Biliary fistula was similar in FG and C
group, (10% vs. 11%). There were no differences in overall drainage volume
(11809/2528 vs. 9609/1253 mL) or days of postoperative drainage (7.99/5
vs. 7.19/4.7).
Conclusions. Application of fibrin sealant in the raw surface of the liver does
not seem justified. Blood loss, transfusion, incidence of biliary fistula and
outcome is comparable to patients without fibrin glue. Therefore its
systematic use is not recommended.
PL 1.4
LONG-TERM SURVIVAL AND METASTATIC PATTERN OF
PANCREATIC CANCER AFTER ADJUVANT CHEMORADIATION
OR OBSERVATION; LONG-TERM RESULTS OF EORTC-TRIAL
40891
Smeenk, Henri1; van Eijck, Casper1; Tran, Khe1; Debois, Muriel2; Klinken-
bijl, Jean3; Cutsem, Eric2; Obertop, Huug4; Jeekel, Hans4
1Erasmusmc, Surgery, Rotterdam, Netherlands; 2EORTC, Brussels, Bel-
gium; 3Rijnstate, Arnhem, Netherlands; 4Erasmusmc, Rotterdam, Nether-
lands
Background/Aim. The role of adjuvant chemoradiation in pancreatic
cancer remains unclear. This report presents the long-term follow-up results
of EORTC trial 40891, which assessed the role of chemoradiation in
resectable pancreatic cancer.
ISSN 1651-5323 print/ISSN 1477-2574 online # 2006 Taylor & Francis
DOI: 10.1080/16515320600855338
HPB, 2006; 8(Suppl 2): 3255
Methods. 218 patients were randomized after resection of the primary
tumour. Eligible patients had T1-2 N0-N1a M0 pancreatic cancer or T1-3
N0-N1a M0 periampullary cancers, all histological proven. Patients in the
treatment group (n/110) underwent post-operative chemoradiation (40 Gy
plus 5-FU). Patients in the control group (n/108) had no further adjuvant
treatment. Findings After a median follow-up of 11.7 years, 173 deaths
(79%) have been reported. The overall survival did not differ between the two
treatment groups (Chemoradiation treatment versus Controls: death rate
ratio 0.91, 95% CI: 0.68 1.23, p-value 0.54). The 10-year overall survival
was 18% in the whole population of patients (8% in the pancreatic head
cancer group and 29% in the periampullary cancer group). Interpretation
These results confirm the previous short-term analysis, indicating no benefit
of adjuvant chemoradiation over observation in patients with resected
pancreatic cancer or periampullary cancer. Patients with pancreatic cancer
may survive over 10 years. Only 1 of 31 cases recurred after year 7.
PL 1.5
A PROSPECTIVE EVALUATION OF LONG-TERM SURVIVAL
FOLLOWING 1005 CONSECUTIVE HEPATIC RESECTIONS FOR
METASTATIC COLORECTAL CANCER-A MULTIFACTORIAL
MODEL
Rees, Myrddin1; Tekkis, Paris2; Welsh, Fenella1; John, Timothy1
1North Hampshire Hospital, Dept. of Hepatobiliary Surgery, Basingstoke,
UK; 2St Mary’s Hospital, Dept. of Biosurgery and Surgical Technology,
London, UK
Background. The ability to predict individual patient outcomes and offer
tailored therapy enhances cancer treatment.
Aims. To identify factors associated with cancer-specific survival in patients
undergoing liver resection for metastatic colorectal cancer and develop a
predictive model (nomogram) for risk-stratification of treatment.
Methods. Clinical, pathological and complete follow-up data were collected
prospectively following primary (n/925) or repeat hepatic resection (n/80)
for metastatic colorectal cancer at a single centre (19862005). Multivariate
Cox-regression and parametric survival analysis were used to identify
predictors of cancer-specific survival and develop a nomogram. The model
was validated internally using measures of discrimination and calibration.
Results. The mortality and morbidity were 1.4% and 24.7% respectively.
The 5-year and 10-year survival rates were 36% and 23%. On multivariate
analysis, 7 risk factors were identified as independent predictors of poor
survival: /3 hepatic metastases (hazard ratio (HR)/1.3, p/0.05), node
positive primary tumour (HR/1.3, pB/0.01), poorly differentiated primary
tumour (HR/1.5, p/0.03), extra-hepatic disease (HR/2.0, PB/0.01),
liver tumour diameter 59 cm (HR/1.2, p/0.12) or ]/10 cm (HR/2.0,
pB/0.01), serum carcinoembyonic antigen level /60 ng/ml (HR/1.4, p/
0.02) and positive liver resection margin (R1: HR/2.4, pB/0.01; R2: HR/
1.7, pB/0.01). The first 6 criteria were used in a pre-operative scoring system,
the last 6 post-operatively. Patients with worst or best prognostic criteria had
a predicted median survival of 1.4 and 9 years and 5-year survival rates of 0
and 59% respectively. When tested both nomograms fitted the data with no
significant differences between observed and predicted outcomes.
Conclusions. These data show that resection of colorectal liver metastases
provides predictable long-term survival benefit. This nomogram may identify
patients to benefit from intensive surveillance or adjuvant therapy.
PL 1.6
LIVER TRANSPLANTATION FOR HEPATOCELLULAR CARCI-
NOMA IN EUROPE: ANALYSIS OF 8086 CASES
Adam, Rene1; Karam, Vincent1; Salizzoni, Mauro2; Castaing, Denis1; Mir,
Jose3; Garcia-Valdecasas, Juan4; Muhlbacher, Ferdinand5; Mazzaferro,
Vincenzo6; Klempnauer, Jurgen7; De Carlis, Luciano8; Figueras, Joan9;
Boudjema, Karim10; Margarit, Carlos11; Jaeck, Daniel12; Neuhaus, Peter13;
Filipponi, Franco14; Burra, Patricia15
1Paul Brousse Hospital, Villejuif, France; 2Centro de Trapianti di Fegato,
Turin, Italy; 3Hospital Universitario La Fe, Valencia, Spain; 4Hospital Clinic
I Provincial de Barcelona, Barcelona, Spain; 5Klinishe Abteilung fu¨r
Transplantation, Wien, Austria; 6Istituto Nazionale Tumori, Milan, Italy;
7Medizinische Hochschule Hannover, Hannover, Germany; 8Ospedale
Niguarda-Pizzamiglio II, Milan, Italy; 9Hospital Universitari de Bellvitge,
Barcelona, Spain; 10Hoˆpital de Pontchaillou, Rennes, France; 11Unidad de
Trasplante Hepatico, Barcelona, Spain; 12C.H.R.U. de Strasbourg, Stras-
bourg, France; 13Charite´- Campus-Virchow klinikum, Berlin, Germany;
14Ospedale Cisanello, Pisa, Italy; 15University Hospital, Padova, Italy
Background. From 1968 to 2004 the European Liver Transplant Registry
(ELTR) has collected data for 8086 patients transplanted for Hepatocellular
Carcinoma (HCC).
Objective. To assess results and identify prognostic factors of LT for HCC.
Methods. This analysis was restricted to the 8086 patients transplanted after
1995 for 3 reasons: (1) standardization of selection criteria for HCC, (2)
advent of living donor (LD) and Domino (DO) alternatives, and, (3)
standardization of immunosuppression. Uni- and multivariate analysis was
used to determine risk factors for graft loss (GL).
Results. The annual number of HCC patients transplanted has increased
from 164 in 1993 to 889 in 2003 with 1-yr graft survival now standing at
81%. The indications for LT were HCC with cirrhosis (HCC/Cir) (89%),
followed by HCC without cirrhosis (HCC-Cir) (10%) and Fibrolamellar
(1%). In the HCC/Cir group the etiology was viral in 55%. Corresponding
5-yr graft survivals were 62% for HCC/Cir, 56% for HCC-Cir and 21% for
fibrolamellar (pB/0.01). In cirrhotic patients, 5-yr graft survival was higher in
non-viral than in viral cirrhosis (65% vs 60%-pB/0.001). For viral cirrhosis,
Hep B had the higher survival (70%) while alcoholic etiologies had the higher
survival in non-viral cirrhosis (69%). Regarding donor type, 5-yr survival was
66% in LD, 62% in cadaveric full size graft and 40% in DO (pB/0.01).
Overall, the risk of GL increased with uncompatible blood group-matching,
DO transplant, donor age ]/60 yrs, ischemia time /12 hours, female
recipient, UNOS status 5/2, and LT prior to 2000 (all pB/0.001). For the
HCC/Cir cohort viral etiology of cirrhosis was an additional significant risk
factor (p/0.042). For the HCC-Cir cohort, only the UNOS status 5/2 (p/
0.004) was independently associated with GL.
Conclusion. Results of LT for HCC have dramatically improved during the
last decade. In addition to tumor selection criteria not assessed in this study,
seven additional risk factors should be taken into consideration when
evaluating HCC for LT.
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YIP 1.01
DISPARITY IN PANCREATIC CANCER SURVIVAL BY SOCIO-
ECONOMIC GROUP IS EXPLAINED BY RATE OF TREATMENT
INTERVENTIONS
Brown, James J1; Ashton, Beverley1; Charnley, Richard M1; Forman, David2;
Jaques, Bryon C1
1Freeman Hospital, HepaticoPancreaticoBiliary Unit, Newcastle upon Tyne,
UK; 2Northern and Yorkshire Cancer Registry, Leeds, UK
Background. We have previously shown that higher socioeconomic status
correlates with a survival advantage in pancreatic cancer. The cause for this
apparent inequality is unknown.
Aims. To investigate the impact of deprivation on management for a cohort
of 3976 patients representing all pancreatic cancers registered with the
Northern and Yorkshire Cancer Registry (NYCRIS) from January 1998 to
December 2002.
Methods. The data was retrospectively collected from the NYCRIS
database. The cohort was divided into five matched Quintiles with a
graduated deprivation profile derived from the Index of Multiple Depriva-
tion, Quintile 1 being the most deprived and Quintile 5 the most affluent.
Quintiles were compared by mean survival and by type of intervention.
Intervention subgroups measured were surgery, chemotherapy and other
palliative treatments. A relative intervention rate for each Quintile was
calculated by dividing the rate of intervention for each Quintile by the average
rate for all Quintiles. A value greater than 1.00 represented relative excess and
a value below 1.00 relative lack of intervention.
Results. There was no difference in mean survival between the Quintiles for
each of the treatment modalities. The relative intervention rates for Quintiles
1 to Quintile 5 for each type of intervention was: Surgery: 0.8, 0.84, 0.81,
1.23 and 1.3; Chemotherapy: 0.73, 0.83, 0.93, 1.1 and 1.42; Other palliative
treatments: 0.78, 0.79, 0.76, 1.24, and 1.44. The relative intervention rates
were higher in patients with higher socioeconomic status. Specifically in
Quintile 5 the relative rate of intervention was almost twice that in Quintile 1
for all interventions.
Conclusion. The apparent survival advantage from pancreatic cancer for
patients in higher socio-economic groups is not explained by improved
survival following intervention but by a disproportionate rate of intervention.
Further studies are needed to determine whether this represents inequality in
access to service.
YIP 1.02
PRE-OPERATIVE LYMPHOCYTE COUNT AS A PROGNOSTIC
FACTOR IN RESECTED PANCREATIC DUCTAL ADENOCARCI-
NOMA
Clark, EJ; Connor, S; Taylor, MA; Madhavan, KK; Garden, OJ; Parks, RW
Royal Infirmary of Edinburgh, Clinical and Surgical Sciences (Surgery),
Edinburgh, UK
Background. Recognised prognostic factors for resected pancreatic ductal
adenocarcinoma (PDAC) include tumour size, differentiation, tumour at the
resection margin and lymph node metastases. Pre-operative lymphocyte
count has previously been identified to have prognostic significance in
patients with PDAC 1
Aim. The aim of this study was to investigate if pre-operative lymphocyte
count is a prognostic indicator in patients with PDAC.
Methods. Patients who had undergone a potentially curative pancreatico-
duodenectomy (PPD) for PDAC between 19952005 and had subsequently
died were analysed. Standard prognostic factors, pre-operative lymphocyte
count and survival data were collected. Continuous data are presented as
median (inter-quartile range).
Results. Forty-four patients who had undergone PPD and had subsequently
died were analysed. On univariate analysis, predictors of a poor survival were,
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lymph node status (node positive (/ve) 314 [164636] days vs node
negative (/ve) 434 [331955] days, p/0.038), posterior resection margin
invasion (margin /ve 214 [156455] days vs margin "Cve 398 [303859],
p/0.024) and lymphocyte count below the reference range (B/1.5/109/litre
268 [213398] days vs ]/1.5/109/litre 434 [214859] days, p/0.029).
Low lymphocyte count (p/0.027) and posterior margin invasion (p/0.023)
were significant on multivariate analysis. Tumour size, resection margin
invasion (any margin) and differentiation were not found to be significant
prognostic factors.
Conclusion. Pre-operative lymphocyte count is a significant prognostic
factor in patients with PDAC. 1. Yamaguchi K, Noshiro H, Shimizu S,
Morisaki T, Chijiiwa K, Tanaka M. Long-term and short-term survivors after
pancreatectomy for pancreatic cancer. Int Surg 2000;85(1):716.
YIP 1.03
META-ANALYSES OF THE MANAGEMENT OF LOCALLY
ADVANCED AND METASTATIC PANCREATIC CANCER
Sultana, A1; Tudur-Smith, C2; Ghaneh, P1
1Royal Liverpool University Hospital, Division of Surgery and Oncology,
Liverpool, UK; 2University of Liverpool, Centre for Medical Statistics,
Liverpool, UK
Background. There are a large number of randomised controlled trials
(RCTs) involving chemotherapy, radiotherapy (RT) and combination
therapy in the management of advanced pancreas cancer. There is no
consensus on which modality and agents to be used.
Aims. The aim of these meta-analyses is to examine the following
comparisons: (i) chemotherapy versus best supportive care (BSC) (ii) 5FU
versus 5FU combination chemotherapy (iii) gemcitabine versus gemcitabine
combination chemotherapy (iv) RT versus chemoradiotherapy (chemoRT)
(v) chemotherapy versus chemoRT, followed by chemotherapy.
Methods. Relevant RCTs were identified by searching databases, trial
registers and conference proceedings. The primary end point was overall
survival (OS) and secondary endpoints were progression free survival (PFS) /
time to progression (TTP), response rate (RR) and adverse events (AE).
Meta-analyses of OS, PFS and TTP were summarised using hazard ratio
(HR) with RR and AEs summarised using relative risk.
Results. 110 RCTs were identified, and 43 trials involving 7925 patients
selected. Comparing chemotherapy to BSC, survival was improved in
the former (HR 0.64; 95% confidence interval 0.42 to 0.98). 5FU
combination chemotherapy did not result in better overall survival compared
to 5FU (HR 0.94; 95% CI/0.82 to 1.08). Survival was improved following
gemcitabine combination chemotherapy compared to gemcitabine (HR 0.89;
95% CI 0.83 to 0.96). Indirect comparisons demonstrated gemcitabine
combined with a platinum derivative or capecitabine are superior to
irinotecan or 5FU based combinations. ChemoRT improved survival over
RT alone (HR 0.70; 95% CI 0.52 to 0.94). ChemoRT followed by
chemotherapy did not lead to a survival advantage over chemotherapy (HR
0.79; CI 0.32 to 1.95).
Conclusions. There was a significant survival benefit for chemotherapy over
BSC, gemcitabine combinations over gemcitabine and chemoRT over
radiation. This supports the use of gemcitabine based combination che-
motherapy in the treatment of advanced pancreatic cancer.
YIP 1.04
A COMPARISON OF PANCREATICODUODENECTOMY WITH
EXTENDED PANCREATICODUODENECTOMY: A META-
ANALYSIS OF 1, 421 PATIENTS
Iqbal, Naureen1; Lovegrove, Richard2; Tilney, Henry S2; Abraham, Ajit T1;
Bhattacharya, Satya1; Tekkis, Paris P2; Kocher, Hemant M1
1St Bartholomew’s and The Royal London Hospital, Dept. of Hepatobiliary
and Pancreatic Surgery, London, UK; 2Imperial College London, Dept. of
Biosurgery and Surgical Technology, London, UK
Background. The need for radical lymphadenectomy for peri-ampullary
tumours of the pancreas has not been established despite promising studies
from Japanese centres.
Aim. To compare outcomes between pancreaticoduodenectomy (PD) and
extended pancreaticoduodenectomy (EPD) from all published comparative
studies in the literature.
Methods. Using meta-analytical techniques the present study compared
operative details, post-operative adverse events and survival following PD and
EPD. Comparative studies published between 1988 and 2005 of PD versus
EPD were included. End points were classified into peri-operative details,
post-operative complications including 30 day mortality, and survival as
measured during follow up. A random effect model was employed, with
significance reported at the 5% level.
Results. Twelve studies comprising 1, 421 patients (642 PD and 779 EPD),
including 3 randomized controlled trials with 454 patients (226 PD and 228
EPD) were identified for inclusion. Tumour size was comparable between the
groups (weighted mean difference (WMD) /0.14 cm, p/0.820). Signifi-
cantly more lymph nodes were harvested from those patients undergoing
EPD (WMD 5.6 nodes, p/0.010). Operative time was longer in EPD
(WMD 46.7 mins, pB/0.001) and there was a trend towards fewer positive
resection margins (odds ratio (OR) 1.78, p/0.080). This was offset by a
shorter length of stay in the PD group in studies published since 2000 (WMD
/3.0 days, pB/0.01.040). Peri-operative adverse events were similar between
the groups with only delayed gastric emptying (OR 0.50, p/0.02) occurring
less frequently in the PD group. Peri-operative mortality (OR 1.80, p/
0.160) and long-term survival (hazard ratio 0.75, p/0.110) showed a non-
significant trend favouring EPD.
Conclusions. EPD is associated with a greater nodal harvest and
fewer positive resection margins than PD. However, the risk of delayed
gastric emptying is increased and no significant survival benefit has been
shown.
YIP 1.05
PROGNOSTIC FACTORS IN RESECTED CARCINOMA OF THE
PANCREATIC BODY AND TAIL
Higashida, Masaharu; Atsushi, Urakami; Tsunoda, Tsukasa
Kawasaki Medical School, Dept. of Gastroenterological Surgery, Kurashiki,
Japan
Background. Invasive ductal carcinoma in the body and tail of the pancreas
is less frequent than pancreatic head carcinoma and its prognosis is worse,
because curative resection is difficult and long-term survival is rare. The aim
of this study was to evaluate the prognostic significance of clinicopathological
factors in patients with resected invasive ductal carcinoma of the body and
tail of the pancreas using multivariate analysis.
Methods. We reviewed the medical records of 30 patients with surgically
treated invasive ductal carcinoma of the body and tail of the pancreas
between 1985 and 2004. Age, gender, tumor location, diameter, serosal
invasion (s), retroperitoneal invasion (rp), portal venous invasion (pv),
arterial invasion (a), nervous plexus invasion (pl), lymph node metastasis
(n), pancreatic cut end margin (pcm), dissected peripancreatic tissue margin
(dpm), residual tumor (R), histological differentiation, tumor infiltration
(INF), lymphatic invasion (ly), venous invasion (v), nervous invasion (ne),
and chemotherapy were investigated. The accumulative survival rates were
calculated using the Kaplan-Meier method. Multivariate analysis was used to
determine significant prognostic factors.
Results. The 30 patients (15 males, 15 females) reviewed had a mean age of
61.9 years old (4178). The total 50% mean survival time was 14 months,
and the five-year survival rate was 5.7%. Five factors, including histological
differentiation (p/0.0029), INF (p/0.0470), ly (p/0.0285), a (pB/
0.0001), pl (p/0.0029) were analyzed as being significant by univariate
analysis. Those five factors were reanalyzed by multivariate analysis. Two
factors, a (p/0.0019, hazard ratio/3.101), and pl (p/0.0238, hazard
ratio/2.260) were found to be the significant prognostic factors.
Conclusion. Our results showed arterial invasion and pancreatic nervous
plexus invasion to be the significant prognostic factors for resected invasive
ductal carcinoma in the body and tail of the pancreas.
YIP 1.06
PANCREATICODUODENECTOMY WITH DOUBLE LOOP
RECONSTRUCTION FOR TUMORS OF THE AMPULLA OF
VATER’S: REPORT ON 74 CONSECUTIVE PATIENTS
Haddad, Luciana B; Jukemura, Jose´; Andraus, Wellington; Almeida, Jose´ L;
Montagnini, Andre´; Jureidini, Ricardo; Perini, Marcos; Siqueira, Andre´;
Abdo, Emı´lio; Penteado, Soˆnia; da Cunha, Jose´ E
Clinical Hospital of Sa˜o Paulo University, Sa˜o Paulo, Brazil
Background. Ampullary tumors are relatively rare and had better prognosis
after resection than others periampullary neoplasms. Only the complete
resection of the ampullary carcinoma can offers the possibility of cure, and
certain clinical and pathologic characteristics influence its long-term
survival.
Patients and methods. From January 1995 through December 2005, 74
patients were submitted to pancreaticoduodenectomy with reconstruction in
double loop for ampullary neoplasm at Hospital das Clinicas of Sao Paulo
University. The correlation between clinicopathologic variables and survival
was tested by Kaplan-Meier method and log-rank test.
Results. There were 45 men (60, 8%) and 29 women with a mean(s.d.)
age of 59(11) years. Jaundice (91, 2%), weight loss (79, 6%) and abdominal
pain (57, 8%) were the most common presenting symptoms. Fifty (67,
5%) were submitted to pylorus-preserving pancreaticoduodenectomy
and 24 (32, 4%) to Whipple procedure. Median operative time was 5819/
126 minutes. The surgical morbidity rate was 38%. Thirty-day mortality was
4, 1% (3 of 73 patients). Median follow-up for patients still alive was 47
months (range 7140 months). Median survival was 115 months. The
overall 5-year survival was 57, 1%. Five-year survival was 30, 7% in node-
positive patients. Survival was found to be significantly affected by tumor
grade (PB/0,001), nodal status (p/0,0014) and tumor differentiation (pB/
0,001). There were no deaths due to disease after 3 years of survival were
reached.
Conclusion. Pancreatoduodenectomy is the treatment of choice for ampul-
lary carcinoma, with a good chance of long-term survival. Surgical resection
remains the most important factor influencing outcome. Furthermore, tumor
grade and nodal status are important prognostic factors.
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YIP 1.07
PROPHYLACTIC PROBIOTICS REDUCE INTESTINAL PERME-
ABILITY IN THE EARLY PHASE OF EXPERIMENTAL ACUTE
PANCREATITIS
Lutgendorff, Femke1; Sandstro¨m, Per A1; Trulsson, Lena M1; van Minnen,
L Paul2; Rijkers, Ger T3; Timmerman, Harro M2; Gooszen, Hein G2;
Akkermans, Louis MA2; So¨derholm, Johan D1
1University Hospital, Surgery, Linko¨ping, Sweden; 2University Medical
Center, Surgery, Utrecht, Netherlands; 3University Medical Center, Pedia-
tric Immunology, Utrecht, Netherlands
Background. Infection of pancreatic necrosis is a major cause of mortality in
patients with severe acute pancreatitis. Small bowel bacterial overgrowth and
increased intestinal permeability facilitate bacterial translocation, causing
these infections. Prophylactic probiotics have been shown to reduce bacterial
translocation during experimental pancreatitis. Whether this is a direct effect
of probiotics on mucosal barrier is unknown.
Aim. The aim of this study was to determine if prophylactic multispecies
probiotics can maintain integrity of mucosal barrier during the early phase of
experimental pancreatitis.
Methods. 35 Male Spraque-Dawley rats were allocated into groups: 1)
controls (sham operated, no treatment), 2) pancreatitis, no treatment, 3)
pancreatitis, probiotics and 4) pancreatitis, placebo. Pancreatitis was induced
by intraductal glycodeoxycholate infusion (15 mM) and intravenous cerulein
(5 mg/kg/hr, for 6 hours). Daily probiotics or placebo were administered
intragastrically, starting four days prior to induction of pancreatitis. After
cerulein infusion, ileal mucosa was collected for measurement of permeability
to 51Cr-EDTA, horseradish peroxidase (HRP) and fluorescent Escherichia
coli K12 in Ussing chambers.
Results. Pancreatitis increased transmucosal flux of 51Cr-EDTA, HRP and E.
coli compared to controls (1.3 vs 0.41 106 cm/s, P/0.001, 97.6 vs 19.2
pmol/h/cm2, P/0.002 and 316 vs 39.4 fluorescence units, P/0.001,
respectively). Probiotic treatment reduced passage of E. coli compared to
placebo (50.2 vs 180 fluorescence units, P/0.026). Also 51Cr-EDTA and
HRP permeability was reduced by probiotics, compared to placebo (0.48 vs
1.3 106 cm/s, P/0.002 and 30.2 vs 105 pmol/h/cm2, P/0.003 respectively).
Conclusion. Acute pancreatitis caused increased ileal permeability to
bacteria. Barrier function was normalized by prophylactic probiotics.
YIP 1.08
TIMING OF SURGICAL INTERVENTION IN NECROTIZING PAN-
CREATITIS: A 10 YEAR CONSECUTIVE CASE SERIES AND
SYSTEMATIC REVIEW
Besselink, Marc1; Schoenmaeckers, Ernst1; Buskens, Erik2; Ridwan, Ben3;
Visser, Maarten3; Nieuwenhuijs, Vincent1; Gooszen, Hein1
1University Medical Center Utrecht, Surgery, Utrecht, Netherlands; 2Uni-
versity Medical Center Utrecht, Julius Center for Health Sciences and
Primary Care, Utrecht, Netherlands; 3University Medical Center Utrecht,
Microbiology, Utrecht, Netherlands
Background. Surgical intervention in infected necrotizing pancreatitis (NP)
is advocated in the third or fourth week after onset of disease.
Aim. To determine the impact of timing of surgical intervention for NP on
outcome.
Methods. Retrospective study of 445 acute pancreatitis patients in a tertiary
referral center over a 10 year period and a systematic review of single center
studies comprising 25 or more patients with NP published in the previous
decade.
Results. Fifty-three patients underwent surgical intervention for NP, 42
(79%) of whom had been referred. Median timing of first intervention was 28
days. Eighty-three percent had infected necrosis. Fifty-five percent had organ
failure. The mortality rate was 36%. Sixteen patients were operated within 14
days, 11 patients from day 1528 and 26 patients on day 29 or later (29/
subgroup). APACHEII, Ranson scores and preoperative organ failure and
intensive care stay were comparable between the three subgroups. The 29/
subgroup received prophylactic antibiotics for a longer period of time (4, 17
and 25 days, P/0.0001) and Candida and antibiotic resistant organisms
were more often cultured from the (peri-)pancreatic necrosis (1, 1 and 9, P/
0.022). Mortality was decreased in the 29/ subgroup (75, 45 and 8%, P/
0.0001). During the second half of the study, necrosectomy was further
postponed (43 versus 20 days, P/0.062) and mortality decreased (47 versus
22%, P/0.085). Nine studies with a total of 879 patients were included in
the systematic review. Median NP surgical volume was 8.3 patients per year
(5.315.6), timing of surgical intervention 27 days (331 days) and
mortality 25% (656%). An association was observed between (postponed)
timing and (decreased) mortality (r//0.741, P/0.022).
Conclusion. Postponing necrosectomy in NP until after the fourth week is
associated with decreased mortality, prolonged use of antibiotics and
increased incidence of Candida and antibiotic resistant organisms.
YIP 1.09
CONTINUOUS VENO-VENOUSE HAEMOFILTRATION IN THE
TREATMENT OF SAP: 6-YEAR EXPERIENCE
Plaudis, Haralds1; Pupelis, Guntars1; Grigane, Anda2; Purmalis, Gunars1
1Clinical Hospital ‘‘Gailezers’’, Dept. of Surgery, Riga, Latvia; 2Clinical
Hospital ‘‘Gailezers’’, Dept. of Nephrology, Riga, Latvia
Background. Continuous veno-venouse haemofiltration (CVVH) is promis-
ing treatment option for attenuation of systemic complications in severe acute
pancreatitis (SAP), however, experience with clinical application of the
method is limited.
Aim. Of the study was implementation of the CVVH in the complex
treatment protocol of SAP.
Methods. 111 patients with Balthazar CTSI grade ‘‘E’’, and/or necrotizing
SAP were prospectively enrolled during years 2000 2005. CVVH was
applied in all patients as an integral part of the treatment protocol. APACHE
II score at admission, symptoms of SIRS, organ dysfunction and incidence of
MODS, dynamics of serum lipase and CRP were recorded. Complication
rate, ICU, hospital stay and main outcomes were analysed in learning curve
and routine period (first and second 3 year period).
Results. Totally 39 patients corresponded to criteria for Balthazar grade ‘‘E’’
and 72 for Necrotizing SAP (NSAP) with average APACHE II score 7 and 8,
5 points. CVVH was started during the first 48 hours from admission in 82%
of patients. Average duration of CVVH increased in both subgroups from 42,
5 h to 70, 9 h in grade ‘‘E’’ and from 51, 9 to 92 h in NSAP, comparing
learning curve and routine period, p/0.006. Overall incidence of SIRS and
MODS were not different in both subgroups, however pulmonary dysfunc-
tion were more often recorded in NSAP, p/0.048. Incidence of peripan-
creatic infection decreased from 37, 9% during learning curve to 23, 3% in
routine period. Consequently, necessity for surgical intervention dropped
down from 72, 4% to 34, 8%. Early routine application of CVVH reduced
average hospital stay to 15, 9 days in grade ‘‘E’’ and to 29, 4 days in NSAP.
Finally routine application of CVVH was associated with 6, 9% and 27, 9%
mortality in both subgroups, respectively.
Conclusion. Early routine application of CVVH is reasonable in the
treatment of SAP. Further clinical trials are justified fore more selective
approach in the application of CVVH in this category of patients.
YIP 2.01
COMPARISON BETWEEN RECIPIENTS OF CADAVERIC EX-
SITU RIGHT LOBE, WHOLE LIVER ‘‘MARGINAL’’ AND ‘‘NON
MARGINAL’’ DONOR LIVER TRANSPLANTATION
Metha, Naimish1; Gunson, Bridget K1; Jarufe, Nicholas2; Buckels, John A1;
Bramhall, Simon R1; Mayer, David A1; Wigmore, Stephen J1; Mirza, Darius
F1
1Queen Elizabeth Hospital, HPB and Liver Transplant Surgery Unit,
Birmingham, UK; 2Hospital Clinico, Universidad Cato´lica de Chile, Dept.
of Digestive Surgery, Santiago, Chile
Background. There is a widening gap between number of potential
recipients and cadaveric donors. Liver splitting and ‘‘marginal livers’’ are
both used to bridge this gap.
Aim. To compare outcome of adult liver transplant patients receiving split
livers, ‘‘marginal’’ whole liver and non-marginal whole cadaveric liver grafts.
Methods. All 58 adult recipients of ex-situ right split liver allograft (SLT),
transplanted between 1/2000 and 12/2005 were matched to recipients
receiving a ‘‘marginal’’ liver allograft (MLT) and those receiving a non-
marginal whole liver (WLT). The groups were matched by: recipient age,
gender, indication for transplantation and cold ischaemic time. Graft type
and peri-operative factors were analysed with respect to complications, graft
and patient survival.
Results. Mean blood transfusion was comparable 5 (SLT), 4 (MLT), 4
(WLT) (p/ns). The median peak post operative transaminase (AST) was
1092 (SLT), 1052(MLT) and 893(WLT) (p/ns). Primary non-function was
present in only two WLT cases. The incidence of hepatic artery thrombosis
was 3.4%(n/2), 1.7%(n/1) and 5.2%(n/3) (p/ns) respectively and
portal vein thrombosis (partial) was seen in MLT(n/2) (p/ns). Biliary
complications were significantly higher in SLT at 27.5% (n/16) in
comparison to MLT-12% (n/7) and WLT- 8.6% (n/5) (p/0.01). 30
day graft failure in SLT was 13.8% (n/8); in MLTat 3.4% (n/2) and WLT
at 5.2% (n/3); SLT vs. MLT (p/0.05). 30 day patient mortality in SLT
was 10.3% (n/6); MLT: 3.4% (n/2) and WLT 1.7% (n/1) (p/ns). 3, 12
and 60 months actuarial patient survivals were lower (pB/0.001) in the SLT
group 75%, 74% and 63%; MLT: 93%, 91% and 89% and WLT: 98%, 96%
and 94% respectively. Deaths were due to sepsis/multi-organ failure; SLT:
7(12%); MLT: 3 (5%) and WLT: 1 (non function of the graft).
Conclusion. In this matched series, SLT was associated with an inferior
outcome in terms of biliary complications and patient survival.
YIP 2.02
PROSPECTIVE DOWN-STAGING PROTOCOL FOR HCC NOT
MEETING THE MILAN CRITERIA
Ravaioli, Matteo; Grazi, Gian L; Ercolani, Giorgio; Cescon, Matteo; Varotti,
Giovanni; Del Gaudio, Massimo; Vetrone, Gaetano; Zanello, Matteo; Tuci,
Francesco; Pezzoli, Francesca; Amaduzzi, Annalisa; Ramacciato, Giovanni;
Pinna, Antonio D
Sant’Orsola-Malpighi Hospital, University of Bologna, Dept. of Surgery and
Transplantation, Bologna, Italy
Background. Strategies to extend the liver transplant selection criteria for
HCC are debated.
Methods. From September’02 to April’05, we prospectively evaluated with
an intent-to-treat principle the outcome of 31 patients with T3-HCC, who
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were enrolled in a ethically approved down-staging protocol with TACE, PEI,
RFA and liver resection. Patients were included if single HCC 5/ 8 cm, 2
HCCs 5/ 5 cm, 35 HCCs 5/ 4 cm, no vascular or biliary tumor infiltration
and they were listed for OLT after becoming T2-HCC (T3*). The outcome
of T3* on list was to be compared with T1 and T2. Organ allocation was
based on MELD score. HCCs had additional points to their real-MELD
according to tumor stage and waiting time.
Results. Among the 31 T3, 5 (16%) were not down-staged to T2, mainly for
tumor progression. The remaining 26 became pre-op. T2 (T3*) and they
were listed for OLT; in the same period 68 T1 and 70 T2 were listed. The
median real-MELD was comparable: 14 for T1, 13 for T2 and 11 for T3*.
During the study period the transplantation and the drop-out rates were
equally distributed: 58.8% and 16.2% for T1; 55.7% and 20% for T2; 53.8%
and 15.4% for T3*. The HCC recurrences were 4 out of 93 OLTs performed
(4.3%) and they were all in the T2 group. Among the 14 OLTs in the T3*
group, one patient died for MOF and the remaining 13 are alive without
recurrence and with a median follow-up after OLT of 18.8 months (range
6.535.3). Histological evaluation of T3* patients showed that: 2 cases
(14.3%) had complete tumor necrosis, but 6 cases (43%) remained T3.
Eleven cases (78.6%) had G3 tumor grade or/and micro-vascular tumor
invasion.
Conclusion. down-staging procedures allowed listing several HCCs out of
the Milan criteria as T2. Since listed, down-staged patients (T3*) had the
same outcome on list and after OLT than T1-T2. Histological analysis of
T3* showed tumors with high risk of recurrence, which suggests a longer
follow-up for definitive conclusions.
YIP 2.03
LONG-TERM VENOUS OUTFLOW COMPLICATIONS AFTER
LIVING DONOR LIVER TRANSPLANTATION IN MODIFIED
RIGHT GRAFT: A SINGLE-CENTER EXPERIENCE
Ogata, Satoshi1; Song, Gi-Won2; Ahn, Chul-Soo2; Moon, Deok-Bog2; Kim,
Ki-Hun2; Kim, Bum-Soo2; Ha, Tae-Yong2; Hwang, Shin2; Ku, Yonson1;
Lee, Sung-Gyu2
1Kobe University Hospital, Dept. of Liver Surgery and Transplantation,
Kobe, Japan; 2University of Ulsan College of Medicine and Asan Medical
Center, Seoul, Korea
Background & aim. The incidence of early and late venous outflow
complications has not been evaluated after living donor liver transplantation
(LDLT) using a right liver graft without the middle hepatic vein (MHV)
(modified right liver graft: MRLDLT). Moreover, the long-term patency of
V5 and V8 venous graft are still unknown. The aim of this study was to
evaluate the long-term venous outflow complications after MRLDL.
Methods. Between Jan. 2002 and Dec. 2004, 504 consecutive adult patients
underwent LDLT. The incidence of early and late venous outflow complica-
tions in MRLDLT (n/232: median age 55 years) and the efficacy of
therapeutic interventions were assessed. The median follow-up period was
11.7 months (range, 2.56.0).
Results. Among 232 patients who received MRLDLT, V5 only (n/24), V8
only (n/44) and both of them (n/164) were reconstructed. RIHV was
reconstructed in 133 patients (57%). Forty-six stenosis were identified in 39
patients (17%) within 7 days after MRLDLT. However, severe hepatic
venous congestion was observed only in 16 patients (7%). Stent placement
was performed in these patients and the clinical success was achieved in 14 of
16 patients (88%). Late RHV stenosis occurred in 6 patients (3%). Three of
them presented hepatic venous congestion with ascites, but the remaining 3
showed complete venous perfusion with significant increase of diameter in
reconstructed MHV or RIHV. Late V5 or V8 stenosis occurred in 45 patients
(19%) without significant venous congestion. 1, 4 and 50 weeks patency of
V5 and/or V8 venous graft after stent placement were 91%, 83% and 72%,
respectively.
Discussion. Severe venous congestion does not always occur after stenosis in
one of the reconstructed RHV, MHV or RIHV. This would be because of
intrahepatic venous anastomosis formation and compensated increase of
venous outflow in the other veins. Thus, multiple conduits for venous outflow
could decrease the incidence of hepatic venous congestion by their
compensated effect.
YIP 2.04
GREEN TEA EXTRACT AMELIORATES LIVER ISCHEMIA-RE-
PERFUSION INJURY IN RATS
Liang, Rui1; Nickkholgh, Arash1; Kern, Michael2; Schneider, Heinz3;
Benzing, Steffen4; Zorn, Markus5; Gebhard, Martha M6; Schmidt, Jan1;
Bu¨chler, Markus W1; Schemmer, Peter1
1Ruprecht-Karls-University, Dept. of General Surgery, Heidelberg, Ger-
many; 2Ruprecht-Karls-University, Dept. of Pathology, Heidelberg, Ger-
many; 3HealthEcon AG, Basel, Switzerland; 4Fresenius Kabi, Bad Homburg,
Germany; 5Ruprecht-Karls-University, Central Laboratory, Heidelberg,
Germany; 6Ruprecht-Karls-University, Dept. of Experimental Surgery,
Heidelberg, Germany
Background. Green tea (Camellia sinenesis) and its polyphenolic constitu-
ents have been shown to be potent scavengers of reactive oxygen species.
Objectives. To assess green tea effects after liver ischemia-reperfusion.
Methods. Fasted rats were gavaged with different concentrations of green tea
extract (GTE) 2 hours before 90 minutes of warm ischemia of the left lateral
liver lobe (30% of liver). Controls were given the same volume of GTE-
vehicle (normal saline). After reperfusion, transaminases, liver histology,
hepatic microcirculation, and both phagocytosis of Kupffer cells and
expression of TNF-a to index cellular activation were investigated. Analysis
of variance (ANOVA) followed by t-test or Chi-square (or Fisher’s exact) test
were used as appropriate. Results are presented as mean9/SEM.
Results. After 90 minutes of warm ischemia AST, ALT, and LDH increased
dramatically to 16149/254/15599/164 U/l, 17709/472/12139/182 U/l and
71919/2076/8529/116 U/l at 2/6 hours, respectively. GTE (200 mg/kgBW)
greatly prevented this increase in a dose dependent manner by 21% to 51%
(pB/0.05) and 29% to 34% (pB/0.05), respectively. Histology confirmed the
protective effects while both TNF-a expression and phagocytosis of latex
beads by Kupffer cells were significantly reduced. In parallel, in vivo
microscopy revealed an improved flow velocity of red blood cells as well as
acinar and sinusoidal perfusion after GTE (pB/0.05).
Conclusion. These data show that GTE ameliorates ischemia-reperfusion
injury in liver. Decreased cellular activation and improved microcirculation
are the proposed mechanisms, which are most likely Kupffer cell-dependent.
YIP 2.05
INHIBITION OF HEPATIC ISCHEMIA/REPERFUSION INDUCED
APOPTOSIS AND NECROSIS VIA DOWN-REGULATION OF
NF-KB, AND CASPACE-3 BY EGCG
Giakoustidis, Alexander1; Giakoustidis, Dimitrios1; Koliakou, Kokkona2;
Iliadis, Stavros3; Papageorgiou, George3; Tsalie, Eleutheria2; Kontos, Ni-
cholas1; Antoniadis, Nikos1; Ouzounidis, Nikos1; Papanikolaou, Vasillios1;
Takoudas, Dimitrios1
1Aristotle University, Hippokration Hospital, Dept. of Transplantation
Surgery, Thessaloniki, Greece; 2Aristotle University, Dept. of Embryology
& Histology, Thessaloniki, Greece; 3Aristotle University, Dept. of Biological
Chemistry, Thessaloniki, Greece
Background. Ischemia/reperfusion (I/R) activates Kupffer cells and initiates
a severe oxidative stress with enhanced production of reactive oxygen species
mediating the expression of nuclear factors triggering apoptosis and lipid
peroxidation.
Aim. Evaluate the effect of (/)-epigallocatechin-3-gallate (EGCG) admin-
istration in inhibition of lipid peroxidation and apoptosis by attenuating the
expression of NF-kB and caspace-3 in severe hepatic I/R.
Methods. Thirty wistar rats, weighting 250300 g, were divided into three
groups. Group A sham operation, B I/R, C I/R-EGCG 50 mg/kg. EGCG
administrated 15 min before ischemia. Ischemia was induced for 60 min by
Pringle’s maneuver. Analysis of MDA, MPO, AST, and ALT, TUNEL,
immunocytochemistry for NF-kB, caspace-3, transmission electron micro-
scopy and light histology examinations of the liver was performed 120 min
after reperfusion.
Results. Apoptosis as indicated by TUNEL was increased in I/R group
compared with sham and EGCG pretreated groups. Activated Caspace-3 was
widely expressed in I/R group although very limited was found in sham and
EGCG groups. Liver was stained positive for NF-kB, in I/R group but
negative in EGCG treated group. I/R increased (pB/0.05) the levels of AST
and ALT in serum to 2715 and 2193 IU/L, respectively. MDA and MPO in
liver increased (pB/0.05) to 1.595 nmol/g and 6.13 U/g in the group
subjected to I/R compared to 1.045 nmol/g and 1.76 U/g in the sham
operation group respectively. EGCG pretreatment decreased (pB/0.05)
serum levels of AST and ALT to 1196 and 1108 IU/L respectively. It also
decreased (pB/0.05) MDA and MPO in liver to 1.115 nmol/g, and 1.86 U/g
respectively. Transmission electron microscopy and light histology examina-
tion revealed significant protection of hepatic parenchyma in the EGCG
treated group.
Conclusions. Administration of EGCG is likely to protect liver from
ischemia/reperfusion injury by inhibition of apoptotic signal transduction
pathways and reduction of lipid peroxidation.
YIP 2.06
LIVING DONOR LIVER TRANSPLANTATION FOR HCV-POSITIVE
PATIENTS
Ito, Takashi1; Takada, Yasutsugu1; Haga, Hironori2; Ueda, Yoshihide3;
Sakamoto, Seisuke1; Ogawa, Kohei1; Oike, Fumitaka1; Ueda, Mikiko1;
Egawa, Hiroto1
1Kyoto University, Dept. of Transplantation and Immunology, Kyoto, Japan;
2Kyoto University, Dept. of Pathology, Kyoto, Japan; 3Kyoto University,
Dept. of Hepatology, Kyoto, Japan
Purpose. Whether hepatitis C recurrence occurs earlier and with greater
severity for LDLT has recently become a subject of debate. We retro-
spectively evaluated clinical outcomes for HCV-positive patients who under-
went LDLT at Kyoto University.
Patients. From March 1999 to September 2005, 112 patients underwent
LDLT for HCV-related cirrhosis including 66 patients of HCC. The median
MELD score was 16 (range: 436). Median follow-up period was 30
months.
Results. Overall 5-year patient survival for HCV patients was similar to that
for non-HCV adult patients (n/267) (72% vs. 69%). Survival rate of
patients without HCC (n/46) tended to be better than that of patients with
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HCC (n/66) (80% vs. 65%, p/0.203). Based on annual liver biopsy, rate
of fibrosis progression to stage 2 (Metavir score) or more was 68% at 3 years
after LDLT. Univariate analysis showed that female recipient and male donor
represented significant risk factors for fibrosis. Progression to liver cirrhosis
(F4) was observed in 5 patients including 2 with cholestatic hepatitis. To
date, 52 patients received the antiviral therapy for recurrent hepatitis C. The
sustained virological response rate was 32%. As a new strategy for recurrent
hepatitis C, the antiviral therapy combined double filtration prasmapheresis
(DFPP) was performed to 10 patients. ALT decreased dramatically from
pretreatment value of 39256 (79) IU/l to 1354 (34) IU/l at two weeks after
DFPP and HCV-RNA value also decreased from 15005000 (3700) KIU/ml
at pretreatment to 52100 (110) KIU/ml at two weeks after DFPP.
Conclusions. Postoperative patient survival was similar for HCV-positive
and -negative recipients in our adult LDLT series. Rates of progression to
severe disease due to HCV recurrence seemed comparable between LDLT
recipients and DDLT recipients described in the literature. Although longer-
term follow-up is required, the present study suggests that LDLT may
constitute an optional treatment with acceptable outcomes also for patients
suffering from HCV-related cirrhosis.
YIP 2.07
EXPANDING THE DONOR POOL: USE OF OLDER LIVING
DONORS (/50) IN ADULT LIVING DONOR LIVER TRANSPLAN-
TATION
Shah, Shimul; Levy, Gary; McGilvray, Ian; Adcock, Leslie; Gallagher, Gary;
Selzner, Markus; Greig, Paul; Cattral, Mark; Grant, David
University Health Network/University of Toronto, Multi-Organ Transplanta-
tion Unit, Toronto, Canada
Many centers are reluctant to use older patients for right-lobe living donor
liver transplantation (R-LDLT). We reviewed our experience with living
donors /50 to see if there was increased morbidity in this population or
poorer outcomes in the recipients of these grafts.
Methods. Since 2000, 130 adult R-LDLTs have been performed at our
institution using donors ranging from age 18 to 61 years of age. Two cases
were not included in the study due to recipient mortalityB/1 week post-op. To
determine the outcomes with donors/50 years, we divided the recipients
into those who received a right lobe graft from a donorB/age 50 (n/100,
78%; mean age 33) and those who received a liver graft from a donor age /
50 (n/28, 22%; mean age 54). The two donor and recipient populations had
similar demographic and operative profiles throughout the study period.
Donor and recipient morbidity and outcomes were assessed.
Results. Median follow-up was 22 months. Complications in older donors
were similar to those in younger recipients. No living donor died. There were
no differences in donor morbidity or length of stay comparing older donors
vs. younger donors. Older donor allografts had higher peak AST (742 vs.
552; p/0.04) and bilirubin (163 vs. 132; p/0.05) post-transplant, but had
similar peak INR levels (2.3 vs. 2.2; p/0.38). Graft rejection rates, overall
complications, median hospital stay and the incidence of recurrent hepatitis
C were similar among recipients. There was a higher bile duct stricture rate
with the older donor grafts (36% vs. 12%; p/0.003) resulting in graft loss in
one recipient of an older allograft. One-year recipient graft survival was 86%
for older donors and 85% for younger donors (p/0.95).
Conclusions. Despite previous reports, our data suggests the use of selected
older living donors (/50) is safe and does not result in more complications in
the donor or adverse outcomes in the recipient. Routinely accepting healthy
patients/50 years of age would expand the pool of potential donors for R-
LDLT.
YIP 2.08
HOW WELL DO CLINICIANS PREDICT SURVIVAL AFTER LIVER
TRANSPLANTATION?
Hoot, Nathan R; Feurer, Irene D; Austin, Mary T; Porayko, Michael K;
Wright, J Kelly; Lorenzi, Nancy M; Pinson, C Wright; Aronsky, Dominik
Vanderbilt University Medical Center, Nashville, Tennessee, USA
Background. Due to the scarcity of cadaveric livers, clinical judgment must
be used to avoid futile transplants. However, the accuracy of human
judgment, in terms of predicting outcomes following liver transplantation,
is unknown.
Aims. To assess the ability of expert clinicians to predict survival, and to
compare their performance to published survival models.
Methods. Case reports were prepared based on 16 actual, randomly selected
liver transplant patients. Each case report was reviewed for quality control.
We invited liver transplant specialists to participate in a survey. Based on pre-
operative data, they assessed the likelihood of 90-day graft survival for each
patient using 1) a 4-point Likert scale ranging from poor to excellent, and 2)
a visual analog scale denoting the probability of survival. Four models from
the literature were also used to predict survival for the 16 patients.
Results. 20 clinicians returned completed surveys (66% response rate; 19
males; age 479/6 years; experience 119/6 years; 4 medical, 16 surgical).
Prognostic estimates on the two scales were highly correlated (median
Pearson’s r/.86). No relationship was found between clinician agreement,
by coefficient of variance, and outcome (p/.96). For three cases, clinicians
estimated the probability of survival to be 889/8%, 889/11%, and 889/7%;
however, these patients had early graft failures due to post-operative
complications. Individual clinicians’ predictive ability was .609/.16, by area
under the receiver operating characteristic curve. The performance of the
published models was MELD .59; Desai .66; Ghobrial .61; Thuluvath .45.
Conclusions. Clinicians varied in their ability to predict survival for a set of
pre-transplant scenarios, but performed similarly to published models. When
clinicians overestimated the chance of success for a transplant, either sepsis or
hepatic artery thrombosis was involved; such events may be hard to predict
prior to surgery.
YIP 2.09
CYSTIC TUMOR OF THE PANCREAS. ‘‘WAIT AND SEE’’?
Kubyshkin, Valery; Grishankov, Sergey; Karmazanovski, Grigory; Shegolev,
Alexander; Ivanov, Nikolay
Vishnevski Institute of Surgery, Moscow, Russia
Background. Cystic neoplasm of the pancreas (CNP) include benign serous
cystic neoplasm (SCN), potentialy malignant mucinous cystic neoplasm
(MCN), and malignant cystadenocarcinoma (CAC). The management of
theses entities remains controversial.
Goals. To study the changes in size and symptomatology of various CTP
using clinical observation and imaging modalities(wait & see politic).
Patients and methods. Between 1992 and 2004 we have treated a total of
49 patients with various CNP. Thirty two patients were operated upon
admission; 17 patients declined the operation and chose to be observed. The
length of observation varied from 6 to 54 months (median 37 months);
eventually all patients underwent surgery. The diameter of CNP has been
determined by US or spiral CT once a 6 months and compared with
intraoperative. All diagnoses were confirmed histologically (SCN -9, MCN -
7, CAC-1).
Results. The size of the tumor increased in all 17 patients CAC showed the
highest rate of increase (10 mm in 6 months). MCN had rate of increase 69/2
mm in 6 months. For SCN 39/2 mm in 6 months. Ten patients developed
symptoms (abdominal pain and discomfort) simultaneously and were
operated in 6 to 24 months (CAC-1, MCN-7, SCN-2). Seven patients
with SCN showed the slow changes in size without symptoms and they were
operated in 24 to 54 months. Intraoperative size of the tumors varied: SCN
3.59/1.2 cm, MCN 7.49/0.9 cm, CAC 7.99/1.7 cm. The difference in size
between SCN and MCN, SCN and CAC is statistically significant (pB/0.05).
No significant difference in size was found between MCN and CAC.
Conclusion. 1) All of CTP tend to increase in size. 2) The rate of increase is
higher in patients with CAC and MCN. 3) Development of symptoms are
more typically for CAC and MCN too.4) The SCN are asymptomatic with
small size and slow rate of increasing.
YIP 3.01
SIMULTANEOUS RESECTION OF HEPATIC COLORECTAL
METASTASIS (CRM) AND SYNCHRONOUS EXTRA HEPATIC
DISEASE (EHD)
Are, Chandrakanth; Gonen, Mithat; DeMatteo, Ronald; Jarnagin, William;
Fong, Yuman; Blumgart, Leslie; D Angelica, Michael
Memorial Sloan Kettering Cancer Centre, New York, USA
Background. Hepatic resection for CRM in the presence of synchronous
EHD is performed in select patients although its benefit is not proven.
Aim. The aim of this study was to analyze our results of hepatic resection for
CRM in the presence of synchronous EHD and determine the criteria that
influence survival in these patients.
Methods. From a prospective database (19912003) patients that under-
went simultaneous resection of CRM and synchronous EHD (locally invasive
and distant locations) were identified. The influence of treatment and tumor
related factors on survival was analyzed by the Kaplan-Meier method.
Clinical risk score (CRS) was defined as the sum of a single point for CEA /
200, disease free interval less than 12 months, liver tumor size /5 cm,
number of liver tumors /1 and a node positive primary.
Results. A total of 1120 patients were analyzed. 136 patients (12%)
underwent simultaneous resection of CRM and synchronous EHD with a
5 yr survival of 26% as compared to 39% for the 959 patients that underwent
CRM resection without EHD (p/0.01). The influence of the factors on
survival is summarized in the table. Criteria associated with poor survival
were high CEA, greater than 1 liver tumor, node positive primary, bilateral
resection and a high CRS.
Conclusion. In a select group of patients, simultaneous resection of CRM
and EHD is associated with long- term survival. The main determinants of
survival were extent of liver disease, CEA, nodal status of the primary and a
high clinical risk score.
FACTOR n Median surival (months) p
Completeness of resection
R 0 103 36
R 1 26 29 0.95
Disease free interval
/12 months 77 38
B/12 months 54 29 0.38
8 Abstracts
Table (Continued )
FACTOR n Median surival (months) p
Margin width
B/1 cm 28 29
/1 cm 106 35 0.35
Tumour size
B/5 cm 76 42
/5 cm 55 26 0.17
Type of EHD
Locallly invasive 28 34
Distant 103 24 0.08
CEA
B/200 42 47
/200 5 8 B/0.01
Number of liver tumours
1 65 36
/1 62 26 0.02
Nodal status of primary
Negative 41 45
Positive 86 24 0.02
Extent of liver resection
Unilateral 73 42
Bilateral 57 24 0.01
Clinical Risk Score
5/2 63 42
]/3 46 24 0.01
YIP 3.02
IF FEASIBLE, SEGMENTECTOMY (SGX) IS THE ONCOLOGIC
EQUIVALENT OF HEMI-HEPATECTOMY (H-HPX) FOR UNILO-
BAR (U) COLORECTAL LIVER METASTASES (CLM)
Nesbitt, Craig1; Glendinning, Richard J1; Glendinning, Paula1; Wu,
Andrew2; Poston, Graeme2
1University of Liverpool, Faculty of Medicine, Liverpool, UK; 2University
Hospital Aintree, Surgery, Liverpool, UK
Background. HPX is the only potentially curative treatment for CLM. As
methods of detection of CLM and awareness of the benefits of HPX improve,
smaller volume disease is being diagnosed increasingly. Historically, most
patients underwent hemi(H)-HPX, but the recent trend is towards more local
resections, so increasing hepatic preservation. Furthermore, many patients
with initially inoperable disease are now coming to HPX (often SGX) after
successful downstaging with systemic chemotherapy. This trend raises
questions of oncological benefit, whether this approach increases the risk of
residual disease in the ipsilateral(I) remnant liver.
Aims. This study examines the site of liver only recurrence (LOR) with
reference to operative mortality (OM), survival and repeat(R)-LOR after
HPX, stratified for operation type: U-SGX; bilateral(B)-SGX; H-HPX;
extended(E)-HPX.
Methods. Prospectively collected single centre 5-yr follow-up of 376 patients
post-HPX for CLM. Data stratified for type of surgery, OM, LOR (I, contra
[C] and B-lateral), R-HPX, 3 and 5-yr survival.
Results. 10% I-LOR and 10% C/B-LOR following U-SGX. 80% of LOR
after U-SGX amenable to R-HPX with curative intent. LOR following B-
SGX 33%; H-HPX 17%; E-HPX 21%, all frequently amenable to R-HPX.
Conclusions. These data support the continuing use, when feasible of SGX
for unilobar CLM. B-SGX offers a possibly safer, but equally effective
alternative to E-HPX for the management of bilobar disease.
YIP 3.03
LYMPHADENECTOMY FOR LIVER TUMORS: A SAFE PROCE-
DURE IN A TERTIARY CENTER WHICH IMPROVES THE
STAGING OF THE DISEASE
Ravaioli, Matteo; Grazi, Gian L; Ercolani, Giorgio; Cescon, Matteo; Varotti,
Giovanni; Del Gaudio, Massimo; Vetrone, Gaetano; Zanello, Matteo; Tuci,
Francesco; Lauro, Augusto; Dazzi, Alessandro; Zanfi, Chiara; Pinna,
Antonio D
Sant’Orsola-Malpighi Hospital, University of Bologna, Dept. of Surgery and
Transplantation, Bologna, Italy
Background. The role of regional lymphadenectomy for liver metastases
and primary liver tumors, but not extra-hepatic bile duct cancer, is debated.
Methods. From April’99 to December’04, we prospectively evaluated 142
patients treated with liver resections and with the following pre-operative
diagnosis: 63 (44.4%) colorectal metastases (M-CR), 48 (33.8%) hepato-
cellular carcinoma (HCC), 16 (11.3%) non-colorectal metastases (M-NCR)
and 15 (10.6%) intra-hepatic cholangiocellular carcinoma (CCC). The
regional lymphadenectomy of the hepato-duodenal ligament and of the
common hepatic artery was performed in all cases. The incidence and the
influence on survival of lymph node metastases were analyzed.
Results. 42 ‘‘wedge’’ resection (29.6%), 55 segmentectomies (38.7%) and
45 major hepatectomies (31.7%) were performed. The mean operative time
was 2929/131 minutes and 96 cases (67.6%) had no blood transfusions
during the procedures. Operative mortality (within 30 days) was 3.5%, 48
cases (33.8%) developed post-operative complications and the most common
was ascites. The mean hospital stay was 99/5 days. The mean number of
nodes (LN) removed were 6.59/5 (range 630) and 63 LN (6.5%) had
micro-metastases. The incidence of lymph node metastases (LN/) accord-
ing to the pre-operative diagnosis was: 15.9% M-CR, 4.2% HCC, 37.5% M-
NCR and 40% CCC. The mean follow-up was 37.49/22.6 months, 107
patients (75.4%) are alive and 44 (31.7%) developed tumor recurrence,
which was more frequent in LN/ (54.2% vs. 27%, pB/0.05). The 1-and 3-
years patient survival was significantly affected by lymph node metastases:
92% and 85% LN- vs. 79% and 64% LN/, pB/0.05.
Conclusion. The regional lymphadenectomy for liver tumors is a safe
procedure in tertiary referred centers. The presence of lymph node
metastases was an important prognostic factor, which should be evaluated
to improve the treatment strategies.
YIP 3.04
OUTCOME FOLLOWING LIVER RESECTION FOR COLOREC-
TAL LIVER METASTASES: EFFECT OF TYPE OF RESECTION
Hamady, Zaed; Finch, Robert; Malik, Hassan; Adair, Robert; Lodge, Peter;
Prasad, Rajendra; Toogood, Giles
St James’s University Hospital, Leeds, UK
Introduction. Liver resections for colorectal metastases have traditionally
been performed using anatomical resections based on the segmental anatomy
of the liver. Recently non-anatomical liver resections have become more
common in an attempt to preserve liver parenchyma and with the knowledge
that smaller margins do not effect long term survival. This study looked at
survival and patterns of recurrence in a large cohort of patients with
colorectal liver metastases.
Methods. All data was prospectively collected and stored on a data-base. All
patients were operated on at St James’ University Hospital Leeds between
1995 and 2003. Statistical analysis was performed using SPSS for windows.
Results. 484 patients were available for analysis. 96 patients underwent non-
anatomical resection, 280 patients had anatomical liver resections and 108
patients had a combination of non anatomical and anatomical resection.
Minimum follow-up for the cohort is 24 months. Survival for the entire
group is 42% at 5 years. Overall survival is significantly worse for the
combined group, although there was no significant difference in overall
survival between the anatomical and non anatomical groups (p/0.53).
There is no difference in 5 year disease free survival between the anatomical
and the non anatomical group (p/0.10). Intra-hepatic recurrence is
significantly less in the anatomical group, whilst morbidity and mortality
are less in the non anatomic group.
Conclusion. Non anatomical resection can be performed with lower rates of
surgical morbidity and mortality than anatomical or combined resection.
Non anatomical resection does not disadvantage the patient in terms of
overall survival.
YIP 3.05
EUROPEAN SURVEY ON THE APPLICATION OF VASCULAR
OCCUSION IN LIVER SURGERY
van der Bilt, Jarmila DW; Livestro, Daan P; Borren, Alie; Hillegersberg,
Richard; Borel Rinkes, Inne HM
University Medical Center Utrecht, Dept. of Surgery, Utrecht, Netherlands
Aim. The aim of this study was to obtain insight in the frequency, indications
and techniques of vascular occlusion during liver surgery, as used by Europe’s
experienced HPB surgeons.
Methods. A survey was undertaken amongst more than 450 surgeons,
including all members of the European chapter of the International Hepato-
Pancreatico-Biliary Association (IHPBA). The online questionnaire con-
sisted of four parts, i.e. demographic data, liver resections, focal heat
destruction techniques and suggestions/comments.
Results. Interim analysis revealed an initial response rate of 40% (194).
Amongst liver surgeons experienced in liver resections (176), vascular
clamping is applied routinely in 16%, never in 14% and on indication in
70%. Indications for vascular occlusion are: blood loss/600 ml (72%), non-
anatomical resection (23%), major resection (20%) and close proximity to
vessels/ducts (18%). Reluctance to clamping is present for steatotic (79%),
Operation
type
Nos.
patients
OM
(%)
I-
LOR
C/B-
LOR
% 3-yr
survival
% 5-yr
survival
R-HPX
for LOR
(%)
U-SGX 138 0 14 15 66 56 23 (80)
B-SGX 57 1 (2)  19 47 24 6 (31)
H-HPX 96 5 (5)  16 62 48 12 (75)
E-HPX 85 11 (13)  18 47 27 7 (38)
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cirrhotic (78%) and post-chemotherapy (77%) livers. Intermittent inflow
occlusion is the clamping method of choice in more than 65% of cases, with a
typical clamping strategy of 23 cylces of 1520 minutes ischemia and 510
minutes of reperfusion, with a mean ischemia time of 15 60 minutes (79%).
During local ablation techniques, as performed by 151 participants, routine
clamping is rarely used (7%), omitted very frequently (57%) and performed
on indication in 37%. Indicatively, vascular occlusion is used either
continuously (41%) or intermittently (42%) for a meanB/30 minutes
(83%), when tumor size exceeds 4 cm (72%) or when large vessels/ bile
ducts are near (59%).
Conclusion. The results of this survey show that vascular clamping
techniques are frequently applied during liver resections, but only when
necessary and with a distinct preference for intermittent clamping. During
local ablation therapies, vascular clamping is applied infrequently and
primarily in large tumors or in cases of close proximity to vessels/ ducts.
YIP 3.06
CLINICAL SIGNIFICANCE OF BONE MARROW MICROMETAS-
TASES IN PATIENTS UNDERGOING LIVER TRANSPLANTATION
FOR HEPATOCELLULAR CARCINOMA (HCC)
Battula, Narendra1; Sutcliffe, Robert1; Maguire, Donal1; Portmann, Ber-
nard1; Rela, Mohamed1; O’Sullivan, Gerald2; Mufti, Ghulam1; Heaton,
Nigel1
1Kings College Hospital, London, UK; 2Mercy Hospital, Cork, Ireland
Background. Despite using restricted criteria, tumour recurrence is a
significant cause of death in patients undergoing orthotopic liver transplanta-
tion (OLT) for HCC. Preoperative detection of bone marrow micrometas-
tases (BMM) by immunocytochemistry has prognostic significance in breast
and other epithelial cancers, but there is little evidence for its role in patients
with HCC.
Aim. To correlate the presence of BMM in patients with HCC with tumour
histology and outcome after liver transplantation.
Patients & methods. Bilateral iliac crest bone marrow (BM) aspirates were
collected from 18 patients undergoing OLT for HCC (17 patients met Milan
criteria preoperatively) and from 14 controls. Cytospun samples were stained
with liver-specific monoclonal antibody Hep Par-1 and the presence of
micrometastases was correlated with tumour stage, histology and post-
operative tumour recurrence.
Results. 12 out of 18 patients (67%) with HCC had Hep Par-1 positive
BMM before transplantation. There was one false positive in the control
group. Hep Par-1 positive micrometastases were detected in 75% of patients
with microscopic vascular invasion, 75% with poorly differentiated tumours,
71% of patients with satellite lesions and 67% who were outside Milan
criteria histologically (6 patients) on the explanted liver. At a median follow-
up of 42 months (range 2550), six patients have developed tumour
recurrence, including 5 patients with micrometastases (83%). Of the
remaining 7 patients with positive BM analysis, 6 are alive without tumour
recurrence at latest follow-up.
Conclusions. The presence of BMM in HCC patients meeting transplant
criteria correlated well with adverse histological features and postoperative
tumour recurrence at a median follow up of 42 months. Preoperative BM
analysis may provide additional prognostic information that may influence
patient management. Further work is needed to understand the significance
of micrometastases found in patients without recurrence.
YIP 3.07
ARE CHANGES IN TUMOUR MARKERS AFTER B131BI-META-
IODO-BENZYL-GUANIDINE (MIBG) THERAPY CONSISTENT
WITH SYMPTOMATIC IMPROVEMENT IN PATIENTS WITH
CARCINOID SYNDROME?
Bendelow, John1; Apps, Edward1; Jones, Louise2; Vinjamuri, Sobhan3;
Poston, Graeme2
1University of Liverpool, Faculty of Medicine, Liverpool, UK; 2University
Hospital Aintree, Surgery, Liverpool, UK; 3Royal Liverpool University
Hospital, Nuclear Medicine, Liverpool, UK
Background. The tumours of /50% of symptomatic carcinoid patients
(SCPs) will actively take up MIBG and it is being used with increasing
frequency to treat their symptoms. Little is known of any correlation between
symptomatic/quality of life (QOL) and tumour marker (urinary-24-hour-5-
HIAA excretion [U5HIAA] improvement, Chromogranin-A [CGA] and
B[CGB]).
Aims. To compare biochemical and QOL changes after MIBG treatment of
SCPs.
Methods. 62 SCPs were screened, 32 showing MIBG avidity, each receiving
a single 5MBq dose. Fasting blood CGA and CGB, and U5HIAA levels were
measured before and one month after treatment. QOL was measured pre-
and post-treatment using the EORTC neuroendocrine QOL questionnaire,
currently under development. Statistical comparison used Mann-Whitney
test (pB/0.05 significant).
Results. 18 reported improved QOL post-MIBG. U5HIAA levels: improved
in 16 (11 QOL improvement); static in 10 (3 QOL improvement), increased
in 6 (1 improved QOL). CGA levels were unchanged in 18 (8 improved
QOL), decreased in 8 (7 improved QOL), increased in 6 (3 improved QOL).
CGB unchanged in 20 (11 improved QOL), decreased in 10 (6 improved
QOL), increased in 2 (1 improved QOL). No improvements in tumour
markers were statistically significant.
Conclusions. MIBG treatment improved QOL in 18/32 (56%) of SCPs, but
these improvements did not correlate with any statistically improved tumour
marker responses. These data would support the hypothesis that carcinoid
syndrome is not directly due to U5HIAA, CGA or CGB.
YIP 3.08
MODULATION OF SYSTEMIC REACTIONS TO LIVER
SURGERY: A PROSPECTIVE RANDOMIZED STUDY IN 120
PATIENTS
Pulitano`, Carlo1; Arru, Marcella1; Finazzi, Renato1; Catena, Marco1;
Guzzetti, Eleonora1; Soldini, Laura2; Comotti, Laura3; Aldrighetti, Luca1;
Ferla, Gianfranco1
1San Raffaele Scientific Institute, Vita-Salute San Raffaele University, Dept.
of Surgery Liver Unit, Milan, Italy; 2San Raffaele Scientific Institute, Vita-
Salute San Raffaele University, Laboraf, Milan, Italy; 3San Raffaele Scientific
Institute, Vita-Salute San Raffaele University, Dept. of Anestesiology, Milan,
Italy
Background. Hepatic injury secondary to warm ischemia-reperfusion (I/R)
injury and alterations in haemostatic parameters are often unavoidable events
after major hepatic resection. The release of inflammatory mediator is
believed to play a significant role in the genesis of these events. It has been
suggested that preoperative steroids administration may reduce I/R injury
and improve several aspects of the surgical stress response.
Aims. To investigate the clinical benefits on I/R injury and systemic
responses of preoperatively administered corticosteroids.
Methods. One Hundred and twenty patients undergoing liver resection were
randomized either to a steroid group or to a control group. Patients in the
steroid group received preoperatively 500 mg of methylprednisolone. The
intermittent Pringle maneuver was applied at the time of liver transection and
consisted in cross-clamping the hepatoduodenal ligament for 20 minutes and
releasing the clamp for 10 minutes until the transection was completed.
Serum levels of alanine aminotransferase (ALT) aspartate amminotransferase
(AST), total Bilirubin (t-bil), coagulation parameters, and inflammatory
mediators, interleukin-6 (IL-6) and tumor necrosis factor alpha (TNF-a)
were compared between the two groups. Length of stay, and type and number
of complications were recorded as well.
Results. Postoperative serum levels of ALT, AST, T-bil, and inflammatory
cytokines were significantly lower in the steroid than in the control group at
Post Operative Day (POD) 1 and 2. Changes in haemostatic parameters were
also significantly attenuated in the steroid group. The incidence of post-
operative complications in the steroid group tended to be significantly lower
than the control group.
Conclusions. It is of clinical interest that preoperative steroids administra-
tion before major surgery may reduce IR injury, maintain coagulant/antic-
oagulant homeostasis and reduce postoperative complications by modulating
the inflammatory response.
YIP 3.09
MIP-2 PROMOTES ANGIOGENESIS AND TUMOR GROWTH OF
COLORECTAL LIVER METASTASIS AND CONTRIBUTES TO
LIVER RESECTION-INDUCED ACCELERATION OF HEPATIC
TUMOR GROW
Kollmar, Otto1; Menger, Michael2; Schilling, Martin1
1University of the Saarland, Dept. of Surgery, Homburg/Saar, Germany;
2Univ. Saarland, Homburg, Dept. of Experimental Surgery, Homburg/Saar,
Germany
Background. In a mouse model of hepatic metastasis, we studied whether
MIP-2, stimulates angiogenesis and tumor growth and contributes to
resection-induced acceleration of tumor growth.
Methods. 1/105 CT26.WT cells were implanted into the left liver lobe of
syngeneic BALB/c mice, and 10 nM, 100 nM, and 1000 nM MIP-2 or PBS
(controls) were injected into the peritumoreal area. (n/6). Furthermore,
tumor cells were implanted into the left liver lobe after a 50% hepatectomy
(Phx; n/7). Additional animals with 50% hepatectomy were treated with a
monoclonal antibody (MAB452) neutralizing MIP-2 (Phx/mAB; n/7).
Non-resected and non-mAB-treated mice served as controls (Con; n/7).
After 7 days, angiogenesis, proliferation, tumor growth, apoptosis and
CXCR-2 expression were analyzed using intravital fluorescence microscopy,
histology, immuno-histochemistry.
Results. MIP-2, in particular in a dose of 100 nM and 1000 nM, induced an
increase of tumor capillary density (pB/0.05) and a widening of the angiogenic
front (pB/0.05) at the tumor margin. Tumor volume was found increased, in
particular after 100 nM MIP-2 stimulation, when compared with PBS-treated
controls, while only 1000 nM MIP-2-treated animals additionally showed a
higher frequency of apoptotic cell death within the tumor margin. Partial
hepatectomy (Phx) increased the expression of the MIP-2 receptor CXCR-2
on tumor cells (pB/0.05) and markedly accelerated (PB/0.05) angiogenesis
and metastatic tumor growth. Neutralization of MIP-2 by MAB452 (Phx/
mAB) treatment significantly (pB/0.05) depressed CXCR-2 expression and
inhibited the liver-resection induced acceleration of angiogenic response (pB/
0.05) and tumor growth (pB/0.05). Of interest, liver resection-induced
hepatocyte proliferation was not effected by anti-MIP-2 treatment.
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Conclusion. With the use of our liver metastasis model, we demonstrate for
the first time, that the CXC chemokine MIP-2 induces angiogenesis and
tumor growth and contributes to liver resection-induced acceleration of
colorectal CT26.WT liver metasta.
YIP 4.01
ARE T-TUBES NEEDED AFTER LAPAROSCOPIC COMMON
BILE DUCT EXPLORATION?
Alhamdani, Ali; Mahmud, Sajid; Caplin, Scott; Brown, Tim H
Morriston Hospital, General Surgery, Swansea, UK
Background. Prior to laparoscopic surgery bile duct exploration was usually
followed by t-tube drainage. Laparoscopic common bile duct exploration
(LCBDE) is now a possibility but there is ongoing debate regarding the need
and indications for post operative t-tube drainage.
Aims To review our experience of LCBDE comparing indications, compli-
cations and outcome with primary closure or t-tube drainage.
Methods. All patients undergoing LCBDE are entered into a computer
database incorporating demographic and clinical data. These data includes
the indication for surgery, the type of LCBDE performed, the use of t-tubes
and the clinical outcome.
Results. Between Nov 2000 and Dec 2005 126 patients underwent LCBDE.
The male to female ratio was 1:2 and the median age 57 (range 2289). The
indications were failed ERCP with apparent ductal stones 26%, jaundice
17%, pancreatitis 13%, cholangitis 5.5%, pre-operative imaging 12%,
positive intra-operative cholangiogram 21% and others 5.5%. The numbers
of transcystic exploration versus choledochotomy and the use of t-tube are
shown in the table.
t-tube No t-tube
Transcystic 1 67 68
Choledochotomy 9 49 58
10 116 126
The indications for placing a t-tube included surgical learning curve,
difficulty in ensuring complete clearance of duct and operative decision
related to anatomy. Complication rate was 1/10 (10%) with a t-tube and 7/49
(14%) with primary closure. 7 patients (5.6%) were converted to open
ECBD and 5 of these occurred in the first 35 procedures. 1 patient required
re-operation and placement of a t-tube. Median post-operative stay was 5
days with primary closure and 8 days with t-tube.
Conclusion. Primary duct closure following LCBDE is safe, with no
increase in complications, hospital stay or conversion rate. We would not
recommend routine use of a t-tube but reserve this for particular indications.
YIP 4.02
MALPRACTICE LITIGATION BY BILE DUCT INJURY PATIENTS:
ASSOCIATED FACTORS FOR SUBMITTING A CLAIM AND THE
EFFECT OF THE VERDICT ON QUALITY OF LIFE
de Reuver, Philip R1; Sprangers, Mirjam AG2; Gouma, Dirk J1
1Amsterdam Medical Center, Surgery, Amsterdam, Netherlands; 2Amster-
dam Medical Center, Medical Psychology, Amsterdam, Netherlands
Background. Bile duct injury (BDI) is associated with major patient
morbidity, increased costs, impaired quality of life (QoL) and high rates of
litigation claims from BDI patients. Studies from the United States showed
the association between medical litigation and poor quality of life (QoL) in
BDI patients. However it is not known which factors are associated with
submitting a claim by BDI patients, and what the effect of the verdict is on
QoL outcome.
Aim. The aim of this study was to evaluate the factors associated with
medical litigation in BDI patients and the effect of the verdict on QoL
outcome.
Results. Of a total of 462 patients referred to our center between 1991 and
March 2005, Quality of life was assessed in 403 eligible participants. The
assessment was performed with a questionnaire containing the SF-36 and
the GIQLI questionnaire. Additional questions were included, concerning
the involvement in legal activity and if so the outcome of the verdict. Of the
278 patients (69%) who completed the questionnaire, 53 BDI patients (19%)
reported involvement in legal activity and 225 (81%) patients reported no
legal activity. The independent predictive factor for submitting a claim after
cholecystectomy was a complete transsection of the common bile duct (odds
ratio/7.5, 95% confidence interval/1.8530.63). To date, litigation claims
has been resolved in 38 cases (72%). Patients in whom the legal case was
resolved in the patients favour through settlement or verdicts (n/17, 32%)
scored significantly higher on the total GIQLI score (719/13, 8 vs 579/20.6,
P/0.02).
Conclusion. Medical litigation claims are mostly submitted by patients with
a complete transsection of the common bile duct. Although BDI patients
involved in medical litigation report a poorer QoL, if the verdict was in the
patient’s favour QoL scores significantly improves.
YIP 4.03
IS GALLBLADDER CANCER (GC), OFTEN FOUND INCIDEN-
TALLY AT LAPAROSCOPIC CHOLECYSTECTOMY (LC),
USUALLY EVIDENT ON THE INITIAL DIAGNOSTIC ULTRA-
SOUND SCAN (DUS)?
Brown, Sean1; White, David2; Smethurst, Andrew2; Ghaneh, Paula3; Wu,
Andrew3; Poston, Graeme3
1University of Liverpool, Faculty of Medicine, Liverpool, UK; 2University
Hospital Aintree, Radiology, Liverpool, UK; 3University Hospital Aintree,
Surgery, Liverpool, UK
Background. GC is usually incurable at detection and is increasing in
incidence. The only potentially curative treatment for GC is radical surgery,
yet many patients with GC are only diagnosed as an incidental finding after
LC.
Aims. The purpose of this study was to review pre-operative DUS of patients
suspected or diagnosed with GC to assess potentially suspicious DUS
findings that might arouse clinical suspicion of GC.
Methods. Retrospective review of 32 patients initially thought on DUS or
subsequently found after LC to have GC. DUS were reviewed by 2 blinded
consultant radiologists using a proforma assessing malignant risk. We
assessed the following characteristics: asymetric wall changes (polyp forma-
tion, global/focal thickening), luminal features (presence of stones, sedi-
ment), presence of calcification/soft tissue mass, adjacent liver pathology
(focal abnormality, duct dilatation).
Results. 17 of the reviewed scans were deemed as exhibiting significant
radiological stigmata to warrant suspicion of malignancy. 13 had a polyp/soft
tissue mass identifiable; 11 exhibited focal thickening of the gallbladder wall.
Others had signs of calcification (8), frank intra hepatic (5) and common duct
dilatation (7). None of the cases undergoing LC and subsequently found to
have GC and whose DUS suspected GC underwent subsequent successful
curative surgery.
Conclusions. We conclude that GC is frequently identifiable on DUS and
that any degree of suspicion warrants referral to a specialist tertiary centre for
‘‘radical cholecystectomy and lymphadenectomy’’. LC is absolutely contra-
indicated in these cases, as there is a risk of perforating the GC and spreading
the malignancy throughout the peritoneum.
YIP 4.04
QUALITY OF LIFE ASSESSMENT AFTER PALLIATIVE STENT-
ING IN PATIENTS WITH GALLBLADDER CARCINOMA
Saluja, Sundeep1; Pal, Sujoy1; Pal, Hemraj2; Garg, Pramod3; Gulati,
Manpreet4; Sahni, Peush1; Chattopadhyay, Tushar1
1All India Institute of Medical Sciences, Gastrointestinal Surgery, New
Delhi, India; 2All India Institute of Medical Sciences, Psychiatry, New Delhi,
India; 3All India Institute of Medical Sciences, Gastroenterology, New Delhi,
India; 4All India Institute of Medical Sciences, Radiology, New Delhi, India
Background. Biliary decompression in patients with advanced unresectable
carcinoma gallbladder (CaGB) with jaundice does not improve survival. We
assessed the change in the quality of life (QOL) before and after palliative
stenting in such patients as a part of a prospective randomized clinical trial.
Patients and methods. All patients with advanced unresectable CaGB with
jaundice were enrolled. Patients with Bismuth type 2 and 3 hilar block were
randomized to either percutaneous (PTBD) or endoscopic drainage (ES)
using plastic stents. The QOL was assessed using EORTC QLQ-30 and
WHO-QOL BREF questionnaires before, and 1 and 3 months after stenting.
All patients were followed up till death.
Results. 54 patients (36 women) were included and 27 each were
randomized to the PTBD and ES group. At baseline, 88% of patients had
pruritis. The mean bilirubin was 20 mg/dl in the PTBD and 21.6 mg/dl in the
ES group. Successful stenting was done in 26 of 27 in the PTBD and in 22 of
27 in the ES group. At 1 month, 24 patients (PTBD) and 22 patients (ES)
were alive. 9 patients in both groups were alive at 3 months. Although the
physical and psychological scores (WHO-QOL) were better in the PTBD
group (1 month: 10.4 and 11.6; 3 months: 11.6 and 11.7) than ES group (1
month: 8.8 and 10.5; 3 months: 9.1 and 10.2), the difference was not
significant. The EORTC-QLQ30 global health status at 3 months was
significantly better in the PTBD group (75 vs 30.5, p/0.02). The EORTC
symptom scores showed improvement in both group but only fatigue showed
significant improvement in the PTBD group.
Conclusions. Compared with palliative ES, PTBD in advanced unresectable
CaGB patients provided better QOL in terms of global health status and
relief from fatigue. The other functional scales and symptom scores did not
show any significant difference in the 2 groups. PTBD should be used as the
primary modality for palliation in such patients.
YIP 4.05
SIGNIFICANCE OF BILE DUCT RESECTION TO PREVENT
LYMPH NODE METASTASIS AND LOCAL RECURRENCE OF
ADVANCED GALLBLADDER CANCER
Higuchi, Ryota1; Araida, Tatsuo2; Oota, Takehiro2; Hamano, Mie2; Takesita,
Nobuhiro2; Yosihito, Kotera2; Yamamoto, Masakazu2; Yosikawa, Tatsuya3;
Takasaki, Ken2
Abstracts 11
1Gastroenterology, Tokyo Women’s Medical University, Tokyo, Japan;
2Tokyo Women’s Medical University, Tokyo, Japan; 3Tokyo Metropolitan
Ebara Hospital, Tokyo, Japan
Background. There is no convincing data concerning bile duct resection of
advanced gallbladder cancer.
Objective. We examined the significance of bile duct resection (BDR) to
prevent lymph node (LN) metastasis and local recurrence of advanced
gallbladder cancer.
Method. We retrospectively examined results of a questionnaire survey on 4,
243 cases of gallbladder cancer conducted by the 34th Japanese Society of
Biliary Surgery. We included 838 cases in which curative resection was
obtained, without infiltration to the bile duct, T2 or deeper, and which were
not located at the cystic duct (cases in which pancreaticoduodenectomy was
performed were excluded as well). We examined the survival rates and types
of recurrence both for cases which had LN metastasis and those which did
not.
Result. 593 cases had no LN metastasis (BDR: 194 (5-years survival rate
66%), no bile duct resection (NBDR): 399 (5-years survival rate 75%).
There was no differences in survival rate between cases in which BDR had
been performed and those in which it had not (P/0.10). There were 16 cases
with LN recurrence (BDR: 9, NBDR: 7), 26 cases with local recurrence
(BDR: 11, NBDR: 15). LN recurrence was significantly more common in
cases in which BDR had been performed (P/0.04). There was no difference
local recurrence rate between performed and those in which it had not. (P/
0.29). 245 cases had LN metastasis (BDR: 127 (5-years survival rate 34%),
NBDR: 118 (5-years survival rate 42%). There was no difference in survival
rate between cases in which BDR had been performed and those in which
it had not (P/0.12). 24 cases had LN recurrence (BDR: 11, NBDR: 13)
and 18 cases had local recurrence (BDR: 11, NBDR: 7). There was no
difference in LN and local recurrence rates between cases in which BDR had
been performed and those in which it had not (P/0.54 and 0.41,
respectively).
Conclusion. No evidence was found that BDR helps prevent LN metastasis
and local recurrence of advanced gallbladder cancer.
YIP 4.06
A BRIGHTER FUTURE FOR HILAR CHOLANGIOCARCINOMA-
RADICAL RESECTION AND PALLIATIVE PHOTODYNAMIC
THERAPY (PDT) IMPROVE SURVIVAL
Quyn, Aaron1; Polignano, Francesco M1; Highley, Martin2; Tait, Iain S1
1Ninewells Hospital & Medical School, Surgery & Molecular Oncology,
Dundee, UK; 2Ninewells Hospital & Medical School, Medical Oncology,
Dundee, UK
Background. Most patients with hilar cholangiocarcinoma are ineligible for
curative resection, and undergo palliative therapies that have minimal survival
benefit. However extended radical resection and palliative photodynamic
therapy (PDT) are novel approaches that may improve survival in this patient
population.
Aims. This prospective concurrent clinical cohort study evaluates the impact
of (i) radical resection and (ii) palliative Photofrin-PDT, on hilar cholangio-
carcinoma over a 5 year period.
Methods. Thirty-nine patients (Jan 2000 Dec 2005) staged by CT, MRI,
laparoscopy, then stratified into 4 cohort groups. All irresectable patients
offered PDT or CXT. Group 1-Stent only (n/6, 15%); Group 2-
chemotherapy (n/8, 20%). ECF or Gemcitabine until disease progression;
Group 3-PDT (n/20, 51%). Photofrin-PDT (2 mg/kg) as single treatment;
Group 4-Resection of bile duct/hepatectomy (n/5, 13%). Pre-op PVE for
right trisectionectomy in 3. End-points-treatment morbidity, mortality, QoL,
and survival.
Results. Median age 68 [range 2384]. Bismuth type II-4, IIIa-9, IIIb-5, IV-
21. Positive histology in 26/39 (66%). No treatment related deaths, 1 re-
laparotomy for bile leak. PDT morbidity-phototoxicity (25%), cholangitis
(47%), pain & pyrexia (45%). Cohort survival is summarised in the table
below.
No
Cases
Morbidity
(%)
Mean survival
(days) [95 CI]
Median survival
(days) [95CI]
STENT 6 48 161 [30, 292] 69 [0, 199]
CXT 8 68 289 [226, 352] 285 [97, 473]
PDT 20 48 757 [486, 1027] 540 [495, 584]
RESECTION 5 38 1382 [601, 2164] 1182 [100, 2682]
Kaplan-Meier (Log rank) survival analysis confirmed substantial survival
gains with radical resection (p/0.01) and PDT (p/0.001). In these cohorts
survival after chemotherapy & stent alone (p/0.46), and survival after
radical resection and palliative PDT (p/0.26) were similar.
Conclusion. This prospective concurrent cohort study demonstrates a
substantial survival benefit for radical resection and palliative PDT in hilar
cholangiocarcinoma. An aggressive policy of extended radical surgery and
Photofrin-PDT should improve the outlook for more patients with hilar
cholangiocarcinoma.
YIP 4.07
IS EXTRAHEPATIC CHOLANGIOCARCINOMA INVADING
FIBROMUSCULAR LAYER A LOCAL DISEASE?
Nagahashi, Masayuki1; Shirai, Yoshio1; Wakai, Toshifumi1; Ajioka, Yoichi2;
Sakata, Jun1; Hatakeyama, Katsuyoshi1
1Niigata University Graduate School of Medical and Dental Sciences,
Division of Digestive and General Surgery, Niigata City, Japan; 2Niigata
University Graduate School of Medical and Dental Sciences, Division of
Molecular and Diagnostic Pathology, Niigata City, Japan
Background. Pathologic T1 classification of extrahepatic cholangiocarcino-
ma includes tumor invading subepithelial connective tissue or tumor invading
fibromuscular layer.
Aim. This study was designed to address whether tumor invading fibro-
muscular layer is a local disease.
Methods. A retrospective analysis of 20 patients with pathologic T1
extrahepatic cholangiocarcinoma (8 with tumor invading subepithelial
connective tissue and 12 with tumor invading fibromuscular layer) was
conducted. Twelve patients underwent a Whipple procedure or a pylorus-
preserving pancreaticoduodenectomy, 4 underwent a resection of extrahepa-
tic bile duct, and a combined hepatectomy and bile duct resection was
performed in 4. A total of 217 regional lymph nodes were examined for
metastasis. The median follow-up time was 190 months.
Results. No patients had blood vessel or perineural invasion. Lymphatic
vessel invasion was seen in 3 patients with tumor invading fibromuscular
layer. Both overt metastasis and micrometastasis were absent in all lymph
nodes examined. Postresectional survival was better in patients with tumor
invading subepithelial connective tissue (cumulative 5-year survival rate,
100%) than in patients with tumor invading fibromuscular layer (cumulative
5-year survival rate, 71%), although the difference was not significant (P/
0.111). Among 12 patients with tumor invading fibromuscular layer, 2
patients died of local recurrence 48 and 54 months after resection and one
patient with lymphatic vessel invasion died of tumor recurrence in distant
sites 74 months after resection.
Conclusions. Extrahepatic cholangiocarcinoma invading subepithelial con-
nective tissue is a local disease. Considering that both lymphatic vessel
invasion and recurrence after resection are not rare, tumor invading
fibromuscular layer appears to be a potentially regional disease.
YIP 4.08
FACTORS INFLUENCING OUTCOME OF METAL STENT ENDO-
PROSTHESIS IN MALIGNANT HILAR BILIARY OBSTRUCTION
Mehta, Naimish N; Tamijmarane, Appou; Bellagamba, Riccardo; Coldham,
Chris A; Buckels, John A; Olliff, Simon P; Mangat, Kam; Mayer, David A;
Bramhall, Simon R; Wigmore, Stephen J; Mirza, Darius F
Queen Elizabeth Hospital, Birmingham, UK
Background. Curative surgery is feasible in minority of patients with
malignant hilar biliary obstruction (HBO). Palliative surgery is associated
with mortality upto 33%. Percutaneous transhepatic (PT) wall-stent inser-
tion is an effective treatment in palliating jaundice with minimal mortality/
morbidity.
Aim. To study the efficacy, resource use and outcome of palliative metal
stenting in HBO in different aetiologies.
Methods. Data was analyzed retrospectively on 160 patients with HBO
undergoing palliative metal stenting, between 8/2000 and 12/2005.
Results. Patient diagnoses included hilar cholangiocarcinoma(HC) (n/68,
43%), gallbladder carcinoma (n/37, 23%), other cholangiocarcinoma (n/
23, 14%), colorectal metastases (n/10, 6%), other metastases (n/19, 12%)
and hepatocellular carcinoma (HCC) (n/3, 2%). Palliative metal stents
were placed by PT approach in 154 and endoscopically in 6 patients. Single
metal stent was inserted in 122 patients and 38 had bilateral stents. Median
pre procedure bilirubin was 267 and post-procedure (day 7):140(mmol/dl).
Of 38(23%)patients who developed stent occlusion, 25 required restenting: 6
with single, 10 with double wall stents and 9 with plastic stents; 13 patients
had wall stent dilatation alone. Median hospital stay was, total:13 (145) and
post procedure:5 (036) days. Multivariate analysis showed stent occlusion
and aetiology as independent factors affecting survival. Overall median
survival was 110 (0997) days; HC: 244(0754) days; HCC/other metas-
tases: 30 (31432) days (pB/0.05). Overall 30 day mortality was 16% (n/
26). Median stent patency was 66 days overall, HC: 156 and HCC/other
metastases:27 days. Complications were cholangitis in 10% (16) and
haemobilia in 6% (10).
Conclusion. Aetiology of hilar obstruction and stent occlusion were
independent risk factors affecting survival post biliary wall stenting. Outcome
was better in patients with hilar cholangiocarcinoma compared to HCC and
other metastases in terms of stent patency and survival.
YIP 4.09
SURGICAL TREATMENT OF LIVER HYDATID DISEASE
Akcan, Alper; Akyildiz, Hizir; Artis, Tarik; Kucuk, Can; Ok, Engin; Sozuer,
Erdogan
Erciyes University Medical Faculty, General Surgery, Kayseri, Turkey
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Background. Three treatment alternatives are available, medical treatment,
percutaneous drainage and surgery. Although medical treatment and
percutaneous drainage have gained acceptance day by day surgical treatment
is still the best treatment option of the hepatic hydatid disease.
Aim. This study is a retrospective evaluation of 503 patients diagnosed with
hydatid cyst and treated surgically in a single institution between January
1985 and January 2005. A review of our experience on the surgical treatment
of the hepatic hydatid diseases was performed to determine the optimal
surgical technique management which has been changing in years and
outcomes of patients.
Results. Partial pericystectomy (PP) and capitonnage in 44, PP and
intraflexion in 14, PP and omentoplasty in 115, hepatectomy and total
cystectomy in 35, laparoscopic pericystectomy in 8 and PP and drainage of
the cyst was performed in 287 patients. Length of hospital stay was
significantly shorter in PP and drainage group than capitonnage and
omentoplasty groups (pB/0.05). Overall post-operative morbidity and
recurrence rates were 10.7% and 3.2% respectively while these rates were
not statistically different among groups (p/0.05). Common bile duct
exploration performed in 86 patients which had intrabiliary ruptured hydatid
disease. There were two mortality.
Conclusions. Radical procedures such as hepatic resection and total
cystectomy, should not be used routinely because of benign nature of hydatid
disease. We suggest PP and drainage technique for this disease because of
safeness, simplicity and effectiveness. In case of suspicious biliary fistula or
free biliary drainage obstruction, biliodigestive anastomosis should be added.
Free Communication Abstracts
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2250 CONSECUTIVE HEPATECTOMIES FOR LIVER TUMORS
AT A SINGLE CENTER: INCREASED SELECTION OF PATIENTS
VS WIDENING OF INDICATIONS: THE TWO SIDES OF THE
MEDAL
Azoulay, Daniel; Pascal, Gerard; Andreani, Paola; Adam, Rene; Castaing,
Denis
Paul Brousse Hospital, Hepato-Biliary Center, Villejuif, France
Objective. To assess the changes in liver resectional surgery over the last 20
year period.
Methods. From 1985 to 2005, 2250 consecutive hepatectomies (1831 first,
333 second, 72 third, 13 fourth, 1 fifth) were performed. Operative morbidity
and mortality were analyzed from a prospective database. Trends over the
study period were analyzed.
Results. The diagnosis were colorectal metastases (n/1100, 49.3%),
primary hepatic or biliary cancers (n/625, 27.9%), miscellaneous malignant
disease (n/355, 15.8%), and benign disease (n/169, 7.1%). The liver
parenchyma was normal in 1756 cases (78.0%), cirrhotic in 237 cases (10%),
fibrotic in 106 cases (5%), steatotic in 110 cases (5%), cholestatic in 41cases
(2%). Resections were performed without vascular clamping in 475 cases
(21.1%) and needed in 1775 cases (78.9%) some form of clamping ranging
from triad clamping to total vascular exclusion. Anatomical resections were
performed in 1383 cases (61.5%). Blood transfusion ranged from 0 (771
cases, 34.3%) to 76 blood units (mean/1.79/4.5 blood units). Morbidity
rate was 29.1% and mortality rate was 2.4%. With experience, indications for
liver resection were widened to significantly more severe patients, and/or
significantly more complex procedures. This was realized at the price of
significantly increased morbidity and mortality rates (from 1985 to 1995 vs
from 1995 to 2005, morbidity and mortality rates were 21.6% vs 34.4% (pB/
0.0001) and 0.9% vs 2.9% (p/0.01) respectively. Mortality and morbidity
rates were similar when comparing patients of similar severity and/or
resections of similar complexity.
Conclusion. As liver resection is the only chance of cure for most liver
tumors we have favored the use experience as a mean to extend the
indications for resection. This was possible ‘‘at the price’’ of increased
morbidity and mortality rates still acceptable. We consider this attitude
preferable to the one using experience to favor early results by a stringent
selection excluding high risk patients and/or procedures.
FC 1.02
INCIDENCE AND MANAGEMENT OF BILIARY LEAKAGE
AFTER PARTIAL LIVER RESECTION
Erdogan, Deha1; Busch, Olivier RC1; van Delden, Otto M2; Rauws, Erik AJ3;
Gouma, Dirk J1; van Gulik, Thomas M1
1Academic Medical Center, Dept. of Surgery, Amsterdam, Netherlands;
2Academic Medical Center, Dept. of Radiology, Amsterdam, Netherlands;
3Academic Medical Center, Dept. of Gastroenterology, Amsterdam, Nether-
lands
Partial liver resection is effective treatment for patients with malignant and
symptomatic benign hepatobiliary diseases. The incidence of biliary leakage
is reported to be 4.812% and associated with substantial morbidity and
even mortality. The aim of this study was to identify risk factors and to assess
management and outcome of biliary leakage in our centre. Between January
1992December 2004, 234 patients underwent liver resection without
biliary reconstruction. Postoperative biliary leakage was defined as bile
effluent from abdominal drain /1 day, bile collection or leakage detected
on radiological imaging or found during relaparotomy. Postoperative biliary
leakage occurred in 6.8% (16/234) of patients. Patients with biliary leakage
were mainly male (75 vs.46%; P/0.037) and underwent more reoperations
(25 vs. 3.2%; P/0.002). On univariate analysis, major liver resection (]/3
segments) (P/0.004), prolonged operation time (P/0.001), right sided
hemihepatectomy (P/0.005), tumor size (P/0.026), duration of vascular
occlusion (P/0.030) and surgical irradicality (P/0.001) were risk factors.
Multivariate analysis revealed only prolonged operation time as independent
factor (P/0.013, OR/1.014). The site of biliary leakage was the resection
surface in 63% (10/16 patients) and the extrahepatic bile ducts in 37%. The
biliary leakage was observed in 19% (3/16 patients) and resolved sponta-
neously. Endoscopic stent placement was performed in 9 (56%) patients and
4 patients were treated by percutaneous biliary drainage. One patient with
early biliary leakage eventually died of liver failure.
Conclusion. In spite of improved techniques for parenchymal dissection,
biliary leakage is a persisting complication after liver resection. Duration of
surgical procedure was the only independent factor for postoperative biliary
leakage. Percutaneous drainage and endoscopic stenting are effective inter-
ventions in the management of most cases of biliary leakage after liver
resection.
FC 1.03
FAST TRACK MAJOR LIVER SURGERY; INITIAL EXPERIENCE
WITH AN ENHANCED RECOVERY PROGRAMME
Van Dam, Ronald M1; Coolsen, Marie¨lle M1; Van de Poll, Marcel C1; Von
Meyenfeldt, Maarten F1; Bemelmans, Marc H1; Greve, Jan W1; Soeters,
Peter B1; Lassen, Kristoffer2; Revhaug, Arthur2; Dejong, Cornelis H1
1University Hospital Maastricht, Dept. of Surgery, Maastricht, Netherlands;
2University Hospital Tromso, Dept. of Surgery, Tromso, Norway
Background. Evidence is accumulating that significant improvement in
recovery and outcome can be achieved using multimodal, evidence-based
peri-operative care protocols in various surgical procedures. Pre-operative
oral carbohydrate loading, epidural analgesia and limited use of opioids
reduce nausea and allow removal of naso-gastric (NG) tubes and oral feeding
early after surgery.
Aim. Of this study was to evaluate whether an enhanced recovery
programme can accelerate postoperative recovery after liver resection (LR).
Methods. A consecutive series of 27 patients undergoing LR was studied.
(Group I, n/27, 59% major resections). The collaborative ERAS group
multimodal core protocol for colonic surgery was modified to cover all
aspects of liver surgery. Data on NG drainage, restart of oral intake after
surgery, length of postoperative hospital stay (LOS), readmissions, morbidity
and mortality were collected prospectively and compared with historical data
from a prospectively collected data base of all liver resections in our hospital
from 2000 to 2004 (group II, n/110, 45% major resections).
Results. In 25 patients the NG tube could be removed and oral intake
restarted within 4 h after surgery. Median LOS including readmissions was 6
days (482) in group I and 8 days (664) in group II (p/0, 07, Mann
Whitney U), with 48% of patients discharged within 5 days without
readmission. Readmission rate was 15% in group I and 11% in group II
(NS). The complication rate was 37% in group I and 27% in group II (NS).
Main complications in group 1 consisted of 3 bile leakages, 2 temporary liver
failures and 2 intra abdominal collections, all were managed non operatively.
Mortality for the subgroups was 0% and 2%, group I and II respectively (NS).
Conclusion. An enhanced recovery programme after liver resection can
accelerate postoperative recovery and is safe. Oral intake can be restarted
within 4 hours after surgery. Median length of postoperative hospital stay is
reduced to 6 days without an increase in morbidity or mortality.
FC 1.04
INTERMITTENT PORTAL TRIAD CLAMPING VS. ISCHEMIC
PRECONDITIONING FOR MAJOR LIVER RESECTION: A RAN-
DOMIZED CONTROLLED TRIAL
Petrowsky, Henrik; Selzner, Markus; McCormack, Lucas; Trujillo, Martha;
Clavien, Pierre-Alain
University Hospital Zurich, Visceral and Transplant Surgery, Zurich,
Switzerland
Background. Ischemic preconditioning (IP) with continuous clamping and
intermittent clamping (IC) of the portal triad are distinct protective
approaches against ischemic injury which proved to be superior in rando-
mized controlled trials to continuous inflow occlusion alone.
Aims. To evaluate whether IP with continuous clamping or IC of the portal
triad confers better protection during liver surgery.
Methods. Non-cirrhotic patients undergoing major liver resection were
randomized to receive IP with inflow occlusion (n/36) or IC (n/37).
Primary end points were postoperative liver injury and intra-operative blood
loss. Postoperative liver injury was assessed by peak values of AST and ALT,
as well as the area under the curve (AUC) of the postoperative transaminase
course. Secondary end points included resection time, the need of blood
transfusion, ICU and hospital stay as well as postoperative complications and
mortality.
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Results. Both groups were comparable regarding demographics, ASA score,
type of hepatectomy, duration of inflow occlusion (range: 3075 min), and
resection surface. The transection-related blood loss was 146 vs. 250 mL
(p/0.008), and when standardized to the resection surface 1.2 vs. 1.8 mL/
cm2 (p/0.01) for IP and IC, respectively. Transfused patients in the IC
group received in mean one blood unit more than transfused patients in the
IP (2.9 vs. 1.7 units, p/0.05). Although peak AST, AUCAST, and
AUCALT were lower for IC, the differences did not reach statistical
significance. Overall (42 vs. 38%) and major (33 vs. 27%) postoperative
complications as well as median ICU (1 vs. 1 d) and hospital stay (10 vs. 11
d) were similar between both groups.
Discussion. Both IP and IC appear to be equally effective in protecting
against postoperative liver injury in non-cirrhotic patients undergoing major
liver resection. However, IP is associated with lower blood loss and shorter
resection time. Therefore, both strategies can be recommended for non-
cirrhotic patients undergoing liver resection.
FC 1.05
REMNANT LIVER VOLUME TO BODY WEIGHT RATIO OF 0.5%:
A NEW CUT-OFF TO ESTIMATE POSTOPERATIVE RISKS
AFTER EXTENDED RESECTION IN NON-CIRRHOTIC LIVER
Truant, Ste´phanie1; Oberlin, Olivier1; Sergent, Ge´raldine2; Lebuffe, Gilles3;
Gambiez, Luc1; Ernst, Olivier2; Pruvot, Franc¸ois-Rene´1
1University Hospital, Dept. of Digestive Surgery, Lille, France; 2University
Hospital, Dept. of Radiology, Lille, France; 3University Hospital, Dept. of
Anesthesiology, Lille, France
Background. Before extended hepatectomy //5 segments, the remnant
liver volume (RLV) measurement is mandatory and is usually calculated as a
ratio to total liver volume (RLV-TLV), with a theoretical minimum tolerable
RLV-TLV of 2025%. However, this method may lead to compare parts of
normal liver parenchyma to others compromised by biliary or vascular
obstruction or by portal vein embolisation (PVE). Consequently, safety
volume limit remains questionable. Extrapolating the model of living donor
liver transplantation (LDLT), we hypothesized that the RLV/ body weight
ratio (RLVBWR) could more accurately assess the functional limit of
hepatectomy.
Objective. To assess the RLVBWR as a new calculation method of the RLV
acceptable after extended hepatectomy.
Methods. From September 2000 to December 2004, volumetric measure-
ments of the RLV using computed tomography were obtained before right
extended hepatectomy in 31 patients with liver tumors and normal liver.
Preliminary results determined a RLVBWR cut-off value of 0.5% as a critical
point for patient course. We successively studied the impact of RLV-TLV (B/
/25% or /25% and B//20% or /20%) and of RLVBWR (B//0.5% or
/0.5%) on postoperative outcome.
Results. Duration of hospitalization, 3-months morbidity and -mortality
were not significantly different between Groups RLV-TLV B// and /25%
and between Groups RLV-TLV B// and /20%. Conversely, the 3-months
overall morbidity and mortality increased significantly in Group RLVBWR B/
/0.5% compared to Group RLVBWR/0.5% (P/0.038 and P/0.019
respectively), while death from liver failure approached significance (P/
0.077).
Conclusions. In our series, the RLVBWR was more specific than the RLV-
TLV in predicting postoperative course after extended hepatectomy. Patients
with an anticipated RLVBWR of less than 0.5% of the body weight are at
significant risk for hepatic dysfunction and postoperative mortality.
FC 1.06
DELAYED COELIOTOMY OR LAPAROSCOPY AS PART OF THE
‘‘NONOPERATIVE MANAGEMENT’’ OF BLUNT LIVER INJURY
Letoublon, Christian1; Chen, Yao1; Arvieux, Catherine1; Voirin, David1;
Risse, Olivier1; Delannoy, Pierre1; Broux, Christophe2
1CHU Grenoble, Digestive and Emergency Surgery, Grenoble, France;
2CHU de Grenoble, Surgical ICU, Grenoble, France
At present, nonoperative management (NOM) is the standard of treatment of
blunt hepatic trauma (BHT) for more than 80% of patients. NOM is
associated by some complications that may necessitate delayed operation
(DO). The DO (by coeliotomy or coelioscopy) is usually considered as a
criteria of failure for NOM. Nevertheless DO may be considered as part of
the management scheme.
Aim. The purpose of the current study is to review our experience with DO
in patients initially treated by NOM.
Patients and methods. A retrospective case note review was performed on
257 consecutive patients of median age 32, 7 years admitted in our unit over
the 12-year period from 1994 to 2005 with BHT. We considered the 186
patients (72%) who had an initial indication of NOM, and focused on the 29
patients who were secondarily operated on (DO) and form the core of this
report.
Results. Grade of severity of these 29 patients was: 2 gradeI, 10 grII, 12
grIII, 4 grIV, 1 grV. The timing of DO varies from day 0 (4) to day 11. For 6
patients the indication for DO was management of associated injuries, and no
one had any treatment of the liver injury. 23 patients underwent DO for liver-
related indication: suspicion of hemorrhage 3, abdominal compartment
syndrome 4, hepatic ischemia from subcapsular hematoma 2, bilioperito-
neum 1, bile leak through a thoracic drain 1, typical inflammatory response 6,
incomplete inflammatory response 4. Death occured in 3 patients, at day 2,
10 and 120. Two of them were respectively due to underestimation of hepatic
necrosis, and delayed indication of laparotomy for an unrecognised inflam-
matory syndrome. Complications underwent in 34% of cases.
Discussion/Conclusion. Our data suggest that BHT treated by NOM
must be frequently reevaluated, and that DO is an actual part of the so
called non-operative treatment. The use of laparoscopic lavage has to be
proposed as soon as day 35 in patients with large hemoperitoneum and
any sign of inflammatory response (fever, leukocytosis, discomfort, tachy-
cardia).
FC 1.07
SURGICAL RESECTION VERSUS OPEN APPROACH RADIO-
FREQUENCY DESTRUCTION FOR THE TREATMENT OF
HEPATOCELLULAR CARCINOMA IN CIRRHOTIC PATIENTS
Lucidi, Valerio1; Adam, Rene2; Lienard, Francois1; Azoulay, Daniel2;
Bourgeois, Nadine3; Adler, Michael3; Gelin, Michel1; Castaing, Denis2;
Donckier, Vincent1
1Erasme University Hospital, Digestive Surgery, Brussels, Belgium; 2Hopital
Paul Brousse, Centre Hepato Biliaire, Villejuif, France; 3Erasme University
Hospital, Hepatology Dept., Brussels, Belgium
Background. The optimal treatment for hepatocellular carcinoma (HCC) in
cirrhotic patients remains debatted. As recent reports indicated that radio-
frequency (RF) is an efficient local destructive method for liver tumors, it was
proposed as a potential alternative to surgical resection (SR).
Objective. Compare the results of SR versus open approach RF performed
as first-line treatment for HCC in cirrhotic patients in 2 different surgical
units.
Methods. From January 2000 to June 2005, 137 patients underwent either
SR (SR group, n/81) or RF (RF group, n/55). Analysis was restricted to
the results observed in Child A patients without preoperative tumoral portal
vein thrombosis, in the SR group (n/60) versus the RF group (n/48).
Operative morbidity and mortality, 1, 3 and 5-year overall and disease free
survivals (DFS) were compared.
Results. Operative morbidity and mortality were 51% and 6, 6% in the SR
group vs 43, 7% and 4, 1% in the RF group (p/NS). Among patients who
underwent major hepatectomy (?3 segments, n/21), operative morbidity
and mortality were 66 and 19% compared to 43 and 0% for minor
hepatectomies, respectively. One, 3 and 5-year overall survivals were 87, 74
and 55% in the SR group, vs 79, 55 and 32% in the RF group (p/0.12).
One, 3 and 5-years DFS were 53, 19 and 19% in the SR group, vs 47, 21 and
17% in the RF group (p/0.6). In patients with single HCC B/3 cm, 1, 3
and 5-years overall survivals were 94, 88 and 70% following SR vs 87, 63 and
44% following RF (p/0.091) and DFS were 65, 29 and 29 following SR vs
56, 31 and 25% following RF (p/0.67).
Conclusion. SR and open approach RF are associated with similar
morbidity and mortality rates in the treatment of HCC in cirrhotic patients.
As compared with local destruction using RF, SR offers a trend for better
long-term overall and disease-free survivals. Accordingly, SR remains the first
option treatment of small peripheral HCC in cirrhotic patients while RF
might represent an acceptable alternative for centrally located tumors
requiring major hepatectomy.
FC 1.08
LIVER STEATOSIS IS A RISK FACTOR FOR POSTOPERATIVE
COMPLICATIONS AFTER HEPATECTOMY: A MATCHED CASE-
CONTROL STUDY
McCormack, Lucas1; Petrowsky, Henrik1; Furrer, Katarzyna1; Jochum,
Wolfram2; Clavien, Pierre-Alain1
1University Hospital Zurich, Dept. of Visceral and Transplant Surgery,
Zurich, Switzerland; 2University Hospital Zurich, Dept. of Pathology,
Zurich, Switzerland
Background. While steatosis of a liver graft is an established risk factor in
transplantation, its impact on liver resection remains unclear.
Aim. To assess the impact of micro (MiS) and macrosteatosis (MaS) on the
short-term postoperative outcome following hepatectomy.
Methods. Fifty eight patients with liver steatosis who underwent major
hepatectomy were matched 1:1 with patients displaying normal liver
histology according to age, gender, ASA score, diagnosis, extent of
hepatectomy, and need of hepatico-jejunostomy. Liver steatosis was evaluated
quantitatively and qualitatively. Primary end points were mortality and post-
operative complications. Secondary end points were operation time, blood
loss, transfusion requirement, biochemical profiles, ICU and hospital stay.
Results. Pure MiS and MaS were present in 3 and 10 patients, respectively,
while mixed steatosis were observed in the remaining 45 patients. Forty four
patients (75%) had mild (B/30%) and 14 (25%) moderate/severe (/30%)
steatosis. Steatotic patients had significantly higher changes in AST/ALT,
prothrombin time, and bilirubin levels. Blood loss (p/0.04), transfusions
(p/0.03), and ICU stay (p/0.001) were increased in steatotic patients.
Overall (50% vs. 25%, p/0.007) and major complications (27.5% vs. 6.9%,
p/0.001) were significantly higher in the steatotic group compared with the
lean group. Patients with pure MaS had increased mortality (MaS: 20% vs.
MiS: 6.6% vs. Mixed: 0%, p/0.36) and major complication rates (MaS:
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66% vs. MiS: 50% vs. Mixed: 24%; p/0.59) but without statistical
significance.
Discussion. Steatosis per se regardless the type is a risk factor for post-
operative complications and should be considered in the planning of
extended liver resections.
FC 1.09
HEALTH RELATED QUALITY OF LIFE: RETURN TO BASELINE
AFTER MAJOR AND MINOR LIVER RESECTION
Martin, Robert; Lewis, Angela; Scoggins, Charles; Stromberg, Arnold; Ellis,
Susan; McMasters, Kelly
University of Louisville, Surgery, Louisville, USA
Introduction. Assessment of quality of life (QOL) after major surgery has
become increasingly pertinent to patient care and may be as important as
long term survival in cancer patients. A recent study presented (Lodge et al,
AHPBA 2006) the return to baseline QOLwas 1 year following hepatic
resection. This time interval (1 year) appears longer than seen in clinical
practice. Thus the aim of this study is evaluate the time to return to baseline
QOL after major and minor hepatectomy.
Methods. This was a prospective observational study in which 40 patients
with malignant liver tumors were enrolled. The patients completed the
Functional Assessment of Cancer-Hepatobiliary (FACT-Hep), FACT-FHSI-
8, EORTC QLQ-C30, Profile of Mood States (POMS), EORTC QLQ-
Pan26, and Global Rating Scale at the time of consent, discharge, first post-
operative visit, 6 weeks, 3, 6 and 12 months.
Results. 34 patients underwent major (/2 segments) and 8 minor
hepatectomy. In the patients who underwent major hepatectomy there was
a significant loss in their FACT-physical and functional at first post-operative
visit and at 6 weeks (p/0.04) with return to baseline at 3 months. For
POMS there was a significant loss at 6 weeks (p/0.03) with a return to
baseline at 3 months. Similar nadir in all the quality of life assessment scores
were seen for QLQ-PAN, EORTC QLQ-C30, FHSI-8, and certain global
rating scales at 6 weeks, with a return to baseline at 3 months. For minor
hepatectomy the nadir for most quality of life scores occurred at the first
postoperative visit with a return to baseline at 6 weeks.
Conclusion. Patients undergoing major hepatectomy return to their baseline
quality of life at 3 months with a progressive and sustained increase in
physical, emotional, and global rating scale at 6 months. Minor hepatec-
tomies recover quicker with return at 6 weeks. This is the first study to
demonstrate that major hepatectomy can be performed with short term
adverse QOL effects and long term improvements in overall QOL.
FC 1.10
DISTANT SERVICE FOR COMPUTER-ASSISTED IMAGE AND
RISK ANALYSIS IN PLANNING OF ONCOLOGICAL LIVER SUR-
GERY AND LIVING DONOR LIVER TRANSPLANTATION
Bourquain, Holger; Schenk, Andrea; Hennemuth, Anja; Zidowitz, Stephan;
Prause, Guido; Peitgen, Heinz-Otto
MeVis, Bremen, Germany
Background. In planning of liver surgery and living donor liver transplanta-
tion (LDLT) it is crucial to ensure a sufficient functional liver volume that is
not impaired by venous congestion or reduced inflow.
Aim/Objective. This study reports about establishment and evaluation of a
new approach using a distant service for image data and risk analysis.
Methods. Over a period of two years (12/200212/2004) data from 834
patients (388 LDLT, 371 liver tumors, 24 liver regeneration, 17 pancreas
surgery, 34 renal surgery) from 54 hospitals worldwide have been evaluated
with the software assistants MeVisLiverAnalyzer and MeVisLiverExplorer in a
research project. In 23 other patients, analysis was not possible due to
insufficient quality of the image data. Analysis consisted of the segmentation
of the organs, vessels, and tumors if applicable. Patient individual vascular
territories, affected vessel for different resection margins, and territories at risk
of impaired blood flow were calculated. Resection proposals for different
strategies were proposed based on the individual 3D model of the patient’s liver.
Results. The results provided to the surgeons consisted of volumetric informat-
ion in a structured Word document, screenshots, and short video sequences
which allowed inspection in the clinics on standard PCs. During the study the
number of cases per month increased from 11 to a maximum of 52. Visual com-
parison of the preoperative analyses with the intra-operative findings showed an
excellent correlation. In many cases the risk analysis had a significant impact on
the surgical strategy. In the transplantation team of Kyoto the new risk analysis
promoted a new decision making algorithm for selection of LDLT donors.
Conclusion. Distant service for image and risk analysis can provide effective
impact on surgical decision making. It provides state-of-art-technology to
centers with a limited number of procedures without the need for investing
into special soft- and hardware and training of specialized staff.
FC 2.01
GASTRO-OESOPHAGEAL RESECTION MORTALITY STATIS-
TICS: A LESSON FROM INDUSTRY?
Fairhurst, Katherine1; Strickland, Andrew1; Festing, Michael2; Veitch, Peter1
1Leicester General Hospital, General Surgery, Leicester, UK; 2University of
Leicester, Dept. of Toxicology, Leicester, UK
Background. The medical community is being prompted to be more
transparent particularly over easily measurable outcomes such as surgical
mortality. Recent mortality data for cardiac surgery has been displayed using
a league table format in which results over a short period are tabulated. This
permits comparison between surgeons to be made and inferences, not
necessarily accurate, to be drawn. Potentially more reliable performance
monitoring may be found using statistical techniques more commonly found
in industry.
Objectives. The aims of this study were to evaluate the applicability of
control charts in analysing trends in mortality in surgery for gastro-
oesophageal cancer for a single specialist over a 19-year period.
Methods. Thirty-day mortality figures following gastric and oesophageal
surgery were obtained. Yearly variations in mortality were analysed using
control charts. This method is commonly used in industry for quality control
purposes to detect whether outcomes fall outside expected parameters.
Control limits of 2 and 3 standard deviations (SD) were set.
Results. Over 19 years 465 resections were performed: 237 gastric and 228
oesophageal with 40 deaths within 30 days. Total mortality was 8.6% (gastric
6.3%; oesophageal 10.9%). Overall, no year lay outside control limits of 2SD
(1:20) however, mortality after gastric resection showed a single year over
2SD but none at 3SD. For oesophageal resections two years lay outside the
2SD control limits; one year approached 3SD (1:1000) from the norm.
Conclusion. Overall mortality for this surgeon performing gastro-oesopha-
geal surgery was acceptable though considerable variations in yearly mortality
rates were noted, the results from one year being almost 3SD from the
norm. Displaying outcomes in a yearly league table format could result in very
misleading conclusions regarding surgical performance being drawn; the use
of control charts would be a more reliable method of presenting such data.
FC 2.02
GASTRIC CANCER SURGERY-A BALANCE OF RISK AND RADI-
CALITY
Lamb, Peter J; White, Martin; Shanmugam, Siva; Irving, Mark; Wayman,
John; Raimes, Simon A
Cumberland Infirmary, Carlisle, UK
Background. The widespread adoption of radical gastric cancer surgery in
the West has been prevented by the high associated morbidity and mortality.
Aim. The aim of this study was to determine whether using tailored
procedures and a modified D2 lymphadenectomy would allow such surgery
to be performed with an acceptable outcome.
Methods. 180 consecutive patients (median age 70 (range 2086) years,
male: female ratio 2:1) undergoing resection for gastric adenocarcinoma with
curative intent were studied prospectively. The extent of lymphadenectomy
was based upon preoperative and intraoperative staging and balanced against
the age and health of the patient. Spleen and pancreas were not routinely
resected.
Results. 85 patients underwent subtotal (n/56) or partial gastrectomy (n/
29) for distal tumours and 95 patients underwent total (n/89) or completion
gastrectomy (n/6) for tumours involving the proximal stomach. 62 patients
underwent a D1 lymphadenectomy, 85 patients a modified (spleen and
pancreas preserving) D2 lymphadenectomy, 30 patients a formal D2
lymphadenectomy, and 3 patients an extended lymphadenectomy. 20 patients
(11.1 per cent) underwent a palliative resection. 45 patients were TNM stage
1, 37 patients stage 2, 61 patients stage 3, and 37 patients stage 4.
Postoperative complications were identified for 48 patients (26.5 per cent),
including major surgical complications for 17 patients (9.4 per cent). The in-
hospital/30-day mortality was 1.7 per cent (3 of 180). The mean ASA grade
was 2.18 and the predicted mortality according to the POSSUM and P-
POSSUM equations was 21.4 and 7.8 per cent, respectively. The overall
stage-specific 5-year survival was 68.2, 54.2, 23.3, and 5.9 per cent.
Conclusion. By tailoring the extent of resection and balancing risk and
radicality for the individual patient, gastric cancer surgery can be performed
with low mortality in the United Kingdom.
FC 2.03
ACCURACY OF PET-CT IN STAGING OESOPHAGEAL AND
JUNCTIONAL CANCER PRIOR TO MINIMALLY INVASIVE
OESOPHAGECTOMY
Farrant, Glen1; Wong, Wai-Lup2; Mitchell, Keith1; Wajed, Saj1; Berrisford,
Richard1
1Royal Devon & Exeter NHS Foundation Trust, Thoracic and Upper GI
Surgery, Exeter, UK; 2Mount Vernon Hospital, Paul Strickland Scanner
Centre, Middlesex, UK
Background. Minimally invasive oesophagectomy (MIO) allows operative
staging at the time of surgery without commitment to resection. Separate
operative staging procedures are unnecessary in most patients. We have
employed PET-CT as an additional staging modality to increase our
confidence in committing patients to induction therapy and/or resection.
Aim. To assess the role of PET-CT in staging patients for MIO with
potentially resectable disease.
Methods. Fifty consecutive patients presenting with potentially operable
oesophageal or oesophagogastric junctional tumours were sent for FDG PET-
CT scan after conventional staging with CTand EUS. Patients with junctional
tumours who had N1 disease on PET-CT confined to the left gastric artery
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group were deemed suitable for induction chemotherapy followed by surgery.
Staging laparoscopy and thoracoscopy was performed as part of their
subsequent minimally invasive oesophagectomy.
Results. Patients were divided into those who had no CTor EUS evidence of
N1 or M1 disease (Group A, n/27) and patients who had CT or EUS
evidence of N1 disease, bulky tumours or borderline evidence of M1 disease
(Group B, n/23). Overall, PET-CT re-categorised 12% patients as inoper-
able (3 in Group A, 3 in Group B) and confirmed operability in borderline
patients for 38% of the whole group (n/50), or 83% of the borderline group
B (n/23). Of the patients subsequently undergoing minimally invasive
resection (n/39), 5% (2/39) were found to have metastatic disease at
thoracoscopy prior to mobilization of the oesophagus; none had metastatic
disease at laparoscopy.
Conclusion. The inclusion of PET-CT in preoperative staging allows a
significant proportion of ‘‘borderline operable’’ patients to undergo minimally
invasive oesophagectomy with acceptably low pickup of unexpected meta-
static disease.
FC 2.04
LAPAROSCOPIC ROUX-EN-Y GASTRIC BYPASS- DOES A TWO
CONSULTANT APPROACH ELIMINATE THE LEARNING
CURVE?
Byrne, James P; Abu Hilal, Moh’d; Vandenbossche, Michael; Sampson,
Andrew; Sutherland, Roda; Bailey, Ian S
BUPA Hospital, Southampton, UK
Background. The demand for laparoscopic bariatric surgery is increasing
in the UK, but few surgeons in the UK have significant experience of
this. Laparoscopic Roux Y Gastric Bypass(LRYGBP can be a technically
challenging procedure, with a learning curve during which there may be an
excess of morbidity and mortality.
Aim. Define outcome over the first 2 years of a newly set up bariatric surgical
service, utilizing a 2-consultant surgeon approach for LRYGBP.
Methods. Data were collected prospectively from inception of the LRYGBP
service in April 2004 to March 2006. The surgical team comprised three
upper GI surgeons. Procedures were performed by two of the three surgeons.
Results. 8 males and 72 females, age and starting BMI were normally
distributed with mean age 42.4 years (s.d. 11.7 years), and mean starting BMI
46.6 kg/m2 (s.d. 7.9 kg/m2) were studied. No mortality or conversions
occurred in this series. 7 major complications were observed (8.75); 3 patients
developed anastamotic leaks, 2 underwent re-operation, 1 patient had a
negative laparoscopy for pain and 1 a blood transfusion for bleeding.
Operation time was not correlated with patient age or BMI and only decreased
slowly with number of operations with median operating time being 135 mins
(95% CI 127184 mins) in the first 30 operations and 110 mins (95% CI 99
122 mins) for the following 50 (Mann-Whitney test p/0.0004). Median
hospital stay was 4 days (range 37). Percentage excess body weight loss was
47.6%, 55.1%, 62.9% and 69.4% at 3, 6, 9, and 12 months post procedure
respectively.
Conclusion. LRYGBP is an effective procedure for the treatment of morbid
obesity; however advanced surgical skills and adequate training are required.
The two consultant approach may eliminate the detrimental effects on
patients of the learning curve in LRYGBP.
FC 2.05
DOES BODY MASS INDEX INFLUENCE PROGNOSIS IN OESO-
PHAGEAL CANCER PATIENTS AFTER SUBTOTAL OESOPHA-
GECTOMY?
Sultan, Javed; Jennings, Neil; Wynne, Kamil; Preston, Shaun R; Karat, Daya;
Hayes, Nick; Griffin, S Michael
Royal Victoria Infirmary, Northern Oesophago-Gastric Cancer Unit, New-
castle upon Tyne, UK
Background. Oesophagectomy remains the mainstay of potentially curative
treatment in patients with oesophageal cancer with long-term survival being
governed by various factors. Tumour stage is the strongest known prognostic
factor but body mass index (BMI) is an important prognostic indicator in
common cancers of the western world which include breast, lung and colon
cancers.
Aims. The aim was to compare recurrence rates, cancer related deaths
(CRD) and operative details according to BMI in all patients who received
potentially curative subtotal oesophagectomy at one specialist centre.
Methods. From prospectively collected data, all patients who had undergone
a R0 subtotal oesophagectomy for adeno- or squamous cell carcinoma
between March 1991 to March 2005 were grouped firstly, into those with
node negative (stage 1 and 2a) or node positive disease (stage 2b and 3) and
secondly, those with a BMI of either B/20.00 (underweight), 20.0125.00
(normal), 25.01 30.00 (overweight) or /30.01 (obese) and these groups
were compared.
Results. A total of 426 patients were identified but complete data was only
present in 325. Of these, 37 patients were underweight, 109 were normal
weight, 115 overweight and 65 were obese. Total operation time and blood
loss were significantly lower in the underweight group (pB/0.01). There was a
greater proportion of patients transfused in the underweight compared to the
obese group (pB/0.001). Based on nodal yields, lymphadenectomy was not
compromised in those with a BMI /25. There was no significant difference in
time to recurrence or CRD in either node negative or node positive
oesophageal cancer.
Discussion. BMI does not appear to influence the prognosis of those with
either node negative or node positive oesophageal cancer despite more
challenging surgery in the obese with longer operation times and greater
blood loss.
FC 2.06
INFLUENCE OF SOCIO-ECONOMIC DEPREIVATION ON OUT-
COMES FOR PATIENTS DIAGNOSED WITH OESOPHAGEAL
CANCER
Morgan, Matthew1; Chan, David2; Burrows, Sarah2; Stephens, Micheal2;
Hopper, Neil2; Brewster, Alison3; Crosby, Tom3; Havard, Tim4; Clark,
Geoff2; Lewis, Wyn2
1University Hospital of Wales, Upper GI Surgery, Cardiff, UK; 2University
Wales College of Medicine, Cardiff, UK; 3Velindre Hospital, Dept. of Clinical
Oncology, Cardiff, UK; 4Royal Glamorgan Hospital, Llantrisant, UK
Background. Socio-economic deprivation influences outcomes for patients
diagnosed with breast, gastric, colorectal and bronchial cancer, but there is
little data on its relationship with oesophageal cancer.
Aim. The aim of this study was to determine the influence of deprivation on
outcomes for patients with oesophageal cancer.
Methods. One thousand one hundred and ninety-six consecutive patients
with oesophageal carcinoma presenting to a regional multidisciplinary team
between January 1, 1998 and August 31, 2005 were studied prospectively and
deprivation scores calculated using the National Assembly for Wales’ Indices
of Multiple Deprivation (IMD). The patients were sub-divided into quintiles
for analysis.
Results. Inhabitants of the most deprived areas (quintile 5) were younger at
presentation (median 67 years vs. 70 years, p/0.01), and were more likely to
have abnormal body mass indices (BMI overweight or malnourished, rho/
0.175, p/0.03) when compared with patients from the least deprived areas
(quintile 1). Operative mortality was threefold higher for patients from the
most deprived areas when compared with patients from less deprived areas
(6% vs. 2%, Chi2 1.162, df 1, p/0.281). There was no correlation between
stage of disease and socio-economic deprivation. For patients undergoing
potentially curative surgery, the 5-year survival for patients from the most
deprived areas was 37%, compared with 27% for patients from the least
deprived areas (log rank 0.01, p/0.9105).
Conclusion. Although deprived patients were younger, less fit, and more
likely to suffer operative mortality, survival after oesophagectomy was
unrelated to deprivation. These findings lend strong support to the concept
of regional specialist multidisciplinary team management.
FC 2.07
TRENDS IN PERFORATED PEPTIC ULCER: RISK FACTORS,
TREATMENT AND PROGNOSIS- A STUDY OF 300 CASES
Bhatnagar, Ashok; Pandya, Saurabh; Mohite, Prashant; Darshan, Jitendra
Medical College Board, Dept. of Surgery, Vadodara, India
Background. Peptic ulcer perforation is a more serious and life-threatening
complication of peptic ulcer disease and still remains a dramatic surgical
emergency. Surgeons practice early operative intervention as a policy with
non-operative management in very selective patients. This Presentation is an
attempt to study the Changing Trends in 300 patients of Perforated Peptic
Ulcer disease at a Teaching Hospital.
Aims and objectives. 1. To evaluate the risk factors affecting morbidity and
mortality, 2. To demonstrate the usefulness of the Risk Stratification based on
major risk factors, 3. To confirm the feasibility of Simple Closure as standard
operation for PPU and 4. To know the current trends in Perforated Peptic
Ulcer disease.
Methods. This is a study of 300 patients of Perforated Peptic Ulcer admitted
and treated during last five years in our hospital.
Results. The average age of all patients was 47.4 years and 83% were less then
60 years of age. Most of the perforations were duodenal (46.3%); prepyloric
(41.2%) and only 12.5% were gastric. Patients were evaluated with x ray
abdomen, free gas was found in 238 patients and on Ultrasonography free
fluid was detected in 102 patients. The average duration of the perforation was
46.7 hours till the time of operation. Management was largely operative (276
patients), percutaneus drainage (18 patients) and only 06 were treated
conservatively. Correlation with drugs, smoking and H.Pylori was studied
and tabulated. Interrelationship of various risk factors like more than 60 years
of age, delay more than 24 hours, shock, moribund illness and contamination
of peritoneal cavity were also studied and are being represented graphically.
These risk factors were given scores and further analyzed.
Conclusions. Smoking and concurrent medical illness are significant risk fact-
ors. Emphasis should be on shortening of delay in operation as complications
and lethality increases. Simple Closure of perforation is still the gold standard.
FC 2.08
OPTIMAL GASTRIC POUCH RECONSTRUCTION POST GAS-
TRECTOMY
Nanthakumaran, Shayanthan1; Suttie, Stuart A1; Chandler, Howard W2;
Park, Kenneth GM1
16 Abstracts
1Aberdeen Royal Infirmary, Dept. of Upper Gastrointestinal Surgery,
Aberdeen, UK; 2University of Aberdeen, Dept. of Engineering, Aberdeen,
UK
Background and aim. Gastric pouches have the potential to improve
nutrition following total gastrectomy compared with standard reconstruction,
however studies have failed to show evidence of clinical benefit. This may
relate to a lack of standardisation of pouch design or size. This study was
undertaken to identify optimal conditions for pouch design.
Methods. Pouches were designed to hold a minimum volume of 300 ml, with
an intra-luminal pressure not exceeding 20 cmH20. A mathematical model
was established and a porcine model constructed to verify this and evaluate
pressure/volume dynamics of the pouch. A ‘‘J’’ pouch was constructed at
anastomotic lengths of 5, 10, 15 and 20 cm. Each pouch was distended with
saline and the pressure/volume relationship established.
Result. Mathematically, increasing anastomotic length of the pouch to 15 cm
increases the volume significantly, thereafter there is minimal benefit of
increasing the pouch length further. For smaller pouches i.e. 5 and 10 cm a
300 ml volume is never achieved until large pressures i.e. 45 cmH20 are
applied. However, in the larger pouches i.e. 15 and 20 cm a 300 ml volume is
readily achieved at a resting pressure of 15 cmH20. The behavior of the larger
pouches vary considerably with regard to pressure/volume dynamics when
distended beyond resting pressures such that the 20 cm pouch allows for
larger volumes for smaller increases in pressure.
Conclusion. Smaller pouches never achieve adequate volumes with pres-
sures B/20 cmH20, accordingly it is unlikely that they will lead to any clinical
benefit. Further in-vivo studies should therefore be based upon 1520 cm
pouch designs.
FC 2.09
PRE-OPERATIVE EUS BASED STAGING CAN ACCURATELY
PREDICT OUTCOME IN OESOPHAGOGASTRIC CANCER
Rees, Jonathan RE1; Hardwick, Richard H2; Vowler, Sarah3; Alderson,
Derek4; Fitzgerald, Rebecca C1
1MRC Cancer Cell Unit, Oesophagogastric Group, Cambridge, UK;
2Addenbrookes Hospital, Oesophagogastric Surgery, Cambridge, UK;
3Dept. of Public Health and Primary Care, Forvie Site, University of
Cambridge, Centre for Applied Medical Statistics, Cambridge, UK; 4Queen
Elizabeth Hospital, Academic Dept. of Surgery, Birmingham, UK
Background. Oesophagogastric cancer (OC) is increasing in incidence,
presents late and has a poor outcome. T and N stage are significant
prognostic markers as are age, complete pathological resection (R0 resection)
and proportion of involved nodes in some studies.
Aims. To identify prognostically significant clinical features using uni and
multivariate analyses in a clinical dataset.
Methods. 167 OC’s were resected at the Bristol Royal Infirmary over 5 years,
samples for molecular analysis and prospective data were collected. Pre and
post-operative stage, histological type, grade, endoscopic and endoscopic
ultrasound findings (EUS) and survival were recorded. Uni & multivariate
analyses were undertaken.
Results. 30 day mortality was 4.79%; longitudinal R0 resections were
obtained in 93.4% and circumferential R0 resections in 51.5%. Survival at 2
and 5 years were 44% & 24% respectively. Univariate analysis of post-operative
T-stage (pB/0.0001), N stage (pB/0.001), nodal load (/5 or B/5/ive nodes)
(pB/0.01) and tumour differentiation (moderately/poorly vs. well) (p/0.01)
showed worse survival, whilst a /ive CRM did not statistically significantly
alter survival (p/0.06). Multivariate analysis using cox regression model
identified post op N stage (HR/1.05, x2/59.392, pB/0.001) and pre-
operative N stage (HR/1.05, x2/58.755, pB/0.001)as independent prog-
nostic markers with excellent correlation, (Kappa/0.93, pB/0.0001).
Conclusion. Systematic use of prognostically significant clinical markers has
not occurred in OC cancer, because this information is only available post
operatively and cannot guide neo-adjuvant therapy. We have confirmed that
post operative nodal stage is an independent prognostic marker of outcome,
furthermore we have shown in this group that pre-operative EUS N stage
correlates very well with post operative N stage and is also a statistically
significant independent prognostic marker and so may be used in pre-
operative treatment planning.
FC 2.10
IMPROVED OUTCOME FOLLOWING CENTRALISATION OF
OESOPHAGEAL RESECTION IN ENGLAND
Al-Sarira, Ali A1; David, Gerald G1; Singer, Simon1; Slavin, John P1; Deakin,
Mark2; Corless, David J1
1Leighton Hospital, Leighton Research Unit. Dept. of Surgery, Crewe, UK;
2University Hospital North Staffordshire. Keele University, University Dept.
of Surgery, Stoke on Trent, UK
Background. Surgical treatment of cancer of the oesophagus and gastro-
oesophageal junction (GOJ) remains complex and challenging. Centralisa-
tion of oesophagectomy (OE) and oesophagogastrectomy (OEG) has been
recommended to improve outcomes.
Aims. We analyesd Hospital Episode Statistics data (HES) to evaluate
national trends in practice and outcomes following OE and OEG in England
between 1997 and 2003.
Method. HES data were obtained from the Department of Health for the
years 1997 to 2003. Patients were included in the study if they underwent OE
or OEG for cancer. Hospital volume threshold was determined based on the
median (50th percentile) hospital volume of 8 resections per year, this point
divided the hospitals into two equal sized groups and allowed comparison
with studies from Europe and USA.
Results. In total 11838 resections were performed over the study period.
The proportion of resections performed at high volume hospitals increased
from 76.4% during time period 1 (1997 to 1999) to 88% during time period
3 (2002 to 2003), (PB/0.001). The overall in-hospital mortality rate was
10.1% which showed a significant reduction from 11.7% to 7.6% during the
study period (PB/0.001). High volume hospitals demonstrated significant
decline in mortality rate over time (11.3% to 7%, PB/0.001). On the other
hand, low volume hospitals had higher mortality rate and did not show
improvement over time (13.2% to 11.9%). There was a trend towards fewer
patients undergoing resection-new cases of cancer in the England 5672 in
1997 (31.5% resected) to 6230 in 2003 (26% resected) (PB/0.001). Length
of stay remained unchanged at 16 days (IQR, 13 to 25 days) but there
appeared to be a significant increase in the median waiting time for resection
by 5 days (P/0.001).
Conclusion. Fewer patients are undergoing oesophageal resection. Improve-
ment in the mortality rate may be explained by increasing centralisation over
time but also could be due to improved preoperative selection.
FC 3.01
ENDOSCOPIC VERSUS PERCUTANEOUS BILIARY DRAINAGE
FOR HILAR BLOCK DUE TO GALLBLADDER CARCINOMA: A
RANDOMIZED PROSPECTIVE TRIAL
Saluja, Sundeep1; Pal, Sujoy1; Garg, Pramod2; Gulati, Manpreet3; Sahni,
Peush1; Chattopadhyay, Tushar1
1All India Institute of Medical Sciences, Gastrointestinal Surgery, New
Delhi, India; 2All India Institute of Medical Sciences, Gastroenterology, New
Delhi, India; 3All India Institute of Medical Sciences, Radiology, New Delhi,
India
Aim. To compare the efficacy of unilateral percutaneous transhepatic biliary
drainage (PTBD) with endoscopic stenting (ES) in patients with advanced
unresectable carcinoma gallbladder (CAGB) with a hilar block.
Patients and methods. All patients with advanced unresectable CaGB were
enrolled. Patients with Bismuth type 2 and 3 hilar block were randomized for
either PTBD or ES using plastic stents. The outcome measures included
technical success, relief of jaundice, early cholangitis, early and late
complications, procedure-related mortality, 30-day mortality and survival.
Both intention-to-treat and per protocol analysis were done.
Results. Between October 2003 and July 2005, 127 patients with CAGB
with obstructive jaundice were evaluated. 73 patients were excluded from the
study (exclusion criteria: 48; refused treatment: 25). Of these, 54 patients
were randomized to undergo PTBD (n/27) or ES (n/27). The baseline
characteristics were similar in both groups. Technical success was similar in
both groups (PTBD: 93% vs ES: 81%; p/0.19). Relief from jaundice was
achieved significantly more in the PTBD group than ES group (89% vs 41%;
p/B/0.001). Both early cholangitis and early complications were signifi-
cantly more in the ES group than PTBD group (48% vs 11%; p/0.002 and
52% vs 18%; p/0.04). Procedure-related mortality (4% vs 8%) and 30-day
mortality (4% vs 8%) were similar in the two groups. The most common late
complication was recurrent jaundice due to stent occlusion (32% vs 39%).
Median survival was similar [PTBD group: 60 d (4377); ES group 60 d
(2892); p/0.71].
Conclusions. Palliative stenting in advanced unresectable CaGB using the
percutaneous route achieved significantly better relief of jaundice with a lower
incidence of cholangitis compared to the endoscopic route.
FC 3.02
SEPSIS-ASSOCIATED CHOLESTASIS IS CRITICALLY DEPEN-
DENT ON P-SELECTIN-DEPENDENT LEUKOCYTE RECRUIT-
MENT IN VIVO
Thorlacius, Henrik1; Laschke, Mattias1; Menger, Michael2; Lindell, Gert1;
Jeppsson, Bengt1
1Malmo¨ University Hospital/Lund University, Surgery, Malmo¨, Sweden;
2University of Saarland, Inst for Clinical and Experimental Surgery,
Homburg, Germany
Background. Cholestasis is a major complication in sepsis and the aim of
this study was to evaluate the role of hepatic recruitment of leukocytes in
endotoxemia-associated cholestasis.
Methods. Endotoxemia was induced in C57BL/6 mice by intraperitoneal
injection of LPS and D-galactosamine. Six hours after induction of
endotoxemia, the common bile duct was cannulated for determination of
bile flow and biliary excretion of bromosulfophthalein (BSP). Hepatic levels
of myeloperoxidase (MPO), TNF-a, CXC chemokines, and apoptosis in the
liver as well as serum levels of ALT and AST were determined.
Results. Endotoxin induced a significant inflammatory response with
increased TNF-a and CXC chemokine concentrations, leukocyte infiltration,
liver enzyme release and apoptotic cell death. This was associated with
pronounced cholestasis, as indicated by a /70% decrease of bile flow and
biliary excretion of BSP. Immunoneutralization of P-selectin significantly
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attenuated endotoxin-induced leukocytic infiltration, as reflected by a /60%
reduction of hepatic MPO levels. Interference with P-selectin also decreased
endotoxin-mediated hepatocellular apoptosis and necrosis, but did not affect
hepatic levels of TNF-a and CXC chemokines. Of interest, inhibition of P-
selectin restored bile flow and biliary excretion of BSP to normal levels in the
endotoxin-challenged animals.
Conclusions. Our study demonstrates for the first time that P-selectin-
mediated recruitment of leukocytes, but not the local production of pro-
inflammatory mediators, is the primary cause of cholestasis in septic liver
injury.
FC 3.03
MANAGEMENT OF BENIGN BILIARY STRICTURES BY PERCU-
TANEOUS INTERVENTIONAL RADIOLOGIC TECHNIQUES
(PIRT)
Ramos, Antonio1; Reid, Kaye M1; Misra, Sanjay2; Sarr, Michael G1
1Mayo Clinic College of Medicine, Surgery, Rochester, MN, USA; 2Mayo
Clinic College of Medicine, Radiology, Rochester, MN, USA
Background. Some biliary strictures may be amenable to management by
percutaneous interventional radiologic techniques (PIRT), thereby avoiding
morbidity of an operative approach. Data on the long-term efficacy of this
approach is scarce however.
Aim. To determine the results of PIRT for benign biliary strictures.
Methods. We reviewed retrospectively all patients with biliary strictures
secondary to traumatic bile duct injury or who had a strictured bilioenteric
anastomosis. Patients managed by PIRT from 1998 through 2003 were then
selected, excluding those with primary sclerosing cholangitis, hepatic
transplantation, or malignant strictures. Data were obtained from the hospital
record and/or direct patient contact. Comparisons between groups were
made by Fisher’s exact test and the Wilcoxon rank-sum test.
Results. 27 patients with biliary strictures were treated by PIRT. Mean age
was 54 years (range 11 to 86). The most frequent etiology of biliary stricture
was post-laparoscopic cholecystectomy injury in 11 patients (41%). Seven
patients (26%) had undergone a pancreatoduodenectomy and eight (29%)
biliary resection for malignancy; none were secondary to tumor recurrence.
Overall, treatment was considered a success in 63% of patients. PIRT was
successful in 10 of 11 patients (91%) with bile duct strictures secondary to
laparoscopic cholecystectomy and in 7 of 15 patients (41%) with strictured
bilioenteric anastomosis. 20 patients (74%) were stent-free at last follow-up.
Anastomotic biliary strictures were more likely to have treatment failure than
laparoscopic cholecystectomy injuries (p/0.02).
Conclusion. Percutaneous management with balloon dilatation and stenting
can be an effective management strategy for select patients with bile duct
strictures, especially those related to laparoscopic cholecystectomies. Ana-
stomotic strictures are associated with less good results when managed by
PIRT but, nevertheless, can be successful in up to 40% of patients.
FC 3.04
NUTRITIONAL RISK INDEX PREDICTS A HIGH-RISK POPULA-
TION IN PATIENTS WITH OBSTRUCTIVE JAUNDICE
Paterson, Hugh M; Clugston, April; Yuill, Kerry; Garden, O James; Parks,
Rowan W
Royal Infirmary of Edinburgh, Edinburgh, UK
Background. Malnutrition is common in obstructive jaundice but is difficult
to define. The aim of this study was to compare definitions of malnutrition in
patients with obstructive jaundice to identify correlation with mortality,
complications and length of hospital stay after intervention.
Methods. Prospective case-control study comparing 40 inpatients with
obstructive jaundice with 21 controls. Body mass index (BMI), skin-fold
thickness (TSF), mid-arm muscle circumference (MAMC), percentage
weight loss, nutritional risk index (NRI) and malnutrition universal
screening tool (MUST) were measured and compared. Duration of
admission, interventions, complications and outcome were recorded pro-
spectively.
Results. Patients with obstructive jaundice were significantly malnourished
compared to controls. Severe malnutrition was equally prevalent in benign
and malignant disease. Malnourished patients had higher mortality and
longer duration of stay after intervention compared to non-malnourished
patients. NRIB/83.5 was significantly associated with mortality and longer
duration of hospital admission but not complication rate.
Conclusion. NRI is simple to use and defines a high-risk sub-group of
patients with obstructive jaundice.
FC 3.05
BILE DUCT INSTRUMENTATION PREDISPOSES TO BILIARY
INFECTION AND ITS RELATED COMPLICATIONS BUT NOT
MORTALITY
Pai, Madhava1; Limongelli, Paolo1; Bansi, Dev2; Thillainayagam, Andrew2;
Williamson, Robin CN1; Jiao, Long R1
1Hammersmith Hospital, Imperial College, Hepatobiliary Surgery, London,
UK; 2Hammersmith Hospital, Imperial College, Gastroenterology, London,
UK
Background. Controversy exists regarding the impact of preoperative
factors in predicting accurately intraoperative bacterobilia and positive
intraoperative bile culture (IBC) on postoperative morbidity and mortality
rates after pancreatic surgery.
Aims. The current study was conducted to address certain aspect of this
issue by examining the potential relationship between IBC and postoperative
morbidity and mortality rate after pancreatic operation in a tertiary referral
centre.
Materials & methods. Perioperative morbidity and mortality rates were
evaluated in 220 patients who presented with obstructive jaundice and
underwent a pancreatic operation. Routinely, before performing the biliary-
enteric anastomosis, an intraoperative bile specimen was taken immediately
after division of the bile duct, and was then sent for bacteriological
examination for both aerobic and anaerobic micro-organisms. Univariate
and multivariate analyses were performed to determine risk factors for
bacterobilia and to evaluate postoperative morbidity and mortality.
Results. Of 220 patients evaluated, 113 patients (51.4%) had a positive
intraoperative bile culture. One hundred and one patients (45.9%) developed
one or more complications. Death occurred in 10 patients (4.5%). The risk
factors for bacterobilia were age over 70 years (p/0.007), history of coronary
artery disease (p/0.006), diagnosis of neoplasia (p/0.01), preoperative
ALP/100 IUL (p/0.03), and preoperative biliary drainage (p/0.03).
Infectious complications were high in-patients with positive intraoperative
bile culture (p/0.007).
Conclusions. Preoperative bile duct instrumentation significantly increases
the risk of bacterobilia, which in turn predisposes to postoperative rate of
infectious complications but not the mortality rate.
FC 3.06
GALL BLADDER CANCER WITH DUODENAL INFILTRATION:
IS IT STILL RESECTABLE?
Agarwal, Anil K; Mandal, S; Singh, S; Sakhuja, P; Puri, S
GB Pant Hospital & MAM College, Dept. of GI Surgery, New Delhi, India
Background. Duodenal infiltration in a patient of gallbladder cancer is
generally regarded as a sign of advanced disease and an indicator of
unresectability by most of the surgeons. Some surgeons however regard
this as an indication for performing hepato pancreato duodenectomy (HPD).
We herein present our experience of Gall Bladder cancer with duodenal
involvement.
Methods. The prospectively collected data of 252 patients of gallbladder
cancer who underwent surgery during the period from January 2000 till
December 2004 were analyzed for duodenal involvement. The study group
comprises of 43 patients of Gall bladder cancer with duodenal infiltration.
Results. Out of the 252 patients 43 had duodenal involvement on per-
operative assessment (17.06%). Out of the 43 patients 17 had unresectable
disease (39.54%), 16 underwent palliative gastrojejunostomy while 1 patient
underwent only a feeding jejunostomy. The remaining 26 underwent R0
resection (61.9%), 9 underwent distal gastrectomy with D1 (first part of
duodenum) resection (34.62%), while 16 underwent duodenal sleeve
resection (61.54%), only one patient underwent HPD (3.85%). Of the
resected patient 8 also had associated obstructive jaundice, 2 underwent
extended right hepatectomy, 7 colonic resection, 3 vascular reconstruction,
one partial pancreatic head resection and one HPD. The postoperative
morbidity and mortality was 15 (34.9%) and 3 (7%) respectively. All the
three deaths were in the resected group i.e. 11.5% (3 of 26). Morbidity was
12 and 3 in the resected and palliative group respectively. The survival was a
mean of 26.5 months, median 20.5 months (range 12 to 54 months).
Conclusion. Duodenal infiltration in Gall bladder cancer does not preclude
resection and should not be viewed as a sole indicator for performing hepato-
pancreato-duodenectomy (HPD). Ro resection can be achieved with limited
duodenal resection in a majority of patients resulting in improved survival.
FC 3.07
TOTALLY LAPAROSCOPIC MANAGEMENT OF CHOLEDO-
CHAL CYSTS USING A FOUR HOLE METHOD
Jang, Jin-Young; Kim, Sun-Whe; Han, Ho-Seong; Yoon, Yoo-Seok; Han,
Seong-Sik
Seoul National University College of Medicine, Surgery, Seoul, Korea
Background. Choledochal cyst is a rare benign disease in the biliary tract.
However, once diagnosed it must be excised with the gallbladder (GB)
because of the risk of cancer developing in the biliary tree including GB.
Aim(s)/Objective. Here we introduce a new surgical technique for totally
laparoscopic excision of choledochal cyst and hepaticojejunostomy using a
four hole method.
Methods. Between October 2003 and March 2006, we performed totally
laparoscopic choledochal cyst excision in fourteen patients. All patients were
female except one and the mean age was 37.3 (range:17 62) years.
According to the Todani classification, five were type Ia, four type Ic and
three type IV. Choledochal cyst excision and Roux-en-Y hepaticojejunostomy
were performed laparoscopically using the four port technique.
Results. The mean operation time was 228 (150330) minutes. There was
no operative or postoperative transfusion required. An oral diet was started
on the third operative day. The average length of hospital stay was 5.8 days.
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There was no major complication associated with anastomosis leakage or
obstruction. No patient had adverse response by clinical or laboratory
evaluation, during two to 28 months of follow-up.
Conclusions. Considering that choledochal cyst is common in young
women who are especially interested in cosmetic results in addition to
complete resolution of medical problems, the laparoscopic management of
choledochal cyst may be an attractive treatment option.
FC 3.08
IS VEGF INVOLVED IN JAUNDICE? IN VITRO EFFECTS OF BILE
ACIDS ON VEGF EXPRESSION
Lupo, Luigi; Rotelli, Maria Teresa; Bocale, Domenica; D’Elia, Giovanna;
Signorello, Angelo Francesco; Memeo, Vincenzo
University of Bari, General Surgery and Liver Transplantation, Bari,
Italy
Background. Bile acid accumulation and hypotension, cardiodepression,
acute renal failure, edema, sepsis have been observed In jaundiced patients.
Since the vascular endothelial growth factor(VEGF) increases vascular
permeability and vasodilatation, which may cause hypotension and edema,
it might be hypothesized as a possible pathogenic factor implicated in
jaundice.
Aim. This study was designed to test the hypothesis that hepatic cells
stimulated by deoxycholic acid(DCA) or taurodeoxycholic acid (TDCA)
stimulation could overexpress and release VEGF.
Materials and method. The human hepatoblastoma cell line, Hep3B, was
stimulated by scaled addition of DCA and TDCA to final concentration of 0,
50, 100, 200, 400, 500, 1000 mM. After bile acids addition, supernatants
were collected and cells were harvested for RNA and protein extraction at 1,
3, 6, 12, 24 and 48 h. VEGF expression was analyzed by RT-PCR, Western
Blotting (WB) on RNA extracted and protein lysate, by confocal microscopy
(Leica TCS SP2) on fixed cells and by Elisa test of supernatants.
Densitometric analysis of WB and RT-PCR was performed using the
Quantity One† 1-D Bio-Rad software.
Results. Elisa analysis demonstrated a significant increase in VEGF
expression at 24 h after addition of 100 mM DCA (control median: 722.94
pg/ml, 100 mM median: 883.9 pg/ml; p/0.01). At the same concentration,
an increase was also observed with WB analysis after 48 h. Confocal
microscopy confirmed WB data (p/0.03 100 mM DCA 24 h; pB/0.0001
100 mM DCA 48 h;T test). When analyzed with RT-PCR the highest level of
VEGF expression was observed at 36 hours after DCA administration, at
concentration ranging between 200500 mM (1.52 times normal range of
activation).
Conclusions. VEGF could have a major role in determining the clinical
features associated with jaundice and therefore may be a target for
therapies.
FC 3.09
TREATMENT OF INTRAHEPATIC DUCT STONES
Lee, Keun-Ho; Lee, Sang-Kwon; Kim, Ki-Hwan; Won, Yong-Sung; You,
Young-Kyoung; Park, Il-Young; Lee, Seong; Kim, Dong-Goo; Kim, Eung-
Kook
College of Medicine, The Catholic University of Korea, Surgery, Seoul,
South Korea
Background. There are many options including endoscopic or surgical
approaches in the treatment of intrahepatic duct stones. But recurrence is
common although high clearance rate can be achieved. Intrahepatic duct
stones cause cholangitits, frequently. The relationship of intrahepatic duct
stones and cholangiocarcinoma has been reported.
Aim/Objective. To evaluate the effectiveness and safety of hepatic resection
as a treatment of intrahepatic duct stones.
Patients and methods. The authors performed retrospective analysis
of medical records of 92 patients with intrahepatic duct stones who under-
went surgical treatment between June 1996 and May 2005. Past medical
history, methods of surgical treatment, morbidity and recurrence rates were
assessed.
Results. Methods of surgical treatment were choledochotomy (30.4%),
choledocho-enterostomy (20.7%), left lateral sectionectomy (5.4%), left
hepatectomy (34.8%), right hepatectomy (6.5%), right anterior sectionect-
omy (1.1%) and right posterior sectionectomy (1.1%). Major hepatic
resection was performed in a half of patients. Choledochotomy was used
with Intraoperative choledochoscopy and electrohydraulic lithotripsy for
patients with acute cholangitis. Roux-en-Y choledochojejunostomy with
subcutaneous access limb was made in 3 patients who had intrahepatic bile
duct strictures or bilateral distribution of intrahepatic bile duct stones. There
was no postoperative death. Cholangiocarcinoma and severe dysplasia was
found in each patient who underwent hepatic resection. Another cholangio-
carcinoma occurred in a patient who underwent choledochojejunostomy
during follow-up.
Conclusion. Major hepatic resection is safe and definitive treatment for
patients with intrahepatic duct stones. It can provide not only cure of
intrahepatic duct stones but also prevention against malignant transforma-
tion. Major hepatic resection is a treatment of choice for intrahepatic duct
stones.
FC 3.10
TIMING OF LAPAROSCOPIC CHOLECYSTECTOMY FOR
ACUTE CHOLECYSTITIS. RESULTS FROM A PROSPECTIVE
NON RANDOMIZED STUDY
Tzovaras, George; Zacharoulis, Dimitris; Liakou, Paraskevi; Theodoropou-
los, Theodoros; Baloyiannis, Ioannis; Hatzitheofilou, Constantine
University Hospital of Larissa, Dept. of Surgery, Larissa, Greece
Background. Early laparoscopic cholecystectomy has been shown to be safe
for patients with acute cholecystitis. It is not always feasible, however, to
operate on these patients during the first 72 hrs. It is unclear how to best
manage acute cholecystitis outside this time frame.
Setting. Prospective non-randomized study, University Hospital.
Methods. Between January 2002 and December 2005, all ASA I, II and III
patients with acute cholecystitis were treated laparoscopically during the
urgent (index) admission. Patients were divided into three groups, according
to the timing of surgery: I) within the first 3 days, II) between 4 and 7 days and
III) beyond 7 days from the onset of symptoms. We aimed to examine the
impact of timing on conversion rate, morbidity and postoperative hospital stay.
Results. One hundred and twenty nine patients had attempted laparoscopic
cholecystectomy for acute cholecystitis during the index admission. Thirty six
were assigned to group I, 58 to group II, and 35 to group III. Conversion rate
and morbidity for the whole cohort of patients were 4.6% and 10.8%,
respectively. There was no significant difference in conversion rate, morbidity
and postoperative hospital stay between the three groups.
Conclusion. Laparoscopic cholecystectomy for acute cholecystitis during the
index admission is safe, regardless of the time elapsed from the onset of
symptoms. This policy will result in overall shorter hospitalization.
FC 4.01
IS A POSITIVE HISTORY FOR A MALIGNANT NEOPLASIA IN
THE FAMILY A RISK FACTOR FOR PANCREATIC CANCER?
Leder, Gerhard1; Muche, Rainer2; Stra¨ter, Jo¨rn3; Beger, Hans1; Henne-
Bruns, Doris1; Prokopczyk, Bogdan4
1University of Ulm, Surgery, Ulm, Germany; 2University of Ulm, Biometry,
Ulm, Germany; 3University of Ulm, Pathology, Ulm, Germany; 4Pennsylvania
State University, Pharmacology, Philadelphia, USA
Background. Smoking, as a risk factor for pancreatic cancer (PC), was shown
to accelerate its development.
Aim. We seeked to find out, whether a positive history for a cancer in the family,
other than PC, would also be a risk factor for PC and accelerate its onset.
Methods. All patients (pts) treated at our department for histo- or cytologically
proven adenocarcinoma of the pancreas between19982005 were interviewed
for their smoking history and history for cancer in the family other than
pancreatic cancer. Following our hypothesis, that a risk factor will accelerate the
onset of PC, age at diagnosis of PC was modeled as a function of smoking/non-
smoking and existence/absence of cancer in the family in a bivariate linear
model.
Results. Linear regression among the 67 female pts. revealed an intercept
(mean age) of 70.391 years for non-smokers without history of cancer in the
family. Smoking female pts without history of cancer in the family acquired PC
9.421 years (95% CI 4.838 14.004) earlier (p/0.0002). The effect of a
positive history of cancer in the family was estimated to lead to a 6.201 years
(95% CI 1.387 11.014) earlier onset of the disease in non-smoking female pts
(p/0.014). The intercept for the 76 men was 63.654 years. Smoking was
estimated to reduce age of diagnosis of PC by 6.067 years (95% CI 1.234
11.010, p/0.018). A history of cancer in the family did not affect age of onset
of PC in men (p/0.935).
Discussion. Smoking has again been etimated to accelerate onset of PC by
approx. 9 years in women and 6 years in men. A positive history for cancer in the
family accelerated the onset of PC by 6 years in women. Altogether, an approx.
15 years earlier onset of PC in female smokers with a positive history of cancer in
the family could be estimated. The lack of an effect of a positivehistory of cancer
in the family on the onset of PC in men may potentially have been covered by the
varying smoking intensity.
FC 4.02
COMPARISON OF THREE-DIMENSIONAL AND TWO-DIMEN-
SIONAL LAPAROSCOPIC ULTRASOUND IN STAGING OF PAN-
CREATIC CANCER
Fristrup, Claus; Pless, Torsten; Durup, Jesper; Hovendal, Claus P; Nielsen,
Henning O; Mortensen, Michael B
Odense University Hospital, Dept. of Surgical Gastroenterology, Odense,
Denmark
Background. Currently surgery is the only curative treatment for patients with
pancreatic cancer. Since surgical resection has a significant morbidity and
mortality, a careful selection of patients for surgery is necessary. Laparoscopic
ultrasound (LUS) is effective in finding the non-resectable patients. However,
the anatomy in the region is complex and it can be difficult to detect tumor
invasion in adjacent vessels. A three-dimensional (3D) reconstruction of the
LUS images might improve the staging. Therefore a method for 3D LUS was
developed and tested.
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Aim. The aim of the study was to test 3D LUS compared to 2D LUS in staging
of patients with pancreatic cancer.
Methods. All patients with pancreatic cancer scheduled for LUS were eligible,
and consecutively included in the study. All patients were evaluated by EUS and
found resectable prior to inclusion. The T-, N-, M-stage and resectability was
assessed by both 2D LUS and 3D LUS. Patients found to be resectable by
either 2D or 3D LUS was surgically explored, and the findings at surgery and/or
pathology were used as gold standard. For patients found to be non-resectable
by both 2D and 3D LUS the results of 2D LUS served as gold standard.
Results. A total of 41 patients with pancreatic cancer were included. For 2D
LUS the sensitivity/specificity for T4-tumors was 0.72/0.91. For 3D LUS the
sensitivity/specificity for T4-tumors was 0.78/0.96. The sensibility/specificity
for non-resectability was 0.78/0.94 for 2D LUS and 0.87/1.00 for 3D LUS.
The differences were not significant. 3D LUS did not detect any lymph nodes or
liver metastasis not seen on 2D LUS. The overall accuracy was 0.78 for the N-
stage assessment and 0.93 for the M-stage assessment for both 2D and 3D
LUS. There were no complications due to LUS.
Conclusion. The sensitivity and specificity for non-resectability and T-stage
was higher with 3D LUS than with 2D LUS, but the difference was not
significant. The use of 3D LUS did not detect any extra lymph nodes or liver
metastasis.
FC 4.03
PROGNOSTIC SIGNIFICANCE OF PERITONEAL WASHING
CYTOLOGY IN RESECTABLE PANCREATIC CARCINOMA
Kajiwara, Masatoshi; Konishi, Masaru; Nakagohri, Toshio; Takahashi, Shi-
nichiro; Gotohda, Naoto; Kinoshita, Taira
National Cancer Center Hospital East, Surgery, Kashiwa, Japan
Background. The prognostic significance of peritoneal washing cytology of
pancreatic carcinoma is still controversial especially in resectable cases. The
aim of this study is to delineate the meaning of malignant cells in peritoneal
washing in resectable pancreatic carcinoma.
Methods. Between July 1992 and December 2005, peritoneal washing
cytology was performed in 134 patients who underwent surgical resection for
pancreatic invasive carcinoma (including 18 patients derived from intraductal
papillary mucinous neoplasm (IPMN)). Every patient was confirmed without
liver metastases and peritoneal dissemination at laparotomy. Results of the
washing cytology were correlated with their clinicopathological findings and
survival retrospectively.
Results. The washing cytology was positive in 9 patients (6.7%). Patients with
tumors in the body or tail of the pancreas were more associated with positive
cytology than in the head tumors, but the size of the tumor and the status of
lymph node involvement were not related to the result of cytology. The
incidence of microscopically curative resection (R0) in the positive and negative
cytology group was 55.6 and 88.0%, respectively. In negative cytology group,
21.8% of patients developed peritoneal dissemination. In contrast, all patients
but one whose follow-up period was 6 months, developed peritoneal relapse in
positive cytology group. Median overall survival was much shorter in positive
cytology group (7.2 months) than in negative group (17.0 months), and
prognosis was significantly worse in positive cytology group (p/0.0003). In
multivariate analysis, the positive cytologic result as well as the lymph node
metastases and the non-curative resection was significant prognostic risk factor
for the patients with resectable pancreatic carcinoma.
Conclusion. Positive washing cytology in resectable pancreatic carcinoma is
highly associated with peritoneal dissemination and poor prognosis. Surgical
indication should be reconsidered.
FC 4.04
DEPTH OF PORTAL VEIN WALL INVASION IS A PROGNOSTIC
FACTOR FOR SURVIVAL AFTER CURATIVE RESECTION OF
PANCREATIC ADENOCARCINOMA
Oussoultzoglou, Elie; Bachellier, Philippe; Rosso, Edoardo; Nakano, Hiroshi;
Scurtu, Radu; Jaeck, Daniel
CHU de Hautepierre, Centre de Chirurgie Visce´rale et de Transplantatio,
Strasbourg, France
Background. Portal vein (PV) wall invasion is considered as a prognostic
factor for survival after curative pancreatic resection for pancreatic ductal
adenocarcinoma. However, little is know about the significance of the depth of
PV invasion for survival.
Aim. To asses the significance of depth of PV invasion on survival after curative
resection for adenocarcinoma of the pancreas.
Methods. From 1990 to 2002, 121 patients underwent curative pancreatic
resection for ductal adenocarcinoma of the pancreas. Among them, 37
pancreatic resections combined with PV resection have been performed.
Results. The morbidity and mortality rates did not differ between patients
undergoing or not PV resection (32.4% and 2.7% versus 38.1% and 2.4%).
The 3-year survival rate after curative pancreatic resection was significantly
associated with the depth of PV wall invasion. Indeed, 3-year overall survival
rate was similar for patients with no PV invasion and that with superficial
invasion into tunica adventitia (40.0% versus 32.9% respectively, p/0.8539).
Deeper PV wall invasion into tunica media or intima was associated with a
poorer 1-year survival rate similar to that of patients undergoing non-curative
resection (21.5% versus 34.4% respectively; p/0.53). Multivariate analysis
showed that the depth of PV wall invasion, the number of involved lymph
nodes, and the volume of blood transfusion were independent factors of overall
and disease-free survival. Tumor size of 45 mm or more (evaluated by CT scan)
and angiographic type C or D on portography were significantly correlated with
depth of PV wall invasion. Patients presenting simultaneously these two factors
should be contraindicated for PD with PV resection.
Conclusion. Depth of PV wall invasion significantly alters survival after
curative pancreatic resection combined with PV resection. Tumor size and
angiographic type on portogram could be useful preoperative factors predicting
the depth of PV wall invasion, and could help to select the best candidates for
PD with PV resection.
FC 4.05
THE IMPACT OF BIOLOGICAL MARKERS AND MARGIN STATUS
ON OUTCOME AFTER PANCREATICODUODENECTOMY FOR
PANCREATIC HEAD ADENOCARCINOMA
Christein, John1; Leeth, Ruth R1; Jhala, Nirag2; Arnoletti, Juan1; Heslin,
Martin1; Vickers, Selwyn1
1Univeristy of Alabama at Birmingham, Surgery, Birmingham, USA; 2Uni-
veristy of Alabama at Birmingham, Pathology, Birmingham, USA
Background. Biological markers have not specifically been associated with
outcome after pancreaticoduodenectomy (PD) for pancreatic adenocarci-
noma. Predictors and implications of margin status and biological markers as
they pertain to outcome after PD for pancreatic adenocarcinoma are unclear.
Aim. To determine associations between p53, p16, and MUC4 mutations and
outcome in patients after PD for pancreatic adenocarcinoma. To determine
predictors and impact of margin status on those undergoing PD for pancreatic
adenocarcinoma.
Methods. Patients who underwent PD for pancreatic adenocarcinoma from
19972005 were analyzed. Margin status and stage was updated with the
AJCC 6th edition. A single pathologist immunohistochemically stained and
interpreted specimens for p53, p16, and MUC4. For p53 and p16, percentage
greater than the mean plus 2 standard deviations was considered positive.
MUC4 results were grouped as low (B/20%) or high expression (/20%). The
Kaplan-Meier method was used to determine survival. Logistic regression
analysis was used to determine predictors of margin status.
Results. 126 patients underwent PD for adenocarcinoma (67% male, mean
age 65 years). Follow-up was available on 96%. Fifteen patients underwent R1
resections (12%). The mortality rate was 2.3%. Median survival was 23
months. P53 or p16 positivity did not affect survival. High MUC4 (18 vs. 12
months) expression had a significantly longer survival(pB/0.03). R0 resections
(24 vs. 13 months) had a significantly longer survival (HR 2.1, pB/0.01). P16
positivity was associated with R1 resections (OR 8.2, pB/0.01). African
Americans were more likely to be p16 positive (pB/0.01) whereas Caucasians
were more likely to be p16 negative (pB/0.02). Margin status was the only
independent predictor of survival after PD for pancreatic head adenocarci-
noma.
Conclusions. P16 positivity is associated with R1 resection and African
American race. High MUC4 expression and negative surgical margins are
associated with longer survival after PD for pancreatic adenocarcinoma.
FC 4.06
COMBINATION OF IRINOTECAN ANDANTI-DEATH RECEPTOR
5 ANTIBODY INHIBITS PANCREATIC CANCER IN AN ORTHO-
TOPIC TUMOR MODEL
DeRosier, Christopher1; Buchsbaum, Donald2; Sellers, Jeffrey3; Huang, Zhi-
Qiang1; Oliver, Patsy4; Vickers, Selwyn1
1University of Alabama at Birmingham, Surgery, Birmingham, USA; 2Uni-
versity of Alabama at Birmingham, Radiation Oncology, Birmingham, USA;
3University of Alabama at Birmingham, Comprehensive Cancer Center,
Birmingham, USA; 4University of Alabama at Birmingham, Radiation
Oncology Radiobiology, Birmingham, USA
Aims. We evaluated the response of 2 human pancreatic cancer lines to a mAb
(TRA-8) to human death receptor 5, in combination with Irinotecan (CPT-
11).
Methods. Pancreatic cancer lines MIA PaCa-2 (MP2) and S2VP10 (S2) were
evaluated for in vitro response to combination therapy (TRA-8 and CPT-11).
ATP assays were used to determine cell viability. Cell viability was calculated as
a percent of untreated controls9/std error and statistical analysis was performed
(Students t-test). Protein changes were evaluated by Western blot. Orthotopic
pancreatic tumors were established by injecting 2/106 MP2 cells into the
pancreas of SCID mice. The treatment group received 3 doses of TRA-8 (day
35/39/42) and CPT-11 (day 36/40/43). On day 46 mice were sacrificed, tumor
weights recorded, and data analyzed (Student’s t-test).
Results. MP2 cells showed sensitivity to 5 ng/ml TRA-8 and 10 mM CPT-
11. Combination treatment yielded reduction in cell viability (769/5%)
greater than individual treatment with CPT-11 (269/4%, pB/0.001) or TRA-
8 (359/7%, pB/0.001). In comparison, S2 was resistant to TRA-8 (25 ng/
ml), but more sensitive to CPT-11 (10 mM). Combination treatment yielded
reduction in cell viability (839/6%) greater than individual treatment with
CPT-11 (509/5%, pB/0.001) or TRA-8 (119/4%, pB/0.001). Western blot
analysis demonstrated activation of caspases 3, 8, and 9 and enhanced
substrate cleavage with combination treatment compared to either agent
alone in both lines. Bcl-XL (MP2), and XIAP (S2), were downregulated
with combination treatment greater than with either agent alone. Orthotopic
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tumor growth was significantly reduced in mice receiving combination
treatment compared to untreated controls (mean tumor weight 0.049/0.02
g vs 1.369/0.22 g, pB/0.001).
Discussion. TRA-8 is a mAb that produces synergistic effects with CPT-11
through multiple proteins in the apoptotic pathway. These findings, with
significant inhibition of mouse orthotopic tumor growth with combination
treatment, provide a novel treatment for pancreatic cancer.
FC 4.07
INTRATUMORAL INJECTION OF MACROPHAGE-ACTIVATING
LIPOPEPTIDE (MALP-2) IN PATIENTS WITH PANCREATIC
CARCINOMA: A PHASE I/II TRIAL
Schmidt, Jan1; Welsch, Thilo1; Mu¨hlradt, Peter2; Bu¨chler, Markus1; Ma¨rten,
Angela1
1University of Heidelberg, Heidelberg, Germany; 2Wound Healing Research
Group, Braunschweig, Germany
Patients with not complete or unresectable carcinoma of the exocrine
pancreas have an especially bad prognosis. Chemotherapy is actually the
therapy of choice but has only a marginal life prolonging effect. Here we
tested Macrophage Activating Lipopetide-2 (MALP-2) in a phase I/II
study for toxicity, optimal dosage, immunomodulatory effects and as
secondary objective for influence on overall survival. MALP-2 was injected
intraoperatively in unresectable tumors or parts of tumors; after finishing
of wound healing the patients were treated with gemcitabine. 10 patients
with unresectable, debulked or R2 resected pancreatic adenocarcinoma
were included up to now in the trial. Side effects were only observed in
patients treated with /20 mg MALP-2 (one possible related myocardial
infarction, one asystole and one probably related endotoxin shock). The
median survival with a mean follow-up of one year is 13.69/2.6 months
(CI 8.5; 18.8), five patients are still alive (/14 months). The immuno-
monitoring was more difficulty than expected as long operations have a
strong impact on the immune system. We observed stable to increased NK
cell mediated cytotoxicity compared to samples from control patients
which showed immunosuppression postoperatively. Furthermore, lympho-
cytes, monocytes, CD28/ cells and CD40/ are increased in the
peripheral blood as well as in the wound secretion. Interestingly, patients
who lived longer than 9 months after operation showed within the first
three postoperative days a significant more pronounced course of CRP
than those living less than 9 months. In conclusion, treatment with
MALP-2 in a dosage of up to 20 mg seems to be safe, it protects the
immune system from suppression, induces partly an activation of the
immune system and might have in combination with chemotherapy
therapeutic effects.
FC 4.08
RESPONSE RATES WITH LAPATINIB (ERBB1/ERBB2 TYROSINE
KINASE INHIBITOR) AND CHEMOTHERAPY FOR ADVANCED
PANCREATICOBILIARY CANCER
Iannitti, David A1; Safran, Howard2; Resnick, Murray3; Joshua, Shipley2;
Suga, Marie2; Thomas, Miner1
1Brown Medical School, Surgery, Providence, USA; 2Brown Medical School,
Division of Oncology, Providence, USA; 3Brown Medical School, Pathology,
Providence, USA
Background. Therapies that block aberrant growth factor signal transduc-
tion pathways have substantial promise in pancreaticobiliary cancer. Epider-
mal growth factor receptor (ErbB1) is commonly expressed in
pancreaticobiliary cancer. ErbB2 is frequently amplified in biliary cancer
and is the preferred heterodimer partner for other ErbB receptors. Lapatinib
reversibly inhibits ErbB1 and ErbB2 tyrosine kinases.
Objective. Evaluate the effect of lapatininb and gemcitabine (gem), and
gemcitabine and oxaliplatin (GEMOX) on patients with advanced pancrea-
tico-biliary cancers.
Methods. Patients with advanced adenocarcinoma of the pancreas or bile
ducts were treated with lapatinib and either weekly gemcitabine (1 gm/m2/
week, 3 weeks on, 1 week off) or GEMOX (gemcitabine 1g/m2 over 100
minutes and oxaliplatin 100 mg/m2, every 14 days). Cohort 1: Weekly gem/
lapatinib, 1000 mg/day. Cohort 2: Weekly gem/lapatinib, 1500 mg/day.
Cohort 3: GEMOX/lapatinib 1000 mg/day. Cohort 4: GEMOX/lapatinib
1500 mg/day.
Results. 21 patients have been treated; pancreatic cancer (n/15),
biliary cancer (n/6). Median age was 64 (4178). Dose limiting toxicites
occurred in 4 patients. No decline in cardiac function has been detected
in serial echocardiograms. Five of the first 12 patients have responded
including two patients with pancreatic cancer and diffuse liver metastases,
one patient with a locally advanced pancreatic cancer and one two patients
with biliary cancer and hepatic and peritoneal carcinomatosis. Overall
response rate was 25%. Mean survival by the Kaplan-Meier method is
13.5 months.
Conclusions. Dramatic responses have been demonstrated in patients with
diffuse liver and peritoneal metastases suggesting that erbB1/erbB2 signaling
may be important in pancreaticobiliary cancers. Lapatinib can be adminis-
tered will full dosage gemcitabine. Accrual is continuing at cohort 4 with
GEMOX/lapatinib. We are also evaluating tumor expression of erbB1/erbB2
in relationship to response and survival.
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LONG-TERM OUTCOME IN PATIENTS WITH PAINFUL PAN-
CREATITIS RECEIVING ANTOX -A COMPOUND SELENIUM-
METHIONINE BASED ANTI-OXIDANT THERAPY
Bagul, Anil
Manchester Royal Infirmary, Manchester, UK
Background. The generation of short-lived oxygen free radicals(oxidative
stress) has been implicated in the pathogenesis of chronic pancreatitis(CP).
Anti-oxidants are endogenous inhibitors/scavengers of oxygen free radicals
and their levels are depleted in the disease process. There is some evidence
that supplementation with exogenous anti-oxidants cause relief of symptoms
in CP. This study reports long term outcome in a cohort of CP patients on
oral anti-oxidant therapy.
Methods. Patients (N/39) diagnosed as CP and having their index
presentation to a regional hepatobiliary centre in the calender year
1993 were identified by using ICD (version 9:577.1). These patients had
undergone assays for anti-oxidant levels prior to commencing on
antox (Pharmanord, UK) an anti-oxidant preparation. The patient records
were reviewed to confirm that they had either CT/ERP confirming a
diagnosis of CP. Data for annual levels of anti-oxidants, opiate
use (documented weekly prescriptions to signify ‘‘regular’’ requirement),
pain, endocrine/exocrine insufficiency, surgical intervention and mortality
over the 10 year study period was recorded. Data are presented as median
(range).
Results. Serum ascorbic acid levels at recruitment were 14.7 (1.928.3) mg/
l compared to 15.05 (1.927.1) mg/l at 10year interval [P/0.52;Mann-
Whitney U test]. Selenium at recruitment were 87 (28214) mgm/l compared
to 143 (86245) mgm/l at 10 years [P/B/0.0001 Mann-Whitney U test].
The laboratory reference range for ascorbic acid was 420 mg/l and for
selenium was 83152 mgm/l. At recruitment, 2 patients (5%) were diabetic
and by 10 years this rose to 20(51%) while 26(78%) presented with pain
compared to 25(75%) at end period (2003), 8 (27%) were on regular opiates
at baseline compared to 21(73%) at end point [P/0.01;Fisher’s 2-sided].
Conclusion. Although long-term anti-oxidant therapy appears to sustain
selenium levels the supplementation with anti-oxidants dont appear to have a
sustained modulating effect on either the symptomatic picture or the disease
progession.
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CARCINOMA IN TROPICAL CHRONIC PANCREATITIS-A COM-
PARATIVE STUDY
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Meenu2
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Background. Carcinoma developing in tropical chronic pancreatitis is a well
known complication. Clinically and pathologically this malignancy behaves in
a different manner compared to de novo pancreatic ductal adenocarcinoma.
Objective. This paper analyses and compares the pancreatic carcinoma
occurring along with tropical chronic pancreatitis and that occurring de novo.
Methods. All patients with carcinoma pancreas presenting to the Depart-
ments of Medical and Surgical Gastroenterology, Medical College, Trivan-
drum, India from January 1993 to December 2004 were retrospectively
studied and prospectively followed up. The data was analyzed as 2 groups:
Group A-Tropical chronic pancreatitis with malignancy. Group B-Patients
with de novo pancreatic ductal adenocarcinoma.
Results. There were 102 cases of carcinoma associated with tropical chronic
pancreatitis out of a total number of 392 tropical pancreatitis patients in
Group A and 267 patients with de novo pancreatic cancer in Group B. Group
A patients had a significantly lower age-median age of 36 yrs (2669 years)
and duration of symptoms ranging from 3 months to 15 years. Intractable
pain, significant loss of weight and worsening of diabetes were the
commonest presenting symptoms in cancers with tropical pancreatitis, noted
in 70% of cases. The distribution of tumors was similar in Groups A & B with
maximum involvement of the pancreatic head. Hepatic metastasis was less
common in malignancies developing in Group A. In Group A local invasion
of the tumor was high and overall resectability of the tumor was poor. Very
high CA19.9 level was syn-qua-non with unresectable carcinoma.
Conclusion. Carcinoma occurs in approximately 26% of cases of tropical
chronic pancreatitis. There is a predilection for involvement of head of
pancreas. However involvement of body and tail of pancreas is higher than
that in de novo pancreatic cancer. Both local infiltration and peritoneal
dissemination are higher in CCPT with carcinoma while liver metastasis is
rare.
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LAPAROSCOPIC VERSUS OPEN LIVER RESECTION FOR BE-
NIGN HEPATIC TUMOURS
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Introduction. Laparoscopic surgery has revolutionized modern medicine. A
minimally invasive approach to abdominal surgery has resulted in the
reduction of patient pain and postoperative intestinal dysfunction. This
approach has also enabled patients to return more rapidly to their daily
activities. There has been no large comparison of a laparoscopic to open
approach to resections for benign hepatic tumours.
Methods. Retrospective comparison of laparoscopic (n/66) to open
resection (n/198) for benign liver tumors using a multi-institutional
database. Patient demographics, indications and outcomes were analyzed.
Results. There were no sigificant differences in median tumour size or
number of lesions.
M/F Age
(years)
Lobe/Seg
(%lobes)**
Blood
Loss (ml)
LOS
(days)
Bile Leaks
Laparscopic
(n/66)
22/46 47.7 22/46
(48%)
125 2.5 4.0%
Open
(n/198)
40/158 43.1 42/133
(32%)
300 7 8.8%
p-value p/0.04 p/0.019 p/0.021 pB/0.001 pB/0.001 NS
There were 2 deaths in the open liver resection group. Deaths were from
HELP Syndrome and the other from necrotizing pancreatitis. All but 2 bile
leaks resolved with conservative management.
Conclusion. Laparoscopic liver resection is a safe and feasible approach to
the management of benign hepatic tumours. This also results in a significant
reduction in blood loss, length of stay, and patient disablity.
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LAPAROSCOPIC LIVER RESECTION AT THE UNIVERSITY OF
CINCINNATI
Buell, Joseph; Tevar, Amit; Thomas, Mark
University of Cincinnati, Surgery, Cincinnati, USA
Background. Laparoscopic hepatic resection is a procedure in evolution.
Initial experiences were limited to benign and smaller lesions.
Objective. This current study examines the applicability of minimally
invasive liver resections.
Methods. We examined the pt and tumor characteristics of all laparoscopic
resections performed at the University of Cincinnati over the last three
years.
Results. 151 resections were performed in 126 pts. The mean pt age was
52.99/15.5 yrs. The majority of pts (53%) underwent resection for benign
disease. Malignant tumor diagnoses included: CRC n/20, HCC n/14,
Non-CRC n/22, Cholangio n/3. 16 (12.7%) of the pts were cirrhotic
ranging from Child’s A to C. The mean tumor size was 4.99/3.8 cm.
Resections performed included 2 trisegmentectomy, 5 caudates, 18 right
lobes, 14 left lobes, 112 multi-segment resections and 44 uni-segment
resections. Parenchymal transection was performed utilizing a combination of
TissueLink and Autosuture 2.5 staplers. Mean EBL was 2389/259 cc with 10
(8%) of pts transfused. 35 pts had prior abdominal surgery with 2 with prior
hepatic resection. 33 pts had concomitant surgery including: chole n/26,
Diaphragm resection n/3, subtotal gastrectomy n/1, colectomy n/1,
nephrectomy n/1, and RFA n/1. Mean surgical margin was 1.29/1.3 cm.
No local recurrences were noted at any margin. 2 operative conversions were
encountered. The complication rate for this series was 12.7%, including bile
leak n/2, operative rebleed n/3, pulmonary embolism n/2, death n/2,
hepatic insufficiency n/1, other n/4. Both deaths were in cirrhotics and
related to pt co-morbidities.
Conclusions. Laparoscopic hepatic resection is a procedure in evolution.
The resection margin obtained appears to be oncologically sound with no
tumor recurrence. As with any major hepatic resection series the combined
mortality of this series was under 1.5%. The safety of the procedure is directly
related to the co-morbidities of the pts.
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PET/CT VS CT VS SPIO (SUPERPARAMAGNETIC IRON OXIDE)-
MRI IN PATIENTS WITH METASTASES FROM COLORECTAL
CANCER: A STUDY WITH INTRAOPERATIVE CORRELATION
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Peter1; Noergaard Larsen, Peter3; Mellon Mogensen, Anne4; Wettergren,
Andre´3; Rasmussen, Allan3; Hillingsoe, Jens3; Kirkegaard, Preben3; Thom-
sen, Carsten1
1Rigshospitalet, Radiology, Copenhagen, Denmark; 2Rigshospitalet, Clinical
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Background. The lesion-by-lesion sensitivity of PET in detection of liver
metastases (LM) is debated. Few prospective studies comparing PETand CT
with surgical reference have been published and none comparing PET and
MRI. We also wanted to assess the ability of PET/CT to detect extra-hepatic
spread.
Purpose. Compare contrast-enhanced-FDG-PET/CT with PET, CT and
SPIO-MRI in patients with LM from colorectal-cancer (CRC) using intra-
operative findings as reference standard.
Methods and materials. 35 candidates for liver surgery had PET/CT with
a biphasic contrast-enhanced CT-protocol and SPIO-MRI. 31 patients
finally had surgery. Prospective blinded interpretation of SPIO-MRI, PET/
CT, CT-part and PET-part of the PET/CT-study was performed. Liver-
lesions and suspected extra-hepatic tumors were registered. For LM surgical
findings including intraoperative ultrasound and histology were the gold
standard.
Results. 71 LM were found at surgery. Lesion-by-lesion sensitivity for
detection of LM was 54%, 66%, 82% and 89% for PET, PET/CT, SPIO-
MRI and CT respectively. CT and SPIO-MRI were significantly more
sensitive than PET (pB/0.0001; McNemar-test) and PET/CT (p/0.0003
and 0.0164; respectively). Particularly LMB/1 cm were PET-negative.
Specificity was 99%, 99%, 81% and 67% for PET, PET/CT, SPIO-MRI
and CT respectively. Four patients had chemotherapy within one month prior
to PET/CT; with these patients excluded sensitivity was 61%, 75%, 84% and
86% for PET, PET/CT, SPIO-MRI and CT respectively. Twelve patients had
verified extra-hepatic tumor sites. PET/CTand CT detected ten and seven of
these sites respectively. In three patients CT was false positive for extra-
hepatic tumor and PET/CT was false positive in one patient.
Conclusion. CTand SPIO-MRI are more sensitive than PET in detection of
individual LM especially for smaller LM. PET is a very specific test for LM.
PET and PET/CT can detect patients with extrahepatic tumor not detected
by conventional imaging.
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A POTENTIAL ROLE FOR THE CLINICAL RISK SCORE IN
PREDICTING YIELD OF STAGING LAPAROSCOPY IN PA-
TIENTS WITH COLORECTAL LIVER METASTASES
Mann, Christopher D; Neal, Chris P; Metcalfe, Matthew S; Pattenden, Clare
J; Dennison, Ashley R; Berry, David P
Leicester General Hospital, Dept. of Surgery, Leicester, UK
Introduction. Resection offers the only realistic chance of cure for hepatic
colorectal metastases, but is precluded by the presence of extra-hepatic or
extensive intra-hepatic disease. The potential of laparoscopy and intra-
operative ultrasound (IOUS) in detecting this disease is recognised, however
it is still not known which patients should undergo this additional procedure.
Aim. The aim of this study was to determine whether the clinical risk score
(CRS) is useful in selecting patients for laparoscopy prior to hepatic
resection.
Methods. Patients having staging laparoscopy and IOUS for potentially
resectable hepatic colorectal metastases between January 2000 and Decem-
ber 2004 were identified from our Hepatobiliary database. A preoperative
CRS was determined for each patient, a score derived from nodal status of
the primary lesion, disease-free interval, number of hepatic metastases, size
of the largest metastasis, and preoperative CEA level. This was correlated
with the outcome at both laparoscopy and laparotomy.
Results. Two hundred patients underwent staging laparoscopy and IOUS for
potentially resectable colorectal liver metastases. 133 patients were resectable
at laparotomy. Laparoscopy detected 39 of the 67 patients with unresectable
disease (58.2%). CRS correlated with the likelihood of detecting radiologi-
cally occult unresectable disease: CRS/01, 6.4%; 23, 27.3%; and 45,
76.9% (PB/0.001). The potential benefit of laparoscopy also progressively
increased with increasing CRS, preventing unnecessary laparotomy in: 0%
with CRS/01; 11.6% in CRS/23; and 48.7% in CRS/45 (PB/
0.001).
Conclusion. The clinical risk score may allow targeting of laparoscopy to
patients most likely to benefit. Laparoscopy had a very low yield in patients
with CRS/01 and therefore routine use in this group of patients is not
recommended. Laparoscopy is an invaluable part of preoperative workup;
however it does not need to be performed routinely in all patients prior to
hepatic resection for colorectal metastases.
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TIMING OF RESECTION OF LIVER METASTASES SYNCHRO-
NOUS TO COLORECTAL TUMOR: PROPOSAL OF PROGNOSIS-
BASED INDICATIONS
Vigano’, Luca; Ferrero, Alessandro; Lo Tesoriere, Roberto; Sgotto, Enrico;
Polastri, Roberto; Muratore, Andrea; Capussotti, Lorenzo
Ospedale Mauriziano, Torino, Italy
Background. Timing of liver resection in metastases synchronous to
colorectal cancer is still debated and no clear selection criteria have been
defined.
Aim. to analyze and compare prognostic factors after synchronous and
delayed liver resections in order to define selection criteria for choosing
timing of liver resection.
Methods. The study was performed on 127 patients affected by synchronous
metastases undergone radical hepatectomy. Patients with preoperative
chemotherapy, portal vein embolization or portal branch ligature because
of initially no resectable disease were excluded. We divided patients according
to the timing of hepatectomy: 70 synchronous (group A) and 57 delayed
(group B).
Results. Overall survival after liver resection was similar into the two groups:
3-yrs survival 44.7% vs 54.6% in A vs B, p 0.406. In group A, at the univariate
analysis 3 prognostic factors were identified: T staging of primary tumor (T4 vs
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T2-3), number of liver metastases (B//3 vs/3) and liver metastases
infiltration of close structures. The multivariate analysis confirmed the 3
variables as independent prognostic factors: T4 vs T2-3 (OR 4.37, CI 1.63
11.77, p 0.0035), //vsB/3 metastases (OR 6.98, CI 2.6518.35, p 0.0001),
infiltration of close structures (OR 20.46, CI 5.23 84.08, p B/0.0001). In
group B, no significant prognostic factor was identified. Comparing survival in
presence of the negative prognostic factors previously identified, patients
with/3 metastases or with infiltration of close structures had a significantly
worse survival in group A (3-yrs 15.0% vs 34.3%, p 0.007; 0% vs 57.1%, p
0.050 respectively). Borderline significant difference was encountered in
patients with T4 primary tumor (3-yrs 16.7% Vs 60%, p 0.064)
Conclusion. Patients with liver metastases synchronous to colorectal cancer
with more than 3 metastases or metastases infiltration of close structures
should be scheduled for neoadjuvant chemotherapy before liver resection.
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PROGNOSTIC SIGNIFICANCE OF VASCULAR CLAMPING
DURING LIVER SURGERY ON LONG-TERM OUTCOME IN
COLORECTAL CANCER PATIENTS
van der Bilt, Jarmila D; Nijkamp, Maarten W; Livestro, Daan P; Kranenburg,
Onno; van Hillegersberg, Richard; Borel Rinkes, Inne H
University Medical Center Utrecht, Dept. of Surgery, Utrecht, Netherlands
Background. Vascular clamping during liver surgery causes hepatic ischemia/
reperfusion injury and accelerates the outgrowth of residual micrometastases
in a preclinical model.
Methods. From 1996 to 2005, 128 patients who underwent intentionally
curative hepatectomy for colorectal liver metastases were collected from a
prospective database and analyzed for tumor recurrence and disease free
survival (DFS). The prognostic significance of various factors was determined
by uni-and multivariate analyses, with emphasis on vascular clamping.
Results. Median follow up time was 3, 5 years. Overall 5- and 10-year survival
rates were 35, 7% and 27, 1%. Median DFS was 1, 3 years. Forty five patients
(35, 2%) had liver recurrence during the course of their follow up. By univariate
analyses, positive lymph nodes of the primary, disease free interval B/12
months, preoperative CEA /50 ng/mL, positive resection margin and blood
transfusions significantly inversely affected DFS. No difference in DFS was
seen between continuous and intermittent clamping. In contrast, DFS and
time to liver recurrence were significantly decreased when continuous clamping
exceeded 20 minutes and when intermittent clamping exceeded 30 minutes
(PB/.05). Stratification for age and gender revealed a more pronounced
adverse effect of prolonged clamping for males and patients older than 60 years.
Logistic multivariate regression analyses confirmed preoperative CEA levels,
lymph node status and positive margins as indipendent predictors of DFS (PB/
.05). Prolonged vascular clamping was not maintained as an independent
factor in the multivariate analyses (P/.06), in this relatively small series.
Conclusion. Prolonged vascular clamping during hepatic resection is
associated with accelerated tumor growth and decreased time to (hepatic)
recurrence. The adverse effect of prolonged vascular clamping is prominent in
male and older patients and appears to occur irrespective of the clamping
method used. In case of inevitable clamping, total ischemia time should kept to
a minimum.
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RESECTION MARGIN DOES NOT INFLUENCE RECURRENCE
RATES IN CURATIVE RESECTED COLORECTAL CANCER
LIVER METASTASES
Bodingbauer, Martin; Tamandl, Dietmar; Herberger, Beata; Plank, Christine;
Kandutsch, Sandra; Gruenberger, Thomas
Medical University Vienna, Vienna, Austria
Background. Magnitude of surgical resection margin is an unresolved issue in
patients treated for colorectal cancer liver metastases. Under new dissection
techniques requirement for adequate resection margin have to be redefined.
Purpose of this prospective study was the evaluation of local and distant
recurrence rates under different histological margin depth.
Aims. Between 2000 and 2003 176 patients underwent liver resection for
CRCLM at our institution. Liver resection was performed using CUSA
technique in all patients, requiring a destruction of several millimetre of
normal liver tissue during transaction. Univariate and multivariate analyses
were performed for both recurrence-free (RFS) and overall survival (OS) with
specific reference to size of surgical margin. Local recurrence rates at the
resection site were analysed separately.
Results. Final pathological examination revealed 43 patients with tumour at
the resection margin (R1), 110 patients with a resection margin below 9 mm
and 23 patients with a margin above 9 mm. Local recurrence rate was 2.8%,
irrespective of the magnitude of resection margin. After a median follow-up of
3 years 129 patients developed a recurrence at any site (73%). Intra- and/or
extrahepatic recurrence was uninfluenced by the size of the resection margin.
Magnitude of resection margin did not influence RFS and OS both in
univariate and multivariate analysis. Positive lymph nodes of the primary were
the only independent variable in the Cox model (pB/.005).
Conclusion. Surgical resection margin does not play an important role in
modern liver surgery as long as macroscopic curative resection is possible using
CUSA technique. Proximity of essential vascular structures to CRCLM
should not preclude potentially curable surgery.
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PROGNOSTIC INFLUENCE OF MULTIPLE HEPATIC METAS-
TASES FROM COLORECTAL CANCER
Hamady, Zaed Z R1; Malik, Hassa2; Adair, Robert2; Finch, Robert2;
Toogood, Giles2; Prasad, Rajendra2; Lodge, J Peter2
1St James’s University Hospital, HPB and Transplant Unit, Leeds, UK; 2St
James’s University Hospital, HPB, Leeds, UK
Background. Traditionally the management of patients with multiple or
bilobar metastases has been regarded as controversial. Many patients with
colorectal liver metastases (CRLM) are declined surgical resection on the basis
of multiple metastases or bilobar disease.
Aim. to explore the impact of multiple metastases on patient outcome
following hepatic resection for CRLM.
Methods. Using a prospectively collected database, this was a retrospective
analysis of 484 consecutive patients who underwent liver resection for CRLM
between 1993 and 2003. The cohort was divided into 2 groups, those with 13
metastases and those with ‘‘multiple’’ metastases, namely 4 or more lesions.
This multiple group was subdivided into those with less than 8 (‘‘several’’) or 8
or more (‘‘numerous’’) separate lesions. Demographic, pathological and
outcome data were compared between the groups.
Results. There were 136 (28%) patients with multiple metastases. There was
an association between synchronous disease (p/0.0005) and closer resection
margins (p/0.0005) and the presence of multiple metastases. On multivariate
analysis the presence of multiple metastases was the only predictor for both
poorer overall survival (p/0.007) and disease free survival (p/0.031).
However, when patients with multiple metastases are analysed in detail this
survival disadvantage appears to be only present in patients with numerous (8
or more) lesions.
Conclusion. Although patients with multiple metastases appear to have a
poorer outcome (34.2% 5 year survival compared to 43.3% for patients with
less than 4 tumors), significant proportions of patients with multiple metastases
survive to 5 years or more and should not be denied surgery. Only patients with
numerous (8 or more) metastases showed a statistically significant survival
disadvantage (24.2% 5 year survival). This latter subgroup of patients may best
be treated with a combination of neo-adjuvant therapy and surgery.
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THE ONCOSURGE DECISION MODEL: WE QUESTION THE
VALIDITY OF THEIR RECOMMENDATION!
Niu, Rui; Chu, Francis; Gunasegaram, Aravin; Morris, David
St George Hospital Campus, University of New South Wales, Dept. of
Surgery, Sydney, Australia
Background. In the recent publication ‘‘OncoSurge Decision Model’’ by
the OncoSurge expert panel group, it was claimed that for patients with
/4 metastases and bilobar liver involvement, resection was considered
appropriate only after pre- operative chemotherapy-induced tumour shrink-
age.
Aim. The purpose of this study was to analyse the validity of this claim from
the experience of a tertiary referral liver surgery unit.
Patients/Method. Between January 1990 to December 2005, 596 patients
underwent liver resection and or ablation for colorectal cancer liver metastases.
The policy of the St George Hospital liver unit was hepatectomy if lesions were
deemed resectable irrespective of their number and location. 80 patients who
matched the ‘‘OncoSurge’’ criterion of /4 metastases with bilobar liver
involvement were analysed. Kaplan-Meyer Survival curves were constructed
for the cohort with median survival and 5-year-survival as the primary
outcome measures.
Results. A total of 80 eligible patients identified from the database were
treated with liver resection and/or ablation without pre-operative chemother-
apy. The median survival was 27 month (95% CI: 2330) and the 5-year-
survival was 26%.
Conclusion. Liver resection is the treatment of choice for patients with /4
metastases and bilobar liver involvements without the absolute requirement of
pre-operative chemotherapy.
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DECREASED TOBACCO EXPOSURE IN PATIENTS WITH PAN-
CREATIC DUCTAL ADENOCARCINOMA WHO HAVE A FAMILY
HISTORY OF CANCER IN FIRST DEGREE RELATIVES
Lochan, Rajiv1; Daly, Ann2; Reeves, Helen3; Charnley, Richard1
1Freeman Hospital, Hepato-Pancreato-Biliary Unit, Dept.: of Surgery, New-
castle upon Tyne, UK; 2University of Newcastle upon Tyne, School of
Laboratory and Clinical Sciences, Newcastle upon Tyne, UK; 3University of
Newcastle upon Tyne, School of Clinical Medical Sciences, Newcastle upon
Tyne, UK
Background and aim. Apart from age, tobacco exposure is the only
established risk factor for pancreatic cancer. We sought to examine gene-
environment interaction in patients with pancreatic adenocarcinoma by
correlating history of cancer in first-degree relatives with tobacco smoking in
index cases.
Methods. Patients with pancreatic ductal adenocarcinoma were prospectively
identified and consented. Details of tobacco exposure and history of cancer in
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first-degree relatives (FDR) was among the data collected. Cumulative
tobacco exposure in patients with and without a family history of cancer in
FDR was analysed.
Results. Between June 2005 and Feb 2006, 104 patients diagnosed with
pancreatic ductal adenocarcinoma were included. A history of any cancer in
FDR was present in 40, absent in 41, uncertain in 17 and unavailable in 6
patients. Of the 40 patients with a family history of cancer-25 had one, 10 had 2
and 5 had 3 FDRs with cancer. There were 4 patients with history of pancreatic
cancer in their FDRs. The mean (range) age at presentation was 64 (4688)
years in patients with FDR with cancer and 64 (3988) years in those without.
Present, past and non-smokers accounted for 12, 18, 10 and 13, 19, 9 patients
in the FDR positive and FDR negative groups respectively. Total pack-years of
tobacco smoking {mean (range)} were significantly lower (p/0.02 t test) in
the group of patients with a family history of cancer {26.18 (0.4105)} versus
those without {40.76 (0.7148)}.
Conclusion. A statistically significantly greater exposure to tobacco was
found in index cases of pancreatic adenocarcinoma who did not have a history
of cancer in their first-degree relatives. Patients with a genetic predisposition to
pancreatic cancer appear to require less of a genotoxic (tobacco) exposure than
those patients without a family history of cancer. This suggests that genetic
susceptibility is modified by life-style or environmental factors in pancreatic
cancer.
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PATTERNS OF LYMPH NODE METASTASIS IN EARLY OESO-
PHAGO-GASTRIC MALIGNANCY
Jennings, Neil; Sultan, Javed; Gill, Michael; Wynne, Kamil; Preston, Shaun R;
Karat, Daya; Hayes, Nick; Griffin, S Michael
Royal Victoria Infirmary, Northern Oesophago Gastric Cancer Unit, New-
castle upon Tyne, UK
Background. Radical (D2) lymphadenectomy has a role in the management
of early gastric cancer (EGC) as an appreciable number of patients present
with lymph node metastasis (LNM). There is little published data regarding
the pattern of LNM in early oesophageal adenocarcinoma.
Aim. To evaluate to rate of LNM in early (T1) adenocarcinoma of the
oesophagus, oesophago-gastric junction (OGJ) and stomach, with respect to
current operative management.
Method. Prospectively collected data were analysed from 152 patients
with early adenocarcinoma (oesophageal/65, OGJ/26, gastric/61). Pa-
tients were subsequently grouped in to an oesophageal or gastric group
depending on the site of their tumour and the operation they received. Results
are presented with regard to depth of invasion and LNM for each group.
Patients underwent an extended lymph node dissection with the locations of
the nodal stations confirmed in the fresh specimen and subsequently
examined.
Results. LNM and depth of invasion by site were as follows. Oesophageal
LNM/1.5% (1/65) and the sub mucosa was involved in 60% (39/65) of
patients. OGJ LNM/23% (6/26) and the sub mucosa was involved in 65%
(16/24) of patients. Gastric LNM/23% (14/61) and the sub mucosa was
involved in 79% (48/61) of patients. Sub mucosal invasion and the proportion
of LNM were greater in the gastric group of patients compared to the
oesophageal group, (79.9% (59/74) vs. 62.8% (49/78) P/0.008, 24.3% (18/
74) vs.3.8% (3/78) P/0.001, respectively). Sub group analysis failed to
demonstrate a significant difference between the depth of invasion and LNM
in either group although there were no LNM seen in oesophageal tumours
confined to the mucosa.
Conclusion. Early tumours arising in the oesophagus appear to show a
different pattern of LNM when compared to EGC. The rate of LNM in this
group was significantly lower and no metastases were seen with lesions
confined to the mucosa. These findings have implications wit regard to the
potential management of these patients.
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IMPAIRED ANTIGEN PRESENTATION BY HUMAN MONOCYTES
IN OBSTRUCTIVE JANUDICE IS ASSOCIATED WITH A TH2
SHIFT
Bullock, Rachel1; Robins, Adrian2; Aithal, Guru3; Fiuza, Carmen4; Rowlands,
Brian4
1Queen’s Medical Centre University Hospital, Division of Surgery, Notting-
ham, UK; 2Queens Medical Centre University Hospital, Immunology,
Nottingham, UK; 3Queens Medical Centre University Hospital, Gastroenter-
ology, Nottingham, UK; 4Queens Medical Centre University Hospital,
Section of Surgery, Nottingham, UK
Background. Patients with obstructive jaundice (OJ) are at high risk of sepsis
after surgery. Understanding factors that initiate and modulate immune
function may be useful in developing therapies for these patients.
Aim. To examine the peripheral blood of OJ patients for evidence of monocyte
dysfunction.
Methods. 14 patients with OJ and 14 healthy controls (HC) were included in
the study. The expression of HLA-DR (marker of monocyte antigen-
presenting capacity, the initial step in the acquired immune response) was
quantified in whole blood by flow cytometry. Whole blood was cultured for
24 h with TSST (100 ng/ml) or T-cell stimulants anti-CD3 (2.5 mg/ml) /anti-
CD28 (0.5 mg/ml). Cytokine production was measured in the culture super-
natant by Cytokine Bead Assay. The research protocol was approved by the
local ethics committee.
Results. (mean9/SD): OJ patients showed profound suppression of monocyte
HLA-DR expression (67089/6305 v 197469/8345 receptors/ cell, pB/0.001).
TSST resulted in significantly reduced TNFa, IFNg and IL-10 in OJ v HC,
p/B/0.05 (TNFa: 1129/88 v 10179/978; IFNg: 3369/663 v 15579/1673;
IL-10: 729/109 v 3939/416) whilst production of IL-2, IL-4 and IL-5
remained the same. Following CD3/ CD28 stimulation there was no difference
in cytokine production between the groups.
Discussion. Reduced whole blood cytokine production following TSST
stimulation but not CD3/ CD28 cross-linking indicates monocyte dysfunc-
tion. Reduced monocyte HLA-DR resulting in impaired antigen presentation
may cause the observed reduction in cytokine production and a Th2 shift as
indicated by whole blood culture with TSST. This may cause deficient
initiation of the acquired immune response and may contribute to the immune
dysfunction in obstructive jaundice. The observed Th2 shift indicates a
reduced capacity of peripheral blood to respond to an inflammatory stimulus
which may further compromise immunity with the subsequent development of
infection.
FC 6.04
CENTRALISATION OF UPPER GI CANCER TREATMENT RE-
DUCES THE PERCENTAGE OF PATIENTS HAVING SURGERY
Leeman, Matthew F1; Rees, Jonathan RE2; Greenberg, David3; Xia, Guiling1;
Vowler, Sarah4; Dwerryhouse, Simon J1; Hardwick, Richard H1
1Addenbrooke’s Hospital, Cambridge Oesophagogastric Centre, Cambridge,
UK; 2University of Cambridge, MRC Cancer Cell Unit, Cambridge, UK;
3Addenbrooke’s Hospital, Eastern Cancer Registration and Information
Centre, Cambridge, UK; 4Dept. of Public Health & Primary Care, University
of Cambridge, Centre for Applied Medical Statistics, Cambridge, UK
Background. Adenocarcinoma of the gastro-oesophageal junction is becom-
ing more common in the UK, continues to present late and has a poor
prognosis. Patients with metastatic disease rarely benefit from surgery and
identifying them at the outset can save needless suffering. The UK has recently
undergone major re-organisation of its Upper GI cancer services in an attempt
to improve outcomes of treatment.
Aims. To identify any changes in management for patients with Oesophago-
gastric (O-G) cancer in the Eastern Region (population 2.8 m) after
centralisation of surgery.
Methods. Two three year periods were selected pre & post centralisation of
services; Period A (199597) and Period B (20013). Details of incidence
and treatment were obtained from the Eastern Cancer Registration and
Information Centre (ECRIC) for all patients with O-G cancer diagnosed
during these periods.
Results. Between Period A and B the annual incidence rate of O-G cancer
rose 10.9% from 23.8 (95%CI 2.7) to 26.4 (95%CI 1.5) per 100,000, as a
result of increases in oesophageal and gastric cardia adenocarcinoma. At the
same time, the number of patients having surgery as part of their treatment fell
from 818 (41%) to 764 (34.5%), a 6.6% reduction. This reduction was slightly
larger for gastric cancer (48 to 40%) than oesophageal cancer (32 to 27%).
Conclusions. Centralisation of Upper GI cancer services in the Eastern
Region has reduced the percentage of patients undergoing surgery. We
can speculate that this is due to better staging of tumours and the
multi-disciplinary team meetings which decide patient management.
Further analysis is now needed to see if this change in practice has improved
outcomes.
FC 6.05
CLINICAL AND COMPUTERISED TOMOGRAPHY IMAGING
BASED PREDICTORS OF NEOPLASTIC POTENTIAL OF CYSTIC
LESIONS OF THE PANCREAS
Rahman, Sakhawat H1; Gomez, Dhanwant1; Wong, Lee F1; Sheridan, Maria2;
Verbeke, Caroline3; McMahon, Michael J1; Guillou, J Pierre1; Menon, K V1
1Leeds Teaching Hospitals NHS Trust, Division of Surgery, Leeds, UK;
2Leeds Teaching Hospitals NHS Trust, Dept. of Radiology, Leeds, UK;
3Leeds Teaching Hospitals NHS Trust, Dept. of Pathology, Leeds, UK
Background. Cystic lesions of the pancreas (CLP) are increasingly being
recognized due to the widespread use of cross-sectional imaging. The vast
majority are asymptomatic, although may be associated with malignant
potential and prove to be a diagnostic challenge. Therefore the ability to
predict neoplastic potential based on imaging and simple biochemistry is
important.
Methods. From 19952005, all radiology & pathology records were reviewed
for the presence of CLP. Patients with evidence of pancreatitis were excluded.
CLP was divided into three groups; Gp1; Solid/cystic papillary tumors,
lymphoepithelial cysts & simple cysts, Gp2; serous & mucinous cystic
neoplasms, and Gp3; intraductal papillary mucinous neoplasm, cystic
neuroendocrine tumors, & cystadenocarcinomas.
Results. In total 121 patients had CLP, of whom 75 patients without
documented pancreatitis were included (62%); Gp1 (n/37), Gp2 (n/13),
Gp3 (n/25). Cysts were located proximally [head/uncinate] in 52%, neck
13%, body 24%, and tail 11%. Abdominal pain was equally common in all
groups, although jaundice was more prevalent in Gp3 (48%) /Gp2 (15%) /
Gp1 (0%), PB/0.01. Cyst size on CT (x2/24, PB/0.001) was an independent
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predictor of malignant potential on univariate analysis  irrespective of cyst
location. Proximal cysts were more frequently Gp3 lesions (/50%), and Gp1
in the neck/body (/70%). In proximal lesions, jaundice [PB/0.001], cyst size
(PB/0.001), and serum ALT concentration (P/0.006) were associated with
malignant potential. Similar relationships were demonstrated for cysts in the
neck/body of pancreas (P/0.02), but not for more distal lesions. The
association of ALT concentration with malignancy was independent of biliary
dilatation on imaging.
Conclusion. Our data suggests that cyst location, size on CT, elevation in
serum ALT concentration, and the presence of jaundice are independent
predictors of neoplastic potential for cysts located proximal to the tail of
pancreas.
FC 6.06
EVALUATION OF AN INFLAMMATION-BASED PROGNOSTIC
SCORE (GPS) IN PATIENTS SELECTED FOR POTENTIALLY
CURATIVE RESECTION OF GASTRO-OESOPHAGEAL CANCER
Crumley, Andrew; McMillan, Donald; McKernan, Margaret; Shearer,
Christopher; Going, James; Stuart, Robert
Glasgow Royal Infirmary, Glasgow, UK
Background. Gastro-oesophageal cancer is the third most common cause of
cancer death in United Kingdom. Surgery confers the greatest chance of long-
term cure but is associated with appreciable morbidity and mortality. Selection
of patients most likely to benefit from radical surgery is therefore crucial. There
is increasing evidence that the presence of an on-going systemic inflammatory
response, is associated with poor outcome in patients undergoing resection for
a variety of tumours.
Aims/Objectives. The aim of the present study, was to examine whether an
inflammation-based prognostic score; Glasgow Prognostic Score (GPS), was
associated with survival, in patients selected for potentially curative surgery for
gastro-oesophageal cancer.
Patients and methods. 104 patients attending the Royal Infirmary, Glasgow
between the 1st January 1999 and the 31st December 2004 were included in
the study. A blood sample was obtained for measurement of albumin and C-
reactive protein concentrations, at the time of diagnosis.
Results. Patients with an elevated C-reactive protein (/10 mg/l) and
hypoalbuminaemia (B/35 g/l) were allocated a Glasgow Prognostic Score
(GPS) of 2. Patients in whom only one of these biochemical abnormalities was
present were allocated a GPS score of 1 and patients with a normal CRP and
albumin were allocated a score of 0. On multivariate survival analysis, the ratio
of nodes containing tumour to the total number of nodes excised (HR 2.60,
95%CI 1.76 3.84, pB/0.001) and the GPS (HR 4.33, 95%CI 1.763.84, pB/
0.001) were the only significant, independent predictors of cancer survival. 3
year survival in patients with a GPS of 0 was 64%, compared with 18% with a
GPS of 1.
Conclusion. In the present study, the GPS predicted cancer specific survival,
independent of stage, in patients selected for curative surgery for gastro-
oesophageal cancer.
FC 6.07
COMBINED BILIARY STENTING: RESULTS FROM ONE HUN-
DRED AND THREE CONSECUTIVE PROCEDURES AND IDEN-
TIFICATION OF PREDICTORS OF ADVERSE OUTCOME
Neal, Christopher P; Thomasset, Sarah C; Sutton, Christopher D; Bools,
Denise; Pattenden, Claire J; Garcea, Giuseppe; Rees, Yvonne; Newland,
Carol; Robinson, Richard; Dennison, Ashley R; Berry, David P
Leicester General Hospital, Dept.s of Hepatobiliary Surgery and Radiology,
Leicester, UK
Background and aim. Combined percutaneous and endoscopic biliary
stenting permits drainage of biliary obstruction not treatable by endoscopic
means alone, but has been associated with 30-day mortality in excess of 25%
and morbidity of over 50%. We present the largest reported series of combined
procedures and examine factors that may predict morbidity and mortality
post-procedure.
Patients and methods. A retrospective study of patients who had failed
attempted endoscopic biliary stenting and were transferred for biliary
decompression at our tertiary referral unit was performed between January
2001 and December 2005. Sixteen pre-procedure clinicopathological and
laboratory variables were correlated with patient outcome.
Results. Combined biliary stenting was attempted in 111 patients over the
study period and was technically successful in 103 cases (93%). Underlying
pathology included pancreatic carcinoma (n/45), cholangiocarcinoma (n/
26), metastases (n/17), benign disease (n/12), ampullary carcinoma (n/
2) and gallbladder carcinoma (n/1). 30-day mortality was 17% and in-
hospital morbidity 25%. Of the pre-procedure variables examined, low
serum albumin, elevated serum creatinine, elevated white cell count and
clinical evidence of sepsis were significantly associated with morbidity (PB/
0.05). High ASA grade, low serum albumin, elevated serum urea, elevated
serum creatinine, elevated white cell count and clinical evidence of sepsis
were associated with increased 30-day mortality on univariate analysis (PB/
0.05). Of these factors, high ASA grade (PB/0.0001), elevated serum urea
(P/0.026), elevated white cell count (P/0.031) and clinical evidence of
sepsis (P/0.016) were independently associated with increased 30-day
mortality.
Discussion. Combined biliary stenting is associated with a high technical
success rate in our centre and acceptable morbidity and mortality. Early
recognition/treatment of sepsis and optimisation of renal function may
further improve patient outcome.
FC 6.08
SYMPTOMATIC FIRST-DEGREE RELATIVES OF PATIENTS
WITH OESOPHAGEAL ADENOCARCINOMA ARE PREDIS-
POSED TO BARRETT’S OESOPHAGUS
Robinson, Sarah; Di Franco, Filippo; Preston, Shaun, R; Karat, Daya;
Hayes, Nick; Griffin, S Michael
Royal Victoria Infirmary, Northern Oesophago Gastric Cancer Unit, New-
castle-upon-Tyne, UK
Background. Oesophageal adenocarcinoma is thought to arise on a back-
ground of Barrett’s oesophagus (BO) secondary to gastro-oesophageal reflux
disease (GORD). Previous studies have identified certain alcohol dehydro-
genase 3 (ADH3) and uridine 5?-diphosphate-glucuronysltransferase
(UGT1A7) polymorphisms as being associated with an increased risk of
carcinoma.
Aims. The study aim was to assess the frequency of GORD and BO in first
degree relatives (FDRs) of oesophageal adenocarcinoma patients and
determine an association with either ADH3 or UGT1A7 genotypes.
Methods. On receipt of ethical approval, FDRs were asked to complete
the Mayo GORD questionnaire. If symptomatic, endoscopy was offered
and a blood sample for DNA extraction taken. UGT1A7 and ADH
specific PCR amplification products were visualized using agarose and
polyacrylamide gels to determine genotypes. The control group for the
questionnaire phase was formed by members of the public attending the
daycase surgery unit. Age and sex-matched endoscopic controls, under-
going investigation of GORD symptoms, were recruited from routine
endoscopy lists.
Results. Analysis of the questionnaire results yielded trends, but no
significant difference, in frequency of reflux (p/0.17), regurgitation (p/
0.07) or dysphagia (p/0.37) between the FDRs (n/151) and controls (n/
254). Within the endoscopic study the controls (n/34) experienced
significantly more symptoms (p/0.004). However, FDRs (n/38) were
statistically more likely to have a positive endoscopy (p/0.01), longer hiatus
hernia (p/0.003) and histologically proven BO (odds ratio 19.25; 95%CI
2.4156.6; pB/0.001). No difference was found in the frequency of putative
carcinogenic genotypes between FDRs and control groups for both ADH3
and UGT1A7.
Conclusions. This study confirms the increased incidence of BO in FDRs
(OR 19.25), despite a similar incidence of GORD symptoms, and indepen-
dent of ADH3 and UGT1A7 polymorphisms.
FC 6.09
DELAY INCREASES THE CONVERSION RATE IN LAPARO-
SCOPIC CHOLECYSTECTOMY FOR ACUTE CHOLECYSTITIS
Hadad M, Sirwan; Vaidya S, Jayant; Koh C, Hoy; Heron P, Timothy;
Thompson M, Alistair
Ninewells Hospital and Medical School, Dept. of Surgery and Molecular
Oncology, Dundee, UK
Background. Laparoscopic cholecystectomy (LC) is frequently performed
at the time of the first admission for acute cholecystitis. We assessed whether
there was any correlation between the delay from onset of symptoms and
conversion rate.
Methods. Case notes from patients who underwent cholecystectomy
between Jan 2002 to Dec 2003 were sought. Of the 320 elective cases 297
were planned laparoscopic and only the conversion rate was recorded for
these. For the 344 emergency cases, data sought on the exact duration of
symptoms, and details of the operation-the time, the duration and whether it
was converted to open. The diagnosis of acute cholecystitis was confirmed
with histopathology. The patients were ranked according to the delay in hours
from the onset of symptoms and then divided into 4 quartiles of increasing
delay.
Results. A total of 344 emergency cholecystectomies were performed. Of
those, 48 (14%) were planned open. Of the 296 that were planned
laparoscopic, 42 (14%) were converted to open. This conversion rate was
higher than the 4% conversion rate for elective LC (12/297). Two hundred
and eleven (71%) case notes of emergency cases were available for analysis.
The conversion rates were the highest for acute cholecystitis (19/75/
25.33%) intermediate for obstructive jaundice/pancreatitis (6/42/14.3%)
and lowest for biliary colic (7/94/7.44%). In patients with acute cholecys-
titis the conversion rate increased with increasing delay (Chi Square for
trend: 9.33, p-value: 0.0023); it was 0% (0/19) when LC was performed
within 54 hrs from the onset of symptoms; this rose to 26% (5/19) between
55 to 92 hrs and to 32% (6/19) between 93 to 172 hrs. Finally, 44% (8/18) of
planned LC after 172 hours were converted to open.
Conclusion. Laparoscopic cholecystectomy for acute cholecystitis should
not be delayed beyond the first 23 days after onset of symptoms. Further
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delay is likely to increase the conversion rate to a level much higher than for
an elective operation.
FC 7.01
STAGING FOR HEPATOCELLULAR CARCINOMA (HCC): 11C-
ACETATE IS SUPERIOR TO 18F-FLUORODEOXYGLUCOSE
(FDG)-BASED POSITRON EMISSION TOMOGRAPHY (PET)
Doyle, Majella1; Glasgow, Sean1; Dehdashti, Frank2; Siegal, Barry2; Wang,
Hanlin3; Chapman, William1
1Washington University, Abdominal Transplantation, St Louis, USA; 2Wa-
shington University, Dept. of Nuclear Medicine, St Louis, USA; 3Washing-
ton University, Dept. of Pathology, St Louis, USA
Background. While FDG-PET is widely accepted for the evaluation of
many metastatic tumors, sensitivity for detecting HCC is poor. Pre-
transplantation staging of patients with HCC is crucial to optimize resources.
Aim. 11C-acetate (AC) may be a better PET radiopharmaceutical for the
detection of HCC in patients undergoing hepatic directed therapy including
liver transplantation.
Methods. Patients with biopsy-proven or suspected HCC, were prospectively
enrolled in this IRB-approved trial. Subjects underwent synchronous FDG-
and AC-PET, and the imaging studies were interpreted in a blinded manner by
two nuclear radiologists. Further evaluations and therapies were performed at
the discretion of the treating surgeon. Participants were then followed to
determine whether either functional imaging test influenced treatment
decisions.
Results. 32 patients participated, with a total of 48 separate HCC lesions
greater than 1 cm diameter evaluated by both FDG- and AC-PET. AC-PET
was positive in 41 lesions (sensitivity 84%), whereas FDG-PET was positive
in only 13 (sensitivity 28%, pB/0.001). Only one lesion was undetectable by
either PET modality (false-negative rate 2.2%). The sensitivity of AC-PET in
patients with normal serum AFP levels was 88.9%, compared to only 22.2%
for FDG-PET (p/0.015). In nine patients evaluated following HCC-
specific treatment (RF ablation or transplantation), the specificity of AC-
PET was 100%. Additionally, AC-PET was the sole diagnostic modality to
detect HCC in two subjects: HCC recurrence following liver transplantation
in one patient allowed timely RF ablation, while HCC metastatic to the
adrenal gland was detected in a second patient.
Conclusions. This pilot study demonstrated the utility of AC-PET in the
management of patients with HCC, while confirming the lack of sensitivity of
standard FDG-PET for this malignancy. AC-PET may have a role in
screening certain patients prior to liver transplantation and may also prove
useful in following disease progression after ablative procedures.
FC 7.02
IMPACT OF MODEL FOR END-STAGE LIVER DISEASE (MELD)
SCORE ON PROGNOSIS AFTER HEPATECTOMY FOR HEPA-
TOCELLULAR CARCINOMA ON CIRRHOSIS
Ercolani, Giorgio; Cucchetti, Alessandro; Cescon, Matteo; Ravaioli, Matteo;
Del Gaudio, Massimo; Varotti, Giovanni; Zanello, Matteo; Vetrone, Gae-
tano; Grazi, Gian Luca; Pinna, Antonio D
Hospital Sant’Orsola-Malpighi, Dept. of Surgery and Transplantation,
Bologna, Italy
Background. Model for end-stage liver disease (MELD) score is currently
accepted as a disease severity index of cirrhotic patients awaiting liver
transplantation; however, its impact on prognosis after resection of HCC on
cirrhosis has not been investigated.
Objective. To predict postoperative liver failure and morbidity after
hepatectomy for hepatocellular carcinoma (HCC) on cirrhosis.
Methods. 197 patients resected in a tertiary care setting for HCC (154 on
cirrhosis and 43 with chronic hepatitis) were retrospectively analyzed.
Preoperative MELD score was calculated and related to postoperative liver
failure and morbidity, in-hospital stay and one-year survival.
Results. In 74 (48%) cirrhotic patients MELD score was less than 9, in 56
(36.4%) it was between 9 and 10 and in 24 (15.6%) it was above 11. The
median preoperative MELD score in Child A patients was 8 (range 614),
while it was 11 (range 915) in Child B patients (pB/0.01). Eleven
patients (5.6%), all having cirrhosis (7 Child A and 4 Child B patients),
experienced postoperative liver failure leading to death or transplantation.
The median MELD score among them was 11. ROC analysis identify
cirrhotic patients with MELD score ]/11 at high risk for postoperative liver
failure (AUC/0.92, 95% C.I./0.870.96; Sensibility/82%;
Specificity/89%). Forty-six cirrhotic patients (29.9%) developed at least
one postoperative complication: ROC analysis identify patients with MELD
score ]/9 at major risk for postoperative complications (AUC/0.85, 95%
C.I./0.780.89; Sensibility/87%; Specificity/63%). By increasing pre-
operative MELD score, a significant increase in postoperative hospital stay
was shown. Cirrhotic patients with MELD scoreB/9 have no postoperative
liver failure and low morbidity (8.1%), similar to that of non-cirrhotic
patients.
Conclusions. MELD score can accurately predict postoperative liver
failure and morbidity in cirrhotic patients with HCC and should be used
to select the best candidates for partial hepatectomy.
FC 7.03
DEVELOPMENT AND VALIDATION OF JAPANESE TUMOR-
NODE-METASTASIS STAGING FOR HEPATOCELLULAR CAR-
CINOMA
Minagawa, Masami1; Ikai, Iwao2; Makuuchi, Masatoshi1
1University of Tokyo, Dept. of Hepato-Biliary-Pancreatic Surgery, Tokyo,
Japan; 2Kyoto University, Dept. of Gastroenterological Surgery, Kyoto, Japan
Background. The Liver Cancer Study Group of Japan(LCSGJ) revised the Japa-
nese Tumor-Node-Metastasis (TNM) staging for primary liver cancer in 2000.
Objective. The aims of this study were to present evidence to develop and
validate this system and to compare its discriminatory ability with that of the
American Joint Committee(AJCC) TNM staging.
Methods. The LCSGJ prospectively collected clinicopathological data of
63, 736 patients with primary liver cancer from 1995 to 2001. Among
them, 14, 588 patients received curative hepatic resection. Based on
survival analyses, Japanese TNM staging was developed. The predictive
accuracy for patient survival based on Japanese TNM staging was
compared with that determined by AJCC TNM staging using the cross-
validation method.
Results. The independent prognostic factors (relative risk) were vascular or
bile duct invasion (1.36), liver cirrhosis (1.26), diameter (2 cm) (1.21),
alpha-fetoprotein (1.20), single/multiple (1.18), liver damage (1.15), hepatic
involvement (1.14), histological differentiation (1.14), gross classification
(1.13), and esophageal varices (1.07). Based on these results, 3 criteria
(vascular or bile duct invasion, diameter, and single/multiple) were selected.
Patients with none of these three factors were considered T1, and those with
1, 2, and 3 factors were T2, T3, and T4, respectively. The number of patients
and 5-year survival rates of T1, T2, T3, and T4 were 2, 078, 70%; 6, 854,
58%; 3, 021, 41%; 582, 24% (PB/0.0001), while those for AJCC -T were 8,
457, 61% in T1, 2, 888, 46% in T2, and 1, 189, 30% in T3 (PB/0.0001).
While both the LCSGJ-T and AJCC-T had good discriminating ability, the
former was significantly superior (P/0.0007).
Conclusions. Our findings provide support for the development of LCSG-
Stage. While both staging systems allow for the clear stratification of patients
into prognostic groups, the current AJCC staging may not be appropriate for
stratifying patients with early-stage HCC.
FC 7.04
DIABETES AS A RISK FACTOR FOR HEPATOCELLULAR CAR-
CINOMA IN NON-CIRRHOTIC PATIENTS: A CASE-CONTROL
STUDY
Gleisner, Ana L; Assumpcao, Lia R; Pawlik, Timothy M; Michaels, Maria;
Choti, Michael A
Johns Hopkins University School of Medicine, Surgery, Baltimore, Mary-
land, USA
Background. The incidence of hepatocellular carcinoma (HCC) is increas-
ing worldwide, largely due to the epidemic of hepatitis C. However, a
considerable number of cases are not associated with viral infection in the
United States. Recent studies have suggested that metabolic conditions such
as diabetes, obesity and hyperlipidemia may increase the risk of non-alcoholic
fatty liver disease (NAFLD) and potentially lead to HCC. It has not been
established whether the development of cirrhosis is a prerequisite in the
NAFLD pathway for the development of HCC.
Objectives. To determine the association between risk factors for NAFLD as
well as environmental factors (tobacco and alcohol) with HCC in patients
without evidence of chronic hepatitis or cirrhosis.
Methods. Between 1984 and 2004, 80 patients with no hepatic cirrhosis or
hepatitis infection were identified from an institutional database. A case-
control analysis was performed using sex, age and race-matched controls
selected from the National Health and Nutritional Examination Survey
(NHANES) III. Diabetes, body mass index/30, current tobacco use,
alcohol consumption/60 ml/day (past or current) and use of antihyperli-
pemic drugs were also included in the analyses.
Results. This study included 70% male patients in both groups with mean
age of 63 years. Diabetes was seen in 28.8% of the HCC patients compared
with only 9.6% in the matched group. Both univariate and multivariate
analysis revealed a strong association of diabetes with HCC in non-cirrhotic
patients, with an odds ratio of 3.8 (2.07.3). This was greater than that seen
in patients with high alcohol consumption. Obesity, hyperlipidemia and
tobacco use were not associated with HCC in this study.
Conclusions. There is an increased risk for HCC in patients with diabetes
even in the absence of cirrhosis. This finding raises the possibility that
diabetes, perhaps by predisposing to nonalcoholic steatohepatitis, increases
the risk of HCC independent of the presence of cirrhosis.
FC 7.05
ANATOMIC RESECTION INDEPENDENTLY IMPROVES LONG-
TERM SURVIVAL IN PATIENTS WITH T1-T2 HEPATOCELLULAR
CARCINOMA
Wakai, Toshifumi; Shirai, Yoshio; Sakata, Jun; Kaneko, Kazuhiro; Cruz,
Pauldion V; Hatakeyama, Kaytsuyoshi
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Niigata University Graduate School of Medical and Dental Sciences,
Division of Digestive and General Surgery, Niigata City, Japan
Background. This study aimed to evaluate the effect of anatomic resection
on long-term outcomes in patients with pathologic T1-T2 (pT1-T2)
hepatocellular carcinoma (HCC).
Methods. A retrospective analysis was conducted of 158 consecutive patients
who underwent either anatomic (n/95) or nonanatomic (n/63) resection
for pT1-T2 HCC. Anatomic resection was defined as the complete removal
of at least 1 Couinaud’s segment containing the tumor; nonanatomic
resection was defined as removal of the tumor plus a rim of nonneoplastic
liver parenchyma. The median follow-up time was 83 months.
Results. Anatomic resection group was characterized by a lower prevalence
of cirrhosis (P/0.015), a more favorable hepatic function (P/0.001), a
larger tumor size (P/0.029), and a higher prevalence of vascular invasion
(P/0.008) compared with nonanatomic resection group. Anatomic resection
provided better survival (median survival time, 122 months) than nonana-
tomic resection (median survival time, 76 months; P/0.0358). Patients who
underwent anatomic resection showed better disease-free survival (P/
.0121). Anatomic resection independently improved both survival (hazard
ratio, 0.46; 95% confidence interval, 0.27 0.76; P/0.003) and disease-free
survival (hazard ratio, 0.51; 95% confidence interval, 0.330.77; P/0.002).
When stratified for pT classification, the effectiveness of anatomic resection
remained only in patients with pT2 tumor in terms of survival (P/0.0012)
and disease-free survival (P/0.0004).
Conclusions. Anatomic resection independently improves long-term survi-
val in patients with pT1-T2 HCC. Among these patients, those with pT2
tumor appear to be good candidates for anatomic resection.
FC 7.06
MOLECULAR CHANGES ASSOCIATED WITH PROGNOSIS OF
PATIENTS WITH HEPATOCELLULAR CARCINOMA
Lai, Paul BS1; Wong, John1; Lee, KF1; Chan, Kathy YY2; Sy, Shirley MH2;
Wong, Nathalie2
1Prince of Wales Hospital, The Chinese University of Hong Kong, Dept. of
Surgery, Hong Kong, China; 2The Chinese University of Hong Kong, Dept.
of Anatomical and Cellular Pathology, Hong Kong, China
Background & aim. Hepatocellular carcinoma (HCC) is a highly malignant
tumor that is commonly fatal. In an effort to gain insight into the gene
expression changes associated with disease progression, we undertook
expression array profiling on surgical specimens of HCC tumors and
correlated findings with clinical outcome of patients.
Methods. Microarray analysis was performed on 54 HCC tumors (37
early T1/2 stages and 17 advanced T3/4 stages HCC) and 6 dysplastic
liver samples. The array platform utilized contained 19,000 cDNA clones
covering the entire human genome with a resolution of /150kb. Self-
organizing tree algorithm (SOTA), which is an unsupervised hierarchical
neural network tool, was employed in the clustering of genes expression
patterns. The significant analysis for microarray (SAM) was further utilized
to define genes that can differentiate patients groups with disease character-
istics and outcome.
Results. Expression patterns derived from 60 tumors did not illustrate
significant differences with patients’ pathological characteristics nor AJCC
tumor stagings (p/0.05). However, patient stratification according to the
clustering by SOTA effectively identified a group with distinctively poorer
survival (Kaplan-Meier test, p/0.0016). Upon SAM analysis, a total of 28
transcripts were identified to be associated with poorer patient survival. At a
false discovery rate of B/1.0%, down-regulation of ataxin 2 (ATXN2) and
up-regulation of candidate genes including ring finger protein 19 (RNF19),
ceruloplasmin (CP) and angiopoietin 2 (ANGPT2) were suggested at a
differential expression of more than 5-fold.
Conclusion. SOTA analysis on expression profiling has led to our
identification of a subset of genes associated with poorer patient survival.
Candidate genes identified may represent potential molecular markers for
patient prognosis. Further function investigations into these candidates might
hold value in understanding the progression of HCC tumors.
FC 7.07
OUTCOME OF HEPATOCELLULAR CARCINOMA COMPLI-
CATED BY PORTAL THROMBOSIS TREATED WITH PROTEC-
TIVE PORTAL METALLIC STENT: A CASE-CONTROL STUDY
Vibert, Eric; Castaing, Denis; Perdigao, Fabiano; Carbonaro, Giulia;
Colombo, Pierre-Emmanuel; Adam, Rene´; Azoulay, Daniel
Hopital Paul Brousse (AP-HP), Centre Hepato-Biliaire, Villejuif, France
Background. The presence of macroscopic portal tumoral thrombosis in
hepatocellular carcinoma (HCC) cannot be cured.
Aim(s)/Objective(s). This study analyses the results of palliative
resections compared to the deployment of a metallic stent (MS) from portal
trunk to a non-obstructed branch to protect portal trunk from tumour
invasion.
Methods. From 1992 to 2005, 74 patients were treated for HCC with
macroscopic portal invasion (PVI) by hepatectomy (n/28) or MS (n/46).
Patients classified CHILD B or C were excluded from the study (n/23). 24
patients treated with MS were matched to 24 patients treated by hepatect-
omy. The two groups were comparable in terms of age, presence of cirrhosis,
prothrombin time, bilirubin concentration, albumin concentration, delay
between diagnosis of HCC and PVI, number of nodules, size of largest
nodule, presence of bilobar involvement, extension of PVI, level of AFP and
presence of ‘‘neo-adjuvant’’ treatment. The only difference between the two
groups was a systemic chemotherapy to 56% of patients after resection versus
only 8% after MS (p/0, 001).
Results. In the hepatectomy group, more than 3 segments were resected
in 23/24 (95%) patients. The mortality rate was 1/24 (4%) and the
morbidity rate was 8/24 (33%). The duration of hospitalisation was 13
days. Successful deployment of MS was performed in 22/24 (91%) patients
using an ileal approach in 7/22 (31%) patients and a percutaneous
approach in 15/22 (69%) patients. The mortality rate was 1/24 (4%).
Morbidity was 2/24 (8%). Duration of hospitalisation was 6 days. At a
mean follow-up of 11 months, MS were patent in 16/22 (72%) patients.
The morbidity (p/0,03) and the hospitalization (pB/0,001) was signifi-
cantly lower after MS. The 6, 12 and 24 months survival rate was 83%,
72% and 71% respectively after hepatectomy and 62%, 62% and 46%
respectively after MS (p/0,27)
Conclusion. For patient with HCC complicated by PVI, treatment with MS
is associated with lower morbidity. Trends towards better survival following
resection need to be confirmed.
FC 7.08
ANALYSIS OF TREATMENT OUTCOME OF HEPATOCELLULAR
CARCINOMA PATIENTS WITH HIGH RISK VASCULAR INVA-
SION
Sirichindakul, Boonchoo; Sriuranpong, Virote; Chandrakamol, Bhana;
Kosolbhand, Permyot; Janchai, Akkawat; Tantivatana, Jarturon; Khorprasert,
Chonlakiet
King Chulalongkorn Memorial Hospital, Bangkok, Thailand
Background. Invasion of major hepatic vessels in hepatocellular carcino-
ma(HCC)patients generally prohibits the surgical treatment. The aim of this
study was to perform an analysis of outcomes of non-surgical approaches in
this high risk HCC.
Methods. From January 2003 to December 2005, there were 648 HCC
diagnosed at King Chulalongkorn Memorial Hospital. Vascular invasion was
defined as clinical involvement of portal vein, inferior vena cava (IVC) or
their branches identified by imaging techniques. Patient hepatic functions-
Child-Pugh A were eligible for non-surgical treatments including transarterial
chemoembolization (TACE) or systemic chemotherapy (CT) other than
supportive care.
Results. There were 71 unresectable HCC patients enrolled into this study.
57 were treated with TACE and 14 were prescribed for CT. In the TACE
group, there were 39/57 (68%), 7/57 (12%) and 11/57 (19%) who displayed
portal vein, IVC and both vessels invasion respectively. Similarly, in the CT
group, patients showed 11/14 (78%), 1/14 (7%) and 2/14 (14%) invasion of
portal vein, IVC and both vessels. Median overall survival in both groups was
158 days (114201 days). Univariate analysis demonstrated that AFP level
B/1000 ng/ml, tumor sizeB/10 cm, unilobar involvement, number of
tumorB/3 and CT treatment significantly influenced survival. Additional
multivariate analysis confirmed that extent of tumor, diameter of tumor and
receiving CT were the independent prognostic factors for good survival.
Furthermore, a survival analysis showed longer survival in the CT than that
of TACE (325 vs154 days, p/0.03).
Conclusions. In addition to previously known prognostic factor like extent
of tumor involvement in liver, this study demonstrated a strikingly better
survival of HCC patients with major vessels invasion when treated with CT
compared to TACE. Future prospective study in larger population to
investigate the hypothesis is warranted.
FC 7.09
HYPERTROPHY OF THE FUTURE LIVER REMNANT VOLUME
FOLLOWING PORTAL VEIN OCCLUSION: PORTAL VEIN
EMBOLIZATION VS PORTAL VEIN LIGATION
Bouzari, Hedayat; Amisano, Marco; Zorzi, Daria; Vigano`, Luca; Capussotti,
Lorenzo; Muratore, Andrea
IRCC, Surgical Oncology, Candiolo, Italy
Background. Some investigators have suggested that Portal Vein Emboliza-
tion (PVE) is superior to Portal Vein Ligation (PVL) in terms of volume gain.
Aims. We sought to compare this two different approaches in order to assess
the efficacy for the induction of controlateral hypertrophy.
Methods. From December 2000 to December 2004, 56 patients candidates
to major hepatic resection but with a small estimated future liver remnant
(FLR), underwent occlusion of the right portal branch. Nine patients of the
PVL group were matched with 18 of the PVE group. PVE or PVL were
performed when FLR was less or equal 25% in normal liver, or less or equal
30% in non-normal liver.
Results. The two groups of the study were comparable in terms of
preoperative features. There were no deaths or complications related to the
procedure type. The baseline, post-PVE/PVL estimated volumes, and the
percent increase of segments 23, 4, and of the Caudate lobe are reported in
the table. There were no statistically significant differences between the two
groups of our study regarding the baseline and the post-occlusion volumes.
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The mean estimated baseline percent remnant liver volume of segments 23
was 16.4% in the PVE group and 19.9% in the PVL group (p/0.1);
following portal vein embolization or ligation, it increased to 26.6% and
28.4%, respectively (p/0.5). The segments 23 volume increase was similar
between the two groups (71.4% in PVE group vs. 55.8% in PVL one, p/
0.2). On the contrary, the percent volume increase of segment 4 was
significantly higher after right portal vein embolization than after ligation
(54.3% versus 13.7%, p/0.04). No differences were noted about caudate
lobe volumes.
Conclusion. PVE and PVL are feasible and safe methods of increasing the
remnant functional liver volume. Both occlusion techniques provide a
comparable increase of segments 23 volumes.
FC 8.01
PANCREATIC RESECTION FOR M1 PANCREATIC DUCTAL
ADENOCARCINOMA
Shrikhande, Shailesh1; Kleeff, Jorg1; Reiser, Carolin1; Weitz, Jurgen1; Hinz,
Ulf1; Esposito, Irene2; Schmidt, Jan1; Friess, Helmut1; Buchler, Markus1
1University of Heidelberg, Dept. of General Surgery, Heidelberg, Germany;
2University of Heidelberg, Dept. of Pathology, Heidelberg, Germany
Background. Improved safety of pancreatic surgery has led to consideration
of more aggressive approaches, such as resection for primary pancreatic
ductal adenocarcinoma (PDAC) with metastatic disease (M1).
Methods. 29 patients who underwent pancreatic resection with resection of
associated metastatic disease (interaortocaval lymph node dissection, liver
resection and/or multiorgan resections) were retrospectively identified from a
database of 316 R0/R1 pancreatic resections for PDAC. An explorative data
analysis of peri-operative and clinico-pathological parameters as well as
overall survival was performed using Kaplan-Meier estimation, log-rank test,
and Fisher’s exact test.
Results. The median age of patients was 65 years (IQR 6074 years). The
overall in-hospital mortality and morbidity of R0/R1 pancreatic resections
for M1 disease (n/29) was 0% and 24.1% compared to 4.2% and 35.2%
of R0/R1 pancreatic resections for M0 disease (n/287). The median
overall survival time was 13.8 months (95% CI: 11.420.5 months), and
the estimated 1-year overall survival rate was 58.9% (95% CI: 34.8%
76.7%) for patients with M1 disease. The median survival in those with
metastatic interaortocaval lymph nodes was 27 months (95% CI: 9.627.0
months), while it was 11.4 months (95% CI: 7.816.5 months) and 12.9
months (95% CI: 7.220.5 months) for those with liver and peritoneal
metastases.
Conclusion. Major pancreatic resections with M1 disease can be
performed with acceptable safety in highly selected patients of advanced
pancreatic cancer. The median survival of 27 months after interaortoca-
val lymph node resection is comparable to that of other lymph nodes
that do not constitute M1 disease and suggests that this approach may
be an option for intra-operatively discovered metastatic but locally
resectable pancreatic cancer. Resection of liver and peritoneal metastases
(median survival 11.4 and 12.9 months, respectively), though safe in this
series, cannot be generally recommended pending further controlled
trials.
FC 8.02
PANCREAS PRESERVING TOTAL DUODENECTOMY FOR PA-
TIENT WITH FAMILIAL ADENOMATOUS POLYPOSIS OF THE
DUODENUM: A COMPARISON WITH PANCREATODUODE-
NECTOMY
de Castro, Steve1; Smeenk, Hans2; Rutten, Jan-Paul3; Dejong, Cees3; van
Goor, Harry4; van Eijck, Casper2; Busch, Olivier1; van Gulik, Thomas1;
Gouma, Dirk-Jan1
1Academic Medical Center, Amsterdam, Netherlands; 2Erasmus Medical
Center, Rotterdam, Netherlands; 3University Hospital Maastricht, Maas-
tricht, Netherlands; 4University Medical Center St. Radboud, Nijmegen,
Netherlands
Background. Duodenal adenomatosis remains a leading cause of death in
Familial adenomatosis polyposis (FAP) patients who have previously under-
gone colectomy. Many endoscopic and surgical approaches are available
including the recently introduced pancreas preserving total duodenectomy
(PPTD) and pancreatoduodenectomy (PD).
Methods. A retrospective review was performed to analyze the results of for
PPTD for FAP and compare the results with PD for neoplasms of the
ampulla of Vater (considered to be relatively comparable since both diseases
are generally limited to the duodenum).
Results. Between January 2000 and December 2004, all patients who
underwent PPTD (n/20) in four academic centers in the Netherlands were
included and compared with the cohort who underwent PD (n/63) for
ampulla of Vater adenocarcinoma in the Academic Medical Center during
the same time period. Patients who underwent PPTD were significantly
younger compared to patients who underwent PD (51 years vs. 62 years,
respectively, PB/0.001). Patients who underwent a PPTD had Spigelman III
(5%) and Sigelman IV (95%) disease at preoperative endoscopy. Median
operative time was significantly longer in patients who underwent PPTD
compared to PD (315 min. vs. 271 min., respectively, p/0.014). Morbidity
did not differ significantly (PPTD 75% vs. PD 57%, p/0.513). Anastomtic
leakage was the most common complication in both procedure (PPTD 35%
vs. PD 25%, p/0.405). The relaparotomy rate was comparable in both
procedures (PPTD 20% vs. PD 19%, p/1.000). Two patients in both
groups died (PPTD 10% vs. PD 3%, p/0.224). During follow-up
recurrence occurred in 20% of the patients after PPTD and in 16% of the
patients after PD.
Conclusion. The present study found that operative time for PPTD is
significantly longer compared to PD and that, although not significant,
PPTD had a trend towards a higher postoperative morbidity and mortality
rate compared to PD.
FC 8.03
PANCREATICOJEJUNAL ANASTOMOSIS IS PREFERABLE TO
PANCREATICOGASTROSTOMY AFTER PANCREATODUODE-
NECTOMY IN TERMS OF THE LONG-TERM OUTCOME OF
PANCREATIC EXOCRINE FUNCTION
Rault, Alexandre; Sa Cunha, Antonio; Klopfenstein, Daniel; Collet, Denis;
Masson, Bernard
1CHU Bordeaux, Hopital Haut Le´ve´que, Digestive Surgery, Pessac, France
The aim of this study was to evaluate pancreatic exocrine and endocrine
function after pancreatoduodenectomy(PDD). Fifty-two patients underwent
PDD for benign and malignant diseases (chronic pancreatitis and previous
digestive surgery excluded) in a delay of more than 24 months before the
study. Pancreatic exocrine function was evaluated by a patient questionnaire
and medical examination of stools and fecal output after discontinuing
pancreatic enzyme supplements at least 10 days. Severe steatorrhea was
defined as frequent stools, nauseating smell, yellow and pasty stools, fecal
output /200 g/d. To evaluate endocrine function, fasting blood sugar level
was measured. Association between severe steatorrhea and age, indication for
surgery, histological obstructive pancreatitis, type of pancreatic anastomosis
(pancreaticojejunal anastomosis (PJA) pancreaticogastric anastomosis
(PGA)), and morbidity was studied. Median age was 61 year old and median
follow-up was 75 months (range 25166). Complications occurred in 17
patients (33%) (12 pancreatic leakages). PJA was performed in 41 patients
(79%), PGA in 11 patients (21%). At a median follow-up of 75 months (24
156 months), 65% of the patients of the study received enteric-coated
pancreatic supplements. Nearly 50% of patients presented weight loss. Severe
steatorrhea was observed in 22 patients (38%). Incidence of postoperative
diabetes was 14.6%. Patients age (/60 years old), postoperative complica-
tion, obstructive pancreatitis were not associated with postoperative severe
steatorrhea. In case of nonhistological obstructive pancreatitis, PGA was
most frequently associated with severe steatorrhea than PJA (70% vs 21.7%,
PB/0.025). None of these factors significantly influenced the incidence of
postoperative diabetes. After PDD, 40% of patients presented severe
steatorrhea. PJA allows better pancreatic exocrine function preservation
than PGA and should be recommended. The type of anastomosis didn’t
influence the endocrine function.
FC 8.04
FAVOURABLE IMPACT OF COG AND HIGH HOSPITAL VOLUME
ON OUTCOMES FOR PANCREATICO DUODENECTOMY: A
SINGLE UK HPB CENTRE EXPERIENCE
Mukherjee, Samrat; Kocher, Hemant; Hutchins, Robert; Bhattacharya,
Satya; Abraham, Ajit
St Bartholomew’s & The Royal London Hospital, Hepatobiliary & Pancreatic
Surgery, London, UK
Background. Review of the literature suggests that high hospital volume
consistently has a favourable impact on surgical outcomes for major
procedures including pancreaticoduodenectomy (PD). This is also supported
by the early UK specialist pancreatic centres’ data in terms of mortality
outcomes for PD.
Aim. To evaluate the impact of UK cancer outcome guidelines (COG) and
consequent increase in surgical workload (correlating with a catchment
population increase from 1.6 to 3.1 million) on outcomes for PD in a single
UK HPB specialist centre.
Patients and methods. A review of all 302 patients with pancreatic
pathologies undergoing surgical procedures at our institution from Aug
1999 to Jan 2006 was carried out. Patients who underwent PD (Whipple’s or
pylorus preserving pancreaticoduodenectomy) were evaluated. The annual
caseload for PD and corresponding outcomes for hospital stay, morbidity,
mortality, and survival were analysed.
Results. Between Aug 1999 to Jan 2006, 108 patients underwent a PD. PD
for pancreatic cancer (n/100). M: F ratio was 1.03:1. Median age was 64
yrs, (range 3883 yrs). Median hospital stay was 16 days (range 7318
days). The 30-day mortality was 1.8%, in-hospital mortality was 6.48% and
morbidity was 36.1%. Pancreatic leak/fistula rate was 10.9%. Median
survival was 17.7 mths (range 1.4 77.3 mths). Over the six year period,
PDs/yr increased 5.5 fold from 6 procedures in 1999 to 33 in 2005. Yearly
morbidity decreased from 50% in 1999 to 24.2% in 2005 and yearly
mortality reduced from 8.3% in 2000 to 3% in 2005.
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Year PD
Morbidity
(n/39) Morbidity %
Mortality
(n/7) Mortality %
1999 6 3 50 0 0
2000 12 3 25 1 8.3
2001 11 5 45.5 2 18.2
2002 12 6 50 1 8.3
2003 18 8 44.4 1 5.6
2004 16 6 37.5 1 6.3
2005 33 8 24.2 1 3
Conclusion. The centralisation of UK pancreatic cancer services has
resulted in increased hospital volume at our specialist institution, and
impacted favourably on our outcomes for PD.
FC 8.05
LAPAROSCOPIC DISTAL PANCREATECTOMY. LESSONS
LEARNT FROM 45 CONSECUTIVE CASES
O’Rourke, Nicholas A; Taylor, Craig; Ghusn, Michael; Layani, Laurent;
Martin, Ian; Fielding, George; Nathanson, Les; Hopkins, George
Royal Brisbane Hospital, Dept. of Surgery, Brisbane, Australia
Introduction. The advantages of laparoscopic surgery over conventional
open surgery continue to be demonstrated for an expanding range of
abdominal procedures. Whilst laparoscopic staging and palliation of pan-
creatic malignancy has gained widespread acceptance, the role of laparo-
scopic surgery in resecting lesions of the pancreas remains poorly defined.
This paper describes the indications, pre-operative work up, technical
aspects, problems and post-operative results of laparoscopic resection of
pancreatic lesions based on our own experience and of the reported
literature.
Methods. All pancreatic resections that were commenced laparoscopically
by six surgeons at 2 institutions over a 10 year period were retrospectively
reviewed.
Results. 45 patients underwent laparoscopic resection of the distal
pancreas for a variety of benign and malignant lesions. Hand ports were
not used. All but 2 patients had the procedure completed laparoscopically.
The median length of stay was 4 days with a range of 2 to 21 days. There
were no in-hospital deaths. The most common post-operative problem was
pancreatic fistula, (15%). There was a trend in leakage reduction in the
latter half of the series associated with liberal use of fibrin sealant
(Tisseal).
Conclusion. Laparoscopic resection of pancreatic lesions, particularly those
in the distal pancreas, is feasible and safe, with all of the benefits of minimal
access surgery. The use of fibrin sealant may reduce the problem of
pancreatic leak.
FC 8.06
LAPAROSCOPIC VERSUS OPEN DISTAL PANCREATECTOMY;
AN ASSESSMENT OF PRE-OPERATIVE RISK FACTORS AND
SURGICAL OUTCOMES
Garwood, Robert A; Reece, T. Brett; Smith, Robert L; Adams, Reid B
University of Virginia Health System, Dept. of Surgery, Charlottesville,
Virginia, USA
Background. Although the reported experience of laparoscopic distal
pancreatectomy continues to increase, pre-operative risk assessment and
surgical outcomes analysis comparing laparoscopic to open techniques
remains limited.
Objective. To compare risk factors and surgical outcomes of laparoscopic
versus open distal pancreatectomy using a private sector hopsital National
Surgical Quality Improvement Program database.
Methods. A retrospective case-control study with statistical analysis was
performed. Analysis was limited to patients treated for either neuroendocrine
or cystic pancreatic tumors.
Results. Thirty-two patients were identified who underwent distal
pancreatectomy over a 5-year period. Laparoscopic distal pancreatectomy
(LDP) was completed in 13 of 18 patients (a 29.4%conversion rate).
Open distal pancreatectomy (ODP) was performed in the remaining 19
patients. There were no significant differences in patient demographics,
comorbidities, or final pathology. Splenic preservation was accomplished
54% of time in LDP versus 21% in ODP. The mean operative times
were longer for LDP (5.5 hours vs. 4.1 hours; p/0.05) but the mean
estimated blood loss was lower (195 cc vs. 720 cc; p/0.05). Patients
requiring conversion had a higher mean BMI (31.4 vs. 27.5; p/0.05).
The complication rate was lower in LDP (17% vs. 47%) with post-
operative infections being the most common. The pancreatic leak rate
was 6.3%, none occurring after LDP. There were no post-operative
deaths in either group. The mean length of stay was shorter after LDP
(5.8 vs. 6.7 days).
Conclusion. With proper patient selection, laparoscopic distal pancreatect-
omy is a safe approach for treating neuroendocrine and cystic pancreatic
tumors and has outcomes comparable to the open procedure.
FC 8.07
PANCREATIC ENDOCRINE TUMOR EXCISION: 25-YEARS EX-
PERIENCE
Pasquali, Claudio1; Sperti, Cosimo1; Scappin, Sabrina1; Liessi, Guido2;
Pedrazzoli, Sergio1
1University of Padova, Clinica Chirurgica 4/Istituto Oncologico Veneto,
Padova, Italy; 2Castelfranco Veneto Hospital, Radiology, Castelfranco
Veneto, Italy
Background. Enucleation of pancreatic endocrine tumors (PETs) is a
simple procedure, but an high pancreatic fistula rate is reported after open
and laparoscopic procedure. We report a retrospective evaluation of our series
of PETs.
Methods. From 1980 to 2004, 109 patients underwent surgery for PET.
Enucleation was performed in 33 patients, while 76 underwent several
different procedures; 24 (73%) were insulinoma. Age, sex, site and size of the
tumor, associated diseases, hospital stay and complications were retro-
spectively reviewed by the clinical records. Since 1986 intraoperative
ultrasonography (IOUS) was used to choose among different surgical
procedures and to verify that the Wirsung duct was intact at the end of the
procedure.
Results. Patients (12 males, 21 females) averaged 56.8 years, range 2086
years. Mean size of the tumor was 1.7 cm and 54.5% were in the pancreatic
head; 78.8% of cases had medical associated diseases. Overall hospital stay
averaged 12 days (range 681 days) and it was reduced to 8.9 days in the last
5 years. Mean period of gastric suction was 4 days. Sixty percent had an
uneventful postoperative course. Complications related to pancreatic surgery
were 6/33 (18.2%); 5 pancreatic fistulas (4 low output) and 1 acute
pancreatitis, while 5/33 had a general surgery complication (2 leaking due
to gastric and duodenal associated operations). Medical complications were
recorded in 7 cases. No patient underwent surgery for pancreatic complica-
tion; No mortality occurred. Of notice, the fistula rate of the 24 insulinoma
was 8% (2/24), and no fistula was registered since 1986 among 17 insulinoma
patients in whom IOUS was applied.
Conclusion. In our experience enucleation of PETs can be performed with a
very low pancreatic fistula rate provided that IOUS is performed.
FC 8.08
LAPAROSCOPIC PANCREATIC RESECTION: RESULTS OF A
UNICENTRIC STUDY OF 60 PATIENTS
Sa Cunha, Antonio; Rault, Alexandre; Laurent, Christophe; Beau, Cedric;
Collet, Denis; Masson, Bernard
Hoˆpital Haut Le´veˆque CHU Bordeaux, Pessac, France
Background. The reported experience with laparoscopic pancreatic resec-
tions remains limited.
Methods. In 1999, we started a prospective evaluation of laparoscopic
pancreatic resection.
Results. From 1999 to February 2006, 60 patients with presumed pancreatic
neoplasm were enrolled. Final diagnoses included benign pancreatic diseases
in 57 patients (30 cystic tumors, 23 neuroendocrine tumors, 4 others benign
tumors) and 3 patients had malignant tumors (ductal and ampullary
carcinomas and one malignant neuroendocrine tumor). The mean tumor
size was 37 mm (37); 46 lesions (76%) were located in the left pancreas, 9
(15%) in the neck, 4 (7%) in the head and one panglandular. The conversion
rate was 20%. After the exploration, in 5 (8%) patients laparoscopy was
converted to open laparotomy on account of inability to localize the tumour
(n/3), and occult neoplasm (n/2). After the exploration, 55 procedures
were planned, and the conversion rate was 12.7%. Laparoscopically
successful procedures included 16 enucleations, 20 distal pancreatectomies
with spleen preservation, 5 distal splenopancreatectomies, 5 medial pancrea-
tectomies, 1 pancreticoduodenectomy and one total pancreatectomy. There
was one (1.6%) postoperative death (mesenteric ischemia). The overall
postoperative complication rate was 36%. The rate of pancreatic-related
complications was 25% for the whole series, including a 13% rate of
symptomatic pancreatic fistula. Splenic complications occurred in 3
(17.6%) patients after distal pancreatectomy with spleen preservation with-
out splenic vessels preservation. The final spleen preservation rate was 88%.
Reoperation was required in 5 (8%) patients. In laparoscopically successful
operations the mean postoperative hospital stay was 12.7(6) days, signifi-
cantly decreased compared with patients requiring conversion to open
pancreatectomy.
Conclusion. Resection of the pancreas can be performed safely via the
laparoscopic approach with all the potential benefits to the patients of
minimally invasive surgery.
FC 8.09
SPLEEN-PRESERVING DISTAL PANCREATECTOMY WITH
EXCISION OF SPLENIC VESSELS: A CASE-MATCHED
COMPARISON WITH DISTAL PANCREATECTOMY WITH
SPLENECTOMY
Carrere, Nicolas1; Abid, Skander1; Selves, Janick2; Julio, Charles H1; Bloom,
Eric1; Pradere, Bernard1
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1Purpan Hospital, Dept. of Surgery, Toulouse, France; 2Purpan Hospital,
Dept. of Pathology, Toulouse, France
Introduction. The value of spleen preservation during distal pancreatect-
omy (DP) still remains controversial. Spleen preserving distal pancreatect-
omy with excision of splenic artery and vein is a simplified technique for
spleen preservation. The aim of this retrospective study was to compare the
postoperative course of DP with or without splenectomy.
Patients and methods. From 1985 to 2005, 36 consecutive patients with
benign or low-grade malignant disease underwent DP with spleen preserva-
tion but excision of splenic artery and vein (Conservative group). They were
compared with 38 patients who underwent conventional DP with splenect-
omy over the same time period (Splenectomy group) and matched for age,
American Society of Anesthesiologists (ASA) score, and pathological
diagnosis. Preoperative features, intraoperative parameters, and postoperative
course were analyzed and compared between Conservative group and
Splenectomy group. Factors that may influence intra-abdominal complica-
tion rate were determined by univariate and multivariate analyses.
Results. Spleen preservation was effective in 36 of 38 attempts (95%).
Postoperative complications and particularly infectious intra-abdominal
complications were significantly higher in the splenectomy group (34% and
18%, respectively) compared with the conservative group (14% and 3%,
respectively) (p/0.04 and p/0.03, respectively). Length of surgery,
perioperative blood loss or transfusions, perioperative mortality and length
of hospital stay did not differ between the two groups. Univariate and
multivariate analysis showed that splenectomy was the only risk factor for
postoperative complication.
Conclusions. Spleen preserving distal pancreatectomy with excision
of splenic artery and vein is a fast, safe and effective procedure associated
with a reduction of postoperative complications compared with convent-
ional distal pancreatectomy with splenectomy. This technique should be
considered in patients with benign or low-grade malignant disease of the
pancreas.
FC 8.10
LAPAROSCOPIC DISTAL PANCREATECTOMY: RESULTS ON A
CONSECUTIVE SERIES OF 58 PATIENTS’
Melotti, Gianluigi1; Butturini, Giovanni2; Piccoli, Micaela1; Casetti, Luca2;
Bassi, Claudio2; Pederzoli, Paolo2
1Ospedale Baggiovara, Modena, Italy; 2Policlinico Borgo Roma, Surgical and
Gastroenterological, Verona, Italy
Background. Laparoscopic distal pancreatic resection has been increasingly
described by several surgeons as a feasible and safe procedure but with an
high conversion rate and morbidity.
Aim. To describe clinical characteristics, indications, technical procedures
and outcome of a consecutive series of laparoscopic distal pancreatic
resections performed by the same surgical team.
Methods. A consecutive series of Patients suffering from solid and cystic
tumors, were selected prospectively to be undergone to laparoscopic distal
pancreatectomy performed by the same surgical team. Clinical characteristics
as well as diagnostic preoperative assessment and intra and postoperative data
were prospectively recorded. A follow up of at least three months was
available for all patients.
Results. 58 Patients underwent to laparoscopic resections in the period
between may 1999 and November 2005. All the operations were successfully
performed laparoscopically and no one needed an intraoperative blood
transfusion. Splenic vessel preservation was possible in 84.4% of spleen-
preserving procedures. Mortality was nil. An overall postoperative pancreatic
fistula of 27.5% was registered with a median hospital stay of 10.5 days in this
complicated group. Follow up was available for all patients who are alive but
one.
Discussion. Our technique was able to avoid conversion in 58 consecutive
patients with acceptable postoperative pancreatic fistula rate and morbidity.
Laparoscopy resulted of particular benefit in the complicated subgroup who
experienced low postoperative hospital stay. Whenever possible solid and
cystic tumors of the distal pancreas represent an indication to laparoscopic
resection.
FC 9.01
SURGICAL RESECTION FOR PROXIMAL CHOLANGIOCARCI-
NOMA
Cleary, Sean1; Adams, Reid2; Shah, Shimul1; Greig, Paul1; Taylor, Bryce1;
Langer, Bernard1; Gallinger, Steven1; Wei, Alice1
1Toronto General Hospital-UHN, Surgery, Toronto, Canada; 2University of
Virginia, Charlottesville, USA
Introduction. Until recently, the outlook for patients diagnosed with
cholangiocarcinoma has been very poor. We sought to review our experience
with proximal cholangiocarcinoma to determine if a more aggressive
approach has led to an increase in the rate of curative (R0) resection and
an improvement in overall survival (OS).
Methods. All patients who underwent a resection for proximal cholangio-
carcinoma at two university affiliated hospitals between 1984 and 2000
were identified and data was obtained by retrospective chart review. Risk
factors for disease recurrence were analyzed using the Mann-Whitney U test
or the chi-square test. Univariate and multivariate analysis of OS was
performed using the log -rank test and Cox proportional hazards model,
respectively.
Results. 66 patients underwent resection for proximal cholangiocarcinoma.
Median (range) age was 59.1(3285) years. There were 3 (4.5%)
perioperative deaths and 7 patients had a R2 resection. A total of 56
patients underwent a R0 resection. 34/56 (60%) resections included hepatic
lobectomy, including 17 (30%) tri-sectionectomies. Hepatic resection
(p/0.004), caudate lobe resection (p/0.04), early stage (I/II) cancer
(p/0.05) and negative lymph node (p/0.01) were associated with
microscopically negative margins (R0). Actual 5 year DFS was 37.5%
and median DFS was 44.3 (1.6165) months. Actual 5 year OS was
46.4% and median OS was 55.5 (6280) months. Positive lymph nodes
(p/0.01), T2/3 tumours (p/0.03) and Stage 2A/2B tumours (pB/0.001)
were associated with poor OS by univariate analysis. Jaundice at presenta-
tion (HR/3.0; 95%CI 1.27.4) and Stage 2A/2B tumours (HR/3.2;
95%CI 1.66.3) were independent predictor of poor OS by multivariate
analysis.
Conclusion. Aggressive surgical resection for proximal cholangiocarcinoma
can be performed safely and is associated with a higher rate of R0 resection.
However, despite aggressive resection locally advanced disease continues to
be associated with a poor prognosis.
FC 9.02
HAPATIC TRISECTIONECTOMY FOR HILAR CHOLANGIOCAR-
CINOMA: IS IT WORTHWHILE?
Nishio, Hideki; Nagino, Masato; Ebata, Tomoki; Igami, Tsuyoshi; Yo-
koyama, Yukihiro; Nimura, Yuji
Nagoya University Graduate School of Medicine, Dept. of Surgery, Nagoya,
Japan
Background. Although right trisectionectomy has been reported to be the
best surgical procedure for hilar cholangiocarcinoma, left trisectionectomy
has not been analyzed.
Aim. To evaluate value of a hepatic trisectionectomy for treating hilar
cholangiocarcinoma.
Methods. This study included 246 patients with hilar cholangiocarcinoma
who underwent right hepatectomy (RH) (n/90), right trisectionectomy
(RT) (n/14), left hepatectomy (LH) (n/103) or left trisectionectomy (LT)
(n/39) during the past 15 years (19912005). Postoperative mortality,
morbidity, and survival were analyzed.
Results. Right sided hepatectomy: Curative resection was possible for 71
patients (79%) in RH group, while for 9 (64%) in RT group (p/0.1).
Mortality was found in RT group (n/3, 21%) more frequently than in RH
group (n/4, 4%) (p/0.049). Thirty eight patients (42%) in RH group and 9
(64%) in RT group developed postoperative complications (p/0.1). The 3-,
5-year survival rates and median survival time for RH group and those for RT
group were 35%, 24%, and 1.88 years, and 29%, 21%, and 0.61 years,
respectively. There were no significant differences between the two groups.
Left sided hepatectomy: Curative resection was performed for 76 patients
(74%) in LH group and 31 (79%) in LT group (p/0.1). Three patients (3%)
in LH group and 3 (8%) in LT group died of postoperative complications (p/
0.1). Postoperative morbidity was encountered in LT group (n/20, 51%)
more frequently than in LH group (n/29, 28%) (p/0.010). The 3-, 5-year
survival rates and median survival time for LH group and those for LT group
were 28%, 23%, and 1.99 year, and 20%, 0%, and 1.27 years, respectively.
Although patients undergoing LT survived shorter than those undergoing LH
(p/0.016), they survived longer than unresected patients (pB/0.001).
Conclusions. Both right and left trisectionectomies are still challenging
procedures. However they are worthwhile in treating selected patients with
locally advanced hilar cholangiocarcinoma as the long-term outcomes were
acceptable.
FC 9.03
COMBINED HEPATOCELLULAR-CHOLANGIOCARCINOMA IN
A SINGLE EUROPEAN CENTER: CLINICO-PATHOLOGIC
FEATURES AND OUTCOME
Dondero, Federica1; Cazals-Hatem, Dominique2; Paradis, Valerie2; Bedossa,
Pierre2; Belghiti, Jacques1
1Beaujon, Hepatobiliary Surgery, Clichy, France; 2Beaujon, Pathology,
Clichy, France
Background. Combined hepatocellular-cholangiocarcinomas (HCC-CC)
are rare and described in Asia as an aggressive hepatocellular carcinoma
(HCC) variant. In United States, none of the HCC-CC reported arose in
cirrhosis.
Aim. We study clinical, pathological and prognostic features of 29 HCC-CC
operated in a single European center.
Methods. Between 1988 and 2005, 880 patients underwent resection or liver
transplantation for primary liver cancer in a single center; HCC-CC was
diagnosed in 29 patients on histological analysis. Clinical, pathological,
immunohistochemical and follow-up data were retrospectively analyzed
(using antibodies of cytokeratin (CK)7, CK19, CK20, of Hep Par 1 and p53).
Results. All patients (mean age at diagnosis: 589/15 years) were Caucasian
and 90% were men (26 out of 29 patients). The prevalence of positive
hepatitis B or C serology and of genetic hemochomatosis cirrhosis was 38%
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and 10% respectively. 12 patients (41%) displayed cirrhosis and 12 (41%) a
normal background liver. Mean tumor size was 6.2 cm (range 114 cm); 19
patients (66%) underwent a major hepatectomy and 7 patients (24%) were
transplanted. Most HCC-CC presented with a single mass with admixed
hepatoid and cholangiolar components both positive for CK7 and/or CK19;
p53, Hep Par1 and CK20 expression were present in 50%, 41% and 23% of
them respectively. Vascular invasion, satellite nodules and metastasis were
observed in respectively 90%, 62% and 21% of all HCC-CC. The median
overall survival after resection was 34 months. One, 3, 5 years survivals were
respectively 69%, 45%, and 36%. Five of the 7 transplanted patients were
alive at 3 years without recurrence (489/28 months).
Conclusion. HCC-CC in Europe presented with intermediate clinico-
pathologic features between Eastern and Western series and similar adverse
outcome. LT should offer curative treatment for HCC-CC if Milano criteria
are respected, similarly to HCC.
FC 9.04
HEPATECTOMY FOR PERIPHERAL CHOLANGIOCARCINOMA
IN ELDERLY PATIENTS
Liu, Yu-Yin; Yeh, Chun-Nan; Jan, Yi-Yin; Chen, Miin-Fu
1Chang Gung Memorial Hospital/ Chang Gung University, Surgery,
Taoyuan, Taiwan
Background. Peripheral cholangiocarcinoma (CCC) is less common than
hepatocellular carcinoma. Little is known about CCC patients older than 70
years old who have undergone hepatectomy.
Methods. Between 1977 and 2004, the clinical features of 33 elderly-CCC
patients (more than 70 years old) undergoing hepatectomy were reviewed
and 185 CCC patients younger than 70 years old (younger-CCC) were used
for comparison.
Results. 218 CCC patients undergoing hepatectomy were investigated with
an age range between 28 and 93 years (median: 59.0). The elderly and
younger CCC groups had similar gender ratio, and a similar positive rate of
CEA and CA 19-9. A similar rate of hepatolithiasis, mucobilia, papillary
pattern, stage distribution, and curative hepatectomy, morbidity and mor-
tality for CCC was also observed between the two groups. Ten patients died
within one month after hepatectomy (surgical mortality rate: 4.6 per cent).
Follow-up duration ranged from 1.0 to 167.6 months (median: 5.7 months).
Elderly CCC and younger CCC patients had similar prognosis after
hepatectomy (p/0.681). Elderly-CCC patients with low CEA level,
intraductal papillary growth pattern, curative hepatectomy, and post-opera-
tive chemotherapy tended to have favorable survival. However, elderly-CCC
patients with low CEA level independently predict favorable survival.
Conclusion. CCC patients older than 70 years old undergoing hepatectomy
had similar clinopathological features and prognosis to those younger than 70
years old undergoing hepatectomy. Elderly-CCC patients with low CEA
level, intraductal papillary growth pattern, curative hepatectomy, and post-
operative chemotherapy tended to have favorable survival. However, elderly-
CCC patients with low CEA level independently predict favorable survival.
FC 9.05
INFLAMMATORY PSEUDOTUMOR OF THE LIVER MIMICKING
MASS FORMING CHOLANGIOCARCINOMA
Kang, Koo J1; Kim, Yong H1; Lim, Tae J1; Park, Kyung S2; Kang, Yu N3;
Kwon, Jung H4
1Keimyung University Dong San Medical Center, Surgery, Daegu, Korea;
2Keimyung University, Medicine, Daegu, Korea; 3Keimyung University
Dong San Medical Center, Pathology, Daegu, Korea; 4Keimyung University
Dong San Medical Center, Radiology, Daegu, Korea
Backgrounds. Inflammatory pseudotumor is not uncommon disease devel-
oping in the liver. Differentiation of this lesion from malignant tumor is very
important to prevent unnecessary surgery, particularly when a nodular mass
was found at the radiologic study after surgery of the liver or biliary tract
cancer.
Aim. We report our experience of eighteen patients of inflammatory
pseudotumor.
Methods. Between July 2001 and June 2004, we experienced eighteen
patients(twelve males and six females) who were diagnosed as inflammatory
pseudotumor of the liver. We analyzed characteristics of the patients
retrospectively.
Results. Mean age of eighteen patients was sixty. Ten patients were
diagnosed by needle biopsy, five by surgical resection, and the other three
patients were diagnosed by sequential radiologic imaging study that showed
disappearance of initial tumor-like lesion later on. Nine of eighteen patients
were suspected as pseudotumor by initial imaging study. Five and four
patients were suspected initially as mass forming cholangiocarcinoma and
hepatic abscess, respectively. Thirteen of 18 patients were associated with
biliary tract diseases such as biliary stone, gallbladder cancer, gallbladder
abscess, or cholangiocarcinoma. One patient who has two nodular session
showed combined pseudotumor and cholangiocarcinoma those are similar in
imaging study. The lesions were solitary in 16 and multiple in 2 patients.
Most commonly involved segment was segment 4. The lesions were regressed
spontaneously in 9 patients. Four were treated by antibiotics and five were
surgical resection, respectively.
Conclusions. Inflammatory pseudotumor of liver should be differentiated
from malignant hepatic tumor, particularly mass forming cholangiocarci-
noma to prevent unnecessary surgery. Needle biopsy is mandatory for this
differentiation.
FC 9.06
SPONTANEOUS RUPTURE OF HEPATOCELLULAR CARCI-
NOMA (HCC): KINGS COLLEGE HOSPITAL EXPERIENCE
Battula, Narendra; Madanur, Mansoor; Priest, Oliver; Marangoni, Gabriele;
Srinivasan, Parthi; Karani, John; Heaton, Nigel; Rela, Mohamed
Kings College Hospital, London, UK
Background. Spontaneous rupture of HCC is a life-threatening presenta-
tion with an incidence of less than 3% in Western countries. The reported
overall mortality is up to 50% in Asian countries where the incidence is 12
14%.
Aim. To report a single centre experience of ruptured HCC over a 10-year
period.
Methods. A retrospective review of all patients who presented with ruptured
HCC between 1995 and 2005. Data were collected on clinical features,
treatment strategies and survival outcomes. Statistical methods included
univariate analysis and Kaplan-Meier survival estimates with the log-rank test.
Results. Cohorts of 21 patients (15 male, 6 female) were identified. The
median age at presentation was 65 (interquartile range {IQR} 5569). Initial
control of bleeding was attempted by trans-arterial embolisation (TAE) in 9
(43%) and by emergency surgery in 10 (48%). 2 (9%) had palliative
treatment only. Definitive treatment included emergency resection in 5,
staged hepatectomy in 4 and chemo-embolisation in 2 patients The median
survival of those who had emergency resection or staged procedures was 25
months (IQR 1782) and 8 months (IQR 332) respectively. Patients with
cirrhosis (n/12) had a median survival of less than 30 days, while that of
non-cirrhotics was 20 months (IQR 231). The Child’s-Pugh score at
presentation (median 7, IQR 58) correlated strongly with both disease-free
survival and overall survival (pB/0.0001). The overall median survival was 3
months (IQR 114).
Conclusion. Ruptured HCC is an uncommon presentation in Western
countries. Emergency or staged hepatic resection following initial control of
bleeding is the treatment of choice. The median survival in patients initially
treated with surgery was better than that observed in patients who had initial
TAE, although this was not statistically significant. Patients with cirrhosis had
poor prognosis. An improved survival in patients following emergency
resection is noted in our study when compared to Asian experiences.
FC 9.07
PROSPECTIVE SCREENING INCREASES DETECTION OF PO-
TENTIALLY CURABLE HEPATOCELLULAR CANCER: RESULTS
FROM 5670 HIGH-RISK PATIENTS
Gannon, Christopher J1; Izzo, Francesco2; Di Giacomo, R2; Melucci, MT2;
Cremona, F2; Ferraro, A2; Mastro, AA2; Aloia, Thomas A1; Curley, Steven A1
1U.T. M. D. Anderson Cancer Center, Dept. of Surgical Oncology, Houston,
USA; 2G. Pascale National Cancer Institute, Naples, Italy
Background. Less than 10% of patients diagnosed with symptomatic
hepatocellular cancer (HCC) present with disease amenable to curative
therapy.
Objectives. We prospectively screened patients with chronic hepatitis B
(HBV) or C virus (HCV) infection to determine 1) the rate of detection of
early stage HCC and 2) the 5-year survival rate of patients treated with
curative intent.
Methods. 5670 patients from the Campania region of Italy with chronic
HBV (n/1077), HCV (n/4139), both HBV and HCV (n/397), or other
hepatitis infections (n/57) were enrolled in a HCC screening program
between July 1993 and July 1998. Follow-up data on all patients was obtained
through July 2005. All patients were screened initially and every 6 months
thereafter with serum alpha-fetoprotein measurements and abdominal
ultrasonography. Patients treated with curative intent underwent resection,
liver transplant, or definitive tumor ablation via radiofrequency ablation or
ethanol injection.
Results. Asymptomatic HCC was diagnosed in 464 (8.2%) patients; 173
(37.3%) at initial screening and 291 (62.7%) during follow-up. Early stage
HCC treated with curative intent was diagnosed in 319 patients (68.7%),
while 145 (31.3%) had advanced disease. The 5-year overall and disease-free
survival rates in patients treated with curative intent were 51.4% and 30.0%,
respectively. The advanced disease group had no 5-year survivors; the 2-year
survival rate was 9.6% (pB/0.001 vs. 68% early stage).
Conclusion. A large screening program of high-risk, chronic HBV and HCV
infected patients: 1) led to diagnosis of early stage, potentially curable HCC
in 68.7% of patients and 2) resulted in a 5-year survival rate of 51.4% in these
patients. These results support screening of patients with chronic HBV or
HCV to detect early stage, treatable HCC.
FC 9.08
LONG-TERM OUTCOMES OF HEPATECTOMY VERSUS PER-
CUTANEOUS ABLATION FOR THE TREATMENT OF HEPATO-
CELLULAR CARCINOMA B//4 CM
Wakai, Toshifumi1; Shirai, Yoshio1; Suda, Takeshi2; Sakata, Jun1; Kawai,
Hirokazu2; Matsuda, Yasunobu2; Aoyagi, Yutaka2; Hatakeyama, Katsuyoshi1
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1Niigata University Graduate School of Medical and Dental Sciences,
Division of Digestive and General Surgery, Niigata, Japan; 2Niigata
University Graduate School of Medical and Dental Sciences, Division of
Gastroenterology and Hepatology, Niigata, Japan
Aim. The current study was performed to determine which treatment
modalityhepatectomy or percutaneous ablation  is more beneficial for
patients with small (B//4 cm) hepatocellular carcinoma (HCC) in terms
of long-term outcomes.
Methods. A retrospective analysis of 149 patients with HCC B//4 cm was
conducted. Eighty-five patients underwent partial hepatectomy (anatomic in
47 and non-anatomic in 38) and 64 underwent percutaneous ablation
(percutaneous ethanol injection in 37, radiofrequency ablation in 21, and
microwave coagulation in 6). The median follow-up period was 69 months.
Results. Hepatectomy was associated with larger tumor size (PB/0.001),
whereas percutaneous ablation was significantly associated with impaired
hepatic functional reserve. Local recurrence was less frequent following
hepatectomy (PB/0.0001). Survival was better following hepatectomy
(median survival time: 122 months) than following percutaneous ablation
(median survival time: 66 months; P/0.0123). When tumor size was divided
into B//2 cm versus /2 cm, the favorable effects of hepatectomy on long-
term survival was only seen in patients with tumors/2 cm (P/0.0001). The
Cox proportional hazards regression model revealed that hepatectomy (P/
0.006) and tumors B//2 cm (P/0.017) were independently associated with
better survival.
Conclusion. Hepatectomy provides both better local control and better
long-term survival for patients with HCC B//4 cm compared to percuta-
neous ablation. Of the patients with HCC B//4 cm, those with tumors/2
cm are good candidates for hepatectomy, provided that the hepatic functional
reserve of the patient permits resection.
FC 9.09
IS SYSTEMATIC SUBSEGMENTECTOMY SUPERIOR TO
PARTIAL RESECTION FOR PREVENTING RECURRENCE OF
HEPATOCELLULAR CARCINOMA?
Kubota, Keiichi; Kita, Junji; Shimoda, Mitsugi; Sawada, Tokihiko
Dokkyo University School of Medicine, Dept. of Gastro-enterological
Surgery, Tochigi, Japan
Background. Although systematic subsegmentectomy (SS) was developed
to resect the total portal area containing a hepatocellular carcinoma (HCC)
and tumor thrombus, it remains unclarified how the recurrence pattern (RP)
is influenced by the procedure.
Aim. To clarify the utility of SS by comparing RPs of HCC after SS and non-
SS (partial resection).
Methods. 52 SS and 69 non-SS cases for one HCC which were perfor-
med between April 2000 and March 2005 were included in this study.
Their clinicopathological data and disease-free survival time (DFST)
were evaluated retrospectively. The resection area by SS was determined
by puncturing the portal venous branch under ultrasonic guidance and
injecting dye, while resection of HCC with some margin was defined as
non-SS.
Results. Group characterisitics (SS vs non-SS): Age; 65y vs 69y, ICG15;
14.8% vs 22.4% (pB/0.01), Alb (g/dl); 3.8 vs 3.4 (pB/0.01), Tumor size
(cm); 2.7 vs 2.5, LC; 32/52 vs 55/69. Pathological data: portal invasion
(vp); 11 vs 9, intrahepatic metastasis (im); 10 vs 7. RP: (SS) 20 of 52
patients (38%) developed recurrence (Liver; 18, Lung; 1, Bone; 1). 3 of 11
patients with vp and 3 of 10 with im developed recurrence in the liver. 8 of
the 18 patients (44%) underwent re-resection, while the remaining 10
received TAE. (non-SS) 44 of 69 patients (64%) developed recurrence
(Liver; 43, Lung; 2). 8 of 9 patients with vp and all 7 patients with im
developed recurrence in the liver. 6 of 43 patients underwent re-resection,
while the remaining 37 received TAE. Cumulative survival rate at 5
years: 89.8% vs 84% (p/0.453). DFST at 3 years: 44.5% vs 29.7% (p/
0.042).
Discussion. After SS one-third of patients with vp or im developed
recurrence and re-resection rate was high, while after non-SS, most patients
with vp or im developed recurrence.
Conclusion. Although SS was indicated to patients with better liver
function, SS was considered superior to non-SS in terms of decreasing the
recurrence rate and prolonging DFST.
FC 9.10
REHEPATECTOMY FOR RECURRENT HEPATOCELLULAR
CARCINOMA-WHAT IS THE LIMIT?
Wu, Cheng C1; Cheng, Shao B1; Yeh, Dah C1; Yu, Chan C1; Jan, Yei J2
1Taichung Veterans General Hospital, Surgery, Taichung, Taiwan; 2Taichung
Veterans General Hospital, Pathology, Taichung, Taiwan
Background. Although some controversial, rehepatectomy may improve the
survival in patients with recurrent hepatocellular carcinoma (HCC). How-
ever, the limit of repeated times remained unknown.
Aim(s)/Objective(s). The aim of study is to find out the roles and the limits
of rehepatectomy for recurrent HCC.
Methods. This study included 1010 patients newly diagnosed HCC who
underwent liver resection for HCC between 1989 and 2005. After follow-up
until March 2006, 538 patients had cancer recurrence. Among the 538
patients with recurrent HCC, 130 patients underwent repeat hepatectomy:
103 patients rehepatectomy once, 21 patients rehepatectomy twice, 5 patients
rehepatectomy three times, and one patient received rehepatectomy six times.
The patient selection criteria and resectional extent in repeat hepatectomy are
almost similar. The clinicopathological characteristics, results of each
hepatectomy were compared.
Results. The tumors size in repeat hepatectomy is smaller than the first
hepatectomy. Patients with recurrent HCC who could undergo repeat liver
resection had a better long-term survival time than those who received other
non-operative treatments. Postoperative morbidity and mortality of first re-
hepatectomy are comparable to first hepatectomy. These figures were also
found in further hepatectomies. One patient in rehepatectomy died of liver
failure. No operative mortality occurred in patients underwent more than 2
times of rehepatectomy. The long-term results of multiple repeat hepatec-
tomies are also comparable.
Conclusion. Repeat hepatectomy provides the chance of long-term disease-
free for recurrent HCC, however, the limitation of repeat times of
rehepatectomy remains unclarified.
FC 10.01
PORTAL VEIN EMBOLIZATION REDUCES INTRA-HEPATIC
RECURRENCE RATE AFTER RIGHT HEPATECTOMY FOR UNI-
LOBAR COLORECTAL LIVER METASTASES
Ooussoultzou, Elie; Bachellier, Philippe; Rosso, Edoardo; Nakano, Hiroshi;
Scurtu, Radu; Lucescu, Ioan; Jaeck, Daniel
CHU de Hautepierre, Centre de Chirurgie Visce´rale et de Transplantatio,
Strasbourg, France
Background. Recent researches suggest that colorectal liver metastases
(CLM) could spread retrogradely through the portal vein. Portal vein
embolization (PVE) may reduce tumor shedding by the occlusion of distal
portal branches. However, no study reported the clinical effect of PVE on
intra-hepatic recurrence after CLM resection.
Aim. To asses the effect of PVE on intra-hepatic recurrence after curative
resection for unilobar CLM.
Methods. Between 1995 and 2003, 44 patients requiring a right hepatect-
omy for unilobar CLM were operated in our institution. Right hepatectomy
was performed after PVE in 23 patients (Group A) and without PVE in 21
(Group B). Surgical outcome and site of recurrence were analyzed.
Results. The postoperative mortality was nil. Overall morbidity and
transitory liver failure rates were similar in Group A and B (43.4% and
17.3% versus 33.3% and 14.2% respectively). The 3- and 5-year overall
survival rates did not differ in Group A and B patients (61.2% and 43.7%
versus 49.7% and 35.5% respectively; p/0.862). The disease-free survival
rate was similar in both groups. Thirty patients (68.2%) developed
recurrences. Recurrences were intra-hepatic in 22 patients (50%) and
extra-hepatic in 27 (61.3%). Intra-hepatic recurrence rate was significantly
lower in Group A compared with Group B (26.0% versus 76.1% respectively;
pB/0.001). PVE, number of CLM and administration of neoadjuvant
chemotherapy were independent prognostic factors for intra-hepatic recur-
rences.
Conclusion. This study showed that PVE reduces intra-hepatic recurrence
rate after right hepatectomy for unilobar CLM.
FC 10.02
PERIOPERATIVE MORBIDITY AFFECTS LONG TERM SURVI-
VAL IN PATIENTS FOLLOWING LIVER RESECTION FOR COL-
ORECTAL METASTASIS
Schiesser, Marc1; Chen, John1; Maddern, Guy2; Padbury, Rob1
1Flinders Medical Centre, Surgery, Adelaide SA, Australia; 2Queen Elisabeth
Hospital, Surgery, Adelaide SA, Australia
Background. Hepatic resection is the treatment of choice in patients with
colorectal liver metastasis. Several factors like positive resection margin are
known to have an influence on the outcome. Perioperative morbidity is
associated with poor survival in different cancers.
Aim. The aim of this study was to assess the impact of prognostic factors in
liver resection for colorectal metastases, especially perioperative morbidity.
Methods. 197 patients from Flinders Medical Centre, Ashford Community
Hospital and Queen Elizabeth Hospital in Adelaide undergoing liver
resection for colorectal metastasis with curative intent were included in a
prospective database. The influence of prognostic factors was investigated
using univariate and multivariate analysis. Complications were defined
according to an established surgical classification.
Results. The overall five year survival rate was 38%, with a median follow up
of 4.5 years. The disease free survival rate at five year was 24%. The
perioperative morbidity and mortality rates were 29%, and 2.6% respectively.
Positive resection margins, perioperative complications, sex as well as age
were associated with a significantly worse outcome in the univariate analysis.
In the multivariate analysis only positive resection margins and perioperative
complications were significantly related to the overall survival. The median
survival of patients with perioperative complications was 3.4 years compared
to 4.8 years in patients without (pB/0.01). Patients with involved resection
margins and complications had also a significantly shorter disease free
survival.
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Conclusion. Perioperative morbidity as well as positive resection margins
has an impact on the long term survival in patients following liver resection
for colorectal metastasis.
FC 10.03
SAFE LIVER RESECTION FOLLOWING CHEMOTHERAPY FOR
COLORECTAL METASTASES IS A MATTER OF TIMING
Welsh, Fenella1; Tekkis, Paris2; John, Timothy1; Rees, Myrddin1
1North Hampshire Hospital, Dept. of Hepatobiliary Surgery, Basingstoke,
UK; 2St Mary’s Hospital, Dept. of Biosurgery and Surgical Technology,
London, UK
Background. Neoadjuvant chemotherapy (NC) is increasingly used to
improve the resectability of colorectal liver metastases. However, there is
concern regarding its impact on post-operative morbidity.
Aims. To determine whether the impact of NC on post-operative complica-
tions following liver resection for colorectal metastases is related to the timing
of surgery and chemotherapy.
Methods. 750 consecutive liver resections performed for colorectal metas-
tases in a single unit between 1996 and 2005 were entered on a prospective
database. On retrospective review, 245 resections were performed in patients
who had never been exposed to chemotherapy pre-operatively (controls)
(mean age 63 years, 67% male) and 252 in patients who had NC prior to liver
resection (mean age 62 years, 67% male). Details of chemotherapeutic
regimens and surgery were reviewed. Outcome measures were post-operative
mortality and morbidity.
Results. There was no significant difference in post-operative mortality
(2% versus 2%, p/1.0) or morbidity (27% versus 29%, p/0.34) between
the control and NC groups. There was a non-significant increase in surgical
complications with duration of NC, from 0% if given for less than 3 months
to 17% if given for more than 6 months prior to liver resection (p/0.23)
and a similar increase in mortality (0% to 11%, p/0.65). In addition,
there were significantly more surgical complications if the interval
between stopping NC and undergoing surgery was 4 weeks or less (11%),
compared to waiting 58 (5.5%) or 912 (2.6%) weeks (Gamma//0.35,
p/0.009).
Conclusions. Liver resection for colorectal metastases can be performed
safely following chemotherapy. However, more complications may occur if it
is given for a prolonged duration or if patients have not had sufficient time to
recover before surgery.
FC 10.04
PATIENTS WITH MULTIPLE HEPATOCELLULAR ADENOMA
COULD BE MANAGED WITH A CONSERVATIVE SURGICAL
APPROACH
Belghiti, Jacques; Dokmak, Safi; Paradis, Vale´rie; Vilgrain, Vale´rie; Farges,
Olivier; Sauvanet, Alain; Valla, Dominique; Bedossa, Pierre
Hospital Beaujon, Clichy, France
Adenoma is a rare benign liver tumor with a significant risk of bleeding and
malignancy. Management of patients with multiple tumors is difficult,
especially in those with/10 tumors which are considered as a specific
entity called adenomatosis. In order to evaluate the rationale of this
classification we reviewed the clinical features and outcome of all patients,
excluding those with glycogen storage, who underwent resection of
adenoma in a single institution from 1990. 119 patients (109 females)
were arbitrary divided in three groups: single adenoma (n/60), multiple
adenomas if B/10 (n/29) and adenomatosis if /10 (n/30). The mean
follow-up was 64 months (range 6180). Patients with single adenoma
were resected while in other groups, resection was performed for tumors/
5 cm. Transplantation was performed in case of multiple malignant tumors.
As shown in table, there was no significant difference between the 3 groups
concerning gender, use of oral contraceptive (OC), rate and type of
complications. Among the 10 males, 5 experienced malignancy. In 25/26
bleeding tumors had a diameter /5 cm and all cases with malignancy
tumor size was/8 cm.
Single adenoma
n/60
Multiple (210)
n/29
Adenomatosis
(/10) n/30
Female% 85 100 96
Mean age
(years)
37 35 40
OC/10years 92% 93% 92%
Mean size (cm) 8.9 8.8 9.5
Bleeding, n(%) 15 (25%) 6 (20%) 4 (14%)
Malignancy,
n(%)
7 (12%) 2 (8%) 3 (10%)
Complete
resection
100% 37% 0%
The 3 transplanted patients died with malignant recurrence within 2 years.
The other 9 with malignancy who underwent resection were alive with a
mean follow-up of 47 months (6120). Among the 49 patients with
multiple adenomas incompletely resected, 6 (12%), experienced tumor
progression requiring re-resection in 2; while 4 (7%) experienced tumor
regression.
Conclusions. Whatever the number of adenoma, the risk of bleeding and
malignancy is quite exclusively observed in tumors /5 cm. Risk of
malignancy is specially high in men. Resection of all tumors 5 cm is necessary
and sufficient.
FC 10.05
LONG-TERM OUTCOMES IN PATIENTS UNDERGOING HEPA-
TIC RESECTION FOR METASTATIC COLORECTAL CANCER
WITH SYNCHRONOUS RESECTABLE EXTRA-HEPATIC DIS-
EASE
John, Timothy1; Tekkis, Paris2; Welsh, Fenella1; Rees, Myrddin1
1North Hampshire Hospital, Dept. of Hepatobiliary Surgery, Basingstoke,
UK; 2St Mary’s Hospital, Dept. of Biosurgery and Surgical Technology,
London, UK
Background. Extra-hepatic disease has been shown to have an adverse
impact on survival following liver resection for colorectal metastases.
Aims. To evaluate cancer-specific survival in patients undergoing hepatic
resection for metastatic colorectal cancer with synchronous resectable extra-
hepatic disease.
Methods. Clinical, pathological and compete follow-up data were prospec-
tively collected from 925 consecutive patients undergoing primary hepatic
resection for colorectal liver metastases at a single centre from 1986 to 2005.
Histopathological analysis defined 778(84.1%) patients with negative
hepatic resection margins (R0-group), 68(13.6%) patients with positive
margins without extrahepatic disease (R1-group) and 79(8.5%) patients
who had synchronous extrahepatic disease resected (R2-group). Multi-
variate Cox-regression analysis was used to compare outcomes between
these groups.
Results. At a median follow up of 2.2 years, the actuarial 5-year survival for
R0, R1 and R2-groups was 38.7%, 9.5% and 9.7%; median survival was 3.9,
2.0 and 2.1 years respectively (pB/0.01). Of the R2-group, 18 (23%) patients
underwent liver resection with radical local lymphadenectomy and 11 (14%)
with subsequent resection of synchronous lung metastases. The actuarial 5-
year survival for this subgroup of 29 patients compared with remaining R2
patients was 31.9% versus 0%, and median survival was 3.5 years versus 2.1
years respectively (pB/0.01). Having adjusted for stage and grade of the
primary cancer, carcinoembyonic antigen level, number and diameter of
tumour at the time of liver resection, multivariate analysis revealed that
patients with resectable extra-hepatic lymph nodes or lung metastases had a
similar long-term survival compared to the R0 group (Hazard ratio/1.1, 0.4;
p/0.3).
Conclusions. These data suggest that aggressive resection of extra-hepatic
disease in selected patients may offer a survival benefit similar to that of a
‘curative’ (R0) liver resection.
FC 10.06
PERITONEAL CARCINOMATOSIS WITH LIVER METASTASES
FROM COLORECTAL ORIGIN TREATED BY COMPLETE RE-
SECTION AND INTRAPERITONEAL CHEMOTHERAPY: FEASI-
BILITY AND RESULTS
Goe´re´, D1; Benizri, E1; Pocard, M1; Ducreux, M2; Boige, V2; Elias, D1
1Institut Gustave Roussy, Surgical Oncology, Villejuif, France; 2Institut
Gustave Roussy, Medical Oncology, Villejuif, France
Background. Peritoneal carcinomatosis (PC) discovered during hepatect-
omy is usually a contraindication to surgery. Likewise, liver metastases (LM)
are considered as a contraindication to potentially efficient treatment of PC
with resection of macroscopic disease and immediate intraperitoneal che-
motherapy for residual microscopic disease. The aim of this study was to
report the tolerance and the oncological results in patients with LM and
synchronous PC treated by hepatectomy, complete cytoreductive surgery of
PC and immediate intraperitoneal chemotherapy.
Patients and methods. Twenty four patients with moderate PC and LM
from colorectal origin were treated with a curative intent between 1993 and
2003. The selection criteria before complete resection and intraperitoneal
chemotherapy were: ageB/65 years and a good performance status, moderate
extent of peritoneal carcinomatosis, not complex or risky hepatectomy, an
objective response or stabilization of LM after 3 months of systemic
chemotherapy.
Results. The mean operative time was: 3579/112 min and median blood loss
was 719 ml [2004500]. One postoperative death (4.1%) occurred and
postoperative morbidity reached 58%. The mean hospital stay was 21.49/4.2
days. Three-year overall and disease-free survival rates were respectively
41.5% [CI: 2363] and 23.6% [CI: 1145]. Seven patients are disease-free
with a mean follow-up of 27.8 months after their last surgery (3 underwent a
repeat hepatectomy). Only 3 patients developed a peritoneal recurrence, but
13 recurred in the liver. The only significant good prognostic factor was a
number of LMs of less than 3 (pB/0.01).
Conclusion. This combined treatment of LM plus PC is feasible and is
beneficial in selected patients presenting a moderate peritoneal carcinoma-
tosis, no more than 2 (possibly 3) liver metastases, and who are responder to
chemotherapy.
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SIMULTANEOUS VERSUS STAGED LIVER RESECTION OF
SYNCHRONOUS LIVER METASTASES FROM COLORECTAL
CANCER
Thelen, Armin1; Jonas, Sven1; Beckert, Christoph1; Spinelli, Antonino1;
Lopez-Ha¨nninen, Enrico2; Rudolph, Birgit3; Neumann, Ulf1; Neuhaus,
Peter1
1Campus Virchow Clinic, Charite University Medicine, General, Visceral
and Transplant Surgery, Berlin, Germany; 2Campus Virchow Clinic, Charite
University Medicine, Dept. of Radiology, Berlin, Germany; 3Campus
Virchow Clinic, Charite University Medicine, Dept. of Pathology, Berlin,
Germany
Background. The surgical strategy for treatment of synchronous liver
metastases from colorectal cancer remains controversial.
Objective. This retrospective analysis was conducted to compare the
postoperative outcome and survival of patients receiving simultaneous
resection of liver metastases and primary colorectal cancer to those receiving
staged resection.
Methods. Between January 1988 and August 2004, 202 patients under-
went liver resection for synchronous colorectal liver metastases of whom 38
patients received simultaneous resection of liver metastases and primary
colorectal cancer and 164 patients staged resections. Patients were
identified from a prospective database and records were retrospectively
reviewed. Patient, tumor and operative parameters were analyzed for their
influence on postoperative morbidity and mortality as well as on long-term
survival.
Results. Simultaneous liver resections tend to be performed for colon
primaries rather than for rectal cancer (p/0.004), for fewer liver metastases
(p/0.054) and used less extensive liver resections (pB/0.001). The post-
operative morbidity was comparable between both groups, whereas the
mortality was significantly higher in patients with simultaneous liver resection
(p/0.012). The mortality after simultaneous liver resection (n/4) occurred
after major hepatectomies and three of these four patients were 70 years of
age or older. There was no significant difference in long-term survival after
formally curative simultaneous and staged liver resection.
Conclusion. In selected patients simultaneous liver and colorectal resection
is safe and efficient in the treatment of patients with colorectal cancer and
synchronous liver metastases. The most important criteria to select patients
for simultaneous liver resection are age of the patient and extent of liver
resection.
FC 10.08
EFFECT OF NEOADJUVANT CHEMOTHERAPY (NEC) ON
LIVER RESECTION FOR COLORECTAL LIVER METASTASES
(CLM)
Mehta, Naimish N; Imber, Charlie J; Coldham, Chris A; Ravikumar, Reena;
Buckels, John AC; Hubscher, Stefan G; Bramhall, Simon R; Wigmore,
Stephen J; Mayer, David A; Mirza, Darius F
Queen Elizabeth Hospital, Birmingham, UK
Background. The use of NeC is improved tumour resectability rate and
outcome for patients with CLM. However, NeC causes morphological
changes involving hepatic microvasculature or parenchyma which could
potentially affect outcome.
Aim. To compare the effects of NeC on liver parenchyma morphology,
morbidity and mortality after liver resection for CLM.
Methods. Prospectively collected data on 173 patients undergoing liver
resection for CLM between 1/2003 and 9/2005 was analysed in three groups:
A:pre-operative oxaliplatin(Ox; n/70), B: other chemotherapeutic agent-
s(OC, n/60); and C:surgery alone without chemotherapy(SA; n/43).
Major liver resection(hemi/extended hepatectomy) was performed in
Ox:72.9%; OC:80% and SA:67.4%(p/ns). Blood transfusion, hospital stay,
operative procedure, peak post operative bilirubin levels, complications and
histopathology of the resected liver were compared.
Results. Blood transfusion required was:Ox:34%(n/24), OC:17%(n/8),
SA-19%(n/8)(pB/0.05). Mean blood transfusion was 1(114), 0(14)
and 1(16)units respectively. The incidence of intensive care admission:
Ox:7(10%), OC:2(3%), SA:1(2%)(range:126, 19 and 1 day/s)(p/ns).
The median hospital stay was 7 days (range:4 31(Ox), 422(OC) and 4
40(SA) days). Biliary complications were:Ox:16%(n/11), OC:2%(n/
1)and SA:12%(n/5)(pB/0.05). Median follow-up:Ox-12(135), OC-
14(132) and SA-8(1 34) months. NeC was associated with mild
sinusoidal dilatation:Ox:32(46.4%), OC:16(27%), SA:10(23%) (pB/0.05);
moderate:Ox:1(1.4%), OC:2(3.4%), SA:0 and severe:Ox: (5)7.2%, OC:0
and SA:0(p/ns). Mild steatosis;Ox:42(61%), OC:33(60%), SA:25(58%),
moderate:Ox:10(14.5%), OC:12(20%), SA:6(14%) and sever-
e:Ox:6(8.7%), OC:3(5%), SA:3(7%)(p/ns). Post operative bilirubin level
that reached twice the normal had equal distribution: 43%, 45% and
44%(p/ns). Postoperative mortality was 2%, 1% and 9% respectively
(p/ns).
Conclusion. Oxaliplatin based NeC is associated with significant changes in
native liver histopathology, increased per-operative blood transfusion and
biliary leaks.
FC 10.09
RESECTION OF LIVER METASTASES FROM COLORECTAL
CANCER DOWNSTAGED BY PREOPERATIVE HEPATIC ARTER-
IAL INFUSION CHEMOTHERAPY: MORBIDITY AND LONG
TERM RESULTS
Pulitano`, Carlo1; Arru, Marcella1; Vitali, Giordano2; Ronzoni, Monica2;
Aldrighetti, Luca1; Catena, Marco1; Finazzi, Renato1; Villa, Eugenio2;
Gianfranco, Ferla1
1San Raffaele Scientific Institute, Vita-Salute San Raffaele University, Dept.
of Surgery Liver Unit, Milan, Italy; 2San Raffaele Scientific Institute, Vita-
Salute San Raffaele University, Dept. of Oncology, Milan, Italy
Background. Preoperative hepatic arterial infusion (HAI) and systemic
chemotherapy can be used for downstaging of unresectable colorectal liver
metastases, but as yet the optimal approach is unknown. Data concerning the
results of curative hepatectomy in patients whose metastases are downstaged
by HAI chemotherapy are scarce.
Aims. To assess the impact of preoperative HAI chemotherapy on remnant
liver parenchyma, morbidity and long term results.
Methods. Among 85 patients treated with HAI chemotherapy with
floxouridine (FUDR) for unresectable liver disease between 1996 and 2003
in a single institution, 34 patients (40%) underwent secondary liver resection
(HAI group). The Locoregional chemotherapeutic treatment in the HAI
group was realized by using a percutaneous angiographic with a catheter
placed in the hepatic artery. Morbidity, pathology of the resected liver, and
survival in the HAI group were compared with 121 patients (NoCh group)
who did not receive preoperative chemotherapy.
Results. There was one in-hospital death for pulmonary embolism in the
HAI group in a patient that underwent a right hepatectomy. Postoperative
morbidity rate were comparable between the two groups (N.S). The median
follow-up period after liver resection for the 155 patients was 27.0.
Comparing outcomes between the HAI and NoCh, 1, 3, and 5 year overall
survival rates after hepatectomy were 95.1%, 53.2%, and 39.1% in the HAI
group versus 96.0%, 54.3%, and 30.5% in the NoCh. No significant
difference was seen between the HAI group and the NoCH group. Rates
for liver recurrence at 1 and 3 years after hepatectomy were 69.0% and 47.3%
in the noCh group and 56.7% and 18.3% in the HAI group. The HAI group
trended toward increased disease-free survival, without reaching significant
difference (P/0.078).
Conclusions. Liver resection may be achieved in some previously
unresectable patients using HAI of FUDR with low morbidity. The
benefit in survival seems comparable to that obtained with primary liver
resection.
FC 10.10
COLORECTAL LIVER METASTASES (CLM). MANAGEMENT
STRATEGY WITH A MULTIDISCIPLINARY APPROACH
Mira, Paulo; Pinto M, Hugo; Santos C, Joa˜o; Martins, Ame´rico; Barroso,
Eduardo
Hospital de Curry Cabral, Centro Hepato-bilio-pancrea´tico e Transplanta-
c¸a˜o, Lisbon, Portugal
Introduction. In untreated CLM the longest survival was 23% and 8% at 3
and 5 years (Wagner JS et al:1984). 3035% of CLM patients (PTS) are
candidates for resection; 2026% of these will be definitely cured (67% of
the total population).
Objectives. To obtain validation of a multidisciplinary management of
CLM.
Methods. 169 CLM patients studied retrospectively (Kaplan-Meier and
logrank (Mantel-Cox) tests). Prognostic factors analysed: liver disease
presentation, timing of diagnosis, surgical margins, neoadjuvant and
adjuvant chemotherapy (QXT), primary tumour, number and size of
CLM.
Results. 201 CLM operations in 169 PTS (April 1996January 2006).
Operative mortality: 3.37%. 5 year expected overall survival (OS) and
disease-free survival (DFS): 46.7% and 35.9%. 5 year DFS better for
unilateral CLM than for bilateral CLM (39.5% versus 30.9%; p/0.016);
OS difference not significant. Timing of diagnosis (synchronous versus
metachronous CLM): no differences in OS and in DFS. Surgical margins
(B/1 cm; /1 cm): significance in OS (36, 7% versus 48%; p/0.000) and in
DFS (14.3% versus 50%; p/0.000) at 30 months. PTS without neoadju-
vant QXT: better OS (66.8% versus 38.1%, p/0.014) and DFS (61.6%
versus 35%, p/0.000) at 30 months than PTS with it. PTS without
adjuvant QXT: better OS and DFS at 30 months than PTS with it (54.1%
versus 24.8%, p/0.004 and 52.4% versus 25.5%, p/0.010, respectively).
PTS with/2 CLM: worse DFS at 30 months than PTS withB/2 CLM
(32% versus 56.6%, p/0.007). 61 PTS immediately resected without prior
QXT (36% of PTS).
Conclusions. CLM management is multidisciplinary. Isolated or unilateral
metachronous CLM: immediate resection; bilateral and/or synchronous
CLM: submitted to a period of neoadjuvant QXT, both to study tumour
biological behaviour and to make a sharper selection of PTS for resection.
New kind of QXT regimens allow to convert non-resectable CLM in
resectable ones (25, 44% PTS in our serie).
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A PROSPECTIVE RANDOMIZED TRIAL OF DSRS VS. TIPS FOR
REFRACTORY VARICEAL BLEEDING IN CHILD’S CLASS A & B
PATIENTS
Henderson, J Michael1; Rikkers, Layton2; Livingstone, Alan3; Abu-Elmagd,
Kareem4; Galloway, John5
1Cleveland Clinic, Division of Surgery, Cleveland, OH, USA; 2University of
Wisconsin, Madison, WI, USA; 3University of Miami School of Medicine,
Center for Liver Disease, Miami, FL, USA; 4University of Pittsburgh
Medical Center, Thomas E. Starzl Transplantation Institute, Pittsburgh,
PA, USA; 5Emory University, Digestive Diseases, Atlanta, GA, USA
Background. Variceal bleeding refractory to medical treatment with b
blockers and endoscopic therapy can be managed by variceal decompression
with either surgical shunts or transjugular intrahepatic portal systemic shunt
(TIPS). This prospective randomized trial tested the hypothesis that patients
receiving distal splenorenal shunt (DSRS) would have significantly lower
rebleeding and encephalopathy rates than TIPS in management of refractory
variceal bleeding.
Methods. A prospective randomized controlled clinical trial at 5 centers.
One hundred and forty patients with Child-Pugh class A and B cirrhosis and
refractory variceal bleeding were randomized to DSRS or TIPS. Protocol and
event follow up for 28 years (mean 469/26 months) for primary endpoints
of variceal bleeding and encephalopathy, and secondary endpoints of death,
ascites, thrombosis and stenosis, liver function, need for transplant, quality of
life and cost.
Results. There was no significant difference in rebleeding, DSRS- 5.5%,
TIPS- 10.5% (P/0.29), or first encephalopathy event, DSRS- 50%, TIPS-
50%. Survival at 2 and 5 years, DSRS 81% and 62%, TIPS 88% and 61%
were not significantly different (P/0.87). Thrombosis, stenosis, and
reintervention rates (DSRS 11%, TIPS 82%) were significantly (pB/.001)
higher in the TIPS group. Ascites, need for transplant, quality of life, and
costs were not significantly different.
Conclusions. DSRS and TIPS are similarly efficacious in the control of
refractory variceal bleeding in Childs’A & B patients. Reintervention is
significantly greater for TIPS compared to DSRS. As both procedures have
equivalent outcomes, the choice is dependent on available expertise and
ability to monitor the shunt and reintervene when needed.
FC 11.02
LIVING DONOR LIVER TRANSPLANTATION: A EUROPEAN
LIVER TRANSPLANT REGISTRY (ELTR) REPORT ON 1709
CASES
Adam, Rene1; Karam, Vincent1; Rogiers, Xavier2; Tokat, Yaman3; Lerut,
Jan4; Broelsch, Christopher5; Neuhaus, Peter6; De Hemptine, Bernard7;
Castaing, Denis1; O’Grady, John8; Kalicinski, Piotr9; Boillot, Olivier10;
Klempnauer, Jurgen11; Revillon, Yann12; Belghiti, Jacques13; Garcia-Valde-
casas, Juan14; Burra, Patricia15
1Paul Brousse Hospital, Villejuif, France; 2Universitatskrankenhaus Eppen-
dorf, Hamburg, Germany; 3Dept. of Surgery, Izmir, Turkey; 4Cliniques
Universitaires Saint Luc, Brussels, Belgium; 5C. U. K. GHs Essen, Essen,
Germany; 6Charite´- Campus-Virchow klinikum, Berlin, Germany; 7Univer-
sitair Ziekenhuis, Ghent, Belgium; 8King’s College Hospital, London, UK;
9Children’s Memorial Health Institute, Warsaw, Poland; 10Hoˆpital E.
Herriot, Lyon, France; 11Medizinische Hochschule Hannover, Hannover,
Germany; 12CHU Necker, Enfants Malades, Paris, France; 13Hoˆpital
Beaujon, Clichy, France; 14Hospital Clinic I Provincial de Barcelona,
Barcelona, Spain; 15University Hospital, Padova, Italy
Background. Living Donor Liver Transplantation (LDLT) is increasingly
used in Europe.
Objective. To evaluate the results of LDLT for donors and recipients in the
European Liver Transplant Registry (ELTR).
Methods. From October 1991 to December 2004, LDLT accounted for
1709 of the 54270 (3%) transplants performed at 64 centers in Europe.
Based on data from the ELTR the outcome of LDLT was compared to that of
Full Size Cadaveric Liver Transplantion (FSCLT).
Results. Annual LDLT has increased from 17 reported in 1992 to 296
performed in 2003. Initially reserved for pediatric recipients, LDLT is now
mainly used in adults (67% of cases in 2004). The right liver was donated to
91% of adults and the left lobe to 86% of children. Following LDLT, overall
graft and patient survivals at 5 yrs were 70% and 76%. Survivals were better
in children (77% and 83%) than in adults recipients (60% and 69%-pB/
0.01). Postoperative mortality occurred in 4 of the 1709 donors (0.23%) due
to pulmonary embolism (1), sepsis (2) and cardiac failure (1). Early donor
morbidity (5/3 months) was 20%. Compared to FSCLT, the percent of
LDLT used to treat cirrhosis was similar (62% vs 59%, p/NS), but LDLT
was used more often for cancers (25% vs 12%, pB/0, 01) and less often for
fulminant hepatitis (3% vs 8%, pB/0.01) and retransplantation (2% vs 11%,
pB/0.01). Compared to 2284 pediatric FSCLT, graft and patient survivals
following pediatric LRLT were better (77 and 83% vs 70% and 81%-pB/
0.01). By contrast, adult LRLT graft and patient survivals were lower than
those following adult FSCLT (60% and 69% vs 63% and 70%-pB/0.01).
Conclusion. Although LDLT represents only 3% of all transplant proce-
dures, the number has significantly increased over time, particularly for adult
recipients. Donor mortality is 0.23% with an early morbidity of 20%.
Disparities in graft and patient survivals are likely due to differences in the
indications for transplantation, including more frequent application of LDLT
to adult patients with cancer.
FC 11.03
LONG TERM FOLLOW-UP OF LIVING DONOR LIVER TRANS-
PLANTATION (LDLT) FOR HEPATOCELLULAR CARCINOMA
(HCC)
Maurette, Rafael1; Uva, Pablo1; Del Pozo, Ana Carolina1; Roayaie, Sasan1;
Schiano, Thomas1; Gondolesi, Gabriel2; Schwartz, Myron1
1Mount Sinai Hospital, Transplant Institute, New York, USA; 2Fundacion
Favaloro, Transplant Institute, Buenos Aires, Argentina
The long-term results of LDLT for (HCC) have not yet been established. We
report on 44 patients who underwent LDLT for HCC with a median follow-
up of 4 years.
Methods. Data obtained from record review included underlying liver
disease, mean waiting time, pretransplant treatment, tumor variables, and
survival. Patients were followed with CT scan every 6 months and alpha-
fetoprotein levels every 3 months for 5 years. Univariate and multivariate
analysis were done to analyze tumor variables; Kaplan-Meier and log rank
were used to compare survivals.
Results. Underlying liver diseases included HCV (28), HBV (10), crypto-
genic cirrhosis (1), ethanol cirrhosis (1), hemochromatosis (1), primary
biliary cirrhosis (1) and others (2). Median time from listing until LDLT was
273 days (range, 72190); median time from initiation of donor evaluation
until LDLT was 77 days. At median follow-up of 1600 (range 22528) days,
there have been 21 deaths: 7 due to HCC recurrence, and 14 due to other
causes. One additional patient with recurrence is alive. Based on imaging,
HCC exceeded Milan criteria in 17 patients (38%) at diagnosis and in 23
(52%) on the last scan before LDLT. Survival rates at 1, 3, and 4 years were
75%, 61%, and 52%; recurrence rates at 1, 3 and 4 years were 15%, 25%,
and 25%. HCC beyond Milan at diagnosis was associated with increased
recurrence (49% vs. 10%, p/0.01) and a trend towards decreased survival at
4 years (62% vs. 39%, p/0.15). This trend approached significance when
Milan criteria were assessed based on the last imaging before LDLT (69% vs.
39%, p/0.055), and was highly significant when based on explant pathology
(80% vs. 33%, p/0.005).
Conclusion. Once donor evaluation is initiated, LDLT permits expeditious
transplantation for HCC. A strategy delaying LDLT evaluation until tumor
progression jeopardizes candidacy for deceased donor transplantation sig-
nificantly worsens LDLT outcome. When a patient with HCC has a potential
living donor, evaluation and transplantation should proceed without delay.
FC 11.04
WHAT IS THE OPTIMAL SURGICAL THERAPY FOR EARLY
HCC? AN INTENTION-TO-TREAT ANALYSIS OF RESECTION
VS. TRANSPLANTATION
Shah, Shimul1; Wei, Alice2; Tan, Jensen1; Cleary, Sean2; Cattral, Mark2;
McGilvray, Ian2; Gallinger, Steven2; Grant, David2; Greig, Paul2
1University of Toronto, Surgery, Toronto, Canada; 2University Health
Network, Surgery, Toronto, Canada
The reported survival after liver transplantation (LT) for early hepatocellular
carcinoma (HCC) is superior to the results of liver resection (LR), but few
analyses have considered patient drop-offs due to tumor progression while
waiting for a donor organ. We compared, in an intention-to-treat analysis, the
outcome of patients at our institution who underwent LR with that of LT for
HCC within Milan criteria over a 10-year period.
Methods. From 19952005, 347 patients with HCC were evaluated at our
institution and underwent either LR (n/174) or placed on the LT waiting
list (n/173). Patients who only underwent ablation were not included. After
eliminating patients with 1) incidental tumors after LT, 2) tumors outside of
Milan criteria and 3) preoperative vascular invasion prior to LR, 261 patients
(LR/121; LT/140) were included in this analysis. Disease-free survival
(DFS) and overall survival (OS) were determined by Kaplan-Meier and
compared with the log-rank test.
Results. Median follow-up time was 35 months. Pathology revealed more
tumor nodules in the LT group (mean 2.4 vs. 1.3; pB/0.001), but larger
tumors in the LR group (mean 4.0 vs. 3.1 cm; pB/0.001). Median waiting
time for LT was 7.8 months; during this time, 30 patients were taken off the
waiting list because their tumors grew beyond the Milan criteria, vascular
invasion on imaging, or the patient died. OS from time of listing/LR was not
different between the two groups; 1, 3 and 5 year OS after LR was 89%, 75%
and 56% compared to 90%, 70% and 64% for LT (p/0.84). Only patients
who waitedB/4 months for LT (n/67) had better survival than those who
underwent LR (p/0.05).
Conclusion. Unless waiting time is short (B/4 months), the survival of
patients with early HCC is similar between LR and LT in an intention-to-
treat analysis. Considering the shortage of deceased donor organs and in the
absence of a live donor, patients with adequate hepatic reserve should
undergo LR as primary treatment for HCC.
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BILIARY STRICTURES AFTER RIGHT LOBE LIVING DONOR
LIVER TRANSPLANTATION
Shah, Shimul; McGilvray, Ian; Greig, Paul; Lilly, Les; Girgrah, Nigel; Levy,
Gary; Cattral, Mark; Grant, David
University Health Network, Multi-Organ Transplant Unit, Toronto, Canada
Biliary complications remain the most common and challenging aspect of
adult to adult right lobe living donor liver transplantation (RLDLT).
Methods. Between 04/2000 and 10/2005, 130 consecutive RLDLTs were
performed in our center and maintained in a prospective database. We
analyzed the incidence, risk factors, management and outcomes in all
recipients.
Results. After a median follow-up time of 23 months, 1-year graft and
patient survival was 85% and 87% respectively. 2 patients were not included
because of perioperative mortality. Duct-to-duct (D-D) or a Roux-en-Y (R-
Y) anastomosis were performed equally (n/64 each) with no difference in
bile leaks (p/0.65) or strictures (p/0.31). Overall incidence of biliary leaks
(n/19) or strictures (n/22) was 32% (41/128) in 33 patients (26%). 63
grafts (49%) had a single duct for anastomosis, while 65 grafts (51%) had ]/2
ducts. After ductoplasty in 24 patients, 85 grafts (65%) then had 1 duct for
engraftment and only 17% then developed a complication. A duct-to-duct
(D-D) or a Roux-en-Y (R-Y) anastomosis were performed equally (n/64
each) with no difference in bile leaks/strictures. Strictures developed more
frequently in patients with bile leaks (p/0.002), grafts with/1 duct for
anastomosis (p/0.02) and donors/50 years old (p/0.003). Management
of strictures was conservative initially, (observation 6, PTC 11, ERCP 5) but
4 patients ultimately required conversion from D-D to R-Y. 96% (123/128)
of patients are currently free of any biliary symptoms. One graft was lost due
to stricture in a patient who is now relisted for transplant.
Conclusions. D-D anastomosis is safe after RLDLT and provides access for
future endoscopic therapy in cases of leak or stricture. When presented with
]/2 bile ducts, ductoplasty should be considered to reduce the chance of
stricture. Although biliary strictures after RLDLT are common, they can
usually be managed nonoperatively and do not affect short-term graft
survival.
FC 11.06
A COMPARISION OF OUTCOMES BETWEEN RIGHT LOBE
LIVING DONOR AND DECEASED DONOR LIVER TRANSPLAN-
TATION ANAYLZED FROM THE TIME OF LISTING
Shah, SA; Levy, GA; McGilvray, ID; Smith, R; Adcock, LD; Gallagher, G;
Girgrah, N; Lilly, LB; Greig, PD; Cattral, MS; Grant, DR
University of Toronto, Multi-Organ Transplantation Unit, University Health
Network, University of Toronto, Toronto, Canada
Right lobe living donor liver transplantation (RLDLT) has not been adopted
as a fully accepted therapy for patients with end-stage liver failure (ESLD) in
the western hemisphere because of concerns about donor safety and
potentially inferior recipient outcomes.
Methods. An analysis of outcomes from the time of listing for all adult
patients who were listed for liver transplantation from 20002006 at our
center was performed. Populations were compared using descriptive statis-
tics, chi-square tests, and log rank analysis of Kaplan-Meier survival curves.
Results. From 04/2000 to 04/2006, 1091 patients were listed for liver
transplantation. 154 patients (Group 1; 14%) had suitable live donors and
underwent RLDLT. No patient were removed from the waiting list or died
with a suitable live donor available. There were no live donor deaths and no
donor suffered any permanent disability. Of the remaining patients (Group 2;
n/937), 350 underwent DDLT; 299 died or dropped off the waiting list;
and 288 were still waiting at the time of this analysis. Recipient age, diagnosis,
and hospital status, were not different between the two groups. Group 1 had
shorter mean waiting times (6.0 vs. 9.4 months; pB/0.001). Groups 1 and 2
had similar medical MELD scores at the time of listing (14.7 vs. 15.8; p/
0.142). Medical MELD scores at the time of transplant were significantly
different between RLDLT and DDLT (15.4 vs. 19.5;p/0.002) Patients in
Group 1 had a significant survival advantage with RLDLT from the time of
listing (Figure 1; pB/0.001). From 20002006, ninety-day, 1-year and 5-year
patient survival after transplantation were equivalent (RLDLT: 99%, 91%,
80% vs. DDLT: 97%, 93%, 81%; p/0.764).
Conclusions. To our knowledge, this is the first report to document a
survival advantage at time of listing for RLDLTover DDLT. With experience,
survival after RLDLT is comparable to survival after DDLT.
FC 11.07
LIVING DONOR LIVER TRANSPLANTATION FOR PATIENTS
WITH HCC EXCEEDING MILAN CRITERIA
Takada, Yasutsugu; Ito, Takashi; Ueda, Mikiko; Egawa, Hiroto; Uemoto,
Shinji
Kyoto University, Surgery, Kyoto, Japan
Background. Optimal indications for living donor liver transplantation
(LDLT) for patients with hepatocellular carcinoma (HCC) have yet not been
established.
Aim. At our institute, the patient exclusion criteria include only those with
extrahepatic metastasis or macroscopic vascular invasion. In the study
presented, results of our LDLT for HCC patients, including those who
exceeded Milan criteria, were evaluated.
Patients and methods. Between February 1999 and October 2005, 123
patients with HCC underwent LDLT. Except for 11 cases with incidental
tumors, 62 patients met Milan criteria (MC) and 50 did not (over-MC) by
preoperative imaging studies. The median follow-up period was 36 months.
Results. Patient survival rates at 5 years in MC and over-MC groups were
similar and 73% and 63%, respectively. To date, postoperative recurrence of
HCC occurred in 16 patients. Cumulative recurrence rates at 5 years were
significantly higher in over-MC group (31% vs. 13% pB/0.05). In over-MC
group, a subgroup of patients (n/28) with no more than 10 tumors and all
no larger than 5 cm in diameter showed significantly lower 5-year recurrence
rate than the others (n/22) (10% vs. 65%, pB/0.05). In addition, 5-year
patient survival rates differed significantly between the subgroups (88% vs.
29%, pB/0.05).
Conclusion. Although the recurrence rate was significantly higher for the
over-MC group than for the MC group, the results of subgroup analysis
suggest the criteria may be safely extended up to no more than 10 tumors and
all no larger than 5 cm in diameter with acceptable outcome.
FC 11.08
PRIMARY LIVER TRANSPLANT WITH LEFT LATERAL SEG-
MENT GRAFTS: RESULTS IN 199 CHILDREN
Corno, Vittorio; Dezza, MariaClara; Lucianetti, Alessandro; Pinelli, Dome-
nico; Zambelli, Marco; Guizzetti, Michela; Maldini, Gregorio; Giovanelli,
Mara; Alberti, Daniele; Codazzi, Daniela; Melzi, Maria L; Torre, Giuliano;
Colledan, Michele
Ospedali Riuniti, General Surgery Liver-Lung Transplant Unit, Bergamo,
Italy
Introduction. Use of split liver grafts have reduced mortality on the waiting
list to near 0%.
Methods. From October 1997 to February 2006 we performed 309 liver
transplants in 272 children. A total of 243 (79%) split liver grafts were
used. We analyzed 199 children (median age 0, 98, range 0, 0814, 55
years; weight median 8, 0, range 2, 335 kg) who received a left lateral
segment split graft as a primary liver transplant. 4 children received a
concomitant kidney transplant. 198 children received a primary liver
transplant and one child received a primary liver transplantation at our
Center as a late re-transplant. Indications for were biliary atresia (62,
5%), Byler disease (4%), Alagille syndrome (8, 5%), cancer (5%),
fulminante hepatic failure (4, 5%), metabolic (5%), cryptogeneic (3%),
others (7, 5%). Among the recipients 14 (7%) children were in UNOS
status 1, 12 (6%) in status 2A, 68 (34%) in status 2B and 105 (58%)
were in status 3.
Results. Apart from status 1 no child died on the waiting list. Overall 1 and 5
years patient/graft survival was 89%/83% and 85%/79% respectively. Con-
sidering separately the periods of the years 19972003 and 20042005, 1
year patient/graft survival were 88%/82% and 94%/87% respectively. Hepatic
artery thrombosis occurred in 10 (5%) children. Portal vein thrombosis
(PVT) occurred in 16 (8%) patients. In 9 cases was an early thrombosis and
in 7 patients was a late thrombosis. Through the entire period mortality for
PVT was 25%; no mortality due to PVT occurred during the last 2 years.
Overall, incidence of biliary complications was 31%, those surgically
managed were 8% and those conservatively managed were 23%. Re-
transplantation rate was 10%.
Conclusion. Also at a high volume split procedure center a continuous
learning curve and technical improvements allowed for these short and long
term results. Use of split liver graft revealed to be the technique of choice for
pediatric liver transplantation.
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EMERGENCY SUBTOTAL HEPATECTOMY WITH TEMPORARY
HEPATIC SUPPORT BY AUXILIARY LIVER TRANSPLANTATION
FOR PARACETAMOL INDUCED ACUTE LIVER FAILURE
Lodge, J Peter A; Dasgupta, Dowmitra; Attia, Magdy; Prasad, K Rajendra;
Toogood, Giles J; Davies, Mervyn; Millson, Charles; Wyatt, Judith;
Robinson, Philip J; Bellamy, Mark C; Pollard, Stephen G
St James’s University Hospital, HPB and Transplant Unit, Leeds, UK
Background. Paracetamol (acetaminophen) overdose (POD) has recently
emerged as the leading cause of acute liver failure (ALF) in the United States,
with an incidence approaching that seen in the UK.
Objective. We describe a new way to treat POD ALF patients fulfilling
King’s College criteria for ‘‘super-urgent’’ liver transplantation.
Methods. Beginning in June 1998 we have been piloting a clinical program
of subtotal hepatectomy and auxiliary orthotopic liver transplantation (ALT)
for POD ALF. Our technique is based on the following principles: [1]
Subtotal hepatectomy; [2] Auxiliary transplantation of a whole liver graft; [3]
Gradual withdrawal of immunosuppression after recovery. Results were
compared with patients who had an orthotopic liver transplant (OLT) for
POD ALF in the same period. Quality of Life comparisons were carried out
using the SF36 questionnaire.
Results. 13 patients underwent this procedure between June 1998 and
March 2005. Median survival is 48 months (range 071m). Actual survival
data shows: 9 of 13 patients are alive (69%) compared to 7 of 13 OLT
patients (54%). One ALT patient required a retransplant with an OLT due to
hepatic vein thrombosis and immunosuppression is therefore maintained.
The other 8 surviving ALT patients are off immunosuppression. These 8
ALT patients have normal liver function and have a better QOL compared to
the 7 surviving OLT patients.
Conclusion. Our results with this new technique are encouraging: 69%
actual survival, no long-term immunosuppression requirement and improved
quality of life in the 60% successful cases.
FC 11.10
PORTA-CAVAL SHUNTING IN PIGGY-BACK LIVER TRANS-
PLANTATION
Currie, Ian1; Walsh, Tim2; Garden, James1; Madhavan, Krishnakumar2;
Fleming, Simon3; Parks, Rowan1
1University of Edinburgh, Clinical and Surgical Sciences (Surgery), Edin-
burgh, UK; 2Royal Infirmary of Edinburgh, Scottish Liver Transplant Unit,
Edinburgh, UK; 3Royal Cornwall Hospitals Trust, Dept. of Gastroenterol-
ogy, Plymouth, UK
Background. Surgical occlusion of the portal vein in piggy-back orthotopic
liver transplantation (OLTx) may cause adverse visceral and systemic
sequelae.
Aim. A randomised study was conducted to determine whether temporary
porta-caval shunting during OLTx would reduce adverse effects of portal
occlusion.
Methods. Informed consent was obtained from 22 patients who were
assessed electively as suitable for OLTx. After anaesthesia, patients were
randomised to undergo OLTx with (n/11) or without (n/11) porta-caval
shunting. Portal and systemic pressures, and biochemical indices of
ischaemia, were measured in portal and arterial blood. Pre- and post-
operatively, gut permeability was determined using a dual sugar (Lactulose/
Rhamnose) absorption test.
Results. Portal venous pressures (Median (Interquartile Range)) were
similar at the start (shunt; 21(1828) vs no shunt; 23(1826)mmHg)
and end (15(12 17) vs 15(1116.5)mmHg) of surgery. In the shunt
group of patients, portal pressure fell on establishing shunt flow (30
(23.536) vs 11(818) P/0.005). This increased the arterio-portal
pressure gradient (gut perfusion pressure) from 45 (38.5 51.5) to 65.5
(50.570.5)mmHg (P/0.005). Portal venous H/, bicarbonate or lactate
was unchanged by shunting. Total blood loss was similar (3829 (3135
7905) vs 3855 (18404589) ml; P/0.673) as was operative duration
(410 (342438) vs 325 (316386) minutes; P/0.231) in shunt and no-
shunt groups respectively. There was a significant increase in gut
permeability ratio 24 hours after OLTx in the no-shunt group (0.032
(0.0240.035) vs 0.206 (0.1220.331) P/0.043) which was not ob-
served in the shunt patients (0.032 (0.027 0.053) vs 0.164 (0.076
0.277) P/0.161).
Conclusions. Porta-caval shunting during piggy-back OLTx reduces portal
pressure intra-operatively and gut barrier dysfunction post-operatively. These
data suggest that porta-caval shunting may provide modest benefits in piggy-
back liver transplantation.
FC 12.01
RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED
TRIAL OF INTRAVENOUS ANTI-OXIDANT THERAPY IN
SEVERE ACUTE PANCREATITIS
Siriwardena, Ajith1; Mason, James2; Balachandra, Srinivasan1; Bagul, Anil1;
Galloway, Simon3; Formela, Laura4; Hardman, Jon1; Jamdar, Saurabh1;
Virlos, Ioannis1
1Manchester Royal Infirmary, HPB Unit, Dept. of Surgery, Manchester, UK;
2Wolfson Research Institute, School for Health, University of Durham,
Durham, UK; 3Wythenshawe Hospital, Upper GI Unit, Manchester, UK;
4Hope Hospital, Oesophago-gastric Unit, Salford, UK
Introduction. Although several small studies have suggested that anti-
oxidant supplementation ameliorates acute pancreatitis, there is no sub-
stantive evidence. This study undertakes the first randomised, double-blind,
placebo-controlled trial of anti-oxidant therapy in human severe acute
pancreatitis.
Methods. Patients admitted with a clinical diagnosis of acute pancreatitis
were eligible for inclusion if their admission APACHE II score was 8 or more.
Principal inclusion criteria were ability to give informed consent, disease
durationB/72 hours and patients not on anti-oxidant therapy. Patients were
randomised to receive intravenous n-acetylcysteine, selenium and ascorbic
acid or three equivalent volume placebos. All complications were character-
ized according to Atlanta conference criteria. Principal end-point was daily
organ dysfunction scores during the first 7 days.
Results. 43 patients were randomized. Groups were statistically similar in
terms of age, gender, etiology, and APACHE II. Anti-oxidant levels fell in
from admission in placebo but not in the treatment group. Analysis of
primary endpoint showed 7 patients to have triggered organ dysfunction
during the first 7 days in the anti-oxidant group (7/22 [31%]) compared
to 4 of 21 (19%) in placebo. This difference was not statistically
significant (P/0.49 Fisher’s exact 2-sided). There was no difference in
the incidence of individual organ dysfunction, complications or mortality.
Overall 4 patients died (all in the anti-oxidant group) [P/0.11; Fisher’s].
Although the trial was underpowered to detect change: with 43 patients
the original power calculation has a 60% risk of a type II error (or 40%
power) further recruitment is unjustified as the probability of benefit is
low.
Conclusion. The results show no evidence of benefit from treatment.
Although underpowered, the final analysis suggests that there is unlikely even
to be a trend towards benefit from treatment. Anti-oxidant therapy should
not be used in severe acute pancreatitis outwith further trials.
FC 12.02
BILE ACID AND ETHANOL METABOLITE POTENTIATE
SECOND MESSENGER-DEPENDENT INTRACELLULAR CA2
RELEASE WITH NECROTIC CELL DEATH WHEN ATP IS
ABSENT
Murphy, John1; Criddle, David N2; Tepikin, Alexei V2; Neoptolemos, John
P1; Petersen, Ole H2; Sutton, Robert1
1Royal Liverpool University Hospital, Division of Surgery and Oncology,
Liverpool, UK; 2University of Liverpool, Physiological Laboratory, Liver-
pool, UK
Introduction. A sustained rise in the cytosolic [Ca2] causes premature
intracellular digestive enzyme activation. Bile salts and alcohol metabolites
produce such pathological [Ca2] elevations. Here we evaluate the role of the
second messengers inositol trisphosphate (IP3), nicotinic acid adenine
dinucleotide phosphate (NAADP), cyclic-ADP-ribose (cADPr) and their
receptors mediating Ca2 release from the endoplasmic reticulum.
Methods. Mouse pancreatic acinar cells loaded with a Ca2-sensitive
fluorescent dye were examined by confocal microscopy. IP3, NAADP or
cADPr were applied internally via a patch pipette. Taurolithocholic-3-
sulphate (TLCS) or palmitoleic acid ethyl ester (POAEE) were perfused
extracellularly (10 mM, which did not induce [Ca2] elevations alone).
Whole-cell recordings of Ca2-dependent Cl current were made. Cell
viability was assessed by propidium iodide uptake with high (4 mM), or zero
(0 mM) ATP in the pipette.
Results. IP3 (12 mM) induced typical local [Ca2] rises in the granular
pole. Extracellular TLCS or POAEE transformed this response into
prolonged (/30 sec), global [Ca2] elevations (TLCS 20 of 24 cells;
POAEE 24 of 29) prevented by the IP3 receptor antagonist caffeine (20
mM). Similar transformations occurred when TLCS (27 of 28), but not
POAEE (15 of 15), were added on top of cADPr (1015 mM) and when
POAEE (17 of 19), but not TLCS (11 of 12), were added on top of NAADP
(50 nM). Prolonged, global transformation consistently induced cellular
necrosis, which was prevented by supplementary ATP (8 of 8). No cellular
necrosis was observed without Ca2 signal globalisation.
Conclusion. Low dose bile salt or a non-oxidative alcohol metabolite can
induce pancreatic injury by sensitizing Ca2 release channels to physiological
second messengers, causing pathological Ca2 release, mitochondrial
depolarisation and necrotic cell death, which can be prevented by adding
ATP intracellularly. We suggest internal Ca2 release channels may be
suitable therapeutic targets in acute pancreatitis.
FC 12.03
REDUCTION OF HEMEOXYGENASE-1 EXPRESSION IS AC-
COMPANIED BY INCREASED PRODUCTION OF REACTIVE
OXYGEN SPECIES IN THE LIVER DURING ACUTE PANCREA-
TITIS
Yip, Vincent S1; Powell, James J1; Bellamy, Christopher O2; Black, James R1;
Wigmore, Stephen J3; Ross, James A1; Garden, O James1
1University of Edinburgh, Dept. of Clinical and Surgical Sciences, Edin-
burgh, UK; 2Royal Infirmary of Edinburgh, Dept. of Pathology, Edinburgh,
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UK; 3University of Birmingham, Liver Unit, Dept. of Surgery, Birmingham,
UK
Background. Reactive oxygen species (ROS) are produced during oxidative
stress causing damages to surrounding cells. Inducible hemeoxygenase 1
(HO1) is a heat shock protein that protects cellular structures from oxidative
damage. Modulation of oxidative stress has been proposed as a potential
intervention in acute pancreatitis (AP).
Aims. Given the central role of the liver during periods of oxidative insult,
levels of hepatic HO1 expression and ROS were determined during
experimental AP.
Methods. AP was induced by intraperitoneal injection of either arginine (Ar)
or cerulein (Ce). 90 Fischer/Lewis rats were divided into 3 groups (Ar, Ce
and control) and were euthanized (n/6/group) at fixed time points between
day 1 and day 14 post-induction. Specimens of liver were immediately frozen
or formalin fixed. AP was confirmed by histology and biochemistry. HO1
expression was localised by immunohistochemistry and quantified by
Western blot. ROS production was quantified indirectly by measuring
malonaldehyde (MDA) in lipid peroxidation and glutathione peroxidase
(GPx) activity. Appropriate statistical tests were used.
Results. HO1 expression in the liver was localised to Kupffer cells and was
up-regulated in Ar and Ce groups at Day 1 (pB/0.01 both groups). HO1
expression at Day7 (p/0.01) and Day 14 (p/0.02) was significantly
reduced in the Ar group vs control. MDA concentration increased signifi-
cantly in the Ar group at Day 3 (p/0.001) and Day 10 (pB/0.05). This
increase of lipid peroxidation at day 3 in the Ar group was coherent with a
significant reduction of GPx activity vs control (pB/0.01). A similar pattern
of MDA concentration and GPx activity was observed in the Ce group but
did not achieve statistical significance.
Conclusion. During experimental AP, hepatic expression of HO1 is
initially increased but falls during the recovery period. In Ar-induced AP,
increased ROS occurs at the time when HO1 is falling. Interventions that
alter levels of HO1 expression may influence the oxidative status in the liver
during AP.
FC 12.04
MACROPHAGE MIGRATION INHIBITORY FACTOR IS AN
EARLY MARKER OF PANCREATIC NECROSIS IN ACUTE PAN-
CREATITIS
Rahman, Sakhawat H; Menon, Krishna V; Holmfield, John HM; McMahon,
Michael J; Guillou, J Pierre
Leeds Teaching Hospitals NHS Trust, Division of Surgery, Leeds, UK
Objective. To determine if 24-hr blood concentrations of Macrophage
migration inhibitory factor (MIF), soluble CD14 and CD163 receptors,
could predict complications associated with acute pancreatitis (AP). Sum-
mary Background Data: Soluble receptor proteins derived from the macro-
phage-monocyte lineage potentiate the inflammatory cytokine response early
in AP. Understanding the temporal expression of these molecules could
afford better measures for therapeutic intervention.
Methods. Patients with AP (amylase /5x normal) were recruited within 24-
hrs of onset of pain. Peripheral blood was analysed for MIF, sCD163, and
sCD14 levels and levels correlated with CRP, APACHE-II score, and clinical
disease severity (Atlanta criteria); sub-classified as multi-organ dysfunction
(MOF), pancreatic necrosis (PN /30% on contrast CT), and death.
Results. In total 64 patients with AP [severe 19-8 had MOF alone, 7 both
PN and MOF, 2 PN without MOF, and 2 single organ-failures with local
septic complications] were recruited. Both sCD14 and MIF concentrations
were elevated in patients with severe attacks (P/0.004 and PB/0.001
respectively), and patients who developed MOF (P/0.004 and PB/0.001).
However, only serum [MIF] was significantly raised in patients who
subsequently developed PN (median; 92.5 ng/ml [IQR:26 181] vs. 31.1
ng/ml [IQR:5 82], PB/0.001), independently of MOF (P/0.01). Multi-
variate analysis demonstrated serum [MIF] as an independent predictor of
PN (P/0.01, O.R/2.73 (95% C.I. 2.722.74).
Conclusion. The prognostic utility of 24-hr plasma MIF concentration in
predicting PN has major clinical and health care resource implications. Its
mechanistic pathway may afford novel therapeutic interventions in clinical
disease by using blocking agents to ameliorate the systemic manifestations of AP.
FC 12.05
ROLE OF D-DIMER IN EARLY PREDICTION OF SEVERITY IN
ACUTE PANCREATITIS
Radenkovic, Dejan1; Bajec, Djordje1; Ivancevic, Nenad1; Milic, Natasa2;
Karamarkovic, Aleksandar1; Jeremic, Vasilije1; Gregoric, Pavle1; Djukic,
Vladimir1; Karadzic, Borivoje1; Stefanovic, Branislav1
1Center for Emergency Surgery, Emergency Center, Clinical Center of
Serbia and School of Medicine University of Belgrade, Belgrade, Serbia and
Montenegro; 2Institute for Medical Statistics, School of Medicine, University
of Belgrade, Belgrade, Serbia and Montenegro
Background. Clinical studies in acute pancreatitis (AP) suggest activation of
haemostatic system. Early, accurate and reliable prediction of severity in AP
is very important in the clinical practice.
Aim. Aim of this prospective study was to assess whether early haemostatic
abnormalities play a role in prediction of severity in AP.
Methods. From January 2004 until April 2005 a total of 91 patients with AP
treated in our Institution were included. Measurement of coagulation,
anticoagulation and fibrinolysis parameters: prothrombin time, activated
partial thromboplastin time, fibrinogen, antithrombin III, protein C,
plasminogen activator inhibitor-1, d-dimer, a2-antiplasmin and plasminogen
were done on admission and 24 h after. The severity of AP was defined
according to the Atlanta classification system. At the end of study, groups of
33 patients with severe and 58 patients with mild form of disease were
compared.
Results. On admission, the mean d-dimer concentration was 682 mg/l
(sd.460) for severe and 258 mg/l (sd. 182) for mild disease (pB/0, 001). On
first day after admission respective values were 835 mg/l (sd.428) and 336 mg/l
(sd.206 pB/0, 001). The sensitivity, specificity, positive predictive, and
negative predictive values of the test to show severe AP compared with mild
AP on admission (/414, 00 mg/l or 1, 7 fold higher than uperr limit), were
73%, 91%, 83%, and 82% respectively, and 24 h after admission (/525, 50
mg/l or 2, 1 fold higher than upper limit), were 76%, 82%, 72.%, and 82%.
The levels of all other measured parameters were significantly different
between the patients with severe and mild AP, but all values were within
physiological limits.
Conclusion. Prediction of severity is already possible on patients admission
to the hospital with high sensitivity and specificity. D-dimer as single test
parameter significantly contributes to an improved stratification of patients at
risk to develop severe AP and deserves routine clinical application.
FC 12.06
GUT BARRIER DYSFUNCTION IN CRITICALLY ILL SURGICAL
PATIENTS WITH ABDOMINAL COMPARTMENT SYNDROME
Al-Bahrani, Ahmed1; Schofield, David2; Darwish, Ammar2; Snider, RH3;
Nylen, ES3; Becker, Kenneth3; Barclay, Robin4; Ammori, Basil2
1Hemel Hempstead Hospital, Hemel Hempstead, UK; 2Manchester Royal
Infirmary, Surgery, Manchester, UK; 3George Washington University and
Veterans Affairs Medical Center, Washington DC, USA; 4The Royal
Infirmary, Scottish National Blood Transfusion Services, Edinburgh, USA
Background & aims. Abdominal compartment syndrome (ACS) refers to
the association of intra-abdominal pressure of 12 mmHg or greater with
organ(s) failure. The aim of this study was to investigate the effect of ACS
and of enteral feeding on gut barrier function in critically ill surgical patients.
Methods. This prospective study involved patients with severe acute
pancreatitis or intra-abdominal sepsis. Intra-abdominal pressure (IAP) was
measured serially, and blood samples were obtained simultaneously for
measurement of xanthine oxidase (XO) activity (a mediator of gut barrier
dysfunction), and systemic markers of gut barrier dysfunction [IgG and IgM
anti-endotoxin antibodies, calcitonin precursors (CTpr)].
Results. Amongst 32 patients included in this study, 16 (50%) patients
developed ACS with a median (range) peak IAP of 20 (1534) mmHg.
Patients with ACS had significantly higher systemic XO activity (p/0.0001),
depleted IgG antibodies (p/0.0002), more significant depletion of IgM
antibodies (pB/0.0001), and higher CTpr concentrations (p/0.013). A
significant negative correlation was observed between IAP and serum IgG
concentrations (p/0.003). Day-to-day tolerance of enteral nutrition was
significantly more frequent in patients without ACS (p/0.047). Adminis-
tration of enteral nutrition for continuous 7 days or more (n/8 patients) was
associated with a significant reduction in systemic XO activity (p/0.025)
and significant recovery of serum concentrations of IgG (p/0.028) and IgM
(p/0.028) compared with pre-feed levels.
Conclusions. ACS in critically ill surgical patients is associated with greater
systemic oxidative stress and gut barrier dysfunction. Enteral feeding has no
detrimental effect on IAP and enhances the recovery of gut barrier function.
FC 12.07
DELAYED TRANSABDOMINAL LAPAROSCOPIC PANCREATIC
DEBRIDEMENT (LPD) IS A SAFE AND FEASIBLE TREATMENT
OPTION FOR NECROTIZING PANCREATITIS
Parekh, Dilip
University of Southern California, Surgery, Los Angeles, USA
Introduction. Pancreatic debridement is associated with a substantial
morbidity (/50% from sepsis, enteric or wound complications) and
mortality. Delayed pancreatic debridement allow a sequestrum to form and
has a substantially lower mortality. The indications, timing and outcome of
LPD are unclear since only anecdotal reports have appeared.
Methods. A retrospective analysis of a prospective database. LPD was
performed utilizing a hand access device (Gelport†). A preop CT scan
identified areas of pancreatic necrosis for debridement.
Results. 23 patients with severe pancreatitis requiring surgery for recurrent
septic episodes or intractable symptoms were evaluated. 17/23 patients failed
conservative treatment with radiological intervention. Nineteen patients
underwent LPD and in 18 the procedure was completed, one patient
converted for an enteric injury. In the LPD group the mean age was 54 yr,
BMI 32.09/2.6, ASA score 3.4 and 7/19 had organ failure. The median
duration of conservative treatment was 65 (22154) days. The operating
time for LPD was 1539/10 min, blood loss 352.69/103 cc, there were no
enteric fistulae or major wound problems and mortality was 11%. The time
from onset of pancreatitis to surgery in 9 patients who developed at least one
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adverse event during their hospitalization (initial open or open re-operative
surgery, conversion, death) was 33.99/15.5 compared 89.99/9.5 days in 14
discharged from hospital without any adverse events (pB/0.005). When time
to surgery was after 5 weeks, 2/15patients (13%) developed an adverse event
compared to 5/7 patients (86%) operated earlier (pB/0.005). There were no
differences in age or sterile vs. infected necrosis between the two groups.
Conclusions. In this largest study reported to date we show that LPD is a
feasible and safe new treatment for necrotizing pancreatitis. LPD may
become the preferred surgical option for delayed pancreatic debridement if
a wider experience confirms our results with this procedure.
FC 12.08
VIDEOSCOPIC ASSISTED RETROPERITONEAL DEBRIDE-
MENT IN INFECTED NECROTISING PANCREATITIS AS A
PILOT STUDY TO INTRODUCE A RANDOMISED CON-
TROLLED TRIAL
van Santvoort, Hjalmar C1; Besselink, Marc GH1; Nieuwenhuijs, Vincent B1;
Bollen, Thomas L2; van Ramshorst, Bert3; Gooszen, Hein G1; and Members
of the Dutch Acute Pancreatic Study Group, Netherlands
1University Medical Center Utrecht, Surgery, Utrecht, Netherlands; 2St.
Antonius Hospital, Radiology, Nieuwegein, Netherlands; 3St. Antonius
Hospital, Surgery, Nieuwegein, Netherlands
Background. The current standard for intervention in patients with infected
necrotising pancreatitis (INP) is necrosectomy by laparotomy. Mortality and
morbidity remain high. As an alternative, videoscopic assisted retroperitoneal
debridement (VARD) was introduced as a minimally invasive treatment
strategy. No randomized controlled trial (RCT) has yet compared a
minimally invasive strategy with laparotomy in INP.
Aim. To evaluate our first experience with VARD in preparation for a RCT.
Methods. In case of (suspected) INP a retroperitoneal percutaneous drain is
placed in the (peri-)pancreatic collection, preferably at least 30 days after
onset of disease. If surgery cannot be obviated after a maximum of two
drainage procedures, the collection is approached via a 5 cm subcostal
incision using the drain as guidance and videoscopic assisted debridement is
performed. Patients in whom retroperitoneal access is not possible undergo
laparotomy. All patients treated with VARD in the period April 2001 to
September 2003 were analyzed.
Results. 13 out of 24 patients with INP underwent VARD. Nine complica-
tions occurred in 7/13 patients (54%). An additional laparotomy was needed
in 4/13 patients (31%). One patient (8%) died. Median preoperative
hospital stay was 41 days (range 190), total hospital stay was 100 days
(range 41240). PANTER (pancreatitis, necrosectomy versus minimally
invasive step-up approach) is a RCT in which patients with (suspected)
INP are randomly allocated to maximal necrosectomy by laparotomy
or percutaneous drainage, if necessary followed by VARD. Primary endpoint
is the total of major morbidity and mortality. Patients will be allocated
from 20 hospitals of the Dutch Acute Pancreatitis Study Group in a 3-year
period.
Conclusion. VARD is a feasible technique in a proportion of patients with
INP that needs further definition. PANTER is the fist RCT to compare a
minimally invasive treatment strategy with conventional necrosectomy by
laparotomy.
FC 12.09
AVAILABILITY OF OPEN AND MINIMALLY INVASIVE METH-
ODS OF NECROSECTOMY REDUCES TOTAL HOSPITAL STAY
AND ITU STAY IN INFECTED PANCREATIC NECROSIS
Lochan, Rajiv1; Manas, Derek1; Gould, Kate2; Kilner, Andrew3; Scott,
John4; Oppong, Kofi1; O’Suilleabhain, Christopher1; Jaques, Bryon1;
Charnley, Richard1
1Freeman Hospital, Hepato-Pancreato-Biliary Unit, Dept. of Surgery, New-
castle upon Tyne, UK; 2Freeman Hospital, Dept. of Microbiology, Newcastle
upon Tyne, UK; 3Freeman Hospital, Dept. of Peri-Operative and Critical
Care, Newcastle upon Tyne, UK; 4Freeman Hospital, Dept. of Radiology,
Newcastle upon Tyne, UK
Background and aim. We have employed percutaneous necrosectomy
(from 1999) and endoscopic necrosectomy (from 2002) for the treatment of
infected pancreatic necrosis in an effort to decrease the complications of open
surgery. The impact of these techniques has been assessed.
Methods. Data was collected to compare APACHE 2 score on admission,
ITU stay, total hospital stay and mortality in patients with bacteriologically
confirmed infected necrosis between 1995 and 2005. Comparison was made
between 3 different time periods related to the introduction of each
technique: 19951999 (Group 1: open necrosectomy only, n/33); 1999
2002 (Group 2: open and percutaneous, n/37); 2002- Dec 2005 (Group 3:
open, percutaneous and endoscopic, n/50).
Results. The mean APACHE 2 scores over the three time periods were 10.8,
13.1, 13.3; (p/0.08 ANOVA). Performing multiple linear regression of
outcome as measured by duration of hospital stay against APACHE 2 scores
and availability of each method of necrosectomy, there was a statistically
significant reduction in total hospital stay (p/0.03) and a more significant
reduction in ITU stay (p/0.000) in Group 3 patients {Median (range): 39
(6170) and 7.5 (062) days respectively}who were treated in the time
period when open, percutaneous and endoscopic techniques were offered.
There was no significant difference in mortality rates between the 3 groups.
The APACHE 2 scores, mortality, ITU and total hospital stay among
patients who underwent only open necrosectomy before and after 2001
(when endoscopic necrosectomy was introduced), were unchanged indicating
that the shorter hospital and ITU stays in Group 3 patients were due to the
impact of minimally invasive techniques.
Conclusion. Minimally invasive techniques of necrosectomy reduce total
hospital stay and ITU stay of patients with infected pancreatic necrosis
independent of disease severity. Continued experience with these techniques
will be needed to confirm this in terms of improved mortality and morbidity
rates.
FC 13.01
PREVALENCE OF NONALCOHOLIC STEATOHEPATITS IN A
COHORT OF BARIATRIC SURGICAL POPULATION
Kow, Lilian1; Collins, Jane1; Stahl, Jurgen2; Toouli, James1
1Flinders Medical Centre, Dept. of General and Digestive Surgery, Adelaide,
Australia; 2Adelaide Pathology, Pathology, Adelaide, Australia
Background. Non-alcoholic fatty liver disease NAFLD is increasingly
being recognized to occur more commonly in the obese with a clinico-
pathologic entity that extends beyond uncomplicated steatosis to steatohe-
patitis, advanced fibrosis, liver failure and, in some cases, hepatocellular
carcinoma.
Aims. To determine the prevalence of NAFLD and nonalcoholic steatohe-
patitis NASH in morbidly obese patients undergoing bariatric surgery and to
correlate age, weight, BMI, histologic degree of steatosis and other features
commonly associated with NAFLD, with histologic NASH.
Method. 180 morbidly obese patients (median Body Mass Index BMI 41,
range 3065.7), median age 43, range 1565 yrs) conforming to the
bariatric selection criteria for laparoscopic gastric banding underwent liver
biopsy. A trucut liver biopsy was performed at the time of surgery and
analysed by a single pathologist. The liver biopsies were assessed by applying
histopathological criteria that are accepted in the pathology literature as
useful in the diagnosis and grading of steatohepatitis.
Results. 94% patients underging bariatric surgery were found to have
steatosis. Moderate to severe steatosis (more than 33% & 66% respectively)
occurred in 50.5%. 39% had NASH (defined as steatosis intimately
associated with lobular inflammation of neutrophilic &/or mononuclear type)
of which 48% were classified ranging from mild to moderate. Severe fibrosis
and established cirrhosis were evident in 12.8%. The prevalence of NASH
appeared to correlate with the degree of histologic steatosis. NASH was also
found to be more prevalent in diabetic patients (25%). There was no
correlation between NASH and age, weight or BMI of patients.
Discussion. Hepatic steatosis is very prevalent in our cohort of patients
presenting for bariatric surgery. NASH is also alarmingly prevalent occurring
in 39% of patients with steatosis. These findings support current evidence
that NASH is generally clinically silent and may be another cause for the
excess mortality in the obese population.
FC 13.02
SURGICAL REINTERVENTION AFTER ANTIREFLUX SURGERY
FOR GASTRO-OESOPHAGEAL REFLUX DISEASE; A PRO-
SPECTIVE COHORT STUDY IN 130 PATIENTS
Draaisma, Werner A1; Furnee, Edgar J1; Broeders, Ivo A1; Smout, Andre J2;
Gooszen, Hein G1
1University Medical Centre Utrecht, Surgery, Utrecht, Netherlands; 2Uni-
versity Medical Centre Utrecht, Gastroenterology, Utrecht, Netherlands
Background. Surgical reintervention after antireflux surgery for gastro-
oesophageal reflux disease (GORD) is required in 36% of patients. The
subjective outcome after reintervention has been reported in several studies,
but objective results after these reoperations have hardly been published.
Objectives. The purpose of this study was to assess the symptomatic and
objective outcome in patients who underwent reoperation because of recurrent
reflux symptoms or troublesome dysphagia after primary antireflux surgery.
Methods. Between 1994 and 2005, 130 patients (mean age 48.49/14.1
years) undergoing surgical reintervention after antireflux surgery for GORD
were prospectively studied. Symptomatic outcome was determined by
questionnaires and oesophageal manometry and 24-hr pH monitoring were
performed to assess the objective outcome.
Results. 144 reinterventions were performed in 130 patients, for recurrent
reflux in 75 (65.3%) and troublesome dysphagia in 43 patients (34.7%).
Belsey Mark IV fundoplication through a left-sided thoracotomy was
performed in 78 (54.2%) and re-Nissen or partial fundoplication in 66
patients (45.8%), including 16 laparoscopic procedures. After a mean follow-
up of 60.19/37.2 months, heartburn and dysphagia on a daily basis were
absent or significantly improved in 70% of patients. Oesophageal acid
exposure was normalised in 70.2% of patients who underwent reoperation
for recurrent reflux. In this group of patients, there was a significant
correlation between acid reflux and usage of proton pump inhibitors. In
contrast to those who needed a thoracotomy, objective results were better in
patients with dysphagia who had a laparotomy and correlated with the
decrease in lower oesophageal sphincter pressure.
Conclusion. Reoperative antireflux surgery yielded good symptomatic and
objective results in 70% of patients in this prospective cohort study.
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Morbidity is far from negligible so expectations should be discussed in detail
before reoperation.
FC 13.03
QUALITY OF LIFE DURING POTENTIALLY CURATIVE NEOAD-
JUVANT TREATMENT AND SURGERY OR CHEMORADIOTHER-
APY FOR LOCALLY ADVANCED OESOPHAGEAL CANCER
Avery, Kerry N L1; Barham, C Paul2; Metcalfe, Chris1; Nicklin, Joanna2;
Alderson, Derek3; Donovan, Jenny L1; Falk, Stephen2; Blazeby, Jane M4
1University of Bristol, Dept. of Social Medicine, Bristol, UK; 2United Bristol
Healthcare Trust, Dept. of Surgery, Bristol, UK; 3University of Bristol,
Clinical Sciences at South Bristol, Bristol, UK; 4Clinical Sciences at South
Bristol, University of Bristol, Dept. of Surgery, United Bristol Healthcare
Trust, Bristol, UK
Background. Evidence suggests that survival after definitive chemora-
diotherapy for locally advanced oesophageal cancer may be similar to that
achieved by neoadjuvant treatment and surgery. Little is known about the
relative impact of treatments on quality of life (QOL).
Aim. This prospective study compared QOL between patients undergoing
chemoradiotherapy or neoadjuvant therapy and surgery for stages 2/3
oesophageal cancer.
Methods. Consecutivepatients completedtheEORTCQLQ-C30andOES18
before chemotherapy and 6 weeks, 3, 6 and 9 months after surgery or at similar
time points after starting chemoradiotherapy. Linear regression adjusting for
age, gender, stage, performance status and histology compared QOL.
Results. 131 patients started treatment (80 neoadjuvant and surgery, 51
chemoradiotherapy). Patients selected for chemoradiation were older (69 vs.
62 yrs pB/0.01) and more likely to have squamous cell tumours (33% vs.
80% pB/0.01) than patients selected for surgery. Baseline QOL scores were
similar in both groups. After adjusting for relevant variables, at the 6-week
assessment, scores for physical, role and social function and dyspnoea were
significantly worse in the surgical group (pB/0.01). Comparisons at 3 months
showed that QOL scores were similar in both groups except that dysphagia
was significantly worse in the chemoradiotherapy group. At the 9-month
assessment, QOL scores were mostly similar, except that reflux symptoms
were worse in the surgery group.
Conclusion. Quality of life is temporarily diminished more after neoajduvant
treatment and surgery than after potentially curative chemoradiation treat-
ment. Data may be used to inform consent and a randomised trial comparing
these treatment modalities is required.
FC 13.04
CARDIOPULMONARY ASSESSMENT IN POTENTIAL OESO-
PHAGECTOMY PATIENTS-THE SHUTTLE WALK TEST
Salim, Elnazeer1; Murray, Paul1; Hutchinson, Steven2; Chris J, Stoddard1;
Ackroyd, Roger1
1Royal Hallamshire Hospital, Oesophago-gastric Unit, Sheffield, UK; 2Royal
Hallamshire Hospital, Dept. of Anaesthesia and Intensive Care Unit,
Sheffield, UK
Background. Significant cardiopulmonary disease is a frequent contra-
indication to thoraco abdominal oesophago-gastrectomy in patients with
oesophag -gastric carcinoma. Exercise testing can provide an objective
assessment of cardiac and respiratory reserve. Formal cardiopulmonary
exercise testing (CPX) is expensive and time consuming and not widely
available. The shuttle walk test (SWT) is a simple test used in assessment of
patients with chronic cardiac and respiratory disease. Distance achieved in
SWT correlates closely with CPX measures of oxygen delivery.
Aims. To assess the SWT in the assessment of patients being considered for
oesophago-gastric resection and determine its predictive value of post
operative morbidity and mortality.
Method and results. Of 93 patients undergoing thoraco abdominal
oesophago-gastrectomy 51 patients (55%) undertook a SWT as part of their
pre operative assessment. The distance covered in the SWT in a fixed time
was measured. The overall 30 day mortality was 9% (n/8). Within the SWT
group a clear threshold value was evident. Of 9 patients with a SWT of 350m
or less 5 patients had died within 30 days from cardio respiratory problems
and 2 others remained in ITU. There was no 30 day mortality in patients with
a SWT of /350m.
Conclusion. The shuttle walk test is a simple useful predictor of potential
post operative cardiopulmonary failure in patients being considered for
oesophago-gastric resection.
FC 13.05
INTEROBSERVER AGREEMENT OF LAPAROSCOPIC ULTRA-
SOUND IN STAGING OF UPPER GASTROINTESTINAL MALIG-
NANCIES
Fristrup, Claus; Pless, Torsten; Durup, Jesper; Nielsen, Henning Overgaard;
Hovendal, Claus Peter; Mortensen, Michael B
Odense University Hospital, Dept. of Surgical Gastroenterology, Odense,
Denmark
Background. Patients with upper gastrointestinal malignancies (UGIM)
are often found at advanced stage and only a minor proportion of patients
are candidates for curative surgery. Therefore, preoperative evaluation
is necessary in these patients in order to avoid futile surgical explorations.
For all staging modalities it is important that the results are reproducible
and that interobserver agreement is good. However, the interobserver
agreement has not been evaluated for laparoscopic ultrasound (LUS)
before.
Aim. The aim of the study was to evaluate the interobserver agreement of
laparoscopic ultrasound in staging of upper gastrointestinal malignancies.
Methods. Patients with UGIM scheduled for LUS were eligible, and were
consecutively included in the study. LUS was performed twice during the
same anesthesia by two separate examiners, each blinded for the other
examiners results. Both examiners evaluated the T-, N-, M-stage, and the
resectability. Kappa values were used to evaluate the interobserver agreement.
Results. A total of 109 patients were included in the study (esophagus N/
16, stomach N/32, pancreas N/37, liver N/13, duodenum N/5, bile
duct N/6). There was no significant difference between the overall accuracy
for the examiners. The kappa values for T-stage, N-stage, M-stage, and
resectability was 0.47 (0.350.58), 0.65 (0.480.81), 0.93 (0.741.00),
0.67 (0.530.81), 95% confidence intervals in parenthesis. There were no
false positives with regard to non-resectability.
Conclusion. The interobserver agreement was excellent for assessment of
the M-stage, good for the N-stage and resectability assessment, and moderate
for the T-stage assessment.
FC 13.06
THE VALUE OF ROUTINE CONTRAST RADIOLOGY IN DIAG-
NOSING ANASTOMOTIC LEAKS FOLLOWING ESOPHAGECT-
OMY FOR ESOPHAGEAL CANCER
Van der Zee, Jill A; Tran, Khe TC; Tilanus, Hugo W
Erasmus Medical Center, General Surgery, Rotterdam, Netherlands
Background. Postoperative leakage at the site of the esophago-gastric
anastomosis is a feared complication following esophagectomy because of
its high morbidity and mortality. Therefore most centers perform a routine
contrast swallow postoperatively. However, the value of contrast radiology
with non-ionic watery contrast is still a matter of debate, while apparently not
all leaks are detected with this modality and most detected leaks prove
irrelevant.
Aim(s)/Objective(s). To measure the sensitivity of the contrast swallow in
diagnosing a clinically relevant anastomotic leak.
Methods. Analysis of a prospectively collected esophageal carcinoma
database (19782004) was performed at a single institution. Contrast
radiology with non-ionic watery contrast to evaluate the esophago-gastric
anastomosis was performed routinely before oral intake was begun at a mean
of 7 days postoperatively.
Results. During this 26-year period 1197 patients underwent an
esophagectomy with gastric tube reconstruction. Eighty-three percent (992
patients) received a cervical anastomosis and 17% (198 patients) an
intrathoracic anastomosis. Contrast swallow was performed on 1042
patients (87.1%). Contrast leakage was present in 106 patients (10.2%),
including 92 cervical anastomosis and 14 intrathoracic anastomosis. Seventy-
nine leakages (74, 5%) had no further clinical consequences. Reasons to
abstain from contrast radiology were a clinically apparent leak presenting
with a fistula (N/68), reoperation because of ischemia of the graft or
other reasons including 10 patients that died postoperatively. Routine
contrast radiology identified 27 of 58 patients (46.6%) with clinical signs of
leakage.
Conclusion. With the routinely performed contrast swallow only a marginal
sensitivity of 47% could be achieved, therefore the value of the routine watery
contrast swallow should be questioned.
FC 13.07
ENDOSCOPIC ULTRASOUND REDUCES THE RATE OF R2
RESECTIONS AND OPEN AND CLOSE LAPAROTOMIES IN
OESOPHAGO-GASTRIC CANCER
Jennings, Neil; Sultan, Javed; Wynne, Kamil; Preston, Shaun R; Karat, Daya;
Hayes, Nick; Griffin, S Michael
Royal Victoria Infirmary, National Oesophago-Gastric Cancer Unit, New-
castle upon Tyne, UK
Background. The inability to identify patients with incurable disease prior
to surgery for oesophago-gastric cancer is an ongoing problem. Open and
close laparotomy or residual macroscopic tumour following operation (R2
resection) in patients previously deemed curable represents a failure of
staging.
Aim. To evaluate the effect of endoscopic ultrasound (EUS) in the staging of
oesophago-gastric cancer patients, in terms of the proportion of patients that
subsequently underwent an open and close laparotomy or R2 resection.
Method. Prospectively collected data from 840 patients (511 oesophageal,
329 gastric) presenting from 1993 to 2004 were analysed. Sub-total
gastrectomies were not included in the analysis, as they are occasionally
undertaken with palliative intent. 437 patients underwent EUS as part of
their staging regime. Results compared patients staged with or without EUS.
Analysis with regard to the number of patients that underwent an open and
close laparotomy or an R2 resection for all patients with oesophago-gastric
cancer is presented.
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Results. The addition of EUS to the staging of oesophago-gastric cancer
patients was associated with a significant reduction in the proportion of
patients that underwent an open and close laparotomy or R2 resection
(13.1% to 7.1% (p/0.004)) and (9.7% to5.0% (p/0.01)). Sub-group
analysis for gastric cancer showed a reduction in the laparotomy only rate
(16.9% to 7.1% (p/0.01)). No significant change was seen for R2
resections. Similar sub-group analysis for oesophageal cancer patients failed
to demonstrate any effect with the addition of EUS. Analysis of data
following the introduction of helical CT scanning revealed the same pattern
with a reduced laparotomy only rate seen for gastric cancer patients (36% vs.
8% (p/0.024))
Conclusions. The inclusion of EUS in the staging protocol for gastric cancer
significantly reduces the number of patients with potentially curable tumours
who subsequently undergo an open and close laparotomy. No significant
change was observed for oesophageal cancer.
FC 13.08
PATTERN AND PREDICTOR OF RECURRENCE IN RESECTED
OESOPHAGEAL CANCER
Ayantunde, Abraham; Welch, Neil; Parsons, Simon
Nottingham City Hospital, Oesophagogastric Unit, Dept. of Surgery,
Nottingham, UK
Introduction. The prognosis for oesophageal cancer is poor and significant
numbers of the patients still experience recurrence soon after radical
resection.
Aim. To evaluated the pattern of recurrence after curative oesophagectomy
for cancer and identified factors predictive of recurrent disease.
Patients and methods. A total of 310 consecutive patients who underwent
curative resection for oesophageal cancer between January 2001 and
December 2004 were followed up for evidence of recurrence. Physical
examination was complimented by imaging and endoscopy where indicated.
Results. Of 310 patients, 144 (46.45%) developed recurrence after median
follow up period of 23 (161) months. 80% (116/144) of the recurrences
occurred within two years after surgery and median time to recurrence was 13
(155) months. Recurrence was locoregional in 31.2%, haematogenous in
47.2%, peritoneal dissemination alone in 0.7%. 18.2% had combined
involvement of two or more outlined areas. The median survival after
recurrence was 2.5 (150) months. The perioperative mortality was 8.4%,
40% of the patients died of their cancer and 12.3% from other causes. 14% of
patients with recurrence and 32.6% of those without recurrence are still alive.
The significant predictors of recurrence were nodal involvement, T-stage,
grade of differentiation, involved resection margin on univariate analysis and
only nodal and T-stage on multivariate regression analysis.
Conclusion. Recurrence is common after oesopahgectomy for cancer and
the majority occurred within the first two years after surgery. The most
common recurrence is haematogenous followed by locoregional. Our findings
suggest that systemic treatment is required in addition to surgery to minimise
haematogenous spread.
FC 13.09
REDUCTION IN ADVERSE EVENTS OVER A DECADE IN
1224 PATIENTS DYING WITH GASTRIC CANCER-ROOM FOR
IMPROVEMENT?
Young, Jamie1; Thompson, Alistair1; Kerr, Lynsey2; Stonebridge, Peter3
1Ninewells Hospital, Surgery and Molecular Oncology, Dundee, UK;
2Scottish Audit Of Surgical Mortality, Paisley, UK; 3Ninewells Hospital,
Institute for Cardiovascular Research, Dundee, UK
Background. Despite a declining incidence, gastric cancer still requires
surgical intervention and is a common cause of death worldwide. The aim of
this analysis was to identify adverse events associated with the death under
surgical care for patients with gastric cancer.
Methods. Since 1994, the Scottish Audit of Surgical Mortality (SASM) has
sought peer review of deaths under surgical care in Scotland. Areas of
CONcern or for CONsideration (ACONs) are identified and fed back to the
originating surgical team. Data for patients dying between 19942003
(inclusive) with a diagnosis of gastric cancer were extracted from the SASM
database and analysed for trends over the decade.
Results. A total of 1224 deaths were audited from a total 44, 947 all patients
who died under surgical care and an estimated 10,000 patients diagnosed
with gastric cancer over the decade. The median age was 73 years (range 22
97). The annual number of deaths with gastric cancer under surgical care has
fallen by 58% from 180 in 1993 to 78 in 2003. In the 565 (46%) who had an
operation, 309 distinct ACONs were identified. 65 (21%) from 1994 and
1995 are unknown, 102 (33%) related to operation, 52(17%) medical care,
41(17%) critical care and 18(7%) anaesthetic. Since 1998, there has been a
dramatic fall in the number of ACONs by 80%, even allowing for fewer
operative procedures in recent years. However, in contrast, an anastomotic
leak contributing to death rose steadily to 20% of operative deaths in 2003.
Among the 659 (54%) who did not have an operation only 13 ACONs were
recorded (usually related to terminal care access).
Discussion. This data suggests that attention to technical performance
during gastric cancer surgery may reduce the number of patients who develop
an anastomotic leak and die under surgical care. However, although this
group is a minority of patients diagnosed with gastric cancer, surgical
technical expertise within the context of multidisciplinary team working may
improve the outcome.
FC 14.01
ROLE OF VENOUS DRAINAGE IN PANCREAS TRANSPLANTA-
TION ALONE
Boggi, Ugo; Vistoli, Fabio; Croce, Chiara; Del Chiaro, Marco; Signori,
Stefano; Mosca, Irene; Sgambelluri, Francesco; Gabriella, Amorese; March-
etti, Piero; Rizzo, Gaetano; Mosca, Franco
Regional Referral Center for the Treatment of Pancreatic Diseases, Pisa, Italy
Introduction. Portal drainage (PD) of pancreas grafts has been associated
with improved metabolic profile and fewer rejection episodes than systemic
drainage (SD). These advantages, although not finally proven, would be
especially useful in pancreas transplant alone (PTA) recipients.
Methods. Between December 2000 and February 2006 the venous effluent
of 66 PTA was managed by PD (n/49) or SD (n/17). Exocrine secretions
were drained enterically in all but two recipient. The two groups were well
matched for all baseline characteristics and managed with equivalent
immunosuppressive regimens.
Results. The rate of delayed endocrine pancreas function was 0 in the SD
group vs 2.0% in the PD group. Five grafts were lost in the early post-
transplant course due to vascular thrombosis (1 SD vs 1 PD) and humoral
rejection (0 SD vs 3 PD). One further graft was lost to arterial thrombosis 6
months after PTA. The initial hospital stay averaged 19 days in the SD group
and 20 days in the PD group. Relaparotomy rate (B/3 months) was 11.8% in
SD vs 16.3% in PD. At the longest follow-up all but one recipient (PD, CMV
infection) are alive and well. The overall incidence of infection was 5.9% in
SD vs 12.2% in PD. After a mean follow-up period of 11.0 months 4 acute
rejection episodes (23.5%), all steroid resistant, occurred in SD and 2 grafts
were lost to chronic rejection. Equivalent figures for PD, after a mean follow-
up period of 31.7 months, were 7 acute rejections (14.3%), 6 steroid
resistant, and 5 grafts lost to chronic rejection. Glycemic control was
excellent in both groups, but fasting serum insulin levels were significantly
lower in PD. Patient survival at 1 and 2 years was 100% (SD) vs. 97.8% (PD)
at either time points. Equivalent figures for insulin independence were 85.5%
and 71.3% (SD) vs. 89.6% and 85.0% (PD).
Conclusions. Either routes of venous drainage are suitable for PTA,
although more recipients experience rejection with SD (23.5%) as compared
with PD (14.3%).
FC 14.02
REDUCTION OF SURGICAL COMPLICATION RATE IN PAN-
CREAS TRANSPLANTATION
Boggi, Ugo; Vistoli, Fabio; Croce, Chiara; Del Chiaro, Marco; Signori,
Stefano; Moretto, Carlo; Mosca, Irene; Sgambelluri, Francesco; Amorese,
Gabriella; Marchetti, Piero; Rizzo, Gaetano; Mosca, Franco
Regional Referral Center for the Treatment of Pancreatic Diseases, Pisa, Italy
Introduction. Surgical complications (SC) in pancreas transplantation (PT)
are relevant because they frequently result in graft loss and increase recipient
mortality.
Methods. Between May 1996 and February 2006, a total of 220 PT were
performed, including 114 simultaneous pancreas kidney transplants (SPKTx),
and 106 solitary PT (SPTx). Antithrombotic and antimicrobic prophylaxes
were always instituted and tailored on individual needs. Venous effluent was
created in the portal vein in most instances (52 SPKTx vs 76 SPTx); drainage
of exocrine secretions was enteric (Roux en-Y) in 181 patients (80 SPKTx vs
101 SPTx) and urinary in 39 recipients (34 SPKTx vs 5 SPTx). SC were
defined as the need for relaparotomy (R) during the first 3 months after PTor
during the initial hospital stay, if it was longer than 3 months.
Results. SC occurred in 13.2% of recipients (12.3% SPKTx vs 14.2% SPTx)
after a mean post-transplant period of 10.3 days (11.2 days SPKTx vs 9.7 days
SPTx). Thrombosis (5.2% SPKTx vs 3.8% SPTx) and hemorrhage (4.4%
SPKTx vs 3.8% SPTx) accounted for most R. Duodenal segment leaks
occurred in 1.7% SPKTx recipients and in 0.9% SPTx recipients. R had no
impact on recipient mortality but was associated with decreased kidney graft
survival in SPKTx recipients (p/0.008) and poorer insulin independence in
SPTx recipients (p/0.005). One- and 5-year patient survival for recipients
with or without SC were 90.0% vs 95.1%, and 90.0% vs 90.8%, respectively.
Equivalent figures for kidney graft (SPKTx) was 61.5% vs 94.9% (p/0.008),
and 61.5% vs 87.1% (p/0.008), respectively. Pancreas graft survival, at the
same time points, was 50.0% vs 92.7% (p/0.0001), and 37.3% vs 81.4% (p/
0.0001), respectively.
Conclusions. The impact of SC, consistently achieved below 15%, on graft
survival remains high, but there seems to be less risk on recipient’s life with
prompt diagnosis and immediate R.
FC 14.03
PANCREATICOGASTROSTOMY AS A SALVAGE PROCEDURE
TO TREAT SEVERE POSTOPERATIVE PANCREATIC FISTULA
AFTER PANCREATICODUODENECTOMY
Rosso, Edoardo; Bachellier, Philippe; Ooussoultzoglou, Elie; Nakano, Hir-
oshi; Oshita, Akihiko; Scurtu, Radu; Lucescu, Ioan; Jaeck, Daniel
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Strasbourg, France
Background. PF is the most severe surgical complication after PD. Re-
laparotomy is mandatory for severe PF associated with sepsis or hemorrhage.
Peripancreatic drainage or total pancreatectomy are the procedures most
commonly used. However they are associated with high morbidity and
mortality.
Aim. To report the results of pancreaticogastrostomy as a salvage procedure
for the treatment of severe pancreatic fistula (PF) after pancreaticoduode-
nectomy (PD).
Methods. Between June 1988 and June 2005, 403 patients underwent PD
(pancreaticojejunostomy n/85, pancreaticogastrostomy n/318). During the
same period, 30 patients were treated for postoperative PF after PD including 3
patients referred to our department after pancreatic head resection compli-
cated by PF. Among these 30 patients with PF after PD with, 12 with
pancreaticojejunostomy required re-laparotomy. Eight patients underwent a
total pancreatectomy (Group A) and 4 patients (Group B) underwent a
telescoped pancreaticogastrostomy of the pancreatic remnant. No patient with
pancreaticogastrostomy complicated by PF required a relaparotomy.
Results. The mortality rate was 37, 5% in group A and 0 in group B (p/0,
490). Overall morbidity rate was 83, 3%. Specific and general complications as
well as the length of hospital stay were similar in both groups. One patient in
group B developed a minor postoperative PF which was managed conserva-
tively. Postoperative diabetes occurred in all patients in group A (100%) and in
1 patient in group B (25%) respectively (p/0.018).
Conclusions. The present study suggests that pancreaticogastrostomy should
be considered as an efficient and less invalidating alternative to total
pancreatectomy for treatment of severe PF after pancreaticoduodenectomy.
FC 14.04
RISK FACTORS OF MORTALITY AND MORBIDITY AFTER PAN-
CREATICO-DUODENECTOMY: A MULTIVARIATE ANALYSIS
Muscari, Fabrice1; Suc, Bertrand1; Sharaan, Mohamed1; Duffas, Jean P1;
Hay, Jean M2; Fingerhut, Abe3;, 4
1University Hospital of Rangueil, Digestive Surgery, Toulouse, France;
2University Hospital, Digestive Surgery, Colombes, France; 3University
Hospital, Digestive Surgery, Poissy, France; 4
Background. The aim of this study was to define, by multivariate analysis, the
pre and per-operative risk factors of mortality, intra-abdominal morbidity and
pancreatic fistula after pancreaticoduodenectomy.
Patients. 300 patients (186 men and 114 women) with a mean age of 58 years
(range: 2281) were included in this study. The data were collected
propsectively from 3 French multicentric randomized studies concerning
pancreatic surgery. The primary disease was a pancreatic cancer in 225 cases
(74.6%) and a benign disease in 75 cases (25.4%). The pancreaticodigestive
anastomosis was pancreaticojejunal in 170 cases and pancreaticogastric in 130.
Methods. Eighteen factors were studied. Univariate analysis used Chi square
test and student’s test. The multivariate analysis used a logistic regression
model with the maximum likelyihood ratio (Odds ratio, OR).
Results. The mortality rate was 9% (28/300). Two risk factors were found:
age/70 years (OR/3) and extensed resection (OR/5). The morbidity rate
was 30.5% (90/300). Two risk factors were found: the size of main pancreatic
duct inferior to 3 mm (OR/2) and extended resection (or/5). The rate of
pancreatic fistula was 16.6%. Only one risk factor was found: the size of main
pancreatic duct inferior to 3 mm (OR/2.5).
Conclusion. This study demonstrated that age/70 years was an indepen-
dant risk foctor of mortality, and a main pancreatic duct inferior to 3 mm
independant risk factor of intra-abdominal morbidity and pancreatic fistula.
Furthermore, an extensed resection was a risk factor of mortality and intra-
abdominal morbidity.
FC 14.05
PARTIAL RESECTION OF THE PORTAL VEIN IN PANCREATI-
CODUODENECTOMY DOES NOT INCREASE MORBIDITY AND
MORTALITY
Aselmann, Heiko1; Winkler, Michael1; Oeser, Michael1; Neipp, Michael1;
Hoy, Ludwig2; Mordukhovych, Julia1; Klempnauer, Ju¨rgen1
1Medizinische Hochschule Hannover, General Visceral and Transplantation
Surgery, Hannover, Germany; 2Medizinische Hochschule Hannover, Bio-
metry, Hannover, Germany
Introduction. Pancreaticoduodenectomy (Whipple’s operation) is the treat-
ment of choice for malignancies of the head of the pancreas and the
juxtapapillary region of the duodenum and is an option in chronic
pancreatitis. Especially in malignant diseases, tumor invasion or adherence
of the portal vein is a common occurrence. Therefore, vascular resection is
necessary to achieve R0 situation. The clinical value of this procedure,
however, is still discussed controversially.
Patients and methods. Retrospective analysis of the treatment results of 189
patients undergoing Whipple’s operation from January 2000 until March 2005.
Results. Resection of the portal vein was performed in 45 (17%) patients,
216 (63%) underwent surgery without vascular resection Median age was 62
in patients with and 61 years without vascular resection. Overall hospital
mortality in patients with and without portal vein resection /2/45 (4, 4%) vs.
10/216 (4, 6%), overall morbidity (37% vs. 44%) did not differ significantly
(p/0, 05). Postoperative hemorrhage occurred in 3 patients (7%) with and
27 patients (12%) without portal vein resection. No bleeding from
reconstructed vessels occurred. For types of vascular resection see. Recon-
struction of the portal vein was performed as end/end anastomosis in 34 cases
(75%), in 10 patients (22%) implantation of alloplastic prosthesis was
required and one patient received a venous allograft.
Conclusion. Pancreaticoduodenectomy combined with partial resection of
the portal vein is not associated with increased morbidity and mortality.
Performed by an experienced surgeon, portal venous resection can expand the
resection rate without significantly endangering the patient. Therefore this
treatment option should be considered in these otherwise irresectable patients.
FC 14.06
ASSESSMENT OF COMPLICATIONS AFTER PANCREATIC SUR-
GERY: A NOVEL GRADING SYSTEM APPLIED TO 633 PATIENTS
UNDERGOING PANCREATICODUODENECTOMY
de Oliveira, Michelle L1; Winter, Jordan M2; Schafer, Markus1; Cunning-
ham, Steven C2; Cameron, John L2; Yeo, Charles J2; Clavien, Pierre-Alain1
1University Hospital of Zurich, Dept. of Visceral and Transplant Surgery,
Zurich, Switzerland; 2The Johns Hopkins Medical Institutions, Baltimore, USA
Objective. To define a simple classification of complications following
pancreaticoduodenectomy (PD) based on a severity grading system.
Background. While mortality is rare after PD, morbidity remains high. The
lack of standardization in evaluating morbidity after PD has hampered
meaningful comparisons. We adapted a novel classification of complication to
stratify morbidity by severity, to test whether the incidence of pancreatic
fistula (PF) has changed, and to identify risk factors (RF) in a North
American center.
Material & Methods. The classification was applied to 633 pat. undergoing
PD between 2/2003 and 8/2005. Another series of 227 pat. treated between
1987 and 1990 was also analyzed to identify changes in the incidence and
severity of PF. Uni and multivariate analyses were performed to link
respective complications with different parameters.
Results. 263 (41.5%) pat. had no complications, while 370 (58.5%) had
at least one complication. 62 (10%) pat. had grade 1 complications (no
need for specific intervention), 192 pat. (30%) had grade 2 (need for
drug therapy), 85 pat. (13.5%) grade 3 (need for invasive therapy), and
19 pat. (3%) grade 4 complications (organ dysfunction, ICU stay). Grade
5 (death) occurred in 12 pat. (2%). 57 pat. (9%) developed PF, of which
33 (58%) were classified as grade 2, 17 (30%) as grade 3, 5 (9%) as grade 4,
and 2 (3%) as grade 5. Delayed gastric emptying was found in 80 pat.
(12.7%), half of them were scored grade 2 and the other half grade 3.
Comparable rates (8% vs 9%) and severity (p/0.2) of PF were noted
between the two groups. RF for overall morbidity and complication severity
was cardiovascular disease, while texture of the gland and cardiovascular
disease were RF for PF.
Conclusion. This study demonstrates the applicability and utility of a new
classification in grading complications after pancreatic surgery. This novel
approach may provide a standardized, objective and reproducible assessment
of pancreas surgery enabling meaningful comparison among centers and over
time.
FC 14.07
OBESITY IS A RISK FACTOR OF PANCREATIC FISTULA AFTER
DISTAL PANCREATECTOMY
Rault, Alexandre; Balladur, Pierre; Parc, Rolland; Tiret, Emmanuel; Paye,
Franc¸ois
Hopital Saint Antoine, Paris, France
Introduction. Morbidity after distal pancreatectomy (DP) remains high.
Intra-abdominal complications and pancreatic fistula (PF) are the principal
causes of this morbidity.
Aim. This retrospective study included 67 patients undergoing DP between
november 1996 to november 2003 (acute pancreatitis or pancreatic trauma
excluded). Distal pancreatectomy included a pancreatic section to the left of
the superior mesenteric vein, with or without preservation of the spleen. The
pancreatic remnant was either closed by a linear stapler or hand sutures or
anastomosed to a Roux-en-Y loop.
Results. Median age was 56 years-old. Spleen was preserved in 11 patients.
Indications for resection was malignancy in 31% (11 extra-pancreatic
malignancies, 7 pancreatic adenocarcinomas, 2 pancreatic metastases, 1
sarcoma) and in 69%, benign lesions (25 cystic tumors, 12 neuro-endocrine
tumors, 6 chronic pancreatitis, 3 pancreatic fistulas following necrosectomy.
In 7 cases a gastrectomy was performed. Pancreatic stump was stapled in 14
patients (21%), hand-sewn with main pancreatic duct ligation in 47 patients
(70%). Pancreatico-jejunal anastomosis was performed in 6 cases. Octreotide
was delivered as a prophylactic treatment to 23 patients (34%) Pancreatic
fistula occurred in 20 patients (30%). It has been mainly treated medically
(16 cases by maintaining the drain, 3 radiologic drainage, and 1 surgical
treatment). There was no mortality. Median hospital stay was 14 days
(significantly increased by PF). In univariate analysis only weight (75 kgs/ 63
kgs, pB/0.025), splenic preservation (63%/23%, pB/0.025) and BMI more
than 25 kg/m2(pB/0.005) were identified as risk factors of PF. In multivariate
analysis, BMI/25 kg/m2 was the only risk factor of PF.
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Conclusion. PF is a complication of DP in approximatively 33% of cases.
Obesity is a risk factor of PF which can be treated mostly medically.
FC 14.08
FATTY PANCREAS: A FACTOR IN POSTOPERATIVE PANCREA-
TIC FISTULA
Mathur, Abhishek1; Pitt, Henry A1; Marine, Megan1; Saxena, Romil2;
Schmidt, C. Max1; Howard, Thomas J1; Lillemoe, Keith D1
1Indiana University School of Medicine, Dept. of Surgery, Indianapolis,
USA; 2Indiana University School of Medicine, Dept. of Pathology, Indiana-
polis, USA
Background. Pancreatic fistula continues to be a major cause of post-
operative morbidity and increased length of stay following pancreatoduode-
nectomy. Factors associated with postoperative pancreatic fistula include a
‘‘soft’’ normal pancreas, the underlying pancreatic pathology, the regional
blood supply, and surgeon experience. Fat in the pancreas has been
correlated with age, obesity and diabetes. However, fatty pancreas previously
has not been considered as a contributing factor in the development of
postoperative pancreatic fistula.
Aim. To determine whether patients who develop a pancreatic fistula
following pancreatoduodenectomy are more likely to have pancreatic fat
than matched controls.
Methods. Seventeen patients who developed a pancreatic fistula following
pancreatoduodenectomy were identified. Seventeen controls who did not
develop a fistula, matched for age, gender, pancreatic diagnosis, type of
procedure, and surgeon were chosen from a database of over 500 patients.
Patient demographics including weight, BMI, diabetes, hyperlipidemia and
hypertension (metabolic syndrome) were recorded. Surgical pathology
specimens from the pancreatic neck were reviewed for fat, inflammation,
fibrosis and vessel density. These parameters were scored (04/) by a
pathologist who was blinded with respect to patient demographics and
outcomes.
Results. Control and fistula patients did not differ with respect to BMI (29
vs 27), diabetes (29 vs 12%), hyperlipidemia (12 vs 29%) or hypertension (47
vs 53%). Pancreatic histology scores and percent patients with increased
scores were:
Fat Inflammation Fibrosis Vessels
Controls 1.09/0.0 0.29/0.1 0.89/0.3 2.29/0.3
Fistulas 1.39/0.1* 0.09/0.0* 0.09/0.0* 1.99/0.2
Controls 6% 0% 29% 77%
Fistulas 41%* 0% 0%* 69%
*pB/0.05 vs Controls.
Conclusions. These data suggest that patients with postoperative pancreatic
fistula have 1) increased fat, 2) decreased inflammation and fibrosis and 3)
normal blood vessel density. Therefore, we conclude that fatty pancreas is
another risk factor for postoperative pancreatic fistula.
FC 14.09
138 PANCREATECTOMIES ASSOCIATED WITH VASCULAR RE-
SECTION
Boggi, Ugo1; Del Chiaro, Marco1; Croce, Chiara1; Sgambelluri, Antonio F1;
Signori, Stefano1; Mosca, Irene1; Vistoli, Fabio1; Mazzeo, Salvatore2;
Cappelli, Carla2; Campani, Daniela3; Mosca, Franco1
1University of Pisa, Division of General and Transplant Surgery, Pisa, Italy;
2University of Pisa, Radiology, Pisa, Italy; 3University of Pisa, Pathology,
Pisa, Italy
Background. Traditionally, pancreatic resections are not indicated for
tumors of the pancreas involving main vascular trunks.
Aim. To define the results and prognostic implications of pancreatectomies
associated to vascular resection (PaVR).
Methods. From November 1987 to December 2004, 138 patients under-
went PaVR including 102 isolated vein resections, 16 isolated arterial
resections and 20 combined venous and arterial resections. The results of
this group were compared with patients who underwent ‘‘conventional’’
pancreatectomies (CP) and palliative procedures (PP) for locally advanced
pancreatic cancer.
Results. Overall, 37.6% of patients in the PaVR group developed post-
operative complications as compared to 36.2% in the CP group and 25.8% in
the PP group (p/NS). Mortality rates in the PaVR, CP and PP groups were
5.8%, 5.7% and 3.2%, respectively (p/NS). One, 3 and 5-year actuarial
survival rates of patients diagnosed with pancreatic cancer (110; 79.7%) were
55.3%, 17.6% and 7.9%, respectively. These results were comparable to CP
group (p/NS) and significantly improved on respect to PP group (pB/
0.0001). In PaVR group, for patients diagnosed with ductal adenocarcinoma,
a statistically relevant difference in 1, 3 and 5-year survival rates was found
between no actual tumor invasion or tumor invasion limited to the tunica
adventitia or media as compared to tumor growth till the tunica intima
(63.8%, 21.6%, and 10.7% vs 36.5%, 4% and 4%; pB/0.001). Multivariate
analysis showed that the following parameters were significantly related to
improved survival: antiblastic therapies, tumor grade G1-2, and no actual
vessel involvement or invasion limited to the tunica adventitia or media.
Conclusions. PaVR are comparable to CP and PP as regard to morbidity
and mortality rates. Deep of tumor vascular infiltration, histological grading
and adjuvant or neoadjuvant treatments seem to be the most important
prognostic factors in the outcome of PaVR.
FC 14.10
IMPROVED LONG-TERM RESULTS OF THE PANCREATIC
HEAD CANCER AFTER RESECTIONAL SURGERY; HOW TO
ACHIEVE 5-YEAR SURVIVAL RATE OVER 30%?
Seyama, Yasuji; Kokudo, Norihiro; Hashimoto, Masao; Sano, Keiji; Im-
amura, Hiroshi; Abe, Hideki; Makuuchi, Masatoshi
University of Tokyo, Hepato-Biliary-Pancreato Surgery Division, Tokyo,
Japan
Background. Long-term result of pancreatic head (Ph) cancer after
resection is still poor, therefore patient selection is important for extensive
operation, such as pancreatoduodenectomy (PD).
Aims and objectives. To show the adequate operative indication for Ph
cancer and to elucidate the prognostic factors.
Patients & methods. Between 1994 and 2005, hundred consecutive patients
with Ph cancer were treated by the same operative indication and reviewed
retrospectively. Contraindications for radical resection are distant metastasis,
invasion to perivascular neural plexus at the root of the superior mesenteric
artery (SMA), the celiac artery, and the common hepatic artery (CHA), and
circular invasion to the portal vein. Standard procedure was PD with regional
lymphadenectomy and with retroperitoneal dissection behind the Ph.
Clinicopathological factors were analyzed by uni- and multi-variate analysis.
Results. PD was performed in 66 patients with no mortality. Portal vein
resection and reconstruction was performed in 17 patients. The overall 5-year
survival rate after PD was 35.4%, and mean and median survival was 21.5
and 22.3 months, respectively. Portal vein resection did not influence to the
patient survival significantly. Univariate analysis disclosed that duodenal
invasion, pancreatic cut-end margin, lymphatic invasion, and venous invasion
were significantly influenced to the patient survival. We classified pN1 into
two groups according to the number and the location of lymph node
metastasis; early pN1, up to three metastasis only around the Ph; advanced
pN1, four or more metastases or metastasis along the CHA or the SMA.
Multivariate analysis showed that duodenal invasion and advanced pN1 were
independent prognostic factors.
Conclusion. If adequately indicated, PD provided 5-year-survival of over
30% for patients with Ph cancer. The survival of the patients with early pN1
is not different from that of patients without LN metastasis.
FC 15.01
BILE DUCT INJURY DURING LAPAROSCOPIC CHOLECYS-
TECTOMY: A MULTICENTER STUDY IN JAPAN
Urakami, Atsushi; Tsunoda, Tsukasa; Iki, Katsumichi; Hato, Shinji;
Matsumoto, Hideo; Yamashita, Kazuki; Hirai, Toshihiro
Kawasaki Medical School, Dept. of Gastroenterological Surgery, Kurashiki,
Japan
Background. Bile duct injury (BDI) during laparoscopic cholecystectomy
(LC) is still one of the most serious complications. A survey of a large series
has not been previously performed in Japan. Therefore, we carried out a
retrospective multicenter study to assess the incidence and characteristics of
BDI in Japan.
Method. A questionnaire structured to focus on BDI during LC was sent to
233 hospitals affiliated with the Japanese Society of Biliary Surgery. It
included: the number of LC during five year period (19972002), the
number of BDI, gender, age, preoperative diagnosis, site and type of injury,
Strasberg’s classification, suspected cause, timing of diagnosis, primary
treatment, secondary or further treatment, and prognosis in patients with
BDI during LC.
Results. 201 cases of BDI among 31,000 LC were reported with the
incidence being 0.65%. Of the 201 patients, 96 were male and 106 were
female, and the average age was 56.5 years old. Cholecystolithiasis and
cholecystitis were the operative indications in 89.1%. Regarding the injured
site, the common bile duct was involved in 44.8% and the common hepatic
duct was in 21.9%. As for injury type, partial injury occurred in 56.7% and
transaction in 33.8%. Type D was the most frequent (44.8%), followed by
type E2 (16.4%) according to Strasberg’s classification. Severe inflammation
and misidentification were the two most common causes. Although two
thirds of BDI were diagnosed intraoperatively, 60 BDI (29.9%) were
diagnosed postoperatively. Open surgery was the primary treatment in
71.1%. Laparoscopic treatment was carried out for 18.4% and non-operative
treatment was used for 9.5%. 30 BDI (14.9%) required second or further
procedures, including open surgery, laparoscopic surgery, or radiological
interventions. The overall mortality rate in LC was 0.016% and the mortality
rate after BDI was 2.5%.
Conclusion. The incidence and mortality of BDI in Japan were found to be
similar to those in other Western national surveys.
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REFERRAL AND TIMING OF REPAIR OF BILE DUCT INJURY
PREDICTS OUTCOME
de Reuver, Philip R; Grossmann, Irene; Busch, Olivier R; van Gulik, Thomas
M; Gouma, Dirk J
Amsterdam Medical Center, Surgery, Amsterdam, Netherlands
Introduction. Surgical reconstruction is necessary for severe bile duct injury
(BDI) caused during laparoscopic cholecystectomy. Controversy exists about
the optimal conditions for a reconstructive procedure; the optimal referral
pattern to a tertiary center and the timing of repair are debated.
Aim. To analyse the outcome of reconstructive surgery in BDI patients, and
specifically to assess the role of referral pattern and the timing of the surgical
procedure.
Results. Of a total of 500 patients referred with BDI between 1991 and
2006, 151 patients (30%) underwent reconstructive surgery. Seventy two
patients (47.7%) were primarily referred and 78 patients (57.6%) were
referred after therapeutical interventions in the referring center. Three groups
of patients were categorized according the interval between the laparoscopic
cholecystectomy and the reconstructive procedure. Group A (n/15, 9.9%)
was operated in the acute phase (within 6 weeks), group B (n/96, 63.5%)
underwent a delayed repair (after 6 weeks) and group C (n/40, 26.5%)
included patients operated after ischemic strictures or revision of previous
reconstructions. No hospital mortality occurred in these series and 29
patients (19.2%) were treated for postoperative complications. Complica-
tions occurred in 7.9% of the primary referred patients and in 26.4% of the
secondary referred patients (p/0.04). Postoperative complications occurred
in 33.3% in group A, 15.6% in group B, and 22.5% in group C (p/0.22).
Three factors were independently prognostic for major complications after
reconstructive surgery in BDI patients. Proximal injuries (OR/3.7, 95% CI
1.310.3), secondary referral (4.4, 1.116.8) and repair in the acute phase
after injury (5.4, 1.2 24.4) are associated with a worse outcome.
Conclusion. Proximal injuries, secondary referral to a tertiary center and
acute timing of repair are independent negative predictors on outcome after
reconstructive surgery for bile duct injury.
FC 15.03
MINIMALLY INVASIVE TREATMENT OF OPERATIVE AND
TRAUMATIC TRANSECTION OF MAIN BILIARY DUCT
Fiocca, Fausto1; Salvatori, Filippo Maria2; Santagati, Alessio1; Ceci,
Vincenzo1; Donatelli, Gianfranco1; Fanelli, Fabrizio2; Corona, Mario2;
Vagnarelli, Simone2
1Policlinico Umberto I-University, Emergency Endoscopic Surgery, Rome,
Italy; 2Policlinico Umberto I-University ‘‘La Sapienza’’, Radiology, Rome,
Italy
Introduction. complete transection of the common bile duct (CBD) is a
dramatic and often extremely difficult to repair event that can follow
abdominal trauma or cholecystectomy either laparoscopic or open. Abdom-
inal biliary collection, present also if the CBD is clipped, is the first symptom
and usually ERCP is determinant for diagnosis.
Patients and methods. Since 1991 20 pts with a complete transection of
the CBD, 2 post trauma, 2 after open cholecystectomy and 16 after Lap
cholecystectomy underwent a combined approach for recanalization of the
separate edges of the CBD. After a diagnostic ERCP a small sphincter-
otomy is performed and a guide-wire is passed across the severed edge of
the CBD into the periductal fluid collection. After a cholangiography with
the Chiba needle. A duct of the VI hepatic segment is cannulated and a
snare loop is advanced through the hepatic hilum in the free abdomen to
catch the free end of the wire pushed endoscopically then pulled outside the
body: a 10 F catheter and an internal-external drainage through the papilla
is positioned. After multiple dilatations and a left transhepatic approach, 3
or 4 plastic stents are inserted. After 812 months the stents can be
removed endoscopically. The pts without stents were followed-up with US
and MRI.
Results. After the first external-internal biliary drainage all the pts improved.
3 pts decided to undergo immediate surgery. 17 pts underwent a conservative
treatment: 12 are in good health with a good biliary canalization after
62 years (2 pts died for non related conditions). 5 pts are still under
treatment.
Conclusions. Traumatic interruption of biliary tree does not represent an
indication to an often difficult surgical treatment as the CBD is thin into a
biliary peritonitis, but can be treated with a ‘‘rendez-vous’’ technique for a
complete recanalization. Surgery can be performed in elective conditions
with slight dilatation of the main duct or completely avoided when
conservative therapy is selected.
FC 15.04
FAILURES FOLLOWING SURGICAL REPAIR OF POST CHOLE-
CYSTECTOMY BENIGN BILIARY STRICTURES- MANAGE-
MENT AND RISK FACTORS
Pottakkat, Biju; Kapoor, Vinay K; Sikora, Sadiq S; Kumar, Ashok; Saxena,
Rajan
Sanjay Gandhi Postgraduate Institute of Medical Sciences, Surgical Gastro-
enterology, Lucknow, India
Background. Failures following surgical repair of post cholecystectomy
benign biliary strictures (BBS) pose challenging management problems.
Aim. To define risk factors for failure following surgical repair in patients
with BBS and to analyze their management and out come.
Patients and methods. Records of 276 patients, who underwent Roux-en-
Y hepaticojejunostomy (HJ) for post cholecystectomy BBS between 1989
and 2003, with a minimum follow up of 2 years, were retrospectively analyzed
from a prospectively maintained database. Failure of surgical repair was
defined as cholangitis, deranged liver function tests or re-stricture which
required re-intervention. Univariate and multivariate analyses were done to
define risk factors for failure.
Results. 19/276 (7%) patients had failure following HJ. Patients became
symptomatic after a median of 20 (1144) months following HJ. Post-
operative bilirubin and anastomotic leak following HJ were associated with
failure on univariate analysis. Previous attempts of bilio-enteric repair before
the definitive repair, bile extravasation following bile duct injury, cirrhosis
and atrophy-hypertrophy complex of the liver were significant on multivariate
analysis. 9/19 patients are being managed with antibiotics for occasional
cholangitis. 10/19 patients underwent re-intervention for failures- 4 were
successfully managed with percutaneous transhepatic balloon dilatation,
another 5 with revision HJ and one patient underwent right hepatectomy
for atrophy of the right lobe. One patient died following revision HJ and
another was lost follow up; remaining 8 patients had successful outcome
following re-intervention.
Conclusions. Multiple attempts of bilio-enteric repair predispose to failure
of surgical repair in patients with post cholecystectomy BBS. Judicious
management with combination of percutaneous transhepatic balloon dilata-
tion and revision HJ yields successful outcome in majority of patients who
develop recurrent stricture following HJ.
FC 15.05
PREOPERATIVE DETERMINANTS OF COMMON BILE DUCT
STONES DURING LAPAROSCOPIC CHOLECYSTECTOMY
Sheen, Aali J; Asthana, Sonal; Al Mukhtar, Ahmed; Attia, Magdy; Toogood,
Giles
St James Hospital, Leeds, UK
Background. Over the years it has been debated whether routine or selective
intra-operative cholangiography (RIOC or SIOC) during laparoscopic
cholecystectomy is the preferred method of management to detect asympto-
matic common bile duct (CBD) stones.
Aims. The aim of this study is to determine whether there are any clinical or
biochemical predictors of CBD stones in patients undergoing laparoscopic
cholecystectomy.
Methods. A prospective database of nearly 1000 laparoscopic cholecystec-
tomies performed under the care of a single surgeon with a standardised
technique between 1999 and 2006, was analysed. Clinical presentation,
ultrasound, immediate pre-operative biochemical results as well as the
operative cholangiogram findings were reviewed. Routine cholangiography
was attempted in most patients and the primary outcome variable was the
detection of bile duct stones. The data was analysed using chi-square test for
categorical variables. Significant variables on univariate analysis were further
characterised to identify independent predictors of bile duct stones using a
logistic regression model (significance pB/0.05).
Results. A total of 757 out of 988 patients (77%) underwent cholangio-
graphy. Male to Female ratio was 1:3 with a median age of 54 years (range
1793). 10% of patients had bile duct stones identified on cholangiography.
On univariate analysis Biliary colic (pB/0.001), Jaundice (p/0.019),
Cholangitis (pB/0.001), Alanine transaminase, ALT /100 (p/0.024),
Alkaline phosphatase, ALP/350 (pB/0.001) and CBD /10 mm (p/
0.01) were significant markers for predicting bile duct stones. Bilirubin /
30 (x2 normal) was found not to be significant (p/0.145). On a logistic
regression model ALP/350 and/or Cholangitis were found to be indepen-
dent predictive factors of CBD stones (odds ratio 6.1).
Conclusion. If a policy of RIOC is not adopted a history of Cholangitis or a
raised ALP immediately pre-operatively should lead to a high suspicion of
CBD stones.
FC 15.06
THE IMPACT OF LIVER TRAUMA MANAGED IN A TRAUMA
CENTRE INDEPENDENT OF SURGICAL SPECIALITY
Konig, Thomas1; Aylwin, Christopher2; Walsh, Michael2; Hutchins, Robert3
1St Bartholomew’s and the Royal London Hospital, Trauma Surgery,
London, UK; 2St Bartholomew’s and the Royal London Hospital, Vascular
and Trauma Surgery, London, UK; 3St Bartholomew’s and the Royal
London Hospital, Hepatobiliary and Pancreatic Surgery, London, UK
Aims. To assess the outcome of liver trauma under the care of non-specialist
trauma surgeons.
Background. Liver trauma series in the UK have been reported from
tertiary referral liver units, with a mortality varying from 8.5 to 23%. Modern
management of liver trauma is increasingly conservative. We reviewed our
liver trauma to assess non-liver surgeon’s ability to make correct management
decisions.
Results. 132 patients with liver trauma were admitted over a six year period
(19992005). 6% were transferred from other hospitals. Males made up
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81% and 66% were blunt trauma. The median age was 32 and 16 cases were
paediatric. The average injury severity score was 26. The range of liver
injuries (AAST score) was 21.2% grade I, 31.8% grade II, 23.5% grade III,
17.4% grade IV and 3.7% grade V. This spread did not differ between the in-
house liver team and other trauma surgeons. 75% of patients had other
injuries. Associated injuries are tabulated
Site % cases
Head and face 45
Thoracolumbar spine 17
Cervical spine 6
Chest 63
Other abdominal 40
Pelvic 25
Urological 16
Limb 49
53% of cases were managed conservatively. There were 61 operations. 38% of
cases underwent debridement///suture repair, 2% use of haemostats, 46%
packing and 24% no treatment to the liver. However, only 6.6% of cases had
an operation for the liver only, where no treatment was given. Of the
conservatively-managed cases, the results are tabulated
Grade of injury
% grade treated
conservatively
% conservative treatment
throughout
I 71.4 100
II 61.9 100
III 48.4 97 (one missed jejunal injury)
IV 34.8 100
V 12.5 100
The morbidity overall was 30% and mortality 22.7%. Liver-related morbidity
and mortality however was 6.6% and 10.6% respectively. 5.7% of cases
undergoing conservative treatment died and 16.4% of cases operated upon.
Survival according to severity score was 100%, B/16, 100%, 1625 and
52%, /25. Survival according to grade of liver injury was grade I 100%,
grade II 100%, grade III 93%, grade IV 74% and grade V 25%.
Conclusion. Liver trauma managed in a trauma centre by non-hepatobiliary
surgeons, results in appropriate decison-making and low morbidity and
mortality. Mortality is mainly governed by polytrauma and, in the case of the
liver, by severity of grade of injury.
FC 15.07
PANCREATIC TRAUMA-HOW CAN OUTCOME BE IMPROVED?
Scollay, John M; Yip, Vincent SK; Garden, O James; Parks, Rowan W
University of Edinburgh, Clinical and Surgical Sciences (Surgery), Edin-
burgh, UK
Introduction. The aim of this population based study was to assess the
incidence, mechanisms, management and outcome of patients who sustained
pancreatic trauma in a country with a well defined population (5.06million)
over an eleven year period from 1992 2002.
Methods. The National Trauma Audit Group database was searched for
details of any patient with pancreatic trauma. Data on identified patients were
analysed for demographic information, mechanisms of injury, associated
injuries, haemodynamic stability on presentation, management and outcome.
Results. 111 of 52676 patients (0.21%) were identified as having sustained
pancreatic trauma. The male to female ratio was 3:1 with a median age of 32
years. Blunt trauma accounted for 66% of injuries. Road traffic accidents
were the most common mechanism of injury (44%) followed by assaults
(35%). 34 patients (31%) were haemodynamically unstable on arrival at
hospital. Pancreatic trauma was associated with injuries to the chest (56%),
head (30%) and extremities (30%). 81 patients (73%) had other intra-
abdominal injuries, most commonly liver (23%) and spleen (20%).19
patients (17%) died in the emergency department. Of the 92 patients who
left the emergency department alive at least 71 required a laparotomy. The
overall mortality rate (46%) was directly proportional to the number of
injuries sustained (pB/0.05) and was higher in patients with increasing age
(pB/0.05), haemodynamic instability (pB/0.05) and blunt trauma (pB/0.05).
Conclusions. Pancreatic trauma was rare in this well defined patient
population. This population based study has demonstrated that pancreatic
trauma was associated with significant mortality related principally to the
presence of other abdominal or extra-abdominal injuries. This study has
identified that efforts to improve outcome should be directed at those patients
with multiple injury, advanced age, haemodynamic instability at presentation
and blunt trauma.
FC 15.08
SURGICAL APPROACH TO PANCREAS INJURY: A 15 YEARS
EXPERIENCE
Akcan, Alper; Akyildiz, Hizir; Artis, Tarik; Yilmaz, Namik; Sozuer, Erdogan;
Yilmaz, Zeki
Erciyes University Medical Faculty, General Surgery, Kayseri, Turkey
Background. The diagnosis of the pancreatic trauma is difficult and many
times, late. Pancreas injuries are generally have high mortality and morbidity
rates because of related organ injuries and difficulties on determining injury
severity.
Aim. Fifty one patients that were operated for pancreas injury between
January 1980 and December 2005 evaluated retrospectively. We aimed to
evaluate 51 surgically treated patients.
Results. Etiologic causes were blunt traumas in 11, penetrating injuries in
26, and gun shot injuries in 14 cases. There were 44 male and 7 female with a
mean age 31.2 years. Grade I injury was there in 19, grade II in 14, grade III
in 15, and grade IV in 3 patients. Externally drainage performed in grade I
injuries, distal pancreatectomy with/without splenectomy in grade II injuries,
external drainage, distal pancreatectomy and subtotal pancreatectomy in
grade III, pancreaticoduodenectomy in grade IV cases. Postoperative
morbidity and mortality rates were 41.2% and 13.7% respectively. Atelectasis
was the most frequent complication (23.5%). Pancreatic fistula, intraabdom-
inal abscess and wound infection were the other frequent complications.
Pancreatic fistulas were treated medically, whereas one of intrabdominal
abscess drained percutaneously and the other one with relaparotomy. Mean
hospital stay time was 15.9 days.
Conclusions. Surgical preference in pancreas injury depends on ductus
involvement, parenchymal injury grade, additional organ injuries and
anatomical localisation. Major injuries of the pancreas are uncommon,
but may result in considerable morbidity and mortality because of the
magnitude of associated vascular and duodenal injuries or underestimation of
the extent of the pancreatic injury. Prognosis is influenced by the cause and
complexity of the pancreatic injury, the amount of blood lost, duration of
shock, speed of resuscitation and quality and nature of surgical intervention.
FC 15.09
PUBLIC AWARENESS OF PANCREATIC DISEASE IS INADE-
QUATE
Hussain, Amer; Gilmour, Jeff; Jardine, Nicola; Kontoyannis, Angel; Puntis,
Malcolm C
University Hospital of Wales, Hepatopancreatobiliary Surgery Unit, Cardiff, UK
Introduction. Pancreatic cancer is the fifth most common cause of cancer
death in Europe and USA. It has the lowest five year relative survival rate
when compared with the other 20 most common cancers. Hospital admis-
sions from Pancreatitis are rising. In our experience patients and their
relatives have very little knowledge of the pancreas and its disease.
Aim. To assess public knowledge of pancreatic function and awareness of its
disease.
Methods. 204 members of the general public were interviewed after random
selection from a busy city centre street. The interview was conducted in two
sections. The first consisted of fixed questions with multiple choice responses
to assess levels of knowledge. The second was a more open ended dialogue on
public awareness of pancreatic disease.
Results. 87 males and 117 females were interviewed. 90% knew that the
pancreas was located in the abdomen. 33% had some knowledge of
pancreatic function but very few were aware of its exocrine function. 42%
had not heard of pancreatitis before. 17% named alcohol as a cause but none
cited gallstones. Less than 2% of the interviewees correctly selected
pancreatic cancer from a list of the 20 most common cancers as being the
most aggressive and least survivable. In the second section of the interview
following feedback on pancreatic disease, 94% of the respondents reported
being surprised by how aggressive and common a cause of death pancreatic
cancer was. Only 4% believed that the general public were sufficiently aware
of pancreatic caner and pancreatitis.
Conclusion. We believe that public awareness of pancreatic disease falls far
short of its impact on society. More should be done to educate people about
its causes and effects.
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PRIMARY CLOSURE VERSUS T-TUBE DRAINAGE AFTER
LAPAROSCOPIC CHOLEDOCHOTOMY FOR CHOLEDOCHO-
LITHIASIS: A PROSPECTIVE RANDOMIZED TRIAL
Ha, Joe PY; Tang, CN; Tsui, KK; Yang, GPC; Li, MKW
Dept. of Surgery, Pamela Youde Nethersole Eastern Hospital, Hong Kong,
China
Background. The controversies related to the use of T-tube drainage after
exploration of common bile duct (CBD) continues in the laparoscopic era. T-
tube drainage may prolong hospital stay of patients and hence negate the
beneficial effects of laparoscopic surgery.
Aim. To compare the hospital stay of patients receiving either primary
closure of CBD or T-tube drainage after laparoscopic choledochotomy.
Methods. A prospective, randomized study of consecutive patients who
underwent successful laparoscopic choledochotomy for choledocholithiasis
was conducted. The selection criteria for laparoscopic choledochotomy were
multiple and large ductal stones, failed transcystic duct exploration and a
CBD size ]/9 mm on cholangiogram. Patients who had previous gastrectomy
were excluded for randomization. A routine magnetic resonance cholangio-
pancreatography (MRCP) was performed 3 months after surgery. Outcome
measures included postoperative hospital stay, operating time, perioperative
complication, CBD stricture and recurrent choledocholithiasis.
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Results. From January 2004 to December 2005, 24 patients underwent
successful laparoscopic cholecystectomy and laparoscopic choledochotomy
were randomized. Twelve patients received primary closure and 12 had T-
tube drainage after laparoscopic choledochotomy. Both groups were similar
in age, sex, presentation, ASA grading, CBD diameter, the number and
maximal size of the choledocholithiasis. The median postoperative hospital
stay was significantly shorter in the primary closure group [4 Vs 8 days, pB/
0.001]. There was no mortality in both groups. One patient suffered from
acute retention of urine in the primary closure group. There was no evidence
of CBD stricture on follow up MRCP in both groups. At a median follow up
of 15 months, one patient in the T-tube group suffered from recurrent
choledocholithiasis.
Conclusion. Primary closure of CBD after laparoscopic choledochotomy for
choledocholithiasis is safe and associated with shorter hospital stay when
compared with T-tube drainage.
FC 16.01
INTRADUCTAL PAPILLARY MUCINOUS TUMORS (IPMT’S) OF
THE PANCREAS: CONTRIBUTION OF 18-FDG PET TO SURGI-
CAL DECISION MAKING
Sperti, Cosimo1; Pasquali, Claudio1; Bissoli, S2; Chierichetti, Franca2;
Liessi, Guido3; Pedrazzoli, Sergio1
1University of Padova, Clinica Chirurgica 4/Istituto Oncologico Veneto,
Padova, Italy; 2Castelfranco Veneto Hospital, Nuclear Medicine, Castel-
franco Veneto, Italy; 3Castelfranco Veneto Hospital, Radiology, Castelfranco
Veneto, Italy
Background. Pancreatic IPMTs are increasingly recognized. Even with
current imaging modalities, discrimination between benign and malignant
tumour is still unreliable. This study was designed to evaluate the role of 18-
Fluorodeoxyglucose positron emission tomography (18-FDG-PET) in deci-
sion making of IPMTs.
Methods. From January 1998 to June 2005, 50 patients with suspected
IPMTs were prospectively investigated with 18-FDG-PET in addition to
conventional imaging techniques (helical-CT and/or magnetic resonance
cholangiopancreatography). 18-FDG-PET was analyzed using the standard
uptake value (SUV). Positivity was assumed when a focal uptake occurred
with a SUV of at least 2.5. The validation of diagnosis was made by surgical
operation (n/34), biopsy (n/4), or follow-up (n/12). Median follow-up
time was 24 months (range 884).
Results. There were 25 males and 25 females, mean age of 64.3 years (range
3780). Seventeen patients were asymptomatic. Thirty-two patients under-
went pancreatic resection, 2 palliative surgery, and 16 did not undergo
surgery. An adenoma was diagnosed in 11 patients, a borderline tumour in 8,
a carcinoma in situ in 4, and an invasive cancer in 15. Histology was missing
in 12 patients. 18-FDG-PET was negative in 11/11 adenomas and 7/8
borderline IPMTs, while was positive in 3/4 carcinomas in situ and in 14/14
invasive cancers. Positive 18-FDG-PET findings influenced surgical decision
making in 9 patients (18%): suggesting surgical resection in 6 patients (4
asymptomatic) without features of malignancy on conventional imaging,
allowing resection of unsuspected colon cancer in 1 patient, and avoiding
laparotomy in 2 patient with distant metastases. Furthermore negative 18-
FDG-PET findings allowed more limited resections in 6 patients and follow-
up strategy in 12.
Conclusion. 18-FDG-PET is accurate in distinguishing benign from
malignant IPMTs, including non invasive carcinomas. 18-FDG-PET is an
alternative, non invasive, method useful to select patients for surgical
treatment or observation.
FC 16.02
A REVIEW OF MUCINOUS CYSTIC NEOPLASMS OF THE
PANCREAS DEFINED BY OVARIAN-TYPE STROMA: CLINICO-
PATHOLOGICAL FEATURES OF 344 PATIENTS
Goh, Brian K P1; Tan, Yu-Meng2; Chung, Yaw-Fui A1; Chow, Pierce K H1;
Cheow, Peng-Chung1; Wong, Wai-Keong1; Ooi, London L P J2
1Singapore General Hospital, General Surgery, Singapore; 2National Cancer
Centre, Surgical Oncology, Singapore
Background. Despite formal definitions of mucinous cystic neoplasms
(MCN) and intraductal papillary neoplasms (IPMN) by WHO and AFIP,
several controversies with regard to MCN remain.
Aim. The aim of the presence review is to determine the clinicopathological
features of MCN defined by ovarian-type stroma (OS) as proposed by the
WHO and AFIP and to compare them with MCN defined by less stringent
criteria.
Methods. A MEDLINE search was conducted to identify English language
articles on pancreatic MCN from 1996 to 2005. Twenty-five studies were
identified. The studies were divided into 2 groups: Group A; included 10
studies with 344 patients whereby the presence of OS was a criteria for the
diagnosis of MCNs and Group B; which included 15 studies comprising 761
patients whereby the presence of OS was not mandatory for the diagnosis of
MCN.
Results. Patients in group A (MCN as defined by OS) were almost always
female (99.7%), had a mean age of 47 years (range, 1895 years), were
located predominantly in the body or tail of the pancreas (94.6%) and had
a mean size of 8.7 cm (range, 0.635 cm).76% were symptomatic
and 6.8% demonstrated ductal communication. 27 percent of neoplasms
were malignant. At a mean follow-up of 57.5 months (range, 1264
months) and 43 months (range, 2257 months) after surgery, 97.9% of
benign and 61.9% of malignant neoplasms were disease-free respectively.
Patients in Group B were older, had a higher proportion of males, were
more evenly distributed in the pancreas, were smaller, communicated more
frequently with the pancreatic duct and were composed of a higher
proportion of malignant tumors compared to Group A. Their clinicopatho-
logical features were intermediate between those of Group A and patients
with IPMN.
Conclusions. Pancreatic MCN with OS have unique and distinct clinico-
pathological features. MCN should be defined by the presence of OS as it is
the most reliable way for distinguishing MCN from IPMN. Adoption of
‘‘looser’’ criteria will result in misclassification of some IPMN as MCN.
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FOLLOW-UP STRATEGY AFTER SURGICAL RESECTION OF
INTRADUCTAL PAPILLARY MUCINOUS NEOPLASM OF THE
PANCREAS
Hatori, Takashi1; Fukuda, Akira1; Onizawa, Shunsuke1; Oohara, Toshiya1;
Furukawa, Kenji1; Matsuura, Hiroshi1; Imaizumi, Toshihide2; Takasaki,
Ken1
1Tokyo Women’s Medical University, Gastroenterological Surgery, Tokyo,
Japan; 2Tokai University, Surgery, Isehara, Japan
Background. IPMN (Intraductal papillary mucinous neoplasm) of the
pancreas has a favorite prognosis and it is very important to follow up the
patients who underwent pancreatectomy for IPMN.
Objectives. The aim of this study is to evaluate the method of follow-up after
surgical resection for IPMN.
Methods. A total of 236 patients who underwent pancreatectomy for IPMN
were at Tokyo Womens Medical University Hospital between 1981 and 2005
were chosen in this study. The average age was 64.7 years old and the
proportion of men was 67%. Adenoma was seen in 19% of the patients,
borderline dysplasia was seen in 25%, non-invasive carcinoma was seen in
35%, and invasive carcinoma was seen in 21%.
Results. 1) The 5-year survival rate was 40% in patients with an invasive
IPMN. Liver metastasis and peritoneal dissemination were often recognized
in the mode of tumor recurrence. 2) Five patients (2.1%) underwent
pancreatectomy again for a metachronous multifocal IPMN with invasive
carcinoma in the remaining pancreas and 4 of these had a main duct IPMN.
3) 35 patients (15%) had other malignant tumors in addition to synchronous
or metachronous IPMN.
Conclusion. It is suggested that the follow-up after surgical resection for
IPMN should be performed paying attention to tumor recurrence in patients
with an invasive IPMN, metachronous multifocal IPMN in the remaining
pancreas, and the possibility of other malignant tumors associated with
synchronous or metachronous IPMN.
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SKIP LESIONS: A PITFALL IN THE SURGICAL MANAGEMENT
OF INTRADUCTAL PAPILLARY MUCINOUS NEOPLASIA
(IPMN) OF THE PANCREAS
Adham, Mustapha1; Hervieu, Valerie2; Courbiere, Marion3; Partensky,
Christian1
1Edouard Herriot Hospital, Dept. of Digestive Surgery, Lyon, France;
2Edouard Herriot Hospital, Dept. of Pathology, Lyon, France; 3Edouard
Herriot Hospital, Dept. of Radiology, Lyon, France
Partial pancreatectomy (PP) for IPMN may be non curative, even with
negative frozen sections (FS) due to skip lesions (SL), bifocal lesions
separated by a free interval. The aim of the study was to review patients
who had to be reoperated for totalizating pancreatectomy (TP) due to SL.
Among 70 patients operated for IPMN (6/19934/2005) 6 patients, 4
men, 2 women, mean age 62.49/11.3 years (4375) had TP for SL.
Preoperative investigations included US, CT-scan, MRCP. 5 patients had
EUS and 2 had intraductal US (IUS). All had intraoperative US, 5 had
ductoscopy (ultrathin endoscope). All patients had negative pancreatic
margins (FS/definitive pathology) after 4 pancreaticoduodenectomies
(PD), one distal pancreatectomy (DP), 1 middle pancreatectomy. All had
invasive adenocarcinoma (1N/). 5 were of combined type, 1 was main
duct type. Follow-up included yearly MRCP which if abnormal was
followed by EUS. 5 patients were symptomatic (bleeding, jaundice, pain,
2 de novo diabetes), 1 was asymptomatic. Diagnosis of SL was made by
MRCP (n/6) completed by CT (n/4) and EUS (n/3). Retrospective
radiological review identified the overlooked SL in 1 case: small cystic
lesion present at the distal pancreas. TP was done by PD (n/1) DP (n/
1), splenopancreatectomy (n/3), PD/DP (n/1). Median delay between
the operations was 31.2 months (23.556). Pathological examination of the
TP specimen showed IPMN with invasive adenocarcinoma in 5 (1N/,
1M/) and borderline tumour in 1. Median overall survival was 57 months
(42.9106.4) after the first pancreatectomy and 15 months (9.975) after
TP. Two patients died, one from metastatic diffusion and one from
intercurrent disease. 4 patients are presently alive with NED. Careful
attention is needed to diagnose SL by pre and introperative investigations
before attempting PP for IPMN. FS of the pancreatic margins are
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mandatory but are insufficient to rule out SL. Therefore a systematic
follow-up of patients with invasive tumours involving the MPD by yearly
MRCP completed if abnormal by EUS is advocated.
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MATRIPTASE-A NEW HYPOXIA INDUCIBLE REGULATOR OF
TUMOR CELL INVASION AND METASTASIS.
Buchler, Peter1; Su, Yun1; Kelleg, Shereen1; Hines, Joe2; Reber, Howard A2;
Buchler, Markus W1; Friess, Helmut1
1University of Heidelberg, Dept. of General Surgery, Heidelberg, Germany;
2UCLA, Heidelberg, Germany
Background. A growth condition of low oxygen is a hallmark in the growth
of pancreatic cancer and may induce a specific epigenetic gene expression
profile. It is known that angiogenic cytokines are upregulated under this
condition but little is known of pro-metastatic genes.
Aim. In the present study we aimed to clone new hypoxia inducible genes
and characterize possible new genes in growth of pancreatic cancer.
Methods. Cloning of new hypoxia inducible genes was achieved by the
RDA (representative differential analysis) method, where the Capan-2 cell
line was cultured for 14 h in hypoxic conditions. Hypoxic induction of
identified genes was confirmed by Northern blot analysis and all clones were
sequenced. Expression studies in human pancreatic cancer specimens and
cell lines was done by real time quantitative PCR and Western blot. Tissue
specimens were analyzed by immunohistochemistry and in situ hybridiza-
tion. Tumor cell invasion was studied with matrigel invasion assays and cell
viability with MTT assays. Recombinant overexpression of identified clones
was achieved by stable transfection of MIA PaCa-2 cells with the full length
cDNA clones.
Results. After hypoxic exposure for 14 h a gene was cloned called,
Matriptase, in a series of RDA experiments. Hypoxic induction of
Matriptase expression was confirmed by Northern blot analysis. Analysis
of Matriptase in pancreatic cancer showed a signifanct increase of
Matriptase mRNA and protein levels. Localization of Matriptase expression
in tissue specimens revealed expression primarily by ductal cancer cells close
to the invasion front of tumors. Among pancreatic cancer cell lines the
undifferentiated AsPC-1 cell line expressed highest levels of Matriptase.
Experimental overexpression of Matriptase resulted in an increased invasive
tumor phenotype, which was even more pronounced under conditions of
low oxygen. Inhibition studies using an specific Matriptase inhibitor (CJ
730) reverted the invasive tumor phenotype without affecting tumor cell
viability.
Conclusion. In the present study we have identified Matriptase as a new
hypoxia inducible gene. Characterization of Matriptase gene expression in
human tissue specimens and recombinant overexpression of Matriptase
revealed an important function of this gene in growth of human pancreatic
cancer by regulation of tumor cell invasion and metastasis.
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MALNUTRITION IN HEPATO-BILIARY-PANCREATIC CAN-
CERS: A PROSPECTIVE MULTIVARIATE ANALYSIS OF RISK
FACTORS IN 1089 PATIENTS
Mallath, Mohandas; Shirodkar, Mrunal; Mehta, Shaesta; Shukla, Parul;
Shrikhande, Sailesh
Tata Memorial Hospital, Mumbai, India
Background. Malnutrition is increases the morbidity, mortality of cancer
treatments. There are few studies on the prevalence and determinants of
malnutrition in patients with Hepato-biliary-pancreatic (HBP) cancers.
Aims. A prospective audit was done to identify the factors in patients with
HPB cancers.
Methods. Consecutive patients managed in our nutrition clinic from January
2000 to December 2005 were included. Among 8877 cancer patients
audited, 1211 (659 males) aged 15 to 95 (mean 53) years had HBP cancers.
Severity of malnutrition was graded by Subjective Global Assessment (SGA).
The cancer was Hepatic in 98, Biliary in 691 and Pancreatic in 423 patients.
Results. Severe malnutrition (SGA-C) was seen in 23.4%, 24.0%
and 34.4% of patients with hepatic, biliary and pancreatic cancers respec-
tively, [p-trend/0.001]. Severe malnutrition (SGA-C) was seen in 15.3%,
23.0% and 34.7% in patients undergoing chemotherapy, surgery and
endoscopic palliation respectively, [p-trend/0.001]. In univariate analysis,
old age (/65 years), poverty, site of the cancer (Pancreas), previous
treatment, tobacco related cancer, low albumin (B/3.5 g/dl), anemia and
low BMI (B/20.00 Kg/M2) were statistically significant risk factors for severe
malnutrition. The independent risk factors by multivariate analysis were:
Poverty [OR/1.9, 95%CI 1.42.6]; Old age [OR/1.5, 95%CI 1.12.2];
BMI less than 20 [OR/7.9, 95%CI 5.611.3]; Albumin less than 3.5
[OR/1.8, 95%CI 1.32.6]. Patients for endoscopic palliation [OR/2.2,
95%CI 1.43.6] were more malnourished than those undergoing che-
motherapy or surgery.
Conclusion. This audit shows that malnutrition is the commonest co-
morbid illness in HBP cancer patients. Patients with pancreas are more likely
to have malnutrition than other sites. Higher prevalence of malnutrition in
patients selected for endoscopic palliation can explain the increased incidence
of postoperative infections after pre-operative biliary drainage.
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LONG-TERM SURVIVAL AFTER R-0 RESECTION FOR PAN-
CREATIC AND PERIAMPULLARY CANCER: A PIVOTAL ROLE
FOR THE EGF-R
Erdmann, Joris I1; Smeenk, Hans G1; Tran, Khe1; Van Dekken, Herman2;
Van Marion, Ronald2; Hop, Wim3; Jeekel, Johannes1; Van Eijck, Casper1
1ErasmusMC, Surgery, Rotterdam, Netherlands; 2ErasmusMC, Pathology,
Rotterdam, Netherlands; 3ErasmusMC, Epidemiology & Biostatistics, Rot-
terdam, Netherlands
Background. Pancreatic cancer has a dismal prognosis. Periampullary
adenocarcinoma, however, has a slightly better prognosis and is thought to
be a biologically different tumor. Even after radical (R0) resection survival
remains poor and most patients will die of disseminated disease. Adjuvant
therapy may only be of marginal benefit.
Aim/Objectives. Aim of this study was to find clinical, pathological and
molecular factors that could predict survival after R-0 resection for pancreatic
and periampullary cancer.
Methods. We analyzed clinical and pathological data from 93 patients who
underwent a true R0 resection for pancreatic or periampullary cancer.
Furthermore we performed a Tissue Micro-Array protein expression analysis
for several growthfactor receptors and oncogenes: HER-2, EGF-R, ER, PR,
C-myc, P53, P16, RB-1 and Chromogranin A as a neuroendocrine
differentiation marker.
Results. Neither operative technique (Pylorus Preserving or standard
Whipple resection) nor postoperative complications correlated with survival.
Overall survival was better for women than for men. Age was not a prognostic
variable. Preoperative pain was a negative predictor of survival. Histological
factors that had a negative predictive value to survival were: tumor grade,
nodal status (N) and perineural invasion. Tumor size (T) and vaso-
invasiveness did not influence survival. Adjuvant chemoradiation did not
improve survival. EGF-R overexpression was a negative predictor of survival
for pancreatic cancers but not for periampullary cancers. Expression was also
higher in this group (24 vs. 4%). Expression of the other molecular factors
was not significantly different between both groups.
Conclusion. Gender, pre-operative pain, tumor differentiation, nodal status
are independent prognostic factors for pancreatic and periampullary cancer.
Overexpression of EGF-R in pancreatic cancers has a negative effect on
survival. This may be a feasible target for molecular therapy.
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FIVE YEAR SURVIVORS OF INVASIVE DUCTAL CARCINOMA
OF THE PANCREAS IN JAPAN
Egawa, Shinichi1; Sunamura, Makoto1; Matsuno, Seiki2; Unno, Michiaki1;
Tanaka, Masao3
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Background. Japan Pancreas Society (JPS) has been conducting national
pancreatic cancer registry since 1981. In 12612 patients with invasive ductal
carcinoma, 540 cases survived 5-years and longer.
Aim(s)/Objective. To clarify the key to long term survival from invasive
ductal carcinoma of the pancreas, the clinicopathological features were
compared between 5-year survivors and shorter survivors.
Methods. Cumulative survival was calculated by actuarial and by Cox
multivariate methods.
Results. Trends revealed that median survival was significantly elongated in
the third decade compared to the previous decades possibly due to the
introduction of gemcitabine in 2001. The 5-year survivors, however, did not
increase since 1990s. Papillary adenocarcinoma was more frequent and
moderately and poorly differentiated ductal adenocarcinoma was less in 5-
year survivors. Among 5-year survivors 26.1% were T2 or less, 66.9% N0 and
91.3% M0. Out of 43 M1 cases who survived 5-years, 34 cases (79.1%) were
metastases to distant lymph nodes. Out of 453 valid cases of 5-year survivors,
Stage I were 44 (9.7%), Stage II; 58 (12.8%), Stage III 122 (26.9%), Stage IVa
122 (26.9%) and Stage IVb 62 (13.7%), respectively, which was significantly
earlier compared to the shorter survivors. Out of 102 Stage I cases, 58 cases
(56.8%) died before 5 years. Radical dissection of the retroperitoneal tissue did
not improve the survival, while postoperative chemotherapy significantly made
a progress both in univariate and multivariate analyses.
Conclusion. Histological grade correlates with the extension of the tumor
resulting in the favorable grade in earlier stage. Early diagnosis and effective
chemotherapy significantly improves the median survival. Mysterious key of
the 5-year survivors are, however, still remains to be solved.
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DOES ENDOSCOPIC SPHINCTEROTOMY PRIOR TO PAN-
CREATICODUODENECTOMY INFLUENCE THE RISK OF LIVER
METASTASIS AND POOR OUTCOME IN PATIENTS WITH
NODE-NEGATIVE AMPULLARY CANCER?
Saxena, Rajan; Ranjan Dash, Nihar; Balachandran, P
Sanja Gandhi Post Graduate Institute of Medical Sciences, Lucknow, India
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Background. Following pancreaticoduodenectomy (PD) for ampullary
cancer, patients with node-negative tumors have a better prognosis than
the node-positives. We observed that some of our node-negative patients had
an outcome similar to node positive patients. Tumor metastases following
incision of tumor have been documented. As endoscopic spincterotomy (ES)
was the only invasive procedure done in some of our cases prior to PD, we
specifically looked for its association with the outcome.
Objective. To asses whether ES prior to PD influenced the outcome in
patients with node-negative ampullary tumors.
Method. Data of 124 patients with diagnosis of node negative ampullary
tumors (T1orT2, N0) after PD was analyzed retrospectively. The patients
were classified into 2 groups: those who had preoperative ES (ES group, n/
71) and those who did not (nES group, n/53). Both groups were compared
for (I) clinical and laboratory parameters, (ii) incidence, timing and pattern
of recurrences and (iii) survival.
Results. The groups were matched for age, sex, hemoglobin and albumin.
PD was performed at a median of 30 days following ES. 10 patients died in
the postoperative period. 8 of these were from ES group. Recurrent disease
was observed in 29/114 (25.4%) patients at a median time of 20 months post-
PD. At 24 months, the ES group had a higher recurrence (93.3% v/s 50%,
p/0.014) and a higher incidence of liver metastases (73.3% v/s 35.7%, p/
0.045). The liver was the only site of recurrent disease in the ES group. The
overall median survival after PD was 45 months with a survival advantage of
11 months over the nES group.
Discussion. ES involves cutting through the ampullary tumor into the
normal tissue, which possibly predisposes to dissemination in the portal
circulation, and may be responsible for the inordinately high incidence of liver
metastases and poor outcome in early ampullary tumors treated with PD.
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ROLE OF SURGERY IN PANCREATIC METASTASES FROM
RENAL CELL CARCINOMA
Ortolano, Enrico1; Borri, Anna2; Zerbi, Alessandro1; Balzano, Gianpaolo1;
Rocchetti, Simona1; Varale, Roberta1; Di Carlo, Valerio1
1San Raffaele Scientific Institute, Surgery, Milan, Italy; 2San Raffaele
Scientific Institute, Internal Medicine, Milan, Italy
Background and aim. In the last years pancreas has been recognised as a
possible site of metastasis from renal cell carcinoma (RCC); aim of this study
was to better define the role of surgery in these clinical situations.
Methods. We retrospectively analysed clinical records of 29 consecutive
patients with diagnosis of pancreatic metastasis from renal cell carcinoma and
treated at our Institution between 1998 and 2005. Patients were categorized
into 3 risk groups (favourable, intermediate and poor) according to the
modified Memorial Sloan-Kettering Prognostic Factors Model, (J Clin Onc,
2005, 23, 83244).
Results. 19 patients (65.5%) were male; mean age was 66.3 years. The
median interval from nephrectomy was 8.2 years (range 023 years). Twenty
of the 29 patients underwent resection: 12 distal pancreatectomy (9 with
splenectomy), 2 pancreatoduodenectomy, 1 total pancreatectomy, 1 median
pancreatectomy, 5 enucleations. There was no operative mortality. All
operated patients were in the prognostic favourable risk group. Surgical
treatment was excluded in 8 cases because of locally advanced disease and/or
general poor conditions. In this group 4 patients were at favourable risk, 3 at
intermediate, 1 at poor risk. All of the not surgically treated pts received other
therapies, as 80% of patients who underwent resection. In the group of
patients undergoing surgery the 5-years Kaplan Meier survival rate was 86%
with a mean survival time of 64.9 months; progression rate was 42%, with a
mean progression time of 30.6 months. No pancreatic recurrence was
observed. Patients who did not undergo surgery had a 5-years survival rate
of 55%, with a mean survival time of 37.2 months.
Conclusion. RCC is a systemic disease in which pancreatic metastases are
possible localizations. Surgical resection in patients with pancreatic metas-
tases from RCC, belonging to a favourable risk group, allows good local
control and is related with high long-term survival.
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LIVER TRANSPLANTATION FROM NON-HEART BEATING DO-
NORS: ANALYSIS USING MATCHED PAIRS
Aldouri, Amer; Almuktar, Ahmed; Young, Alister; Santana, Werbena; Ismail,
Wisam; Pollard, Stephen; Millson, Charles; Davies, Mervyn; Lodge, J Peter;
Toogood, Giles; Prasad, K Raj
St James’s University Hospital, Leeds, UK
Background. The main obstacle to an expansion of human liver transplan-
tation is the lack of donor organs. Organs from non- heart beating donors
(NHBD) have been used to provide an expansion to the donor pool, however
there is concern that it may associated with inferior outcomes than grafts
from heart beating donors (HBD). To address this issue we retrospectively
analysed the outcomes of 21 recipients received grafts from NHBD in
comparison with matched 21 recipients received grafts from HBD.
Methods. Between 2002 and 2005, 23 recipients grafted with livers from
NHBD. Twenty-one adult recipients of liver transplantations from NHBD
were matched to recipients of grafts from HBD according to the criteria of
the European predictive model, which include: recipient age, year of
transplantation, indication for liver transplantation, donor age, United
Network for Organ Sharing (UNOS) status, total ischemic time.
Results. Overall one year patient’s and graft’s survival of recipients received
grafts from NHBD (number/23) were 86% and 68%, respectively. Data from
the matched 21 recipients revealed that the 3 months patient survival rates after
transplantation in NHBD and HBD groups were 90.4% and 100%, respect-
ively (log rank p/0.152). One year patient survival rates after transplantation
in NHBD and HBD groups were 85% and 90%, respectively (log rank p/
0.497). However one year graft survival was significantly lower among the
matched 21 recipients of liver transplantations from NHBD (60.3%)
compared to those received grafts from HBD (100%), (log rank p/0.015).
Conclusion. Liver transplantation using grafts from NHBD associated with
lower graft survival, but with comparable patient’s survival, and therefore
NHBD is a valuable expansion to the donor pool.
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DIFFERENTIATION OF HUMAN MESENCHYMAL STEM CELLS
INTO HEPATOCYTES AND TRACING TRANSPLANTED CELLS
USING MOLECULAR IMAGING
Choi, Dongho
Soon Chun Hyang University Hospital, Seoul, South Korea
Introduction. Whole liver transplantation has limitations including donor
shortage and fatal surgical complications. Even though clinical trials have
been done, hepatocyte transplantation still can’t substitute liver transplanta-
tion. Many scientists suggested that stem cells could overcome problems of
hepatocyte transplantation. Hepatocyte transplantation using human bone-
marrow derived hepatocytes will be one of the most possible therapeutic tools
for chronic liver disease patients. Considerable progress has been made in
developing effective methods for culturing different types of stem cells and
transplanting them into animal models. Molecular imaging technique using
magnetic resonance (MR) imaging opens a new era for stem cell therapy.
Methods. We differentiated human mesenchymal stem cells to hepato-
cytes in vitro condition by modified Kunder Lee method. Human mesench-
ymal stem cells labeled with iron oxide nanoparticles were injected into portal
vein of rats (n/5) and liver of nude mice(n/5) traced with MR imaging.
Results. After 5 weeks of cultivation period, human mesenchymal stem cells
differentiated into hepatocytes. Those differentiated hepatocytes were
identified with morphology, RT-PCR, and PAS staining. In vivo tracing of
transplanted human mesenchymal cells were done by 1.4T MRI. Trans-
planted human mesenchymal stem cells in the liver of rats and nude mice
showed decreased signal intensity in T2 weighted image for one week. MR
imaging of the liver were compared histologically with Prussian blue staining.
Conclusions. Human mesenchymal stem cells can differentiate into
hepatocytes in a proper culture condition. Magnetic labeling of stem cells
with iron oxide may enable cellular MR imaging and tracking in experimental
in vivo setting, especially in the liver.
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PREDICTION OF DONOR LIVER STEATOSIS USING THE NEW-
CASTLE ORGAN RETRIEVAL IMAGING SYSTEM (NORIS)
Reddy, Mettu S1; Bhati, Chandra S2; Bashir, Arfan3; Mirza, Darius2; Manas,
Derek M1
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Background. NORIS is a web based instrument designed to enable remote
donor liver assessment. At retrieval, digital images of liver(DI), visual grading
of steatosis(VG) and organ quality score(OQS) calculated from graft (colour,
edge, texture) and donor (age, BMI) variables is uploaded to a central server.
It can be accessed by transplant surgeon(s) at any centre(s) immediately,
enabling prompt assessment & placement of the graft. It is currently being
used on a pilot basis by two UK liver transplant units.
Methods. Data (DI, VG, OQS) of all livers uploaded to the NORIS until 1st
Feb 2006 was retrieved. Graft/implantation biopsies were reviewed to identify
extent of graft steatosis (GS). Correlation between VG, OQS and GS was
analysed. Accuracy of VG and OQS in predicting moderate and severe graft
steatosis was evaluated.
Results. Data from 57 donor livers was uploaded to NORIS. 31 grafts were
used locally, 21 were exported and 5 were not used. GS data for 34 grafts (31
locally used and 3 unused) was available. 27 grafts were transplanted into
routine recipients (2 split grafts), 4 were transplanted into patients on super-
urgent list. Three patients needed re-transplantation-one for early hepatic
artery thrombosis (HAT), one for early graft dysfunction and one for late HAT.
Six (58) (median, IQR) images were uploaded for each graft. GS revealed nil,
mild (B/30%), moderate (31%60%) and severe (61% to 100%) steatosis in
15, 9, 4, 6 grafts respectively. There was significant correlation between VG &
GS (Rho: 0.730, pB/0.01) and OQS & GS (Rho/0.611, pB/0.01). VG and
OQS/3 had sensitivity, specificity, positive predictive value and negative
predictive values of 70% and 75%; 91% and 85%; 78% and 60%; 88% and
92% respectively for predicting moderate or severe graft steatosis.
Conclusion. Remote assessment of graft livers using web based model is
feasible. Accurate prediction of graft steatosis is possible with NORIS.
Further refinements in the model are being done using the pooled data.
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MODEL OF DONOR/RECIPIENT VARIABLES IMPROVES LIVER
TRANSPLANT GRAFT SURVIVAL
Kelly, Beau; Feurer, Irene; Wright, J Kelly; Hoot, Nathan; Gordon, D Lee;
Geevarghese, Sunil; Pinson, C Wright; Chari, Ravi
Vanderbilt University Medical Center, Hepatobiliary and Liver Transplant
Surgery, Nashville, USA
Background. In the US, liver allocation is prioritized by MELD score
without defined inclusion of weighted donor factors. With increasing MELD
scores and use of ECD’s, it is unclear that the present allocation system
optimizes donor-recipient pairing.
Aim. Statistical modeling that incorporates both donor and recipient factors
can identify grafts at increased risk of failure, and more appropriately match a
donor liver with a recipient to optimize graft survival.
Methods. The UNOS data from 1995 to 2005, N/42, 845, were analyzed.
Pediatric, living-donor and multi-organ transplant recipients, and donors
after cardiac death were excluded. The sample was randomly split into
training (TS) and validation (VS) samples. Cox regression models of graft
survival were developed in the TS to identify the final covariate set. The
resulting prognostic index (PI) was tested in the VS. PI values were stratified
by quintile in the VS and the stratification effect on graft survival was tested
by Kaplan-Meier methods and the log-rank test.
Results. A model comprising 5 donor and 9 recipient covariates predictive of
graft outcome was developed in the TS (n/16, 209, pB/0.001, all covariate
main effects pB/0.05). Added recipient covariates significantly improved the
model (change pB/0.001). The significant donor variables included age,
gender, race, BUN at procurement, and whole vs. split graft. The recipient
covariates included age, race, previous liver transplant, serum creatinine,
Karnofsky score, mechanical ventilation, and dialysis. Statistically significant
differences in graft survival were observed in the VS when cases were
stratified by calculated PI values (n/16, 115 all pairwise pB/0.001).
Discussion. Using this statistical model, we have identified donor and
recipient factors that significantly impact graft failure after liver transplantation.
Conclusion. A model-based system that incorporates donor and recipient
factors can optimize donor liver allocation and improve use and success of
cadaveric liver grafts.
FC 17.05
OUTCOME OF PEDIATRIC LIVER RETRANSPLANTATION AT
THE UNIVERSITY OF HAMBURG
Kim, Jong-Sun1; Grotelueschen, Rainer1; Wilms, Christian1; Walter, Jessica1;
Fischer, Lutz1; Hillert, Christian1; Ganschow, Rainer2; Helmke, Knuth2;
Burdelski, Martin2; Rogiers, Xavier1; Broering, Dieter C1
1University Hospital Hamburg-Eppendorf, Hepatobiliary Surgery, Ham-
burg, Germany; 2University Hospital Hamburg-Eppendorf, Pediatrics,
Hamburg, Germany
Background. Orthotopic liver transplantation (OLT) has become
the standard of care for end-stage liver disease in pediatric patients.
However, retransplantation has been associated with higher mortality and
morbidity for pediatric recipients with acute and chronic graft failure. The
aim of this study is to analyse the outcome of retransplants compared to
primary OLT.
Methods. Between 1999 and 2004, 208 primary and 33 first retransplants
using all techniques have been performed at the University Hospital
Hamburg-Eppendorf. The median body weight of the recipients who
underwent retransplantation was 12 kg (range 412), median height 84 cm
(54141) and median age 2 y (0.0215). 49% of the patients were on a high-
urgent status at the time of retransplantation.
Results. The 3-month and actual patient survival rates after 208 primary liver
transplantations were 98% and 94%, respectively. The 3-month and actual
graft survival rates were 92% and 80%, respectively. The 3-month and actual
patient survival rates after 33 retransplants were 91% each. The 3-month and
actual graft survival rates were 85% and 78%, respectively. After 33
retransplants, three patients (9%) developed biliary and one (3%) patient
arterial complications. Bowel perforation was observed in three (9%) patients.
Two (6%) patients each developed primary-non-function (PNF) and chronic
rejection of the second graft during further follow-up and had to undergo third
liver transplantation. All four are currently alive with good functioning grafts.
Conclusion. The actual patient and graft survival rates after liver retrans-
plantation are not significantly lower compared to that after primary
OLT. Postoperative morbidity is well comparable in both groups. Since
showing that patient and graft survival after retransplantation is not
significantly lower compared with that after primary OLT, we consider liver
retransplantation as a safe procedure for pediatric patients with acute and
chronic graft failure.
FC 17.06
A PILOT STUDY ON THE EFFECT OF ISCHEMIC PRECONDI-
TIONING IN WHOLE LIVER TRANSPLANTATION FROM DE-
CEASED DONORS
Cescon, Matteo1; Grazi, Gian L1; Grassi, Alberto2; Ravaioli, Matteo1;
Vetrone, Gaetano1; Ercolani, Giorgio1; Varotti, Giovanni1; D’Errico, Anto-
nietta3; Ballardini, Giorgio2; Pinna, Antonio D1
1Liver and Multiorgan Transplant Unit, Policlinico Sant’Orsola-Malpighi,
University of Bologna, Dept. of Surgery and Transplantation, Bologna, Italy;
2Policlinico Sant’Orsola-Malpighi, University of Bologna, Internal Medicine,
Cardioangiology and Hepatology, Bologna, Italy; 3‘‘Felice Addarii’’ Institute,
Policlinico Sant’Orsola-Malpighi, University of Bologna, Dept. of Oncology
and Hematology, Bologna, Italy
Background. The effect of ischemic preconditioning (IPC) in orthotopic
liver transplantation (OLT) has not yet been clarified.
Aims. We performed a pilot study to evaluate the effects of IPC in OLT.
Methods. We compared the outcomes of recipients of grafts from deceased
donors randomly assigned to receive (IPC/ group, n/23) or not (IPC-
group, n/24) IPC (10 min. ischemia/15 min. reperfusion). In 10 cases in
the IPC/ group and in 12 in the IPC- group, the expression of inducible
nitric oxide synthase (iNOS), neutrophil infiltration and hepatocellular
apoptosis were tested by immunohistochemistry in pre-reperfusion and
post-reperfusion biopsies.
Results. Median aspartate aminotransferase (AST) levels were lower in the
IPC/ group vs. the IPC- group on postoperative days 1 and 2 (398 vs. 1234
U/l, P/0.002; and 283 vs. 685 U/l; P/0.009). Alanine aminotransferases
(ALT) were lower in the IPC/ vs. the IPC- group on postoperative days 1, 2
and 3 (333 vs. 934 U/l, P/0.016; 492 vs. 1040 U/l, P/0.008; and 386 vs.
735 U/l, P/0.022). Bilirubin levels and prothrombin activity throughout the
first 3 postoperative weeks, incidence of graft non-function and graft and
patient survival rates were similar between groups. Pre- and post-reperfusion
immunohistochemical parameters did not differ between groups. INOS was
higher post-reperfusion vs. pre-reperfusion in the IPC- group (P/0.008).
Neutrophil infiltration was higher post-reperfusion vs. pre-reperfusion in
both groups (IPC/: P/0.007; IPC-: P/0.003). Pre-reperfusion and post-
reperfusion apoptosis was minimal in both groups.
Conclusion. IPC reduced ischemia/reperfusion injury through a decrease of
hepatocellular necrosis, but it showed no clinical benefits.
FC 17.07
CLASSIFICATION AND PROGNOSIS OF INTRAHEPATIC BILI-
ARY STRICTURES AFTER LIVER TRANSPLANTATION
Lee, Hae W; Suh, Kyung S; Yi, Nam J; Yang, Sung H; Cho, Eung H; Cho, Jai
Y; Cho, Yong B; Lee, Kuhn U
Seoul National University, College of Medicine, Seoul National University
Hospital, Dept. of Surgery, Seoul, Korea
Intrahepatic biliary stricture (IHBS) after liver transplantation (LT) may
develop because of hepatic artery thrombosis, chronic ductopenic rejection,
ABO incompatibility, ischemia-reperfusion injury, and LT from non-heart-
beating donors (NHBDs). However, proper management methods and
prognosis of post-LT IHBS have not been made clear yet. Thus, the purpose
of this study was to classify post-LT IHBS into subtypes according to
cholangiographic pattern and to establish its proper management strategy. All
170 patients had undergone liver transplantation from NHBD in China from
Jul 2002 to Jun 2005 and have followed-up in Seoul National University
Hospital. 45 of these developed IHBS on cholangiography and their medical
data were reviewed retrospectively. According to cholangiographic pattern,
the patients were classified into four subtypes, i.e., unilateral focal (UF),
confluence (CO), bilateral multifocal (BM), and diffuse necrosis (DN) types.
8 (17.8%) and 11 (21.1%) patients were included in UF and CO types,
respectively. Only 3 in CO type were underwent interventional dilatation and
all showed good prognoses. Most 19 (42.2%) patients were included in BM
type. One died of biliary sepsis and 5 (26.3%) have hold PTBD catheters in a
mean time of 14.8 months after LT in spite of aggressive intervention.
However, 4 (21.1%) did not require any intervention and 6 (31.6%) showed
good prognoses after intervention. The last, DN type showed the worst
prognoses. Of all 7 (15.6%), one died of biliary sepsis and two underwent
retransplantations. 4 have hold PTBD catheter in a mean time of 11.2 month
after LT and not showed any sign of improvement. Their mean serum total
bilirubin level was 14.2 mg/dL. In conclusion, we could find good prognosis
in UF and CO types. In BM type, we could expect a success rate of more than
50% although aggressive interventions were required. However, DN type
showed the worst prognosis and showed little response to intervention.
Therefore, early retransplantation is recommended in DN type.
FC 17.08
A DECISION ANALYSIS MODEL DETERMINES THE EFFICACY
OF TRANSARTERIAL CHEMOEMBOLIZATION FOR CIRRHO-
TIC PATIENTS WITH HCC AWAITING LIVER TRANSPLANTA-
TION
Thomas, Aloia; Adam, Rene; Samuel, Didier; Azoulay, Daniel; Castaing,
Denis
Paul Brousse Hospital, Villejuif, France
Background. For liver transplant candidates with HCC, the ability of
neoadjuvant TACE to reduce waitlist drop-out rates remains unproven.
Given the complex nature of this clinical issue and the low likelihood that it
will be addressed in randomized trials, computer-aided decision modeling
may be the optimal means to study this problem.
Objective. To determine the time thresholds where neoadjuvant TACE
significantly decreases the number of delisted patients.
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Methods. A decision analysis model was developed to simulate a randomized
trial of neoadjuvant treatment with TACE vs. no TACE in 300 virtual patients
with HCC and cirrhosis. Transition probabilities for decision points were
assigned by systematic review of the English language literature (18 relevant
reports), including TACE morbidity (1%9/1%), TACE response rates (40%9/
15%), and progression of malignant disease (7%9/7% per month). Median
wait list times were varied from 1 to 18 months at one month intervals. An
assumption was built into the model that TACE treatments would be repeated
every 2.5 months up to a maximum of 3 total treatments. Sensitivity analyses
were performed to determine the time thresholds where TACE would
significantly decrease the number of delisted patients.
Results. TACE treatment had statistical benefit at waitlist time breakpoints
of 4 and 9 months (all PB/0.05). When waitlist times were less than 4
months, waitlist attrition was similar (20% vs. 34%, P/0.08). When waitlist
times exceed 9 months cumulative morbidity from repeated TACE treat-
ments and disease progression outweighed the benefits of TACE and led to
reequilibration of waitlist drop out rates (33% vs. 46% P/0.06).
Conclusions. By increasing the number of transplanted patients, neoadju-
vant TACE is likely to improve survivals. Patients transplanted from 4 to 9
months from first TACE are predicted to receive the most benefit. Similar
decision models may be used to further determine the optimal multimodality
treatment strategy for liver transplant candidates with HCC.
FC 17.09
JUSTIFICATION OF A SMALL-VOLUME PROGRAM OF ADULT
LIVER TRANSPLANTATION
Nieuwenhuijs, Vincent; Chen, John; John, Libby; Ring, John; Harley, Hugh;
Padbury, Robert
Flinders Medical Centre, HPB and Liver Transplant Unit, Adelaide,
Australia
Background. Results of liver transplantation have improved significantly
over the last 3 decades. Hospital volume is percieved as an important
prognostic factor (Adam et al., Lancet 2000). The South Australian (SA)
program commenced in 1992 as the 4th centre in Australia.
Aim. to evaluate the results of a small-volume program.
Methods. Patient and graft survival curves were computed from the
Australian and New Zealand Liver (ANZ) Transplant Registry. SA results
were compared with the rest of ANZ. All recipients of a cadaveric liver from
the start of the SA program in 1992 until the 100th case in 2005 were
included and compared with recipients from ANZ in the same period.
Results. In SA, 100 recipients received 104 grafts (average 8.0/yr). In the
same period 1438 recipients received 1530 grafts in ANZ (mean 23.4/yr per
unit). The median follow up was 6.0 years. Patient and graft survival curves
were similar (p/0.51, log rank test.) Survival rates at 1, 5 and 10 years were
93, 83, 61 and 88, 80 and 72 for SA and ANZ respectively (p/NS). There
was trend towards a higher mortality rate of recurrent hepatitis C in SA
patients when compared to ANZ (4.0% vs 1.3% resp., p/0.06). Recipient
and donor variables such as age, primary liver disease and donor age did not
differ between SA and ANZ. For the SA patients the biliary anastomotic
stricture rate was 20%, PNF rate was 2%, hepatic artery thrombosis 1% and
portal vein thrombosis 2%.
Conclusion. Good results are possible in a small-volume unit for cadaveric
adult liver transplantation.
FC 17.10
RESULTS OF LIVER TRANSPLANTATION IN PATIENTS OLDER
THAN 65 YEARS OLD
Bilbao, Itxarone; Dopazo, Cristina; Caralt, Mireia; Escartin, Alfredo;
Lopez, In˜igo; Bergamini, Silvina; Balsells, Joaquin; Lazaro, Jose L; Armen-
gol, Manel
Hospital General Vall d?Hebron, General Surgery Dept., Barcelona, Spain
Background. The upper limit of age in liver transplantation (LT) is
controversial due to organ shortage. Many centers have stablished the limit
in 65 years old.
Objectives. To analyse our early and long-term results of LT in patients
greater than 65 years of age.
Material. Between 1996 and 2004, 373 patients underwent 415 LT in our
centre. Main indication for LT were post-necrotic cirrhosis in 55%, followed
by HCC over cirrhosis in 31%. Half of the patients (53%) were HCV /.
Overall, 72 patients were/65 years of age. Actuarial survival, causes of
mortality, and post-operative complications, were compared between both
groups, under and over 65 years of age. Risk factors of bad outcome in the
subgroup of patients older than 65 years old were analysed.
Results. The older group had more patients at Child A stage, more HCC as
indication for LT and more patients HCV (/), pB/0.05. There were no
differences in donor and surgery characteristics. Actuarial survival at 1-5-9
years was 82%72%69%B/65 years age-group vs 77%55%55%/65
years age-group (p/0.03). ICU and hospital stays were similar (p/ns). Main
causes of mortality in patients/65 years of age were recurrence of underlying
disease (HVC and HCC), infection-sepsis, medical causes, primary dysfunc-
tion and de novo tumours. In the older age-group, there were lower infections
(p/ns) and rejections (p/0.017). Risk factors for bad outcome in patients
/65 years were:Child C elderly patients (p/0.05), pre-LT renal insufficiency
(pB/0.001), IDDM (p/0.01), or the combination of all of them (p/0.002).
Conclusion. Patients/65 years of age are high risk patients with lower
survival than younger ones. However, carefully selected elderly patients could
do as well as younger ones, with similar survival. The combination of factors as
Child C, pre-LT renal insufficiency and IDDM should be avoided in patients
over 65 years. Overimmunosuppression should be avoided in older candidates,
because the main cause of death is recurrence of underlying disease.
FC 18.01
CHOLANGIOCARCINOMA: 564 CONSECUTIVE PATIENTS
FROM A SINGLE INSTITUTION
DeOliveira, Michelle L; Cunningham, Steven C; Kamangar, Farin; Ca-
meron, John L; Lillemoe, Keith D; Choti, Michael A; Yeo, Charles J;
Schulick, Richard D
The Johns Hopkins Medical Institutions, Surgery, Baltimore, USA
Background. Cholangiocarcinoma is associated with a poor long-term
survival and its incidence rates are increasing. Because few centers have
significant experience with the disease and classification schemes are incon-
sistent, little is known regarding surgical outcomes and determinants thereof.
Aim. Using a previously validated three-tiered classification system, our goal
was to assess long-term survival and prognostic factors in a large series of
cholangiocarcinoma patients.
Methods. We studied 564 consecutive patients with cholangiocarcinoma
operated upon between 1973 and 2004. Based on the location of the primary
tumor, patients were divided into intrahepatic, perihilar, and distal groups,
and clinicopathologic data, long-term survival, and prognostic factors were
analyzed.
Results. Of the 564 patients with cholangiocarcinoma, 44 (8%) had
intrahepatic, 281 (50%) had perihilar and 239 (42%) had distal tumors.
Approximately half (294, 52%) were treated before 1995, while 270 (48%)
were treated thereafter. Overall perioperative mortality rate was 4%. Long-
rank analyses showed long-term survival to be higher in the later time period
(PB/0.001), in patients with intrahepatic disease (PB/0.001), and in those
with negative margins of resection (PB/0.001), well/moderate differentiation
(PB/0.001), and negative nodal status (P/0.015). In a multivariate analysis,
negative margins (P/0.03), tumor differentiation (PB/0.001), and negative
nodal status (PB/0.001) were significant independent prognostic factors. Of
only those patients in whom an R0 margins of resection was achieved, lymph
node status (P/0.015), but not size, histology, or differentiation, further
predicted survival. The overall median actuarial survival for R0-resected
intrahepatic, perihilar and distal tumors was 60, 38, 22 months and 5-year
survival was 68%, 27%, and 21%, respectively (Figure 1).
Conclusion. R0 surgical resection at the earliest stage remains the best
chance for long term survival, and lymph-node status is the most important
prognostic factor following R0.
FC 18.02
THE DIAGNOSTIC VALUE OF TUMOR VESSELS IN PERCUTA-
NEOUS TRANSHEPATIC CHOLANGIOSCOPY
Ozden, Ilgin1; Kamiya, Juunichi2; Nagino, Masato2; Nishio, Hideki2; Ebata,
Tomoki2; Igami, Tsuyoshi2; Yokoyama, Yukihiro2; Nimura, Yuji2
1Istanbul University, Istanbul Faculty of Medicine, Dept. of General Surgery
(HPB Surgery Unit), Istanbul, Turkey; 2Nagoya University, Graduate School
of Medicine, Dept. of Surgery (Div. of Surgical Oncology), Nagoya, Japan
Background. Tumor vessels -irregularly oriented, tortuous and engorged
vessels on a tumor mass or stricture margin- are markers of malignancy on
percutaneous transhepatic cholangioscopy (PTCS).
Objective. To determine the diagnostic value of tumor vessels on PTCS.
Patients and methods. The charts of 313 patients who underwent PTCS
between 1990 and 2004 were reviewed. The results of 310 patients with
complete data on the final diagnosis were evaluated.
Results. The frequencies of tumor vessels were 53/96 (55%) in bile duct
carcinoma, 17/37 (46%) in gallbladder carcinoma, 11/20 (55%) in pancreatic
carcinoma, 6/16 (38%) in cholangiocellular carcinoma, 3/9 in ampullary
carcinoma, 3/8 in hepatocellular carcinoma and 2/6 in metastatic tumors.
This finding was absent in 118 patients with benign conditions (cholelithiasis:
76, benign stricture: 20, primary sclerosing cholangitis (PSC): 12, chronic
pancreatitis (CP):3, others: 7). Hypervascular areas not fulfilling the tumor
vessel criteria were observed in some patients with PSC (5/12) and CP (2/3).
Tumor vessels were present in 63% (47/75) of the malignant strictures. In the
110 patients with various biliary strictures, the diagnostic performance of
tumor vessels for malignancy were as follows: sensitivity 63%, specificity
100%, positive predictive value 100% negative predictive value 56% and
overall accuracy 75%.
Conclusion. Although tumor vessels are absent in approximately half of the
patients, this finding is a very specific marker of malignancy on PTCS.
FC 18.03
NEOADJUVANT CHEMOTHERAPY SUSPENDS RECURRENCES
BUT DOES NOT IMPROVE LONG-TERM SURVIVAL FOLLOW-
ING RESECTION OF HEPATIC COLO-RECTAL METASTASES
Ben-Haim, Menahem; Lubezky, Nir; Geva, Ravit; Shmueli, Einat; Figer,
Arie; Nakache, Richard
Tel-Aviv Sourasky Medical Center, Surgery, Tel-Aviv, Israel
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Aim. To compare the survival benefit of neoadjuvant vs. adjuvant approaches
for patients with resectable colo-rectal hepatic metastases, who are at high
oncological risk for recurrence.
Methods. A non-randomized prospective comparative study of patients with
disease confined to the liver and technically resectable who were at high risk
for recurrence (MSKCC clinical score /1). Staging was with CT and PET-
CT. Patients were assigned for surgery followed by adjuvant chemotherapy
(group 1) or were treated in a neo-adjuvant approach and then referred to
surgery (group 2) according to the oncologist’s and the patient’s preferences.
Chemotherapy was based on oxaliplatin (FOLFOX) or irinothecan (FOL-
FIRI). Minimal follow-up is of 12 months.
Results. Of 110 resections of hepatic C-R metastases (20022004), 49
patients meets he inclusion criteria; 17 in group 1 and 32 in group 2. The 2
groups were comparable for demographics, tumor characteristics and
MSKCC scores. There were more complications (wound and infectious) in
group 2. The overall survival rates after 1, 2 and 3 years were: 93%, 90% and
79% in group 1 vs. 100%. 94% and 69% in group 2, respectively. Disease free
survival rates were 64%, 45% and 45% in group 1 vs. 92%, 49% and 49% in
group 2 respectively. Mean intervals to recurrence of new hepatic metastases
were 15 mo. in group 1 vs. 20 mo. in group 2 and of extra-hepatic metastases,
8 mo. vs. 18 mo, respectively.
Conclusions. The observed effect of neoadjuvant approach is to suspend but
not prevent recurrences. There was no long-term survival benefit to this
approach which on the other hand was involved with higher complications rate.
FC 18.04
IMPACT OF SURGICAL MARGIN ON THE LONG TERM PROG-
NOSIS OF PATIENTS WITH COLORECTAL LIVER METASTASES
Frilling, Andrea1; Neuhaus, Jan1; Bockhorn, Maximillian1; Fruehauf, Nils1;
Broelsch, Christoph1; Schmid, Kurt2
1University Hospital Essen, Dept. of Surgery, Essen, Germany; 2University
Hospital Essen, Dept. of Pathology, Essen, Germany
Background. Several parameters such as primary tumor stage or number of
hepatic metastases have been reported as predictive for outcome after hepatic
resection for colorectal metastases.
Objective. To assess surgical margin status as an additional independent
predictor of survival.
Methods. Data of 482 patients with colorectal liver metastases who were
subjected for liver surgery from 1998 to 2005 in a tertiary referral center were
implemented in a prospective data base. Surgical margin status and tumor
characteristics were analyzed in regard to survival.
Results. Median follow-up was 36 months. In case of complete tumor
resection (R0), the 1-, 3-, and 5-year overall survival rates were 89%, 64%,
37%, respectively compared to 83%, 42%, 23%, respectively for patients in
whom surgical margins were microscopically positive (R1) (p/0.01).
Tumor-free 3- and 5-year survival rate was 53% and 28%, respectively after
R0 resection, and 33% and 20%, respectively in the R1 situation. When
determined the margin width (10 mm versus 15 mm), no difference in
overall and tumor-free survival was evident. At multivariate analysis of
traditional prognostic predictors positive lymph nodes (p/0.009), number of
metastases (pB/0.001), and CA 19-9 (p/0.019) were of negative prognostic
value.
Conclusion. Our data indicate that survival after resection of colorectal liver
metastases is significantly influenced by the surgical margin (R0 vs. R1). The
1-cm margin, however, may not be considered anymore as prerequisite.
Further factors with negative impact on survival are lymph node metastases,
number of hepatic metastases and CA 19-9 level.
FC 18.05
HEPATIC TUMOR ABLATION WITH CLUSTERED MICROWAVE
NEEDLE PROBES: THE US PHASE II TRIAL
Iannitti, David1; Martin, Robert2; Simon, Carolyn3; McMasters, Kelly2;
Dupuy, Damian3
1Brown Medical School, Surgery, Providence, USA; 2University of Louis-
ville, Surgery, Louisville, USA; 3Brown Medical School, Diagnostic Imaging,
Providence, USA
Background. Microwave Ablation (MWA) is an emerging technology for
treatment of various malignancies. This paper reviews the preliminary US
experience of hepatic microwave ablation using single and clustered 913
MHz needle probes.
Objective. Ongoing prospective phase II multicenter clinical trial utilizing
the VivaWave† Microwave Coagulation System (ValleyLab/Tyco, Boulder,
CO, USA) for patients with hepatic malignancies. Follow-up data was
gathered from post-ablation clinical visits in conjunction with imaging studies
to assess technical success, ablation size, complication/morbidity, residual/
recurrence, and mortality.
Methods. 80 patients with hepatic malignancies were treated There were 46
males, 34 females. Mean patient age was 64.33 years (range 39 79). Tumor
histology included primary hepatocellular carcinoma (20) and secondary liver
metastases from colorectal (31), renal Carcinoid (6) breast (11), renal(3),
ovarian(2), lung(3), gallbladder(1), duodenal(1), ovarian(1), and mela-
noma(1) primaries.
Results. 158 hepatic tumors (mean 3.6 cm diameter, 0.5 9.0) were
successfully ablated. 22 lesions were greater than 4 cm. Two patients had
expected and three unexpected residual disease following ablation requiring
further treatment. There were no treatment related mortalities. One patient
had a skin burn. Two patients developed a bile leak/fluid collections were
treated with percutaneous drainage. The ablation volume for clustered
probes was 50.5 cc (21.1146.5) and single needle 10.0 cc (7.814.0).
Mean follow-up interval is currently 13.5 months. Three lesions developed
local recurrence, while 24 patients developed liver recurrence.
Conclusions. MW ablation is safe and effective for local hepatic tumor
control via the percutaneous, laparoscopic, and open surgical approaches.
Differences in residual/recurrence rates may be due to a multiplicity of
factors, including the diverse patient population enrolled in this study.
Controlled trials based on pathology are needed to determine the effect of
tumor ablation on survival.
FC 18.06
DEVELOPMENT OF A PERFUSED EX VIVO TUMOR-MIMIC
MODEL FOR TRAINING LAPAROSCOPIC RADIOFREQUENCY
ABLATION
Hildebrand, Philipp; Mirow, Lutz; Kleemann, Markus; Roblick, Uwe; Bu¨rk,
Conny; Bruch, Hans-Peter
University of Schleswig-Holstein, Campus Luebeck, Dept. of Surgery,
Luebeck, Germany
Background. Laparoscopic Radiofrequency-ablation offers a save and
effective method for tumor destruction in patients with unresectable liver
tumors. However, accurate probe placement using laparoscopic ultrasound
guidance is required to achieve complete tumor ablation.
Aims. This study aims to devolop a perfused ex vivo tumor-mimic model for
learning laparoscopic radiofrequency ablation.
Material and methods. After explantation of a porcine liver, tumor-mimics
were created by injection of a cellulose based mixture, creating hyperechoic
lesions. Then the liver was perfused with heparinized blood throw the portal
vein, followed by a connection of the perfuion tube with the vena cava via a
pump for continuous perfusion of the porcine liver. After that, the liver was
placed in a laparoscopic box-trainer.
Results. The simulated tumors were clearly visible on laparoscopic ultra-
sound and not felt during placement of the RFA probe. Besides that the color
duplex ultrasound showed clear signals indicating a good perfusion of the
liver.
Discussion. Laparoscopic radiofrequency ablation requires advanced la-
paroscopic ultrasound skills for accurate placement of the RFA probe. The
perfused tumor-mimic model offers a safe, easy, effective and economic
method for learning laparoscopic RFA in ex vivo livers.
FC 18.07
INLINE RADIOFREQUENCY COAGULATOR FOR REDUCED
BLOOD LOSS AND TRANSECTION TIME-A MULTINATIONAL
STUDY
Gunasegaram, Aravin1; Haghighi, Kouroush1; Chu, Francis1; Pistorius,
Georg2; Lindermann, Werner2; Schilling, Martin2; Zuckerman, Randall3;
Machi, Junji4; Daniel, Steven5; Yan, Tristan1; Morris, David1
1St George Hospital Campus, University of New South Wales, Dept.
of Surgery, Sydney, Australia; 2University of Saarland, Dept. of
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Background. Liver resection has become standard practice in the treatment
of liver tumors. Recent innovations in technology and surgical technique have
improved its safety and efficacy. We have previously shown in animal and
human trials that the use of InLine Radiofrequency (ILRF) Linear
Coagulator (Resect Medical Inc, Fremont, CA) to precoagulate the liver
transection plane prior to resection is safe and effective in significantly
reducing intra-operative blood loss and transection time.
Aim. To report blood loss, transection time and post-operative complications
in patients in a multi-centre, multi-national trial using ILRF precoagulation
in liver resection.
Patients/Method. 61 liver resections were performed in 4 institutions using
ILRF Coagulator followed by CUSA transection. There were 35 men and 26
women. Median age was 65 (3085) years. 5 patients had cirrhotic liver (4-
Childs A and 1-Childs B). 31% of patients (19 of 61) had formal lobectomies
or extended resections and 30% (18 of 61) had non-anatomical resections.
Pringle maneuvre was applied only when required. Blood loss was measured
calculation of sponge weights and suction bottle contents. Data was collected
prospectively in standardized data sheets.
Results. Median number of coagulator deployments was 3 (range 112)
with a median coagulation time of 9(range 336)min. Median operative
blood loss was 150 mls (range 5675 ml) with a median transection surface
area of 53 cm2 (range 7236 cm2). Median transection blood loss per unit
resection area was 2.34(0.1412)ml/cm2. Mean blood loss in cirrhotics was
2.46 ml/cm2. Median transection time was 25 (2129) min with 11% of the
transections requiring Pringle maneuvre. 3% of the patients (2 of 61)
developed bile leaks and 15% (9 of 61) developed non-bile abdominal
collections requiring CT-guided drainage.
Abstracts 51
Conclusion. ILRF Coagulator is a safe, effective technique for liver
resections which significantly reduces blood loss and transection time without
increasing bile leak. Cirrhotic resections may benefit additionally.
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PATTERNS OF RECURRENCE FOLLOWING LIVER RESECTION
FOR COLORECTAL METASTASES: IMPACT OF PRIMARY REC-
TAL SITE
Assumpcao, Lia; Choti, Michael; Gleisner, Ana; Schulick, Richard; Pawlik,
Timothy
Johns Hopkins University School of Medicine, Dept. of Surgery, Baltimore,
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Background. Compared with colon cancer, patients (pts) with rectal
adenocarcinoma are at an increased risk of locoregional recurrence within
the pelvis. This may adversely affect prognosis of curative resections aimed at
metastatic hepatic disease.
Objective. To determine the pattern of recurrence, as well as disease-free
and overall survival, of pts undergoing curative hepatic resection of liver
metastases from rectal adenocarcinoma.
Methods. Between 19842004, 376 pts with liver metastases from a primary
colorectal adenocarcinoma underwent hepatic resection. Clinical/pathologic
parameters were collected and analyzed using chi-square and log-rank tests.
Results. Of the 376 pts, 101 had liver metastases from a rectal primary. 68%
pts underwent a low anterior resection and 32% an abdominal perineal
resection. Most pts (72%) had T3/T4 rectal tumors with N1 (29%) or N2
(24%) disease; chemoradiation therapy was used in 62% of pts. In pts with
metachronous disease (67%), the median interval to hepatic metastases was
1.4 yrs. Hepatic metastectomy included both major (at least 3 segments)
(42%) and minor resections (58%). At a median follow-up of 25 mon, 52 pts
recurred, including 13 (13%) who recurred with pelvic disease as a
component of their recurrence. In those pts with pelvic recurrence, the
majority also had a recurrence within the liver (54%). Four pts recurred in
the pelvis alone. Only N2 disease predicted pelvic recurrence (PB/.01).
Although the median disease-free survival was shorter in those pts with pelvic
recurrence (pelvic recurrence: 12 mon vs. no pelvic recurrence: 25 mon; P/
.02), the overall 5-yr survival rate was no different between the two groups
(28% vs. 33%, respectively; P/.41).
Conclusion. Following resection of hepatic rectal metastases, pelvic
recurrence is relatively common (/10%) and most pts who recur in the
pelvis will also recur within the liver. Resection of pelvic and liver recurrences
is warranted as these pts have long-term survival approaching 30%.
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LAPAROSCOPIC LIVER RESECTION: CANADIAN SINGLE CEN-
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Background. As laparoscopic liver resections are gaining popularity and an
increasing number of articles are being published, to our knowledge, no
Canadian series has been presented so far.
Objective. To prospectively assess the feasibility, safety and the outcome of
laparoscopic liver resections and to present the first Canadian experience.
Methods. Between December 2004 and February 2006 twenty-three
patients (mean age of 53.4 years) underwent 24 liver resections for
symptomatic hemangioma (n/2), focal nodular hyperplasia (FNH) (n/
1), adenoma (n/2), cystadenoma (n/2), polycystic liver disease (n/2),
symptomatic simple biliary cyst (n/1), metastatis (n/10), hepatocellular
carcinoma (n/2) and cholangiocarcinoma (n/1). Liver transection was
done using a harmonic scalpel or a vessel sealing device.
Results. Resections were as follow: 9 left lateral segmentectomies, 7 left
lobectomies, 3 bisegmentectomies, 4 segmentectomies and one nonanatomical
resection. Thirteen patients had previous laparotomy and 8 patients had
underlying liver disease. Mean tumor size was 5.55 cm. The mean margin of
resection was 1.66 cm with one (4.1%) positive margin (FNH). The mean
operative time was 194.8 minutes. Mean peroperative blood loss was 221.9 ml.
No patient experienced intra-operative complications or conversion. Post-
operative complications occurred in 6 (26%) patients: urinary infection (n/1),
arterial hypertension (n/1), migraine (n/1), cellulitis (n/1), respiratory
insufficiency (n/1), prolonged drainage (n/2) and biliary leak (n/2). No
patients received blood transfusion. The mean hospital stay was 4.4 days.
Conclusions. Laparoscopic liver resection is feasible and safe. Extensive
experience in hepatic and laparoscopic surgery is imperative. Lesions located
to the left lateral segments or in the anterior segments of the right liver are the
best indications. Our complication rate is low and this technique seems to
offer short-term benefits. Late outcome should be further studied.
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Background. Liver metastasis (LM) can be synchronous or more frequently
the way of recurrence after curative gastrectomy for adenocarcinoma. This
recurrence, occuring generally within 2 years, is rapidly fatal. Recent japanese
short series report 20 to 38% five years survival rate after LM resection.
Objective. To study the results of gastric adenocarcinoma LM resection and
analyse the prognostic factors.
Methods. 126 patients underwent resection of gastric liver metastasis This
series represents 8,7% of the 1452 hepatectomies performed from 1980 to
2004 for noncolorectal liver metastasis in 41 institutions of the French
Association of Surgery: 101 resections concerned LM of gastric adenocarci-
noma, including 34 of the gastroesophageal (GE) junction.
Results. There were 81,8% of male, median age/60,8 y. Metastasis
were synchronous in 44,4% of the cases, and for the metachronous
LM, the mean delay between gastrectomy and diagnosis of LM was
20,6m/// LM were solitary in 57,1% of the cases. In 35,6% of the cases,
patients received neoajuvant chemotherapy. Resection was R0 in 86,7%.
Operative mortality and morbidity were respectively 6,4% and 35%
Overall and disease-free survival rate were 22% /29,7% at 3 years and
16,7%/15,3% at 5 years. Eleven 5 years-survivors were reported. After
exclusion of cancer of GE junction, five year survival rate was better 27,1%
Factors associated with better survival by univariate analysis included R0
resection, and size of LM (B/5 cm). On multivariate analysis only the absence
of extra hepatic disease achieved statistical significance. Other factors such as
the number of LM, the delay of occurrence did not reached statistical
significance.
Conclusion. This series is the largest ever reported. It shows that, if
complete gastric carcinoma (maybe excluding GE junction) LM resection
can be achieved, surgery is justified, allowing survival rate which is not so
different than in case of colorectal LM. Progress in adjuvant chemotherapy
should probably improve those results.
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THE UTILITY OF WHOLE BODY FDG-PET IN THE ASSESS-
MENT OF COLORECTAL LIVER METASTASES PRIOR TO SUR-
GICAL RESECTION: A PROSPECTIVE STUDY
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Abraham, A
St Bartholomews and the Royal London Hospital, HPB Surgery Unit,
London, UK
Background. The role of whole-body 18-Fluoro-deoxy-glucose positron
emission tomography (FDG-PET) in assessing colorectal liver metastases is
increasingly recognised in the literature.
Aims. We have prospectively evaluated the impact of FDG-PET on surgical
decision making for patients with colorectal liver metastases (CRLM) being
considered for liver resection.
Methods. From Jan 2001 to Jan 2006, 136 consecutive patients were
prospectively evaluated. These patients were deemed on contrast enhanced
CT (ceCT) to have resectable CRLM. All 136 patients also underwent
contemporaneous FDG-PET scans. The final decision regarding the treat-
ment strategy for CLRM was surgical. Surgical findings in terms of bimanual
palpation and intra-operative ultrasound, histopathology findings in the
resected liver specimens, and clinical outcomes were compared with pre-
operative imaging results for ceCT and FDG-PET to determine test
characteristics and overall impact FDG-PET on management of patients
with CRLM being considered for liver resection.
Results. FDG PET compared favourably with ceCT for test characteristics,
in overall terms, and for intra-hepatic disease, and especially so for
extrahepatic disease. FDG PET downstaged disease in 9 patients (6.6%)
and enabled liver resection. FDG PET also accurately upstaged disease in 39
patients (28.7%) and led to the cancellation of proposed resections. Overall,
FDG PET altered the management in 48 (35.3%) of the 136 patients with
CRLM who were initially considered suitable candidates for liver resection on
the basis of ceCT.
Conclusions. FDG-PET should be an essential part of the staging algorithm
prior to resection of colorectal liver metastases.
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LIVERMETSURVEY: ANALYSIS OF PROGNOSTIC CLINICO-
PATHOLOGIC FACTORS IN 3,216 PATIENTS WITH COLOREC-
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Background. LiverMetSurvey is an international, internet-based registry
designed to assess the efficacy of multimodality treatment options for
colorectal liver metastases (CLM).
Objective. To analyze outcomes following hepatic resection (HR) in a large
number of patients (pts) with CLM.
Methods. Data for 3,216 pts entered into the LiverMetSurvey
from inception to February 2006 were analyzed (HR: 19742006;
2,007 M: 1,199 F; mean age: 59 years). The distribution of prognostic
factors were compared to survivals using univariate and multivariate
statistics.
Results. Metastases originated in the colon in 61% of pts and
were synchronous (B/3 months) in 44% of pts. One-third of pts had
3 or more CLM and tumors were distributed bilaterally in 43% of pts
(mean size: 32.3 mm). Forty-four percent received preoperative systemic
chemotherapy. Median, 5-year, and 10-year overall survivals (OS) were
45 mo, 42%, and 25%, respectively. Variables independently associated
with poor prognosis included number of metastases ]/3 (p/0.001),
bilateral metastases (p/0.04), and size of the largest metastasis ]/5 cm
(p/0.05). Preoperative chemotherapy (PC) did not appear to benefit pts
with solitary CLM (5-yr OS: PC 49% vs. noPC 57%), but was associated
with improved survival in pts with /5 metastases (5-yr OS: PC 20% vs.
noPC 15%).
Conclusions. Assessment of the first 3,216 registrants to LiverMetSurvey
emphasizes the prognostic importance of intrahepatic tumor burden and
confirms the efficacy of HR, with 25% of patients surviving 10 years after
resection. Although not useful for pts with solitary metastases, preoperative
chemotherapy appears to benefit patients with multifocal disease. In addition,
this analysis highlights the potential for LiverMetSurvey, which is now
prospectively enrolling pts from over 40 centers, to determine the therapeutic
value of current and future treatment strategies.
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PORTAL CAVAL NODAL INVOLVEMENT MAY NOT BE A CON-
TRAINDICATION TO RESECTION OF COLORECTAL LIVER
METASTASES
Chu, Francis; Gunasegaram, Aravin; Clingan, Philip; Morris, David
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Introduction. The presence of extra hepatic disease has long been
considered a contra-indication to liver resection for colorectal cancer
metastases. This has recently been challenged by a French Unit, who
reported on 5 year survival rates of 28% in patients with resectable extra
hepatic disease. Importantly, there were 12 patients had involved portocaval
node, with a 5-year survival of 33%. A question that has not been addressed is
there a survival benefit in resecting patients with portocaval node involve-
ment?
Patients/Method. Between 1990 and 2004, 460 liver resections and/or
cryoablations were performed for colorectal cancer liver metastases at the St
George Hospital Liver Unit. Forty-nine patients had liver resection and
ablation or resection of their extra hepatic disease. There were also 20
patients with potentially resectable liver metastases but were not resected
because of portocaval node involvement. These patients had insertion of
Hepatic Artery Catheter (HAC), and were given a combination of systemic
and regional chemotherapy. During the same period, 29 patients had liver
and portocaval node resection for metastatic colorectal cancer.
Results. The overall 5-year survival of patients with extra hepatic disease that
have undergone a liver resection was 17%. The medium survival for the
resection group (in patients with involved portocaval lymph node) was 30
months, with a 3 year survival of 17%. The median survival for the HAC
group was 16 months, with a 3-year survival of 7%.
Conclusion. Liver resection in the presence of portocaval nodal involvement
shows a significant survival benefit over systemic and regional chemotherapy
alone. Five year survival of 17% can be achieved in patients undergoing a
liver resection with resectable or ablatable extra hepatic disease.
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Chiche, Laurence1; Adam, Rene´2; Salmon, Re´my3; Elias, Dominique4;
Rivoire, Michel5; Jaeck, Daniel6; Saric, Jean-Jacques7; Delpero, Jean-
Robert8; Ayav, Ahmet9; Letoublon, Christian10; Mentha, Gilles11; Tiberio,
Ga12; Partensky, Christian13; Cherqui, Daniel14
1University Hospital of Caen, HepatoBiliary and Transplantation Dept.,
Caen, France; 2Paul Brousse Hospital, HepatoBiliary and Transplantation
Dept., Villejuif, France; 3Institut Curie, Paris, France; 4Institut Gustave
Roussy, Villejuif, France; 5Centre Le´on Be´rard, Lyon, France; 6University
Hospital of Stransbourg, Strasbourg, France; 7St Andre´ Hospital, Bordeaux,
France; 8Institut Paoli-Calmettes, Marseille, France; 9University Hospital of
Nancy, Nancy, France; 10Hopital Albert-Michallon, Grenoble, France;
11Hopital Cantonal, Gene`ve, Switzerland; 12Unversity Hospital of Brescia,
Brescia, Italy; 13Hopital Edouart Herriot, Lyon, France; 14Hopital Henri
Mondor, creteil, France
Background. Melanoma is a rare tumor, mainly arising from the skin and
the uvea. Its prognosis is generally poor due to distant spreading. Among the
different metastatic sites, the liver is a main location, and liver metastasis
(LM) can be isolated mainly for uveal melanoma (5090% of cases). Very
few series of liver resection for metastatic melanoma, including less than 25
patients, have been reported; therefore, results of liver surgery in that
indication are poorly known.
Methods. Among 1452 hepatectomies for non colorectal non neuroendo-
crine LM performed from 1983 to 2004 in 41 french centers, 148 were
carried on for metastases of uveal (104) or cutaneous(44) melanoma. We
studied the presentations of the metastasis at diagnosis treatment, the
hepatectomy, mortality, long-term survival and recurrence.
Results. LM were more likely to be metachronous (91%-unique (44.1%)
and unilobar (63.2%) with an average size of 4.3 cms. The hepatectomy was
limited in 46% of patients with a R0 resection achieved in 72.2% of cases.
Hospital mortality was of 2.9%. 77,6% of patients had a hepatic recurrence
after a mean of 9.6 months of the surgery. Fifteen patients did undergo a
second hepatectomy. Overall 5-year survival was of 20.9% but 5-year disease
free survival was only 1.5%. 10 patients were alive after 5 years. On univariate
analysis, favourable prognostic factors are a delay of diagnosis (DD)/24
months between treatment of the primary and diagnosis of LM, R0 resection,
the number of metastasis, a minor resection, preoperative chemotherapy and
re hepatectomy. Only the DD was significant on multivariate analysis (5y
Survival 27,2% vs 5,9%).
Conclusion. Long term survival after liver resection for metastatic mela-
noma remains poor. Nevertheless, it seems that an extremely selected
population of patients presenting with 1 to 3 metastatic nodules, after 2
years of the treatment of primary tumor and who could undergo a limited
hepatectomy could benefit from a surgical treatment and even from a
rehepatectomy.
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ITERATIVE CYTOREDUCTIVE SURGERY (CS) ASSOCIATED
WITH INTRAPERITONEAL HYPERTHERMIC CHEMOTHERAPY
(IPHC) FOR TREATMENT OF PERITONEAL CARCINOMATOSIS
(PC) FROM COLORECTAL ORIGIN WITH OR WITHOUT LIVER
METASTASES (LM): A MULTIMODAL STRATEGY
Kianmanesh, Reza; Scaringi, Stefano; Sabate, Jean-Marc; Coffin, Benoit;
Hay, Jean-Marie; Grandjean, Michel; Flammant, Yves; Msika, Simon
Louis Mourier, Colombes, France
The aim of this unicentric study was to evaluate the results of an aggressive,
multidisciplinary strategy in patients presenting PC from colorectal cancer
with or without LM. From 1996 to 2005,132 patients had 170 CS/IPHC
for PC from digestive and non-digestive origin. Among them 43(17W/26M)
had 54 CS/IPHC for colorectal PC (appendix pseudomyxoma, neuroendo-
crine, GIST excluded). CS removed all macroscopic nodules, omentectomy,
peritonectomy9/extended to the diaphgram followed by IPHC(Mitomy-
cine:120 mg, Cisplatine:200 mg/m2,12L/2 h 40438C). The mean age was
539/15. PC was synchronous in 18 patients(42%). 16 patients(37%)
presented LM. 32 patients (75%) recieved chemo after primary tumor
resection. For 11 patients (25%) PC was discovered by an occlusion. The
mean number of CS/IPHC per patient was 1.23 (11 patients had one or
more routine second looks). PC was classified Gilly 3 (diffuse nodules,.5 2
cm) in 12% and Gilly 4 (diffuse nodules/2 cm) in 65% of the patients. An
ascites was present in 12 patients(28%). A major intestinal resection was
performed in 65% of the cases(49 anastomosis,4 stomies). The CS was
considered as CCR0(no macroscopic residual nodules) or CCR1(millimetric
residual nodules) in 30 patients(70%). Seven patients had concomitant and 3
had differed liver resection (2 right hepatectomies). The mortality was 2.3. 17
patients (39%) presented one or multiple complications (morbidity per
procedure 31%). Complications included, profond collection(6), wound
infection(5), pleural effusion(5), digestive fistula(4) delayed gastric empty-
ing(4), renal insuffisancy(3). 2 patients(3.6%) were reoperated (peritonitis).
75% of the patients rceive second line chemo after CS/IPHC. The median
survival was 38.4 months (CI:32.843.9). The actuarial survival was 72% at
2 and 44% at 4 years. Iterative CS/IPHC is an effective treatment in PC
from colorectal cancer. The presence of resectable LM associated to PC does
not contraindicate the perspective of a carcinologic treatment in these
patients.
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A COMPARISON OF CT VERSUS ULTRASOUND (US)/CHEST
X-RAY (CXR) FOLLOW UP (FU) FOLLOWING HEPATECTOMY
(HPX) FOR COLORECTAL LIVER METASTASES (CLM)
Glendinning, Richard J1; Nesbitt, Craig1; Ghaneh, Paula1; Wu, Andrew2;
Poston, Graeme2
1University of Liverpool, Faculty of Medicine, Liverpool, UK; 2University
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Background. HPX is the only treatment for CLM that offers potential cure.
However /60% recur after HPX for CLM, and patients increasingly are
undergoing repeat-HPX with further curative intent. However there is no
consensus regarding FU protocol after HPX for CLM. CT scans are
expensive, involve considerable radiation exposure, whereas US/CXR is
cheaper but might be less accurate.
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Aims. To compare efficacy CT vs. US/CXR FU post-HPX for CLM
comparing liver only (LOR), extra-hepatic (HER) recurrence and resect-
ability of recurrent disease.
Methods. Comparison of prospective 5-yr FU from two (184 patients using
CT, 190 patients using US/CXR) centres post-HPX for CLM. Data
stratified for timing and site of LOR, extra-hepatic recurrence (HER), and
repeat-HPX with curative intent.
Results. CT 108 (59%) recurred (34% LOR) during first 5 years after HPX,
14 (8%) repeat-HPX. US/CXR 106 (56%) recurred (16% LOR), 12 (6%)
repeat-HPX.
Time of
detection
(months)
CT
LOR
CT
EHR
CT
repeat-
HPX
US/
CXR
LOR
US/
CXR
EHR
US/CXR
repeat-
HPX
3 1 4 0 2 5 0
46 21 10 1 6 6 1
79 13 5 3 6 4 3
1012 10 11 3 3 11 1
1318 6 3 2 6 12 3
1924 5 2 2 3 7 2
2560 8 9 3 3 18 2
Conclusions. Efficacy of detecting LOR amenable to repeat-HPX with
curative intent was comparable between the two FU techniques. In both
groups, very few cases recurring B/6 months post-HPX were amenable to
repeat-HPX. Early (B/6 month) detection indicates poor prognosis, and
although amenable to palliative chemotherapy, contributes to psychological
morbidity. The peak incidence of LOR amenable to repeat-HPX in both
groups occurs between 624 months post-HPX. Therefore a reasonable
follow up FU protocol would be at 6, 12, 24, 36, 48 and 60 months post-HPX.
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EPIDURAL ANALGESIA IN PANCREATICODUODENECTOMY IS
NOT SUPERIOR TO INTRAVENOUS ANALGESIA
Pratt, Wande1; Steinbrook, Richard2; Maithel, Shishir1; Vanounou, Tsafrir1;
Callery, Mark1; Vollmer, Charles1
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Background. Epidural analgesia has emerged as the preferred method to
improve pain management and reduce perioperative complications in major
abdominal surgery. However, there is no detailed analysis of its efficacy for
pancreatic resections.
Aim. We retrospectively compared clinical and economic outcomes following
epidural and intravenous pain management for pancreaticoduodenectomy.
Methods. 181 consecutive patients underwent pancreaticoduodenectomy
from 10/01 to 2/06. Postoperative pain management was by a standardized
clinical pathway for pancreatic resections. All patients were eligible for
thoracic epidural analgesia (EA), and those who declined received intravenous
patient-controlled analgesia (PCA). Clinical and economic outcomes were
analyzed and compared for PCA and EA.
Results. 153 patients received EA and 28 received intravenous PCA, with
equivalent patient demographics between the groups. Patients administered
EA had significantly longer hospital stays, higher rates of major complications,
and increased hospital costs (Table). Postoperative ileus and clinically relevant
pancreatic fistulas occurred more frequently, and patients with EA more often
required discharge to rehabilitation settings. Furthermore, 30% of epidural
infusions were aborted before the third postoperative day due to hemody-
namic compromise and/or inadequate analgesia. These select patients
required more transfusions, aggressive fluid resuscitation, and more often
developed intra-abdominal and respiratory complications.
Conclusion. Thoracic epidural analgesia following pancreatic resections was
associated with hemodynamic instability, which may compromise enteric
anastomoses, gastrointestinal recovery, and respiratory function. These
findings suggest that epidural analgesia may not provide optimal postoperative
pain management for pancreaticoduodenectomy.
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A COMPARISON OF THE EFFECTIVENESS OF EARLY ENTERAL
AND NATURAL NUTRITION FOLLOWING PANCREATODUODE-
NECTOMY
Grizas, Saulius1; Gulbinas, Antanas2; Barauskas, Giedrius1; Pundzius,
Juozas1
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Background. Although nutritional supplementation is established in surgical
practice, studies on feeding patients undergoing pancreatoduodenectomy
show disparate results.
Aim. To evaluate efficacy of different methods of postoperative feeding and
their impact on early outcomes following pancreatoduodenectomy.
Methods. The prospective randomized study was carried out. Sixty patients
participated in the study and were randomized to early oral nutrition (EON,
n/30) and early enteral nutrition (EEN, n/30) groups. Groups were
comparable according to preoperative data, duration of surgery, intraoperative
complications rate. Changes in total protein, albumin concentrations and
weight loss after pancreatoduodenectomy as well as the rate of postoperative
complications depending on the method of postoperative nutrition was
evaluated.
Results. Statistically significant reduction in total protein and albumin
concentrations was observed on day 5 in both groups. From day 5 to day 10
there was significant increase in total protein concentration in both groups.
However, significant increase in albumin concentration was observed in early
enteral nutrition group only. There were more complications in EPN group
(53,3% vs 23,3%) however the difference was not statistically significant.
Odds ratio for development of infectious complications in early oral nutrition
group was 1,56 and the difference was statistically significant (46.7 vs.
16.7%). Within the EON group preoperative plasma albumin level (median
34.5 g/l) was significantly lower in patients who developed infectious
complications.
Conclusion. Patients of EEN group were significantly less likely to develop
postoperative infectious complications. EEN could be reccomended in
patients with preoperative hypoalbuniemia.
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COMPLETION PANCREATECTOMY IS A USEFUL DAMAGE
CONTROL OPTION FOR POST PANCREATIC SURGERY COM-
PLICATIONS
Tamijmarane, Appou; Ahmed, Irfan; Mirza, Darius F; Mayer, David;
Buckels, John; Wigmore, Stephen; Bramhall, Simon R
Queen Elizabeth Hospital, Birmingham, UK
Introduction. Management of post pancreatic surgery complications is
complex with high mortality rates between 8% to 88%. Despite the critically
ill nature of these patients, relaparotomy might be required when the
conservative options have failed.
Aim. To analyse the results of completion pancreatectomy (CP) which was
done as a last resort option.
Patients & methods. 25 patients (3.6%) who had CP from among 677
patients who had pancreatoduodenectomy or distal pancreatectomy over a
period of 18 years were analysed regarding indications for CP, outcome and
survival data. Those who had total pancreatectomy and completion pancrea-
tectomy for positive resection margins, multifocal disease or chronic pancrea-
titis were excluded.
Results. Median age of patients who had CP was 62.8 years. The index
operation were pancreatoduodenectomy in 23 patients (92%) and distal
pancreatectomy in 2 (8%) patients. Indications for CP include pancreatic leak
in 12 patients (48%); both bleeding and pancreatic leak in 8 (32%) and
haemorrhage alone in 5 (20%) patients. 18 (72%) patients also had
splenectomy. Median ITU stay was 4 and 8 days for those who survived
and died post CP, respectively. 36% patients had septicaemia and 32%
patients had multiple organ failure. 12 patients survived CP with a median
survival of 52 months. All surviving patients developed diabetes.
Conclusion. While most of the postpancreatic surgery complications were
managed with aggressive non-surgical means, 25 (3.6%) patients required
surgical intervention. The incidence of splenectomy was 84.6% in those who
died after CP compared to 58.3% of those who survived (Fishers Exact test 2-
sided 0.20). 12 (48%) patients survived CP and 9 out of 13 patients died due
Table. Outcomes according to postoperative pain management following
pancreaticoduodenectomy.
Outcome
Intravenous
PCA
All
Epidurals
Functional
Epidurals
Aborted
Epidurals
N 28 153 107 46
LOS (mean, days) 7.8 10.7 10.7 10.7
ICU Duration
(mean, days)
0.8 1.3 1.2 1.6
Major
Complications
0% 16% 14% 20%
Hemodynamic
Instability
21% 38% 26% 65%
Postoperative Ileus 0% 12% 10% 15%
Bowel Recovery
(mean, days)
4.5 5.8 5.7 6.1
Pancreatic Fistula 7% 17% 15% 22%
Respiratory
Complications
7% 8% 5% 17%
Fluid
Resuscitation
61% 63% 57% 76%
Blood
Transfusions
18% 16% 11% 28%
Discharge to
Rehabilitation
Facilities
4% 21% 20% 24%
Total Costs (mean) $21, 071 $27, 418 $26, 423 $29, 731
54 Abstracts
to multiple organ failure or sepsis. The median survival for those who survived
was 52 months. Despite significant morbidity and mortality, completion
pancreatectomy has a role in the management of post pancreatic surgical
complications.
FC 20.04
MORBIDITY AFTER PARTIAL PANCREATODUODENECTOMY:
INFLUENCE OF SURGICAL TECHNIQUE AND POSTOPERA-
TIVE OCTREOTIDE APPLICATION
Timm, Stephan; To¨pfer, Claudia; Steger, Ulrich; Maier, Markus; Thiede,
Arnulf
University Hospital of Wuerzburg, Surgery, Wuerzburg, Germany
Background. Inspite of decreasing mortality rates after partial pancrea-
toaduodenectomy morbidity is still high and it is mainly influenced by the
rate of postoperative insufficiency or fistula from the pancreato-jejunal
anastomosis.
Aim. In a prospective study we analysed the influence of two factors on the
complication rate after pancreato-jejunostomy: 1. Technique of pancreato-
jejunostomy, 2. Application of octreotid in the postoperative course.
Methods. Between 6/2000 and 6/2005 120 patients underwent a partial
pancreatoduodenectomy. The following techniques were performed: End-to-
side telescope (ES n/20), Catell-Warren either with or without silicon tube
drainage of the pancreatic duct (CW/, n/25, CW/, n/75). In the CW/
group octreotid administration was prospectively randomised in 2 groups: 3/
200 mg vs. control. Anastomotic insufficiency was defined as persisting
amylase/lipase-rich fluid after postoperative day 4 plus signs of sepsis and
abdominal symptoms. It was always followed by operative revision. Pancreatic
fistula met the above mentioned criteria without clinical symptoms and was
treated conservatively (1228 days).
Results. Altogether the rate of insufficiency was 5,8% (7/120), for ES-
technique it was 10% (2/20), for CW- 5% (1/25) and for CW/ 5,3%
(4/75). Pancreatic fistulas were found in 24 of 120 patients (20%), the
rate was 10,5% for the ES group and significantly higher in the CW groups
(22,5%). The 4 patients with insufficiency in the CW/ group did not receive
octreotid.
Conclusion. In our hands ES-technique resulted in a higher rate of
insufficiency and less fistulas compared to CW-technique. The small
pancreatic ducts on the resection plane of the pancreas, which are not drained
into the jejunum in CW-technique might explain the higher rate of fistulas. In
75 CW/ patients octreotid application significantly reduced the rate of
insufficiency.
FC 20.05
PANCREATIC SURGERY IN ITALY: AN ANALYSIS OF DATA
FROM THE ITALIAN MINISTRY OF HEALTH DATA-BASE
Balzano, Gianpaolo; Zerbi, Alessandro; Capretti, Giovanni; Rocchetti,
Simona; Ortolano, Enrico; Di Carlo, Valerio
San Raffaele Scientific Institute, Surgery, Milan, Italy
Background. In specialist units operative mortality after pancreatic surgery is
low, whereas large populations -based studies in Europe and North America,
show still high mortality rates, because of the volume-outcome relationship.
Aim. To evaluate the outcome of pancreatic surgery in Italy.
Methods. Analysis of data from the Nationwide data-base of the Italian
Ministry of Health on inpatient discharges in 2003. Data were stratified
according to different operations and to the pancreatic surgery volume (low B/
15, medium /15B/70, high /70). 49.5% of pts were operated in low-
volume, 34.5% in medium-volume and 16% in high-volume hospitals.
Analysis was made by logistic regression models.
Results. 2933 pts underwent pancreatic surgery in Italy in 2003. 244 were
excluded from the analysis (ICD.9 codes 52.22 and 52.96) because of the
equivocal definition. 96.4% of operations was publicly granted by the
National Health Service (NHS). Overall death rate (in-hospital mortality)
was 7.8%. It was: 17.5% after 137 total pancreatectomy (TP); 8.2% after
1773 pancreaticoduodenectomy (PD), 4.7% after 148 pseudocyst internal
drainage (PID) and 3% after 530 distal pancreatectomy (DP). Death rate was
related to volume, both considering overall operations (death rate 10.6%,
6.4%, 1.7%, respectively) and each single operation (TP 20%, 16.7%, 0%,
PD 11.5%, 5.6%, 3.5%, PID 6.3%, 3.2% and 0%, DP 3.7%, 3.7% 0%). Also
mean postoperative stay for pts surviving the operation was related to volume
(TP 19, 23, 17 d.; PD 23, 21, 18 d.; PID 14, 13, 10 d.; DP 15, 14, 13 d.). If all
operations were performed in high-volume hospitals, 64% of death will be
prevented (137 pts/year), and the NHS would save 7317 days of hospital stay/
year.
Conclusions. The volume-outcome relationship is clear for all pancreatic
surgery procedures, not only for PD. Strategies should be developed to make
the patients and the NHS aware of the outcome differences among different
hospitals.
FC 20.06
EARLY AND LATE OUTCOME AFTER PANCREATICODUODE-
NECTOMY FOR CANCER IN THE ELDERLY
Oussoultzoglou, Elie; Bachellier, Philippe; Rosso, Edoardo; Lucescu, Ioan;
Scurtu, Radu; Jaeck, Daniel
CHU de Hautepierre, Centre de Chirurgie Visce´rale et de Transplantatio,
Strasbourg, France
Background. Radical surgery is the only valid treatment for pancreatic
cancer and for periampullary tumors. Before the early 1990s pancreatico-
duodenectomy was not recommended in patients over 70 years because of
associated high mortality and morbidity. Currently, increased experience,
advances in perioperative care and a better patient selection have reduced the
mortality and morbidity rates after pancreaticoduodenectomy. Therefore
pancreaticoduodenectomy had been performed in patients over 70 and even
75 years with acceptable results.
Aim. The aim of this study was to identify if there is any threshold in patients’
age over which pancreaticoduodenectomy would be deleterious.
Methods. From June 1995 to October 2003, 70 elderly patients (range:70
84 years) underwent pancreaticoduodenectomy for cancer. 38 patients were
younger than 75 years (group A) and 32 (group B) were older. Postoperative
morbidity, mortality, length of hospital stay, overall and disease free survival
were analyzed.
Results. Patients from both group had similar characteristics and were
identically managed. There were no statistical differences between the
recorded postoperative mortality, morbidity, mean length of hospital stay in
the two groups of patients. The mean overall survival was similar in
both groups (15 months) and it was significantly influenced only by the
histological tumor type, with the worst results in patients with pancreatic
adenocarcinoma.
Conclusion. Outcomes after pancreatoduodenectomy in patients over 75
years old does not differ from those recorded in younger patients. It appears
that there is no threshold in patients age contraindicating pancreaticoduode-
nectomy. Overall survival is influenced only by the tumor pathology type. Key
words: pancreaticoduodenectomy, elderly patients, post-operative outcome.
FC 20.07
PRIMARY TUMOR RESECTION DOES NOT IMPROVE SURVIVAL
IN PATIENTS WITH NONFUNCTIONING METASTATIC ENDO-
CRINE PANCREATIC CARCINOMAS (NF-MEPC): RESULTS OF A
PROSPECTIVE CONTROLLED STUDY ON 51 PATIENTS
Falconi, Massimo1; Bassi, Claudio1; Bettini, Rossella1; Capelli, Paola2;
Mantovani, William3; Boninsegna, Letizia1; Butturini, Giovanni1; Pederzoli,
Paolo1
1Policlinico GB Rossi, Dept. of Surgery, Verona, Italy; 2Policlinico GB Rossi,
Departement of Pathology, Verona, Italy; 3University of Verona, Departement
of Human Health, Verona, Italy
Aim. To evaluate whether resection of the primary tumor improves survival,
using a group patients in whom resection of either the primary tumor or liver
metastases was not possible as controls.
Patients and methods. From 1990 to 2004, 51 patients suffering from NF-
MEPC with unresectable liver metastases were enrolled. Nineteen patients
underwent complete resection of the primary tumor, while 32 did not
undergo resection due to the unresectable nature of the tumor. All relevant
clinical and laboratory data were collected and pathological revision was
performed. Additional parameters such as grade of differentiation, and the
Ki-67 proliferation index were considered in univariate and multivariate
models.
Results. In the non resected group 9 (28.1%) patients underwent to a
surgical palliative procedures (1 biliary, 3 gastric, 5 biliary and gastric gastric
by-passes, respectively). The resected patients underwent to a left-pancrea-
tectomy and pancreaticoduodenectomy in 14 (73.7%) and 5 (26.3%) cases,
respectively. The postoperative mortality was nil. After a median follow-up of
26 months (range 1180.8), the median disease related survival was 39.6
months (95% CI: 12.966.3). Resected and unresected patients were
comparable. No difference in survival was observed between the two groups
[resected: median 54.3 months (95% CI: 2583.6); unresected: median 39.5
months (95% CI: 5.473.6); log Rank test: p/0.74]. Upon munivariate
analysis only vomiting (HR 5.12; 95% CI 1.418.8; p/0.014), poor
differentiation (HR 6.6; 95% CI 1.6 26.5; p/0.008) and a Ki-67/10%
(HR 3.4; 95% CI 1.29.8; p/0.02) correlated with survival.
Conclusion. Resection of the primary pancreatic tumor in patients with
unresectable liver metastases affected with nonfunctioning endocrine carci-
nomas does not improve survival. Resection can be considered as sympto-
matic palliative therapy in patients without vomiting with well differentiated
endocrine carcinomas and a proliferative less than 10%.
FC 21.01
IS DUCTAL EVALUATION ALWAYS NECESSARY BEFORE OR
DURING SURGERY FOR BILIARY PANCREATITIS?
Ito, Kaori; Ito, Hiromichi; Ashley, Stanley; Whang, Edward
Brigham and Women’s Hospital, Surgery, Boston, USA
Background. The role of intraoperative cholangiography (IOC) among
patients with biliary pancreatitis (BP) and persistent liver function test (LFT)
abnormalities is well-established. However, the need for IOC among patients
with normal or only transient LFT abnormalities remains controversial.
Aim. To test the hypothesis that routine IOC has low yield and is therefore
unnecessary in patients recovering from BP without persistent LFT
abnormalities.
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Methods. Medical records of all 892 patients diagnosed with acute
pancreatitis at our institution from January 1995 through December 2005
were analyzed. Of 337 patients who underwent cholecystectomy (CCT) for
BP, 178 met study inclusion criteria: 1) they had no preoperative ERCP and
2) they had normal or falling LFTs just prior to CCT. Patients were allocated
to one of two groups: group I (IOC performed, n/39) and group II (no IOC
performed, n/139). Data were evaluated using Student’s t-test and chi-
square analysis, as appropriate.
Results. Groups were comparable with respect to demographic variables. In
group I, IOC was associated with a true-positive rate of 5% and a false-
positive rate of 5%. No differences between groups I and II were evident with
respect to frequencies of recurrent pancreatitis (7.7% vs 8.6%, p/0.85),
retained common bile duct stone detected on postoperative ERCP (2.6% vs
1.4%, p/0.63), reoperation (5.1% vs 2.2%, p/0.32), overall hospital day
(4.2 vs 4.4 days, p/0.84), postoperative hospital stay (2.4 vs 2.1 days, p/
0.64), readmission (17.9% vs 15.1%, p/0.65), or overall morbidity 15.4%
vs 15.8%, p/0.94). There were no deaths in either group.
Conclusion. Among patients undergoing CCT following an episode of BP
who have normal or falling LFTs, IOC has low yield and is not associated
with improved outcomes, including retained stone-related morbidity rates.
Therefore, routine IOC can be omitted safely in this setting. This finding has
direct implications for clinical practice.
FC 21.02
USEFULNESS OF FOLLOW UP AFTER PANCREATODUODE-
NECTOMY FOR CARCINOMA OF THE AMPULLA OF VATER
Alkofer, Barbara1; Chiche, Laurence1; Rouleau, Vincent2; Parienti, Jean-
Jacques3; Salame, Ephrem4; Samama, Guy4; Segol, Philippe4
1University Hospital of Caen, HepatoBiliary and Transplantation Dept.,
Caen, France; 2University Hospital of Caen, Pathology Dept., Caen, France;
3University Hospital of Caen, Caen, France; 4University Hospital of Caen,
Dept. of General Digestive Surgery: LC, Caen, France
Background. The prognosis of carcinoma of ampulloma of Vater (CAV)is
better than pancreatic cancer. 5 year-survival median rate after resection of
CAV is 45%, but late recurrences remain possible. Several survival factors have
been identified (lymph nodes, peri-neural invasion), but few data are available
on the type of recurrences, their impact on survival and their management.
Objective. To analyze prognostic factors and recurrence (type and cur-
ability) after curative pancreatoduodenectomy (PD) for CAV
Methods. 41 patients treated by PD for CAV from 1985 to 2003 have been
reviewed. Patient selection, long term survival recurrence rate and recurrence
treatment were analysed. Univariate and multivariate proportional hazards
analysis were conducted.
Results. The mean follow up was 48 months. Five year survival was of
62,8%. Eleven patients recurred (6 to 67 months). Recurrence was associated
with time to all-causes death (hazard ratio [HR] 4.3, P/0.003). Factors
predictive of recurrence were perineural invasion (HR 5.3, P/0.02), lymph
node invasion (HR 5.3, P/0.02) and differentiation (HR 0.2, P/0.05).
Three underwent surgical R0 treatment of their recurrences. Two of them
who presented with unique liver metastasis are alive and disease free.
Conclusions. Recurrence represents a serious threat in the prognostic of
CAV after surgery. They can occur lately. Some of them, in particular liver
metastases are accessible to a curative treatment. This supports the
usefulness of a close and long term follow up after surgery in order to
improve survival of CAV.
FC 21.03
THE SYSTEMIC CYTOKINE RESPONSE DURING EXPERIMEN-
TAL ACUTE PANCREATITIS: IMPACT OF ENTERAL PROBIO-
TICS
van Minnen, Paul L1; Timmerman, Harro M1; de Jager, Wilco2; Konstanti-
nov, Sergey R3; Lutgendorff, Femke1; Visser, Maarten R4; Smidt, Hauke3;
Gooszen, Hein G1; Akkermans, Louis M1; Rijkers, Ger T2
1University Medical Center, Dept. of Surgery, Utrecht, Netherlands; 2Uni-
versity Medical Center, Dept. of Pediatric Immunology, Utrecht, Nether-
lands; 3Agrotechnology and Food Sciences Group, Wageningen University,
Laboratory of Microbiology, Wageningen, Netherlands; 4University Medical
Center, Dept. of Medical Microbiology, Utrecht, Netherlands
Background. During severe acute pancreatitis, early mortality is often
associated with severe systemic inflammatory response syndrome (SIRS).
Late mortality is usually associated with infection of pancreatic necrosis. In
both phases, the gut flora plays an important regulatory role. Selected
probiotics are able to modulate intestinal flora.
Aims/Objectives. Aims of this study were: 1) correlate early and late phase
plasma levels of various cytokines and chemokines to clinical outcome, and 2)
assess the effect of probiotics on immune responses.
Methods. Acute pancreatitis was induced in male Sprague-Dawley rats by
intraductal glycodeoxycholate (0.5 ml, 15 mM) and intravenous cerulein (5
m/kg/hr, for 6 hours). Probiotics or placebo were administered intragastrically
from five days prior to until seven days after induction of pancreatitis. Plasma
cytokine levels were determined before, and 6 hrs, 24 hrs and 7 days after
induction of pancreatitis. The presence of bacteraemia was assessed 7 days
after induction of pancreatitis.
Results. Specific ‘cytokine signatures’ were predictive for outcome of acute
pancreatitis: 1) elevated IL-6, IL-10 and CXCL1 levels were associated with
early mortality, 2) increased TNF-a and IL-1b predict bacteraemia, 3) an
early and self-resolving IL-10 response was found in rats protected from early
mortality, whereas sustained IL-10 levels were associated with bacteraemia.
Probiotics reduced late phase mortality and bacteraemia. Effects of probiotics
on acute pancreatitis cytokine responses were: 1) reduced CXCL1 levels,
preventing neutrophil activation and associated remote organ damage, 2)
reduced variation of key pro-inflammatory cytokines, preventing hyper- and
hyporesponsiveness of the immune system.
Conclusion. Specific pro-inflammatory and regulatory cytokine combina-
tions are predictive for mortality and bacteraemia during severe acute
pancreatitis. Probiotics prevent unfavourable hyper- or hyporesponsive
immune reactions and improve outcome.
FC 21.04
GALANIN ANTAGONISM REDUCES HYPERENZYMEMIA
ASSOCIATED WITH ACUTE PANCREATITIS (AP) A POSSUM
MODEL
Bhandari, M1; Thomas, AC2; Carati, CJ3; Kawamoto, M1; Brooke-Smith,
ME1; Saccone, GTP1; Toouli, J1
1Flinders Medical Centre, General and Digestive Surgery, Bedford Park,
Australia; 2Flinders Medical Centre, Anatomical Pathology, Bedford Park,
Australia; 3Flinders Medical Centre, Anatomical and Histology, Bedford
Park, Australia
Aim. Severe AP is associated with significant morbidity and mortality, and is
characterized by microcirculatory and secretory disturbances, leading to
necrosis of the pancreas and plasma hyperenzymemia. To date, there is no
specific treatment for AP. We have shown that the neurotransmitter galanin
(GAL) is abundant in the pancreas of the Australian possum, and affects
pancreatic vascular perfusion. In this study, we investigated the effect of
GAL, and its antagonist galantide (GT) on plasma enzymes, in an AP
possum model.
Methods. AP was induced in anaesthetized possums by pancreatic duct
ligation and simultaneous hyperstimulation with i.v. cholecystokinin-secretin
for 6 hours. In experimental groups (n/510), GAL (110 nmol/hour) or
GT (330 nmol/hour) were investigated by administering bolus injections 15
minutes prior to duct ligation followed by a continuous i.v. infusion for the
duration of experiment (prophylactic administration). In order to simulate a
clinical situation, GT was also administered 2 hours post AP onset
(therapeutic administration) in separate animals. Blood was collected at
hourly intervals for 8 hours and analysed for plasma lipase and amylase
activity. The pancreas was harvested at the end of the experiment (8 hours)
for histological assessment. Statistical analysis used ANOVA.
Results. AP was associated with significantly increased plasma lipase which
plateaued at 3 hours. This change was exacerbated by prophylactic GAL and
significantly ameliorated by prophylactic GT. At 8 hours therapeutic GT also
significantly reduced the plasma lipase activity (mean9/SE, 5899/54 IU)
compared with the AP group (mean9/SE, 9429/71 IU). Statistically
significant similar effects were noted for plasma amylase levels (PB/0.05).
Conclusion. Prophylactic and therapeutic administration of GT significantly
decreased the plasma lipase and amylase levels, perhaps by ameliorating the
severity of AP. Ongoing histological studies are assessing the effect of GT on
pancreatic necrosis in AP.
FC 21.05
PRECUT FISTULOTOMY CANNULATION IN ERCP-AN
EQUALLY SAFE TECHNIQUE OF CANNULATION OF THE
COMMON BILE DUCT IN DIFFICULT ACCESS SITUATIONS
Balaji, Nagammapudur; Moorthy, Krishna; Cheruvu, CV; Durkin, Damien;
Deakin, Mark
University Hospital of North Staffordshire, Upper GI Surgery, Stoke on
Trent, UK
Background. With the increasing use of ERCP for only therapeutic purposes
the spectrum of presentations for the procedure has changed. Increasingly
complex situations and difficult cannulations are encountered requiring
alternate techniques to standard cannulation. Pre-cut Pappillotomy (PCP)
and Pre-cut fistulotomy (PCF) are alternates for access to difficult ducts but
have been fraught with varying levels of complications. They are associated
with a higher level of complications, anecdotally in the medical literature.
Aims. To analyse the safety and complications after PCF for ductal
cannulation.
Methods. Consecutive patients who underwent ERCP and PCF for bile duct
cannulation over an 8 year period formed the study group. A Pre-cut
fistulotomy was performed early in the presence of difficult cannulation and
suitable papillary anatomy. The different indications, mode of presentation
were noted and the complication rates in terms of bleeding, pancreatitis,
infection and perforation were analysed.
Results. A total of 129 patients (M: F 1:1.5) with a median age of 73 (IQR
6280) underwent Precut fistulotomy for bile duct cannulation over the
study period. 83 (64%) were urgent procedures for inpatients with
the remainder as outpatient elective referrals. The final diagnosis was
malignancy of the pancreatobiliary system in 52(40%), CBD stones causing
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jaundice///sepsis in 34 (26%), pancreatitis secondary to gall stones in
22(16%), a normal system in 12(9%) and others in 9(7%). Pancreatitis
related to the procedure was seen in 2(1.5%) patients and bleeding needing
transfusion in3 (2.3%). No perforation or infection was observed in any of
the patients in the series. The overall complication rate was 5/129(3.8%).
Conclusion. Precut fistulotomy is a safe procedure for bile duct access in
conditions of difficult access to the CBD in ERCP. The lower rate of
complications may be explained, by resorting to a pre-cut fistulotomy
(avoiding the papilla)early in the procedure.
FC 21.06
ROLE AND INDICATIONS OF FLUORODEOXYGLUCOSE POSI-
TRON EMISSION TOMOGRAPHY (FDG-PET) IN NEUROENDO-
CRINE PANCREATICO-DUODENAL TUMORS
Pasquali, Claudio1; Sperti, Cosimo1; Scappin, Sabrina1; Chierichetti,
Franca2; Liessi, Guido3; Pedrazzoli, Sergio1
1University of Padova, Clinica Chirurgica 4/Istituto Oncologico Veneto,
Padova, Italy; 2Castelfranco Veneto Hospital, Nuclear Medicine, Castel-
franco Veneto, Italy; 3Castelfranco Veneto Hospital, Radiology, Castelfranco
Veneto, Italy
Background. Neuroendocrine pancreatico-duodenal tumors (NPDT) de-
tection by imaging is still a problem. Few studies reported the ability of FDG-
PET to differentiate benign from malignant NPDT. Aim of this study was to
evaluate the role of FDG-PET in patients with NPDT.
Material and methods. From 1994 to 2004, 70 patients 33 male and 37
female, (mean age 52.2 years, range 1884) with NPDT (82.8% pancreatic)
were investigated with FDG-PET. PET results were compared with CT-scan,
MRI, Octreoscan scintigraphy and clinico-pathologic features of patients and
survival.
Results. Overall PET sensitivity was 55.7%; 79% of malignant tumors,
and 17% of benign tumors were detected by FDG-PET. No duodenal tumor
was detected by PET scan. Only 16% of primary less than 2 cm in size was
localized by using PET scan. In 17.9% of cases PET scan provided new
informations able to change therapeutic management. In PET positive
patients the addictive informations obtained by PET scan when compared
with Octreoscan, MRI and CT scan were respectively 40.5% more, 21.7%
more and 25.6% more. In malignant neuroendocrine tumors PET positivity
was related to short survival. No patient with PET negative malignant tumor
died for disease progression in the follow-up, while 13/30 with PET positive
malignant tumor died (pB/0.03).
Conclusions. FDG-PET proved to be a second line technique in NPDTs.
PET results improved clinical staging of disease and were related to survival
in malignant cases; in 17% of cases PET changed the therapeutic option.
From our experience FDG-PET should be reserved for patients with
suspected malignant tumor or pancreatic mass more than 2 cm or MEN 1
cases with at least one visible lesion. PET is useless in duodenal tumors,
benign insulinomas and small single pancreatic neuroendocrine lesion.
FC 21.07
EVALUATION OF PANCREATICOJEJUNOSTOMY AFTER PAN-
CREATICODUODENECTOMY IN OUR INSTITUTION; A 40-
YEAR EXPERIENCE IN 474 PATIENTS
Ishikawa, Hiroto; Kinoshita, Hisafumi; Sakai, Takenori; Kawahara, Ryuichi;
Furukawa, Satoshi; Yasunaga, Masafumi; Utida, Shinji; Aoyagi, Shigeaki;
Shirouzu, Kazuo
Kurume University School of Medicine, Surgery, Kurume City, Fukuoka,
Japan
Background. Many types of pancreaticoenteric anastomosis for reconstruc-
tion in pancreaticoduodenectomy (PD) have been devised, nevertheless
leakage from the anastomosis inevitably occurs in a certain percentage of
patients. The aim of study was to evaluate the results of pancreaticojeju-
nostomy in our institution from 1965 to 2005.
Patiens and methods. A total of 474 consecutive patients who underwent
PD (n/397) or pylorus-preserving PD (PpPD) (n/77) for various
diagnosis between 1965 and 2005. Pancreatic reconstruction was used to
be the traditional pancreatic invagination anastomosis (end to end) (n/268).
In recent year, we have selected from the pancreatic duct to mucosal
anasotomosis (end to side) (n/69) or the pancreatic duct dunking
anastomosis (end to side) (n/132) according to the main pancreatic duct
size and the pancreatic texture. Furthermore, we changed the technique of
approximation of the pancreatic stump and jejunal wall to prevent ischemia
and necrosis of the cut surface of pancreas (Kakita method) from 2002.
Results. Pancreaticojejunal anastomotic leakage was identified in 8.9% (42/
474) of the patients, and 26.1% (11/42) of these patients died. Of the 42
patients who developed pancreatojejunal anastomotic leakage, 6.7% (18/474)
had undergone the traditional pancreatic invagination anastomosis and
11.7% (24/474) had undergone the pancreatic duct dunking method or
pancreatic duct to mucosal anastomosis. Investigation of intra-abdominal
hemorrhage, which is serious complication that result from anastomostic
leakage, reveal that intra-abdominal hemorrhage occurred in 33.3% (11/42)
of the patients. Soft pancreas and the main pancreatic duct size were risk
factors of pancreaticojejunal anastomotic leakage (pB/0.05).
Conclusion. Pancreatic duct to mucosal anastomosis and pancreatic duct
dunking anastomosis with one layer suture of pancreatic stump and jejunal
wall, as a safe, easy and useful anastomotic technique, can reduce pancreatic
leakage rate after PD or PpPD.
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RETRO-HEPATIC VENA CAVA SARCOMA
Resende, Alexandre; Nascimento, Sı´lvia; Franc¸a, Marcelo; Lima, Agnaldo;
Santos, Fernando
Hospital Vera Cruz, Belo Horizonte-MG, Brazil
Background. Surgical procedures over the retro-hepatic vena cara are rarely
reported. Sharing some technical aspects in this procedure is very important
to the increase global experience.
Objective. to demonstrate in video the special technical aspects related to
the retro-hepatic vena cava ressection and reconstruction.
Methods and results. 53 years old patient had the diagnosis of a retro-
hepatic sarcoma with vena cava invasion by CT and percutaneous biopsy
performed elsewhere. The tumor was considered irressecable based on CT
findings by two other centers, and the patient was submitted to chemother-
apy, with no answer. Two years after diagnosis, the patient was sent to our
institution, with large local tumor and no metastasis. He presented a large
mass on RM, with retro-hepatic vena cava invasion and oclusion. He had an
atrofic left kidney and invasion of the right renal vein ostium. Surgey was
performed without by-pass. It was used an 20 mm Dacron graft to replace the
vena cava, and the right renal vein was implanted lateraly on the graft. The
vena cava clamping time was from 55 minutes, and renal pedicle clamping,
with warm isquemia, was from 72 min. The were no need to blood
transfusion. The patient presented on post operatory period a transitory
poliuric renal failure, not needing dialisys. The histopatologic study showed a
low degree of malignity leiomiosarcoma originary from the venous wall, with
free margins. No vascular complications were seen on follow up. The patient
presented four bilobar liver metastases, detected 30 months after surgery, and
is been considered to radiofrequency ablation.
Discussion. the retro-hepatic vena cava resection can be safelly performed,
leading pacients previously considered irressecable into patients that can be
treated with curative intent.
FV 1.02
COMPLEX BILE DUCT INJURY. TREATMENT WITH A
POSTERIOR RIGHT SECTIONECTOMY AND HEPATICOJEJU-
NOSTOMY
de Santiban˜es, Eduardo; Martı´n, Palavecino; Sa´nchez Claria´, Rodrigo;
Christian, Bertona; Ardiles, Victoria
Hospital Italiano de Buenos Aires, Buenos Aires, Argentina
Background. Laparoscopic cholecystectomy is the treatment of choice for
symptomatic gallstones. This approach is associated with a higher incidence
of biliary injuries. Complex injuries could lead to hepatic resections.
Objective. To show a case of a complex bile duct injury that required an
hepatectomy.
Population and methods. A 29 year-old female patient referred to our Unit
with an E5 (in Strasberg Classification) bile duct injury. The cholecystectomy
was carried out 3 months before. The patient was reoperated 7 days later with
a choleperitoneum (laparotomy and drainage placement). The patient was
admitted in our Hospital with fever and bacteremia. A CT Scan showed a
persistent collection and the drainage was replaced. The surgery was
programmated 10 weeks later. An angiography showed no associated vascular
injury.
Results. We performed a posterior right hepatectomy, due to the atrophy of
this lobe. We used an ultrasonic dissector for the resection. The biliary
reconstruction was made with a Roux-en-Y hepaticojejunostomy (including
the left and anterior right hepatic ducts). The patient was discharged at day 7
without postoperative complications.
Conclusions. in selected cases, an hepatectomy is needed to treat complex
bile duct injuries. These cases must be treated in tertiary centers with HPB
specialists.
FV 1.03
SURGICAL TREATMENT OF GIANT LIVER HAEMANGIOMA BY
ENUCLEATION
Belli, Giulio; D’Agostino, Alberto; Fantini, Corrado; Cioffi, Luigi; Russolillo,
Nadia; Belli, Andrea; langella, Serena
Loreto Nuovo Hospital, Naples, Italy
Haemangioma is the most frequent focal liver lesion. It affects mainly women
and may cause symptoms such as abdominal pain, mass, or complications
such as heart failure or coagulopathy. There are several options for treatment
in symptomatic patients. However, surgical resection is the only curative
treatment. The video demonstrates the technique of giant liver hemangioma
enucleation in a 40 year-old female patient. The patient suffered progressive
pain in the right upper quadrant irradiated to the back before admission.
Ultrasonography and computed tomography scan revealed the liver haeman-
gioma in the segments 5, 6 and 7 (according to Couinaud classification). The
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different steps of the operation are shown. Intra-operative ultrasonography to
rule out other liver lesions and to value biliary and vascular rapport was
employed. The dissection was performed in the cleavage plane between the
capsule of the hemangioma and surrounding liver tissue. During the
dissection we attempted neither to damage the capsule of the hemangioma
nor to enter deeply into the liver parenchyma. The postoperative period was
uneventful and the patients was discharged on the 8 day. Enucleation can be
successively performed with low morbidity rates in most of the patients and
recurrences are rare.
FV 1.04
INFERIOR VENA CAVA SYNDROME BY COMPRESSION FROM A
GIANT HEPATIC HEMANGIOMA. TREATMENT BY ENUCLEA-
TION WITH PRINGLE’S MANEUVER AND TOTAL VASCULAR
EXCLUSION
Pekolj, Juan; Palavecino, Martı´n; de Santiban˜es, Martı´n; Sa´nchez C,
Rodrigo; de Santiban˜es, Eduardo
Hospital Italiano de Buenos Aires, Buenos Aires, Argentina
Background. Hemangiomas are the most frequent benign tumors of the
liver. Most of them are asymptomatic and surgical treatment is not required.
Big hemangiomas, symptomatic and/or compressing adjacent structures must
be treated.
Objective. To show technical tips for a hemangioma enucleation using
vascular clampings.
Methods. In a 49 year-old female patient with abdominal pain and lower
extremities edema, ultrasound, CT scan and MRI showed an 18 cm hepatic
hemangioma, adjacent to the hepatic veins with compression of the retro-
hepatic inferior vena cava.
Results. We performed an enucleation of the hemangioma, preserving the
right and left hepatic vein and sectioning the middle one. The enucleation
was made dissecting the field between the hemangioma and the normal liver
parenchyma. Monopolar electrocautery and Tissuelink† were employed. We
performed a 5 minutes total vascular exclusion and 3 Pringle’s maneuvers (10
minutes each one). The patient was discharged at day 7 without post-
operative complications and a complete remission of the vena cava syndrome.
Conclusion. The enucleation is the best procedure to treat hepatic
hemangiomas. The Pringle’s maneuver reduces the tumor tension, making
easier the enucleation. Total vascular exclusion is needed when the tumor is
adjacent to hepatic or inferior vena cava veins to avoid massive bleeding or air
embolism.
FV 1.05
SURGICAL TREATMENT OF RECURRENT HEPATIC HYDATID
DISEASE WITH SPONTANEOUS RUPTURE INTO THE RETRO-
HEPATIC INFERIOR VENA CAVA AND THROMBOSIS OF THE
RIGHT ATRIUM
Vicente, Emilio; Quijano, Yolanda; Loinaz, Carmelo
Monteprı´ncipe, General Surgery, Boadilla del Monte, Spain
Spontaneous rupture of the recurrent hydatid cyst into the retrohepatic
inferior vena cava (IVC) accompanied with intravascular thrombus
extended to the right atrium is a severe but unusual complication.
Historically the potentially high operative morbidity rate and presumed
poor prognosis have discouraged aggressive surgical treatment. However,
the absence of any other effective treatments, the refinement of surgical
technique and better criteria for patients selection have led to a more
frequent and safe use of resection. Five years after non radical surgical
treatment, a 62 year old man was diagnosed of recurrent hydatid cyst
adjacent to the inferior vena cava located in segment I. Chest radiographs
reveal multiple and bilateral pulmonary cysts. Ultrasonography, CT and
MRI demonstrated a thrombus extending into retrohepatic, supraphrenic-
intrapericardial IVC and right atrium. The video shows the preoperative
diagnostic procedures to evaluate the location of the cyst, the vascular
invasion and extent of thrombus as well as the surgical procedure. Through
a bilateral subcostal laparotomy, total cystoperiystectomy and resection of
retrohepatic IVC was performed with total liver vascular exclusion. The
transabdominal and transpericardial approach to the intrapericardial IVC
and right atrium avoided median sternotomy. Intravascular trombectomy
with intraoperative transesophageal echocardiogram was performed. Three
years after the operation, the patient remains alive and well without
evidence of hydatid disease recurrence.
FV 1.06
ARANTIUS’ LIGAMENT MANEUVER TO CONTROL THE LEFT
HEPATIC VEIN AND THE COMMON TRUNK
Dumont, Frederic1; Mauvais, Franc¸ois1; Fuks, David1; Cook, Marie C1;
Morjane, Ahmed1; Duval, Herve1; Yzet, Thierry2; Regimbeau, Jean M1
1CHU Amiens Nord, Surgery, Amiens, France; 2CHU Amiens Nord,
Radiology, Amiens, France
Background. Control of left hepatic vein (LHV) and common trunk (CT)
during hepatic resection for tumours localised in top of segment VI or
involving segments IVIII is difficult. Knowledge of Arantius’ ligament (AL)
anatomy, described by Majno et al (J Am Coll Surg 2002), make this control
easier. We report the result of this approach from work of dissection and
hepatic resection for hepatic metastases from colorectal carcinoma.
Patients & methods. From 55 dissections and 12 left hepatic resections
(laparoscopic n/1 and laparotomy n/11) for hepatic metastases from
colorectal carcinoma, since December 2004, we described AL anatomy and
detailed the Arantius maneuver (video).
Results. AL is present in all cases and its anterior and posterior sides are
always individualizable. Average length was 5.4 cm (1.7 to 7 cm) and average
width was 0.7 cm (0.3 to 1.5 cm). Inferior phrenic vein flowed into inferior
vena cava in 62% (LHV 28%, CT 10%) and the CT was found in 96%.
Control of LHV was possible in 100% and control of CT in 96%. We applied
this technique during hepatic resection and it was possible in all cases.
Conclusion. AL is always present. The lowering of the top of segment I and
traction after section of AL allow the control of both LHV and CT.
FV 1.07
LAPAROSCOPIC LIVER RESECTION USING THE LIGASURE
DEVICE
Jacobs, Michael John
Providence Hospital, Surgery, Southfield, USA
Background. Laparoscopic liver resection has been performed using a
variety of parenchymal transection techniques. The optimal method of
transection has yet to be determined.
Methods. Twelve patients have undergone laparoscopic liver resection with
parenchymal transection using the laparoscopic Ligasure device. The method
incorporated 34 ports. Patient selection was based on the presence of an
abnormal peripheral lesion hepatic lesion. Video recording was performed.
Blood loss, length of stay, and complications were recorded.
Results. Twelve patients were selected to undergo laparoscopic liver
resection from January 2004 to February 2006. The pathology consisted of
both benign and malignant etiologies. The average blood loss was less than
200 mL and the length of stay was less than 4 days. None of the patients
required open conversion.
Conclusion. Laparoscopic liver resection with Ligasure parenchymal
transection can be performed safely. The videos demonstrate the 34 port
technique that has not previously been described.
FV 1.08
RADIOFREQUENCY, HAND-ASSISTED, LAPAROSCOPIC LIVER
RESECTION
Tierris, John; Pai, Madhav; Healey, Andy; Habib, Nagy A; Jiao, Long R
Hammersmith Hospital Campus, Imperial College London, General and
Hepatopancreatobiliary Surgery, London, UK
Background. It is currently accepted that laparoscopic liver resection (LLR)
is feasible and safe in selected patients with tumours localised peripherally in
the left lateral segments of the liver, or in segments IVVI. The LLR has the
same rates of mortality and morbidity as open liver resection with reduced
blood loss and postoperative hospital stay. Still, the major technical challenge
is control of bleeding during transection of liver parenchyma. To tackle this
problem, radiofrequency energy has been increasingly used by a number of
surgeons to perform an actual, bloodless liver resection, ablating liver tissue
along an intended line of division. We present here our technique for
radiofrequency assisted LLR.
Materials and method. 3 patients with malignant liver tumours are
presented (2 m, 1 f, m.a. 62 yrs, localization of tumours seg. V, VVI, VI
respectively). After induction of pneumoperitoneum, 4 trocars were intro-
duced and intraoperative ultrasonography and coagulative desiccation were
performed along a plane of tissue 1 cm away from the edge of the lesion using
the Cool-Tip radiofrequency probe. The necrotised band of parenchyma then
was divided and the specimen removed through a mini laparotomy incision.
Results. The mean operative time was 300 min with a mean resection
time of 240 min. The mean intraoperative blood loss was 75 ml. The
postoperative course was uneventful in all three patients and mean hospital
stay was 7 days. Mean follow-up time was 6 months. One patient presented
with disease recurrence at the mini laparotomy incision 3 months post-
operatively.
Conclusions. The radiofrequency assisted LLR may be beneficial for
selected patients with all the advantages of minimally invasive surgery. The
role of the pneumoperitoneum in tumour seeding and the narrow free
margins of the resected specimens are issues that need special attention.
Increasing experience among surgeons and further development of endo-
scopic instruments will certainly proliferate the indications for this procedure
in the future.
FV 1.09
RADIOFREQUENCY-ASSISTED LAPAROSCOPIC SEGMENT 4B
LIVER RESECTION
Colliver, Daniel1; Evans, Kathryn1; Awan, Altaf2; Beckingham, Ian2
1Queen’s Medical Centre, Dept. of Paediatric Surgery, Nottingham, UK;
2Queen’s Medical Centre, Dept. of HPB Surgery, Nottingham, UK
Removal of cancer of the liver by surgical means is the treatment of choice. In
many patients surgery is not possible because of the extent of the tumor or the
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co-morbidity of the patient that poses an excessive risk of morbidity or
mortality after the surgery. Radiofrequency Ablation (RFA) is frequently an
option in patients in whom surgical excision of the tumor is not possible. RFA
is a safe and well tolerated procedure that is associated with few complica-
tions. It is, however, not viewed as a curative procedure, rather as a procedure
that could lead to increased survival and quality of life. Segment 4B is a
difficult area of the liver to resect laparoscopically as a result of variability of
the blood supply and retraction problems in achieving tumour clearance and
ligation of portal structures. The methods used to overcome these factors are
demonstrated. A technique whereby RFA was used not in tumour destruc-
tion, but to achieve haemostasis in the liver surrounding the tumour is
described. We believe that RFA can be a useful adjunct to minimise blood
loss during laparoscopic liver resections whilst decreasing total liver ischaemic
time. This technique is illustrated on a high- risk 85 year old patient with a
solitary segment 4B colorectal metastasis.
FV 2.01
PANCREATICODUODENECTOMY USING BIPOLAR TISSUE
SEALING SYSTEM FOR 82 YEARS OLD BILE DUCT CANCER
Takehide, Asano; Yamamoto, Hiroshi; Kainuma, Osamu; Cho, Akihiro; Ryu,
Masamune; Takiguchi, Nobuhiro; Souda, Hiroaki; Mori, Mikito; Narumoto,
Soichi; Onai, Yasuhide
Chiba Cancer Center, Digestive Surgery, Chiba, Japan
Increasing longer life expectancy, treatment of peri-pancreatic head carci-
noma in elderly patients has become a clinical issue. Surgical resection is not
only chance of cure but also for better quality of life in any age of patients.
Here, we show a video of one solution. A 82 years old female visited to our
department with jaundice. Endoscopic retorograde bile duct drainage was
introduced with plastic tube stent. Images from d-CT and MRCP showed
stricture of mid bile duct and diagnosed bile duct cancer. She had
regurgitation of dilated right ventricle and atrial fibrilation. Operation,
therefore, has to be shorten time and transfusion should be minimum.
Bipolar tissue sealing system was applied to satisfy this condition. Following
upper median laparotomy, most of procedure of preparation, dissection,
icision were proceeded using a bipolar tissue sealing system (LigaSure
AtlasTM20). All vessels except gastroduodenal artery were dissected by
Ligasure Atlas 20. Clearing arteries, SMV and PV was done with closed
Ligasure head. And Lymph node dissection and exposure vessels before
dissection also done using dissecting sealer. LigaSure head is closed and
moved. It had been used like Surgeon’s finger to divide tissues and expose
vessels and lymphnode. 3 cm of PV was resected due to direct cancer invasion
at superior portion of the pancrease head. Pyrous preserving pancraticoduo-
denectomy (PpPD) was then carried out. Reconstruction was performed
pancreatico-jejunosotomy (mucosa to mucosa fashion) with lost tube stent
and choedochojejunosotomy without stent. Duodeno-jesunosotmy was made
at 50 cm anal side of choledojejunostomy. Three closed suction drains were
inserted. Operation time is 4 hours 50 minuetes, no blood or plasma
transfusion. The patient was discharged on 15 days postoperatively. No
complication is observed. p TNM: T4,N1,M0, Stage IV The electro-thermal
dissection sealer system make PpPD safer and easier and is especially useful
in elderly patients.
FV 2.02
INSERTION OF ARTIFICIAL PORTAL GRAFT AS A BRIDGING
PROCEDURE AFTER EXTENDED PANCREATICODUODENEC-
TOMIES
Vladov, Nikola1; Takorov, Ivelin1; Mutafchiiski, Ventzislav1; Sergeev, Sergei1;
Katzarov, Krum2; Odiseeva, Evelina3
1Military Medical Academy, Clinic of Hepato-Biliary and Pancreatic
Surgery, Sofia, Bulgaria; 2Military Medical Academy, Clinic of Gastroenter-
ology and Hepatology, Sofia, Bulgaria; 3Military Medical Academy, Clinic of
Critical and Intensive Care, Sofia, Bulgaria
Background. The tumor invasion of the mesenterial vessels can not always
be precisely observed with the present image techniques. Partial or complete
portal vein resections were performed in 12 to 60 per cent of cases with
cancer invasion.
Aim. The aim of this video is to present our technique of performing a
complete resection with insertion of artificial graft.
Methods. From April 2003 to February 2006, 65 radical resections of
pancreatic cancer were performed in our clinic. In 13(20%) cases there was
portal vein invasion. Partial wedge resection was done in 10 cases,
segmental resection with primary closure in one. Artificial vascular
prosthesis was inserted in two patients-50 years old women and 63 years
old man, after complete resection of portal vein(4.5 and 3.2 cm length
respectively).
Results. The clamping time was 17 minutes for the first graft and 11 minutes
for the second. In both cases intra-abdominal hemorrhage was observed and
required reoperation on third or second day after operation respectively. The
bleeding did not come from the grafts. The postoperative hospital stay was 16
days for the women. The man stayed 36 days, because of wound disruption,
observed on the 14-th day after operation. Almost total occlusion of the
synthetic graft and developed collateral vessels were observed on the fifth
month after the operation in both cases. The blood flow and pressure in the
portal system was normal. The synthetic graft serves as a bridging procedure
in order to assure the hepatic blood flow, till collateral vessels are formed.
Patients were followed up for 15 and 9 months respectively.
Conclusions. Vascular grafting of portal vein, after complete resection
increases morbidity levels and length of stay, but does not impact mortality
levels. Partial or segmental venous resection and reconstruction is an ideal
means of managing tumor adherence to the superior mesenteric portal vein
and can achieve survival equivalent to any margin negative resection. It is
recommend such type of resections to be done on selected patients.
FV 2.03
PANCREATICODUODENECTOMY: SUPERIOR MESENTERIC
ARTERY FIRST APPROACH
Pessaux, Patrick; Arnaud, Jean-Pierre
University Hospital, Angers, France
Background. Pancreaticoduodenectomy (PD) is the only effective treatment
method for tumors of the periampullary region. Technique of resection
followed in most centers is similar. One of the important predictive factors of
prognosis is the presence of retroperitoneal lymph node metastasis which is
present in 2077 percent of resected specimens of patients with carcinoma of
the head of pancreas. Hence, lymph node dissection to the right of Superior
Mesenteric vessels is the minimum required. Another common technical
difficulty encountered during classical pancreaticoduodenectomy is the
presence of a replaced right hepatic artery from superior mesenteric artery
(SMA) which occurs in 1520 percent of patients and inadvertent injury to
this vessel can occur during the dissection of the uncinate process, especially
in cases of advanced tumors. En bloc resection and reconstruction of the vein
can be performed without increased morbidity and mortality. However,
infiltration of the SMA is considered a contraindication for resection.
Infiltration of these major vessels is usually identified only towards the end
of the resection process when the surgeon is committed to resection and ends
up with a ‘margin positive’ resection. These patients with ‘margin positive’
resection have worse prognosis and is not better than unresected patients.
Technique. To overcome these technical difficulties and to achieve an
oncologically acceptable lymph node clearance, we describe a technique of
pancreaticoduodenectomy in which the SMA is dissected first and the
posterior pancreatic capsule is dissected early during the operation. The
posterior part of the head is dissected off the vessels first without dividing the
neck and thus avoids theB/point of no return/of the classical operation and
early identification of non resectability. This method also accomplishes
adequate lymphadenectomy and easier identification and safeguarding of a
replaced right hepatic artery, if present.
FV 2.04
MODIFICATION OF TECHNIQUE OF PANCREATICODUODE-
NECTOMY: SUPRACOLIC DIVISION OF JEJUNUM HELPS IN
UNCINATE RESECTION
Shukla, Parul; kanitkar, Gajanan
Tata Memorial Hospital, GI Surgical Oncology, Mumbai, India
Background. Pancreaticoduodenectomy is a standard procedure for peri-
ampullary and pancreatic head tumours. The dissection of the uncinate
process from the superior mesenteric vessels is a key step in the procedure.
Aims & objectives. To modify the technique of jejunal division in order to
facilitate the complete removal of the uncinate process.
Methods. In this video, we describe a modification in which jejunum is
divided in the supracolic instead of the infracolic compartment and traction
on the proximal jejunal mesentery in the supracolic compartment is used to
facilitate exposure of the uncinate process of pancreas.
Results. This method has resulted in an easier exposure of the uncinate
process and simplifies the dissection along the superior mesenteric vessels.
Conclusions. The jejunal mesentery and uncinate process of pancreas are
anatomically and embryologically contiguous. Thus, when the jejunum is
divided in supracolic compartment, the traction on the jejunal mesentery
aligns the uncinate process and assists in its complete removal.
FV 2.05
ISOLATED PANCREATODUODENECOTMY FOR PANCREATIC
HEAD CANCER
Nakao, Akimasa; Takeda, Shin; Nomoto, Shuji; Kanazumi, Nohito; Sugi-
moto, Hiroyuki; Kodera, Yasuhiro; Fujii, Tsutomu
Nagoya University Graduate School of Medicine, Dept. of Surgery II,
Nagoya, Japan
Background. Basic radical surgery for pancreatic head carcinoma is isolated
pancreatoduodenectomy (PD). Because of the anatomical features, pancrea-
tic head carcinoma is often accompanied by tumor invasion into the portal
vein. Pancreatic head carcinoma accompanied by portal invasion has been
regarded as not indicated for surgical resection, for the following reasons:
Poor prognosis, it was difficult to cope with portal congestion (that occurs
during acute portal obstruction) or hepatic ischemia (caused by simultaneous
obstruction of the hepatic artery), and gastrointestinal surgeons had
insufficient experience with vascular surgery.
Aims. To resolve these problems, we developed an antithrombogenic
bypass catheter for the portal vein in 1981. In our department, the basic
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surgical procedure for pancreatic head carcinoma became isolated pancrea-
toduodenectomy by the non-touch isolation technique using this bypass
method.
Methods. Diagnosis of portal invasion and extrapancreatic nerve plexus
invasion is made using intraportal endovascular ultrasonography. Before
manupulation of the pancreatic head, region arteries such as gastrododenal
and inferior pancretoduodenal arteries which flow into the pancreatic
head region, and splenic, superior mesenteric, and portal veins which
drain the venous blood of the pancreatic head region are ligated and divided.
Then, pancreatoduodenectomy is completed. During portal occulusion,
conjested mesenteric venous blood is bypassed from the one branch of
the superior mesenteric vein to the femoral vein via greater saphenous
vein.
Results. During 24 years, 211 portal vein resections have been performed in
our department with safety and ease.
Conclusion. Isolated pancreatoduodenectomy is ideal surgical procedure for
pancreatic head cancer and performed with safety and ease using catheter-
bypass method of the portal vein.
FV 2.06
A NEW TECHNICAL METHOD OF PANCREATOGASTROSTOMY
USING AN ISOPERISTALTIC GASTRIC TUBE FOLLOWING A
PYLORUS PRESERVING PANCREATODUODENECTOMY
Costa, Roland; Lucas, Lucio
Hospital Brasilia, Brasilia, Brazil
Aim. Describe a new surgical technique for a safer pancreatogastrostomy,
which thus far has been performed with no leaks, or other significant
complications.
Methods. Our series consisted of twelve men and seven women, with age
ranging from 34 to 74 years. Twelve of them presented with carcinoma of the
head of the pancreas, four with carcinoma of the papilla of Vater, two with
chronic pancreatitis, and one with a single metastasis to the head of the
pancreas from a primary gallbladder tumor. All patients underwent a pylorus-
preserving pancreatoduodenectomy. Two of them underwent a simultaneous
resection of the right lobe of the liver. Following removal of the specimen, a
75 mm long and 50 mm wide isoperistaltic gastric tube was created along the
greater curvature of the stomach without ligation of the left gastroepiploic
vessels. A length of approximately 4 to 5 cm of the pancreatic body was
dissected, intussuscepted into the gastric tube, and fixed to it with a 2.0
Prolene purse-string suture.
Results. No leakage was detected. One patient presented with amylase-rich
fluid drainage restricted to the first two post-operative days, 355 and 267 I.U/
dl, respectively. The nasogastric tube was used for delayed gastric emptying
and a feeding jejunostomy was performed in four patients. Subsequently,
we have replaced jejunostomy with a nasoenteral feeding tube for early
feeding.
Conclusion. In this small group of patients, the intussusception of the
remnants of pancreas into a short isoperistaltic gastric tube following a
pancreatoduodenectomy was shown to be a simple, effective and useful
technical alternative to avoid the disruption of the pancreatogastrostomy.
FV 2.07
INDICATION, SURGICAL DESIGN AND OUTCOME OF DUO-
DENUM-PRESERVING PANCREATIC HEAD RESECTION FOR
BENIGN AND LOWGRADE MALIGNANCY
Miyakawa, Shuichi; Horiguchi, Akihiko; Ishihara, Shin; Ito, Masahiro;
Nagata, Hideo; Asano, Yukio; Shimizu, Tomohiro
Fujita Health University, Surgery, Toyoake, Japan
Background/Aims. To apply duodenum preserving pancreatic head resec-
tion (DpPHR) as radical procedure for Intraductal papillary neoplasms
(IPMNs), we make clear the selection of the patients, the area of resection in
the head of the pancreas, and the preservation of the pancreatico-duodenal
vessels.
Methods/Results. IPMNs are classified into the main duct type and the
branch duct type. IPMNs occured in the Santorini duct, the Wirsung duct,
the main pancreatic duct, the superior head branch duct and the inferior head
branch duct. Multiple occurrence and superficial extension was recognized in
some cases. Histologically, IPMNs consisted of invasive carcinoma, non-
invasive carcinoma or intraductal papillary adenoma, however, almost all
cases were noninvasive carcinoma or adenoma. The DpPHR can be applied
in the majority of the patients with IPMNs and also in benign tumors.
However, it is necessary to resect completely the head of the pancreas to
avoid tumor remnant. The unbalanced development of the arterial arcades of
the pancreatico-duodenal region was recognized in an analysis of 3D-
angiogram by MD-CT. The anterior arcade predominates in 43%. And
also the supurapancreaticoduodenal vein(SPDV) have to preserve to avoid
congestion of the preserved duodenum. Therefore, we modified DpPHR to
include a total resection of the pancreatic head and the preservation of both
anterior and posterior arterial arcades and the SPDV. The postoperative early
results were satisfactory. Gastric emptying and pancreatic exocrine and
endocrine function following DpPHR are superior than those following
pylorus-preserving pancreato-duodenectomy.
Conclusion. It is nesessary to reconcile pancreatic head resection and blood
supply to the duodenum and the bile duct for prevention against eraly
postoperative complication. It is important to establish of the methods of the
preservation of the aretrial arcades and the venous drainage of the duodenal
pancreatic region.
FV 2.08
PANCREATIC HEAD RESECTION WITH SEGMENTAL DUODE-
NECTOMY (PHRSD) FOR INTRADUCTAL PAPILLARY MUCI-
NOUS NEOPLASMS OF THE PANCREAS
Nakao, Akimasa; Takeda, Shin; Nomoto, Shuji; Kanazumi, Nohito; Sugi-
moto, Hiroyuki; Kodera, Yasuhiro; Fujii, Tsutomu
Nagoya University Graduate School of Medicine, Dept. of Surgery II,
Nagoya, Japan
Background. The basic surgical procedure for benign or low grade
malignancy tumor of the pancreatic head region has been pylorus preserving
pancreatoduodenectomy. Recently duodenum preserving pancreatic head
resection is sometimes indicated for these kinds of tumors.
Aims. We have been proposing pancreatic head resection with segmental
duodenectomy (PHRSD) for benign or low grade malignancy tumor of
the pancreatic head region as a function-preserving operation instead of
pylorus preserving pancreatoduodenectomy (PpPD). We introduce operative
procedure of PHRSD, because this operation is simple, easy and safe
procedure compared with duodenum preserving pancreatic head resection
(DpPHR).
Methods. By conserving the right gastric artery and gastroduodenal artery, 5
to 7 cm of the first portion of the duodenum is preserved with good arterial
circulation. The anterior superior pancreatoduodenal artery and posterior
superior pancreatoduodenal artery are ligated and divided. In addition, by
conserving the anterior inferior pancreatoduodenal artery, the third portion
and anal side of the second portion of the duodenum are preserved with good
arterial circulation. Resection of the pancreatic head with 3 to 4 cm of
segmental duodenectomy including minor and major papilla completes
PHRSD. Reconstruction of the alimentary tract is then performed with
pancreatogastrostomy, end to end duodenoduodenostomy and end to side
choledochoduodenostomy.
Results. During recent 17 years, 40 PHRSD have been performed in out
department, and no operative mortality was observed.
Conclusion. PHRSD is simple, easy, safe and function-preserving opera-
tions for benign or low grade malignancy tumor of the pancreas.
FV 2.09
PANCREATIC HEAD RESECTION WITH SEGMENTAL DUODE-
NECTOMY (PHRSD) FOR INTRADUCTAL PAPILLARY MUCI-
NOUS TUMORS OF THE PANCREAS (IPMT)
Ferna´ndez-Cruz, Laureano; Olvera, Cristo´bal; Lozano-Salazar, Rodrigo
Hospital Clı´nic de Barcelona, Surgery, Barcelona, Spain
Background. Organ-preserving pancreatic resection for benign and non-
invasive IPMT include duodenum- preserving pancreatic head resection and
PHRSD. There have been only four reports concerning PHRSD in the
English literature. The major concerns are ischemia of the common bile duct
and duodenum.
Aim. To describe the technique of PHRSD with preservation of arterial
blood supply to the duodenum and common bile duct. The technique of
retroportal lymphadenectomy is also shown in the video.
Patients and methods. Organ preserving pancreatic resection was per-
formed in 11 patients with IPMT. By conserving the right gastric artery and
gastroduodenal artery, 5 to 7 cm of the first portion of the duodenum is
preserved with good arterial circulation; in addition, by conserving the
anterior inferior pancreaticoduodenal artery, the third portion of the
duodenum and distal side of the second portion of the duodenum are
preserved with good arterial circulation (Nakao’s technique). Reconstruction
of alimentary tract: end-to-end duodenoduodenostomy, end-to-side pan-
creatico-jejunostomy and end-to-side choledocho-jejunostomy.
Results. The mean operative time was 311///30 minutes. No patients
required perioperative blood transfusions. No postoperative complications.
The mean hospital stay was 11 days. There were no in-hospital deaths. Final
pathological diagnosis was adenoma.
Discussion. These results suggested that organ-preserving pancreatic
resections should be indicated for the branch duct type of IPMT.
Conclusions. PHRSD allows complete resection of the pancreatic head,
preserves a major portion of the duodenum and maintains satisfactory
postoperative pancreatic endocrine and exocrine function.
FV 2.10
THE DAGRADI-SERIO-IACONO OPERATION: CENTRAL PAN-
CREATECTOMY. A CONSERVATIVE TECHNIQUE PRESERVING
FUNCTIONAL PANCREATIC PARENCHYMA
Iacono, Calogero; Bortolasi, Luca; Facci, Enrico; Frisini, Marco; Ruzze-
nente, Andrea; Guglielmi, Alfredo
University of Verona, Dept. of Surgery and Gastroenterology, Verona, Italy
Background and aim. Central pancreatectomy (CP) is an operation that
allows to resect benign or low malignant tumor located in the pancreatic
histmus that are not suitable for enucleation. The main advantage of this
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operation compared with major resections is that it permits to spare normal
pancreatic parenchima.
Method. Operation requires a midline or a bilateral subcostal incision; the
lesser sac is entered through dissection of the transverse colon from the
omentum or by transecting the gastrocolic ligament. The pancreatic segment
harboring the lesion is then mobilized and its posterior surface carefully
dissected from the splenic vein and artery. Subsequently, the pancreatic
portion harboring the tumor is isolated at its superior margin from the splenic
artery. The extent of the resection of the central segment is limited on the
right by the gastroduodenal artery and on the left by the need to leave at least
5 cm of normal pancreatic remnant. After the pancreas is transected. The
resected pancreatic specimen is sent to the pathologist to check that the
resection margins are adequate. Hemostasis of the two raw surfaces is
achieved with interrupted 4/0 non absorbable stitches. When it is not stapled
the Wirsung’s duct of the cephalic stump is sutured selectively with a figure-
of-eight non absorbable stitch. An end-to-end invaginated pancreaticojeju-
nostomy is carried out with a single layer of 3/0 non absorbable interrupted
stitches. The operation is concluded with the construction of an end-to-side
jejuno-jejunostomy about 50 cm distal to the pancreatic anastomosis. A soft
drain is brought out on the right hand side.
Conclusion. We can conclude that CP is a safe technique for benign or low
malignant tumor of the pancreatic neck that allows to cure the tumor with
evident functional results without increasing the risk for the patient.
FV 2.11
LAPAROSCOPIC CENTRAL PANCREATECTOMY WITH ROUX-
EN-Y DUCT TO MUCOSA PANCREATICOJEJUNOSTOMY
Rotellar, Fernando; Pardo, Fernando; Cervera, Maria; Valenti, Victor;
Pastor, Carlos; Montiel, Custodia; A-Cienfuegos, Javier
University Clinic. University of Navarra, General Surgery, Pamplona, Spain
Background. Laparoscopic pancreatic surgery is mainly used for staging
malignant tumors and for treatment of some cases of pancreatitis. In the last
years some reports and small series of laparoscopic pancreatectomy have been
reported. They show that laparoscopic resection is feasible and safe, but are
mostly distal pancreatectomy and enucleations. In this video we show a
laparoscopic central pancreatectomy with Roux-en-Y duct to mucosa
pancreatojejunostomy.
Method. The patient was placed in a modified lithotomy position and
reverse Trendelenburg. A five-port technique was used, being a Hasson
trocar the initial port. The approach to the pancreas is done by dividing some
vessels of the greater curve. This exposes the anterior face of the pancreas,
from the neck to the tail. After identifying the superior mesenteric vein and
the gastroepiploic artery, we dissect a retropancreatic tunnel, anterior to the
vein. The pancreas is sectioned with adecuate margin with an endostapler.
The next step is to prepare the Roux en Y transmesocolic jejunal limb. The
transected jejunum is brought through a small incision in the transverse
mesocolon to the right of the middle colic vessels, and a two-layer, end-to-
side, duct-to-mucosa pancreaticojejunostomy is performed over a small
Silastic stent.
Discussion. Laparoscopic pancreatic surgery is a difficult and tecnically
demanding surgery. With the experience of the surgical teams, more difficult
procedures can be performed succesfully and with the benefits of the
laparoscopic approach.
FV 2.12
LAPAROSCOPIC EN-BLOCK DISTAL PANCREATECTOMY,
SPLENECTOMY AND PARTIAL GASTRECTOMY DUE TO COM-
PLICATED SOLID-PSEUDOPAPILLARY TUMOR
Rotellar, Fernando; Pardo, Fernando; Pastor, Carlos; Valentı´, Victor;
Poveda, Ignacio; Montiel, Custodia; A-Cienfuegos, Javier
University Clinic. University of Navarre, General Surgery, Pamplona, Spain
Background. In december 2003 we began our program of laparoscopic
pancreatic surgery. In this time we have improve our knowledge of this
technique in a way that has allow us to apply it in difficult cases such as big or
complicated tumors or in patients with previous laparotomies or retro-
peritoneal surgery. In this video we show a laparoscopic en-block distal
pancreatectomy, splenectomy and partial gastrectomy due to a complicated
solid-pseudopapillary tumor.
Case report. An asymptomatic, incidentally discovered 6x5,5 cm tumor in
the tail of the pancreas in a 28-year-old woman (IMC/40). An US-
endoscopic guided biposy was performed to achieve an histological diagnosis.
The patient reentered the hospital one week later fefering high temperature
and pain in the upper left abdomen. A CT-scan revealed an abscessed
enlarged tumor in contact with the greater gastric curve. After 15 days of i.v.
and 7 days of oral antibiotic treatment the CT-scan images hadn’t changed
much, so we decided the surgical treatment.
Surgical technique. The patient is placed in a modified lithotomy position
and reverse Trendelenburg. A five-port technique was used. After entering
the lesser sac through the gastrocolic ligament, the inspection of the left
hipocondrium (visual and with US-lap) showed an inflammatory mass
affecting tail of the pancreas, spleen and greater gastric curve, so that these
structures were removed in-block. At the end of the procedure, we perform a
small incision, placing a hand-assisted port in order to complete the
movilization of the spleen and remove the specimen.
Conclusion. Laparoscopic approach seems is excelent to distal pancrea-
tectomy or ennucleations of bening tumors. With more experience of the
surgical teams we can apply it to difficult cases with success.
FV 3.01
THREE-PORT CLIPLESS LAPAROSCOPIC SPLENECTOMY
USING LIGASURE AND PRETIED LOOP
Okada, Toshihiro; Yamanaka, Junichi; Iimuro, Yuji; Kuroda, Nobukazu;
Hirano, Tadamichi; Oh, Koushi; Saito, Shinichi; Asano, Yasukane; Mor-
ikawa, Shiro; Sugimoto, Takaaki; Son, Gakuhei; Fujimoto, Jiro
Hyogo College of Medicine, First Dept. of Surgery, Nishinomiya, Japan
Aim. Laparoscopic splenectomy has become widely accepted as the
approach of choice for the surgical treatment of hematologic diseases.
Challenges, however, still remain to reduce postoperative complications
such as bleeding and pancreatic leak. Here we report a clipless laparoscopic
splenectomy using an electrothermal bipolar tissue sealing system and pretied
loop with a three-trocar technique.
Patients & methods. In 19912005, 922 patients underwent laparo-
scopic surgical procedures, including 746 laparoscopic cholecystectomies.
(80.9%) and 21splenectomies (2.4%). Since 2002, we have performed
laparoscopic cholecystectomy with three-trocar technique in more than
300 cases. We have also introduced the three-port technique to laparo-
scopic splenectomy since 2003. LigaSure trade mark vessel sealing system
(Valleylab, Boulder, Colorado) and pretied loop further facilitated safe
divisioin of splenic vascular pedicle and complete preservation of pancreas tail.
Operative procedure. This video presents a clipless splenectomy, which was
performed prior to ABO-incompatible living donor renal transplantation for
chronic renal failure. Splenic hilum was dissected carefully and pancreas tail
was mobilized and preserved to avoid pancreatic leak. The splenic vascular
pedicle was ligated with a pretied loop and divided by the Ligasure system
peripherally.
Results. The clipless splenectomy was performed in 9 cases without any
conversion to open surgery. No postoperative complication occurred.
Conclusions. The three-port clipless splenectomy using Ligasure and pretied
loop was a safe and time-sparing laparoscopic procedure, which facilitates
acceptance of minimally invasiveness and cost-effectiveness of the laparo-
scopic surgery.
FV 3.02
A SIMPLE, SAFE AND COST-EFFECTIVE TECHNIQUE FOR
CLOSURE OF DIFFICULT LAPAROSCOPIC PORT SITES
Guruswamy, Raman; Studley, John
James Paget Healthcare NHS Trust, General Surgery, Great Yarmouth, UK
Introduction. It is common practise to leave the abdominal wall sheath at the
port site open in difficult and obese patients. As a consequence port site
herniation and Richter’s type of strangulation of the bowel is a recognised
complication.
Method. We present this operative video which demonstrates how an
aneurysm needle can be modified and used to close port sites. Moreover
port site bleeding, especially where the vessel is close to the sheath and in the
pre-peritoneal fat, can be easily controlled using the technique shown. It can be
undertaken blindly without riskIng trauma to intra peritoneal structures.
Results. The above technique has been used successfully for both closure of
difficult port sites and for port site bleeding. It was performed blindly in 80% of
the cases without complications.
Discussion. Using the modified aneurysm needle to close the sheath at port
site appears to be safe, quick and cost-effective. The technique can be easily
learnt.
FV 3.03
APPLICATION OF CURETTAGE AND ASPIRATION TECHNIQUE
IN CURATIVE GASTRECTOMY
Liu, YingBin; Peng, ShuYou
Second Affiliated Hospital, Zhejiang University, Hangzhou, China
Introduction. Our group has performed gastrectomy for 53 cases, to estimate
the benefit of the application of Curettage and Aspiration Technique(CAT) in
Curative Gastrectomy for Cancer.
Methods. All 53 cases were divided into two groups: pre-group and post-
group. CAT was applied in all of the operations. The time of operations,
volume of bleeding and amount of lymph nodes in pathological specimens
were recorded.
Results. Of 23 cases in pre-group, 20 cases underwent radical gastrectomy
and D2 or D2/ lymphadenectomy, but the other three cases underwent
palliative operations because of extensive celiac metastasis. In the post-group,
27 of all the 30 cases underwent D2 or D2/ lymphadenectomy, one case
underwent (D3/PDL) lymphadenectomy, while the other two were given up
to radical gastrectomy because of extensive celiac metastasis. The curative rate
of pre-group is 87.0%, while that of the post-group is 93.3%, which is higher
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than that of the pre one. Operative time of the two groups were (4.030.94)h
and (3.390.74)h, and volume of bleeding were (525.0294.0)ml and
(350.0278.6)ml, which had significant difference between pre-group and
post-group(PB/0.05). Dissection of N1 lymph nodes of advanced gastric
carcinoma in two groups were 14.69 2.50 and 15.272.53, respectively, which
had no significant difference(P/0.05). The number of dissected N2 lymph
nodes were 6.562.58 and 8.863.86, which had significant difference(PB/0.05);
and the number of N3 lymph nodes were 1.560.63 and 2.862.36, which also
had significant difference(PB/0.05). Lymph nodes of early gastric cancer in the
two groups had no statistical significance.
Conclusion. Because of the virtues of CAT in Curative Gastrectomy for
Cancer, the time of operation has been shortened, the volume of bleeding has
been reduced, the curative rate of cancer and the dissected rate of lymph nodes
both have been improved. The CAT is a useful technique in Curative
Gastrectomy for Cancer.
FV 3.04
A NEW TECHNIQUE FOR PARTIAL SPLENECTOMY USING
RADIOFREQUENCY
Tierris, John; Spalding, Duncan; Pai, Madhav; Healey, Andy; Milicevic,
Miroslav; Pellici, Riccardo; Navarra, Giuseppe; Habib, Nagy A; Jiao, Long R
Hammersmith Hospital Campus, Imperial College London, General and
Hepatopancreatobiliary Surgery, London, UK
Background. Management of splenic injury has changed dramatically over
the past decades with emphasis on spleen preservation rather than splenect-
omy. Currently, splenectomy is only considered in a minority of patients who
are, either haemodynamically unstable on presentation, despite resuscitation,
or have failed a period of conservative management. Technically, various
methods have been used for spleen preservation with unsatisfactory results,
due to significant blood loss. Radiofrequency (RF) has increasingly been used
in liver surgery and its role has been expanded from a mere ablation to an
actual liver resection, achieving virtually bloodless liver resection. Based on the
same principle, RF has been successfully used for splenectomy. We present
here a case undergoing a spleen preservation procedure with this technique.
Materials and method. A 26 yr old female patient presented with,
progressively worsening, left upper quadrant pain over a period of 4 weeks.
She also reported a traumatic injury of the same area following an RTA, several
years ago. Imaging revealed a cyst in the lower pole of the spleen, possibly post-
traumatic in origin. A partial, RFassisted splenectomy was decided. In brief,
following mobilization of spleen, ablation of tissue to induce coagulative
desiccation is carried out, along an intended line of division with a ‘‘cool-tip’’
radiofrequency probe. Subsequently the splenic parenchyma is divided with a
scalpel.
Results. The operative time was 60 minutes and blood loss was minimal.
The postoperative course was uneventful and the patient was discharged on
the 4th postoperative day. A duplex scan one month postoperatively showed
normal blood circulation in the porto-splenic venous system and the splenic
artery.
Conclusions. This technique, with increasing experience, may allow surgeons
to perform splenic preservation procedures or non-anatomical resections, with
a total control of intraoperative hemorrhage and may prove to be an
indispensable tool in the armamentarium of modern splenic surgery.
FV 4.01
BENIGN BILIARY STENOSIS TREATED BY MULTIPLE STENT-
ING, WITH REPEATED CHOLANGITIS AND SALVAGED BY
STENT EXTRACTION AND BILIARY-DIGESTIVE ANASTO-
MOSIS
Loinaz, Carmelo; Ochando, Federico; Ferna´ndez, Jose´ Marı´a; Herna´ndez,
Pilar; Vorwald, Peter; Rueda, Jose´ Antonio; Jime´nez, Pedro; Pacheco, Pedro;
Fiuza, Carmen; Garcı´a-Sesma, Alvaro; Lasala, Manuel; Vega, Daniel; Alvarez,
Mariano; Martı´n, Jaime; Pardo, Mar; Quinta´ns, Antonio
Fundacio´n Hospital Alcorco´n, Surgery, Alcorco´n, Spain
Introduction. The use of metallic stents in biliary stenosis due to benign or
malignant disease is widespread. Their usefulness in malignant disease with
short-term survival is beyond doubt. But patients with long survival may
develop obstructive and septic complications in the long run.
Patient. the case of a 62 year old female with a central liver hydatid cyst and
previous surgery 8 years before is shown in the film. She developed severe
repeated cholangitis due to left hepatic duct stenosis and lithiasis, that led to
the implantation of two biliary metallic stents and subsequently two coated
stents coaxially located.
Results. The persistence of septic complications determined a surgical
approach that consisted in removal of the metallic stents and the performance
of a wide biliary-digestive anastomosis between the hepatic confluence and
Roux-en-Y jejunal loop
Conclusion. biliary stents staying for long can determine severe complica-
tions that in certain cases can be favoured by a surgical approach
FV 4.02
SPONTAENOUS RUPTURE OF CHOLEDOCHAL CYST
Rajasekar, Arthanari
Sri Gokulam Hospital, Surgical Gastroenterolgoy, Salem, India
Background. Biliary cystic disease is uncommon in Asia and very rare in
Europe and America. Choledochal cysts can rarely rupture and present with
bile peritonitis. We present a case of ruptured choldochal cyst in a four-year-
old child.
Patient. A four-year-old female child presented with 3 days history of
abdominal discomfort and vomiting. On admission child was pyrexial, and
had a tender mass in the right upper quadrant. Ultrasonography of the
abdomen showed a Type I choledochal cyst with free fluid in the abdomen.
A CT scan of the abdomen was planned, however the child detoriated
and developed features of septic shock. An emergency laparotomy was
done. At laparotomy there was bile peritonitis and the choledochal cyst had
ruptured in three sites. Excision of the cyst with roex en y hepaticojejunostomy
was done. In the postoperative period child had bile leak which settled after
10 days.
Discussion. Spontaneous rupture of Choledochal cyst is a rare complication
and it could be managed either by T-tube drainage or definitive procedure. As
drainage procedure was not possible due to multiple perforations excision was
done in this patient.
FV 4.03
CHOLEDOCHOLITHIASIS ASSOCIATED WITH UNSUSPECTED
BILIARY PATHOLOGY
Nefa, J; Bustos, Sergio; Omelanczuk, Pablo; Minatti, Walther
General Surgical Services of the Hospital Italiano de Mendoza, Argentina
Background. Although the surgeon during cholecistectomy is aware that
unsuspected Common Bile Duct Stones could be discovered during an
Intraoperative Cholangiography, another biliary pathology may appears and
doubt about the correct treatment. This is the case in which in a Mirizzi Type II
Syndrome intervened by laparoscopy presented association with a CBD polyp.
The incidence of the pathology is 0,01%.
Aims and objectives. To present in a Video the simultaneous resolving of
choledocholithiasis and CBD polypus by Laparoscopy. A Video Case report,
Institution, Surgical Service. Hospital Italiano de Mendoza Argentina.
Patient and material. An 82 years old female undergoing Laparoscopy for
Jaundice and pain in the upper-right abdominal quadrant, was intervened by
Lap. Presented a Mirizzi type II syndrome is suspected by the laparoscopic
images. An IOC is performed by puncturing the CBD. A great lithiasis
occupying the CBD and a dilated cystic duct is found. By means of a cystic-
Choledochotomy the calculi is removed. A T-tube IOC is performed showing
uncompleted CBD fill. The CBD reexploration showed a polyp growth in the
posterior CBD. After the removing a Choledochorraphy with a T-tube was
performed.
Discussion. Being the presence of CBD polyp an uncommon pathology the
adequate treatment is not in mind of the surgeon at the moment of surgery.
Many issues for treatment must be taken into account.
Conclusion. When CBD lithiasis is associated with another biliary pathology
the adequate treatment coul be discussed generating doubt at the moment of
surgery. Over 335 CBS Lap exploration this case represent in our serie 0,33%
of the CBD pathology. Key Words Choledocholithiasis. Biliary Polyp.
Laparoscopic Choledocholithotomy. Mirizzi Syndrome. Common Bile Duct
Stones.
FV 4.04
LAPAROSCOPIC CHOLECYSTECTOMY IN A PATIENT WITH
SITUS INVERSUS TOTALIS
Rajasekar, Arthanari
Sri Gokulam Hospital, Surgical Gastroenterolgoy, Salem, India
Background. Laparoscopic cholecystectomy is one of the commonest
laparoscopic procedure performed today. Occasionally patient with situs
inversus will require, laparoscopic cholecystectomy. We discuss the surgical
difficulties encountered and how they were overcome in one such case.
Case presentation. A 34 years old female a known case of situs inversus
presented with features of biliary colic. Ultrasongraphy confirmed chole-
lithiasis and thickened gall bladder wall. Laparoscopic cholecystectomy was
performed and the patient made an uneventful recovery. All the laparoscopic
theatre equipments were placed on the left side of the patient. The ports were
inserted in the ususal way on the left side (10 mm port subumblical, 10 mm
port left subcoastal along midclavicular line, 5 mm port left subcoastal more
laterally and 5 mm epigastric port). The epigastric port was used to retract
the hartman’s pouch and the medial most subcoastal port for dissection and
the lateral most subcoastal port was used to retract the fundus. Surgery was
completed without any complications and the patient was discharged the
next day.
Conclusion. Laparoscopic cholecystectomy can be performed safely in situs
inversus patient, however care must be taken to re-arrange the equipment set-
up in theatre and to recognize the mirror image anatomy.
FV 4.05
LAPAROSCOPIC RADICAL ANTEGRADE MODULAR PAN-
CREATOSPLENECTOMY FOR PANCREATIC CANCER
Ferna´ndez-Cruz, Laureano; Lo´pez-Boado, Miguel A; Astudillo, Emiliano;
Bollo, Jesu´s
Hospital Clı´nic de Barcelona, Surgery, Barcelona, Spain
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Background. Recently, Strassberg et al (Surgery 2003;13:521 7) have
described a modified technique of distal pancreatectomy in an attempt to
improve the likelihood of a negative margin /N1 resection with a distal
pancreatectomy for cancer. Some, have suggested that pancreatic adenocar-
cinoma is a contraindication to laparoscopic resection.
Aim. To determine if laparoscopic distal pancreatectomy may be performed
with the oncological goals of treatment.
Patients and methods. Nine patients (five men, four women; mean age 67
years) with carcinoma of the body-tail of the pancreas (4 ductal, 3 cystoade-
nocarcinomas) were prospectively evaluated using the laparoscopic radical
antegrade modular pancreatosplenectomy. Details are shown in the video.
Results. Laparoscopic resection was completed in six patients and 3 patients
were converted to open surgery for invasion to the neighbouring organs. No
postoperative deaths occurred. Two patients developed pancreatic fistula.
Negative resection margins were obtained in 8 patients. The nodal count
ranged from 8 to 22. Lymph node metastasis were detected in 6 patients.
Mean hospital stay was 7 days.
Conclusion. The laparoscopic antegrade approach provides: 1 dissection of
the hepatic artery, celiac and splenic lymph nodes. 2 early division of the neck
of the pancreas, and control of the splenic vessels. 3 dissection plane anterior
to the adrenal gland. It seems effective in providing negative margin /N1
resection with the advantages of a minimally invasive approach.
FV 4.06
LAPAROSCOPIC SPLEEN-PRESERVING SUBTOTAL PANCREA-
TECTOMY FOR A MUCINOUS CYSTADENOMA IN A 36 YEAR
OLD WOMAN
Helton, W Scott; Espat, N Joseph
University of Illinois at Chicago, Surgery, Chicago, USA
Background. Laparoscopic resection of benign mucinous pancreatic cystic
neoplasms (MCN) is safe and minimally morbid but laparoscopic subtotal
pancreatectomy (LSP) for a MCN with spleen preservation has rarely been
reported.
Objective. To illustrate the technical aspects of performing laparoscopic
subtotal pancreatectomy for MCN with spleen preservation.
Results. A 36 year old woman presented with abdominal pain and found to
have a 5/5 cm cyst in the body of the pancreas suspicious for MCN vs.
pseudocyst with atrophy of the pancreatic tail. ERCP demonstrated com-
munication between the cyst and the pancreatic duct with obstruction of the
proximal duct. Endoscopic ultrasound-guided aspiration showed a cyst fluid
CEA of 462 and amylase of 54,000 u/ml. The video illustrates the diagnostic
work up, imaging, and surgical technique for spleen preserving LSP.
Intraoperative ultrasound is used to identify margins for pancreatic parench-
ymal transaction at the spleen hilum. The pancreatic neck is divided to the
right of the portal vein with a linear endocutter stapler reinforced with
bioabsorbable seamguard†. The tumor and pancreas were removed through
a 5 cm infra umbilical incision. The patient was fed on the first post operative
day, discharged home on the third day, returned to work within 7 days and
had an excellent cosmetic result.
Conclusions. LSP for cystic neoplasms is feasible and safe and can be
accomplished with minimal morbidity. Spleen preservation is easy without
dissection of the pancreas from the splenic vein or artery.
FV 4.07
RESECTION OF PANCREATIC BODY AND TAIL FOR INTRA-
DUCTAL PAPILLARY-MUCINOUS CARCINOMA
Cavallaro, Antonino; Brozzetti, Stefania; Sterpetti, Antonio; De Angelis,
Monica; Siciliano, Iole
Policlinico Umberto I, Pietro Valdoni, Rome, Italy
In 1999, a 62 year-old female underwent emergency surgery because of
intestinal obstraction by a fibrous band. At laparotomy a pancreatic mass was
found but no resected. In 2003 the patient was referred to our istitution. A
computed tomography (CT) confirmed the presence of a pancreatic mass of
10/6 centimetres. Resection of body and distal pancreas was performed.
Histology revealed an intraductal papillary mucinous carcinoma. A follow-up
CT, 7 months later, revealed a mass of 6 centimetres invading the gastric wall
and the pancreatic stump that was resected. Histology of the speciement
revealed a pseudopancreatic cyst. Equipe (1999): Cavallaro A.;Sterpetti
A.;Siciliano I.
Equipe (2003):Cavallaro A.;Brozzetti S.;De Angelis M.
FV 4.08
THREE PORT TECHNIQUE FOR LAPAROSCOPIC DISTAL PAN-
CREATECTOMY AND SPLENECTOMY
Jacobs, Michael; Kuruba, Rajesh
Providence Hospital, Surgery, Southfield, USA
Background. Laparoscopic distal pancreatectomy and splenectomy is an
alternative to open surgery. The optimal method has yet to be determined.
Herein, we present our methods using a three-port technique.
Aims. A video presentation that demonstrates the three-port technique.
Methods. The patient selected for this video presentation is an 80-year old
female with a symptomatic cystic mass in the tail of the pancreas. A
laparoscopic distal pancreatectomy and spenectomy were performed using
a three-port technique. The three-port technique includes: A 5-mm medial
port and 210 mm lateral ports. The central or lateral port can be converted
into a 2-cm port for bagged specimen extraction.
Results. The selected patient performed well and was discharged on
postoperative day two. Minimal blood loss occurred and there were no
complications. The pathology was consistent with an intraductal papillary
mucinous neoplasm with negative margins.
Conclusion. The aforementioned technique is a modification of the
laparoscopic splenectomy port technique that we employ. The three port
technique is not any more difficult than a four or five port technique. This
method offers an alternative to laparoscopic pancreas resection.
FV 4.09
LAPAROSCOPIC LOCALISATION AND RESECTION OF INSU-
LINOMA
Casey, John J1; Visser, Brendan1; Garden, O James2
1Royal Infirmary of Edinburgh, Transplant Unit, Edinburgh, UK; 2Royal
Infirmary of Edinburgh, Clinical and Surgical Sciences (Surgery), Edin-
burgh, UK
This 45 year old female presented with profound hypoglycaemia unrespon-
sive to medical therapy. Due to the urgency of her clinical condition and the
classical presentation we elected to proceed directly to laparoscopic ultra-
sound and laparoscopic resection of a suspected insulinoma. A classical 1.2
cm lesion was identified on lap ultrasound on the superior border of the body
of the pancreas adjacent to the splenic artery. This was resected laparosco-
pically and the pathology confirmed an insulinoma. The patient was
discharged without complication on the 4th post operative day. This
demonstrates that in centres with appropriate expertise in laparoscopic
ultrasound and laparoscopic surgery, insulinoma can be diagnosed and
managed in a one stage procedure.
FV 5.01
CENTRAL BISECTIONECTOMY WITH SEGMENTECTOMY 1 OF
THE LIVER AND PANCREATICODUODENECTOMY FOR SYN-
CHRONOUS DOUBLE CANCER OF THE GALLBLADDER AND
BILE DUCT
Uesaka, Katsuhiko; Matsunaga, Kazuya; Maeda, Atsuyuki; Kanemoto,
Hideyuki
Shizuoka Cancer Center Hospital, Hepato-Biliary-Pancreatic Surgery, Na-
gaizumi-cho, Sunto-gun, Japan
Background. Hepatopancreaticoduodenectomy (HPD) is a challenging
procedure with high morbidity and mortality.
Aim. We present a video of a case with synchronous gallbladder carcinoma
and widely spreading bile duct cancer successfully treated by central
bisectionectomy with segmentectomy 1 and pancreaticoduodenectomy (PD).
Patient and procedure. The patient is a 74-year-old gentleman. An
elevated lesion of the gallbladder was pointed out by ultrasonography.
Multidetector helical CT (MDCT) clearly demonstrated a protruded lesion
of the gallbladder and bile duct abnormalities. Bile duct walls of the right and
left hepatic ducts, right anterior and left medial sectional ducts, and common
bile duct were thickened. Especially, intrapancreatic bile duct was markedly
stenotic by the thickened wall. These findings were compatible with widely
spreading bile duct cancer. We did not perform direct cholangiography
worrying about cholangitis. His serum total bilirubin level was 0.7 mg/dl.
Based on the MDCT findings, central bisectionectomy with segmentectomy
1 and PD were planned. On laparotomy, there was no liver metastasis nor
peritoneal dissemination. Skeletonization resection of the hepatoduodenal
ligament was performed following Whipple procedure. Right anterior portal
vein and tiny portal twigs for the segment 1 were ligated and divided. Middle
and right anterior hepatic arteries were also ligated and divided. The segment
1 was detached from the inferior vena cava. After ligation and division of the
left medial portal branches, central bisectionectomy and segmentectomy 1
were carried out. Bile duct stumps of the left lateral and right posterior
sections were negative for cancer by frozen section examination. He was
discharged from our hospital 42 days after surgery and is now doing well
without recurrence 15 months after the operation.
Conclusions. Although HPD is still accompanied by some difficult
perioperative problems, it provides long term survival and good quality of
life for selected cases with biliary malignancies.
FV 5.02
TRANSHEPATIC ANTERIOR APPROACH-CAUDATE LOBECT-
OMY IN A PATIENT WITH BISTHMUTH TYPE I HILAR CCC
Lee, Sung-Gyu; Kim, Ki-Hun; Ahn, Chul-Soo; Moon, Deok-Bog; Ha, Tae-
Yong; Song, Gi-Won; Moon, Ki-Myung
Asan Medical Center, Division of HPB Surgery and Liver Transplantation,
Seoul, Korea
Curative resection of hilar cholangiocarcinoma cannot be obtained if the
microscopic cancer cells are left at the ductal resection margin. To obtain
the tumor-free margin, the bile duct resection(BDR) alone is frequently an
inadequate and the combined liver resection is necessary in advanced hilar
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cholangiocarcinoma. In Bismuth type 1 hilar cholangiocarcinoma, the
microscopic cancer cells often remain at the proximal ductal resection
margin if the resection is carried out by BDR alone. BDR alone may leave
the cancer cell at the caudate lobe ducts, provide the limited working
space for division of the right- and left-ducts with the additional risk of the
tumor-positive proximal margin and is associated with the difficulty of the
biliary reconstruction for numerous ductal opening including many B1.
Combined caudate lobectomy is recommended for Bismuth type 1 hilar
cholangiocarcinoma by many expertises to achieve the curability and the
better survival. There are several approaches to resect the caudate lobe
concomittently for Bismuth 1 tumor. Especially, the transhepatic anterior
approach-caudate lobectomy by bisecting the liver and seperating the right-
and left-ducts apart from the tumor provides a few advantages than BDR
alone? It provides the wide working space for division of the proximal
ducts with the no risk of the tumor-positive margin, it completely eradicate
the tumor area by resecting S1, and it does not give any risk of
postoperative liver failure by preserving the parenchymal liver tissues as
much as possible. The 73 year-old male patient underwent BDR and
transhepatic anterior approach-caudate lobectomy for Bismuth type 1 hilar
cholangiocarcinoma.
FV 5.03
LAPAROSCOPIC RESECTION FOR CHOLEDOCHAL CYST
Pekolj, Juan; Bertona, Christian; Sa´nchez Claria´, Rodrigo; Palavecino,
Martı´n; Mazza, Oscar; de Santiban˜es, Eduardo
Hospital Italiano de Buenos Aires, Buenos Aires, Argentina
Background. Choledochal cysts are an infrequent pathology in adult
population. The surgical resection is the gold standard treatment because
of the possibility of cancer development.
Objective. To show technical tips for the laparoscopic resection of
choledochal cysts (Type I in Todani’s classification).
Population. A 44 year-old female patient with abdominal pain. The
ultrasound and MRI showed a choledochal cyst (Type I in Todani’s
classification).
Method. Closed pneumoperitoneum, the intraoperative cholangiography
showed a pathological bilio-pancreatic junction. The hepatic artery was
dissected, clipping the pyloric and gastroduodenal artery. The proximal neck
of the cyst was dissected and cut. The posterior wall was separated from the
portal vein. The distal neck was ligated and sectionated. An extracorporeal
Roux-en-Y loop was performed (through the umbilical access). A hepatico-
jejunostomy was done. A cholangiography by transjejunal punction con-
firmed the patency of biliodigestive anastomosis. An abdominal drainage was
left in place.
Resutls. The patient was discharged at the 4th postoperative day without
complications. In the long-term follow-up the patient is asymptomatic and
with normal liver function tests and ultrasound controls.
Conclusions. Type I (in Todani’s classification) choledochal cysts can be
laparoscopically resected following the steps described for the open proce-
dure. This approach must be performed by surgeons with experience in
laparoscopic suturing techniques.
FV 5.04
RE-RESECTION OF TYPE IVA CHOLEDOCHOCYST WITH
RY-HEPATICOJEJUNOSTOMY IN A 28 YEAR OLD WOMAN
MISDIAGNOSED AS A TYPE I CHOLEDOCHOCYST AT AGE 13
Helton, W. Scott; Espat, N. Joseph
University of Illinois at Chicago, Surgery, Chicago, USA
Background. Choledochocysts (CC) presenting in child hood are often mis-
classified and inappropriately treated due to a lack of understanding of the
extent of disease. This leads to recurrent biliary problems and cholangitis
later in life requiring repeat operation.
Objective. This movie illustrates the work up and surgical treatment of an
adult woman presenting with recurrent cholangitis from an inadequately
previously operated Type IVa CC.
History. A 28 year old woman presented with RUQ pain and abnormal liver
function tests. At age 13 she reported having resection of a biliary tumor. She
lived a normal life until presenting with the above complaints. A CT scan and
MRCP revealed a dilated extrahepatic biliary tree at the biliary bifurcation with
air/fluid levels and filling defects. Percutaneous transhepatic cholangiography
and drainage revealed cystic dilation of the segment IV bile duct proximal to a
dilated extrahepatic biliary tree and strictured hepaticojejunostomy.
Results. Operation revealed a tight stricture of the anastamosis between the
jejunum and the remnant CC at the hepatic hilus. Choledochoscopy and
cholangiography demonstrated absence of right and left hepatic ducts and
independent drainage of segments I, the sector duct draining IIIII, segment
IV, the right anterior sector duct to VVIII, and the segment VII duct into
the back wall of the CC. Excision of the entire CC was performed except the
back wall which was anastomosed side to side with to the RY limb. Liver
biopsy showed no evidence of fibrosis or cirrhosis. Post operatively the
patient was relieved of her biliary symptoms and pathology showed no
malignancy.
Conclusion. Type IVa CC are often misdiagnosed in childhood as type I CC
and are therefore incompletely resected resulting in future biliary stasis,
recurrent cholangitis and intrahepatic biliary strictures and cirrhosis.
Complete excision of the entire CC except the back wall usually results in
long term clinical relief.
FV 5.05
ENDOSCOPIC NASO-GALLBLADDER DRAINAGE: CUTTING-
EDGE TREATMENT OF ACUTE CHOLECYSTITIS.
Toyota, Naoyuki; Takada, Tadahiro; Nagashima, Ikuo; Amano, Hodaka;
Yoshida, Masayoshi; Miura, Fumihiko; Isaka, Takahiro; Wada, Keita; Takagi,
Kenji; Kato, Kenichirou
Teikyo University School of Medicine, Surgery, Tokyo, Japan
Background. Endoscopic Naso-Gallbladder Drainage (ENGBD) is newly
introduced a technique to alleviate gallbladder inflammation as well as to
simplify the Laparoscopic CHOLECYSTECTOMY (LC).
Objective. We demonstrate detailed procedure of ENGBD in this video.
Patients and method. 28 patients were subjected to ENGBD. The
technique was as follows: First, endoscopic retrograde choledochopancreato-
graphy (ERCP) was performed to allow ENGBD. A Radiofocus guidewire
was inserted into the bile duct and directed toward the gallbladder. A
FleximaTM 6 Fr Nasobiliary catheter was inserted to aspirate the gallbladder
contents. Initial aspiration produced bile mixed pus, with subsequent biliary
secretions similar to normal ENBD. The patient’s symptoms of high fever
and abdominal pain resolved following aspiration of the infected bile. One or
two days later, patients received LC. During LC, ENGBD tube could help to
clearly identified the cystic duct.
Result. The patient’s postoperative course was highly satisfactory in 28
patients.
Conclusion. We have seen no prior reports of ENGBD to perform acute
cholecystitis surgery for the relief of acute inflammation with follow-up use of
the ENGBD catheter to fix the operator’s aim in LC. Our results indicate
that this procedure can be successfully applied to provide early, safe, and
minimally invasive surgery.
FV 5.06
LAPAROSCOPIC PANCREATICODUODENECTOMY FOR A
CHOLANGIOCARCINOMA OF THE LOWER THIRD OF THE
BILE DUCT
Menon, Krishna1; Hayden, Jeremy1; Prasad, Raj1; Verbeke, Caroline2;
Guillou, Pierre1; Hinchcliffe, Mark3
1St.James’s University Hospital, HPB Surgery, Leeds, UK; 2St.James’s
University Hospital, Pathology, Leeds, UK; 3St.James’s University Hospital,
Medical Illustration, Leeds, UK
Background. Pancreaticoduodenectomy is one of the most technically
challenging laparoscopic procedures.
Aim. Video of laparoscopic pancreaticoduodenectomy
Methods. Patient details The patient was a sixty five year old male who had
presented with obstructive jaundice and on imaging (Computerised tomo-
graphy and Magnetic Resonance Imaging) had a mass lesion of 1.5
centimetres obstructing the lower third of the common bile duct. There
was no evidence of distant disease or local contraindication to curative
resection. It was also noted that the patient had a right hepatic artery
originating from the superior mesenteric artery.
Results. Operative summary The patient was placed in the steep reverse
Trendlenberg position with a left lateral tilt. Six ports were used for the
operation. Staging laparoscopy was first performed that confirmed no
evidence of distant disease. All steps of the laparoscopic pancreaticduode-
nectomy were similar to the open procedure except for the use of Harmonic
scalpel for dissection and use of stapling devices. After completion of
resection the specimen was placed in a bag. Reconstruction was done
retrocolic on a single loop of jejunum commencing with the pancreas,
followed by the bile duct and lastly the stomach. Intracorporeal suturing was
used to complete the pancreatic and biliary anastomosis and a stapler for the
gastroenterostomy. The specimen was retrieved through a small Pfannensteil
incision. Post-operative recovery The patient made a good recovery and
histology confirmed the tumour to be a cholangiocarcinoma of the lower
third of the bile duct T3 N1 (5/17 nodes) and the patient has commenced
adjuvant chemotherapy.
Conclusion. Laparoscopic pancreaticoduodenectomy is technically feasible.
Careful patient selection both in terms of the primary tumour and patient
may be necessary. The oncological results can be assessed only when long
term results are available.
FV 5.07
RESECTION OF UNCINATE PROCESS OF THE PANCREAS
FOR BENIGN BRANCH-DUCT INTRADUCTAL PAPILLARY
AND MUCINOUS TUMOR (IPMT)
Sauvanet, Alain; Ogata, Satoshi; Kianmanesh, Reza
Hospital Beaujon, Clichy, France
IPMT can benign and limited to ducts of uncinate process. In this setting,
resection of the only uncinate process can be indicated. A 46-year man
presented with recurrent attacks of mild acute pancreatitis. Preoperative
imaging (CT-scan, magnetic resonance pancreatography, endoscopic ultra-
sound) suggested benign IPMT limited to a dilated duct located deeply in the
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uncinate process and communicating with a normal main duct through a thin
branch-duct. Peroperatively, ultrasound confirmed both localization of the
dilated duct and absence of main duct abnormality. A Kocher manoeuvre was
done and the medial edge of the uncinate process was progressively freed
from the superior mesenteric vessels. Inferior pancreatico-duodenal arterial
arcade was preserved to avoid ischemia of the third portion of the duodenum.
The papilla was identified by palpation through the duodenal wall and the
course of the main pancreatic duct was located by ultrasound. Pancreatic
transection was progressively done to separate uncinate process from the
upper part of the pancreatic head. The communicating duct was transected
close to the main duct. Frozen section was done on both communicating duct
and dilated duct to ensure that resection was complete and no invasive
carcinoma was present. The communicating duct was sutured and the
resection cavity was filled with an omental flap. Postoperatively, the patient
developed transient pancreatic external fistula which healed within 3 weeks.
Pathologic examination confirmed complete resection of a branch-duct
border-line IPMT. One year later, the patient had no symptoms and magnetic
resonance pancreatography revealed neither tumor recurrence nor main duct
stenosis Resection of uncinate process is an acceptable option for treatment
of benign branch-duct IPMT limited to uncus. This procedure avoids some
drawbacks of pancreaticoduodenectomy and could increase the possibilities
of pancreatic preservation if subsequent surgery is needed for tumor
recurrence.
FV 5.08
LAPAROSCOPIC SPLEEN PRESERVING DISTAL PANCREATEC-
TOMY:A POSTERIOR APPROACH
Honore, Charles; Detroz, Bernard; Deroover, Arnaud; Detry, Olivier;
Honore, Pierre
C.H.U Sart Tilman, Surgery, Liege, Belgium
We present an illustrative video of a distal pancreatectomy,preserving the
spleen and its blood vessels using a laparoscopic approach. The indication
was a presumed pancreatic neuroendocrine tumor,based on an arterioscan.
The laparoscopic distal pancreatectomy(or spleno-pancreatectomy) could be
carry out identically to open approach. Because of technical diferences when
using laparoscopy,we feel an anterior approach does not fully exploit the
advantages of this technique. We present a video with a posterior approach
which is particulary suited for distal pancreatectomy
FV 5.09
LAPAROSCOPIC TREATMENT OF PANCREATIC PSEUDO-
CYSTS
Pekolj, Juan; Palavecino, Martı´n; Sa´nchez Claria, Rodrigo; Mazza, Oscar; de
Santiban˜es, Eduardo
Hospital Italiano de Buenos Aires, Buenos Aires, Argentina
Background. Acute pancreatic pseudocysts may be treated in different
therapeutic approaches: endoscopy, percutaneous drainage, open and laparo-
scopic surgery. The benefits of laparoscopic surgery should be considered in
the moment we treat a pancreatic pseudocyst.
Objective. To describe technical aspects and results of laparoscopic
treatment of acute pancreatic pseudocysts.
Population and methods. We present two cases of laparoscopic treatment
of pancreatic pseudocysts. Case 1: A 48 year-old male patient with a 10 cm
pancreatic pseudocyst. The surgery was carried out 8 weeks after the acute
pancreatitis. A Roux-en-Y cystojejunostomy was performed. Case 2: A 63
year-old male patient with a 13 cm pancreatic pseudocyst. The laparoscopy
was performed 10 weeks after the pancreatitis. A cystogastrostomy was
carried out. In both cases, laparoscopic US was done.
Results. There were no conversions to open surgery. Case 1: Operating time
was 150 minutes. The patient was discharged at day 4 without postoperative
complications. The patient is free of recurrence in the 36 months follow-up.
Case 2: Operating time was 100 minutes. Length of stay was 3 days
without complication. The patient is free of recurrence in the 18 months
follow-up.
Conclusions. Laparoscopic treatment of pancreatic pseudocysts can
be safely performed, reproducing all maneuvers we used in the open
approach.
FV 6.01
EXTENDED RIGHT HEMIHEPATECTOMY, BILE DUCT AND
PORTAL VEIN RESECTION FOR HEPATIC ALVEOLAR ECHINO-
COCCOSIS
Petrowsky, Henrik; McCormack, Lucas; Clavien, Pierre-Alain
University Hospital Zurich, Dept. of Visceral and Transplant Surgery,
Zurich, Switzerland
Background. Hepatic alveolar echinococcosis is a rare disorder with
infiltrating growth behavior. Often, these lesions infiltrate the bile duct or
main vascular structures and make the surgical treatment difficult.
Patient. Here, we present a 27 year old female patient with jaundice due to
bile duct compression of a hepatic alveolar echinococcosis. CT imaging
demonstrated an alveolar echinococcosis lesion in segment 4b & 5 with
infiltration of the portal vein and right hepatic artery. The left liver was
supplied by an aberrant left hepatic artery originating from the left gastric
artery.
Technique. The video shows the technical aspects of an extended right
hemihepatectomy, bile duct and portal vein resection for hepatic alveolar
echinococcosis. The right extended hemihepatectomy was only possible
because of an aberrant left hepatic artery which bypassed the echinococcosis
lesion. The operative strategy was similar to that of a Klatskin tumor. Due to
infiltration of the portal vein bifurcation, the left portal vein was resected and
anastomosed with the portal vein. After completion of the extended right
hemihepatectomy, two separate bile ducts were implanted as hepaticojeju-
nostomy.
Discussion. Although hepatic alveolar echinococcosis is a non-malignant
disease, the cancer-like growth of this disorder requires often complex liver
surgery to achieve complete disease clearance
FV 6.02
RIGHT TRISEGMENTECTOMY WITH RESECTION AND RE-
CONSTRUCTION OF LEFT HEPATIC VEIN FOR INTRAHEPATIC
CHOLANGIOCARCINOMA UNDER HYPOTHERMIC TOTAL
VASCULAR EXCLUSION
Ercolani, Giorgio; Grazi, Gian L; Del Gaudio, Massimo; Cescon, Matteo;
Ravaioli, Matteo; Pinna, Antonio D
Hospital Sant’orsola-Malpighi, Bologna, Italy
The video shows a right trisegmentectomy with resection and reconstruction
of the left hepatic vein. for an advanced intrahepatic cholangiocellular
carcinoma. The tumor, deeply located in the central segments of the liver,
involved all the 3 major hepatic veins. The extra hepatic bile duct was
removed. The portal trunk and the hepatic artery were schelotonized. The
right branches of portal vein and hepatic artery were sectioned. A partial
dissection of the lateral aspect of the retrohepatic vena cava was accomplished
with the interruption of some accessory hepatic veins. Due to the huge mass
of the tumor and involvement of the main hepatic veins, after sectioned of the
portal pedicles of segment 4 on the right of the umbilical portion, an
extended right trisegmentectomy under hypotermic total vascular exclusion
was completed and left hepatic vein was resected and reconstructed end-to-
side to inferior vena cava (total time of hypothermic ischemia: 40 minutes).
Accurate dissection of lymph nodes and perineural tissue around the hepatic
pedicle, retropancreatic space, and common hepatic artery was carried out.
Frozen section of few samples did not reveal lymph node metastases.
Eventually, biliary reconstruction was with a Roux-an-Y loop on the left
hepatic duct. Postoperative course was uneventful and patient discharged 15
days after surgery
FV 6.03
ANATOMIC RESECTION OF SEGMENTS 5, 6 AND 7 OF THE
LIVER FOR HCC: PRIOR CONTROL OF ANTERIOR GLISSONS
Nanashima, Atsushi; Sumida, Yorihisa; Abo, Takafumi; Sawai, Terumitsu;
Yasutake, Toru; Nagayasu, Takeshi
Nagasaki University Graduate School of Biomedical Sciences, Division of
Surgical Oncology, Nagasaki, Japan
Background. Anatomic resection, i.e., systematic removal of a liver segment
confined by portal branches, is theoretically effective in eradicating intrahe-
patic metastasis of hepatocellular carcinoma (HCC). The procedure seems to
reduce postoperative recurrence rate and enhance survival of HCC patients.
In patients who undergo a larger volume of hepatectomy or who have hepatic
dysfunction, the extent of hepatectomy is limited to avoid postoperative
hepatic failure.
Case. A 62-year-old male was found to have a 12-cm HCC in segments 5, 6
and 7, with alcoholic liver disease. ICGR15 was 11% and LHL15 by
99mTc-GSA liver scintigraphy was 0.94. The total liver function was Child-
Pugh grade A. The resected liver volume of right hemi-hepatectomy
estimated by CT volumetry was 72% and the permitted resected volume
based on Takasaki’s formula applying ICGR15 was 65%. As the portal
branches of segment 8 was free from HCC involvement and the estimated
volume of segments 5, 6 and 7 was 51%, we scheduled anatomic resection
of these segments to secure remnant liver function. Intraoperative ultra-
sonography showed that HCC involved the portal branches of segments 57
similar to preoperative imaging. Hepatic transection on the border between
right and left liver was performed and the anterior Glisson’s branch was
exposed in the cut area in the first step. Branches of segment 5 were
subsequently divided and the border between segments 5 and 8 was
confirmed. Then, the posterior section was resected and the right hepatic
vein draining segment 8 was secured. Clamping and operating times were 55
and 364 minutes, respectively, and intraoperative bleeding was 850 ml,
which did not require red cell transfusion. Postoperative course was
satisfactory and the patient was free from tumor relapse for 6 months after
hepatectomy.
Conclusion. Under a balance between tumor location and hepatic func-
tional reserve, anatomic resection would be necessary for the treatment of
HCC patients.
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FV 6.04
LEFT LOBECTOMY WITH MIDDLE HEPATIC VEIN AND TOTAL
CAUDATE LOBECTOMY USING COUNTERSTAINING TECHNI-
QUE AND BILE DUCT RESECTION FOR HILAR CHOLANGIO-
CARCINOMA
Kim, Ki H; Lee, Sung G; Lee, Young J; Park, Kwang M; Hwang, Shin; Ahn,
Chul S; Moon, Deog B; Ha, Tae Y
Asan Medical Center, Surgery, Seoul, South Korea
Surgical strategy in the therapy of hilar cholangiocarcinoma is radical
resection. It is important to recognize the distribution of the bile duct in
the caudate lobe of the liver for a HB surgeon who has a plan to perform
surgery the hilar cholangiocarcinoma. In the Spiegel lobe, the branches drain
into the left hepatic duct system in about 83%. The confluence of the
paracaval branch is the left hepatic duct, right hepatic duct, and posterior
segment branch, all with the same frequency of approximately 30%. In the
face of bile ductal distribution of the caudat lobe, total caudate lobectomy is
needed. When we perform right lobectomy with caudate lobectomy, we can
easily resect total caudate lobe. However, in case of left lobectomy with
caudate lobectomy, it is very difficult to resect total caudate lobe because of
the paracaval portion. The right and the ventral borders of the paracaval
portion may be unclear. Kumon reported individual variability in the size of
the paracaval portion; there were patients in whom the paracaval portion
extended past the right border of the IVC. Sasaki suggested that the caudate
lobectomy should extend past the right border of the IVC for adequate
resection of the paracaval portion. Takayama reported a counterstaining
identification technique, which stains the posterior segment, to determine the
right border of the caudate lobectomy. Here we report left lobectomy with
middle hepatic vein, total caudate lobectomy using counterstaining technique
and bile duct resection for hilar cholangiocarcinoma.
FV 6.05
LEFT HEPATECTOMY WITH CAUDATE LOBECTOMY FOR
HILAR CHOLANGIOCARCINOMA
Takehito, Otsubo; Takeshi, Asakura; Takayuki, Asano; Satoshi, Koizumi;
Hiroshi, Nakano; Norihiko, Okamoto; Yuji, Jinnouchi; Hiroyuki, Komor-
iyama
St. Marianna University School of Medicine, Dept. of Gastrointestinal and
General Surgery, Kawasaki, Japan
Background. The surgical procedure for hilar choralngicaricinoma including
its safety and oncologic efficacy has been a debatable issue to be improved.
Objective. A 63 year-old man with a hilar choralngiocaricinoma who has been
undertaken left hepatectomy with caudate lobectomy with some modifications.
Operation method. An inverted L shape skin incision was made under
general anesthesia. The hepatic artery and the portal vein were first
skeltonized toward the hilus of the right lobe. Consecutively the left hepatic
artery and the left portal vein were ligated and dissected. The bile duct was
dealt with a bundle of connective tissue. During the manipulation lymph
nodes in the hepatoduodenal ligament and that around common hepatic
artery were dissected. To minimize blood loss during dissection of the liver
parenchyma we performed Pringle maneuver and clamping of the vena cava
inferior at the portion just below the liver. The clamping was carried out
repeatedly for 15 minutes with 5 minutes interval. After dissection of the liver
parenchyma between the right and the left lobe as well as that between the
right and the caudate lobe, the bile ducts that were recognized as a bundle of
connective tissues were cut at the surface of dissected liver parenchyma. The
bile ducts were observed as two holes; the anterior and the posterior
branches. We verified that the margins of the bile ducts were negative for
malignant involvement by stump cytology. The hepatojejunostomy was
performed without reconstruction of the bile ducts. Namely a silicon tube
was installed in each bile duct and a stoma of jejunum was anastomosed to
the bile duct with connective tissue around the ducts.
Conclusion. The left hepatectomy with caudate lobectomy for a hilar
cholangiocarcinoma has been performed safely by employing the vena cava
inferior clamping and the modified anastmosis procedure as described.
FV 6.06
HEPATIC COLORECTAL METASTASIS: LAPAROSCOPIC RE-
SECTION WITH PRINGLE’S MANEUVER
Pekolj, Juan; Sa´nchez Claria´, Rodrigo; Palavecino, Martı´n; Ardiles, Victoria;
de Santiban˜es, Eduardo
Hospital Italiano de Buenos Aires, Buenos Aires, Argentina
Background. Laparoscopic hepatic surgery has increased its indications in
the last years; but there are few reports in literature for the secondary tumors
management.
Objective. To show the technique for the laparoscopic resection of hepatic
metastasis.
Methods. Case 1: 71 year-old female patients, operated 4 years before to
resect a colon cancer. During the follow-up, the patient increased the CEA
level and appeared a tumor in the IVb hepatic segment (2.7 cm diameter).
Case 2: 72 year-old male patient with a colon cancer operated 1 year before.
In the follow-up presented an elevation of the CEA and a 4 cm tumor
appeared in the segment IVb. In both cases a translaparoscopic ultrasound
and Pringle’s Maneuver was performed. The resection was performed with
the monopolar suction irrigation device.
Results. Both patients were resected with a margin greater than 1 cm. In
both cases we performed a metastasectomy with 2 vascular clampings of 10
minutes each one. No transfusions were needed. Mean operative time was 3
hours. There were no postoperative complications and the patients were
discharged at days 3 and 2 respectively.
Conclusions. Laparoscopic hepatic resection for colorectal metastasis can
be safely performed by experienced surgeons. Pringle’s Maneuver can be
used during laparoscopic approach and it is useful to control bleeding in non
anatomical resections.
FV 6.07
RESECTED CASE OF HEPATOCELLULAR CARCINOMA WITH
VISIBLE HEMORRHAGE FROM BILE DUCT TUMOR THROM-
BUS PREOPERATIVELY
Yutaka, Takahashi
Tokyo Women’s Medical University, Dept. of Surgery, Tokyo, Japan
The patient is a 73 year-old man with hepatocellular carcinoma. He underwent
TACE (trance arterial chemoemborization) two times in other hospital. He
complained of tally stool and upper abdominal pain. So he came to our hospital
and the result of total bilirubin was increase. After his admission in our
hospital, he underwent ERBD (endoscopic retrogrede biliary drainage).
During the ERBD we could see the hemorrhage and an impacted tumor
thrombus macroscopicly by the endoscopy. Ultrasonography and CT scan
reveal the tumor at a segment 8 about 20 mm in diameter and the intrabile duct
tumor thrombus at lateral segment of the liver with the dilatation of the
peripheral bile duct. Cholangiography by ENBD didn’t show bile duct of the
anterial segment of the liver, and showed filling defects of common bile duct.
So based on a diagnosis of hepatocellular carcinoma with hemobiria from
intrabile duct tumor thrombus we performed central bisegmentectomy
resection and the common bile duct cutting for removal of tumor thrombus
and coagulla. The result of pathology revealed moderately differrentiated
hepatocellular carcinoma. We will present this case with a video operation.
FV 6.08
RESECTION OF GIANT HEPATOCELLULAR CARCINOMA
(HCC) UTILIZING LIVER HANGING TECHNIQUE (LHT) FOL-
LOWING TAE AND PORTAL VEIN EMBOLIZATION (PTPE)
Hoshino, Takanobu; Ishida, Takashi; Hashimoto, Daijo
Saitama Medical University, Medical Center, Surgery, Kawagoe-city, Japan
How best to resect extremely huge liver tumor with extensive invasion to the
surrounding tissues will be demonstrated.
Method. 61-year-old male patient was admitted with diagnosis of giant HCC
(18 cm in diameter), which occupied majority of right abdominal and right lower
thoracic cavities, pressing even right atrium as well as IVC and thoracic/lumbar
vertebrae, causing back and lumbar pain. Because of the extreme size of the
tumor and impaired liver function, combined TAE and PTPE were performed,
first. The volumes of right liver and tumor itself were substantially reduced
(2771 ml to 1386 ml, 2029 ml to 1159 ml, respectively) for the following three
months, during which liver function was improved (ICG15: 28.4% to 15.9%)
and tumor markers were also markedly reduced (PIVKA-2: 5670 to 329 mAU/
ml, AFP: 7.0 to 2.7 ng/ml). Thereafter, liver resection was performed.
Surgical operation. Because mobilization of the right liver, including the
huge tumor, was not possible at all, anterior approach with LHT had to be
employed for right hepatectomy. Following careful placement of a tape
between IVC and the caudate lobe for LHT, liver parenchyma was transected
utilizing forceps fracture method, CUSA, and bipolar scissors. After division
of liver parenchyma was completed, right hepatic vein and short hepatic veins
were clamped, divided, and suture-closed. Then, right liver together with
surrounding tissues was finally retrieved.
Result. Postoperative Course was uneventful. In spite of the advanced stage
of HCC, the patient has been survived, free of disease, for three years
following surgery.
Conclusions. For the safe resection of giant liver tumors with extensive
direct invasion to surrounding tissues, anterior approach utilizing LHT
appears to be extremely useful. Combined TAE and PTPE appears to 1)
decrease the volume of both tumor and liver parenchyma to be retrieved, 2)
increase the volume of liver parenchyma to be preserved, 3) thus, could well
provide better chance for safe resection of giant liver tumor.
FV 6.09
TWO-STAGE HEPATECTOMY COMBINED WITH PORTAL VEIN
EMBOLIZATION TO ACHIEVE CURATIVE RESECTION FOR
BILOBAR NEUROENDOCRINE LIVER METASTASES
Aldrighetti, Luca; Pulitano`, Carlo; Arru, Marcella; Catena, Marco; Finazzi,
Renato; Ferla, Gianfranco
San Raffaele Scientific Institute, Vita-Salute San Raffaele University, Dept. of
Surgery Liver Unit, Milan, Italy
Background. The aggressive surgical management of neuroendocrine hepatic
metastases has been reported to improve survival and relief symptoms. Liver
resection in the majority of cases is contraindicated due to multiple and bilobar
liver involvement. A Two-Stage hepatectomy procedure combined with portal
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vein embolization is an established procedure for the treatment of colorectal
metastases to the liver. However, the use of this strategy for the treatment of
neuroendocrine liver metastases has not been previously described.
Case report. The patient is a 43-year-old man, affected by symptomatic
pancreatic glucagonoma with synchronous bilobar liver metastases
initially treated with curative resection of primary tumor and subsequent
therapy with lanreotide and intrahepatic chemotherapy. At the time of
percutaneous transaxillary placement of the intra-arterial device for che-
motherapy, the left hepatic artery had been occluded by embolization. Five
months later, he underwent a first-stage hepatectomy consisting in the
clearance of the left hemiliver by wedge resection of three metastases
(segment I, II, III). Subsequently, a right portal vein embolization was
performed to induce hypertrophy of the left hemiliver. Finally, a second-stage
hepatectomy consisting in a right hepatectomy extended to the segment IV
was performed. Liver transection was performed combining ultrasonic
dissector and harmonic scalpel. Right dorsal and ventral pedicle were
separately transected transparenchimally to preserve two collateral arterial
vessels for left lobe (described in previous angioCT). No portal clamping was
used. Length of operation and intraoperative blood losses were respectively
410 minutes and 450 mL. The patient was discharged on post operative day
7. The patient is presently asymptomatic, insulin-free and disease free at 8
months after surgery.
Conclusions. Two-Stage Hepatectomy should be considered a valid
therapeutic option to achieve curative resection for multiple and bilobar
neuroendocrine liver metastases.
FV 7.01
RIGHT TRISEGMENTECTOMY FOR ADVANCED GALLBLAD-
DER CANCER DEVELOPING IN A PATIENT WITH ANOMALOUS
JUNCTION OF PANCREATICO-BILIARY DUCTAL SYSTEM
Kubota, Keiichi; Kita, Junji; Kato, Masato
Dokkyo University School of Medicine, Dept. of Gastro-enterological
Surgery, Tochigi, Japan
Background. Gallbladder cancer (GC) may develop in patients with
anomalous junction of pancreatico-biliary ductal system (AJPBDS) with a
high incidence. In this video, we will demonstrate our technique of right
trisegmentectomy (RT) preceded by portal embolization (PE) for advanced
GC in a patient with AJPBDS.
Patient. A 54-year-old female was found to have an advanced GC with
significant invasion to the liver including segment 4. MRCP demonstrated
AJPBDS. Although RT with bile duct resection was considered necessary, the
volume of the lateral segment was only 261 ml, corresponding to 21.8% of
the whole liver, and subsequently PE was performed. The lateral segment
increased its volume to 395 ml after 2 weeks.
Technique. Thoraco-abdominal incision was employed. Although the
duodenum appeared to be invaded by GC, it could be dissected from the
GC. In order to evaluate the resectability of the GC, the proper hepatic artery
and left hepatic artery were dissected and found to be intact. Since the giant
GC interfered lymph node dissection, we decided first to perform RT.
Common bile duct was dissected into the pancreas and divided. The right
hepatic artery was divided, but the right portal vein could be only ligated.
The left hepatic artery was dissected into the liver. The small vessels to the
segment 4 were divided. Then the right lobe was mobilized and the right
hepatic vein was divided. Under Pringle maneuver, the liver parenchyma
between the lateral segment and segment 4 was divided, followed by the
division of the left hepatic duct. Finally the right portal vein was divided.
Then the lymph node dissection was added. The bile duct was reconstructed
by bilio-enteric anastomosis. The operation time was 10 h and 42 min and
the bleeding amount was 686 ml. She recovered uneventfully and is doing
well without signs of recurrence 5 months after surgery. As patients
with AJPBDS have a high risk of developing GC, they should be carefully
followed up.
FV 7.02
SURGICAL TREATMENT FOR KLATSKIN TUMOR. RIGHT TRI-
SECTIONECTOMY AND HEPATICOJEJUNOSTOMY
de Santiban˜es, Eduardo; Ardiles, Victoria; Sa´nchez Claria´, Rodrigo; Bertona,
Christian; Palavecino, Martı´n
Hospital Italiano de Buenos Aires, Buenos Aires, Argentina
Background. Surgical resection of extrahepatic bile duct associated to
hepatic resection and porta hepatic lymphadenectomy is the potencially
curative treatment for Klatskin tumors.
Objective. To show technical steps to perform a hepatic resection to treat a
Klatskin tumor.
Population and methods. A 63 year-old male patient with a Type IIIa
Klatskin tumor. Doppler US showed a left lateral segment weight of 325 gr.
We performed a percutaneous portal empbolization 40 days previous the
surgery. A laparoscopy ruled out carcinomatosis or contralateral metastasis.
We continued with a laparotomy, we carried out a resection of the
extrahepatic bile duct, a porta hepatis lymphadenectomy. Main vessels
were ligated distally and the segment IV branches were ligated at the
parenchyma. We used an ultrasonic dissector (CUSA†) to perform a right
trisectionectomy with resection of the caudate lobe. The biliary reconstruc-
tion was done with a Roux-en-Y hepaticojejunostomy with a transanasto-
motic drainage.
Results. The patient was discharged at day 8 without postoperative
complications. In the 12th month follow-up there is no evidence of tumoral
recurrence.
Conclusions. Lymphadenectomy, biliary and hepatic resection can be safely
performed in tertiary center with HPB surgeons. Preoperative portal
embolization in patients with a small left lateral segment is useful to prevent
hepatic failure.
FV 7.03
TWO-STAGE NEAR TOTAL HEPATECTOMY FOR ADVANCED
COLORECTAL LIVER METASTASIS
Machado, Marcel A1; Makdissi, Fabio F1; Martino, Rodrigo B1; Surjan,
Rodrigo1; Herman, Paulo2; Bacchella, Telesforo1; Machado, Marcel C1
1University of Sao Paulo, Surgery, Sao Paulo, Brazil; 2Cancer Hospital,
Abdominal Surgery, Sao Paulo, Brazil
Background. Hepatectomy may prolong survival time of colorectal cancer
patients with liver metastases. Two-stage liver surgery is a valid option for the
treatment of advanced or synchronous colorectal liver metastasis.
Aim. To present the video from the surgical treatment of a 40-year-old male
with rectal cancer and synchronous colorectal liver metastasis occupying all
liver segments.
Methods. The patient underwent a preoperative oxaliplatin-based che-
motherapy followed by surgical treatment. The first stage: rectosigmoidect-
omy followed by anatomical resection of segment 2, caudate lobe resection
(S1), enucleation of metastasis from segment 3 and ligature of right portal
vein. After 6 weeks the patient was re-evaluated and the remaining segment 3
has regenerated. Second stage: Extended right hepatectomy (resection of
segments 4, 5, 6, 7 and 8).
Results. The recovery after the first and the second operations were
uneventful and the patient was discharged on the 5th and 6th postoperative
day, respectively. The CEA levels decreased from 800 to 400 after
chemotherapy, 400 to 250 after the first stage and decreased to 1.5 after
the second stage operation. He remains well without evidence of the disease.
Conclusion. The use of modern techniques may increase the resectability
rate of advanced colorectal liver metastasis.
FV 7.04
RADICAL SURGERY OF EXTRAHEPATIC AND INTRAHEPATIC
RECURRENCES OF COLORECTAL LIVER METASTASES
Vicente, Emilio; Quijano, Yolanda; Loinaz, Carmelo
Monteprı´ncipe, General Surgery, Boadilla del Monte, Spain
Resection of liver metastases from colorectal cancer is accepted as the only
form of treatment that offers a chance of long-term survival with rates ranging
from 25% to 39%. After curative resection, hepatic recurrence is seen in
approximately 40% of patients. Only 10%-20% of them present a resectable
liver recurrence. Number of metastatic lesions, disease-free interval after
resection of the primary tumor, serum carcinoembryonic antigen value, and
margin of resection are considered prognostic factors after hepatectomy. The
video details the presentation of a 32 year old patient with recurrent
colorectal liver metastases. A right hemicolectomy and left hepatectomy
was performed, four and two years before for colon cancer and single liver
metastases occupying the segment II, III and IV of the liver, respectively. The
patient came to our hospital for clinical evaluation of jaundice. The
ultrasound study, CT scan and percutaneous transhepatic cholangiogram
demonstrated hepatic recurrence located in the cut surface of the liver
affecting portal vein extrahepatic and intrahepatic biliary tract, and duode-
num. Hepatectomy associated to hemigastrectomy, portal vein resection and
extrahepatic and intrahepatic biliary duct resection was performed.
FV 7.05
MESOHEPATECTOMY (SEGMENTS 4, 5 AND 8) UNDER HEPA-
TIC VASCULAR EXCLUSION WITH PRESERVATION OF THE
CAVAL FLOW FOR LIVER METASTASIS.
Giuliante, F; Ardito, F; Vellone, M; Giovannini, I; Nuzzo, G
Hepato Biliary Surgery Unit, Catholic University, Rome, Italy
Mesohepatectomy (removal of liver segments 4, 5 and 8, with preservation of
lateral segments) may be indicated for centrally located liver tumors, to avoid
extended hepatectomies and the sacrifice of a large amount of functioning
parenchyma, especially in patients with cirrhosis or severe steatosis after
chemotherapy. This is a complex operation because liver transection is
performed in proximity of major vascular and biliary structures of the lateral
segments, which must be preserved to avoid ischemic or congestive injury to
the remnant liver. Furthermore, the double plane of resection increases the
risk of bleeding and the need for blood transfusions. This video shows a
mesohepatectomy performed under hepatic vascular exclusion, intermittently
applied, with preservation of the caval flow, and demonstrates the safety and
efficacy of this vascular control technique. This is the case of a 78 year old
female patient with a centrally located adrenal gland liver metastasis,
embedded in the hepatic dome and invading the middle hepatic vein. After
bilateral subcostal incision extended to the xiphoid, intraoperative ultrasound
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excluded the infiltration of portal pedicles. After complete mobilization of the
right and left hemiliver, the right hepatic vein and the common trunk of left
and middle hepatic veins were encircled by tapes. After lowering the hilar
plate, the right anterior portal pedicle was encircled and clamped by a
suprahilar approach. Liver transection was performed on the right side along
the ischemic demarcation line, and on the left side along the umbilical fissure,
by dividing the portal pedicles to segments 5 and 8 intraparenchymally, and
that to segment 4 just to the right of the round ligament. Kellyclasia
technique and bipolar forceps were used for the transection, and thin
transfixed sutures and absorbable clips for hemostasis and biliostasis. Central
venous pressure during transection was maintained below 4 mm Hg.
Intermittent clamping of the pedicle and of hepatic veins (right hepatic
vein and common trunk) resulted in hepatic vascular exclusion with
preservation of caval flow. Total duration of clamping was 68 min. The
middle hepatic vein was divided intraparenchymally at the end of the
resection. No blood transfusions were required, the postoperative outcome
was uneventful.
FV 7.06
SEGMENTAL LIVER RESECTION USING THREE-DIMEN-
SIONAL HEPATECTOMY SIMULATION
Yamanaka, Junichi; Saito, Shinichi; Sugimoto, Takaaki; Iimuro, Yuji; Hirano,
Tadamichi; Okada, Toshihiro; Kuroda, Nobukazu; Asano, Yasukane; Fuji-
moto, Jiro
Hyogo College of Medicine, First Dept. of Surgery, Nishinomiya, Japan
Background & aim. Liver resection offers a potential cure for hepatic
malignancies when the resection margin is negative. In cases of hepatocellular
carcinoma (HCC), impaired hepatic function due to accompanying chronic
liver disease further restricts liver resection volume. Hence, preoperative
assessment of liver resection volume and resection margin is crucial for safe
and curative hepatectomy. We have reported usefulness of virtual hepatic
resection via three-dimensional (3D) image analysis software based on
hepatic circulation (Hepatology 2005;41:12971304). This video presents
cases of segment 7 and segment 5/6/7 resection using our 3D hepatectomy
simulation system.
Patients & methods. In 20012006, 135 patients underwent preoperative
hepatectomy simulation via 3D image processing software, which was
developed by Hitachi Medical Corporation. Briefly, 3D images of the tumor,
portal vein, hepatic vein, and hepatic parenchyma were reconstructed by a
region-growing technique and were overlapped to create the integrated 3D
images. Clipping of the tumor-bearing portal branch prompted volumetric
calculation of the proposed liver resection volume, based on the portal
perfusion. Moreover, the resection margin was estimated by measuring the
minimal parenchymal thickness in the predicted coronal section. The
predicted liver resection volume and the resection margin were compared
with the actual weight and margin of the resected specimen.
Results. The simulation-predicted liver resection volume was correlated with
the actual specimen weight (r/0.96; pB/.001). The difference between the
estimated volume and the actual weight was 8.19/6.0 mL. The difference
between the predicted and the actual margin was 1.99/2.6 mm.
Conclusions. Our 3D simulation system based on hepatic circulation
demonstrated volumetric and stereotactic accuracy. This virtual hepatectomy
may be useful for complex liver resection in patients with limited hepatic
functional reserve.
FV 7.07
MAJOR LIVER RESECTION ASSISTED BY A NEW MULTIPROBE
BIPOLAR RADIOFREQUENCY DEVICE (HABIB† 4X)
Ayav, Ahmet; Jiao, Long; Healey, Andy; Dickinson, Robert; Bachellier,
Philippe; Milicevic, Miroslav; Pellicci, Ricardo; Habib, Nagy; Pai, Madhava
Hammersmith Hospital, London, UK
Background. Coagulating liver parenchyma with monopolar radiofrequency
before cutting with a knife has been already described, but it is time
consuming and carries the risk of grounding pad skin burn. A novel bipolar
multiprobe radiofrequency device (Habib† 4X) has been designed to counter
these drawbacks.
Objective. To evaluate the effectiveness of major liver resection assisted with
a new bipolar multiprobe radiofrequency device.
Methods. The Habib† 4X has been used to perform major liver resection in
clinical practice on 8 consecutive patients. Data were collected prospectively
to assess the outcome including operative time, intraoperative blood loss,
blood transfusion requirement, morbidity and mortality rates, liver function
tests and hospital stay.
Results. The mean parenchyma transection time per cm2 was 329/27 sec.
The mean volume of bleeding per cm2 was 4.79/6.1 mL. No patient required
hepatic inflow occlusion. No patient developed ground pad skin burn. There
was no mortality. Morbidity occurred in 2 patients: one right pleural effusion
treated with physiotherapy and one intraabdominal collection treated
conservatively with antibiotics without the need for drainage. No patient
developed postoperative haemorrhage, biliary leak or liver failure. Mean
hospital stay was 89/3 days.
Conclusion. This novel multiprobe bipolar radiofrequency device allows to
perform major liver resection with minimal blood loss and reduced morbidity
rates.
FV 7.08
CAUDATE LOBECTOMY THROUGH AN ANTERIOR APPROACH
Peng, Shu Y1; Liu, Ying B1; Li, Jiang T1; Wang, Jian W1; Xu, Bin2; Qian,
Hao R2; Hong, De F2; Mou, Yi P2; Cai, Xiu J2
1Second Affiliated Hospital, Zhejiang University, Dept. of Surgery, Hang-
zhou, China; 2Sir Run Run Shaw Hospital, Zhejiang University, Dept. of
Surgery, Hangzhou, China
Introduction. Our group has performed caudate lobe resection for 121
cases, among them 11 cases underwent isolated complete caudate lobe
resection through anterior approach CRTAA owing to the huge tumor size or
to the extremely close relationship between the tumor and the major hepatic
veins, while the innocent right and left lobe are to be preserved.
Method. This video shows the important steps of CRTAA for a huge
hepatoma which was closely attached to the hepatic veins. The patient was a
51-year-old male complaining of upper abdominal discomfort for 1 mo. CT
scan demonstrated a tumor situated in the caudate lobe, just behind the right
hepatic vein(RHV) and middle hepatic vein(MHV). AFP value was within
normal range. HBsAg (/) The liver was split through the mid-plane until the
tumor was visualized. Situated just at the corner of IVC and the roots of
major hepatic veins, the tumor bulged out in between the RHV and MHV,
nearly the whole length of which were closely attached to the tumor. Careful
and meticulous dissection was carried out to separate the tumor from the
RHV and the MHV All the caudate portal triads were divided and ligated
individually. As the huge tumor was firmly sitting on the IVC, the division of
short hepatic veins(SHV) were left to the final stage of the operation. After
the tumor was completely free from the liver pedicle and the major hepatic
veins, the lower pole of the tumor was raised up from the IVC and gradually
separated from it with several SHVs ligated or sutured until the tumor was
completely removed. The whole length of RHV, MHV and retrohepatic IVC
could now be clearly seen at the same time. RESULT: The gentleman made
an uneventful recovery. He is still alive 15 mo after the operation.
Conclusion. CRTAA is a good and safe way for isolated and complete
resection of the caudate lobe when the tumor is large and particularly when it
is extremely close to the major hepatic veins while the innocent right and left
lobe are to be preserved.
FV 7.09
ANTERIOR APPROACH FOR LEFT HEPATECTOMY
Nakamura, Noriaki; Noguchi, Norio; Kudoh, Atsushi; Kurokawa, Toshiaki;
Tanaka, Shinji; Kawamura, Tohru; Teramoto, Kenichi; Arii, Shigeki
Tokyo Medical and Dental University, Tokyo, Japan
Anterior approach is frequently performed to the patients who have huge
tumors in the right lobe of the liver. In the present video, we applied this
surgical technique to left hepatectomy. The appropriate indications are the
cases who have huge liver tumors at the left lobe, hypertrophied left lateral
segment, liver tumors invading to the left coronary ligament, tumor
thrombus in the left portal vein and left hepatic vein. Surgical techniques:
Penrose tape is inserted just above the IVC by mobilizing caudate lobe from
IVC and is directed to the space along the ventral side of IVC between right
hepatic vein and middle hepatic vein at the suprahepatic portion, so called
Belghiti hanging maneuver. After completing this procedure, caudal side of
penrose tape is extracted behind the right Glissonean pedicle. Pringle
maneuver or hemihepatic blood inflow occlusion is carried out to reduce
blood loss during the parenchymal resection. At the halfway of the
parenchymal resection left each vessel including left hepatic duct is ligated
and cut. At the end of the parenchymal transection trunk of the left hepatic
vein is cut and ligated. Whether the middle hepatic vein is kept or removed is
dependent on the extent of the tumor.and the hepatic functional reserve. By
these procedures, all vessels except short hepatic veins are completely
dissected, and retrohepatic IVC is clearly exposed, leading to good surgical
view to dissect of the short hepatic veins draining left hepatic lobe and left
caudate lobe. Finally, adhesion to the coronary ligament, diaphragma and
left triangular ligament are dissected by extracting the left lobe to the left
laterocaudal side, thereby completing the removal of left hepatectomy
combined with left caudate lobe. In conclusion, this surgical procedure is
useful not only in the above-mentioned indications but also to almost all
patients requiring left hepatectomy, and thus can be a standard surgical
technique for left hapatectomy.
FV 7.10
EXTENDED LEFT HEPATECTOMY UNDER IN SITU COOLING
PRESERVATION AND BY USE OF COMPUTER-ASSISTED RISK
ANALYSIS IN THE 3-D-RECONSTRUCTED LIVER
Lang, Hauke1; Radtke, Arnold1; Hindennach, Milo2; Peitgen, Heinz O2;
Broelsch, Christoph E1
1Universita¨tsklinikum Essen, Klinik fu¨r Allg-Viszeral-und Transplant-Chir.,
Essen, Germany; 2MeVis-Centre for Medical Diagnostic Systems, Bremen,
Germany
Summary of the Video. The video shows the resection of a centrally located
intrahepatic cholangiocarcinoma (IHC) infiltrating all three major hepatic
vein. Preoperative diagnostic findings of two-dimensional CT and in the
threedimensional reconstructed liver are demonstrated. Resection planning is
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made with regard to the three-dimensional reconstructed vascular tree of the
portal vein, hepatic artery and the liver veins. Resection planning includes
two different resection proposals with calculation of the corresponding
volumes of the liver remnant having preserved vascular blood supply and
hepatic venous drainage. The planned operation is an extended left resection
removing segments I-IV plus a transsegmental partial resection of segments
V and VIII. In addition to the left and middle hepatic vein also the right
hepatic vein has to be dissected shortly before reaching the inferior vena
cava at the confluence of two large contributaries, requiring reconstruction
of the right vein under total vascular occlusion of the liver. This operative
step is performed under in situ cooling of the liver to reduce ischemic
damage. To ensure hemodynamic stability during vascular exclusion and
to decompress the mesenteric system a veno-veno bypass is achieved after
cannulation of the inferior mesenteric vein which is large sized in the
demonstrated case.
FV 7.11
SYSTEMATIC SEGMENTECTOMY AND SUBSEGMENTECT-
OMY USING THE GLISSON’S PEDICLE APPROACH
Yamamoto, Masakazu; Katagiri, Satoshi; Takasaki, Ken
Institute of Gastroenterology, Tokyo Women’s Medical University, Surgery,
Tokyo, Japan
Systematic segmentectomy and subsegmentectomy using the Glisson’s
pedicle approach Masakazu Yamamoto, Satoshi Katagiri, Kenji Yoshitoshi,
Shunichi Ariizumi, Mie Hamano, Yoshihito Kotera, Yutaka Takahashi, Ken
Takasaki Department of Surgery, Tokyo Women’s Medical University,
Tokyo, Japan The liver can be divided into three segements (left, middle,
and right) on the basis of the ramifications of Glisson’s pedicles (the portal
pedicles wrapped in their Walaean sheaths) at the hepatic hilus. The
ramifications of Glisson’s pedicles are located outside the liver and the
pedicles can easily be taped after blunt dissection. When the branch of the
middle segment is taped and clamped, the borderlines of the left and middle
segments and middle and right segements can easily be identified. Therefore,
middle segmentectomy can be performed systematically without dissecting
the hepatic artery, portal vein and hepatic bile duct at the hepatic hilus. Left
or right segmentectomy can be performed as the same maneuver. When
resecting subsegment 8 of the liver, we cut the liver parenchyma between the
middle and left segements and detect Glisson’s branch toward segment 8.
After detecting and clamping Glisson’s branch toward segment 8, the area
which should be resected can easily be identified because of cyanotic change
of the area. Another subsegmentectomy can be performed as the same
maneuver. The Glisson’s pedicle approach is a simple and easy method to
perform systematic liver resection.
FV 7.12
RIGHT POSTERIOR SEGMENTECTOMY OF THE LIVING DO-
NOR WITH A LEFT-SIDED GALLBLADDER FOR ADULT DUAL
LIVING DONOR LIVER TRANSPLANTATION
Kim, Ki H; Lee, Sung G; Lee, Young J; Park, Kwang M; Hwang, Shin; Ahn,
Chul S; Moon, Deog B; Ha, Tae Y; Song, Ki W
Asan Medical Center, Surgery, Seoul, South Korea
A left-sided gallbladder usually means that the gallbladder is located to the
left side of the round ligament without situs inversus viscerum. Additionally,
the middle hepatic vein should run to the right of the gallbladder and the
round ligamentitself should originate from the left portal vein to meet its
definition.(ref: Hwang et al, Liver Transpl 2004;10:141 6) 45-year-old
female cousin of the recipient was one of the living donors. The CT sacn
showed the presence of a left-sided gallbladder with type IV portal vein
anomaly during preoperative evaluation of the donor. Her body weight and
height were 79.7 kg and 165 cm, respectively. There was no fatty change in
the liver biopsy. The right posterior segment was estimated as 510 ml in CT
volumetry, but it did not seem to be enough for 68 kg recipient with UNOS
status IIA. We decided to perform dual LDLT using right posterior segment
and left lobe. After laparotomy, we confirmed the anomaly of a left-sided
gallbladder. The intraoperative cholangiogram showed classical anatomy of
the bile duct. We dissected and encircled right posterior portal vein and
hepatic artery with vessel loops after mobilization of right lobe. The hepatic
parenchyma was divided using CUSA along the left side of the right hepatic
vein and then the right posterior bile duct was cut using our method of the
radio-opaque rubber band tagging. The donor and recipient have recovered
without any problem.
Poster Prize
PZ 1.01
PATIENTS WITH OBSTRUCTIVE JAUNDICE PRESENT AL-
TERED LEVELS OF B LYMPHOCYTES, CD4/ AND CD45RA//
CD27/ EFFECTOR CD8/ T LYMPHOCYTES IN PERIPHERAL
BLOOD
Bullock, Rachel1; Robins, Adrian2; Aithal, Guru3; Fiuza, Carmen1; Row-
lands, Brian1
1Queens Medical Centre University Hospital, Division of Surgery, Notting-
ham, UK; 2Queen’s Medical Centre University Hospital, Immunology,
Nottingham, UK; 3Queen’s Medical Centre University Hospital, Gastro-
enterology, Nottingham, UK
Background. Patients with obstructive jaundice (OJ) are at high risk of
sepsis after surgery. There is no data in the literature describing lymphocyte
subpopulations in the blood of OJ patients. Lymphocyte phenotype exerts a
strong effect on cytokine production and may be important in OJ because an
anti-inflammatory response has been suggested in these patients.
Aims. This study examined T-, B- and NK- cell populations and T
lymphocyte subpopulations.
Methods. Using 4 colour flow cytometry, we estimated the distribution of
functionally different lymphocyte subpopulations in the peripheral blood of
14 OJ patients and 14 healthy controls (HC). Simultaneous staining with the
following panels of monoclonal antibodies was employed: CD45/ CD3/
CD16/CD56/ CD19; CD3/ CD4/ CD8/ CD25; and CD8/ CD27/ CD28/
CD45RA. Surface marker expression was evaluated in terms of the
percentage of positive cells. The research protocol was approved by the local
ethics committee. RESULTS (mean9/SD): Compared to HC, the B
lymphocyte fraction of CD45/ leucocytes was reduced in OJ (4.359/2.66
v 8.879/2.42%, p/0.001). Of CD3/ T cells, CD4/ cells were reduced in
OJ (52.569/12.84 v 63.719/10.11%, p/0.048). The CD8/ T-cell subset
CD45RA// CD27- were increased in OJ (56.139/15.06 v 38.419/16.30%,
p/0.019).
Conclusion. Patients with OJ have reduced B and CD4/ T lymphocytes
which may contribute to the immune dysfunction in OJ. It is of interest that
they also present increased CD8/ effector cells which are important in
antitumour defence.
PZ 1.02
SURGICAL APPROACH IN HILAR CHOLANGIOCARCINOMA:
DOCTOR JIANGS’ EXPERIENCE
Jiang, XiaoQing; Zhang, BaiHe; Yi, Bin; Lou, XiangZhi; Qiang, Bo; Tan,
WeiFeng
Eastern Hepatobiliary Hospital, Dept. of Biliary Surgery, Shanghai, China
Background. As surgical techiniques and preoperative approach have
improved, hilar tumor resection can be performed more safety but significant
experince still has been limited to a small number of centers and surgeons.
Aims. this paper presented Drs JIANGs experince in treatment of hilar
cholangiocarcinoma through surgical strategy.
Methods. Of 214 patients with hilar cholangiocarcinoma who were treated
by Dr Jiangs’ team from 1999 to 2005,187(87%) underwent surgical
resection. Most of them underwent skeletonization of the hepatoduodenal
ligament with partial hepatectomy for hilar cholangiocarcinoma,especially
with caudate lobe excision. These patients were evaluated with respect to
postoperative morbidity and mortality,tumor margins and survival time.
Results. 147(69%) patients had undergone a margin-negative resection,
21(14%) patients combined with portal vein resection and reconstruc-
tion,48(33%) patients combined with hepatic artery resection. The post-
operative complications occurred in 43%(80/187) of resected patients in
total,while overall mortality was 7%(11/187). The overall 1-,2- and 5-year
survival rates were 71%,42% and 23% respectively. The median survival was
25.6 months in patients undergoing radical resection,while 11 months and 4
months undergoing non-radical resection and only palliation respectively.
Combined with hepatic artery and portal vein resection has lead to more
margin-negative resection. Patients with lymph node metastasis and blood
vessel invasion survived significantly shorter than those without one,although
survival was better than in patients with unresected tumors.
Conclusion. Partial hepatectomy for hilar cholangiocarcinoma with skele-
tonization of the hepatoduodenal ligament is a safe surgical techniques
contributing to a higher rate of curative resections and offers good outcomes.
PZ 1.03
CT EVALUATION OF REGIONAL LYMPH NODE METASTASIS IN
PATIENTS WITH BILIARY CANCER
Noji, Takehiro; Kondo, Satoshi; Hirano, Satoshi; Tanaka, Eiichi; Shichinohe,
Toshiaki; Takeuchi, Motoya; Senmaru, Naoto; Suzuki, Onn; Hazama,
kazuaki
Hokkaido University, Surgical Oncology, Sapporo, Japan
The extent of regional lymph node metastasis is one of the most important
factors affecting the prognosis of patients with biliary carcinoma. Several
authors have emphasized that both the size (/10 mm) and the shape
(heterogeneous internal structure) of nodes, as revealed by computed
tomography (CT) scans, are useful in the diagnosis of regional lymph
node metastasis. In the current study, we evaluated the usefulness of CT
scans in diagnosing nodal metastases on the retrocholedochal node (RC),
retroportal node (RP), node ventral to the common hepatic artery (HA),
those were highly found metastasis in biliary carcinoma patient. We sought
to determine whether CT scans could gather information and show high
positive predictive value(PPV) (/50%) useful for the selection of appro-
priate surgical procedures and lymphadenectomies in this retrospective
study.
Patients and methods. Between December 1999 and October 2005,
173 patients were operated upon for biliary carcinoma at our institute. To
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evaluate the regional lymph nodes, we measured the long and short
axis diameters of lymph nodes at RC, RP, and HA and calculated the axial
ratios (short axis diameter/long axis diameter). The internal structures were
also evaluated. Nodes were considered round if their axial ratios were
over 0.7.
Results. Of the 173 patients, 27 did not undergo regional lympha-
denectomy. Thus, 146 patients were included in our study. We detected a
total of 76 metastatic lymph nodes by histopathological examination.
Using the metastatic criteria of round nodes /16 mm in short axis
diameter provided an acceptable PPV of 56%. The PPV determined by
regarding nodes with heterogeneous internal structures as metastatic was
64%. The highest PPV(67%) was obtained by using the criteria of round
nodes /18 mm in short axis diameter. Our results suggested that en-block
resection should be considered when a CT scan reveals round nodes /16
mm in the short axis diameter or nodes with heterogeneous internal
structure.
PZ 1.04
THE EXPRESSION OF P16, ERB B2, AND SURVIVIN IN HEPA-
TOLITHIASIS AND CHOLANGIOCARCINOMA
Kim, Hyung-Chul; Chu, Chong-Woo
Soonchunhyang University Hospital, Dept. of Surgery, Wonmi-Gu, Bu-
cheon-Si, Gyeonggi-Do, South Korea
Backgroud. Hepatolithiasis has been regarded as having a potential of
cholangiocarcinogenesis. In the previous studies, the molecular mechanisms
of cholangiocarcinoma have been figured out.
Objectives. The aim of this study was to examine the expression of p16, c-
erb B2, and Survivin in stone-containing intrahepatic bile ducts (IHD) and
cholangiocarcinoma and try to predict whether hepatolithiasis has a predis-
position to development cholangiocarcinoma.
Methods. Thirty-four surgically resected specimens of hepatolithiasis and
ten specimens of stone-containing cholangiocarcinoma were subjects for this
study. Immunohistochemical staining was done on p16, c-erb B2, and
Survivin to check their expression in hepatolithiasis and stone-containing
cholangiocarcinoma.
Results. Thirty-four surgically resected specimens of hepatolithiasis were
divided to 17 hyperplasia and 17 dysplasia. Overexpression of Survivin
was found in cholangiocarcinoma (90%) at levels significantly higher than
hepatolithiasis (26.5%) (pB/0.001). And the expression rate of Survivin
was 5.9% in hyperplasia, 47.1% in dysplasia, and 90% in adenocarci-
noma (pB/0.001). The immunoreactivity of c-erb B2 also showed more
increased expression in cholangiocarcinoma (60%) than hepatolithiasis
(32.4%). However, the expression of p 16 was not significant in both
groups.
Conclusion. We conclude that the overexpresssion of survivin in cholangio-
carcinoma could lead to enhanced tumor cell proliferation. At the same time,
the sequentially increased expression of Survivin in stone-containing IHD
could suggest a close relationship between hepatolithiasis and cholangiocar-
cinoma.
PZ 1.05
OUTCOME AFTER SURGICAL RESECTION OF HILAR CCC: 310
CASES IN ASAN MEDICAL CENTER
Song, Gi-Won; Lee, Sung-Gyu; Lee, Young-Joo; Park, Kwang-Min; Hwang,
Shin; Kim, Ki-Hun; Ahn, Chul-Soo; Moon, Deok-Bog; Ha, Tae-Yong
Asan Medical Center, Division of HPB Surgery and Liver Transplantation,
Seoul, Korea
Background. In this report, we retrospectively analyzed outcome of surgical
resection of hilar CCC to elucidate survival data in single institute with large
volume and relating prognostic factors.
Method. Between February 1993 and December 2005, surgical intervention
with curative intent were performed on 382 patients and 310 patients
underwent resection. We retrospectively analyzed survival data of 310
patients and prognostic factor with review of medical record.
Results. Among the 310 cases of resection, curative resection with tumor-
free margin has been resulted in 218 cases (70.3%). Of these 218 cases, 208
patients (95.4%) underwent various hepatectomy with caudate lobectomy
and bile duct resectionand the remaining 10 patients under went bile duct
resection only. In-hospital mortality was developed in 5 (2.3%) of 218
patients and causes of death were posthepatectomy hepatic failure, hepatic
artery pseudoaneurysm and biliary sepsis. The 1-,3-,5-year survival rate of
218patients undergoing curative resection and 92 patients undergoing
palliative resection were 82.4, 40.8 and 27.3%; 66.2% 32.9% and 11.2%,
respectively. The survival rate of patient undergoing curative resection was
significantly better. Of patients undergoing curative resection, 104 patients
(47.7%) developed recurrence with mean 17.5 month of disease-free interval.
The most common type of recurrence was liver metastasis and peritoneal
seeding. Univariate analysis revealed that TNM stage, lymph node involve-
ment, and perineural invasion were associated with patient’s survival.
Multivariate analysis showed that TNM stage and lymph node involvement
were statically significant prognostic factors.
Conclusion. Aggressive surgeon’s efforts to attain clearance of the tumor can
minimize postoperative mortality and maximize survival.
PZ 1.06
NUMBER OF POSITIVE LYMPH NODES INDEPENDENTLY
AFFECTS LONG-TERM SURVIVAL AFTER RESECTION IN PA-
TIENTS WITH AMPULLARY CARCINOMA
Sakata, Jun; Shirai, Yoshio; Wakai, Toshifumi; Yokoyama, Naoyuki; Sakata,
Eiko; Hatakeyama, Katsuyoshi
Niigata University Graduate School of Medical and Dental Sciences,
Division of Digestive and General Surgery, Niigata, Japan
Background. The nodal status is an established prognostic factor in
ampullary carcinoma.
Aim. The aim of this study was to compare the prognostic power of the
anatomic location of positive nodes with that of the number of positive nodes.
Methods. Of 73 consecutive patients treated for ampullary carcinoma, 62
underwent pancreaticoduodenectomy with regional lymphadenectomy. A
survival analysis of these 62 patients by nodal status was conducted
retrospectively. A total of 1942 lymph nodes taken from the patients were
examined histologically for metastasis. The location of positive regional
nodes was classified into 4 categories, according to the Japanese staging
system. The number of positive regional nodes was recorded for each patient.
The median follow-up period was 124 months.
Results. Nodal disease was found in 31 patients, of whom 23 had 1-3
positive regional nodes and 8 had ]/4 positive regional nodes. Univariate
analysis revealed that both the location (PB/.0001) and the number (PB/
.0001) of positive nodes were significant prognostic factors. Multivariate
analysis revealed that the number of positive nodes was an independent
prognostic factor (P/.007), while the location failed to remain as an
independent variable. The median survival time was 59 months with a 5-
year survival rate of 48% in patients with 1-3 positive nodes, whereas all
patients with ]/4 positive nodes died of the disease within 29 months of
resection (P/.0001).
Conclusion. The number, not the location, of positive regional lymph nodes
independently affects long-term survival after resection in patients with
ampullary carcinoma.
PZ 1.07
ANATOMY OF THE LEFT IHD(INTRAHEHATIC DUCT) FOCUS-
ING ON U-PORTION TO EVALUATE THE CLINICAL EFFICACY
AND PITFALL OF LEFT LATERAL SECTIONECTOMY
Jang, Jin-Young; Lee, Seung Eun; Han, Sung-Sik; Yang, Sung Hoon; Kim,
Sun-Whe
Seoul National University College of Medicine, Surgery, Seoul, South
Korea
Background. Left lateral hepatobiliary system is the most commonly
involved site in hepatolithiasis owing to anatomical reason. Therefore left
lateral sectionectomy has beed widely performed in the management of
hepatolithiasis. But considering the possibity of injury of left medial hepatic
duct, recently some surgeons prefer left hemihepatectomy.
Aims. We investigated the proper treatment for left IHD stone by means of
the evaluation of the anatomy and variation of left heaptic duct system in
normal population and the analysis of the clinical outcome of liver resection
for IHD stone.
Methods. We reviewed MRI(Gd-BOPTA enhanced 3D GRE) of 115
normal persons who underwent work-up as living related liver donor and
analyzed 181 patients who were treated with left lateral sectionectomy or left
hemihepatectomy for their IHD stone from 1996 to 2005.
Results. In 100(87.0%) normal persons, B2 and 3 united just above the
umbilical portion or laterally to it and B4 joined medially to the umbilical
portion. In 11(9.6%), B4a joined laterally to the umbilical portion and in
4(3.5%), B4b joined laterally. In patients with left IHD stone, left
hemihepatectomy was performed for 79 patients and left lateral sectionect-
omy for 102 patients. There was no difference in the incidence of
complications such as biliary leakage, intrahepatic abscess or abscess at
resection margin between two groups(17 Vs. 29, p/0.307). There was no
difference in recurrence of stone(7 Vs. 7, p/0.780).
Conclusion. This study revealed that in most cases(87.0%) B4 united
medially to the umbilical portion and there was no significant difference in
postoperative complication and recurrence of stones after left hemihepatect-
omy or left lateral sectionectomy. Left lateral sectionectomy is adequate
treatment for left IHD stone in case of no pathologic condition in left medial
hepatic duct. However the possibility of injury of left medial hepatic duct
after typical left lateral sectionectomy for some patients demands great
caution during operation.
PZ 1.08
THE REVERSED IN SITU SPLIT TECHNIQUE. ANATOMICAL
BASIS FOR INCREASED TUMOR CLEARANCE IN SURGERY
FOR KLATSKIN’S TUMOURS
Majno, Pietro1; Allemann, Pierre1; Mentha, Gilles1; Morel, Philippe1; Toso,
Christian1; Fasel, Jean2
1University Hospitals, Visceral Surgery and Transplantation, Geneva,
Switzerland; 2University Medical Center/Faculty of Medicine, Anatomy,
Geneva, Switzerland
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Background. No-touch removal of the tumors and satisfactory margin
clearance are difficult to achieve during resection of hilar cholangiocarcinomas.
Objectives. To describe and quantify the anatomical rationale of an
operationthe reversed in situ split procedure - that increases the chance of
achieving the above-mentioned aims in Klatskin’s tumors sparing the left lobe
(segments 2 and 3).
Methods. Anatomical study in 20 autopsy livers (11 males and 9 females).
The dissection consisted of opening of the round ligament, full mobilization
of the left portal vein with section of the ligamentum venosum, and exposing
a section plane on the left of the umbilical plate. Measurements of the
distance between the biliary confluence and the traditional section plane (#1)
or the new section plane (#2)were obtained in all cases, complemented with
corrosions casts and radiographs of anatomical specimen.
Results. Are summarized in Table 1. Distances are expressed in mm
Conclusions. The anatomy of left duct, winding around the elbow of the
left portal vein, allows to gain extra clearance form a hilar tumor by a
thorough exposure of the umbilical plate. The technique also permits a
primary portal resection and anastomosis, with ‘‘no touch’’ of the region
invaded by the tumor. This operation has become the standard approach in
our center for patients with proven tumors of the hilar region sparing the
left duct.
PZ 2.01
IP-10 PLAYS AN IMPORTANT ROLE IN TRAFFICKING OF
GENE-MODIFIED T LYMPHOCYTES IN PATIENTS WITH
COLORECTAL HEPATIC METASTASES
Subar, Daren1; Riyad, Kallingal1; Gilham, David2; Cheadle, Eleanor3;
Sherlock, David1; Hawkins, Robert4
1North Manchester General Hospital, Manchester, UK; 2Paterson Institute
for Cancer Research, Medical Oncology, Manchester, UK; 3Paterson Institute
for Cancer Research, Manchester, UK; 4Christie Hospital, Manchester, UK
Background. We have previously reported the potential of gene-modified T
cells to target colorectal liver metastasis. The T cells are modified using
recombinant retrovirus to express an antigen specific chimeric receptor that
specifically directs their cytotoxic function against CEA expressing tumour
cell lines and autologous tumour in vitro. A major issue concerns the ability of
these gene modified T cells to migrate to tumour sites when systemically
administered.
Aim. This study aimed to investigate this aspect using functional migration
assays and cell phenotype analysis to predict whether these T cells possess the
capacity to target to colorectal hepatic metastasis.
Methods. T cells were isolated from patients with colorectal hepatic
metastases prior to surgery. After retroviral modification and expansion,
the T cells were examined for the expression of chemokine receptors and
were also assessed for their ability to be attracted by recombinant homing
factors in cell culture experiments.
Results. Gene-targeted T cells from patients with advanced cancer were
effectively transduced and expanded ex vivo. Phenotypic analysis indicated
that the T lymphocytes expressed the chemokine receptor CXCR3 (the
receptor for the chemokine IP-10) to high levels. T cells demonstrated
a chemotactic response to recombinant IP-10, a factor that is overexpressed
in colorectal hepatic metastases. Furthermore, the T lymphocytes also
demonstrated a chemotactic response to tumour supernatent but not to
supernatent from normal liver, a response which could be reduced by
blocking IP-10.
Discussion. Understandings of the factors which influence T cell movement
to tumour are critical to the success of adoptive immunotherapy. Our data
suggests that ex vivo expanded T lymphocytes should migrate towards factor
IP-10, a potentially important factor in the targeting of colorectal hepatic
metastases. Alternatively, surgical intervention to permit the localised
delivery of gene-modified T cells to the liver may prove to be a more
attractive option.
PZ 2.02
HEPATOCELLULAR ADENOMA: OBSERVATION OR SURGICAL
RESECTION
van der Windt, Dirk J1; Kok, Niels FM1; Hussain, Shahid M2; Alwayn, Ian
PJ1; Zondervan, Pieter E3; de Man, Robert A4; IJzermans, Jan NM1
1Erasmus MC, Dept. of Surgery, Rotterdam, Netherlands; 2University of
Nebraska Medical Center, Dept. of Radiology, Omaha, USA; 3Erasmus MC,
Dept. of Clinical Pathology, Rotterdam, Netherlands; 4Erasmus MC, Dept.
of Hepato-Gastro-Enterology, Rotterdam, Netherlands
Background. The diagnosis of hepatocellular adenoma can significantly
impact on the lives of young females. Adenomas are associated with the risk
of rupture and malignant degeneration. Treatment of lesions suspected of
hepatocellular adenoma (HA) remains controversial. The aim of this study
was to evaluate the management of HA in an era in which MRI and CT are
highly sensitive in diagnosing HA.
Methods. From January 2000 until January 2005 data of 48 consecutive
women with HA (median age 36 years) were prospectively collected. All
patients were discussed in a weekly multidisciplinary meeting. The protocol
for diagnostic work-up consisted of multiphasic MRI or CT and preferred
treatment was observation if the adenoma was B/5 cm.
Results. Median follow-up was 24 months (range 373). In sixteen patients
(33%) the adenoma was an incidental finding. Forty-five patients (94%) used
oral contraceptives. Sixteen patients (33%) presented with a solitary
hepatocellular adenoma and thirty-two patients (67%) presented with
multiple adenomas. In the latter group liver steatosis was significantly more
often present (59% vs. 19%, P/0.008). Invasive procedures were applied to
14 patients (29%), because of tumour size /5 cm, malignant characteristics
or haemorrhage. Thirty-four patients (71%) were observed; haemorrhage
and malignant degeneration did not occur and none of the lesions showed
progress in size after withdrawal from oral contraceptives.
Conclusion. Observation of adenomas B/5 cm is justified due to improved
radiological reliability. Resection should be reserved for patients with
malignant tumour characteristics or with single lesions with tumour size
/5 cm.
PZ 2.03
INTRAHEPATIC LYMPHATIC INVASION DETECTED USING D2-
40 MONOCLONAL ANTIBODY IS AN ADVERSE PROGNOSTIC
FACTOR IN COLORECTAL CARCINOMA LIVER METASTASIS
Takizawa, Kazuyasu; Wakai, Toshifumi; Shirai, Yoshio; Cruz, Pauldion V;
Sakata, Jun; Nagahashi, Masayuki; Tani, Tatsuo; Iiai, Tsuneo; Okamoto,
Haruhiko; Hatakeyama, Katsuyoshi
Niigata University Graduate School of Medical and Dental Sciences,
Division of Digestive and General Surgery, Niigata, Japan
Background. The mode of intrahepatic spread from colorectal carcinoma
liver metastasis has been well documented; however, its prognostic value is
unclear. To clarify predictive factors of postresectional survival, 22 clin-
icopathologic factors including intrahepatic lymphatic invasion were
examined.
Methods. A retrospective analysis was conducted of 106 consecutive
patients who underwent partial hepatectomy for colorectal carcinoma liver
metastasis. Intrahepatic spread was defined as discrete cancerous lesions
which were separated from the main tumor by a rim of nonneoplastic liver
parenchyma. Intrahepatic spread was classified as follows: invasion to portal
vein, hepatic vein, sinusoid, lymphatics, bile duct, and Glissonian stroma
(noncontiguous). D2-40 monoclonal antibody and CD34 monoclonal anti-
body were used to differentiate lymphatic and vascular invasion by
immunohistochemistry, respectively. The median follow-up time was 110
months.
Results. Portal vein invasion was present in 39 (37%) of 106 patients,
hepatic vein invasion in 19 (18%), sinusoid invasion in 33 (31%), lymphatic
invasion in 12 (11%), bile duct invasion in 14 (13%), and Glissonian stromal
invasion in 10 (9%). The incidence of intrahepatic spread found within 1 cm
from the main tumor was 95% (307/324 lesions). Intrahepatic lymphatic
invasion (RR, 8.740; 95% CI, 4.06718.780; PB/0.001), hepatectomy
margin status (PB/0.001), extrahepatic disease (P/0.022), distribution
(P/0.029), and histologic grade of hepatic metastasis (P/0.032) were
independent prognostic factors. Median survival time was 16 months in
patients with margin 0 mm, 32 months in those with marginB/10 mm, and 89
months in those with margin ]/10 mm; hepatectomy margin status
significantly influenced postresectional survival (PB/0.0001).
Conclusion. The currently accepted 10 mm hepatectomy margin appears to
be adequate. Intrahepatic lymphatic invasion is an adverse prognostic factor
in colorectal carcinoma liver metastasis.
Results table for PZ 1.08
AGE WEIGHT
LIVER
VOLUME
(ml)
LEFT LOBE
VOLUME
(ml)
DISTANCE
# 1
DISTANCE
#2
DIFFERENCE
DISTANCE
SECTION #1
AND #2
PATIENTS
WITH 2
DUCTS,
SECTION #1
PATIENTS
WITH 2
DUCTS
SECTION #2
MEDIAN 78 65 1450 330 36 52 16 4 17
MEAN 71 67 1474 357 36 51 15
SD 24 22 610 191 11 14 5
P B/0.001* B/0.001**
* Student t test/** x2 test PZ 2.02 continued
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PZ 2.04
PARENCHYMAL SPARING LIVER RESECTIONS AS AN ALTER-
NATIVE TO RIGHT HEPATECTOMY IN THE TREATMENT OF
COLORECTAL LIVER METASTASES
Ferrero, Alessandro; Vigano`, Luca; Lo Tesoriere, Roberto; Sgotto, Enrico;
Polastri, Roberto; Muratore, Andrea; Capussotti, Lorenzo
Ospedale Mauriziano, Torino, Italy
Background. Liver surgery for colorectal metastases has moved toward a
parenchymal sparing strategy with an increasing number of segmentectomies
and wedge resections alternative to classic major liver resections.
Aim. To elucidate short- and long-term surgical outcomes of the parench-
ymal sparing strategy for colorectal metastases of the right liver.
Patients and methods. The study focuses on 124 patients affected by 1, 2
or 3 liver metastases sited in the right liver with a maximum diameter B//5
cm. We divided these patients according to their surgical treatment: 35 right
hepatectomies (RH) and 89 more limited resections (LR).
Results. The two groups of patients had similar preoperative characteristics
but preoperative CEA tumor diameter. The procedures performed in LR
group were 33 anatomic resections and 56 wedge resections. Radical
resection rates were similar. Postoperative mortality was nil in both groups.
Morbidity rate was borderline significantively higher in RH patients (20% vs
8%, p 0.055) with an increased liver dysfunction rate (5.7% vs 0%, p 0.078).
Hospital stay was similar into the two groups. RH patients had a
significantively lower overall survival: their one-, three- and five-years survival
rates were 94.3%, 51.1% and 34.1% vs 100%, 77.4% and 55.1% in LR
patients (p/0.0067). Disease-free survival was similar into the two groups.
The overall recurrence rate was similar, but isolated extrahepatic recurrence
rate was significantively higher after RH (40% vs 21%, p 0.0376).
Considering overall hepatic recurrences, both isolated and associated to
extra-hepatic one, reresection rate was higher in LR group. Overall survival
from the date of liver recurrence was poorer in RH patients with one-, three-
and five-years survival of 40%, 20% and 0 vs 88%, 57% and 57% in LR
patients (p/0.00416).
Conclusion. Colorectal liver metastases in the right liver should be always be
treated by limited resections provided that a radical intervention is
performed.
PZ 2.05
SIGNIFICANCE OF PREOPERATIVE SINGLE DOSE HEPATIC
ARTERIAL INFUSION CHEMOTHERAPY FOR HEPATOCELLU-
LAR CARCINOMA WITH EXTENSIVE TUMOR THROMBI
Hoshimoto, Sojun; Sugioka, Atsushi; Ikeda, Masahiro; Kato, Takazumi;
Morise, Zenichi
Fujita Health University, Surgery, Aichi, Japan
Background. The prognosis of the patients with hepatocellular carcinoma
(HCC) associated with extensive tumor thrombi is extremely poor. However,
our novel protocol of preoperative single dose hepatic arterial infusion
chemotherapy consisted of carboplatin, adriamycin and mitomycinC (CAM)
showed a remarkable effect on some patients.
Aim. To identify the optimal patients for CAM and to elucidate the
significance of CAM.
Methods. Eighteen patients with HCC with extensive tumor thrombi who
underwent hepatic resection after CAM were evaluated on changes in tumor
markers (AFP or PIVKA-II), imaging findings, histological findings, survival
time and disease-free survival time. Tumor thrombi were extended to the
portal trunk (n/11), major portal branches (n/1), major hepatic veins (n/
4), and inferior vena cava (n/3).
Results. Effectiveness of CAM was correlated to the changes in tumor
markers and the vascularity of tumor thrombi. According to these factors 8
cases were classified into the effective group and 10 into the ineffective group.
Significantly favorable 5year-survival rate and 5year-disease-free survival rate,
62.5% and 58.3% respectively, were obtained in the effective group. Four cases
showed more than 90% necrosis. Four cases of the effective group survived
more than 5 years while all of the ineffective group died within 2 years.
Discussion. CAM brought about a significantly favorable outcome in 8 out
of 18 cases (44.4%). The effect was predicted by the changes in tumor
markers and vascularity of tumor thrombi. It means that the patients
classified into the effective group could be benefited by hepatic resection
even though in a far advanced cancer stage. In this context, progress in
neoadjuvant therapies could enhance the significance of aggressive surgery
and improve a prognosis of far advanced HCC.
Conclusion. The novel preoperative neoadjuvant chemotherapy (CAM)
contributed to determine appropriate operative indication and to improve the
prognosis of HCC with extensive tumor thrombi.
PZ 2.06
SURVIVAL AND PROGNOSTIC FACTORS FOR 158 PATIENTS
WITH HEPATIC METASTASES FROM SARCOMA TREATED
WITH HEPATIC RESECTION
Adam, Rene1; Chiche, Laurence2; Bonvallot, Sylvie3; Rivoire, Michel4;
Belghiti, Jacques5; Delpero, Jean-Robert6; Figueras, Joan7; Le Treut, Yves
P8; Mentha, Gilles9
1Paul Brousse Hospital, Villejuif, France; 2CHU Caen, Caen, France;
3Institute Gustave Roussy, Villejuif, France; 4Centre Le´on Be´rard, Lyon,
France; 5Hoˆpital Beaujon, Clichy, France; 6Institut Paoli Calmettes, Mar-
seille, France; 7Universidad de Barcelona, Barcelona, Spain; 8Hopital de la
Conception, Marseilles, France; 9Geneva University Hospital, Geneva,
Switzerland
Background. Previous reports documenting long-term outcomes for pa-
tients with liver metastases (LM) from sarcoma treated with hepatic resection
(HR) have analyzed small numbers of highly-selected patients at single
centers.
Objective. To clarify the efficacy and prognostic factors for patients with
sarcoma LM in a large number of resected patients from multiple centers.
Methods. 158 patients (M:F/2:3, mean age/53 years) treated with HR for
sarcoma LM at 26 centers from 1970 to 2004 were included. Survivals were
determined and prognostic factors were analyzed using a multivariate risk
model.
Results. LM were solitary in 50% of patients and unilateral in 62% of
patients (mean diameter: 70 mm). Extrahepatic metastases were previously
or simultaneously treated in 28% of patients. The most common primary
sites were soft tissue (mainly retroperitoneal) (40%), gastrointestinal (39%),
and uterine (13%). In 33 patients (21%) gastrointestinal primary tumors
were classified as GIST. R0 resection was achieved in 80% of cases. The 60-
day mortality rate was 2.7% and local and general complications were
observed in 20% and 16% of patients, respectively. At a mean follow-up
interval of 34 months (range: 0.1 to 207 months) 66% of patients recurred
(liver: 21%; extrahepatic: 23%; both: 22%). The 5- and 10-year overall
survivals were 39% and 20%, and the 5- and 10-year disease-free survivals
were 17% and 10%, respectively. Multivariate analysis, determined that the
independent factors associated with decreased survivals were soft tissue origin
(5-yr OS: 30% vs. 53%; P/0.0003), non-GIST histology (5-yr OS: 31% vs.
70%; P/0.0017), and disease-free interval B/12 months (5-yr OS: 33% vs.
43%; P/0.016).
Conclusions. These data indicate that HR for sarcoma is safe and effective,
with outcomes mainly dependent on primary tumor type and disease-free
interval. In addition, for patients with stromal tumors these results serve as a
basis for comparison to outcomes achieved with recent improvements in the
classification and treatment of GIST tumors.
PZ 2.07
ASSESSMENT OF ACUTE PHASE RESPONSE IN PATIENTS
UNDERGOING RADIOFREQUENCY ABLATION OR PARTIAL
LIVER RESECTION FOR LIVER TUMORS
Jansen, Maarten1; van Wanrooy, Sander1; van Hillegersberg, Richard2;
Rijken, Arjen3; van Coevorden, Frits4; Prevoo, Werner5; van Gulik, Thomas1
1Academic Medical Centre, Surgery, Amsterdam, Netherlands; 2Utrecht
Medical Centre, Surgery, Utrecht, Netherlands; 3Amphia Hospital, Surgery,
Breda, Netherlands; 4Antoni van Leeuwenhoek, Netherlands Cancer In-
stitute, Surgery, Amsterdam, Netherlands; 5Antoni van Leeuwenhoek,
Netherlands Cancer Institute, Radiology, Amsterdam, Netherlands
Background. Although local therapies for liver tumors are considered to be
safe, substantial morbidity has been reported. Cryoablation has been
associated with an exaggerated systemic inflammatory response (SIR)
syndrome. The SIR in patients undergoing heat ablation is uncertain.
Aim(s)/Objective(s). Aim of this study was to assess the degree of SIR after
radiofrequency ablation (RFA) in comparison with major (MR,/2 seg-
ments) or minor (mR,B/2 segments) liver resection.
Methods. In this prospective study, 39 patients were treated with RFA (11),
MR (n/10) or mR (n/18). All RFA procedures were performed during a
laparotomy. Blood samples were analyzed pre-operatively, intra-operatively,
and 1 hour, 4 hours and 1, 2, 3 and 7 days postoperatively. SIR parameters
[White Blood Count (WBC) and C reactive protein (CRP)], proinflamma-
tory mediators [IL-6, TNF-alpha and sPLA2], liver damage parameters
[AST\ALT] and coagulation parameters [platelet count] were determined.
Results. RFA induced a moderate SIR, as demonstrated by a significant
elevation of CRP (77 mg/L vs 3 mg/L), IL-6 (96 pg/ml vs 4 pg/ml) and
sPLA2 (41 vs 7 ng/ml, pB/0.05). SIR parameters and proinflammatory
mediators occurred earlier after RFA, indicating an early SIR after RFA.
Time to time comparison revealed even slightly increased levels of CRP (77
mg/L [59,160]) 24 hours after RFA when compared to patients undergoing
MR or mR (50 mg/L [28,66]) and 59 mg/L [24,91], respectively) and
increased levels of IL-6 (67 pg/ml [42,131]) 4 hours after RFA when
compared to patients undergoing mR (29 pg/ml [20,55]). Postoperative levels
of ASTand LDH correlated significantly with the ablated liver volume (RC/
0.860 and RC/0.868, respectively, pB/0.05).
Conclusion. Although the patients in this study underwent RFA of relatively
small liver fractions, it induced a moderate SIR of the same magnitude as in
patients undergoing partial liver resection. None of the patients showed signs
of an exaggerated SIR, as has been reported after cryoablation.
PZ 2.08
EVOLUTION OF LIVER TRANSPLANTATION IN EUROPE:
REPORT OF 63,430 TRANSPLANTS IN THE EUROPEAN LIVER
TRANSPLANT REGISTRY (ELTR)
Adam, Rene1; Karam, Vincent1; Buckels, John2; O’Grady, John3; Castaing,
Denis1; Klempnauer, Jurgen4; Jamieson, Neville5; Neuhaus, Peter6; Lerut,
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Jan7; Pollard, Stephen8; Salizzoni, Mauro9; Rogiers, Xavier10; Garcia-
Valdecasas, Juan11; Muhlbacher, Ferdinand12; Mir, Jose13; Broelsch, Chris-
topher14; Burra, Patricia15
1Paul Brousse Hospital, Villejuif, France; 2The Queen Elizabeth Hospital,
Birmingham, UK; 3King’s College Hospital, London, UK; 4Medizinische
Hochschule Hannover, Hannover, Germany; 5Addenbrooke’s Hospital,
Cambridge, UK; 6Charite´- Campus-Virchow klinikum, Berlin, Germany;
7Cliniques Universitaires Saint Luc, Brussels, Belgium; 8St Jame’s & Seacroft
University Hospital, Leeds, UK; 9Centro de Trapianti di Fegato, Turin, Italy;
10Universitatskrankenhaus Eppendorf, Hamburg, Germany; 11Hospital
Clinic I Provincial de Barcelona, Barcelona, Spain; 12Klinishe Abteilung
fu¨r Transplantation, Wein, Austria; 13Hospital Universitario La Fe, Valencia,
Spain; 14C. U. K. GHs Essen, Essen, Germany; 15University Hospital,
Padova, Italy
Background. From May 1968 to December 2004 the ELTR has accumu-
lated data on 63,430 grafts transplanted in 56,863 patients at 135 centers and
23 countries.
Objective. To analyze the evolution of liver transplantation (LT) in Europe.
Results. The annual number of LT has increased reaching a peak of 5,057
in 2002. One-year (yr) patient survival has continually improved, most
recently reaching 85%. Five-yr survival is currently 70% for patients and
62% for grafts. Cirrhosis was the most frequent indication for LT (59%)
followed by cancer (12%), cholestatic diseases (11%), and acute hepatic
failure (9%). Patient survivals at 5 yrs were 72% for cirrhosis, 61% for
acute hepatic failure and 54% for cancer (pB/0.001). In cirrhotic patients,
5-yr survival was better for primary biliary cirrhosis (78%) than for
alcoholic (73%) or viral cirrhosis (70%)(pB/0.001). In patients transplanted
for viral cirrhosis, survival with Hep B was better than with Hep C (73% vs
66% at 5 yrs, pB/0.01). The 5-yr survival in pediatric recipients was 77%
and was independent of patient age. In contrast, age influenced 5-yr
survival in adults (72%: 1645 yrs, 69%: 4660 yrs, 64%: /60 yrs)(pB/
0.001). When retransplantation (Retx) was indicated, 5-yr graft survival for
2nd and 3rd LT was 44% and 36%, respectively. Alternatives to full size
cadaveric transplant (FSCT) were increasingly used during the last 10 yrs
accounting for 11.8% of all LT, including split liver grafts (SL,5%), living
donor grafts (LD, 4%), reduced liver grafts (RL, 2%), and domino
transplants (DT, 0.8%). In order of survivals, 3-yr graft and patient
survivals were 60% and 75% for SL, 72% and 78% for LD, 60% and
73% for RL, 63% and 70% for DT. FSCT survivals were 68% and 75% for
the same period.
Conclusions. Refined indications, improved surgical technique, and more
effective immunosuppression have lead to significant improvements in
outcome following LT. This analysis also indicates that ELTR data may
be used to draft consensus statements that address areas of continued debate
in LT.
PZ 2.09
ASSESSMENT OF FUTURE REMNANT LIVER BEFORE PARTIAL
LIVER RESECTION: COMPARISON BETWEEN LIVER VOLUME
AND FUNCTION MEASURED BY HEPATOBILIARY SCINTI-
GRAPHY
de Graaf, Wilmar1; Bennink, Roelof J2; van Lienden, Krijn P3; van Gulik,
Thomas M1
1Academic Medical Center, Dept. of Surgery/Surgical Laboratory, Amster-
dam, Netherlands; 2Academic Medical Center, Dept. of Nuclear Medicine,
Amsterdam, Netherlands; 3Academic Medical Center, Dept. of Radiology,
Amsterdam, Netherlands
Background. Guidelines for safe liver resections are based on future
remnant liver (FRL) volume by CT volumetry. However, in patients with
parenchymal liver disease, liver volume may not represent liver function.
Hepatobiliary scintigraphy (HBS) using 99mTc- mebrofenin is a quantitative
method for evaluating total and regional liver function. Recently, 99mTc -
mebrofenin SPECT was developed to assess functional liver volume, in
addition to liver function.
Aim(s). To assess the use of SPECT for measurement of liver volume and to
compare liver volume with liver function, measured by HBS.
Methods. Patients, planned for liver resection, were divided into patients
with normal livers (n/8) and compromised livers (n/10). Liver volu-
me(LV) was determined by CT volumetry. HBS, and SPECT were used to
determine liver function (LF) and liver fuctional volume (LFV), respectively.
Preoperatively, total liver function (TLF), total functional liver volume
(TLFV) and total liver volume (TLV), as well as estimated FRL function
(FRLF), FRL functional volume (FRLFV) and FRL volume (FRLV) were
determined. Three days after resection, actual remnant liver functional
volume (RLFV) was measured.
Result. TLFV assessed with SPECT correlated (r/0,85) with TLV
measured by CT. There was a strong correlation (r/0,91) between pre-
operative FRLFV, and actual postoperative RLFV. In patients with normal
livers, there was a strong correlation between FRLV and FRLF (r/0,97), as
well as FRLFV and FRLF (r/0,97). However, patients with compromised
livers, only had a moderate correlation between FRLV (r/0,71) and FRL
function, and no significant correlation between FRLFV (r/0,62) and FRL
function.
Conclusion. This study indicates that SPECT can be used for the
estimation of FRL functional volume, and that it relates to volume measured
by CT. In patients with normal livers, liver volume correlates with function.
However, in patients with compromised livers, CT volumetry of the liver is
unreliable and additional functional assessment, such as HBS, is required.
PZ 2.10
LAPAROSCOPIC HEPATECTOMY FOR HAPATOCELLUAR CAR-
CINOMA
Chen, Hong-Yaw; Ker, Chen-Guo
1Yuan’s General Hospital, HBP Surgery, Kaohsiung, Taiwan
Background. Laparoscopic liver surgery is now a tendency. To investigate
the role of laparoscopic hepatectomy in the short- and long-term outcomes of
patients with hepatocellular carcinoma (HCC). We present our results from
using laparoscopic hepatectomy for HCC and discuss the result comparing
with conventional open hepatectomy.
Aims. Comparing the results of laparoscopic hepatectomy and conventional
open hepatectomy, we define the better way for the hepatectomy for HCC
patients.
Patients and methods. To compare the result of laparoscopic hepatectomy,
116 patients with HCC who underwent laparoscopic hepatectomy (laparo-
scopic hepatectomy group) were compared with 204 patients who underwent
conventional open hepatectomy (open hepatectomy group) during the period
of June1997 to November 2006.
Results. Significant differences in blood loss, rate of blood transfusion, or
incidences of postoperative complications were found between the two
groups. No differences in operation time and recurrence time were found
between the two groups. The postoperative hospital stay for the laparoscopic
hepatectomy group (mean 6.239/2.98) was significantly shorter than for the
open hepatectomy group (mean 12.379/6.84). With long-term prognosis, no
difference was found in survival rate and disease-free survival rate between
the two groups.
Conclusions. Compared with conventional open hepatectomy, laparoscopic
hepatectomy has resulted in a better short-term outcome after surgery. The
long-term prognosis in the laparoscopic hepatectomy group was similar to
that in the open hepatectomy group. Laparoscopic hepatectomy is a good
alternative method with rising importance, but it can’t completely replace the
traditional open hepatectomy.
PZ 2.11
THE TOTAL NUMBER OF INTRA AND EXTRA-HEPATIC RE-
SECTABLE COLORECTAL METASTASES IS MORE IMPORTANT
THAN THE SITE OF METASTASES
Elias, D1; Goe´re´, D1; Liberale, G1; Pocard, M1; Boige, V2; Ducreux, M2
1Institut Gustave Roussy, Surgical Oncology, Villejuif, France; 2Institut
Gustave Roussy, Medical Oncology, Villejuif, France
Background. The presence of extrahepatic disease (EHD) is considered as a
contraindication to hepatectomy in patients with colorectal liver metastases.
The aim of this study was to report the survival after synchronous resection of
hepatic and extrahepatic metastases, and the prognostic value of presence
and number of extrahepatic metastases.
Patients and methods. Between January 1987 and January 2000, 308
patients with colorectal cancer underwent hepatectomy. Among these
patients, 84 (27%) also underwent resection of EHD. These extrahepatic
metastases were known before surgery in 55 patients and discovered at
laparotomy in 29. When considering the total number of resected metastases,
each liver metastasis and each EHD location was counted as one lesion.
Results. The median follow-up was 99 months. The overall 5-year survival
rate was 32%. Considering the total number of resected metastases (whatever
their site), 5-year survival rates were 38% (SD: 4%) in the group with one to
three metastases, 29% (SD: 5%) in patients with four to six metastases, and
18% (SD: 5%) in patients with more than six metastases (P/.002). In the
multivariate analysis, the total number of resected metastases (inside or
outside the liver) and the radicality of the resection (R0 vs R2) had a greater
prognostic value than the criteria ‘‘presence or absence of EHD’’.
Conclusion. Extrahepatic disease, when resectable, is no longer a contra-
indication to hepatectomy. More importantly, the total number of the
metastases and their radical resection, whatever their location, have extra-
hepatic disease a stronger prognostic effect than the site of these metastases.
PZ 2.12
SEQUENTIAL ARTERIAL AND PORTAL VEIN EMBOLIZATIONS
(PVE) BEFORE RIGHT HEPATECTOMY IN CIRRHOTIC PA-
TIENTS WITH HEPATOCELLULAR CARCINOMA (HCC)
Ogata, Satoshi; Belghiti, Jacques; Farges, Olivier; Varma, Deepak; Sibert,
Annie; Vilgrain, Vale´rie
Hospital Beaujon, Clichy, France
Background. Selective TACE and portal vein embolization (PVE) could
improve the rate of hypertrophy of the future liver remnant (FLR) in patients
with chronic liver disease. We evaluate the feasibility and the efficacy of this
double preparation.
Method. From 1998 through 2004, 36 cirrhotic patients with HCC
underwent right hepatectomy after PVE. Additional TACE preceded PVE
by 34 weeks (TACE/PVE group) in 18 patients. This group was compared
with 18 patients with PVE only (PVE group).
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Results. PVE was well tolerated in all patients. The mean increase of%FLR
was significantly higher in the TACE/PVE group as compared to the PVE
group (129/5% vs. 89/4%, P/0.022). The rate of hypertrophy was/10% in
12 (67%) in the TACE/PVE group, as compared to 5 (28%) in the PVE
group (P/0.044). Duration of surgery, blood loss, incidence of liver failure
(11% vs. 17%) and mortality (11% vs. 11%) were similar in the two groups.
When the increase of%FLR was/10%, no death (0/17) was observed while
4/19 (21%) deaths were observed when%FLR 5/ 10%. The incidence of
complete tumour necrosis was significantly higher in the TACE/PVE group
(83% vs. 6%, PB/0.0001) with a higher 5 years disease-free survival rate
(37% vs.19%, P/0.041).
Conclusions. Preoperative, sequential TACE and PVE increase the rate of
hypertrophy of the future remnant liver and provide a high rate of complete
tumour necrosis which is associated with a better recurrence-free survival.
PZ 2.13
RESECTION VERSUS RADIOFREQUENCY ABLATION FOR HCC
IN CHILD’S A OR B CIRRHOTIC PATIENTS WITH A SINGLE
NODULE B/5 CM
Lupo, Luigi; Panzera, Piercarmine; Tandoi, Francesco; Di Palma, Giovanni;
Gallerani, Andrea; Memeo, Vincenzo
University of Bari, General Surgery and Liver Transplantation, Bari, Italy
Introduction and aim. Surgical resection (Res) is the standard treatment
for Child’s A or B cirrhotic patients with a single HCC nodule, but
Radiofrequency Ablation (RFA) is gaining wide popularity, thanks to its
simplicity and effectiveness. However, the procedure has not yet been
validated by surgical trials and long-term results are limited. Aim of our
study was to compare the outcome of the two therapies.
Patients and methods. In this Audit, 44 Res patients (median age: 63
years, range 3077; Child’s A: 33, B: 11) and 132 RFA patients (median
age: 64, range 3080; Child’s A: 86, B: 46), with a single noduleB/5 cm in
size, were compared. Patients with a peripheral nodule underwent Res and
with a central nodule, RFA. The two groups were similar for age, Child’s
distribution, cancer stage and grade of liver disease. The end-points of the
study were survival and disease-free (DF) survival, assessed by Kaplan-Meier
tables.
Results. No early mortality was observed, but major and minor complica-
tions occurred in 11/132 RFA patients and 8/44 Res. Survival at 5 years was
significantly lower in RFA patients: 26% vs 49% for Child’s A and 10% vs
27% for Child’s B. DF survival results mirrored these were even more
significant already by 2 years; 24% Child’s A RFA vs 49% Res, B: 24% vs
44%, pB/0.02.
Conclusion. In this selected group of patients, Res yields significantly
superior overall survival at 5 years and vastly longer DF survival.
PZ 2.14
PROSPECTIVE EVALUATION OF A PROTOCOL FOR TWO
STAGE HEPATECTOMY COMBINED WITH SELECTIVE POR-
TAL VEIN EMBOLISATION AND SYSTEMIC CHEMOTHERAPY
FOR PATIENTS WITH UNRESECTABLE BILOBAR COLOREC-
TAL LIVER METASTASIS
Pamecha, Viniyendra; Nedjat-Shokouhi, Balham; Davidson, Brain
Royal Free Hospital, Royal Free and University College Medical School,
Liver Transplant and Hepato-Pancreato-Biliary Surg, London, UK
Background. Patients with bi-lobar multiple colorectal liver metastasis are
usually considered for palliative chemotherapy. However two-stage hepatect-
omy in which cancer is resected from one lobe, regeneration allowed prior to
contra lateral lobe resection is potentially curative in selected patients.
Objective. To assess feasibility, risks, and patients outcomes in unresectable
bilobar colorectal metastasis with a prospectively applied strategy for two
stage hepatectomy.
Methods. Over a 6 year period, 14 patients were considered for a two stage
hepatectomy. Surgery was combined with chemotherapy in all the patients
considered for two stage hepatectomy and portal vein embolisation was done
in 5 patients.
Results. Both stages were completed in 11 of 14 patients (78%). There were
no deaths following initial or second liver resection. Post operative complica-
tion rate were 0% and 27% respectively. Median follow up was 22 months.
Median disease free survival was 17 months from second hepatectomy with 5
patients’ disease free at 6, 7, 8, 43 and 52 months and one patient dying at 9
months.
Conclusion. A prospective strategy of two stage hepatectomy integrated with
systemic chemotherapy and portal vein embolisation as indicated can result
in a survival advantage for patients with multiple bilobar colorectal liver
metastasis.
PZ 2.15
LIVER MANIPULATION LEADS TO HEPATOCELLULAR INJURY
AND SYSTEMIC INFLAMMATION IN MAN
van de Poll, Marcel1; Derikx, Joep1; Buurman, Wim1; Peters, Wilbert2;
Roelofs, Hennie2; Wigmore, Stephen3; Dejong, Cornelis1
1University Hospital Maastricht, Nutrition and Toxicology Research Institute
Maastricht (NUTRIM), Maastricht University, Dept. of Surgery, Maas-
tricht, Netherlands; 2University Medical Center Nijmegen, Dept. of Gastro-
enterology, Nijmegen, Netherlands; 3Queen Elisabeth Hospital, Liver Unit,
Birmingham, UK
Introduction. Cell injury leads to release of danger signals that activate the
immune system. Our aim was to test the hypothesis that liver manipulation
during surgery induces hepatocellular injury and a subsequent inflammatory
response.
Methods. We studied 20 patients undergoing upper gastrointestinal surgery.
Markers of hepatocyte injury (AST, LDH, GSTa and L-FABP), enterocyte
injury (I-FABP) and inflammation (IL-6) were measured in arterial blood.
To study the involvement of the gut and the liver in the inflammatory process,
arteriovenous concentration differences for IL-6, GSTa and L-FABP were
measured across intestines and liver.
Results. Markers of hepatocyte damage AST, LDH and L-FABP increased
already significantly (4-fold, 1.8-fold, 45-fold respectively, all pB/0.01)
during liver mobilization. No further increase was observed during sub-
sequent intermittent hepatic inflow occlusion. L-FABP concentrations
decreased immediately postoperative (p/0.037) concomitant with its rapid
renal clearance (fractional extraction 34%, r2/0.75, pB/0.001). L-FABP
was significantly released from the liver during liver mobilization (hepatic
venous-portal concentration difference (mean9/SEM) 4199/103 ng/mL, p/
0.001). Intestinal release of L-FABP (portal-arterial concentration difference
/159/52 ng/mL, NS) was negligible and arterial I-FABP remained
undetectable throughout the study. The postoperative IL-6 peak (3229/53
pg/mL) was significantly correlated with hepatocyte injury assessed by the
area under the plasma concentration curves of L-FABP (p/0.78, p/0.017)
and AST (p/0.77, p/0.021). Organ balance analysis revealed that both
liver and intestines were involved in IL-6 production.
Conclusions. Liver manipulation during surgery rapidly leads to hepatocel-
lular injury, which subsequently induces an inflammatory response. The
clinical importance of this should be clarified in future studies.
PZ 3.01
CYSTIC LESIONS OF THE PANCREAS: ROLE OF ENDO-
SCOPIC ULTRASOUND (EUS) AND FINE NEEDLE ASPIRATION
(FNA)
Shah, Ankur J1; Shah, Jayshri2; Wallace, Doreen1; Norton, Sally A3
1Bristol Royal Infirmary, Upper GI Surgery, Bristol, UK; 2Southmead
Hospital, Gastroenterology, Bristol, UK; 3Southmead Hospital, Upper GI
Surgery, Bristol, UK
Background. Due to increased imaging, cystic lesions of the pancreas are
being identified more often as incidental findings as well as in symptomatic
patients. Differentiating benign cysts and pseudocysts from malignant or
premalignant cystic lesions is difficult and percutaneous Fine needle
aspiration (FNA) may be inappropriate. Endoscopic ultrasound (EUS)
enables both a close assessment of such lesions and a safer route for FNA.
Aims. To assess the accuracy of EUS characteristics and the accuracy and
safety of EUS-FNA in diagnosing cystic lesions of the pancreas.
Methods. Retrospective analysis of EUS database over a 28 month period.
22 patients with known cystic lesions on CT scan were referred for further
evaluation with EUS and FNA. The EUS characteristics of the lesion with
provisional diagnosis were recorded, as well as FNA cytology, amylase and
tumour marker results. Histology, operative findings or clinical follow up
were used as reference standards to assess the accuracy of presumed diagnosis
based on EUS imaging and FNA.
Results. EUS imaging accurately predicted the diagnosis in 17/22 patients
(77%), with two false positives. In the remaining 3 patients EUS imaging
features were inconclusive. FNA was attempted in all 22 patients. In 6,
the sample was inadequate for diagnosis. FNA accurately predicted the
diagnosis in 15/16 patients. There were no complications. The overall
accuracy rate of FNA was 68% (15/22) in this series with an inadequate
yield in 27% (6/22) of cases. Out of the 16 patients with an adequate yield the
accuracy was 94%.
Conclusions. EUS imaging with EUS guided FNA is a safe technique and is
useful in diagnosing the nature of cystic lesions of the pancreas. Measures to
improve the diagnostic yield of EUS-FNA will further enhance the value of
this technique.
PZ 3.02
RECTAL CANCER STAGING FOR DISTANT METASTASES:
ULTRA SMALL PARAMAGNETIC IRON OXIDE (USPIO) EN-
HANCED WHOLE BODY MRI VERSUS PET-CT
Van Dam, RM1; Bloemen, JG1; Lahaye, M2; Vliegen, RFA2; Lammering, G3;
Arens, A4; Teule, GJJ4; Beets, GL1; Dejong, CHC1; Beets-Tan, RGH2
1University Hospital Maastricht, Dept. of Surgery, Maastricht, Netherlands;
2University Hospital Maastricht, Dept. of Radiology, Maastricht, Nether-
lands; 3University Hospital Maastricht, Dept. of Radiation Oncology,
Maastricht, Netherlands; 4University Hospital Maastricht, Dept. of Nuclear
Medicine, Maastricht, Netherlands
Background. Metastases is the major problem influencing long-term survival
in patients with rectal cancer. Resectional surgery of metastases confined to
liver and lungs offers a chance of cure for these patients. To plan type and
sequence of treatment detailed anatomical information on distant extent of
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the disease is therefore as important as information on the loco regional status.
Aim. Of the study is to compare Whole Body 18F-FDG PET-CT (PET-CT)
and USPIO enhanced Whole Body MRI (USPIO MRI) in depicting liver and
lung metastases in patients with rectal cancer.
Methods. A consecutive series of 38 patients with rectal cancer was studied
prospectively. All underwent PET-CT and USPIO MRI. All lesions suspi-
cious for metastases were identified on PET-CTand on USPIO-MRI. Results
were compared. Each patient’s staging results with USPIO-MRI and PET-
CT were then presented with a 2 week interval to a specialist rectal/liver
surgeon who was asked to determine the treatment strategy. The number of
patients with an altered treatment strategy was assessed.
Results. There were 4 T2, 24 T3 and 10 T4 tumours as staged on USPIO-
MRI. Suspicious liver lesions were found in 16 patients (42%), 10 (26%)
detected by PET-CT and 15 (40%) by USPIO-MRI. Suspicious lung lesions
were found in 8 patients (21%), 6 (16%) detected by PET- CTand 6 (16%) by
USPIO-MRI. (All p/0.05, chi-square). TME was postponed in 6 patients.
To conduct a livermets resection in 2, a primary lungtumor resection in 2, for
neoadjuvant chemotherapy to downsize livermetastases in 2 patients. TME
was abandoned in 4 for extensive metastases. TME was preceded once by a
bladder resection for bladder cancer identified by MRI only. All 11 (29%)
patients were identified by USPIO MRI, 10 (26%) by CT-PET
Conclusion. In patients with rectal cancer USPIO enhanced Whole Body
MRI and Whole Body PET-CT are comparable in the detection of distant
metastases and alter the treatment strategy in 2629% of patients. Larger
series are needed to draw definitive conclusions.
PZ 3.03
EARLY GASTRIC CANCER PRESENTS WITH DYSPEPSIA
Jennings, Neil; Sultan, Javed; Wynne, Kamil; Karat, Daya; Preston, Shaun R;
Hayes, Nick; Griffin, S Michael
Royal Victoria Infirmary, National Oesophago-Gastric Cancer Unit, New-
castle upon Tyne, UK
Background. The long term outlook for patients with advanced gastric
cancer remains poor; however, patients with gastric cancer who are identified
at an early stage can be offered an excellent chance of cure. There has been
considerable recent controversy about the referral guidelines for patients
complaining of upper GI symptoms requiring upper GI endoscopy and the
potential of early cancers being missed.
Aims. To review the cohort of patients treated in our unit with EGC with
reference to their previous treatment and reported symptoms.
Method. Patients were identified via the prospectively collected unit
database. The medical notes were reviewed and the presenting complaint,
duration of symptoms, previous treatment and H.pylori status recorded.
Results. 87 patients were diagnosed as having an EGC and this was
confirmed histologically on resection in 79 patients. 8 patients did not
undergo operation as a result of poor fitness. Of the operative cohort the mean
age was 68.5 years (3089) with 10% of the cohort being less than 55 at the
time of diagnosis. 60.9% of patients were H.pylori negative and 62.1% had
been treated with a PPI or H2 antagonist prior to endoscopy. 70% of the
patients presented with dyspepsia alone. 67% of patients reported their
symptoms had been present for less than six months. Increasing depth of
invasion was associated with lymph node metastasis with 5% of mucosal
lesions having lymph node involvement compared to 44% of sub-mucosal
lesions (P/0.016).
Conclusion. Dyspepsia alone is the predominant presenting complaint of the
majority of patients with early gastric cancer. This condition can only reliably be
diagnosed by endoscopy and it is therefore essential that patients presenting with
new onset dyspepsia be appropriately investigated. Progression from mucosal to
sub-mucosal invasion is an associated with increased lymph node metastasis.
PZ 3.04
DISCRIMINATIVE VALUE OF PATIENTS SYMPTOMS IN PRE-
DICTING UPPER GASTROINTESTINAL CANCER
Al-Sarira, Ali A1; Ballal, Moh S2; Selvachandran, S N2; Cade, David C2;
Deakin, Mark3; Corless, David J2
1Leighton Hospital. Keele University, Leighton Research Unit. Dept. of
Surgery, Crewe, UK; 2Leighton Hospital, Leighton Research Unit. Dept. of
Surgery, Crewe, UK; 3University Hospital North Staffordshire. Keele
University, University Dept. of Surgery, Stoke on Trent, UK
Background. Published guidelines for symptomatic Upper Gastrointestinal
(GI) referrals have resulted in an increased referral rate. While this has
improved the service to patients it has created a logistical problem in
processing the volume of referrals. Inaccurate initial symptoms assessment
leads to inappropriate patient management and hence reduces the cost
effectiveness of the service. Previous work using a patient consultation
questionnaire (PCQ) linked to an electronic patient record (EPR) and a
computer generated scoring system has been shown to be an effective and
objective way of predicting colorectal malignancy and streamlining referrals.
Objective. The aim of this study was to derive and evaluate diagnostic
determinants of gastric and oesophageal cancer based on patients’ symptom
profile derived from an Upper GI PCQ. Method. A detailed upper GI PCQ
was sent to all patients coming for first time endoscopy. All symptoms and
diagnostic outcomes were collected and stored in the EPR to create a
databank.
Results. 402 patients were included. 4% of which were found to have cancer,
and 31.3% of which had curative surgery. Univariate and multivariate
analysis resulted in four factors being positive predictors for cancer. These
were age, retrosternal dysphagia, duration of abdominal pain less than 6
months and progressive abdominal pain. On the other hand there was one
negative predictor, being female sex. When a generated scoring system was
applied on the study population it excluded 40% of the workload and
produced a cancer detection rate of 10% in those endoscoped with AUC
(area under curve) of 0.87 in the ROC (receiver-operating characteristic)
analysis.
Conclusion. Scoring for upper GI symptoms, as a predictor of cancer is
possible and could result in reducing the workload in endoscopy by
prioritisation of referrals. Other referrals can then be automatically redirected
to a more appropriate patient pathway.
PZ 3.05
PREDICTORS OF OUTCOMES OF GASTRECTOMY FOR GAS-
TRIC CANCER IN THE ELDERLY (/75 YEARS)
Moorthy, Krishna; Balaji, NS; Seenath, Marlon; Deakin, Mark; Cheruvu,
Chandra VN
University Hospital of North Staffordshire, Dept. of Surgery, Stoke on Trent,
UK
Background. There is very little data on the outcomes of patients under-
going gastrectomy for gastric cancer in the western world.
Aim. To identify the predictors of operative morbidity and mortality.
Methods. There were 201 gastrectomies performed for cancer in the period
between 1997 and 2005 of which 80 were performed on patients over 75
years of age. All resections were carried out by upper gastrointestinal
surgeons.
Results. There were 47 men and 33 women with a median age of 80 years
(range 7589). Dyspepsia (30%), obstruction (23%), anaemia (18%) and
bleeding (16%) were the common presenting features. 80% had elective
resections while 20% underwent emergency surgery. 53% had significant co-
morbidity of which 60% were cardio-respiratory. 70% were subtotal and 30%
were total gastrectomies. In 45% of resections the surgeon considered the
procedure to palliative. 80% of the resections were D1. The median lymph
node harvest for D1 was 15 (Inter quartile range- 15) and for D2 resections
was 27 (IQR). 47% of patients had significant post-operative morbidity.
Cardio-respiratory and major surgical complications occurred in 40% and
15% of the patients respectively. The in-hospital mortality was 13%. On
univariate and multivariate analysis pre-operative cardio-respiratory co-
morbidity was the only significant predictor of post-operative morbidity
(p/0.02) while other important variables such as presenting symptoms,
method of admission, ASA status, type and extent of resection were not
significant. The type of resection (total vs sub-total) was the only significant
predictor of post-operative mortality (p/0.01). Of 121 concurrent resections
in patients below 75 years of age the medical and surgical complication rates
and mortality rate were 24%, 17% and 8% respectively.
Conclusion. Cardio-respiratory co-morbidity predicts post-operative mor-
bidity in elderly patients undergoing gastrectomy and total gastrectomy is
associated with a high mortality.
PZ 3.06
PERSISTENT ‘BENIGN’ GASTRIC OUTLET OBSTRUCTION-
RESECT IT OR REGRET IT
Speake, William J1; Longdon, Elizabeth1; Parsons, Simon L2; Welch, Neil T2
1Queens Medical Centre, Dept. of Surgery, Nottingham, UK; 2Nottingham
City Hospital, Dept. of Surgery, Nottingham, UK
Background. Gastric outlet obstruction (GOO) is usually caused by a
benign peptic stricture or cancer. We hypothesized that ‘benign’ GOO not
responding to optimal medical management should be assumed to be
malignant and best managed with resection rather than bypass.
Aim. To examine the natural course of GOO that appears initially benign.
Methods. Endoscopy reports were reviewed from 2 hospital sites over 4 years
to identify patients with GOO who had not had oesophago-gastric surgery.
Records were reviewed to study the cause and management of GOO.
Results. The endoscopy database identified 91 cases of GOO. The final
cause was due to gastric adenocarcinoma in 43 (48%), 13 (14%) due to
extrinsic malignant compression (Pancreatic 8, Colonic 2, Breast 2,
Gallbladder 1), 2 due to lymphoma and 1 patient had gastric Crohns
disease. A definitive benign cause was eventually found in 32 (36%) patients.
However, after initial endoscopy with histopathology, and CT imaging where
extrinsic compression was suspected, there were 34 patients who had not had
malignancy confirmed. These 34 patients were all managed with optimal
medical treatment (Proton pump inhibition and H. Pylori eradication where
positive), 5 patients also had balloon dilatation. A further 5 patients failed to
improve and had surgery. In 2 patients distal gastrectomy was performed; one
was malignant. Three patients had a gastrojejunostomy; one died shortly
post-operatively due to aspiration, one has short follow up (4 months) and
one re-stenosed and at subsequent laparotomy had metastatic gastric cancer.
Conclusion. There were only 5 patients with ‘benign’ GOO not settling with
optimal medical management and requiring surgery. In these the risk of
occult malignancy was at least 40% (2/5 with follow up being inadequate in 2
of these). Laparotomy with a view to distal gastrectomy appears justified.
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PZ 3.07
OUTCOME OF SURGICAL THERAPY FOR EARLY STAGE OE-
SOPHAGEAL CANCER
Singh, Joy C; Evans, Martyn; Morgan, Matthew; Lewis, Wyn G; Clark,
Geoffrey W B
University Hospital of Wales, Cardiff, UK
Background. Patients undergoing surgical resection for high grade dysplasia
(HGD) or early oesophageal cancer have high expectations for cure.
Endoscopic therapies to treat these lesions are associated with good short-
term results but the risk of local recurrence may prove prohibitive.
Methods. We evaluated the results of surgical therapy in a cohort of patients
operated between 19982006 who were staged by endoscopy with multiple
biopsies, endoscopic ultrasound & CT. Subtotal transhiatal oesophagectomy
was performed with abdominal lymphadenectomy, resection of the lower
mediastinal nodes, and reconstruction with the tubularised stomach via a left
neck approach.
Results. There were 28 patients, (median age 66.5 yrs, range 3579, 20
males). The pre-operative diagnosis was 4 HGD, 22 T1 adenocarcinoma
and 2 T1 SCC. Of the 26 patients with HGD or adenocarcinoma, 24 (92%)
arose from Barrett’s mucosa, median 8 cm long (range 313). Fifteen
(58%) of patients were diagnosed from endoscopic surveillance pro-
grammes. Seven patients had Barrett’s oesophagus without a visible lesion.
After resection, 4 had HGD and 3 had invasive adenocarcinoma. In
contrast, 21 patients with a visible lesion at endoscopy had stage T1
invasive cancer in the resected specimen (pB/0.01). Mortality was 2/28
(7%). The median lymph node harvest was 14 (range 536). One patient
(with SCC) had a solitary node metastases. Five year survival was 75%.
Four patients died between 2072 months post operatively, one at 52
months from recurrent cancer.
Conclusions. The presence of a visible lesion at endoscopy was predictive of
invasive carcinoma. None of our patients with T1 adenocarcinoma had
lymph node metastases. Consequently we consider that patients with early
adenocarcinoma do not require an extended lymphadenectomy and are ideal
for laparoscopic oesophagectomy.
PZ 3.08
WORKLOAD, RESOURCE AND TRAINING IMPLICATIONS OF
UPPER GI CANCER SURGICAL CENTRALISATION IN SOUTH
EAST WALES
Escofet, Xavier; Goodson, Mark; Morgan, Matt; Bailey, Karen; Tillet, Jane;
Clark, Geoff; Lewis, Wyn; Singh, Joy C
University Hospital of Wales, Upper GI Surgical Unit, Cardiff, UK
Background. Compliance with the COG guidelines for the commissioning
of cancer services, supported strongly in England, has received lesser
resource in Wales.
Aim. Determine whether one specialist unit could manage all patients
diagnosed with oesophagogastric cancer in Gwent and Cardiff and Vale NHS
Trusts over a six-month period.
Methods. The patient caseload diagnosed with oesophageal and gastric in
Gwent and Cardiff and Vale NHS Trusts over the 6 month period from July 1
until December 31, 2005 were studied prospectively and compared with the
previous 6 month caseload at UHW. Outpatient and inpatient workload inclu-
ding operating theatre, ITU, HDU and hospital bed utilisation were analysed.
Results. Outpatient workload increased from 160 new and 533 follow up
patients between January 1, and June 30, to 290 new and 865 follow up
patients between July 1, and December 31, 2005. Thirty-three patients were
diagnosed with oesophagogastric cancer during the former compared with 68
patients during the latter period. The number of OGDs performed increased
from 214 to 451 diagnostic and from 20 to 51 therapeutic procedures
(oesophageal stent insertion 7 vs. 8). Staging EUS increased from 43 to 60
examinations, and staging laparoscopy increased almost threefold from 8 to 22
procedures. The number of patients undergoing radical potentially curative
surgery increased from 14 to 23 (D2 gastrectomy 8 vs.13; Oesophagectomy 6
vs.10). Utilisation of ITU decreased from 50 to 30 days, and HDU increased
from 15 to 27 days. There was no operative mortality. Oesophagogastric
cancer related work in the latter 6 months generated 138 intermediate (hernia)
equivalents of operative work for 2 Consultant surgeons which occupied 38%
of the time available on 104 scheduled operating theatre lists.
Conclusion. Centralisation of oesophagogastric cancer surgery is feasible
and desirable if national guidelines are to be satisfied, and as the above audit
demonstrates, this strategy carries significant positive implications for
surgical training.
PZ 4.01
LIVER METASTASES FROM PANCREATIC CANCER: IS THERE
A PLACE FOR HEPATIC RESECTION?
Adam, Rene1; Chiche, Laurence2; Jaeck, Daniel3; Rivoire, Michel4; Laurent,
Christophe5; Cherqui, Daniel6; Mantion, Georges7; Nordlinger, Bernard8;
Partensky, Christian9
1Paul Brousse Hospital, Villejuif, France; 2Hopital Cote de Narce, Caen,
France; 3Hopital de Hautepierre, Strasbourg, France; 4Centre Leon Berard,
Lyon, France; 5Hoˆpital St Andre´, Bordeaux, France; 6Hopital Henri
Mondor, Creteil, France; 7Hoˆpital Jean-Minjoz, Besanc¸on, France; 8Hoˆpital
Ambroise Pare´, Boulogne, France; 9Hoˆpital Edouard Herriot, Lyon, France
Introduction. Although liver metastases (LM) from pancreatic cancer (PC)
are usually considered an indication of widespread disease, when they are
amenable to complete resection and represent the only site of distant
metastases, patients with LMPC may be candidates for hepatic resection (HR).
Objective. To define the place of HR for patients with LM from PC by
assessing a multi-center experience.
Methods. Data from 16 centers was retrospectively collected using a
standardized questionnaire that included patient, primary tumor, and liver
metastases characteristics. The prognostic value of study factors was deter-
mined by comparing their distribution to survivals in univariate and multi-
variate analysis.
Results. The survey accrued 40 pts (16 M:24 F, mean age: 54 yrs) treated with
HR from 1993 to 2004. Adenocarcinoma was the most frequent histology
(87%). For the 19 patients (44%) with metachronous presentation (/3
months) the mean disease-free interval was 22.4 mos. Metastasis was unique in
52% of pts and B/3 in 80% of pts. Hepatectomy was limited (B/3 segments) in
60% of pts and potentially curative (R0) in 87% of pts. HR was concomitantly
performed with pancreatectomy in 18 pts (45%). Operative mortality at 2 mos
was 2.6% (1/40) with local and general complication rates of 19% and 27%,
respectively. After a mean follow-up of 22 mos (196), hepatic recurrence
occurred in 56% of pts. Median, 3-year, and 5-year overall survivals (OS) were
19 mos, 43% and 25% with 3 pts alive more than 5 years after HR. Significant
prognostic factors were disease-free interval /12 mos (median OS: 57 vs 14
mospB/0.02), non-adenocarcinoma histology (median OS: 40 vs 18 mos-
pB/0.05) and curative hepatectomy (median OS: 31 mos for R0 vs 13 mos for
R1 vs 6 mos for R2- pB/0.05).
Conclusions. HR for LMPC can be associated with long-term survivals,
particularly in pts with prolonged disease-free intervals after pancreatic
resection and when HR is curative. The efficacy of HR in this disease may
further increase with improvements in adjuvant therapy.
PZ 4.02
MOLECULAR AND IMMNOHISTOCHEMICAL ANALYSIS OF IN-
TRADUCTAL PAPILLARY MUCINOUS NEOPLASM OF PAN-
CREAS TO VERIFY THE GENETIC ALTERATION ACCORDING
TO THE ADENOMA-CARCINOMA SEQUENCE
Jang, Jin-Young1; Kim, Sun-Whe1; Kim, Woo-Ho2; Han, Ho-Seong1; Yoon,
Yoo-Seok1; Han, Seong-Sik1; Han, Seong-Sik1; Lee, Kuhn Uk1
1Seoul National University College of Medicine, Surgery, Seoul, Korea;
2Seoul National University College of Medicine, Pathology, Seoul, Korea
Background. Intraductal papillary mucinous tumor (IPMT) comprises a
broad histological spectrum, which ranges from adenoma to invasive
carcinoma, and show a variety of biological behaviors. This pathological
characteristics suggests adenoma-carcinoma sequence.
Aim. The aim of this study was to find the genetic alterations in adenoma-
carcinoma sequence.
Methods. Forty-one patients with IPMT who underwent resection between
1994 and 2003 were enrolled in this study. The paraffin-embedded tumors
from patients with 27 intraductal papillary-mucinous adenoma/borderline
(IPMA/B) and 14 intraductal papillary-mucinous carcinoma of the pancreas
(IPMC) were provided for immunohistochemical staining and DNA extrac-
tion after laser captured microdissection. After review of pathological slides
by one gastrointestinal pathologist, immunohistochemical staining using 17
biological markers selected by bioinformatic method and direct DNA
sequencing analysis for k-ras mutation were performed.
Results. K-ras mutations at codon 12 were dectected in 30% of IPMA/B and
63.6% of IPMC(p/0.045). In immunohistochemical staining, Progesterone
receptors expression is higher in IPMA/B(70.4%) than IPMC(28.6%) (p/
0.033). The expression of S100A4 (7.4% vs 42.8%)(p/0.023) and MUC2
(33.3% vs 71.4%)(pB/0.033) are different according to the histological
grading(IPMA/B vs IPMC). There were no statistical difference in the
expression of estrogen receptors, MSH2, e-cadherin, MUC1, MUC5,
MUC6, APC, COX-2, p53, b-catenin, p21, a-inhibin, etc.
Conclusion. K-ras mutation, MUC2, S100A4, progesterone receptor may
be associated with or differential biological marker for the adenoma-
carcinoma sequence in papillary mucinous tumor of pancreas.
PZ 4.03
NUCLEAR NOTCH3 OVEREXPRESSION IN PANCREATIC
CANCER, AND ITS CORRELATION WITH CLINICAL FEATURES
Doucas, Helena1; Sutton, Christopher D1; Garcea, Guiseppe1; Neal,
Christopher P1; Manson, Margaret M2; Dennison, Ashley R1; Berry, David1
1Leicester General Hospital, Hepatobiliary and Pancreatic Surgery, Leice-
ster, UK; 2University of Leicester, Dept. of Cancer Studies and Molecular
Medicin, Leicester, UK
Background and aims. Reactivation of the Notch signalling pathway has
been demonstrated in a range of human malignancies. Previous research
suggests that Notch3 is particularly likely to be expressed in pancreatic
adenocarcinomas, but the association of Notch expression with clinical
parameters has not previously been described.
Methods. An immunohistochemical study was performed on prospectively
collected samples of pancreatic tissue. Twenty three cases of human
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pancreatic ductal adenocarcinoma and 12 samples of normal pancreas were
assessed for the expression of Notch3. The degree of staining, and cellular
location of the protein were assessed. Clinical data including tumour size,
presence of metastases, and patient survival were available for all cases.
Results. Notch3 was significantly overexpressed in the cytoplasm of 73.9%
of tumours (p/0.013). Nuclear expression, which was never observed in
normal ductal tissue, was noted in 43.5% of cases (p/0.009). No tumours
expressing nuclear Notch3 were surgically resectable (p/0.019). There was
also a significant correlation between nuclear Notch3 staining and increasing
levels of CA19-9, with tumours without nuclear Notch3 expression having a
mean CA19-9 of 186, compared to 8218 for tumours expressing nuclear
Notch3 (pB/0.001). Patients expressing nuclear Notch3 also tended to have
a reduced survival time, although this relationship was not statistically
significant.
Conclusion. The presence of Notch3 in tumour nuclei is likely to represent
functional activation of the protein, and is clearly linked to more aggressive
tumours. This is the first study to localise nuclear Notch staining in
pancreatic cancer, and to correlate it with adverse clinical features. These
data suggest a pivotal role for this protein in pancreatic carcinogenesis.
PZ 4.04
STAGING OF PATIENTS WITH PERIAMPULLARY CARCINOMA
WITHOUT DIAGNOSTIC LAPAROSCOPY
Van Der Gaag, NA; Van Berge Henegouwen, MI; Gulik, TM; Busch, OR;
Gouma, DJ
Academic Medical Center, Amsterdam, Dept. of Surgery, Amsterdam,
Netherlands
Background. A significant number of patients who undergo explorative
laparotomy with curative intent for a suspected periampullary malignancy are
found irresectable due to distant metastases. Controversy exits over the
additional value of diagnostic laparoscopy (DL) in order to bring the number
of unnecessary laparotomies down. After publication of a study in 1998 DL
was eliminated from the diagnostic protocol in our institution since a yield of
only 13% was found with a histologically proven accuracy of 60% for distant
metastases.
Objective. To evaluate the occurrence of distant metastases and accuracy of
preoperative radiological imaging (US/CT/MRCP/EUS) in a diagnostic
protocol for pancreatic/periampullary tumours without routine use of DL.
Methods. Between January 2000 and December 2005, 444 consecutive
patients, suspected to have a pancreatic/periampullary malignancy, under-
went an explorative laparotomy with the intention to perform a curative
resection after (radiological) staging without DL. The incidence, reasons of
unresectability and the accuracy of radiological imaging for distant metas-
tases were assessed.
Results. A resection was performed in 300 patients (68%), while 144
patients (32%) underwent a palliative bypass procedure (gastroenterostomy
and/or hepaticojejunostomy). A bypass procedure was performed in 76
patients (53%) due to locoregional tumour ingrowth and in 68 patients
(47%) due to distant metastases.
Conclusions. In patients undergoing explorative laparotomy for suspected
periampullary malignancy, 15% appears to have distant metastases peropera-
tively after preoperative staging without DL. Since the accuracy of DL in
detecting distant metastases is limited (around 60%), a diagnostic protocol
without routine DL is justified.
PZ 4.05
USEFULNESS OF LAPAROSCOPIC ULTRASOUND AND THE
IMPACT OF HEPATIC ARTERY LYMPH NODE BIOPSY IN THE
STAGING OF CANCER OF THE HEAD OF PANCREAS
Shah, Ankur J; Ledwidge, S; Teare, T; Alderson, D; Finch-Jones, Margaret
Bristol Royal Infirmary, Upper GI Surgery, Bristol, UK
Background. The role of laparoscopy combined with ultrasound (LUS) for
staging of pancreatic cancer is controversial. The survival of patients with
metastatic hepatic artery lymph node (HALN) is similar to other patients
with metastatic disease at presentation. We have analysed our experience of
LUS for staging cancer of head of the pancreas (CAHOP). Our recent
practice of HALN biopsy at laparoscopy was evaluated to assess the influence
on staging for unresectabiltiy.
Aims. To assess the role of LUS in the staging of CAHOP. To evaluate the
influence of HALN biopsy in altering the staging of pancreatic cancer.
Methods. Information was retrospectively collected over the last five years
from the regional multidisciplinary team (MDT) cancer database, patient
notes, operative and pathology records.
Results. 78 patients with CAHOP were put forward by the regional MDT
for further staging on the basis of computerised tomography (CT) scans
consistent with potentially resectable tumours. Histology or laparotomy
findings were used as the gold standard for measuring accuracy in most
cases. 9 patients were excluded due to medical reasons or patient choice.
The sensitivity, specificity, positive predictive value (PPV), negative pre-
dictive value (NPV) and accuracy for unresectability of pancreatic tumour
was 35%, 100%, 100%, 53% and 63% respectively. In a pilot study of
HALN biopsy to predict unresectability in 25 patients, the sensitivity,
specificity, PPV, NPV and accuracy for unresectability without HALN
biopsy was 13%, 100%, 100%, 43% and 48% respectively. With the
addition of HALN biopsy results these figures increased to 47%,
100%,100%, 56% and 68% respectively.
Conclusions. LUS is a useful tool in staging pancreatic cancer. In our series
LUS prevented a surgical exploration in a significant number of patients. The
addition of HALN biopsy during LUS increased the sensitivity and accuracy
in predicting unresectability, thereby complementing LUS in avoiding
unnecessary laparotomies.
PZ 4.06
GENETIC PREDICTION OF GEMCITABINE SENSITIVITY FOR
PANCREATIC CANCER PATIENTS
Sata, Naohiro1; Bai, Jianfeng2; Koizumi, Masaru1; Shimura, Kunihiko1;
Nagai, Hideo1
1Jichi Medical University, Surgery, Shimotsuke, Japan; 2The First Affiliated
Hospital of Nanjing Medical University, Surgery, Nanjing, China
Background & aims. In vitro drug-sensitivity tests have limitations and
disadvantages. The aim of this study was to use gene expression data to
predict the sensitivity of pancreatic cancers to gemcitabine.
Methods. Cancer cells isolated from 14 pancreatic cancer patients were tested
in vitro for gemcitabine sensitivity using the collagen droplet drug sensitivity
test (CD-DST). On the basis of this test, 9 of the 14 cancers were identified as
either gemcitabine-sensitive or gemcitabine-resistant. Total RNA was ex-
tracted from each of those nine cancers and used as templates to synthesize
Cy3-labeled cDNA. Pancreatic RNA extracted from six normal individuals
was used as control. Labeled probes were hybridized to an Atlas Glass Human
1.0 Microarray chip, after which the chips were washed and scanned, and the
data analyzed using Microsoft Excel-embedded software. The expression
profiles of selected genes were confirmed used real-time PCR analysis.
Results. Statistical analysis of the microarray data showed four genes were
significantly highly or lowly expressed in gemcitabine-sensitive cancers;
microsomal glutathione S-transferase 1 (GSTT1), topoisomerase II alpha
(TOP2A), caspase 3 and ATP-binding cassette and sub-family C member 2
(ABCC2). More than 20 other genes were additionally identified as possible
candidates associated with drug resistance.
Conclusions. Expression of drug resistance-related genes appeared to predict
whether a cancer was gemcitabine-sensitive or -resistant. Further study will
enable the establishment of a drug resistance scoring system using gene
expression. Such a system will allow more efficient application of chemother-
apy.
PZ 4.07
IMPROVEMENT OF DELAYED GASTRIC EMPTYING IN
PYLORUS-PRESERVING PANCREATICODUODENECTOMY:
RESULTS OF A PROSPECTIVE, RANDOMIZED, CONTROLLED
TRIAL
Yamaue, Hiroki; Tani, Masaji; Kawai, Manabu; Ina, Shinomi; Hirono, Seiko;
Nishioka, Ryohei; Miyazawa, Motoki; Uchiyama, Kazuhisa
Wakayama Medical University, Second Dept. of Surgery, Wakayama, Japan
Persistent complications of pylorus-preserving pancreaticoduodenectomy
(PpPD) have been reported and include pancreatic fistula, intra-abdominal
abscess, intra-abdominal hemorrhage, and delayed gastric emptying (DGE).
Background. The pathogenesis of DGE after PpPD has been speculated to
be related to factors such as inflammation, ischemia, gastric atony, motilin
levels, and type of surgical procedure. Previous retrospective studies have
shown a lower incidence of DGE after antecolic duodenojejunostomy. A
prospective trial is needed.
Objective. To determine if an antecolic or a retrocolic duodenojejunostomy
during PpPD was associated with the least incidence of DGE, in a prospective,
randomized, controlled trial.
Methods. Forty patients were enrolled in this trial between May 2002 and
April 2004 in Wakayama Medical University Hospital (WMUH). Just before
duodenojejunostomy during PpPD the patients were randomly assigned to
undergo either an antecolic or a retrocolic duodenojejunostomy.
Results. DGE occurred in 5% of patients with the antecolic route for
duodenojejunostomy versus 50% with the retrocolic route (P/0.0014).
Those with the antecolic route had a significantly shorter duration of
postoperative nasogastric tube drainage than did those with the retrocolic
route (4.2 days vs. 18.9 days, respectively, P/0.047). By postoperative day
14, all patients with the antecolic route could take solid foods, while only 55%
(11/20) of the patients with the retrocolic route could take solid foods (P/
0.0007). The length of stay in the hospital was 28 days for the antecolic group
versus 48 days for the retrocolic group (P/0.018).
Conclusions. Antecolic reconstruction for duodenojejunostomy during
PpPD decreases postoperative morbidity and length of hospital stay by
decreasing DGE. Our data suggest that PpPD with antecolic duodenojeju-
nostomy is a safer operation.
PZ 4.08
EARLY REMOVAL OF PROPHYLACTIC DRAINS REDUCES THE
RISK OF INTRAABDOMINAL INFECTIONS IN PANCREATIC
HEAD RESECTION: PROSPECTIVE STUDY OF 104 PATIENTS
Tani, Masaji; Terasawa, Hirosi; Ina, Shinomi; Hirono, Seiko; Nishioka,
Ryohei; Miyazawa, Motoki; Uchiyama, Kazuhisa; Yamaue, Hiroki
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Wakayama Medical University, School of Medicine, Second Dept. of Surgery,
Wakayama, Japan
Objective. The significance of prophylactic drains after pancreatic head
resection is still controversial. No report discusses the association of the period
of drain insertion and postoperative complications. The aim of this prospective
study was designed to determine whether the period of drain insertion
influences the incidence of postoperative complications.
Methods. One hundred and four consecutive patients who underwent
pancreatic head resection were enrolled in this study. To assess the value of
prophylactic drains, we prospectively assigned the patients into 2 groups:
group I underwent resection from January 2000 to January 2002 (n/52,
drain to be removed on postoperative day 8); group II underwent resection
from February 2002 to December 2004 (n/52, drain to be removed on
postoperative day 4). Postoperative complications in the 2 groups were
compared.
Results. The rate of pancreatic fistula was significantly lower in group II
(3.6%) than in group I (23%) (P/.0038). The rate of intra-abdominal
infections, including intra-abdominal abscess and infected intra-abdominal
collections, were significantly reduced in group II (7.7%) compared with
group I (38%) (P/.0003). Cultures of drainage fluid were positive in 16 of
52 (30.8%) patients in group I, and in 2 of 52 (3.7%) patients in group II
(P/.0002). Intraoperative bleeding (/1500 mL), operative time (/420
min, and the period of drain insertion were significant risk factors for intra-
abdominal infections (P/.043, .025, .0003, respectively). The period of
drain insertion was the only independent risk factor for intra-abdominal
infections by multivariate analysis (odds ratio: 6.7).
Conclusion. Drain removal on postoperative 4 was clarified to be an
important factor in reducing the incidence of complications with pancreatic
head resection, including intra-abdominal infections. (Kawai et al: Ann Surg
2006, in press)
PZ 4.09
RESCUE SURGERY FOR UNRESECTABLE PANCREATIC CAN-
CER DOWNSTAGED BY CHEMOTHERAPY
Eveno, Clarisse; Castaign, Denis; Vibert, Eric; Adam, Rene; Azoulay, Daniel
Hopital Paul Brousse (AP-HP), Centre Hepato-Biliaire, Villejuif, France
Background. Invasion of the superior mesenteric artery, hepatic metastases,
peritoneal carcinomatosis and invasion of distant lymph nodes are contra-
indications for surgical resection of pancreatic adenocarcinoma. Never-
theless, resection may become possible in highly selected patients following
downstaging of advanced disease by chemotherapy.
Objective. The objective of our study was to determine the postoperative
outcome and long-term survival of patients with advanced pancreatic
adenocarcinoma who had been downstaged by systemic chemotherapy.
Patients and methods. From May 1997 to December 2005, 195 patients
considered to have unresectable pancreatic adenocarcinoma (ADK) on pre-
operative imaging were offered systemic chemotherapy with protocols
including gemcitabine, oxaliplatin or cisplatine. In 10.8% (12 men, 6 women,
median age 56 years, range 4378) tumoral response to chemotherapy
allowed resectability after careful analysis of follow-up imaging. All these
patients had pathologically confirmed pancreatic ADK. Median time interval
between diagnosis and resection was 11.7 months. They were considered
unresectable at presentation due to invasion of the SMA (n/5), hepatic
metastases (n/6), enlarged coeliac lymph nodes (n/1) and peritoneal
carcinomatosis (n/1).
Results. Resection could be performed in all patients: 10 patients underwent
a standard Whipple procedure whereas a left spleno-pancreatectomy was
performed in 8 patients. Postoperative mortality was nil. Postoperative major
morbidity rate was 5.6%. Median survival was 23.5 months. With a median
follow up of 17 months (range 168) overall survival and disease free survival
at 1 and 3 years were 60%,30%, and 25%,18% respectively. Twelve patients
(60%) had recurrence: local (n/1), lymph node (n/4), lung (n/1), or liver
(n/5), and carcinomatosis (n/1).
Conclusion. Patients with unresectable pancreatic ADK downstaged by
chemotherapy should be re-evaluated in order to assess resectability. Surgical
resection in this population may result in prolonged survival.
PZ 4.10
IMPLICATION OF VENOUS DRAINAGE IN SIMULTANEOUS
PANCREAS-KIDNEY TRANSPLANTATION
Boggi, Ugo; Vistoli, Fabio; Croce, Chiara; Del Chiaro, Marco; Signori,
Stefano; Moretto, Carlo; Mosca, Irene; Amorese, Gabriella; Marchetti,
Piero; Rizzo, Gaetano; Mosca, Franco
Regional Referral Center for Treatment of Pancreatic Diseases, Pisa, Italy
Introduction. Portal venous drainage (PD), as compared with systemic
effluent (SE), improves the metabolic profile and reduces the occurrence of
acute rejection episodes (ARE) of simultaneous pancreas-kidney transplant
(SPKTx).
Methods. Data from 114 consecutive SPKTx were analyzed to determine
the implication of venous drainage (PD vs SE) on outcome, occurrence and
severity of ARE, and metabolic profile. Overall, 52 SPKTX with PD were
compared to 62 SPKTx with SE. The two groups were well matched for all
donor and recipient baseline characteristics and managed with equivalent
immunosuppressive regimens: low-dose steroids, basiliximab (48 SE vs 51
PD) or thymoglobulin (14 SE vs 1 PD; p/0.001), cyclosporine (35 SE vs 26
PD) or tacrolimus (27 SE vs 26 PD), and mycophenolate mofetil.
Results. The rate of delayed endocrine pancreas function was 8.1% in SE vs
0% in PD (p/0.04). Equivalent figures for the kidney were 11.3% vs 11.5%,
respectively. Initial hospital stay averaged 37 days in SE vs 29 days in PD.
Overall, 13 recipients (11.4%) required a relaparotomy during the first 3
post-SPKTx months (SE 11.3% vs PD 13.5%), including 3 allograft
pancreatectomies (2.6%) due to vascular thrombosis (2 SE vs 1 PD). One
patient from either groups died from sepsis, although the overall incidence of
infection was higher in SE (45.2%) vs PD (19.2%) (p/0.003). Twenty-seven
(43.5%) ARE were recorded in SE vs 13 (25.0%) in PD (p/0.04). Glycemic
control was excellent in both groups, but fasting serum insulin levels were
significantly lower in PD. One-year patient and kidney survival were
equivalent in SE vs PD (93.1% vs 94.1% and 89.4% vs 92.3%, respectively).
Pancreas graft survival, on the contrary, was improved with PD (90.4%) as
compared with SE (86.1%) (p/0.05).
Conclusion. Our experience shows that PD is not detrimental for SPKTx
recipients and can actually be associated with immunologic and metabolic
advantages.
Biliary Posters
P1.01
DOES ENDOSCOPIC ULTRASOUND HAVE ANYTHING TO OF-
FER IN THE DIAGNOSIS OF SUSPECTED COMMON DUCT
STONES?
Frost, Ben1; Lewis, Wyn1; Morris-Stiff, Gareth2; Webster, Phillip2; Puntis,
Malcolm2; Roberts, Ashley2
1Royal Gwent Hospital, Newport, UK; 2University Hospital of Wales,
Cardiff, UK
Background. The advent of endoscopic ultrasound (EUS) in the 1990s
provided an alternative to endoscopic retrograde and magnetic resonance
cholangiopancreatography (ERCP/MRCP) in the evaluation of the biliary tree.
Aims. To assess the value of selective EUS in the diagnosis of gallbladder and
common bile duct (CBD) stone disease in patients with negative conven-
tional imaging.
Methods. All patients undergoing biliary EUS between January 2000 and
December 2004 were identified from the radiology computerised database.
Forty-two patients (25 male, mean age 539/3.2 years) with negative prior
USS, CT and MRCP underwent EUS to evaluate for the presence of
gallstones or microlithiasis. Prior and later radiological investigations,
hospital readmission, and the need for further surgical intervention were
also analysed.
Results. EUS was normal in 17 patients and demonstrated signs of recent
acute pancreatitis in 8 patients. Cholelithiasis or microlithiasis was identified
in 14 patients, and choledochal stones in 6 patients. In 1 patient, calculi were
seen in the CBD but not the gallbladder. In a further case with recurrent
acute pancreatitis, chronic pancreatitis was diagnosed on EUS. All patients
with CBD stones underwent ERCP and sphincterotomy, and stones were
universally confirmed. One patient with gallbladder calculi alone underwent
cholecystectomy and the latter developed jaundice whilst awaiting cholecys-
tectomy and underwent ERCP which demonstrated CBD microlithiasis. No
patients with a normal EUS have subsequently been diagnosed with
cholelithiasis.
Conclusions. EUS provided additional diagnostic information in 16 of the
41 (39%) patients. Moreover, exclusion of gallstones/microlithiais is also
important as it facilitates a search for other causes of pancreatitis. In
conclusion, most cases of cholelithiasis can be diagnosed with standard
imaging modalities but when these fail to identify a cause, EUS has an
important role.
P1.02
A SURVEY OF CURRENT SURGICAL TREATMENT OF ACUTE
GALLSTONE DISEASE IN THE WEST OF SCOTLAND
Campbell, Jenny; Montgomery, David A; MacKay, Colin J; Carter, Ross;
Cooke, Timothy G
Glasgow Royal Infirmary, Dept. of Surgery, Glasgow, UK
Background. Acute cholecystitis and acute pancreatitis are two potentially
life threatening complications of gallstone disease. There are national
guidelines for the treatment of gallstone pancreatitis, but none exist for the
management of acute cholecystitis (AC). Consequently, the management of
AC is subject to great variation.
Aims/Objectives. To establish the preferred management of uncomplicated
AC and adherence to the guidelines for management of mild gallstone
pancreatitis among all consultant surgeons in the West of Scotland.
Methods. A postal survey of all 100 consultant general surgeons in the West
of Scotland.
Results. 71 responses were received. 67 of these were suitable for further
analysis. For uncomplicated AC, 24 (36%) perform urgent laparoscopic
cholecystectomy (LC), 16 (24%) perform same admission LC after clinical
improvement. 23 (34%) perform interval LC after discharge. Within this
group, 9 surgeons (13% of all replies analysed) manage AC conservatively
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due to insufficient operating time or equipment when on call. Factors found
to increase the likelihood of carrying out same admission LC are undertaking
regular laparoscopic work, being an upper GI surgeon and being a vascular
surgeon. In mild gallstone pancreatitis, 33 (49%) would perform same
admission LC, 13 (19%) would perform sphincterotomy, 3 (4.5%) would
perform one of these, depending on the patient and 6 (9.5%) would refer to
an upper GI colleague.
Conclusions. Uncomplicated AC and mild gallstone pancreatitis are
conditions managed by all subspecialties within general surgery in the West
of Scotland. The majority of surgeons (over 60%) now manage AC with same
admission LC. Of those who do not, more than a third report lack of
resources as being the reason. The vast majority of surgeons in the West of
Scotland perform urgent cholecystectomy or prophylactic sphincterotomy for
mild gallstone pancreatitis as per current guidelines.
P1.03
ABCB4 GENOTYPING IN YOUNG ADULTS WITH SYMPTO-
MATIC CHOLELITHIASIS
Labori, Knut J1; Nakken, Karl E2; Eiklid, Kristin3; Raeder, Morten G2
1Ullevaal University Hospital, Department of Gastroenterological Surgery,
Oslo, Norway; 2Ullevaal University Hospital, Institute for Experimental
Medical Research, Oslo, Norway; 3Ullevaal University Hospital, Department
of Medical Genetics, Oslo, Norway
Background. Monogenic subtypes of cholelithiasis appear to be rare.
ABCB4 gene mutations and low biliary phospholipid concentration have
been associated with symptomatic and recurrent cholelithiasis in young
adults. Few human association studies have characterized the ABCB4 gene in
patients with symptomatic cholelithiasis.
Aims. To describe the frequency and types of ABCB4 gene mutations and
variations in patients with symptomatic cholelithiasisB/40 years of age
undergoing laparoscopic cholecystectomy.
Methods. Thirty-eight patients were included in the study (mean age 29
years). Genomic DNA was extracted form peripheral white blood cells. Exon
6 to 32 in the ABCB4 gene were sequenced.
Results. Mutations were detected in three of 38 patients (7.9%): Patient 1:
heterozygous for c.523A/G resulting in an amino acid change from Thr to
Arg (T175A). Patient 2: heterozygous for c.3136C/T resulting in a change
to a stop codon, R1046X. Patient 3: heterozygous for c.1399_1400 ins10, an
insertion of 10 base pairs in the reading frame leading to a frameshift,
N466fs, which can lead to an early stop codon and termination of translation.
Heterozygous or homozygous variations were detected in 36 patients
(94.7%).
Discussion. Our preliminary results show that three of 38 patientsB/40
years of age with symptomatic cholelithiasis undergoing laparoscopic
cholecystectomy had ABCB4 gene mutations. Patient 1 had a mutation
that previously has been described. This mutation is associated with recurrent
biliary pain and extrahepatic cholesterol gallstones in the extrahepatic bile
ducts many years after cholecystectomy. The two other mutations have not
been described before.
Conclusion. Surgeons should be aware of the ABCB4 monogenic form of
cholelithiasis (low phospholipid associated cholelithiasis) for which research
laboratories offer genetic testing. Long term curative or prophylactic
ursodeoxycholic acid therapy could be initiated in these patients to solubilize
or prevent recurrence of cholesterol gallstones after cholecystectomy.
P1.04
EFFECTIVENESS OF THE LAPARO-ENDOSCOPIC ‘‘RENDEZ-
VOUS’’ TO TREAT CHOLECYSTO-CHOLEDOCOLITHIASIS.
EXPERIENCE WITH 61 CONSECUTIVE CASES
la Greca, Gaetano; Barabagallo, Francesco; Castello, Giorgio; Sofia, Maria;
Gagliardo, Salvina; Latteri, Saverio; Lombardo, Rosario; di Stefano, Andrea;
di Blasi, Michele; Russello, Domenico
University of Catania-Ospedale Cannizzaro Via Messina 829, Surgical
Sciences and Transplantation, Catania, Italy
Background. The management of patients affected by gallstones and
common bile duct stones is still a challenge as there are different successful
options. An alternative to both sequential approach or totally laparoscopic
treatments consists of the simultaneous laparo-endoscopic ‘‘Rendez-Vous’’
(RV) procedure which combines laparoscopic cholecystectomy, intra-opera-
tive cholangiography and endoscopic common bile duct clearance.
Method. The authors report their experience with the ‘‘Rendez-vous’’ in a
group of 61 consecutive patients aging 984. The relevant technical features
and the results concerning feasibility, effectiveness, safety, morbidity, post-
procedural hyper-amylasemia, time of the procedure, endoscopists compli-
ance and hospital stay are analyzed.
Results. The RV procedure was feasible in 59 patients (96,7%). The
effectiveness of the procedure was 100% concerning the clearance of CBD
stones, sludge, or and resolution of problems at the papilla. A transcystic
guide wire passage was necessary in only in 35,5% of the procedures. Minor
morbidity and mortality all unrelated to RV itself affected the same two high
risk patients 3,3%. The endoscopist considered that the laparoscopic help led
to easier and faster CBD clearance in 55.9% of the patients. The whole
operating time was prolonged by a mean of 16 minutes. Only three patients
(5%) developed asymptomatic pathologic increase of amilase (3/n.v) after
the procedure. The mean hospital stay was 3.6 days. Only one patient (1,6%)
had a recurrence of a stone.
Conclusions. This experience shows that the laparo-endoscopic approach is
always feasible and carries a very high effectiveness that is comparable or
better than those reported for both the sequential ERCP approach and totally
laparoscopic. The minimal morbidity render the procedure safer than the
other available and these results suggest that this approach could be the
preferable not only for the patient but also for the surgeon, endoscopist, and
the hospital.
P1.05
CAN SEX, AGE AND ASA GRADE BE USEFUL IN SELECTING
PATIENTS SUITABLE FOR DAY CASE LAPAROSCOPIC CHO-
LECYSTECTOMY (L.C.)?
Cain, Henry; Khout, Hazeem; Grayson, Louise; Farrell, Rory
Queen Elizabeth Hospital Gateshead, Surgery, Tyne and Wear, UK
Background. NHS directives and the opening of a surgical treatment centre
at this hospital illustrated the need to select patients who may be suitable for
day case L.C.
Aim. To ascertain if sex, age and ASA alone are useful in patient selection for
day case L.C.
Method. A case review of elective LC performed between April 2004
and April 2005 at this centre. An analysis of patient demographics, ASA,
length of post-operative stay (LOS.) and the reasons for prolonged
admission.
Results. 183 elective LC were reviewed, 87% of the patients were female.
The average age was 51.6 years (range 1687). The average post-op LOS
was 2.44 days, median/1 day, range/123 days. 81 patients LOS exceeded
1 day. The reasons for LOS /1 day are shown in the table. There was no
significant correlation between sex and LOS (p/1.0), and no correlation
between ASA and LOS (p/0.1) Length of stay was significantly associated
with patient age. In patients aged 65 years or less 61% of those went home the
next day in comparison to 32% of older patients (p/0.01). There was no
significant correlation between the patients ASA grade 1 aged less than 65
and LOS (p/0.1.).
Discussion. The consideration of age is useful when selecting patients
for day case L.C., though even in the patients aged 65 years or less, 39%
of them required a longer post op stay. Reasons for an extended stay
are varied and not predicted by sex, age and ASA alone. A further study into
the predictive value of BMI and the indication for surgery is currently in
progress.
Reason for LOS/1 day. Number of Patients.
Converted to open 18
High drain output 16
Pain 11
Nausea/vommiting 9
Medical condition 9
Social reasons 5
Re-operation 2
Not documented 11
Total 81
P1.06
DAY CASE LAPAROSCOPIC CHOLECYSTECTOMY CAN BE
SUCCESSFULLY PERFORMED IN AN UNSELECTED PATIENT
GROUP
Smith, Marty; Ariyarathenam, Arun; Misra, Nikhil; Hardwick, Richard;
Dwerryhouse, Simon
Addenbrookes Hospital, Oesophago-Gastric Centre, Cambridge, UK
Background. Day Case Laparoscopic Cholecystectomy (DCLC) is increas-
ingly being used in the NHS for patients with symptomatic cholelithiasis but
some studies have suggested restricting its use. Criteria such as high BMI, age
/55 yrs, thick Gall Bladder (GB) walls and large stones have been shown to
be predictors of admission after DCLC. However, many patients will not be
eligible for DCLC if these criteria are applied. To utilise our Day Surgery
facilities for DCLC effectively, we have include all patients with gallbladder
disease deemed fit enough with adequate social support. Here we examine
the early outcomes in a cohort of patients undergoing DCLC.
Methods. Patients were identified from Theatre and Hospital Databases as
having undergone DCLC between 1/7/2001 and 30/1/2006. A retrospective
case note audit of these patients was undertaken. Thick walled GB’s were
classified as those with a wall thickness of 3 mm or above and large gallstones
as those above 10 mm on ultrasound. All patients were booked to have
DCLC in our Day Surgery Unit but could stay up to 23 hrs-an overnight
stay.
Results. One hundred and sixty two (n/162) patients were identified (31
M:131 F). Median age was 46 years (range 1774); Median BMI was 28
(range 1945). 129 (80%) patients were referred with biliary colic and 18
(11%) after cholecystitis. Fifty (36%) had thick walled GB, and 61 (38%)
had large stones. One (0.6%) patient was converted to open surgery for a
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duct stone. 89 (55%) were discharged on day of surgery; 68 (42%) stayed
overnight and five patients (3%) were admitted. In the first year all of patients
stayed overnight but this fell to 35% in the fifth year.
Discussion. Our results suggest that relaxing the selection of patients for
DCLC has not negatively affected the LOS. Conversely, we have been more
able to discharge patients on the day of procedure across this series. We
attribute this to better informed patients and improved practices in the Day
Surgery Unit. We advocate a non-selective policy of DCLC for symptomatic
gallstones.
P1.07
EARLY ENDOSCOPIC RETROGRADE CHOLANGIOPANCREA-
TICOGRAPHY AFTER CHOLECYSTECTOMY: INDICATIONS
AND OUTCOMES
Karigiri, Ajay; Roberts, Ashley; Thomas, Gareth AO; Scott-Coombes,
David; Rees, Brian; Clark, Geoff WB
University Hospital of Wales, Cardiff, UK
Introduction. Cholecystectomy is the standard of care for patients with
gallstone disease. In the majority the procedure is uneventful. The perfor-
mance of an unplanned Endoscopic retrograde cholangiopancreaticography
(ERCP) in the post operative period is likely to be a marker for those patients
in whom the procedure was associated with complications.
Aim. To determine the indications for post operative ERCP and the
interventions performed.
Methods. Retrospective 3 year study (Jan 02-Dec 04). The study comprised
all patients who had a cholecystectomy for gallstones. Data was collected
using ICD codes, patient management system and case-notes.
Findings. In total 1248 patients had a cholecystectomy performed by a
group of 12 surgeons. In 987 the procedure was laparoscopic and in 261,
open. Fifty two patients had on-table cholangiography (4%). Twenty four
patients underwent open common bile-duct exploration. There were 3 bile-
duct injuries, one recognised intraoperatively and 2 at post operative ERCP.
Fifty six patients underwent a post-operative ERCP (4.5%). The most
common indication for ERCP was persistent pain and deranged liver
function tests. Thirty six ERCPs were performed within 2 weeks of the
operation and most within 6 weeks.
ERCP Findings. CBD calculi (25), bile leak (11), bile duct sludge (12),
normal (8). CBD calculi were managed by sphincterotomy, stone extra-
ction///stenting while patients with sludge/debris underwent a
sphincterotomy///stenting. Bile leaks were managed as follows:
Choledochojejunostomy/Bile duct repair 2
Left lateral sectionectomy 1
Small bowel fistula (stenting /TPN) 1
HIDA and antibiotics 1
Laparoscopic washout/ERCP stent 1
Sphincterotomy & stent 5
Conclusions. In our institution selective on table cholangiography was
performed in 4% of patients, endorsed by the findings of a low bile duct
injury rate of 0.24%. Post operative ERCP was requested in 4.5% of patients.
An abnormality was identified in 48/56 patients that was successfully
managed by therapeutic intervention with sphincterotomy, stone extraction
or stenting, while further surgery was only required in 3/56 (5.3%) of
patients.
P1.08
INSULIN ADMINISTRATION FURTHER DETERIORATES GALL-
BLADDER DYSMOTILITY IN NONOBESE DIABETIC MICE
Mathur, Abhishek; Al-azzawi, Hayder; Debao, Lu; Swartz-Basile, Deborah;
Nakeeb, Attila; Pitt, Henry A
Indiana University School of Medicine, Department of Surgery, Indianapo-
lis, USA
Background. Diabetes is a known risk factor for gallstone formation.
Previous studies from our laboratory have shown that gallbladders of
nonobese diabetic mice have decreased responses to neurotransmitters
compared to lean nondiabetic mice. Administering insulin to Type I diabetics
ameliorates the hyperglycemia. However, the effect of exogenous insulin
administration on gallbladder motility in Type I diabetes is unknown.
Aim. To determine whether injecting insulin to nonobese diabetic mice
would decrease resting gallbladder volume and improve in vivo and in vitro
gallbladder contractility.
Methods. 15 eighteen-week old nonobese diabetic mice were fed a lithogenic
diet for 4 weeks. 5 mice received daily intraperitoneal injections of NPH
insulin (0.5 Units/day). The remaining mice received an equal volume of
saline intraperitoneally. At 17 and 21 weeks of age mice were fasted overnight
and underwent an ultrasonography of the gallbladder to determine in vivo
resting volume and residual volume after an IP injection of 1 nmol/kg CCK.
At 22 weeks cholecystectomies were performed, and in vitro gallbladder
response to neurotransmitters was determined.
Results. No difference with respect to serum glucose or to gallbladder
resting volume, residual volume, or ejection fraction existed between groups
at 17 weeks. Insulin did not alter in vitro gallbladder responses. Results for
serum insulin, resting volume, residual volume, and gallbladder ejection
fraction at 21 weeks were:
Group Insulin (ng/ml) Resting
Volume (ul)
Residual
Volume (ul)
Ejection
Fraction (%)
Saline 0.19/0.1 559/4 79/2 899/2
Insulin 0.69/0.2* 379/10 179/4$ 549/13*
* pB/0.005 vs. Saline, $pB/0.05 vs. Saline
Conclusions. These data suggest that in nonobese diabetic mice daily
insulin 1) increases residual gallbladder volume, 2) decreases in vivo
gallbladder ejection fraction, but 3) does not alter resting gallbladder volume
or in vitro gallbladder contractility. Therefore, we conclude that insulin
paradoxically worsens gallbladder emptying which may increase the propen-
sity for gallstone formation.
P1.09
MIRIZZI’S SYNDROME-RESULTS FROM A LARGE WESTERN
EXPERIENCE
Gomez, D; Rahman, SH; Balasubramaniam, R; Prasad, KR; Toogood, GJ;
McMahon, MJ; Lodge, JPA; Guillou, PJ; Menon, KV
Leeds Teaching Hospitals NHS Trust, Leeds, UK
Background. Mirizzi’s syndrome is a rare complication of long-standing
gallstone disease.
Aim. We report our experience in a series of 33 patients with Mirizzi’s
syndrome who were managed at our institution over an 11-year (19942005)
period.
Methods. Patients with a definitive or possible diagnosis of Mirizzi’s
syndrome stated in radiology reports were identified using the hospital’s
radiology computer coding system.
Results. The median age of diagnosis was 70 (range: 3590) years and male
to female ratio was 15:18. Liver function tests on admission were deranged in
all our patients. Pre-operative diagnosis was achieved in 28 patients with USS
(n/4), CT scan (n/3), MRCP (n/10) and ERCP (n/11). The type I
Mirizzi’s syndrome was reported in 27 patients. Eighteen patients were
treated with laparoscopic cholecystectomy of which six patients were
converted to open cholecystectomy. Six patients had endoscopic biliary stent
insertion only and three were conservatively managed. Six patients had type
II Mirizzi’s syndrome of whom four patients were treated with cholecystect-
omy and Roux-en-Y hepaticojejunostomy. One patient underwent an open
subtotal cholecystectomy with closure of the gallbladder remnant and one
had a percutaneous biliary stent insertion only. The morbidity rate in our
study was 29% (n/8) and the mortality rate was 6% (n/2). The median
follow-up period in 18 patients was 2 (17) months. 10 patients are still
under follow-up.
Conclusion. We conclude that USS is an appropriate first-line investigation
followed by an MRCP in cases suspected to have Mirizzi’s syndrome. ERCP
should be reserved for patients that are unfit for surgery or require biliary
drainage prior to definitive surgery. Laparoscopic cholecystectomy for type I
Mirizzi’s syndrome is a feasible and safe option with a low threshold for convers-
ion to an open procedure. Type II Mirizzi’s syndrome can be treated with Roux-
en-Y hepaticojejunostomy or subtotal cholecystectomy with fistula closure.
P1.10
MOTOR INSURANCE COVER (MIC) AFTER LAPAROSCOPIC
SURGERY: THE NEED FOR GUIDELINES
Alhamdani, Ali; Mahmud, Sajid; Abdulkader, Henad; Rawat, Nihat; Alam,
Imran; Caplin, Scott; Brown, Tim Hudson
Morriston Hospital, General Surgery, Swansea, UK
Background. Following surgery patients are advised as to when they can
resume normal activities including driving. Laparoscopic cholecystectomies
(LC) allow faster post-operative recuperation and an earlier return to normal
activities. Doctors give differing advice regarding driving after LC. The aim
of this study was to assess whether insurance companies and the DVLA were
aware of the implications of LC and if they had any policies or guidelines in
recognition of these.
Methods. A telephone survey was conducted of 40 UK insurance companies
and the DVLA. The questionnaire covered their knowledge of LC and any
modifications in MIC related to this. The DVLA was asked if there was any
alteration in advice for driving after LC.
Results. 50% of insurers knew that laparoscopic surgery is utilised for
gallbladder procedures. None were aware of issues such as day-case LC,
reduced analgesia requirement and early return to normal activities. None
had altered their advice regarding the period of abstaining from driving in
recognition of LC relying on the operating surgeon to advise on this. The
DVLA did not recognise any potential difference for advice regarding driving
between LC or open procedures.
Conclusion. Insurance companies have negligible knowledge, understand-
ing or awareness of LC. Advice is ad-hoc and is not evidence based. There is
need to develop sound and specific guidelines for doctors who give advice
regarding when to drive after LC.
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P1.11
PREVALENCE OF SHOULDER TIP PAIN POST LAPAROSCOPIC
CHOLECYSTECTOMY AND LAPAROSCOPIC APPENDECTOMY
Kheradmand, Farhad1; Alam, Imran2; O Grady, Helen3; Cross, Ks4; Farrell,
Paul1; Hurley, Michael5
1Royal College of Surgeons Ireland, Anatomy, Dublin, Ireland; 2Morriston
Hospital, Surgery, Swansea, UK; 3Cork University Hospital, Surgery, Cork,
Ireland; 4Waterford Regional Hospital, Surgery waterford, Waterford, Ire-
land; 5Saint Lukes General Hospital, Surgery, kilkenny, Ireland
Background. Laparoscopic techniques have been used commonly for
number of abdominal procedures. Cholecystectomy remains the most
commonly performed laparoscopic procedure. Postoperative shoulder tip
pain (STP) occurs frequently following laparoscopic abdominal intervention.
Aims/Objectives. The aim of this study was to compare and contrast the
incidence and severity of post-operative STP following laparoscopic chole-
cystectomy and laparoscopic appendicectomy.
Methods. Data was collected prospectively. Fifty patients were recruited in
the group A (cholecystectomy group) and fifty in group B (appendectomy
group). Patient demographics, intra-operative events were recorded and a
specific post-operative questionnaire was filled.
Results. In the group A, 6% males and 94% were females, mean age was
37.5 years (range: 2173 years). The incidence of STP was 24%, mean
severity was 6.0 (median: 6.0 and range: 48) on visual analog score of 010
and mean duration was 5 days (median: 5, range: 121 days). 91% of
patients required analgesia. In the group B, 64% males and 36% were females
mean age was 29 years (range: 1669 years). The incidence of STP was 6%.
The mean severity of pain was 6 (median: 6 and range: 58) on visual analog
scale and mean duration was 6 days (median: 4, range: 114 days). 67% of
patients required analgesia. All patients with STP in laparoscopic cholecys-
tectomy group had bile spillage intraoperatively where as in the post
appendectomy group all the patients with STP had gangrenous appendix
and abscess.
Conclusion. In our study population, shoulder tip pain is more common
after laparoscopic cholecystectomy than laparoscopic appendicectomy.
Shoulder tip pain is a distressing phenomenon commonly requiring
analgesics post-operatively and sometimes delays the discharge. The possi-
bility of bile spillage intra operatively as a causative factor requires further
investigation.
P1.12
SELECTIVE MRCP REDUCES THE NEED FOR ENDOSCOPIC
CHOLANGIOGRAPHY AND SPHINCTEROTOMY IN THE MAN-
AGEMENT OF SUSPECTED COMMON BILE DUCT STONES
Mercer, Stuart; Singh, Sukhpal; Paterson, Iain
Frimley Park Hospital, Frimley, UK
Background. Diseases caused by gallstones in the common bile duct (CBD)
are a common cause of hospital admission. Opinion differs as to whether
endoscopic retrograde cholangiography with sphincterotomy (ERC&S) or
laparoscopic common bile duct exploration is the optimal treatment modality.
Methods. Gallstone disease is managed in our unit by 2 specialist upper GI
surgeons, who investigate suspected CBD stones according to an algorithm
including liver function tests, ultrasound and selective magnetic resonance
cholangio-pancreatography (MRCP). When indicated, the upper GI sur-
geons perform ERC&S; cholecystectomy is then offered if appropriate. This
study reviews all patients admitted in 2004 with suspected CBD stones.
Results. 156 patients were admitted with clinical and biochemical suspicion
of choledocholithiasis; 14 had previously undergone cholecystectomy. 62 of
142 patients with cholelithiasis and a high suspicion of CBD stones
underwent ERC&S, while 80 equivocal cases were investigated with
MRCP. MRCP confirmed CBD stones in 25 patients (31%), who subse-
quently underwent ERC&S; in 55 patients (69%) the MRCP demonstrated a
clear CBD, avoiding the need for ERC. In 14 patients with prior
cholecystectomy, 6 with a high suspicion of CBD stones underwent
ERC&S; MRCP in 8 equivocal cases demonstrated CBD stones in 2,
avoiding the need for ERC in the remaining 6. All 8 patients with CBD stones
underwent successful ERC&S and clearance of the CBD. Overall, ERC was
successful in 91 of 95 patients (96%), and CBD stones were demonstrated
and treated in 79 patients (87%). No patient suffered ERC-induced
pancreatitis or haemorrhage requiring transfusion.
Conclusion. MRCP with selective ERC&S is a safe and effective means of
treating suspected CBD stones, especially after previous cholecystectomy. It
remains a valid treatment strategy, particularly where the expertise, equipment
or theatre time for laparoscopic CBD exploration are not routinely available.
P1.13
SERUM ADIPONECTIN IN CHOLESTEROL AND PIGMENT
CHOLELITHIASIS
Lee, King-Teh
Kaohsiung Medical University Hospital, Dept. of Surgery, Kaohsiung,
Taiwan
Background. Altered adiponectinectinemia is asssociated with metabolic
abnormalities.
Aim. The purpose of this study was to explore the role of adiponectin
cholelithiasis.
Methods. Radioimmunoassay was used to analyze serum adiponectin levels
of 58 cholesterol and 47 pigment gallstone patients, and 101 healthy controls.
The chemical composition of extracted gallstones was determined by Fourier
transform infrared spectroscope.
Results. Adiponectin level was decreased in cholesterol gallstone patients
(7.62(4.07)mg/ml, pB/0.001) but elevated in pigment gallstone patients
(17.91(9.02)mg/ml, pB/0.001) when compared to healthy controls
(11.69(6.47)mg/ml). Hypoadiponectinemia (odds ratio 0.85, 95 per cent
confidence interval 0.76 to 0.96, p/0.008) and female gender (OR 6.06, 95
per cent c.i. 2.10 to 17.46, p/0.001) were associated with cholesterol
gallstone formation, while hyperadiponectinemia (OR 1.11, 95 per cent c.i.
1.01 to 1.22, p/0.025) and increased age (OR 1.06, 95 per cent c.i. 1.01 to
1.12, p/0.029) were associated with pigment gallstone formation. In
addition, elevated serum aspartate aminotransferase level was a determinant
of risk for both cholesterol (OR 1.16, 95 per cent c.i. 1.03 to 1.30, p/0.013)
and pigment gallstone (OR 1.23, 95 per cent c.i. 1.10 to 1.38, pB/0.001).
Conclusion. We demonstrated that altered serum adiponectin levels were
associated with gallstone formation and might serve as a novel marker for
cholesterol and pigment cholelithiasis.
P1.14
THE CHANGING PRACTICE OF EMERGENCY CHOLECYS-
TECTOMY FOR ACUTE CHOLECYSTITIS: TEN YEARS EXPERI-
ENCE
Ha, Joe P; Tsui, KK; Tang, CN; Yang, GP; Li, MK
Dept. of Surgery, Pamela Youde Nethersole Eastern Hospital, Hong Kong,
China
Background. Laparoscopic cholecystectomy is a gold standard for uncom-
plicated gallstone disease but whether it can totally replace open approach in
case of acute cholecystitis is uncertain.
Aim. To assess the outcome of emergency cholecystectomy for acute
cholecystitis and the changing practice from open to laparoscopic approach
in the past decade.
Methods. A cohort of 609 patients who underwent cholecystectomy for
acute cholecystitis within the period from January 1994 to December 2003
was evaluated. Perioperative outcomes of the patients in the first (group I)
and second halves (group II) of this period were compared. Factors
associated with mortality and morbidity were also analyzed.
Results. During the ten years period, there were 334 male and 275 female
with the mean age of 60 years (SD16). Open and laparoscopic cholecys-
tectomy (conversion rate of 19.7%) was performed on 117 and 492 patients
respectively. The overall mortality and morbidity were 0.8% and 15.3%
respectively. On univariate and multivariate analysis, medical comorbidities,
complicated cholecystitis (empyema and perforation) and open approach
were the significant predictors of morbidity, whereas, complicated cholecys-
titis was the only predictor of mortality. The two groups had similar
demographic and pathological characteristics. Group II had significantly
higher proportion of laparoscopic cholecystectomy (96.4% Vs 52.3%) and
lower conversion rate (15.0% Vs 35.4%). The mortality, overall, pulmonary
and biliary complication rate were similar in two groups but group II had
shorter total hospital stay (mean 8 Vs 10 days, pB/0.001) and operating time
(mean 79 Vs 90 minutes, pB/0.001) as well as less blood loss (mean 83 Vs
164 ml, p/0.008) and wound complication (1.8 Vs 7.9%, pB/0.001).
Conclusion. The perioperative outcome of emergency cholecystectomy has
improved in the past decade with the increased use of laparoscopic approach
and decrease in conversion rate. Complicated cholecystitis remains the key
factor in both mortality and morbidity.
P1.15
THE ROLE OF EARLY LAPAROSCOPIC CHOLECYSTECTOMY
IN SUBACUTE CALCULOUS CHOLECYSTITIS
Yu¨ksel, Osman; Salman, Bu¨lent; Akyu¨rek, Nusret; Yy´lmaz, Utku; Tatly´-
cy´oðlu, Ertan
Gazi University Medical School, General Surgery, Ankara, Turkey
Background. The treatment modality in the patients who refer in the first
72nd hour of the acute calculos cholecystitis is the early laparoscopic
cholecystectomy (EL). On the other hand the patients who refer later than
72 hours (subacute cholecystitis) are generally undergone interval laparo-
scopic cholecystectomy (IL).
Aim. For this reason we aimed to investigate the role of EL in the patients
with subacute calculous cholecystitis (SCC).
Patients and methods. The study was performed between January 2000-
February 2005. The patients whose symptoms had started 72 hours before the
admission but not more than 7 days were included in the study prospectively.
The patients were grouped as EL and IL group. EL was composed of the
patients who were undergone LC after the diagnosis, whereas IL was
composed of the patients who were cooled down and undergone LC after
812 weeks. Two groups were compared according to conversion to open
cholecystectomy, length of total hospital stay, post-operative complications,
dissection difficulty of Calot’s triangle and cost of treatment.
Results. There were 31 patients in EL and 43 patients in IL group. Length of
total hospital stay was longer in IL group (PB/0.05). Cost of treatment in IL
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group was higher than in EL group. Dissection difficulty of Calot’s triangle
score was higher in IL than the EL group (PB/0.05). In IL group urgent LC
was performed for 5 patients, choledocholithiasis and biliary pancreatitis
were seen in 4 and 2 patients respectively in the waiting period.
Discussion. Some patients in IL group are lack of success and also have
complications like recurrent cholecystitis attacks, biliary pancreatitis stones in
biliary system. Also there has been some cases that no cure has been seen in
the waiting period of SCC. Neovascularization, increased fibrosis are all
results of inflammation which mature in the waiting period that lead
dissection difficulty in Callot’s triangle.
Conclusion. As a result, EL can be performed confidently in selected SCC
patients.
P1.16
THE ROLE OF MRCP IN IMAGING THE AXIAL BILIARY TREE
IN PATIENTS WITH ACUTE GALLSTONE PANCREATITIS
Mofidi, Reza; Lee, Andrew C; Madhavan, KK; Garden, O James; Parks,
Rowan W
University of Edinburgh, Dept. of Clinical and Surgical Sciences, Edinburgh,
UK
Background. MRCP is an emerging modality in the management of acute
gallstone pancreatitis (AGP).
Aims. The aim of this study was to assess the impact of introduction of
MRCP in the management of AGP in a tertiary referral unit.
Methods. Patients with AGP from January 2002 to December 2004 were
reviewed to assess the impact of the introduction of MRCP in June 2003. The
indication for MRCP was suspected CBD stone in absence of biliary sepsis.
Definitive treatment for AGP was laparoscopic cholecystectomy, with ERCP
and sphincterotomy reserved for patients unfit for cholecystectomy and those
with biliary sepsis.
Results. 249 patients were identified of whom 36(14.5%) underwent ERCP
and sphincterotomy as definitive treatment. 96 patients with a non-dilated
CBD and normal or resolving LFTs proceeded to laparosocopic cholecys-
tectomy and IOC, 8(8.5%) of whom had CBD stones intraoperatively. Eleven
patients underwent cholecystectomy during pancreatic necrosectomy. Of
those undergoing preoperative diagnostic biliary tract imaging, ERCP was
undertaken in 57 patients and MRCP in 49 patients. There was no significant
difference in serum bilirubin levels [ERCP: 43 mmol/l (18204) vs MRCP 39
mmol/l (24180) (P/NS)] or the proportion of patients with CBD stones
between the two groups [ERCP: 10(17.5%) vs MRCP 7(14.2%) (P/NS)].
Patients who underwent MRCP had a shorter median hospital stay [MRCP: 5
days (range: 314) vs ERCP: 9(range: 420) days, (PB/0.01)] and higher rate
of cholecystectomy during the index admission [MRCP: 83.3% vs ERCP:
67.2%, (PB/0.05)]. There was full agreement between preoperative MRCP
results and findings of subsequent IOC or therapeutic ERCP.
Conclusions. MRCP is an accurate modality for imaging the axial biliary
tree in AGP. Selective use of MRCP reduces the need for ERCP and results
in shorter hospital stay.
P1.17
USEFULNESS OF HO-YAG LASER FOR THE TREATMENT OF
COMPLICATED CHOLECYSTO-CHOLEDOCHOLITHIASIS
Mizuki, Ichiro1; Hatada, Yasumasa1; Sasaki, Yoshio1; Shimoyama, Tadashi2;
Munakata, Akihiro2
1Aomori City Hospital, Aomori, Japan; 2Hirosaki University, Hirosaki, Japan
Background. Combination of endoscopic sphincterectomy (EST) and stone
extraction is commonly used as the first choice for the treatment of
choledocholithiasis. However, extraction of stones is difficult in some cases.
Particularly, some elderly patients with severe heart or lung disorders are not
able to receive both surgery and EST.
Aims. We examined the usefulness of percutaneous transhepatic cholangio-
scopic lithotripsy (PTCSL) with holmium-YAG (Ho-YAG) laser in the
treatment of cholecysto-choledocholithiasis in complicated patients.
Methods. During April 2004 and October 2005, 13 out of 187 patients with
cholecysto-choledocholithiasis underwent PTCSL using Ho-YAG laser. All
the 13 patients had difficulty for transpapillary access or high risks for
surgery. There were 9 males and 4 females, mean age of 77.5 (6191) years
old, 4 patients with cholecystolithiasis and 9 patients with choledocholithia-
sis. All the patients underwent PTBD or PTGBD when the patients were
diagnosed to have cholecystolithiasis or choledocholithiasis and decided as
the indication of PTCSL. At the time of PTBD or PTGBD, drainage tube of
18 Fr was inserted. One week after the insertion of the tube, PTCSL using
Ho-YAG laser was performed using cholangioscopy (Olympus, CHF type
240 or CHF type P-20). The treatment condition of Ho-YAG laser was 0.5
0.8 J and 5 Hz.
Results. PTCSL was successful and all stones were fragmented and cleared
in all patients. Mean treatment session was only 1.4 and no severe
complication, such as perforation, bleeding and damage of the bile duct,
was observed. Utilization of PTCSL with Ho-YAG laser enabled us the
complete lithotripsy in all the patients with cholecysto- choledocholithiasis.
Conclusions. If patients are considered as indication, PTCSL should be a
choice of the treatment before surgery or EST. Ho-YAG laser is an effective
and safe lithotriptor because operator can identify stones easily and move-
ment of the objects is small during the procedure.
P1.18
OPEN CHOLECYSTECTOMY: WHAT PLACE IN THE LAPARO-
SCOPIC ERA?
Jenkins, Paul J; Paterson, Hugh M; Garden, O James
Royal Infirmary of Edinburgh, Edinburgh, UK
Background. Laparoscopic cholecystectomy is the current treatment of
choice for symptomatic gallstone disease. Contraindications to the laparo-
scopic approach are diminishing as surgical technique and experience evolve.
What then is the place of open cholecystectomy in modern practice?
Methods. We reviewed data from our regional Surgical Audit database over a
5-year period from November 2000 to October 2005 and documented
reasons for choosing a primary open procedure as well as mortality data and
length of stay. Cases where open cholecystectomy was performed as part of a
hepatobiliary resection were excluded.
Results. In 5 years a total of 3181 patients underwent cholecystectomy of
which 358 patients (11.3%) underwent open cholecystectomy. Of these, 126
patients (35.2%) underwent primary open cholecystectomy9/bile duct
exploration whilst 232 (64.8%) were converted from a laparoscopic
procedure. The primary open cholecystectomy group was significantly older
than the laparoscopic group (mean 65 years vs. 52 years, pB/0.0001) and
comprised a significantly higher proportion of males (M:F ratio 1:1 vs. 1:3,
pB/0.0001). The 30-day (in-hospital) mortality rate was 4.8% (6 of 126
patients) vs 0.1% and median length of stay was 10 days (vs. 2 days). Reasons
documented for open surgery were known bile duct calculi (25 patients)
previous upper abdominal surgery (25 patients), emergency presentation
with peritonitis (24 patients), incidental procedure during laparotomy for
other non-hepatobiliary condition (22 patients) empyema/inflammatory mass
(12 patients) and suspected gallbladder malignancy (10 patients). The
annual rate of primary open cholecystectomy fell year-on-year from 8% in
2001 to 4% in 2005.
Conclusion. The role for primary open cholecystectomy appears to be
diminishing as experience in managing difficult cases laparoscopically
increases. Nevertheless, the procedure is likely to remain indicated in the
setting of emergency laparotomy, previous upper abdominal surgery and
suspected malignancy.
P1.19
DIFFERENCE IN COMPUTERIZED TOMOGRAPHY DENSITY
OF GALLSTONES IN BENIGN AND MALIGNANT DISEASES
Sharma, Ajay; Singh, Jagdish R; Vijayaragavan, Paari; Verma, Ashish;
Kathuria, Manoj; Kapoor, Vinay
Sanjay Gandhi Post-Graduate Institute of Medical Sciences, Dept. of
Surgical Gasteroentrology, Lucknow, India
Background. Gallbladder cancer (GBC) is associated with gallstones in
65% cases. Incidental GBC may occur in 0.11.5% of all cholecystectomies
done for benign gallstone disease. Cause and effect relationship between the
GBC and gallstones is not well established. Suspicion of GBC on ultra-
sonogram and contrast enhanced (CE) computerized tomography (CT) scan
relies on the increased gallbladder wall thickness. But a normal wall thickness
can’t exclude GBC.
Aims and objectives. To identify the difference in CT density of gallstones
in benign and malignant diseases and to predict the probability of malignancy
based on CT density.
Methods. Densities of GBC stones (n/30) and age-controlled chronic
cholecystitis (CC) stones (n/60) were measured by non-contrast (NC) CT
in vitro. Density was measured in hounsfield units (HU) at various sites in the
same stone (or group of stones) and a maximum and a minimum density
were recorded. All measurements were done by two blinded radiologists
separately.
Results. The mean maximum and minimum densities for GBC (/92.52 &
/331.42 HU, respectively) and CC (/347.37 &/391.04 HU, respectively)
were analyzed. There was significant difference between mean maximum
density (p/0.000) and between mean minimum density (p/0.001) of GBC
and CC. Significant correlation was also found between the maximum
density and the etiology (GBC or CC) with p-0.001, Exp B- 1.005, 95% CI-
1.002 1.008. The probability of predicting a GBC stone by CT density was
62% and that of CC stone was 82%.
Conclusions. There was a significant difference between density of GBC
and CC stones. The NCCT density of gallstone predicted the probability of
GBC.
P1.20
FEASIBILITY OF LAPAROSCOPIC CHOLEDOCHOLITHOTOMY
WITHOUT T-TUBE
Kurauchi, Nobuaki; Kimura, Jun; Hara, Yutaka; Suzuki, Shinsaku; Kasajima,
Hiroyuki; Moriya, Hiroshi; Tohyama, Shigeru
Hakodate Municipal Hospital, General Surgery, Hakodate, Japan
Background. Several different modalities are now available for treatment of
choledocholithiasis. The choice of each modality depends on endoscopists or
surgeons by their specialty. We had chosen laparoscopic treatment with several
manners in selected cases, and at the present time we mostly apply
laparoscopic choledochotomy and stone extraction without T-tube placement.
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Aim. To evaluate the safety and feasibility of laparoscopic choledocholithot-
omy via choledochotomy, the outcome of the operation is retrospectively
disclosed.
Patients and methods. We have treated 48 patients with choledocholithiasis
with several laparoscopic procedures since 1991. Male and female ratio is 16:
32, and mean age is 63 years old ranging from 18 to 90 years old. The
removal of common bile duct stones (CBD stones) and procedure-related
complications were documented.
Results. In 43 out of 48 cases, we could reach laparoscopic bile duct
exploration. Among them, the procedure of laparoscopic choledocholithot-
omy consisted from transcystic approach in 7 cases and transcholedochal
approach in 36 cases. Biliary drainage was set by cystic tube in 4 cases, by T-
tube in 4 cases and percutaneous transhepatic tube in 8 cases. Primary
closure was carried out in all transcystic approach cases, and in 32
transcholedochal approach cases. Transcholedochal approach with T-tube
placement has not been applied since 1996. Among the 43 cases with
attempting laparoscopic stone retrieval, it was successful in 39 cases (90.7%).
The mean (///SD) operation time was 216///84 minutes (97490 min),
and the mean (///SD) length of postoperative stay was 16.4///13.3 days
(378 days). Intraoperative complications were as follows: visceral injury
(duodenum, common bile duct), Postoperative complications were recorded,
including bile leak, stone remaining and biliary stricture needing post-
operative treatment in 3 cases (6.3%). However, the biliary stricture of
suturing site of choledochotomy occurred in one out of the 3 cases.
Conclusion. Laparoscopic choledocholithotomy via choledochotomy with-
out T-tube needs special attention of biliary stricture and surgical skill.
However, it can be performed relatively easily and safely without increasing
the considerable morbidity rate.
P1.21
OPEN AND LAPAROSCOPIC SURGERY VERSUS ERCP FOR
COMMON BILE DUCT STONES
Martin, David J1; Vernon, David2; Toouli, Jim3
1University of Heidelberg, Heidelberg, Germany; 2Flinders Medical Centre,
Adelaide, Australia; 3Flinders University, Adelaide, Australia
Background. 15% of patients having a cholecystectomy for gallstones have
common bile duct (CBD) stones. Treatment options for these stones include
pre- or post-operative ERCP, or open or laparoscopic (lap) surgery.
Objectives. To systematically review the clearance of CBD stones by 4
comparisons: (1) ERCP vs open surgery. (2) Pre-operative ERCP vs lap
surgery. (3) Post-operative ERCP vs lap surgery. (4) ERCP vs lap surgery in
patients with previous cholecystectomy.
Methods. Data from randomised trials from key databases were used to
conduct fixed- and random-effects models meta-analyses, with heterogeneity
and sensitivity analysis as required.
Results. 13 trials randomised 1351 patients. 8 trials (n/760) compared
ERCP with open surgery, 3 (n/425) pre-operative ERCP with lap surgery,
and 2 (n/166) post-operative ERCP with lap surgery. There were no trials
of ERCP vs lap clearance in patients without an intact gallbladder.
Methodology was adequate in at least 2 of 3 fields in 10 trials. Increased
procedures per patient was seen in ERCP arms of all 3 comparisons with
(WMD) differences of 0.62 (95% CI 0.15 to 1.09), 0.96 (0.96 to 0.96), and
1.09 (0.93 to 1.24), respectively. ERCP was less successful than open surgery
in CBD stone clearance (OR 2.89, 1.81 to 4.61) with a trend towards higher
mortality (OR 2.01, 0.72 to 5.60 P/0.18). Lap CBD stone clearance was as
efficient as pre- (OR 1.00, 0.53 to 1.80) and post-operative ERCP (OR 2.27,
0.37 to 13.9 P/0.37) and with equivalent morbidity and mortality. Lap trials
reported shorter hospital stays in surgical arms. Insufficient data were
reported for cost analysis.
Conclusions. In the era of open cholecystectomy, open bile duct surgery was
superior to ERCP in achieving CBD stone clearance. In the laparoscopic era,
surgery and ERCP are equally safe though further studies are required to
confirm this for choledochotomy as opposed to transcystic clearance. The use
of ERCP necessitates an extra procedure per patient.
P1.22
NMR STUDY OF GALLSTONES FROM MALIGNANT AND BE-
NINGN GALLBLADER DISEASES
Sharma, Ajay1; Srivastava, Madhulika2; Gowda, Nagana2; Kapoor, Vinay K1;
Khetrapal, CL2
1Sanjay Gandhi Postgraduate Institute of Medical Sciences, Department of
Surgical Gastroentrology, Lucknow, India; 2Sanjay Gandhi Postgraduate
Institute of Medical Sciences, Centre of Biomedical Magnetic Resonance,
Lucknow, India
Background. Gallbaladder carcinoma (GBC), Xanthogranulomatous cho-
lecystitis (XGC) and chronic cholecystitis (CC) are associated with gallstones
(GS). 13% of cholecystectomies done for GS disease turn out to have GBC
and about 6090% of GBCs are associated with GS. Detailed studies are
required to understand the differences in the composition of stones in benign
and malignant disease and its role in aetio-pathology.
Aim. To evaluate the biochemical composition of GS in GBC, XGC and CC
and hence to find the difference in the composition of stones of three diseases.
Methods. GS collected after cholecyctectomy from the age matched patients
of GBC (n/11) XGC (n/11) and CC (n/23), were analyzed. The
diagnosis was based on histopathological examination. GS were washed with
water, dried and used for analysis. Accuracy of cholesterol analysis in GS was
verified and the GS were analyzed for cholesterol using 1H NMR spectra of
pulverized GS dissolved in CDCl3. Calcium and magnesium were deter-
mined, simultaneously, via their EDTA (ethylenediaminetetraacetic acid)
complexes in aqueous extracts of GS using simple pulse 1H NMR. All NMR
experiments were performed on a Bruker Biospin Avance 400 MHz
spectrometer using 5 mm broadband inverse probe.
Results. Significantly less cholesterol (GBC -338.5, XGC-595.09, and CC
686.6), high calcium (GBC -1.62 XGC-0.27, and CC- 0.35) and magnesium
(GBC -0.19, XGC-0.02, and CC- 0.02) were observed in GS with GBC
compared to those in CC (pB/0.0001; pB/0.009 and pB/0.0001, respec-
tively) or XGC (pB/0.0001; pB/0.03 and pB/0.04, respectively); and in GS
between CC and XGC did not show any difference (p/NS, in all). All values
are measure in mg/g.
Conclusion. These marked differences in the GS composition of the
malignant and benign GS were obtained rapidly and accurately, using 1H
NMR.
Methods. These observations may be potentially useful in the light of
increasing interest in finding the molecular events involved in the study of
gallbladder carcinoma.
P1.23
IMMEDIATE AND LONG-TERM OUTCOMES OF HEPATECT-
OMY FOR HEPATOLITHIASIS
Lee, Ming-Hsien; Chen, Yao-Li; Lee, Tung-Yan; Ko, Chih-Jan
Chang-Hua Christian Hospital, General Surgery, Chang-Hua, Taiwan
Background. Surgical and nonsurgical procedures for management of
hepatolithiasis have been discussed.
Aim. The aim of this study was to evaluate the immediate and long-term
results of hepatectomy for hepatolithiasis.
Methods. Immediate and long-term outcomes of 123 consecutive patients
with hepatolithiasis who underwent hepatectomy from 2000 to 2005 were
analysed retrospectively.
Results. Acute cholangitis was the major presenting symptom (86.2%). The
immediate stone clearance rate was 92.7% and the final stone clearance rate
was 96% after subsequent T-tube route or endoscopic retrograde cholangio-
pancreatography (ERCP). Residual stone presented in 5 patients (4%). The
surgical morbidity and mortality were 33.3% and 1.6%, respectively. Three
patients had associated cholangiocarcinoma at the time of hepatectomy. With a
median follow-up of 40.3 months (range, 558), recurrent stone developed in
7 patients and cholangiocarcinoma developed in 2 patients. Ten patients had
died during the follow-up period, four patients died of recurrent stone with
sepsis.
Discussion. Hepatolithiasis is a common disease in East Asia. Though
uncommon in the West, it is being encountered with increasing frequency in
some Western countries, such as the United States. 1 To prevent the
immediate and late sequelae of hepatolithiasis, such as suppurative cholangi-
tis, septicemia, secondary biliary cirrhosis with resultant portal hypertention,
bleeding varices, and hepatic failure, 2 aggressive treatment is needed.
Conclusion. In conclusion, hepatectomy is a safe and effective treatment for
hepatolithiasis, with a high stone clearance rate and fair surgical complica-
tions. Recurrent stone had induced sepsis and cholangiocarcinoma compro-
mising the long-term survival in patients with hepatolithiasis.
P1.24
IMPACT OF SUBSPECIALISATION ON MANAGEMENT OF
ACUTE GALLSTONE DISEASE
Simpson, Duncan J; Wood, Alexander M; Paterson, Hugh M; Nixon,
Stephen; Paterson-Brown, Simon
Royal Infirmary of Edinburgh, Edinburgh, UK
Background. Subspecialisation is associated with improved outcomes in
elective major abdominal surgery but it is unknown whether this is true of
emergency surgery. Following reorganisation of upper and lower GI surgical
services within our region into separate hospitals we examined the impact of
subspecialisation on management of acute gallstone disease.
Methods. We performed retrospective analysis of the regional surgical audit
database comparing 30 months before and after reorganisation of services in
August 2002. All non-elective admissions with acute gallstone disease were
retrieved and analysed. The primary outcome measure was the proportion of
patients managed definitively at index admission.
Results. 1146 patients were admitted in the first period and 1335 in the
second. The proportion of patients treated definitively at index admission
(cholecystectomy, endoscopic sphincterotomy or cholecystostomy) increased
from 54% to 73% (pB/0.0001). Of those patients treated by cholecystectomy,
there was no change in the rate of laparoscopic cholecystectomy (88 vs.
89%), conversion from lap to open cholecystectomy (7% vs. 6%) or primary
open cholecystectomy (5% vs. 5%). The number of patients discharged for
subsequent elective management fell from 28% to 14% (pB/0.0001) whilst
those treated conservatively fell from 16% to 13% (p/0.037). Inpatient
mortality was unchanged (0.7% vs. 1.1%, p/0.37) and unplanned read-
mission fell from 7% to 5% (p/0.03).
Conclusions. Subspecialist management of acute gallstone disease achieved
definitive treatment at index admission in nearly 75% of cases without excess
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mortality and was associated with a significantly reduced unplanned read-
mission rate.
P1.25
REPEAT HOSPITAL ADMISSIONS WITH CHOLECYSTITIS IN
ENGLAND -2003/2004
David, Gerald; Al-Sarira, Ali; Corless, David J; Slavin, John P
Leighton Hospital, Dept. of General Surgery, Crewe, UK
Objectives. Acute cholecystitis is a common surgical emergency. Recent
literature suggests that acute cholecystitis is best managed by cholecystect-
omy preferably within 72 hours of admission. We set to analyse the
management of emergency admission with biliary disease in England and
to analyse predictors of repeat admission.
Methods. Hospital Episode Statistics (HES) data were obtained from The
Department of Health. The data was exported to an Access database for
analysis.
Results. There were 26,537 emergency hospital admissions with acute
cholecystitis or biliary colic between April 2003 and March 2004. The male
to female ratio was 1:2.5. The mean age of males at presentation was 62.9
years and of females was 54.1 years. There were 4786 emergency repeat
admissions with one or more further episode of acute cholecystitis/biliary
colic (18.04% of all admissions). In multivariate regression analysis, age was
identified as a factor to predict repeat admission (Age group less than 45
compared to age group more than 75, O.R 1.995 C.I 1.5232.613 P value B/
0.001). Gender played no role in predicting repeat admission (P value 0.39)
Four thousand eight hundred and seventy four patients (20.34% of all
patients) underwent cholecystectomy during their emergency admission
(Open cholecystectomy - 1749[35.88%], Laparoscopic cholecystectomy-
2789[57.23%] and Lap converted to open cholecystectomy-336[6.89%]).
Of these, 2549 patients (52.30% or 10.67% of all patients) underwent their
operation within 72 hours of admission.
Conclusion. In spite of mounting evidence of the safety of cholecystectomy
within 72 hours of admission, the majority of patients in England do not
undergo surgery within that time frame or that admission. A significant
proportion of patients are admitted as an emergency on a further occasion.
Age less than 45 strongly predicts a repeat admission.
P1.26
IMPACTED DORMIA BASKET, A RARE YET CHALLENGING
COMPLICATION OF ERCP
Abdurrahman, Abbas1; Matar, Zafer1; Alomair, Ahmad2; Alabdulkarim,
Yousof1
1King Fahad Medical City-Riyadh, General Surgery, Riyadh, Saudi Arabia;
2King Fahad Medical City-Riyadh, Gastroenterology, Riyadh, Saudi Arabia
Choledocolythiasis is a common surgical problem which can result as
a complication of cholelythiasis (secondary CBD stone) or as a Primary
CBD stone (De Novo stone formation), Nowadays a routine ERCP is done
for all patients with CBD stones or dilatation of the biliary tree
after ultrasound, for diagnostic and therapeutic purposes in the form of
drainage, stone extraction, sphencterotomy or stinting. . .etc. Most patients
tolerate ERCP very well and only experience mild discomfort which resolves
totally in few hours, only limited number of them develops serious
complication like bleeding, perforation, and pancreatitis and in extreme
condition even death can occur. One of the rare -but recognizedcomplica-
tions is an impaction of the Dormia basket while trying to retrieve a stone
from a CBD, this unusual complication is a challenging situation that
requires urgent action, and mandates unplanned surgical extraction which
end up most of the time with open cholecystectomy and exploration of CBD,
and retrieval of the basket & the stones. In this article we present one
challenging case of (Impacted Dormia basket in the CBD) & we review the
literature & scattered reports in concern with the same subject. We tried to
study all the alternative ways for dealing with such an emergency & we
provide our centre experience.
Methodology. We are presenting a case report with retrospective multi-
centric reported cases from three hospitals in Saudi Arabia. And we reviewed
the different opinions in management by literature review.
Results. Impacted dormia basket although operator dependent is a rare
complication of ERCP (around 0.8%) which most of the time is dependent
on the stone size and sphincterotomy, despite the fact that there are other
available options for removal of the impacted basket (ESWL, Endoscopic)
the surgical exploration of CBD and removal of the basket remains the best
and relatively the safest option.
CBD/Common bile duct
ERCP/Endoscopic Retrograde Cholangiopancreatography
ESWL/Extracorporeal shock wave lithotripsy
P1.27
SYMPTOMATIC RADIO-OPAQUE GALLSTONES IN THE LA-
PAROSCOPIC CHOLECYSTECTOMY ERA
Mahmud, Sajid; Alhamdani, Ali; Abdulkader, Henad; Alam, Imran; Caplin,
Scott; Brown, Timothy H
Morriston Hospital, Department of Surgery, Swansea, UK
Background. According to popular wisdom 10% of gallstones are radio-
opaque (RGS). Although an abdominal x-ray (AXR) is not a pre-requisite in
the assessment of gallstone disease, many patients, especially those presenting
acutely, will have had an AXR.
Aims. The aim of this study was to determine the local incidence of
symptomatic RGS and look at their clinical presentation and histology.
Methods. All notes of patients undergoing laparoscopic cholecystectomy
between Jan 2001 and Dec 2005 were reviewed and correlated with x-ray
records. If the patient had undergone an AXR in the 4 years preceding
surgery the report was verified. Other data reviewed included presentation,
serum calcium and histology.
Results. 1027 laparoscopic cholecystectomies were performed over the 4
year study period. 695 patients (68%) had undergone an AXR in the
preceding 4 years and 39 (5.6%) of these were reported to show RGS. In
this latter group the median age was 63 years (range 2589 years). 26 of
these patients (66%) presented with biliary colic or acute cholecystitis, but
in 13 patients (34%) the presentation suggested bile duct stones
(obstructive jaundice, pancreatitis or acute cholangitis). The gall bladder
histology was chronic inflammation in 35 (89%), acute on chronic
inflammation in 3 (7%) and moderate dysplasia in 1. Serum calcium
was normal.
Conclusion. The local incidence of RGS in patients with symptomatic
gallstones is 5.6% challenging the commonly quoted incidence of 10%. A
third of this group presented with findings suggestive of ductal stones, a
higher incidence than anticipated in the overall study population. The finding
of RGS on an AXR suggest the possibility of bile duct stones must be
considered.
P1.28
LAPAROSCOPIC CHOLECYSTECTOMY-A 9 YEAR EXPERI-
ENCE
Vergos, Orestis; Kosmadakis, Nikolaos; Katsouli, Ekaterini; Christopoulos,
Georgios; Xanthopoulos, Dimitrios; Aktypis, Dionysios; Palli, Erato; Kap-
sambellis, Paylos
Agios Dionysios Gen. Hospital, Surgical, Zakynthos, Greece
Aim. The aim of this study is to present our experience and the results in
laparoscopic surgery for biliary stones in a 9year period (19962005) on a
small Greek island (appr.50.000 pop.).
Material and methods. From March1996 to December 2005 totally 1000
patients underwent laparoscopic cholecystectomy due to chololithiasis. 714
were women (71,4%)1395 years old (M/53,2 yrs.) and 286 men (28,6%)
1788 years old (M/52,1 yrs). All patients were symptomatic and presented
with a various range of symptoms (biliary colic, dyspepsia, nausea etc.).
Patients with choledocholithiasis had ERCP and papillotomy prior the
cholecystectomy. All patients with calculous pancreatitis underwent surgery
at least 30 days after the ERCP. Finally patients with acute cholecystitis had
their gall bladder laparoscopicaly removed either the first 72 h. or at least a
month later. The hospital stay was 2472 h.
Results. 174(17,4%) patients had acute cholecystitis,12 (1,2%) hydrops,9
(0,9%) empyema and 11 (11,1%) adenomyomatosis.106 (10,6%) patents
had previous surgery in the abdomen, 139 (!3,9%) adhesions and in 18 cases
(1,8%) the surgery diverted to open cholocystectomy due to perioperative
difficulties(anatomic abnormal ities, hemorrhage, injuries of the external
biliary tree and stiff adhesions).82 (8,2%) patients were urgently operated the
day of their admission to the hospital. Mortality was 0% and morbidity 7,5%
(wound infection 57, bile leak 8, hemorrhage10) and there was no re-
operation.
Conclusions. Laparoscpic cholecystectomy is the treatment of choice for
chololithiasis and it can be also performed for acute cases without any major
clinically relevant differences in postoperative outcome, morbidity and
recovery. Key words. Chololithiasis, laparoscopic cholocystectomy, cholo-
cystitis, ERCP.
P2.01
ABDOMINAL WALL NECROSIS AFTER LAPAROSCOPIC CHO-
LECYSTECTOMY
Oms, Luis; Mato, Raul; Guell, Dolors; Sala, Joan
Hospital de Terrassa, Terrassa, Spain
Background. Abdominal wall necrotizing infections are characterized by
their severity, with mortality rates reaching 100% if diagnosis is delayed or
septic shock appears. Even though minimally invasive procedures would be
useful in preventing this kind of infection, some cases have been described
after laparoscopic procedures.
Methods. We report a 62-year-old man with an MBI of 45, supraventricular
tachycardia, high blood pressure and subcutaneous diffuse lipomatosis. He
underwent elective cholecystectomy after a mild gallstone pancreatitis.
Results. Pneumoperitoneum was created through a supraumbilical trocar.
Cholecystectomy was carried out without incident and the gallbladder was
removed through the supraumbilcal incision, with the cystic stump allocated
into the trocar. After an uneventful early postoperative period, some left-side
abdominal tenderness required analgesia. Abdominal exploration was nor-
mal. One day later, hypotension and oliguria were followed by dishwater
exudate in the supraumbilical incision. The patient was re-operated and
myonecrosis of the left abdominal wall was found. Cholecystectomy site and
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hollow viscus exploration excluded visceral injury. Wide debridement and
mesh placement were performed. Polymicrobial flora with Clostridium
perfringens were isolated in the muscular culture. Supportive treatment in
an ICU setting allowed repeated debridements and replacement of abdom-
inal wall prosthetic meshes. The patient was finally discharged after 64 days.
Discussion. Few necrotizing abdominal wall infections have been previously
reported in laparoscopic procedures, most of them after cholecystectomy.
Obesity appears to be a risk factor for these infections and could delay an
early diagnosis.
P2.02
ANTIHELICOBACTERIAL THERAPY FOR ACUTE DISEASES
OF HEPATOPANCREADUODENAL REGION
Lisienko, Valentina M; Vasilieva, Elena A
Ural State Medical Academy, Surgical Diseases, Ekaterinburg, Russia
Much attention is paid to elimination of helicobacterial infection (Hp-
infection) in treatment of diseases of organs of hepatopancreaduodenal
region and their complications.
Objective. To demonstrate significance and efficacy of antihelicobacterial
therapy (aHpt) in patients with acute diseases of hepatopancreaduodenal
region during preoperative and postoperative periods.
Results. aHpt used in complex postopetative treatment in 95 patients with
sutured duodenum perforated ulcer allows to decrease a number of post-
operative inflammatory complications by a factor of 2,4 and also to reduce
frequency of ulcer symptom recurrences by a factor of 5 (X2/22,208) in the
main group compared with the control group. There were no lethal cases. In
patients with benign obstructive jaundice and cholangitis due to cytological
examination of choledoch wall performed in our clinic the presence of
Helicobacter pylori bacteria was detected in 44% of cases against a
background of lymphoplasmatic infiltration. The high level of semination
was found in 50% of these patients. Reliable improvements of clinical and
laboratory rates were observed in all patients undergone aHpt in comparison
with control group patients. Considering anatamophysiological connection of
bile and pancreatic ducts and pressure prevalence in bile-excreting ducts
during obstruction of choledoch distal region we do not exclude the
connection of Hp-infection with the appearance of acute, in particular
purulent, pancreatitis. Therefore there is a chance of successful aHpt use in
treatment of acute and may be chronic pancreatitis.
Conclusion. aHpt is effective for postoperative treatment of patients with
sutured duodenum perforated ulcer and cholangitis and can be used effectivety
in patients with other diseases of organs of hepatopancreaduodenal region.
P2.03
ACUTE ACALCULOUS CHOLECYSTITIS (AAC): CHALLENGING
THE MYTHS
Iyer, Shridhar; Diddapur, Ravishankar; Huang, Eugene
National University Hospital, Surgery, Singapore
Background. Traditionally AAC is a disease that is commonly seen in
critically ill patients with high rates of morbidity. We observed several patients
presenting from the community with acute cholecystits without stones with no
severe co- morbid conditions.
Aim. To review the instituitional experience with acute acalculous cholecys-
tits.
Methods. A retrospective review of all patients with acute cholecystitis who
underwent surgery from Jan 2001 to May 2005, with a focus on acute
acalculous cholecystitis.
Results. 133 patients underwent surgery for acute cholecystitis during the
study period of which 11 patients (8.3%) had AAC. All patients were below 70
years of age,7 patients were below 60years and there were 9 males and 2 females
in this study. Overall 4 patients had no comorbidities. No patient was critically
ill or from ICU. Most patients presented with right upper outer quadrant
abdominal pain and only 3 patients had associated fever at presentation. 5
patients underwent laparoscopic and 6 had open cholecystectomy. 6 patients
had gangrenous gall bladder at surgery. Most patients underwent surgery
within 72 hours of presentation to hospital and discharged within 6 days of
surgery. There was no major post-operative morbidity or mortality.
Discussion. AAC is considered to be associated with a high morbidity and
mortality and is seen in critically ill patients in ICU setting. Our series
demonstrates that the traditional myths about AAC are unfounded and we may
see these cases in community setting. It is possible that the presentation,
morbidity and mortality may be no different from acute calculous cholecystitis.
P2.04
PYOGENIC ABSCESS: A REVIEW OF 36 CASES
Chan, Chi K1; Tam, Tak L1; Wong, John1; Lee, Kit F2; Lai, Paul B1
1Prince of Wales Hospital, Dept. of Surgery, Hong Kong; 2Prince of Wales
Hospital, Diagnostic Radiology and Organ Imaging, Hong Kong
Background. Pyogenic liver abscess (PLA) is an uncommon intra-abdominal
infection with significant morbidity and even mortality. Source of infection is
usually postulated to originate from biliary tract or large bowel.
Objective. To evaluate the outcome of different treatment for PLA and the
value of biliary tree and colonic work up for underlying cause.
Methods. Thirty-six patients with PLA who had percutaneous drainage, open
drainage or hepatectomy performed during 2004 to 2006 were identified. All
patients were offered investigation including magnetic resonance cholangio-
pancreatography (MRCP) or endoscopic retrograde cholangiopancreatogra-
phy (ERCP) for the biliary tract and colonoscopy or barium enema for the large
bowel. Case notes were evaluated.
Results. There were 24 male and 12 female. Age ranged from 39 to 89. Abscess
culture yielded klebsiella in 23 patients, E.Coli in 4, Strept. Milleri in 3 and
Citobacter in 1 patient, 5 had no growth. All had percutaneous drainage
initially, 10 required repeated drainage, 5 required open drainage or hepatect-
omy. There were 2 mortality with 1 patient died of advanced renal carcinoma
and 1 patient died of acute leukemia. All other patients recovered and
discharged home. Three patients declined further investigation. Nine patients
had known biliary tract disease. MRCP or ERCP were performed in 22
patients. Positive findings included 1 choledochal cyst and 1 gall stone. The
same 22 patients had further large bowel investigation except one who had
known colonic cancer. Positive findings included 6 diverticuli, 1 sigmoid cancer
and 4 colonic polyp (B/5 mm).
Conclusion. Percutaneous drainage would be the initial treatment option for
PLA with open drainage or hepatectomy for refractory cases. Significant
numbers of patients suffered liver abscesses would have biliary tree or colonic
pathology. Large bowel and biliary tree investigation to evaluate the etiology
would provide useful information for subsequent management.
P3.01
BILIARY PAPILLOMATOSIS: A DETAILED CLINICOPATHOLO-
GIC ASSESSMENT OF A RARE ENTITY
Evans, Ramona1; Sielaff, Timothy2; Freeman, Martin3; Mallery, Shawn3;
Batts, Kenneth4
1University of Minnesota, Pathology, Minneapolis, USA; 2Virginia Piper
Cancer Institute, Surgery, Minneapolis, USA; 3Hennepin County Medical
Center, Gastroenterology, Minneapolis, USA; 4Virginia Piper Cancer Insti-
tute, Pathology, Minneapolis, USA
Background. Biliary papillomatosis is a rare entity with evolving diagnostic
options.
Aim. To describe the clinical evaluation, management and histopathology of a
patient with unilateral biliary papillomatosis.
Methods. A 67 year old man developed painless jaundice. CTand MRI studies
revealed an intraductal mass at the hepatic duct bifurcation associated with
bilateral intrahepatic duct dilation and multiple filling defects in the left lobe.
Endoscopic retrograde cholangiogram (ERCP) with mother daughter cholan-
gioscopy confirmed the mass with multiple left sided papillomas and a normal
right hepatic duct and common bile duct below the cystic duct. Endoscopic
ultrasound showed no evidence of transmural bile duct wall invasion. Cytology
and biopsy at endoscopy revealed no evidence of malignancy.
Results. The preoperative evaluation predicted the surgical findings and a left
hepatectomy with en bloc radical bile duct resection was performed. Pathologic
evaluation revealed biliary papillomatosis with a dominant 4.5 cm left hepatic
duct villous adenoma, innumerable 0.10.7 cm intrahepatic biliary papillo-
mas, and obstructive duct dilatation/ectasia, but no malignancy. No abnorm-
alities in the gallbladder, cystic duct or distal common bile duct were seen.
Discussion. Biliary papillomatosis (BP) is rare condition characterized by
multiple papillomas of varying size and distribution involving the intra- and/or
extra-hepatic biliary system. It may represent the biliary counterpart of
intraductal papillary mucinous neoplasm (IPMN) of the pancreas. BP can be
unilobar or bilobar and may be associated with invasive carcinomas in 50
percent of cases. Preoperative evaluation with direct duct imaging can direct
complete surgical resection. Liver transplantation may be considered for
diffuse, bilobar disease.
Conclusion. Biliary papillomatosis is a rare condition that predisposes to the
development of adenocarcinoma. Cholangioscopy can play an important role
in patient selection and surgical planning.
P3.02
IS THERE ANY ASSOCIATION BETWEEN POLYMORPHISM
OF 5,10-METHYLENETETRAHYDROFOLATE REDUCTASE
(MTHFR) AND THE RISK OF CHOLANGIOCARCINOMA
Kwon, Chang-Il; Lee, Ji H; Choi, Ki H; Ko, Eun H; Ko, Kwang H; Hong, Sung
P; Hwang, Seong G; Park, Pil W; Rim, Kyu S
Bundang CHA General Hospital, College of Medicine, Pochon CHA
University, Gastroenterology, Sungnam, South Korea
Background. 5,10-methylenetetrahydrofolate reductase (MTHFR) is a key
enzyme of folate metabolism and DNA methylation. C677T polymorphism
of MTHFR, results in substitution of valine for alanine reduces the activity of
MTHFR and elevates the level of plasma homocysteine. In TT genotype of
MTHFR, increased risk of gastric cancer and esophageal cancer and decreased
risk of acute lymphocytic leukemia and colon cancer patients with increased
folate level have been reported. There was no data about association between
polypmorphism of MTHFR and risk of cholangiocarcinoma.
Aim. We have studied the genotype frequency of MTHFR and homocysteine
level of healthy controls and cholangiocarcinoma patients.
Methods. 102 controls (control group) without habitual abortion, cancer,
anemia, cerebrovascular accident and 79 patients with cholangiocarcinoma
(CCC group) diagnosed at Bundang CHA university hospital from May 2001
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to January 2006 were enrolled. DNA from control and CCC group was
genotyped for MTHFR using PCR-RFLP (restriction fragment length
polymorphism) method with the HinfI restriction enzyme.
Results. Ratio of male:female was 45:57 in control group and 46:32 in CCC
group, respectively. Mean age was 60.3 Y/O in control group and 67.3 Y/O in
CCC group. 30 patients with CBD cancer, 23 patients with Klatskin tumor, 16
patients with peripheral CCC, and 6 patinets with GB cancer were diagnosed.
In control group 677CC genotype was 36 (35.3%), 677CT was 51 (50.0%),
677TTwas 15 (14.7%) and in CCC group 677CC was 28 (35.4%), 677CTwas
37 (46.8%) and 677TT was 14 (17.7%)(p/0.842). Homocysteine level was
9.5///2.9 umol/L in control group and 8.7///4.2 umol/L in CCC group
(p/0.132).
Conclusion. MTHFR 677TT genotype is not statistically significant in CCC
patient compared with control. Homocysteine level is not significantly lower in
CCC patients than control. Conclusively, no association was found between
polypmorphism of MTHFR and the risk of cholangiocarcinoma in our study.
P3.03
INTRAHEPATIC CHOLANGIOCARCINOMA: A DIAGNOSTIC
AND THERAPEUTIC CHALLENGE
Lee, Kit F; Cheung, Yue S; Chan, Chi K; Wong, John; Lai, Paul BS
Prince of Wales Hospital, Surgery, Hong Kong
Background. Intrahepatic cholangiocarcinoma (ICC) is a rare tumor of liver
with very poor prognosis.
Objective. To review the presenting features and operative results for
resectable ICC, and to work out if there are better diagnostic and operative
techniques.
Patients & methods. From Jan 1997 to Dec 2004, 20 patients with ICC under-
went liver resection with curative intent. The final diagnosis was all confirmed by
histological examination of specimens. The pre-operative data, operative
outcomes, recurrence and survival data were reviewed retrospectively.
Results. There were 15 female and 5 male patients. Age ranged from 41 to 74
years (median/61). Fifteen patients (75%) presented with abdominal pain, 1
patient with cholangitis and 4 patients were asymptomatic. A palpable liver
mass was found in 6 patients (30%) and the rest of patients had no physical sign.
Tumor markers and hepatitis serology did not help in making diagnosis. The
appearances of ICC on ultrasound and CT scan were not conclusive. Without
pre-operative biopsy, only 2 patients were correctively diagnosed to have ICC
(10%). The pre-operative diagnosis was hepatocellular carcinoma in 7 patients,
indeterminate liver mass in 5, liver abscess in 2, haemangioma in 2, and
recurrent pyogenic cholangitis in 2. Major hepatectomies were required in 13
patients while 7 patients had resection of 2 liver segments or less. Lymphatic
dissection was not preformed in all cases. There were 3 operative mortality and
8 patients had complications. On follow-up of remaining 17 patients, 13
patients (76%) developed recurrence. Sites of recurrence included liver, lung
and abdominal lymph nodes. The 3-year and 5-year survival were 25% and 5%
respectively.
Conclusion. It is difficult to diagnose ICC pre-operatively without biopsy.
Despite aggressive liver resection, the incidence of recurrence was very high.
With our current data, concurrent lymphatic dissection and adjuvant che-
motherapy may be required for ICC.
P3.04
ENDOSCOPIC MICROWAVE COAGULATION THERAPY FOR
TREATMENT OF BILIARY METALLIC STENT (EMS) OCCLU-
SION
Ogata, Kenji; Maeshiro, Kensei; Yasunami, Yohichi; Ikeda, Seiyo
Dept. of Surgery I, Fukuoka University School of Medicine, Nanakuma,
Johnan-ku, Fukuoka, Japan
Background. In patients with obstructive jaundice caused by unresectable
malignant biliary tumors, insertion of the metallic stents (EMS) has become a
popular procedure for palliative treatment. Currently, one of major problems
includes occlusion of EMS after the placement. Optimal management of the
EMS occlusion remains to be determined. The purpose of this prospective
study was to evaluate the clinical efficacy of endoscopic microwave coagulation
therapy (EMCT).
Methods. Totally, 51 patients with malignant biliary obstruction were treated
with EMS. Among them, 9 patients ranged in age from 6296 years-old with
occluded EMS received EMCT. The causes of occlusion were tumor ingrowth
(n/7), acute obstruction (n/1), tumor bleeding (n/1). The average follow-
up period was 9.8 months (range 519 months). Patient survival and duration
of stent patency were examined.
Results. Four out of 9 patients received with EMCT underwent the EMS
removal. In 2 patients, additional stent was not required since the obstruction
was completely resolved by the EMCT. Plastic stent was successfully placed in
all 7 patients. The median length of stent patency after EMCTwas 6.6 months
(range 410 months). The median survival after EMCTwas 9.2 months (range
519 months). During the follow-up period, 8 patients died due to progression
of the underlying malignancy. For all patients who underwent EMCT, there
was no severe complication in association with EMCTand reocclusion was not
developed.
Conclusions. Thus, the present study shows that EMCT has beneficial effect
on immediate resolution of metallic stent occlusion. EMCT favors treatment of
tumor ingrowth as well as tumor bleeding into the EMS. EMCT may provide a
safe and less invasive procedure with an acceptable clinical outcome.
P3.05
ANALYSIS OF PROGNOSTIC FACTORS AFTER SURGERY FOR
GALLBLADDER CANCER
Ahn, Seung Ik; Lee, Kun Young; Lee, Kang Yeun
Inha University Hospital, Surgery, Incheon, Korea
Background. Gallbladder cancer, which is the most common malignancy of
the biliary tract, is frequently associated with poor prognosis.
Aim. The aim of this study was to evaluate outcomes with gallbladder cancer
according to the surgical treatment, pathologic stage, and prognostic factors.
Patients & methods. The medical records of 52 consecutive patients with
gallbladder cancer treated at our institution from June 1996 through June 2005
were reviewed retrospectively. Survival was analyzed using the Kaplan-Meier
method (mean followed period 60 months) and the log-rank test. Prognostic
factors were analyzed using Cox regression.
Results. Mean patient age was 67 years. Fiftysix percent of patients were
females. Twentyeight patients(56%) underwent curative resection (5 simple
cholecystectomies and 23 radical cholecystectomies). There were no proce-
dure-related deaths. The overall 5-year survival was 18%. Patients who
underwent curative resection had a higher 5-year survival rate (40%) than
patients who underwent palliative surgery(0%, P/0.0001). The palliative
surgery, high T stage, positive lymph node metastasis were significant factors
predictive of worse survival.
Conclusion. The good long-term survival may be achieved by an early
diagnosis and radical resection.
P3.06
ASSESMENT OFARTERIAL INFILTRATION BY CANCER OF THE
BILE TRACT USING ULTRASONOGRAPY WITH PULSE DOP-
PLER METHOD
Yazawa, Takehisa; Katagiri, Satoshi; Araida, Tatuo; Oota, Takehiro; Hamano,
Mie; Takeshita, Nobuhiro; Higuti, Ryota; Kodera, Yoshihito; Yamamoto,
Masakazu; Takasaki, Ken
Tokyo Women‘s Medical Univercity, Gastroenterological Surgery, Tokyo,
Japan
Introduction. Diagnosis of arterial infiltration in cancer of the bile tract system
is very important to determine whether curative resection is possible or not and
a surgical method. We sought to assess on ultrasonography with pulse Doppler
method whether the hepatic artery is involved in cancer of the bile tract system
or not.
Subject and method. We investigated the flow velocity and flow patterns in
the right, left and proper hepatic arteries in 21 patients with a cancer of the bile
tract system using pulse Doppler method. We hypothesized that the artery is
infiltrated by tumor if the change of waveform in pulse Doppler is found. We
statistically compared between these results and pathological findings.
Results. The rate of accuracy is 57.1% in all cases, is 22.2% in gallbladder
cancer, compared with pathorogical examination. That is 80.0% in bile duct
cancer.
Conclusion. It is suggested that ultrasoudgrahy examination with pulse
Doppler method for diagnosis of arterial infiltration is useful in bile duct
cancer, but in gallbladder cancer.
P3.07
CLINICAL COURSE OF GALLBLADDER CANCER DIAGNOSED
AFTER LAPAROSCOPIC CHOLECYSTECTOMY
Lim, Tae J; Kang, Koo J; Kim, Yong H
DongSan Medical Center, Keimyung University, Surgery, Daegu, South
Korea
Background. The survival rate of the gallbladder cancer is closely related to
the degree of invasion of cancer cells into the gallbladder wall. Surgical
treatment varies from simple cholecystectomy to hepato-pancreato-duodenec-
tomy(HPD).
Aims. This study evaluates clinical course of gallbladder cancer confirmed
after laparoscopic cholecystectomy(LC).
Methods. A total of 1919 laparoscopic cholecystectomies was performed
between March 1999 and February 2005 at the Dongsan Medical
Center, Keimyung University. Gallbladder cacner was suspected preopera-
tively in 103 patients and the diagnosis was confirmed in 16 patients
postoperatively. This study analyzed clinical characteristics, preoperative and
postoperative diagnoses, pathological findings, additional surgeries if any and
the survival rate according to their T stages. In T1 patients, tumor cells were
confined to the muscle layer, and in T2 patients, tumor cells extended beyond
the muscle layer.
Results. The mean age of 16 cancer patients was 67.8 and sexual distribution
was equal. Preoperatively malignancy was suspected in 12 patients
(polypoid mass), gallstone with cholecystitis in three and adenomyomatosis
in one. The tumor was confined within the mucosa in five patients(T1a),
invaded into the muscle layer in four(T1b) and extended beyond the muscle
layer in seven(T2). Additional surgery was performed in four of seven T2
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patients and one died of cancer recurrence. Three patients did not have
additional surgery and only one died of cancer recurrence. Two of nine T1
patients developed recurrences and these two patients had perforations during
laparoscopic cholecystectomy.
Conclusion. This study suggests that bile spillage during laparoscopic
cholecystectomy could be a prognostic factor for poor outcome. To get
guide-line to chosse laparoscopic cholecystectomy or open cholecystectomy
for the polypoid mass suspected malignancy prospective randomized study
with more patients is recommended.
P3.08
CLINICAL FEATURES OF MUCIN-PRODUCING BILIARY
TUMORS: COMPARISON WITH INTRADUCTAL PAPILLARY
CHOLANGIOCARICNOMA
Katayose, Yu; Oda, Akira; Masaya, Oikawa; Yamamoto, Kuniharu; Onogawa,
Toru; Mutoh, Mitsumsa; Unno, Michiaki
Tohoku Graduate School of Medicine, Hepato-Biliary-Pancreatic Surgery,
Sendai, Japan
Background. Biliary tumors with mucin hyper-secretion, ‘‘mucin-producing
bile duct tumors (MPBTs),’’ have not been clarified yet and not been fully
recognized yet in the world wide. Pathological classification is good because
pathologic features are related with prognosis. However, this classification is
impossible before resection.
Purpose. Here, we tried to find out the typical imaging and clinical features of
MPBTs associated with prognosis.
Methods. At first, we selected cases of similar MPBT like tumors form our
resested-intrahepatic cholangiocarcinoma cases. Criteria of MPBTs are as
follows: 1) retention of fluid in cystic lesions and/or markedly dilated ducts
radiographically, 2) confirmation of the fluid as mucin by percutaneous
transhepatic biliary drainage and/or endoscopic retrograde cholangiography
and/or in the surgically removed specimens, 3) arising from macroscopically
identifiable intrahepatic or extrahepatic bile duct, and 4) cyst formation and/or
dilatation of bile duct, like pancreatic IPMN (Yonezawa S. et al, Am J Surg
Pathol. 2004;28(3):32738).
Results. Thirteen cases are smililar to MPBTs. In those cases, three cases from
thirteen cases were suitable for MPBT criteria. Bile duct of hese cases were
dilated. This finding were associated with mucin-hypersecretion. MPBT in our
cases were arising from left side of bile duct. This mean some unknown stimuli
is there like hepatolithiasis.
Conclusion. MPBTs and intraductal papillary tumors of biliary tumors are
similar. Localization and macro type may be important. Therefore, 3D-CTand
cholangiography are useful for evaluation of prognosis.
P3.09
CLINICOPATHOLOGIC ANALYSIS OF EXTRAHEPATIC BILE
DUCT CANCER WITH A MICROSCOPIC POSITIVE DUCTAL
MARGIN
Han, Sung-Sik1; Jang, Jin-Young1; Kang, Gyeong-Hoon2; Yang, Sung-Hoon1;
Lee, Seung-Eun1; Lee, Kuhn-Uk1; Kim, Sun-Whe1
1Seoul National University College of Medicine, Surgery, Seoul, Korea; 2Seoul
National University College of Medicine, Pathology, Seoul, Korea
Background. Although the resection margin is known to be a predictive factor
for extrahepatic bile duct cancer, the clinical features and prognostic
significance of a microscopic positive margin have not been evaluated.
Objectives. To analyze the clinicopathologic features of extrahepatic bile duct
cancer with a microscopic positive ductal margin.
Methods. A total of 288 patients underwent surgical resection for
extrahepatic bile duct cancer between 1995 and 2004 and the clinico-
pathologic data of 45 patients with a microscopic positive margin
were reviewed retrospectively(median follow-up 21.9 months). Pathologic
slides were re-evaluated to confirm the resection margin status and the
result was classified as invasive carcinoma, carcinoma in situ (CIS), and
dysplasia.
Results. Four patients(8.9%) were excluded after histological re-evalua-
tion(3 no tumor, 1 dysplasia). According to tumor location, tumor was
present microscopically at the resection margin in 26.3%(30/114) of patients
after bile duct resection or hepatobiliary resection for proximal bile duct
cancer, and 6.3% (11/174) after pancreatoduodenectomy for mid or distal
bile duct cancer(pB/0.01). Of the margin(/) cases, proximal margin was
involved in 33 cases (80.5%), distal margin in 4 cases(9.8%), and both in 4
cases(9.8%). In 20 cases(6.9%), the frozen section diagnosis had changed
from negative to positive in a final report. Three patients(1 CIS, 2 invasive
carcinoma) were alive after 5 years after surgery and hemoradiation. In
patients with margins(/), the outcome was significantly better in patients
with residual CIS (n/12; median survival 44.3 months) than in those with
residual invasive carcinoma (n/29; median survival 18.7 months)(p/
0.020).
Conclusion. More objective standardized criteria are needed because it is
hard to confirm the histologic status of the ductal margin including frozen
section. Active surgical resection should be attempted because some patients
with positive margin could survive more than 5 years after resection and
chemoradiation.
P3.10
CLINICOPATHOLOGICAL FACTORS PREDICTING LONG-
TERM OVERALL SURVIVAL AFTER HEPATECTOMY FOR PER-
IPHERAL CHOLANGIOCARCINOMA
Jan, Yi-Yin1; Yeh, Chun-Nan2; Chen, Miin-Fu2
1Chang Gung Memorial Hospital/ Chang Gung UniversityG, Surgery,
Taoyuan, Taiwan; 2Chang Gung Memorial Hospital/ Chang Gung Uni-
versityG, Surgery, Taoyuan, Taiwan
Background. Peripheral cholangiocarcinoma (PCC) is clinically challeng-
ing because patients typically do not present until the disease is relatively
advanced. Three-year to 5-year survival rates even with resection thus remain
dismal. This study aimed to determine the clinicopathological factors for
predicting overall survival longer than 5 years in PCC patients treated with
hepatectomy.
Method. From 1977 to 1997, the clinicopatholgical features of 11 PCC
patients who underwent hepatectomy with long-term overall survival (group
A) were reviewed. Comparison was made with the clinical features and
factors influencing the outcome of 70 PCC patients who survived less than 5
years after hepatectomy (group B).
Result. Of 81 PCC patients undergoing hepatectomy, 11 (13.6%) were 5-
year survivors. The 81 PCC patients comprised 32 men and 49 women, with a
mean age of 56.0 years (range: 3483 years). Univariate analysis showed that
female gender, absence of physical findings, a higher percentage of presence of
mucobilia, early staged tumor, intraductal papillary tumor growth, and
curative hepatic resection were more frequent in group A patients than group
B patients. However, multivariate logistic regression analysis showed that
absence of physical findings, presence of mucobilia, early staged tumor, and
curative hepatic resection were the four independent factors differentiating
group A from B patients. The 1-, 3-, 5-, and 10-year survival rates of the
group A patients were 100%, 100%, 100%, and 40%, whereas those of the
group B patients were 46.0%, 9.5%, 0%, and 0%, respectively.
Conclusion. Absence of physical findings, presence of mucobilia, early
staged tumor, and curative hepatectomy could independently predict PCC
patients with long-term overall survival after hepatectomy.
P3.11
VALIDATION OF A NEW CLINICAL-BIOCHEMICAL-RADIOLO-
GICAL STAGING SYSTEM FOR GALL BLADDER CANCER
Shukla, Parul; Shrikhande, Shailesh; Ahire, Sanjay; Ravichand, CS
Tata Memorial Hospital, GI Surgical Oncology, Mumbai, India
Background. At the 6th World Congress of the IHPBA we had proposed a
new Staging system based on Clinical-Biochemical-Radiological parameters.
Aims/Objectives. To validate this Staging system in order to pre-operatively
predict the resectability and help in formulating treatment options.
Methods. Approximately 160 new patients having gall bladder cancer are
received annually at our centre. These include patients having resectable
disease, incidentally diagnosed (post-cholecystectomy) disease or having
advanced disease. These patients were evaluated within this new staging
system, which includes: the CT scan features, the presence/absence of
jaundice and the serum CA-19-9 tumour marker levels. The staging system
scores patients out of a maximum of 10 points (with a higher score suggesting
advanced disease and inoperability).
Results. The new staging system (which includes: Prescence of jaundice,
Elevated CA-19-9 and CT- scan features suggesting extension of disease
medially towards the porta hepatis/nodal disease) correlated very favorably
with predicting unresectability. 90% of the patients with unresectable disease
had at least one or more adverse factors on the staging system.
Conclusions. By pre-operatively staging the disease in these patients with
the proposed new system, it is possible for us to streamline treatment
strategies for these patients with objectives of predicting resectability and
prognostication. We believe that this system complements the existing TNM
and Nevin staging systems and provides a practical clinical based system.
P3.12
DIFFERENTIATION BETWEEN BENIGN AND MALIGNANT
HILAR BLOCKS USING LABORATORY AND RADIOLOGICAL
INVESTIGATIONS: A PROSPECTIVE STUDY
Saluja, Sundeep1; Sharma, Raju2; Pal, Sujoy1; Sahni, Peush1; Chattopad-
hyay, Tushar1
1All India Institute of Medical Sciences, Gastrointestinal Surgery, New
Delhi, India; 2All India Institute of Medical Sciences, Radiology, New Delhi,
India
Background. Preoperative determination of the aetiology of bile duct
strictures at the hilum is often difficult. We evaluated the diagnostic accuracy
of laboratory parameters and imaging modalities in differentiating between
benign and malignant causes of biliary obstruction at the hilum.
Methods. 58 patients (26 men) with a history of obstructive jaundice, liver
function tests and ultrasound suggestive of biliary obstruction at the hilum
were studied. They were evaluated with tumor marker assay (CA19-9), CT
and MRI/MRCP. A single experienced radiologist, blinded to the results of
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other tests, evaluated the imaging. The final diagnosis was made either from
histology of the resected specimen, operative findings or image-guided biopsy
in inoperable patients. A receiver operator characteristic (ROC) curve was
constructed for each laboratory parameter to determine the optimal
diagnostic cut-off to predict a malignant biliary stricture (MBS).
Results. 34 patients had a benign and 24 a malignant aetiology. The mean
age of benign patients was 38 years compared to 54 years for MBS. 47
patients were treated with surgery while 11 had ERC/PTC and stenting. The
ROC curve showed that a preoperative bilirubin level ]/8.4 mg/dl (sensitiv-
ity: 83.3%, specificity: 70%), alkaline phosphatase level ]/478 i.u. (sensitiv-
ity: 63%, specificity: 49%) and CA19-9 levels ]/100 U/L (sensitivity: 45.8%,
specificity: 88.2%) predicted a malignant stricture. The sensitivity, specificity
and diagnostic accuracy of MRI/MRCP (87.5%, 85.3%, 82.7%) was
marginally superior to CT (79.2%, 79.4%, 79.3%).
Conclusions. Patients with a bilirubin level ]/8.4 mg/dl and CA19-9 level
]/100U/L were more likely to have a malignant aetiology. MRI/MRCP was a
better imaging modality than CT.
P3.13
EFFICACY OF GEMCITABINE AND CISPLATIN COMBINED
CHEMOTHERAPY FOR GALL BLADDER CANCER
Nakamura, Noriaki; Teramoto, Kenichi; Noguchi, Norio; Kudoh, Atsushi;
Kurokawa, Toshiaki; Tanaka, Shinji; Kawamura, Tohru; Arii, Shigeki
Tokyo Medical and Dental University, Tokyo, Japan
Background. Although the first treatment of gallbladder cancer is an
operation, still sufficient results are not expected. Furthermore, in unresect-
able gallbladder cancer, a prognosis is very poor. We will report the
gemcitabine/cisplatin (GEM/CDDP) combined chemotherapy we have tried
recently.
Material and method. 34cases of gall bladder cancer were treated from
April, 2000 to December, 2005 in the department of Hepato-biliary
pancreatic surgery, Tokyo medical and dental university hospital. The three
weeks protocol of the GEM/CDDP chemotherapy tried mainly for the
unresected cases was that the CDDP (50 mg/mm2) was administrated
intravenously on the day 8, GEM (1000 mg/mm2) was on the both day 1 and
8 and no treatment was on the day 15. The radiological images and the tumor
marker (CEA and CA19-9) were examined RESULT: The number of
resected case was 22 (64.7%) among 34 cases. The median survival time
(MST) was about 12 months and the five-year probability of survival was
31.5%. According to the treatment, although MSTof 22 cases of the resected
group was about 23 months, in 12 cases of unresected group, about 7.2
month. This difference was significant statistically. Then, the GEM/CDDP
treatment was enforced as the chemotherapy against for unresected group.
The eight patients were enrolled in this chemotherapy group from December,
2004 to December, 2005. Average age was 70.6 years old. One case was an
adjuvant treatment after operation others were clinical stage IVb. Although
MST of a GEM/CDDP group is about seven months and the significant
difference was not statistically accepted to 3 months of MST in no
chemotherapy group before GEM/CDDP treatment trial, extension of
MST for about 4 months was seen. In the evaluation of efficacy, the overall
response rate was 42.8% (3 out of 7 cases). Adverse events were observed in
one case of reduction of blood platelet (Grade3) and 2 cases of leukocyto-
penia (Grade2).
Conclusion. This combined chemotherapy had few adverse events and was
good response rate(42.8%).
P3.14
EXPRESSION OF P63 IS A USEFUL INDICATOR OF POOR
PROGNOSIS AFTER RESECTION OF ADENOCARCINOMAS OF
THE GALLBLADDER AND PANCREAS
Yamamoto, Tatsuyoshi1; Oda, Koji2; Yamamoto, Hideo1; Hayakawa, Nao-
kazu1; Nagino, Masato2; Nimura, Yuji2
1Tokai Hospital, Surgery, Nagoya, Japan; 2Nagoya University Graduate
School of Medicine, Division of Surgical Oncology, Dept. of Surgery,
Nagoya, Japan
Background. p63, a homologue of the p53 family, has been reported to
be expressed mainly in squamous cell carcinoma, but rarely in adenocarci-
noma. There have been few reports about the relationship between the
immunohistochemical expression of p63 and the prognosis in adenocarcino-
mas of the gallbladder and pancreas. The aim of this study was to evaluate
whether p63 protein is a useful parameter of high-grade malignancy in these
diseas.
Methods. Tissue samples were obtained from resected specimens of patients
with adenocarcinoma of the gallbladder (n/91) and pancreas (n/19). The
monoclonal antibodies were p63 (clone A4A, Neomarkers) and cytokeratin
14 (CK14, squamous differentiation marker, clone LL002, Neomarkers).
Tyramide signal amplification system (NEN; Life Science Products) was
used for p63 immunostaining to plan augmentation of a signal. The tumors
were considered to have p63-high expression if 5% or more tumor cells
showed nuclear staining.
Results. High expression of p63 was evident in 46 patients with adenocarci-
noma of the gallbladder (50.5%) and in 14 with pancreatic adenocarcinoma
(73.7%). There were no differences in gender, age, tumor type, pN and pT
between p63 high expression (p63-H) and low expression (p63-L). The
immunoreactivity between p63 and cytokeratin 14 was not correlated. The
expression of p63 was not associated with the squamous differentiation of
adenocarcinomas. Patients in p63-H group had a poorer survival than these
in p63-L group; 3-year survival of 32.2% vs. 47.9% in gallbladder carcinomas
(p/0.047), 2-year survival of 7.1% vs. 66.7% in pancreatic carcinomas (p/
0.004). Our results suggest that high expression of p63 protein is associated
with high-grade malignancy.
Conclusion. In adenocarcinomas of gallbladder and pancreas; 1. p63
expression was not associated with squamous differentiation of adenocarci-
noma. 2. p63 expression was correlated with highly aggressive behavior of the
tumor and poor survival.
P3.15
FREQUENCY AND PROGNOSTIC SIGNIFICANCE OF OCCULT
DISSEMINATED TUMOUR CELLS IN PATIENTS WITH ADENO-
CARCINOMA OF THE PAPILLA OF VATER
Scheunemann, Peter1; Stoecklein, Nikolas H1; Rehders, Alexander1; Bidde,
Minu2; Knoefel, Wolfram T1; Hosch, Stefan B1
1Universita¨tsklinik Du¨sseldorf, Klinik f. Allgemein-, Viszeral- u. Kinderchir-
urgie, Du¨sseldorf, Germany; 2Universita¨tsklinikum Hamburg-Eppendorf,
Klinik f. Allgemein,- Viszeral- u. Thoraxchirurgie, Hamburg, Germany
Background. Occurrence of tumour relapse is frequent in patients with
carcinoma of the papilla of Vater despite the absence of residual tumour
detectable at primary surgery. Therefore it has to be assumed that current
tumour staging procedures fail to identify minimal amounts of tumour cells
disseminated to secondary organs, which might be precursors of subsequent
metastatic relapse. Objectives: The aim of the study was to assess the
frequency and prognostic impact of minimal tumour cell spread in lymph
nodes classified as ‘‘tumor free’’ in routine histopathologic evaluation.
Methods. A total of 41 ‘‘tumour-free’’ lymph nodes from 23 patients with
adenocarcinoma of the papilla of Vater who underwent curative tumour
resection (R0) were examined by immunohistochemistry with the mono-
clonal anti-EpCAM antibody Ber-EP4 for minimal disseminated tumor cells.
Results. Twelve 12 (29.3%) of the 41 ‘‘tumour-free’’ lymph nodes obtained
from 9 (39.1%) of the 23 patients displayed EpCAM-positive cells.
Univariate Kaplan-Meier survival analysis revealed that patients with
EpCAM-positive cells in lymph nodes tended to have both a reduced
relapse-free survival and overall survival. Six (66.7%) of 9 patients with
EpCAM-positive cells developed tumor relapse within a median time of 12
months and 5 (55.9%) of them died tumour-releated within a median time of
14 months compared to 5 (35.7%) and 4 (28.6%) of 14 patients without such
cells, respectively, with a median relapse-free survival and overall survival of
/15 months and /20 months, respectively. However, these differences were
not statistically significant (p/0.13 for relapse-free survival, p/0.11 for
overall survival).
Conclusion. Immunohistochemical assessment may refine the staging of
resected lymph nodes in patients with carcinoma of the papilla of Vater.
However, the presence of minimal disseminated tumour cells in lymph nodes
had no significant impact on the prognosis in these patients.
P3.16
GALLBLADDER CANCER-A CASE FOR AGGRESSIVE AND
RADICAL RESECTION
Chueng, Yue Sun; Lee, Kit Fai; Wong, John; Lai, Paul Bo San
Prince of Wales Hospital, Dept. of Surgery, Hong Kong
Background. Carcinoma of gallbladder (Ca GB) is a relatively rare
malignancy with a poor prognosis. Aggressive surgery had been shown to
improve long-term survival in a number of studies.
Aim. To review the experience in a single institute on the management of Ca
GB and to determine the prognostic indicators for long-term survival.
Methods. A retrospective review from January 1995 to Jan 2006 was
conducted for patients receiving surgery for Ca GB. Patient records, imaging
and pathology results were reviewed. Cholecystectomy was considered
curative in T1 tumor where cholecystectomy with segment IVb & V resection
and porta LN dissection were considered curative in more advanced disease.
Results. Forty-seven patients were included over a 11-year period. There
were 27 female and 20 male. Twenty-one patients (45%) had palliative
surgery where seven patients (15%) had exploration and biopsy only. Two
patients (4%) were treated with curative cholecystectomy without liver
resection. Seventeen patients (36%) had cholecystectomy with segment IVb
& V resection and porta LN dissection (T2/10, T3/7). The median
survival in curative resection group was 23 months as compared to 5 months
in palliative resection group. In univariate analysis, curative resection (PB/
0.001) and T-staging (P/0.028) were both significant prognostic indicators
for longer survival. By multivariate analysis, only curative resection remained
as independent prognostic factor of long-term survival (P/0.003). Com-
pared to non-curative resection, curative resection tends to have a higher 30-
day mortality (10.5% vs 7.1%, P/1.00) and operative complications (26.3%
vs 7.1%, P/0.102) although the difference did not reached statistical
significance.
Conclusion. Curative resection is important in determining long-term
survival for carcinoma of gallbladder and is independent of the T-staging.
Although it carries significant morbidity and mortality, it should be
considered in good risk patients.
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HILAR CHOLANGIOCARCINOMA: CURRENT MANAGEMENT
Saeki, Shuji; Takiyama, Wataru; Hirabayashi, Naoki; Hisamatsu, Kazuhumi;
Yamashita, Yoshinori; Mukaida, Hidenori; Sato, Yukio
Hiroshima City Asa Hospital, Surgery, Hiroshima, Japan
Introduction and aim. Hilar cholangiocarcinoma is generally considered to
be one of the most difficult malignant tumors with poor prognosis. Long-
term survival can be achieved only after surgical resection, when possible.
The aim of this study is to present our experience of the management of 29
patients with hilar cholangiocarcinoma.
Patients and methods. From April 1999 to December 2005, 31 patients
(men 21 women 10) with cholangiocarcinoma referred to our department.
The diagnosis was based on the clinical evaluation, laboratory tests, tumor
marker levels, and careful evaluation of the extent of the tumor(US, CT,
MD-CT, MRI, ERCP, PTCD, biliary fiber scope). 12 patients had resection
of all gross disease and 8 had negative hisotologic margins. Patiens underwent
left hepatectomy combained with caudate lobe resection, 8patients had Right
hepatectomy with caudate lobe resection. The 30-day mortality rate after
resection was 0%. 19 patients underwent non-surgical treatment(mainly self-
expandable metallic stent).
Results. The resectability rate was 38.7%. Overall survival rate for
patients with tumor resection ranged from 3 months to 3 years(median 14.8
months) and for patients with palliative treatment from 1 month to 30
months(median 5 months). The mean survival rate in patients with a negative
hisotologic margin was 15 months while in those with a positive margin it was
12.6 months.
Conclusion. An aggressive surgical approach is warranted in patients with
hilar cholangiocarcinoma because resection offers the only hope for long term
survival. Our findings emphasize the importance of achieving tumor-free
margin.
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HOW TO MANAGE BENIGN GALLBLADDER POLYPS?
Chae, Kwonmook; Yang, Binna; Park, Dongen
Wonkwang University Hospital, Dept. of Surgery, Iksan, Korea
Background. After the laparosocopic cholecystectomy became usual proce-
dure, operative indications about the gallbladder polyps have tendency to
widen.
Aims. In the case the patiens want to take operation immediately or dislike to
take regular follow up, we need to make a management guideline for the benign
gallbladder polyps except well known opertive indications.
Patients and methods. We analysed 106 patients with gallbladder polyps
retrospectively who were diagnosed preoperatively by ultrsound and CT from
Jan.-1991 to Jan.-2005. The gallbladder polyps which were suspected to the
gallbladder cancer strongly were excluded.
Results. Among the 106 patients, 87 patients were taken operation, polypoid
lesions disappeared during the follow up in 3 patients,and 16 patients didn’t
take follow up. The pathologic diagnosis of 87 operated cases were
pseudopolyp in 69 patients(79.2%) and true polyp in 18 patients(11.8%).30
patients were taken operation by the patient’s demand without any operative
indications. 19 patients received operation immediate after diagnosis and 11
patients during the follow up period. The pathologic diagnosis were
cholesterol polyp in 26 patients(86.6%), no polyp in 2 patients, and
adenomatous hyperplasia in 2 patients. The correlation of the polyp size and
the pathological dianosis were as follows. The polyps above 10 mm;19
patients(cholesterol polyp7, inflammatory polyp6, adenoma5, adenomatous
hyperplasia 1),the polyps between 5 mm to 10 mm; 39 patients(cholesterol
polyp28, inflammatory polyp1, adenoma 4, adenomatous hyperplasia 6), the
polyps below 5 mm; 29 patients(cholesterol polyp16, inflammatory polyp11,
adenomatous hyperplasia 2).
Conclusion. According to the abave results, we propose the regular follow up
examination is enough for the benign gallbladder polyps below 10 mm without
cancer risk. And we can recommend the regular follow up examination for the
gallbladder polyp patients who want to take immediate operation without
indication.
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IMMUNOHISTOCHEMICAL DEMONSTRATION OF C-KIT
PROTO-ONCOGENE PRODUCT IN GALLBLADDER CARCI-
NOMA
Tanaka, Shogo1; Tanaka, Hiromu2; Yamamoto, Takatsugu3; Takemura,
Shigekazu2; Uenishi, Takahiro3; Hai, Seikan2; Kubota, Daisuke1; Lee, Sang
Hun1; Matsuyama, Mitsuharu1; Shuto, Taichi4; Hirohashi, Kazuhiro4; Kubo,
Shoji2
1Joto Central Hospital, Dept. of Surgery, Osaka, Japan; 2Osaka City
University Graduate School of Medicine, Dept. of Hepato-Biliary-Pancreatic
Surgery, Osaka, Japan; 3Ishikiri Seiki Hospital, Dept. of Surgery, Higashio-
saka, Japan; 4Osaka City University Graduate School of Medicine, Division of
Graduate Medical Education and General, Osaka, Japan
Background. Although some gallbladder carcinomas are immunoreactive for
c-Kit, reasons underlying c-Kit expression and its clinicopathologic implica-
tions are still unknown.
Methods. Clinicopathologic records of 47 patients who underwent macro-
scopically complete gallbladder carcinoma resection were retrospectively
reviewed. Numbers of patients at pathologic stages I to IV according to
current TNM-based staging were 10, 5, 18, and 14, respectively. Immuno-
histochemical examination used monoclonal antibodies against c-Kit and CD
34 (progenitor cell markers), cytokeratin 19 (cholangiocyte marker), and
OCH1E5 (a hepatocyte marker). Control tissue samples included 5 cases each
of chronic cholecystitis, polyp, and adenoma. We investigated prevalence of c-
Kit immunoreactivity, clinicopathologic correlates, including microvessel
density and postoperative outcome, and possible mechanisms of c-Kit
expression.
Results. Cytoplasmic immunostaining for c-Kit was detected in 21 of 47
gallbladder carcinomas (45%), and 1 of 15 controls (diagnosis, chronic
cholecystitis). Young age patient was significantly associated with c-Kit
positivity, however, there were no significantly differences in incidence of
c-kit positivity among other variables, including tumor stage and outcome.
While, microvessel density was more frequent in c-Kit positive gallbladder
carcinoma compared with c-Kit negative gallbladder carcinoma. All 47 cancers
and 15 controls were unstained for CD34 and OCH1E5, but stained for
cytokeratin 7 and 19.
Conclusion. Gallbladder carcinomas positive for c-Kit are unlikely to arise
from immature cells, but may be associated with neovascularization. Angio-
genesis inhibitors, such as tyrosine kinase inhibitors, therefore might suppress
growth of some gallbladder cancers.
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INCIDENTAL CARCINOMA OF THE GALLBLADDER: DELAY IS
DETRIMENTAL!
Singh, S; Mandal, S; Chaudhary, A; Sachdev, AK; Sakhuja, P; Agarwal, Anil K
GB Pant Hospital & MAM College, Dept. of GI Surgery, Delhi, India
Background. Unsuspected Gall Bladder Cancer is reported on histology in 1
to 3% of Cholecystectomies. To compare patients of IGBC managed by
Completion Radical Cholecystectomy (CRC) Vs Patients of IGBC deemed
unresectable.
Methods. This study is an analysis of 79 patients of incidental carcinoma of the
gallbladder- who presented to our center over a duration of 4 years. The patients
underwent preoperative work to detect evidence of any residual disease or
evidence of distant metastatic disease. Patients with no evidence of distant
metastasis were taken up for surgery with the aim of performing Completion
Radical Cholecystectomy.
Results. 32 (40.51%) of the patients presented with obstructive jaundice, out
of which 25 underwent surgery, only one was resectable. 47 (59.49%) patients
did not have jaundice, 39 underwent surgery with a curative intent, 21 were
resectedwith a subgroup resectability 53.85% and an overall resectability rate of
27.85%. Out of the 22 patientswho underwent curative resection 19 underwent
segment IV B-V wedge resection of the liver with standard lymphadenectomy, 1
extended right hepatectomy 1 only lymphadenectomy and 1 wide local excision
of parietal wall tumor. 4 patients underwent duodenal sleeve resection, 5
underwent CBD excision and reconstruction in the form roux-en-Y hepatioc-
jejeunostomy, 2 distal gastrectomy and D1 resection, 2 underwent vascular
reconstruction and 2 right hemcolectomy also. There was 2 mortality out of
the 22 resected patients(6%). There was a post operative morbidity of 30%.
Patients who were resectable had a mean time to second surgery of 30.47 days, a
median of 27 days as compared to 185.65 days and 174 days in patient who were
unresectable.
Summary. The time to definitive resection is an important predictor of
resectability. All in house IGBC patients resectable with a standard Completion
Radical Cholecystectomy. Delay results in unresectability & increases the
magnitude of Surgery in resectable patients. Patients of IGBC who have a
delayed presentation with obstructive jaundice have a very small chance of
respectability.
Conclusion. Incidental Gall bladder Cancer (IGBC) should be re-operated for
Completion Radical Cholecystectomy Early, Delay results in unresectability,
increased magnitude of surgery and decreased survival
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TUMOR RELATED FACTORS INFLUENCE SURVIVAL FOLLOW-
ING RESECTION FOR AMPULLARY ADENOCARCINOMA
Barauskas, Giedrius1; Gulbinas, Antanas2; Pundzius, Juozas1
1Kaunas University of Medicine, Dept. of Surgery, Kaunas, Lithuania;
2Kaunas University of Medicine, Institute for Biomedical Research, Kaunas,
Lithuania
Background. Adenocarcinoma is the most common malignant tumor of
ampulla, but in general it is still rare. Therefore factors, influencing survival
following radical operations due to ampullary adenocarcinoma are still ill
defined.
Aim. To evaluate long-term survival of patients surgically treated for pancreatic
adenocarcinoma and to determine independent factors influencing survival.
Methods. We have prospectively investigated 25 consecutive patients with
adenocarcinoma of the papilla of Vater and evaluated preoperative clinical data,
pathology reports, UICC tumor stage, postoperative morbidity, mortality and
long-term follow-up results.
Results. Postoperative mortality was 4%. Overall morbidity was 32%.
Pancreas associated morbidity was 8% in the series. Overall 1-, 3- and 5-year
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actuarial survival rates after resection were 85.2, 75.2 and 75,2 per cent
respectively with mean survival time of 53.8 months (95% CI: 43.264.5) after
resection. Three-year survival of patients with stage I-II tumor was significantly
better than that with stage III-IV disease. Patients with T1-T2 and/or N
negative tumors had significantly better three year survival comparing with T3-
T4 and/or N positive patients. Patients who had ampullary tumors with high or
moderate differentiation of cells (G1 and G2) survived better than patients with
poor cell differentiation (G3), though significant difference was not achieved.
Presence of and lymphatic invasion and blood vessel infiltration by malignant
cells significantly worsened survival rates, whereas another tumour related
factor-neural invasion had no significant influence to overall survival rates. Age
of the patient at the cut-off of 70 years was the significant predictor of the
survival. However multivariate analysis revealed no independent predictors of
the survival after resection for ampullary adenocarcinoma.
Conculsion. Tumor related factors were the main predictors of survival after
resection for ampullary adenocarcinoma.
P3.22
MUCIN PRODUCING CHOLANGIOCARCINOMA AS A COUNTER
PART OF INTRADUCTAL PAPILLARY MUCINOUS NEOPLASMS
OF THE PANCREAS
Kang, Koo Jeong1; Kim, Yong Hoon1; Lim, Tae Jin1; Kang, Yu Na2; Kwon,
Jung Hyuk3
1Keimyung University School of Medicine, Surgery, Daegu, Korea; 2Kei-
myung University School of Medicine, Pathology, Daegu, Korea; 3Keimyung
University School of Medicine, Radiology, Daegu, Korea
Background. Mucin producing intrahepatic cholangiocarcinoma(MPIC) is
an uncommon papillary adenocarcinoma arising at the intrahepatic bile duct
proximal to the hilar area. When the mucin flows down and filled in the distal
common bile duct, entire lumen of the bile duct is dilated. The papers regarding
this disease are reported in limited number. The features are mimicking
intraductal papillary mucinous neoplsms of the pancreas in terms of patho-
physiology and biologic behaviour.
Aim. We report our experience of eight patients with MPIC, and analyze the
data to reveal the clinicopathologic features and biologic behavior.
Method. Between 2002 and 2005, eight consecutive patients (six men and two
women; mean age 62.3) who were diagnosed as a mucin producing intrahepatic
bile duct carcinoma. We analysed the clinical characteristics, radiologic
findings, clinicopathologic characteristics and the prognosis after surgical
resection of the eight patients.
Result. Clinical manifestations include right upper abdominal pain and
jaundice. Half of the patients show hyperbilirubinemia and three were elevated
of CA19-9. CT scan and/or MRCP show typical dilatation of the entire bile
ducts without any lesions occluding the lumen in the distal bile duct. Mucin was
observed in the distal bile duct of all patients during endoscopic retrograde
cholangiopancreatography or percutaneous trahshepatic cholangiography. Six
were treated with hemihepatectomy including caudate lobectomy, two were
segmentectomy. Six were curative resection but the resection margin was tumor
positive in two patients. Seven were alive without any recurrence for median
follow up duration 27 months and one of the patients who were resected
curatively was recurrent and dead 26 months after surgery.
Conclusion. The mucin producing cholangiocarcinoma has unique clinical
characteristics those are mimic intraductal papillary mucinous tumors of the
pancreas in terms of clinical, radiologic, pathologic and biologic features.
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NEW STRATEGY FOR PREOPERATIVE STAGING AND MAN-
AGEMT OF HILAR CHOLANGIOCARCINOMA: A PRELIMINARY
REPORT FROM THE NEWEST CANCER CENTER IN JAPAN
Uesaka, Katsuhiko1; Maeda, Atsuyuki1; Matsunaga, Kazuya1; Kanemoto,
Hideyuki1; Furukawa, Hiroyoshi2
1Shizuoka Cancer Center Hospital, Hepato-Biliary-Pancreatic Surgery, Na-
gaizumi-cho, Sunto-gun, Japan; 2Shizuoka Cancer Center Hospital, Diagnos-
tic Radiology, Nagaizumi-cho, Sunto-gun, Japan
Background. Preoperative staging and management of hilar cholangiocarci-
noma (CC) were very complicated.
Aim. To clarify the efficacy of our new strategy using multidetector helical CT
(MDCT) for preoperative staging and management of hilar CC.
Patients and methods. Thirty-one consecutive patients with hilar CC, who
underwent resection with curative intent for 38 months until Dec. 2005, were
enrolled in this study. In principle, MDCT study was performed before biliary
drainage. After assessment of cancer extent by MDCT, the operative procedure
was decided based on the MDCT findings. Biliary drainage was performed only
for the future remnant hepatic segments when the patient was icteric. Resection
line of the bile duct was decided based on both MDCT and direct cholangio-
graphic findings. Preoperative portal embolization was performed if necessary
and angiography was not done as a general rule.
Results. MDCT study before biliary drainage was carried out in 23 patients
(71%). Eight patients had undergone biiary drainage at the previous hospitals.
In all patients, major hepatic resection (resection of more than three Couinaud’s
segments) with caudate lobectomy was performed. Combined resection of the
portal vein was carried out in six patients (19%) and right hepatic artery in two
(6%), and concomitant pancreaticoduodenectomy was performed in six
(19%). Curative resection with negative surgical margins was achieved in 27
patients, giving a curative resection rate of 87%. The cause of non-curative
resection in four patients was residual mucosal cancer of the proximal or distal
bile duct stump. There was no in-hospital mortality. Complications developed
in 11 patients (35%). With a median follow-up period of 15 months (238
months), twenty-three patients are still alive without recurrence, five are alive
with recurrence, and three are dead with recurrence.
Conclusions. MDCT before biliary drainage provides us with reliable
information for tumor staging and decision making of the operative procedure
of hilar CC.
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PALLIATIVE SURGICAL TREATMENT OF PERIAMPULLARY
CARCINOMA
Montagnini, Andre L1; Jukemura, Jose1; Abdo, Emilio E2; Penteado, Sonia1;
Jureidini, Ricardo1; Perini, Marcos V1; Almeida, Jose LJ1; Kunitake, Tiago1;
Yamanari, Mauricio1; Cunha, Jose EM1; Cecconello, Ivan1
1Hospital das Clinicas, Dept. of Gastroenterology, Sao Paulo, Brazil; 2Hospital
das Clinicas, Dept. of Pathology, Sao Paulo, Brazil
Introduction. Palliative treatment of obstructive jaundice from advanced
periampullary cancer is still controversial. Jaundice, gastric outlet obstruction
and pain are the main symptoms to be managed in patients with unresectable
periampullary tumor.
Aim. Analyze the results of surgical palliative treatments for periampullary
carcinoma.
Methods. Medical records of 132 patients with primary or secondary
malignant biliary obstruction who were operated between June 1993 and
August 2005 were reviewed. Parameters evaluated were: age, gender, non-
resecability criteria, site of tumor. Outcome measures were: effectiveness of
biliary drainage, postoperative hospital stay; need for hospital readmission due
to cholangitis or jaundice recurrence. Early complication (in hospital) includes
bleeding, bile leak, venous thrombosis, infection, renal, cardiac or respiratory
failure and necessity of reoperation. Late complication (after discharge)
comprises new gastric outlet or biliary obstruction.
Results. Sixty (45,5%) patients were males and 72 (54,5%) females, the mean
age was 61 years. Tumor sites: pancreatic head or neck (78,8%), distal common
bile duct (3,8%), papilla of Vater (7,8%) and duodenum (5,3%). Nonresec-
ability criteria: 43% had locally advanced disease and 57% had metastasis. Type
of surgery: 70,8% patients were treated with choledochojejunostomy plus
gastrojejunostomy, 19,9% with choledochojejunostomy or cholecystojejunost-
omy alone, and 9.2% with gastrojejunostomy alone. Overall mean bilirrubin
level dropped from 14.3 mg/dL to 1.3 mg/dL in 3 weeks after surgery. Bile leak
occurred in 2 patients and median post operative hospital stay was 10 days. Two
patients needed hospital readmission because of jaundice and cholangitis.
Overall early complication rate was 23,4% and late complications rate was
14.5%. of the patients, with a median patency time of 7.5 months.
Conclusion. Operative biliary bypass is an efficient palliative procedure for
jaundice with excellent long term results and low complication rates
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PREDICTORS OF EARLY RECURRENCE OF CANCER OF
THE AMPULLA OF VATER AFTER PANCREATICODUODENECT-
OMY
Hsu, Hui-Ping1; Shan, Yan-Shen1; Hsieh, Yu-Hsiang2; Yang, Ta-Ming3; Lin,
Pin-Wen1
1National Cheng Kung University Hospital, Department of Surgery, Tainan,
Taiwan; 2Johns Hopkins Hospital, Dept. of Emergency, Baltimore, USA;
3Tainan Municipal Hospital, Dept. of Surgery, Tainan, Taiwan
Background and purpose. The ampullary cancer is one of the periampullary
cancers with better prognosis, but relapse earlier still noted in some patients.
The study tried to find the predictors of early recurrence to facilitate
postoperative adjuvant therapy.
Patients. Between January 1989 and April 2005, information on patients
undergoing pancreaticoduodenectomy with regional lymphadenectomy for the
ampullary cancer in National Cheng Kung University Hospital was enrolled.
The clinical histopathological studies and long-term outcome were collected,
and predictors for recurrence were identified.
Results. In 110 eligible patients; 53 patients (48%) survived without evidence
of recurrence (non-recurrence), while 57 patients (52%) died due to recurrent
diseases (recurrence). Median follow-up for these non-recurrence patients
were 56 months and the recurrence patients were 19 months. There were 31
(54%) liver metastasis, 26 (46%) locoregional recurrences, and 9 (16%)
peritoneal carcinomatosis in recurrence group. These recurrence patients had
higher level of preoperative direct bilirubin and CA-125, complicated operative
conditions (operative time, blood loss and blood transfusion), and advanced
diseases (large tumor size, advanced tumor stage, lymph node involvement,
pancreatic invasion). After multivariate analysis, the pancreatic invasion and
lymph node involvement were the significant predictors for disease recurrence.
Conclusion. Pancreatic invasion and lymph node involvement are the
predictors for disease recurrence and they can be used as indicators for
postoperative adjuvant treatment.
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PROGNOSTIC SIGNIFICANCE OF MUCIN CORE PROTEIN IN
CARCINOMA OF THE GALLBLADDER
Abe, Tsuyoshi1; Takuro, Saito2; Takashi, Tsuchiya2; Akira, Kenjo2; Takashi,
Kimura2; Toshiyuki, Takeshige1; Goichi, Endo1; Mitsukazu, Gotoh2
1Fukushima Prefectural Aizu General Hospital, Aizuwakamatsu, Japan;
2Fukushima Medical University, Surgery I, Fukushima, Japan
Background. Aberrant or incomplete glycosylation and/or synthesis of
glycoproteins of mucins results in mucin core protein expression in various
malignant neoplasms.
Aim. The aim of this study was to investigate the correlation between mucin
core proteins (MUC1, MUC2, MUC3, MUC4, MUC5AC, MUC5B, and
MUC6) and clinicopathological factors, and its prognostic implications in
carcinoma of the gallbladder.
Methods. Thirty-eight patients (11 males and 27 females) who had a tumor
invading beyond the subserosal layer, and who had operation during the period
from 1982 to 2002 were included in this study. Seven sections from each block
were immunohistochemically stained for MUC1, MUC2, MUC3, MUC4,
MUC5AC, MUC5B, and MUC6 apomucins.
Results. There was no significant difference between mucin core proteins
expression and clinicopathological characteristics. In univariate analyses
significant variables for postoperative disease-free interval were lymphatic
invasion, perineural invasion, and MUC5B expression. Among 6 patients with
no expression of MUC5B, 5 patients, with the exception of one who died of
another cancer 35 months postoperatively, did not show a recurrence in more
than five years.
Discussion. These results suggest that MUC5B expression may be a valuable
prognostic marker in the patients with gallbladder carcinoma.
P3.27
PROGNOSTIC VALUE OF P53, KI-67 AND HER2/NEU EXPRES-
SION IN AMPULLA OF VATER CARCINOMA AFTER CURATIVE
RESECTION
Park, Joon S1; Yoon, Dong S1; Park, Young N2; Chi, Hoon S1; Kim, Byong R1
1Yonsei University Medical Center, Surgery, Seoul, South Korea; 2Yonsei
University Medical Center, Pathology, Seoul, South Korea
Background. Ampulla of Vater carcinoma have a higher resection rate, low
recurrence and more favorable prognosis than other malignant tumor of the
periampullary region. Various clinicopathological factors have been thought to
influence the prognosis of ampulla of Vater carcinoma. Recent advances in
molecular biology should provide useful information on the prognostic factors
of ampullar of Vater carcinoma.
Aim. The aim of this study was to evaluate whether the expression of Ki-67
and Her2/Neu are of prognostic significance in ampullar of Vater Carcinoma.
Methods. We reviewed the records of the 65 patients with ampulla of Vater
carcinoma who underwent a curative surgery at Yonsei University Hospital
from 1992 to 2002. We performed Ki67 and Her2/Neu immunohistochemical
stainingusing paraffin embedded tissues with an antibody.
Results. Among 65 patients Ki-67 and Her2/Neu was over expressed in
18(27.7%) and 35(53.8%) patients, respectively. A significant overexpression
of Ki-67 was observed in the tumor with positive Her2/Neu expression
compared with that of negative Her2/Neu expression (p/0.00). The expres-
sion of Ki-67 was closely related lymph node metastasis (p/0.01). But, no
correlation was seen between Her2/Neu and clinicopathological variables. Ki-
67 and Her2/Neu expression were not correlated with prognosis. In multi-
variate analysis, only lymph node metastasis and cell differentiation were
significant factors in ampulla of Vater carcinoma.
Conclusion. Ki-67 is positively correlated with Her2/Neu in ampulla of Vater
carcinoma and may play an important role in lymph node metastasis of
ampullary carcinoma. But, Ki-67 and Her2/Neu overexpression are not useful
as biomarkers of ampullary cancer.
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RESULTS OF SURGERY FOR BILIARY CYSTADENOMA
Tellioglu, Gurkan1; Emre, Ali1; Gulluoglu, Mine2; Ozden, Ilgin1; Bilge, Orhan1
1Istanbul University Istanbul Faculty of Medicine, General Surgery(Hepato-
pancreatobiliary Surg. Unit), Istanbul, Turkey; 2Istanbul University Istanbul
Faculty of Medicine, Dept. of Pathology, Istanbul, Turkey
Background. Biliary cystadenoma is a benign lesion which carries an
undetermined malignant potential. The optimal approach to these lesions is
undefined.
Objective. To review the results of surgery for biliary cystadenoma.
Patients and methods. The charts of 5 women who underwent surgery for
biliary cystadenoma between 2002 and 2005, were reviewed.
Results. Median patient age was 42 years (range: 2751). Three patients had
abdominal pain, twowere asymptomatic. Two patients had undergone previous
laparotomy with the preoperative diagnosis of hydatid disease; partial excision
had been performed in one patient; in the other, the smaller of the two lesion had
been resected. The preoperative diagnosis for definitive surgery was made by
examination of the previous surgical specimen (n/2), measurement of the cyst
fluid carbohydrate antigen 19-9 (CA 19-9) (/10000 U/mL) and carcinoem-
bryonic antigen (27 and 577 ng/L) levels in 2 patients with a uniloculated liver
cysts or demonstration of a multiloculated cystic mass with septations
(n/1). Hepatic resection was performed in 3 patients and enucleation
in 2. There was no mortality. Preoperative serum CA 19-9 level was increased
in one patient only; it returned to normal range after tumor removal.
Histopathological examination showed one biliary cystadenoma with me-
senchymal stroma (MS) and four biliary cystadenoma without MS. There have
been no recurrences during a median follow up of 8 months (range: 515
months).
Conclusion. Biliary cystadenoma is a rare tumor which should be considered
in the evaluation of cystic liver masses especially in countries where hydatid
disease is still common. Attention to the presence of multiloculated appearance
and internal septations as well as the measurement of cyst fluid CA 19-9 and
CEA levels are useful for diagnosis. Total excision is the curative treatment.
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ROLE OF DIHYDROPYRIMIDIDINE DEHYDROGENASE MRNA
IN INTRAHEPATIC CHOLANGIOCARCINOMA
Shimada, Mitsuo; Morine, Yuji; Imura, Satoru; Ikemoto, Tetsuya; Miyake,
Kotaro; Shinohara, Hisamitsu; Mori, Hiroki; Arakawa, Yusuke; Kanamoto,
Mami
The University of Tokushima, Japan, Dept. of Digestive and Pediatric Surgery,
Tokushima, Japan
Background. Dihydropyrimidine dehydrogenase (DPD) is an important
enzyme to metabolize 5-fluorouracil and a possible prognostic indicator in
gastrointestinal cancers. However, little has been reported about significance of
DPD in intrahepatic cholangiocarcima (IHCC). The aim of this study was to
clarify the role of DPD mRNA expression in IHCC.
Patients and methods. Twenty-eight patients with IHCC who underwent
surgical resection were included. Intratumoral DPD mRNA expressions were
examined by using the Danenberg tumor profile method consisted of laser
microdissection of tumor cells on FFPE specimens, RNA extraction and cDNA
synthesis and quantification of mRNA expression by real-time PCR. The
expression was classified into 2 groups according to medianvalues: high and low
DPD groups. Significant prognostic factors were determined using the
clinicopathological variables including DPD mRNA expression. The clini-
cooathological variables were then compared between the high and low DPD
expression groups.
Results. Postoperative survival rate in curability A was significantly higher
compared with those in curability B and C, and there was no siginificant
difference between curability B and C. Incidence of mass-forming/periductal
infiltrative type, lymph nodes metastasis and perineural invasion were
significant poorer prognostic factors. While no difference in background
variables except for macroscopic type was observed between high and low
DPD expression groups, postoperative survival rate in low DPD expression
group was significantly lower than that in high DPD expression group.
Conclusions. The significant poor prognostic factors in IHCC were macro-
scopic type (mass-forming/periductal infiltrative type), lymph node metas-
tasis and perinueral invasion as well as low expression of DPD mRNA.
Therefore, DPD mRNA expression in tumor cells is suggested to be a new
prognositic indicator in IHCC.
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ROLE OF TUMOR ANGIOGENESIS IN GALLBLADDER
CARCINOMA: A SPECIAL REFERENCE TO THYMIDINE
PHOSPHORYLASE
Morine, Yuji; Harino, Yukari; Fujii, Masahiko; Soejima, Yuji; Imura, Satoru;
Ikemoto, Tetsuya; Shimada, Mitsuo
The University of Tokushima, Japan, Dept. of Digestive and Pediatric Surgery,
Tokushima, Japan
Background and aim. Angiogenesis plays an important role in tumor growth
and metastasis. Thymidine phoshorylase (TP), as well as Vascular endothelial
growth factor (VEGF), is known to be angiogenic factor. The aim of this study
was to clarify whether TP regulates angiogenesis and the clinicopathological
role of expression of TP on gallbladder cancer.
Patients and methods. Thirty-seven patients with gallbladder cancer who
underwent surgical resection were included in this study. Intratumoral TP gene
expressions were evaluated by using Danenberg tumor profile method. TP gene
expression was classified into 2 groups according to median values: high and
low. Immunohistochemical staining of TP was randomly classified into 2
groups (positive and negative). Immunohistochemical staining of VEGF was
randomly classified into 2 groups (strong and weak). The immunohistochem-
ical expression of tumor microvessel density (MVD) was evaluated using CD34
monoclonal antibody, and counted with specific staining in the tumor. The
clinicopathological variables were compared between the positive and negative-
staining groups.
Results. No correlation was observed between TP gene expression (high and
low groups) and any clinicopathological variables. However, the survival rate
was significantly lower in thehighgroup(pB/0.05). TheTPgeneexpressionwas
associated with tissue TP expression evaluated by immunohistochemical
staining (pB/0.05). In addition, MVD was significantly higher in the TP gene
high group (pB/0.05). However, there was no correlation between TP gene
expression and tissue VEGF expression.
Conclusions. The TP gene expression in gallbladder carcinoma is associated
with angiogenesis and may be a new independent prognostic parameter.
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SEGMENT VIB/V RESECTION USING SELECTIVE EXTRA-
HEPATIC VASCULAR CONTROL AND EXTENDED HILAR
LYMPHADENECTOMY AS STANDARD SURGICAL TREATMENT
FOR GBC
Schilling, Martin; Scheingraber, Stefan; Kollmar, Otto; Igna, Dorian; Richter,
Sven
Dept. of Surgery, Homburg/Saar, Germany
Background. Up to 50% of patients suffering from respectable GBC do not
undergo surgical resection for various reasons.
Aim. To study short and long term outcome after a standardized treatment
protocol for GBC including segment VIb/V resection using a selective extra-
hepatic vascular control and extended hilar lymphadenectomy with or without
bile duct resection in stage 13 GBC.
Methods.AsurgicalstandardforGBCincludingsegmentVIb/Vresectionusinga
selectiveextrahepatic vascularcontrolandextendedhilar lymphadenectomywith
or without bileduct resection was introduced in 03/01and 37patients underwent
explorative laparotomy according to that protocol since that time point.
Results.21 patients staged intraoperatively as not stage IVunderwent resection
(Table I). Compared to a limited approach performed in the 5 years prior to 03/
01, long termsurvivalwas improvedsignificantlywithamedian4year survivalof
50%.
Conclusion. A standardized approach to GBC allows a very high R0 resection
rate with high long term survival and can be taught and applied easily in high
volume HBP centers.
Staging (UICC 2002) 3/20011/2006 RO
I a 1 100%
I b 7 100%
II a 1 100%
II b 9 89%
III 3 66%
IV 13 0
recurrent tumor 3 0%
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SURGICAL MANAGEMENT OF GALL BLADDER CARCINOMA:
REVIEW OF 233 CASES
Khandelwal, Manish1; Khandelwal, C2; Goel, Ashish2
1Aberdeen Royal Infirmary, Aberdeen, UK; 2Mahavir Cancer Sansthan,
Dept. of Surgical Oncology, Patna, India
Introduction Carcinoma Gall Bladder is one of the most aggressive
malignancies, with a poor outcome. It is very common in certain regions of
the world including North India. Most cases are locally advanced at the time
of presentation. Surgery is the only option for cure and to achieve useful
palliation. Methods We present a retrospective analysis of 233 cases of
Carcinoma gall bladder from Jan 1995 to December 2005 for clinical
presentation & surgical outcome. Results The average age at presentation was
47.1 yrs for males and 46 yrs for females with overall female preponderance
(M: F 1:2.6). Six patients were less than 15 years age. 25% presented with
obstructive jaundice & 20% with gastric outlet obstruction requiring some
form of palliation. Calculi were associated in 70% cases. GB fundus was
involved in 26%, body in 18% & neck in 16% cases. Entire gall bladder was
involved on 36% cases. Spread of tumor was mainly through direct invasion
to liver, bile duct, duodenum & colon. However, 22% cases had only wide
spread lymphadenopathy, without liver infiltration. Out of 233 cases; 178
(76%) underwent resection. Most of these patients were in advanced stage at
presentation (36% & 18% in Stage III & Stage IV respectively). Curative
resection was attempted in 28.7% cases & palliative resection in 46.7% cases.
Bypass was done in 39 cases. Curative surgery included extended cholecys-
tectomy with liver resection & lymph node dissection, extended resection
with bile duct excision & pancreatoduodenectomy. Fourteen cases underwent
completion surgery. The overall mortality was 5.5%. Conclusions Surgery is
a safe option for palliation and improves quality of life in locally advanced
disease. In early cases extended cholecystectomy prolongs survival. In
carefully selected cases revision (extended) surgery is strongly recommended.
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SURGICAL MANAGEMENT OF CARCINOMA OF THE MID AND
DISTAL COMMON BILE DUCT
Frena, Antonio; La Guardia, Giuseppe; Martin, Federico
Regional Hospital of Bolzano, Dept. of General Surgery, Bolzano, Italy
Introduction. Carcinoma of the mid or distal third of the common bile duct
(CBD) is a fairly rare nosological entity in the West, accounting for 13 23%
of tumours of the extrahepatic bile ducts. The surgical treatment varies in
relation to the site: in the case of carcinomas of the distal CBD the operation
of choice is duodenopancreatectomy (DP), whereas for tumours of the mid
CBD there is still no unanimous consensus of opinion regarding the type of
surgery.
Aim. He prognosis of these tumours is, on the whole, better than that of
carcinomas of the proximal choledochus.
Methods. We retrospectively assessed 37 pts. with non-hilar extra-hepatic
bile duct tumours observed from 1985 to 2005. The patient series comprised
21 men and 16 women, with a mean age of 71 years. The presenting
symptom was jaundice in 95% of cases. In 23 pts. the carcinoma affected the
distal CBD and in 14 pts. the mid CBD.
Results. 15 pts. were treated with a radial intent by either DP (13) or by
resection of the CBD (2). Ten pts. with local inoperability or liver metastases
were treated with a palliative biliodigestive anastomosis. Twelve pts. were
excluded from surgery. Postoperative staging identified 1 pt as stage Ia, 2 pts
as stage Ib, 8 pts as stage IIa, 3 pts as stage IIb, and 1 pt as stage III according
to the new TNM classification. There was no operative mortality. Survival at
1, 2 and 5 years was 51%, 27% and 14%, respectively.
Conclusion. Carcinoma of the mid or distal portion of the CBD is a tumour
that offers fairly good prospects of survival. Surgical radicality is achieved
essentially by obtaining ductal and radial margins which are free of
microscopic infiltration and by means of a thorough lymphadenectomy.
These conditions can be achieved more easily in carcinomas of the distal
portion of the duct owing to the extent of the DP they require. In carcinomas
of the mid CBD the anatomical contiguity with the portal vein is responsible
for a low vein is responsible for a lower resectabili
P3.34
THE EFFECT OF PREOPERATIVE BILIARY DRAINAGE IN
PATIENTS WITH DISTAL COMMON BILE DUCT CANCER:
FOCUSED ON THE RATE OF DECREASE IN SERUM BILIRUBIN
Lee, Keon-Young1; Cho, Eung-Ho2; Ahn, Seung-Ik1; Hong, Kee-Chun1
1Inha University College of Medicine, Surgery, Incheon, South Korea;
2Seoul National University Hospital, Surgery, Seoul, South Korea
Background. The effect of preoperative biliary drainage in patients under-
going pancreaticoduodenectomy remains controversial.
Aims. This study was designed to examine the effect of biliary drainage prior
to pancreaticoduodenectomy in terms of the rate of decrease in serum
bilirubin, as well as its absolute preoperative level.
Methods. A retrospective study was performed on 52 consecutive patients
who underwent pancreaticoduodenectomy due to distal common bile duct
cancer from July 1996 to June 2005. The patients were divided into two
groups according to the presence or absence of surgical complications.
Various clinical and laboratory values were compared between the two
groups, including serum total bilirubin level at presentation (Bi), at operation
(Bo), the ratio (Bi-Bo/Bi) and the rate (Bi-Bo/duration of biliary drainage in
days) of decrease in serum bilirubin in those patients who underwent
preoperative biliary drainage.
Results. Postoperative morbidity and mortality rates were 42.3% (22/52)
and 5.8% (3/52), respectively. Preoperative biliary drainage was performed in
42 patients (80.8%). The presence or absence of biliary drainage was not
different between the complicated and uncomplicated groups. Among those
patients with preoperative biliary drainage, neither the absolute level nor the
rate of decrease in the serum bilirubin was different between the two groups,
respectively. When the patients were regrouped according to the rate of
decrease in serum bilirubin after biliary drainage, those with rapid decrease
preoperatively showed significantly faster decrease during the first post-
operative week as well, compared to those with slower decrease rate
preoperatively (P/0.004). This difference was not observed during the
second postoperative week.
Conclusion. Preoperative biliary drainage did not affect the surgical
outcome of pancreaticoduodenectomy in patients with distal common bile
duct cancer.
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THE INCIDENCE OF MALIGNANCY IN GALLBLADDER
POLYPS
Ozen, Yilmaz; Ozturk, Ersin; Tasar, Pinar; Kaya, Ekrem; Kilicturgay, Sadik
Uludag University Medical Faculty, General Surgery, Bursa, Turkey
Background. Management of gallbladder polyps is still controversial. Their
potential for cancer transformation is not fully understood. Ultrasonography
(USG) is the main diagnostic tool, but its accuracy is not well established.
Aim. To determine malignity incidence among gallbladder polyps and the
efficacy of USG in differentiating polyps from gallstones. Method: The
records 41 patients (15 men, 26 women), who had been operated on the
diagnosis of gallbladder polyps from 2001 to 2006, were retrospectively
reviewed. Age, gender, histopathological features, USG results were studied.
Results. Mean age was 48,399/10,53 (2671) years. During the same
period 1300 cholecystectomies had been performed, which makes the
incidence of gallbladder polyps as 3,15%. When pathological charts were
examined, it was seen that only 46,3% (19 cases) of the patients had polyps,
indeed. Of these 19 cases, 14 had cholesterol polyps, 3 had hyperplastic
polyps, 1 had metastasis of intestinal melanoma and 1 had tubulary adenoma
(5,3%) and there was no primary carcinoma of the gallbladder. Of the 19
cases, 9 patients were older than 50 years old and only one of them had
coexisting gallstones. Polyps were 10 mm in two patients and in the rest they
were smaller than 10 mm. In two cases there multiple were polyps and the
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rest has only one polyp. Mean diameter of the polyps was 6,11 mm. There
was no difference in incidence of polyps between men and women.
Conclusion. USG has a high false positive rate for diagnosing gallbladder
polyps and malignant transformation of gallbladder polyps is rare.
P3.36
THE INCIDENCE AND MACROSCOPIC ASPECTS OF UNEX-
PECTED CARCINOMA AFTER CHOLECYSTECTOMY: LITTLE
NEED FOR ROUTINE HISTOPATHOLOGICAL EXAMINATION
Beenen, Edwin1; Grond, Joris2; van der Voort, Peter H1; Pierie, Jean Pierre E1
1Medisch Centrum Leeuwarden, General Surgery, Leeuwarden, Netherlands;
2Laboratorium voor de Volksgezondheid Friesland, Pathology, Leeuwarden,
Netherlands
Background. Many surgeons are being trained with the motto that everything
worth removing is also worth examining histopathologically (HE). However,
the incidence of unexpected gallbladder carcinoma is very low and the routine
use of HE has been questioned. Therefore we have determined the incidence of
unexpected gallbladder carcinoma in our patients and related this incidence to
its macroscopic features.
Methods. Histopathological exams of all cholecystectomies were analysed
retrospectively. The reason of resection, their macroscopic aspects as described
by the pathologist (thickened, irregular or hardened wall, polyps, ulceration)
and there microscopic outcome were scored. The medical files of all patients
with a histologically proven or preoperative suspicion of gallbladder carcinoma
were restudied. Statistical analysis (spec, sens, LR/, LR-, pre- and posttest
odds) was performed after deducting all patients in whom a cholecystectomie
was performed for a different carcinoma (n/89) or a primary suspicion for
gallbladder carcinoma (n/18).
Results. In 5 years 4546 cholecystectomies were performed. In this group the
overall incidence of unexpected gallbladder carcinoma was 0.248%, ranging
from 0.06% (2/3194) if no macroscopic abnormalities were found to 5,5% (2/
37) if three abnormalities were found. 18 patients had a strong suspicion of
gallbladder carcinoma before HE. 6 turned out to have a chronic fibroid
cholecystitis. In 7 patients the pre-operative diagnosis of carcinoma was
confirmed and in 5 patients there was a clear diagnosis during the operation.
25 patients turned out to have a HE proven gallbladder carcinoma, leaving 13
patients to have an unexpected carcinoma.
Conclusion. If there is no suspicion for gallbladder- or any other car-
cinoma preoperatively, and no macroscopic abnormalities during operation
are found, the incidence of unexpected gallbladder carcinoma is very low
(0.06%). In these cases routine histopathological examination seems super-
fluous.
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TWO STAGE OPERATION IN A PATIENT WITH RECURRENT
BILE DUCT CANCER
Chu, Chong W; Kim, Hyung C
Soonchunhyang University Hospital, Surgery, Gyeonggi-Do, South Korea
Reoperation for recurrent bile duct cancer is almost impossible. We report a
successfully managed case with recurrent bile duct cancer. A 45-year-old male
was referred to our hospital with a relapsed Klatskin tumor 7 months after
resection of extrahepatic bile duct and Roux-en-Y hepaticojejunostomy(HJ)
for extrahepatic bile duct cancer. CT scan showed type IV Klatkin tumor with
peritoneal dissemination. However, PET-CT scan didn’t find any tumor
evidence. Choledochoscopic biopsy of the strictured HJ site showed adenoma.
We decided to perform exploratory laparotomy to check operability and
confirm the diagnosis. No peritoneal dissemination was found. After heavy
adhesiolysis, the jejunum was detached from the HJ site and frozen biopsy was
carried out at the strictured HJ site. Pathologic examination confirmed
adenocarcinoma. Right trisectionectomy and caudate lobectomy were per-
formed with keeping right and left side inflow and outflow. HJ was performed in
normal S2 and S3 bile ducts. The preoperatively measured left lateral section
was only 17% of the whole liver. Two external drainge catheters were placed for
anterior and posterior right bile duct. Portal vein embolization (PVE) under-
went one week after the first operation. The left lateral section became 30% of
the total liver volume three weeks after PVE. The second operation underwent
one month after the first operation. We safely and completely removed the right
trisection and caudate lobe. And then resection of the confluent portion of
portal vein that was adhered to hilar plate was performed and end-to-end
anastomosis was done. He recovered well and discharged 4 weeks after the last
operation.
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THE SURGICAL MANAGEMENT OF INCIDENTAL CARCINOMA
OF THE GALLBLADDER
Frena, Antonio; La Guardia, Giuseppe; Marinello, Peter; Ciola, Michele;
Martin, Federico
Regional Hospital, Dept. of General Surgery, Bolzano, Italy
Background. Carcinoma detected at histological examination of the gall-
bladder after cholecystectomy for gallstone disease or acute cholecystitis is
defined as incidental. It is a fairly rare event, but the increase in the number of
cholecystectomies performed as a result of the success of the laparoscopic
technique has led to a rise in the number of incidental carcinomas detected.
Histologically, in most cases, these are pT1 and pT2 carcinomas, i.e., tumours
that do not penetrate beyond the muscular wall of the gallbladder.
Aim. Up until the’nineties it was believed that these carcinomas could be
adequately treated by simple cholecystectomy, whereas today the treatment of
choice entails a radical second operation.
Methods. This study, conducted at a single institute, constitutes a review of 20
years’ experience: the data base consists of 3012 cholecystectomies with a
0.66% incidence of incidental gallbladder carcinoma.
Results. Survival data are carefully calculated in relation to the evolution of
surgical treatment over the years, thus making it possible to correlate tumour
staging, patient survival and surgical therapy.
Conclusion. The contributions made by literature reports since the’nineties
have prompted hepatobiliary surgeons to modify their attitudes towards
incidental gallbladder carcinoma. Detection of previously unrecognised
microinfiltrations of the serosa and of neoplastic involvement of distant
lymph-node stations has led to the introduction of the concepts of radical
and extended cholecystectomy. Comparison between the historical survival
curves of patients treated with simple cholecystectomy and the distinctly better
curves of those treated with a radical second operation accounts for the
evolution of surgical treatment over the past two decades.
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3 PORTS, CLIPLESS LAPAROSCOPIC CHOLECYSTECTOMY. IS
IT SAFE?
Subramaniam, Manisekar; Yamin, Abu Y; Naidu, R.Ragupathy
Hospital Alor Star, Department of Surgery, Alor Star, Malaysia
Introduction. Laparoscopic cholecystectomy is currently the gold standard
treatment for gallstone disease. With technological advancement smaller and
thinner instrument are being used. Tradisionally Laparoscopic cholecystect-
omy is performed via 4 ports and clips are used to secure cystic artery and duct.
In this study, we have embarked on a modified method of laparoscopic
cholecystectomy using 3 ports and no clips using harmonic scalpel.
Objective. To study the feasibility, looking into duration of the surgery,anal-
gesic requirements, wound infection and post operative stay and safety profile
of this new technique(post operative bile leak or bleeding).
Method. This is a prospective, non randomized study, comparing 3 ports
clipless procedure and conventional laparoscopic cholecystectomy. Patients
undergoing this procedure for all indications were included in this study. This is
a single surgeon’s experience from a single center. 60 patients were recruited
with equal distribution in both arms.
Results. Dermographic distribution of both the study and control group were
similar. The 3 ports, clipless procedure is successfully done in 86.7% of the
cases(pB/0.05). All cases were done with only one assistant. Mean duration of
surgery 25 min in the study group and 28 min in the control group (p/0.05).
Post op stay was shorter in the study group 13 hrs vs 16 hrs in the control group
(pB/0.05). There was a strong correlation between no of ports overall hospital
stay. Postoperative analgesic requirements were lesser in the study group.
Normal activity was resumed on 3rd day in both groups. Superficial wound
infection seen in one patient of the study group. Both the groups did not show
any evidence of post operative bile leak or bleeding.
Conclusion. 3 port, clipless laparoscopic cholecystectomy has been demon-
strated to be safe and feasible method. It has demonstrated to be economical as
the number of disposable ports and instruments are reduced.
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THE PERFORMANCE OF A MULTIDISCIPLINARY TEAM IN THE
TREATMENT OF BILE DUCT INJURY PATIENTS
de Reuver, Philip R1; Rauws, Erik A2; Lameris, Johan S3; Busch, Olivier RC1;
van Gulik, Thomas M1; Gouma, Dirk J1
1Amsterdam Medical Center, Surgery, Amsterdam, Netherlands; 2Amsterdam
Medical Center, Gastroenterology, Amsterdam, Netherlands; 3Amsterdam
Medical Center, Radiology, Amsterdam, Netherlands
Background. Bile duct injury (BDI) caused during laparoscopic cholecys-
tectomy is a major problem in current surgical practice. A study from the
United States showed the detrimental effect of BDI on survival. These results
are in contrast with the excellent results reported by surgeons, gastroenterol-
ogists and radiologists treating BDI patients. Although a multidisciplinary
approach is recommended in BDI patients, it is unknown if this approach is
performed in a tertiary center and what the impact is on survival.
Aim. To analyse if a multidisciplinary approach is performed in a tertiary
center and to analyze the effect on survival in BDI patients.
Methods. From a consecutive series of 500 BDI patients referred to a tertiary
center, the referral pattern to the departments of surgery, gastroenterology and
radiology are analyzed. Additionally the referral patterns between the three
departments are determined. The effect of referral pattern on survival will be
analyzed.
Results. Hundred-forty-six BDI patients (29.2%) were referred to the
department of surgery, 329 patients (65.8%) to gastroenterology, 25 patients
(5.0%) to the department of radiology. The referral rates between the
departments ranged from 7.0% (patients referred from gastroenterology to
radiology) to 40% (patients referred from radiology to surgery). Final
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treatment was performed by a surgeon in 32% (n/160), a gastroenterologist in
53% (n/264) and a radiologist in 12% (n/58). In 18 patients (3%) there was
no indication for additional treatment. Referral between different departments
within a tertiary center has no negative effect on survival (Odds ratio/1.1, 95%
Confidence Interval 0.62.2).
Conclusion. There is a significant difference in referral rate of BDI patients to
the departments of surgery, gastroenterology and radiology. Referral of BDI
patients within a tertiary center has no negative effect on survival.
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CLINICOPATHOLOGIC ANAYLSIS OF AMPULLARY ADENOMA
WITH A FOCUS ON THE FEASIBILITY OF ENDOSCOPIC SNARE
EXCISION
Yoon, Dong S; Park, Joon S; Son, Tae Il; Chi, Hoon S; Kim, Byong R
Yonsei University College of Medicine, Surgery, Seoul, South Korea
Background. Ampullary adenomas are uncommon lesions that may arise
form the surface of the papilla of Vater or from the inner epithelial lining of the
ampulla it self. The accurate preoperative histological diagnosis of ampullary
adenoma is often difficult and inconclusive, leading to controversy over the
adequate treatment of these lesions.
Aim. The aim of this study was to evaluate whether endoscopic snare excision
can substitute for radical resection in ampullary adenoma by clinicopathologic
study.
Methods. We reviewed the records of the 37 patients with a pathologic
diagnosis of ampullary adenoma at Yonsei University Medical Center from
1986 to 2005.
Results. Among the 37 patients, 16 patients were treated by endoscopic
snare excision(ESE), 13 patients by pylous preserving pancreaticoduodenect-
omy (PPPD), 3 patient by transduodenal local resection (TDLR) and
5 patients by no procedure. Final pathologic diagnosis of the 37 patients
resected ampullary tumor was adenoma in 24 cases, and both adenoma
and carcinoma in 13 cases. False negative of endoscopic biopsy was
40.6%. Margin positive rate after initial treatment was confirmed in 7
patients (68.7%) among ESE group. Recurrence was confirmed in 3 patients
(18.8) among ESE, but there was none in radical excision group (PPPD,
TDLR).
Conclusion. Diagnosis and surgical outcome of ampullary adenoma by
endoscopic biopsy and snare excision was unreliable. Transduodenal local
resection can be performed with low rates of recurrence. Randomized
controlled studies are needed to establish the correct indications for pylous
preserving pancreaticoduodenectomy, transduodenal local resection and
endoscopic snare excision.
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ABERRANT BILE DUCTS ASSOCIATED WITH CHOLEDOCHAL
CYST: RISK FACTOR FOR INCREASED POST-OPERATIVE BILE
LEAK
Vijayaragavan, Paari; Behari, Anu; Lal, Richa; Sharma, Ajay; Singh, Rajneesh
K; Kumar, Ashok; Saxena, Rajan; Kapoor, Vinay K
Sanjay Gandhi Postgraduate Institute of Medical Sciences, Surgical Gastro-
enterology, Lucknow, India
Introduction. Aberrant bile ducts associated with choledochal cyst (CDC) are
prone for injury during CDC excision and their reconstruction is a technical
challenge.
Aim. To assess if aberrant bile duct in CDC affects its management and post
operative complications.
Patients and methods. Between 1990 and 2005,180 patients with CDC
were treated at a tertiary care referral hospital. Review of the prospective
medical database revealed 14 patients had aberrant bile ducts. The clinical,
imaging, operative, post-operative and follow-up details of these patients were
analysed.
Results. There were 12 female and 2 male patients with a mean age of
23(range 2 to 60) years. Pain (42%) and jaundice (37%) were the
commonest symptoms. One patient had spontaneous rupture of CDC
for which a T-tube drainage was done at first stage. Pre-operative imaging
was in form of ultrasonography in all, CT scan-3, MRCP-2, ERCP-1 and
T-tube cholangiogram in 1 patient. The type of CDC was type 1 and type 4a
in 7 patients each. Except in the 2, the pre-operative diagnosis of aberrant
bile duct was missed in all the patients. All the patients underwent a
cyst excision and reconstruction was performed with a single anastomosis
in 7 patients (2 patients had a ductoplasty between the aberrant and the main
duct and in 5 a rim of cyst was preserved between the aberrant and the main
duct), double anastomosis in 5 patients and in 2 patients the aberrant duct was
injured and was ligated. 21% (as against 10% patients without aberrant ducts)
patients had post-operative bile leak which was managed conservatively in all.
At a mean follow up of 23 months, all the 12 patients having follow up were
asymptomatic and the liver function tests and scintigraphy of these patients are
normal.
Conclusion. Aberrant ducts associated with CDC are likely to be missed pre-
operatively. The small size of most of these ducts contributes to a higher
incidence of bile leak postoperatively. The surgeon should be familiar with
variety of techniques for their reconstruction.
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ACUTE BILE DUCT INJURIES FOLLOWING CHOLECYSTECT-
OMY: ANALYSIS OF CLINICAL PRESENTATION AND THE
EARLY AND LATE OUTCOME
Vijayaragavan, Paari; Sikora, Sadiq S; Sharma, Ajay; Behari, Anu; Singh,
Rajneesh K; Kumar, Ashok; Saxena, Rajan; Kapoor, Vinay K
Sanjay Gandhi Postgraduate Institute of Medical Sciences, Surgical Gastro-
enterology, Lucknow, India
Background. Acute postcholecystectomy bile duct injuries (BDI) present
with a variety of clinical presentations.
Objective. The management and outcome in each of these clinical groups was
analyzed to identify factors predicting the early and late outcome.
Patients and methods. Between 1989 and 2004, 164 patients with acute BDI
were categorized into four clinical presentations: external biliary fistula (EBF)
[n/76], bilioma (n/57), bile peritonitis (n/23) and bile ascites (n/8). BDI
was classified into partial or complete based on cholangiography or nuclear
scintigraphy. Patients underwent various interventions to obtain a controlled
EBF and then followed up for fistula closure and biliary stricture.
Results. Cholecystectomy was open in 128 and laparoscopic in 38 patients. 72
(44%) patients presented with jaundice. 61 (42%) patients had partial injury
and 83 (58%) complete. The proportions of partial and complete injuries in the
various groups were: EBF (37% vs. 63%), bilioma (49% vs. 51%), bile
peritonitis (48% vs. 52%) and bile ascites (38% vs. 62%). Biliary fistula closed
in 91 (60%) patients after a median interval of 24(4190) days. The fistula
closure rates were 62%, 66%, 45% and 43% and the stricture development was
seen in 84%, 78%, 76%, and 100% in the above four groups respectively. On
univariate analysis, bile peritonitis and/or bile ascites, jaundice and complete
injury co-related with a persistent EBF. On multivariate analysis, bile
peritonitis and/or ascites and jaundice at presentation predicted a persistent
EBF. Complete injury was the only predictor of future stricture formation on
univariate and multivariate analysis.
Conclusions. Acute BDI can be designated into clinical groups for manage-
ment and prognosis. 94% BDI eventually form an external biliary fistula: 60%
of which close and 81% develop biliary stricture. Jaundice at presentation and
biliary peritonitis /ascites are predictors of a persistent EBF. Complete BDI is
the only determinant of formation of biliary stricture.
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AGGRESSIVE SURGICAL APPROACH FOR GALL BLADDER
CANCER RESULTS IN IMPROVED RESECTABILITY AND
SURVIVAL
Mandal, S; Singh, S; Chaudhary, A; Sachdev, AK; Uppal, R; Sakuja, P;
Agarwal, Anil K
GB Pant Hospital & MAM College, Department of GI Surgery, Delhi, India
Background. Carcinoma of the gallbladder is a common disease in north India
and carries a poor prognosis. Here we are presenting a single center experience
over 4 years duration.
Methods. 252 patients of gallbladder cancer who underwent surgery in the
period from January 2000 till December 2004 were analyzed with regards to
radical resection performed, post-operative morbidity and mortality and long
term follow up.
Results. Out of the 252 patients, 99 (39.29%) presented with symptoms of
obstructive jaundice due to the gallbladder carcinoma, the rest 153 (60.71%)
presented with symptoms of pain or gastric outlet obstruction. Out of 99
patients who had presented with jaundice 31 were considered unresectable on
pre-operative imaging, out of the remaining 68 who underwent resection with a
curative intent 26 underwent R0 resection (21 underwent Segment IVb & V
Wedge resection, 5 extended right hepatectomy) with a resectability rate of
38.24%. All the patient underwent resection of the extra hepatic biliary ducts
with reconstruction in the form of a roux-en-Y hepaticojejunostomy. Of the
patients who did not present with jaundice 6 were considered unresectable on
preoperative imaging. Ultimately 51 underwent R0 resection (resectability
34.69%), 44 underwent Segment IVb & V Wedge resection, 4 underwent
extended right hepatectomy, 1 each hepatopancreatoduodenectomy, only
lymph node dissection and wide local excision. The morbidity and mortality
rate was 15% and 5.88% respectively. The survival was a mean of 23.5 months
(range 4 to 60 months) in the jaundiced group. The survival was a mean of 25.5
months (range 4 to 61 months) in the non-jaundiced group.
Conclusion. Aggressive resection of gallbladder carcinoma can improve
resectability and result in meaningful long term survival.
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ALTHOUGH BILE DUCT INJURY HAS A DETRIMENTAL EFFECT
ON QUALITY OF LIFE, OUTCOME IS NOT INFLUENCED BY THE
SEVERITY OF INJURY OR DURATION OF FOLLOW-UP
de Reuver, Philip R1; Rauws, Erik A2; Lame´ris, Johan S3; Sprangers, Mirjam
AG4; Gouma, Dirk J1
1Amsterdam Medical Center, Surgery, Amsterdam, Netherlands; 2Amsterdam
Medical Center, Gastroenterology, Amsterdam, Netherlands; 3Amsterdam
Medical Center, Radiology, Amsterdam, Netherlands; 4Amsterdam Medical
Center, Medical Psychology, Amsterdam, Netherlands
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Introduction. Bile duct injury (BDI) is associated with reduced survival, and
increased morbidity. Quality of life (QoL) after BDI is under discussion, since
several authors published discrepant findings.
Aim. To assess QoL in BDI patients after a long term follow-up and compare
outcome with control data from patients who underwent an uneventful LC and
Healthy Dutch Controls. In addition the impact of clinical factors like the type
of injury, type of treatment and duration of treatment will be examined. Finally
the influence of duration of follow-up will be examined in a longitudinal
assessment.
Methods. Of a total of 462 patients referred to our center between 1991 and
March 2005, Quality of life was assessed in 403 eligible participants. The
assessment was performed with a questionnaire containing the SF-36 and the
GIQLI questionnaire. QoL outcome was compared between BDI patients,
patients without BDI, and the general Dutch population. In a subgroup of BDI
patients QoL outcome is measured twice, after an interval of 5 years.
Results. The SF-36 scores of BDI patients (n/278, median follow-up 6 years)
were significantly lower in 3 of the 8 domains compared to the patients without
an injury (n/80) (PB/0.05). In 7 of the 8 SF-36 domains BDI patients scored
significantly worse than the general population (PB/0.05). The domains
physical functioning and emotional functioning in the GiQli assessment were
significantly lower in BDI patients compared with patients without an injury
(both PB/0.01). However none of the clinical factors were found to significantly
affect the QoL outcome. The longitudinal QoL assessment measured no
significant difference after five years of follow-up.
Conclusion. BDI has a detrimental effect on generic and disease specific
Quality of Life, and no improvement is measured after 5 more years of follow-
up. Remarkable however is that QoL in BDI patients is not influenced by the
severity of injury, type of treatment and duration of treatment.
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BENEFIT OF INTRAOPERATIVE REALTIME VIRTUAL NAVIGA-
TION BY CO2 ENHANCED MDCT ARTERIO-CHOLANGIO-PAN-
CREATOGRAPHY
Sugimoto, M; Yasuda, Hideki; Yamazaki, Masato; Tezuka, Tohru; Kosugi,
Chihiro; Watayo, Yoshihisa; Ootaki, Reiko
Teikyo University Ichihara Hospital, Dept. of Surgery, Tokyo, Japan
Background and aim. Hepato-pancreato-biliary surgery requires detailed
planning operation. Using recent multi-detector computed tomography
(MDCT) allow simulation of complex surgeries preoperatively. We has been
evaluated our MDCT technique using carbon dioxide (CO2) gas as a negative
contrast agent for hepato-pancreato-biliary assessment which enabled on
image-guided virtual image analysis. In this study we describe a new fusion
technique of hepato-pancreato-biliary imaging by CO2MDCT enabled syn-
chronous visualization of abdominal vessels, and gastrointestinal organs, which
enabled to provide realtime three-dimensional (3-D) navigated surgery.
Materials and methods. Total of 90 patients who were thought to have
hepato-pancreato-biliary disease were included in this study. 16-slice MDCT
was performed under per-oral, per-anal or trans-papillary infusion of CO2.
Synchronously intravenous contrast material administration was applied for
CT-Angiography acquisition. Postprocessing these downroaded data to a
workstation, we generated virtual arterio-cholangio-pancreatography
(CO2CT-ACP). Also 3-D reconstructions (volume and surface rendering,
maximum intensity projection and multiplanar reformation) were incorpo-
rated as movie, could be viewed on the workstation-based display in the
operating room by surgeons. Capability of these pre- and intra-operative virtual
navigations by CO2CT-ACP was evaluated.
Results and discussions. For computer-assisted surgery including laparo-
scopic surgery, CO2CTA-CP provided accurate information for localizing the
target lesions of hepato-pancreato-biliary and gastrointestinal benign and
malignancies with its relationship to the surrounding vessels compared with
open laparotomy. CO2CT-ACP could avoid grater radiation and contrast
medium administration as used multiphase fusion without any complications.
This procedure could help decreasing the intraoperative complications.
Conclusion. Synchronous fusion CO2CT-ACP provides intraoperative re-
altime 3-D navigation for detailed planning operation in complex hepato-
pancreato-biliary surgeries.
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BILE DUCT INJURIES
Hogan, Aisling; Tucker, Olga; Geoghegan, Justin; Maguire, Donal; Traynor,
Oscar
St Vincents University Hospital, Hepatobiliary Surgery, Dublin, Ireland
Aims. To review all cases of bile duct injuries referred to our service over a
twenty year period (19862006).
Methods. We performed a retrospective chart review of seventy four charts.
Results. 75.6% of patients were female, 24.4% male.71.6% had had
laparoscopic cholecystectomy, 28.4% had had open cholecystectomy. Of the
laparoscopic procedures, 43% were converted to open at the time of the original
operation. The ages ranged from 24 to 77 with an average age of 51.6 years. In
36.5% of these cases the bile duct injury was recognised immediately intra-
operatively, and in 25.6% of these cases immediate repair was unsuccessfully
attempted. Presenting complaints included pain, fever, chills, jaundice, pale
stools and dark urine. Outcome ranged from complete recovery, to persistent
symptoms and abnormal liver function tests to death.
Conclusions. Most iatrogenic bile duct injuries occur following cholecystect-
omy in young females with a long life expectancy. Results can be devastating
with significant morbidity and mortality. Early recognition and transfer to a
specialist unit is vital to ensure longterm success rate.
P4.10
CLINICOPATHOLOGIC CHARACTERISTICS AND PROGNOSIS
IN YOUNG PATIENTS (B/40 YEAR) AMPULLA OF VATER CARCI-
NOMA
Son,Tae Il; Park, Joon Seong;Yoon,DongSup;Chi,Hoon Sang;Kim,ByongRo
Yonsei University Medical Center, Surgery, Seoul, South Korea
Background. Ampulla of Vater carcinoma is more prevalent in older patients,
but it can occur in young patients, too. The question of whether ‘‘young age’’ is a
single prognostic factor for ampulla of Vater carcinoma has been controversial.
Aim. The aim of this study was to evaluate its clinical characteristics, and
prognosis from older age onset ampulla of Vater carcinoma.
Methods. We reviewed the records of the 92 patients with ampulla of Vater
carcinoma who underwent a curative surgery at Yonsei University Hospital
from 1989 to 2004. The clinicopathological characteristics, and the survival
time of patients under 40 years of age were compared with older patients.
Results. The young age group patients numbered 5 (5.4%) patients among 92
patients with ampulla of Vater carcinoma. There was no difference in
clinopathologic factors between the two groups. 5 year survival rate was
75.0% in the younger group and 45.0% in the elderly group, respectively (P/
0.05).
Conclusion. Young age patients with ampulla of Vater carcinoma who
underwent a curative resection showed a similar survival rate to that of whole
age patients. So, curative resection and early diagnosis are mandatory in young
age patients with ampulla of Vater carcinoma.
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CHOLANGIOGRAPHIC SPECTRUM OF INTRADUCTAL PAPIL-
LARY MUCINOUS NEOPLASM OF THE BILE DUCTS
Yeh, Ta-Sen1; Tseng, Jeng-Hwei2; Chiu, Cheng-Tang3; Liu, Nai-Jen3; Chen,
Tse-Ching4; Jan, Yi-Yin1; Chen, Miin-Fu1
1Chang Gung Memorial Hospital, Chang Gung University, Taipei, Surgery,
Taoyuan Hsien, Taiwan; 2Chang Gung Memorial Hospital, Chang Gung
University, Taipei, Radiology, Taoyuan Hsien, Taiwan; 3Chang Gung Memor-
ial Hospital, Chang Gung University, Taipei, Gastroenterology, Taoyuan
Hsien, Taiwan; 4Chang Gung Memorial Hospital, Chang Gung University,
Taipei, Pathology, Taoyuan Hsien, Taiwan
Backgrounds. To propose a cholangiographic classification for intraductal
growth type intrahepatic cholangiocarcinoma (IG-ICC) and its precursor,
collectively termed intraductal papillary mucinous neoplasm of the bile ducts
(IPMN-B).
Methods. A total of 124 patients with IPMN-B were retrospectively studied.
Numbers of IPMN-B type 1, type 2, type 3 and type 4 were 33, 17, 15 and 59,
respectively. A cholangiographic classification was proposed based on the
presence of hepatolithiasis, mucobilia, neoplasia localization, and concomitant
malignancies. The demographics, histological grading, management, and
survival were also analyzed.
Results. All 33 IPMN-B type 1 and 12 of 17 IPMN-B type 2 displayed
cholangiographic pattern IA demonstrating hepatolithiasis-related biliary
stricture. The remaining five IPMN-B type 2 displayed cholangiographic
pattern IB or IC, which demonstrated mucobilia without discernible neoplasia.
Seven of 15 IPMN-B type 3 and 52 of the 59 IPMN-B type 4 displayed
cholangiographic pattern IIA or IIB, which demonstrated overt intraductal
neoplasia. Seven IPMN-B type 3 or 4 displayed cholangiographic pattern IIIA
or IIIB, which demonstrated IPMN-B and concomitant malignancies. For
those presenting with cholangiographic pattern IA, IC, IIA, IIB and IIIA,
straightforward hepatectomies for the diseased lobes were performed. For
those with pattern IB, surgical resections were performed only when there was
emergence of mucin- producing neoplasia. For those with IIIB, the concomi-
tant malignancies were considered inoperable. No disease- related death
occurred in IPMN-B type 1and 2. The mean survival rates of IPMN-B type
3 and type 4 were 55.59/17.1 months and 36.99/6.3 months, respectively.
Conclusion. The presented cholangiographic classification facilitates the
management for IPMN-B. Significant survival discrepancy at the various stages
warrants a more aggressive surgical strategy.
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CHOLEDOCHAL CYST IN INFANTS: A DISTINCT CLINICAL
ENTITY
Vijayaragavan, Paari; Lal, Richa; Sharma, Ajay; Singh, Rajneesh Kumar;
Behari, Anu; Kumar, Ashok; Sikora, Sadiq Salim; Saxena, Rajan; Kapoor,
Vinay Kumar
Sanjay Gandhi Postgraduate Institute of Medical Sciences, Surgical Gastro-
enetrology, Lucknow, India
Background. Choledochal cysts (CDC) presenting in infancy are associated
with distinct clinical features and rapid progression to cirrhosis.
Objective. The clinical presentation, management and outcome in 13 such
infants are presented.
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Patients and methods. Between 1989 and 2005, 65 children (ageB/12 years)
with CDC were treated in a tertiary referral care hospital in India of which 13
(20%) were infants. There were 10 male and 3 female infants with a median age
of 3 months (range 6 weeks to 12 months). CDC was differentiated from cystic
variants of biliary atresia wherein the intrahepatic bile ducts were hypoplastic
and irregular in biliary atresia.
Results. All 13 infants presented with jaundice. The other presenting features
were in form of complications namely, cholangitis in 8 (62%) which
necessitated a preoperative transhepatic drainage in 2 patients and history of
spontaneous rupture of CDC in 1 (8%). Cyst excision and Roux-en-Y
hepaticojejunostomy was performed in 12 (92%) patients. 1 patient with
advanced liver disease did not report for surgery following a initial percuta-
neous biliary drainage. One child had bilio-enteric anastomotic leak and
succumbed to sepsis. The liver histology was available in 8 and revealed
cirrhosis and bridging fibrosis in 3 (38%) infants each and portal fibrosis and no
fibrosis in 1 (13%) infant each. At mean follow up duration of 23 months, all the
8 infants who followed up were asymptomatic with well functioning bilio-
enteric anastomosis.
Conclusion. Majority of infants with CDC present with complications
and 15% need a multi staged treatment. Excellent outcome can be
achieved in patients who undergo cyst excision in spite of cirrhosis or advanced
fibrosis being present in more than three-fourth of these infants by the time of
surgery.
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CORRECTION OF A MISPERFORMED ANISOPERISTALTIC
ROUX- EN- Y RECONSTRUCTION BY PRESERVING PRIOR
HEPATICOENTERIC ANASTOMOSIS
Kalafat, Hasan; Saribeyoglu, Kaya; Kilic, Ilknur
Istanbul University, Cerrahpasa Medical Faculty, Department of General
Surgery, Istanbul, Turkey
Background. Correction of a misperformed hepaticojejunostomy by preser-
ving prior anastomosis.
Aim. To present a patient who underwent surgical management of a
misperformed anisoperistaltic Roux- en- Y hepaticojejunostomy by preserving
prior hepaticoenteric anastomosis.
Patient and method. In a 41 year-old female patient, a Roux-en-Y
hepaticojejunostomy reconstruction was performed owing to resection of a
choledochal cyst, one year ago. Subsequent to surgery she had been recurrent
attacks of cholangitis, and was admitted to our clinic with nausea, weight loss
fatigue and abdominal pain. Abdominal computerized tomography revealed
excessive dilatation of the proximal part of the jejunum, so surgery was
considered with a diagnosis of an afferent-loop-like syndrome.
Results. During abdominal exploration, the short proximal limb of the Roux
reconstruction was significantly dilated and found to be anastomosed to biliary
duct, so that the construction was in anisoperistaltic direction. The enteric
content was being emptied through a side-to-end jejunojejunostomy between
short and long limbs of the small bowel. The distal end of 2.5 cm of this
proximal limb, where the hepaticoenteric anastomosis had been carried out,
was preserved and the remaining part of the proximal limb was resected
together with prior jejunojejunostomy. The enteric mesenterium was dissected
as near as possible to the small bowel wall in order to keep the vasculature intact.
Thereafter distal jejunal segment was pulled up and anastomosed to anasto-
mosis-holding segment and another jejunojejunostomy was done 50 cm
distally, as well. No early complication was encountered and the patient was
discharged on postoperative day 10. After a one year follow up she is still free of
complaints.
Conclusion. The correction of an anisoperistaltic Roux-en-Y reconstruction
by reason of technical failure with a second anastomosis may be difficult in this
location and it can be carried out successfully by preserving prior hepaticoen-
teric anastomosis.
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DOES PREVIOUS ACUTE GALLSTONE PANCREATITIS AFFECT
THE OUTCOME OF LAPAROSCOPIC CHOLECYSTECTOMY?
Amonkar, Sunil J; Cain, Henry; Khout, Hazem; Farrell, Rory J
Queen Elizabeth Hospital, General Surgery, Gateshead, UK
Background. Acute gallstone pancreatitis (AGP) is a strong indication for
elective laparoscopic cholecystectomy (LC).
Aim. We assessed whether surgery for this indication is more challenging or if
length of post operative stay is affected.
Methods. Case notes of 20 patients with AGP who underwent LC between
April 2004 and April 2005 were reviewed. These were compared to a control
group who underwent LC in the same time period for alternative reasons.
Analysis of patient demographics, ASA grade, length of operation, conversion
rate and post operative stay was performed.
Results. 174 elective LC were performed in the control group (87% female:
ages 1686, mean 51 yrs, mean ASA grade 1.67). Duration of surgery varied
from 25182 minutes (mean 75 minutes). 20 cases were converted to an open
procedure (11.5%) and 94 patients (54%) were discharged within 24 hrs. 14
patients underwent LC for mild AGP (11 female, 3 male: ages 22 81, mean 52
yrs, mean ASA grade 1.64). Duration of surgery varied from 45213 minutes
(mean 76 minutes). 2 were converted (14.3%) and 8 patients (57%) were
discharged within 24 hrs. 6 patients underwent LC for severe AGP (5 female, 1
male: ages 5275, mean 64 yrs, mean ASA grade 1.83). Duration of surgery
varied from 61132 minutes (mean 82 minutes). 1 case was converted (16.7%)
and 2 patients (33%) were discharged within 24 hrs, however this group was
older and thus not suitable for day case surgery. 4 patients had further
readmissions with AGP between initial attack and LC. No apparent difference
in outcome was found in these cases, furthermore, timing from initial AGP
attack to LC did not affect outcome of LC.
Conclusion. This retrospective study shows AGP does not significantly affect
the outcome of elective LC. This is irrespective of severity of initial AGP attack,
unplanned readmissions with further AGP, or interval to surgery.
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DUCT-TO-DUCT BILE DUCT RECONSTRUCTION: DOES IT
HAVE A PLACE IN GENERAL SURGERY?
Schaeffer, David F; Buczkowski, Andrew K; Chung, Stephen W; Scudamore,
Charles H
University of British Columbia, Hepatobiliary and Pancreatic Surgery,
Vancouver, Canada
Introduction. Bile duct injury is a rare but morbid complication of either
laproscopic or open cholecystectomy. Recent reports quantified injuries with a
frequency rate of 1 to 5 per 1000 cases as a result of an increase in number of
operations performed. The surgical treatment of choice after bile duct injury is
considered to be a Roux-en-Y hepaticojejunostomy (HJ). This study was
undertaken to compare the feasibility and outcome of a standard HJ approach
to a spatulated end-to-end choledocho-choledochostomy (CD) repair.
Methodology. A retrospective analysis of fourteen patients (n/14), who
underwent a biliary reconstruction due to either bile leaks or bile duct strictures
after an initial orthotopic liver transplantation (OLTx) with a primary duct-to-
duct anastomosis of the bile duct was conducted. Seven patients were treated
with a HJ, were as a second group (n/7) received a CD repair.
Results. The two groups were similar in demographic parameters as well as
in indication for bile duct reconstruction. Minimum follow-up time in
both groups was 6 months. There was one late complication in the HJ group
and none in the CD group. The late complication was a recurrent biliary
stricture that required revision of the heapticojejunostomy 2 years post-
operatively.
Conclusion. In this report, we describe our experience in the management
of fourteen patients who underwent a bile duct reconstruction after an initial
OLTx. This study is the first to show the possibility of using a duct-to-duct
reconstruction in this setting as opposed to a Roux-en-Y hepaticojejunost-
omy. This observation of biliary reconstruction in a liver transplant setting
might be applicable to refine biliary reconstruction techniques in general.
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EVALUATION OF GADOBENATE DIMEGLUMINE ENHANCED
MRI AS THE SINGLE INVESTIGATION IN THE WORKUP OF
PATIENTS WITH ACUTE BILE DUCT INJURY: A PILOT STUDY
Vijayaragavan, Paari1; Nag, Piyal2; Sikora, Sadiq S1; Jain, Sunil K2; Kapoor,
Vinay K1; Gupta, Rakesh K2
1Sanjay Gandhi Postgraduate Institute of Medical Sciences, Surgical
Gastroenterology, Lucknow, India; 2Sanjay Gandhi Postgraduate Institute
of Medical Sciences, Radiology, Lucknow, India
Introduction. Acute bile duct injuries (BDI) usually require multiple
investigations like ultrasonogram, computerised tomography,nuclear scinti-
graphy, endoscopic retrograde cholangiopancreatogram,etc for a complete
evaluation.
Aim. Gadobenate dimeglumine (MultihanceR) contrast enhanced MRCP
(CE MRCP) was evaluated as a single investigation in the workup of acute
BDI.
Patients and methods. Eleven patients with BDI underwent T2-MRCP
and T1 weighted FSPGR sequences before and till 2 hours after adminis-
tration of Gadobenate dimeglumine. MR angiography of the hepatic artery
and portal vein was obtained and the FSPGR images were reconstructed to
get contrast enhanced (CE) T1 MRCP. Biliary, vascular anatomy and bile
leak in T1 and T2 MRCP was noted.
Results. Conventional MRCP revealed BDI of Bismuth type III in 4, type II in
3 and 2 each of type IV and V. In all patients type of injury on CE MRCP
correlated with conventional MRCP and good quality CE MRC was obtained in
5. Biliary leak was detected in 10 patients on TI FSPGR images and in 6 patients
on post contrast T2 MRCP images. CE T1 MRCP detected the origin of leak as
to be from hilum in 5, duodenum in 1 and indeterminate in 4 patients. The MR
angiogram revealed normal portal vein in all and a right hepatic artery injury in
one patient. The study demonstrated complete loss of biliary continuity in 9. Of
the 6 patients with suggestion of internal fistula on CE MRCP,it was confirmed
in 4 out of 5 patients who were operated upon. On review, CE MRCP provided
complete information in 9 (81%) patients without the need for any further work
up. Percutaneous drainage for ongoing bile leak (n/3) and avoidance of ERC
(n/5) were the decisions influenced by CE MRCP.
Conclusion. CE MRCP appears to be a promising and effective single
investigation in workup of acute BDI.
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EVALUATION OF THE OPERATIVE OUTCOME FOR HILAR
CHOLANGIOCARCINOMA IN THE RECENT DECADE
Ota, Takehiro; Araida, Tatuo; Yamamoto, Masakazu; Takasaki, Ken
Tokyo Women’s Medical University Institute of Gastroenterology, Tokyo,
Japan
Background. Hilar cholangiocarcinoma was considered as one of the most
poor prognostic carcinoma but recent advances of the operative procedure
may improve the prognosis.
Aim. In this study, we evaluate the operative outcome of 70 patients who
underwent radical operation from 1996 to 2005 in our institute.
Results. Of the 70 patients, 54 were men and 16 were women. Their ages
ranged from 38 to 89 years (mean: 65.7 years). As for the operative
procedure, extra bile duct resection with (extended) right lobectomy under-
went in 25 patients, with (extended) left lobectomy in 23 patients and other
hepatectomy in 22 patients. Combined vascular resection and reconstruction
underwent in 18 patients. Curative resection was achieved in 40 patients
(57%). Postoperative complication occurs in 25 patients (36%) and operative
death occurs in 2 patients (2.8%). The 3-, 5-year survival rates for all patients
were 46%, 33% respectively. Those for 40 patients who had curative
resection and 30 patients who had non-curative resection were 59%, 47%
and 31%, 15% respectively (p/0.06). Those for 29 patients with lymph
node metastasis and 40 patients without metastasis were 36%, 36% and 54%,
30% respectively. Those for 18 patients with combined vascular resection and
52 patients without vascular resection were 26%, 9% and 54%, 44%
respectively (p/0.005).
Conclusion. Recent advances in operative procedure and perioperative
management certainly improve the operative outcome for hilar cholangio-
carcinoma especially in the patients without combined vascular resection.
However, the prognosis of the 18 patients with combined vascular resection is
still not satisfactory and more advanced management is necessary.
P4.18
EXPLORATIVE RELAPAROTOMY IS STILL PERFORMED FOR
MINOR BILE DUCT INJURY
de Reuver, Philip R; Busch, Olivier R; van Gulik, Thomas M; Gouma, Dirk J
Amsterdam Medical Center, Surgery, Amsterdam, Netherlands
Background. Adequate classification of bile duct injury (BDI) is essential in
determining a surgical or non-surgical treatment in BDI patients. A non
surgical treatment is recommended in patients with minor injury, i.e. cystic
duct leakage. Although an explorative relaparotomy is contraindicated in
patients with minor injury, the current incidence is unknown.
Aim. to analyze the incidence of relaparotomy procedures in patients with
minor injury over the last fifteen years.
Methods. In a consecutive series of 500 BDI patients referred between 1990
and 2006 to a tertiary center the type of injury was classified as minor (i.e.
cystic duct leakage) and major injury (i.e. leakage, stricture or transection of
the common bile duct). Additionally data from operative procedures in the
referring center are obtained. A relaparotomy was classified as a reconstructive
relaparotomy (RR) or an explorative relaparotomy (ER). Patients treated
between 1990 and 1998 were compared with patients between 1999 and 2005.
Results. A relaparotomy was performed in 136 (27.2%) patients before
referral. Fifty-four patients (29.7%) underwent a relaparotomy between
19901998 and 82 patients (25.8%) between 19992005 (p/0.3). A minor
injury was diagnosed in 136 patients (27.2%) and a major injury in 364
patients (72.8%). Fifty-six of the 364 patients (15.4%) with a major injury
underwent a RR and 48 patients (13.2%) an ER. From the 136 patients with
a minor injury no patient underwent a RR; however an ER was performed in
32 patients (23.5%).
Conclusion. 27.2% of the referred BDI patients underwent a relaparo-
tomy before referral and no decrease was found over the last fifteen years.
One fifth of the patients with minor injury underwent an explorative
relaparotomy, although a non-surgical treatment is recommended. Adequate
classification of the injury before relaparotomy could have prevented
unnecessary morbidity.
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HOW TO PREVENT INJURIES DURING THE CREATION OF
PNEUMOPERITONEUM IN LAPAROSCOPIC SURGERY
Chung, Hyuk Jun; Park, Il-Young
Holy Family Hospital, Catholic University of Korea, Dept. of Surgery,
Bucheon, Korea
Background. Abdominal access in the laparoscopic surgery carries a risk of
several injuries. Potential complications such as bleeding, subcutaneous
emphysema, gastro-intestinal perforation and major or minor vascular injury
are associated with abdominal access for the creation of pneumoperitoneum.
Material & methods. Between October 2003 and February 2006, we
experienced gastrointestinal perforation (3), subcutaneous hematoma (1),
renal capsular hematoma (1) and subcutaneous emphysema (3) during the
creation of pneumoperitoneum either by direct trocar insert or blind Veress
needle insert. We tried several methods to prevent injuries such as direct
trocar insert, using ultrasonography and others. Especially, we underwent
ultrasonographic examination of the abdominal wall in patients with previous
abdominal surgery. Before the operation, we checked the viscera slides using
the ultrasound probe. A reduction in slides was considered a positive sign of
underlying adhesions.
Results. From November 2005 to February 2006, we underwent ultra-
sonography in 20 patients. This method is valuable in patients with previous
abdominal or pelvic surgery. And it is also useful in the operation at lateral
position, such as laparoscopic adrenalectomy.
Conclusion. We conclude that this examination using ultrasound scanning
can detect intra-abdominal adhesion and prevent injuries during the creation
of pneumoperitoneum.
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HUMAN FACTOR APPROACH IN SURGERY: CAN LAPARO-
SCOPY BE THE TEST FIELD FOR AN INCREASE IN SAFETY?
Sockeel, Philippe1; Chatelain, Eric1; Cortes, Alexandre2; Buffat, Stephane3;
David, Patrice1; Cazeres, Christophe1; Steiner, Thierry4; Michel, Philippe1
1Military Hospital LEGOUEST, Digestive Surgery, Metz, France; 2Beujon
Hospital, Digestive Surgery, Clichy, France; 3Aeronautic Medical Study
Center, Cognitive Psychology Department, Bretigny, France; 4Military
Hospital LEGOUEST, Anaesthesic Department, Metz, France
Anywhere in Europe and North America, human factors (HF) study is
mandatory to get air transport pilot licences. In civil aviation, as well as in
military, crew resource management (CRM) and declaration of adverse
events (feedback) result in improving of air traffic safety. Air missions and
surgical procedures have similarities; bridging the gap is tempting, despite
severe warnings against simplistic adaptation. Putting HF theory into
surgical practice: how to? Educational principles derived from aviation
CRM improve professional attitudes of a team. We propose to translate
concepts of aviation CRM to clinical teams. CRM training applying in
surgical and especially laparoscopic activities could allow the work environ-
ment to be restructured to substantially reduce human error. The necessary
teamwork involved in such surgical cases makes it a good candidate.
Feedback: Pilots have to announce adverse events encounter. In Air Forces,
the Bureau of Flight Safety deals with investigations for air events. Pilots, air
traffic controllers, flight engineer can anonymously declare nuisance,
resulting in a favourable feedback for the whole air force. Adverse events
are rigorously analysed, according to SHELL system, James Reason’s
model. . . Usually, multilevel problems are found, rather than the only
responsibility of the last operator. Understanding the mechanisms of human
failure finally improves safety. In surgical teams, CRM and feedback would
probably be helpful. Anyway, it requires time; people have to change their
mind. It is probably a large challenge. Nevertheless people such as fighter
pilots, who were very unwilling at the beginning, now consider HF as a
corner stone for security. But it is difficult to estimate the extent of HF
related morbidity and mortality.
Conclusion. HF deals with the mechanisms of human errors and the ways to
improve safety, which can probably improve surgical team’s efficacy. We
propose as a first step to implement CRM and feedback in laparoscopic
surgical procedure to improve surgical safety.
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ILEAL LOOP INTERPOSITION IN THE MANAGEMENT OF
NEOPLASIC OBSTRUCTIVE JAUNDICE: AN ALTERNATIVE BY-
PASS TECHNIQUE
Coimbra JF, Felipe; Herman, Paulo; Montagnini, Andre L; Sallum, RAA;
Machado, Marcel AC; Diniz, Alessandro
Hospital do Cancer AC Camargo FAP, Abdominal Surgery Department, Sao
Paulo, Brazil
Background. Obstructive jaundice is a common condition in patients with
advanced digestive cancer. Usually a Roux-en-Y hepaticojejunostomy is
utilized for good performance status patients. When surgical bypass is not
possible, biliary drainage can be done by endoscopic or transparietal stents.
When the hepaticojejunostomy is not feasible due to a jejunum mesenteric
retraction, transparietal or endoscopic stents are the only alternatives.
Aim. To describe an alternative surgical bypass technique to patients where
in the surgical finding there is no possibility to use the jejunum, creating an
internal bypass with an ileal loop interposition.
Methods/Patient. A 47-year-old man with good performance status, and a
previous gastrectomy (including cholecystectomy) for advanced gastric
cancer, was referred with obstructive jaundice. CT scan disclosed a dilated
bile duct with distal stricture and no other signs of metastasis were observed.
At surgery, a choledocal duct obstruction with extensive retroperitoneum
infiltration and mesenteric retraction was observed. This condition did not
permit to ascend the jejunum. We opted for the construction of an ileal loop
bypass between the bile duct and the jejunum.
Surgical technique. The authors describe in details this alternative bilio
enteric bypass technique illustrated by a case report.
Results. Recovery was uneventable. The bilirrubin levels normalized after
one week and the patient was referred for systemic chemotherapy being
asymptomatic after 5 months of chemotherapy.
Conclusion. This new billiary bypass technique is feasibly and is an
alternative to patients where the jejunum doesn’t reach the biliary tree in
surgical field findings.
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BILIARY DRAINAGE USING (EPTFE) GRAFT FOR IATROGENIC
OBSTRUCTIVE JAUNDICE; CONTROLLED EXPERIMENTAL
STUDY IN DOGS
Helmy, Ahmed1; Zeidan, Ahmed1; Hamam, Olfat2; Abdel-Azim, Hatim3; El
Kased, Ahmed3; Badawy, Mahmoud3; Ezzit, Hussine1
1Theodore Bilharze Research Institute, ASU and Exp Surgical Laboratory,
Giza, Egypt; 2Theodore Bilharze Research Institute, Histopathology, Giza,
Egypt; 3Faculty of Medicine, Menoufeya University, General Surgery
Department, Menoufeya, Egypt
Background. Bile duct injury is a complication related to biliary surgery, after
cholecystectomy and other types of upper abdominal operations. Treatment of
this injury represents a serious challenge. The standard management is Roux-
en-Y hepatico-jejunostomy and other non-surgical treatment.
Aim. This study is designed to use thin-walled polytetrafluoroethylene
(ePTFE) rigid grafts as an option for repair of bile duct injury.
Methods. 20 dogs were used in this study. In the 1st laparotomy we induce
(iatrogenic) obstructive jaundice ligating the common bile duct. After 7 days
the 2nd laparotomy for biliary drainage doing hepatecio dudenostomy using
the (ePTFE) grafts. Then 3rd laparotomy to obtain the pathological samples
(liver bx, the graft and serum samples of bilirubin, and alkaline phosphatase)
after 1, 4, 12 and /32 weeks.
Results. 5, 6, 6 and 3 dogs were sacrificed after 1,4,12 and/32 weeks
respectively. All animals had no (leakage, fistulae, bleeding and peritonitis).
Jaundice was relived after the 2nd laparotomy detected by the stool colour,
weight gain, serum bilirubin and alkaline phosphatase. There was no
mortality in this study. The main complications were wound infection and
burst abdomen which was repaired in the 2nd laparotomy. Dogs start to gain
weight after 2 weeks of 2nd laparotomy. Bil and alk phos returned to normal
after 24 weeks from the 2nd laparotomy. Histologicaly the liver architect
showed relief of the obstructive jaundice and sealed fibrosis around and from
within the graft in all intervals.
Conclusion. The use of (ePTFE) graft to correct iatrogenic obstructive
jaundice is an efficient, effective technique and could be used clinically as an
alternative to other procedures.
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ISO FLOW DISSECTED MINILAPCHOLE AND CONVENTIONAL
LAP-CHOLE, A COMPARISON OF TWO PROCEDURES
Ganguly, Narendra N
Gauhati Medical College and Hospital, Dept. of Surgery, Guwahati, India
Introduction. This modern open technique is comparable with the lap chole
in all aspects (5).
Materials and methods. A total of 976 patients were taken up for open
cholesystectomy in the last 7 years. A 3.5 cms.to 5.00 cms. Long incision was
used in all patients to start with. The gallbladder was dissected with a fixed
plan. The pedicles were ligated first to avoid spillage of stones. The gall
bladder dissected fundus onwards (ISO FLOW) and any strand, which can’t
be blunt dissected, were ligated and cut. During the same period 226 patients
were operated by laparoscopy. Duct and artery were polyclipped and before
severing these gall bladders were elevated from the bed by extensive posterior
dissection to attain the similarity between the two procedures. Gall bladders
were delivered through the epigastric port.
Results and observations: Open cholecystectomy. No deaths, no retained
stone, no wound disruptions, no ugly scars were detected in these cases.
Lap chole. No deaths, no retained stones in these cases too. The request for
analgesia was received more frequently by the lap chole group 3 cases were
found to be having T1 (A) ca GB. The report caused alarm and subjected to
six cycles of chemo.
Discussion. Some reports are available from the early nineties on day care
open cholecystectomies (1, 2, 3). In the eighties some surgeons produced
minimal trauma cholecystectomies with surprisingly good results (4, 5). Some
workers tried to evaluate the period of hospital stay after billiary surgery (6).
Comparative results between laparoscopic surgery and modified open chole-
cystectomies are available (7). In the present study the results of small incision
minimal trauma iso-flow open cholecystectomies were analyzed. It was proved
beyond doubt that the modification of the procedure (ISO- FLOW) definitely
reduced the complication rate in Chocystectomy, both lap, mini-lap and open.
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LAPAROSCOPIC CHOLECYSTECTOMY UNDER SPINAL
ANAESTHESIA: A PILOT STUDY
Tzovaras, George1; Fafoulakis, Frank1; Pratsas, Constantinos2; Georgopou-
lou, Stavroula2; Stamatiou, Georgia2; Hatzitheofilou, Constantine1
1Dept. of Surgery, University Hospital of Larissa, Larissa, Greece; 2Dept. of
Anaesthesiology, University Hospital of Larissa, Larissa, Greece
Background. Regional anaesthesia has not been used as the sole anaesthetic
procedure other than in the scenario of a patient at high risk to undergo
laparoscopic cholecystectomy with CO2 pneumoperitoneum under general
anaesthesia.
Methods. Fifteen ASA I or II patients underwent laparoscopic cholecys-
tectomy with low pressure CO2 pneumoperitoneum under spinal anaesthe-
sia. Intraoperative parameters, postoperative pain and recovery in general, as
well as patient satisfaction at follow-up were prospectively recorded in a pilot
study to assess the feasibility and safety of the procedure.
Results. All operations were completed laparoscopicaly and conversion from
spinal to general anaesthesia was not required in any of the cases. Median
pain score at 4 hrs postoperatively was 1.5 (range 05), at 8 hrs 1 (range 0
6) and at 24 hrs 1 (range 04). All patients were discharged after 24 hrs.
Follow-up at two weeks postoperatively showed all but one patient to be
satisfied and strongly recommending the anaesthetic procedure.
Conclusion. Laparoscopic cholecystectomy with low pressure CO2 pneu-
moperitoneum can be successfully and safely performed under spinal
anaesthesia. Furthermore, it seems that spinal anaesthesia is associated
with minimal postoperative pain and at least an equally good recovery as with
general anaesthesia.
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LAPAROSCOPIC CHOLEDOCHOLITHOTOMY; ‘‘A RATIONAL
APPROACH’’
Bhalerao, Suryabhan; Rege, Aparna
K.E.M. Hospital & Research Centre, Dept. of Surgery, Pune, India
Background. CBDstones are treated by open, laparoscopic choledocho-
lithotomy (CDL) & ERCP/ES. These procedures are associated with some
short & long term morbidity & sequalae.
Aims & objectives. To minimise morbidity of CDL & preserve function of
sphincter of Oddi (SOD).
Methods. In 2005 10 patients(pts) of CBD stones & cholelithiasis were
treated by lap. CDL & cholecystectomy. CBD stones were removed after
supraduodenal choledochotomy. Rigid ureteroscope was used for cholangio-
scopy to detect residual stones. Antegrade stent using 5F infant feeding tube
was inserted & choledochotomy sutured. Subhepatic tube drain was kept for
48 hrs. Pts were fit for discharge after 72 hrs. 10 days later, pts underwent
UGI scopyfor stent removal.
Results. All 10 pts had complete stone clearance. Stone size varied from 3
mm to 25 mm. Average time required for surgery was 2.5 hrs. In 4 pts stents
had been passed spontaneously &in 6 they were removed by UGI scopy.
Discussion. Laparoscopic CDL & cost effective antegrade simple stenting
will bring back surgical disease from the physician. ERCP is a technically
demanding procedure with few early & late sequalae in the form of bacterial
contamination of billiary tree,loss of SOD function,pancreatitis & potential
for malignant change. ‘T’ tube drainage has significant morbidity of external
appliance,leakage & infection post removal.
Conclusion. Lap choledocholithotomy, cholangioscopy & simple antegrade
stenting with primary CBD closure are feasible methods for treating CBD
stones. This is cost effective & reduces hospital stay. It preserves the function
of SOD & avoids residual stones. Larger studies are needed in order to
document cost effectiveness & longterm out come.
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LAPAROSCOPIC EXPLORATION OF THE LEFT MAIN HEPATIC
DUCT
Yoo, Yong-Oon; Baek, Bum-Su
Daegu Catholic University Hospital, Dept. of Surgery, Daegu, South Korea
Introduction. Laparoscopic removal of the stones in the left main hepatic
duct through choledochotomy at the level of common bile duct is very
difficult, because of long tract and relatively narrow common hepatic duct.
We report a patient in whom 1.5 cm sized stone(old blood clot in the
prmanent biopsy) in the left main hepatic duct was removed through
laparoscopic exploration of the left main hepatic duct.
Case report. A 47 year old male was admitted to IM department because of
cholelithiasis and stones in the common bile duct. Endoscopist removed CBD
stones by use of endoscopic sphincterotomy technique and placed ENBD
tube in the bile duct. We performed preoperative cholangiography, which
revealed filling defect in the left main hepatic duct with proximal intrahepatic
ductal dilatation. The filling defect was regarded as previously undetected
intrahepatic stone. We proposed to do laparoscopic cholecystectomy and
laparoscopic exploration of the left main hepatic duct. After laparoscopic
exposure of the left main hepatic duct with merticulous dissection of the soft
tissue around the hepatic hilum, ductotomy was applied on it. Followed by the
removal of the intrahepatic stone, which revealed benign mass in the frozen
section biopsy. After open exploration of the left intrahepatic duct, the
ductotomy site was primarily closed. There was no specific complications in
the postoperative period. In conclusion, laparoscopic exploration of the left
main hepatic duct can be one of the therapeutic option for the removal of the
stones around the left main intrahepatic duct. And this technique seems to
promote the ability of laparoscopic exploration of the left intrahepatic duct.
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LAPAROSCOPIC MANAGEMENT OF ACUTE CHOLECYSTITIS-
CAN THE STANDARD OF CARE BE MAINTAINED IN THE POST-
TRIAL PERIOD?
Chong, CN; Teoh, AYB; Wong, J; Lee, KF; Lai, PBS
Prince of Wales Hospital, The Chinese University of Hong Kong, Dept. of
Surgery, Hong Kong, China
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Background. Early laparoscopic cholecystectomy (LC) has recently become
the ¡§gold standard¡ for the treatment of acute cholecystitis. However, some
surgical units do not adopt a policy of early LC because of the perceived
higher conversion rate in the acute setting and the limited availability of
skilled surgeons on call. At our institution, early LC for patients with acute
cholecystitis had been a routine practice after the conduction of a randomized
trial of early versus delayed LC in 1997. The aim of this review is to assess the
clinical outcomes of the LC for acute cholecystitis in the post-trial period.
Methods. The medical records of all patients admitted to our hospital with
the clinical diagnosis of acute cholecystitis and had attempted early LC from
July 1997 to June 2004 were reviewed retrospectively. The patients¡j
demographics, procedure, conversion rate, length of hospital stay, operative
time, complication and mortality rates were studied.
Results. 209 patients were included in this study. The mean age was 57.5
years (range 29 ¡V 87). The mean operation time was 104.9 minutes (range
55370) while the mean total and post-operation hospital stay were 7.77
days (range 322) and 5.26 days (range 120) respectively. The complica-
tion rate was 13.7% and the overall conversion rate was 36.3%. There was no
in-hospital mortality. Operations were done by a similar group of surgeons.
When this cohort of patient was compared to the previous studies cohort,
there were no significant differences in the complication rate, bile duct injury
rate and the length of total hospital stay. However, the conversion rate
increased significantly from 20.8% to 36.3%.
Conclusion. Despite an overall higher conversion rate in the post-trial
period, there was a gradual reduction over the years. There was no increase in
the incidence of complications and bile duct injury. Thus, with proper
training and increasing experience in laparoscopic surgery, early LC for acute
cholecystitis is safe and feasible.
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LIVER RESECTION FOR LAPAROSCOPIC CHOLECYSTECT-
OMY ASSOCIATED BILE DUCT INJURIES
Sielaff, Timothy1; Humar, Abhinav2; Payne, William D.2
1Virginia Piper Cancer Institute, Surgery, Minneapolis, USA; 2University of
Minnesota, Surgery, Minneapolis, USA
Background. Bile duct injuries remain a major cause of long term morbidity
and reduced quality of life even after surgical reconstruction.
Aim. To review the results of liver resection as part of the management of
complex bile duct injuries.
Methods. Four patients with laparoscopic cholecystectomy associated bile
duct injuries who underwent liver resection (ages-26 71 years) as part of
definitive therapy were reviewed. Three patients had acute injuries (1 to 3
months) and controlled bile fistulae, one patient presented 11 years post
cholecystectomy. Biliary tract imaging demonstrated an intact confluence of
the left hepatic duct with the common hepatic duct (n/3, 2 acute, 1
chronic). The fourth patient had a bile fistula and liver ischemia.
Results. Of the 3 patients with presumed intact left duct confluences, 2
patients underwent right hepatectomy alone (1 acute, 1 chronic), the other
had common hepatic duct ischemia and underwent right hepatectomy and
biliary enteric reconstruction to the left hepatic duct. The fourth patient
(Strasberg E4 injury with left portal vein and hepatic artery ligation)
underwent left lobectomy and right hepaticojejunostomy to the two sectoral
ducts. Follow up ranged between 12 months to 5 years and shows all patients
have been free of hospitalization.
Discussion. Bile duct injuries associated with high unilateral hepatic duct
injury, though rare, may be definitively treated with resection. In this study,
resection was felt to obviate the potential risk of anastomotic stricture and
repeated biliary tract intervention associated with bile duct repair to a
compromised hemiliver. Biliary tract injuries with unilateral vascular in flow
compromise also warrant consideration of resection as part of definitive
therapy. After control of bile peritonitis, multimodality preoperative evalua-
tion of the biliary tract will assist in the identification of candidates for
resection and allow optimal surgical planning.
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LONG-TERM RESULTS (/5 YEARS) OF BILIARY RECON-
STRUCTION FOR IATROGENIC INJURY
Ozden, Ilgin1; Erkan, Mert2; Bilge, Orhan1; Tekant, Yaman1; Acarly´, Koray1;
Alper, Aydy´n1; Emre, Ali1; Poyanly´, Arzu3; Rozanes, Y´zzet3; Ary´oðul,
Orhan1
1Istanbul University, Istanbul Faculty of Medicine, Dept. of General Surgery
(HPB Surgery Unit), Istanbul, Turkey; 2Heidelberg University, School of
Medicine, Department of General Surgery, Heidelberg, Germany; 3Istanbul
University, Istanbul Faculty of Medicine, Dept. of Radiology, Istanbul,
Turkey
Background. Approximately two-thirds of the recurrent strictures following
biliary reconstruction occur within two years. However, at least 5 years of
follow up is considered necessary for a satisfactory evaluation.
Objective. To review the long-term results (/5 years) of biliary reconstruc-
tion for major iatrogenic biliary tract injuries (loss of bile duct continuity).
Patients and methods. The charts of the 72 patients who underwent biliary
reconstruction for iatrogenic injury between 1997 and 2000 were reviewed.
All patients were treated with a strategy based on preoperative control of
cholangitis and subhepatic infection, accurate delineation of biliary anatomy
(with percutaneous transhepatic biliary drainage and cholangiography in the
majority) and construction of a tension-free, mucosa-to-mucosa anastomosis.
Results. The injury levels were Bismuth I in 3 patients, II in 22, III in 32 and
IV in 15. Twelve patients had undergone a biliodigestive anastomosis for
repair. Roux-Y hepaticojejunostomy was performed in 70 patients (combined
with hepatectomy in 6), hepaticoduodenostomy in 1 and pancreatoduode-
nectomy with portal vein reconstruction (for concomitant portal vein injury)
in 1. Four patients (6%) died of postoperative bleeding and septic
complications. After discharge, 3 patients died of unrelated causes (one after
5 years). Fifty-two patients (79%) could be followed for longer than 5 years-
median (range) 83(61109) months. The outcome of surgery alone was
excellent (no symptoms, normal cholestasis enzymes) in 33 patients, good in
14 (no symptoms, elevated cholestasis enzymes), fair in 4 (decrease in the
frequency and severity of cholangitis attacks), poor in 1 (persistent or
progressive cholangitis).
Conclusions. The strategy outlined achieves a successful, long-term
functional outcome in approximately 90% of the patients. Percutaneous
transhepatic balloon dilation may be required in the remaining patients.
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MANAGEMENT OF IATROGENIC BILIARY INJURIES IN A RE-
FERRAL CENTER: ANALYSIS OF 34 PATIENTS
Firat, Ozgur; Gurcu, Baris; Aydin, Unal; Uguz, Alper; Parildar, Mustafa;
Memis, Ahmet; Ersoz, Galip; Tekesin, Oktay; Ilter, Tankut; Zeytunlu,
Murat; Coker, Ahmet
Ege University Medical School Hospital, G.Surgery, HPB Unit, Izmir,
Turkey
Background. Aim(s). To evaluate the changes in the pattern of iatrogenic
biliary injury and its consequential effects on treatment stategy and outcome.
Methods. Thirty five patients treated for iatrogenic biliary injury (IBI)
between 20032005 at a tertiary care center in Izmir, Turkey were
retrospectively analysed
Results. Underlying diseases were missed tumor(n/2, 5,9%), biliary
surgery (n/29, 85,3%), and hydatid disease (n/3, 8,8%). In recent years,
with a gradual increase in the availability of endoscopic and radiological
expertise, the majority of patients underwent extensive preoperative diag-
nostic and therapeutic procedures including endoscopic retrograde cholan-
gio-pancreatography (n/8) and percutaneous transhepatic cholangiography
(n/6). Definitive surgery was performed in all patients. Roux-en-Y
hepaticojejunostomy was the reconstruction most frequently performed
(n/16, 47%). There was only one (2,9%) hospital mortality. All patients
were followed-up for a period of minimum one month, maximum 28 months.
129/2 months (range 128). Restenosis developed in 1 patient (2,9%), and
was reoperated. Percutaneous balloon dilatation was failed in 3 patients as a
first treatment option. None of patients died of disease related causes during
the follow-up period. Overall, a successful outcome was achieved in 91,2% of
patients.
Conclusion. Increased experience in laparoscopic biliary surgery might be
caused to attempt more challenging cases and increased biliary tract injuries.
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MANAGEMENT OF INTRAOPERATIVE BILE DUCT INJURY
DURING LAPAROSCOPIC CHOLECYSTECTOMY
Tanaka, Jun-ichi; Deguchi, Yoshio; Kato, Hirohisa; Niiya, Takashi; Hidaka,
Eiiji; Kasugai, Hisashi; Kudo, Shin-ei
Showa University Northen Yokohama Hospital, Digestive Disease Center,
Yokohama, Japan
Background. Preoperative DIC-CT and intraoperative cholangiography
(IOC) were introduced to evaluate an anatomy of bile duct, and also to
avoid intraoperative bile duct injury (IBDI) during laparoscopic cholecys-
tectomy (LC).
Aim. Feasibility of DIC-CT and IOC for IBDI was investigated.
Patients.: During resent four and half years, we performed LC for 475
patients in our hospital.
Results. DIC-CT revealed anatomical anomaly on 20 patients out of 475.
IOC was performed completely on 96% patients. Two patient out of 475
patients who underwent LC encountered IBDI due to marked inflammation
around the cystic duct, and they were treated with T-tube drainage or direct
repair of injured cystic duct under laparoscopic guidance and postoperative
course was uneventful.
Summary. IOC is still controversial, however it is reported to be useful for
intraoperative examination of CBD stones, and also to be useful to avoid
injury of bile duct. Routine IOC during LC including skeletonization of
cystic duct and catheterization into cystic duct could improve skill of
laparoscopic surgical procedures such as CBD exploration, colorectal surgery
and gastric surgery.
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MINIMALLY INVASIVE TRANSDUODENAL PAPILLOTOMY
(MTDPT)
Hodakov, Valery
Ural State Medical Academy (USMA), Clinic of General Surgery, Yekater-
inburg, Russia
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Endoscopic retrograde papillotomy (ERCP) is currently a procedure of
choice for elimination stenosis of Vater papilla. The ERCP can be technically
difficult when peri-papillary diverticulum, unusual anatomic variations or
post-gastrectomy changes are present. In these cases it is necessary to resort
to laparotomy and transduodenal papillotomy for the correction of patholo-
gical changes in papilla. To reduce traumatic intervention in USMA
MTDPT is applied since 1994. The tools include a standard base set for
biliary surgery (MC SAN). Technique of operation. Patient is supine with the
platen placed under the back at the level of xyphoid. 5 to 7 cm
minilaparotomy is performed 1.52 cm below right costal margin and 2
2.5 cm off the medial line. Operational space is formed with 45 retractors.
We carry out the revision of bilious ducts, cholangiography, cholecystectomy;
dissect peritoneum at the lateral contour of duodenum, mobilize it according
to Kocher. Intestine is moved up and forward and kept in this position with
gauze napkins placed in retroduodenal space. We carry out longitudinal
supraduodenal choledocholithotomy; with a Dogliotti probe determine
papilla’s location. Then the transverse duodenotomy in length up to 1.5
cm above palpated Vater papilla is performed. Papilla is brought into the
duodenal wound, is fixed by two guy sutures between which papilla is
dissected by small portions. We suture the lateral edge of the papilla first;
carry out revision of dissected papilla for detection of the ostium of Wirsung’s
duct. The revision in distal direction must confirm that Vater papilla
had been dissected up to its outside aperture. Then we suture the medial
edge of papilla. The duodenum is closed in transverse direction. Common
bile duct is drained with peri-papillary drainage. MTDPT was performed on
9 patients: 8 patients had been operated on due to chronic gallstone
cholecystitis, 1-with acute cholecystitis. Average postoperative day is 14. 1
patient died.
P4.33
SURGICAL TREATMENT FOR HEMATOLOGIC DISEASE USING
LAPAROSCOPIC SPLENECTOMY (LS)
Yasunaga, Masafumi; Morinaga, Akio; Okuda, Koji; Sakai, Hisafumi; Ogata,
Toshiro; Kinoshita, Hisafumi; Aoyagi, Shigeaki
Kurume University School of Medicine, Surgery, Kurume, Japan
Introduction and aim. Though the splenectomy has mainly been done
under the laparotomy with wide skin incision. A visual field is insufficient and
massive hemorrhage was seen in some cases. In this paper, we evaluate the
clinical results with LS.
Patients and methods. 14 patients (3 patients under hand-assisted method)
underwent the LS (Idiopathic thrombocythemia/10, hereditary sphero-
cytosis/1, Liver cirrhosis/3). Technique: 1) Thoraccer insertion. 2) Dissec-
tion of proximal side of the spleen (lig. Gastrolienale, lig. Phrenicolienale
and lig. lienorenale) 3) Dissection of distal side of the spleen(Mobilization)
4) Ligation & cut of the blood vessels in hilus lienis 5) Removing of the
spleen
Results. Mean operating time was 180 minutes(range 110 280). Average
blood loss was 255 g. Platelet count was 4.37/10000/ml preoperatively and it
increased to 25.0/10000/ml postoperatively. In terms of complications,
massive hemorrhages occurred in 2, injuries of adjacent organs in 2, portal
vein thrombosis in one and pancreatic fluid fistula in one.
Conclusion. The essential prevention and countermeasure for massive
hemorrage are a good visual field in operation, a simple technique for splenic
artery and vein processing, sufficient mobilization of the spleen with laparo-
scopic forceps and best using of hemostatic device. Laparoscopic splenectomy
is useful and safe for benign hematologic disease and Hand-assisted laparo-
scopic splenectmy can be recommnended for some cases of liver cirrhosis.
Accurate and meticulous laparoscopic surgical technique are essential for a
successful surgery. The countermeasure of LS are nece
P4.34
PRIMARY CLOSURE OF BILE DUCT FOR BILIARY STONE
DISEASE WITHOUT T-TUBE
You, Youngkyoung; Kim, Jeongku; Lee, Dongho; Ahn, Changjoon
The Catholic University of Korea, Daejon St. Mary’s Hospital, General
Surgery, Daejon, South Korea
Background. Until recently, in the surgery for bile duct stones, conventional
T-tube insertion has been performed, band it has been recommended that if the
diameter of bile duct were small or depending on the condition of the bile duct,
to perform selective T-tube insertion.
Aim. The aim of this study is to examine whether the conventional primary
closure of the bile duct without routinely inserting a T-tube could be performed
after all surgeries for choldocholithiasis.
Methods. From April 2002 to July 2005, in 125 bile duct stone disease patients
performed the primary closure of the bile duct, various clinical events were
analyzed retrospectively by considering the size of the bile duct diameter, the
history of previous surgery on the bile duct system, the emergency operation,
the age, the presence of recurrent lithiasis, etc..
Results. As surgical complications, wound infection was the most frequent
one, and it occurred in 4 cases of 14 who had a bile duct surgery previously, and
it showed a trend higher than 13 cases of 111 without the previous biliary
operation, and it showed a trend to be slightly higher in the recurrent biliary
stone cases (6/22) than the de novo cases(11/103), however, it was not
statistically significant. In regard to postsurgical hyperamylasemia, although a
statistically significant difference could not be detected, it was developed in 3
cases of 12 cases in whom endoscopic nasobiliary drainage (ENBD) tubes were
inserted, which shows a trend to be higher than 13 cases of 113 patients in
whom endoscopic nasobiliary drainage tubes were not inserted. Concerning
the postsurgical hospitalization period, it was significantly longer in the cases
who developed complications (P/0.018).
Conclusion. It appears that the primary closure of bile duct is a technique that
could be performed safely after all choledocolithotomy patients regardless of
the size of the bile duct diameter, the history of the surgery on the bile duct
system, etc..
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REFINEMENT OF BILE DUCT RECONSTRUCTION TECHNIQUE
IN OUR CENTER
Haberal, Mehmet1; Boyvat, Fatih2; Moray, Gokhan1; Sevmis, Sinasi1;
Karakayali, Hamdi1; Torgay, Adnan3; Arslan, Gulnaz3
1Baskent University Faculty of Medicine, General Surgery and Transplanta-
tion, Ankara, Turkey; 2Baskent University Faculty of Medicine, Radiology,
Ankara, Turkey; 3Baskent University Faculty of Medicine, Anesthesiology,
Ankara, Turkey
Background. Biliary complications are one of the most important problems in
liver transplantation. Despite various improvements of surgical technique,
different types of liver transplantation are associated with significant numbers
of biliary problems.
Aim. We describe our novel ‘‘intraoperative transhepatic biliary catheter
insertion’’ technique for biliary reconstruction, and compare results before and
after its implementation.
Method. Since November 2004, we have used this technique in 53 patients(26
children, 27 adults). In the new technique, a 5 F Kumpe catheter is inserted
into the biliary system in two steps. One step is completed at the back table,and
the second during the recipient operation.
Results. Thirteen patients(2 children and 11 adults) received whole-liver
grafts, 18(all adults) received a right lobe, and 22(all children) received a left-
lateral lobe or left lobe. The mean weight of the living-donor grafts was 734 g
(range,2291173 g). The mean graft weight-to-body weight ratio in the
LDLTs was 1.6%9/1.0% (range,0.8% to 4.1%). Intraoperative transhepatic
biliary catheter insertion was performed with duct-to-duct anastomosis in 48
cases, and with Roux-en-Y hepaticojejunostomy in 5 cases. Biliary complica-
tions were 3 cases (5.6%) of bile leakage from the anastomosis site. This rate is
significantly lower than the rate for biliary reconstruction methods used prior
to our new catheter technique (34.9%) (pB/0.05).
Discussion. Transhepatic biliary stenting prevents biliary complications
and makes it simple to maintain percutaneous access in case such
problems arise. Intraoperative transhepatic biliary catheter insertion at the
back table is a safe way to provide good biliary drainage after liver transplanta-
tion. However, further studies are needed to compare incidence rates of biliary
complications when our novel technique is used versus other surgical
techniques.
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ROUTINE RESECTION OF THE PORTAL BIFURCATION IN
RIGHT HEPATECTOMYAND BILE DUCT RESECTION FOR
ADVANCED HILAR BILIARY MARIGNANCIES
Hirano, Satoshi; Kondo, Satoshi; Hazama, Kazuaki; Suzuki, On; Shichinohe,
Toshiaki
Hokkaido University Graduate School of Medicine, Surgical Oncology,
Sapporo, Japan
Background. Locoregional recurrence is the most common form of recur-
rence following resection for Hilar cholangiocarcinoma. One of the possible
reasons of such recurrence is that an exposure and microscopic dissemination
of the cancer could happen during the procedure of dissection of the portal vein
(PV) at the hilar region. Anatomically, umbilical portion of the PV and portal
trunk can be anastomosed directly after the resection of the portal bifurcation
with right-sided liver resections. Considering this anatomical character, a new
procedure of right hepatectomy and bile duct resection, which includes
preventive and routine resection of portal bifurcation without attempt to
preserve the PV regardless of preoperative diagnosis of portal infiltration of the
tumor, has been performed. A technique and surgical outcome of the
procedure are presented.
Methods. Since 1999, 51 cases of right-sided hepatectomy and bile duct
resection for hilar bile duct or gallbladder cancer were carried out. In 31 cases,
PV was resected concomitantly with bile duct and reconstructed before
transecting hepatic parenchyma. In 16 of the last 31 patients preventive
resection and end-to-end anastomosis was performed after dividing the PV at
the umbilical portion and main trunk far from the tumor.
Results. Direct anastomoses were achieved without difficulty in all cases with
preventive PV resection. Occlusion time of portal flow was 20 minutes on
average and was not different from the cases with conventional PV resection.
Comparing with the cases performed by conventional procedure, and having
no portal resection, there were no differences in the operative time, blood loss,
and postoperative hepatic function.
Conclusions. The preventive resection of the portal bifurcation in the right
hepatectomy for hilar bile duct malignancies was feasible in the viewpoint of
surgical technique and postoperative course. The procedure may contribute to
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improvement of the curability of both bile duct and gallbladder cancer with
hilar invasion.
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ROUX-EN-Y GASTRIC BYPASS WITH CONCOMITANT CHOLE-
CYSTECTOMY THROUGH THE MINI-LAPAROTOMY INCISION
Halmi, Denis; Kolesnikov, Evgeni
Obesity Surgery Center, Potomac Hospital, Woodbridge, VA, USA
Background. Morbid obesity is a serious health problem and the number of
bariatric surgical procedures has increased significantly during the last 5 years
worldwide. The incidence of cholelithiasis is high in morbidly obese individuals
and rapid weigh loss further increases the risk of gallstone formation. Routine
prophylactic cholecystectomy as part of the bariatric procedure has been
suggested but it remains controversial.
Objective. The aim of this study was to define a rational approach to the
management of the gallbladder during the Mini-open Roux-en-Y Gastric
Bypass (MORYGB).
Methods. 981 morbidly obese patients (849 Female, 132 Male) underwent
MORYGB. Concomitant cholecystectomy was performed on 123 patients
(12.5%) with sonographic evidence of gallstones. Cholecystectomy was done
immediately following MORYGB through the same small (78 cm) upper
midline incision.
Results and discussion. Average operative time for MORYGB was 60.1
(4289)min, with concomitant cholecystectomy-75.9 (6391) min. The
average hospital stay was 3.1 days and was the same for the patients with
or without simultaneous cholecystectomy. There were no leaks or other
complications connected specifically to the cholecystectomy. In two cases of
super obese patients, cholecystectomy was not performed because of hepato-
megaly, high risk of intra-operative complications and postoperative rhabdo-
myolysis.
Conclusion. Concomitant cholecystectomy can be safely performed as a part
of MORYGB operation. Indications for removal of the gallbladder should be
based on sonographic evidence of gallstones or/and clinical symptoms of
cholelithiasis and intra-operative assessment of anatomy and risk for prolong-
ing operation in super obese patients.
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ROUX-EN-Y HEPATICOJEJUNOSTOMY WITH STOMATIZED
LIMB FOR BENIGN BILIARY STRICTURES: OUTCOME OF 30
PATIENTS
Kakavoulis, Timoleon; Avgoustou, Constantinos; Koniaris, Hlias; Penlides,
Paul
Konstantopoulio Agia Olga, 2nd Surgical Dept., Athens, Greece
Benign strictures of the extrahepatic biliary tract pose a surgical challenge,
while further corrective procedures are required in 1535% of cases. During
the period 19902005, 30 patients (21females,9males) aged 3875
(mean:56.5years) with benign strictures of the extrahepatic biliary tract
were surgically managed. Twenty-eight strictures developed as a result of
common duct injury during cholecystectomy (19 open, 9 laparoscopic).
Two cases had a history of penetrating abdominal injury. All the patients
had been undergone 14 (mean:1.7) biliary operations before referral. For
the precise localization of the obstruction, percutaneous transhepatic
cholangiography (PTC) in the first 16 cases and PTC combined with
MRCP in the last 14 cases were performed. According to the Bismuth
classification, 18 of the stenoses were level II, 7 were level III, 2 were level
IV and 3 level V. All the patients underwent Roux-en-Y hepaticojejunostomy
with exteriorization of the extended limp of the Roux loop to the skin. The
30-day mortality was zero. Complications occurred in 6patients: anastomo-
tic leak in 3(with biliary fistula closed spontaneously within 8 days), wound
infection in 3, and one of each of pulmonary infection and incisional hernia.
The mean postoperative hospitalization was 9.7 days (716). Postoperative
trans-stoma cholangiogram or introduction of an endoscope via the
stomatized jejunal limp was routinely performed to examine the anasto-
moses and to dilate restrictures if needed. Only patients with level IV and V
stenoses required repeated balloon dilatations. During a mean follow-up
period of 8.9 years(215), no recurrent stricture or intrahepatic stone
formation needed further surgery. Limp stomas were closed at 4 years; their
blind end remained subcutaneously. Roux-en-Y hepaticojejunostomy for
Bismuth II to V benign biliary stenoses affords satisfactory long-term
outcome. Routine stoma formation of the Roux loop secures access for
radiological imagination or endoscopic intervention, but it is unnecessary for
level II lesions.
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SHORT- AND LONG-TERM OUTCOMES OF BILIO-ENTERIC
ANASTOMOSES
Khorsandi, Shirin; Bhattacharya, Satya; Hutchins, Robert
St Bartholomew’s and the Royal London Hospital, Hepatobiliary and
Pancreatic Surgery, London, UK
Background. Bilio-enteric anastomoses are performed for a variety of
pathologies. Despite refinements in technique, these anastomoses are still
associated with early and late complications. At present the literature does
not clarify whether bile leaks predispose to stricturing. Additionally, the
incidence of complications from these anastomoses is unknown, other than in
the context of post-cholecystectomy injury.
Aims. We reviewed our experience of bilio-enteric anastomoses between
2000 and 2005 for complications, their inter-relationship and treatment.
Results. 275 bilio-enteric anastomoses were performed. Indications were:
192 malignancy, 36 inflammatory conditions, 27 benign tumours, 11
cholecystectomy injuries, 5 choledochal cysts, 1 trauma and 3 others. The
operations were cholecysto-jejunostomy 2, choledocho-duodenostomy 4,
choledocho-jejunostomy 81, hepatico-jejunostomy 161 (125 pancreatic
resections), hepatico-gastrostomy 3, right and left hepatico-jejunostomy 7,
left hepatico-jejunostomy 11, right hepatico-jejunostomy 3, right anterior and
posterior and left hepatico-jejunostomy 1, right anterior and posterior,
segment IV and left lateral hepatico-jejunostomy 1. The 30 day mortality
was 6%. There were 12 (4%) early bile leaks, treated by laparotomy (3),
PTBD (3) or expectant treatment. Late strictures occurred in 9 (3%), only
two were preceded by a biliary leak. Strictures were treated by reconstruction
in all but three patients. Reconstructions involved re-do single anastomoses
(2), two anastomoses (2) and hepatico-gastrostomy (2). Mortality for
reconstruction was 11%. No subsequent stricture has been seen. The other
three patients underwent successful stenting either through choice or because
of tumour recurrence.
Conclusion. Bilio-enteric anastomoses carry a low incidence of early and
late complications with acceptable mortality. Early complications/leak do not
necessarily result in the development of stricture disease. However, recon-
struction for stricture can be safely carried out with good subsequent patency.
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STANDARD SURGICAL PROCEDURE FOR CARCINOMA OF
THE AMPULLA OF VATER; IS LOCAL RESECTION POSSIBLE?
Baba, Hiroyuki; Kurata, Masanao; Tsuruta, Koji; Okamoto, Atsutake
Tokyo Metropolitan Komagome Hospital, Surgery, Tokyo, Japan
Background. Carcinoma of the apulla of Vater often shows good prognosis
by surgical resection. Pancreaticoduodenectomy may be too aggressive.
Aim/Objective. The aim of this study is to evaluate the long term results in
patients who had undergone surgical procedures against the carcinoma of the
ampulla of Vater and define most suitable procedure for curative treatment.
Methods. 61 patients who were diagnosed as the carcinoma of the ampulla
of Vater were briefly reviewed. Pathological evaluation including the dissected
lymph nodes was carried out according to the TNM classification (6th
edition, 2002).
Results. There were 27 males and 34 females, with the average age of 65. 47
patients received pancreaticoduodenectomy (PD) where as 14 patients
received pylorus preserving pancreaticoduodenectomy (PpPD). Macrosco-
pically, 40 cases were mass forming type and 2 cases were ulcerative type. 19
cases were combined type of both. According to the pT classification, there
were 14 pT1 cases, 10 pT2 cases, pT3 and pT4 were 14, 10, 24, and 13
cases, respectively. Furthermore, five year survival were 84%, 64%, 63% and
0% (pB/0.0001), respectively. Lymph node metastasis were present in 27
cases (44%) and five year survival of pN0 was 74% whereas 30% in pN1.
14% of pT1, 40% of pT2, 42% of pT3 and 85% of pT4 were node positive.
However, distant lymph node metastasis was not evident. 18 out of 20
patients with macroscopic appearance of ulcer formation were pT2 or more.
Conclusion. T1N0 cases are candidates for local resection of the tumor.
However, preoperative diagnosis of T1N0 is not quite easy. Ulceration of the
tumor indicates the high percentage of pT2 that these cases should be
excluded. PpPD, not PD, is reasonable procedure for the carcinoma of the
ampulla of Vater.
P4.41
SURGICAL MANAGEMENT OF DUODENAL AMPULLARY NEO-
PLASM: TRANSDUODENAL PAPILLECTOMY OR PANCREATO-
DUODENECTOMY FOR A SEEMINGLY EARLY-STAGE TUMOR
Koizumi, Masaru; Sata, Naohiro; Shimura, Kunihiko; Tsukahara, Mune-
toshi; Kurihara, Katsumi; Hyodo, Masanobu; Yasuda, Yoshikazu; Nagai,
Hideo
Jichi Medical University School of Medicine, Department of Surgery,
Shimotsuke, Tochigi, Japan
Backgroud/Aim. The clinicopathological features of duodenal ampullary
neoplasms were retrospectively analyzed to determine the indication of
transduodenal papillectomy (TP) in contrast with pancreatoduodenectomy
(PD).
Methods. We investigated the medical records of 53 patients with
duodenal ampullary neoplasm in all stages undergoing surgical resection
from 1992 through 2005. They had the following profiles: 3 adenomas and
50 adenocarcinomas on histology; 28 males and 25 females; average age of
67.6 years.
Results. All the adenomas underwent TP since they were intraoperatively
suspected and postoperatively confirmed to be localized within the
mucosa and to have negative surgical margins. All the 50 cases of
adenocarcinoma had PD performed with or without pylorus preservation
because of uncertainty concerning the depth of invasion and lymphatic
spread. According to the invasion depth on postoperative histological
examination, the carcinoma cases were divided into three categories;
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m-cancer (limited to the mucosa, n/6), od-cancer (limited to the sphincter
of Oddi, n/10), and advanced cancer (beyond the sphincter of Oddi,
n/34). No lymph node metastases were observed in m-cancers. 40% of od-
cancers and 44% of advanced cancers had lymphatic deposits. 60% of
m-cancers and 83% of od-cancers were over-diagnosed as advanced cancer
by preoperative intraductal ultrasonography and/or endoscopic ultrasono-
graphy. The overall accuracy of the preoperative diagnostics in terms of
invasion depth attained only 27% in m- and od-cancers.
Conclusions. As od-cancers showed the same amount of lymph node
metastases as advanced cancer, TP should be strictly indicated for m-cancers
and adenomas. In a case of seemingly early-stage neoplasm, accurate
diagnosis of invasion depth appears possible only with histological investiga-
tion of the total specimen of the ampullary tumor. We propose a two-step
strategy in such a case; firstly TP as a total biopsy followed by PD if necessary.
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SURGICAL MANAGEMENT OF TUMORS OF THE AMPULLA
OF VATER; LOCAL RESECTION OR PANCREATODUODENECT-
OMY
Konishi, Masaru; Kinoshita, Taira; Nakagohri, Toshio; Takahashi, Shini-
chiro; Gotohda, Naoto
National Cancer Center Hospital East, Surgery, Kashiwa, Japan
Background. Indications for local resection or adequate lymph node
dissection for tumors of the ampulla of Vater have not been established.
The present study evaluated suitable surgical treatments for patients with
tumors of the ampulla of Vater.
Patients. Clinicopathological factors were reviewed for 60 patients who
underwent surgical treatment for tumors of the ampulla of Vater between
1993 and 2005.
Results. The 12 patients with adenoma confirmed by preoperative biopsy
were treated by local resection with ampullectomy (n/9) or pancreas-
sparing duodenectomy (PSD; n/3). Postoperative pathology revealed
carcinoma in situ in 6 of the 12 adenoma patients (50%). The 48 patients
with adenocarcinoma confirmed by preoperative biopsy were treated using
PD with lymph node dissection (n/45), or local resection in cases of poor
surgical risk (n/3; ampullectomy 2, PSD 1). Histologically involved margins
were evident in 3 ampullectomy cases and 1 PSD case, but no local
recurrence has been encountered. Lymph node metastasis was identified in
26 patients who received radical resection (58%) including 1 patient with
tumor limited to sphincter of Oddi. In patients who received ampullectomy,
postoperative complications were observed in only 1 patient (wound
infection), and hospital stay was significantly shorter than in other patients.
Patients who underwent local resection had an overall 5-year actual survival
of 68% and a disease-specific survival of 100%. Patients who underwent PD
had 41% and 45%, respectively.
Discussion/Conclusion. Since positive surgical margins exist in some cases
and lymph node metastasis can be present even in patients with pT1 cancer,
local resection as a therapeutic approach to tumors of the ampulla of Vater is
indicated only for patients with preoperatively diagnosed benign tumors or in
patients with malignant tumors who cannot withstand PD. In other cases, PD
with regional lymph node dissection is suitable.
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SURGICAL REPAIR AFTER BILE DUCT AND VASCULAR INJU-
RIES DURING LAPAROSCOPIC CHOLECYSTECTOMY
Nakano, Hiroshi; Bachellier, Philippe; Oussoultzoglou, Elie; Rosso, Edoardo;
Zacharias, Thomas; Lunescu, Ionut; Wolf, Philippe; Jaeck, Daniel
Hopital Universitaire de Hautepierre, Centre de Chirurgie Viscerale et de
Transplantatio, Strasbourg, France
Background. Bile duct injuries (BDI) combined with other injury, for
example, hepatic arterial injury or secondary biliary cirrhosis, has yet to be
fully described.
Aim/Objective. To investigate when and how patients with bile duct injuries
(BDI) combined with hepatic arterial injury or with other complication after
laparoscopic cholecystectomy (LC) should be treated.
Method. Fifteen patients with BDI following LC, in whom 3 presented with
arterial injury, one with biliary cirrhosis referred 4 years after LC, the other
with internal biliary metallic stent referred 2.5 years after LC, were surgically
treated in our institution. Patients who were referred several years after LC
and who were referred after primary hepaticojejunostomy were included with
patients with complicated history (n/4, group B), and the other patients
were included with patients with simple history (n/11, group A).
Results. Simultaneous right hepatic arterial occlusion was observed in 3 of
these 15 patients, and arterial reconstruction was performed in 2 of the 3
patients in addition to biliary reconstruction. No postoperative complication
occurred in these three patients. Mean hospital stay was significantly longer
in group B (30.3///6.9 days) than in group A (18.5///2.5 days, pB/
0.05). Rehospitalization was more frequent in group B than in group A (pB/
0.01). However, long-term outcome was successful in both groups. The
patient with biliary cirrhosis and the other with biliary stent were successfully
treated.
Conclusion. The present results showed that arterial reconstruction may be
performed when the distal right hepatic artery can be exposed, and suggested
that patients with BDI during LC should be immediately referred to surgical
institutions in which surgeons have adequate experience of bile duct repair
and hepatic arterial reconstruction.
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SURVIVAL IN BILE DUCT INJURY PATIENTS AFTER TREAT-
MENT IN A TERTIARY CENTRE
de Reuver, Philip R1; Rauws, Erik A2; Lameris, Johan S3; Busch, Olivier
RC1; van Gulik, Thomas M1; Gouma, Dirk J1
1Amsterdam Medical Center, Surgery, Amsterdam, Netherlands; 2Amster-
dam Medical Center, Gastroenterology, Amsterdam, Netherlands; 3Amster-
dam Medical Center, Radiology, Amsterdam, Netherlands
Background. Bile duct injury (BDI) caused during laparoscopic cholecys-
tectomy (LC) is a major problem in current surgical practice. A recent
population based study from the United States demonstrated the detrimental
impact of BDI on survival. This is in contrast with the excellent outcome
reported by tertiary centres.
Aim. The aim of this study was to determine survival in BDI patients, treated
in a tertiary center and to compare survival within groups of BDI patients
according to referral pattern, severity of injury, moment of diagnose, and type
of treatment.
Methods. From a consecutive series of 500 BDI patients referred to a
tertiary centre, clinical data, and survival data are analysed. To compare
survival within patient groups, Kaplan-Meier plots are analyzed
Results. Five years survival was 92% (standard error/0.01). Survival was
not significantly worse in patients in whom BDI was diagnosed after
discharge from the initial hospital (Hazard Ratio [HR]/0.5, 95% Con-
fidence Interval [CI]/0.31.1), in patients referred after a repair in the
initial center (HR/1.57, CI/0.92.9), in patients with a major injury
(HR/1.89, CI/0.84.3), or in patients with a non-surgical treatment
(HR/2.3, CI/1.05.15). Survival was significantly worse in male patients
(HR/3.13, CI/1.75.8), and in patients referred after a surgical interven-
tion in the referring hospital (HR/2.0, CI 1.13.9). A multivariable
analyses showed that male gender (HR 2.01, CI/1.083.76), older age
(HR/1.12, CI/1.091.16), and primary repair in the referring center
(HR/2.12, CI/1.074.21) are independent prognostic factors for worse
survival in BDI patients.
Conclusion. Five years survival in BDI patients is 92%. Male gender, older
age, and referral after a primary repair are associated with poor survival.
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THE EFFECT OF EXTENDED LYMPH NODE DISSECTION AND
INTRAOPERATIVE RADIOTHERAPY FOR BILIARY TRACT
CANCER
Kotaka, Masahito; Konishi, Masaru; Gotohda, Naoto; Takahashi, Shini-
chiro; Nakagohri, Toshio; Kinoshita, Taira
National Cancer Center Hospital East, Kashiwa, Japan
Purpose. The effect of extended lymph node dissection(ELND) and
intraoperative radiotherapy(IORT) for the biliary tract cancer (including
papilla vater carcinoma) are not clarified. In our hospital, ELND/IORT was
performed in the early term(1992.91999.3), and D2 lymph node dissec-
tion(LND) without IORT was performed in the latter term(1999.42004.4).
We reviewed the effect of ELND and IORT by comparing the early term and
the latter term.
Patients and methods. Among 186 operatve cases in the biliary tract
cancer, we included 63(papilla vater carcinoma(papilla) 13, middle-lower
cholangiocarcinoma(middle-lower)) 16, hilar cholangiocarcinoma(hilar) 23,
gallbladder carcinoma(gallbladder) 11) in the early term and 68 (papilla 20,
middle-lower 23, hilar 14, gallbladder 11) in the latter term except for cases
of stage1, M1 and R2 resection.
Result. The postoperative morbidity rate did not differ significantly (73% in
the early term and 65% in the latter term), but the mortality rate decreased
significantly from 21% to 6%. The overall survival rate at 1,3,5 years was 69,
46, 39% in the early term vs. 88, 46, 46% in the latter term in the papilla and
was 50, 38, 25% vs. 73, 45, 33% in the middle-lower and was 57, 13, 4%
vs.64, 17, 17% in the hilar and was 55, 27, 18% vs.73, 49, 0% in the
gallbladder. No significant differences were observed between groups in each
sites. As a result of having compared a recurrence pattern, both groups did
not have the significant difference, but local recurrence rate including a
lymph node recurrence in the papilla vater carcinoma was higher in the latter
term. The SMA circumference recurrence that was absent for the early term
in particular was found in 5 cases for the latter term.
Conclusion. In this retrospective analysis, the significance of the ELND
and the IORT in the biliary tract cancer were not recognized. However, the
need of SMA circumference LND in the papilla vater carcinoma was
suggested.
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THE MODES OF SURGICAL TREATMENT OF CHOLEDOCHO-
LYTHIASIS-TEN YEARS’ EXPERIENCE IN A REGIONAL SURGI-
CAL CENTRE
Jovanovic, Milan1; Milojevic, Vladeta1; Trifunovic, Nenad1; Zdravkovic,
Rade1; Filipovic, Goran1; Zajic, Sasa1; Smiljkovic, Miroljub1; Kitanovic,
Aleksandar1; Andric, Branislav2
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1Health Center Krusevac, Dept. of Surgery, Krusevac, Serbia and Montene-
gro; 2Health Center Krusevac, Dept. of Gastroenterology, Krusevac, Serbia
and Montenegro
Aim. The objective of the paper is to show the results of the surgical
treatment of choledocholythiasis.
Methods. All the data were collected through the retrospective analysis of the
operative protocol, the patients’ protocols and the patients’ history.
Results. During the period between 01.01.1995. and 31.12.2004. our Surgery
Ward hospitalised 31778 patients; 3553 (11,18%) were hospitalised due to
hepatopancreatobiliar diseases. During the same period there were 13192
operations; 1842 operations (13,96%) were results of hepatopancreatobiliar
diseases, and 190 (10,32%) were the cases of choledocholythiasis. With 190
operatively treated cases of choledocholythiasis, 127 (66,84%) had opstructive
jaundice, while 63 (33,16%) were cases of anicteric choledocholythiasis.
Regarding the sex 112 cases (58,95%) were women and 78 cases (41,05%)
were men. The average age of the operated patients was 56,66. Choledocho-
lythotomy and T-tube drainage were done in 166 cases (87,37%), while with
24 patients (12,63%) choledocholythotomy and biliodigestive bypass proce-
dures were done.
Conclusion. Choledocholythiasis is a serious complication of the gallstone
diseses that leads to opstructive jaundice in great number of cases (in our
series 66,84%). This increases the morbidity and mortality of the operated
patients. A great number of cases of asymptomatic choledocholythiasis
(33,16% in our series) confirms the great importance of intraoperative
cholangiography. Choledocholythotomy and T-tube drainage is a method of
choice in the treatment of choledocholythiasis. However, it should be noted
that with very old patients, patients who are in generally bad condition and
patients with great risk of repeated choledocholythiasis, choledocholythot-
omy and some of the biliodigestive bypass procedures should be done due to
the increased risk of reoperative procedures in which case the operative and
the early postoperative mortality is unacceptably high.
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THE OUTCOME OF SURGICAL TREATMENT FOR DUODENAL
PERFORATION AFTER ENDOSCOPIC RETROGRADE CHO-
LANGIOPANCREATOGRAPHY (ERCP)
Park, Dong-Eun; O, Jung-Taek; Chae, Kwon-Mook
Wonkwang University Hospital, Surgery, Iksan, South Korea
Background. Although duodenal perforation after ERCP is very lower than
other complications, it will result into fatal outcomes.
Aim. To find out the best effective treatment method for it, we reviewed the
cases experienced in our hospital.
Method. A retrospective chart review at the author’s hospital between 1995
to 2005 identified 12 cases of duodenal perforation on ERCP, a rate of
0.45%.
Results. Eight patients were initially managed by surgery. Four patients were
managed conservatively at first but three patients failed nonsurgical treat-
ment and required extensive procedures with long hospital stays with two
deaths. The types of surgical procedures were eight sphincteroplasties, two
simple closures of perforation site and 1 pyloric exclusion. Reoperation were
performed in three cases and their causes were three in failure of duodenal
closure and one in perforation at sphincteroplasty site. All reoperation cases
were delayed for operation and two of them passed away. The time from
ERCP to operation was mean 34.3 hours in reoperation group and 22.5
hours in non-reoperation group.
Conclusion. Early detection should be important for the treatment of
duodenal perforation after ERCP. If surgical treatment is needed, it must be
done within 24 hours. Conservative treatment will be applied to most cases
except lateral duodenal wall perforation after throughout evaluation. Selec-
tion of surgical procedures may be dependent on surgeon’s preference but
less invasive procedure such as simple closure and drainage will be adequate
because more invasive procedures with opening duodenum such as sphinc-
teroplasty will result to terrible duodenal fistula.
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THE ROLE OF HEPSIN IN RESPONSE TO CHOLESTASIS
Liu, Erh-Hao1; Chu, Pao-Hsien2; Chen, Tse-Ching3; Yu, I-Shing4; Chen,
Miin-Fu1; Lin, Shu-Wha5; Yeh, Ta-Sen1
1Chang Gung Memorial Hospital, Chang Gung University, Surgery,
Taoyuan Hsien, Taiwan; 2Chang Gung Memorial Hospital, Chang Gung
University, Internal Medicine, Taoyuan Hsien, Taiwan; 3Chang Gung
Memorial Hospital, Chang Gung University, Pathology, Taoyuan Hsien,
Taiwan; 4National Taiwan University Hospital, College of Medicine,
National Taiwan University, Taipei, Dept. of Clinical Laboratory Sciences
and Med, Taipei, Taiwan; 5National Taiwan University Hospital, College of
Medicine, National Taiwan University, Taipei, Dept. of Laboratory Medi-
cine, Taipei, Taiwan
Aims. Hepatocellular damage following cholestasis is largely dependent on
the activation of neutrophils, cytokines and protease cascades. The role of
hepsin, a type II transmembrane serine protease, in response to cholestatic
stress remains unexplored.
Methods. In the present study, we attempted to investigate the following
questions using the hepsin-deficient bile duct -ligated (BDL) mice model: (1)
the role of hepsin involving in hepatocyte apoptosis and necrosis during
cholestasis; (2) what is the long-term fate of hepsin-deficient BDL mice? (3)
is it feasible to employ a synthetic serine protease inhibitor, mimicking
hepsin-deficient phenotype, to palliate the cholestasis-related hepatocellular
damage?
Results. Based on our data, decreased short-term and long-term hepatocel-
lular damage was observed in hepsin-deficient BDL mice compared to wild-
type (WT) BDL mice. The involved mechanisms were as follows: (1) slightly
increased Fas-mediated hepatocyte apoptosis cascade in hepsin-deficient
mice; (2) remarkably reduced IL-8 activation and neutrophil recruitment in
hepsin-deficient mice; and (3) in net, the liver necrosis was much reduced in
hepsin-deficient BDL mice. Administration of synthetic serine protease
inhibitor on WT BDL mice provided a comparable protective effect as that
seen in hepsin-deficient BDL mice.
Conclusions. Hepsin plays an important role in IL-8 activation and
neutrophil recruitment during cholestatic stress. Depletion of hepsin
attenuates acute parenchymal necrosis and late biliary cirrhosis of cholestatic
disorders. Administration of synthetic serine protease inhibitor may palliate
cholestasis- related hepatocellular damage.
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THE SAFETY AND EFFICACY OF LAPAROSCOPIC LIVER
RESECTIONS
Garwood, Robert A; Reece, T. Brett; Dengel, Lynn; Smith, Robert L;
Adams, Reid B
University of Virginia Health System, Dept. of Surgery, Charlottesville,
Virginia, USA
Background. Minimally invasive approaches to liver resections are evolving,
but the safety and the efficacy of the techniques are still unknown.
Objectives. To determine if laparoscopic liver resections can be performed
safely, while taking sufficient tumor margins.
Methods. All liver resection performed by a single surgeon at a single
institution between 2002 and 2005 were retrospectively reviewed. All
laparoscopic cases (LAP) were included. Open cases (OPEN) were included
unless: the resection could not be performed laparoscopically or there was
another indication for an opened procedure. The groups were compared
based on preoperative comorbidities, intraoperative statistics and postopera-
tive complications.
Results. From over 140 liver resections over the three year period, 15 LAP
and 37 OPEN resections were identified. The groups were comparable in
terms of male:female (both 40:60) and age (54.6 Lap vs 57.5 OPEN) with
similar rates of preoperative diabetes, cirrhosis, cerebrovascular disease,
and heart disease, but known cancer was more prevalent in OPEN (LAP 13%
vs OPEN 51%). In the study, one open patient required ventilation greater
than 24 hours, five had ileus, and one had a UTI (all not significant vs none
inLAP). There were no wound infections, no cardiac events, or deaths in
either group. Final pathology confirmed adequate resection margins in all
cases.
Conclusions. Although this study depicts our early experience, these data
demonstrate that laparoscopic liver resection can be performed a least as
safely as open resections with sufficient oncologic margins. Minimally
invasive approaches should be considered in patients with anterior or lateral
tumors amenable to segmental resection.
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TOTALLY LAPAROSCOPIC CHOLEDOCHAL CYST EXCISION
WITH ROUX-EN-Y HEPATICOJEJUNOSTOMY
Kim, Kee-Hwan1; An, Chang-Hyeok1; Kim, Jeong-Soo1; Lim, Keun-Woo1;
Lee, Keun-Ho2; Park, Il-Young3
1Uijeongbu St. Mary’s Hospital, Surgery, Uijeongbu, South Korea; 2Our
Lady of Mercy Hospital, Surgery, Bupyeng, South Korea; 3Holy Family
Hospital, Surgery, Bucheon, South Korea
Background. Type I choledochal cyst is a rare saccular or fusiform
congenital dilatation of the extrahepatic biliary tract. It is usually treated by
laparotomy at which the cyst is completely excised and a Roux-en-Y
hepaticojejunostomy is performed to establish biliary enteric drainage. With
increased familiarity with the laparoscopic anatomy of the biliary tract and
advances in minimally invasive techniques, surgeons have ventured further to
operate on technically difficult cases such as choledochal cyst that were until
recently managed by laparotomy.
Patients and methods. We present our experience with one woman and one
man aged 35 and 37 years with choledochal cyst (type I according to the
Alonzo-Lej classification) that were successfully excised with construction of
a Roux-en-Y hepaticojejunostomy entirely laparoscopically.
Results. Both patients had an uneventful recovery, with no major morbidity.
The first patient had a bile leak, which resolved over 5 days. Both were
discharged by the 13th and 8th postoperative day.
Conclusion. Laparoscopic resection of congenital choledochal cyst and
hepaticojejunostomy in adult patient is feasible. We feel that there is a
considerable learning curve with the technique. Future studies will have to
prove the feasibility of laparoscopic Roux-en-Y bowel anastomosis without
the need for bowel exteriorization. In the near future, laparoscopic
choledochal cyst excision represents an alternative treatment option in
carefully selected patients.
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XANTHOGRANULOMATOUS CHOLECYSTITIS
Jeon, Jang Y
Hallym University Sacred Heart Hospital, General Surgery, Anyang-si,
Gyeonggi-do, South Korea
Background. Xanthogranulomatous cholecystitis (XGC) ia an unusual and
destructive inflammatory process of the gallbladder (GB) that is character-
ized by yellow-brown intramural nodule,severe proliferative fibrosis and
foamy histiocytes. XGC usually presents with features of chronic cholecystitis
or acute cholecystitis but radiologically and macroscopically, XGC may be
difficult to differentiate it from GB cancer.
Aim. The aim of our study was to evaluate the radiologic features of
XGC,correlating the clinical,pathologic and surgical findings.
Methods. XGC was pathologically diagnosed in 14 patients from March
1999 to December 2005. Clinical features, radiologic and operative findings
of XGC were analysed retrospectively.
Results. 14 cases of XGC were found among 1132 cases of cholecystectomy
(1.2%). Obstructive jaundice was observed in 35.7%,which were associated
with 2 CBD stone,2 Mirizzi syndrome and 1 distal CBD ca. Choledocho-
lithiasis and a thickened gallbladder wall were frequent findings. The most
characteristic CT finding was a hypodense intramural nodule (35.7%). The
most characteristic sonographic finding was a hypoechoic nodule in the GB
wall (33%).9 patients underwent open cholecystectomy including 2 cases of
T-tube choledocholithotomy.4 of 5 patients who underwent laparoscopic
cholecystectomy required conversion to open surgery. Laproscopic failures
were attributable to dense fibrotic adhesions in Calot’s triangle. A malignancy
was suspected preoperatively in 1 case, requiring frozen biopsy.
Discussion. XGC is an infrequent form of chronic cholecystitis or acute
cholecystitis;given the thickening of GB wall,it makes cholecystectomy
difficult. Although the preoperative diagnosis of XGC is difficult,the presence
of hypodense intramural nodule on CT or hypoechoic nodule in the GB wall
on sonography,is highly suggestive of XGC. As XGC may resemble
malignancy,differentiation is essential by means of intraoperative frozen
biopsy to ensure optimal surgical treatment.
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COMBINED MAJOR HEPATECTOMY AND PANCREATICODUO-
DENECTOMY FOR LOCALLY ADVANCED BILIARY CARCI-
NOMA
Wakai, Toshifumi1; Shirai, Yoshio1; Tsuchiya, Yoshiaki2; Tatsuya, Nomura2;
Sakata, Jun1; Hatakeyama, Katsuyoshi1
1Niigata University Graduate School of Medical and Dental Sciences,
Division of Digestive and General Surgery, Niigata, Japan; 2Niigata Cancer
Center Hospital, Division of Surgery, Niigata, Japan
Background. This study aimed to clarify the indication of combined major
hepatectomy and pancreaticoduodenectomy for locally advanced biliary
carcinoma.
Methods. A retrospective analysis was conducted of 28 patients who
underwent a combined major hepatectomy and pancreaticoduodenectomy
for extrahepatic cholangiocarcinoma (n/17) or gallbladder carcinoma (n/
11). A major hepatectomy was defined as a hemihepatectomy, central
hepatectomy, or more extended resection. Hepatectomy procedures included
right hemihepatectomy in 5 patients, left hemihepatectomy in 1, central
hepatectomy in 1, and right hemihepatectomy plus resection of the medial
portion of Couinaud’s segment IV in 21. Of the 28 patients, 5 underwent
resection of the caudate lobe. Eleven patients underwent a Whipple
procedure and 17 had a pylorus-preserving pancreaticoduodenectomy. The
median follow-up period was 118 months.
Results. Morbidity and in-hospital mortality was 82% and 21%, respec-
tively. Overall cumulative survival rates after resection were 32% at 2 years
and 12% at 5 years (median survival time, 9 months). Among 15
conventional prognostic variables, residual tumor status was a strong
independent prognostic factor by univariate (the log rank test; P/.0012)
and multivariate (the Cox proportional hazards regression model; relative
risk, 8.072; 95% confidence interval, 2.437 26.735; P/.001) analyses.
The median survival time was 6 months with a cumulative 2-year survival
rate of 0% in 11 patients with residual tumor (R1 or R2), while the median
survival time was 26 months with a cumulative 2-year survival rate of 53%
in 17 patients with no residual tumor (R0). The outcome after resection
was significantly better in patients who underwent R0 resection (P/
.0012).
Conclusions. Combined major hepatectomy and pancreaticoduodenectomy
is indicated for locally advanced biliary carcinoma only if potentially curative
(R0) resection is feasible.
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HEMOSTASIS PROBLEM IN HEPATOBILIARY SURGERY: COM-
PARISON OF LASER AND ELECTROCAUTERY
Sovtsov, Sergey; Kozel, AI; Pryahin, AN
Ural State Medical Academy, Genaral Sergery, Chelyabinsk, Russia
The electrocautery is often used in hepatobiliary surgery for hemostasis.
However, the electrosurgery can be a source of complications. So, the
investigations in other hemostatic techniques, laser radiation in particular, are
of great interest.
Purpose. To compare the results of high-intensity diode the laser (970 nm
wavelength) and electrocautery in liver surgery.
Materials & methods. We performed 506 laparoscopic operations (236
with laser/270 with electrocautery): cholecystectomy-183/216, liver cyst
excision-21/18, liver biopsy-32/36). The subdivision into groups was
randomized. The patients were comparable in sex, age and severity of disease.
Results & discussion. The body hyperthermia (t/378C) after the opera-
tions with electrocoagulation was observed for 2.679/0.76 days, and after
laser application for1.079/0.8 days (pB/0.05). The levels of alanine amino-
transferase (ALT) and aspartate aminotransferase (AST) in 2 days after
electrocautery were: ALT, 1249/12.3 IU/L; AST, 1159/11.2 IU/L (the
normal ranges for AST and ALT are around 0 to 40 IU/L), after laser
exposure: ALT, 579/8.7 IU/L; AST, 569/7.2 IU/L (pB/0.05). These data
testify for smaller liver tissue damage by laser in comparison with electro-
cautery. Two days after the operation, the ultrasonic study revealed that the
thickness of structurally changed tissue in the liver wound was 6.19/1.1 mm
for electrocautery, and 1.69/0.6 mm for laser (pB/0.05) that testifies for
smaller inflammatory reaction of tissues after laser exposure in comparison
with electrocautery. There were no complications from laser coagulation.
After electrocautery surgery, two skin burn cases were observed in the field of
the patient’s electrode.
Conclusion. Laser coagulation has advantages before electrocautery and can
be used as one of hemostasis methods in hepatobiliary surgeries.
P4.54
OUTCOME OF HEPATICOJEJUNOSTOMY WITHOUT ACCESS
LOOP FOR REPAIR OF IATROGENIC BILE DUCT INJURY
Barrow, Paul; Siriwardena, Ajith
Manchester Royal Infirmary, Hepatobiliary Unit, Dept. of Surgery, Man-
chester, UK
Background. Roux hepaticojejunostomy is the accepted treatment for
transectional biliary injury at cholecystectomy. Many authors advocate
leaving a long redundant jejunal access loop to facilitate subsequent access.
Reasoning that percutaneous access can be achieved transhepatically in
patients with stenosis this study reports the outcome of a policy of biliary
repair without the use of a jejunal access loop.
Methods. All patients undergoing biliary reconstruction by a specialist
Hepatobiliary surgeon (AKS) over a 5-year period constitute the study
population. During this time there were 9 patients (8 tertiary, 1 colorectal
service) with biliary injury at laparoscopic cholecystectomy. Two (22%) were
male and the median (range) age at injury was 53 (2675) years. 3 had
primary repair prior to referral (choledochoduodenostomy in 1 and primary
end-end repair over a t-tube in 2). Median delay from injury to repair was 2
(060) months. Bismuth stage was: stage I/3, stage II/4 and III/2. 3 had
concomitant arterial injury. All underwent surgical repair by Roux hepatico-
jejunostomy without access loop.
Results. The median follow-up is 28 (460) months. The principal post-
operative complication was a hepatic abscess in 1. There were no deaths
during follow-up. One patient (11%) with a type III injury presented with a
symptomatic recurrent biliary stricture 6 months after repair and was
successfully managed by percutaneous biliary dilatation using a combination
of trans-hepatic and jejunal loop puncture.
Conclusions. Experience in repair of biliary injury is largely derived from
the accrual of single-surgeon or single-institutional series. The nature of
biliary injury is such that randomised comparisons are unlikely. This
series successfully questions the dogma of routine jejunal access loop
usage: only a minority of patients require re-intervention and when recurrent
stricture is present, percutaneous trans-hepatic access to dilated ducts can be
utilised.
P4.55
MANAGEMENT OF BILIARY INJURY DURING CHOLECYST-
ECTOMY
Briezat, Abdel-Hadi; Al-Dmour, Awad; Kharabsheh, Abdel-Hafiz; Eldirdiri,
Sami
Al-basher Hospital, Amman, Jordan
Background. Biliary injuries are well known problems during open
cholecystectomy. They are common, severe and associated with other injuries
in laparoscopic cholecystectomy. Laparoscopic surgery burst into the practice
of general surgery in 1989 and within a couple of years became the standard of
practice in many hospitals all over the world.
Objective. The aim of this study is to evaluate our experience in the
management of biliary injuries during cholecystectomy.
Methods. We analyzed 36 patients who presented with different types of post-
cholecystectomy injuries and managed in the period from 1992 to 2004 with
different surgical procedures.
Results. 50% of the patients (18) were referred cases and the other 50% were
consulted at different stages of management. 58.3% of patients following open
cholecystectomy and 41.7% following laparoscopic cholecystectomy. Differ-
ent types of injuries ranging from minor injury to severe biliary destruction
were noticed, where complete common hepatic duct wall loss or occlusion
being the most frequent 38.9%. Six patients underwent immediate lapar-
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otomy and repair over a T-tube prior to referral. The most commonly
performed operation, as a definitive procedure was Roux-en-Y hepatico-
jejunostomy 44.4% and caries the best outcome. However the poorest
outcome was observed in patients who underwent multiple attempts of
correction before referral or consultation.
Conclusion. In order to obtain optimal management of post-cholecystect-
omy biliary injury: recognition, early consultation and referral to specialized
center, avoids secondary trauma and achieves satisfactory results.
P4.56
CHOLEDOCHO-CHOLEDOCHOSTOMIES, WITH OR WITHOUT
T-TUBE DRAINAGE?
Blegvad L, Henrik1; Kannerup, Anne S1; Oxlund, Hans1; Yasuda, Yoshikazu2;
Funch J, Peter1; Rokkjaer, Mogens1; Viborg M, Frank1
1Aarhus University Hospital, Dept. of Gastrointestinal Surgery L, Aarhus,
Denmark; 2Jichi Medical School, Tochigi-Ken, Japan
Background. The utilization of T-tube drainage in reconstructive surgery of
the common bile duct (CBD) has been much debated.
Aim. The aim of the present study was to investigate the effect of T-tube
drainage on the healing of choledocho-choledochostomies.
Methods. Twenty pigs with a mean weight of fifty-six kilos were used for the
experiments. The pigs were randomized to two groups of ten pigs. In all pigs
the gallbladder was removed and the CBD transected. In both groups
continuity was re-established by standardized single-line, interrupted and
inverted sutures. In one group a T-tube for decompression was inserted. On
postoperative day six a laparotomy was performed. Pigs were investigated for
signs of cholascos and an intraoperative cholangiography was performed. The
anastomosis was excised. A standard-sized piece was isolated for determina-
tion of breaking strength. Another standard-sized piece was used for
determination of collagen contents. Blood samples were drawn prior to the
first and the final operation.
Results. In both groups standard liver parameters were unaffected by surgery
and cholangiography showed no signs of extra-hepatic stenosis and/or
intrahepatic dilatation. The T-tube drained choledocho-choledochostomies
showed a significantly higher breaking strength (p/0.028) compared to the
group which had no drainage. Collagen content per volume were unaffected
by T-tube drainage.
Conclusion. T-tube drainage had a significant stimulatory effect on the
healing of choledocho-choledochostomies in pigs but was without effect on
collagen content. These findings indicate that T-tube drainage stimulates the
healing of choledocho-choledochostomies in pigs.
P4.57
SURGICAL TRAINING IN KAMEDA MEDICAL CENTER
Kano, Nobuyasu; Kusanagi, Hiroshi
Kameda Medical Center, Surgery, Kamogawa, Chiba, Japan
Purpose. In the era of endoscopic surgery, how to educate young surgeons is
becoming more and more challenging issue. We present our method of
educating surgical residents in Kameda Medical Center.
Materials and Methods. We teach our surgical residents both of open
surgery and endoscopic (laparoscopic and thoracoscopic) simultaneously.
Their progress is appreciated and rated in six grades. Their levels were
assessed periodically.
Results. Many of our surgical residents got one or two grades progress in 6
months of training in our department.
Conclusion. Teaching both of open surgery and endoscopic surgery can
realize synergetic effect in educating surgeons today.
P4.58
THE EFFICACY OF VASCULAR CLOSURE STAPLE (VCS) FOR
PRIMARY CLOSURE OF COMMON BILE DUCT
Shinozuka, Nozomi; Takeda, Akihiko; Miyazawa, Mitsuo; Ozawa, Shutaro;
Ogawa, Nobuji; Murakami, Saburo; Otani, Yoshihide; Koyama, Isamu
Saitama Medical School, Surgery, Moroyama-machi, Iruma-gun, Saitama,
Japan
Introduction. Vascular closure staples(VCSs) have been developed for
vascular anastomosis,and they have been shown not to penetrate into the
vascular lumen. We have performed direct common bile duct closure in
choledocholithiasis patients using the VCS. The efficacy of VCS for direct
closure of the common bile duct was evaluated in this study.
Methods. We performed this procedure in a total of 20 patients (7 laparotomy
operations and 13 laparoscopic operations) with common bile duct stones,
and followed them for up to 6 years and 6 months.
Results. In laparoscopic choledochotomy, to close common bile duct directly
using the VCS was possible by using stay sutures and forceps, however bile
reakage and stenosis of bile duct were occurred after operation in two cases. In
one patient, re-operarion (choledochojejunostomy) was needed, and endo-
scopic naso biliary drainage (ENBD) was effective in another patient. In one
patient who had laparoscopic closure on common bile duct by using VCS,
periodically underwent MRCP, choledocholithiasis recurred one year after
surgery, and stones of common bile duct were removed by EST. However, no
association was found between the recurrence and the clipping procedure, and
the remaining patients had no recurrence of common bile duct stones. In a
patient who developed biliary fistula and stenosis immediately after surgery,
follow-up MRCP showed no evidence of bile duct stenosis, and there were no
elevated levels of biliary tract enzymes. On abdominal X-P and ultrasound, the
VCS clip remained at the site of bile duct closure, and no clip detachment was
seen.
Conclusions. With the improvement of instruments, laparoscopic common
bile closure using the VCS may become a treatment option for choledocho-
lithiasis, but close follow-up is needed.
P4.59
POSSIBILITES AND LIMITATIONS OF THERAPEUTIC ENDO-
SCOPY IN THE MANAGEMENT OF BENIGN BILE DUCT STRIC-
TURES
Shapovalyants, Sergey; Orlov, Stanislav; Boodzinsky, Stanislav; Fedorov,
Evgeni; Matrosov, Andrei; Milnikov, Andrei
Russian State Medical University. University Hospital 31, Laboratory of
Surgical Gastroenterology & Endoscopy, Moscow, Russia
Management of postoperative benign biliary strictures (PBBS) is one of the
most actual and difficult problem of abdominal surgery. AIM is to evaluate the
effectiveness and limiting factors of the endoscopic management of PBBS.
Methods. We have studied 45 patients mean age 57.9, which were exposed to
endoscopic treatment in period from 1991 to 2005. Jaundice was the main
manifestation of PBBS, which took place in 40 cases, including 17 patients
with cholangitis. 33 patients had strictures of common and lobules hepatic
ducts and 12 patients had common bile ducts occlusion. Endoscopic
papillotomy (EPT) was performed in all cases. Bilioduodenal drainage was
performed in 31 cases. It was demand bougienage as a first stage in 29 cases,
which was combined with balloon dilation in 12. Only balloon dilation before
stenting was performed in 2 cases. Later we accomplished restenting of PBBS
with help of endoprotheses of more diameter in 5 cases, insertion of 2 stents in
14 cases and 3 prostheses-in 6 cases.
Results. Good immediate results of endoscopic management of the PBBS
were received in 33 (73.3%) cases. In this group endoscopic treatment of
PBBS was definitive method of therapeutic correction. Satisfactory results had
place in 8 (17.8%) cases. In that group planned surgically treatment was
accomplished. We received unsatisfactory immediate results in 4 (8.9%) cases.
They needed to perform urgent surgery. It is possible to evaluate long-term
results of the endoscopic management in 23 cases now. 22 patients have good
results and 1-satisfactory. We had 4 complications: 2 bleedings after EPT, 1
acute pancreatites and 1 migration of the stent. 1 man died after hard bleeding.
Conclusion. Endoscopic treatment of PBBS can be alternative method to
surgical operations. Endoscopic correction of PBBS became the final method
of treatment more then in 2/3 cases. In other group endoscopic management
of the PBBS allowed to prepare patients for planned surgical operations.
P5.01
ADEQUATE PREOPERATIVE BILIARY DRAINAGE IS THE DE-
TERMINANT TO DECREASE POSTOPERATIVE SURGICAL
SITE INFECTION IN PATIENTS UNDERGOING PANCREATICO-
DUODENECTOMY
Lin, Shau-Chieh; Shan, Yan-Shen; Lin, Pin-Wen
National Cheng Kung University Hospital, Dept. of Surgery, Tainan, Taiwan
Background and objective. To analyze the effectiveness of preoperative
biliary drainage (PBD) in patients with periampullary lesions who received
pancreaticoduodenectomy.
Patients. 240 consecutive cases, who received the pancreaticoduodenectomy
from Jan. 1989 to May 2005 at the National Chen Kung University Hospital,
Taiwan, were reviewed retrospectively by chart record. Factors possible
affecting postoperative outcomes, postoperative morbidity and mortality
within 30 days were collected.
Results. 143 patients (59.5%) received preoperative biliary drainage. After
operation, 119 of the 240 patients (50.0%) had postoperative complications,
including delay gastric emptying (21.7%), wound infection (18.3%),
intraabdominal abscess (13.3%), pancreatic fistula (7.92%), and etc. Post-
operative mortality was 3%. More incidence of postoperative sepsis/
bacteremia was noted in these patients with preoperative biliary drainage
(p/0.03), but more cardiovascular events (p/0.05) was found in these
patients without drainage. However, if biliary drainage performed, patients
had lower preoperative serum bilirubin level (B/5 mg/dL) would have less
intraabdominal abscess (p/0.036), infectious complication (p/0.01) and
wound infection (p/0.056).
Conclusion. Preoperative biliary drainage increased postoperative sepsis but
it decreased cardiovascular events. Furthmore, adequate preoperative biliary
drainage is the key to decrease those surgical site infections.
P5.02
EMPHYSEMATOUS CHOLECYSTITIS: CASE REPORT AND
RETROSPECTIVE ANALYSIS OF SIX CASES
Papavramidis, Theodossis; Michalopoulos, Antonios; Papadopoulos, Vasilis;
Paramythiotis, Daniil; Nikolaos, Harlaftis
AHEPA University Hospital, 1st Propedeutic Surgical Clinic, A.U.Th,
Thessaloniki, Greece
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Introduction. Emphysematous cholecystitis is an uncommon variant of
acute cholecystitis, wherein the gallbladder is invaded by gas-producing
organisms, creating a characteristic radiographic appearance.
Material and methods. The present study retrospectively analyses seven
patients, diagnosed as having emphysematous cholecystitis that were treated
surgically in the 1st Propedeutic Department of Surgery of A.H.E.P.A
university hospital.
Results. Five patients were males, while 2 were females. The mean age was
69.43 years (range 6082 years). All patients presented upper right quadrant
pain, leucocytosis (/16000 106/l) nausea and fever (/388C). Five patients
presented nausea and vomiting, while 4 jaundice (Total serum bilirubin /1.8
mg/dl). One patient showed abdominal mass. Five patients had an anamnesis
of diabetes mellitus. The abdominal radiographs were positive for air in the
biliary tree in four cases. Ultrasonography reveals a diagnostic image in five
cases, while the diagnosis was confirmed in all cases by computerized
tomography. Stones in the gallbladder were found in five cases, while in two
the cholecystitis was alithiasic. Four patients underwent open cholecystect-
omy, while 3 had subtotal cholecystectomy with cholecystostomy. Cultures of
the bile showed the presence of Clostridium Perfringens in 3 cases,
Escherichia Coli in 2 cases, Clostridium difficile in 1 case and Citrobacter
in 1 case. The mean hospitalization was 13 days (range 5 to 16). Two patients
died postoperatively due to multiple organ failure secondary to sepsis.
Conclusion. Emphysematous cholecystitis, a rare form of cholecystitis,
carries high mortality. Vascular occlusion can be very important in the
development of this potential catastrophe. Antibiotic therapy should begin
quickly and include coverage for common pathogens, particularly Clostridia.
Surgical intervention should take place as early as possible with consideration
of the patient’s potential for deterion.
P5.03
CHOLEDOCHAL CYST IS A RISK FACTOR FOR GALL BLAD-
DER CANCER!
Agarwal, Anil K; Singh, S; Mandal, S; Agarwal, S; Gondal, R; Bhojwani, R
GB Pant Hospital & MAM College, Dept. of GI Surgery, Delhi, India
Background. Choledochal Cyst (CDC) is known to have a malignant
potential which has been variably reported to be 2.5% to 30%. The risk of
malignancy is age related and while the malignancy is more commonly
present as cholangiocarcinoma in the Choledochal Cyst, the rest of the
Hepato-pancreato-biliary (HPB) tract is also at risk. Abnormal Pancreato-
biliary duct junction (APBDJ) with an undilated CBD is a well accepted risk
factor for Gall Bladder Cancer(GBC). However GBC with CDC is a rare
entity and though described is not a well recognized association.
Material and methods. We analyzed our experience of Choledochal cysts
managed over 5 years (Jan 2001 to Dec 2005) to study the association
between Choledochal Cyst and Gall Bladder Cancer. Ours is a tertiary
referral centre for HPB diseases in Northern India.
Results. Total 149 patients of CDC were managed during January 2001 to
December 2005. 425 pts of Gall Bladder Cancer were managed during this
period. The incidence of CAGB in patients of CDC was 9 of 149 (6.04%)
and the incidence of CDC in patients of CAGB was 9 of 425 (2.1%).
Metastatic disease on pre-operative work up was detected in one of these nine
patients(Pts.). CDC was Type I in 4 patients and Type IVA in 5 patients; R0
resection was performed in 4 of 8 (50%). CDC infiltration was present in 2 of
4 (50%). Stage of malignancy was IIA in 2 Pts., IIB in 1 Pt. and III in 1
patient. All 4 patients with resectable disease are recurrence free & surviving
(Survival 6 to 52 months).
Conclusion. Choledochal Cysts have a definite risk potential of developing
Gall Bladder Cancer in adults. Even though patient may present with
advanced disease, a sizable fraction are resectable and show good long term
outcome with R0 resection. Therefore one should suspect & inspect all gall
bladders when operating for Choledochal Cysts in adults.
P5.04
CHOLEDOCHAL CYSTS-RETROSPECTIVE ANALYSIS OF 50
CASES
Khandelwal, Manish1; Goel, Ashish2; Khandelwal, Chiranjiva2
1Aberdeen Royal Infirmary, Aberdeen, UK; 2Mahavir Cancer Sansthan,
Dept. of Surgical Oncology, Patna, India
Background. Choledochal cysts are congenital anomalies of the bile ducts.
They consist of cystic dilatations of the extrahepatic biliary tree, intrahepatic
biliary radicles, or both. It poses a considerable challenge in terms of
diagnosis & management.
Objective. We analysed the fifty cases that presented to us over the last 17
years in terms of age of presentation, clinical features, type of cyst &
perioperative complications.
Method. Retrospective analysis of 50 cases over the last 17 years.
Results. Fifty patients with choledochal cyst were treated over a period of 17
years. Twenty (40%) patients were under 12 year’s age. Thirty five (70%) of
patients were females. Upper abdominal pain was the most common
presenting symptom (66%) followed by jaundice & fever (28%). Investiga-
tions included Ultrasonography in all cases, Endoscopic Retrograde Cho-
langio Pancreatogram (ERCP) in most (60%), Percutaneous Transhepatic
Cholangiogram (PTC) & Peroperative Cholangiogram in two cases each.
Commonest type was Todani Type I (76%). Complete excision was possible
in 41(82%) cases (Type I & II) & excision of extra hepatic cyst with wide
drainage of intra hepatic cyst in 6 (12%) cases (Type IVA). Submucosal
excision of cyst (Lilly’s technique) was done in 2 cases & internal bypass in
one. Overall we had only one (2%) perioperative mortality. 60% of our
patients were adults but cholangitis and hepatitis was more common in
children (20%). No patient had cholangiocarcinoma.
Discussion. Choledochal cyst, though are congenital anomalies may not
present until adulthood. If presented in childhood, patients tend to have
serious hepatobiliary complications (cholangitis, hepatitis & cirrhosis) more
commonly as compared to their adult counterparts. Choledochal cysts should
be treated by early surgical intervention. With experience most choledochal
cysts can be excised safely.
P5.05
CLINICAL IMPACT OF THE DUODENAL PAPILLA IN PATIENTS
WITH SEPARATE ORIFICES FOR BILE AND PANCREATIC
DUCTS
Yoneda, Masato; Fujisawa, Toshio; Takahashi, Hirokazu; Inamori, Masahiko;
Abe, Yasunobu; Kirikoshi, Hiroyuki; Saito, Satoru; Nakajima, Atushi;
Kubota, Kensuke
Yokohama City University Graduate School of Medicine, Gastroenterology,
Yokohama, Japan
Background. Clinical significance of Separate orifices (SO) has not been
elucidated.
Aim. The aim of this study is to determine the clinical significance of SO.
Methods. Patients with SO that underwent ERCP and endoscopic biopsies
of duodenal papilla were studied. Both the endoscopic features and the
histopathological findings using COX-2 and ki-67 immunostaining were
retrospectively reviewed. These findings of SO (n/1,W) were compared to
those of without SO (n/22).
Results. The features of duodenal papilla in SO cases were classified
endoscopically into three types. Type A: the incomplete type, in which
both orifices were recognized within one major papilla. Type B: incomplete
type, in which major papilla was divided into two orifices. Type C: complete
type, in which a hooding fold was interposed between the two orifices. The
distribution of the types was follows: of the 18 cases with SO, 7 were type A, 7
were type B and 4 were type C. One type B and two type C cases with
choledochlithiasis had a long oral protrusion over the orifice for bile duct.
One type A case, two type B cases and three types C cases complicated
choledochlithiasis. The endoscopic biopsy specimens showed that six of the
eight SO cases had papillitis in the background of plasma cell infiltration as
well as epithelial hyperplasia; cases without SO had no epithelial hyperplasia.
There were no significant differences between the SO cases and the without
SO cases with respect to the positivity of the COX-2 and ki-67 labeling index.
The intensity of the COX-2 of the SO cases tended to be stronger than that of
without SO cases. The oral protrusion of three SO cases with choledo-
chlithiasis was long and exposed over the orifice for bile duct.
Conclusion. Patients with SO tended to have chronic papillitis in the
background of epithelial hyperplasia as well as the orifice for bile duct covered
with long oral protrusion, both of which suggested impairment of bile duct
out flow. Our results strongly suggested that SO was a risk group of
choledochlithiasis.
P5.06
CLINICAL UTILITY OF PERORAL CHOLANGIO-PANCREATO-
SCOPY FOR DIAGNOSIS OF CHOLANGIO-PANCREATO-DIS-
EASES
Yoshimura, Tetsuro; Shimoyama, Tadashi; Fukuda, Shinsaku; Munakata,
Akihiro
Hirosaki University School of Medicine, First department of Internal
Medicine, Hirosaki, Japan
Background. Cholangio-pancreatoscopy has been used for diagnosis of
biliary and pancreatic diseases which are difficult to diagnose by other
imaging modalities. However, the utility and the complications of cholangio-
pancreatoscopy have not been clearly described.
Aims. To evaluate the utility and the complications of cholangio-pancreato-
scopy, examination time was measured and the level of c reactive protein
(CRP) and serum amylase were studied.
Methods. In 102 patients (43 with malignant diseases, 59 with benign
diseases) who underwent retrograde cholangiopancreatography in our
hospital. Eleven patients with cholangiopancreato-diseases which were
difficult to diagnosis received peroral cholangio-pancreatoscopy from Octo-
ber 2002 to October 2005.
Results. Ten patients had biliary diseases and one patient had IPMN.
Cholangio-pancreatoscope was inserted successfully into the pancreatic or
bile duct and the predetermined intraductal lesions were observed in all
patients (100%). Excellent images were provided by electronic scope (n/8)
compared with fiber scope (n/3). Biopsy samples were taken from 8
patients, and 4 cases were diagnosed as malignant disease histologically. In 3
patients, surgical resection was performed and the diagnosis was confirmed as
malignant disease. The remaining 4 cases were not identified as malignant
lesion by biopsy samples, however 3 cases of them were confirmed as
malignant diseases with following examination (ERCP or CT). The mean
time of the examination was 32.29/17.7 min. Although serum amylase was
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significantly higher after the examination, there was no significant difference
in the level of CRP before and after the examination.
Conclusion. Peroral cholangio-pancreatoscopy contributed to the diagnosis,
however careful following up examination was necessary in some cases.
Although the examination was performed safely, examination time was
longer. Development of more flexible and slimmer scope is required.
P5.07
COMMONEST ETIOLOGY OF HILAR OBSTRUCTION IN
NORTHERN INDIA IS GALL BLADDER CANCER!
Mandal, Sanjoy; Singh, Shivendra; Puri, S; Mishra, PK; Agarwal, S;
Agarwal, Anil K
GB Pant Hospital & MAM College, Dept. of GI Surgery, Delhi, India
Background. The etiology of hilar obstruction in most western series is
reported to be hilar cholangiocarcinama, followed by mirrizi syndrome and
carcinoma GB. Gall Bladder Cancer with Hilar obstruction is very common
in Northern India. We performed this study to analyse the etiology of hilar
obstruction in a tertiary Referral centre of Northern India.
Methods. This study is an analysis prospectively collected data of 74 patients
of obstructive jaundice with hilar obstruction who underwent surgery at our
center over a duration of 2 years (Jan 2004 to Dec 2005). The patients
underwent preoperative work up including CT scan, MRI, MRCP/ERCP,
Doppler and other relevant investigation. These patients were assessed for the
etiology of hilar obstruction.
Results. All of these patients presented with symptoms of obstructive
jaundice. Out of the 74, 53(71%) had Carcinoma Gall Bladder(CA GB),
17(22.9%) had mirrizi’ syndrome while only 4 had hilar cholangio CA
(5.4%). 17 out of the 53 patients of CAGB underwent R0 resection, out of
which 12 underwent only segment IVB & V resection, 4 underwent extended
Rt. Hepatectomy and 1 underwent HPD. All 17 underwent CBD excision
and reconstruction in the form of RYHJ, 4 underwent distal gastrectomy and
D1 resection, 5 duodenum sleeve resection,5 underwent HA resection an 4
PV resection. Of the patients with mirrizi’s syndrome 4 underwent
reconstruction in from of RYHJ, 7 underwent CBD exploration with T-
tube drainage, 4 underwent choldochorraphy with T-tube drainage while 2
underwent CBD exploration with choledochoduodenostomy. Of the 4
patients with hilarcholangiocarcinoma 2 underwent R0 resection.
Conclusion. In India the most common cause of hilar obstruction is Gall
Bladder Cancer (71%) which is followed by mirrizi’s syndrome (22.9%).
Hilar cholangiocarcinoma was seen in only 5.4% of patients. This is quite in
contrast to the reported etiology of hilar obstruction in western literature.
P5.08
FENOFIBRATE REDUCES HEPATIC DAMAGE AND CYTOKINES
RESPONSE IN EXPERIMENTAL OBSTRUCTIVE JAUNDICE
Cindoruk, Mehmet1; Karakan, Tarkan1; Salman, Bu¨lent2; Kerem, Mustafa2;
Ekinci, O¨zgu¨r3; Aky´n, Okhan4; Akyol, Gu¨len3; U¨nal, Selahattin1
1Gazi University, School of Medicine, Dept. of Gastroenterology, Ankara,
Turkey; 2Gazi University, School of Medicine, Dept. of General Surgery,
Ankara, Turkey; 3Gazi University, School of Medicine, Dept. of Pathology,
Ankara, Turkey; 4Kecio¨ren Education and Research Hospital, Dept. of
Clinical Biochemistry, Ankara, Turkey
Background. Peroxisome proliferator activated receptors (PPARs) regulate
lipid metabolism, cell proliferation and apoptosis. Fenofibrate is a PPAR-
alpha agonist.
Objective. To investigate the effects of fenofibrate on cytokines, tissue
damage, apopitosis and PPAR-alpha expression in experimental obstructive
jaundice.
Material and methods. Forty eight male Wistar-albino rats were assigned
into four equal groups composed of 10 rats. In group 1 animals sham were
operated. In group 2, 3 and 4, common bile duct ligation (CBDL) and
division were performed. Group 3 was received 3% sterile Gum Arabic and
group 4 received fenofibrate (100 mg/kg body weight suspended in%3
aqueous sterile solution of Gum Arabic) by daily gavage for 7 days. All rats
were sacrificed on the 7th postoperative day. Levels of ALT, AST, ALP,
GGT, bilirubin, TNF-alpha, IL-1beta in serum and histopathologic damage
scores, apopitosis and PPAR-alpha expression in the liver tissue were
investigated.
Results. CBDL procedure has lead significant increase in serum AST, ALT,
ALP, GGT, bilirubin, TNF-alpha and IL-1beta; in liver tissue damage and
apopitosis, whereas PPAR-alpha expression decreased significantly (PB/
0.001). There were not significant difference in terms of all biochemical
and histopathological parameters between the group 2 and 3 (P/0.05).
PPAR-alpha expression increased and, apopitosis and hepatosit damage score
decreased in the group 4 compared with the groups 2 and 3. Levels of AST,
ALT, TNF-alpha and IL-1beta measured on the 7th day in the fenofibrate
treatment group were significantly higher than the other obstructive jaundice
groups.
Discussion. Administration of fenofibrate in experimental jaundice has
produced improvement in liver functions, significant reductions in serum
AST, ALT, TNF-alpha and IL-1beta, and in liver damage and apopitosis,
whereas it has brought an increase in the liver PPAR-alpha expression.
Conclusion. Further studies are needed to assess the role of fenofibrate in
human cholestatic disorders.
P5.09
HEPATIC ARTERY PSEUDOANEURYSMS ASSOCIATED WITH
BILE LEAKS FOLLOWING LAPAROSCOPIC CHOLECYSTECT-
OMY
Madanur, Mansoor A; Battula, Narendra; Sethi, Harsheet; Deshpande,
Rahul; Heaton, Nigel; Rela, Mohamed
Kings College Hospital, London, UK
Background. Laparoscopic cholecystectomy (LC) is the operation of choice
for removal of the gallbladder. Despite its many advantages, there is a
continuing incidence of biliary and vascular injuries. Initially unrecognised
bile duct injuries present with peritonitis, bile leak or abdominal collections.
Failure to deal with bile leaks early in the postoperative course may result in
pseudoaneurysm (PA) formation and subsequent rupture.
Aim. To analyse the incidence and outcome of our management of PA in
patients with bile leaks following LC.
Methods. A retrospective analysis of a prospectively maintained database
between 1st Jan 1995 to 31st Dec 2005 was performed. 86 patients were
referred with bile leak following LC. The aetiology, therapeutic interventions,
complications and outcome of patients with pseudoaneurysm were reviewed.
Results. 4 patients (4.6%) had hepatic artery PA following LC complicated
by bile leak. All of these patients initially presented with haematemesis
and subsequent endoscopy revealed haemobilia. Hepatic arteriogram
confirmed PA of the right hepatic artery in two cases; cystic artery in one
and arteriography was inconclusive in one. However he subsequently
presented with a ruptured right hepatic artery. Effective haemostasis
was achieved in 3 patients with coil embolisation; the fourth case required
ligation of the hepatic artery aneurysm. On subsequent follow up, 2 patients
developed common hepatic duct strictures requiring hepatico-jejuno-
stomy. All 4 patients are alive at a median follow up of 16.5 (range 1 to
65) months.
Conclusions. Hepatic artery pseudo aneurysm is a rare and life threatening
complication of bile leak following LC. Infected biliary collections have been
associated with pseudoaneurysm formation. The majority of patients can be
managed initially by radiological intervention. Late bile duct strictures are
common either due to unrecognised vascular injury at initial surgery or from
ischemia after embolisation.
P5.10
PRE-OPERATIVE PERCUTANEOUS TRANSHEPATIC BILIARY
DRAINAGE (PTBD) IN HILAR CHOLANGIOCARCINOMA:
EXPERIENCE OF 40 RESECTABLE CASES IN A REGIONAL
HOSPITAL
Fung, Ting Pong; Lam, Siu Ho
United Christian Hospital, Dept. of Surgery, Hong Kong, Sar, China
Background. Starting from 1998 to 2005, we had performed 40 aggressive
resection for hilar cholangiocarcinoma. From 1998 to 2002, we relied on
ERCP (Endoscopic retrograde cholangiopancreatography and stenting or
combined with PTBD for relieving jaundice before operation. Since 2003, we
followed the Nagoya’s technique to perform PTBD solely in draining the bile
duct of the future liver remnant side and the draining catheter was confined
to the common bile duct only. Additional PTBD was considered when there
is no improvement in jaundice or sepsis is not controlled.
Aim. The aim of this study is to compare the chance of sepsis post-
operatively using PTBD versus ERCP stenting for pre-operative workup in
hilar cholangiocarcinoma
Method. The 40 cases of cholangiocarcinoma from 1998 to 2005 under-
going resection were reviewed. And the relationship between presence of
sepsis versus either pre-op PTBD drainage or ERCP stenting was reviewed.
RESULT: Among the 40 cases, 12 cases got pre-op ERCP stenting. 6 of
them got sepsis and there was significant difference between the non ERCP
stenting group (p/0.035). There was no difference in sepsis among the
PTBD/ERCP stenting group and the PTBD only group.
Conclusion. Pre-operative PTBD to future remnant liver side not only
enables us to define the site and extent of the lesion in hilar cholangiocarci-
noma, it also provides adequate drainage for the preserved side so that the
septic complication is lowered.
P5.11
SIGNIFICANCE OF PANCREATICOBILIARY MALJUNCTION IN
ADULT CHOLEDOCHAL CYSTS
Liau, Kui Hin; Ho, Choon Kiat; Chan, Chung Yip; Kow, Alfred; Chong,
Siew Ying; Chew, Soo Ping
Digestive Disease Centre, Tan Tock Seng Hospital, Dept. of Surgery,
Singapore
Background. The diagnosis of pancreaticobiliary maljunction (PBM) has
never been an integral part of our diagnostic Endoscopic Retrograde
Cholangiopancreaticogram (ERCP) or Magnetic Resonance Cholangiopan-
creaticogram MRCP investigations.
Objective. The purpose of this study was to clarify the significance and
implication of PBM in adult patients with choledochal cysts.
Method. The data of 12 adult patients with choledochal cysts who had pre-
operative ERCP from 19942002 were reviewed retrospectively. We re-
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viewed all the ERCP and MRCP films to identify pancreaticobiliary
junction (PBJ) and measured the distance from the junction to ampulla of
Vater. PBM is defined as a union of the main pancreatic and common bile
ducts outside the wall of the duodenum that forms a long common channel
(/8 mm).
Results. Reviewing all radiographs of the12 patients, PBJ was visualized
adequately in 5 (42%) of them. For these 5 patients, PBM with a common
channel length /8 mm was noted in all (100%) the patients. One (20%)
patient had Type I PBM (Fig 1) and 4 (80%) patients had Type II (Fig II).
The mean common channel was 20 mm (1127 mm). One (20%) patient,
who had adenocarcinoma within the choledochal cyst, had Type II PBM and
27 mm long common channel.
Conclusion. This study supports the existing reports on the association of
PBM with choledochal cyst. Type II PBM is more common in choledochal
cyst. Due to the small number of patients, we were not able to draw the
conclusion on the incidence of biliary cancer development in PBM. A
prospective effort to examine this anatomy and the length of the common
channel during ERCP or MRCP should be encouraged to identify potential
late onset choledochal cysts.
P5.12
WHETHER OR NOT PROPHYLACTIC EXCISION OF THE EX-
TRAHEPATIC BILE DUCT IS APPROPRIATE FOR PATIENTS
WITH PBM WITHOUT BILE DUCT DILATATION
Toshiomi, Kusano1; Takao, T2; Tachibana, K2; Furukawa, M3; Uchimura,
Masayuki4
1Tenjinkai Shin-Koga Hospital, General Surgery, Kurume, Japan; 2Tenjinkai
Shin-Koga Hospital, Kurume, Japan; 3Nishi-Isahaya Hospital, Isahaya,
Japan; 4Hamamatsu Iryo Center, Hamamatsu, Japan
Background/Aims. The standard treatment for the patients with a pancrea-
tic biliary maljunction (PBM) without bile duct dilatation remains contro-
versial.
Methodology. We followed up 30 patients with such PBM who mainly
underwent a cholecystectomy alone. The ages of the patients ranged from 3
to 76 yrears (average age 46.9 years) and the ratio of males to females was 8
vs. 22. When the diameter of the common bile duct was less than 10 mm,
such bile duct were diagnosed to have no dilatation. The main clinical
indications for surgery were cholecystlithiasis in 16 patients, choledocho-
lithiasis in 3, cholecystcholedocholithiasis in 2, and gallbladder polyp in 2,
adenomyomatosis in 2, cholecystitis in 2, and protein plug in 1.
Results. The amylase levels of gallbladder bile in 20 patients ranged from 115 to
460,200 IU/mL (a mean of 191,698 IU/mL). One patient died of gastric cancer
182 months after surgery and two patients died of other dideases 153, 171
months after surgeries, respectively. The remaining 27 patients have all been
doing well for 36 months to 326 months aftr surgery (a mean follow up period,
161.3 months). The 10-year and 15-year survival rate were 100% and 89.7%.
Conclusions. In conclusion, a prophylactic resection of the extrahepatic bile
duct and biliary diversion could be unnecessary for the patients with PBM
without bile duct dilatation.
P5.13
UNUSUAL CAUSES OF OBSTRUCTIVE JAUNDICE
Spalding, Duncan; Abraham, Ajit; Bhattachrya, Satya; Hutchins, Robert
Royal London Hospital, London, UK
Background. Common causes of obstructive jaundice are benign (common
bile duct [CDB] stones 38%, chronic pancreatitis 8%), primary malignancy
(carcinoma of head of pancreas [HOP] 30%, cholangiocarcinoma [ChCA]
8%, carcinoma of ampulla of Vater, duodenal carcinoma 2%) or secondary
malignancy (portahepatis nodes 8%). Occasionally miscellaneous pathology
mimics malignant causes of obstructive jaundice.
Methods. Patients undergoing investigation and treatment for obstructive
jaundice from 20002005 were prospectively reviewed and uncommon
causes documented.
Results. Seven patients were identified, all presented with obstructive
jaundice. Three patients had a pre-operative diagnosis of extrahepatic
ChCA. One was found to be caused by a pseudotumour after external
biliary tree excision; 1 was due to migration of embolisation coils and
ligaclips following a laparoscopic cholecystectomy and embolisation of a
right hepatic artery pseudoaneurysm, following CBD exploration; 1 was
found to be secondary to ectopic pancreas after a Whipples procedure.
Two had a diagnosis of carcinoma of HOP. One was due to TB of HOP
and duodenum after biopsy, which responded to medical treatment, the
other was due to a vascular anomaly of HOP and treated with a double
bypass. One patient had a pre-operative diagnosis of metachronous
colorectal liver metastases with involvement of the CBD following an AP
resection for a Dukes A rectal cancer. After extended right hepatectomy
and excision of external biliary tree, obstruction was found to be due to
biliary embolisation of colorectal liver metastases. One patient with a
previous aortic dissection and superior mesenteric artery involvement,
presented with obstructive jaundice and haemobilia due to a pseudoaneur-
ysm of a replaced right hepatic artery and was treated with endoscopic
stenting and embolisation. No morbidity or mortality was observed in any
of the patients.
Conclusions. Although uncommon, miscellaneous pathology should be
considered in the differential diagnosis of obstructive jaundice.
P5.14
MANAGEMENT OF COMPLICATIONS OF LAPAROSCOPIC
CHOLECYSTECTOMY
Shokouh-Amiri, Hosein; Shimuzi, Atsushi; Vera, Santiago R; Gaber, Ahmed
O; Shokouh-Amiri, Mohammad
Methodist Transplant Institute, University of Tennessee, Transplantation,
Memphis, USA
Background. Laparoscopic cholecystectomy has become the treatment of
choice and standard of care for patients suffering from cholecystolithiasis
and/or chronic cholecystitis. Complications include bile leakage, peritonitis,
bowel perforation, cholangitis, biliary stricture, and secondary biliary
cirrhosis leading to liver transplant. Majority of complications such as leakage
from cystic duct stump and duct of lushka can be managed by percutaneous
drainage, ERCP and sphemctory/biliary stent placement. Very serious,
though less frequent complications such as transection of common bile
duct can occur with serious morbidity/mortality.
Objective. To verify the short and long term of surgical management of
complications of laproscopic cholecystectomy.
Methods. Restropective review of charts of patients with complications after
laproscopic cholecystectomy who were referred to our center between 1990
2005.
Results. Between 19902005, 39 patients (7 men and 32 women, ages 19
to 70) were referred to our center for management of serious bile duct
injury during laparoscopic cholecystotomy. Majority of the damages were
recognize shortly after the incident and few cases were diagnosed or
referred late.97% of the cases were managed by hepatico-jejunostomy and
one patient was managed by selective hepatic duct to Roux and y loop. One
patient who was managed by hepato-jejunostomy locally had to have liver
transplant due to secondary biliary cirrhosis as a consequence of stricture at
hepato-jejunostomy, which failed to multiple dilatations. One patient with
three hepato-jejunostomies has had multiple episodes of cholangitis and is
under control with prolonged antibiotic therapy. One patient who was
managed by biliary stent placement finally came to have hepato placement
10 years later. The rest of patients are doing well 115 years after hepato-
jejunostomy.
Conclusion. When patients are referred in a timely manner to experienced
HPB surgeons, the result of surgical management of this serious complication
of laparoscopic cholecystectomy is good.
General UGI Posters
P11.01
THE VALUE OF ENDOSCOPIC ULTRASOUND IN THE WORKUP
OF FOCAL LESIONS OF THE PANCREAS
Van der Zee, Jill A1; Poley, Jan-Werner2; Hermans, John J3; Van Eijck, Casper HJ1
1Erasmus Medical Center, General Surgery, Rotterdam, Netherlands;
2Erasmus Medical Center, Gastro-Enterology, Rotterdam, Netherlands;
3Erasmus Medical Center, Radiology, Rotterdam, Netherlands
Background. With a five-year survival of 24%, pancreatic adenocarcinoma
is the fourth leading cause of cancer-related death in the United States. At
time of diagnosis only 522% is considered resectable. However, not all focal
lesions are malignant. To evaluate character and local resectability different
diagnostic tools are available, Computed Tomography (CT) being a widely
accepted modality. With the introduction and increasing use of Endoscopic
Ultrasound (EUS) to evaluate the pancreas, surgeons get confronted with a
new modality for the workup of patients with jaundice. However, the value of
this rather new modality remains unclear.
Aim(s)/Objective(s). To determine the value of EUS (compared to the
conventional CT-scan) in the workup of jaundiced patients with a focal lesion
of the pancreas.
Methods. A retrospective review of this hospitals first experience with EUS
of the pancreas was undertaken. Primary outcome measures were its
capability to determine character (with pathology as the gold standard) and
local resectability (compared to per-operative evaluation) of the lesion. In
case of locally advanced disease, the secondary outcome measure was the
capability of EUS (in combination with FNA) to confirm malignancy
cytologically.
Results. From April 2003 to October 2005 153 EUSs were performed.
EUS managed to diagnose 25 of 41 by pathology confirmed malignancies
(sensitivity 61%), compared to 22 by the widely used CT-scan (sensitivity
54%). Of 34 patients that were considered resectable per-operative and thus
underwent surgery, 22 were considered resectable at EUS (sensitivity 65%)
compared to 18 on CT-scan (sensitivity 53%). Finally three out of five
FNAs were able to confirm a suspected malignancy in locally advanced
disease.
Conclusion. EUS seems to be an alternative to the widely accepted CT-scan
in the workup of jaundiced patients to determine malignancy, local
resectability and in combination with FNA to confirm malignancy in patients
with locally advanced disease.
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P11.02
ROLE OF ENDOSCOPIC ULTRASOUND (EUS) AND FINE NEE-
DLE ASPIRATION CYTOLOGY (FNA) IN THE DIAGNOSIS OF
SOLID LESIONS OF THE PANCREAS
Shah, Jayshri A1; Shah, Ankur J2; Wallace, Doreen2; Norton, Sally3
1Southmead Hospital, Gastroenterology, Bristol, UK; 2Bristol Royal Infirm-
ary, Bristol, UK; 3Southmead Hospital, Upper GI Surgery, Bristol, UK
Background. For patients with pancreatic adenocarcinoma surgery is the
only curative option. Chemo/radiotherapy may provide palliation in patients
with unresectable tumour. Less common pancreatic lesions may require
alternative treatment. Endoscopic ultrasound (EUS) with Fine needle
aspiration (FNA) could enable accurate diagnosis of equivocal lesions
allowing an appropriate management plan to be determined.
Aims. To assess accuracy of EUS in diagnosing solid pancreatic lesions. To
evaluate the safety and accuracy of EUS-FNA in diagnosing solid lesions of
the pancreas.
Methods. Retrospective analysis of the EUS database over a 28 month
period identified 27 patients referred for EUS and FNA of equivocal solid
lesions of the pancreas. EUS imaging features were noted and FNA results
recorded. Histology or minimum follow up of 6 months were used as the
reference standard to assess accuracy of EUS and FNA in making a diagnosis.
Results. EUS imaging accurately predicted diagnosis in 22/27 patients (81%).
EUS predicted benign morphological features in 2 patients with a final
diagnosis of cancer and identified malignant features in 1 patient with benign
disease. EUS features were equivocal in 1 patient. One patient died 2 weeks
after EUS with FNA due to portal vein thrombosis and splenic rupture. FNA
was performed in 25 patients with an inadequate sample in 8. FNA was not
performed in 2 patients due to clotting abnormalities. FNA diagnosis was
accurate in 14/17 patients with an adequate yield. In 3 patients with final
diagnosis of cancer, FNA cytology was benign. Overall FNA accuracy was
56%. However, in samples with an adequate yield, the FNA accuracy was 82%.
Conclusion. EUS in combination with FNA is a useful method for
diagnosing solid lesions of the pancreas. However, EUS-FNA of solid
pancreatic lesions is difficult and may yield inadequate material for diagnosis
in up to a third of cases.
P11.03
SUCCESSFUL MANAGEMENT OF RECTALVARICES USING COM-
BINED ENDOSCOPIC VARICERAL LIGATION AND SCLEROSING
TECHNIQUE IN PATIENTS WITH PORTAL HYPERTENSION
Oh, Koushi; Yamanaka, Jyunichi; Suzumura, Kazuhiro; Yoshida, Yasuhiko;
Morikawa, Shiro; Okada, Toshihiro; Hirano, Tadamichi; Iimuro, Yuji;
Fujimoto, Jiro
Hyogo College of Medicine/ First Dept. of Surgery, Nishinomiya, Japan
Background and aim. Recent advances in diagnostic and therapeutic
options continue to evolve in the field of portal hypertension and important
technical developments have been made to control life-threatening variceal
bleeding. Gastro-esophageal varices are the most common site of variceal
bleeding. Although bleeding from ectopic varices such as duodenal, jejunal,
ileal, colonic, and rectal varices is less common, it can also cause life-
threatening problem, which is often difficult to diagnose and treat success-
fully. Here we present a novel endoscopic approach for hemorrhagic rectal
varices using endoscopic injection sclerotherapy with ligation (EISL).
Patients and method. In 20002005, we performed 655 endoscopic
treatment sessions in 189 patients with portal hypertensive varices. Among
those, four cases of hemorrhagic rectal varices were treated with the
combined EVL and sclerosing technique. The etiology of portal hypertension
included idiopathic portal hypertension in one and HCV cirrhosis in the
others, of whom one had hepatocellular carcinoma. They consisted of one
Child’s A, two Child’s B, and one Child’s C patients. All patients had a
history of prior abdominal surgery or endoscopic treatment for gastro-
esophageal varices.
Results. Hemostasis was obtained easily by the EVL initially. Furthermore,
to avoid recurrent bleeding, the patients underwent endoscopic varicerogra-
phy injection sclerotherapy (EVIS) using 5% ethanolamine oleate with
iopamidol. Namely, the feeding vein was visualized under fluoroscopy and
sclerosed.successfully. Follow-up endoscopy revealed disappearance of rectal
varices. No major complication occurred during the entire course of the
treatment.
Conclusions. It is important to recognize the possibility of ectopic varices as
a cause of gastro-intestinal haemorrhage especially in patients with a history
of variceal therapy or abdominal surgery. The EISL technique is useful to
control the initial and recurrent bleeding from rectal varices.
P11.04
ENDOSCOPIC SPHINCTEROTOMY FOR ACUTE BILIARY PAN-
CREATITIS: THERAPEUTIC MANAGEMENT OF DUODENAL
PERFORATION
Neri, Vincenzo; Ambrosi, Antonio; Fersini, Alberto; Valentino, Tiziano Pio;
Santacroce, Caterina
Polyclinic of Foggia-University of Foggia, Dept. of Surgical Sciences, Foggia,
Italy
Background. There is not uniformity, in literature, in the management of
the duodenal perforative complication of the endoscopic retrograde cholan-
giopancreatography (ERCP) with endoscopic sphincterotomy (ES).
Aim. The aim of the study was to define, with uniformity, the therapeutic
program in the treatment of the perforative complication in course of ERCP
with ES in the management of biliary pancreatitis.
Methods. In the period 1997/2004, there were 5 perforations in course of
121 ERCP/ES (4.13%), executed in two digestive endoscopic centres. Three
patients were operated in urgency (duodenostomy, external biliary drainage,
gastric-enteric-anastomosis). Two patients, in contrast, were conservatively
treated with nose-duodenal drainage in aspiration.
Results. The post-operative complications were modest. There were not
septic infiltrates or retro/endoperitoneal gatherings. The biliary drainage,
upon radiologic control, and the duodenostomy were removed in the course
of 4th postoperative week. There was no mortality.
Conclusions. The urgent surgical treatment was performed because of the
leakage and the persistence of the radio-contrast in the retroperitoneum. In
case of retroperitoneal and small perforations, we choose to not treat directly
the site of the perforation and we start the early oral intake because of the
diversion of the biliary and duodenal secretions. The minimal perforations,
without persistence of radio-contrast, were treated by conservative approach.
The proposed treatment was efficacious and safe, and cancelled every risk of
septic evolution.
P12.01
THE ACCURACY OF THE DIFFERENT MODALITIES AVAIL-
ABLE FOR PRE-OPERATIVE IMAGING OF BIOLOGICALLY
PROVEN INSULINOMAS
Van der Zee, Jill A1; Hermans, John J2; Van Eijck, Casper H1
1Erasmus Medical Center, General Surgery, Rotterdam, Netherlands;
2Erasmus Medical Center, Radiology, Rotterdam, Netherlands
Background. With an occurrence of four in a million per year, insulinoma is
a rare condition. Considering the high impact of the clinical symptoms and its
malignant potential, surgery is the treatment of choice. In planning the
optimal surgical procedure and approach, pre-operative localization and
extension of biologically proven insulinoma is an essential step. A step that
remains challenging while 6075% of insulinomas is less than 1.5 cm in
diameter.
Aim(s)/Objective(s). To analyse the accuracy of the different modalities
available for pre-operative imaging of clinically suspected insulinomas
compared to intra-operative localization.
Methods. A retrospective review was performed on all biologically proven
insulinomas that underwent at least part of their workup at our institution.
The modalities evaluated were pre-operative ultrasound (pre-op-US),
Computed Tomography (CT), Magnetic Resonance Imaging (MRI), Endo-
scopic Ultrasound (EUS) and Somatostatin Scintigraphy (SMS).
Results. From January 1998 till June 2005, 17 insulinomas were analysed.
One of five (1/5) performed pre-op-USs, four out of 13 (4/13) CTs, three of
four (3/4) MRIs, two out of two (2/2) EUSs and five of 11 (5/11) SMS-scans,
located the insulinoma. All tumours were either seen or palpated during
operation (100% accuracy). Operation was carried out in 15 patients. Seven
of nine laparoscopic procedures had to be converted to an open approach
because of inaccurate pre-operative imaging.
Conclusion. The only modalities approaching the 100% accuracy of
per-operative assessment were MRI and EUS. Unfortunately both were
rather scarcely performed due to their recent introduction in imaging of
the pancreas. Therefore a prospective randomised control study should be
conducted evaluating MRI and EUS as diagnostic tools in locating insulino-
mas.
P13.01
ACUTE CHOLECYSTITIS AND LIVER CIRRHOSIS
Severtsev, Alexey; Tchudaev, Dimitri; Mezhgikh, Telman
The Central Clinical Hospital#1 of the OAO, HPB-Surgical Dept., Moscow,
Russia
Background. Acute cholecystitis is one of the most frequent surgical
pathologies. There is no sufficient information about the course of such acute
process during the liver cirrhosis. The combination of these two pathological
conditions leads to significant stress for surgeons.
Aim. The purpose of this study is to estimate the clinical experience of the
treatment in this group of patients.
Methods. Within the period of existence of multi-specialized hepatological
department (19982005) we observed 27 patients who had such combined
pathology is exposed. The ratio of men:women was approximately
identical (15:12), the age structure was also identical (43:45). The
cirrhosis was diagnosed on the basis of standard criteria (plus biopsy).
The diagnosis of an acute cholecystitis: Visualizing techniques (US, CT),
blood tests for an inflammation, clinical course. 23 patients have been put as an
acute cholecystitis (with small calculi). Considering that it was impossible to
exclude the destruction of the wall of gall bladder, 16 patients have been
operated.
Results. In all situations it has been done the conventional cholecystectomy
(not laparoscopic one). There were technically intraoperative difficulties with
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impossibility traditional suturing of gall bladder bed and long time post-
operative external drainage (abdomen). During the surgery in all acute
cholecystites (the extended adhesive process in this zone, enlarged gall bladder
walls) was visually confirmed. However biliary calculi have been confirmed
only for 1 patient. At postoperative histological investigation, the hypertrophy
of gall bladder walls without attributes of their destruction was marked.
Conclusion. Obtained results have allowed us to consider, that most often it
take place the mimicry of acute process on a background of strengthening of
activity of the basic process in a liver. Therefore another 11 patients with such
diagnosis got non surgical treatment only of the basic process of a liver.
P14.01
BLEEDING DUODENAL PEPTIC ULCER: ROLE OF OVERSEW-
ING IN THE ERA OF PROTON PUMP INHIBITOR (PPI)
Brehant, Olivier1; Dumont, Frederic1; Duval, Herve1; Fuks, David1; Ver-
haeghe, Pierre1; Yzet, Thierry2; Bartoli, Eric3; Brazier, Franck3; Mauvais,
Franc¸ois4; Dupas, Jean L3; Regimbeau, Jean M1
1CHU Amiens Nord, Surgery, Amiens, France; 2CHU Amiens Nord,
Radiology, Amiens, France; 3CHU Amiens Nord, Gastroenterology, Amiens,
France; 4CH Beauvais, Surgery, Beauvais, France
Background. The gold standard surgical treatment of bleeding duodenal
peptic ulcer (BDPU) is vagotomy with antrectomy. The use of PPI in high dose
(chimical antrectomy) and the endoscopic hemostasis decrease the number of
recurrent bleeding and surgical procedure. Currently, when a surgical
procedure is necessary, no recommendation is made on the best surgical
procedure. The goal of this work is thus to judge effectiveness of the suture
associated or not with a gastroduodenal artery (GDA) ligation in the treatment
of haemorrhage ulcer with PPI.
Method. From 1995 to 2005, 19 consecutive patients were operated in
emergency, in two centers, of BDPU. The procedure was a suture of ulcer
associated or not with a GDA ligation, without antrectomy nor vagotomy. All
patients received PPI in high dose in post-operative, 7 (37%) by electric
syringe.
Global population 20022005
Patients n (%) 19 8
Male (%) 15/19 (80%) 5/8 (63%)
Mean age 619/19 649/14
Shok n (%) 9/19 (47%) 5/8 (63%)
Number of procedures 1,69/1 1,759/1,3
Unit of blood 9,79/7,5 99/5,8
Bleeding recurrence and mortality were analyzed in global population
according to the treatment PPI and surgical procedure.
Results. Only two patients had a bleeding recurrence. Among the died
patients, none died of recurrence. None of patients having a binding of GDA
(9/19) and none of patients having a PPI treatment by the electric syringe in
post operative (7/19) had recurrence.
19972005 20022005
Surgical procedure: otherswing 10/19 (53%) 1 /8 (13%)
PPI by electric seringe 7/19 (37%) 7/8 (87%)
Recurrence n (%) 2/19 (11%) 0 (0%)
Death n (%) 0 (0%) 2/8 (25%)
Conclusion. At the hour of IPP, this study shows that overswing of BDPU
associated with a binding of GDA followed by a PPI treatment by electric
syringe is an effective treatment with low rate of haemorrhagic recurrence.
The dogma of the vagotomy antrectomy in this indication must be
questionnable
P14.02
BLOCKADE OF LEUKOCYTE MIGRATION BY NSAID IN VITRO
AND IN VIVO
Ryschich, Eduard1; Paskauskas, Saulius1; Lizdenis, Paulius1; Kerkadze,
Vachtang1; Sperandio, Markus2; Nobiling, Rainer3; Gebhard, Martha M3;
Bu¨chler, Markus W1; Schmidt, Jan1
1University of Heidelberg, Dept. of Surgery, Heidelberg, Germany; 2Uni-
versity of Heidelberg, Dept. of Pediatry, Heidelberg, Germany; 3University of
Heidelberg, Dept. of Exp. Surgery, Heidelberg, Germany
Introduction. The ability to move is an important feature of all leukocytes.
According to our hypothesis, the identification and application of substances
which block leukocyte migration lead to the inhibition of inflammatory
reaction and immune response.
Aim. The aim of the study was to investigate the effect of NSAID on
leukocyte locomotion in vivo and in vitro.
Methods. The migration of isolated neutrophils and activated lymphocytes
in collagen gel was investigated after application of different doses of NSAID
(ketoprofen, doclofenac, SC-560). The number of migrating cells and the
velocity of migration were estimated by time-lapse microscopy and in 96 wells
assay. The leukocyte migration in vivo was studied in rat mesenteric tissue
and in cutaneous tissue of Lys/EGFP mice by time-lapse intravital micro-
scopy after application of ketoprofen and diclofenac. The change of
intracellular calcium in vitro was investigated by ultrasensitive single-cell
emission spectrometry.
Results. Baseline measurement of leukocyte migration showed the mean
velocity of 9.09/1.8 mm/min and the mean percent of migrating cells of 87.09/
5.7%. All NSAIDs caused an immediate dose-dependent inhibition of
leukocyte migration in all experiments both in vitro and in vivo. The dose
of 0.51.0 mg/ml caused an immediate blockade of migration of all
neutrophils and activated lymphocytes. This effect was reversible after
removal of NSAID. The intracelular calcium was significantly reduced after
the treatment with NSAID.
Conclusions. High doses of NSAID blockade leukocyte migration. The
inhibition of intracellular calcium is a mechanism of this effect. The blockade
of leukocyte migration by NSAID could represent a permissive method for
the effective treatment/prevention of local inflammation or immune re-
sponse.9/
P14.03
DIFFICULTIES IN PREOPERATIVE DIAGNOSIS OF MECKEL
DIVERTICULUM: 5 YEARS EXPERIENCE IN CHILDREN
Paraian, Ioan1; Budusan, Anca1; Ordeanu, Calin2; Vezan, Remus1
1University of Medicine, Pediatric Surgery, Cluj-Napoca, Romania; 2Clinical
Children’s Hospital, Pediatric Surgery, Cluj-Napoca, Romania
Background. Meckel diverticulum is the most common congenital anomaly
of the gastrointestinal tract, occurring in 23% of the population. The most
common complications are hemorrhage from peptic ulceration, small
intestinal obstruction and diverticulitis. The preoperative diagnosis is rarely
made because of nonspecific nature of symptomatology.
Objective. The aim of this study is to evaluate various presentations of
complicated Meckel diverticulum in children.
Materials and Methods. We made a retrospective analysis of hospital
records carried out the department of pediatric surgery in the last 5
years (from 2001 to 2006). The study group includes 40 symptomatic
patients, 25 boys and 15 girls and does not include patients with incidental
discovery of Meckel diverticulum during abdominal surgery. Clinical
presentation, pathological findings and management of all patients were
analysed.
Results. The most common presentations were acute abdominal pain
(50%), gastrointestinal bleeding (25%), bowel obstruction (15%) and
incarcerated inguinal hernias (10%). Preoperative diagnosis was acute
surgical abdomen in 36 patients and incarcerated inguinal hernias in 4
patients. All cases with gastrointestinal bleeding from peptic ulceration was
diagnosed by Technetium 99m scan and were subsequently confirmed
surgically. Intraoperative diagnosis were as follows: Littre‘s hernia in 4 cases,
diverticulitis in 12, perforation of the diverticulum in 8 cases, intestinal
obstruction in 6 (volvulus or invagination) and peptic ulceration in 10 cases.
While diverticulectomies were performed in 31 patients, 9 of them needed
small bowel resection and anastomosis. Heterotopic tissue was found in 10
cases. Postoperative complications included 2 wound infections. We had no
mortality in our group of study.
Conclusions. Although the clinical, pathologic and radiologist features of
the complications of Meckel diverticulum are well known, the diagnosis of
Meckel diverticulum is difficult to establish preoperative.
P14.04
IS THERE A ROLE FOR ADJUNCTIVE IMATINIB FOLLOWING
GASTROINTESTINAL STROMAL TUMOUR (GIST) SURGERY?
Alchami, Fouad; Mulchandani, Manoj; Khan, Omar
Medway Maritime Hospital, General Surgery, Gillingham, Kent, UK
Background. GIST accounts for most mesenchymal tumours arising within
the gastrointestinal tract. They are rare and account for 0.1%-3.0% of all
gastrointestinal neoplasms. Imatinib is only given to unressectable or
metastatic GIST.
Purpose. To investigate the anatomic distribution; follow up, recurrence rate
and metastasis in patients with stromal tumors in a district general hospital.
The role of Imatinib in GIST was examined, to see whether high risk (size/5
cm, mitotic rate/5/hpf) patients should be started on Imatinib.
Materials and Methods. The medical records of 18 out of 20 patients with
a histological diagnosis of stromal tumors between 1997 and 2005 were
reviewed. The investigations, treatment, follow up plans and histology reports
were assessed.
Result. In this review there were 20 stromal tumors including 10 GISTover a
period of 8 years. Their median age was 63.5(46 92 years). Thirty percent of
these patients presented with melaena, 20% anaemia, 20% bowel obstruction
and 20% were incidental. 50% were initially investigated with OGD, 30%
with CT at presentation. The sites of tumors were: Esophagus-1; Stomach-
11; Small bowel-5; Sigmoid colon-1; unknown primary-2. Eleven out of these
20 tumors were /5 cm, 3 had mitosis/5/hpf and 2 had metastasis at
presentation. Sixty five percent of patients were followed up for 5 years of
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which 50% had CT follow up and/or OGD 55%., and there was late
metastasis in 20%, and 5% recurred. Imatinib was started in only 1 patient
with metastasis.
Conclusion. Twenty percent of patients developed metastases after surgery
and all were in high risk group. Should imatinib be a therapeutic option in
high risk GIST?
P14.05
MINIMALLY INVASIVE SURGERY FOR ACUTELY PRESENTING
GASTROINTESTINAL STROMAL TUMOURS: STUDY OF NINE
CASES
Alam, Imran1; Kheradmand, Frahad2; Jamil, Anwar3; Alam, Sadia1; Rawat,
Nihat1; Alhamdani, Ali1; Mahmud, Sajid1; Wilson, I3; Hurley, Michael3
1Morriston Hospital, Surgery, Swansea, UK; 2Royal College of Surgeons
Ireland, Anatomy, Dublin, Ireland; 3St. Lukes General Hospital, Surgery,
Kilkenny, Ireland
Background. The gastrointestinal stromal tumours (GIST) are rare, account-
ing for less than 1% of all gastrointestinal tumours. Nevertheless, some may
present acutely with life threatening haemorrhage or intestinal obstruction.
Aims/Objectives. Is to review the various modes of presentation of GIST
specially haemorrhage and obstruction, and to assess the role of minimally
invasive surgery in the management of acute cases and correlation of such cases
with malignant potential.
Methods. Data was collected from patient’s notes and prospective database.
Their presentation, management, histological features and follow-up period
were analysed.
Results. Nine cases of GIST were collected over a period of 4 years (2001
2005). The median age was 67.5 years (range: 3278). Four (45%) presented
with gastrointestinal haemorrhage, three (33%) with intestinal obstruction
and two (22%) with tender epigastric mass. Six had gastroscopy, and six
had CT scan of the abdomen and pelvis. Six (67%) patients underwent
partial gastrectomy and gastrojejunostomy (three open, three laparoscopic
procedures); three (33%) had resection and anastomosis of the bowel. 86%
had emergency and 14% had unplanned surgery. Laparoscopic approach
was adopted in 55% cases of which 60% was successful and 40% cases
were converted to open. All the patients who had laparoscopic treatment
had lesser pain, quicker recovery and short hospital stay as compared to
those who had open surgery. Immunohistochemistry revealed positive
C-kit and CD34 for all the tumours. Four were benign and five were
malignant tumours. Two patients received imatinib mesylate (specific inhibitor
of KIT receptor tyrosine kinase). Median follow-up is 24 months with one
recurrence.
Conclusion. Our experience showed that GISTs can present acutely and may
need immediate surgical intervention. Laparoscopic treatment is safe and
practical in experienced hands. Tumour size and haemorrhage at presentation
can predict malignant potential.
P14.06
MANAGEMENT AND PROGNOSIS OF PATIENTS WITH RIGHT-
SIDED COLONIC ADENOCARCINOMA DIRECTLY INVADING
THE DUODENUM OR PANCREAS
Fuks, David1; Pessaux, Patrick2; Tuech, Jean-Jacques3; Brehant, Olivier1;
Mauvais, Franc¸ois4; Chatelain, Denis5; Dumont, Frederic1; Yzet, Thierry6;
Regimbeau, Jean-Marc1
1CHU Amiens Nord, Surgery, Amiens, France; 2CHU Angers, Surgery,
Angers, France; 3CHU Rouen, Surgery, Rouen, France; 4CH Beauvais,
Surgery, Beauvais, France; 5CHU Amiens Nord, Pathology, Amiens, France;
6CHU Amiens Nord, Radiology, Amiens, France
Background. Only few series have been published about locally advanced
carcinoma of the right colon adherent to the duodenum or pancreas. We report
results of a multicenter study focusing on management and prognosis of this
rare entity.
Methods. We reviewed the complete data of patients operated between 1988
and 2005 in 4 surgery departments.
Results. 17 patients were managed [13 men, mean age of 64 years (4386)].
Complicated forms were found in 10 patients (hepatic metastases
n/4, duodenocolic fistula n/3, carcinosis n/2, abscess n/2, perforation
n/5). Among 17 patients, 2 were treated with palliative intestinal
diversion (generalized carcinosis). Fifteen patients underwent en bloc resec-
tions: 12 were treated by colectomy with partial duodenectomy (tumours
involving only a part of the duodenum); 3 were treated by pancreaticoduode-
nectomy. All patients were resected with clear resection margins. Tumours were
well, moderately and poorly differentiated adenocarcinomas in respectively
29%, 47% and 23%. Perioperative mortality was 13%. Postoperative morbidity
included 2 anastomotic leaks from the ileo-colic anastomosis. One patient with
en bloc pancreaticoduodenectomy had pancreatic fistula medically treated. No
patient experienced duodenal fistula after partial duodenectomy. Eleven
patients had postoperative systemic chemotherapy. Liver metastasis treatment
included preoperative radiofrequency ablation n/1, secondary left lobectomy
n/1, exclusive chemotherapy n/2 The mean long-time survival in resected
patients was 22 months (2122). One and three years overall survival were 68%
(n/7) and 56% (n/4). After partial duodenectomy, 41% (n/5) patients had
local recurrence within 15 months after surgery.
Conclusion. Morbimortality after colectomy and partial duodenectomy or
pancreaticoduodenectomy was acceptable and associated with prolonged
survival time. The high rate of local recurrence after partial duodenectomy
makes questionable this procedure in patients in whom pancreaticoduode-
nectomy could be realized
P14.07
MANAGEMENT OF MECKEL’S DIVERTICULUM DURING OPEN
APPENDICECTOMYAN EASTANGLIAN SURGEON’S PERSPEC-
TIVE
Velchuru, Vamsi R; Rimal, Debesh; Schankat, Kerstin; Studley, John GN
James Paget Healthcare NHS Trust, General Surgery, Gorleston, Great
Yarmouth, UK
Background. Management of incidental Meckel’s Diverticulum (MD) found
during open appendicectomy has been controversial. Recent studies have
suggested a MD should be resected at appendicectomy if the appendix is
normal, particularly in the case of a male of B/40 yrs of age, a long or narrow
necked MD or if there is heterotopic tissue suggested by thickening.
Aim. To identify the current practice of Consultant Surgeons in East Anglia in
the management of MD during open appendicectomy.
Methods. Questionnaires were sent to 80 Consultant Surgeons. Questions
were related to their management of MD during open appendicectomy, both in
normal and inflamed appendix scenarios.
Results. Response rate to the questionnaire was 49% (n/39). Apart from 1
surgeon all partook in the on-call rota. If the appendix was normal: Ninety two
percent would examine for an MD. If a normal looking MD was found: / 59%
would leave alone / 20% would resect / The remaining 21% (n/8) would resect
if there was a narrow neck (n/5), long length (n/2) and if the patient is under
40 years of age (n/2). In Acute appendicitis: Fifteen percent (n/6) would
examine for MD and all of them would resect a normal looking MD if there was
thickening suggestive of heterotopic tissue.
Conclusion. During appendicectomy the approach of surgeons in the
management of an incidental MD is varied.
P14.08
GASTROINTESTINAL CARCINOID TUMOURS-VARIED PRE-
SENTATIONS
Ganga, Ramarao; Mullerpatan, Prashant; Mathur, Dilip
Grantham & District Hospital, Grantham, UK
Background. Gastrointestinal(GI) carcinoids are often diagnosed inciden-
tally because of lack of specific symptomotology. There are no recognised
macroscopic appearances to facilitate the diagnosis. Only measure that helps
in diagnosis of these intriguing tumours is increased awareness of varied
presentations.
Objective. To highlight the varied presentations of these tumours.
Methods. We studied all the GI carcinoid tumours diagnosed between
January 2002 and December 2005 in our trust. A total of 20 cases were
identified. A retrospective case note study was carried out looking into their
presentation, investigations and management.
Results. None of the 20 patients had any features of classical carcinoid
syndrome. Most common location of primary tumour was Appendix in 11
cases (7-tip,2-base & 2-midpart). Ileal primaries identified in 6 cases (2-
multiple lesions). One each Caecal, Rectal and Pancreatic tumors were
identified. 10 of 11 appendicular carcinoids presented with appendicitis and
were diagnosed incidentally on histology. Two of these with basal tumours
underwent right hemicolectomy with no residual disease. Other patient from
appendicular group presented as mass in pelvis. At laparotomy mass was
found be arising from body of appendix adherent to bladder. Subsequently
right hemicolectomy needed in view of tumour size. 4 of 6 ileal carcinoids
presented with bowel obstruction. Other two were diagnosed on investiga-
tions for anaemia and abdominal pain. Rectal carcinoid was identified as
polyp following per rectal bleeding. Caecal carcinoid with diffuse metastatic
mesenteric infiltration presented with extensive gangrene of bowel. Pancrea-
tic carcinoid presented with mass in head of pancreas and diffuse peritoneal
metastases.
Conclusion. Increased awareness of the possibility of these tumours will help
in early diagnosis and successful management.
P14.09
THE TREATMENT OF CARCINOID SYNDROME WITH THE USE
OF OCTREOTIDE BEFORE AND AFTER SURGERY
Severtsev, Alexey; Tchudaev, Dmitry; Ovtchinnikov, Vladimir
Non-governmental Medical Institution, HPB-Surgical Dept., Moscow,
Russia
Background. The carcinoid tumor is the rare tumor. The diagnosis before
surgery is difficult before surgery, especially when the main tumor is localized
in small intestine and there are multiple liver metastases. Usually the
diagnosis confirmation is very controversial (even to use such new modalities
as PETand Octreoscan). Sometimes the clinic data are much more important
that other investigations. According to basic data octreotide is very effective
for such kind of tumors.
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Aim. The purpose of this study was to present the opportunity using of
octreotide as diagnostic and treatment test in the course of carcinoid disease.
Methods. During 1 year period (2005) we treated 2 patients with carcinoid
tumors located at the upper part of jejunum and in the last part of ileum with
the development of carcinoid syndrome (and multiple liver metastases). All
conventional tests before surgery confirmed the presence of malignant
tumors without primary origin. Because of suspicion of carcinoid syndrome
we used high doses of octreotide for prophylactic treatment.
Results. We had got the decline of symptoms before surgery for both
patients. These results confirmed the diagnosis of carcinoid, so during the
surgery we search the tumor along small intestine. The surgery confirmed our
preoperative diagnosis and the presens of tumors in above mentioned part of
bowl. After intestine resection (in both cases) we made citoreductive surgery
of liver tumor nodules and the implantation of catheter into hepatic artery.
During postoperative patients received high doses of octreotide and
Sandostatin LAR. Carcinoid syndrome resolved completely and the lost
metastases in liver were reduced dramatically.
Conclusions. Our results confirmed that the use of octreotide is an effective
treatment of carcinoid tumors and carcinoid syndrome before and after
surgery and could be use as diagnostic modalities for these patients.
P14.10
REDUCTION OF GASTRIC MOTILITY AND SECRETION WITH
THE USE OF OCTREOTIDE FOR PATIENTS WITH CYSTOGAS-
TROSTOMY (JURASZ OPERATION)
Severtsev, Alexey; Tchudaev, Dimitry; Ovtchinnikov, Vladimir
Non-governmental Medical Institution, HPB-Surgical Dept., Moscow,
Russia
Background. Nowadays cystogastrostomy (Jurasz operation) is carried out
very seldom, but sometimes it is the unique one for the patients with
pancreatic cysts. The reason to reduce the number of this surgery is the high
rate of postoperative complications. The most often occurring complications
are abscess formation (inside of cysts) and the bleeding from the anastomosis.
These complications are interconnected. The improvement of the safety of
this surgery will increase the number of these (much easier) surgeries.
According to the basic data octreotide reduces the upper GI-motility and
secretion.
Aim. The purpose of this study is to assess the use of octreotide for the
patients with Jurasz operation.
Methods. From December 2003 till December 2005 4 patients with
pancreatic cysts had Jurasz operation. During postoperative period all
patients were treated with octreotide (7 postoperative days, 100 mkg/3
times per day s.c. plus 500 mkg per day i.v. bolus). All patients had naso-
gastro-cystic intubations postoperatively (7 days).
Results. The restoration of bowel peristalsis was registered on the fifth
postoperative day (clinically and US). The gastric volume (through naso-
cysto-gastric tube) was 500 ml per day. As a result, no postoperative
complications were noted. The absence of cystic cavity was confirmed by
the X-ray films. All patients were discharged on the seventh postoperative
day. The long term results (30 days and 45 days after surgery) demonstrated
the absence of pancreatic cysts, upper GI-motility disorders, and other upper
GI malfunctions.
Conclusions. These results show that the use of octreotide in postoperative
period could reduce the number of postoperative complications for the
patients with Jurasz operation and hospital stay. The reason of these good
results is the reduction of gastric motility and secretion.
Liver Posters
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HUMAN PROTEIN-C ADMINISTRATION REDUCES APOPTOSIS
VIA CYTOCHROME-C MITOCHONDRIAL PATHWAY IN LIVER
PARENCHYMA FROM SEPTIC RATS
Memos, Nikolaos1; Kataki, Agapi1; Messaris, Evangelos2; Chatzigianni,
Emmy2; Contis, John1; Boutsikou, Maria1; Paizis, Basilios3; Betrosian,
Alexander4; Konstadoulakis, Manoussos1
1University of Athens Medical School, Laboratory of Surgical Research, A?
Dept. of, Athens, Greece; 2KAT Hospital, Dept. of Pathology, Athens,
Greece; 3Hippocratio Hospital, Dept. of Surgery, Athens, Greece; 4Hippo-
cratio Hospital, ICU, Athens, Greece
Background. Sepsis induced deficiency of Protein-c, a circulating plasma
zymogen, that is converted to activate protein c (APC) in the presence of the
thrombin/thrombomodulin complex. In patients with severe sepsis treatment
with recombinant hAPC significantly reduces mortality. In vitro studies have
recently documented that APC besides the antithrombotic, pro-fibrinolytic
and anti-inflammatory properties acts as an anti-apoptotic factor.
Aim. The evaluation of the anti-apoptotic effect of protein c concentrate
(PC-con) administration in liver parenchyma from septic rats.
Materials and Methods. Using the cecal ligation and puncture (CLP)
model, sepsis was induced in 90 pathogen-free male Wistar rats, which were
randomly divided to receive intravenously 3 doses of 100IU/Kg human PC
concentrate (40 animals) or placebo (50 animals) 1, 7, 13 hours post CLP.
Animals were supervised for 120 hours. Immediately after each death, liver
tissue was post-fixed in paraffin sections for H&E, TUNEL bax, bcl-2, and
cytochrome-c staining.
Results. In septic rats PC-con treatment reduced inflammatory infiltration
(p/0.018), necrosis (p/0.009) and hemorrhagic infiltration (p/0.0001).
In addition cytochrome-c immunodetection was decreased in liver compared
to placebo. Furthermore, apoptotic cells were far less evident in the liver
parenchyma (p/0.027) of PC-con treated animals. Septic animals receiving
PC-con therapy had favorable prognosis compared to controls (Survival
rate:CLP 54% vs CLP-PC 75%). Both PC-con treatment and reduction of
apoptosis in liver were associated with favorable prognosis from sepsis (p/
0.03 and p/0.005 respectively).
Conclusion. Protein C concentrate administration offers a cytoprotective
effect in septic animals by reducing apoptosis via inhibition of a mitochon-
drial dependent pathway. As protein c gains antiapoptotic properties in
vivotogether with its anti-inflammatory and anticoagulant properties it can be
an attractive agent for the management of inflammatory disease.
P21.02
ACUTE ABDOMINAL MANIFESTATIONS OF HYDATID CYST
Frizis, Haim; Papadopoulos, Anastasios; Akritidis, Georgios; Frizis, Renee
Hanna; Hatzitheoharis, Georgios
Ippocration Hospital, 1st Surgical Dept., Thessaloniki, Greece
Background. Hydatid cyst is an unusual cause of acute abdomen and
seldom is included in the differential diagnosis when a patient with acute
abdominal manifestations is examined.
Aim. The purpose of this study is to review our cases of acute abdominal
manifestations of hydatid cyst and to investigate the existence of any element
that might increase the diagnostic accuracy of the practicing surgeon.
Methods. During a 30 year period (19762005) 13 patients (29 to 87 years
old- F/M/9/4), with no history of hydatid disease, were admitted urgently
because of acute abdominal complaints.
Results. The most common complaints were abdominal pain, sensation of
heaviness in the abdomen, fever (38398C), yellow colour of sclera and
urine. The clinical examination revealed sings of peritoneal irritation in 3,
sings of sepsis in 5, interstitial obstruction in 1 and obstructive jaundice in 4
patients. WBC ranged from 18000 to 22000/mm3 and bilirubin level from 5
to 8 mg% (predominantly of direct type). All patients were operated on in
less than 72 hours, 8 of whom in less than 48 hours. In 9 cases the cyst was in
the right lobe, in 3 in the left lobe and in 1 in the mesentery of the terminal
ileum. The final diagnosis was: liver abscess in 5 patients, rupture into
peritoneal cavity in 3, rupture into biliary tree in 5 and interstitial obstruction
in one. Mortality was nil. Postoperatively, 2 cases of wound suppuration, 3
cases of postoperative fever and 3 cases of biliary fistula, lasting 2 weeks, were
noted. The review of clinical presentation and of laboratory findings could
not lead to preoperative diagnosis of acute abdomen due to hydatid disease.
Conclusion. Acute abdomen caused by hydatid cyst although rare poses a
diagnostic challenge and demands an aggressive diagnostic approach and
operative management.
P21.03
COMPARISON OF DIFFERENT TREATMENT METHODS OF
LIVER HYDATID CYST
Frizis, Haim; Papadopoulos, Anastasios; Akritidis, Georgios; Frizis, Renee
Hanna; Hatzitheoharis, Georgios
Ippocration General Hospital, 1st Surgical Dept., Thessaloniki, Greece
Background. The questions if complete cystectomy is more effective than
partial for the treatment of liver hydatid cyst and which is the best method of
management of the residual cavity still remain.
Aim. The purpose of the study is to review our experience and to compare
the effectiveness and safety of different treatment methods applied to our
cases.
Methods. During a 30year period 76 patients (Male/Female/43/33) with
93 liver hydatid cysts were treated. 64 patients suffered from a solitary cyst
(51 in the right, 13 in the left lobe) and in 12 patients multiple cysts were
found (2 in the right, 2 in the left and 8 in both lobes).
Results. Total excision was applied to 21 cysts whereas in 72 cases partial
cystectomy was performed with management of the residual cavity as follows:
external drainage in 37 cysts, omentoplasty in 12, and filling the residual
cavity with N/S in 23. The hospitalization was 19.9/9.0, 19.3/9.8, 17.3/
4.2, 12.6/8.7 days respectively (pB/0.05). Mortality was nil. Postoperatively
we noted 24 complications in the resection group and 25, 3 and 15 in the rest
groups respectively (pB/0.10). No case of recurrence was noted in any of our
patients. The most serious complications occurred in the 1st and 2nd
methods of treatment. Drainage of bile was noted in 8 and 9 cases (38% and
24.3% respectively) and biliary fistula developed in 2 cases in each of these
groups (9.5% and 5.4% respectively).
Conclusion. 1) Resection is associated with a high complication rate and a
long hospitalization. 2) Partial cystectomy is as radical method as total
resection. 3) Omentoplasty or filling the residual cavity with N/S should be
preferred over external drainage.
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DIAGNOSIS AND MANAGEMENT OF HEPATIC ALVEOLAR
ECHINOCOCCOSIS
Artis, Tarik; Yilmaz, Zeki; Sozuer, Erdogan; Kucuk, Can; Ok, Engin;
Karahan, Ibrahim; Akcan, Alper; Yilmaz, Ergin
Erciyes University Medical School, General Surgery, Kayseri, Turkey
Background and aim. Alveolar echinococosis (AE) is a serious disease
primarily effects liver in humans. It has the characteristics of a malignant
disease which invade adjacent organs and metastasize to distant organs. In
Turkey eastern part of the country is endemic for AE. Radical resection is
effective for resectable disease. with chemotheraphy and benzimidazole
derivates. In this study we aimed to present our experience with AE.
Material and methods. We performed a retrospective study on our patients
with the diagnosis AE between January 2000 and February 2006 at our
department of surgery. Patient demograhics, characteristisc of the lesions,
operative data and postoperative course were analyzed.
Results. Total of 9 patients underwent surgery for AE. Of those, 8 were
female and 1 male with the mean age 50.59/9.5. Liver function tests were
within the normal limits. Abdominal discomfort and hepatomegaly were also
positive in all cases. Lesions were located in right lobe in 5 patients, 3 in right
and left lobes and 1 in left lobe only. Mean diameter of the lesion was 11.29/4
cm. Color Doppler US, CT and MRI were used for the diagnosis in all
patients. Right hepatectomy was performed on 1 patient, nonanatomic liver
resection in 7 patients and left lateral segmentectomy in 1 patient. One
patient had bilioma postoperatively. One patient had recurrent disease which
had second laparotomy and it was nonresectable. Postoperatively no patient
received chemotheraphy but albendazole was started for all of them. No
recurrence detected in the mean follow up of 2 years.
Conclusion. Early detection is essential for curative disease. Color doppler
US, CT and MRI are complimentary in the diagnosis. Resection seems
effective in the treatment for the resectable disease.
P21.05
LAPAROSCOPIC DRAINAGE OF RUPUTRED LIVER ABSCESS
Rajasekar, Arthanari
Sri Gokulam Hospital, Surgical Gastroenterology, Salem, India
Introduction. The mainstay of the management of liver abscesses has been
an intravenous antibiotic and ultrasongrapphy guided percutaneous aspira-
tion or drainage. However some require surgical intervention, particularly
ruptured liver abscess with generalized peritonitis.
Aim. To report our experience of performing laparoscopic drainage of
ruptured liver abscess.
Methods. Between April 2001 to March 2005 10 patients with ruptured liver
abscesses were managed laparoscopically. The results and complications of
these patients are presented.
Results. The Mean age was 36 years. Male:Female ratio was 9:1.
Six patients presented with one or more organ failure -3 patients
Acute Renal Fauilure (ARF), 2 patients ARF & Adult Respiratory
Distress Syndrome (ARDS), and 1 patient ARDS. Mean delay in presenta-
tion or referral was 4 days. Only one patient had associated loose stools. The
size of abscess measured by ultrasongraphy was between 8 cm to 19 cm.
Six patients had single right lobe abscess, 2 patients multiple right lobe and
1 patient both right and left lobe abscesses. Laparoscopic drainage
was successful in 9 patients, in 1 patient conversion was required, as the
previous aspiration had resulted in significant haemoperitoneum. The
Culture and sensitity of the pus showed in 2 patients Klebsiella, 1 patient
pseudomonas and in 7 patients no growth. Four patients required Ventilatory
support, 1 patient required renal dialysis and 7 patients required ionotrophic
support. There was no mortality. One patient required USG guided
aspiration of residual collection, as postoperative pyrexia did not settle.
Two patients developed minor wound infection. Mean hospital stay was 4
days (39).
Conclusion. Laparoscopic drainage of the ruptured liver abscess is feasible
and can be performed with less morbidity and mortality.
P21.06
PERCUTANEOUS CATHETER DRAINAGE OF LIVER ABSCESS
USING SELF OPERATED ULTRASOUND GUIDANCE: RESULTS
OF A LONG TERM STUDY FROM A UNIVERSITY HOSPITAL
Kapadia, Sumit; Yeluri, Sashidhar; Madhok, Brijesh; Dadayal, Guneesh;
Duttaroy, Dipesh
Sir Sayajirao Gaekwad University Hospital, Unit C, Dept. of Surgery,
Baroda, India
Background. Hepatic abscess, particularly amoebic, continues to be a
major public health problem in the developing countries. Though ultra-
sound (USS) percutaneous catheter drainage is now a well established
technique, availability of a radiologist in developing countries is a major
limiting factor.
Aim. To evaluate results of percutaneous catheter drainage of liver abscess in
a developing country university hospital under self operated USS guidance.
Patients and methods. Between June 1999 and June 2005, a total of 66
patients with liver abscess underwent percutaneous drainage with pig tail or
malecot catheter using the Seldinger’s technique and were included in the
study. Diagnosis of liver abscess was made on the basis of clinical history and
examination followed by USS. Chest X-ray, haemogram and clotting profile
were assessed in all patients. CT scan and serological tests were not routinely
performed in our study. Indications for catheter removal included an
asymptomatic patient; no drainage and follow-up ultrasound showing a
cavity size less than 3 cm.
Results. Most patients presented with non-specific clinical and biochemical
features. Raised alkaline phosphatase was the most common biochemical
abnormality in 45 patients (68%). The volume of pus drained ranged from 85
ml to 3300 ml. Average period of catheter drainage was 17.5 days with a
range of 641 days. Though about 30% of our patients had minor
complications, there was no major morbidity or mortality encountered in
the procedure. The study shows a success rate of 84%.
Conclusion. The study confirms that percutaneous catheter drainage of liver
abscess is successful with a low morbidity. It is recommended as the first line
of management in liquefied moderate to large sized abscesses. General
surgeons in developing countries, who are likely to see a large number of such
cases, should develop a working knowledge of USS to be able to perform this
procedure independently, without the help of a sonologist.
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PREVALENCE OF ANTIBODY TO HELICOBACTER HEPATICUS
INFECTION AND ITS INFLUENCE ON HEPATITIS IN PATIENTS
WITH CHRONIC HEPATITIS C
Shimoyama, Tadashi1; Yoshimura, Tetsuro1; Danjo, Kazuma1; Takahashi,
Ryoki2; Ohmura, Takeo2; Sakamoto, Juichi1; Munakata, Akihiro1
1Hirosaki University, Hirosaki, Japan; 2Wakamoto Pharmaceutical Co. Ltd,
Kanagawa, Japan
Background. Infection of Helicobacter hepaticus has been associated with
the development of hepatocellular carcinoma in mice. Incidence of hepato-
cellular carcinoma in patients with chronic hepatitis C is high in Japan.
However, prevalence of H. hepaticus infection has not been understood in
patients with chronic hepatitis C.
Aims. We examined the prevalence of antibody to H. hepaticus in order to
study the significance of H. hepaticus infection in chronic hepatitis C.
Methods. Serum samples were obtained from 151 patients who were
diagnosed as chronic hepatitis histologically and detected HCV-RNA. There
were (86 males and 65 females, mean age 47.4). Serum samples obtained
from 142 subjects not infected with hepatitis virus (69 males and 73 females)
were also studied. Seropositivity of H. hepaticus was tested by antigen-
capture ELISA using monoclonal antibody to H. hepaticus antigen. The
levels of ALT, AST, GTP, ALP, and ZTT were measured. Hemoglobin and
platelet count were also examined.
Results. H. hepaticus seropositivity was significantly higher in patients
with chronic hepatitis C (33.1%) comparing control subjects (13.7%,
pB/0.05). Mean (9/SEM) ALT, AST, GTP, ALP, ZTT in 51 H. hepati-
cus-positive patients and 100 negative patients were 62.8(9/5.9 and 65.1(9/
4.8, 83.5(9/9.7 and 89.9(9/6.8, 69.4(9/11.9 and 77.9(9/8.5, 86.9(9/10.3
and 103.5(9/8.9, 15.1(9/0.7 and 14.3(9/0.5, respectively (NS). Mean
hemoglobin and platelet count were 13.1 g/dl and 18.0/104 in H.
hepaticus-positive and 14.1 g/dl and 18.7/104 in H. hepaticus-negative
patients (NS).
Conclusions. Prevalence of H. hepaticus infection is high in patients
infected with hepatitis C virus. However, infection of H. hepaticus might
not seem to have significant influences on severity of hepatitis.
P21.08
LIVER MORPHOLOGY AND APOPTOSIS IN ICU PATIENTS
DYING FROM SEPSIS: A CLINICO-PATHOLOGICAL STUDY
Memos, Nikolaos1; Gomatos, Ilias1; Koskinas, John2; Tiniakos, Konstan-
tina2; Boutsikou, Maria1; Garatzioti, Aspasia2; Paizis, Basilios3; Archiman-
dritis, Athanasios2; Betrosian, Alexander4
1University of Athens, Medical School, Lab of Surgical Research, A’ Dept. of
Prop. Surgery, Athens, Greece; 2University of Athens, Medical School, 2nd
Dept. of Internal Medicine, Athens, Greece; 3Hippocrateio Hospital, Dept.
of Surgery, Athens, Greece; 4Hippocratio Hospital, Intensive Care Unit,
Athens, Greece
Background. Sepsis induced liver dysfunction is a common event in ICUs
with unclear and multifactorial pathophysiology.
Aim. To determine end-stage pathologic changes in the liver of septic
patients dying in the intensive care unit and correlate these findings with
laboratory values and clinical characteristics.
Patients and methods. Needle liver biopsies were obtained immediately
after death from 15 consecutive patients with sepsis and no underlying liver
disease, that were hospitalized in ICU. Bioptic material was subjected to
routine histological examination and immunohistochemistry for bax and bcl-
2 apoptosis-related proteins. Liver function tests and clinical monitoring
measurements were also recorded.
Results. Liver biochemistries were increased in the majority of patients
before death. Histology of liver biopsy specimens showed portal inflamma-
tion in 73.3%, centrilobular necrosis in 80%, lobular inflammation in 66.7%,
hepatocellular apoptosis in 66.6% and cholangitis/cholangiolitis in 20%
patients. Mixed hepatitic/cholestatic type of liver injury was observed in
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6/15(40%) patients and hepatitic in 9/15 (60%). Steatosis was observed in
11/15 (73.3%) patients with a severity ranging from 580%. Bax but not Bcl-
2 immunopositivity was observed in 4/10 (40%) patients who had morpho-
logical evidence of apoptosis in their liver tissue.
Conclusions. Hepatitic like injury and steatosis in the liver are observed in
the majority of patients dying from sepsis. Apoptosis, through the bax
pathway, appears to be a significant mechanism contributing to sepsis-related
liver damage.
P22.01
3-DIMENSIONAL LIVER RECONSTRUCTION BASED ON CT
AND MRI DATA SETS: A METHOD FOR PREOPERATIVE RISK
ANALYSIS IN PATIENTS WITH LIVER TUMOURS
Kleemann, Markus1; Brehm, Steffen1; Hildebrand, Philipp1; Mirow, Lutz1;
Roblick, Uwe1; Bourquain, Holger2; Prause, Guido2; Peitgen, Heinz-Otto2
1University Hospital Schleswig-Holstein-Campus Luebeck, Dept. of Surgery,
Luebeck, Germany; 2MeVis-Center for Medical Diagnostic Systems and
Visualization GmbH, Bremen, Germany
Background. An exact 3-dimensional reconstruction, based on digital CT
and MRI data, of the territorial vascular supply of the liver in relation to
tumour’s size and position could be a new base for preoperative risk analysis.
Aims/Objectives. In this study we evaluated possibilities and precision of
this method by comparison between the reconstructed data and the operative
findings.
Methods. From June to December 2005 we studied 33 patients (13 female,
20 male) with primary and secondary liver tumours (24 metastasis,5 hepato-
cellular carcinoma, 2 haemangiomas, 1 cholangiocellular carcinoma, 1
adenoma). Data of CT and MRI scans were analyzed and reconstructed
into an individual 3-D model to use them as a base for operation planning.
We evaluated the correlation between preoperative imaging, the preoperative
reconstructions, and the intraoperatively identified tumour spread.
Results. 18 patients were treated by resection alone, in combination with
radiofrequency ablation in one patient, and 3 by radiofrequency ablation
alone. 11 patients were primarily excluded from surgery (4 chemoembolisa-
tion, 7 radio and/or chemotherapy). Results obtained form MRI data
showed major vessels and tumours only due to the lower resolution
compared to CT data. In 16 cases (72.7%) we found an exact match of
pre- and intraoperative results, 2 cases (9.1%) showed more and in 2 cases
(9.1%) there were fewer lesions within the operation than expected by
digital scans before. 2 further patients (9.1%) had had pre- and intraopera-
tive more than 10 metastases.
Conclusion. This procedure allows a high detailed preoperative description
of the relation between tumours and their supplying and draining vessels and
presents a virtual view of anatomic findings within the operation. Moreover,
the calculation of functional volume of the liver remnant will helps in
identifying the patient individual surgical strategy.
P22.02
5 YEAR SURVIVAL AFTER LIVER RESECTION FOR COLOR-
ECTAL METASTASES
Langer, Daniel; Ryska, Miroslav; Bı`lina, Frantisˇek; Strnad, Robin; Panto-
flı´e`ek, Jaroslav; Dolezˇel, Radek
Central Military Hospital, Surgery Dept., Prague, Czech Republic
Background. Almost 85% of all liver tumours are metastatic and mostly
primary colorectal in origin. Czech Republic is leading world colorectal
cancer statistics with incidence 80/100 000. Liver resection for hepatic
metastatic colorectal cancer is nowadays only potentially curabile treatment
modality for patients with this diagnosis. All of 25% of colorectal hepatic
metastases are suitable for liver resection.
Methods. This is a retrospective study examining our group of patients who
underwent liver resections for LMCC. The records of 182 patients, who
underwent this kind of treatment for metastatic colorectal cancer in our
department from IV/98 to XII/05, were reviewed.
Patients. During this period we performed 88 hepatic resections in 84
(46%) patients (37 women, 47 men, mean age 59 years, range: 2679 years).
In our group of patients we maked 51% anatomical resections (27 right or left
lobectomies, 18 bi and segmentectomies), rest of the group was treated by
nonanatomical resetion (43 cases). Combination of the resection and
ablation methods we used in 41 cases (HAIC 36x, RFA 17x, cryosurgery
2x, ethanolisation 2x). We realized 63 palliative procedures in 51 (28%)
patiens.
Results. Early mortality in our group of resected patients was 1.15%,
postoperative complications were seen in 18% of patients. Survival of
R0 resected patiens was computed by survival analysis by Kaplan-
Meier method: 1 year 85%, 2 years 65%, 3 years 47%, 4 years 39%, 5 years
30%.
Conclusion. When metastatic colorectal cancer is only in liver located,
curabile hepatic resection seems to be the best benefit for these patients.
Radical resection procedures offer the statistically significant survival
prolongation, low early mortality is necessary. Survival, early mortality and
morbidity of these theatment modalities are in our group acceptable and
similar to the other centres.
P22.03
POSTOPERATIVE AND DELTA MELD SCORE FOLLOWING
HEPATIC RESECTION FOR HEPATOCELLULAR CARCINOMA
PREDICTS PATIENT OUTCOMES
Teh, Swee1; Sheppard, Brett1; Billingsley, Kevin1; Diggs, Brian1; Orloff,
Susan2
1Oregon Health & Science University, Dept. of Surgery, Portland, USA;
2Oregon Health & Science University, Portland Veterans Administration
Medical Center, Dept. of Surgery, Portland, USA
Background. The Model for End-Stage Liver Disease (MELD) has been
shown to predict survival in patients with cirrhosis undergoing hepatic
resection (HR). The role of postoperative MELD score and delta (D) MELD
postop, in patients with and without cirrhosis undergoing HR for hepatocel-
lular carcinoma (HCC) is unknown.
Aims. To determine the value of the postoperative MELD score and the D
MELD postoperatively in predicting length of hospital stay, perioperative
morbidity and mortality following HR for HCC.
Methods. Consecutive patients from 1995 through 2005 undergoing HR for
HCC were retrospectively studied.
Results. 95 patients underwent HR for HCC; 59 patients were excluded
(data still in collection), and 36 (26 M, 10 F) with a mean age of 59 years,
were included. The mean tumor size was 7.8 cm. T-stage were 1 in 6, 2 in 7, 3
in 22 and 4 in 1 patients and vascular invasion was present in 17 patients.
Sixteen patients had cirrhosis; 23 patients had major, and 13 had minor HR.
The mean preop, postop and D MELD score was 8.2, 15.4 and 7.2,
respectively. The mean hospital stays was 10 days; 18 patients (50%) had
periop morbidity, and 4 patients (11%) had periop mortality. Postop MELD
scores were elevated in 18 (90%) of patients without, and in 15 (94%) with
cirrhosis. Regression model analysis showed that both postop and D MELD
significantly correlated with increased length of hospital stay (p/0.017),
higher periop morbidity (p/0.033), and periop mortality (p/0.024). The 4
periop mortality patients had a preop MELD score of 6, 9 (in non cirrhosis)
and 9, 11 (in cirrhosis), respectively. The postop MELD scores were 22, 31
and 18 and 40, respectively.
Conclusions. Postoperative and delta MELD score were strong predictors of
perioperative morbidity and mortality in patients with HCC, with and
without cirrhosis, undergoing HR. Postoperative and delta MELD score may
provide a powerful tool to predict outcomes and guide patient selection for
hepatic resection for HCC.
P22.04
SURGICAL RESECTION OF LIVER METASTASIS FROM ADE-
NOCARCINOMA OF THE APPENDIX
Hyung-Chul, Hwang; Son, Gi-Tak; Dong-Shik, Lee; Sung-Su, Yun; Hong-
Jin, Kim
Yeungnam University Hospital, Surgery, Daegu, Korea
Primary appendiceal adenocarcinoma is a rare neoplasm that constitutes less
than 0.5% of all gastrointestinal neoplasm. Very few cases of primary tumor
of appendix have been reported in the literature, and there was no case report
of surgical resection of appendiceal adenocarcinoma with liver metastasis. So
we report first case of surgical resection of liver metastasis from adenocarci-
noma of appendix. (Case) A 53-year-old man was admitted with intermittent
abdominal pain. The level of CEA was a mild elevation with 30.8 ng/mL,
AFP was 1.93 ng/mL and other blood tests were normal. The abdominal CT
revealed 9 cm sized malignant appearing peripheral enhancing mass in right
liver. To rule out metastatic cancer from GI origin, we performed gastro-
endoscopy and colonoscopy. But we can’t find malignant lesions. So, we
performed whole body fusion PET scan that revealed hot uptake of FDG at
right liver and terminal ileum lesion. We concluded that diagnosis was
metastatic liver cancer form small bowel malignancy and performed opera-
tion. In operative finding, we can see huge malignant tumor in right liver and
malignant suspicious appendix measuring 8.0 cm in length and 1.5 cm in
diameter. The frozen biopsy of appendix at operative room confirmed
malignant adenocarcinoma of appendix with vascular invasion. So, we
performed right hemihepatectomy and right hemicolectomy. Post operative
course was uneventful, and patient was discharged POD #21 after systemic
chemotherapy. There was no evidence of recurrence 5 months after
operation.
P22.05
A PILOT STUDY OF ORAL SILIBININ, A PUTATIVE CANCER
PREVENTIVE AGENT, IN PATIENTS WITH PRIMARY COLOR-
ECTAL CANCER AND COLORECTAL LIVER METASTASES
Hoh, Carmen1; Gescher, Andreas2; Garcea, Giuseppe1; Steward, William2;
Dennison, Ashley1; Berry, David1
1Leicester General Hospital, Dept. of Hepatobiliary and Pancreatic Surgery,
Leicester, UK; 2University of Leicester, Dept. of Oncology, Leicester, UK
Background. Silibinin, possesses cancer chemopreventive efficacy in
rodent models of colorectal carcinogenesis. Silibinin preparations are used
clinically as hepato-protectants against alcohol- and drug-related damage.
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Silibinin is a strong antioxidant and modulates the insulin-like growth factor
(IGF) system by increasing circulating levels of IGF binding protein 3
(IGFBP-3). AIM(s): We wish to test the hypothesis that consumption of
silibinin furnishes pharmacologically active levels of agent in blood, liver and
colorectum.
Methods. 12 patients with resectable colorectal carcinoma and 12 with
colorectal liver metastases received silibinin at total daily doses of 360, 720,
or 1440 mg silibinin for seven days. Blood, normal and malignant colorectal
or liver tissue were obtained before and after silibinin intervention. Levels of
silibinin were quantified using HPLC-UV. Plasma metabolites were identified
by mass spectrometry. Levels of IGFBP-3 and IGF-1 in serum and of the
oxidative DNA damage pyrimidopurinone adduct of deoxyguanosine
(M1dG) in leukocytes were determined as potential pharmacodynamic
markers of silibinin efficacy.
Results. Dietary silipide was well tolerated. Silibinin recovered from plasma
between 14 h post final silipide dose were 0.34.0 mM. Silibinin
monoglucuronide (m/z 657), silibinin di-glucuronide (m/z 833), silibinin
mono-sulphate (m/z 561) and silibinin glucuronide sulphate (m/z 737) were
identified as silibinin metabolites in the plasma. Silibinin concentrations in
liver and colorectal tissues obtained by resection 36 h post last silipide dose
were 0.32.5 and 20141 nmolesg-1, respectively. Intervention with silipide
did not affect blood levels of IGF-1, IGFBP-3 or M1dG.
Discussion/Conclusion. The results suggest that ingestion of silibinin at
safe doses can achieve detectable levels of agent in plasma and liver, and that
silibinin concentrations reached in the GI tract are of an order of magnitude
which has been shown to elicit pharmacological effects in cells in vitro.
P22.06
A SINGLE INSTITUTIONAL EXPERIENCE IN THE MANAGE-
MENT OF HEPATIC METASTASES FROM GASTROINTESTINAL
STROMAL TUMOURS
Gomez, D; Al-Mukthar, A; Toogood, GJ; Lodge, JPA; Prasad, KR
Leeds Teaching Hospitals NHS Trust, Hepatopancreatobiliary Unit, Leeds,
UK
Background. We report a series of patients with hepatic metastases from
gastrointestinal stromal tumours (GIST) managed at our institution.
Methods. Retrospective clinicopathological analysis of 11 patients that were
managed for hepatic metastases from GIST over a five-year (19982003)
period.
Results. The median age at diagnosis was 55 (3278) years. The primary
site of GIST were stomach (n/4), small bowel (n/4), sigmoid (n/1),
peritoneum (n/1) and pancreas (n/1). 1 patient presented with synchro-
nous primary GIST with hepatic lesions and 10 patients had metachronous
hepatic metastasis with a median time interval of metastasis following
primary resection of 12 (5168) months. Patients were managed with
hepatic resection; right hepatic trisectionectomy (n/5), right hepatectomy
(n/1), right hemi-hepatectomy with left metastectomies (n/1), left
hepatectomy with right metastectomy (n/1) and multiple metastectomies
(n/3). The median period of recurrence following initial resection was 16
(327) months in 8 patients and 2 patients are currently disease free for 44
and 72 months. The disease free rate following hepatic resection at 2-years
was 30%. There was no statistically significant association between age at
diagnosis, time interval of hepatic metastasis following primary resection,
tumour size, number of hepatic metastases and resection margin with disease
free rate of less or more than 2-years. Recurrent disease was managed with a
combination of further surgery (n/3), open radio-frequency ablation (n/2)
and Imatinib (n/8). 2 patients with recurrent disease are currently disease
free; 8 and 13 months respectively. Overall morbidity was 64% (n/7) with
one post-operative death. 10 patients are currently under follow-up with a
median period of 44 (2972) months.
Conclusion. Hepatic resection in hepatic metastases from GIST may
improve survival in selected patients. Recurrent disease can be managed
with a combination of further surgery, radio-frequency ablation and Imatinib.
P22.07
A STUDY OF THE CANCER CHEMOPREVENTIVE AGENT SILI-
BININ IN PATIENTS WITH RESECTABLE COLORECTAL LIVER
METASTASES
Hoh, Carmen1; Gescher, Andreas2; Garcea, Giuseppe1; Steward, William3;
Dennison, Ashley1; Berry, David1
1Leicester General Hospital, Dept. of Hepatobiliary and Pancreatic Surgery,
Leicester, UK; 2University of Leicester, Dept. of Cancer Studies, Leicester,
UK; 3University of Leicester, Dept. of Oncology, Leicester, UK
Background. Silibinin, a constituent of milk thistle, has long been used as a
hepatoprotectant in the treatment of liver disease. More recently, in vitro
studies suggest silibinin at mM concentrations has pharmacological effects.
Dietary silibinin reduced adenoma numbers in the ApcMin mouse model of
intestinal carcinogenesis. These findings intimate the possibility of using oral
silibinin to reduce the risk of hepatic metastasis following colorectal cancer
resection.
Aim(s)/Objective(s). We tested the hypothesis that pharmacologically
active levels of silibinin can be achieved in humans after oral dosing.
Methods. Twelve patients with resectable colorectal liver metastases received
silibinin formulated with phosphatidylcholine (SilipideTM, Indena, Milan) at
total daily doses of 360, 720, or 1440 mg silibinin for 7 days. Samples of
peripheral, portal blood and hepatic tissue were obtained at surgery, between
15 hours following last ingestion. Silibinin and its metabolites were detected
and quantified by reverse phase HPLC.
Results. Systemic levels of silibinin after doses of 0.36, 0.72 or 1.44 g silipide
daily, respectively, were 0.269/0.07, 1.379/0.95 and 4.049/5.34 mM (mean9/
SD, n/4). Levels in portal plasma were 0.669/0.12, 0.459/0.43 and 1.609/
0.34 mM. Tissue levels were 0.979/0.86, 1.219/1.11 and 2.499/2.42 nmoles/
g in normal liver and 0.579/0.54, 0.279/0.12 and 0.589/0.69 nmoles/g in
malignant hepatic tissue.
Discussion/Conclusion. These tissue levels of silibinin are consistent with
concentrations found to exert biochemical changes associated with cancer
chemopreventive activity. The results suggest that the exploration of oral
silibinin to prevent colorectal hepatic metastases prevention may be feasible.
P22.08
SURGICAL TREATMENT FOR PULMONARY METASTASIS
FROM HEPATOCELLULARCARCINOMA
Hashizume, Junji; Itamoto, Toshiyuki; Ushitora, Yuichirou; Matsumoto,
Tomio; Momisako, Hiroyuki; Amano, Hironobu; Miyata, Yoshihiro; Asa-
hara, Toshimasa
1Divison of Frontier Medical Science, Hiroshima University Hospital, Dept.
of Surgery, Hiroshima, Japan
Background. According to a nationwide survey of liver cancer study group
of Japan, extrahepatic metastases of hepatocellular carcinoma (HCC)
occurred in about 7% of patients who underwent curative hepatectomy.
Most of patients with pulmonary metastasis had no indication of pulmonary
resection, because of concomitant intrahepatic recurrences and/or impaired
liver function. However, some patients might have the benefits of surgical
treatment for pulmonary metastasis. We report here our experiences and
results of resection for pulmonary metastasis from HCC.
Methods. Ten patients with pulmonary metastasis from HCC under-
going pulmonary resection between 1995 and 2005 were enrolled in this
study. Indication of pulmonary resection was decided according to
Thomford’s criteria. Mean number of resected tumor was 3.5, ranging
from 1 to 8.
Results. Eight patients had undergone curative treatment for the primary
lesion and were candidates for a pulmonary metastasectomy for complete
resection. Among the 10 patients, 5 died: 4 from hepatic failure, and 1 from
brain metastasis due to recurrence of the HCC. At the latest observation, four
of the 5 survivors were doing well without HCC recurrence, and one survived
with recurrence. The overall survival rates after the initial pulmonary
resection were 71% at 3 years and 53% at 5 years.
Conclusion. The selected patients with pulmonary metastasis from HCC
were candidates for pulmonary metastasectomy and could benefit from the
complete resection.
P22.09
ANALYSIS OF PRIMARY LIVER TUMORS IN NON-CIRRHOTIC
LIVERS
Alfredo, Escartin; Grau, Silvia; Villalonga, Ramo´n; Castro, Ernesto; Dopazo,
Cristina; Lo´pez, In˜igo; Bergamini, Silvina; Bilbao, Itxarone; Balsells, Joaquin
Hospital Vall d’hebron, Liver Transplantation Unit, Barcelona, Spain
Primary liver tumors in non-cirrhotic livers (PTNL) are unfrequent. Mostly
are hepatocellular carcinoma (HC) and cholangiocarcinoma (CC). PTNL
have usually a non symptomatic behaviour until advanced stages, with a big
size at the moment of diagnosis.
Aim. To describe a single institution experience of PTNL.
Patients & Methods. From 1988 to 2004, 567 liver resections were
performed. Of those,32 patients underwent major hepatectomies for
PTNL. No patients had history of viral hepatitis or liver disease. The
diagnosis was as follow: HC (n/12), CC (n/15), and on case of squamous
carcinoma, neuroendocrine, cholangiohepatocarcinoma, hepatoblastoma and
sarcoma. CC was more frequent in women (67%) and HCC in men (58%).
Mean age was similar in both (609/11 years). CA19.9 was increased in 70%
CC and alfa-fetoprotein was increased in 78% HC. Follow-up was at least
two years.
Results. Significant differences were found in pathological tumor character-
istics: necrosis (CC 13%, HC 50%), capsulation (CC 7%, HC 50%),
vascular invasion (CC 33%, HC 0%). Free margins /1 cm were reached in
60% CC and in 82% HC (pB/0,05). Abdominal extrahepatic disease during
the surgical procedure was present in 53% of CC and 17% of HC (pB/0.05).
Size was 7.6 cm for CC and 11.8 for HC. There was 1 (3,7%) postoperative
death. Actuarial patient survival at 1, 3 and 5 years was 57%, 49% and 49%
for CC and 92% 82% and 44% for HC (Log Rank/0,4). Sixteen patients
(59,3%) had tumor recurrence, being most frequent in liver (CC 40%, HC
50%) rather than systemics (CC 20%, HC 33%). Disease free survival at 12
years was 42%29% for CC and 80%30% for HC. If the analysis is
performed excluding patients with extra hepatic invasion at surgery, patient
survival at 2 years is 80% in CC and 87% in HC.
Conclusion. In PTNL the frequency of HC and CC is similar. Complete
resections are possible in most of cases, despite a high recurrence rate (during
first year for CC, second year for HC). Extrahepatic invasion at surgery
determinates results of CC.
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ARE THE SURGICAL RESULTS OF HEPATIC TUMORS WITH
BILE-DUCT TUMOR THROMBUS IMPROVED BY POST-OP-
ERATIVE MULTI-DISCIPLINARY TREATMENT?
Kubota, Keiichi; Kita, Junji; Shimoda, Mitsugi; Rokkaku, Kyu; Kato,
Masato; Sawada, Tokihiko
Dokkyo University School of Medicine, Dept. of Gastroenterological
Surgery, Tochigi, Japan
Background. Hepatic tumors (HT) with bile-duct tumor thrombus
(BDTT) develop early recurrence after surgery with poor survival periods.
Aim. The aim of this study is to evaluate the role of multi-disciplinary
treatment after resection of HT with BDTT.
Methods. During the last 5 years, 12 patients with BTT underwent
hepatectomy at our department (Median age: 66, Male/Female: 10/2,
hepatocellular carcinoma (HCC)/cholangiocellular carcinoma (CCC)/meta-
static tumor (Meta): 6/3/3). Their clinical courses and post-operative multi-
disciplinary treatments were discussed.
Results. 5 patients (HCC/Meta/CCC: 2/1/2) required extended right
lobectomy with (n/4) or without (n/1) bile duct resection. Central
bisegmentectomy and anterior segmentectomy with bile duct resection
were performed in one HCC patient each. The remaining 5 patients
underwent left lobectomy (3), resection of S4 and partial resection. There
was no postoperative mortality. 3 patients (HCC/Meta: 2/1) are alive without
recurrence (2141438 days), while 9 developed recurrence (liver/lung: 6/3).
3 of the 4 HCC patients with recurrence in the liver received repeated
transcatheter arterial embolizations (TAE) and the remaining one with lung
metastasis received adjuvant chemotherapy (5-Fu/leucovolin). All 3 CCC
patients with recurrence received weekly gemcitabine (1000 mg/m2). One
Meta patient underwent resection of lung metastasis on POD 308, resulting
in 1302 disease-free days. 3 patients died of cancer. The median disease-free
survival period, survival period and survival period after recurrence were 191,
512 and 455 days, respectively.
Discussion. Although the patients with HT with BDTT developed early
recurrence, they could survive by TAE, chemotherapy or resection. 455 days
or their survival period after recurrence is considered to justify the multi-
disciplinary treatment.
Conclusion. Hepatic resection combined with multi-disciplinary treatment
can prolong the survival periods of patients with HT with BDTT.
P22.11
ARTERIAL CHEMOEMBOLIZATION (CE) FOR THE TREAT-
MENT OF CARCINOID LIVER METASTASES (CLM)
Tarazov, Pavel; Polikarpov, Alexey
St.Petersburg Research Institute of Roentgenology, Intervention Radiology,
St.Petersburg, Russia
Purpose. To study the long-term results of oily chemoembolization for
unresectable carcinoid liver metastases.
Material & methods. Between 1995 and 2005, we treated 20 pts with CLM
by arterial oily CE using mixture of 4060 mg doxorubicin-in-iodized oil and
gelfoam.
Results. Totally, 18 pts received 60 courses of CE, 2 to 8 per patient. There
were no serious treatment-related complications. At present, 12 of 14 pts
with CLM from unknown primary tumor localization died (mean and
median survival 30.2/5.3 and 25 mo) and two are alive for 8 and 10 mo with
tumor progression; the 1-2-3-yr survival is 90-50-30%. All 6 pts with
successfully resected primary carcinoid tumor are alive for 2 to 9 years
(mean 54.5/7.2 mo). The 1-2-3-5-yr survival of all 18 pts is 80-60-49-46%.
Conclusion. Arterial CE is safe, effective, and potentially curative treatment
of unresectable CLM.
P22.12
CLINICAL ANALYSIS OF HEPATOCELLULAR CARCINOMA
WITH OTHER SYNCHRONOUS PRIMARIES
Ikumoto, Taro; Konishi, Masaru; Kinoshita, Taira; Nakagori, Toshio;
Takahashi, Shinichiro; Gotoda, Naoto
National Cancer Center Hospital East, Kashiwa, Japan
Background. The factor which influenced the treatment of hepatocellular
carcinoma (HCC) with synchronous other primaries is not clear.
Objective. We investigated the treatment of HCC with synchronous other
primaries, and revealed the factor which influenced decision of the treatment
policy.
Methods. We analyzed 1,454 cases that had a checkup in HCC at our
hospital from July 1992 to December 2005.
Results. The incidence of HCC with other primaries was 10.8% (157 cases).
The site of other primaries was stomach in 4.1%, head and neck in 1.6%,
esophagus in 1.2%, colon in 1.1% and lung in 1.0%. In 39 of 157 cases, other
primaries were synchronous; esophagus in 7 cases, stomach in 22 cases, colon
in 3 cases, pancreas in 2 cases, lung in 2 cases and other organs in 6 cases. We
divided the treatments for patients with synchronous other primaries into 5
patterns. (1) For abdominal primaries, simultaneous resection was selected.
In 14 cases the resection was done. Death related to HCC was 6 cases and
related to other primaries was 1 case. Median survival time (MST) was 25.5
months. (2) For primaries except abdomen, sequential treatment was
selected. In 7 cases, the treatment for other primaries (operation/radiation)
was performed at first, then treatment for HCC. In those cases, non-surgical
treatment such as TACE, PEI and MCT was selected for HCC. MST was
14.4 months. (3) For intramucosal carcinoma of digestive tract, endoscopic
mucosal resection and endoscopic polypectomy were performed in parallel
with treatment of HCC in 5 cases. (4) With judgement not to influence
prognosis because other primary (stomach cancer) was early cancer, only the
treatment for HCC was performed in 3 cases. In all cases, patients died for
progression of HCC before stomach cancer went worse. (5) No treatment
was available due to severe liver cirrhosis in 5 cases.
Conclusion. The location of other primaries greatly influenced a treatment
policy of HCC with synchronous other primaries.
P22.13
CLINICAL RISK SCORE: AN IMPROVED PROGNOSTIC STA-
GING SYSTEM FOR LIVER METASTASIS FROM COLORECTAL
CANCER?
Pulitano`, Carlo1; Arru, Marcella2; Aldrighetti, Luca2; Castoldi, Renato2;
Stella, Marco2; Orsenigo, Elena2; Gavazzi, Francesca2; Di Carlo, Valerio2;
Staudacher, Carlo2; Ferla, Gianfranco2
1San Raffaele Scientific Institute, Vita-Salute San Raffaele University, Dept.
of Surgery, Milan, Italy; 2San Raffaele Scientific Institute, Vita-Salute San
Raffaele University, Dept. of Surgery Liver Unit, Milan, Italy
Background. Several prognostic score have been proposed to improve
patient selection for liver resection for metastatic colorectal cancer. Previous
reports have found the clinical risk score (CRS) a prognostic tool developed by
Fong et al, to correlate with outcome and resectability. The CRS takes into
account five variables that can be evaluated preoperatively: disease-free
interval less than 12 months, size greater than 5 cm, more than one metastasis,
node-positive primary cancer, and preoperative CEA level greater than 200
ng/mL. A possible limitation of CRS is that only preoperative variables are
included, and major surgical findings known to influence survival including
surgical margin status and extrahepatic disease are not evaluated.
Aims. We hypothesized that for identifying patients at high risk for
recurrence after liver resection, the CRS may be improved by adding two
major pathological findings.
Methods. The CRS was calculated in 160 patients who underwent
liver resection for colorectal metastases. Each variable is assigned one point
and the sum represents the CRS, creating a minimum CRS of 0 and a
maximum of 5. Then a modified CRS (MCRS) was built including surgical
margin status and extrahepatic disease, creating a minimum MCRS of 0 and
a maximum of 7.
Results. The calculated CRS and MCRS were analyzed with respect to
patient survival and were found to be highly predictive of long-term outcome
(P/0.023 and P/0.00001, respectively). No patient had a MCRS of 7.
Five-year survival rates for CRS of 1, 2, and 3 were found to be 47%, 28.6%,
and 21.8%, respectively and was 0% for CRS/3. Five-year survival rates for
MCRS of 1, 2, 3, and 4 were found to be 46%, 38.2%, 27.2%, and 4%
respectively and was 0% for MCRS/4.
Conclusions. For the selection of patients at high risk for recurrence after
liver resection who may benefit from adjuvant therapy the MCRS may
represent a better score system than CRS.
P22.14
CLINICAL TRIALS OF YTTRIUM-90 RESIN MICROSPHERES IN
THE TREATMENT OF HEPATOCELLULAR CARCINOMA AND
METASTATIC NEUROENDOCRINE TUMOR: PRELIMINARY
DATA
Meranze, Steven1; Chari, Ravi2; Gorden, D Lee2; Bream, Peter1; Berlin,
Jordan3; Martin, William1; Grzeszczak, Ewa1; Feurer, Irene2; Wolverton,
Sandra1; Wright, J Kelly2; Pinson, C Wright2
1Vanderbilt University Medical Center, Radiology, Nashville, USA; 2Van-
derbilt University Medical Center, Surgery, Nashville, USA; 3Vanderbilt
University Medical Center, Medicine, Nashville, USA
Background. The efficacy and toxicity of yttrium-90 resin microspheres
(SIRT, SIR-Spheres†) for the treatment of unresectable hepatocellular
carcinoma (HCC) and metastatic neuroendocrine tumor (MNET) have
not been widely evaluated in prospective trials.
Aim/Objective. These Phase II clinical trials evaluate the short- to medium-
term efficacy and toxicity of SIRT for the treatment of unresectable HCC
and MNET. We present a preliminary data analysis.
Patients and methods. Enrollment criteria are: 1) adults with HCC grades
1 through 3 (via the Cancer of the Liver Italian Program, CLIP grading
system) or symptomatic or progressive MNET; 2) adequate hematological,
hepatic and renal function; and 3) Karnofsky functional performance ]/50.
The primary endpoint is 3- to 12-month tumor response (via response
evaluation criteria in solid tumors, RECIST). Secondary endpoints are toxity,
health-related quality of life, and survival.
Results. Twenty-two patients (12 HCC, 10 MNET) have undergone 26
treatments to date, and tumor response has been evaluated for 20 treatments.
A detailed analysis of toxicity is pending and no appreciable short-term effect
was observed on physical quality of life. Tumor response, mortality, and
mean (9/ SE) survival are outlined below.
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Diagnosis
Patients
(n)
Treatments
(n)
Stable
Disease
Partial
Response
Progressive
Disease
Deaths
(n)
Mean
Survival
(wks)
HCC 12 15 5/11 5/11 1/11 5 599/9
MNET 10 11 6/9 3/9 0/9 2 669/6
Conclusion. Preliminary data demonstrate some short-term efficacy of
SIRT for the treatment of unresectable HCC and symptomatic or progressive
MNET. Analyses of toxicity are pending.
P22.15
CLINICOPATHOLOGICAL FINDINGS OF LARGE, WELL-DIF-
FERENTIATED HEPATOCELLULAR CARCINOMA
Hamano, Mie; Yamamoto, Masakazu; Katuragawa, Hideki; Katagiri, Sa-
toshi; Yoshitoshi, Kenji; Ariizumi, Shunichi; Kotera, Yoshihito; Urahashi,
Taizen; Higuchi, Ryota; Imai, Kenichirou; Takasaki, Ken
Tokyo Women’s Medical University, Surgery, Tokyo, Japan
Seventy-one patients with well-differentiated hepatocellular carcinoma
(HCC) underwent hepatectomy at our institution. Clinicopathological
findings were compared between patients with large tumors (maximum
diameter /3 cm, n/12) and patients with small tumors (maximum
diameter 5/3 cm, n/59). Tumor size was not correlated with age, gender,
or incidence of hepatitis. Large HCCs were associated with significantly
fewer complications of cirrhosis (P/0.0329) than were small HCCs. The
incidence of low concentrations (5/20 ng/ml) of alfa-fetoprotein (P/0.0254)
and of hypervascularity on angiography (P/0.0001) were both higher in
patients with large HCCs. Patients with HCCs 5 cm or larger had a
significantly lower incidence of multicentric lesions (P/0.0346) and of
intrahepatic recurrence after surgery (P/0.0439). Histopathological exam-
ination revealed encapsulation in all large HCCs, and the portal tracts within
the tumors tended to be diminished. Six of the 12 large HCCs (50%)
included moderately differentiated HCC, and Histological grade was not
uniform in large HCCs. Large, well-differentiated HCC is distinct from
small, well-differentiated HCC.
P22.16
CRYOSURGICAL ABLATION AS AN EFFECTIVE METHOD OF
EXTENDING INDICATIONS TO LIVER RESECTION-INITIAL
EXPERIENCE
Zieniewicz, Krzysztof; Najnigier, Boguslaw; Nyckowski, Pawel; Kornasie-
wicz, Oskar; Krawczyk, Marek
Medical University of Warsaw, Dept. of General, Transplant & Liver Surgery,
Warszawa, Poland
Background. Cryoablation is contemporary one of the most efficient
methods of treatment of patients with unresectable liver tumours.
Aim. To review the indications, clinical presentation and the results of
intraoperative cryosurgical ablation (CSA) of the primary and secondary liver
tumours.
Patients & Methods. Among 288 patients with liver tumours treated
surgically in the period Feb 2004-Feb 2006 in 33 (14,5%)-an open CSA
procedure was performed-in 31 patients with metastatic liver diseases and
in 2 patients with HCC in cirrhotic liver. In 10 patients, (3 men, 10
women, mean age 57 years) CSA was combined with liver resection for
metastatic lesions: 5 pts with right hemihepatectomy and CSA in left hemi
liver, 3 pts with left hemihepatectomy and CSA in right segments and 2 pts
with left bisegmentectomy and CSA in the remnant liver. The remaining 23
pts, (13 men, 10 women, mean age 61 years) did not meet the criteria of
the curative resection and underwent the palliative CSA as a definitive
treatment. All of the patients were followed up in the outpatient department
with clinical, biochemical (including tumour markers) and CT examinations
in 3 months intervals. CRYO6 system (ERBE) with liquid nitrogen as a
cooling medium and 3 cryoprobes and flat applicator was used, freezing
temperature was set at /1908C. Accuracy of the freezing was checked
with US.
Results. The operative mortality was 3%-1 patient for liver insufficiency.
CSA related morbidity was 12%: 3 patients required relaparotomy for
intraperitoneal bleeding and 1-drainage of liver abscess. Median follow up
period is 11 months (range 114 months). 30 patients (91%) are alive in
good general condition, 9 of them (30%)-free of the disease.
Conclusion. Liver resection combined with intraoperative cryosurgical
ablation is a safe and effective treatment for the patients with primary and
metastatic liver tumours and allows extending the indications and number of
patients treated surgically with curative intention.
P22.17
DO WE HAVE TO SCAN LARGE AND ASYMPTOMATIC LIVER
HAEMANGIOMA?
Ng, Wing Chi; Cheung, Yue Sun; Lee, Kit Fai; Wong, John; Chong, Ching
Ning; Lai, Paul
Prince of Wales Hospital, The Chinese University of Hong Kong, Dept. of
Surgery, Hong Kong, China
Background. Haemangioma is the commonest benign tumor of liver.
Diagnosis usually relies on ultrasound (USG) or computed tomography
(CT).
Aim. To review the reliability of radiological diagnosis and long term
outcome of large haemangioma (?cm).
Methods. Patients diagnosed to have large liver haemangioma on initial
imaging were recruited to study. Further investigation was offered in cases of
uncertain diagnosis. Patients were regularly followed up with repeated USG
or CT half-yearly or yearly.
Results. A total of 60 patients (female 39; male 21) were included
from February 1996 to February 2006. The median age was 49 (range:
2784). Twenty three patients (38.3%) had abdominal pain on presentation.
The median size of haemangioma was 5.9 cm (range: 4.0 20.3).
Further investigations were performed in 14 patients (23.3%) for uncertain
diagnosis or liver lesions increased in size on follow-up. Out of the
14 patients, two red cell scans, 4 hepatic angiograms and 11 liver biopsies
were performed. No procedure related complication was observed. One
patient was found to have hepatocellular carcinoma with resection done.
Others were confirmed to be haemangioma. Three other patients received
resection surgery for reasons of anxiety and pain. The median duration
of follow up was 34 months. Six patients (10%) developed new symptom
(all were abdominal pain). Ten patients (16.7%) had significant enlargement
of haemangioma (/30%), of which 3 patients (5%) enlarged more than
50%. No rupture or other complication was reported during follow up
period.
Discussion & conclusion. USG and CT scan are reliable imaging tool for
diagnosis of liver haemangioma. However, selective use of angiogram, red cell
scan or biopsy is necessary in cases of uncertainty. Most large haemangioma
will not cause new symptom or complication on follow-up. Thus the practice
of performing regular scan for asymptomatic large haemangioma should be
carefully re-considered.
P22.18
EFFECT OF SYNCHRONOUS COLORECTAL LIVER METASTA-
SIS ON SURGEONS PERFORMANCE DURING CRC RESECTION
Hamady, Zaed ZR1; Malik, Hassan1; Alwan, Nisreen2; Prasad, Rajendra1;
Toogood, Giles1; Lodge, JP1
1St James University Hospital, Leeds, UK; 2Health Protection Agency,
Leeds, UK
Background. Liver resection remains the best potentially curative treatment
for colorectal liver metastases (CRLM). Unfortunately, disease recurrence
occurs in about 70% of patients. Analysis of pattern of recurrence in our own
patients showed that recurrence at the colorectal resection bed and other
intra abdominal sites represents the pattern in most cases. This pattern may
be a consequence of inadequate tumour resection at the time of colorectal
cancer resection.
Aim. To identify the effect of finding synchronous CRLM on the
performance of the surgeons whilst operating on primary colorectal cancer.
Methods. 270 patients underwent primary liver resection for CRLM
between 1993 and 2001 were included. Clinical, pathological and outcome
data were reviewed using a prospectively collected database. Patients
were categorised according to the site of the primary tumour and knowledge
of the presence of liver metastases by the colorectal surgeon (SA/surgeon
aware, SNA/surgeon not aware). Number of retrieved lymph nodes and
colorectal resection margin involvement were used as surgical performance
indicator.
Results. The median survival for the whole cohort was 46 months. There
was no difference in the number of lymph nodes retrieved during the primary
procedure, length of colon or rectum resected and nearest resection margin to
the tumour between the SA and SNA groups. SA group had higher rate of
colorectal resection margin involvement and hence the local and intra-
abdominal recurrence rate was significantly higher in this group (pB/0.001).
Awareness of the presence of liver metastases by the operating surgeon is an
independent predictor of intra abdominal extra hepatic recurrence.
Conclusion. The finding of liver metastases has influenced the curability of
colorectal cancer resection. Liver resection for CRLM has got a good long
term outcome; therefore a curative primary procedure will help achieve better
disease free survival even when the patient has liver metastasis.
P22.19
EOSINOPHILIC LIVER ABSCESS MIMICKING HEPATIC ME-
TASTASIS
Cho, Chol-Kyoon1; Kim, Hyun-Jong1; Jeong, Soon-ju1; Koh, Yang-Seok1;
Kim, Jung-Chul1; Joo, Young-Eun2; Park, Chang -Hwan2; Lee, Wan-Sik2;
Choi, Sung-Kyu2; Rew, Jong-Sun2; Kim, Sei-Jong2; Jang, Nam-Ky003;
Jeong, Yong-Yeon3; Lee, Jae-Hyuk4
1Chonnam National University Medical School, Surgery, Gwang-ju, Korea;
2Chonnam National University Medical School, Internal Medicine, Gwang-
ju, Korea; 3Chonnam National University Medical School, Radiology,
Gwang-ju, Korea; 4Chonnam National University Medical School, Pathol-
ogy, Gwang-ju, Korea
Background. The eosinophilic infiltration in the liver can be seen in the case
of hypereosinophil syndrome, parasite infestation, drugs, allergic disease, and
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gastrointestinal tract malignancy without tumor metastasis. Because of the
reversible disease entity of the eosinophilic liver abscess (ELA), it might not
affect the prognosis of a disease. If multiple low attenuated lesions are
detected during the follow-up period of a malignancy after the resection,
however, ruling out hepatic metastases will not be easy. Even though elevated
eosinophil count in the peripheral blood might help differentiating hepatic
metastases, most ELAs are found incidentally on CT images.
Patients. (Case 1) A 64-year-old male was operated on two hepatic
metastases, which located on 7th segment in April, 2003. His past medical
history was not noticeable without receiving radical subtotal gastrectomy with
Billroth II anastomosis because of early gastric cancer in January, 1997.
Laboratory findings include white blood cell count 6,700/mm3 with 8.2%
eosinophils. (Case 2) A 67-year-old female had hepatic wedge resection on
liver metastasis of unknown origin tumor in November, 2005. She had been
confirmed peritoneal seeding of adenocarcinoma on laparoscopic biopsy.
After receiving 5 cycles of gemcitabine-based chemotherapy, abdominal CT
scan showed remission state of previous carcinoma peritonei without a
suspicious hepatic metastasis. (Case 3) A 53-year-old male was done wedge
resection of the liver on liver metastasis of lung cancer in November, 2005.
Left pneumonectomy was performed on lung cancer in January, 2003. After
the operation, he had taken radiation therapy. In each case, single or two low
attenuated liver lesions suggesting hepatic metastases were revealed on CT
scan and tumor markers were within normal range.
Results. All three cases were reported ELAs pathologically.
Conclusion. We present occasionally-experienced three cases of ELAs
mimicking hepatic metastases.
P22.20
EVALUATION OF TUMOUR M2-PYRUVATE KINASE (TUM2-PK)
IN COLORECTAL CANCER (CRC) LIVER METASTASIS: COM-
PARISON WITH CEA AND CA19-9
Kumar, Yogesh; Pinedo, Inigo R; Tapuria, Niteen; Zabron, Abigail;
Davidson, Brian R
Royal Free Hospital, General Surgery, London, UK
Background. The currently available tumour markers for use in the
management of patients with colorectal metastases are of limited value.
Tumour M2-pyruvate kinase (TuM2-PK), a tumour associated isoenzyme
of pyruvate kinase, is elevated in patients with gastrointestinal cancer.
This study has evaluated TuM2-PK levels in patients with CRC liver
metastases.
Material and methods. Fifty patients with CRC liver metastases had
TuM2-PK levels measured prior to liver resection. 20 patients had levels
measured following resection for an average duration of 5 months.
Preoperative, postoperative (2 weeks) and follow-up samples (5 weeks
and 5 months) were analysed by ELISA (ScheBo†, Gissen, Germany).
CEA and CA19-9 levels were measured at the same time periods. CEA,
CA19-9 and TuM2-PK levels were compared with the tumour number,
volume, and differentiation.
Results. At a cut-off value of 15 u/ml (TuM2-PK), 10 ng/ml (CEA) and 39
u/ml (CA19-9), sensitivity of TuM2-PK was 68%, CEA was 62%, CA19-9
was 40%, TuM2-PK/CEA was 88% and TuM2-PK/CA19-9 was 78%.
Significant correlation was seen between tumour volume and CEA(r/0.34,
pB/0.05) and CA19-9 (r/0.49, pB/0.005). TuM2-PK did not show a
significant correlation with tumour histology, volume or the number of
metastasis. At 2 weeks following liver resection, CEA and CA19-9 levels
decreased to normal value in 60% of patients while TuM2-PK remained
elevated in all patients. At 5 weeks, TuM2-PK, CEA and CA19-9 levels
decreased to normal in 32%, 90% and 74% of patients respectively and at 5
months, these levels decreased to normal in 37%, 89% and 75% of patients
respectively. Of the 4 patients who had recurrent or residual disease at 5
months, post resection TuM2-PK was elevated in 75% and CEA in 25%.
Conclusion. TuM2-PK is commonly elevated in CRC liver metastasis.
Levels do not correlate with tumour volume, number or differentiation.
Levels remain elevated early after liver resection but measurements at 5
months show increased levels with recurrent or residual disease.
P22.21
FATE OF RESIDUAL FLOATING BILE DUCT TUMOR DEBRIS
AFTER CURATIVE RESECTION IN HEPATOCELLULAR CARCI-
NOMA WITH BILE DUCT TUMOR THROMBI
Yun, Sung S; Lee, Dong S; Kim, Hong J
Yeungnam University Hospital, Dept. of Surgery, Taegu, South Korea
Background. Eventhough common causes of jaundice in patients with
hepatocellular carcinoma(HCC) are underlying liver cirrhosis and/or ex-
tensive parenchymal destruction, occasionally, jaundice can be caused by bile
duct tumor thrombi. We can have good outcome after curative hepatectomy
with extrahepatic bile duct resection if the disease is still localized. But we do
not know the fate of remained floating tumor debris after curative resection,
whether it is viable or not.
Aim/Objective. We reviewed our treatment experience of floating bile duct
tumor debris in patients with HCC with bile duct tumor thrombosis to clarify
the viability of floating tumor debris.
Patients and methods. We experienced 15 cases of HCC with bile duct
tumor thrombi for recent two decades. Among them, we had 5 patients with
floating bile duct tumor debris remote from main bile duct tumor thrombus.
We performed curative hepatectomy with extrahepatic bile duct resection in
these 5 patients and reviewed recurrence pattern.
Results. Two patient are alive until now and 2 patients had recurrence in
their liver those were not different from usual recurrence pattern of HCC.
One patient had recurrence in remnant intrapancreatic bile duct. The patient
was 46 years old female who had 9 cm HCC in the left lobe of liver with
tumor thrombus extended to main confluence of hepatic duct. We did left
lobectomy and extrahepatic bile duct resection and Roux-en-Y hepaticoje-
junostomy. Careful review revealed that, at the time of surgery, we did not
remove all of the floating bile duct tumor debris in remnant intrapancreatic
bile duct. Two year later, we found recurrence in remnant intrapancreatic bile
duct and consequently the patient was dead due to multiple tumor recurrence
29 months after operation.
Conclusion. We think that floating bile duct tumor debris is viable, unless
we remove it completely.
P22.22
HAEMATOLOGICAL EFFECT OF 131-I-META-IODO-BENZYL-
GUANIDINE (MIBG) IN THE TREATMENT OF SYMPTOMATIC
CARCINOID PATIENTS (SCPS)
Apps, Edward1; Bendelow, John1; Jones, Louise2; Vinjamuri, Sobhan3;
Poston, Graeme2
1University of Liverpool, Faculty of Medicine, Liverpool, UK; 2University
Hospital Aintree, Surgery, Liverpool, UK; 3Royal Liverpool University
Hospital, Nuclear Medicine, Liverpool, UK
Background. The tumours of /50% of symptomatic carcinoid patients
(SCPs) will actively take up 131-I-meta-iodo-benzyl-guanidine (MIBG) and it
is being used with increasing frequency to treat their symptoms. Little is
known of any haematological toxicity when using MIBG in treating SCPs and
whether such toxicity impacts on quality of life post-MIBG.
Aims. To examine haematological parameters following MIBG therapy in
SCPs.
Methods. 62 SCPs were screened, 32 demonstrating MIBG avidity. Each of
these 32 received a single 5MBq dose of MIBG. Full blood counts
(haemoglobin [Hb], white cell counts [WBC], platelets) were measured
before and one month after treatment. Quality of life (QOL) was measured
pre- and post-treatment using the EORTC neuroendocrine QOL question-
naire, currently under development. Statistical comparison used Mann-
Whitney test (pB/0.05 significant).
Results. 18 reported improved QOL post-MIBG. There was no difference in
Hb from 12.8 pre- to 12.7 post-MIBG (p/0.830). Although there was a fall
in platelets from 260 pre- to 220 post-MIBG, this was not significant (p/
0.121). However WBC fell significantly (p/0.001) from 7.3 pre- to 5.4 post-
MIBG. There were no treatment related septic complications or mortalities.
Conclusions. MIBG treatment improved QOL in 18/32 (56%) of SCPs.
However, these improvements were at an overall cost to the whole patient
population of a significant fall in WBCs. Although we did not witness any
septic complications associated with the fall in post-MIBG WBC, we would
advise caution when using this approach to treat SCPs.
P22.23
HEPATIC ARTERY INFUSION CHEMOTHERAPY (HAI) USING
PERCUTANEOUS IMPLANTABLE CATHETER-PORT SYSTEM
FOR THE TREATMENT OF COLORECTAL LIVER METASTASES
(CLM): PRELIMINARY TECHNICAL RESULTS
Tarazov, Pavel; Balakhnin, Pavel; Generalov, Mihail; Polikarpov, Alexey
St. Petersburg Research Institute of Roentgenology & Radiation Therapy,
Angio/Interventional Radiology, St. Petersburg, Russia
Purpose. To evaluate feasibility and usefulness of percutaneous catheter-
port system implantation for continuous HAI.
Materials & methods. Between May 2005 and February 2006, seven pts under-
went percutaneous transfemoral implantation of catheter-port system for the
treatment of unresectable CLM. In two pts, the catheter tip was fixed in the
proximal part of the gastroduodenal artery (GDA) with coils. In the other five,
catheter tip was positioned in the distal part of the right gastroepiploic artery (RGA)
without coil embolization of GDA or RGA (Hashimoto method). In these five
cases, 45 additional holes were made on the catheter tip for more effective fixation.
Results. No complications occurred during the implantation procedures.
The mean number of HAI cycles per patient was 5 (111). The mean follow-
up period was 145 (31303) days. All patients are alive and continue to
receive HAI through implantable system. One case of catheter thrombosis on
the 7th day after implantation was successfully treated by local thrombolytic
therapy.
Conclusion. Percutaneous transfemoral implantation of catheter-port sys-
tem is feasible and useful technique for the treatment of patients with CLM.
P22.24
HEPATIC RECURRENCES AFTER INTRAOPERATIVE RADIO-
FREQUENCY (IRF) AND/OR HEPATECTOMY FOR LIVER ME-
TASTASES (LM).
Evrad, Serge1; Leblanc, Fabien1; Brouste, Ve´ronique2; Lalet, Caroline2;
Mathoulin-Pelissier, Simone2
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1Institut Bergonie´, Digestive Tumours Unit, Bordeaux, France; 2Institut
Bergonie´, Clinical Research Unit, Bordeaux, France
Background. The aim of this study was to evaluate hepatic recurrences of
IRF alone or combined to hepatectomy compared with resection of LM.
Methods. 102 patients who underwent curative surgery for initial LM were
separated in three groups: 35 patients treated by IRF alone (Group 1), 30
patients by IRF and hepatectomies (Group 2), and 37 patients by
hepatectomies alone (Group 3). Second hepatic recurrences were excluded.
Criteria for IRF were lesions of small sizes, isolated, deeply situated, close
from vessels. Criteria for hepatectomies were, large lesions, grouped together,
superficial, close from large bile ducts. Comparison included 30-day post-
operative mortality and morbidity, number and sizes of the LM and delay and
type of recurrences.
Results. 61 LM were of a colorectal origin and 41 were not. There were no
postoperative mortality. Morbidity was 14% for group 1, 11% for group 2
and 11% for group 3. For group 1, group 2 and group 3: follow up was 37, 26
and 30 months respectively.; the median numbers of lesions were 3, 4 and 1
respectively (pB/0,001); median sizes were 11, 10 and 20 mm (p/0,003)
respectively; bilobar lesions were observed in 34, 83 and 16% (pB/1.107)
respectively. For group 2, 67% of the patients had more than 3 lesions and
57% of group 1 patients had only 1. Isolated recurrences of treated lesions
appeared respectively in 4 patients (11%) in group 1, in 2 patients in group 2
(7%) and in 2 patients of group 3 (5%) (p/0,61 NS). New hepatic lesions
appeared in 14 patients in group 1 (40%), in 14 patients in group 2 (47%),
and in 14 patients in group 3 (38%) (p/0,75 NS). Both recurrences of
treated lesions and new lesions were observed in 2 patients (11%) for the
group 1, in 4 patients (13%) for the group 2 and 2 in the group 3 (5%) (p/
0,56 NS). Delays of recurrences were respectively 7, 7 and 8 months.
Conclusions. Resection must be done whenever it is possible. But facing
numerous bilobar lesions, IRF is a safe and efficient technique adjuvant to
resection to achieve R0 treatment of LM.
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HEPATIC RESECTION FOR COLORECTAL LIVER METAS-
TASES: THE VALUE OF PROGNOSTIC SCORING SYSTEMS
Aldrighetti, Luca; Arru, Marcella; Pulitano`, Carlo; Castoldi, Renato; Stella,
Marco; Orsenigo, Elena; Gavazzi, Francesca; Ferla, Gianfranco; Di Carlo,
Valerio; Staudacher, Carlo
San Raffaele Scientific Institute, Vita-Salute San Raffaele University, Dept. of
Surgery Liver Unit, Milan, Italy
Background. Several investigators have proposed prognostic scoring sys-
tems to improve patient selection for liver resection for metastatic colorectal
cancer. Aims: In this study we compared the validity of three different scoring
systems: the clinical risk score (CRS) defined by Fong, the score system
defined by Nordlinger (NSI) and the score system defined by Makuuchi
(MSI).
Methods. Medical records of 297 potentially curative hepatic resections for
colorectal metastases were analyzed. The CRS assesses 5 variables: nodal
status of the primary lesion, disease-free interval, number of metastases, size
of largest metastasis, CEA level. The NSI assesses 7 prognostic criteria: age
/60-years old, stage of the primary tumour, /4 liver metastases, synchro-
nous disease, size of largest lesion, CEA level, positive margins. The MSI
assesses 3 variables: nodal status of the primary lesion, CEA level, positive
hilar nodes.
Results. The calculated CRS, NSI, and MSI were analyzed with respect to
patient survival and were found to be highly predictive of long-term outcome
(P/0.0043, P/0.0001, and P/0.0001, respectively). Five-year survival
rates for CRS of 1, 2, and 3 were found to be 46%, 28.6%, and 21.8%,
respectively and was 0% for CRS/3. Five-year survival rates for NSI in low,
intermediate, and high risk groups were found to be 68.2%, 40.6%, and 9%,
respectively. Five-year survival rates for MSI of 1, 2, and 3 were found to be
45.1%, 6%, and 0%, respectively.
Conclusion. This study validates the CRS, NSI, and MSI as predictive of
patient outcome. The clinical role in patient selection will have to be defined
in prospective studies.
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HEPATIC RESECTION FOR COLORECTAL METASTASIS: IM-
PACT OF TUMOR SIZE
Hamady, Zaed; Malik, Hassan; Finch, Rob; Prasad, Rajendra; Toogood,
Giles J; Lodge, J Peter
St James’s University Hospital, Leeds, UK
Background. Liver resection remains the ¡8gold standard¡9/ curative
treatment for colorectal liver metastasis (CRLM) with a reported median
survival time of 35 to 69 months. Many series report that patients with
metastasis diameter greater or equal to 5 cm have a higher incidence of
recurrence and lower survival. Therefore, some CRLM patients are denied
surgical resection on the basis of tumour size.
Aim. The aim of this study was to explore the impact of metastasis size on
modern liver resection.
Methods. Using a prospectively collected database, this was a retrospective
analysis of 484 consecutive patients who underwent liver resection
for colorectal liver metastases between 1993 and 2003. The cohort was
divided into 2 groups, smaller metastases (B/8 cm) and larger metastases
(B/8 cm). Those with larger metastases were then further stratified into big
metastases (812 cm) and giant metastases (/12 cm). Demographic,
pathological, surgical technique and outcome data were compared between
the groups.
Results. There were 88 (18%) patients with metastases measuring 8 cm or
larger. There was an association between higher CEA and CA19-9 levels and
larger metastases. The actuarial 5-year survival for patients with larger
metastases was 43% compared to 39% for smaller metastases (not statisti-
cally significant). Whereas, for patients with giant metastases (/12 cm) was
29%. Only giant metastases did have a poorer impact on survival and disease
free survival.
Conclusion. Patients with colorectal liver metastasis greater than 8 cm and
up to 12 cm in size should not be treated differently from those with smaller
lesions.
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HEPATIC RESECTION FOR HEPATOCELLULAR CARCINOMA
WITH OBSTRUCTIVE JAUNDICE DUE TO BILIARY THROMBI
Chen, Miin-Fu; Yeh, Chun-Nan; Jan, Yi-Yin
Chang Gung Memorial Hospital/Chang Gung UniversityG, Surgery,
Taoyuan, Taiwan
Background. Hepatocellular carcinoma (HCC) with obstructive jaundice
due to biliary tumor thrombi is uncommon, and few studies have examined
the outcome of hepatectomy for HCC with this unusual entity. This study
examined the clinicopathologic factors influencing the outcomes of 17 HCC
patients with obstructive jaundice due to biliary tumor thrombi undergoing
hepatectomy.
Method. The clinical features of 17 HCC patients with obstructive jaundice
due to biliary tumor thrombi (group A) undergoing hepatectomy from 1986
to 1998 were reviewed. The clinical features and factors influencing the
outcome of 555 HCC patients without biliary tumor thrombi (group B)
undergoing hepatectomy were used for comparison.
Results. Of 572 patients with surgically resected HCCs, 17 (3.0%) were
classified into group A. Right upper quadrant pain, physical signs of jaundice,
low albumin level, elevated bilirubin level, small tumor size, more vascular
invasion, and tumor rupture were characteristic of group A patients.
Multivariate stepwise logistic regression analysis revealed no independently
significant factor differentiating group A patients from group B patients. The
disease-free survival was similar between the group A and B patients,
although group B patients exhibited significantly better overall survival
(p/0.014). Vascular invasion may adversely influence overall survival in
group A patients undergoing hepatic resection (p/0.0709).
Conclusion. When feasible, hepatic resection is the preferred treatment
for HCC patients with obstructive jaundice due to biliary tumor thrombi.
It can achieve a disease-free survival comparable to that of HCC
patients without biliary tumor thrombi. However, HCC patients with biliary
tumor thrombi had significantly worse overall survival than did those
without biliary tumor thrombi, especially those with concomitant vascular
invasion.
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HISTOPATHOLOGIC CHARACTERIZATION OF HEPATOCEL-
LULAR CARCINOMAS UNDETECTED BY DYNAMIC COM-
PUTED TOMOGRAPHY
Yamamoto, Takatsugu1; Uenishi, Takahiro1; Sakabe, Katsu2; Ogawa, Ma-
sao2; Tanaka, Shogo2; Ichikawa, Tsuyoshi2; Mikami, Shinichi2; Ikebe,
Takashi2; Hirohashi, Kazuhiro2; Kubo, Shoji2; Ono, Koichi1
1Ishikiri Seiki Hospital, Dept. of Surgery, Higashi-Osaka City, Osaka, Japan;
2Osaka City University Garduate School of Medicine, Dept. of Hepato-
Biliary-Pancreatic Surgery, Osaka, Japan
Background. Most of hepatocellular carcinomas (HCCs) are visualized by
dynamic computed tomography (dynamic CT) and CT during arteriogra-
phy/arterial portography. Some early HCCs are, however, invisible in
dynamic CT or angio CT. In this study, we investigated histopathological
features of HCCs not detected in dynamic CT.
Methods. Liver specimens were obtained from 154 patients with small
HCCs (207 nodules) in a diameter of less than 3 cm. Dynamic CT images
were obtained by scanning the liver in 7-mm thickness at 30 sec (early phase)
and 150 sec (late phase). Tumor size was measured macroscopically. Grade
of differentiation (well, moderate, poor), growth pattern (expansive, repla-
cing), and the presence/absence of fibrous capsule and intratumoral Glisson’s
sheath were pathologically examined.
Results. Among HCCs examined, 39 of 207 nodules were not visible in both
early and late phases of dynamic CT, only being found by the intra or
preoperative ultrasonics or pathologic examination (‘‘not-detected’’ HCC),
while others were visible either in early or late phase (‘‘detected’’ HCC).
There was a significant correlation between dynamic CT images and
pathological figures of fibrous capsule, intratumoral Glisson’s sheath, growth
pattern and grade of differentiation (pB/0.01).
Discussion. The pathologic features of ‘‘not detected’’ HCC resembling to
normal sinusoid and Glissons sheath suggests a direct connection between
the tumorous microvessels and sinusoids of surrounding liver parenchyma
with normal blood flow of both portal vein and hepatic artery. However, the
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present study also demonstrated that some well differentiated HCCs with
intratumoral Glisson’s sheath and replacing growth were detected by
dynamic CT. They were larger in size than ‘‘not detected’’ tumors. This
finding suggests that alterations to the blood supply to the tumor may occur
during the growth of tumors, preceding the changes in the architecture of
microvessels on multi-step fashions.
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INCOMPLETE TISSUE ABLATION: A HISTOLOGICAL COM-
PARISON BETWEEN MICROWAVE, RADIOFREQUENCY AND
CRYOABLATION IN THE RAT LIVER
Bhardwaj, Neil1; Strickland, Andrew1; Atanesyan, Lilit1; Ahmad, Fateh1;
West, Kevin2; Lloyd, David1
1Leicester Royal Infirmary, Surgery, Leicester, UK; 2Leicester Royal
Infirmary, Histopathology, Leicester, UK
Background. For any ablative technique to be successful, complete cell
death within the treated volume is necessary. Microwave tumour ablation
(MTA), radiofrequency (RF) and cryotherapy are ablative systems which
utilise release of heat or cold energy to destroy unresectable primary or
secondary liver tumours. Unlike MTA in which majority of cell death occurs
within a radiated field, RF and cryotherapy rely on conduction of a thermal
insult for their cytotoxicity potentially affecting lesion uniformity.
Aims/Objectives. To compare the uniformity of cell death within the
ablations induced by cryotherapy, MTA and RF in the rat liver.
Methods. Eighty-four rats underwent a laparotomy. For each ablative
modality, 21 rats were assigned to 3 groups in which an increasing volume of
the liver was ablated. All rats were sacrificed at 48 hours and the livers analysed.
Results. All specimens exhibited macroscopic evidence of sharply demar-
cated tissue damage. Microscopically, the boundary between coagulated dead
tissue and parenchyma was most clearly delineated with MTA. No viable
hepatocytes were noted in the ablated region and little evidence of
haemorrhage into normal liver was found. All vessels and bile ducts in the
ablation zone had undergone complete necrosis. Cryotherapy specimens
showed necrotic cells at the ablation centre however peri-vascular hepatocyte
survival was observed with a larger area of inflammation at the transition zone
compared to MTA. Radiofrequency specimens revealed a microscopically
irregular burn edge but also islands of viable hepatocytes within the ablated
tissue and a considerable degree of haemorrhage at the transition zone.
Conclusion. Unlike RF and cryotherapy, MTA induced a microscopically
uniform ablation, with no hepatocyte survival in the treated area. Cell
survival following treatment with alternative ablation techniques may be due
to the relatively prolonged treatment times needed, allowing thermal energy
to be dissipated by vessel blood flow known as the heat sink effect.
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INFANTILE HEPATIC VASCULAR TUMORS: TREATMENT OP-
TIONS
Kotru, Anil1; Namazie, Sheyda2; Shepherd, Ross3; Turmelle, Yumirle3;
Nadler, Michelle3; Chapman, William1; Lowell, Jeffrey1
1Washington Univ. in St. Louis, Abdominal Organ Transplantation, Saint
Louis, USA; 2Saint Louis Children Hospital, Pediatric Critical Care, Saint
Louis, USA; 3Saint Louis Children Hospital, Pediatric Hepatology, Saint
Louis, USA
Hepatic vascular tumors (HVT) are the most common benign liver tumors
which can present in infancy and childhood and are commonly associated
with high output cardiac failure. Pediatric HVT usually are divided into
infantile hemangioendothelioma (IHE), cavernous hemangioma (HC), and
arteriovenous malformations (AVM) The most common is infantile heman-
gioendothelioma, These can be asymptomatic or can present with hepato-
megaly, consumption coagulopathy with anemia, and thrombopenia/
hemorrhage (Kasabach-Merritt-Syndrome) as well as cutaneous/visceral
hemangiomas can occur -up. Medical treatment consists of steroids, a
interferon, and treatment of additional clinical symptoms. Possible surgical
procedures are ligature of feeding vessels, hepatic resection, and liver
transplantation Apart from established medical and surgical options, the
endovascular approach represents an important alternative. In this report, we
present our experience with interventional coil occlusion in 3 patients
suffering from symptomatic vascular tumors of liver.
Methods. Three patients suffering from AVM of liver (age range 30150
days) associated with cardiac failure were treated by endovascular interven-
tions between 19992006
Results. Signs of heart failure resolved in two patients within 3 weeks
of intervention. These two patients after a follow up of 72 months and
36 months remain asymptomatic. Third patient who still remains in
hospital after endovascular coil occlusion of hepatic artery has shown
remarkable improvement in cardiovascular haemodynamics and hepatic
functions. Follow up imaging in these patients showed significant regression
of lesions.
Conclusion. Embolisation of hepatic artery and rest of the collateral arteries
feeding these arteriovenous malformations is a safe and effective treatment.
Liver transplantation is very rarely performed. We do not recommend
endovascular intervention in multifocal hemangioendothelioma.
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INTRACYSTIC HAEMORRHAGE: UNUSUAL PRESENTATION
OF SIMPLE LIVER CYSTS
Erdogan, Deha1; van Delden, Otto M2; Busch, Olivier RC1; Rauws, Erik AJ3;
ten Kate, Fiebo JW4; Gouma, Dirk J1; van Gulik, Thomas M1
1Academic Medical Center, Dept. of Surgery, Amsterdam, Netherlands;
2Academic Medical Center, Dept. of Radiology, Amsterdam, Netherlands;
3Academic Medical Center, Dept. of Gastroenterology, Amsterdam, Nether-
lands; 4Academic Medical Center, Dept. of Pathology, Amsterdam, Nether-
lands
Background. Simple liver cysts are common benign liver lesions that are
increasingly detected because of the widespread use of abdominal imaging.
The diagnosis is made according to specific morphological findings on
imaging. However, it is difficult to differentiate simple liver cysts from
complex cystic liver lesions in case of haemorrhage. We describe 3 patients
with haemorrhage in a simple liver cyst. Two of them were initially diagnosed
as hepatobiliary cystadenomas (HBC).
Results. First patient presented with colicky upper abdominal pain.
Abdominal US showed a gallstone in the gallbladder and a cyst in segment
5 and 6. Laparoscopic cholecystectomy did not resolve her complaints.
ERCP showed two filling defects associated with the biliary system
corresponding with the cyst. MRI showed a multilocular configuration (7
cm) with the ventral part of the cyst fluid inhomogeneously hypointense
whereas the dorsal part was hyperintense on T1-images, compatible with
haemorrhage. Enucleation was performed on the suspicion of a HBC. The
connection of the cyst with the biliary system was suture-closed. Second
patient underwent US and CT for colicky pain in the upper abdomen
showing thin walled cyst with septations and wall irregularities, in segment 7
(12 cm). The cyst was hyperintense on T1-MRI images, compatible with
haemorrhage. A diagnosis of HBC was made and the cyst was excised.
Pathological examination showed a simple cyst with haemorrhagic fluid.
Third patient presented with acute onset of abdominal pain. US showed a
cyst with internal echoic structures in the right liver lobe (20 cm). The
presumptive diagnosis of haemorrhage was made. A catheter was placed for
drainage of haemorrhagic fluid and sclerotherapy was done. US three months
after presentation showed a decrease of the cyst to 9.5 cm.
Conclusion. Simple liver cysts may present with intracystic haemorrhage
and then give rise to internal septations and wall irregularity on imaging.
Surgical resection should be indicated when HBC or malignancy cannot be
excluded.
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INTRAHEPATIC CHOLANGIOCARCINOMA: WHAT BENEFIT
CAN WE EXPECT FROM EXTENDED RESECTION?
Hardwigsen, Jean; Peycru, Thierry; Richa, Hubert; Ananian, Pascal;
Campan, Pierre; Le Treut, Yves Patrice
Hoˆpital de la Conception, Marseille, France
Aim. Intrahepatic cholangiocarcinoma (ICC) is usually a large tumor at the
time of diagnosis that usually requires an aggressive resection. We retro-
spectively compared morbidity and outcome after hepatic resection asso-
ciated or not with regional procedures.
Methods. Between 1988 and December 2005, 58 hepatic resections (5 for
tumor recurrence) were performed in 55 patients. Operative data and follow-
up were retrospectively analysed. To achieve tumoral resection, 23 proce-
dures required regional resections (group RR): diaphragm n: 10, vena cava
n:8, portal vein n:3, biliary tract n:2, spleen n:1, stomach n:1 adrenal gland n:
1, pericardium n:1, liver transplantation n:2. Liver resection only was
performed for others (group LR, n:35). No systematic postoperative adjuvant
therapy was performed.
Results. The median age (62 vs 67 years) was comparable but sex ratio was
different between the groups (M/F 3.4 vs 0.4, pB/0,001). Median tumor
size was significantly higher (11 vs 8 cm) in group RR. Data were
comparable for the rate of complete tumoral resection (87 vs 91%) and
number of resected liver segments (median n:4). Requirement of total
vascular hepatic exclusion was more frequent in group RR (41 vs 6% of
cases, pB/0.05). In group RR and LR, postoperative mortality was
respectively 9% and 6% (NS) and morbidity was 65 vs 29%, (pB/0.01).
Median hospital stay was 18 vs 14 days, (NS). Actuarial survival rates at 1,
3, 5 years were respectively: 64, 38, 7% in group RR and 70, 30, 30% in
group LR (NS).
Conclusion. ICC in men require more frequently hepatic resection with
regional procedure than women. These aggressive surgical approaches were
associated with higher morbidity but it could provide prolonged survival, not
different from ICC treated by liver resection only.
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NOVEL STRATEGY AGAINST UNRESECTABLE LIVER TUMOR
BY CRYO-ABLATION THERAPY WITH IMMUNE REACTION
Osada, Shinji; Sakashita, Fumio; Tokuyama, Yasuharu; Naoki, Okumura;
Matsuhashi, Nobuhiro; Sugiyama, Yasuyuki
Gifu University School of Medicine, Surgical Oncology, Gifu, Japan
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Aim. By releasing intracellular antigen into the circulation, cryogenic
treatment appears to stimulate the immune system of the host, leading to
an anti-tumor immune response. Because helper T-cells, especially Th1
lymphocytes, have been shown to be critically important for induction of
cellular immunity and eradication of the tumor mass, Krestin (PSK) was
used for increasing the ability of the host to defend itself from tumor
progression. Guided by this theoretical background, a developed liquid-
nitrogen-based cryogenic procedure was described herein.
Method. Cryoablation therapy was performed for unresected liver tumors of
18 cases (8 colon, 3 stomach, 3 cholangiocellular, 2 gall bladder, 1 breast
cancer and 1 duodenal tumor) once a week with an overnight hospital stay.
Serum levels of Interleukin (IL)-4, 6, 10, 18 and Amyroid A (AA) and Tumor
necrosis Factor (TNF)-a were measured.
Results. 1. Treated area of tumor was changed to necrosis or the serum level
of tumor marker was decreased in all cases. 2. In 6 cases, untreated area of
tumor was also changed to necrosis (good reaction group; GR). Then, serum
factors with them were compared to poor reaction cases (PR). 3. The serum
level of AA was increased to 672.4 in GR or 620.3 in PR after third times
treatment. 4. The value of IL-6 was noted for parallel movement with C-
reactive protein. 5. The level of IL-10 was higher in PR and not detected
increasing by treatment. 6. The level of TNF-a increased markedly in GR
(1.4 times from pre-treatment level), but not in PR. 7. The level of IL-18
increased with TNF-a movement, but not so hasty. 8. Th1/Th2 (suggested
from IFN-g/IL-4) was increased clearly (6.7 times to pretreatment level) in
GR, but not so much (3.2 times) in PR.
Conclusion. We conclude that the immune response associated with
cryosurgery expands the usefulness of this treatment strategy for unresectable
liver tumors.
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INVASION AND DEDIFFERENTIATION OF HEPATITIS B RE-
LATED HEPATOCELLULAR CARCINOMA UP-REGULATE EZ-
RIN EXPRESSION
Yeh, Chun-Nan; Pang, See-Tong; Jan, Yi-Yin; Chen, Miin-Fu
Chang Gung Memorial Hospital/Chang Gung University, Surgery, Taoyuan,
Taiwan
Background. Hepatocellular carcinoma (HCC) is the fifth most common
malignancy in the world, with the highest incidence in Asian countries. In
Taiwan, HCC is common and the leading cause of cancer-related death
among men, and second among women in Taiwan. However, the under-
standing of the molecular pathways of hepatocarcinogenensis is limited,
although recent molecular biological studies have led to rapid progress in the
understanding of the molecular events involved.
Methods. DNA constructs included the wild type ezrin, dominant negative
and mutant ezrin cDNA clone. These genes are cloned in a pCB6 vector with
a VSVG tag with neomycin selection transfected into Hep3B cell. Invasion
assay and differentiation assay were performed by in vitro study. We also
performed IHC study in 120 hepatitis B related HCC cases. The clinico-
pathological features of 120 hepatits B related HCC patients who underwent
hepatic resection were reviewed.
Results. Wild type Ezrin transfected Hep3B cell had significantly higher level
of AFP secretion and invasion ability than mutant type and dominant
negative Ezrin transfected Hep 3 B cell. IHC study of the hepatitis B related
HCC specimen also demonstrated poorly differentiated HCC had signifi-
cantly higher expression than moderately-and well-differentiated HCC.
Conclusions. Ezrin is important for differentiation and invasion of hepatitis
B HCC cell. Dedifferentiation of human hepatitis B related HCC up-
regulates ezrin expression.
P22.35
IS THE NUMBER OF HEPATIC COLORECTAL METASTASES A
PROGNOSTIC FACTOR AFTER LIVER RESECTION: RESULTS
OF MATURE DATA
Chu, Francis; Gunasegaram, Aravin; Zhu, Jacqui; Niu, Rui; Morris, David
St George Hospital Campus, University of New South Wales, Dept. of
Surgery, Sydney, Australia
Background/Aim. Hepatic resection is both potentially curative and the
most effective therapy for liver metastasis of colorectal carcinoma. The aim of
this retrospective study was to determine whether the number of hepatic
lesions has any prognostic significance on survival in patients treated with
hepatectomy for colorectal metastases.
Patients/Methods. From Jan 1990 to Dec 2005, 596 patients who under-
went curative liver resection for colorectal metastases were identified from a
prospective database. Number of metastases was determined by serial
sectioning of gross specimens by a pathologist and this information was
obtained from post-operative histopathology reports. Patients were categor-
ized into group one, group two and group three if they had 14, 57 and /8
liver metastases respectively. Date of the first metastasectomy and time of
death or last follow-up were collected and Kaplan-Meyer survival analysis
was performed for all three groups.
Results. A total of 498 candidates were identified for analysis with zero peri-
operative mortality. The median follow-up of 498 patients was 60 months.
There were 411 patients in group one, 56 patients in group two and 31
patients in group three. The median survival times were 35, 29 and 23
months respectively. The 5 year survival rates were 33%, 31% and 18% for
group 1, 2 and 3 respectively (P/0.06).
Conclusion. There was no significant difference in survival rates for patients
with seven lesions or less.
P22.36
LEFT TRISECTIONECTOMY FOR THE TREATMENT OF MA-
LIGNANT HEPATOBILIARY TUMORS
Lang, Hauke; Sotiropoulos, Georgios C; Brokalaki, Ereni; Malago´, Massimo;
Frilling, Andrea; Broelsch, Christoph E
Universita¨tsklinikum Essen, Klinik fu¨r Allg.-, Viszeral- und Transplant.-
Chir., Essen, Germany
Introduction & aim. Left hepatic trisectionectomy is the most extended
hepatic resection. Although the technique of this operation has been
described already in 1982 by Starzl et al., so far only little data is available
regarding its role in the treatment of hepatobiliary malignancies.
Patients and methods. Between 06/1998 and 07/2004, a total of 52
patients underwent left trisectionectomy for primary or secondary hepato-
biliary tumors at our Institution. Data were analysed with regard to patients’
characteristics, intraoperative details, pathologic findings, perioperative
morbidity and mortality, and survival.
Results. In addition to left trisectionectomy, the following 43 procedures
were performed in 31 patients: resection of hilar bifurcation (n/15), bile
duct revision (n/5), wedge resection of segment VI/VII (n/10), gastrect-
omy (n/1), and resection/reconstruction of hepatic vessels or the Inferior
Vena Cava (n/12). Operative morbidity and mortality were 50% and 11.9%,
respectively. One-, 3- and 5-year survival rates were 65%, 52% and 33%.
After R0-resection (n/37) the 1-, 3- and 5-year survival rates were 78%,
68%, 44% compared to 38%, 15%, 7% after R1-resection (p/0.0004).
Survival after resection of the four most frequent tumor types (HCC,
intrahepatic and hilar cholangiocarcinoma, CRM) was comparable to
survival data reported in the literature after less extensive resections in these
tumor entities.
Conclusions. Left trisectionectomy provides acceptable survival rates in
primary and secondary hepatobiliary malignancies. Despite major progress
in surgical technique and perioperative management, left trisectionectomy
is still associated with a somewhat higher operative mortality and morbidity
than less extensive resections. Since selection criteria for this type of
procedure are not clearly defined, particular attention should be focused on
the oncologic benefits when considering this operation.
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LIFE SAVING THERAPY FOR BLEEDING LIVER ADENOMAS
USING SELECTIVE ARTERIAL EMBOLISATION
Stoot, Jan1; Van Der Linden, Edwin2; Terpstra, Onno1; Schaapherder,
Alexander1
1Leiden University Medical Center, Surgery, Leiden, Netherlands; 2Leiden
University Medical Center, Radiology, Leiden, Netherlands
Background. There still remains controversy concerning the emergency
treatment for patients with a ruptured hepatocellular adenoma. As surgical
resection coincides with high mortality and morbidity rates, selective arterial
embolisation to stabilise critical patients might be an attractive option.
Aim(s)/Objective(s). The aim of this study was to evaluate the manage-
ment of ruptured adenomas with selective arterial embolisation.
Methods. Eleven consecutive patients treated for ruptured hepatocellular
adenomas in the years 20012005 were included in this study. After initial
hemodynamic support, all patients received selective embolisation of
branches of the hepatic artery. Primary outcome was arrest of the bleeding.
Secondary outcomes were minor and major complications and changes in
tumor size after embolisation.
Results. The bleeding was under control after one (n/10) or three
(n/1) embolisations. Emergency surgery was refrained in all patients.
Five minor complications were seen, predominantly fever. In the follow-up
period of 17 months (median, range 443 months) neither general
complications nor hepatobiliairy complications were observed. All adenomas
including those without signs of bleeding in the same liver lobe were either
smaller or not detectable anymore on follow-up CT scans. The decrease
in size after embolisation (mean 3.96 cm) was statistically significant
(pB/0.0001).
Conclusion. Selective embolisation of the hepatic artery is a save and
adequate first approach in the management of patients with bleeding
hepatocellular adenomas. Furthermore, arterial embolisation reduces the
size of adenomas in the liver and therefore, this might be a therapeutic option
in a selective group of patients with large or multiple adenomas.
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LIVER ABSCESS AFTER RADIOFREQUENCY ABLATION OF
TUMORS IN PATIENTS WITH A ENTEROBILIARY DIVERSION:
A RISK CLOSE TO 50 PERCENT
Elias, D1; Gachot, B2; Goe´re´, D1; Di Pietroantonio, D1; de Baere, T3
1Institut Gustave Roussy, Surgical Oncology, Villejuif, France; 2Institut
Gustave Roussy, Infectious Pathology, Villejuif, France; 3Institut Gustave
Roussy, Interventionnal Radiology, Villejuif, France
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Background. The rate of liver abscesses after radiofrequency ablation
(RFA) of liver tumors is probably high in patients undergoing a biliary tract
procedure connecting the biliary tract to the upper gastrointestinal tract. And
yet, to date, this rate, the time of onset of these abscesses, and the prior status
of the bile ducts have never been reported in the literature.
Patients and methods. Among 574 patients treated with RFA between
January 1997 and January 2005, only 11 patients (1.9%) presented with an
enterobiliary anastomosis or a biliary stenting at the time of RFA. Thirteen
sessions of RFA were performed in these 11 patients, 5 percutaneously and 8
during laparotomy. The RFA was synchronous to the enterobiliary anasto-
mosis in 4 patients.
Results. Among the 9 sessions of RFA in the 7 patients in whom a biliary
tract procedure preceded RFA, 4 developed a liver abscess at the site of RFA,
which emerged between 13 and 62 days after RFA. Liver abscess occurred in
spite of different types of short-term antibiotic prophylaxis. Pathogenic
bacteria were typical of the digestive flora. Abscesses were cured after
percutaneous drainage. No abscess occurred among the 4 patients in whom a
biliary tract diversion was performed synchronously with RFA.
Conclusion. When RFA is performed in a patient with a preexisting biliary
diversion, the risk of developing a liver abscess is close to 4050%; in these
cases, a specific antibioprophylaxis should be evaluated. When RFA is
performed synchronously with a biliary diversion, the risk of a liver abscess
seems to disappear.
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LIVER REGENERATION AFTER SPLENECTOMY AND SPLENIC
ARTERY LIGATION IN CIRRHOTIC RATS
Ogata, Toshiro; Morinaga, Akio; Okuda, Koji; Yoshida, Atsushi; Kinoshita,
Hisafumi; Aoyagi, Shigeaki
Kurume University School of Medicine, Dept. of Surgery, Kurume City,
Japan
Background. In clinical experience, it is reported to be useful that
splenectomy in cirrhotic patients with thrombocytopenia improved platelet
counts and liver function, resulting to achieve successful treatment of HCC
and antiviral interferon therapy. On the other hand, it has also been reported
that splenic artery ligation in liver transplantation or hepatectomy improved
postoperative liver function. (AIM) In this study, differences of liver
regeneration in cirrhotic rats between splenectomy and splenic artery ligation
were investigated.
Methods. Thirty wister male rats were used. Dimethylnitrosamine (DMN)
was administered intraperi-toneally (10 ug/g body weight) for 4 weeks.
The rats underwent splenectomy (DMN/SPL, n/10), splenic artery
ligation (DMN/SAL, n/10), and sham operation (DMN/Sham, n/
10). The improvements in liver function (GPT, TBil), serum TGF-beta
level in the portal vein, liver fibrosis (liver fibrotic rate was assessed by
calculating the proportion of connective tissue area in the hepatocytes area of
the liver using computer image analysis techniques) and liver regeneration
(Ki-67 labeling index was expressed as a percentage of Ki67 stained cells for
all hepatocytes in the section) were investigated on 30 days after operations in
each group.
Results. The levels of GPT and TBil were significantly low in DMN/SPL
compared with DMN/Sham. Serum TGF-beta level in DMN/SPL was
significantly lower than that in DMN/Sham. Serum TGF-beta level in
DMN/SAL was tend to be high compared with that in DMN/SPL. Ki-67
labeling index in DMN/SPL was significantly higher than those in DMN/
Sham and DMN/SAL. Liver fibrotic rates in DMN/SPL were significantly
lower than those in DMN/Sham and DMN/SAL.
Conclusion. Splenectomy significantly improved liver regeneration and liver
fibrosis compared with splenic artery ligation in DMN-treated cirrhotic rats.
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LIVER RESECTION FOR COLORECTAL LIVER METASTASES
PROGRESSING UNDER NEO-ADJUVANT CHEMOTHERAPY
Oussoultzoglou, Elie; Bachellier, Philippe; Nakano, Hiroshi; Rosso, Edoardo;
Scurtu, Radu; Jaeck, Daniel
CHU de Hautepierre, Centre de Chirurgie Visce´rale et de Transplantatio,
Strasbourg, France
Background. Zero 3-year survival rate has been recently reported in patients
presenting colorectal liver metastases which progressed under chemotherapy.
Therefore, progression of colorectal liver metastases under chemotherapy
was considered as a contraindication for liver resection. The natural history of
patients with colorectal liver metastases which progressed under neo-
adjuvant chemotherapy did not exceed 10 months. The outcome of liver
resection in these patients needs to be further evaluated.
Aim. To evaluate long term survival on patients undergoing hepatectomy for
colorectal liver metastases after progression under chemotherapy.
Methods. Between July 1995 and December 2002, 25 patients presenting
colorectal liver metastases progressing under neo-adjuvant chemotherapy
were followed in our institution. Among them 19 patients underwent liver
resection and 6 did not. Short and long-term outcome were retrospectively
analysed.
Results. Patients characteristics were similar in both groups. Operative
mortality was nil. In resected patients 3- and 5-year survival rates were 34.7
and 7% respectively. They were significantly better than that observed in non-
resected patients (3-year survival/0%; p/0,017). It appears that resection
of liver metastases was associated with significantly improved survival.
Conclusion. In patients presenting colorectal liver metastases progression
under neo-adjuvant chemotherapy, liver resection still offers a hope of long-
term survival compared to non-resected patients.
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LIVER RESECTION FOR HEPATOCELLULAR CARCINOMA IN
NON CIRRHOTIC LIVER
Huet, Emmanuel; Lubrano, Jean; Goria, Odile; Teniere, Paul; Scotte´, Michel
CHU, Rouen, France
Hepatocellular carcinoma (HCC) arising in non cirrhotic liver represents
only 10% of all HCC. Among the different treatments, liver resection seems
to be the most efficient, in the absence of underlying liver disease. The aim of
this study is to report the results of surgical resection for HCC in non
cirrhotic liver. Over a period of 6 years, 15 women and 28 men, with a
median age of 57 years, were operated on for HCC occurring in a non
cirrhotic liver in our institution. Risk factors (alcohol, hepatitis, hemochro-
matosis and liver steatosis) were found in 29 cases. Preoperative diagnosis
was assessed using histological examination in 30 cases. The AFP serum level
was over 50 ng/ml in 19 cases. Five patients underwent a simple biopsy
during the operation, while 38 were treated by hepatectomy (19 minor and
19 major hepatectomies). The morbidity or mortality rate was 23% and 11%,
respectively. Histological examination showed fibrosis or inflammatory
lesions in liver surrounding the tumors in 84% cases. The median survival
rate was 22 months. In case of biopsy or R1 resection, the median survival
rate was 2.5 months as compared to 74.5 months for R0 resections. The
actuarial survival rate was 76%, 55% and 45% at 1, 3 and 5 years,
respectively for R0 resections versus 30% and 0% at 1 and 3 years for R1
resections. The recurrence rate was 34% in the 32 patients who underwent a
R0 resection. Recurrences were observed in a median delay of 16 months. 6
patients were reoperated on for recurrence. Their median survival rate was 24
months as compared to 8.5 months in patients not eligible for further surgery.
In conclusion, CHC in non cirrhotic liver occurs rarely in normal liver.
Surgical resection should be attempted only if a R0 resection can be
performed. An aggressive management of the recurrence should be con-
sidered as an effective treatment since it allows long term survival.
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LIVER TRANSPLANTATION FOR MALIGNANCY-‘‘THE GOOD,
THE BAD AND THE UGLY’’
Ringe, Burckhardt; Meyers, William; Reynolds, James; Maroney, Timothy
Drexel University College of Medicine, Philadelphia, USA
Background. Liver transplantation (LTx) for malignancy has always been
controversial. Many studies have shown a benefit for patients with early stage
hepatocellular carcinoma (HCC), however, non-HCCs are often excluded
because of their bad prognosis. We have analyzed our recent experience to see
whether this strict selection is still justified.
Methods. 20 adults had LTx for tumors: 15 HCC in HCV/ETOH related
cirrhosis, including 4 incidental HCC, and 5 without viable tumor in the liver
explants. Tumor stages were pT1/T2 in most cases, and pT4 in one. 3/5 non-
HCC patients had intrahepatic cholangiocarcinoma (CCC, pT3/T4); one
had angiosarcoma, and one presented with Budd-Chiari syndrome secondary
to leiomyosarcoma of the inferior vena cava (IVC).
Results. In the HCC group there was no perioperative mortality, 2/15
patients died after 623 and 921 d from HCV recurrence and pulmonary
fibrosis. Actuarial 2- and 3-yr tumor-free survival is 91 and 76%. No patient
has developed recurrent HCC (mean followup 704 d). In contrast, one
patient with CCC died after 57 d from pergillosis, and all other non-HCC
recipients developed tumor recurrence: 2 died after 340 and 782 d, and 2 are
alive at 547 and 965 d. Actuarial 2-yr patient survival in this group is 60%.
Discussion. ‘‘The Good’’: These data confirm that strict selection of
candidates with HCC can lead to excellent results, comparable to cirrhotic
patients without HCC. The role of pretreatment needs to be defined, but
seems to be beneficial at least for patient selection. Extended criteria are
acceptable, especially with LDLTx. ‘‘The Bad’’: Although the number of
patients in this series is small, 2 patients with CCC have survived for more
than 2 years. We believe that LDLTx in these patients can be particularly
useful and justified. ‘‘The Ugly’’: The other two tumor entities presented in
this series are rare. Angiosarcoma should probably be excluded from LTx
because of the poor outcome. To our knowledge, the IVC leiomyosarcoma is
the first case with LTx published in the literature.
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LONG-TERM RESULTS OF HEPATIC RESECTION WITHOUT
NEOADJUVANT CHEMOTHERAPY FOR LIVER METASTASIS
Minagawa, Masami; Makuuchi, Masatoshi
University of Tokyo, Dept. of Hepato-Biliary-Pancreatic Surgery, Tokyo,
Japan
Background. The indications for surgical resection for liver metastases from
colorectal cancer remain controversial. Several clinical risk factors have been
reported to influence survival.
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Objective. The aim of this study was to retrospectively evaluate the long-
term results of our approach, which consisted of surgically treating every case
in which radical removal of all metastatic disease was technically feasible.
Methods. Between March 1980 and December 2004, 454 patients under-
went hepatic resection for metastatic colorectal cancer without neoadjuvant
chemotherapy. Survival rates as a function of clinical and pathological
determinants were examined retrospectively with uni- and multivariate
analyses.
Results. There was no operative death. The overall 5- and 10-year survival
rates were 44%, and 31%, respectively. Four or more lymph nodes metastasis
around colorectal cancer (pN2 by UICC) (P/0.0001), 50 ng/ml or more
CEA (P/0.0095), multiple liver metastases (P/0.0355), and hepatic lymph
node metastasis (P/0.0486) were significantly associated with a poor
prognosis in multivariate analysis. The 10-year survival rate of patients with
1, 2/3, 4/7, and 8 or more nodules were 39%, 26%, 23%, and 25%,
respectively.
Conclusions. hese results confirm that surgical resection without neoadju-
vant chemotherapy is useful for treating liver metastases from colorectal
cancer. While multiple metastases significantly impaired the patient’s
prognosis, the life expectancy of patients with eight or more nodules makes
their removal mandatory.
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MICROWAVE ABLATION IN PATIENTS WITH UNRESECTABLE
LIVER METASTASES IS ASSOCIATED WITH A LOW LOCAL
RECURRENCE RATE
Bhardwaj, Neil1; Strickland, Andrew1; Elabassy, Moshier2; Ahmad, Fateh1;
Rogers, Peter2; Morgan, Bruno2; Lloyd, David1
1University Hospitals of Leicester, Dept. of Hepatobiliary Surgery, Leicester,
UK; 2University Hospital Leicester, Radiology, Leicester, UK
Background. Several ablative modalities have been developed to treat
unresectable tumours in the liver. All previously developed modalities have
poor results in terms of local recurrence or high rates of complications
following attempted ablation particularly for larger tumours. Microwave
tumour ablation (MTA) has been performed in our centre successfully since
2001 using novel equipment.
Aims. To assess the efficacy of MTA to gain local control in patients with
fewer than 6 unresectable tumours.
Methods. Twenty seven consecutive patients with unresectable liver metas-
tases received MTA between 2002 and 2005. Tumours included colorectal
carcinoma secondaries (23), parathyroid (1), melanoma (1), neuroendocrine
(1) and carcinoid (1). All patients underwent pre-operative cross sectional
imaging and a total of 65 tumours (mean 2.1 cm; range 0.45.0 cm) were
ablated. Most patients underwent concomitant liver resection and were
followed up by three monthly cross-sectional imaging.
Results. No microwave related complications i.e. bleeding, abscess forma-
tion or bile duct injury were observed; there were no post-operative deaths.
Seventeen patients are alive post ablation of whom 9 are disease free (mean f/
u 19 months; range 442), 8 are alive with tumour recurrence (mean f/u 28
months; range 1240). The majority (6/8) have new tumours distant to the
ablation site however 2 patients have developed local recurrence following
treatment of metastases impinging on hilar vessels. The majority (63%) of
patients with recurrence are alive more than 2 years post ablation. Of the
patients who have died mean survival was 15 months post ablation (range
936).
Discussion. MTA is safe, efficient with a low local recurrence rate.
Treatment of hilar disease with microwave ablation remains a challenge,
although these results compare favourably to other ablative modalities such as
radiofrequency and cryotherapy. Further research into tumour ablation near
major vascular/biliary structures is required.
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Background. Many reports of cryoablation for metastatic liver tumors have
been published over the past 40 years. However, there have been few reports
with regards to cryoablation for hepatocellular carcinoma (HCC) in the
literature. Reports of mid-term and long-term results are especially rare.
Aim. The aim of this paper is to report the mid-term results of MR-guided
interstitial cryoablation for HCC.
Materials and Methods. Using a high-pressure argon based MR-compa-
tible cryoablation system, MR-guided percutaneous interstitial cryoablation
is performed. Treatments are guided and monitored with an open MRI.
Criteria for the candidates are as follows: 1. Tumors are limited to the liver. 2.
The number of tumors is less than or equal to 3. 3. The maximum diameter
of the tumor is less than 5 cm when it is solitary. The diameters are less than
or equal to 3 cm when multiple. We employed two freeze-thaw cycles. Our
protocol permits a single session for each tumor.
Results. Sixteen tumors in 15 cases were cryoablated. The average age was
61.4. All tumors were diagnosed as HCC with a fine needle biopsy, tumor
markers or image diagnosis. Fourteen cases were in class A of the Child-Pugh
classification and one case was in class B. The maximum diameters of the
tumors ranged from 1.2 to 4.5 cm and the average was 2.5 cm. The number
of cryoprobes ranged from 1 to 3 for each tumor and the average was 2.1.
The total freezing time ranged from 12 to 23 minutes and the average was
14.5 minutes. The follow up period ranged from 10 to 50.5 months and the
average was 36.7 months. Local recurrences occurred in 3 cases. We
experienced tumor recurrences in another segments of the liver in 8 cases.
In three cases the patients died 10, 27 and 30 months after cryoablation
respectively. There was no recurrence in 5 cases.
Conclusion. MRI-guided percutaneous interstitial cryoablation is a poten-
tial option for HCC.
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TASTASES FROM GASTROINTESTINAL STROMAL TUMOUR
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Background. Tyrosine kinase inhibitor-Imatinib mesylate has revolutionized
the treatment of metastatic gastrointestinal stromal tumors (GIST). Little
literature exists on the type and degree of tumour response.
Methods. Resected specimens of 3 liver metastasis were subjected to
histopathological examination with H&E staining and MIB1 staining (for
mitotic activity). The resections were performed 6 months after therapy with
400 mg/day of imatinib for metastatic GIST, following which partial response
was documented on CT scan and the lesions were negative on FDG-PET
scan.
Results. All 3 lesions showed viable tumour cells identical to the
pretreatment percutaneous biopsy. However, mitotic activity was entirely
absent and only 30% of the macroscopic tumour volume consisted of viable
cells.
Conclusion. Imantinib results in cessation of mitotic activity which may
account for a negative PET scan, however a significant number of viable
tumour cells persist- surgical resection is the best curative option.
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STRICTED TO 6 CYCLES
Pathak, Samir1; Verghese, Miriam1; Foster, Christopher2; Haqqani, Mus-
tafa3; Poston, Graeme4
1Royal Liverpool University Hospital, Surgery, Liverpool, UK; 2University of
Liverpool, Histopathology, Liverpool, UK; 3University Hospital Aintree,
Histopathology, Liverpool, UK; 4University Hospital Aintree, Surgery,
Liverpool, UK
Background. N-FOLFOX is now used routinely prior to R-CLM, but
recently concerns have been expressed about safety and post-operative
complications (P-OCs) post-N-FOLFOX 1, 2. These concerns relate
specifically to the development of sinusoidal dilatation (SD), fibrosis (F)
and steatosis (S) during N-FOLFOX.
Aims. To study prospectively a single-center cohort of R-CLM patients
stratified to N-FOLFOX (6 cycles) or no pre-operative chemotherapy (N-C).
Methods. 20 patients underwent R-CLM (10 N-FOLFOX; 10 N-C) and
normal liver examined by light (LM) and electron (EM) microscopy for SD;
H; NASH. P-OCs, hospital-stay and liver function tests (LFTs) were
compared post-R-CLM.
Results. There were no statistical differences between N-FOLFOX and N-C
groups in confounding factors including previous chemotherapy/alcohol/
medical history or other medications, P-OCs, post-R-CLM hospital-stays or
LFTs,. There was subjective loss on EM of mitochondria and Golgi following
N-FOLFOX. LM: no nodular regeneration, or hemorrhage in either group;
SD, F, S were graded 0, 1, 2: The study is ongoing to 20 in each arm.
SD0 SD1 SD2 F0 F1 F2 S0 S1 S2
10 NC 6 3 1 10 0 0 7 0 3
10 N-FOLFOX 3 6 1 10 0 0 5 3 2
Conclusions. Provided N-FOLFOX is restricted to 6 cycles pre-R-CLM,
there is no clinically significant deleterious effect of N-FOLFOX on normal
liver architecture and function, and recovery post-R-CLM. Six cycles N-
FOLFOX is safe and non-deleterious pre-R-CLM. 1. Ann. Oncol. 2004; 15:
4606 2. J Clin. Oncol. 2005; 23: 90738
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Background. Hepatobiliary cystadenomas (HBC) and cystadenocarcino-
mas are rare neoplasms of the liver or extrahepatic bile ducts, accounting for
less than 5% of all liver cysts. Most patients are asymptomatic, as a result of
which these lesions are incidental findings on abdominal imaging for
evaluation of other complaints. However, presentation with obstructive
jaundice may occur.
Aim/Objective. We describe the diagnostic evaluation, surgical manage-
ment and pathological findings of four patients with HBC and one patient
with hepatobiliary cystadenocarcinoma presenting with obstructive jaun-
dice.
Results. In the past 14 years, 13 patients were diagnosed with HBC or
cystadenocarcinoma in our institution. Five (38.5%) patients presented with
biliary obstruction. The first patient presented with intermittent colicky pain
and recurrent periods of obstructive jaundice. Imaging studies revealed a
polypoid lesion in the left hepatic duct. The second patient had recurrent
periods of jaundice and cholangitis. ERCP showed a cystic lesion at the
confluence of the hepatic duct. In the third patient with intermittent jaundice
and cholangitis, cholangioscopy revealed a papillomatous structure protrud-
ing into the left bile duct system. In the fourth patient with obstructive
jaundice, CT showed slight dilatation of the intrahepatic bile ducts and
dilatation of the common bile duct of 3 cm. ERCP showed filling of a cystic
lesion. All patients underwent liver resection, revealing HBC in the specimen.
In the fifth patient with obstructive jaundice, ultrasound examination showed
a hyperechogenic cystic lesion centrally in the liver. The resection specimen
revealed a hepatobiliary cystadenocarcinoma.
Conclusion. HBC or cystadenocarcinoma should be considered in patients
with obstructive jaundice in the presence of a cystic liver lesion. ERCP and
cross-sectional imaging techniques have great value for establishing the
diagnosis. Excision, usually requiring partial liver resection is the preferred
treatment.
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OUTCOME OF HEPATIC RESECTION AND PROGNOSTIC FAC-
TORS FOR HEPATOCELLULAR CARCINOMA
Lee, Ha Guen; Lee, Kwang Soo; Kyum Pa, Hwon
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Background and aims. In the treatment of HCC (hepatocellular
carcinoma), aggressive medical treatments developed that include liver
transplantation are showing positive treatment results. Among the
various kinds of treatment modalities for HCC, surgical resection is still
recognized main treatment method. Hence, we researched the clinicopatho-
logic features and results on the surgical resection for HCC by the single
operator.
Materials and method. Conducted on 260 patients who have been
diagnosed with HCC and received operative treatment at source hospital
between January of 1985 and December of 2003. Age, sex ratio, operation
method and result, survival duration have been retrograde analyzed by
clinical records and outpatient pursuit observation. RESULT: Males were by
far greater with 86.7% and average age was 52.8 years. Survival rate was
shortest at 1 month and longest at 192 months, and average survival period
was 55.2 months. The rate of survival for 1 year, 3 years, 5 years, 10 years
were 73.9%, 53.5%, 40.5%, 14.4% respectively, and disease free survival rate
was 49.9 months on average. 1 year, 3 years, 5 years, 10 years survival rate
were 68.1%, 46.6%,36.6%, 10.0% respectively. The most common recur-
rence organ was the liver, and the most operated treatment for recurrence
organ was radiofrequency ablation therapy. Average size of HCC was 4.5 cm
and the biggest tumor size was 19 cm. Trabecular type occupied the most
case in histologic classification. In resection, more than 3 lobes removed
occupied 65% with 157 cases.
Conclusion. Since HCC can acquire curative result through aggressive
operation, and the advancement of operative technique and anaesthetic
technique has led to a decrease in operative mortality and morbidity, surgical
resection for HCC can be considered a secure treatment method.
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Background. Less than 30% patients with hepatocelluar carcinoma (HCC)
are considered for curative resection. Without treatment, the median survival
is around 3 months. Transcatheter arterial chemoembolisation (TACE) has
become a standard option for unresectable HCC and is also used to palliate
hepatic metastases. The aim of this study is to evaluate the role of TACE in
management of unresectable HCC.
Methods. A total of 42 patients were diagnosed as having HCC between year
2000 to 2005 based on the biopsy result. Out of these 16 patients had
resection and 22 patients were considered suitable for TACE. Patients with a
decompensated liver function and/or encephalopathy were excluded from
TACE. TACE was performed with either Doxorubicin or Cisplatin as a
chemotherapeutic agent and with either polyvinyl alcohol (PVA) or Gelfoam
as an embolisation agent. All complications related to the procedures were
recorded together with the mortality rate.
Results. A total of 22 patients underwent 41 TACE procedures over a period
of 5 years in our institute. Fourteen patients had 2 TACE sessions, four had 3
sessions, one had 4 sessions and remaining 3 had one session each.
Doxorubicin was used in 88% (n/36) of the procedures while Cisplatin in
the rest. Embolisation was achieved with PVA and Gelfoam in 78% and 12%
of TACE sessions respectively. However, in four sessions (10%) only
chemotherapeutic agent was infused without embolisation. Eighteen patients
had multifocal lesions while four had single unresectable lesion. Twelve
patients (54%) had liver cirrhosis due to alcohol (n/3), viral infection (n/
7) and both (n/2). The median follow-up was 21.5 months (range 761
months) with a 1-, 2- and 3-year survival rate of 80.9%, 62.5% and 50%
respectively. There was no procedure related death or hepatic infarction or
acute liver failure.
Conclusion. These data suggest that TACE can be performed with relative
safety without increased risk of mortality or morbidity in patients with HCC
and a good synthetic liver function.
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Background. The aim was to analyse our results of Percutaneous
Transhepatic Cholangiogram & drainage (PTCD) and compare it with the
outcomes of Endoscopic Retrograde Cholangiopancreaticogram (ERCP)
with stenting.
Method. We conducted a retrospective review in our Liver unit, on 100
consecutive patients who underwent the PTCD procedure between Jan 2002
and Nov 2004. Data was collected from case notes. We compared it with 97
patients who had ERCP with stenting during this period. We analysed the
mortality and morbidity of PTCD and the success of stenting through both
PTCD and ERCP.
Results. We had complete data for 85 patients (Male-41: Female-44, age
range 3196). The indications for PTCD were for malignant disease [n/
74(87%)] and benign disease [n/11(13%)]. The procedure was successful
in 100% of the patients. Complications occurred in 19% of patients [sepsis
13(15%), bile leak 2(2%), Bleeding 1(1%)]. Overall 30-day mortality was
27% and all occurred in patients with malignant disease. 97 patients had
ERCP & stenting in the same period. The results were as follows:
Successful ERCP stent Failed ERCP stent
Hilar 6 9
Upper bile duct 8 6
Middle bile duct 9 1
Lower bile duct 51 7
ERCP & stenting of the mid and low bile duct strictures was largely
successful [60/68 (88%)]. However the success rate for hilar and upper bile
duct strictures was only 48% (14/29) and they subsequently underwent
PTCD.
Conclusion. 1. PTCD is a useful procedure for biliary strictures with a
100% success rate. 2. There is significant morbidity, especially sepsis.
Mortality is higher in patients with malignant disease which could be due
to the disease rather than the procedure. 3. PTCD is the procedure of choice
for hilar and high bile-duct strictures over ERCP.
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PERIOPERATIVE HEPATITIS B VIRUS ACTIVITY IN PATIENTS
UNDERGOING HEPATECTOMY FOR HEPATOCELLULAR CAR-
CINOMA AND ITS INFLUENCE ON PATIENT LONG TIME
SURVIVAL
Chen, Tao
Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Dept. General
Surgery, Guangzhou P.R. China, China
Background. HBV infection is associated with the development of
hepatocellular carcinoma (HCC). The viral activity following partial hepa-
tectomy is not well known.
Objective. This study aims at defining the influence of activity of hepatitis B
virus (HBV) in relation to surgical intervention and its impact on survival in
patients with HCC.
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Methods. Eighty consecutive HCC patients undergoing partial hepatectomy
were prospectively studied. The preoperative serum HBV imummune marker
The patients were further monitored for the virus activity by detecting HBV
DNA in sera 5 days (D5) and 1 month (M1) after the hepatectomyby
branched DNA assay (bDNA). 6 years postoperative overall survival and
recurrence free survival were further investigated and analyzed with HBV
replication status of patient in preoperative period or whether or not patients
encountered one episode of HBV replication enhancement in perioperative
period.
Results. The positive rates of HBsAg, HBeAg, HBeAb and HBcAb were
82%, 29%, 70%, and 97%, respectively. HBV DNA could be detected in
46% of the patients by bDNA assay. In the 57 (71%) sero-HBeAg negative
patients, HBV DNA could be detected in 17 (30%) patients. Overall, 34
(43.59%) patients had one episode of increasing of HBV DNA titer, which
might imply that viral replication was still unstable and might have once been
enhanced by hepatectomy. Recurrence free survival in patients with HBV
DNA reactivation were shorter as compared with patients without HBV
DNA reactivation (p/0.0431).
Conclusion. Reactivation or aggravation of HBV activity occurred in
43.59% of the patients after hepatectomy. Reactivation or aggravation of
HBV activity or simply HBV DNA replication enhancement in perioperative
period might result in poor recurrence free survival.
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Background. In spite of recent remarkable advances of diagnostic and
therapeutic modalities, patients with hepatocellular carcinoma (HCC) has
been showing poor prognosis because of high incidence of recurrence after
initial treatment. Previously studies reported that intrahepatic spread such as
vessel invasion or intrahepatic metastasis has been one of the significant
prospective factors associated with tumor recurrence and survival. Thus
intensive control of these satellite lesions will result in good prognosis. In this
report, we reviewed the correlation between gross classification of HCC
nodules and the clinicopathological findings in patients with HCC, especially
from the view point of the incidence and distribution of microscopic satellite
lesions.
Patients and methods. The base population consisted of 162 patients
who had undergone hepatectomy for initial and curative treatment of HCCs
less than 5 cm at our department between 1990 and 2000. According to
the classification of the general rules for the clinical and pathological study of
primary liver cancer of Japan, we categorized all the clinical samples into
tow groups. Group A includes single nodular type, and Group B includes
single nodular type with extranodular growth and contiguous multinodular
type.
Result. There were no significant differences in all factors analyzed except
the distribution of satellite lesions. The incidence of presence of satellite
lesions was 17.1% in Group A and 33.3% in Group B. The distance from
primary tumor to satellite lesions in Group B group were significantly longer
than in Group A. Average distance is 3.1 mm in Group A and 10.4 mm in
Group B. Wide spread of cancer cells was detected in Group B.
Conclusion. Not only high incidence of the presence of vascular invasion or
intrahepatic metastasizes but also wide spread of cancer lesions were noticed
in Group B nodules. When employing ablation and surgical therapy, Group B
patients should be paid more attention to the satellite lesions than Group A
patients.
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PREDICTIVE VALUE OF TNM, CLIP, JIS STAGING SYSTEM FOR
PATIENTS WITH HCC UNDERGOING SURGICAL RESECTION
Chun, JM; Hwang, YJ; Kim, YI
Kyungpook National University Hospital, Surgery, Daegu, Korea
Background. Several staging systems for hepatocellular carcinoma(HCC)
were proposed to estimate the disease severity and predict the prognosis.
Staging systems include various variables reflecting liver function and tumor
status. However, in surgical candidate, it is not determined which system is
the best predictive staging system.
Aim. We studied the best predictive staging system for the HCC patients
underwent surgical resection.
Methods. We stratified the 294 patients with HCC underwent curative
surgical resection according to AJCC/UICC TNM staging system(6th
edition), Cancer of the Liver Italian Program(CLIP) and Japanese Integrated
Staging score(JIS score) and analyzed predictive value of each systems.
Results. When the patients were stratified according to JIS, there was no
statistically significant difference in survival between JIS 0 vs. JIS 1(p/0.36)
and between JIS 2 vs. JIS 3(p/0.18). The CLIP scoring system also did not
show discriminating ability in survival. Under AJCC/UICC TNM staging
system, there was significant survival difference between each groups.
(between stage 1 vs. stage 2:pB/0.0001, between stage 2 vs. stage 3:p/0.05)
Conclusion. In case of surgical candidate, AJCC/UICC TNM staging
system(6th edition) is the best staging system for predicting the survival.
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Background. We analyze 60 patients with intrahepatic cholangiocellular
carcinoma (ICC) and examine the prognostic factors of this disease.
Methods. From January 1991 to December 2002, 60 patients with ICC
underwent surgical resection at 6 multiinstitutes of Study Group of Surgery
E1 (Osaka University Graduate School of Medicine). Clinicopatologic
factors were examined for prognostic factors.
Results. There were 33 men and 27 were women, with a mean age of 63.9
years. All 60 patients underwent liver resection, and they included 18
extended right or left hepatectomies, 23 right or left hepatectomies, 4
bisegmentectomy, 7 segmentectomy and 8 subsegmentectomy. Macroscopic
findings of the excised tumor showed 37 patients to have the mass-forming
(MF) type, 13 patients, the periductal-infiltrating (PI) type, and 10 patients,
the intraductal growth (IG) type. The cumulative 1, 3 and 5-year survival
rates were 66.5, 41.0 and 27.7%, respectively. The 5-year survival rate of MF,
PI and IG was 18.4, 44.9 and 50.0%, respectively (pB/0.05). Its rate in
patients with or without lymph node metastasis was 8.4 and 41.4%,
respectively (pB/0.05). The survival rates according to curability were
significantly different among three groups. Eight (14.0%) of the 60 patients
with surgical resection survived for more than 5 years, who underwent a
curative resection with cancer-free margin and lymph node metastasis-
negative.
Conclusion. In this study, prognostic factors influencing surgical outcome
may be a macroscopic type of tumor, lymph node metastases, surgical margin
and curability.
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Background. Curative liver resection remains the best treatment option for
colorectal cancer liver metastases (CRCLM). Overall survival is still limited
due to high recurrence rates. Neoadjuvant treatment was explored in regards
to a prolongation of survival in patients with high risk for recurrence.
Aims. 50 patients (pts) were treated with 6 cycles of neoadjuvant
chemotherapy (CHT) prior to liver resection for CRCLM. Chemotherapy
consisted of Oxaliplatin/5-FU/LV according to FOLFOX4 regimen or
Oxaliplatin (130 mg/m2 d1) and Xeloda (2000 mg/m2 d17) q14 over a 3
months period. Primary endpoint was recurrence-free survival (RFS),
secondary endpoints were overall survival, response, extend of liver resection
after CHT and perioperative morbidity/mortality.
Results. Recurrence-free survival was significantly altered by response to
chemotherapy: responders (36 pts) demonstrated a RFS of 25 months
compared to 8 months in patients with stable disease (10 pts) and 3 months
in pts with progressive disease under CHT (4 pts), pB/.005. Comparable
overall survival was significantly prolonged in responders (pB/0.05). The
extent of the liver resection could be substantially reduced in responding
patients. The perioperative mortality was 0% and the morbidity was 4% (1 bile
leak, 1 biloma). Multivariate analyses revealed response to CHT (pB/.005) and
number of metastases (pB/.05) independently related to recurrence of disease.
Conclusion. Oxaliplatin based chemotherapy demonstrates a high response
rate given preoperatively without increasing the perioperative morbidity. No
patient demonstrated with nonresectable disease after CHT. The extend of the
intended liver resection was considerably reduced in responders. Recurrence-
free and overall survival figures appear promising and further exploration of
preoperative CHT is highly recommended.
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RADIOFREQUENCY ABLATION AND COMBINED RESECTION/
ABLATION FOR UNRESECTABLE COLORECTAL LIVER METAS-
TASES
Polischuk, Lilia; Bagmet, Nikolay; Shatveryan, Garnik A; Petrenko, Konstan-
tin; Zavenyan, Zaven S; Skipenko, Oleg G
Russian Research Center of Surgery, Moscow, Russia
Background. Surgical resection is the optimal treatment for liver metastases.
However, due to their multifocality and/or insufficient remnant liver volume,
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the majority of liver metastases are unresectable. Radiofrequency ablation
(RFA) is increasingly used for the local destruction of unresectable hepatic
malignancies.
Methods. Since 2001, 37 patients with colorectal liver metastases were treated
for cure with RFA or combined RFA/hepatic resection. Patients were evaluated
during RFA treatment, throughout the immediate post RFA course, and then
every 3 months for 1 year and every 6 months for 2 following years after
treatment.
Results. Open intraoperative RFA was performed in 36 patients and
ultrasound-guided percutaneous RFA was performed in one case. A total of
50 tumors were treated with RFA, an average of 1.3 tumors per patient with a
range of 13 tumors per patient. A total of 39 RFA procedures were performed
in 36 patients because 2 patients developed new hepatic tumors detected during
follow-up that were treated with a second course of RFA. The size of tumors
treated with RFA ranged between 0.3 and 7.0 cm in diameter (2.6 cm9/1.2
cm). RFA only was performed in 10 patients, combined with resection in 24.
Three patients underwent intraarterial subcutaneous port placement at the
time of the ablational procedure. Six patients had complications: one skin burn;
two perihepatic abscess occurred in patients who underwent resection
combined with RFA; one hepatic abscess arising within a RFA lesion; one
postoperative myocardial infarction and one biliary fistulae. At a median
follow-up of 14 months (range, 136 months), 4 patients have died because of
disease progression and 2 due to other reasons. New liver tumors are developed
in 10 patients; three of them had recurrences at an RFA site.
Conclusions. Hepatic tumor RFA can be performed with low morbidity rates.
RFA alone or in combination with resection may offer a significant benefit by
allowing complete tumour clearance in patients with unresectable liver metastases.
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Background. Radiofrequency ablation (RFA) has been widely applied for the
treatment of hepatocellular carcinoma and liver metastases. The reported
mortality and morbidity rates are low.
Aim. To evaluate the safety and efficacy of RFA in the treatment of malignant
liver tumours.
Patients and methods. From May 2003 to Feb 2006, 79 patients with hepatic
malignancies (59 hepatocellular carcinoma, 20 liver metastases) with a total of
110 lesions underwent RFA in our centre. Post-ablation follow-up assessment
by CT scan, MRI and tumour markers was performed in all patients at 1-
month, 3-month and 6-month interval. Other outcome parameters including
post-operative complications, recurrence rate and survival were collected
prospectively.
Results. The mean age of patients was 60.0 years (range 3793). In 46.8% of
cases, we used a percutaneous approach; in 8.9% of cases a laparoscopic
approach; and 44.3% of cases an open approach. The mean tumour size ablated
was 2.4 cm (range 0.58.0). Among the laparoscopic and open surgery groups,
69% of patients also received concomitant operative procedures such as
cholecystectomy and hepatectomy. All patients tolerated the procedure well
without treatment-related mortality. Immediate complications occurred
in 5 patients (6.3%), including gastric serosal burn (n/1), ground pad
superficial skin burn (n/1), intra-abdominal bleeding (n/2) and pneumonia
(n/1). Post-ablation fever was observed in 20.3% of patients. All patients
except one attended subsequent follow-up, with a mean period of 9.3 months.
The ablation was considered complete in 82.3% of patients. Intra-hepatic
recurrence was observed in 26.6% of patients in subsequent follow-up. Extra-
hepatic recurrence was observed in 15.2% of patients. One-year survival was
90.0%.
Conclusion. Radiofrequency ablation is a safe and effective procedure for
patients with malignant liver tumours. A more prolonged follow-up study is
required to assess longer term outcomes.
P22.59
RISK FACTORS FOR AND MANAGEMENT OF RECURRENCE
AFTER POTENTIALLY CURATIVE RESECTION FOR HEPATO-
CELLULAR CARCINOMA
Shah, Shimul1; Cleary, Sean2; Wei, Alice2; Yang, Ilun2; Taylor, Bryce2;
Grant, David2; Langer, Bernard2; Greig, Paul2; Gallinger, Steven2
1University Health Network, Surgery, Toronto, Canada; 2University of
Toronto, Surgery, Toronto, Canada
Tumor recurrence remains the major cause of death after potentially
curative resection for hepatocellular carcinoma (HCC). The purpose of
this study was to identify risk factors for and long-term outcomes after
recurrence of HCC.
Methods. From 07/1992 to 07/2004, 193 consecutive patients who under-
went hepatic resection as primary therapy with curative intent for HCC were
included in this single center analysis. The perioperative mortality rate was
5%. Time to recurrence (disease free survival, DFS) and overall survival were
primary endpoints and demographic, tumor, and treatment characteristics
were tested for their prognostic significance.
Results. More than half the patients (54%) were diagnosed with HCC by
screening, 58% had hepatitis B and 87% were Child’s A cirrhotics. Median
overall survival was 71///11 months and DFS was 34 months. After a
median follow-up of 34 months, 98 patients (51%) developed recurrent
cancer; initial tumor recurrence was confined to the liver in 86 patients
(88%). By multivariate analysis, preoperative vascular invasion, post-
operative vascular invasion on pathologic assessment, intermediate and
poor tumor differentiation and tumor number were significant independent
predictors of DFS. Of the 98 patients who developed tumor recurrence, 53
(54%) underwent additional therapy (11 re-resection, 31 ablation, 8
transarterial chemoembolization, 3 liver transplant) with prolongation of
survival.
Conclusion. Despite recurrences in more than 50% of patients, long-term
survival can be achieved following resection of HCC. Identification of risk
factors, close follow-up and early detection are mandatory as recurrences
confined to the liver may be amenable to multimodality treatment with an
additional survival benefit.
P22.60
ROLE OF LIVER RESECTION IN THE SELECTION OF PA-
TIENTS FOR LIVER TRANSPLANTATION IN THE SETTING OF
HEPATOCELLULAR CARCINOMA BEYOND MILAN CRITERIA
Facciuto, Marcelo; Rocca, Juan P; Wolf, David C; Kim-Schluger, Leona;
Chun, Hoo G; Marvin, Michael; Rodriguez-Davalos, Manuel; Rozenblit,
Grigory; Manaham, Susan; Sheiner, Patricia A
Westchester Medical Center, New York Medical College, Valhalla, USA
Background. There is no clear consensus on the best treatment strategy for
patients with advance hepatocellular carcinoma (HCC)
Aim. The aim of this study was to analyze the role of liver resection in
patients with T3-T4 HCC
Methods. Fifteen patients underwent LR and 19 patients underwent liver
transplantation (LT). Pathologic tumor staging was based on the American
Liver Tumor Study Group modified Tumor-Node-Metastases (TNM)
classification
Results. No differences were found between the LR and LT groups in sex,
percentage of HCV cirrhosis, number of nodules and presence of vascular
invasion and satellites nodules. Patients in the LR group were older and
within Child-Turcotte-Pugh class A (mean Child score 5 vs. 8 in the LT
group). The biggest tumor size was significantly larger than the LR group
(8.4 cm vs. 4.1 cm) Median follow up for the resected group was 13 months
and 20 months for the transplanted group. During the first year follow up, the
survival in the resected group was significantly lower (67% vs. 95%, p/
0.04), reflecting mainly death due to extrahepatic HCC recurrence. How-
ever, the Kaplan-Meier survival rates at 2 years were 67% for the resected
group and 84% for the transplanted group (p/0.2) Overall Tumor
recurrence was higher in the LR group (60% vs. 19%). Extrahepatic
recurrence was not significantly different between the two groups (27% in
LRvs.19% in LT). Intrahepatic recurrence appeared in 5 patients in the LR
group (33%), 3 of them underwent salvage LT with no recurrence over a
mean follow up of 12 months.
Conclusion. In view of recent published evidence supporting expansion of
the indication of LT for HCC beyond Milan criteria, LR in selected patients
can control the tumor burden especially with the increased waiting times for
LT. Intrahepatic recurrence can be treated with salvage liver transplantation.
Better selection of patients for LT can be achieved after LR. Exclusion of
patients with early extrahepatic recurrences will optimize the use of scarce
organs.
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RUPTURED HEPATOCELLULAR CARCINOMA FOLLOWING
CHEMOEMBOLISATION: A RARE COMPLICATION
Battula, Narendra; Madanur, Mansoor; Srinivasan, Parthi; Karani, John;
Rela, Mohamed; Heaton, Nigel
Kings College Hospital, London, UK
Background. Transcatheter arterial chemoembolization (TACE) is exten-
sively used as the primary therapy for unresectable hepatocellular carcinoma
(HCC). Serious complication like neutropenic sepsis and hepatic decom-
pensation are well known but rupture of HCC following TACE is a rare and
potentially fatal complication.
Aim. The aim of this study is to identify the incidence of ruptured HCC
following TACE and the associated risk factors.
Methods. A retrospective analysis was performed using our liver database
with keywords ‘‘chemoembolisation’’, ‘‘ruptured HCC’’ covering patients
who received chemoembolisation from Jan 1995 to Dec 2005. An extensive
review of published literature using Pubmed search revealed only 1 reported
case of ruptured HCC following TACE till now from western countries in
English language.
Results. A total of 294 patients received chemoembolisation in 530
sessions during this 10 year period of these 2 had ruptured HCC giving
an overall incidence of 0.68%. The mean age was 65 years and the mean
interval between procedure and rupture was 13 days. One patient had
126 Abstracts
2 sessions of chemoembolisation prior to rupture. The common factors
were male sex, large tumour size (range 1113 cm) with exophytic growth
of tumour. None of them had any evidence of arteriovenous fistulas on
digital substraction angiogram (DSA), coagulopathy or toxicity from
chemoembolisation. One patient died 2 days after rupture with hepatic
decompensation while the second is alive at 5 months follow up without
tumour recurrence.
Conclusion. Ruptured HCC following TACE is a rare but serious
complication. Large tumour size, male sex and exophytic growth of tumour
may be predisposing factors for rupture.
P22.62
SELECTIVE INTERNAL RADIATION THERAPY (SIRT) FOR
CARCINOID LIVER METASTASES-A NEW AND EFFECTIVE
MODALITY FOR TREATMENT
Stubbs, Richard S; Rajekar, Harshal
Wakefield Gastroenterology Centre, Wellington, New Zealand
Background. Non-resectable carcinoid liver metastases respond poorly to
most modalities of treatment. Selective Internal Radiation Therapy (SIRT) is
a promising method for treating non-resectable liver cancers, both primary
and secondary. This treatment achieves tumour destruction through the
relatively selective delivery of high dose radiation to liver tumours following
hepatic arterial delivery of 90Yttrium microspheres. This paper presents an
experience of 6 patients with non-resectable carcinoid liver metastases.
Methodology. Between 2.03.0 GBq of 90Yttrium microspheres were given
to all 6 patients between September 1997 and August 2004. Repeat SIRT was
undertaken in one patient after 16 months. Responses were assessed
clinically, with 24 hour urinary 5-HIAA levels, and with serial CT scans.
Results. 5 of the 6 patients had a remarkable clinical response. Median 24-
hour urinary 5-HIAA levels, expressed as a percentage of pretreatment level,
fell to 23%, 24% and 33% at 1, 3, and 6 months respectively. All patients had
regression of carcinoid symptoms for a prolonged period. Repeat treatment in
one patient was associated with a further good response. Mean survival was
26.6 months with 3 of the patients being alive and asymptomatic, at 17
months, 18 months and 51 months following SIRT. One patient is currently
being considered for liver resection. Serial CT scans revealed good responses
in 4/4 patients scanned.
Conclusions. SIRT is a valid and effective treatment option for non-
resectable carcinoid liver metastases and can achieve striking regression in
many instances. Repeat treatment is an option. Liver resection after down-
staging may also be possible.
P22.63
SELECTIVE INTERNAL RADIATION THERAPY WITH SIR-
SPHERES IN PATIENTS WITH NON-RESECTABLE LIVER TU-
MOURS: A PROSPECTIVE STUDY
Adib, Reza; Clouston, John; Walker, Duncan; Martin, Ian; O’Rourke,
Nicholas; Nathanson, Leslie K
Wesley Hospital, Brisbane, Queensland, Australia
Purpose. To evaluate the efficacy and safety of selective internal radiation
(SIR) spheres in unresectable primary or secondary hepatic malignancies.
Methodology. Forty patients were treated between January 2002 and
December 2005. Aetiology included colorectal cancer (n/20), hepatocel-
lular carcinoma (n/10), carcinoid (n/6), neuroendocrine cancer (n/3)
and breast cancer (n/1). Of these, 18 received chemotherapy before
treatment, 18 had no previous chemptherapy and 4 had undergone liver
surgery. The 1.8 to 3.5 GBq SIR-spheres were implanted into the hepatic
arterial system as a single dose through a femoral approach. Following
treatment, 19 continued to receive chemotherapy, and 20, no further
treatment. Three patients underwent laparoscopic ligation of visceral
branches of the hepatic artery to avoid potential malperfusion.
Results. Response to treatment was assessed clinically and radiologically at
regular intervals. The duration of response ranged from 4 months to 2 years.
Most patients experienced abdominal pain within the first two days of
treatment. Severe side effects included peptic ulceration (n/4), liver failure
(n/4), and depression, anorexia, rash and severe pain (n/4). The
remaining 28 experienced no serious longstanding side effects. There was
no procedure-related 30-day mortality. At the end of the study period, 22
patients had died; 18 remained alive. Neuroendocrine and carcinoid tumors
showed better radiological response
Conclusion. In this prospective study, treatment with SIR-spheres appears
to be safe, with an acceptable toxicity profile, and should be considered as a
local treatment modality for patients with metastatic liver tumours. Further
randomized trials are necessary in comparing this therapy with other
modalities of local treatment in metastatic liver disease.
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SUCCESSFUL RESECTION IN PREVIOUSLY CONSIDERED
UNRESECTABLE INTRAHEPATIC CHOLANGIOCARCINOMA
Florez, Carlos W1; Hessheimer, Amelia J2; Fernandez, Rosa A3; Cervantes,
Felipe1; Flores, Luis1; Vidal, Pablo1; Toiber, Mijail1; Enriquez, Enrique4
1The American British Cowdray Medical Center, Surgery, Mexico City,
Mexico; 2Hospital Clinic Barcelona, Barcelona, Spain; 3The American
British Cowdray Medical Center, Internal Medicine, Mexico City, Mexico;
4The American British Cowdray Medical Center, Imaging, Mexico City,
Mexico
Background. Intrahepatic cholangiocarcinoma (ICC) is the second
most common primary hepatic tumor, though its incidence is rare. The
prognosis is poor, but surgical treatment has achieved survival benefits in a
few patients.
Aim. To report a case of a patient whose ICC was initially considered
unresectable but who was eventually surgically intervened with successful
results.
Patient. A 57-year-old woman presented with right upper quadrant (RUQ)
pain. Undergoing evaluation for cholelithiasis, a 13/9 cm tumor in hepatic
segments IV and V and extending into the gallbladder and colon was detected
on US and CT. The patient was clinically Child A; AFP, CA 19-9, and CEA
levels were normal. Fine needle biopsy of the tumor demonstrated well-
differentiated ductal carcinoma, and transarterial embolization was per-
formed. Three weeks later, she developed fever, further RUQ pain,
leukocytosis, and advanced to Child B. Imaging showed acute cholecystitis,
and antibiotic treatment was started. The fever and pain persisted, and
surgical exploration was undertaken, revealing acute cholecystitis and sealed
perforation by the tumor to the transverse colon. Resection of liver segments
IVb and V and right hemicolectomy were performed. The pathology report
described ICC invading gallbladder and sealed perforation of the colon. The
draining lymph nodes were negative for tumor metastases.
Results. Postoperative evolution was satisfactory, with normal analytical
parameters by postoperative day 2. Adjuvant chemotherapy was adminis-
tered. US and CT performed at 6 and 10 postoperative months demonstrated
complete hepatic regeneration and no tumor recurrence.
Discussion. The prognosis of ICC is poor, with 9 and 42% 5-year survival
with and without lymphatic invasion. In our case, there were neither
lymphatic nor vascular infiltration, and the resection margin was tumor-
free, factors that, in spite of tumor invasion of the gallbladder and colon,
seem to influence positively in the patient’s prognosis.
P22.65
SURGERY IN PATIENTS WITH ADVANCED HEPATOCELLULAR
CARCINOMA
Escartin, Alfredo; Grau, Silvia; Villalonga, Ramo´n; Dopazo, Cristina; Bueno,
Javier; Allende, Helena; La´zaro, Jose´ L; Bilbao, Itxarone; Balsells, Joaquin
Hospital Vall d’hebron, Liver Transplantation Unit, Barcelona, Spain
Milan Criteria for Hepatocellular Carcinoma (HCC) are accepted to be the
limit for transplantation and also for surgery. However, indication for
reduction surgery in patients with Advanced HCC are possible in our
opinion.
Aim. To study the feasibility and benefit of liver resection (LR) for
hepatocellular carcinoma (HCC) exceeding the Milan criteria.
Patients and methods. From 1987 to 2005, 156 patients underwent 164
LR for HCC. In a cohort of 64 patients, pathologic examination showed an
intermediate (stage B) HCC (single tumor/5 cm or multinodular/3 cm) in
49 cases and advanced (stage C) HCC in 15 (macrovascular or extrahepatic
invasion). Mean age was 61.99/12 years, 85% were male and 35 were
cirrhotics. 37 major hepatectomies were performed (58%). Mean tumor size
was 8.5 cm; 34.4% were multinodular. Vascular invasion was found in 40.6%
of cases.
Results. Operative mortality was 6.3%. 43 patients presented tumor
recurrence. Treatment of hepatic recurrence included LR in 4 cases and liver
transplantation in 5. 43 patients died, 35 from recurrence. Median survival was
34.3 months. Actuarial patient survival at 1,5 and 10 years was 85%, 43% and
17% for stage B and 59%, 7%, 7% for stage C (p/0.0002). In stage B, a
margin B/1 cm and age over 70 were predictive factors of both worse patient
and tumor-free survival and microvascular invasion only of the later.
Conclusion. Liver resection should be indicated whenever possible in
intermediate-stage HCC, whatever tumor size.
P22.66
SURGICAL MANAGEMENT OF LIVER HEMANGIOMAS
Saribeyoglu, Kaya; Pekmezci, Salih; Tasci, Hasan; Kapan, Metin; Durgun,
Vedat; Kilic, Y´lknur; Kalafat, Hasan; Sariyar, Muzaffer
Istanbul University, Cerrahpasa Medical School, Dept. of General Surgery,
Istanbul, Turkey
Background. The assement of the role of enucleation in liver hemangiomas.
Aim. To report our experience in the surgical management of liver
hemangiomas.
Methods. Between April 2003-July 2005, the patients who were admitted to
our clinic and underwent surgery for liver hemangiomas were taken into the
study. Patients’ records were retrospectively collected and analyzed.
Results. During the study period 13 patients underwent surgery for
hemangiomas of the liver. There were 10 female and 3 male patients and
mean age was 42.9 (2162). Eight and six hemangiomas were localized at
right and left lobe respectively and one tumor was in central location. In
two patients there were two hemangiomas operated. The diameters of the
tumors varied between 830 cm and all were symptomatic. In those with
central localization or huge dimensions, preoperative selective arterial
Abstracts 127
embolization was performed. Hemangioma enucleation was performed in 11
(78.5%) and 3 (21.5%) patients respectively. There was no mortality and
perioperative morbidity. Patients are symptom free on a mean follow-up of 20
months (835).
Conclusion. Enucleation of the liver hemangiomas is the procedure of choice
in selected group of patients who requires surgical treatment.
P22.67
SURGICAL OUTCOME OF HEPATECTOMY FOR LARGE HEPA-
TOCELLULAR CARCINOMA
Cho, Eung-ho1; Suh, Kyung-Suk1; Yang, Sung H1; Lee, Hae W1; Cho, Jai Y1;
Cho, Yong B1; Yi, Nam-Joon1; Choi, Jae W2; Lee, Kuhn U1
1Dept. of Surgery, Seoul National University, College of Medicine, Seoul,
South Korea; 2Dept. of Surgery Chungbuk National University Hospital,
Cheongju-si, Chungbuk, South Korea
Background. Management for large hepatocellular carcinoma (]/10 cm) is
still debatable especially about the role of surgery. The object of this study is to
review the outcome of hepatic resection for patients with large hepatocellular
carcinoma.
Method. Between January 2000 and June 2003, 223 consecutive patients
underwent hepatic resection for HCC. In them, 186 patients with single tumor
were included in this study. The patients were divided into two groups, large
group (the largest tumor diameter ]/10 cm, n/21) and small group (n/165)
to compare clinicopathologic features. Mean age is higher in small group
(55.99/9.6 in small group versus 51.29/10.1 in large group, pB/0.05) and
mean preoperative alpha-fetoprotein (AFP) level was higher in large group
(2557.89/8923.4 vs. 47864.49/125392.4, pB/0.05). Sex, underlying liver
disease, Child score were similar in both groups (p/0.05).
Results. Perioperative mortalities (5/165, 3% vs 0/21, 0%) and postoperative
complication rates (21% vs 23%) were not different between small and large
group (p/0.05). Three postoperative liver failures occurred in small group,
and 2 of them died. In large group, no postoperative hepatic failure occurred.
There was nodifference in recurrence rates (53% vs.68%) and the meandisease
free survival periods (26.49/21.2 months vs. 30.39/28.3 months) between both
groups (p/0.05). However, microscopic vascular invasion was more frequent
(31% vs. 56%) and preoperative AFP level was higher in large group (pB/0.05).
Conclusion. Hepatic resection is safe for patients with large HCC. If
carefully selected, surgical resection can achieve similar disease free survival
to that of smaller tumors.
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SURGICAL TREATMENT FOR INTRAHEPATIC CHOLANGIO-
CARCINOMA COMPARED BY MORPHOLOGICAL FACTORS
Isaka, Takahiro; Takada, Tadahiro; Nagashima, Ikuo; Amano, Hodaka;
Yoahida, Masahiro; Miura, Humihiko; Toyota, Naoyuki; Wada, Keita;
Takagi, Kenji; Kato, Kenichiro
Teikyo University School of Medicine, Tokyo, Japan
Background. Intrahepatic Cholangiocarcinoma is second most common
primary liver cancer. Intrahepatic Cholangiocarcinoma is classified by
morphological and radiological image. According to the definition, Intrahe-
patic Cholangiocarcinoma is cancer primary from secondary branch of bile
duct or intrahepatic bile duct. They are grossing classified into three types,
mass forming type, periductal infiltrating type and intraductal growth type.
Intrahepatic Cholangiocarcinoma is rarely for surgical treatment compared to
Hepatocellular carcinoma. We reported our experienced patients of Intrahe-
patic Cholangiocarcinoma.
Material. We experienced 23 patients of Intrahepatic Cholangiocarcinoma
from 1996 to 2006, and studied surgical treatment compared by morpho-
logical factors.
Results. We experienced 14 of mass forming with periductal infiltrating type,
5 of periductal infiltrating type, 3 of mass forming type and 1 of intraductal
growth type. Metastasis of lymph node was recognized in 7, peritoneal
dissemination was recognized in 5. 18 patients were performed hepatectomy,
trisegmentectomy was performed for 3, extensive bisegmentectomy for 7,
bisegmentectomy for 5, and one or less segementectomy for 3, respectively. 5
patients who had peritoneal dissemination were not performed hepatectomy.
Hepatectomy with en block caudate lobe resection was performed for 14, bile
duct resection for 13, major vessels resection for 5, and 3 of them were
performed hepatic artery resection, respectively. 4 patients who were
performed hepatectomy 5 years survived after treatment, especially 1 patient
who had mass forming with periductal infiltrating type with metastasis of
lymph node was performed extensive bisegmentectomy with caudate lobe
resection and right hepatic artery resection.
Conclusion. Intrahepatic Cholangiocarcinoma has many varieties of infil-
tration and invasion. Resection procedures should be designed based on a
precise diagnosis of the extent of carcinoma, for improves survival of patients
with Intrahepatic Cholangiocarcinoma.
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SURGICAL TREATMENT OF METASTATIC BREAST CANCER
Caralt,Mireia;Escartı´n,Alfredo;Bilbao, Itxarone;La´zaro, Jose´L;Lo´pez, In˜igo;
Bergamini, Silvina; Dopazo, Cristina; Balsells, Joaquim; Margarit, Carles
Hospital Vall Hebron, Barcelona, Spain
Introduction. The indication of liver resection (LR) for metastasic breast
cancer is controversial due to its extrahepatic dissemination. When the
disease is localized in the liver, LR may increase the survival.
Aims. To analise our experience in the surgical treatment of liver metastases
(LM) of breast cancer.
Patients and methods. Between 1988 and 2006, 12 patients underwent 13
hepatectomies. All patients were women and the mean age was 57 years.
The breast surgery performed was mastectomy in 7 cases (58%) and in 5
cases (42%) lumpectomy, both with axillary lymph node dissection. The
primary cancer was infiltrating ductal carcinoma in 11 cases (92%) and
infiltrating lobular carcinoma in 1 case. Only one patient had synchronous
LM, but breast and hepatic surgery were not performed at the same time.
One case had extrahepatic metastases (bone). All patients received adjuvant
therapy. The mean time between the breast surgery and the diagnose of LM
was 91 months, and the mean time between the diagnose and resection of
the LM was 13 months. During that time, 6 (50%) patients received
neoadjuvant therapy.
Results. 6 (50%) patients underwent a major hepatectomy and 6 (50%) a
minor hepatectomy. No patients died after surgery. Few surgical complica-
tions were described: 1 mild hepatic insufficiency, 1 mild biliary leak, 1 mild
ascites, 1 diafragmatic lesion and 1 stenosis of the bile duct. All of them were
successfully resolved. After the LR, 8 (66%) patients received adjuvant
therapy. Six (50%) patients developed hepatic recurrence and the disease free
survival was 25 months. Other systemic metastases appeared in the lung in
one case, and in the brain and bone in another case. Seven (58%) patients are
still alive and only one of them with hepatic recurrence. The mean survival
after the LR is 37 months.
Conclusions. In selected cases, LR for metastasic breast cancer may
increase the survival. It can be an alternative treatment together with
chemotherapy with good results and few complications.
P22.70
SURVIVAL FOLLOWING RESECTION OF MULTIPLE COLOR-
ECTAL LIVER METASTASES: A SYSTEMATIC REVIEW
Smith, Mark D; McCall, John L
Auckland City Hospital, Dept. of General Surgery, Auckland, New Zealand
Background. Liver resection is potentially curative for colorectal liver
metastases (LM). The prognostic significance of the number of LM resected
is difficult to determine accurately from individual studies, because of limited
sample size.
Aim. The aim of this study was to provide an accurate estimate of prognosis
after resection of solitary, 23, or ]/4 LM.
Methods. A systematic review of English language publications between
January 2000 and February 2005 was carried out. Papers that specified long-
term outcome, related to the number of LM resected, were included. Data
was extracted using a standardised proforma and transferred onto a database
for descriptive analysis.
Results. Twenty-seven papers, describing outcomes of 5088 patients, met
the inclusion criteria. Pooled 5-year overall survival for patients with 1, 23,
or ]/4 LM resected was 45% (n/768), 48% (n/230), and 23% (n/892)
respectively.
Conclusion. Survival following resection of LM declined with increasing
numbers of metastases. Nevertheless at least 20% of patients with 4 or more
LM achieved 5-year survival, therefore multiple tumours (]/4) are not an
absolute contraindication to radical treatment.
P22.71
SURVIVAL OF PATIENTS WITH HEPATIC METASTASES FROM
NON-COLORECTAL NON-NEUROENDOCRINE CARCINOMA
Lee, Frederick; Chu, Francis; Aravind, Aravind
St. George Hospital Liver and Peritoneal Unit, Dept. of Surgery, Kogarah,
Australia
Background. Liver resections for NCNN metastases have been advocated
for only very select patients. Other units have conducted studies indicating
long-term survival rates of NCNN metastases of greater than 50%. A review
was conducted of this Unit’s experience.
Objective. To determine long-term survival of liver resections for non-
colorectal, non-neuroendocrine (NCNN) carcinomas.
Methods. Between January 1990 and November 2005, 56 patients under-
went a liver resection at the St.George Hospital Liver & Peritoneal Unit for
NCNN metastases. The gender, age, mode of presentation, disease free
interval, presence of extra hepatic disease at time of surgery, lobar
distribution, size and number of metastases were analyzed. Outcomes were
examined by the Kaplan-Meier method using SPSS v11.5.
Results. The 30 day post-operative mortality was 3.8%. The percentages of
types of metastases resected were 18.9% sarcoma, 15% renal, 13.2%
melanoma, 11.3% gallbladder, 9.4% breast, 5.6% testicular, 5.6% pan-
creatic, 3.7% stomach, 1.8% ovarian and 24.5% other tumours. The
median tumour size was 5 cm and the median number of lesions was 2.
The calculated 5 year survival was 32.4% with a median survival of 31
months.
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Conclusion. Liver resection for selected patients with NCNN metastases is a
treatment option with acceptable mortality, long-term survival and possibility
of cure.
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SQUAMOUS CELL CARCINOMA OF ORAL CAVITY AND META-
CHRONOUSLY DEVELOPED HEPATOCELLULAR CARCINOMA
ARISING FROM FANCONI’S ANEMIA
Park, Jong-Hoon; Min, Jae Seok
Daegu Fatima Hospital, Surgery, Daegu, Korea
Fanconi’s anemia (FA) is a rare familiar form of aplastic anenia (AA) that is
associated with increased chromosomal instability and defective DNA repair,
and it chracterized by progressive pancytopenia, skeletal abnormality,
hyperpigmentation, and an increased risk of leukemia, hepatocellular
carcinoma (HCC) and squamous cell carcinoma (SCC), including head
and neck SCC. We report a 31-year-old man who had AA for 17 years and
who developed SCC of oral cavity and then metachronously developled
HCC. For treatment of his AA, he was given cyclosporin, steroid and
androgen in addition to frequent blood transfusion. At the age of 27, he
presented with SCC of the maxilla and the right maxillectomy was performed.
Four years later in 2003, hepatic resection of the left medial segment of the
liver was performed due to the hepatocellular carcinoma. Confirming of FA
was done by cytogenic analysis. The patient died in 2005 of subdural
hemorrhage and pneumonia without involvement of the SCC and HCC.
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TETRAPLOIDIZATION PROMOTES SENSITIVITY TO GENO-
TOXIC STRESS INDUCED BY DNA-DAMAGING AGENTS
Hau, Pok M1; Siu, Wai Y1; Poon, Randy Y1; Wong, John2; Wong, Nathalie3;
Lai, Paul B2
1Hong Kong University of Science and Technology, Dept. of Biochemistry,
Hong Kong, China; 2Prince of Wales Hospital, The Chinese University of
Hong Kong, Dept. of Surgery, Hong Kong, China; 3The Chinese University
of Hong Kong, Dept. of Anatomical and Cellular Pathology, Hong Kong,
China
Background & aim. Polyploidy occurs naturally in many cell types such as
myoblasts, megakaryocytes, and hepatocytes. A change in ploidy is also one
of the key features of tumorigenesis. In this study, we investigated if the ploidy
affects the responses to genotoxic stress in cancer cells.
Methods. Hep3B cell line (from ATCC) was used as the in vitro model for
this study. The cells were treated with nocodazole (a spindle toxin) to
generate a stable tetraploidy line. The responses of the diploid and the
tetraploid lines to ionizing radiation and topoisomerase inhibitors were also
studied.
Results. We found that the checkpoints that monitor spindle assembly and
tetraploidy were defective in the hepatocellular carcinoma cell line Hep3B.
Prolonged treatment of Hep3B cells with nocodazole promoted mitotic exit
without an intervening cytokinesis, and these cells further re-replicate their
DNA to produce tetraploid cells. However, by reintroducing p53 gene, it was
found that the checkpoints were reactivated and tetraploidization was
suppressed in Hep3B cells. The tetraploidy cell line showed an increase in
the cell volume without significant effect on the cell cycle. Interestingly, the
tetraploid cells were sensitized to genotoxic stress inflicted by ionizing
radiation and topoisomerase inhibitors. Histone H2AX phosphorylation
and foci formation were strongly induced by radiation in the tetraploid cells.
In contrast, the sensitivity to spindle poisons was not affected by tetraploidy.
Conclusion. We observed an increased sensitivity of the tetraploid cells to
ionizing radiation and topoisomerase inhibitors. These results suggest that it
may be beneficial to treat certain cancer cells by first inducing polyploidy with
spindle toxins before treatment with DNA-damaging agents.
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THE ADEQUATE APPROACH TO RADIOFREQUENCY ABLA-
TION OF LIVER METASTASES
Eisele, RM; Schumacher, G; Neuhaus, P
Dept. General, Visceral and Transplantation Surgery, Charite´ Campus
Virchow-Clinic, University of Berlin, Germany
Introduction. Radiofrequency ablation (RFA) extends the scope of surgery
in the treatment of liver metastases. It can be administered percutaneously,
laparoscopically and by means of open surgery. The local tumor control
achieved by these three different techniques as a prerequisite for successful
oncological therapy is compared in the pesented report.
Patients and methods. 80 tumor nodules in 38 procedures at 35 patients
were performed. Indications included colorectal metastases (23 pat., 60%),
gynecological malignancies (3 pat., 9%), neuroendocrine metastases (2 pat.,
6%), metastases of pancreatic cancer (2 pat., 6%) among others (5 pat., 14%).
RFA was performed laparoskopically in 5 (12%), percutaneously in 14 (38%)
and open surgically in 19 (50%) cases, 10 of the latter ones including
simultaneous liver resection. The average tumor size was 2.08 (range 0.8 to
6) cm, the average number of nodules treated was 2.1 (1 bis 10) per session,
average follow-up period was 19 months (median 15 months). Local
recurrence was confirmed histologically in four cases, another four cases
were diagnosed in contrast-enhanced cross-sectional examinations (CT or
MRI).
Results. Local tumor control succeeded in 30 cases (74%). Whereas local
recurrence rate was 4.8% (1/19) using the open surgical approach, percuta-
neous RFA resulted in 50% local tumor recurrence (7/14). None of the
laparoscopic RFAs ended up with local recurrence.
Conclusion. For RFA of hepatic metastatic disease, open surgical or
lapaaroscopic access should be chosen whenever possible due to local tumor
control comparable with the results of resection. Percutaneous RFA has to be
considered a palliative treatment.
P22.75
THE EFFECT OF LIVER METASTASES RESECTION ON THE
SURVIVAL OF COLORECTAL CANCER PATIENTS
Kilicturgay, Sadik; Ozturk, Ersin; Ozen, Yilmaz; Zorluoglu, Abdullah;
Yilmazlar, Tuncay
Uludag University Medical Faculty, General Surgery, Bursa, Turkey
Background. Resection of the metastatic tumors of the liver from colorectal
cancer improves survival.
Aim. Survival analysis of the patients operated for metastatic liver tumors from
colorectal cancers was performed.
Method. From 1995 to 2005, 60 patients having liver metastasis from
colorectal cancer have been able to be followed up. Of these 60 patients, 28
had resection of the metastasis whereas 32 had no resection due to multiple
metastases. Age, gender, data of the primary tumor, degree of the liver
metastases (less than 4 in one lobe, less than 4 in both lobes, more than 4),
method of diagnosis, type of liver metastasis surgery (metastasectomy,
lobectomy, segmentectomy, hepatectomy), metastasis resection vs no resec-
tion, time of metastasis surgery and survival were examined. Kaplan-Meier and
Cox regression analyses were used.
Results. Overall survival was 35,3 months. Resection group had a better
survival than non-resection group (pB/0,001). Cox regression determined the
resection of the metastasis as a prognostic factor (p/0,001) There was a
significant survival difference between the groups formed due to the degree of
liver metastasis (p/0,008). Cox regression analysis also pointed out that
degree of liver metastasis was a factor affecting survival (p/0,004,). Also the
effect of the extent of the metastasis resection on survival was questioned.
Metastasectomy was performed in 18 patients, whereas in 10 patients
metastasis resection with wide margins was performed. Survival times of these
subgroup patients did not differ significantly from each other (p/0,181) Cox
regression analysis did not define this variable as a prognostic factor, either (p/
0,20) However, when a multivariate model was created no significant
prognostic factor was determined. This result is probably due to insufficient
number of cases for such a multivariate model.
Conclusion. Resection of the metastatic liver tumors from colorectal cancers
prolongs the survival, but extent of the resection does not have a significant
effect on the survival.
P22.76
THE EVOLVING ROLE OF EARLY LAPAROSCOPYAND LAPARO-
SCOPIC ULTRASOUND IN THE STAGING OF COLORECTAL
LIVER METASTASES
Shah, Ankur J; Phull, J; Keevil, E; Alderson, Derek; Finch-Jones, Margaret
Bristol Royal Infirmary, Bristol, UK
Background. Between 2030% of patients with potentially resectable color-
ectal liver metastasis are found to have unresectable disease at laparotomy.
Most centres that routinely perform Laparoscopic ultrasound (LUS) prior to
liver resection have found it a valuable staging tool in reducing open and close
surgical exploration. We have analysed our experience with LUS over the last 5
years.
Aims. To evaluate the accuracy of LUS in the staging of colorectal liver
metastases. To analyse the difference in the management of patients after a
LUS.
Methods. Patients were identified from the regional multidisciplinary team
(MDT) cancer database and the operative records over the last 5-year period up
to 2005. Retrospective analysis of the patient notes was done. All patients whose
tumours were deemed resectable on computerised tomography (CT) scan and
proceeded to LUS were included. LUS findings were recorded and the change
in MDT plan was noted. LUS findings were compared to resectability at open
surgery.
Results. 78 patients were identified. In 4 patients LUS could not be completed
due to severe adhesions. These were excluded. LUS wrongly predicted the
malignant nature of lesion and respectability in 4 patients. 3/4 patients had a
liver resection and eventual histology was benign. 1/4 who was staged as
operable was inoperable at laparotomy. In 15/74 patients LUS prevented an
unnecessary laparotomy either by predicting the benign nature of lesions or
diagnosing unresectability.
Conclusions. LUS prevented an unnecessary laparotomy in 20% of patients.
This may reduce inpatient stay, morbidity and mortality allowing some patients
to proceed to palliative treatments earlier. It may be worth considering more
selective use of Laparoscopy and Laparoscopic ultrasound in the staging of
colorectal liver metastases.
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THE IMPACT OF LAPAROSCOPY AND LAPAROSCOPIC ULTRA-
SOUND IN STAGING OF LIVER METASTASES FROM COLOR-
ECTAL CANCER BEFORE LIVER SURGERY
Nielsen, Jesper C; Pless, T; Mortensen, MB; Durup, J; Fristrup, CW; Nielsen,
HO; Hovendal, C
Odense University Hospital, Hepato-Pancreatic-Biliary Centre, Odense, Den-
mark
Background. More than a decade ago TG John showed that staging
laparoscopy and laparoscopic ultrasound (LAP/LUS) changed the treatment
strategy in 46% of patients with liver tumours referred for surgery.
Aim. To evaluate the impact of LAP/LUS in staging of liver metastases.
Methods. From 20022005, 85 patients were referred with a dedicated CTor
MRI for staging of liver metastases after CRC. Thus, the patients were
considered candidates for curative liver surgery when images were reviewed by a
radiologist and the HPB team. Staging LAP/LUS was performed in 61 patients
(72%) and findings were prospectively recorded and compared with the CTor
MRI. In 24 cases (28%) the patient was directly admitted to liver surgery with
intraoperative ultrasound (IOUS) as the final staging before resection.
Results. 60 patients (98%) had a complete LAP/LUS procedure and in one
case the procedure was impossible due to adhesions. In 26 patients (42,6%)
more metastases were found during LAP/LUS than during preoperative CT/
MRI, and in 16 of these patients this meant upstaging to non-resectable disease.
Seven patients (11.5%) had disseminated disease proven by biopsy during
LAP/LUS. None of which had been suspected by CT/MRI. In four patients
(6.6%) fewer metastases were detected by LAP/LUS than on CT/MRI. LAP/
LUS predicted R0 resection with a 100% accuracy. In the 24 patients referred
directly for surgery more metastases were found in 5 patients, disseminated
disease in an additional 3 patients, and in one patient fewer metastases were
found than seen on CT/MRI. Overall, LAP/LUS found non-resectable disease
in 23 patients (37.7%) who were assessed as candidates for curative surgery by
preoperative CT/MRI. In open surgery with intraoperative ultrasound (n/24)
the figure was 20.8%.
Conclusion. Despite the use of modern preoperative imaging modalities CT/
MRI almost 40% of the patients referred for curative surgery turned out to have
non-resectable disease. This figure seems constant over time, and underlines
the importance of LAP/LUS.
P22.78
THE ROLE OF HYPOXIA IN PROMOTING CANCER SPREAD IN
THE LIVER: DOES LAPAROSCOPIC LIVER RESECTION PRO-
MOTE METASTASIS?
Healey, Andrew1; Tran, Maxine2; Shukla, Deepa2; Maxwell, Patrick2; Jiao,
Long3
1Hammersmith Hospital, Imperial College, Dept. of Cancer Surgery, London,
UK; 2Hammersmith Hospital, Dept. of Renal Medicine, London, UK;
3Hammersmith Hospital, Dept. of Cancer Surgery, London, UK
Background. In solid tumours areas of hypoxia are common and correlate
with poor prognosis. In hypoxia, cells activate the transcription complex
Hypoxia Inducible Factor, (HIF). This promotes the expression of a wide range
of target genes, which include angiogenic growth factors. Importantly, cancer
cells have an upregulated HIF response, with partial activation of the HIF
system in normoxia, and a greater level of activation in hypoxia than
untransformed cells.
Aims. 1: To characterise HIF isoform (HIF1 or HIF2) and target gene
expression in resected liver tumours. 2: To assess whether there is any effect on
this expression by the type of liver resection performed. It is hypothesised in this
study that the pneumoperitoneum, required in laparoscopic approach to liver
resection, could cause liver hypoxia, activating HIF in the tumour. This could
subsequently correlate with adverse effects.
Methods. Tissue from 20 resected liver tumours was collected: 10 from open
liver resections and 10 from laparoscopic. The 2 sets were matched for
pathology, (colorectal 14, hepatocellular 4, lung, 2) and liver segment. The
tissue was paraffin embedded, and blocks representing both tumour and
adjacent ‘normal’ liver were selected for sequential sectioning. Immunohis-
tochemistry was performed on these sections for HIF isoforms and target genes,
GLUT-1, VEGF, CaIX and CD10.
Results. 15/17 cases of colorectal metastases expressed HIF2 but only 2/17
HIF1. Both lung metastases and 1/4 hepatocellular carcinomas express both
HIF1 and 2. The remaining 3 HCCs only HIF2. Seven patients showed HIF
expression in the surrounding liver parenchyma, 3 had undergone laparoscopic
resection.
Conclusions. The HIF2 isoform may play a more significant role in the
development of colorectal liver metastases than HIF1. This is in keeping with
previous reports suggesting HIF2 expression in colorectal primaries is a
predictor of liver metastasis. A prospective trial is needed to determine whether
surgical technique plays any role in the activation of HIF the liver.
P22.79
TRANSARTERIAL CHEMOEMBOLISATION (TACE) OF LIVER
TUMOURS: WHO BENEFITS?
Reid, Richard1; Bent, Clare2; McGhie, Jake3; Fotheringham, Tim2; Hutchins,
Robert1
1St Bartholomew’s and the Royal London Hospital, Hepatobiliary and
Pancreatic Surgery, London, UK; 2St Bartholomew’s and the Royal London
Hospital, Radiology, London, UK; 3St Bartholomew’s and the Royal London
Hospital, Nurse Specialist HPB Surgery, London, UK
Aims. This study was performed to audit practice at our institution. BACK-
GROUND TACE: is a recognised treatment option for patients with
unresectable liver tumours, but there is conflicting literature regarding efficacy.
Methods. Eighteen patients (M:F 16:2, age 3081 mean 63) underwent 23
TACEs with epirubicin, lipiodol and PVA particles for hepatocellular carci-
noma.
Results. Sixteen patients had cirrhosis: (13 Child-Pugh class A and 3 class
B) and two patients had non-cirrhotic liver disease. Seven patients had
positive viral serology. All patients underwent triphasic CT before TACE,
demonstrating portal vein patency and tumours confined to the liver but
unresectable due to size (n/3), location (n/4) or multicentricity (n/11).
Procedural success was 91% (n/21). Mean survival following TACE was
263 days (4740). One year survival rate was 43% (n/10). Post procedure
deaths (B/30 days) were seen in 26% (n/6). Of these, half (13%) were due
to comorbidity (n/3). Deaths were secondary to hepatic encephalopathy
related to clostridium difficile toxin, chest sepsis (2), cerebrovascular
accident, gallbladder ischaemia and sepsis, nephritic syndrome and hepatic
decompensation.
Conclusion. Previous literature has reported significant survival advantage
following TACE in specific subgroups but standardised patient selection
criteria have not yet been established. Consequently, many patients have
significant co-morbidities, which may result in early death. Robust patient
selection criteria may provide opportunities to improve overall outcomes and
reduce peri-procedural mortality.
P22.80
TREATMENT OF HEPATOCELLULAR CARCINOMA WITH RE-
NAL DYSFUNCTION
Kato, Takaaki; Katagiri, Satoshi; Yamamoto, Masakazu; Imai, Kenichirou;
Ariizumi, Shunichi; Urahashi, Taizen; Yoshitoshi, Kenji; Takasaki, Ken
Tokyo Women’s Medical University, Gastroenterological Surgery, Tokyo,
Japan
Background. We retrospectively reviewed hepatectomy for hepatocellular
carcinoma with renal dysfunction.
Objective and methods. Between January 1994 and January 1999, 457
patients underwent the first hepatectomy for hepatocellular carcinoma. Of
those, we retrospectively reviewed 148 patients, under 75 years of age,
ICGR15test was under 20%, tumor size was under 5 cm, pathological
infiltration was negative. We used a creatinine rate over 1.5 mg/dl as the cut-
off value.,divided patients into renal dysfunction group (n/15,included
HD/4), and without group (n/133). We reviewed perioperative character-
istics of patients (age, male/female ratio, hepatic virus marker, withdiabetes
mellitus, Child-Pugh,ICGR15 test, tumor size, tumor differentiation), the
short term suvival (operative bleed loss,operating time, postoperative days,
operative complications, postoperative death within 30 days) the long term
survival, creatinine before and after operation.
Results. There were more men than women in perioperative chracteristics.
There was 2 postoperative deaths with renal dysfunction. The rate of suvival
between the groups showed no significant difference. Postoperatively, renal
dysfunction was not worse in renal dysfunction group.
Conclusion. Renal dysfunction did not affect the overall prognosis of
operative treatment of hepatocellular carcinoma.
P22.81
TREATMENT OUTCOME OF CHEMORADIATION FOR PA-
TIENTS WITH UNRESECTABLE MASS-FORMING INTRHEPA-
TIC CHOLANGIOCARCINOMA
Suto, Koichi; Fuse, Akira; Hirai, Ichiro; Mizutani, Masaomi; Takeshita,
Akiko; Kimura, Wataru
Yamagata Uiniversity, School of Medicine, Gastroenterological and General
Surgery, Yamagata, Japan
Background. To date, effective treatment for patients with unresectable
mass-forming intrahepatic cholangiocarcinoma (ICC) is not established.
Aim. The aim of the present study was to clarify the utility of chemoradiation
therapy for patients with unresectable mass-forming ICC.
Patients and methods. Eighteen patients with unresectable mass-forming
ICC were studied. Ten patients underwent external irradiation totaling 42
60 Gy and systemic chemotherapy (9 patients underwent low dose CDDP
and
5-FU, and 1 underwent EPIR and 5-FU) after 1999 (treated group), while no
radiation or chemotherapy was performed for 8 patients before 1999
(untreated group).
Results. No significant differences existed between treated and untreated
patients on imaging, TNM factor or stage. In the treated group, complete
response was achieved in one patient, and partial response was achieved in 2
patients. Disease was stable in four patients, and progressed in the other
three. The median survival for the treated group was 20 months, while that
for the untreated group was 5 months (pB/0.05). Survival rates at 1, 2 and 3
year for the treated group were 70, 42, and 28%, respectively. All untreated
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patients died within 8 months. In the treated group, age, icterus, serum CA
19-9 level and distant metastasis were significant prognostic factor by
univariate analysis.
Conclusion. Chemoradiation therapy seems to improve the prognosis of
patients with unresectable mass-forming ICC.
P22.82
TUMOR ABLATION TREATMENT IS HELPFUL IN PROLONG-
ING THE TUMOR FREE PERIOD IN CIRRHOTIC PATIENTS
WITH HEPATOCELLULAR CARCINOMA
Anwar, Nadeem1; Shapiro, Taryn1; Nsier, Hannan2; Shick, Lawton1; Kim,
Ducksoo3; Shankar, Sridhar3; Cicalese, Luca2
1UMass Memorial Medical Center, Medicine, Worcester, MA, USA;
2UMass Memorial Medical Center, Surgery, Worcester, MA, USA; 3UMass
Memorial Medical Center, Radiology, Worcester, MA, USA
Background. Cirrhotic patients are at risk of developing heptocellular
carcinoma(HCC). Incidence of HCC is on the rise and more such patients
are being referred for transplant. We hypothesize that ablation can keep
the tumor under control and can help keep these patients active on the
transplant list.
Objective. To study the recurrence of HCC in cirrhotic patients treated with
different types of tumor treatment. INCLUSION CRITERIA: All cirrhotic
patients who underwent treatment for HCC at UMass between 1/1/1999 to
2/28/06 and control untreated HCC patients. EXCLUSION CRITERIA:
Patients who did not follow up or underwent multiple modalities were
excluded.
Method. Review of the hospital records, imaging studies, AFP and
pathology slides. 124 patients were reviewed, 106 met the criteria, and
were stratified into three groups, namely control, focal ablation and
chemoembolization (TACE). Each group was analyzed based upon the size
of the tumor. Evidence of tumor recurrence (new enhancing lesions, rising
AFP titers) and time of recurrence were noted. 52 controls included 46 M
and 6 F, age range (4185), Ablation group had 31 (26/5), ages (4781),
TACE group had 23(18/5) ages (43 89)
Results. Patients were followed up for 1 months-7years. Of the 31 patients
treated with ablation 16 recurred (9: tumor sizeB/3 cm), (3: 35 cm), (2:/5
cm), (2:multifocal). The average time to recurrence, separated by tumor size,
was 4 mos. (B/3 cm), 6.03 mos. (35 cm),1.39 mos. (/5 cm), 1.83 mos.
(multifocal). Of the 23 patients treated with TACE, 22 recurred (2: B/3 cm),
(4: 35 cm), (8:/5 cm), (8:multifocal). Of these 22 patients the average
time from treatment to recurrence was 4 mos. (B/3 cm), 1.3 mos.(35 cm),
1.9 mos.(/5 cm), 8.6 mos(multifocal).
Conclusion. Focal ablation offers more tumor free period, more initial
response to treatment and better control of HCC (specially in 35 cm size
group), which can result in maintaining the tumor size within the Milan
Criteria for liver transplantation.
P22.83
WHICH PREOPERATIVE CLINICAL FACTORS PREDICT POOR
OUTCOME IN PATIENTS WITH COLORECTAL CANCER AND
UNRESECTABLE SYNCHRONOUS LIVER METASTASES
Vibert, Eric; Panis, Yves; Alves, Arnaud; Pocard, Marc; Valleur, Patrice
Lariboisie`re Hospital, Paris, France
Background. Colorectal resection in patients with primarily unresectable
synchronous liver metastases (LM) is sometime pointless due to rapid disease
progression and death.
Aim(s)/Objective(s). The aim of this study was to identify predictive
preoperative factors of rapid death (B/3 month) for patients operated in this
situation.
Methods. 80 patients (35M/45F-Mean age: 649/13 years) treated with
resection (n/56) or by-pass (n/24), for colorectal cancer (CCR) (52 colon/
28 rectum) with unresectable synchronous LM (bilobar and number/3)
were retrospectively reviewed. Twenty two (27.5%) of the 80 patients died
within 3 months of colorectal surgery. Univariate and multivariate analysis of
predictive factors of fatal evolution was performed. Analysed parameters
included patient’s age, ASA score, loose of weight, mode of initial cancer
presentation, full biological assessment, morphological features of CCR and
LM and the type of colorectal surgery.
Results. In univariate analysis, age/75 years (p/0.009), ASA score/2
(p/0.01), bowel occlusion (p/0.04), emergency (p/0.01), AST concen-
tration /50 UI/ml (p/0.0083), and alkaline phosphatase concentration /
200 UI/ml (p/0.02) were poor prognostic factors. In multivariate analysis,
age/75 years (RR/7.3; p/0.05) and AST concentration/50 UI/ml
(RR/8.6; p/0.03) were found to be independent risk factors for early
death. In the group of patients who have been resected (n/56), age/75
years (p/0.006), AST concentration /50 UI/ml (p/0.04) and rectal
cancer (p/0.03) were found in univariate analysis as poor prognosis factors
with age/75 years (RR/7.6; p/0.04) retaining independent significance in
multivariate analysis.
Conclusions. Preoperatively available information including first tumour
location in the rectum and age/75 years predict early death in patients
presenting with CCR and unresectable synchronous LM. In addition, hepatic
cytolysis (AST/50 UI/ml) appears to be a marker of tumoral disease
aggressiveness.
P22.84
THE ROLE OF CEA IN ASSESSING LAPAROSCOPIC AND
SURGICAL RESECTABILITY IN COLORECTAL LIVER METAS-
TASES
O’Reilly, Derek; Ghaneh, Paula; Poston, Graeme; Wu, Andrew
University Hospital Aintree, Dept. of Surgery, Liverpool, UK
Background. The role of laparoscopy in suspected colorectal liver metas-
tases is controversial because of the low yield obtained in some series and its
perceived technical difficulty due to adhesions from previous major abdom-
inal surgery. CEA correlates with tumour burden in colorectal cancer and
elevated levels may predict surgically unresectable disease.
Aim. To assess the relationship between CEA and resectability, according to
laparoscopic and open surgical criteria.
Methods. A retrospective review utilising case notes and a prospectively
collected database.
Results. 93 patients considered resectable on radiological (CT/MR)
criteria, underwent further staging with laparoscopy. 19/93 (20%) were
unresectable at laparoscopy. 63/93 (68%) were resectable at laparoscopy and
in 11/93 (12%) the procedure was unhelpful due to the presence of
adhesions. The median CEA for those unresectable at laparoscopy (32.5
ng/ml) was higher than in those with resectable disease or indeterminate
respectability at laparoscopy (12.4 ng/ml), although this did not reach
statistical significance (p/0.11). 8/74 (10%) patients were subsequently
found to be unresectable at open surgery. The median CEA for those who
proceeded to open surgery and were unresectable (65.1 ng/ml) was higher
than in those who proved to be resectable (10 ng/ml), p/0.004.
Conclusion. CEA is significantly elevated in those who ultimately prove to
be unresectable at open surgical exploration. This may form the basis for
strategies that select only high risk groups for laparoscopic or other additional
staging modalities prior to surgery.
P22.85
QUALITY OF LIFE AND ANXIETY AND DEPRESSION STUDIES
FOLLOWING LIVER RESECTION: A PROSPECTIVE STUDY
Dasgupta, Dowmitra1; Smith, Adam2; Brown, Sarah3; Velikova, Galina2;
Prasad, K Rajendra1; Toogood, Giles J1; Lodge, J Peter1
1St James’s University Hospital, HPB and Transplant Surgery, Leeds, UK;
2St James’s University Hospital, Cancer Research UK Psychosocial Oncology
Research, Leeds, UK; 3University of Leeds, Clinical Trials Research Unit,
Leeds, UK
Introduction. There are no studies using a validated quality of life
instrument from Western centres assessing quality of life and anxiety and
depression after liver resections for malignancies.
Aim. To look at the quality of life of patients undergoing liver resections for
hepatobiliary malignancy over a 1 year period. To see whether there is any
correlation between preoperative QOL and survival.
Materials and Methods. Patients undergoing liver resections for primary or
secondary liver tumours in a 1 year period from July 2002 were enrolled.
They were asked to complete the generic questionnaire EORTC QLQ C30
[European Organization for Research and Treatment of Cancer] pre
operatively, 6 months post operatively and 1 year post operatively. Results
were analysed according to diagnosis of liver malignancy, major or minor
resections and presence or absence of complications. The Hospital Anxiety
and Depression Scores were analysed at a fixed time point 1 to 2 years post
resection.
Results. 103 patients were enrolled in this study. Patient compliance at
each stage was 99, 97 and 97%. Regardless of diagnosis, patients showed
a return to baseline levels in all aspects of quality of life except for some
categories of physical functioning. Pain, dyspnoea and fatigue were the
symptoms showing a mild to moderate increase in both major and minor
resections over time. All other aspects of QOL showed little change from
baseline at 1 year. Cholangiocarcinoma patients have the worst preoperative
QOL but show good recovery after liver resections. 66 76% of patients had a
normal anxiety and depression score. Preoperative emotional functioning is
decreased in those who subsequently die.
Conclusion. The general trend is for HRQOL to worsen slightly at 6 months
and then return to baseline at 1 year. Understandably the physical
functioning scales show the main decreases but even they seem to recover
slightly at 12 months. Psychotherapy may increase survival. Liver resection
for malignancy can be justified from a HRQOL point of view.
P22.86
PIN1 INTERACTS WITH A SPECIFIC SERINE-PROLINE MOTIF
OF HEPATITIS B VIRUS/PROTEIN TO ENHANCE HEPATO-
CARCINOGENESIS
Pang, Roberta1; Ronnie, Poon2; Fan, ST2; Kwong, YL1; Tse, Eric1
1The University of Hong Kong, Queen Mary Hospital, Medicine, Pokfulam,
Hong Kong; 2The University of Hong Kong, Queen Mary Hospital, Surgery,
Pokfulam, Hong Kong
Background. We have previously reported that the peptidyl prolyl isomerase
(PIN1) is over-expressed in over 50% of hepatocellular carcinoma (HCC)
cases related to hepatitis B virus (HBV), and it plays a functional role in HCC
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pathogenesis. Hepatitis B virus X protein (HBx), a potent transactivator
implicated in the pathogenesis of HBV-related HCC, has a potential PIN1
binding motif.
Objective. We conducted a study to test the hypothesis that PIN1 may
interact with HBx to exert a synergistic effect in HCC pathogenesis.
Results. Here, we report that PIN1 expression positively correlated with
HBx expression (p/0.024) by immunohistochemistry in HBV-related HCC
cases. Immunofluorescence microscopy confirmed that HBx co-localized
with PIN1 in the nucleus, and co-IP showed that PIN1 bound to ectopically
expressed flag-tagged HBx in Hela cells. GST pull-down assay further
validated the binding between the two proteins. Mutation of either Serine or
Proline in the pSer41-Pro motif of HBx abolished its binding with PIN1. Co-
transfection of PIN1 and HBx transactivated the NF-AT driven luciferase
reporter, with two-fold increase in luciferase activity compared with
transfection of HBx alone, or HBx mutants with abolition of Ser/Pro residues
at the pSer41-Pro motif. Cell proliferation was markedly increased with
stable PIN1-HBx transfectants compared with PIN1-HBx mutant transfec-
tants, stable PIN1 or HBx transfectants alone. Subcutaneous injection of
PIN1-HBx transfectants in nude mice also resulted in development of larger
tumors in comparison with HBx mutants, PIN1 or HBx transfectants alone.
Conclusion. We conclude that PIN1 interacts with a specific Serine-Proline
motif of HBx and augments its transactivating activity and oncogenic
properties. These findings implicate PIN1 expression as an important step
in HBV-associated hepatocarcinogenesis and suggest that PIN1 may repre-
sent a novel molecular target for inhibition of hepatocarcinogenesis.
P22.87
LONG-TERM OUTCOMES OF HEPATECTOMY VS LAPARO-
SCOPIC RADIOFREQUENCY FOR TREATMENT OF HEPATO-
CELLULAR CARCINOMA
Opocher, Enrico1; Santambrogio, Roberto1; Pisani Ceretti, Andrea1; Bar-
abino, Matteo1; Costa, Mara1; Asti, Emanuele1; Montorsi, Marco2
1Ospedale San Paolo, Bilio-pancreatic Surgery Unit, Milano, Italy; 2Istituto
Clinico Humanitas IRCCS, Cattedra e U.O. di Chirurgia Generale, Rozzano
(MI), Italy
Background. Hepatic resection (HR) is still considered the treatment of
choice for hepatocellular carcinoma on liver cirrhosis. Radiofrequency
ablation (RA) is a new emerging modality. Aim of the study is to compare
two groups of patients submitted to either surgical resection or laparoscopic
radiofrequency: the aim of the study was analyzes long-term survival and
intra-hepatic recurrences.
Methods. From 2/97 to 11/05, 147 patients were enrolled in this prospective
study. Inclusion criteria were a single nodule with a diameter less than 5 cm
and Child A-B class of liver function: 66 pts were included in SR group and
81 pts in the RA group.
Results. The two groups were homogeneous for the preoperative staging
according BCLC classification, but not for the liver function (Child’s B class:
42% vs 15%; p/0.004). Operative mortality was nil and there was a similar
rate of operative morbidity: only the incidence of ascites was higher in HR
group (15% vs. 4%; p/0.01). No difference was evident with regard to the
mean follow-up of patients submitted to HR (22.3/19.6 mo.) or RA (25.5/
22.4 mo.; p/0.37). There was a significant higher incidence of intrahepatic
recurrences after RA than after HR (53% vs. 36%; p/0,04). This was mainly
due to local recurrences: 20% in the RA group and only 3% in the HR group.
However, actuarial survival curves at 5 yrs were not significantly different
(53% after HR and 51% after RA; p/0.09). Long-term complications
during the follow-up period were similar in the two groups.
Conclusions. the results of our study showed a significant lower incidence of
intrahepatic recurrences after resection compared to radiofrequency: the
difference was mainly due to local recurrence rate. However, the improved
care of cirrhotic patients and an early detection and effective treatment of
these recurrences did allow a survival curve at 5 years not statistically
different between the two treatments.
P22.88
LARGE VOLUME RADIOFREQUENCY ABLATION AND CRYO-
THERAPY OF HEPATIC TISSUE RESULTS IN A SYSTEMIC AND
ORGAN-SPECIFIC INFLAMMATORY RESPONSE
Ahmad, Fateh; Strickland, Andrew D; Bhardwaj, Neil; Lloyd, David M
Leicester Royal Infirmary, Dept. of Hepatobiliary Surgery, Leicester, UK
Background. Hepatic cryoablation has been complicated by cryoshock, a
variant of an exaggerated systemic inflammatory response syndrome (SIRS).
Aims. This study investigates the inflammatory response following liver
ablation using systemic and organ-specific markers of inflammation.
Methods. Following laparotomy, adult rats underwent cryoablation, radio-
frequency ablation (RFA), microwave tissue ablation (MTA) or surgical
resection of 15%, 33% or 66% of the total liver volume. Control rats
underwent a sham laparotomy. Serial blood sampling was performed pre- and
post-operatively and analysed for the inflammatory cytokines TNF-a, IL-1b
and IL-6. Urine was analysed for the presence of retinol binding protein
(RBP), as a marker of renal damage. Bronchoalveolar lavage (BAL) and the
wet/dry lung ratio were used as markers of lung injury. Levels of heat shock
protein 70 (HSP70) in the lung, liver and kidney for animals in all groups
were quantified. Routine histology was also performed.
Results. At 15% treatment, there was no significant difference between any
of the groups in cytokine induction (p/0.05), or specific organ damage. At
33% treatment, cryotherapy demonstrated higher levels of cytokine induction
(pB/0.05) together with evidence of acute lung injury, with raised BAL
protein, wet/dry lung weight and HSP70 (pB/0.05). At 66% treatment, all
animals in the RFA and cryotherapy groups died within 6 hours of the
procedure. Significant cytokine induction was seen along with an increase in
BAL protein content, and a rise in wet/dry lung ratio (pB/0.01). Urinary
levels of RBP were markedly elevated (pB/0.05) as was HSP70 (pB/0.05).
Histology revealed acute inflammatory foci in both the lungs and the kidneys
of animals from these two groups.
Conclusion. Large volume hepatic ablation using cryotherapy and RFA
results in a significant proinflammatory cytokine response, multi-organ
dysfunction and high mortality. MTA, however, did not induce a similar
response.
P22.89
LAPAROSCOPY AND LAPROSCOPIC ULTRASOUND IN THE
DIAGNOSIS AND STAGING OF SUSPECTED LIVER MALIG-
NANCY
O’Reilly, Derek; Ghaneh, Paula; Poston, Graeme; Wu, Andrew
University Hospital Aintree, Surgery, Liverpool, UK
Background. The role of laparoscopy in suspected liver malignancy is
controversial because of the low yield obtained in some series and its
perceived technical difficulty due to adhesions from previous major abdom-
inal surgery.
Aim. To assess the yield and accuracy of laparoscopy compared to
radiological imaging and final outcome at open surgery.
Methods. A retrospective review utilising case notes and a prospectively
collected database.
Results. 122 patients, 66 male and 56female with a median age of 65
(range 3082) underwent laparoscopy after radiological evaluation with
CT/MR. Additional lesions compared to radiological imaging were
detected in 38/122 (31%) cases. 27/122 (22%) patients were not resectable
at laparoscopy and 14/122 (11%) procedures were non-contributory due
to intra-abdominal adhesions. There was a median in-hospital stay of 2
days (range 110 days). 3 complications occurred, delaying discharge;
there was no mortality. Of 88 patients where it was necessary to proceed
to open surgery, 34/88 (39%) had additional lesions compared to
laparoscopy and 13/88 (15%) were unresectable. Final histological
diagnoses were metastatic adenocarcinoma from colorectal primary (93),
hepatocellular carcinoma (7), benign hepatic tumours (7), and other
malignant tumours (15).
Conclusion. Laparoscopy has an important role in diagnosing unresectable
liver malignancy and benign lesions not requiring surgery; the avoidance of
unnecessary laparotomy facilitates expeditious palliative treatment and
appropriate conservative management in these cases.
P22.90
HSP70 AND VEGF BLOOD LEVELS IN PATIENTS WITH HEPA-
TOCELLULAR CARCINOMA (HCC)
Lupo, Luigi1; Rotelli, Maria Teresa1; D’Elia, Giovanna1; Bocale, Domenica1;
Panzera, Piercarmine1; Di Palma, Giovanni1; Aquilino, Francesca1; Tandoi,
Francesco1; Giannelli, Gianluigi2; Memeo, Vincenzo1
1University of Bari, General Surgery and Liver Transplantation, Bari, Italy;
2Immunology and Infectious Disease, University of Bari, Dept. of Internal
Medicine, Bari, Italy
Heat Shock Protein-70 (HSP-70) is involved in cancer cell proliferation,
apoptosis, metastasis and angiogenesis. Vascular Endothelial Growth Factor
(VEGF) is the most important angiogenic factor and HCC is a hypervascu-
larized tumor.
Aim. To determinate the level of circulating HSP-70 and VEGF in patients
with HCC and to correlate them with liver disease(LD), stage of cancer(ST)
and survival.
Patients & Methods. Forthy patients with histologically proven HCC, 20
with cirrhosis but without HCC and 9 healthy subjects were enrolled: median
age 69 (4491), 52 male and 8 female, HBV (13), HCV (37), HBV/HCV
(6), Child Pugh Class A 24, B 13, C 5. In HCC patients median number of
nodules was 2(15), median of cumulative size 30 mm (17115; size of the
biggest nodule 30 mm (2075). HSP-70 and VEGF were determined in
serum samples, in patients and controls, by Elisa method. Cancer staging
was by Spiral CTand US. All patients underwent RFA of lesion and followed
up. Data were analyzed by Wilcoxon Signed Rank Test, Regression analysis
and Life table.
Results. HSP-70 was present only in patients (median 1.14 ng/ml, 037)
(HCC vs controls p/0.007; cirrhosis vs controls p/0.02) but there was
no significant difference in HSP-70 levels between HCC and cirrhosis. HSP-
70 correlated only with unconjugated bilirubin (p/0.01, R2/0.337).
VEGF levels did not correlate with LD and ST variables, but a VEGF cut
off point of 1.76 separates patients from controls, (0.5 vs 13/24, pB/0.05),
and also patients with good prognosis vs poor (2 years survival: 75% vs 25%,
pB/0.08). VEGF.
Conclusions. Altough HSP-70 was detected only in the serua of patients
with HCC or cirrhosis but not in controls, it did not show specificity for
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HCC. Serum HSP-70 may be considered a general marker of hepatic damage
but not specific for HCC.
P22.91
ASSESSMENT OF VIABLE TISSUE ATTACHED TO NEEDLE
ELECTRODES AFTER LOCAL ABLATION OF LIVER TUMORS
Jansen, Maarten1; Snoeren, Nikol1; Rijken, Arjen2; Slooter, Gerrit3; Klaase,
Joost4; van den Tol, M. Petrousjka5; van de Linden, Edwin6; Ten Kate,
Fibo7; van Gulik, Thomas1
1Academic Medical Centre, Surgery, Amsterdam, Netherlands; 2Amphia
Hospital, Surgery, Breda, Netherlands; 3Maxima Medical Centre, Surgery,
Veldhoven, Netherlands; 4Medisch Spectrum Twente, Surgery, Enschede,
Netherlands; 5VU Medical Centre, Surgery, Amsterdam, Netherlands;
6Leiden University Medical Centre, Radiology, Leiden, Netherlands; 7Aca-
demic Medical Centre, Pathology, Amsterdam, Netherlands
Background. Only a minority of patients with primary or secondary liver
tumors are surgical candidates. Radiofrequency ablation (RFA) and inter-
stitial laser coagulation (ILC) are alternative techniques to obtain local
control of unresectable tumors. Needle track seeding (NTS) potentially
affects long term survival.
Aim. The aim of this study was to analyse remnants of tissue adherent to
electrodes (RFA) and fibers (ILC) after use.
Methods. A total of 41 patients were treated for 51 tumors with 61
local liver applications (47 RFA, 14 ILC). Cells and tissue attached to
the electrodes and fibers were analysed for viability and morphology by
trypan blue test (TBT), Hematoxylin&Eosin (HE), PAP and Giemsa
staining.
Results. Macroscopic tissue adherence to electrodes was visible following 31
applications. Detection of viable tumor cells could be observed after 4
applications (6.6%). Positive TBT could be observed after 21 applications
(34.4%) but could not discriminate between type of cells. Factors that
significantly correlated (pB/0.05) in univariate analysis with increased risk of
morphologically viable tumor cells adherent to the electrodes were poor
differentiation of the primary colon tumor, the use of deployable electrodes
and the omission of needle track ablation.
Conclusion. This study demonstrated morphologically viable tumor
tissue adherent to electrodes after RFA in 6.6%. This finding emphasizes
the need for track ablation to prevent NTS, especially when using deployable
electrodes.
P22.92
GIANT LIVER CELL ADENOMA WITH CO-EXISTING HEPATIC
GRANULOMAS IN AN HIV-POSITIVE PATIENT
Shah, Sudeep1; Lala, Murad1; Soman, Rajiv2; Deshpande, Ramesh3
1PD Hinduja Hospital, Dept. of Surgery, Mumbai, India; 2PD Hinduja
Hospital, Dept. of Medicine, Mumbai, India; 3PD Hinduja Hospital, Dept.
of Pathology, Mumbai, India
Background. Hepatic adenoma is a benign neoplasm that has the potential
of transformation to hepatocellular carcinoma. Among other factors, liver cell
adenoma is strongly linked to excess hormonal exposure especially oral
contraceptives. It is rarely seen in young males. We report a young man
infected with the HIV-1 virus who presented with a giant hepatic adenoma.
Case report. A 28-year- old non-alcoholic, unmarried man presented
with fever since 3 weeks. He also had heaviness in the right hypochondrium
since 1 1/2 years and 4 Kg weight loss in the last 1 year. The patient also
tested positive for HIV by the Western blot assay. His CD4 count was
267 cells/cmm (reference range: 350 1408) and CD8 count was 670 cells/
cmm (2301195). CT scan showed a 11.5 cm/10.1 cm/7.9 cm arterial-
phase enhancing lesion in the right hemi-liver. CT- guided biopsy carried out
elsewhere was reported as hepatocellular carcinoma with oncocytoid features.
Alfa fetoprotein levels were normal and hepatitis B and C serology was
negative. The patient was operated on for excision of the right lobe of liver;
the remnant liver was grossly normal. Histology showed a well-circumscribed
liver cell adenoma. Noncaseating epithelioid cell granulomas were seen in the
non-adenomatous liver lobules. He is currently on the HAART regimen and
well over a follow up of 1 year.
Discussion. Hepatic adenomas are rare, cases are often associated with a
hormonal stimulus i.e oral contraceptive use. This patient had HIV infection,
which may be a potentiating factor. The HIV-1 Tat protein secreted by the
HIV-1 infected cells and taken up by normal cells has growth-promoting
activity, angiogenic functions and anti-apoptotic effect and hepatic adenomas
have been documented in tat-transgenic mice.
P22.93
AN INITIATING ONCOGENIC EVENT IN COLORECTAL TUMOR
DEVELOPMENT (KRAS MUTATION) IS ESSENTIAL FOR META-
STATIC POTENTIAL
Kranenburg, Onno; Smakman, Niels; Steller, Ernst; Borel Rinkes, Inne
UMC-Utrecht, Utrecht, Netherlands
Background. At present it is unclear whether metastatic potential is
acquired by selection of mutant clones from a primary tumor or whether
the genetic changes underlying primary tumor development already
define metastatic potential. One of the key initiating events in the develop-
ment of CRC is mutational activation of the KRAS proto-oncogene
during the early pre-malignant stages. Mutant KRAS is preserved during
progression to metastatic lesions and may therefore contribute to metastatic
potential.
Aims. To assess the contribution of endogenous mutant KrasD12 to
metastatic potential and to preventing immune-mediated tumor cell clear-
ance from the liver sinusoids.
Methods. Liver metastases were induced by intrasplenic or direct intrahe-
patic injection of tumor cells in BALB/c mice. The formation of liver
metastases was analyzed by bioluminescence imaging and intravital micro-
scopy (IVM). Mutant KrasD12 was suppressed by stable RNA interference.
Results. C26 cells develop massive liver metastases within 12 days following
intrasplenic injection into immunocompetent mice. In contrast, Kras-
suppressed C26 cells had completely lost metastatic potential. Unlike
subcutaneous tumor growth, metastatic potential was not restored in
immunodeficient mice. Intravital microscopy analysis showed that C26
control and Kras-suppressed cells displayed equal seeding efficiency in the
liver sinusoids. However, Kras-suppressed cells failed to extravasate from the
liver sinusoids and were rapidly cleared from the liver. In addition, Kras-
suppressed cells showed a strongly reduced invasive capacity in vitro.
Bypassing the need for extravasation by directly injecting tumor cell into
the liver parenchyma restored the tumor-forming potential of Kras-sup-
pressed cells in immunodeficient but not in immunocompetent mice.
Conclusion. We conclude that mutations in Kras, acquired during the very
early pre-malignant stages of tumor development, can contribute to the
acquisition of metastatic potential which becomes apparent much later
during tumor development.
P22.94
A COMPARISON OF HISTOLOGICAL AND MRI APPEARANCES
OF RADIOFREQUENCY AND ELECTROLYTIC ABLATIVE LE-
SIONS ADJACENT TO LARGE HEPATIC VEINS
Metcalfe, Matthew S1; Mullins, Emma J2; Davies, R2; Kew, J2; Berry, David
P1; Dennison, Ashley R1; Maddern, Guy J2
1Leicester General Hospital, Dept. of Surgery, Leicester, UK; 2The Queen
Elizabeth Hospital, Dept. of Surgery, Adelaide, Australia
Introduction. The use of ablation techniques for treating hepatic tumours
relies on radiological evidence of lesion destruction rather than the
histological confirmation available after hepatectomy.
Aim. This study assessed for radiofrequency and electrolytic ablation the
correlation between the size of lesions measured by MRI and at histology.
Methods. 9 eletrolytic and 8 radiofrequency lesions were generated in the
livers of large white pigs under general anaesthesia through midline
laparotomy. After 72 hours the animals were sacrificed and the livers
harvested. They were immediately subjected to T1 weighted MRI imaging,
from which a lesion volume was calculated. The livers were then dissected,
and the actual size of the lesions in the pathological specimen measured.
Results. There were significant correlations between radiological and
pathological lesions sizes, (p/0.04 for radiofrequency, p/0.003 for eletro-
lysis), however there was considerable variation associated with these
correlations (R2/0.78 for radiofrequency and R2/0.47).
Conclusions. From these results, the MRI diameter of a lesion is 1.6 times
the actual diameter that it is possible to be confident has been ablated for
electrolytic lesions. For radiofrequency lesions, the MRI diameter is 1.63
times the diameter of tissue that is possible to be confident has actually been
destroyed. These factors should be considered in the interpretation of MRI
follow-up of ablative lesions.
P22.95
THE CLINICAL RISK SCORE PREDICTS RESECTABILITY FOR
PATIENTS WITH HEPATIC COLORECTAL METASTASES, BUT
NOT SURVIVAL AFTER HEPATECTOMY
Metcalfe, Matthew S; Mann, Christopher D; Pattenden, Clare J; Neal, Chris
P; Dennison, Ashley R; Berry, David P
Leicester General Hospital, Dept. of Surgery, Leicester, UK
Introduction. The clinical risk score (CRS) with values 05, derived from 5
independent variables of prognostic significance for survival after hepatect-
omy for colorectal metastases at the Memorial Sloan Kettering Cancer
Centre, where there were no long term survivors for patients with the highest
clinical risk score (5). Subsequently in Adelaide it was found there were no 2
year survivors with pre-operative CRS of 4 or 5.
Aim. The aim of this study was to examine the 2 year survival after
hepatectomy for colorectal metastases in Leicester, according to the CRS.
Methods. A database was established for all patients undergoing hepatect-
omy for colorectal metastases between April 2001 and October 2004. The
dataset included the constituent variables of the CRS and patient survival. All
patients were staged with MRI of the liver, helical CT chest and abdomen,
and laparoscopy. The survival for patients with CRS of 01, 23 and 45
were plotted on Kaplan Meier curves and compared by log rank analysis.
During the same period all patients radiologically staged as resectable but
surgically inoperable were analysed against CRS. The resectability rate in the
CRS groups were compared using Fishers exact test. P values of less than
0.05 were deemed significant.
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Results. There were 104 resections during the study period, with 3 in
hospital deaths excluded from analysis. For CRS 01 (n/22), 23(n/65)
and 45(n/11) the 2-year survival figures were 69%, 66% and 64%
respectively. These were not different, (p/0.94). 135 patients in the period
were radiologically staged as resectable, 1 of 26 (3.7%) patients with CRS 0
1 was unresectable, compared with 23 of 88 (26.1%) patients with CRS 23
and 12 of 31 (57%) with CRS 45 (57%) (pB/0.0001).
Conclusion. Whilst the resection rate is lower for patients with higher CRS
scores, the survival of patients after resection is the same. An aggressive
surgical approach is justified in all patients with hepatic colorectal metastases
after meticulous staging.
P22.96
THE ROLE OF VASCULAR ENDOTHELIAL GROWTH FACTOR
OF THE LIVER ADJACENT TO HEPATOCELLULAR CARCI-
NOMA IN POSTRESECTION RECURRENCE
Jeng, Kuo-Shyang
Mackay Memorial Hospital, Surgery, Taipei, Taiwan
Background. A higher expression of vascular endothelial growth factor
(VEGF) in hepatocellular carcinoma (HCC) has correlated with an invasive
behavior.
Aim. We try to elucidate the invasive significance of the expression of VEGF
in the liver adjacent to HCC.
Material and method. There is a prospective series of HCC with curative
resection. The clinical follow-up to detect the recurrence is regularly
performed. Thirty-four among 92 patients has HCC recurrence during the
follow-up. A reverse- transcription polymerase chain reaction (RT-PCR) ¡V
based assay was used to study the VEGF mRNA in the HCC tissues and the
adjacent liver obtained from operations. The clinicopathological parameters
were analyzed.
Results. High distribution of VEGF mRNA was in 30 patients (32.2%) at
central portion of HCC, in 58 patients (63.0%) at marginal portion of HCC,
and in 38 patients (41.3%) at adjacent liver tissue. High expression of VEGF
mRNA had a predictive role in postresection of HCC recurrence in above 3
categories respectively (P/0.005, P/0.000, and P/0.000). By ROC curve,
the area under the curve was 0.643, 0.777 and 0.860 for the above 3
categories. Using 0.58 as the cutpoint of VEGF mRNA at the adjacent liver
tissue, the predictive recurrence could reach a sensitivity of 82.4% and a
specificity of 82.8%. Combining the expression patterns in the 3 categories,
low-low-low had a lowest recurrence, high/low-high-high had a highest risk,
and high in either central or marginal portion plus low in adjacent had an
intermediate risk of recurrence.
Conclusion. VEGF mRNA is a useful predictor of postresection recurrence
of HCC and VEGF in the adjacent liver has a best predictability.
P22.97
IMPROVING HOMING OF GENE MODIFIED LYMPHOCYTES
TOWARDS COLORECTAL LIVER METASTASIS BY CO-EXPRES-
SING CHEMOKINE CO RECEPTOR
Riyad, Kallingal1; Subar, Daren1; Gilham, David2; Cheadle, Eleanor2;
Hawkins, Robert2
1North Manchester General Hospital, Manchester, UK; 2Paterson Institute
for Cancer Research, Christie Hospital, Medical Oncology, Manchester, UK
Background. Gene modified lymphocytes have been shown to be effective
in specific killing of Carcinoembryonic antigen (CEA) expressing tumours.
Homing of gene modified lymphocytes towards colorectal (CRC) liver
metastasis will depend on the chemokine profile of the colorectal liver
metastasis.
Aim. 1. To identify the chemokines produced by the Colorectal liver
matastasis. 2. To gene engineer T lymphocyte/Jurkat T cell lines to express
a chimeric immune receptor (CIR) with single chain Fv fragment that
recognises CEA to the CD3 zeta molecule and to co-express the chemokine
receptor for the dominant chemokine overexpressed in the colorectal liver
metastasis.
Methods. ELISA was performed on media after overnight incubation of
resected CRC liver metastasis and normal liver to identify the dominant
chemokine produced by liver metastasis. T lymphocytes/Jurkat cells were
gene modified using a pmp71 CCR3 2A C23 CD3 zeta retroviral vector
to express both receptors. WST1 killing assay for CIR function and
migration assays were performed towards the dominantly expressed CRC
chemokine.
Results. Eotaxin 2 was found to be the dominant chemokine produced
by the colorectal liver metastasis (n/36). Jurkat T lymphocyte cells were
successfully gene modified to express both C23 CD3 zeta chimeric immune
receptor against CEA and CCR3 receptor against Eotaxin 2. Activation of
cells and killing of CEA expressing tumours were confirmed by WST 1 killing
assay. Specific migration towards Eotaxin 2 was demonstrated in transwell
migration assay.
Conclusions. Eotaxin 2 was shown to be overexpressed in colorectal liver
metastasis. Co-expressing CEA specific chimeric immune receptor produces
tumour specific migration and CCR3 allows the cells to functionally migrate
towards the chemokine in vitro and forms a novel approach to treatment of
inoperable colorectal liver metastasis.
P22.98
TRANSCATHETER ARTERIAL CHEMOEMBOLIZATION (TACE)
OF HEPATOCELLULAR CANCER (HCC): ARE THERE PARA-
METERS FOR ASSESSING THERAPEUTIC SUCCESS?
Wullstein, Christoph1; Noth, Phillip1; Gog, Christiane1; Zangos, Stephan2;
Vogl, Thomas2; Bechstein, Wolf1
1Johann Wolfgang Goethe-University, Dept. of General and Vascular
Surgery, Frankfurt am Main, Germany; 2Johann Wolfgang Goethe-Univer-
sity, Dept. of Diagnostic and Interventional Radiology, Frankfurt am Main,
Germany
Background. Many patients diagnosed to suffer from HCC receive
treatment by TACE only. While prognosis of HCC can be estimated by the
‘‘Cancer of the Italian Liver Programm’’ (CLIP)-Score, there are no
parameters allowing to assess the success of TACE treatment.
Methods. Between August 2002 and July 2005 68 patients suffering from
HCC were treated by TACE (12 patients before liver resection, 8 patients
before liver transplantation and 48 with TACE only). TACE was performed
standardized using Mitomycin C and Lipiodol Ultrafluid. Abdominal CT was
performed one day and 4 to 6 weeks after TACE. In this retrospective study
we analyze the course of alpha-fetoprotein serum levels (AFP) before and
after TACE and the retention of Lipiodol Ultrafluid in the CT’s in view of
patient survival in patients treated by TACE only.
Results. CLIP-Score was zero in 17 patients, one in 19 pts., two in 9 and
three in 3 pts. Mean number of HCC’s was 3.1 (range: 111) with a mean
maximum size of 5.7 cm (range: 1.512.2 cm). Patients received an average
of 3 TACE’s. Mean AFP levels before TACE were 44.3 ng/ml (range: 1.5
121000 ng/ml). After the first TACE AFP levels decreased by 43.6%. 15
patients showed a normal AFP after TACE (B/15 ng/ml). Patients with a
decrease in AFP-levels/50% had no longer survival than patients with a less
decrease in AFP-levels (p/0.42). The patients with normal AFP-levels after
TACE showed a longer median survival than patients with persisting elevated
AFP-levels (1309 versus 360 days, p/0.002). In patients with good retention
of lipiodol after 46 weeks median survival was 698 days while it was 360
days in patients with poor retention of lipiodol (p/0.098).
Conclusion. Normal AFP-levels and a good retention of Lipiodol 46
weeks after TACE may help assessing the therapeutic success of TACE in
view of patient survival. Relative changes in AFP-levels seem not to correlate
with patient survival.
P22.99
INTRAOPERATIVE CRYOTHERAPY AND HEPATECTOMY IS
COMPARABLE TO RADIOFREQUENCY ABLATION FOR TREAT-
ING TECHNICALLY UNRESECTABLE COLORECTAL LIVER
METASTASES
Sjarif, Adrian; Phan-Thien, Kim-Chi; Chu, Francis; Morris, David
St George Hospital, Surgery, Kogarah, Sydney, Australia
Background. Cryotherapy and radiofrequency ablation have been estab-
lished as effective modalities of treatment for colorectal liver metastases.
Recent reports in the literature have demonstrated a 2 year survival up to
67% following liver resection, intraoperative radiofrequency ablation and
optimal systemic chemotherapy for technically unresectable liver metastases.
Aim. To examine the survival rate, and rate of recurrence of a group of
patients with technically unresectable liver metastases who underwent liver
resection, intraoperative cryotherapy and systemic chemotherapy.
Patients & Methods. 127 patients with technically unresectable disease
underwent resection of their liver metastases with intraoperative cryotherapy
and postoperative systemic chemotherapy. Their notes were examined and
information regarding survival and disease recurrence calculated. The
median number of liver metastases per patient was 5. The median size of
the largest lesion was 3 cm. Median follow up was to 61.4 months.
Results. The 5 year survival rate was 23%. The median survival was 27
months (31 days to 7.8 years). Of the 127 patients, 30 were diagnosed with
local recurrence; 38 were diagnosed with liver and extrahepatic recurrence,
and 25 were diagnosed with extrahepatic disease.
Conclusion. The use of cryotherapy ablation in combination with anatomic
segmental and wedge resections and optimal systemic chemotherapy in
patients with technically unresectable liver metastases results in a 5 year
survival of 23%.
P22.100
EVALUATION OF CLINICAL RISK SCORE FOR PREDICTING
WHICH PATIENTS SHOULD UNDERGO STAGING LAPARO-
SCOPY WITH LAPAROSCOPIC ULTRASOUND FOR COLOR-
ECTAL LIVER METASTASES
Shah, Ankur J; Phull, J; Alderson, D; Pope, I M; Finch-Jones, Margaret
Bristol Royal Infirmary, Upper GI Surgery, Bristol, UK
Background. Laparoscopic ultrasound (LUS) is currently used to stage
colorectal liver metastases (CRM) prior to liver resection to avoid unneces-
sary laparotomies. A Clinical risk score (CRS) has been used for predicting
survival and recurrence following hepatic resection. At our centre, we
routinely perform a LUS prior to a decision for liver resection. We have
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analysed the results of LUS over the last 5 years and correlated it with the
Memorial Sloan-Kettering CRS system.
Hypotheses. A CRS may be useful to select patients who benefit from a LUS.
Methods. Patients were identified from the regional multidisciplinary
teamdatabase and operative records over a 5-year period. Retrospective
analysis of the patient notes was done. The yield of LUS was analysed in the
context of CRS by assigning 1 point to the following 5 disease related factors:
Lymph node positive primary colorectal tumour, disease free intervalB/1 year,
more than 1 liver metastases, largest liver metastasis /5 cm and carcino
embryonic antigen/200 ng/ml.
Results. Seventy-nine patients were evaluated. Fifty -six patients had a liver
resection. Of these four, thirteen, twenty-six, nine and four patients had a CRS
of 0, 1, 2, 3 and 4 respectively. Seven patients were unresectable on LUS; one
patient scored 0, whereas two, three and one patient had a CRS of 2, 3 and 4
respectively. The remaining patients were benign either on LUS (6 patients) or
final histology (3 patients). LUS thus prevented an operation in only 7% of
patients with a CRS of less than or equal to 2. In patients with a CRS score of
/2, LUS prevented an operation in 24% of patients.
Conclusion. Based on this series, the benefit of staging LUS for colo-
rectal liver metastases may be limited in patients with a clinical risk score of
2 or less.
P22.101
TREATMENT OF TUMOR RECURRENCE AFTER HEPATIC RE-
SECTION OF HEPATOCELLULAR CARCINOMA LARGER THAN
10 CM
Moon, Deok-Bog1; Hwang, Shin2; Lee, Sung-Gyu2; Lee, Young-Joo2; Park,
Kwang-Min2; Kim, Ki-Hun2; Ahn, Chul-Soo2; Ha, Tae-Yong2; Song, Gi-
Won2; Jung, Dong-Hwan2; Kim, Beom-Soo2; Moon, Ki-Myung2
1Asan Medical Center, Ulsan University College of Medicine, Seoul, Korea;
2Asan Medical Center, Ulsan University College of Medicine, Dept. of
Surgery, Seoul, Korea
Background. Tumor recurrence is very common after hepatic resection of
hepatocellular carcinoma (HCC) greater than 10 cm. The purposes of this
study were to identify the prognostic factors after resection and to evaluate the
effect of aggressive treatments to the recurrent tumors.
Methods. Clinical data of 70 huge HCC patients who underwent liver
resection were retrospectively reviewed.
Results. Mean tumor diameter was 13.29/2.6 cm, and 56 (80%) were single
lesions. Systemic and non-systemic resections were performed in 53 (75.7%)
and 17 (24.3%) patients, respectively, with R0 resection achieved in 65
(92.9%). Overall 1-, 3- and 5-year disease-free survival rates were 50.9%,
31.7% and 23.4%, respectively. Risk factors for HCC recurrence were Child-
Pugh class and resection margin less than 1 cm. Forty-one of 49 recurrent
HCC patients received specific treatments. After HCC recurrence, the time to
50% mortality was 13 months; 1-year survival rates with and without specific
treatments were 57.8% and 18.6%, respectively; and 28.8% survived over 3
years. Overall 1-, 3- and 5-year survival rates were 60%, 51.8% and 38.5%,
respectively.
Conclusion. In patients with large HCC, hepatic resection combined with
aggressive recurrence treatment resulted in long-term survival. Early detection
of recurrent tumor is important considering high recurrence rate.
P22.102
CLINICAL EXPERIENCE OF MICROSPHERE TREATMENT IN
MANAGEMENT OF UNRESECTABLE LIVER TUMOURS
Jiao, Long R; Al-Nahhas, A; Tait, P; Canelo, R; Stamp, G; Wasan, H; Woo, K;
Pai, M; Habib, N
Hammersmith Hospital, London, UK
Introduction. Over the past few years, selective internal radiation has been
used clinically for the treatment of non-resectable hepatic metastases in the
absence of extrahepatic disease. Our initial experience in clinical application of
this treatment modality is reported here.
Material and methods. From November 2002, patients who were not
suitable for further conventional treatment with either chemotherapy or
surgery were considered for microsphere treatment after discussion at our
multidisciplinary meeting. None of the patients had extrahepatic diseases. A
pre treatment planning was carried out with a visceral angiography to assess
both tumour volume and extrahepatic shunting in addition to a baseline PET
and CT scan. Two weeks later, a second visceral angiography was performed to
deliver the calculated dosage of microsphere (SIR-Spheres†, SIRTEX
Medical, Australia) into the arterial system supplying the tumour. Patients
were then followed up with repeat PET and CT scan of abdomen at 6 weeks,
and 3 monthly thereafter.
Result. A total of 19 patients with a mean age of 59 years received SIRTEX
treatment, consisting of cholangiocarcinoma (n/3) and liver metastases (n/
16), colorectal (n/10), pancreas (n/2), GIST (n/1), breast (n/1), anus
(n/1) and an unknown primary (n/1). The average dosage of SIRTEX
delivered was 1.99/0.3 GBq. At follow up, 70%patients showed a radiological
response of a reduction in the size of tumour measured on CT scan at 3 months
and 90% a decreased PET activity measured with PET scan at 6 weeks. Four
patients died at follow up (n/1, pancreatic cancer; n/3, colorectal). Others
remain alive with a stable disease.
Conclusion. Microsphere should be considered for those who are no longer
suitable for conventional treatment modality, and would seem to offer an
improved short-term survival.
P22.103
CORE-NEEDLE BIOPSY FOR RADIOFREQUENCY LIVER TU-
MOUR ABLATION ASSESSMENT: REASONS FOR FAILURE
Sergeeva, Olga1; Starikova, Yulia2; Gavrilin, Anatoli3; Vishnevski, Vladimir1
1A.V.Vishnevski Surgery Institute, HPB Surgery Dept., Moscow, Russia;
2A.V.Vishnevski Surgery Institute, Pathology Dept., Moscow, Russia;
3A.V.Vishnevski Surgery Institute, Ultrasound Imaging Dept., Moscow,
Russia
Background. For the majority of the surgical procedures, pathologist finding
is a golden standard of the cure assessment, but isn’t of that for the liver tumour
radiofrequency ablation (RFA).
Aim/Objective. To reveal the reasons of often false core-needle biopsy results
after RFA.
Methods. The histologic changes in RFA zones produced by cool-tip
Radionic RFA system were studied in a) the animal model (3 rats-immediately,
1 day and 7 days after RFA), b) two liver specimens obtained and treated with
RFA immediately after resection and c) four liver specimens excised 0.5, 1.5,
3.0 and 6.0 months after percutaneous RFA procedures. The standard light
microscopy with H&E staining as well as the electron microscopy was
performed. The geometry of the suspected of incompleteness RFA zone also
was studied.
Results. Histologic evolution of RFA zone: The standard light micro-
scopy (H&E staining) fails to reveal any changes in tissue immediately
after RFA, while the electron microscopy demonstrates membranous
structure damage (above all, mitochondrial destruction). One week later, the
cells are still distinguished, thought the dilated sinusoids and thick inflamma-
tory infiltration are evident. Two weeks after the procedure the cellular
boundaries appear indistinct and the focal coagulative necrosis is present. Four
weeks after RFA the coagulative necrosis replaces the treated tissue at the
whole extent.
Spatial considerations. The outer surface of a 3.0 cm in diameter RFA zone
contains 1487 sites for obtaining the tissue by 16 G core needle. Hence, the
poorly imaged portion of the tumor during RFA procedure (suspected of
incomplete RFA) is of the poor imaging for core-needle biopsy.
Discussion and conclusion. The results of core-needle biopsy after RFA
are insecure due to the delayed light microscopy presentation of the
coagulative necrosis and the high heterogeneity of the RFA zone suspected
of residual or recurrent tumor. Imaging techniques are of the priority for RFA
assessement.
P22.104
A CASE OF LYMPHOEPITHELIOMA-LIKE CHOLANGIOCARCI-
NOMA NOT ASSOCIATED WITH EPSTEIN-BARR VIRUS
Cho, Chol-Kyoon1; Kim, Hyun-Jong1; Jeong, Soonju1; Koh, Yang-Seok1;
Kim, Jung-Chul1; Joo, Young-Eun2; Park, Chang-Hwan2; Lee, Wan-Sik2;
Choi, Sung-Kyu2; Rew, Jong-Sun2; Kim, Sei-Jong2; Jang, Nam-Kyoo3; Jeong,
Yong-yeon3; Lee, Jae-Hyuk4
1Chonnam National University Medical School, Surgery, Gwangju, Korea;
2Chonnam National University Hospital, Internal Medicine, Gwangju,
Korea; 3Chonnam National University Hospital, Radiology, Gwangju, Korea;
4Chonnam National University Hospital, Pathology, Gwangju, Korea
Background. Lymphoepithelioma-like carcinoma(LELC) is a tumor with
morphological features identical to undifferentiated nasopharyngeal carci-
noma that occurs outside the nasopharynx. The tumor has been reported to
originate in a variety of organs including salivary gland, stomach, lung,
thymus, skin and several other body sites. In the liver, only a few cases of
LELC have been reported (Lymphoepithelioma-like cholangiocarcinoma).
Most of the reported cases showed strong association with Epstein-Barr
virus(EBV) and a better prognosis clinically.
Aim. Lymphoepithelioma-like cholangiocarcinoma is thought to be a very
rare subtype of intrahepatic cholangiocarcinoma with characteristic patholo-
gic feature. We evaluated the histologic and immunohistochemical character-
istics of the tumor.
Patient/Method. A 57 year-old-female was found to have 2 cm sized mass in
S6 of liver by abdominal CT. Tumor markers and markers for hepatitis B and
C showed non-specific finding. The resection of S6 was performed and the
resected specimen was evaluated by histologic study with immunohisto-
chemical staining. RESULT: The tumor was 2/1.9 cm in size and well-
defined without capsulation. Microscopically, the tumor was composed of 2
components merged together. The first component was undifferentiated
carcinoma similar to nasopharyngeal carcinoma, and the second component
consisted of adenocarcinoma forming ductular structure. Both components
were associated with dense lymphoplasma cell infiltrations and granuloma-
tous reaction was present. In immunohistochemical study, the immunor-
eactivity for CK, CK7, CD30(focal) and EMA was positive, and the
immunoreactivity for others was negative. Characteristically the immunor-
eactivity for EBV was negative.
Conclusion. We report a case of Lymphoepithelioma-like cholangiocarci-
noma that is not associated with EBV. Our case suggest that this tumor can be
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developed without implication of viral infection such as EBV or hepatitis
virus.
P22.105
PERIPHERAL CHOLANGIOCARCINOMA-A SINGLE SPECIA-
LIZED HEPATIC CLINIC EXPERIENCE
Severtsev, Alexey; Tchudaev, Dimitri; Mezhgikh, Telman; Kogonia, Lali;
Grishina, Irina; Bjakhov, Mikhail
The Central Clinical Hospital#1 of the OAO, HPB-Surgical Dept., Moscow,
Russia
Peripheral cholangiocarcinoma is the second on frequency occurred liver
cancer. It is extremely difficult to diagnose this type of cancer (‘‘incidenti-
loma’’ of the liver). In Russia this cancer is extremely rare occured. The
purpose of the study is to estimate the clinical situation by this kind of liver
cancer and to define the prospects in its treatment. For the period from Dec.
2002 till Dec. 2005 in the specialized department of our hospital 12 patients
with the confirmed diagnosis cholangiocarcinoma were observed. In spite of
the fact that bilobar involvement was applied to 7 patients, surgery is
executed to all patients. The volume of liver resection was individual
(lobectomy till up to trisectorectomy), but an obligatory condition was full
(5 patients) or maximal (7 patients) removal of a tumoral tissue (citoreduc-
tive surgery) with extended lymphodissection. During surgery, all tumours
were greater in the sizes (at least up to 5,5 sm and more in diameter). All
patients in the postoperative period received immuno- and chemotherapy and
the hyperthermal intraoperative intraperitoneal chemotherapy. All the
patients got over the surgery successfully. Perioperative mortality was 0%.
The Long-term results. In the group without bilobar process, the minimal
long term observation has made 1 year, the maximal-up to 3years. 3 patients
had an advanced process. In the group with bilobar involvement, the minimal
long time observation has made 4 months, the maximal-up to 2 years. 2 in 7
patients have died (the period of supervision of 5 months and 1,1 year). The
received preliminary results allow to approve, that new intraoperative
techniques and oncologic methods allow to prolong substantially the life in
this group of patients.
P22.106
SKIN METASTASIS AFTER RADIOFREQUENCY ABLATION OF
COLORECTAL LIVER METASTASIS
Tam, Tak L1; Lee, Kit F1; Lee, Paul S2; Lai, Paul B1
1Prince of Wales Hospital, Surgery, New Territories, Hong Kong; 2Prince of
Wales Hospital, Diagnostic Radiology and Organ Imaging, New Territories,
Hong Kong
Background. Radiofrequency ablation (RFA) is now increasingly utilized
for treatment of malignant liver tumors. It has been shown to be a safe
and effective treatment of primary and secondary liver tumors. With
the percutaneous route, the tumor is punctured with RFA needle introduced
through the abdominal wall. The reported incidence of tumor seeding
along needle tract is 0.22.8%. Most of these cases happened after RFA
of hepatocelluar carcinoma while only one case was described after RFA
of a colorectal liver metastasis. We would like to report another case of needle
tract seeding after percutaneous RFA of liver metastasis from colorectal
origin.
Case report. A 48-year-old lady underwent laparoscopic anterior resection
for carcinoma of rectum in January 2005. Percutaneous RFA was performed 2
months later for a 1.7 cm solitary superficial segment V liver metastasis. A 3
cm, 17 G Super-slim LeVeen needle electrode was inserted under computed
tomography guidance and a total of 4 overlapping sites were ablated. A skin
nodule was noted at the RFA needle puncture site 6 months later. Fine needle
aspiration cytology and positron emission tomography confirmed the presence
of metastasis in the skin nodule as well as 4 other new lesions in the left lobe of
liver. Laparotomy and resection of liver tumors as well as the skin nodule were
performed. Histology confirmed the adenocarcinoma in the skin nodule
involving the dermis and subcutis. Post-operatively the patient made a good
recovery.
Discussion. Although the incidence of tumor seeding along needle tract is
low, this rare complication needs to be considered and carefully discussed with
patients before the procedure. Such complication is probably more commonly
encountered in superficially located tumor with multiple needle punctures, as
in this case. Whether needle tract ablation can help to decrease needle tract
seeding remains to be answered.
P22.107
Stubbs, Richard S1; O’Brien, Inga1; Correia, Mauro M2
1Wakefield Gastroenterology Centre, Wellington, New Zealand; 2National
Cancer Institute, Rio de Janiero, Brazil
Introduction. SIRT is a promising new treatment for non-resectable liver
tumours. 90Yttrium microspheres placed via the hepatic artery achieve
selective tumour uptake and irradiation. This paper presents an experience
of SIRT in 100 consecutive patients with non-resectable colorectal liver
metastases treated between January 1997 and March 2003.
Methods. A single dose of between 2.03.0 GBq of 90Yttrium microspheres
was given and followed by regional chemotherapy in 80 patients. Responses
were assessed by serial CT scans, CEA levels and survival.
Results. Median CEA, as a percentage of pre-treatment level, at 3, 6 and 12
months was 12%, 21% and 33%. Survival after SIRT was significantly better
in those patients whose CEA fell by more than 75% in the first 2 months (p/
0.002). Reduction in tumour size was seen in 59/79 patients after 3 months
and 41/65 patients at 6 months. Progressive liver disease was seen in only 5/79
after 3 months and 14/65 after 6 months. Morbidity (mainly gastroduodenal
ulceration) was seen in 8% of patients treated via a port and 31% for femoral
catheter. One treatment related death occurred from radiation hepatitis.
Median survival from diagnosis of liver metastases was 16.2 months (range
1.1101.6). Kaplan-Meier estimated survival9/se at 6, 12, 18, 24 and 30
months after SIRT was 76%9/4.3, 48%9/5, 32%9/4.7, 18%9/3.8 and 9%9/
2.8. The most significant variables affecting survival following SIRT were
extrahepatic disease at the time of SIRT (HR 6,2:1) and lack of regional
chemotherapy following SIRT (HR 3:1). Conclusions: SIRT is a valid
therapeutic option for non-resectable colorectal liver metastases. The use of
a port is a safer approach and permits the use of regional chemotherapy which
adds benefit to the treatment. The best results are to be expected in those with
liver-only disease.
P22.108
RADIOFREQUENCY ABLATION OF HEPATIC MALIGNANCIES:
LAPAROSCOPY OR LAPAROTOMY?
Hompes, Daphne; Aerts, Raymond; Penninckx, Freddy; Topal, Baki
University Hospital Gasthuisberg KUL, Abdominal Surgery, Leuven,
Belgium
Background. Surgical radiofrequency ablation (RFA) of hepatic malignan-
cies is associated with superior clinical and oncological outcome as compared
to percutaneuous RFA.
Aim. The aim of the present study was to analyze morbidity and mortality of
laparoscopic (LRFA) vs open (ORFA) radiofrequency ablation of liver cancer.
Methods. Between October 1999 and December 2005 RFA was performed
in 115 consecutive patients (percutaneous 11, LRFA 70, ORFA 34) for a total
of 221 hepatic tumours (HCC 55, colorectal metastases 125, other 41). The
male/female ratio was 72/43 and the mean (sem) age 62 (0.99) years. Mean
duration of surgery and intra-operative blood loss was 106 (9.55) minutes and
106 (9.55) ml, respectively. Fifty-eight (50.4%) patients simultaneously
underwent additional surgery (LRFA 42.9% and ORFA 61.8%).
Results. The overall RFA-associated morbidity was 9/115 (7.8%), whereas
morbidity of additional surgery was 11/58 (18.9%). Complications following
LRFA were observed in 8.6% and in 35.3% after ORFA (p0.0006). The
highest morbidity was observed in patients treated for colorectal cancer
(21.8%; p 0.01). One patient with cirrhosis died due to post-operative liver
failure following LRFA for HCC. A significantly higher post-operative
complication rate was observed in patients with large tumour volume, in
patients undergoing ORFA and in patients with additional surgery (pB/
0.036). Mean duration of surgery, blood loss and hospital stay was
significantly in favor of LRFA as compared to ORFA (pB/0.0006).
Conclusion. LRFA for hepatic malignancies seems to be preferable above
ORFA, provided long-term oncological control, good patient selection,
adequate equipment and surgical expertise.
P22.109
SURGICAL TREATMENT OF HEPATIC ADENOMA
Chaib, Eleazar; Ribeiro Jr, Marcelo; Herman, Paulo; Saad, William A;
Cecconello, Ivan
Hospital das Clinicas-University of Sao Paulo, Gastroenterology, Sao Paulo,
Brazil
Background. Hepatic adenoma (HA) is a rare benign tumour of the liver.
Tumour resection has been recommended for symptomatic or enlarging HA
because of the risk of intraperitoneal, intrahepatic hemorrhage or even the
development of hepatocellular carcinoma.
Aim. From 1989 to 2003 we reviewed the medical records and radiology files
of 28 patients with a proved diagnosis of hepatic adenoma. 24 patients were
female and 4 were male. Twenty-two patients had a history of oral contra-
ceptive use. Abdominal pain was presented in 19 patients and in 3 of them
have had an acute episode The mean age was 36,3 years. Preoperative
assessment included liver test, ultrasonography and computed tomography in
all patients plus technitium (99mTC)-sulfur colloid and 99mTc-labeled
DISIDA (dimethyliminoacetic acid) liver scintigraphy (n=19) and magnetic
resonance imaging (n=22).
Methods. Operative procedures included enucleation in 3 patients two of
them associated with hepatic segmentectomy; resection of one or two
segments in 14 patients; left and right hemihepatectomy respectively in 7
and 3 patients; right extended hepatectomy in one patient and nonanatomic
resection in one patient.
Results. There was no postoperative death and the complications were: bile
leakage (re-operation) one patient, intraperitoneal abscess (re-operation) one
patient, pleural effusion two patients, venous thrombosis one patient and
wound infection one patient.
Conclusions. Enucleation and anatomically based resections can be per-
formed safely and resection of symptomatic lesions was highly effective in
treating abdominal pain due to hepatic adenoma. We advocate resection of all
hepatic adenoma mainly in symptomatic lesions or when malignancy cannot
be excluded.
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SURGICAL OUTCOME OF YOUNG HCC: SIZE DOSES MATTER
Liao, Jhy-Bin; Chen, Yao-Li; Ko, Chih-Jan; Lee, Tung-Yan; Kuo, Shou-Jen
Chang-Hua Christian Hospital, General Surgery, Chang-Hua, Taiwan
Background. The aims of the study were to evaluate the surgical outcome of
young-hepatocellular carcinoma (HCC).
Materials and methods. The clinical, laboratory, operative and pathological
data of patients younger than 40 years old were retrieved for analysis from the
HCC surgical database of a tertiary hospital.
Results. 25 patients (16 male and 9 female) met the age criteria from May,
1997 to Apr, 2005. The mean age was 33.32+/5.58. All the patients were
HBsAg positive. The overall one-year and 3-year survival rate were 83% and
67% respectively. Tumor rupture, recurrence, size, multiplicity and serum
GPT level were correlated with long-term prognosis, while the serum albumin
level was inversely correlated with mortality. The tumor recurrence rate was
44% (median, 6.6 months). The serum alfa fetoprotein (AFP) level (>400ng/
mL), tumor size (>10cm) and multiplicity of tumor were correlated with the
tumor recurrence, while the serum albumin level was inversely correlated with
tumor recurrence. All the expired cases (median survival 10.4 months) during
follow-up have characteristic of tumor size >10cm. The one-year and 3 year
survival rate were significantly lower for patient with tumor size >10cm than
for those with tumor size B/10cm (55.6% vs 100%, p=0.014 and 33.3% vs
100%, p=0.009). Tumor size >10cm correlated with mortality (r=0.749,
p=0.0001), tumor recurrence (r=0.510, p=0.009), tumor rupture (r=0.458,
p=0.021) and blood loss (r=0.426, p=0.038). There was a trend that the
tumor microinvasion also correlate with tumor size >10cm. (r=0.379,
p=0.06).
Conclusion. All the young-HCC patients were HBV carrier. The surgical
outcomes for patients with tumor size >10cm were poor. Hence, screening of
HCC in young HBV carrier would probably be an important measure in order
to have an earlier detection and better surgical outcomes.
P23.01
URIC ACID MEDIATES KUPFFER CELL RESPONSES TO HEPA-
TOCYTE ISCHEMIA/REPERFUSION INJURY
Schaeffer, David F1; Chung, Stephen W2; Steinbrecher, Urs P1; Powell,
James J3
1University of British Columbia, Dept. of Medicine, Vancouver, Canada;
2University of British Columbia, Dept. of Surgery, Vancouver, Canada;
3University of Edinburgh, Dept. of Clinical and Surgical Sciences, Edinburgh,
UK
Background. Cellular hypoxia/re-oxygenation during liver ischemia/reperfu-
sion (IR) injury generates uric acid. Although not previously examined, uric
acid may be an important mediator of hepatic IR injury.
Aims. To determine the role of uric acid in mediating Kupffer cell (KC)
responses to hepatocyte hypoxia/re-oxygenation injury.
Methods. KC and hepatocytes were isolated from CD-1 mice. KC purity was
/95% by anti-CD68 immunostaining. Hepatocyte purity was /95% by
morphology and cell count. Liver IR injury was simulated using an in-vitro
hypoxia/re oxygenation protocol. Cytokine concentrations were determined
using enzyme-linked immunosorbent assay techniques. Reagents had no
detectable endotoxin contamination by limulus amoebocyte lysate assay.
Results. Supernatants derived from isolated hepatocytes subjected to
hypoxia/re-oxygenation injury induced secretion of interleukin 6 (IL6) by
isolated KC. This response was proportional to the duration of hypoxic injury
(024 hours). KC responses were eliminated by the addition of uricase to the
hepatocyte supernatants. Isolated hepatocyte supernatant uric acid concen-
trations increased following hypoxia-re-oxygenation injury. Physiological
concentrations of uric acid (10100 mg/mL) induced dose dependent
secretion of IL6 and tumor necrosis factor a by isolated KC, but did not
increase secretion of interleukins -1b,-2,-4,-5,-6,-10,-12 or interferon g.
Incubation of uric acid with uricase prior to culture with Kupffer cells
abolished cytokine secretion. KC derived from Toll-like receptor-2 knockout
mice had similar increases in IL6 secretion as wild-type KC in response to uric
acid.
Conclusions. Supernatants derived from isolated hepatocytes subjected to
hypoxia/re-oxygenation injury induced IL6 secretion by Kupffer cells. This
response was abolished by uricase treatment and mimicked by uric acid. Our
results suggest that uric acid may be a novel mediator of IR injury in liver
transplantation.
P23.02
THE USE OF THE INFERIOR MESENTERIC ARTERY IN HEPA-
TIC ARTERIAL RECONSTRUCTION IN LIVER TRANSPLANTA-
TION AND HEPATIC TRAUMA
Astarcy´oðlu, Hu¨seyin1; Karademir, Sedat1; Ozkardeþ, Sevda2; Ozzeybek,
Deniz2; Akan, Mert2; Obuz, Funda3; Astarcy´oglu, Y´brahim1
1Dokuz Eylul University School of Medicine, Surgery, Izmir, Turkey; 2Dokuz
Eylul University School of Medicine, Anesthesiology, Izmir, Turkey; 3Dokuz
Eylul University School of Medicine, Radiology, Izmir, Turkey
Background. Need of extension vascular graft during hepatic arterial
reconstruction in liver transplantation era has been challenging. Use of
sigmoideal, radial and iliac arteries as well as saphaneous venous grafts has
been reported in the literature.
Objectives. Here we present 6 cases of arterial reconstructions using a
segment of autologous inferior mesenteric artery (IMA)under microsurgery.
Patients were consisted of 5 living donor liver transplant (LDLT) recipients
and one with hepatic trauma.
Methods. IMA was interposed for reconstruction between the right branch
of (donor’s) hepatic artery and the root of (recipient’s) common hepatic
artery in all patients. Among the LRLT recipients extention vascular graft was
needed secondary to intimal dissection extending to the root of recipient’s
common hepatic artery in four and hepatic artery thrombosis (HAT) in
another. In the trauma patient, hepatic artery was injured with extensive
tissue loss and successful reconstruction was performed in damage control
surgery concept.
Results. One recipient was complicated with graft thrombosis on postop day
7 and underwent immediate retransplantation. In the remaining, after a mean
follow-up of 9.8 months (4 to 19 mo.), interposition grafts were found patent
which was confirmed by either angiography or angio CT. Liver function tests
were normal in all except one patient who revealed mild elevations of ALP
and GGT secondary to stenosis at bilioenteric anastomosis and treated with
balloon dilatation.
Conclusion. Reconstruction using the arterial extention graft of autologous
IMA may be a good option for revascularization of the hepatic artery in liver
transplant and trauma patients.
P23.03
NOVEL SHORT TERM HYPOTHERMIC OXYGENATED PERFU-
SION (HOPE) SYSTEM PREVENTS INJURY IN RAT LIVER
GRAFT FROM NON HEART BEATING DONOR
Furrer, Katarzyna; Dutkowski, Philipp; Graf, Rolf; Clavien, Pierre-Alain
University Hospital of Zurich, Dept. of Visceral and Transplantation Surgery,
Zurich, Switzerland
Background. While extracorporeal perfusion systems may resuscitate liver
metabolism from NHBD resulting in improved liver function upon reperfu-
sion, the introduction of such strategy in the clinical routine depends on
practicability criteria. We investigated, whether a novel rat liver machine
perfusion applied after in situ warm ischemia and cold storage (mimicking
the clinical situation of severe preservation injury) may rescue NHBD liver
grafts.
Aim. To assess a machine perfusion system to rescue liver grafts from non
heart beating donors (NHBD).
Material and methods. We induced cardiac arrest in male Brown Norway
rats by phrenotomy and ligation of the heart base. No heparin was given
before and during warm ischemia. We studied two experimental groups:
45 min. warm in situ ischemia/5 hr cold storage (n/9) vs. 45 min.
warm in situ ischemia/5 hr cold storage followed by 1 hr hypothermic
oxygenated extracorporeal perfusion (HOPE) (n/9). In both groups,
livers were reperfused in a closed isolated liver perfusion device for 3 hrs at
37 ¢XC.
Results. NHBD livers showed after cold storage and reperfusion necrosis of
hepatocytes, increased release of AST (7.28 ,,b 1.9 U/g liver ww) and
decreased bile flow (0.17 ,,b 0.1 ml/3 hr). NHBD livers treated by HOPE
showed no necrosis, intact sinusoidal endothelial cells, significantly less AST
release (3.94 ,,b 1.3 U/g ww) (pB/0.001) and increased bile flow (0.50 ,,b 0.2
ml /3 hr) (pB/0.001). ATP was restored in livers treated by HOPE and
severely depleted in cold stored NHBD livers.
Conclusion. This study demonstrates effective prevention of injury by short
termed oxygenated perfusion in a clinical highly relevant model of NHBD.
Hypothermic oxygenated machine perfusion may serve as new tool for
optimizing NHBD livers.
P23.04
CONTINUOUS VS. INTERRUPTED SUTURE TECHNIQUE FOR
END-TO-END BILIARY ANASTOMOSIS DURING LIVER TRANS-
PLANTATION GIVE EQUALLY GOOD RESULTS
Castaldo, Eric T; Pinson, C Wright; Feurer, Irene D; Wright, J Kelly;
Gorden, D Lee; Kelly, Beau S; Chari, Ravi S
Vanderbilt University Medical Center, Dept. of Hepatobiliary Surgery,
Nashville, USA
Background. Biliary complications after liver transplantation occur in 10 to
30% of patients. Continuous suture (CS) technique for end-to-end chole-
dochocholedochostomy (EE-CDC), while generally regarded as quicker than
interrupted sutures (IS), has been presumed to have a higher stricture rate. A
comparison of the techniques has not been reported.
Aim. To compare IS and CS techniques during liver transplantation with
primary EE-CDC for biliary complications.
Methods. A single institution retrospective cohort study of all liver
transplants with an EE-CDC over a 19-month period was performed. Biliary
leak was defined as 1) bile drainage into operatively placed drains for
greater than seven days after transplant, 2) imaging study identifying a leak,
and/or 3) reoperation noting a leak. A biliary stricture was defined as having
all of the following: clinical findings consistent with a stricture (such as
elevated bilirubin or alkaline phosphatase), confirmatory imaging, and
treatment of the anastomotic narrowing with resolution of findings. Data
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were analyzed using Kaplan-Meier methods, log-rank tests, and chi square
tests.
Results. There were 100 patients with an EE-CDC (IS/59, CS/41). The
overall biliary complication rate was 11%. There was no difference in the
percentage of leaks (6.8% IS, 7.3% CS, P/0.92) or strictures (3.4% IS,
7.3% CS, P/0.38) between groups. Kaplan-Meier event rates showed no
difference between the groups for leak (P/0.98) or stricture (P/0.44).
There was no difference in the proportions of reoperation (P/0.36) or
endoscopic/percutaneous interventions (P/0.32) for the treatment of biliary
complications between groups. There was no difference in survival between
groups (P/0.62).
Conclusions. There was no difference in the rate of biliary leak, stricture,
reoperation or other interventions for biliary complications, or survival
between the IS and CS groups. IS or CS technique for EE-CDC during
liver transplantation yield equal results.
P23.05
A NEW SURGICAL TECHNIQUE TO TREAT BILIARY STRIC-
TURE AFTER LIVER TRANSPLANTATION
Bacchella, Telesforo; Figueira, Estela RR; Rocha-Santos, Vinicius; Machado,
Marcel AC; Machado, Marcel CC
University of Sao Paulo, School of Medicine, Sao Paulo, Brazil
Background. Biliary strictures after liver transplantation are major surgical
problem and were observed in 4.4% of 114 patients from January 2002 to
November 2005. Because of surgical difficulties and risks many services
prefer less invasive procedures such as endoscopic dilatation and stent to treat
anastomotic strictures. However follow up results are unsatisfactory, compel-
ling patients to repeated procedures generally complicated by cholangitis.
Aim. To present an alternative surgical technique for the treatment of biliary
stricture after liver transplantation.
Methods. Seven patients submitted to duct-to-duct biliary reconstruction
during liver transplantation developed anastomotic strictures. None hepatic
artery thrombosis was detected. Three patients transplanted in somewhere
else had T-tube drains. The diagnosis of biliary stricture was made by ERCP
or RMI between 4 and 133 months after the transplant. These seven patients
underwent Roux-en-Y hepaticojejunostomy with an uninterrupted 5-0 PDS
suture without biliary stent. The bile duct was prepared with a longitudinal
anterior incision of approximately 3 cm being extended below the stricture
area and through its left main branch if necessary. No attempt to isolate the
biliary duct using extensive lateral or posterior dissection was carried out. We
have already published this technique to treat biliary strictures of other
etiologies.
Results. All seven patients had an uneventful postoperative course. No
biliary fistulas or cholangitis were observed. No patient developed biliary
stenosis in the follow-up of 11 to 35 months after surgery. There was no
mortality.
Conclusion. This proposed technique to repair biliary stricture avoid broad
duct dissection, reduces operative time and provides an adequate exposure of
a good quality duct to perform a wide hepaticojejunostomy. The results of the
study added to previous experience shows that this technique is safe and
efficient.
P23.06
ALTERATIONS IN PROTEIN TYROSINE KINASE PATHWAYS IN
RAT LIVER FOLLOWING NORMOTHERMIC ISCHEMIA-REPER-
FUSION INJURY
Cursio, Raffaele1; Miele, Claudia2; Filippa, Nathalie3; Van Obberghen,
Emmanuel3; Gugenheim, Jean1
1Universite´ de Nice Sophia Antipolis, Laboratoire de Recherches Chirurgi-
cales, Nice, France; 2Universita` di Napoli, Dpt. Biologia e Patologia
Cellulare IEOS-CNR, Napoli, Italy; 3Universite´ de Nice Sophia Antipolis,
INSERM U145, Nice, France
Background. Injury from ischemia-reperfusion (I-R) during liver transplan-
tation limits graft success and promotes rejection.
Aim. The aim of this study was to evaluate the effect of normothermic liver I-
R on protein tyrosine phosphorylation, production of angiogenic growth
factors, and on activation of signal proteins in tyrosine kinase pathways.
Materials & methods. A segmental normothermic ischemia of the liver was
induced in rats by occluding the blood vessels including the bile duct to the
median and left lateral lobes for 120 minutes. Liver extracts were prepared at
0, 1, 3, and 6 hours after reperfusion. Liver tyrosine phosphorylation of
proteins was examined by Western blot analysis whereas vascular endothelial
growth factor (VEGF) mRNA was analysed by northern blot.
Results. VEGF mRNA and total protein levels were increased at 1 and 3 h
after reperfusion in parallel with the activation of the transcription factor
HIF-1. Tyrosine phosphorylation of the VEGF receptor Flk-1 and the
PDGF-beta receptor were increased only at 1 h of reperfusion, whilst Shc and
c-Src tyrosine phosphorylation was still increased 3 h after reperfusion. The
tyrosine phosphorylation of the insulin receptor substrate 1 (IRS1) was
completely abolished at 6 h of reperfusion.
Conclusion. I-R leads to alterations in protein tyrosine phosphorylation and
to an increased expression of the VEGF in rat liver. These results suggest that
protein kinase pathways are activated during normothermic liver I-R and may
play an important role in ischemia-induced liver damage.
P23.07
ANALYSIS OF SURVIVAL ACCORDING TO THE TYPE OF
GRAFT IN PRIMARY LIVER TRANSPLANTATION IN CHILDREN
AND ADULTS
Corno, Vittorio1; Alessandro, Lucianetti1; Domenico, Pinelli1; Michela,
Guizzetti1; Gregorio, Maldini1; Marco, Zambelli1; MariaClara, Dezza1;
Mara,Giovanelli1;Giuliano,Torre1;Mario,Strazzabosco2;Michele,Colledan1
1Ospedali Riuniti, Liver-Lung Transplant Unit, Bergamo, Italy; 2CeLiveR,
Bergamo, Italy
Introduction. Different results have been reported with the use of different
type of liver graft. We reviewed and analyzed the results of liver transplanta-
tion according to the type of graft.
Methods. From October 27th 1997 to December 31st 2005 we performed
526 liver transplants (LTx) in 483 recipients (306 LTx in 270 children and
220 in 213 adults). Recipients of a primary LTx in Bergamo were analyzed.
The study population includes 259 children and 204 adult. The children
received 189 (73%) left lateral segments (LLS), 57 (22%) whole liver (WL),
10 (4%) extended right grafts ERG (segments I,IV-VIII) and 3 (1%) full left
graft (FLG). The adults received 177 (86,5%) WL, 21 (10,5%) ERG, 5
(2,5%) FL and 1 (0,5%) full right (FR). In the children group 19 (7%) were
in UNOS status 1, 16 (6%) in 2A, 85 (33%) in 2B and 139 (54%) in status 3.
Among the adults 6 (3%) were in UNOS status 1, 23 (11%) in 2A, 127
(63%) in 2B and 48 (23%) in status 3.
Results. The recipients of a FR graft died intra-operatively. According to
the type of graft, actuarial 1 and 5 year patient and graft survivals were
84%/81% and 80%/76% for WL (83%/82% and 77%/76% in the adults;
86%/79% and 84%/75% in children); 97%/97% and 93%/91% for ERG
(100%/100% and 95%/95% for adults; 90%/80% and 90%/80% for
children); 88%/75% and 66%/50% for FL (80%/60% and 80%/60% for
adults; 100%/100% and 67%/67% for children); 90%/84% and 87%/80% for
pediatric recipients of a LLS graft. No statistical significant difference was
found between the groups except for graft survival among the adult recipients
of different graft (log rank 0,042).
Conclusion. Our results showed no difference on patient/graft survival
according to the type of graft used for LT both in adult and children. Results
of ERG in adults could be related to a better donor selection compared to the
donor selected for whole liver procurement. These results are a further
argument for the wide spread use of split liver graft.
P23.08
ASSOCIATION OF AN ARTERIO-PORTAL FISTULA ON PRE-
OPERATIVE ANGIOGRAPHY WITH PORTAL TUMOUR THROM-
BOSIS IN PATIENTS UNDERGOING TRANSPLANTATION FOR
HEPATOCELLULAR CARCINOMA
Vibert, Eric; Salloum, Chady; Hamadeh, Ahmad; Burns, Andrew; Adam,
Rene; Azoulay, Daniel; Castaing, Denis
Hopital Paul Brousse (AP-HP), Centre Hepato-Biliaire, Villejuif, France
Background. Portal tumour thrombosis (PTT), a recognised complication
of hepatocellular carcinoma (HCC), can be difficult to diagnose prior to liver
transplantation (LT), for which it is a contraindication. It could be
hypothesized that an arterio-portal fistula (APF) is created when the HCC
invades into the lumen of the portal vein system due to arterial vascularisation
associated with this tumour. Consequently the demonstration of an APF in
pre-transplantation angiography may indicate the presence of PTT.
Aims. The aim of this retrospective study was to determine the association of
an APF with macroscopic PTT in the explanted liver, and to assess the
prognostic value of an APF in patients undergoing LT for HCC.
Methods. From 1985 to 2000, 208 patients underwent LT for HCC.
Comparison was made between patients with and without an APF in terms of
overall and disease-free survival, age, sex, presence and aetiology of cirrhosis,
number of tumour nodules, size of the largest nodule, level of AFP, neo-
adjuvant (chemoembolization, local destruction, surgical resection) or
adjuvant treatment (systemic chemotherapy), and the presence or not of
macroscopic PTT. This last parameter was only analysed in 128 patients.
Results. An APF was diagnosed preoperatively in 8 patients, of which two
had had a tumoral biopsy prior to angiography. One, 3 and 5 year overall
survival was respectively 84%, 69% and 59% without APF, and 100%, 87%
and 62% with APF (ns). One, 3 and 5 year disease-free survival was
respectively 80%, 59% and 51% without APF, and 100%, 62% and 62%
with APF (ns). The two groups were comparable for all parameters except for
the presence of macroscopic PTT: 4/8 (50%) with APF versus 13/120
(10.8%) without APF (p/0.0016). One patient with APF after tumoral
biopsy had a macroscopic PTT.
Conclusions. The observation of an APF on preoperative angiography is
strongly associated with tumoral portal thrombosis in patients transplanted
for HCC without incidence on survival and should not be a contra-indication
to LT.
P23.09
BENEFICIAL EFFECTS OF SPLENECTOMY AFTER MASSIVE
HEPATECTOMY IN RATS
Ogasawara, Takashi; Morine, Yuji; Imura, Satoru; Soejima, Yuji; Shimada,
Mitsuo; Arakawa, Yusuke
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The University of Tokushima, Dept. of Digestive and Pediatric Surgery,
Tokushima, Japan
Background and aims. Splenectomy is known to inhibit hepatic fibrosis
and promote liver regeneration. However, little has been reported effects of
splenectomy on massive hepatectomy. The aim of this study is to clarify
effects of splenectomy on massive hepatectomy, small-for-size graft model in
living donor liver transplantation.
Materials and methods. Rats were divided into two groups: SPx group
(n/5), in which 90% hepatectomy and splenectomy were simultaneously
performed; and control group (n/5), in which 90% hepatectomy was only
performed. Following parameters were compared between the two groups:
survival rate, serum alanine aminotransferase (AST), total bilirubin, total bile
acid (TBA), recovery of remnant liver weight and expression of heme
oxygenase-1 (HO-1) by immunohistochemistry.
Results. The survival rate in SPx group was significantly better than that in
control group. The remnant liver/body weight ratio 48 hours after operation in
SPx group was higher than that in control group (1.59/0.04% vs. 1.29/0.12%,
pB/0.05). Postoperative peak values of ALT, total bilirubin and TBA were
similar between the two groups. However, their values in SPx group were more
quickly improved than those in control group. The expression of HO-1 1 at 2
hours after operation in SPx group was stronger than that in control group.
Conclusions. Splenectomy brought improved survival rate, quick recovery
of liver function, promoted liver regeneration after 90% hepatectomy. The
beneficial effect may be related to up-regulation of HO-1, one of heat shock
protein family.
P23.10
BLOOD SALVAGE AUTOTRANSFUSION DURING TRANS-
PLANTATION FOR HEPATOCELLULAR CARCINOMA. DOES
IT INCREASE THE RISK OF NEOPLASTIC RECURRENCE?
Muscari, Fabrice1; Suc, Bertrand1; Sharaan, Mohamed1; Migueres, Isa-
belle2; Rostaing, Lionel3; Fourtanier, Gilles1
1University Hospital Rangueil, Digestive Surgery, Toulouse, France; 2Uni-
versity Hospital Rangueil, Anesthesia, Toulouse, France; 3University Hospi-
tal Rangueil, Organ Transplantation And Nephrology, Toulouse, France
Background. Impact of intraoperative blood salvage autotransfusion (IBSA)
on neoplastic recurrence. during liver transplantations for hepatocellular
carcinoma (LT-HCC).
Study design and methods. Between January 1989 and February 2003, 16
patients received a LT-HCC without IBSA. This group was compared to 31
patients who received the same surgical procedure during the same period,
but with IBSA. Data were prospectively collected. All patients had at least a
one-year postoperative follow-up. Pairing was made according to the size of
the largest nodule.
Results. The percentage of recurrence observed in the two groups was
similar: 6.4% in the IBSA group vs 6.3% in the group without IBSA. The
median amount of transfused salvage blood was 1558 ml. The differences
observed between the two groups concerned the Child score which was A in
58% patients of the IBSA group vs 80% in the other group; the percentage of
severe portal hypertension was 55% in the IBSA group vs 31%; the median
number of packed red blood cell units transfused intraoperatively was 7 in the
IBSA group vs 0, and the median number of frozen fresh plasma units
transfused peroperatively was 11 in the IBSA group vs 4.5.
Conclusion. It appears that IBSA, essentially used during the most
hemorrhagic transplantations, could be used in the case of hepatocellular
carcinoma because it does not modify the risk of neoplastic recurrence.
P23.11
BUCILLAMINE AMELIORATES LIVER WARM ISCHAEMIA
REPERFUSION INJURY IN A RAT MODEL
Junnarkar, Sameer; Tapuria, Niteen; Yang, Wen-Xuan; Seifalian, Alexander;
Davidson, Brian
Royal Free Hospital, Academic Dept. of Surgery, London, UK
Background. Liver transplantation and resection surgery involve a period of
ischaemia and reperfusion to the liver which initiates an inflammatory
cascade resulting in liver and remote organ injury. Bucillamine is a low
molecular weight thiol antioxidant that is capable of rapidly entering cells.
The effect in liver warm ischaemia reperfusion injury has not been studied.
Hypothesis. Bucillamine would protect against warm ischaemia reperfusion
injury through its antioxidant and anti-inflammatory effects.
Aim. To use a well described model of liver ischaemia reperfusion to
determine the effect of Bucillamine administration on liver function, liver
microcirculation and hepatocyte apoptosis.
Materials and Methods. Effect of bucillamine was studied in a rat model of
liver ischaemia- reperfusion injury with 45 minutes partial(70%) ischaemia
and 3 hours reperfusion. Liver injury was assessed by serum Transaminases
(AST and ALT) and by assessing sinusoidal blood flow and staining of
apoptotic hepatocytes by propidium iodide on intravital microscopy.
Results. Liver injury was significant lesser in Bucillamine group as compared
to Control group as assessed by serum AST (9329/200.8 vs 2072.59/511.79,
pB/0.05) and serum ALT (861.49/262.63 vs 2079.259/322.33, pB/0.05).
The number of apoptotic cells at the end of 3 hours of reperfusion was also
significantly lesser in the Bucillamine group (pB/0.001). There also was
better perfusion of sinusoids in the Bucillamine group at the end of 3 hours of
reperfusion (RBC velocity 242.669/16.86 vs 181.119/17.59).
Conclusions. Bucillamine protects hepatocytes from ischaemia- reperfusion
injury through its anti inflammatory and anti oxidant effect.
P23.12
CALCULATING LIVER VOLUME FOR LIVING DONOR LIVER
TRANSPLANTATION: SAFETY OF 3D CT
Emiroglu, Remzi1; Coskun, Mehmet2; Yilmaz, Ugur3; Sevmis, Sinasi1;
Ozcay, Figen4; Karakayali, Hamdi1; Haberal, Mehmet1
1Baskent University Faculty of Medicine, General Surgery and Transplanta-
tion, Ankara, Turkey; 2Baskent University Faculty of Medicine, Radiology,
Ankara, Turkey; 3Baskent University Faculty of Medicine, Gastroenterology,
Ankara, Turkey; 4Baskent University Faculty of Medicine, Pediatric Gastro-
enterology, Ankara, Turkey
Background. Since impaired liver function after resection and transplanta-
tion is caused by insufficient liver volume, a reliable volumetric assessment of
the hepatic segments of potential living donors is a key factor when evaluating
donors preoperatively.
Aim. In this study, we compared conventional 3D computed tomography
(CT) volumetry with the intraoperative findings in 80 transplanted cases
performed at our center from september 2003 through december 2006.
Method. Resection borders were determined preoperatively with the aid of
3D CT by manual delineation using the hepatic vessels as guides. Resected
liver grafts were weighed intraoperativley all cases, and their volumes were
calculated based on the specific weight of 1 g/mL. Statistical analyses were
performed using Pearson’s correlation test. A value for P less than. 05 was
considered statistically significant.
Results. Between 2003 and 2005, 80 living-related liver transplantations were
performed. Of these, 48 were females and 32 were males (mean age, 35.69/9.7
years; range, 2356 months). Forty-one donors underwent right lobectomy,
22 underwent left lobectomy, and 17 underwent left lateral segmentectomy.
Manual volume measurement was completed within 15 minutes. Mean liver
volumes, as measured with the 3D CT, were 15099/243 mL (total liver), 8689/
168 mL (right liver lobe), 4999/136 mL (left liver lobe), and 3939/92 mL(left
lateral liver lobe, segments II and III). Preoperatively, on the back table, the
mean volume of the right lobes was 8279/158 mL, the mean volume of the left
lobes was 4439/140 mL, and the mean volume of the left lateral segments was
3379/87 mL. No significant differences were found between the presented
preoperative volumetry and the intraoperative Measurement.
Discussion. Manual 3D CT volumetric calculation is reliable and less time-
consuming means of calculating liver volume for living-donor liver trans-
plantation.
P23.13
CHALLANGING ISSUES OF A LIVER TRANSPLANTATION PRO-
GRAM IN A SMALL COUNTRY
Stasnisavljevic, Dragoje; Sojar, Valentin
University Medical Centre, Ljubljana, Slovenia
Background. Liver transplantation is an established method of treatment of
end stage liver disease. It is performed in several countries for decades. About
ten years ago a number of small countries arose as the consequence of the
Berlin wall break down and due to weakening of the former depressing
regimes. Slovenia is also among those countries, it has 2 million inhabitants.
The question is whether such a small country needs its own liver
transplantation program since it has been well known, that the volume of
the procedures brings better results.
Objective. Liver transplantation program in Slovenia started in 1998. Since
five years Slovenia is a member of Eurotransplant network. One hospital is a
transplantation center and there are 9 donor hospitals connected in national
network. Slovenia-transplant is national institution for organ sharing. Slovenia
realizes around 15 donors per million in last years, which is above European
average. Transplantation program is financed by national health care system.
LTx are performed by two surgeons. Main occupation of the team is liver
surgery. Surgical team performs about 120 liver resections per year. Team of
hepatologists, anesthesiologists and other participating members is narrow as
well. Until now 86 LTx has been performed in 82 patients in Slovenia. 4
patients were retranslated. That means approximately 1 LTx per month. One
and three years survival rates are comparable to results in the literature.
Discussion. Slovenia is a small country. Transplantation program represents
one of the major challenges in the national health care system and it brings
the opportunity for adequate treatment for the patients who need organ
transplantation. Transplantation program also challenges relative small
number of professionals involved in transplantation to engage all potentials
in its maintenance and further development. From our point of view it brings
all the benefits to the patients and the health care system in professional,
organizational and financial aspects.
P23.14
CLINICAL OUTCOME OF 300 CONSECUTIVE LIVING LIVER
DONORS
Cho, Eung-ho1; Suh, Kyung-Suk1; Yang, Sung Hoon1; Lee, Hae Won1; Yi,
Nam-Joon1; Lee, Kuhn Uk1; Choi, Jae Woon2; Lee, Kuhn Uk1
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1Dept. of Surgery, Seoul National University, College of Medicine, Seoul,
South Korea; 2Dept. of Surgery Chungbuk National University Hospital,
Cheongju-si, South Korea
Background. In living donor liver transplantation (LDLT), donor safety is
of a major concern. The complication rates of living donor were variable in
previous reports. We report clinical outcomes of 300 consecutive living liver
donors.
Method. From January 1999 to November 2005, 300 cases of LDLT were
performed in Seoul National University Hospital. The cases were divided
into 2 chronological periods. From Jan. 2002, we started prospective
investigation of donor complication. So, donors between Jan. 1999 and
December 2001 were included in early group (n/100), and donors between
Jan. 2002 and Nov. 2005 were included in late group (n/200). Clinical
outcomes of the donors were compared. Donor complications were graded
according to modified morbidity classification of Clavien et al.
Result. In early group, there were 55 cases of left hepatectomy and 45 cases
of right hepatectomy. On the contrary, in late group, there were 59 cases of
left hepatectomy and 141 cases of right hepatectomy (pB/0.05). No donor
mortality or reoperation occurred. No intraoperative transfusion was done.
Operation time was short in late group (314.8 min vs. 285.2 min, pB/0.05).
Total bilirubin level at POD7 was higher in late group (0.99 mg/dL vs. 1.35
mg/dL, pB/0.05). Intraoperative blood loss (423.1 ml vs. 383.0 ml, p/0.05)
and postoperative hospital stay (13.1 days vs. 11.6 days, p/0.05) were not
different between two groups. AST/ALT levels at POD7 were not different
between two groups (52.6/90.9 IU/L vs. 64.3/94.0 IU/L, p/0.5). Complica-
tion rate of early group was 4% (4/100), and that of late group was 47.5%
(95/200). In early group, grade II complication occurred in 1 patient, and
grade III in 3. In late group, grade I complication occurred in 58 patients,
grade II 34, and grade III 3 (p/0.00).
Conclusion. Mild complications might be ignored in retrospective studies, so
prospective study about donor complication is needed to uncover any covert
or subclinical medical condition that would place a donor at undue risk.
P23.15
CORRELATION BETWEEN WEB BASED IMAGE TRANSMISSION
OF CADAVER DONOR LIVERS AND HISTOLOGICAL GRADE OF
STEATOSIS IN CADAVER LIVER TRANSPLANTATION
Bhati, Chandra S1; Neil, Desley2; Mehta, Naimish1; Ghaffar, Naveed3;
Bramhall, Simon1; Manas, Derek4; Mayer, David1; Wigmore, Stephen1;
Buckels, John1; Mirza, Darius F1
1Queen Elizabeth Hospital, HPB and Liver Transplant Surgery, Birming-
ham, UK; 2Queen Elizabeth Hospital, Pathology, Birmingham, UK; 3Mind-
ascent, Huddersfield, UK; 4Freeman Hospital, Liver transplant Surgery,
Newcastle, UK
Background. The use of steatotic livers is associated with graft dysfunction.
Fat assessment is based on visual impression by retrieval surgeon. Accuracy
of fat assessment is operator dependant and often does not correlate with
histology, the ‘‘gold standard’’.
Aims. Evaluation of a web based system of image transmission of the donor
liver and comparison of this visual appearance with liver histology and graft
outcome.
Methods. Using the NORIS system (National Organ Retrieval Imaging
System), a set of standardised images (n/6) of each liver graft was taken by a
standardised camera, 1 mega pixel, with flash and macro mode on, without any
external light. These were uploaded (over 10 minutes) using NORIS PDA to
the secure encrypted website www.noris.org.uk. Histology was studied on
postreperfusion core biopsies, evaluated ‘‘blind’’ by a single pathologist (DN).
Results. A total of 27 livers were imaged and 24 were transplanted (3 unused
due to malignancy-2 and severe steatosis-1). The mean donor age was 41
(1366 years), with a median BMI of 24.8 (20.143.3). Median cold
ischemic time was 10.2(3.5 to 12.5 hours). These livers were classified by
histopathology (n/22) into seven groups using a semi-quantitative steatosis
scoring system: Normal: A//5%, Mild: B/615%,C/1630%,Moder-
ate: D/3145%,E/4660%, Severe: F/6175%,G//76%. Median
early peak transaminases were as follows and 6 grafts showed initial
dysfunction (AST: 250012150, INR/1.331). Two patients were re-
grafted (hepatic artery thrombosis, initial poor function). The post perfusion
donor liver images appeared to correlate with severely steatosis.
Groups A B C D E F G
No of patients 9 5 1 1 1 3 2
Conclusion. Use of a web based imaging system (NORIS) is effective for
image transmission and facilitates communication within transplant teams.
There is the potential to achieve correlation between uploaded images and
degree of steatosis.
P23.16
CURRENT STATUS OF PATIENTS 10 YEARS AFTER LIVER
TRANSPLANTATION
Bilbao, Itxarone1; Dopazo, Cristina1; Castells, Luis2; Lazaro, Jose L1;
Balsells, Joaquin1; Margarit, Carles1; Armengol, Manel1
1Hospital Vall d?Hebron, General Surgery Dept., Barcelona, Spain; 2Hospital
Vall d?Hebron, Hepatology Dept., Barcelona, Spain
Background. The quality of life of long-term survival patients after liver
transplantation (LT), is becoming a question of great interest.
Aims. To analyse current status of alive patients, 10 years after LT and to
compare them, with those not surviving this period.
Methods. From 1988 to 1995, 174 patients with a follow-up of /10 years,
have been transplanted in our centre. Sixty patients are alive and 111 are
dead. Causes of death in the group surviving B/10 years have been analysed.
Demographics characteristics of recipient, donor, surgery, postoperative
complications, long-term complications and morbidity related to immuno-
suppression, have been compared between both groups.
Results. Main causes of early mortality (3 months) have been: infection-
sepsis (39%), multiorgan failure (21%), and others. Main causes of long term
mortality were: de novo tumour (17%), HCC recurrence (14%), HCV
recurrence (7%), and others. Patients surviving/10 years had the following
characteristics: greater proportion of cholostatic disease, lower Child C
proportion (0.05), lower UNOS status I, IIa, IIb (p/0.09), higher
percentage of patients under 60 years (p/ns) and lower percentage of
associated diseases (DM, renal insufficiency, and previous surgery). Con-
cerning morbidity, current situation 10 years after LT were: 33% of alive
patients with chronic renal insufficiency; 70% with hypertension; 10% with
IDDM; 25% with dislipemia; 10% with cardiovascular morbidity and 68% of
VHC (/) patients with clinical and histological recurrence of HCV.
Conclusion. Postnecrotic HCV cirrhosis with or without HCC, the
most frequent indication to LT in our country, have shown tendency to
lower long term survival than cholostatic disease. Pre-LT renal insufficiency
is a negative factor for long-term survival. Immunosuppression regimens
avoiding the advers effects of chronic use of anticalcineurincs will be the great
challenge in the future, if we want to reach long term survival with good
quality of live.
P23.17
EARLY WEB BASED IMAGE TRANSMISSION FACILITATES
COMMUNICATION AND IMPROVES LOGISTICS FOR SHARED
EX-SITU SPLIT LIVER TRANSPLANTATION (SLT)
Bhati, Chandra S1; Mehta, Naimesh1; Ghaffar, Naveed2; Millar, Alastair3;
Manas, Derek4; Bramhall, Simon1; Wigmore, Stephen1; Mayer, David1;
Buckels, John1; Mirza, Darius1
1Queen Elizabeth Hospital, HPB and Transplant Surgery, Birmingham, UK;
2Mindascent, Huddersfield, UK; 3Birmingham Children’s Hospital, Liver
Transplant Unit, Birmingham, UK; 4Freeman Hospital, Liver Transplant
Unit, Newcastle, UK
Background. SLT is technically demanding, and is not practised widely.
Individual surgeon’s concerns about allocation of vascular/biliary branches at
splitting, has prevented wider sharing of SLT between centres. Use of a high
quality web-based imaging system would allow the surgeon receiving the
second graft at the remote centre to visualise this well before split completion.
This advance information might enable the surgeon to shorten ischaemia
time, and plan the recipient vascular/biliary reconstruction.
Aim. Evaluation of a web based image transmission system in shared
SLT.
Methods. A total of six images of each ex-situ split graft, using the NORIS
(National Organ Retrieval Imaging System image transmission system), were
taken at the bench split with a standardised camera (1 mega pixel, with flash
and macro mode on), including details of size of allocated vessels and
segmental bile ducts. These images were then uploaded (over 10 minutes)
using NORIS PDA to a secure encrypted website www.noris.org.uk. After
uploading to the website, a text is sent to the remote recipient surgeon who
can view these images by logging onto the password protected website.
Results. A total of nine livers undergoing ex-situ division were studied and
eight were split at the paediatric centre. Seven were shared between the two
Birmingham units and two were shared with other UK centres. Information
provided included colour/appearance of the liver, arterial, portal venous and
biliary anatomy and vessel/duct size. The minimum time interval between
division of the hilar vessels and completion of the split procedure was two
hours, allowing the remote surgeon to view the allocated graft well in advance
of commencing surgery.
Conclusion. Use of a web based imaging system can be effective for precise
image transmission between transplant centres enabling viewing of the graft
well before its arrival. This could reduce some of the barriers to wider
adoption of split liver transplantation.
P23.18
EFFECT OF LOW CENTRAL VENOUS PRESSURE ON BLOOD
LOSS DURING LIVING DONOR HEPATECTOMY
Ushitora, Yuichirou; Itamoto, Toshiyuki; Hashizume, Junnji; Matsumoto,
Tomio; Momisako, Hiroyuki; Amano, Hironobu; Ohdan, Hideki; Tashiro,
Hirotaka; Asahara, Toshimasa
Division of Frontier Medical Science, Hiroshima University Hospital,
Surgery%U, Hiroshima, Japan
Background. We previously reported that maintenance of central venous
pressure (CVP) at a level below 5 mmHg during parenchymal transection is
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important to reduce blood loss in patients with underlying liver disease.
Therefore, in this study, we evaluated the effect of low CVP on blood loss
during living donor hepatectomy.
Methods. A total of 75 living donor hepatectomies were performed from
June 1991 to October 2005. Sixty patients underwent right hepatectomy, and
fifteen patients underwent left hepatectomy. Data for 30 patients whose CVP
values were ]/6 mmHg during parenchymal transection (groupI) were
compared with data for 45 patients whose CVP values wereB/6 mmHg
(groupII).
Results. Blood loss was 581 ml in groupI and 275 ml in groupII (PB/0.05).
Operative time was 490 min in groupI and 404 min in groupII (PB/0.05).
Postoperative hospital stay was 17 days in groupI and 13.6 days in groupII
(PB/0.05). There was no perioperative mortality. None of the donors
received homologous blood transfusion during the perioperative period.
There were four perioperative complications (intraperitoneal hematoma, bile
leakage, duodenal ulcer and depression).
Conclusion. This study suggests that maintenance of CVP below 5 mmHg
during parenchymal transection in living donor hepatectomy is important to
reduce blood loss.
P23.19
EFFECTS OF HYPERTONIC SALINE SOLUTION IN HEPATIC
AND PULMONARY DISTURBANCES SECONDARY TO ISCHE-
MIA REPERFUSION INJURY IN RATS
Figueira, Estela RR; Coelho, Ana M; Sampietre, Sandra N; Molan, Nilza A;
Alexandre, Alcione S; Leitao, Regina M; Bacchella, Telesforo; Machado,
Marcel CC
University of Sao Paulo, Sao Paulo, Brazil
Background. Liver ischemia-reperfusion injury occurs in major liver
resections and transplantation. Experimental studies verified a multistep
process that ends in inflammation and hepatocellular necrosis.
Objective. To evaluate if the treatment of liver ischemia-reperfusion injury
with sodium chloride hypertonic solution (HTS) prevents local and systemic
damage.
Methods. Twenty-four Wistar male rats underwent partial liver ischemia
performed by clamping the pedicle from medium and left anterior lateral
segments during an hour under mechanical ventilation. They were divided in
to 3 groups: group C (n/8): control rats submitted to partial liver ischemia;
group HTS (n/8): rats received HTS (NaCl 7.5%) 0.4 mL/Kg, 10 minutes
before reperfusion; and group S (n/8): rats received normal saline solution
(NaCl 0.9%) 3.4 mL/Kg, 10 minutes before reperfusion. After four hours of
reperfusion Evans blue was intravenously administrated and blood was
collected. Rats were killed for liver histology, phosphorylation of liver
mitochondria and pulmonary vascular permeability analyzes. Six rats were
added to each group to determinate AST and ALT.
Results. Elevation of AST was similar in groups C and S (31419/1133 U/L
versus 31639/776 U/L, p/0.05) and significantly higher than group HTS
(18949/775 U/L, pB/0.05). The same occurred with elevation of ALT (C:
29039/1299 U/l versus S: 27289/873 U/L versus HTS: 15399/777 U/L, pB/
0.05). A significant reduction on mitocondrial dysfunction was observed in
animals of group HTS compared with groups C and S (pB/0.05). Pulmonary
permeability was significantly higher in groups C and S compared with group
HTS (pB/0.05). No difference in liver necrosis was showed among groups C,
HTS and S.
Conclusion. Administration of hypertonic saline solution in experimental rat
model attenuated liver ischemia-reperfusion injury, ameliorating mitocon-
drial dysfunction and decreasing pulmonary vascular permeability. This
study confirms our data in clinical transplantation (not published).
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THE ROLE OF 18F-FDG-PET IMAGING FOR THE SELECTION
OF LIVER TRANSPLANTATION CANDIDATES FROM HEPATO-
CELLULAR CARCINOMA PATIENTS
Yang, Sung Hoon; Lee, Hae Won; Cho, Eung-Ho; Cho, Jai Young; Cho,
Yong Beom; Yi, Nam-Joon; Lee, Kuhn U; Suh, Kyung-Suk
Seoul National University College of Medicine, Dept. of Surgery, Seoul,
Korea
Positron emission tomography using F-18 fluoro-2-deoxy-d-glucose (18F-
FDG-PET) imaging is now well established as a noninvasive diagnostic tool
for the detection of a variety of malignant tumors. However, in the case of
hepatocellular carcinoma (HCC), several investigators have reported con-
troversial conclusions and an inadequate sensitivity for PET (50%?5%).
Nevertheless, a high positive rate of FDG accumulation has been reported
in patients with high-grade HCC and in those with markedly elevated?
fetoprotein (AFP) levels. Here, we retrospectively reviewed 38 HCC cases
that received liver transplantation (LT) at our center between November
2000 and July 2004, and underwent whole-body PET imaging. 18F-FDG
uptake was assessed in liver and its prognostic significance was investigated.
Of the 38 patients enrolled, 13 patients had positive PET scans for a
liver tumor. When we analyzed the association between tumor factors
and PET (/) (increased PET lesion uptake) in liver, preoperative AFP level
and vascular invasion were found to be significantly associated with PET
(/) (p/0.003 and pB/0.001, respectively). However, histological grade
was not found to be significantly associated with PET (/) (p/0.074).
Moreover, the 2-yr recurrence-free survival rate (2-yr RFSR) of PET (/)
patients was significantly higher than that of PET (/) patients (85.1% vs
46.1%) (p/0.0005). Of the 6 PET (/) patients who met the Milan criteria,
four patients (66.7%) recurred, but all 20 PET (/) patients who met the
Milan criteria were recurrence free. Thus, PET imaging could be a good
preoperative tool for estimating the post-LT risk of tumor recurrence,
because histological grade and vascular invasion cannot be determined
preoperatively. Importantly, our results indicate that tumor recurrence can
be highly anticipated for PET imaging positive HCC patients that satisfy the
Milan criteria. We advise that PET (/) HCC patients should be selected
cautiously for LT.
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FAVORABLE OUTCOME OF ORTHOTOPIC LIVER TRANS-
PLANTATION IN VERY HIGH RISK SITUATIONS
Nonthasoot, Bunthoon1; Wisedopas, Naruemon2; Tongyoo, Autsanee1;
Sirichindakul, Boonchoo1; Nivatvongs, Supanit1; Suphapol, Jade1; Leela-
nukrom, Ruenreong3; Poonyathawon, Sahadol3; Burimsittichai, Rattana-
porn3; Komolmit, Piyawat4
1Chulalongkorn University, Dept. of Surgery, Faculty of Medicine, Bangkok,
Thailand; 2Chulalongkorn University, Dept. of Pathology, Faculty of
Medicine, Bangkok, Thailand; 3Chulalongkorn University, Dept. of An-
esthesiology, Faculty of Medicine, Bangkok, Thailand; 4Chulalongkorn
University, Dept. of Internal Medicine, Faculty of Medicine, Bangkok,
Thailand
Background. At present, using marginal donors for orthotopic liver
transplantation (OLT) has been accepted as an alternative way to increase
the donor pools. For improving outcome of using marginal liver graft, the
well controlled perioperative and recipient parameters are the key of success.
The aim of this study was to assess the results of marginal liver graft
associated with prolonged ischemic time and high risk recipients.
Methods. The retrospective data of patients who underwent OLT
between 2001 and 2005 were reviewed. The definition of marginal liver
graft was the graft with at least one of the followings: age/50 years, on high
dose inotropic drug (dopamine /10 mg/kg/minute or any dose of levophed or
adrenaline), sodium/155 meq/L, AST or ALT/3 times, intensive care
unit stay/4 days, and steatosis/30%. The patients were divided into 2
groups. Group 1 were marginal liver grafts with ischemic time ]/12 hours
and recipient UNOS status 1, 2A and 2B. Otherwise marginal liver grafts
which did not meet all 2 criteria were classified in group 2. Initial graft
function and patient’s survival at 1 year were compared between these two
groups.
Results. Thirty-one patients were reviewed. Four patients were excluded
because of incomplete data. In 27 patients, there were 22 marginal
liver grafts. Seven patients were classified in group 1 and 15 patients in
group 2. The initial poor function rate was 85.7% (6 in 7 patients) and
73.3% (11 in 15 patients) in group 1 and 2 respectively. The 1-year survival
rate in group 1 was 85.7% (6 in 7 patients) and 93.3% (14 in 15 patients) in
group 2.
Conclusions. The marginal liver graft can be used with favorable outcome
even in the high risk situations such as prolonged ischemic time and high risk
recipient.
P23.22
HEPATIC RESECTION VS TRANSPLANTATION IN PATIENTS
WITH HCC WHO FULFILL THE MILAN CRITERIA. EXPERI-
ENCE FROM A SINGLE CENTER
Delis, Spiros; Bakoyiannis, Andreas; Athanasiou, Kostas; Touloumis, Zisis;
Bourli, Antonia; Dervenis, Christos
Liver Surgical Unit, 1st Surgical Dept., Athens, Greece
Background. Surgical is the treatment of choice in the group of patients
with HCC,good hepatic reserve and Stage I-II due to shortage of donors and
high drop-out rate. Aa the recurrence rate remains high,the patient can
become a candidate for secondary transplantation.
Objective. We define, the role of liver resection in HCC patients who
fulfill the Milan criteria, and a strategy for optimal candidate selection for
OLT.
Methods. Between 2002 and 2005 30 such patients underwent hepatic
resection, in our unit(22 men and 8 women). The underlying disease was
Hepatitis B(18 pts),Hep C (8 pts),alcoholism(2 pts) and haemochromato-
sis(2 pts)The pts underwent resection had normal bilirubin and no portal
hypertension. In 13 of the pts, cirrhosis was documented either pre or
postoperatively. Microvascular invasion was identified in 5 pts reported at the
permanent section,.equally divided in both cirrhotics and non.8 major
hepatectomies and 22 segmental were performed.
Results. The median hospital stay was 8 days (615). Cirrhotics remained
longer inhospital,compared to non-cirrhotics. Morbidity in cirrhotics was
slightly higher and involve infection rate and incidence of ascites or pleural
effusion. No inhospital deaths were recorded in both groups. In a 3 year
follow up two deaths were reported from lung mets in cirrhotics, no death
was documented in non-cirrhotics. The disease free survival was strongly
related to liver fibrosis. Cirrhotics developed earlier (median16 mo vs 25 mo)
and with higher incidence (45% vs 22%) intrahepatic recurrence compared
to non-cirrhotics.
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Conclusion. HCC patients who fulfill Milan criteria can undergone liver
resection safely. Resection is an effective equivalent to transplantation and is
cost-effective,when time on the waiting list exceeds 6 months. However the
recurrence rate is higher compared to OLT. Due to the heterogenicity of
HCC is very difficult to extract final conclusions and the importance of the
background liver fibrosis play an important role in the management.
P23.23
HEPATIC STEATEATOSIS IS ASSOCIATED WITH INTRAHEPA-
TIC CHOLESTASIS AND TRANSIENT HYPERBILIRUBINEMIA
AFTER LIVING DONOR LIVER TRANSPLANT
Cho, Jai Young1; Suh, Kyung-Suk1; Lee, Hae Won1; Cho, Eung-Ho1; Yang,
Sung Hoon1; Cho, Yong Beom1; Yi, Nam-Joon1; Kim, Min A2; Jang, Ja-
June2; Lee, Kuhn Uk1
1Seoul National University College of Medicine, Dept. of Surgery, Seoul,
Korea; 2Seoul National University College of Medicine, Dept. of Pathology,
Seoul, Korea
Background. A clear understanding of the mechanisms in steatotic livers
that trigger graft dysfunction after living donor liver transplantation (LDLT)
and hyperbilirubinemia after partial hepatectomy remains elusive.
Aim. We hypothesized that microarchitectural disturbance might occur
within regenerating steatotic livers.
Methods. Liver biopsy specimens from 67 LDLT recipients taken at the 10th
postoperative day were scored for the numbers of portal tracts per area (nPT/
A) of liver tissue and for intrahepatic cholestasis, and immunostained by
PCNA and Ki-67. Patients were grouped according to the intraoperative
degree of macrovesicular steatosis (MaS) in grafts as follows: MaS/ (530%
of MaS; n/37) or MaS- (B/5% of MaS; n/30).
Results. The degree of MaS was independently associated with cholestasis
after LDLT (PB/.001). Serum total bilirubin results on the 1st, 3rd, and 7th
days post-LDLT in MaS/ patients were significantly higher than those in
MaS- patients (P/.030, .042, and .019, respectively). No difference in
hepatocellular proliferative activity was observed between MaS/ and MaS-
patients. However, a significant negative correlation was found between the
degree of MaS and nPT/A (P/.013), and nPT/A was found to be correlated
with the grade of histological cholestasis (r/.350, P/.039).
Conclusion. Intrahepatic cholestasis and transient hyperbilirubinemia after
LDLT could be caused by scanty morphologic change of portal tract during
steatotic liver regeneration after partial hepatectomy.
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HEPATITIS B PROPHYLAXIX AFTER LIVER TRANSPLANT
WITH LOW DOSAGE OF HBIG AND LAMIVUDINE
Yu, Ming-Chin1; Kuo, Liang-Mou2; Chan, Kun-Ming2; Chou, Hong-
Shiue2; Wu, Ting-Jun2; Lee, Wei-Chen2
1Chang Gung Memorial Hospital, Chang Gung University, Dept. of Surgery,
Taoyuan, Taiwan; 2Chagn Gung Transplantation Institute, Chang Gung
Memorial Hospital, Dept. of Surgery, Taoyuan, Taiwan
Background. Pre-transplantation using lamivudine and postoperative com-
bination of Hepatitis B immunoglobulin (HBIG) and lamivudine (LAM) had
significantly improved the clinical outcome of patients with HBV-related
cirrhosis. But it was costly and the HBV reinfection rate remained high in the
long-term follow-up.
Aim. Low dosage of hepatits B immunoglobulin (HBIG) and lamivudine
was as effective as high dose of HBIG combined therapy.
Methods. Forty-five patietns was separated into the two groups. We followed
the protocol with high dose of HBIG and LAM to maintain high anti-HBs
level for six months in the first group (n/24) and low dose (total 24,000 IU)
was given in the the first week after liver transplantation in the second group
(n/21). The median follow-up was 75 months and 21 months respectively
(range 44106 months and 1040 months respectively). The end points
were HBV reinfection, liver function, and patients survival.
Results. The median age of the two groups were 44.29/9.0 and 46.49/7.6
(p/0.05) and the demographic data were comparable. The MELD scores
were 25.4 and 25.7 in the two groups. The liver functional state and the
survival rates were comparable. In the low dosage group, the antibody titer
was decreased to negative one month later but the HBV reactivation rate
(10%) was lower than the first group (30.0% n/5/17). Two patients in the
first group had HBV recurrence with YMDD mutant and add-on adefovir
treatment started.
Conclusion. Combination of LAM and low dose of HBIG in the first week
after transplantation was effective in the prophylaxix protocol for HBV-
related end stage liver disease. The result of long-term follow-up was
satisfactory.
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IMPACT OF AB0-TYPE MATCHING ON SHORT TERM AND
LONG TERM OUTCOMES AFTER URGENT ORTHOTOPIC LI-
VER TRANSPLANTATION (OLT).
Bellagamba, Riccardo; Koukoutsis, Ilias; Tamijmarane, Appou; Gunson,
Bridget; Wigmore, Stephen; Mayer, David; Mirza, Darius; Buckels, John;
Bramhall, Simon
Queen Elizabeth Hospital, Liver Unit, Birmingham, UK
Background. OLT is the preferred treatment for Fulimint Hepatic Failure
(FHF).
Objective. To identify the impact on outcomes after urgent OLT according
to donor-recipient blood group matching.
Methods. From 13/9/1984 to 7/11/2005, 280 patients (112 males, 168
females, median age 38 years; range from 16 to 66 years), underwent first
OLT for FHF. They were divided in group A (identical), group B
(compatible) and group C (incompatible). We analyzed the overall and
group mortality, the overall and group graft failure, the incidence of acute
graft rejection during the first 30 postoperative days, the incidence of re-
transplantation, the recipient and the graft 30 days, one-year and five-years
survival.
Result. Group A consisted of 202, group B of 73 and group C of 5
recipients. Retransplantation was carried out in 8.2%; significantly different
in group C. 0verall mortality was 37.1% and overall graft failure was
42.1%; significant difference between A-C groups. In acute rejection rate
statistically significant difference revealed between A-C and B-C groups; in
first year patient and graft survival between A-B, A-C groups; in 5 years graft
survival between A-C groups, while no difference for 5 year patient survival
between the three groups. Kaplan-Meier test did not reveal statistically
significant difference in patient and graft actuarial survival between A and B
groups.
Conclusions. These encouraging results demonstrate ABO compatible OLT
as the best option in urgent situations, when identical donor is unavailable.
ABO incompatible OLT might be an alternative in highly urgent cases.
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IMPROVED OUTCOMES IN RIGHT LOBE LIVING DONOR
LIVER TRANSPLANT RECIPIENTS: EFFECT OF THE LEARN-
ING CURVE
Shah, Shimul; Cattral, Mark; Greig, Paul; McGilvray, Ian; Levy, Gary;
Grant, David
University Health Network/University of Toronto, Multi-Organ Transplanta-
tion Unit, Toronto, Canada
Optimizing right lobe living donor liver transplantation (RLD-LT) to achieve
morbidity and survival rates similar to deceased-donor liver transplantation
(DD-LT) should be one primary endpoint for transplant centers performing
this procedure.
Methods. 130 consecutive RLD-LTs performed at our institution from 2000
to 2005 were divided into two groups chronologically (1st N/65, 2nd N/
65). Modifications in practice during this period included: routine imple-
mentation of recipient gut decontamination; use of middle vein harvesting
and portal vein jump grafts to optimize venous drainage to segments 5 and 8;
more accurate and sharp division of the donor bile duct to preserve hilar plate
tissues; and recipient induction therapy with antilymphocyte globulin. Effects
of changes in practice over time, graft and patient survival were determined
and comparisons of time periods made with the chi-square test and student’s
t-test. Graft and patient survival were determined by Kaplan-Meier analysis
and tested with the log-rank test.
Results. The patient and operative characteristics of the donors were similar
between the two groups. There was no significant difference in MELD score,
graft size or inclusion of the middle hepatic vein in the recipients between the
two groups. Significant reductions were made in the incidence of bile leaks
and strictures, hospital length of stay, reoperation for abdominal sepsis and/or
biliary complications, and hospital mortality in the 2nd group. Ninety-day
and 1-year graft survival was significantly better in the 2nd group compared
to the 1st RLD-LTs (94% and 91% vs. 87% and 79% respectively; p/0.05).
One-year patient survival was 81% in the 1st 65 compared to 94% in the 2nd
65 RLD-LTs (p/0.04; Figure 1). Since 2003, one-year survival after RLD-
LT is equivalent to DD-LT (n/146) at our center (91%).
Conclusions. There is a significant learning curve in adult RLD-LT. With
experience, similar outcomes can be achieved with DD-LT and RLD-LT.
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IS IT STILL A CHALLENGE TO START A NEW PEDIATRIC
LIVER TRANSPLANT PROGRAM?
Ringe, Burckhardt; Soriano, Humberto; Freer, Kurt; Forrest, Laura; Falk-
enstein, Kathleen; Chen, Kathy; Baldridge, Alan
Drexel University College of Medicine, Philadelphia, USA
Background. Liver transplantation (LTx) is offered as treatment for
children with end stage liver disease in many centers. Despite standardization
of patient selection, surgical techniques and postoperative management, new
programs may be confronted with challenges.
Methods. We have analyzed our own experience with a pediatric LTx
program that was restarted in a large metropolitan area. 12 LTx were
performed in 11 children: 4 wereB/1 yr and had a body weight of B/10 kg.
Indications were acute hepatic failure in 4, cystic fibrosis in 3, cryptogenic/
other cirrhosis in 3, and biliary atresia in 2 cases. 6/11 patients were ICU/
hospital bound, including 4 on status 1. Three LTx were performed in
Jehovah’s Witnesses. Except one, all patients had live donor liver transplants.
Initial immunosuppression was steroid-free in all children.
Results. Three patients had postoperative complications, including one
complex course with hepatic artery thrombosis and retransplantation using a
second live donor, followed by severe pericentral cholestasis and small-for
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size syndrome which was completely reversible. At this time, patient survival
is 100% with a followup between 3 months and 3 years.
Discussion. A new pediatric liver transplant program faces numerous
challenges, despite the fact that the hepatologist and the surgeon are coming
from high volume transplant centers: (1) the necessity to accept high-risk
patients that are eventually turned down by other programs; (2) the almost
exclusive utilization of live donors as the prime source of organs, even in
patients with acute hepatic failure; (3) the introduction and application of
innovative techniques and strategies; (4) the management of complex cases
involving multiple specialists; (5) the overall expectation of excellent out-
come, even in sick and complicated patients; (6) the economic burden the
hospital especially during the initial phase of limited activity. Not to forget,
our patients and their families who accepted the greatest challenge-to go to a
new transplant program.
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IS THE PRESENCE OF TRANSJUGULAR INTRAHEPATIC POR-
TOCAVAL SHUNT INFLUENCING THE PROCEDURE OF THE
LIVER TRANSPLANTATION? A CASE CONTROL STUDY
Muscari, Fabrice1; Suc, Bertrand1; Sharaan, Mohamed1; Otal, Philippe2;
Rostaing, Lionel3; Vinel, Jean P4; Fourtanier, Gilles1
1University Hospital of Rangueil, Digestive Surgery, Toulouse, France;
2University Hospital of Rangueil, Radiology, Toulouse, France; 3University
Hospital of Rangueil, Organ Transplantation and Nephrology, Toulouse,
France; 4University Hospital of Purpan, Hepatology, Toulouse, France
Background. A case control study concerning the effect of the presence of a
transjugular intrahepatic portocaval shunt (TIPS) on the procedure hepatic
transplantation as regards, blood loss, intra-operative transfusion and
haemodynamic complications.
Materials and Methods. This study was done on 86 patients of 300
patients with liver transplantation between 1992 and 2005. Thirty two
patients were transplanted with the presence of a TIPS and another control
group of 54 patients who were transplanted without a TIPS. Perioperative
criteria were taken for each patient in a prospective manner.
Results. There were no statistically significant differences between both
groups either as regards pre or post-operative haemodynamic criteria or as
regards the mortality. The only statistically significant difference between
both groups was the pre-operative condition of patients where in the time of
transplantation there were more hospitalized patients belonging to hepatic
transplantation with TIPS group(81% vs 59% p/0.04).
Conclusion. The presence of TIPS in the time of hepatic transplantation
does not affect the rate of haemodynamic complications, transfusions of
blood components, and mortality.
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IS TEMPORARY PORTAL DECOMPRESSION ENOUGH TO
PROTECT A SMALL-FOR- SIZE LIVE DONOR LIVER GRAFT?
Ringe, Burckhardt; Maroney, Timothy; Meyers, William
Drexel University College of Medicine, Philadelphia, USA
Background. Small-for-size (SFS) syndrome is characterized by in-/outflow
imbalance of the graft. It can be caused by various mechanisms contributory
to each other, e.g. venous congestion, small graft size, and portal hyperperfu-
sion. Portosystemic shunts have been suggested to decompress the portal vein
in SFS grafts. We present the first case with a temporary hemiportocaval
shunt.
Methods. A 52-year old male with end stage liver disease received a right
lobe graft. Graft weight and graft-recipient-body weight ratio were 752 g, and
0.82%. Since the patient had significant portal hypertension with an open
umbilical vein, it was felt that the graft might be too small for the high portal
inflow. Recipient and graft right portal veins were anastomosed end-to-end,
and a left hemiportocaval shunt was constructed. Six days later the shunt was
balloon occluded, followed by surgical shunt closure at day 12.
Results. During this time the patient’s portal vein pressure dropped from 40
to 16 mmHg. Liver biopsies showed severe steatosis and necrosis at day 6
which resolved completely. His total bilirubin peaked at 24.9 mg/dL. Eight
months later he has normal liver function, a wedged hepatic vein pressure of
13 mmHg, and a graft volume of 2010 ml.
Discussion. Liver grafts are particularly vulnerable in the early post
transplant phase. Studies have shown that portal vein pressure over 20
mmHg within 14 days is associated with poor graft function and decreased
patient survival. Portal decompression was introduced to protect a SFS graft
from portal overperfusion. It is unknown, whether permanent portocaval
shunts are necessary or even beneficial. This concern lead us to consider
temporary decompression and staged shunt closure. As we could demon-
strate, the graft survived the critical phase. We also learned that deprivation of
portal vein blood can lead to graft steatosis, indicating a potential risk of
permanent portocaval shunts. More data are needed to support this new idea
of temporary protection against portal hyperperfusion.
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IS THE DEATH OF A LIVING DONOR ALWAYS PREVENTABLE?
Ringe, Burckhardt; Soriano, Humberto; Reynolds, James; Meyers, William
Drexel University College of Medicine, Philadelphia, USA
Background. Living donor liver transplantation (LDLTx) has become life
saving for patients who can not get a deceased liver in time. A major concern
has always been the donor safety Although the individual risks can be
assessed, accurate data about donor mortality are not available because of
incomplete and unreliable reporting.
Methods. In our own experience, out of 33 LDLTx performed in 22 adults
and 10 pediatric recipients, only five donors had no risk factors at all: 85%
had one or more risks identified preoperatively, including obesity, smoking,
hypercholesterolemia, hepatic steatosis, hypertension, heterozygous factor V
Leiden mutation, and hypothyreosis.
Results. Except one, all donors have survived their operations without
longterm sequelae. A 36-year old African American female with known illicit
drug history who had donated two segments for her 3-year old son suffering
from acute hepatic failure, died 57 days after uneventful recovery from
surgery secondary to adverse effects of cocaine, as confirmed by autopsy. In
the literature, there are 10 donor deaths reported by the transplant center
involved, including our own and one similar case with drug overdose.
Additional eight possible deaths or transplants can be identified from
various surveys and publications. With 10,000 or more LDLTx performed
worldwide to date, the overall donor mortality risk can be estimated 0.1
0.2%. It is likely to be higher, if all and also late deaths are reported
accurately.
Discussion. This case emphasizes the need for postoperative followup, and a
registry for living donors to document and publish all significant complica-
tions and events after liver resection-early and late. It also reopens the
discussion whether living donors should be utilized in patients with acute
hepatic failure, because the donor evaluation is typically abbreviated. Since
our donor died so soon after her operation we thought it necessary to be
reported, although her death was not related to the surgery, and probably not
preventable.
P23.31
LIFE ON THE LIST: WAITING FOR A DONOR LIVER
Terrace, John D; Barbour, Victoria; Cadogan, Clare; Chandler, David;
Forman, Sarah; Gray, Neil; MacKenzie, Katie; Stoddard, Kate; Summers,
Paul; Hidalgo, Ernest
University of Edinburgh, Clinical and Surgical Sciences, Edinburgh, UK
Background. Expansion in patient numbers requiring liver transplantation
means more patients waiting longer for surgery and an increasing number
facing death prior to receiving their donor organ. Consequently, ‘‘life on the
list,’’ will become an escalating challenge for patients and their families.
Understanding this burden is critical in providing effective patient support,
yet this area is poorly investigated.
Aims. To evaluate the emotional and physical impact on patients awaiting
liver transplantation.
Methods. Medical student-designed, prospective, interview-based study of
all waiting-list patients (January-March 2006) in a single UK transplantation
centre.
Results. Of 22 patients on the waiting list, 11 attended clinic and all were
interviewed. 6 were female, median age was 48 years (range 3666). Median
length of wait was 5 months (range 114). The principal impact of waiting was
physical (47%), including tiredness/lack of mobility. 6 (55%) stated that
elimination of tiredness was their main recovery aim. Emotional effects,
including anxiety/depression, were less important (37%). 5 (45%) coped well
with waiting, the remainder coping only moderately well or badly. 91% thought
their anxiety levels had remained the same (8) or increased (2) since being
placed on the list. All felt that relatives and friends were their principal source
for support. 5 (45%) reported that a relative had required to change their work
pattern, or stop working, to provide support. Only 7 (64%) were aware of the
support services available through the transplantation unit. 5 (71%) found
these impossible to travel to and 2 (29%) did not find them useful.
Discussion. This small, subjectivestudy foundthat, inaddition to theexpected
emotional strain, physical morbidity has a significant impact on the life of those
awaiting liver transplantation. Importantly, the support structure provided
for patients appears to be ineffective. Consequently, relatives and friends are
relied upon heavily, with significant implications for their working life.
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LIVER TRANSPLANTATION FOR ACUTE LIVER FAILURE
BASED ON BUDD-CHIARI SYNDROME IN CONNECTION
WITH AGARICUS SP. MUSHROOM POISONING
Oliverius, Martin1; Janousek, Libor1; Petrasek, Jan2; Adamec, Milos1
1Institute for Clinical and Experimental Medicine Prague, Transplant
Surgery Dept., Prague, Czech Republic; 2Institute for Clinical and Experi-
mental Medicine Prague, Dept. of Hepatology and Gastroenterology, Prague,
Czech Republic
Background. The acute form of hepatic venous outflow obstruction in
Budd-Chiari syndrome may cause acute liver failure.
Aim. We refer to a case report of a patient who was admitted with fulminant
liver failure because of an acute form of Budd-Chiari syndrome with the
factor V Leiden mutation. He had eaten a poisonous mushroom Agaricus sp.
shortly before disease manifestation. The patient was transplanted with the
use of a hepatic artery and portal vein shunt to support portal vein flow
because of his portal, mesenteric and splenic vein thrombosis.
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Patient and methods. A twenty-four year old young man was admitted with
the threat of liver failure. Budd-Chiari syndrome was diagnosed. Genetic
analysis had proved Leiden mutation gene for factor V and the toxicological
examination had showed spores of the poisonous mushroom Agaricus sp.
Liver dysfunction progressed into hepatorenal syndrome. The patient was
listed on a waiting list and subsequently transplanted. Despite repeated
portal, mesenteric and splenic vein thrombectomy, we were not able to
achieve a sufficient portal vein flow during the procedure. A temporary a-v
shunt was constructed to maintain sufficient portal inflow. We closed this
shunt on the postoperative day 20. A severe liver necrosis occurred during the
follow up and 70 days later the patient was retransplanted.150 days after
admition he was discharged with a good health status.
Results. Between April 1995 and December 2005 we have performed 438
liver transplants. Only 7 of them were because of Budd-Chiari syndrome. 1
and 5 years patients and grafts survival rate in our series was 88% and 85%
and 82% a 77% respectively.
Discussion. We assume that the poisonous mushroom Agaricus sp.
consumed by a patient could be the main reason for an acute Budd-Chiari
syndrome manifestation. We believe a temporary a-v shunt could help to
maintain a sufficient portal vein flow and facilitate splanchnic thrombosis
dissolution which we had confirmed during the second operation.
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LIVER TRANSPLANTATION FOR ACUTE LIVER FAILURE IN
ADULTS. ARGENTINEAN’S SINGLE CENTER EXPERIENCE IN
52 CASES
Imventarza, Oscar; Trigo, Pedro; Garay, Vero´nica; Cueto, Graciela; Duek,
Fernando; Quarin, Carlos; Barros S, Pablo; Lendoire, Javier
Hospital Dr Cosme Argerich, Liver Transplantation, Buenos Aires, Argen-
tina
Background. Liver transplantation is the treatment of choice for irreversible
acute liver failure. There are few reports about the experience of liver
transplantation for acute liver failure in South America. In our center acute
liver failure is responsible for 19.5% of the indication for transplantation.
Aim. Analyze a consecutive series of liver transplantation for fulminant
hepatic failure in adults.
Patients and methods. Between June 1995 and November 2004, 52 adult
patients with acute liver failure underwent liver transplantation. King’s
college criteria were used to decide which patients needed transplantation.
Pre transplantation (age, sex, etiology, degree of hepatic encephalopathy) and
intra operative details (red blood units, fresh plasma units, donor’s marginally
criteria) parameters were examined.
Results. Mean age at liver transplantation was 34.229/13 years, 71% were
female. The etiologies were: cryptogenic in 31%, autoimmune 27%, hepatitis
B 17%, hepatitis A 12%, drugs 8%, Budd Chiari 4% and Wilson’s disease
2%. 37 patients (37/52, 71%) were in hepatic encephalopathy degree III-IV.
The median red blood units, fresh frozen plasma units used were 11.06 and
16.49 respectively. In 27% of cases three or more marginally criteria’s donors
were used. The 1 and 5 years survival of patients was 68%.
Discussion. Until recently autoimmune hepatitis has not been recognized as
a frequent cause of acute liver failure. The median age and the female’s
preponderance was in accordance to published data. As described by our
group, in Argentina autoimmune hepatitis is responsible for up to 20% of the
cases of acute liver failure. Although most patients were critically affected the
overall survival is according to series from larger centers.
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LIVER TRANSPLANTATION FOR EARLY STAGE HEPATOCEL-
LULAR CARCINOMA: AN INTENTION TO TREAT ANALYSIS
Dezza, MariaClara; Giovanelli, Mara; Corno, Vittorio; Lucianetti, Alessan-
dro; Maldini, Gregorio; Pinelli, Domenico; Guizzetti, Michela; Zambelli,
Marco; Michele, Colledan
Ospedali Riuniti, General Surgery Liver-Lung Transplant Unit, Bergamo,
Italy
Liver transplantation (LTX) is considered the best treatment for early stage
hepatocellular carcinoma (HCC). Disease progression on waiting list
precluding the use of LTx is still a major problem. Thermo-Ablation (TA),
Percutaneous Ethanol Injection (PEI), Transarterial Chemoembolization
(TACE) and surgical resection have been used to limit tumor progression.
Between October 1997 and November 2005 we performed 519 LTx in 476
recipients. We retrospectively reviewed prospectively collected data in a
cohort of 59 (47 male, 12 female) adult patients who underwent LTx for
HCC. Underlying liver disease was HBV in 22 (37%), HCV in 29 (49%),
HBV/HCV in 3 (5%), alcohol in 3 (5%),Byler disease in 1 (2%) and PBC in
1 (2%). All the patients were listed within the Milan Criteria. Patients
dropped out while awaiting for LTx because of tumor progression in 5 cases
and because of death in 1 case. The mean waiting time was 129,67 days/
128,4 (range7693). The 6 and 12 months drop out probability was 12,8%
and 19,3%. The Kaplan-Meier intention to treat survival was 80,7% and
60,6% at 3 and 5 years respectively. Only 5 patients were not treated before
LTx, the others 54 received pre-LTx therapies (TA 23 [38,9%], TACE 13
[22%], PEI 1 [1,6%], resection 2 [3,3%], TACE-TA 8 [22%], TA-PEI 3
[5%], TA/resection 1 [1,6%], PEI/TA/TACE 3 [5%]). In native liver of 59
patients who underwent LTx, 4 had complete tumor necrosis, while Grading
score was G1 in 10 cases (16,9%), G2 in 33 (55,9%) and G3 in the other 12
cases (20,3%). Tumor was uni-focal in 52,5% (31) of patients and it was
multifocal in the others 47,4% (28). The actuarial 1,3 and 5 year patient and
graft survivals were 87,5/84%, 81/78%, 81/78% respectively. The actuarial
1,3 and 5 year patient disease free survivals was 83%, 78,1%, 78,1%
respectively. LTx for HCC results in excellent survival for patients with early
HCC. Further refinements in pre-LTx staging may increase the effectiveness
of LTx for HCC.
P23.35
LIVER TRANSPLANTATION IN ELDERLY PATIENTS
Aldouri, Amer; Almukthar, Ahmed; Chalmers, Ritchie; Prasad, K Raj;
Pollard, Stephen; Lodge, Peter; Toogood, Giles
St James’s University Hospital, Leeds, UK
Background. In the past two decades liver transplantation (LT) has been
the most important development in the management of end-stage liver
disease. However, the supply of donor livers is insufficient to meet the current
need for liver transplantation. This led to re-evaluation of selection and listing
criteria for liver transplantation, including transplantation of patients older
than 60.
Aim. We are reporting the outcomes of elderly patients undergoing LT in a
single transplant centre.
Methods. Data were extracted from UK transplant database on 991
consecutive liver transplantations performed in our institution between
1994 and 2004. In this study, 826 recipients (83%) were younger than 60
years of age and 165 (17%) were 60 years or older. The following information
were collected: age (both of recipient and donor), sex, etiology of liver
disease, pretransplant levels of prothrombin time, albumin, bilirubin, serum
sodium, creatinine, and cold ischemia time. Survival statistics were calculated
at 30 days and 5 years.
Results. Overall 5-year survival was significantly lower in those older than 64
(61.6%) compared to patients younger than 60 (76.2%, p/0.005).
Decreased graft survival was shown with advancing age (more than 64 year
versus younger than 60) p/0.001. Regression analysis showed that for
patients older than 64, only MELD score /24 and preoprative hyponatremia
were independent risk factors, with hazard ratios of 5.6 and 2.6, respectively.
Conclusion. These findings strongly support the conclusion that, elderly
patients should offered transplantation earlier in the spectrum of end-stage
liver disease, before developing hyponatremia or MELD score more than 24.
P23.36
LIVER TRANSPLANTATION WITH EXTENDED RIGHT SPLIT
LIVER GRAFTS: ANALYSIS OF BILIARY AND VASCULAR COM-
PLICATIONS
Corno, Vittorio; Lucianetti, Alessandro; Pinelli, Domenico; Dezza, Maria-
Clara; Guizzetti, Michela; Maldini, Gregorio; Zambelli, Marco; Giovanelli,
Mara; Torre, Giuliano; Colledan, Michele
Ospedali Riuniti, General Surgery, Liver-Lung Transplant Unit, Bergamo,
Italy
Introduction. There is reluctance about the use of the extended right split
liver graft because of concerns for a higher complications rate. We reviewed
the incidence of vascular and biliary complications among the recipients of an
ERG.
Methods. In 42 patients (29 adults and 13 children) an ERG was used. 37
cases received a primary liver transplant (LTx) 1 case received an ERG as a
second urgent re-transplant. In 18% of cases an interposition graft was used
for arterial reconstruction. Biliary reconstruction was by a duct to duct
anastomosis in 64% of cases and with an Roux en Y hepatico-jejunostomy in
36%.
Results. Overall biliary complications occurred in 11 patients (26%). In 4
cases of biliary complications (10%) a surgical intervention was required: 2
stenosis and a biliary fistula were treated with a conversion to a Roux an Y
hepatico-jejunostomy; a bile leak from the cut surface was directly sutured.
Among the pediatric recipients 2 early and 1 late hepatic artery thrombosis
(HAT) occurred (25%). Re-LTx was performed in the 3 cases and was
successful in 2. No HAT occurred in the adult group. With a median follow
up of 801 days (range 682201) actuarial patient/graft survival at 1 and 5
years is 91%/88% and 88%/86% respectively. 3 out of 5 patient deaths
occurred after a urgent re-LTx and 4 out of 7 graft were lost after re-
transplants (3 urgent and 1 elective). Overall patient and graft survival after
re-LTx with ERG is 40% and 20% respectively. Among the recipients of an
ERG as a primary LTx, 1 and 5 year patient and graft survival is 97%/95%
and 95/92% respectively.
Conclusion. The incidence of HAT using an ERG, in our experience,. is
comparable to that reported in the literature. A slightly higher incidence of
major biliary complications with ERG does not have a negative impact on
patient and graft survival.
P23.37
LIVING-DONOR LIVER TRANSPLANTATION: RESULTS OF A
SINGLE CENTER
Karakayali, Hamdi1; Yilmaz, Ugur2; Bilezikci, Banu3; Arslan, Gulnaz4;
Emiroglu, Remzi1; Moray, Gokhan1; Haberal, Mehmet1
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1Baskent University Faculty of Medicine, General Surgery and Transplanta-
tion, Ankara, Turkey; 2Baskent University Faculty of Medicine, Gastroenter-
ology, Ankara, Turkey; 3Baskent University Faculty of Medicine, Pathology,
Ankara, Turkey; 4Baskent University Faculty of Medicine, Anesthesiology,
Ankara, Turkey
Background. In the absence of deceased donor liver transplantation, living
donor liver transplantation (LDLT) is an alternative source of organs for
patients with end-stage liver disease.
Aim. The objective of this study was to evaluate the outcome of LDLT in a
single center in Turkey.
Method. We analyzed 83 LDLT in 81 patients with end-stage liver disease
retrospectively.
Results. The recipients were 59 men and 22 women (mean age, 21.79/19.4
years; range, 0.2 64 years;mean weight, 43.59/25 kg (range,6.5 95 kg).
Forty-two right and 11 left liver lobes were transplanted,and 30 hepatic
segments II and III were transplanted. Most donors (46%) were parents of
the recipients. Sixteen patients had accompanying hepatocellular carcinoma
and cirrhosis. Retransplantation was performed in 2 cases. The mean
operative time was 109/2.2 hours, the number of blood transfusions required
was 39/3.9 units, the mean hospital stay was 299/26.2 days,and the mean
time spent in the intensive care unit was 3.59/6.9 days. Median graft-to-
recipient weight ratio was 1.89/1.1 (range 0.86.1). Ten hepatic arterial
thromboses and 12 biliary leaks occurred in the early postoperative period.
Most complications were treated with interventional techniques. Three
hepatic vein stenoses,3 portal vein stenoses, and 6 biliary stenoses developed
during the late postoperative period. These patients were managed with
interventional techniques. Mean follow-up was 12.29/10.9 months (range,
150 months). During follow-up,we did not observe any instance of tumor
recurrence in any of the HCC cases. At the time of this writing, 14 patients
had died during follow-up,and the remaining 69 patients (85%) were alive
with good graft functioning.
Conclusion. Complication rates are slightly higher after LDLT compared
with cadaveric liver transplantation. However, most complications can be
treated with interventional techniques,and LDLT continues to be the life-
saving option in countries without satisfactory cadaver donation rates.
P23.38
HEPATIC ARTERY STENOSIS AFTER LIVER TRANSPLANTA-
TION: THE IMPACT OF ANGIOPLASTY AND/OR STENT PLACE-
MENT ON THE ARTERIAL PATENCY AND GRAFT SURVIVAL
Saad, Wael EA1; Davies, Mark G2; Sahler, Lawrence G1; Patel, Nikhil C1;
Lee, David E1; Waldman, David L1
1University of Rochester Medical Center, Dept. of Imaging Sciences,
Rochester, USA; 2University of Rochester Medical Center, Dept. of Surgery,
Rochester, USA
Background. Graft ischemia in liver transplant recipients due to hepatic
artery stenosis (HAS) and/or hepatic artery thrombosis (HAT) carries a high
morbidity and mortality. HAS is one of the least described complications of
liver transplantation.
Aims. To determine the impact of HAS after liver transplantation on arterial
patency and to evaluate the efficacy of hepatic artery percutaneous
transluminal angioplasty with or without stenting (HA-PTA/// St) in the
management of HAS.
Methods. Retrospective analysis was performed of all liver transplant
recipients (01/199506/2005). HAS (/50% stenosis) by angiography
were included. Follow-up was by Doppler ultrasound. HAT and re-stenoses
were confirmed by angiography. Failed HA-PTA proceeded to HA stenting
or surgical revascularization. Patency, HAT and graft survival rates were
determined by the Kaplan-Meier method. Technical success of HA-PTA
was stratified according to the presence of associated hepatic arterial
kinks (HAK: defined as eccentric narrowing on the concavity of a sharp
arterial turn).
Results. 55 patients developed HAS. 10 were observed and 45 were initially
intervened by PTA. HAT rate of untreated HAS was 659/10% at six months.
Technical success and complications of HA-PTA for HAS///HAK were
14% versus 87% and 29% versus 10% respectively (complications for all-
comers: 13%). 24-month primary and assisted primary patency of HA-PTA
for all HAS were 479/10% and 609/10% respectively. 24-month HAT rate
for all comers after HA-PTA were 179/10%. 30-month patency and graft
survival after HA-PTA with either repeat HA-PTA/// St or surgical
revascularization for failed PTA was 73 10% and 719/10% respectively.
Conclusion. Untreated HAS is associated with a high rate of HAT. The
presence of HAK should be considered a contraindication to HA-PTA.
Endoluminal intervention for HAS significantly reduces the HAT rate (by 3
4 folds) and should be considered in the algorithm for the treatment of HAS
after liver transplantation.
P23.39
MELD SCORE AS A PROGNOSTIC MODEL FOR LISTING
ACUTE LIVER FAILURE PATIENTS FOR LIVER TRANSPLANTA-
TION
Zaman, Muhammad B; Hoti, Emir; Maguire, Donal; Geoghegan, Justin;
Traynor, Oscar
St. Vincent’s University Hospital, Liver Unit, Dublin, Ireland
Background. The King’s College Hospital (KCH) criteria are widely used for
listing patients with acute liver failure (ALF) for liver transplantation (LT).
Recent reports have suggested that the Model for End Stage Liver Disease
(MELD) score may be useful in assessing prognosis in ALF (non-paracetamol).
Objectives. This study compares prognostic accuracy of the two systems in
patients with Paracetamol (POD) induced ALF treated in this unit.
Methods. Seventy two patients (average age 38 yrs; F: M ratio 2:1) admitted
from 19942005 with POD related ALF were studied. Clinical and biochem-
ical parameters were recorded. The effect of applying a MELD score of greater
than 30 as listing criteria for LT was calculated and compared with the KCH
Criteria. Outcomes were defined as LT, death or full recovery.
Results. Thirty one patients (43%) recovered with medical therapy, 29 (40%)
patients died and 12 (17%) underwent LT. 65% patients had a MELD/30 and
therefore could potentially be listed on admission, however, using KCH criteria
only 24% patients were listed immediately. Sensitivity (96.55%) and negative
predictive value (95.45%) of MELD was higher then KCH, however, we found
KCH to have much higher specificity (100%) and positive predictive value
(100%).
Conclusion. MELD has higher sensitivity and NPV for POD induced ALF
than the KCH criteria. However, the high false positive rate associated with
MELD limits its clinical utility. The high negative predictive value of MELD
score may allow it to be used in conjunction with KCH criteria to avoid
unneeded LT in patients who will likely recover spontaneously.
P23.40
NEGATIVE IMMUNOMAGNETIC PURGING OFFERS A SAFE
ALTERNATIVE SOURCE OF HEPATOCYTES DERIVED LIVER
RESECTED FOR METASTASES
Gunasegaram, Aravin; Akhter, Javed; Johnson, Loreena; Morris, David
St George Hospital Campus, University of New South Wales, Dept. of Surgery,
Sydney, Australia
Introduction. Hepatocytes isolated from malignant liver resection could
provide an alternative source of healthy hepatocytes for cell therapy. The issue
of microscopic cancerous material however, needs to be addressed. The present
study investigates a novel use for immuno-magnetic beads as a detection and
removal protocol for remaining cancerous cells.
Method. Hepatocyte procurement, perfusion and enrichment protocols were
optimised for the non-tumour sections of liver resected from patients with
hepatic metastases. A novel protocol using Ep-CAM antibody-coated Dyna-
beads, which differentially attached to Ep-CAM present on HT-29 colorectal
tumour cell line (and all epithelial tumour cells), enabling negative magnetic
purging of malignant cells from hepatocytes, was optimised. 39 Balb/C nude
mice were inoculated intra-peritoneally with Dyna-bead treated and untreated
hepatocytes and examined after 28 days incubation. Immunohistochemistry
and RT-PCR techniques were employed to detect and semi-quantitate the
presence of cancer cells throughout the process.
Results. An average yield of 9.3/106 viable cells per gram of liver with a
viability of 70% was achieved. The Dynabead purging protocol was shown to
consistently reduce tumour cell numbers below the detection threshold of
immunohistochemistry and RT- PCR techniques (10 tumour cells in 1 million
hepatocytes). Results from preliminary nude mouse experiments established
that mice inoculated with hepatocyte preparations treated with anti-Ep-CAM
coated magnetic beads failed to form any peritoneal tumours.
Conclusion. Sufficient numbers of viable hepatocytes can be isolated from
resected liver for transplantation. The immuno-magnetic method of cell
separation is an effective method of purging tumour cells to below the threshold
for tumour colonisation.
P23.41
NEW ONSET DIABETES MELLITUS POST LIVER TRANSPLANT-
A MULTIVARIATE ANALYSIS OF PREDICTIVE FACTORS ANDAN
ANALYSIS OF THE OUTCOME RESULTS
Tamijmarane, Appou; Koukoutsis, Ilias; Gunson, Bridget; Mirza, Darius F;
Mayer, David; Buckels, John; Wigmore, Stephen; Bramhall, Simon R
Queen Elizabeth Hospital, Birmingham, UK
Background. New onset diabetes mellitus (NODM) has been reported to
occur in 7.2% to 28% after orthotopic liver transplantation (OLT). This
incidence is up to 60% in the Hepatitis C positive patients. Various risk factors
including Hepatitis C (HCV), male gender, body mass index (BMI), alcoholic
cirrhosis, bolus steroid and tacrolimus have been implicated in the pathogenesis
of NODM. Both pretransplant diabetes and NODM have been reported to be
associated with adverse outcomes.
Aim. To compare NODM and non-diabetic post OLT (control) groups
regarding outcome and to analyse factors predicting the onset of NODM.
Patient and methods. After excluding pretransplant diabetic group, the
prospectively collected data on 1027 patients who had orthotopic liver
transplantation between January 1995 and November 2005 were analysed.
Results. 80 patients (7.7%) developed NODM. There was no significant
difference in age, BMI, gender, ethnic origin and blood group. 60% of
NODM group had been treated with bolus steroids compared to 42.3%
control group (p/N.S). 19% of NODM group who died were HCV positive
versus 16% of control group (p/N.S). There was no significant difference
in patient survival and infection related mortality between NODM and
control groups. One and five year graft survival were significantly different
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(log rank/0.02). 10% of patients who had tacrolimus developed NODM
compared to 3.1% of cyclosporine group. Univariate analysis identified
mean prednisolone, cyclosporine, and tacrolimus dose, number of rejection
episodes and graft failure as important. Multivariate analysis revealed age, graft
failure, number of rejection episodes and tacrolimus as independent risk
factors.
Conclusion. NODM adversely affects graft survival while patient survival was
not affected. Tacrolimus and number of rejection episodes (probably a
surrogate marker for bolus steroid doses) play major role in the pathogenesis
of NODM. Our study did not reveal any significant relationship between HCV
and NODM.
P23.42
PENTOXIFYLLINE INHIBITS TUMOR NECROSIS FACTOR AL-
PHA GENE TRANSCRIPTION FOLLOWING LIVER ISCHEMIA-
REPERFUSION
Cursio, Raffaele1; El-Ghoneimi, Alaa1; Schmid-Alliana, Annie2; Tovey,
Michel3; Lasfar, Ahmed3; Michiels, Jean-Franc¸ois4; Rossi, Bernard2; Gugen-
heim, Jean1
1Universite´ de Nice Sophia Antipolis, Laboratoire de Recherches Chirurgi-
cales, Nice, France; 2Universite´ de Nice Sophia Antipolis, INSERM U364,
Nice, France; 3CNRS, Laboratoire d’Oncologie Virale, UPR 274, Villejiuf,
France; 4Universite´ de Nice Sophia Antipolis, Service d’Anatomo-pathologie,
Nice, France
Background. Pentoxifylline (PTX) has been shown to reduce liver injury after
normothermic ischemia and reperfusion (I-R).
Aim. The aim of this study was to evaluate the effects of PTX on tumor necrosis
factor-alpha (TNF-alpha) gene transcription following normothermic liver I-
R. Materials and Methods. A segmental normothermic ischemia of the liver was
induced by occluding the blood vessels including the bile duct to the median
and left lateral lobes for 90 min. At the end of ischemia the nonischemic liver
lobes were resected. Rats were divided into three groups: group 1, control
Ringer’s lactate administration; group 2, PTX treatment; group 3, sham-
operated control rats. PTX (50 mg/Kg) was injected intravenously 30 min
before and 60 min after induction of ischemia. Survival rates were compared
and the serum activities of TNF-alpha, AST, and ALT were measured.
Histology of the liver was assessed 6 h after reperfusion. Liver TNF-alpha-
mRNA was assessed by PCR amplification at 0, 120, and 270 min after
reperfusion.
Results. PTX treatment significantly increased 7-day survival (93.3%)
compared with non-treated control rats (46.6%, PB/0.007). The extent
of liver necrosis and the release of liver enzymes were significantly decreased
after PTX treatment. Serum activities of TNF-alpha were significantly
decreased and liver expression of TNF-alpha-mRNA was inhibited after
PTX treatment.
Conclusion. PTX protects liver from ischemic injury by inhibition of TNF-
alpha gene transcription.
P23.43
POSITIVE IMPLICATION OF APPLYING EXTENDED DONOR
CRITERIA IN LIVER TRANSPLANTATION
Schemmer, Peter1; Nickkholgh, Arash1; Hinz, Ulf1; Gerling, Till2; Sauer,
Peter3; Encke, Jens3; Friess, Helmut1; Weitz, Ju¨rgen1; Bu¨chler, Markus W1;
Schmidt, Jan1
1Ruprecht-Karls-University, Dept. of General Surgery, Heidelberg, Germany;
2Eurotransplant, Leiden, Netherlands; 3Ruprecht-Karls-University, Dept. of
Internal Medicine, Heidelberg, Germany
Background. Organ shortage has driven many transplant programs to extend
their criteria to accept donors, and graft allocation policies have been modified
accordingly.
Objective. To analyze the effect of extended donor criteria (EDC) on both
graft and patient survival, and to propose a strategy to prioritize recipients who
benefit from such grafts.
Methods. Prospectively collected data from all consecutive cadaveric liver
transplantations (LT) between December 2001 and December 2004 at the
University of Heidelberg were analyzed. The EDC included ventilation
/7 days, ALT or AST /3/normal, bilirubin /3 mg/dL, anti HBc or
HBs Ag positivity, donor age /65 years, steatosis /40%, BMI /30, cold
ischemia time /14 hours, Na /165 mmol/L, history of extrahepatic
malignancy, and previous drug abuse. Variables include recipients’ demo-
graphics, indication for LT, waiting time, urgency, MELD score. Outcome has
been focused on early and late graft survival, patient survival, retransplantation,
ICU/IMC stay, duration of ventilation, complications, and post-transplant
laboratory findings.
Results. One hundred and ninety two grafts were used for 165 primary,
23 secondary, and 4 tertiary LT. Up to three EDC were present in 55% of
all grafts. Twenty-four livers were transplanted after rescue allocation to HU
(8%), T2 (17%), and T3 (75%) patients. Almost 90% of these T3-listed
recipients had hepatocellular carcinoma (HCC), who would otherwise have
had a much longer waiting time. Both uni- and multivariate analysis revealed
that EDC had no impact on outcome. The recipient age (B/55 vs. ]/55 years)
was the only independent prognostic factor for survival (p/0.02), regardless
of EDC.
Conclusion. The use of grafts with EDC is safe. Rescue-allocated livers meet
the need of HCC patients for a timely transplantation. Further, the recipients’
age is an independent factor for survival after transplantation.
P23.44
PRELIMINARY RESULTS OF LIVING RELATED LIVER TRANS-
PLANTATION IN 19 CASES:MANSOURA EXPERIENCE
El Shobari, Mohamed M1; Salah, Tarek1; Sadany, Mohamed2; Yassin, Amr3;
Saraf, Walid3; Wahab, Mohamed1; Fathy, Omar1; Anwar, Nabih1; Sultan,
Ahmed1; Segnard, Piere4; Boillot, Olliver5; Ezzat, Farouk1
1Gastroenterology Surgical Center, Surgery, Mansoura, Egypt; 2Mansoura
University Hospital, Medicine, Mansoura, Egypt; 3Mansoura University
Hospital, Anaesthesia, Mansoura, Egypt; 4Eduard Herriot, Anaesthesia,
Lyon, France; 5Eduard Herriot, Surgery, Lyon, France
Background. Living related liver transplantation is gaining acceptance in
egypt and is the onl hope for end stage liver disease.
Aim. To show our experience in living related liver transpantation.
Methods. From may 2004 to february 2006, 19 cases of living related liver
transplantation using the right lobe has been done. All cases were adults mean
age 48 years, m/f ratio 16/3, 16 hcv cirhosis, 2 hcc and one case buddchiari
syndrome.
Results. One year survival is 88%, no mortality in donors, 4 donors had
bile leak:one case necessitates exploration, 5 cases collection and one case
internal haemorrhge.in the recipient,we have 2 hospital mortality and one
mortality at 6 months. Complications included:reccurent c and acute cellular
rejection in 7 cases,vascular in 3 cases,biliary in 3 cases and internal hge in one
case.
Conclusion. Living related liver transplantation is a good treatment of end
stage liver disease in countries like egypt but with more cost and needs more
skills and training.
P23.45
PRE-LIVER TRANSPLANT LOCOREGIONAL ADJUVANT THER-
APY FOR HEPATOCELLULAR CARCINOMA (HCC) AS A STRAT-
EGY TO IMPROVE LONG-TERM SURVIVAL
Doyle, Majella1; Bharat, Ankit1; Lowell, Jeff1; Browne, Daniel2; Chapman,
William1
1Washington University, Abdominal Transplantation, St Louis, USA; 2Wa-
shington University, Dept. of Radiology, St Louis, USA
Background. Pre-orthotopic liver transplant locoregional therapy (POLT)
for HCC reduces drop-out rates while awaiting orthotopic liver transplant
(OLT).
Aim. The aim was to investigate whether POLT improved long-term survival.
We also reviewed our experience with OLT for HCC and correlated pre-OLT
radiological staging with explant pathology.
Methods. A retrospective analysis of prospectively collected data identified
105 patients with HCC that underwent OLT between April 1985 and Feb
2006. 49 received POLTas transarterial chemoembolization, radio-frequency
ablation, percutaneous ethanol injection or a combination.
Results. The 1-, 3-, and 5-yr survival, regardless of POLT, was 83.7%, 75.3%,
and 68.6%, respectively; with a median survival of 117 months. Demographic
data and waiting time were similar between POLTand untreated groups. Pre-
OLT radiological stage was similar (POLT: 2.299/0.86 vs 2.339/0.91;
p/0.76). At the time of transplant, POLT group had significant tumor
downstaging (1.279/0.97 vs Untreated: 2.529/1.23; p/0.006). POLT
group had better 5-yr survival (84.9% vs 54.8%; p/0.02). Further,
POLT was associated with a trend towards lower disease recurrence (12.2%
vs 18.9% p/0.33). Eighteen POLT patients revealed no viable tumor cells on
explant pathology (pT0). Radiological stage for these patients was T1/6,
T2/10 and T3/2. No pT0 patients developed recurrence and all had
significantly better long-term survival than untreated patients. Correlation
pattern of pre-OLTradiological stage at listing with explant pathology distinctly
varied (Accurate: POLT 24.5%, Untreated 56.0%; Underestimated: POLT
18.4%, Untreated 34.6%; Overestimated: POLT 57.1%, Untreated 9.4%;
p/0.03).
Conclusions. OLT is a viable treatment option for primary HCC. POLT
significantly downstages the primary tumor and improves long-term survival in
patients with advanced disease. Pre-OLT imaging has low correlation with
explant pathology that may be due to tumor down-staging with POLT or net
tumor growth in the untreated group.
P23.46
PROLONGED ANHEPATIC STATE AFTER EARLY LIVER GRAFT
REMOVAL
Honore, Pierre; Detry, Olivier; De Roover, Arnaud; Meurisse, Michel
University of Lie`ge, CHU Sart Tilman B35, of Surgery and Transplantation,
Lie`ge, Belgium
Two-stage liver transplantation, i.e. salvage emergent total hepatectomy with
prolonged anhepatic state, and subsequent liver transplantation, has been
described in the late 80’s as a mean to stabilize some patients with fulminant
hepatic failure, primary non-function after liver transplantation, or
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massive hepatic trauma. The principal drawback of two-stage liver transplanta-
tion is the fact that anhepatic patient survival only depends on the future
availability of a liver graft. The pathophysiologic alterations induced by total
hepatectomy are not fully known, as it is not known how long a patient
may be anhepatic before it is too late for hope of survival. In this report
the authors describe the cases of four liver recipients who had to undergo
salvage liver graft removal early during or after liver transplantation as a
life-saving maneuver. All were afterwards registered for emergent
liver retransplantation. Mean anhepatic period was 30 hours (Range: 1760
hours). Two patients survived and fully recovered. From this experience and
from other cases reported in the literature, the authors concluded that long (/
24 hours) anhepatic phase is compatible with survival without neurologic
impairment.
P23.47
RECURRENCE AFTER SURGICAL TREATMENT OF HEPATO-
CELLULAR CARCINOMA: 13-YEAR OUTCOMES FROM A SIN-
GLE CENTER
Shah, Shimul; Cleary, Sean; Gallinger, Steven; Tan, Jensen; Wei, Alice;
McGilvray, Ian; Cattral, Mark; Greig, Paul; Grant, David
University of Toronto, Surgery, Toronto, Canada
The natural history, treatment, and outcome after recurrence of hepatocellular
carcinoma (HCC) following liver transplantation (LT) or resection (LR) is
unknown.
Methods. 120 patients who developed recurrence after surgical therapy for
HCC in 347 consecutive patients (LT/155, LR/192) from 09/1991 to 09/
2004 were analyzed. Patients who underwent ablation or alone during this time
period were not included. Characteristics of initial tumor, follow-up and
management of recurrences were analyzed. Overall survival from initial
procedure (OS) and survival after recurrence (RS) were the primary endpoints
and variables were then tested for their prognostic significance with univariate
and multivariate analysis.
Results. OS at 1, 3, and 5 years for all patients was better following LT (87, 74
and 65%) compared to LR (85, 68 and 53%) (p/0.01). 120 patients (35%)
developed recurrence (LR: n/98, 51%; LT: n/22, 14%) with a median time
to recurrence of 12.6 months following LR and 16.3 months after LT and a
subsequent worse OS in both groups (pB/0.001 respectively). Of the 98
patients who developed tumor recurrence following LR, 86 (86%) were
confined to the liver. 53 (54%) underwent additional therapy (11 re-resection,
31 ablation, 8 TACE, 3 LT) with a median RS of 22 months. Multivariate
analysis revealed that lack of pathological vascular invasion, time to re-
currence/12 months and additional therapy after recurrence was indepen-
dently associated with longer OS after LR. In contrast, recurrences after LT
presented with disseminated disease (73%); most were too sick for additional
treatment and median RS was only 3 months (pB/0.001 compared to
resection).
Conclusions. If locally advanced, recurrences of HCC after surgery should be
treated with multimodality therapy if possible. Although the recurrence rate
after LT is much less than LR, recurrences after LT have much poorer
prognosis and rapid progression, independent of the stage of disease at the time
of presentation.
P23.48
RESULTS OF INFERIOR VENA CAVA CROSS-CLAMPING IN
LIVER TRANSPLANTATION BY PIGGYBACK TECHNIQUE
Rocha-Santos, Vinicius; Bacchella, Telesforo; Figueira, Estela RR; Barros,
Mauricio F; Machado, Marcel CC
University of Sao Paulo, School of Medicine, Sao Paulo, Brazil
Background. Piggyback is orthotopic liver transplantation (OLT) technique
where inferior vena cava (IVC) is preserved avoiding its cross-clamping.
Nevertheless IVC can be temporally occluded in cases of hemorrhage.
Aim. To compare pre-operative liver function, intra operative aspects,
immediate postoperative evolution, and graft and patient survival among
patients submitted to OLT by piggyback technique with and without IVC
clamping.
Methods. One hundred thirty-five OLT performed from January 2002 to
September 2005 were evaluated. We evaluated 84 OLT with deceased donors
performed in 84 patients with diagnosis of cirrhosis. They were divided in 2
groups; group 1 (G1): 60 cases without IVC clamping, and group 2 (G2): 24
with IVC clamping. IVC was occluded from the end of hepatectomy to the end
of caval anastomosis, when the clamp was relocated. No extracorporeal veno-
venous bypass was utilized.
Results. Both groups were similar in mean age, gender, etiology, MELD
and Child-Pugh scores, and donor nature (Briceno criteria). Mean time of IVC
occlusion was 60.29/11 min. A significant reduction in G2 total hepatectomy
time compared to G1 was observed (163.29/74.8 min vs 194.39/61.8 min, p/
0.045). The number of red blood cell packets transfused was significant higher
in G1 compared to G2 (4.79/4.1 units vs 2.69/2.3 units, p/0.028). No
difference was observed between G1 and G2 in AST postoperative peak
(19819/229 U/L vs 28259/439 U/L, p/0.3), creatinine (1.49/1.0 mg/dl vs
1.89/1.5 mg/dl, p/0.23), postoperative hemodialysis (3,3% vs 8,3%, p/0.3).
There was no significant difference between G1 and G2 one year graft survival
(76% vs 71%) and patient survival (91% vs 83%).
Conclusion. Inferior vena cava cross-clamping can be safely applied during
liver transplantation by piggyback technique. This procedure can also avoid
major surgical bleeding in some situations.
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RHO-ASSOCIATED KINASE INHIBITOR REDUCES TUMOR RE-
CURRENCE AFTER LIVER TRANSPLANTATION IN RAT HEPA-
TOCELLULAR CARCINOMA MODEL
Ogawa, Takayuki; Tashiro, Hirotaka; Miyata, Yoshihiro; Fudaba, Yasuhiro;
Ushitora, Yuichiro; Asahara, Toshimasa
Hiroshima University, Second Dept. of Surgery, Hiroshima, Japan
Background. Calcineurin inhibitor cyclosporine itself promotes the invasive-
ness and metastasis of tumor cell by increasing cancer-cell motility independent
of host immunity, but it remains unresolved whether calcineurin inhibitor
tacrolimus itself promotes the invasiveness and metastasis of tumor cell or not.
The small GTPase Rho/Rho-associated kinase (ROCK) pathway plays an
important role in motility and invasion of tumor cell.
Aims. We examined the effect of tacrolimus on rat hepatocellular carcinoma
cell invasion and whether tacrolimus activated the Rho/ROCK signal pathway.
Furthermore, we investigated whether ROCK inhibitor Y-27632 suppressed
tumor recurrence after experimental liver transplantation in rat hepatocellular
carcinoma model.
Methods. We used rat morris hepatocellular carcinoma cells. Cell motility was
evaluated with cell migration assay. Cell growth was assessed by MTT assay.
Western blotting was performed to determine the level of phosphorylation for
myosin light chain (MLC) and MAPK. Orthotopic liver transplantation was
performed with cuff method.
Results. Tacrolimus enhanced the cancer cell migration and stimulated the
phosphorylation of MLC, a downstream effector of Rho/ROCK signaling. Y-
27632 suppressed the cancer cell migration and the phosphorylation of MLC
induced by tacrolimus. On the other hand, tacrolimus did not enhance the cell
proliferation and phosphorylation of MAPK. Y-27632 suppressed the tumor
recurrence after liver transplantation and prolonged significantly the survival of
liver transplant rats, compared with non Y-27632-treated liver transplant rats.
Conclusion. Tacrolimus stimulates the Rho/ROCK signal pathway to
enhance invasiveness of hepatocellular carcinoma and ROCK inhibitor can
be a new antimetastatic agent for tumor recurrence after liver transplantation.
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RIGHT LOBE ADULT LIVING DONOR LIVER TRANSPLANTA-
TION
Karakayaly´, Hamdi1; Yy´lmaz, Ugur2; Bilezikci, Banu3; Arslan, Gulnaz4;
Emiroglu, Remzi1; Gokhan, Moray1; Haberal, Mehmet1
1Baskent University, General Surgery and Transplantation, Ankara, Turkey;
2Baskent University, Gastroentherology, Ankara, Turkey; 3Baskent University,
Pathology, Ankara, Turkey; 4Baskent University, Anaesthesia, Ankara, Turkey
Background. Living donor liver transplantation is an alternative to cadaveric
liver transplantation in adult patients.
Aim. We report the outcome of 35 right lobe adult living donor liver
transplantations (ALDLT).
Method. We analyzed 35 ALDLT at our institution between April 2003 and
December 2005 retrospectively.
Results. The age of the recipients ranged from 18 to 61 years (mean, 41.79/
12.5 years). The median graft-to-recipient weight ratio was 1.2%9/.0.4%
(range, 0.8 to 2.1). In the recipients, the mean operative time was 10.69/2.7
hours, the number of blood transfusions administered was 4.19/5.1 Unit, the
mean hospital stay was 259/22.9 days, and the mean intensive care unit stay was
2.39/1.5 days. In the recipients, five vascular and 5 biliary complications
occurred during the early postoperative period, and 4 vascular and 2 biliary
complications developed in the late postoperative period. Eight of the 35
recipients studied died within 4 months after surgery. The age of the donors
ranged from 23 to 50 years (mean, 36.69/9 years). In the donors, the mean
operative time was 6.49/1.6 hours, the residual liver volume was 43.3%9/6.1%,
and the mean hospital stay was 9.59/4.5 days (range, 523 days). Two donors
required an intraoperative blood transfusion. No donors died as a result of
having undergone the procedure, although 4 experienced 6 complications. The
mean postoperative follow-up period was 129/4.6 months (range, 132
months).
Discussion. In Turkey, the demand for ALDLT is beginning to exceed donor
availability, and graft size presents a problem for adults who require LDLT.
Because of the greater understanding of hepatic physiology and anatomy, right
lobectomy can now be performed safely in experienced hands. Right lobe
LDLT can be a lifesaving option for some adult patients with hepatic disease.
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SAFETY OF MODIFIED EXTENDED RIGHT HEPATECTOMY IN
LIVING LIVER DONOR
Cho, Eung-Ho1; Suh, Kyung-Suk1; Yang, Sung H1; Lee, Hae W1; Cho, Jai Y1;
Cho, Yong B1; Yi, Nam-Joon1; Choi, Jae W2; Lee, Kuhn U1
1Dept. of Surgery, Seoul National University, College of Medicine, Seoul,
South Korea; 2Dept. of Surgery Chungbuk National University Hospital,
Cheongju-si, South Korea
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Background. In living donor liver transplantation (LDLT), the standard right
graft has been adopted by many centers in order to meet the metabolic demands
of large recipients. In conventional right liver graft, congestion at anterior
section might be problematic especially when graft volume is insufficient. We
previously introduced a technical Modified extended right hepatectomy
(MERH), in which the middle hepatic vein (MHV) was excavated preserving
entire segment 4 to the donor. In this report, we investigated the safety of donor
who received MERH.
Method. Between August 2002 and July 2005, 97 donors underwent right liver
donation. MERH was considered when remnant left liver volume exceeds 35%
of whole liver. Eighteen donors underwent MERH (MERH group, n/18). We
compared clinical outcomes of MERH group with that of donors who
underwent conventional right hepatectomy with remnant liver volume exceed
35% (RH group, n/37).
Results. No donor mortality occurred. No intraoperative transfusion and no
reoperation were done. There were no differences in operative time (290.8 min
in MERH group vs. 297.0 min in RH group, respectively), blood loss(453.3 ml
vs. 426.5 ml), and postoperative hospital stay(12.5 days vs. 12.8 days) between
the two groups (p/0.05). Period of drain removal was longer in MERH group
(12.5 days vs. 9.4 days, pB/0.05). But, there was no difference in complication
rate between two groups (11/18 vs. 23/37, p/0.05). Congestion of segment 4
was occurred in 13 out of 18 MERH donors in early postoperative period, but
all recovered at 4 months. The regeneration of the remnant liver after MERH
and RH were similar (209.8% vs. 200.0% at 4 months) (p/0.05).
Conclusion. Our results show that MERH did not impair recovery or liver
regeneration in donors, and indicate that MERH can be done safely in adult
living donor liver transplantation when the remnant liver exceeds 35%.
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SPLENIC ARTERY STEAL SYNDROME IN LIVING-DONOR LIVER
TRANSPLANTATION
Shimizu, Seiichi; Tashiro, Hirotaka; Fudaba, Yasuhiro; Itamoto, Toshiyuki;
Ohdan, Hideki; Amano, Hironobu; Asahara, Toshimasa
Hiroshima University, Second Dept. of Surgery, Hiroshima, Japan
Background. Arterial steal syndromes are defined by decreased perfusion of
one arterial branch because of diversion of blood flow into a different arterial
branch originating from the same trunk. The splenic artery steal syndrome
(SASS) has only recently been recognized as a potential threat to transplanted
livers.
Aim and method. We report a case of splenic artery steal syndrome with
progressive liver dysfunction that developed after living-donor right robe liver
transplantation (LDLT).
Result. A 51-year-old woman with primary biliary cirrhosis (PBC) developed
progressive jaundice and intractable itching. Her serum total bilirubin was 11.9
mg/dl. LDLT using a right lobe graft with no middle hepatic vein was
performed. After surgery, her liver function deteriorated gradually. Further-
more, the volume of ascites was over 2000 ml/day. Postoperative CT showed
that the diameter of the hepatic artery had decreased and that of the splenic
artery had increased compared with the diameters determined by preoperative
CT. A celiac trunk angiogram showed an enlarged splenic artery and reduced
perfusion of the hepatic artery. Embolization of the splenic artery was
performed. After the embolization, the liver function improved and the volume
of ascites dramatically decreased. Her liver function was almost within the
normal range after 3 months.
Conclusion. SASS was suspected by serial pre- and post-operative CT scans
and was diagnosed by celiac trunk angiography, and it was successfully salvaged
by splenic artery embolization. In this case, the serial examinations of CT scans
were very useful for diagnosing the splenic artery steal syndrome. This case may
show that portal hyperperfusion injury is a cause of liver graft dysfunction in
SASS. The splenic artery embolization is a technically safe procedure that can
be applied for treatment of such injury.
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SPLIT LIVER TRANSPLANTATION IN FULMINANT HEPATIC
FAILURE: RESULTS AND LONG TERM FOLLOW UP
Imventarza, Oscar1; Barros Schelotto, Pablo2; Rojas, Luis3; Duek, Fernando2;
Quarin, Carlos2; Garay, Veronica2; Lendoire, Javier2
1Hospital Dr Cosme Argerich and Hospital Dr Juan P Garrahan, Liver
transplantation, Buenos Aires, Argentina; 2Hospital Dr Cosme Argerich, Liver
Transplantation, Buenos Aires, Argentina; 3Hospital Dr Juan P Garrahan,
Liver Transplantation, Buenos Aires, Argentina
Background. Split liver transplantation is an effective way to increase the
donor pool and reduce the waiting list mortality. Its indication in fulminant
hepatic failure is still controversial.
Aim. Analyze the results and long term follow of split liver transplantation in
patients with fulminant hepatic failure
Patients and methods. From November 1995 to February 2004, 35 splits
liver transplantations were performed in our unit. 13 were transplanted into
patients with fulminant hepatic failure. Split was conventionally performed
(right trisectionectomy graft, RTG and left lateral sectionectomy graft, LLSG)
with ex-situ or in situ technique. Complications and long term survival were
retrospectively analyzed.
Results. 4 patients were male and 9 female. Mean age was 6,8 years
(r 229); 11 pediatrics and 2 adults. Graft were obtained with ex-situ technique
in 10 and in-situ in 3. Two patients were transplanted with grafts of the
same donor. 11 LLSG were used in pediatric patients and 2 RTG in adults.
In two patients postoperative bleeding required reoperation. The biliary
complication rate was 38%, arterial complications occurred in one patient
(7,6%). No portal vein complication or primary nonfunction was observed.
Two patients died 2 months posttransplantation due to sepsis. The graft and
patient survival rate was at 1 year was 77%, 85% and at 5 years 67%, 85%
respectively.
Conclusions. In patients with FHF, the use of partial grafts did not
compromise the outcome and survival. In a country with low rate of donation
split grafts could be an alternative to patients with FHF.
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STRATEGY FOR SMALL-FOR-SIZE LEFT LOBE GRAFT IN LIV-
ING DONOR ADULT LIVER TRANSPLANTATION
Shimada, Mitsuo; Soejima, Yuji; Imurau, Satoru; Morine, Yuji; Ikemoto,
Tetsuya; Miyake, Kotaro
The University of Tokushima, Dept. of Digestive and Pediatric Surgery,
Tokushima, Japan
Introduction. We have advocated that a left lobe graft, usually a small-for-
size graft, is a feasible option in living donor adult liver transplantation
(LDALT) (Arch Surg 2002). We herein show our pathophysiology-oriented
refinements to save a small-for-size left lobe graft. Operative procedures: 1)
Graft procurement: After encircling right first Glisson’s pedicle, a cotton
tape is passed between liver and intrahepatic IVC for liver hanging
advocated by Belghiti. A demarcation line is marked by clamping right first
Glisson’s pedicle. Liver parenchymal division starts 1 cm right side from the
demarcation line and proceeds just left side of right anterior Glisson’s
pedicle. A part of anterior segment added to the left lobe graft in this
procedure demonstrates good perfusion due to preserved tributaries of
middle hepatic vein in this part (supercharge). After parenchymal division,
in situ bile leakage test and cholangiography was performed (Transplanta-
tion 2005), and a left lobe graft with middle hepatic vein and a caudate lobe
is harvested. 2) Procedures in the back table and Recipient operation: After
graft venoplasty to big one hole in the back table, a catheter is place in
portal vein through reopened umbilical vein to use as an intraportal
administration of drugs (PG E1, etc.) to improve graft microcirculation
(Transplant Int 2005). To avoid portal congestion leading to excessive shear
stress after reperfusion, a temporary porto-systemic shunt using a right
portal vein is made in the anhepatic phase. The graft hepatic vein is
anastmosed to the IVC including roots of middle and left hepatic veins to
make sure a big anastomotic diameter and sufficient outflow. To avoid
excessive portal flow (shear stress), splenic artery ligation (or splenectomy)
is performed (Hepatogastroenterol 2005).
Conclusions. Our refined strategy can improve outcome of a small-for-size
left lobe graft in LDALTand increase a feasibility of a left lobe graft leading to
living donor’s safety.
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THE BLOOD SUPPLY OF THE HILAR BILE DUCT AND ITS
RELATIONSHIP TO THE COMMUNICATING ARCADE LO-
CATED BETWEEN THE RIGHT AND LEFT HEPATIC ARTERIES
Gunji, Hisashi1; Cho, Akihiro2; Tohma, Takayuki1; Okazumi, Shinichi1;
Makino, Harufumi3; Shuto, Kiyohiko1; Mochizuki, Ryouyu1; Matsubara,
Katsuhiko1; Hayano, Kouichi1; Mori, Chisato4; Murakami, Gen5; Ochiai,
Takenori1
1Chiba University Graduate School of Medicine, Academic Surgery,
Chiba, Japan; 2Chiba Cancer Center Hospital, Dept. of Surgery, Chiba,
Japan; 3Chiba University, Research Center for Medical Engineering, Chiba,
Japan; 4Chiba University Graduate School of Medicine, Bioenvironmental
Medicine, Chiba, Japan; 5Sapporo Medical University School of Medicine,
Dept. of Anatomy, Sapporo, Japan
Background. Despite increasing demand of living donor liver transplanta-
tion, biliary complication rates are still high, and bile duct ischemia has been
believed to be the major factor contributing to the development of biliary
complications.
Aims. To evaluate the communicating arcade (CA) located between the right
and left hepatic arteries at the hepatic hilum using acrylic corrosion casts and
cadaveric dissections and to clarify its relevance to the blood supply of the
hilar bile duct.
Methods. The anatomy of CA between the right and left livers and its
relevance to the blood supply of the hilar bile duct was evaluated, using 10
formalin fixed adult cadaveric livers and 6 latex resin cast specimens.
Results. In all specimens which were of sufficient quality for evaluation,
CA was recognized as locating extrahepatically in hilar plate and branching
thin tributaries to hilar bile duct. The branching points of CA were
classified into two types on the left side and three types on the right side;
on the left side type 1 was characterized by originating from segment IV
artery (55%), type 2 from left hepatic artery (45%), on the right side type
1 from right anterior hepatic artery (46%), type 2 from right hepatic artery
(27%), type 3 from both right and right anterior hepatic artery (27%). The
average distance between the branching point of the CA and the origin of
right and left hepatic artery (D-com.) was 2.59/0.83 cm, and 1.769/0.86
cm respectively.
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Conclusion. To maintain the adequate blood supply of the hilar bile duct of
the donor graft in living donor liver transplantation, the branching point of
communicating arcade (CA) between the right and left hepatic arteries
should be preserved.
P23.56
THE IMPACT OF DONOR-RECIPIENT MATCHING IN THE OUT-
COME OF LIVER TRANSPLANT
Bilbao, Itxarone; Castro, Ernesto; Dopazo, Cristina; Escartin, Alfredo;
Balsells, Joaquin; Lazaro, Jose L; Armengol, Manel
Hospital Vall d?Hebron, General Surgery Dept., Barcelona, Spain
Aims. To analyze the outcome of liver transplanted patients according to the
type of donor-recipient matching.
Methods. From 1988 to 2003, characteristics of donor-recipients have been
analyzed retrospectively in 460 liver transplantations performed in our
Center. Taking into account our previous multivariate studies, we have
definied ‘‘suboptim donor’’, as donors with ]/2 factors: age/70 years, graft
steatosis/20%, ICU stay/5 days, and Na/160 mEq/l. ‘‘High risk
recipients’’ have been definied as those patients with ]/2 factors: age/65
years, Child C, pre-LT renal insufficiency, previous upper quadrant
abdominal surgery and portal thrombosis. In our Center the mean time in
waiting list is 2 months and usually we have between 15 to 20 patients listed.
Most of the ‘‘suboptim donors’’ have been accepted in the last 5 years.
Results. Distribution of good donors without any risk factors (N/245), with
1 risk factor (N/150) or ]/2 factors (N/36), is similar among the totality of
recipients, and also among the subgroup of ‘‘high risk recipients’’ (N/58).
However some tendencies have been shown. ‘‘Suboptim donors’’ have been
allocated in lower percentage to recipients/65 years, or with previous surgery.
Cold ischemic time has been shortened as much as possible. But, UNOS II
recipients with pre-LT renal insufficiency, have received ‘‘suboptim donors’’ in
greater percentage, probably obliged by the urgency of the situation. Patient/
graft survival at 3 months did not show statistical significance, according to the
donor received. However, there was a tendency to present lower survival for
those ‘‘high risk patients’’ receiving ‘‘suboptim donors’’ (p/ns).
Conclusion. Chronological inclusion order has been the allocation system in
our Center, only altered in recipients with inminent risk of death. However as
the acceptance of ‘‘suboptim donors’’ is increasing in the last 5 years, in
certain cases, we have tried to avoid the matching ‘‘suboptim donor’’ in ‘‘high
risk recipient’’, in order to avoid bad outcome.
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TREATMENT OF VASCULAR COMPLICATIONS AFTER LIVING
DONOR LIVER TRANSPLANTATION USING INTERVENTIONAL
RADIOGRAPHY
Fudaba, Yasuhiro1; Tashiro, Hirotaka1; Toyota, Naoyuki2; Kakizawa, Hide-
aki2; Ohdan, Hideki1; Itamoto, Toshiyuki1; Amano, Hironobu1; Asahara,
Toshimasa1
1Hiroshima University Hospital, Second Dept. of Surgery, Hiroshima, Japan;
2Hiroshima University Hospital, Dept. of Radiology, Hiroshima, Japan
Background. Complications of vascular anastomosis are significant
actors leading to graft loss after liver transplantation. However, surgical
treatments for these complications were sometimes very difficult and too
much invasive for patients. Recently, interventional radiography (IVR)
technique was developed and applied to treat these complications. We
evaluate IVR as a therapeutic strategy for postoperative vascular complica-
tions based on our experience.
Methods and results. We have performed 79 cases of living donor liver
transplantation and applied IVR procedure to 4 cases to treat vascular
complications after transplantation. We employed this technique to treat 2
cases of portal vein stenosis, a case of hepatic vein stenosis, and a case of
splenic artery steal syndrome with reduction of hepatic arterial flow. These
patients showed clinical signs such as ascites, jaundice, and liver dysfunction
after transplantation, and Doppler US were useful to diagnose these
complications. Three-dimensional computed tomography (3D-CT) was
used to confirm the indications for IVR. Both of 2 patients suffering
portal vein stenosis were treated using metallic stent following balloon
dilatation, and showed excellent long-term patency after stenting. The
case of splenic artery steal syndrome was treated using metallic coil to
occlude splenic artery, and showed significant recovery of hepatic arterial
flow after IVR. The patient with hepatic vein stenosis was treated using
balloon dilatation of anastomosed site. Clinical sings were ameliorated soon
after IVR in all patients. We experienced no complications with these IVR
procedures.
Conclusions. IVR can be safely and successfully applied to the treatment of
vascular complications before graft dysfunction becomes irreversible.
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VASCULAR CLOSURE STAPLES FOR PORTAL VEIN RECON-
STRUCTION IN LIVING DONOR LIVER TRANSPLANTATION
Tashiro, Hirotaka; Itamoto, Toshiyuki; Ohdan, Hideki; Fudaba, Yasuhiro;
Amano, Hironobu; Asahara, Toshimasa
Hiroshima University, Second Dept. of Surgery, Hiroshima, Japan
Background. In living donor liver transplantation, complications related to
portal vein reconstruction have been reported to occur in 5% of liver
recipients. Portal vein reconstruction is still a crucial problem. The vascular
closure staples (VCS) has been applied for small peripheral vessels and large
vessels because of the technical ease with which it can be employed.
Aim. We describe here our experience with portal vein reconstruction in
living donor liver transplantation and we compare VCS clips with conven-
tional suture in portal vein reconstruction.
Methods. Between January 2001 and August 2004, 38 adult patients
underwent living donor liver transplantation at Hiroshima University
Hospital. The anastomosis between the donor portal vein and recipient
portal vein or the right external iliac vein graft was created using either VCS
clips or conventional sutures. For VCS clip anastomosis, four 6-0 stay sutures
were placed in equally opposite positions, and the vessel edges were held with
specially designed VCS-approximating forceps to evert the vessel walls.
Medium-sized VCS clips were then applied at approximately 0.5 mm
intervals between stay sutures to complete the anterior wall and the posterior
wall. To evaluate the portal anastomotic stenosis, we measured the portal vein
diameter of the liver allograft and anastomotic diameter by 3-dimensional CT
imaging. The stenotic ratio is equated to the ratio of r (anastomotic site) 2/r
(donor portal vein) 2.
Results. The stenotic ratios were 0.519/0.15 and 0.799/0.25 in the
conventional suture and VCS clip suture, respectively. The anastomotic
stenosis of portal vein was decreased significantly in VCS clip suture
compared with the conventional suture.
Conclusions. VCS clip suturing has the advantage of low risk of anastomotic
stenosis compared with conventional suturing.
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CONTROLED SURGICAL EDUCATION IN CLINICAL LIVER
TRANSPLANTATION IS NOT ASSOCIATED WITH INCREASED
PATIENT RISKS
Jurgaitis, Jonas1; Paskonis, Marius1; Mehrabi, Arianeb2; Kashfi, Arash2;
Schemmer, Peter2; Gragert, Stephanie2; Hinz, Ulf3; Strupas, Kestutis1;
Bu¨chler, Markus W2; Schmidt, Jan2; Kraus, Thomas W2
1Vilnius University Hospital ‘‘Santariskiu Clinics’’, Dept. of Abdominal
Surgery, Vilnius, Lithuania; 2Transplantation Surgery, Dept. of General,
Visceral and, University of Heidelberg, Germany; 3Unit for Documentation
and Statistics, Dept. of Surgery, University of Heidelberg, Lithuania
Introduction. A qualified surgical team is required to perform liver
transplantation (LTX). A retrospective clinical study was designed to
evaluate the process of surgical training for LTX at the University of
Heidelberg. Patient risks associated with or caused by the education process
in clinical LTX were analyzed.
Methods. Perioperative patient data were collected for all consecutive LTX
carried out between 12/2001 and 7/2004. Follow up and operative data were
correlated with the degree of surgical experience of the first operating
surgeon: Two groups were defined (Group A: Experienced transplant
surgeons with/50 personally performed liver transplants (n/3) and Group
B: Visceral surgeons without significant transplant experience (n/3)). All
LTX operations were standardized. Group B operations were performed
under close supervision/assistance of an experienced surgeon. Operative time,
blood loss, liver function, postoperative morbidity and survival rate data were
compared in both groups.
Results. 155 LTX were performed in 131 patients and were analyzed. 106
operations (68.3%) were performed by Group A and 49 operations
(31.6%) were performed by less experienced surgeons. No significant
differences concerning mean patient age, distribution of type of disease,
operating time, MELD score and frequency of category CHILD A, B and C
were detected between groups. Less experienced surgeons performed more
operations in T2 patients. Overall postoperative complication rate was 21.9%
(n/34). Experienced surgeons had a 19.8% (n/21), less experienced
surgeons a 26.5% (n/13) complication rate (n.s.). One and two year patient
survival rate was 78% and 71% respectively. Survival rate, blood loss,
intraoperative transfusion requirements and operating time did not differ
significantly between groups.
Conclusion. Surgical education to perform LTX under close supervision of
experienced transplant surgeons in a well working team is feasible with good
results.
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EFFECT OF METHYLPREDNISOLONE ON LIVER WARM
ISCHEMIA-REPERFUSION INJURY
Saidi, Reza1; Chang, J1; Brooks, S1; Verb, S1; Nalbantoglu, I2; Adsay, V3;
Jacobs, Michael1
1Providence Hospital, Surgery, Southfield, USA; 2St John Hospital, Detroit,
USA; 3Harper Hospital, Detroit, USA
Introduction. Liver ischemia-reperfusion (I/R) injury is cause of morbidity
and mortality in liver transplantation and is closely related to development of
primary graft non-function and graft loss.
Methods. Male wild-type rats (Sprague-Dawley) and Zucker rats were
subjected to 75 minutes of 70% hepatic ischemia and 3 hours of reperfusion.
Each ischemic period was evaluated using two different protocols: continuous
Abstracts 149
clamping (CC) and ischemic preconditioning (IP) by clamping for 10
minutes and 15 minutes reperfusion prior to the prolonged ischemic insult.
Each group then subdivided (7 rats in each subgroup) in control and IV
methylprednisolone (MP) groups. Forty-five minutes before ischemia induc-
tion, rats were pretreated with intravenous methylprednisolone (2 mg/kg) or
normal saline (NS). Warm I/R injury was evaluated using serum levels of
aspartate aminotransferase (AST), serum IL-6, expression of TNF-alpha
gene (PCR), hematoxylin and eosin staining, and specific marker of apoptosis
(TUNEL staining).
Results. Histopathology, serum IL-6 and AST release revealed that MP
treatment provided significant protection as compared with ischemic controls
(both CC and IP groups) only in the normal, not steatotic, liver. TUNEL-
positive cells, as well as TNF expression, were clearly reduced in hepatic
tissue of MP-treated animals with normal liver and not in the Zucker rats.
The inflammatory response was considerably reduced in MP groups with
normal liver not steatotic liver. In general, IP groups showed decrease I/R
injury compare to CC group. However, MP was able to further reduce the I/
R injury only in normal, nor steatotic, liver.
Conclusions. MP attenuated the postischemic apoptotic and inflammatory
response in the normal, and not steatotic, liver. MP pretreatment might be
effective to reduce the warm I/R injury to liver allogarfts without steatosis.
The mechanism of I/R-related hepatocellular damage in steatotic liver is
different than normal liver.
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QUALITY OF LIFE OF LIVING DONORS AFTER LIVING DONOR
LIVER TRANSPLANTATION
Emiroglu, Remzi1; Yilmaz, Ugur2; Akkoc, Hatice3; Karakayali, Feza1;
Mallhan, Simten4; Oksuz, Ergun5; Karakayali, Hamdi1; Haberal, Mehmet1
1Baskent University Faculty of Medicine, General Surgery and Transplanta-
tion, Ankara, Turkey; 2Baskent University Faculty of Medicine, Gastroenter-
ology, Ankara, Turkey; 3Baskent University Faculty of Medicine, Ankara,
Turkey; 4Baskent University Faculty of Medicine, Health Care Management,
Ankara, Turkey; 5Baskent University Faculty of Medicine, Student Health
Center, Ankara, Turkey
Aim. The aim of this study was to compare the post-transplant quality of
lifes(QoL) of the right and left liver lobe donors, using with GIQLI(Gas-
trointestinal Quality of Life Index) and the Medical Outcomes Study Short
Form-36(SF-36).
Method. Fifty-three living liver donors were evaluated with a post-surgery
follow-up of at least 6 months.
Results. Thirty-two of the donors donated right lobes(Group 1) and 21 were
left lobe donors (Group2). In Group 1, the female/male ratio was 14/18, and
it was 9/12 in Group 2. The mean age of the donors n Group 1 was 38.39/
11.8 and it was 35.59/8.1 in Group 2. Eight of the right and 5 of the left lobe
recipients died during the post-transplant period. Regarding to the SF-36
variables of mental health(MH) and role limitations due to emotional
problems(RE), male donors had significant high scores than females,63.8
vs 48 and 73.1 vs 51.5, respectively(pB/0.05). Although, in role limitations
due to physical problems(RP) and vitality (VT) variables,left lobe donors had
high scores,79.5 vs 61.3 and 49.6 vs 37.3 respectively(pB/0.05). The overall
scores were 59.1 and 61.1, in left and right lobe donors respectively (p/
0.05). No statistically significant difference was found between donor age
groups. Comparing the QoL scores of the donors whose recipients did not
survive with healthy recipients’ donors, most variable scores were lower but
statistically non significant (p/0.05). Correlation analysis of GIQLI with
SF-6 revealed that there is strong correlation between the variables of
psychosocial items and mental health dimension (pB/0.01), between disease
specific items and pain dimension(pB/0.01) and between disease specific
items and RP dimension(pB/0.01). The overall scores in GIQLI were 114.2
and 121.1, in left and right lobe donors respectively (p/0.05).
Discussion. The live liver donors, regardless of the right or left lobe
donation were able to resume normal daily life.
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THE NEGLIGIBLE ROLE OF HCV RECURRENCE AFTER OLT
FOR PATIENTS AWATING LIVER TRANSPLANTATION
Grazi, Gian L; Ravaioli, Matteo; Ercolani, Giorgio; Cescon, Matteo; Varotti,
Giovanni; Del Gaudio, Massimo; Vetrone, Gaetano; Zanello, Matteo; Tuci,
Francesco; Vivarelli, Marco; Lauro, Augusto; Ramacciato, Giovanni; Pinna,
Antonio D
Sant’Orsola-Malpighi Hospital, University of Bologna, Dept. of Surgery and
Transplantation, Bologna, Italy
Background. LT achieves the best result when the outcome overcomes the
survival on the waiting list. Unfortunately, HCV recurrence is common after
LT and it is an important cause of graft and patient loss.
Methods. The outcome of 652 patients with HCV/ cirrhosis listed during
’90 ’05 was analyzed with an intention-to-treat principle. One-year patient
survival on list without LT was compared to 1-year patient survival after LT.
Patients were further divided according to the presence of hepatocellular
carcinoma (HCC) and MELD score. The impact of HCV recurrence on the
outcome after LT was analyzed.
Results. During the study period 407 (62.4%) patients were transplanted,
110 (16.9%) died on the list, 29 (4.4%) were excluded and 106 (16.3%) are
still on the list. The rates of patients lost after 3, 6 and 12-months on list
without LT were 27.3%, 35.5% and 46.1%, while the rates of patients died
after LT at 3, 6 and 12-months were 7.1%, 8.6% and 12.8% (pB/0.01). The
outcome on the list without LT and after LT, in different groups of patients
divided according to the presence of HCC and scores of MELD/15 are
presented in Table 1.
Among the 407 LTs, 229 (56.3%) cases developed HCV recurrence and 41
(38.7%) out of the 106 patients who died were lost due to HCV recurrence.
The time of patient loss according to HCV recurrence is reported in Table 2.
Conclusion. LT for HCV/ cirrhotic patients should be performed always
when an HCC is present. HCV recurrence influences the long-term outcome,
but its role is less relevant than the mortality on the waiting list and the
mortality after LT.
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ANALYSIS OF THE VARIABLES RELATED TO THE OUTCOME
OF CIRRHOTIC HCV/ PATIENTS AFTER BEING LISTED AC-
CORDING TO AN INTENTION-TO-TREAT PRINCIPLE
Grazi, Gian L; Ravaioli, Matteo; Ercolani, Giorgio; Cescon, Matteo; Varotti,
Giovanni; Del Gaudio, Massimo; Vetrone, Gaetano; Zanello, Matteo; Tuci,
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Sant’Orsola-Malpighi Hospital, University of Bologna, Dept. of Surgery and
Transplantation, Bologna, Italy
Background. The outcome of patients listed for liver transplantation (LT) is
based on the mortality on list and after LT.
Methods. The outcome of 652 patients with cirrhosis HCV/, listed during
19902005, was analyzed with an intention-to-treat principle. The impact
on survival of the following variables was analyzed in univariate and
multivariate fashion: being transplanted, year of listing, recipient age and
sex, MELD score, presence of hapatocellular carcinoma, ascites, diabetes and
encephalopathy.
Results. During the study period among the 652 patients listed: 407 (62.4%)
were transplanted, 110 (16.9%) died on list, 29 (4.4%) were excluded from
the list and 106 (16.3%) were still on list. According to the intention-to-treat
principle the patient survival at 1, 2 and 3 years was 77%, 65.3% and 60.8%
respectively. Univariate analysis showed that the 1-year patient survival since
listing was affected by the following variables: not being transplanted (44.3%
vs. 93.2%, pB/0.001), recipient age /55 years (76.3% vs. 81.9%, pB/0.01),
MELD /15 (71.6% vs. 84.7%, pB/0.01), presence of ascites (72.4% vs.
83.4%, pB/0.05) and presence of diabetes (70.2% vs. 79.4%, pB/0.005).
Multivariate analysis confirmed as independent variables related to the
outcome of patients not being transplanted (pB/0.01, C.I. 5.114.8),
MELD/15 (pB/0.01, C.I. 1.94.7) and presence of diabetes (pB/0.05,
C.I. 1.22.9).
Conclusion. The presence of diabetes represents an independent factor for
survival of HCV/ patients listed for LT. Therapeutical strategies to minimize
its impact on survival should be further refined to reduce the strong impact of
this condition on survival of patients before and after transplantation.
Table 1.
Patients lost at
1-year on list
without LT
Patients lost at
1-year after LT P
Patients with
MELD5/and
without HCC
13.4% 11.1% n.s
Patients with
MELD5/15 and
with HCC
30.8% 12.8% B/0.05
Patients with
MELD5/15 with
or without HCC
53.2% 10.2% B/0.01
Table 2.
Patients lost
at 1-years
after LT
Patients lost
between 12
years after LT
Patients lost
between 23
years after LT
Patients lost
between 35
years after LT
HCV
recurrence
7.9% 3.5% 3.1% 4.8%
no HCV
recurrence
19.1% 1.7% 1.7% 0.6%
P B/0.05 n.s n.s B/0.05
150 Abstracts
P23.64
AN ALTERNATIVE APPROACH TO PREEXISTING PORTAL VEIN
THROMBOSIS NOT AMENABLE TO THROMBECTOMY IN LIV-
ING DONOR LIVER TRANSPLANTATION
Soejima, Yuji1; Taketomi, Akinobu1; Yoshizumi, Tomoharu1; Uchiyama,
Hideaki1; Shimada, Mitsuo2; Maehara, Yoshihiko1
1Kyushu University, Dept. of Surgery and Science, Fukuoka, Japan; 2The
University of Tokushima, Dept. of Digestive and Pediatric Surgery, Tokush-
ima, Japan
Aims. Preexisting portal vein thrombosis (PVT) often complicates the
procedure in liver transplantation. Thrombendvenectomy (TEV) has been a
preferred choice in most instances. However, PV reconstruction is far
complicated in some situations where TEV is not feasible. The purpose of
the study is to evaluate the effectiveness of our alternative approach to PV
reconstruction in patients with preexisting PVT not amenable to TEV.
Methods. Three patients underwent living donor liver transplantation
(LDLT) for biliary atresia (n/1) and hepatictis C (n/2). The preexisting
PVT due to hypoplastic PV (n/1) or liver cirrhosis (n/2) and large
spontaneous splenorenal shunts, which drained most of the splanchnic blood
flow into the systemic circulation was present in all. TEV was not feasible due
to hypoplastic PV (n/1), calcification of the confluence between the
superior mesenteric vein and the splenic vein (n/1) and portopulmonary
hypertension (n/1). Graft type included left lobe (n/1), right lobe with
(n/1) and without (n/1) the middle hepatic vein. The portal flow to the
graft was established by anastomosing the recipient left renal vein and graft
portal vein using interposition vein grafts such as the external iliac vein graft
of the donor (n/1), the left internal juglar vein (n/1) and the gonadal vein
(n/1) of the recipient.
Results. The graft function was consistently excellent in all. The post-
operative course of case 1 and 3 was complicated by intestinal perforation and
prolonged pulmonary dysfunction, respectively. Currently, all of them lead
normal life with normal liver function at 2.8, 2.1 and 2.0 years after LDLT.
Conclusion. Renoportal interposition is a feasible option in patients with
preexisting PVT and large spontaneous splenorenal shunts which is not
amenable to TEV.
P23.65
BILIARY COMPLICATION IN LIVING DONOR LIVER TRANS-
PLANTATION USING RIGHT LOBE
Lee, Che-Young; Kim, Dong-Goo; Kim, Se-Joon; Cho, Je-young; Lee,
Myung-Duk
Catholic University of Korea, Surgery, Seoul, Korea
Background. Living donor liver transplantation (LDLT) using right lobe
provide enough graft mass for the recipient and is a safe procedure for the
donor. Biliary reconstruction remains a main cause of morbidity in LDLT
and the biliary complication could be cause cholangitis, sepsis and eventually
retransplantation or death.
Methods. From Jan. 2000 to Mar. 2005, 180 patients were undertaken
LDLT using right lobe in Department of Surgery, Catholic University of
Korea. Patients were 130 men and 50 women with a mean age of 49.4 years.
We reviewed 1) biliary anatomy and reconstruction method, 2) biliary
complication and contributing factors.
Results. According to Couinaud classification on biliary anatomy, type 1 is
most common type (70.6%). The reconstruction method depended on
anatomical type and umber of lumen but the most of cases were recon-
structed end to end anastomosis fashion, single or double after ductoplasty in
case of multiple lumens. The biliary complication consisted of leakage
(15.2%) and stricture (15.2%) and the complications were directly correlated
to the biliary anatomy. Treatment of leakage was precutaneous drainage or
conservative treatment with spontaneous healing. In cases of stricture, the
most common procedures were ballon dilatation and stent insertion through
endoscopical or percutaneous.
Conclusion. Duct to duct anastomosis can be performed in the majority of
patient and it is important to define the better plan of transaction biliary tree
to obtain one lumen of biliary tract, which coule be reduce biliary
complication.
P23.66
EXPERIENCE OF DONOR OPERATION IN ADULT LIVING
DONOR LIVER TRANSPLANTATION USING THE RIGHT LOBE
Kim, Dong-Goo; Lee, Che-Young; Kim, Se-Joon; Cho, Je-Young; Lee,
Myung-Duk
Catholic University of Korea, Surgery, Seoul, Korea
Background. This paper is to review our experiences with donor hepatect-
omy in living donor liver transplantations (LDLT) using the right lobe,
particularly in the context of preserving donor safety.
Methods. From January 2000 to August 2005, 206 donor operations for
adult LDLT using the right lobe, were performed. The donor characteristics,
operative findings, postoperative results including the peak value of liver
enzymes (AST, ALT, and bilirubin) and regeneration volumes, as evaluated
by CT volumetry, were reviewed at 1 week, 3 month and 6 month after
surgery. The effects of three risk factors on donor safety were analyzed:
age(B/55 years, ]/55 years), fatty change of donor liver(B/10%, ]/10%) and
remained volume(B/35%, ]/35%).
Results. The liver enzymes and regeneration volumes showed no significant
difference according to age but only ALT was significant increased based on
the severity of fatty change (PB/.05). There were significant differences in
postoperative AST, ALT, regeneration volume between the group with B/
35% and the group with ]/35% remnant liver volume (PB/.05). In further
analysis with a combination of two out of three risk factors, grouping
according to the remained volume and fatty change was meaningful. The
follow up data of donor with ALT returned normal level and remained liver
was regenerated more than 70% of preoperative whole liver after post-
operative third month. There was no donor mortality, but postoperative
complications were observed in 39 patients (39/206, 18.9%). Biliary
complications were encountered in 24 patients; 1 in bile duct injury, 22 in
bile leakage and 1 in bile duct stricture. Other complications consisted of
pleural effusion (n/8), delayed gastric emptying (n/6), atelectasis (n/1)
and hepatic encephalopathy (n/1).
Conclusion. In cases of careful donor selection, a right lobectomy can be
performed safely with minimal risks when the remnant liver volume exceeds
35% of the total liver volume and shows less than 10% fatty changes.
P23.67
LIVER TRANSPLANTATION (LT) FOR HEPATOCELLULAR CAR-
CINOMA (HCC) IN PATIENTS WITHOUT CIRRHOSIS: IS IT
WORTHWHILE?
Scatton, Olivier; Adam, Rene; Plasse, Marylene; Aloia, Thomas; Veilhan,
Luc-Antoine; Azoulay, Daniel; Samuel, Didier; Bismuth, Henri; Castaing,
Denis
Paul Brousse Hospital, Villejuif, France
Introduction. Although the indications for LT are well defined for patients
with HCC and underlying cirrhosis, those for patients with HCC and normal
liver remain unclear. HCC in patients without cirrhosis tend to be diagnosed
later and LT is usually reserved only for unresectable cases.
Objectives. The aim of the present study was to compare the outcome for
LTas a last resort treatment for unresectable HCC developed on normal liver
to that of LT for HCC in cirrhotic patients.
Methods. Of the 298 patients consecutively transplanted for HCC in a single
institution, 34 (11%) had unresectable, non fibrolamellar HCC developed in
normal liver (Group 1) and 264 (89%) had HCC with cirrhosis (Group 2).
For Group 1 patients, LT was indicated based on unresectability and for
Group 2 patients selection for LT was based mainly on the Milan criteria.
Patient and tumor characteristics were compared to outcomes following LT
to determine specific factors associated with improved outcome for Group 1
patients.
Results. Tumor number (4.99/3.9 vs 3.49/3.5- p/0.03) and their max-
imum size (799/62 mm vs 309/19 mm-pB/0.001) were higher in Group 1 vs.
Group 2 patients. After a mean follow up of 53 months, tumor recurrence
was more frequent in Group 1 than Group 2 (70% vs. 16%, pB/0.001).
Resection of recurrence was possible in 50% vs. 10% (pB/0.05), respectively.
Overall 5-and 10-year survivals were 59% vs 61%, and 41% vs 50%,
respectively (both p/NS). In group 1, tumor number and AFP level had no
impact on survivals. However, a maximum tumor size /10 cm decreased 10-
year disease-free survival (31% vs 9%, p/0.04) and resection of tumor
recurrence increased 10-year overall survival (41% vs. 9%, respectively, p/
0.04)
Conclusion. Despite significant differences in intrahepatic tumor burden,
the outcomes following LT in patients with non-cirrhotic HCC are similar to
those observed in patients with HCC and cirrhosis. HCC with normal and
cirrhotic liver are separate entities with different indications but equal
justification to be transplanted.
P23.68
EFFICACY OF RIGHT ANTERIOR SECTOR DRAINAGE RECON-
STRUCTION IN RIGHT-LOBE LIVE-DONOR TRANSPLANTA-
TION
Karademir, Sedat1; Astarcioglu, Huseyin1; Ozbilgin, Mucahit1; Ozkardesler,
Sevda2; Yilmaz, Tugbahan1; Akarsu, Mesut3; Akan, Mert2; Ozzeybek,
Deniz2; Obuz, Funda4; Astarcioglu, Ibrahim1
1Dokuz Eylul University School of Medicine, General Surgery, Izmir,
Turkey; 2Dokuz Eylul University School of Medicine, Anesthesiology, Izmir,
Turkey; 3Dokuz Eylul University School of Medicine, Gastroenterology,
Izmir, Turkey; 4Dokuz Eylul University School of Medicine, Radiology,
Izmir, Turkey
Background. Without including the middle hepatic vein (MHV) into the
right-lobe grafts, venous drainage of the anterior segment (AS) has always
been a concern. The efficacy and the necessity of additional venous
reconstruction in the AS for graft viability and function are still controversial.
Methods. Since Feb 2002, 57 right-lobe grafts were implanted in adult
recipients. The mean of graft to ideal recipient weight ratio (GRWR) was
1.3% (min:0.8%, max:2.1%). All minor venous tributaries to MHV less than
5-mm diameter were ligated. MHV tributaries were classified as; (A) no
major tributaries (n/33), (B) major tributaries; ligated (n/11), (C) major
tributaries; reconstructed (n/13). Reconstructions were established using
vascular grafts (PTF,n/8; cadaveric,n/2) or joining with right hepatic vein
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orifice (n/6). We investigated the volume of ascites, serum bilirubin,
albumin and liver enzyme levels and INR on POD4 and POD21.
Result. Two patients died on POD18 and 23. Their graft weights were 800 g
(47%; group B) and 980 g (62%; group A) respectively. One PTF and
another cadaveric vascular graft were found occluded 4 and 7 days after
implantation without any negative consequence. After 6-month, remaining
55 patients were alive with primary liver grafts and patent vascularization.
Among the three groups, no significant difference was found on POD4.
Three weeks after transplantation, the mean AST level in major-ligated group
(46.79/24.7) was significantly higher than the minor-ligated group (29.69/
17.2) but not than major-reconstructed group (33.79/12.9) (p/0.03 and
p/0.29). The mean albumin level was highest after minor-ligation (3.29/
0.5) and it was significantly better than major-reconstruction (2.79/0.3) but
not than major-ligation (3.19/0.4) (p/0.02 and p/0.13).
Conclusions. Right lobe liver grafts with GRWR of 9/0.8% may reveal
optimum graft function without of additional venous reconstruction in the
AS.
P23.69
PRE-OPERATIVE (PO) PROGNOSTIC FACTORS (PF) ON LIVER
TRANSPLANT (LT) FOR HEPATOCELLULAR CARCINOMA
(HCC): SHOULD WE EXPAND SELECTION CRITERIA?
Mira, Paulo; Santos Coelho, Joa˜o; Pinto Marques, Hugo; Nobre, Ana M;
Martins, Ame´rico; Barroso, Eduardo
Hospital de Curry Cabral, Centro Hepato-bilio-pancrea´tico e Transplanta-
c¸a˜o, Lisbon, Portugal
Introduction. Early HCC LT results equal LT for other indications. Good
results reported in LT for more advanced tumors(tm) (explanted livers).
Objectives: evaluate po selection pf influence on results of LT for HCC:
impact of Milan criteria (MC) expansion to University of San Francisco
criteria (UCSF-C), on long term survival, with or without relapse(rlp).
Methods. Retrospective analysis of 66 LT patients (PTS). 63 (95%):
cirrhosis. 28: po therapy; 11 (17%): chemoembolization (TACE). 7
(11%):/3 nodules (nd), 14 (21%): tm/5 cm. 42 PTS (64%) within MC
and 50 (72%) UCSF-C. 17 PTS (26%): domino LT. Waiting time (wt): 1
14 months. Follow-up: 372 months. Overall (os) and disease-free survival
(dfs) analyzed. pf: age, sex, etiology of cirrhosis, blood group, wt, number of
nd, larger nd size, vascular invasion, satellite nd, po alpha-fetoprotein, pre-
LT TACE, domino LT, OKUDA, CHILD, MC and UCSF-C clinical (cl)
and pathological (pt)-Kaplan-Meier, Log Rank, Cox Proportional Hazards,
ROC.
Results. Per operative mortality (B/3 months): 15.1% (10 PTS). Operative
mortality: 13.6% (9 PTS). Rlp: 13 PTS (19.7%), mainly liver. Rlp risk
factors-bivariate analysis (ba): ageB/40 years (p/0.00), UCSF-C cl (p/
0.009) and pt (p/0.002) and MC pt (p/0.002)-no significant on multi-
variate analysis (ma). 5 years os: 53%; predicted survival better when within
both MC (74% at 5 years, p/0.001) and UCSF-C (65% at 5 years, p/
0.01). Survival with cl and pt MC similar in the 2 groups (same to UCSF-C).
On ba, survival influenced by: ageB/40,/3 nd, nd size/6.5 cm, MC and
UCSF-C exclusion (cl and pt), and wt/4 months. In ma wt/4 months (p/
0.008), pt (p/0.001) and cl MC (p/0.019) exclusion influenced survival.
Conclusions. cl MC and UCSF-C allows good PTS selection for LT. One
can expand MC to UCSF-C with good results. Wt/4 months must be
avoided. Younger PTS have worse prognosis: LT done earlier. Expansion of
indications and need of earlier LT force HCC priority on waiting lists and
donor ‘‘pool’’ increase strategies.
P23.70
ROLE OF 2-[18F] FLUORO-2-DEOXYGLUCOSE POSITRON
EMISSION TOMOGRAPHY IN DETERMINING POST-ORTHO-
TOPIC LIVER TRANSPLANTATION ACUTE CELLULAR REJEC-
TION
Jones, Christopher M.1; Delbeke, Dominique2; Chari, Ravi S1
1Vanderbilt University, Hepatobiliary Surgery and Liver Transplantation,
Nashville, USA; 2Vanderbilt University, Radiology and Radiological
Sciences, Nashville, USA
Introduction. Acute cellular rejection (ACR) following organ transplanta-
tion is associated with activation of T-cells. Activated T-cells have increased
glucose uptake and utilization, analogous to that seen in some malignancies.
The aim of this study was to evaluate the effectiveness of 18[F] Fluoro-2-
Deoxyglucose Positron Emission Tomography (18F-FDG PET) in determin-
ing acute rejection in the clinical setting.
Methods. PET studies were performed on 21 orthotopic liver transplant
patients (12 men, 9 women; mean age 51///6 years) 7 and 17 days post-
operatively; an additional study was performed if patients had suspicion of
rejection. Post-transplant immunosuppression was cyclosporine (Neoral†)
with a targeted C2 level of 1000 ng/dl. Date-matched PET images for 37
non-transplant patients (52///20 years) were used as controls. Patients
fasted for a minimum of 6 hours prior to 18F-FDG administration to
maintain baseline plasma glucose and insulin levels. PET imaging was
initiated 65///10 minutes after injection of 12///2 mCi of 18F-FDG.
CT was used to place a large circular region of interest (ROI) over the liver
parenchyma for semiquantitative evaluation of PET images by means of
standard uptake values (SUVs).
Results. SUVs normalized for body weight in post liver transplant patients
measured 2.00///0.5 (p/.122); whereas, the SUVs for non-transplant
patients was 2.09///0.6 (p/.210). Three of 21 patients in our study
(14.3%) had histologically proven acute cellular rejection during a follow-up
of 30///11 days. FDG-PET images demonstrated no increased uptake in
the liver; furthermore, metabolic activity within the ROI did not differ
significantly in sequential follow-up PET images for these patients.
Conclusions. While the metabolic activity of post-transplant livers is similar
to non-transplant livers 18F-FDG PET, in its current format, does not
provide adequate sensitivity for noninvasive detection of ACR in post-
orthotopic liver transplantation.
P23.71
SURGICAL TECHNIQUES ACCORDING TO ANATOMICAL VAR-
IATION IN LIVING DONOR LIVER TRANSPLANTATION USING
RIGHT LOBE
Kim, Dong-Goo; Che-Young, Lee; Se-Joon, Kim; Je-Young, Cho; Myung-
Duk, Lee
Catholic University of Korea, Surgery, Seoul, Korea
Background. Right lobectomy has recently been shown to be safe for the
donor and has permitted the wider application of living donor liver
transplantation (LDLT). The right lobe has many anatomical variations in
the vascular and biliary tree, which could lead to surgical complications. We
need to define surgical technique according to anatomy.
Methods. From Jan. 2000 to Apr. 2004, 125 LDLTs using right lobe graft
were performed in patients with end-stage liver disease. The graft volume was
measured by CT volumetry. The vascular and biliary trees were evaluated
preoperatively with MR angiography and cholangiography. We classified
anatomical points for safe harvest in hepatic artery, portal vein and biliary
tree are described technical points based on anatomical variations.
Result. The average volume of the right lobe was 878 ml and 520 ml in the
left lobe. There were many anatomical variations in the hepatic artery, portal
vein and bile duct. Right hepatic artery arising from SMA was observed in 11
cases (type IV, 8.0%). Single end-to-end anastomosis using a microscope
were performed in all cases except two patient. Portal vein variation was
observed in 23 cases (18.4%): portal vein trifurcation (type II, 13 cases),
early branching of posterior portal vein from main portal vein (type III, 8
cases), anterior segmental branch originating from the left portal vein (type
IV, two cases). Single anastomosis in type I and single anastomosis with or
without plasty in type II was performed. Double anastomosis was performed
in type III and type IV. Bile duct variation was observed in 10 cases (12.5%):
3 cases in type II and type IV, 4 cases in type III. The biliary reconstruction
consisted of duct-to-duct anastomosis, hepaticojejunostomy and combined
method.
Conclusion. LDLT using the right lobe can be performed safety, but there is
potential operative risk because of various anatomic variants. To minimize
operative complications, anatomical variations should be kept in mind to
ensure a safe and successful operation.
P23.72
VALUE OF PATHOLOGICAL PROGNOSTIC FACTORS (PF) IN
LIVER TRANSPLANT (LT) FOR HEPATOCELLULAR CARCI-
NOMA (HCC)
Pinto Marques, Hugo; Mira, Paulo; Santos Coelho, Joa˜o; Nobre, Ana M;
Martins, Ame´rico; Barroso, Eduardo
Hospital de Curry Cabral, Centro Hepato-bilio-pancrea´tico e Transplanta-
c¸a˜o, Lisbon, Portugal
Introduction. Some tumor histological (hst) characteristics-grade of differ-
entiation (dg), microscopic vascular invasion (mvi)-seem to be indicators of
biological aggressiveness capable of influence prognosis stronger than
‘‘classic’’ selection criteria.
Objectives. To study influence of tumor hst characteristics on long term and
on disease-free survival (dfs) in patients (PTS) who had LT for HCC.
Methods. Retrospective analysis (an) of 66 LT PTS, ages: 22 to 69. 63
(95%) cirrhotic. 28 had pre-operative therapy: 11 (17%) had chemoembo-
lization (TACE). 17 (26%) had ‘‘domino’’ LT. 38 PTS (57.5%): within hst
Milan criteria (MC). 48 PTS (72.7%): within hst University of San Francisco
criteria (UCSF-C). Waiting time: 114 months. Follow-up: 372 months
(no PTS lost). Overall (os) and dfs studied. Hst factors studied as possible pf:
number of nodules (nd), larger nd size, mvi, satellite nd, presence of capsule
(pc), presence of necrosis, dg (Edmondson and Steiner), macroscopic
classification (AFIP), hst pattern classification, cellular type, T of TNM,
MC and UCSF-C-Kaplan-Meier, Log Rank, Cox Proportional Hazard
tests.
Results. Per operative mortality (B/3 months): 15.1% (10 PTS). Operative
mortality: 13.6% (9 PTS). Relapse: 13 PTS (19.7%). In bivariate an, larger
nd size (/6.5 cm), macroscopic AFIP, mvi, pc, hst pattern classification,
exclusion of MC and of UCSF-C influenced dsf. In multivariate an only
macroscopic classification (p/0.009) and pc (p/0.011) influenced relapse..
5 years os: 53%. 5 year survival of PTS within hst MC: 79%. 5 year survival
of PTS within hst UCSF-C: 73%. On bivariate an survival was influenced by:
larger nd size, macroscopic AFIP, MC and UCSF-C; on multivariate an
survival was influenced by: number of nd (p/0.012) and MC (p/0.001).
Conclusions. hst tumor characteristics may constitute important pf. In our
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series dfs was significantly influenced by the absence of capsule and by diffuse
and massive forms of AFIP. Main influences on os: number of nd (/3) and
MC exclusion.
P23.73
WHY NOT TRANSPLANT THE ‘‘BAD’’ TUMORS?
Lee, Kyeong G1; Lee, Kwang-soo1; Meyers, William C2; Ringe, Burckardt H2
1Hanyang University College of Medicine, Dept. of Surgery, Seoul, Korea;
2Drexel University College of Medicine, Center for Liver, Biliary and
Pancreas Disease, Philadelphia, Pennsylvania, USA
Introduction. Liver transplantation for bad hepatic tumors except hepato-
cellular carcinoma(Non-HCC) is still a contraindication because of disap-
pointing results. A discussion about the role of liver transplantation for non-
HCC is continued for malignant tumor including intrahepatic and hilar
cholangiocarcinoma. Can liver transplantation be surgical option for these
patients? The goal of this paper is to evaluate liver transplantation as surgical
modality.
Methods. We retrospectively reviewed clinical records of five patients that
had received liver transplantation for nonresectable non-HCC hepatic
tumors. There were 2 intrahepatic cholangiocarcinoma, 1 mixed hepatocel-
luar-cholangiocarcinoma, 1 angiosarcoma, 1 metastatic leomyosarcoma from
IVC. We analyzed the patient survival, disease free survival and tumor
recurrence, as well as the manner of recurrence.
Results. The one of two cholangiocarcinoma patients survived during 25
months and developed recurrent CCC at 12 months(lumbar spine) after
living donor liver transplantation(LDLT). The other patient developed
recurrent tumor at 11 months (previous incision site), at 32 months
(malignant pericardial effusion) after cadaveric donor liver transplanta-
tion(CDLT) and is alive for 33 months. The angiosarcoma and IVC
leiomyomasarcoma patient recurred in transplanted liver at 8 months and
12 months after CDLT. The former survival was 11 months, and the latter is
alive for 20 months. The mixed hepatocelluar-cholangiocarcinoma patient
expired at 57 days after LDLT due to sepsis.
Conclusion. Liver transplantation of the non-HCC hepatic tumors can be
justified in highly selected patients. Living donor liver transplantation can
expect the longer survival than cadaver donation because it can reduce the
risk of tumor progression and spread by long waiting time. Under these
circumstance, the ‘‘bad’’ tumors should not necessary be excluded from
transplantation.
P24.01
CHOLESTASIS PROTECTS THE LIVER FROM ISCHEMIC IN-
JURY AND POST-ISCHEMIC INFLAMMATION IN THE MOUSE
Georgiev, Panco1; Navarini, Alexander A2; Eloranta, Jyrki J3; Lang, Karl S2;
Kullak U, Gerd A3; Nocito, Antonio1; Dahm, Felix1; Jochum, Wolfram4;
Graf, Rolf1; Clavien, PA1
1University Hospital of Zurich, Dept. of Visceral and Transplantation
Surgery, Zurich, Switzerland; 2University Hospital of Zurich, Institute of
Experimental Immunology, Zurich, Switzerland; 3University Hospital of
Zurich, Division of Gastroenterology & Hepatology, Zurich, Switzerland;
4University Hospital of Zurich, Dept. of Pathology, Zurich, Switzerland
Background. Cholestasis is associated with high morbidity and mortality
rates in patients undergoing major liver surgery, but the responsible
mechanisms remain elusive. Increased ischemic liver injury and inflammation
might contribute to the poor outcome.
Aim. To investigate the impact of cholestasis on ischemic liver injury.
Methods. Common bile duct ligation (biliary obstruction with hyperbilir-
ubinemia) or selective ligation of the left hepatic duct (biliary obstruction
without hyperbilirubinemia) was performed in C57BL/6 mice prior to 1 h of
hepatic ischemia and 1, 4 or 24 h of reperfusion. Infection with the
intracellular hepatic pathogen Listeria monocytogenes for 12 and 48 h was
used to study ischemia-independent hepatic inflammation.
Results. Unexpectedly, cholestatic mice displayed significant protection
from ischemic liver injury as determined by AST release, histological liver
injury, and neutrophil infiltration. In cholestatic mice, reduced injury
correlated with a failure to activate NF-KappaB and TNF-alpha mRNA
synthesis, two key mediators of postischemic liver inflammation. After
selective bile duct ligation, both the ligated and the non-ligated lobes
displayed blocked activation of NF-KappaB as well as reduced induction of
TNF-alpha mRNA synthesis and neutrophil infiltration. In contrast, infec-
tion with Listeria monocytogenes revealed comparable activation of NF-
KappaB and hepatic recruitment of neutrophils 12 h after infection.
Conclusion. Cholestasis does not enhance but rather dramatically protect
from ischemic liver injury and inflammation. This effect is mediated by a
systemic factor, but not bilirubin, and is associated with a preserved capacity to
trigger an inflammatory response to other stimuli such as a bacterial pathogen.
P24.02
IMPACT OF PLATELETS IN THE PATHOGENESIS OF NOR-
MOTHERMIC ISCHEMIA/REPERFUSION INJURY IN THE
MOUSE LIVER
Nocito, Antonio1; Georgiev, Panco1; Dahm, Felix1; Graf, Rolf1; Moritz,
Wolfgang1; Jochum, Wolfram2; Odermatt, Bernhard2; Clavien, PA1
1University Hospital of Zurich, Dept. of Visceral and Transplantation
Surgery, Zurich, Switzerland; 2University Hospital of Zurich, Dept. of
Pathology, Zurich, Switzerland
Background. One of the hallmarks of hepatic ischemia and reperfusion (I/R)
is the formation of leukocyte-platelet aggregates. Upon activation, platelets
generate reactive oxygen species and release proapoptotic and proinflamma-
tory mediators as well as growth factors. In cold hepatic ischemia adhesion of
platelets to endothelial cells mediates sinusoidal endothelial cell apoptosis.
Furthermore, platelet derived serotonin mediates liver regeneration. We
therefore hypothesized that platelets might be mediators of reperfusion injury
after normothermic hepatic ischemia.
Objective. The aim of this study was to investigate the role of platelets in
normothermic hepatic I/R injury in a model of platelet dysfunction and in
immune thrombocytopenia.
Methods. Inhibition of platelet aggregation in mice was achieved by
Clopidogrel feeding. Immune thrombocytopenia was induced by intraper-
itoneal injection of anti-CD41 antibody. All mice were subjected to sixty
minutes of partial hepatic ischemia and various timepoints of reperfusion.
Hepatic injury was determined by aspartate aminotransferase and histological
analysis of necrotic area and leucocyte infiltration. Furthermore, in platelet
depleted animals and in mice lacking peripheral serotonin, liver regeneration
was determined by immunohistochemistry.
Results. Neither inhibition of platelet aggregation nor platelet depletion led
to an improvement of I/R injury. In contrast, liver regeneration and
remodelling were significantly impaired in platelet depleted animals, whereas
mice lacking peripheral serotonin were only deficient in liver regeneration.
Conclusion. Platelets have no direct impact on the pathogenesis of
normothermic I/R-injury, however they mediate tissue remodelling and liver
regeneration. In addition, platelet derived serotonin is a specific mediator of
regeneration in the postischemic liver.
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REPEAT HEPATECTOMY: ANALYSIS OF MORBIDITY, MOR-
TALITY AND SURVIVAL
Bergamini, Silvina G; Bilbao, Itxarone; La´zaro, Jose´ Luis; Escartin, Alfredo;
Lo´pez de C, In˜igo; Ballsels, Joaquin
Hospital Vall d?Hebron, Hepatic Surgery Unit, Barcelona, Spain
Background. Increased morbility (Mb) and mortality (Mt) have been
reported after repeat hepatectomy (ReH), and the long-term benefit needs to
be evaluated: Is a worthwhile operation?
Objective. Analyze the short and long-term results of ReH in comparison to
first hepatectomy in our experience, in orden to assess the expected risk-to-
benefit ratio.
Methods. We review the data base of 618 hepatectomies (H) performed
between 1988 and 2005: 580 first H and 38 ReH in 35 patients (third H in 3
patients), with ages ranging from 26 to 82 years (mean 60). We analyze peri-
operative Mb and Mt, survival and disease-free survival.
Results. Indication for ReH was metastasis in 64% of cases (colorectal origin
in 86%) and primary tumor in 33% (90% hepatocarcinoma). Hepatic
parenchyma was normal in 64% and cirrhotic in 15%. The mean interval
between hepatic resections was 21.5 months (range 275 m). There was no
intraoperative Mt and blood transfusion was required in 50% of cases (mean of
2.5 units). Postoperative Mt (B/30 days) was 6% and complications incidence
was 30% (1 haemorrhage, 1 intestinal fistula, 1 biliary fistula, 3 autolimited
biliorrhagia, 5 mild hepatic insufficiency). Hospital stay was 14///9 days. In
comparison with first H, was not significative differences in operative bleeding,
Mt at 30 days (7%) or Mb (36%), with similar hospital stay (mean 12 days).
Mean survival and disease-free survival after ReH was 33.3 and 26.7 months,
respectively, lower for hepatocarcinoma group than metastasis group. Actuar-
ial patient survival at 1, 2 and 5 years for all ReH was 68, 46 and 27%,
respectively (similar to first H serie). For group of hepatocarcinoma was 58, 35
and 12%. For metastasis group was 83, 66 and 33%.
Discussion. Our results in ReH are comparable with the ones obtained after
the first H in terms of Mb, Mt and survival. ReH is a relatively safe technique
with low risk and acceptable long-term survival.
Conclusion. In appropiately selected patients, ReH es a worthwhile
operation, a viable option of treatment.
P24.04
THE ROLE OF RADIOFREQUENCY ABLATION (RFA) ASSISTED
LIVER RESECTION IN OBTAINING NEGATIVE MARGINS: A
PRELIMINARY REPORT
Prassas, Evangelos; Papaconstantinou, Ioannis; Kontos, Michael; Karavo-
kyros, John; Petrou, Athanasios; Pikoulis, Emmanouil; Klonaris, Christos;
Bakogiannis, Christos; Griniatsos, John; Giannopoulos, Athanasios; Bastou-
nis, Elias; Felekouras, Evangelos
Laiko General Hospital, 1st Dept. of Surgery University of Athens, Athens,
Greece
Background. To evaluate the surgical margin status in RFA (Radionics
Cooltip, Tyco Healthcare Group LP, USA) assisted liver resection for hepatic
malignancy which has never been done before
Methods. This prospective study was contacted to examine the role of RFA
assisted liver resection in obtaining negative margins. Twenty six patients
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underwent 35 RFA assisted liver resections. The indications for hepatectomy
was hepatoma in 15 patients, cholangiocarcinoma in 4 and metastatic tumors
from colorectal cancer and other primaries in 14 patients. In all patients upon
completion of the resection the specimen was sent to pathology as usual
(group A), and 1 cm of the ablated rim of remain liver tissue was excised and
sent to pathology to examine the status of the remaining margins (group B).
The group B margin status compared with the historic control group of
classic liver resection which consists of 45 liver resections of similar
distribution (non RFA assisted liver resection, group C)
Results. On final pathology, margin status of the regular specimens
(group A) was positive in 1/26 (3,84%) cases, less than 10 mm in 2/26
(7,69%) and negative in the rest 23/26 (88,46%). The final pathology of the
‘‘healthy rim of liver tissue’’ was found positive in 4/26 (15,38%) cases and
negative in 22/26 (84,61%). All cases found with positive margin or with less
than 10 mm margin (3/26) in the regular specimen were also found positive in
the pathology of the group B. So, the false negative margins (less than 10
mm) were 3/26 (11,53%). Comparing the group B with group C, the real
negative margins (/1 cm) are 22/26 (84,61%) for group B and 26/45
(57,77%) in group C, a difference which is although slightly, statistically
significant (X2 test, P/0,043)
Conclusions. Our results suggest that real negative margins (greater than 1
cm) can be achieved better with RFA assisted liver resection than the classic
techniques.
P24.05
3 DIMENSIONAL RELATIONSHIP OF LEFT HEPATIC ARTERY
TO PORTAL VEIN AND BILE DUCT-ANALYSIS BY THE 3
DIMENSIONAL INTEGRATED IMAGE
Sakai, Hisamune; Okuda, Koji; Kinoshita, Hisafumi; Aoyagi, Shigeaki
Kurume University School of Medicine, Dept. of Surgery, Kurume City
Fukuoka, Japan
Background. Intra and extra hepatic vasculatures have a lot of anatomical
variations. Preoperative understanding of individual variation of these
vasculatures is essential to achieve safe and curative resection. MD-CT offers
vast and reliable data of anatomical information.
Aim. We evaluated 3D ramification pattern of the left hepatic artery related
to the portal vein and bile duct in the left liver, by 3D CT integrated image of
the hepatic artery, portal vein and bile duct.
Methods. Intravenously enhanced dynamic CT combined CT cholangio-
graphy or DIC CT was performed in 41 patients, and 3D integrated images
was constructed by 3D respective image of the bile duct, portal vein and
hepatic artery.
Results. Ramification of the Left hepatic artery (LHA) were divided into 9
types. In 32 (78%) of the 41 patients, A4 joined to LHA: A2,A3/A4 in 15
patients (36%), A4, A2/A3 in 11 patients(26%). A4 joined to the right
hepatic artery(RHA) in 9 patients (22%). Aberrant LHA in 9 patients (22%).
There is specific type of LHA variation, A2 joined to A4, and A2 joined to
RHA as the middle hepatic artery. In 35 patients (85%) LHA run beside the
left side of the umbilical portion(UP), in 6 patients (15%) beside the right
side of the UP. In the later attention should be to avoid artery injury in during
right trisegmentectomy of the liver, especially bile duct resection at peripheral
site.
Conclusion. Understanding 3D anatomical variations of the left hepatic
artery avoids intra-operative risk of arterial injury, and is enable to curative
resection. 3D CT integrated image was useful to understand vascular
variations.
P24.06
A META-ANALYSIS OF CLINICAL OUTCOME FOLLOWING
FIRST AND SECOND LIVER RESECTION FOR COLORECTAL
METASTASES
Welsh, Fenella1; Antoniou, Anthony2; Lovegrove, Richard2; Tekkis, Paris2;
Tilney, Henry2; Darzi, Ara2; Heriot, Alexander2; John, Timothy1; Rees,
Myrddin1
1North Hampshire Hospital, Dept. of Hepatobiliary Surgery, Basingstoke,
UK; 2St Mary’s Hospital, Dept. of Biosurgery and Surgical Technology,
London, UK
Background. Despite favourable reports, the role of repeat hepatic resection
for patients with recurrent colorectal liver metastases (CLM) remains
controversial.
Aims. A meta-analysis was performed to seek consensus regarding the peri-
operative risk and long-term survival benefit of repeat hepatectomy in
patients with recurrent CLM and to compare the outcomes with those of
first liver resection.
Methods. A literature search interrogated Medline, Embase, Ovid, and
Cochrane databases for studies published up to January 2006 comparing
outcomes following first and second liver resections for CLM. Defined
endpoints included morbidity and mortality, disease recurrence and survival.
A random-effect model was used to aggregate the endpoints and assess
heterogeneity.
Results. Twenty one studies comprising 3741 patients who underwent their
first liver resection for CLM between 1971 and 2005 satisfied the inclusion
criteria. Of these, 892 (24%) underwent a second liver resection for recurrent
disease. The use of adjuvant chemotherapy was similar in both groups [p/
0.92], as was the number of hepatic nodules present at the time of first or
second resection [p/0.38]. Compared with repeat hepatectomy, first liver
resections were associated with a significantly lower incidence of wedge
resections [39% versus 46%] [odds ratio (OR) 0.66, p/0.05] and lower
blood loss [weighted mean difference /238 ml, p/0.002]. There was no
difference in peri-operative morbidity [OR 1.01, p/0.98], mortality [OR
1.01, p/0.99] or long-term survival [hazard ratio 0.90, p/0.53] between
groups.
Conclusions. Repeat hepatectomy in patients with recurrent CLM may be
performed safely with survival benefit equivalent to that of a first liver
resection. In the absence of other proven therapies, repeat hepatectomy
remains the treatment of choice for selected patients with resectable disease.
P24.07
A NEW TECHNIQUE FOR LAPAROSCOPIC HEPATECTOMY:
LAPAROSCOPIC HEPATECTOMY BY CURETTAGE AND AS-
PIRATION (LHCA)
Cai, Xiujun; Peng, Shuyou; Yu, Hong; Liang, Xiao; Wang, Yifan; Huang,
Diyu; Zhen, Xueyong
Sir Run Run Shaw Hospital, College Of Medicine, Zhejiang University,
General Surgery, Hangzhou, China
Background. Laparoscopic abdominal surgery is a minimally invasive
technique resulted in less postoperative pain and faster postoperative
recovery, and laparoscopic hepatectomy is still a new procedure and it was
only performed in a few large institutions worldwide.
Objective. To introduce an effective and safe technique for laparoscopic
hepatectomy: Laparoscopic hepatectomy by curettage and aspiration
(LHCA).
Methods. From August 1998 to February 2006, we had performed 87
laparoscopic hepatectomies using this technique, including 48 anatomical
hepatectomy (45 left lateral segmentetomy, 1 right hemihepatectomy, and 2
left hemihepatectomy) and 39 non-anatomical hepatectomy. A special
instruments (Laparoscopic peng’s multifunction operative dissector,
LPMOD) developed by ourselves was used for transacting liver parenchyma.
Results. The operation of LHCA was completed in 86 patients. Two patients
had to be converted to an open hepatectomy. Mean operating time was 150.9
min (range 40 to 305 min) and mean operative blood loss was 462.3 ml
(range 10 to 2000 ml). All the patients had bedside activity in 24 hours after
operation. The average length of postoperative hospital stay was 7.4 days
(range 1 to 18 days). There was no mortality. Complication occurred in 3
patients.
Conclusion. Our experience leads us to believe that laparoscopic hepatect-
omy by curettage and aspiration is a safe and effective technique for resection
of liver lesions.
P24.08
A SHIFT IN THE RATIO OF N-3/N-6 POLYUNSATURATED FATTY
ACIDS CORRELATES WITH MICROCIRCULATORY DEFECTS
AND ENHANCED ISCHEMIC INJURY IN THE MACROSTEATO-
TIC MOUSE LIVER
Osman, Ashraf; Moritz, Wolfgang; Tian, Yinghua; Clavien, PA
University Hospital of Zurich, Dept. of Visceral and Transplantation Surgery,
Zurich, Switzerland
Background. Macrovesicular hepatic steatosis has a lower tolerance to
ischemic injury than microvesicular steatosis; both have different n-3/n-6
polyunsaturated fatty acid (PUFA) ratios. The impact of PUFA content in
steatotic livers before and after normothermic ischemic injury is unknown.
Materials and Methods. Hepatic content of n-3 and n-6 PUFAs was
investigated in two different models of steatosis: ob/ob mice as a model of
macrovesicular and wild type mice fed a choline deficient diet for micro-
vesicular steatosis. Steatotic and lean livers were subjected to 45 min ischemia
and 3 h reperfusion. Using intravital fluorescent microscopy, microcircula-
tion was assessed by determination of sinusoidal perfusion rate, functional
sinusoidal density, leukocyteendothelial cell interactions and phagocytic
activity of Kupffer cells. In another set of experiments, ob/ob mice were
fed an n-3 PUFA enriched diet and compared to ob/ob mice on control diet.
Results. Comparing lean and microsteatotic livers, macrosteatotic livers had
significantly lower n-3 PUFAs contents correlating with microcirculatory
dysfunction, before ischemia and after reperfusion. Supplementation of ob/
ob mice with enriched n-3 PUFA diet resulted in significant rise in hepatic
content of n-3 PUFAs. The correction of n-3/n-6 PUFA ratio correlated with
significant improvement of hepatic microcirculation before ischemia. Follow-
ing reperfusion, microcirculatory failure was significantly ameliorated with a
reduction of Kupffer cell activity and hepatocellular injury.
Conclusion. Macrosteatotic livers have reduced content of n-3 PUFA that
correlates with microcirculatory defect before ischemia and enhanced injury
following reperfusion. Pre-operative dietary supplementation with n-3
PUFAs protects macrosteatotic livers against ischemic injury via improving
microcirculation. However, protective strategies applied during or after
ischemia are unlikely to be successful.
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ANATOMICAL RESECTION OF RIGHT LIVER SEGMENTS: IN-
TRAHEPATIC ACCESS IN 102 CONSECUTIVE PATIENTS
Machado, Marcel Autran1; Herman, Paulo2; Makdissi, Fabio F.1; Bacchella,
Telesforo1; Machado, Marcel C C1
1University of Sao Paulo, Surgery, Sao Paulo, Brazil; 2Cancer Hospital,
Abdominal Surgery, Sao Paulo, Brazil
Background. The indications for segmental liver resections are increasing.
This type of procedure can be done by deep wedge transparenchymal
transection or by the intrahepatic approach reaching the portal pedicle
through hilar plate.
Aim. To present a systematized technique of right segmental liver resection.
Methods. The technique consists in perform three small incisions around
hilar plate. In a standardized way, it is possible to reach the right posterior
and anterior sheaths combining these incisions. This technique was used in
102 consecutive right-sided liver resections between July 2001 and January
2006. There were 53 men and 49 women with mean age of 58 years. Fifty-
two patients presented liver metastasis, 36 primary liver cancer, ten benign
lesions and four gallbladder cancer.
Results. Right segmental liver resection was feasible using the proposed
technique in every patient of this series. Intraoperative blood loss was
minimal in all cases and fourteen patients (13.7%) received blood transfu-
sion. There was no postoperative death.
Conclusions. This operative procedure standardizes the intrahepatic ap-
proach to the right portal pedicle for right segmental resections and right
hepatectomy. It may reduce the bleeding at the site of hilar plate incisions, the
need for main hepatic pedicle clamping and may facilitate the recognition of
right posterior and anterior sheaths, with excellent immediate results.
P24.10
CARCINOID LIVER METASTASES: WHAT IS THE LIMIT FOR
RESECTION?
Sisco, Pablo; Mazzucco, Juan; Perrone, Nora; Pagliarmo, Gustavo
Pirovano Hospital, Buenos Aires, Argentina
Background. While we know that when we diagnose hepatic metastases the
disease is advanced, the natural history of carcinoid metastases differs greatly
from that of other tumors. Several papers report hepatectomies due to
carcinoid metastases; however, it is not yet clear what benefit the multiple
metastasectomy provides for such pathology.
Aim. To show the benefit achieved in a patient we treated for 68 small bowel
carcinoid metastatic lesions.
Patient and methods. In July 2004 we received a 61-year-old male patient
who was incidentally found to have multiple liver lesions and steatosis in an
US. His general condition was good, with non-specific symptoms, normal
laboratory results and cardiologic evaluation within the physiologic range.
Considering it a carcinoid, we requested video-UGIE, VCC, chest, abdomen
and pelvis CTscan, 5HIAA and plasmatic serotonine; all of them were
normal. We later carried out a diagnostic and staging laparoscopy with a
positive hepatic tumoral biopsy for carcinoid. After that, an octreoscan,
which showed the liver illness and its bowel location, and a new serotonine
assessment, which was increased, were performed.
Results. Forty-five bilobar metastasectomies were carried out assisted by
intraoperative US to treat 53 hepatic lesions; the other 15, considered
unresectable (through metastasectomy) due to their localization, were treated
with RFA and alcoholization (both methods in 3).
Discussion. The laparoscopy allowed us to perform the histological
diagnosis, and to plan the surgical strategy. Controversy focused on the
challenge of the surgical treatment due to the infrequent appearance of
carcinoids and scarce bibliography to support a prolonged and risky surgery.
Conclusions. Indication of multiple metastasectomy was effective in
combination with RFA and alcoholization in order to preserve hepatic
parenchyma for a possible re-resection. At present, the patient is being
treated with somatostatin and imaging does not show progression of the
disease or carcinoid syndrome.
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BENEFICIAL EFFECT OF EDARAVONE AFTER MAJOR HEPA-
TECTOMY USING INTERMITTENT PRINGLE’S MANEUVER IN
SWINE
Shimoda, Mitsugi; Iwasaki, Yoshimi; Sawada, Tokihiko; Kubota, Keiichi
Dokkyo Medical University School of Medicine, Dept. of Surgery, Mibu,
Tochigi, Japan
Objective. Ischemia-reperfusion injury (I/R) is widely accepted as a
significant source of morbidity and mortality in the liver surgery. However,
the mechanism of the I/R is still unclear and it is problem how to protect liver
against I/R after major hepatectomy. We investigated the effect of free radical
scavenger, edaravone is a swine liver resection of reperfusion mode,l to
evaluate its possible therapeutic effects on hepatic I/R injury.
Methods. Swines (n/10) were divided into two groups (edaravone group:
Group I and none edaravone group: Group II). A left hemihepatectomy was
performed using IPM (cycles of 15-min ischemia and 5-min reperfusion) in
all swines. In the group I, edaravone was injected intravenously during liver
resection (3 mg/kg/hr, Mitsubishi Welphama, Osaka, Japan). Hemodynamic
change and plasma concentrations of aspartate aminotransferase (AST),
lactae dehydrogenase (LDH), lactic acid (LA) and hyaluronic acid (HA) were
measured at each observation period (60, 120, 180 minutes). Apoptotic
findings (TUNEL staining and electron microscope), plasma tumor necrosis
factor-alpha (TNF-alpha) and NO2- /NO3- were evaluated after hepatect-
omy for 180 min.
Results. There were no significant differences in the body weight, blood loss,
resected liver weight, Pringle time and hemodynamic change between the two
groups. Group I was significantly reduced plasma NO2- /NO3- levels after
hepatectomy for 180 min (Group I: 38.9///7.2 vsGroup II: 91.9///40.6
mmol/l, p/0.02). Plasma levels of GOT (group I:165///32.3 vs group
II:199.40///37.5 IU/l P/0.1591), TNF-alpha (group I:277.6///183.2
vs group II:760.4///977.9 pg/ml P/0.3095) in the group I tended to be
lower than those in the group II. Apoptotic cells were significantly fewer in
the group I than in the groups II.
Conclusions. Edaravone with intermittently Pringle’s maneuver resulted in
less hepatic injury and apoptotic cell death, compared with control.
Edaravone with intermittent hepatic pedicle clamping has a potential to
reduce I/R in clinical settings.
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BENEFIT OF THORACOABDOMINAL APPROACH ON HEPA-
TECTOMY
Nakayama, Hisashi; Takayama, Tadatoshi; Inoue, Kazuto
Nihon University School of Medicine, Dept. of Digestive Surgery, Tokyo,
Japan
Background. The key to safe successful hepatectomy is sufficient exposure
of the liver with a large skin incision. In this study, we evaluated the effect of
thoracoabdominal approach on hepatectomy.
Methods. The subjects were 396 patients with hepatocellular carcinoma
(HCC) who underwent hepatectomy between 1990 and 2004. Thoracotomy
was performed in 121 patients. For statistical analysis, the Chi-square test, t-
test, and log-rank test were used.
Results. In the thoracotomy group, there were no significant differences
in gender, hepatitis B surface antigen positivity, hepatitis C antibody
positivity, smoking habit, or the presence of hypertension and diabetes.
Furthermore, there were no significant differences in the value of indocyanine
green retention rate at 15 minutes. Wedge resection, subsegmentectomy,
segmentectomy, bi-segmentectomy, and tri-segmentectomy were performed
in 52, 36, 13, 16, and 4 patients in the thoracotomy group, with no significant
differences in proportion compared with the non-thoracotomy group. The
operation time (pB/0.001) and volume of blood loss (p/0.03) were
significantly higher in the thoracotomy group, but no significant difference
was noted in the red blood cells transfusion rate. The maximum diameter of
HCC was significantly larger in the thoracotomy group (p/0.006). There
were no significant differences in the proportion of chronic hepatitis or
cirrhosis in the non-cancerous liver tissue between the 2 groups. The
incidence of
minor postoperative complications was significantly higher in the thoracot-
omy group (pB/0.001). However, there were no significant differences in the
incidence of fatal complications or hospital mortality rate between the
2 groups. While no significant difference was noted in the 5-year survival
rate (p/0.9), many patients survived for a long time in the thoracotomy
group.
Conclusion. For large HCCs, aggressive resection with thoracoabdominal
approach may improve the outcomes.
P24.13
BLOODLESS LIVER RESECTION FOR HILAR CHOLANGIO-
CARCINOMA USING TISSUELINK AND ULTRASONIC SURGI-
CAL ASPIRATOR:PRELIMINARY RESULT
Fung, Ting P; Lam, Siu H
United Christian Hospital, Dept. of Surgery, Hong Kong, China
Introduction. Surgical resection for hilar cholangiocarcinoma resulted in
significant blood loss. In order to reduce blood loss, inflow occlusion with
Pringle’s maneuver was inevitable even after extrahepatic inflow control of
the resected side. Both blood loss and ischemic insult to liver remnant are
important adverse factors.
Aim. To review the result of using combined technique (Tissuelink
and Ultrasonic surgical aspirator) for hilar cholangiocarcinoma liver resect-
ion.
Method. Starting from 2005, we adopted the two surgeons techniques in
using TissueLink to pre-coagulate the liver parenchyma and seal tiny vessels.
Ultrasonic surgical aspirator was used to dissect the large vessels, bile duct
and these structures were either ligated or clipped and divided subsequently.
There were 6 patients with hilar cholangiocarcinoma undergoing liver
resection using this technique. The blood loss and operative time were
reviewed and the results were compared to 6 other hilar cholangio-
carcinoma case undergoing resections with ultrasonic dissector and Pringle’s
maneuver.
Result. There is no difference in the operative time, blood loss. Conclusion:
This combined technique in liver resection for hilar cholangiocarcinoma
appears to be technically safe. It theoretically minimizes the blood loss during
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transaction and minimizes the ischemic insult to the remnant liver. This
combined technique should complement hepatobiliary surgeons existing
armamentarium in hilar cholangiocarcinoma. Comparative studies with
conventional instruments are warranted to further define the role of this
devices combination in resection of hilar cholangiocarcinoma.
P24.14
BLUNT LIVER INJURIES: A NEW INJURY MECHANISM DRIVEN
CLASSIFICATION
Scheingraber, Stefan; Kollmar, Otto; Richter, Sven; Igna, Dorian; Schilling,
Martin
Univ. Saarland, Homburg, Dept. of Surgery, Homburg/Saar, Germany
Introduction. Current liver trauma classifications do not include mechan-
isms of injury and lack directives for surgical or conservative treatment.
Aim. We here present a novel classification of liver injuries following motor
vehicle accidents (MVA) that include the trauma vector and might aid in the
stratification of treatment.
Patients and methods. Between 01/02 and 08/05 438 patients underwent
laparotomy for hepatic pathologies, including 23 patients with blunt liver
trauma. Clinical and operative data including outcome were analysed and
correlated to the trauma vector and associated injuries. Liver trauma was
classified according to Moore und Mirvis and the ISS was calculated. CT
scans were also correlated with intraoperative findings.
Results. 2 characteristic patterns were identified: Type A injuries along the
falciform ligament, including rupture of segments 4a/b, 3 and 2 and type B
injuries along the retroperitoneal attatchements of the posterior sector. Type
A injuries were associated with a frontal force vector, type B injuries mostly
with falls or complex trauma. Type B injuries were associated with a higher
Moore-Score (3,59/0,4 vs. 2,39/0,3) and a higher ISS (25,99/2,9 vs. 19,19/
5,0). Type A injuries in this series were not associated with any mortality, but
3 patients with type B liver injury died (1 due to the liver injury).
Conclusion. This novel classification is highly associated with the force
vector and might guide surgical treatment inasfar as type B injuries (/grade
2) frequently require surgical therapy and are more live threatening than type
A injuries.
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COMBINED SALINE-LINK RADIOFREQUENCY PRECOAGULA-
TION AND ULTRASONIC ASPIRATION TECHNIQUE FOR HE-
PATIC PARENCHYMAL TRANSECTION: INITIAL EXPERIENCE
Khan, Aamir Z; Bann, Simon; McCall, James; Mudan, Satvinder S
Royal Marsden Hospital, HPB Surgery, London, UK
Background. With recognition of its benefits, there has been a trend towards
minimizing blood loss during hepatic parenchymal transection but no one
technique has been shown to be superior to another.
Aims. To analyze our experience with using a novel combined technique of
saline-linked radiofrequency pre-coagulation and ultrasonic aspiration for
hepatic parenchymal transection.
Patients and methods. This combined technique was used in 11 patients
for hepatic parenchymal transection for metastatic hepatic disease and data
was collected prospectively. Total blood loss, bile leaks, parenchymal
transection time, hepatic pedicle clamp requirement and 30 day mortality
were used as outcome measures.
Results. Three minor and 8 major hepatic resections were performed in
eleven patients using intraoperative ultrasound of whom two underwent a
synchronous resection of the rectum. The mean blood loss was 720 mls in
these patients who had a mean postoperative stay of 10 days (714). No
patient required portal triad clamping at anytime and there were no bile leaks
or mortality.
Conclusion. Combined technique of saline-link radiofrequency ablation and
ultrasonic aspiration appears to be comparable to other techniques and
should be considered as an alternative. Larger series are needed before firm
conclusions can be made.
P24.16
COMPARISON OF FOUR DIFFERENT FIBRIN SEALANT METH-
ODS FOR HEMOSTASIS AFTER HEPATECTOMY
Asano, Takayuki; Satoshi, Koizumi; Yuji, Jinnouchi; Takeshi, Asakura;
Hiroshi, Nakano; Ootsubo, Takehito
St. Marianna University School of Medicine, Dept. of Gastrointestinal and
General Surgery, Kawasaki, Kanagawa, Japan
Objective. The objective of this study is to investigate the organization
sticking of the fibrin sealant in an experimental liver surgery model in
rabbits.
Methods. A partial liver resection was performed in four rabbits, and the
wound area covered with four different method of fibrin sealant. Four
application methods were examined in four groups. For Group 1, 1 ml each
of Solution A (fibrinogen) and B (thrombin) were simply sprayed over the
wound surface (spray methods). For Group 2, a small amount of 170%
concentrated Solution A was rubbed into the wound surface and then the
Solution B was sprayed over the wound surface (rubbing methods). For
Group 3, the fibrinogen powder was rubbed into the wound surface
and then the Solution B was sprayed over the wound surface (rubbing
methods). For Group 4, 1 ml each of Solution A (made with physiological
saline) and B were simply sprayed over the wound surface (spray methods).
Results. The wound surface was to ensure hemostasis, no postoperative
hemorrhage was observed in all method, indicating successful hemostasis
throughout. The rubbing methods were significantly sticking to wound
surface compared with the spray methods.
Conclusion. The sealing effect of fibrin sealant on hemostasis after hepatect-
omy was significantly greater with the rubbing method than with the spray
method. The strong sealing effect obtained with the rubbing method is thought
to result from firm linkage between the wound surface and the fibrin.
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DESCRIPTION OF A NEW MULTIPROBE BIPOLAR RADIOFRE-
QUENCY DEVICE (HABIB† 4X) TO ASSIST LIVER RESECTION
Ayav, Ahmet; Dickinson, Robert; Jiao, Long; Weber, Jean-Christophe;
Milicevic, Miroslav; Pellicci, Ricardo; Tracey, Jackie; Bachellier, Philippe;
Habib, Nagy
Hammersmith Hospital, HPB Surgery, London, UK
Background. Coagulating liver parenchyma with monopolar radiofrequency
before cutting with a knife has been already described, but it is time consuming
and carries the risk of grounding pad skin burn. A novel bipolar multiprobe
radiofrequency device (Habib† 4X) has been designed to counter these
drawbacks.
Objective. To evaluate the effectiveness of liver resection assisted with this new
device.
Methods. We prospectively evaluate the effectiveness of the Habib† 4X in
clinical practice. The Habib† 4X is a hand-held electro-surgical instrument
and consists of a 2/2 array of four needles. Pairs of needles are connected
together, and each pair is connected to one terminal of a bipolar RF generator.
Thirty eight consecutive patients underwent liver resection assisted with the
Habib† 4X. Data were collected prospectively to assess the outcome including
operative time, intraoperative blood loss, blood transfusion requirement,
morbidity and mortality rates, liver function tests and hospital stay.
Results. There was 30 minor and 8 major hepatectomies. The mean
parenchyma transection time was 369/25 min and the mean transection
time per cm2 was 329/27 sec. The mean blood loss during parenchyma
transection was 659/49 mL and the mean volume of bleeding per cm2 was 4.79/
6.1 mL. No patient required hepatic inflow occlusion. Only one patient
required blood transfusion. No patient developed ground pad skin burn. There
was no mortality and the morbidity rate was 14%. Mean hospital stay was
89/3 days.
Conclusion. This novel multiprobe bipolar radiofrequency device allows to
perform liver resection with minimal blood loss, low blood transfusion
requirement and reduced mortality and morbidity rates. One of the major
advantage of this technique is that it allows the liver surgeon to perform non-
anatomical resection and therefore to diminish significantly the number of
major hepatectomies.
P24.18
EFFECTS OF A HIGH-FAT DIET WITH PUFAS-v-3 IN EXPERI-
MENTAL LIVER ISCHEMIA AND REPERFUSION IN RATS
Coelho, Ana MM; Andraus, Wellington; Sampietre, Sandra N; Molan, Nilza
AT; Alexandre, Alcione S; Leita˜o, Regina; Bacchella, Telesforo; Machado,
Marcel CC
University of Sa˜o Paulo, Surgery, Sa˜o Paulo, Brazil
Introduction. Hepatic ischemia-reperfusion (I/R) is associated with hepato-
cellular injury and distant organ dysfunction. Previous studies have demon-
strated that a high-fat diet enriched with polyunsaturated fatty acids (PUFAs-
v-3) has a protective effect on the liver, causing only mild liver steatosis.
Therefore, a high-fat diet enriched with PUFAs (fish oil) could be effective on
hepatic and pulmonary disturbances associated with hepatic ischemia-reperfu-
sion injury.
Methods. Thirty-one Wistar rats were divided in 2 groups: Group I (n/
17):rats with fatty liver induced by high-fat diet enriched with PUFAs-v-3 for 4
weeks and Group II (n/14):received standard diet. Ten rats of group I and
seven of group II were submitted to I/R. Hepatic mitochondrial oxidation and
phosphorylation, serum aminotransferases (AST, ALT) and hepatic tissue
histology were determined. The evaluation of the pulmonary lesions was done
using the Evans blue test and mieloperoxidade activity.
Results. In the animals with fatty diet it was observed mild liver steatosis in
the periportal zone, compared to group with a standard diet. Comparing
the groups submitted to I/R, there was an increase in state 3 respiration
(88.389/15.01 vs. 26.339/7.50), in the respiration control rate (2.869/0.59
vs. 1.559/0.36), and the ADP/O ratio(1.729/0.18 vs. 1.219/0.16) in the
group with a high-fat enriched with PUFAs-v-3 diet in relation of group II,
with a standard diet (pB/0.05). The PUFAs-v-3 enriched diet group had
also lower levels of AST:10879/775 vs. 66079/806; ALT:13339/892
vs. 71329/ 1102 and the histological findings were significantly less
intense (pB/0.05). The pulmonary lesion didn’t show difference between the
groups.
Conclusion. The results suggest that a high-fat diet enriched with poly-
unsaturated fat (v-3) may have a protective effect in hepatic ischemia-
reperfusion injury, probably due to PUFAs-v-3 capacity to reduce inflamma-
tory response and the production of reactive oxygen species in the liver.
156 Abstracts
P24.19
EFFICACY OF 2-COMPONENT FIBRIN SEALANT IN CONTROL-
LING FLUID DRAINAGE FROM LIVER RESECTION SURFACE
POSTOPERATIVELY-A RANDOMIZED STUDY
Gunasegaram, Aravin; Chu, Francis; Morris, David
St George Hospital Campus, University of New South Wales, Dept. of Surgery,
Sydney, Australia
Introduction/Aims. Abdominal fluid collection and bile leak are significant
problems during the post-operative period in liver resection often approaching
30% and 10% respectively. 2-component fibrin sealant may allow control of
bile and blood micro-leakage and promote healing in post-operative period
leading to reduction in morbidity and cost. We report a RCT studying fibrin
sealant spray control of post-operative fluid/bile drainage from CUSA liver
resection surface post- liver resection vs untreated control patients.
Patients/Methods. This study has so far involved 47 liver-resection patients in
total, 4 with benign and 43 with malignant lesions. Patients were randomized
utilising a software assisted method at the end of CUSA liver resection into
treatment (1, n/28) and non-treatment (2, n/19) groups. 45 ml Tisseel
Duo (Baxter) spray was applied after macroscopic hemostasis and biliostasis.
Drain/s were inserted around resection margin.. All data was collected
prospectively. Primary outcome measures included fluid drainage (expressed
in ml/cm2), colour of drainage fluid (bilous, hemoserous), abdominal
complications, intervention and duration of abdominal drainage.
Results. Median drainage per unit area was 3.9 ml/cm2 for group 1 and 7.8 ml/
cm2 for group 2 (58% reduction p/0.02). 3 patients in group 1 and 4 patients
in group 2 developed clinically significant abdominal collections requiring CT
evaluation. Of these only 2 of 3 patients in group 1 but all 4 in group 2 required
radiological drainage. 2 of 3 patients in group 1 and 3 of 4 patients in group 2
showed macroscopic bile-stained fluid, one of which developed infected
loculations requiring an 18-day hospital stay. Mean duration of drainage was
5.59/3.5 days in group 1 and 7.5. 3.5 days in group 2 (p/0.07).
Conclusion. There is a significant (58%) decrease in post-operative fluid and
bile drainage per unit area and reduction in hospital stay approaching
significance using fibrin-sealant spray in CUSA liver resections.
P24.20
EVALUATION OF THE REGENERATION PROCESS IN HEPA-
TECTOMY SPECIMENS OF PATIENTS WITH ACUTE LIVER
FAILURE
Demirhan, Beyhan1; Bilezikci, Banu1; Kocby´yy´k, Alper1; Celasun, Bu¨lent1;
Ozcay, Figen1; Haberal, Mehmet2
1Baskent University, Pathology, Ankara, Turkey; 2Baskent University, General
Surgery and Transplantation, Ankara, Turkey
Background. Liver biopsy is essential in determining the nature of injury in
acute hepatic failure. Examination of the resected liver can provide information
about the course of the process.
Aim. This study aims to provide insight into the regenerative process by
examining the morphology of hepatectomy specimens from patients with acute
liver failure. The study population consists of 11 specimens from a total of 117
liver transplantations performed between 2001 2005.
Methods. The following morphological variables are evaluated: The distribu-
tion and degree of hepatocyte injury, presence of extramedullary hemopoiesis,
distribution of bone marrow cells, degree of cholestasis, status of the
reticulin framework and presence of fibrosis. These variables were compared
with the etiology and length of liver failure and the degree of hepatic
encephalopathy.
Results. Necrosis was massive and uniform in 4, grossly heterogenous in 1,
microscopically heterogenous in 5, and submassive in 1 cases. The predomi-
nant etiology in the heterogenous necrosis group was hepatitis A virus infection
(3 of the 6 cases). A partial cirrhosis was seen in a specimen from an
autoimmune hepatitis case. The heterogeneity of parenchymal injury increased
as the length of liver failure. The necrosis was grossly heterogeneous in the case
with the longest period until transplantation (75 days). The degree of hepatic
encephalopathy was higher in cases with uniform necrosis. Cholestasis was a
prominent finding only in the group with an irregular distribution of necrosis.
Hematopoietic cells were seen within portal triads at the earlier phases of
failure, They were detected within the parenchyma at later stages and were
absent in two cases with longest duration.
Discussion. Morphologic evaluation does not only contribute the diagnosis of
liver failure, it can also help understanding the processes that take place during
regeneration.
P24.21
FIVE YEARS EXPERIENCE WITH RADIO FREQUENCY ABLA-
TION OF LIVER METASTASES IN CONJUNCTION WITH SUR-
GERY
Bjoernbeth, Bjoern A; Labori, Knut J; Buanes, Trond; Raeder, Morten
Ullevaal University Hospital, Gastrosurgical Dept., Oslo, Norway
Background. Radiofrequency ablation (RFA) is a technique by which one
may induce local coagulative necrosis in the liver.
Objectives. To evaluate the safety and efficacy of RFA as used in combination
with resectional therapy for liver metastases.
Methods. 113 liver operations were carried out with curative intent on patients
suffering from hepatic metastases from January 2001 to January 2006.
Indications for RFA were: 1. Presence of irresectable metastases in the liver
remnant after formal resection (number5/3, diameter5/40 mm) 2. Recurrence
of tumor after formal resection. 3. Metastases in patients unfit for resection on
medical grounds. RFA was administered by means of LeVeen needles with 35
mm radial array inserted into the liver metastases. Twenty five patients (12
female and 13 male, age between 35 and 83 years, mean age 62) received RFA
treatment. Eighteen of the patients had colorectal metastases, 7 patients had
metastases from other tumours. Altogether 32 metastases were ablated. Twenty
patients were receiving RFA treatment in conjunction with major surgery, 5
were treated by minor laparotomy and RFA. Three patients received RFA
treatment twice.
Results. Mean observation period was 17,6 months (range 160). Five
patients developed registered local recurrence after 2, 3, 4, 9 and 11 months (i.e
20% local recurrence rate). No perioperative complications were registered.
Four patients had the following postoperative complications: Pneumothorax
(1), biloma (1), intrahepatic abscess (1) and perihepatic abscess (1). All were
successfully treated.
Discussion. Local recurrence occures because of insufficient delivered energy
to the metastases and their immediate surroundings or is due to misplaced RFA
needle. RFA may be used in combination with hepatic resection to render more
patients amenable to surgery. In our department we have extended the number
of resectable patients with 25% (28 out of 113).
P24.22
FOCAL NODULAR HYPERPASIA (FNH) AS AN INDICATION FOR
LIVER RESECTION
Cieslak, Bartosz1; Najnigier, Boguslaw1; Mackiewicz, Anna2; Krawczyk,
Marek1
1Medical University of Warsaw, Dept. of General,Transplant and Liver
Surgery, Warsaw, Poland; 2Medical University of Warsaw, Student Reserch
Group, Warsaw, Poland
Liver resection has become an effective method of treatment for hepatic
tumour. In large spectrum of indications for resection of the liver tissue, FNH
constitutes an inconsiderable percentage. In Department of General, Trans-
plant and Liver Surgery, Medical University of Warsaw between 1995 and
2005, 67 patients, 50 women and 17 men were admitted due to suspicion of
FNH in the liver tissue. Most of the lesions were discovered incidentally on
ultrasound investigations. The ultrasound imagings were performed for non
specific symptoms: upper abdominal pain, discomfort, etc. All patients were
investigated for other causes of symptoms also for any malignances. 13 patients
were only observed without any surgical intervention. In that group FNH was
certified by CTor NMR scans with characteristic a central scar in the middle of
the lesion, two of the patients additionally underwent biopsy with histopatho-
logical confirmation of FNH. 54 patients were qualified for surgical interven-
tion. Laparotomy and open biopsy were performed in 3 cases. Laparoscopic
biopsy in one patient. 50 hepatic resections were undertaken with very good
immediate and long results, time of observing 3120 months. Anatomical
hemihepatectomies were performed in 15 cases (9 left hemihepatectomies, 6
right hemihepatectomies), 3 extended left hemihepatectomies and 3 extended
right hemihepatectomies, and in 29 patients anatomical or non-anatomical
resections of one or more segments. FNH may be the indication for liver
resection in patients it is symptomatic and when there is a suspicion of
malignancy. Resection can be also performed when the patient insists on
having the tumour removed even if there is no indication for surgical
treatment. Conclusions: A complete remission of symptoms, explanation of
the tumour malignancy- histopathological diagnosis, particularly in cases of an
unclear preoperation diagnosis, the procedures were safe and complications
hardly occurred.
P24.23
HEPATECTOMY FOR ALL INDICATIONS-THE RESULTS OF A
UK TERTIARY HEPATOBILARY REFERRAL CENTRE
Mann, Christopher D; Neal, Chris P; Pattenden, Clare J; Thomasset, Sarah C;
Johnson, Nick J; Dennison, Ashley R; Berry, David P
Leicester General Hospital, Dept. of Surgery, Leicester, UK
Introduction. Hepatic resection offers the only realistic cure for many
patients with hepatobiliary disease.
Aim. The aim of this study was to evaluate the results of hepatectomy in a
single UK tertiary hepatobiliary referral centre over a 5-year period.
Methods. All patients having undergone hepatic resection between January
1999 and December 2004 were identified from our Hepatobiliary Database.
Results. Three hundred and twenty patients underwent hepatic resections
over the study period. Median age was 60 years (range 2879 years). 57%
were male and 43% were female. Underlying disease included colorectal
metastases (n/207, 64.7%), cholangiocarcinoma (n/42, 13.1%), carcinoid
(n/17, 5.3%), HCC (n/12, 3.8%), gallbladder carcinoma (n/8, 2.5%) and
benign disease (n/30, 9.4%). Resections performed included 97 extended
right hepatectomies, 5 extended left hepatectomies, 56 right hepatectomies, 36
left hepatectomies and 4 central resections. The remainder underwent
segmental or local resection. 90.9% (n/291) of these were first time
resections, 3.8% (n/12) were planned 2-stage procedures, and 5.3% (n/
17) were repeat resections for recurrent disease. Thirty patients (9.4%)
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underwent a synchronous intra-abdominal procedure. Median operating time
was 240 minutes (range 75700 minutes) with 93 patients (29.0%) requiring
intra-operative blood transfusion. The median post-operative hospital stay was
10 days (range 4126 days). The inpatient morbidity rate was 20.8%, with 15
patients (4.6%) requiring re-operation. The 30-day and inpatient mortality
were 1.9% and 3.7% respectively.
Conclusion. These results prove that hepatectomy in a specialist unit can be
performed safely and justifies its inclusion as an integral part of the treatment
of hepatobiliary disease.
P24.24
HEPATIC PRECONDITIONING WITH PENTOXIFYLLINE TO
PREVENT ISCHEMIA-REPERFUSION INJURY
Florez, Carlos W1; Chousleb, Alberto2; Hernandez, Maria del Carmen2;
Cervantes, Felipe1; Fernandez, Rosa A3; Hessheimer, Amelia J4; Ferrer,
Joana5
1The American British Cowdray Medical Center, Surgery, Mexico City,
Mexico; 2The American British Cowdray Medical Center, Brimex II-Experi-
mental Surgery, Mexico City, Mexico; 3The American British Cowdray
Medical Center, Internal Medicine, Mexico City, Mexico; 4Barcelona Clinic
Hospital, Liver Unit, Barcelona, Spain; 5Barcelona Clinic Hospital, Liver
Surgery and Transplantation, Barcelona, Spain
Background. Blood flow reduction (ischemia) and restitution (reperfusion)
are common in hepatic surgery. Ischemia-reperfusion (I/R) injury negatively
affects prognosis, increases postoperative complications, and cannot be
completely prevented. Pentoxyfilline blocks the enzyme xanthine dehydro-
genase (XDH) and the generation of superoxide radicals, both of which are
implicated in I/R injury.
Objective. We theorize that the intravenous (IV) administration of pentoxyfil-
line prior to warm hepatic ischemia may limit I/R injury, in particular in the
initial hours post-reperfusion.
Material and methods. Twenty male Wistar rats were randomly divided
among treatment (n/10) and control (n/10) groups and administered 50
mg/kg IV pentoxyfilline and isotonic saline respectively. The rats were
laparotomized, and baseline liver and blood samples were taken. Thirty
minutes after IV injection, one hepatic lobule in each rat was isolated and
subjected to 10 min of ischemia followed by reperfusion. Twenty four hours
post-reperfusion, blood was again sampled, and the liver lobules were
harvested for histopathological evaluation.
Results. The grade of the hepatic lesion was significantly less (pB/0.05) in the
treatment group with respect to the following parameters: neutrophil infiltra-
tion (2.59/1.7 v 4.09/0.9), hemorrhage (2.19/1.2 v 3.39/1.1), and necrosis
(2.59/1.5 v 4.39/1.8). There were no significant differences in the blood-based
parameters among the groups. Two preoperative deaths occurred in each
group due to anesthesia; there were no postoperative deaths.
Discussion. Many strategies to reduce hepatic I/R injury have been evaluated,
most with positive results. Pentoxyfilline improve blood flow dynamics and
inhibit the release of tumor necrosis factor (TNF-a) and super-oxide anion
from activated Kupffer cells following I/R.
Conclusion. Pentoxyfilline is yet another agent that, when administered prior
to ischemic insult, limits the histopathological damage in the first 24 h post-
reperfusion in the rat liver.
P24.25
HEPATIC RESECTION FOR METASTASES FROM NON-COLOR-
ECTAL NON-NEUROENDOCRINE NEOPLASMS
Spalding, Duncan; Healey, Andrew; Hutchins, Robert; Habib, Nagy; Jiao,
Long
Hammersmith Hospital, HPB, London, UK
Background. Hepatic resection is established as the standard treatment for
colorectal metastases and is increasingly performed for metastatic neuroendo-
crine tumours on the basis that these tumours are slowly growing and clinical
symptoms are known to correlate with tumour bulk. There are, however, few
well-defined guidelines for the heterogeneous group of non-colorectal, non-
neuroendocrine (NCNN) metastases. The aim of this study was to assess the
role of hepatic resections for NCNN metastases based on the experience of two
liver units in affiliated university hospitals.
Methods. Twenty-nine hepatic resections were performed on 25 patients with
NCNN metastases between 19992005, and the clinical outcome reviewed.
Hepatic resections were either TissueLinkTM or radiofrequency assisted
depending on the liver unit.
Results. There were 10 men and 15 women of median age 55 (range 2271)
years. Histology of the primary malignant neoplasms were ovarian 5, breast 4,
gastointestinal stromal tumour (GIST) 4, gastric 2, lung 2, and 1 each of
cerebral tumour, ocular melanoma, limb melanoma, squamous cell carcinoma
(scc) of the anus, pancreas, oesophagus, renal and unknown. Eleven patients
underwent hepatic lobectomy and 18 local resections. Eight patients had de-
bulking procedures, 2 had staged resections and 1 patient 3 consecutive
resections for recurrence. Thirty day mortality was 3.4% (respiratory failure 1)
and morbidity was 6.8% (bile leaks 2, gastric stasis 1). At a median overall
follow up of 14 (range 349) months, 7 patients had died of extra-hepatic
recurrence (lung 2; ovarian, breast, pancreatic, oesophageal, and ocular
melanoma 1 each) and 3 of hepatic recurrence (GIST 2, renal 1). Six patients
with extrahepatic (ovarian 3, gastric 2, cerebral 1) and 2 with hepatic
recurrence (scc and GIST 1 each) remained alive. Seven patients remained
disease free.
Conclusions. Resection of hepatic metastases from NCNN tumours may
offer prolonged survival in selected patients.
P24.26
HEPATIC RESECTION IN ELDERLY PATIENTS-AGEISM IS UN-
JUSTIFIED
Mann, Christopher D1; Neal, Chris P1; Pattenden, Clare J1; Metcalfe,
Matthew S1; Jeyapalan, Indra2; Musto, Patrick2; Dennison, Ashley R1; Berry,
David P1
1Leicester General Hospital, Dept. of Surgery, Leicester, UK; 2Leicester
General Hospital, Dept. of Anaesthetics, Leicester, UK
Introduction. Hepatic resection offers the only realistic cure for many patients
with hepatobiliary malignancy and is increasingly being performed in elderly
patients. The benefit of resection for these patients needs to be evaluated.
Aim. The aim of this study is to assess the safety of hepatic resection in the over-
70 age group by comparing outcomes with those of younger patients.
Methods. Data on patients undergoing hepatic resection for malignant disease
between January 1999 and December 2004 were identified from our
Hepatobiliary Database and outcomes for patients over the age of 70 compared
to those of younger patients.
Results. Over the study period, fifty-five hepatic resections were performed in
patients over 70 years of age, with a median age of 74 years (range 7079). A
further 237 resections were performed in patients under the age of 70 years
(median age 58 years, range 3269). As expected, the over-70 group had
greater co-morbidity, particularly cardiovascular disease than the under-70
group (29.5% cf. 7.5%, pB/0.05). Underlying pathology was not significantly
different. Major resections (removal of 4 or more liver segments) were
performed in 58.2% of the elderly group, compared to 65.4% of the control
group (p/0.35). Operative duration was similar in both groups (median 240
mins cf. 240 mins control). Of the over-70 group, 30.9% required intra-
operative transfusion compared to 31.2% of patients in the control group. The
median post-operative hospital stay was 11 days in the over-70 group and 10
days in the control group. Post-operative complications occurred in 30.9% of
the over-70 group and 22.4% in the control group (p/0.18); 7.2% required re-
laparotomy, compared to 4.2% in the control (p/0.26). The 30-day mortality
rates were 0.0% in the over-70 group and 2.1% in the control group, with in-
hospital mortality rates of 5.4% and 3.3% (p/0.46).
Conclusion. In a specialist centres, major liver resection can be performed
safely in patients over 70 years of age.
P24.27
HEPATIC RESECTIONS USING THE LIGASURE VESSEL SEAL-
ING SYSTEM
Garancini, Mattia; Romano, Fabrizio; Caprotti, Roberto; Uggeri, Fabio;
Conti, Matteo; Cesana, Giovanni; Uggeri, Franco
San Gerardo Hospital, Dept. of Surgery, Monza, Italy
Background. Blood loss, a well-known risk factor for morbidity and mortality
performing liver resection, usually occurs during parenchymal transection, so
many approaches and devices have been developed to limit bleeding. Moreover
biliary leakage from the cut surface affect the results of liver resections.
Aim. the aim of this study was to determine wheter the bipolar vessel sealing
device (Ligasure) allows a safe and careful liver transection achieving a
satisfactory hemostasis and avoiding bliary leaks, thus reducing blood and
bile loss and related complications.
Methods. A total of 50 consecutive patients (24 males, 26 females with a mean
age of 57 years) underwent major and minor hepatic resection for different
disease in which the bipolar vessel sealing device was used without routine
inflow occlusion. A crush technique followed by energy application was used to
perform the parenchymal transection. No other device were applied to achieve
hemostasis and biliostasis.
Results. The Ligasure was effective in 45 hepatic resection, and failed to
achieve hemostasis in five patients three of whom had a cirrhotic liver. Median
blood loss was 450 mL (range: 1002500), and intraoperative blood transfu-
sion were required in 8 patients (16%). Mean operative time was 178 minutes
(range: 50315). The postoperative complication rates was 25%, with one
hemoperitoneum requiring e reintervention. There was no clinical evidence of
postoperative bile leaks of intrabdominal abscess.
Discussion. The Ligasure seems to be an useful tool in standard liver resection
in patients with normal liver parenchyma, achieving a satisfactory hemostasis
and avoiding bile leakeges.
P24.28
HEPATOCELLULAR ARGINASE-1 RELEASE DURING LIVER
SURGERY DOES NOT DECREASE PLASMA ARGININE LEVELS
van de Poll, Marcel; Hanssen, Sebastiaan; Berbee, Maaike; Deutz, Nicolaas;
Buurman, Wim; Dejong, Cornelis
University Hospital Maastricht, Nutrition and Toxicology Research Institute
Maastricht (NUTRIM), Maastricht University, Dept. of Surgery, Maastricht,
Netherlands
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Background. Low arginine (ARG) plasma levels, commonly seen after major
GI surgery may compromise endothelial function, immune function and
postoperative recovery. The enzyme arginase-1, abundantly present in hepa-
tocytes, converts ARG to ornithine (ORN) and urea. Injured hepatocytes
release arginase.
Aim. To see if hepatocyte injury by liver manipulation during liver surgery
leads to arginase-1 release and accelerated ARG breakdown.
Methods. From 16 patients undergoing liver resection blood was sampled
preoperatively (t0) and during surgical manipulation of the liver (t1) to measure
arginase-1 (ELISA), ARG and ORN (HPLC). Plasma and whole blood of 6
patients was incubated for 40 min at 378C to assess arginase activity in vitro.
Changes in ARG and ORN plasma levels were measured and arginase activity
was expressed as the increment of [ORN] per minute (mM/min).
Results. In line with our hypothesis, mean (SE) arginase-1 plasma levels
increased during liver manipulation from 17.8 (4.1) ng/ml (t0) to 133 (30) ng/
ml (t1), (pB/0.01). However, plasma concentrations of ARG and ORN did not
change (p/0.3 and p/0.2 respectively). In accordance with these in vivo
findings, no significant arginase activity was found in plasma samples incubated
at 378C (t0: 0.13 (0.09) mM/min (p/0.2 vs. zero); t1: 0.23 (0.20)mM/min (p/
0.3 vs. zero)). When whole blood samples were incubated similarly, significant
arginase activity was found. However, this activity was independent of arginase-
1 plasma levels (t0: 0.93 (0.19) mM/min (pB/0.01 vs. zero); t1: 0.95 (0.34) mM/
min (p/0.04 vs. zero); (p/0.9; low arginase vs. high arginase)) and can be
explained by ARG uptake and arginase activity by intact erythrocytes.
Conclusion. Hepatocyte injury by liver manipulation leads to arginase-1
release and increased arginase-1 plasma levels. Surprisingly, this does not
stimulate extracellular arginine breakdown, which sheds new light on earlier
reported arginine lowering properties of circulating arginase-1.
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IMPACT OF THREEDIMENSIONAL VASCULAR RECONSTRUC-
TION AND COMPUTER-ASSISTED RISK ANALYSIS ON OPERA-
TION PLANNING OF MAJOR HEPATECTOMY
Lang, Hauke1; Radtke, Arnold1; Hindennach, Milo2; Sotiropoulos, Georgios
C1; Malago´, Massimo1; Peitgen, Heinz O2; Broelsch, Christoph E1
1Universita¨tsklinikum Essen, Klinik fu¨r Allg.-, Viszeral- und Transplant.-
Chir., Essen, Germany; 2MeVis-Centre for medical diagnostic systems,
Bremen, Germany
Introduction and aim. Standard planning of hepatic resection is based on
two-dimensional (2-D) imaging of the liver. Recent developments in CT-
techniques allow an improved three-dimensional (3-D) visualization of the
distribution of intrahepatic vascular branches and a precise calculation of their
depending territories. We evaluated the impact of 3-D-reconstruction and
computer-assisted risk analysis on operation planning and intraoperative
strategy in 55 patients considered for major hepatectomy.
Patients and methods. In the first 25 patients, operation planning
and measurement of the future liver remnant was performed at 2-D-CT.
Thereafter, calculation of the volume of the remaining liver tissue was
repeated with a computer-assisted risk analysis. This volume was defined as
the amount of tissue not being devascularized, but having portal venous blood
supply and hepatic venous drainage after resection. The results of remaining
liver tissue in 2-D-CTand after computer-assisted risk analysis were compared.
In patient 26 to 55, operation planning was made directly at the 3-D-
reconstructed liver.
Results. The deviation of 2-D-CT and computer-assisted risk analysis was
below 20% (n/17/25), between 2030% (n/4/25), and between 3040%
and 4050% in two patients, each. Most extensive deviations were found in
extended left hepatectomies. In 8 patients, the results of computer-assisted risk
analysis led to a change of operation planning with regard to extend of resection
or need for vascular reconstruction. In patients 26 to 55, operation planning
was changed or at least influenced by the findings of 3-D-CT and computer-
assisted risk analysis in 8 cases.
Conclusions. By use of computer-assisted analysis areas at risk for either
devascularization or venous congestion can be calculated precisely prior to
liver resection. In selected cases with small liver remnants or large
anatomic variations, operation planning may be improved substantially by
this technique.
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IMPACT ON THE INCIDENCE OF MRSA RELATED INFECTION:
EFFECT OF PROPHYLAXIS
Malik, Hassan Z; Wong, Vincent; Al-Mukhtar, Ahmed; Abu-Hilal, Mo-
hammed; Lodge, Peter; Toogood, Giles; Prasad, Rajendra
St. James University Hospital, Leeds, UK
Aims. The aim of this study is to assess the impact of a policy of MRSA
prophylaxis on the incidence of MRSA infection in our patient population.
Methods. A total of 585 patients underwent hepatectomy in a tertiary referral
centre between January 2000 and September 2005. In September 2003 a policy
of MRSA prophylaxis was introduced within this unit. Demographic,
pathological and outcome data were compared between the pre- and post-
MRSA prophylaxis cohorts.
Results. The incidence of MRSA infection prior to initiating the prophylaxis
protocol was 8.3% and this fell to 3.8%, p/0.029. Furthermore, patients who
contracted MRSA had a higher incidence of complications compared to the rest
of the cohort, 47.3% versus 25%, p/0.001. Total cost of this protocol per
MRSA case prevented was £116. Furthermore, the cost savings as a result of
MRSA prevention is £80 per patient who received prophylaxis.
Discussion. Introduction of an MRSA prophylaxis policy has had a signi-
ficant impact on the incidence MRSA related infection within our patient
population.
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INCISURA DEXTRA OF GANS AND RESECTION OF SEGMENT VI
OF THE LIVER
Cavalcanti de A. Martins, Antonio1; C. de Sa´, Vladimir1; H. Carvalho, Luis1; P.
C. Martins, Joa˜o1; Autran Machado, Marcel2; Antonio B. Ferraz, A´lvaro1
1Hospital das Clı´nicas-UFPE, Surgery, Recife, Brazil; 2Hospital das Clı´nicas-
USP, Liver Surgery, Sa˜o Paulo, Brazil
Background. The incisura dextra of Gans is a deep sulcus, located on the
inferior surface of the liver, to the right of the gallbladder. In a typical glissonian
distribution, it contains de pedicle of the postero-inferior subsegment (segment
VI) and the paracystic veins. The incisura dextra can be as long as 2,5 cm. When
recognizable, the incisura can be used as a surgical landmark that allows a fast
and safe approach to the posterior pedicles of the right liver.
Objective. Exemplify the use of the incisura dextra as a surgical landmark for
resection of the segment VI.
Results. To exemplify this technique we present the case of a female patient,
32y, harboring a solid, well-circumscribed mass on the segment VI. The
resection was undertaken through the isolation and previous ligation of the
glissonian pedicle of the VI at the level of the incisura dextra. The resulting
ischemic area guided the resection, with no Pringle maneuver.
Conclusion. Refining the morphological knowledge of this region, through the
study of the incisura dextra of Gans, provides for a safe and anatomical liver
resection.
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INFLUENCE OF PREOPETATIVE IMMUNONUTIRITION ON
LIVER RESECTION FOR MALIGNANT TUMOR
Takamatsu, Susumu1; Nakamura, Noriaki2; Kawamura, Toru2; Teramoto,
Kenichi2; Iseki, Hideaki1; Maruyama, Michio1; Arii, Shigeki2
1Aoyama Hospital, Surgery, Tokyo, Japan; 2Tokyo Medical And Dental
University, Hepato-Biliary-Pancreatic Surgery, Tokyo, Japan
Background. The effect of preoperative immunonutrition has already been
indicated in the elective gastrointestinal surgery.
Aim. To estimate the influence of preoperative immunonutrition on liver
resection.
Patients and methods. 45 patients of liver resections for primary or
secondary malignant tumors were enrolled and divided into three groups,
that were group I, C, and N, randomly. The patients of the group I and C were
supplied 750 ml/day of enteral nuturients, which were immune enhancing
nutrient (IMPACT) in the group I and usual nutrient (ENSURE LIQUID) in
the group C, during 5 days before surgery as well as normal diet. The patients of
the group N took only normal diet. Laboratory data contained total lymphocyte
count (TLC) and plasma level of gamma globulin (Glob) was examined
preoperatively and on the postoperative day 1, 7, and 14. Lymphocyte
transformation by phytohemagglutinin (PHA) was also examined preopera-
tively and on the postoperative day 7. We also compared postoperative hospital
stay and the complications, especially infectious complications, among three
groups.
Results. The number of the patients of each group were 15 in the group I, 10 in
group C, and 20 in group N. The backgrounds of the patients, such as age, body
weight, Child-Pugh classification, and liver histology, were not significantly
different among three groups. There were no significant differences in the
factors associated with operation, such as surgical procedure, duration of
operation, blood loss, and weight of resected specimen, among the three
groups. There were no significant differences in TLC, Glob, and PHA, all of
which were regarded as parameters of immune function, among three groups.
Postoperative hospital stay and complications were not demonstratied to be
significantly different among three groups.
Conclusion. The effect of preoperative immunonutrition on liver resection for
malignant tumor was not shown from this study.
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INHIBITION OF TNF-a PRODUCTION IMPROVES HEPATIC
REGENERATION AFTER PARTIAL HEPATECTOMY IN RATS
Martino, Rodrigo B; Coelho, Ana MM; Sampietre, Sandra N; Molan, Nilza
AT; Alexandre, Alcione S; Leita˜o, Regina; Bacchella, Telesforo; Machado,
Marcel CC
University of Sa˜o Paulo, Surgery, Sa˜o Paulo, Brazil
Introduction. Liver regeneration after partial hepatectomy is regulated by
several factors that activate or inhibit hepatocyte proliferation. After hepatect-
omy, cytokines play an important role in injury to the remnant liver and
subsequent impairment of liver regeneration. Tumor necrosis factor-a (TNF-
a) and interleukin-6 (IL-6) are thought to be the initial cytokines associated
with liver injury as well with regeneration. Pentoxifylline is a derivative of
methyl xantine, inhibitor of TNF-a production, and has showed good benefits
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in sepsis, shock and acute pancreatitis. To evaluate if the blockade of the initial
cytokine response by pentoxifylline could modulate the cytokine cascade,
resulting in improved hepatocyte protection and proliferation.
Methods. Thirty-two Wistar rats were submitted to partial hepatectomy
(70%) and divided in 2 groups: Group P (n/16): rats received pentoxifylline
(25 mg/Kg intraperitoneally), and Group C (n/16): control rats that received
saline solution intraperitoneally. Ten rats of each group were sacrificed after 2
hours for determination of serum levels of TNF-a, IL-6 and aminotransferases
(AST, ALT). Liver tissues were obtained 48 hours after surgery and
regenerative activity assessed by proliferating cell nuclear antigen (PCNA)
expression and mitotic index.
Results. Comparing the groups, two hours after surgery it was observed a
significant decrease of serum TNF-a (89/3 vs. 429/15 pg/ml) and serum IL-6
(109/5 vs. 599/ 10 pg/ml) in the group treated with pentoxifylline (pB/0.05).
The levels of aminotransferase didn’t show difference between the groups. The
PCNA labeling and mitotic index of the pentoxifylline group were significantly
higher compared to the control group (pB/0.05).
Conclusion. The results suggest that pentoxifylline inhibits TNF-a produc-
tion, ameliorates liver injury and accelerates hepatic regeneration after
hepatectomy in rats.
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INTRAHEPATIC GLISSONIAN ACCESS FOR ANATOMICAL
RESECTION OF LEFT LIVER SEGMENTS
Machado, Marcel Autran1; Herman, Paulo2; Makdissi, Fabio F.1; Surjan,
Rodrigo1; Bacchella, Telesforo1
1University of Sao Paulo, Surgery, Sao Paulo, Brazil; 2Cancer Hospital,
Abdominal Surgery, Sao Paulo, Brazil
Background. Anatomical resection of left liver segments are rarely mentioned
in the literature. The authors describe an anatomical access to the left liver
segments pedicles without hilar dissection.
Aim. To present an original surgical technique and immediate results.
Methods. This technique was employed in 60 consecutive resections involving
left liver segments between July 2001 and January 2006. There were 36 men
and 24 women with mean age of 55.9 years. Thirty-one patients had liver
metastasis, 16 had primary liver cancer, 9 had benign lesions, and 4 had
gallbladder cancer. The technique consists in small liver incisions according to
anatomical landmarks such as Arantius’ and round ligaments. In a systematized
way, it was possible to reach every glissonian sheath of segments II, III and IV.
Results. Liver resection was feasible using the proposed technique in every
patient of this series and Pringle maneuver was not required in any patient.
Intraoperative blood loss was minimal in all cases and 55 patients did not
require blood transfusion. There was no postoperative death.
Conclusions. This operative procedure allows an easy and fast access for
anatomical resection of left liver segments. It is useful to perform controlled
hepatectomies without the need for main hepatic pedicle clamping and may
facilitate the recognition of all left liver segments sheaths, with excellent
immediate results.
P24.35
INTRAHEPATIC GLISSONIAN ACCESS FOR SEGMENTAL LIVER
RESECTION IN CIRRHOTIC PATIENTS
Machado, Marcel Autran1; Herman, Paulo2; Figueira, Estela R.R.1; Bacchella,
Telesforo1; Machado, Marcel C C1
1University of Sao Paulo, Surgery, Sao Paulo, Brazil; 2Cancer Hospital,
Abdominal Surgery, Sao Paulo, Brazil
Background. The main goal of segmental technique is to preserve the
maximum amount of liver parenchyma in patients that otherwise would require
major liver resections. We have recently described an intrahepatic access for
both right and left segmental liver resection that allows the removal of individual
hepatic segments. Liver-preserving technique is especially important for
patients with hepatocellular carcinoma and cirrhosis. The authors report their
experience with segmental liver resection in cirrhotic patients.
Methods. Twenty-two cirrhotic patients that underwent segmental liver
resections using the intrahepatic pedicle approach technique were prospec-
tively evaluated from September 2001 to September 2005.
Results. Seventeen patients underwent uni-segmentectomies and 5 under-
went bi-segmentectomies. Blood transfusion was required in 2 patients (9.1%).
No patient experienced major bleeding from the liver incisions made for
intrahepatic access. Median hospital stay was 5 days. Eight patients (36.4%)
developed postoperative ascites that required diuretics. No patient developed
liver failure postoperatively and no operative mortality was observed. All
patients had free surgical margins at microscopic examination.
Conclusion. The technique of intrahepatic access may enhance the portal
pedicle identification allowing resection of the involving liver segment. This
procedure may also decrease intraoperative blood loss due to segmental inflow
control. Segmental liver resection with the proposed technique is feasible even
in cirrhotic patients.
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INTRAOPERATIVE ULTRASOUND FOR HEPATIC COLORECTAL
METASTASES: IS IT STILL USEFUL?
Marques, Hugo; Mira, Paulo; Barroso, Eduardo
Hospital Curry Cabral, Hepato-Biliary-Pancreatic and Transplant Centre,
Lisbon, Portugal
Background. Intraoperative ultrasound (IOUS) is an important tool during
hepatic resection for malignant disease. Its efficacy is nowadays lower than in
previous series reported in the literature.
Objectives. To assess the actual utility of IOUS for hepatic colorectal
metastases (HCM) compared to preoperative staging with modern imaging
techniques.
Methods. Review of a prospectively collected hepatobiliary database and
clinical records. Only patients admitted for planned curative resection
from HCM were selected. Pre-operative imaging studies were compared
to intraoperative findings. Preoperative selected strategy was compared to
intraoperative actual strategy. Intraoperative findings were categorized as
attributed to IOUS, inspection/palpation, or both. Factors that were thought
to influence the number of findings, such as preoperative chemotherapy,
previous hepatic resection, small size lesions, and extensive preoperative
workup (Helical CT /MRI/ PET), were analyzed. Statistical analysis was
made with Qui-square, Fisher’s Exact tests, and ROC analysis.
Results. From January 2004 to February 2006, a total of 82 patients were
submitted to elective, potentially curative surgery for HCM, in a total of 88
surgical operations. New findings were identified in 33 operations (37,5%).
The most common findings were additional lesions. IOUS identified new
findings in 31 (35,2%) operations, being exclusively in IOUS in 16 (18,2%). Of
those, operative strategy changed in 15 (17,4%) operations, and iresectable
disease was shown in 3 (3,4%). Patients with a more extensiveworkup had more
additional findings on IOUS (p/0.02).
Conclusions. IOUS is still useful in surgery for HCM, showing new findings in
an important proportion of patients. Moreover, findings in IOUS alone can
frequently change operative plan, even in patients studied with an extensive
preoperative workup.
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IS AGE AN INDEPENDENT PROGNOSTIC FACTOR FOR OUT-
COME AFTER HEPATIC RESECTION IN PATIENTS WITH HCC.
EXPERIENCE FROM A SINGLE CENTER
Delis, Spyros1; Athanasiou, Kostas1; Bakoyiannis, Andreas1; Manes, Kostan-
tinos1; Triantopoulou, Charina2; Demetroulopoulos, Dimitrios3; Gikonti,
Jianna4; Papaeliou, Jiannis2; Kolymbiris, Charis1; Dervenis, Christos1
1Liver Surgical Unit, 1st Surgical Dept., Athens, Greece; 2Computed
Tomography Dept., Athens, Greece; 3‘‘Agios Savvas’’ Hospital, Athens,
Greece; 4‘‘Agia Olga’’ Hospital, Athens, Greece
Backround. The longer the interval of the carrier viral status the higher is the
prevalence of developing HCC. Liver resection in older (/65 yrs) pts remains
the treatment of choice due to the shortage of organs for OLT.
Objective. This study identifies the feasibility of liver resection in this sub-
group of pts and documents the cost-effectiveness of the method.
Methods. Between 2002 and 2006, 40 pts with HCC underwent hepatic
resection. The median age was 55 yo. We classified the patients into two main
groups:The first with pts above and the second with pts below 65 yo. In each
main group, pts were classified in subgroups, in dependence with the existence
of associated diseases. A subgroup of 25 pts with age above 65 years was
compared to a similar group of 15 pts with age less than 65 yrs regarding
morbidity and mortality after HCC resection. All the pts presented with tumors
stage I or II. The disease overall and disease free survival was also calculated. A
40% of pts in the first group had com-morbid disease including COPD or heart
disease compare to24% in the second group. There were performed 15 major
(defined as /2 segments) and 25 segmental hepatectomies.
Results. Inhospital mortality was nil in both groups. The older group overall
had longer hospitalization and developed higher complication rate. In
univariate analysis age was a negative prognostic factor relating to the morbidity
and disease free survival after HCC resection. In multivariate analysis only
com-morbid disease and stage of fibrosis seems to affect prognosis. In a 3year
follow up the following is revealed: 1. Age does not affect morbidity and overall
prognosis, after hepatectomy for HCC. 2. Cirrhosis affects the disease free
survival. 3. Com-morbid disease as heart failure or COPD, are independent
factors for suboptimal outcome.
Conclusion. Age is not a prognostic factor for outcome in patients with
hepatectomy for HCC. Cirrhosis seems to the strongest factor for worse
outcome. Morbidity is strongly influenced (raised), by the existence of
associated diseases.
P24.38
LAPAROSCOPIC ANATOMICAL HEPATIC RESECTION: 9 CASES
Choi, In S; Park, Il K; Park, Ji H; Ko, Dae K; Yoon, Dae S
Konyang University Hospital, General Surgery, Taejeon, Korea
Background. The advances in laparoscopic technology have encouraged
expert hands to extend this new approach to anatomical hepatic resection.
Anatomical resection provides a higher probability of coresecting microscopic
invasions that are predictable but undetectable and preservation of healthy
parenchyma. So, It can be recommended as a standard procedure.
Objective. We report here on our experience with anatomical liver resection
with using the total laparoscopic methods to evaluate the feasibility and safety of
laparoscopic liver resections.
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Methods. From January 2005 to December 2005, a total of 9 laparoscopic
anatomical resections of the liver were retrospectively reviewed. Nine patients
with liver lesions, 3 men and 6 women, aged 37 -73(mean 54.1), including 8
cases of left intrahepatic stone, and 1 case of cholangiocarcinoma, underwent
laparoscopic liver resection. Seven cases of left hemihepatectomy and 2 cases of
left lateral sectionectomy were performed. The laparoscopic procedure was
performed using four to five ports (one 11-mm, two 5-mm, and two 12-mm).
After completion of the dissection, the 8 intrahepatic lithiasis specimens were
inserted into a vinyl bag and it was extracted through a small incision, which was
an extension from the umbilical port site. For preservation of the resected liver,
the other 1 malignant specimen was removed through a extensional incision
about 6 cm in length.
Results. Operation duration was 300660 (mean 420) minutes. The blood
loss in operation was 250800 (mean 390) ml. The postoperative hospital stay
averaged 10 days. Postoperative complications occurred in 3 cases. There were
2 cases of wound infections and a single case of acute renal failure; these
complications were resolved by conservative management.
Conclusion. A promising minimally invasive technique, laparoscopic anato-
mical liver resection can be carried out safely and effectively by experienced
surgeons as one of the first choices for the loci limited to left liver.
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LAPAROSCOPIC ANATOMICAL SEGMENTECTOMY FOR HCC
LOCATED IN SEGMENT SIX GUIDED BY LAPAROSCOPIC UL-
TRASONOGRAPHY
Kang, Koo J; Kim, Yong H; Lim, Tae J
Keimyung University School of Medicine, Surgery, Daegu, Korea
Background. Recent rapid progression of the hepatic and laparoscopic
surgery have extended the possibility of laparoscopic hepatectomy in selected
cases. Application of laparoscopic surgery for a hetatocellular carcinoma is
limited in terms of the location and size of the tumor.
Aim. We report a case of systematic resection of hepatocellular carcinoma
developed in the segment 6 guided by laparoscopic ultrasonography.
Method. A 46 year old female patient who has hepatitis B carrier developed a
single hepatocellular carcinoma 36 mm size in the segment 6 that was detected
by CT scan. Hepatic parenchyma shows nodular surface with cirrhosis of Child
class A. Her alpha fetoprotein level was 9825 ng/ml and ICG R15 was 11.3%.
We tried to resect out the segment 6 anatomically after staining of the segment
by injection of methylene blue dye in the portal vein branching to the segment 6
guided by laparoscopic ultrasonography. Parenchymal transaction was per-
formed by using CUSA, electrocautery and ligation of the vessels and bile duct
by applying surgical clips.
Result. We successfully resected the segment 6 with keeping enough
resection margin laparoscopically. The amount of bleeding for the entire
procedure was 530cc and it took 5 hours for this entire procedure. The resected
specimen weighs 220 gm. The patient was allowed to go home at postoperative
5 days.
Conclusion. Laparoscopic approach for the anatomic resection of the hepatic
segment is feasible for the hepatocellular carcinoma located in the segmen 6 and
also could be applicable for the resection of the left liver and inferior segment of
the right liver.
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LAPAROSCOPIC FENESTRATION FOR CYSTIC LIVER DISEASE
Ueno, Shinichi1; Kubo, Fumitake1; Sakoda, Masahiko1; Hiwatashi, Kiyo-
kazu1; Sasaki, Ken1; Noma, Hidetoshi1; Maemura, Kousei1; Shinchi, Hir-
oyuki1; Takao, Sonshin2; Aikou, Takashi1
1Kagoshima University, Dept. of Surgical Oncology, Kagoshima, Japan;
2Kagoshima University, Dept. of Frontier Science, Kagoshima, Japan
In the case of the laparoscopic fenestration operation to cystic liver disease,
there are some difficulties compared with the fenestration operation under
open-abdomen. 1) The difficulty of the fenestration changes with cyst parts. 2)
It tends to become inadequate the vas run identification of the cyst wall itself 3)
The cauterization of cyst lumen basal surface tends to become inadequate.
Laparoscope fenestration in 12 cases in which it passed one years or more after
the operation was examined focusing on the above viewpoints.
Method of surgery. Using a sand balloon, content liquid suction was done
to verify cytology and bilirubin level. The fenestration was carried out using
the ultrasonic scalpel. To bleeding of a cyst wall amputation stump, when there
was necessity, clipping and ligation were performed. The closed drain was
inserted. The average number of fenestrated cysts: simple cystic dis. 1.7; APLD
620.
Results. (1) simple cyst:  symptoms in particular were not regarded as all
cases one year after surgery. When the cauterization was inadequate, the mean
drainage volume 380 ml on 5th day after the operation, but the problem in
particular was not seen after the drain evulsion. In one case, left hepatic lobe
resection was needed because the left hepatic duct ran solely on the surface of
the large cyst and was injured as a complication when the fenestaration. (2)
APLD*According to Giot’s and others report, it aimed at about 30% of liver
volume reduction. Adequate cauterization could not be done. The average
drainage on 6th day after surgery was 1400 ml. The symptoms relaxation was
not obtained easily when the patients had a decreased renal function, however,
the symptoms relaxation for about 3 years was obtained in the example of
kidney function preserved.
Conclusion. Laparoscopic fenestration is useful for the patients with simple
large cysts, if the pitfall of the procedure is understood. For APLD patients, it
may be useful when the patients renal function is preserved.
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IOSLATED INTRADUCTAL PAPILLARY MUCINOUS TUMOR OF
THE BILE DUCTS
Hsieh, Chan-Chung; Chen, Hong-Yaw; Ker, Chen-Guo
Yuan’s General Hospital, HBP surgery, Kaohsiung, Taiwan
Background. A cystic ductal tumor located at right liver and mimic
encapsulated hepatocellular carcinoma (HCC) was found. We define the
better way to achieve precise diagnosis
Patients and methods. A right hepatic tumor was found at 67 years old male.
This tumor was encapsulated with heterogeneous content inside the capsule
under abdominal sonography. HCC was suspected, though the clinical picture
was still doubtful. We arranged abdominal MDCT, MRCP and liver biopsy to
differentiate the nature of tumor.
Results. The result of biopsy favored adenocarcinoma. Operation was
performed and S5.6 intra-hepatic ductal tumor was resected. Mucin producing
papillomatosis of bile duct was found. S5.6 segmentectomy was performed and
intraoperative choledochoscope was done to make sure of tumor free resection.
Conclusions. Papillary tumors of the bile ducts produce a large amount of
mucin that disturbs bile flow and causes severe biliary dilatation. In this tumor
of subgroup, the entire biliary tree or segmental or lobar bile ducts are dilated
disproportionately, and aneurysmal dilatation may occur. Mucin is depicted at
dilated biliary duct as multiple elongated or cordlike filling defects and the
tumor is depicted on cross-sectional images as a castlike, polypoid, or fungating
mass in the dilated biliary tree. Based on these characteristic imaging features-
duct dilatation, mucin, and tumor-correct diagnosis of intraductal papillary
mucinous tumor of the bile ducts may be made. MDCT, MRCP are useful for
pre-operative differential diagnosis of this unusual appearance disease.
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LAPAROSCOPIC HEPATECTOMY FOR LIVERTUMORS: RESULT
OF INITIAL FOURTEEN CASES
Lee, Kit F; Ng, Wing Ch; Tam, Tak L; Wong, John; Lai, Paul B
Prince of Wales Hospital, Surgery, Hong Kong
Background. The safety and efficacy of laparoscopic hepatectomy for liver
tumors and issue of oncological clearance for malignant tumors are still matters
of concern.
Objective. To evaluate the outcome of laparoscopic hepatectomy for liver
tumors in a single centre.
Patients & methods. From November 2003 to February 2006, 14 con-
secutive patients underwent laparoscopic hepatectomy for liver tumors were
recruited for study. Choice of laparoscopic approach was on discretion of
surgeons before surgery. Data were collected prospectively. A total laparoscopic
technique was utilized. Pringle maneuver (inflow occlusion) was not used in all
cases. Liver resection was carried out with TissueLink, ligasure, vascular
stapler. Specimen was retrieved within plastic bag through extended port site.
Results. Eight patients had resection of two liver segments, while six patients
had resection of one segment or less. Distribution of liver segments included
segment 2, 3, 4b, 5 and 6. There was one conversion due to bleeding during
parenchymal transection. There was no operative mortality or morbidity. Blood
loss ranged from 20 to 800 ml (median/100 ml). Only one patient required
transfusion. Length of hospital stay ranged from 2 to 6 days (median 4 days).
Pathology revealed hepatocellular carcinoma in 9 patients, colorectal metas-
tasis in 2, focal nodular hyperplasia in 2 and haemangioma in one. Mean size of
tumor was 2.52 cm with a mean resection margin 1.23 cm. One patient died 1
year after operation due to multifocal recurrence in the liver. Another patient
was found to have lung and intra-abdominal lymph node recurrence one year
after the procedure. All other patients survived without recurrence with a
median follow-up of 6 months.
Conclusion. In selected cases of liver tumors, laparoscopic hepatectomy is safe
and feasible. Resection margin in this small series was not compromised.
Longer term follow-up is needed to address other oncological outcomes like
tumor recurrence and survival.
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LAPAROSCOPIC LIVER RESECTION ASSISTED WITH RADIO-
FREQUENCY
Healey, Andrew1; Bachellier, Phillipe1; Ayav, Ahmet1; Pai, Madhava1; Weber,
Jean-Christophe2; Rosso, Edoardo2; Jaeck, Daniel2; Habib, Nagy3; Jiao, Long3
1Hammersmith Hospital, Imperial College, Dept. of Surgery, London, UK;
2Hospital Universitaire de Hautepierre, Centre de Chirurgie Viscerale et de
Transplantatn, Strasbourg, France; 3Hammersmith Hospital, Imperial Col-
lege, Dept. of Hepatobiliary Surgery, London, UK
Background. Laparoscopic liver resection (LLR) remains a formidable
procedure with a high conversion rate largely due to inability to control
intraoperative haemorrhage efficiently. Radiofrequency assisted (RFA) liver
resection has been reported previously as a method for ‘‘bloodless liver
resection’’. The current study examined the feasibility and results of this
technique in LLR.
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Methods. Between November 2001 and April 2004, patients suitable for liver
resection were carefully assessed and those who required tumourectomy,
segmentectomy or left lateral hepatectomy were selected for LLR. Details of
patients with site and size of tumour, type of liver resection and, intra and
postoperative data were prospectively collected and analysed to assess the result
of LLR with RFA technique.
Results. A total of 18 patients underwent RFA LLR. Three were converted to
open due to adhesions from previous surgery (n/2) and detection of additional
metastases on intraoperative ultrasound (n/1). LLR was completed success-
fully in 15 cases without vascular clamping, consisting of tumourectomy (n/
9), multiple tumouretcomies (n/2), segmentectomy (n/2) and bisegmen-
tectomies (n/2). The mean operative and resection time was 2139/59 min and
1679/45 min respectively. The mean blood loss was 1219/68 ml. There was no
per- or post-operative transfusion of blood or blood products. One patient
developed pneumothorax intraoperatively after direct puncture of pleura with
the radiofrequency probe, and one had a transient episode of liver failure
requiring only supportive care postoperatively. The mean length of hospital stay
was 6.09/1.5 days. At a mean follow-up of 9.89/6.2 months, all patients
remained well and those with liver cancer had no recurrence.
Conclusion. Radiofrequency can be used safely and effectively to assist liver
resection laparoscopically with a considerably reduced risk of intraoperative
bleeding and a decreased blood transfusion requirement.
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LAPAROSCOPIC LIVER RESECTION REDUCES POSTOPERA-
TIVE IN-PATIENT STAY COMPARED TO OPEN LIVER RESEC-
TION
Hou, David; Roe, Thomas; Parvaiz, Amjad; Abu Hilal, Mohammed; Primrose,
John; Pearce, Neil
Southampton General Hospital, Hepatobiliary Unit, Southampton, UK
Introduction. Laparoscopic liver resection is now a recognised alternative to
open surgery. However, there is little published data comparing postoperative
hospital stay. This study compared the length of postoperative stay between
patients undergoing laparoscopic and open liver resections.
Methods. The length of postoperative stay in 17 patients undergoing
laparoscopic liver resection (200306) was compared retrospectively with 18
consecutive historical patients undergoing open surgery (200003). The
inclusion criteria for both groups were left lateral sectionectomy, left hemi-
hepatectomy and segmental resections from segments 4b, 5, 6 and 8.
Results. 17 patients (13F:4M, median age 59 years, range 21 81) underwent
laparoscopic liver resection (14 segments, median/2, 13/malignant,
4/benign). During the same period 111 open liver resections were performed.
From 200003, 18 of 121 patients (11F:7M, median age 67 years, range
3780) undergoing open liver resection met the same criteria (14 resected
segments, median 2). There were no deaths in either group. Complications in
the two groups were comparable. In the laparoscopic group there was one bile
leak, one postoperative dysrhythmia, one urinary retention and one supraspi-
natus tendonitis. Median postoperative in-patient hospital stay for laparoscopic
liver resection of 4 days (range 29 days) was significantly shorter than for open
liver surgery: median 9 days, range 417 days (pB/0.0001 using Mann-
Whitney U test).
Conclusion. Laparoscopic liver resection significantly reduces the length of
postoperative in-patient hospital stay in selected cases.
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LINEAR RADIOFREQUENCY DEVICE IN LIVER RESECTION
Stojanovic, Miroslav; Radojkovic, Milan; Zlatic, Aleksandar; Jeremic, Ljiljana;
Jeremic, Miroslav; Stanojevic, Goran; Bogicevic, Aleksandar; Jovanovic,
Milan; Stojanovic, Marija
Surgical Clinic, HPB Unit, Nis, Serbia and Montenegro
Background. Linear radiofrequency device (LRFD) is disposable tool
designed for liver parenchyma transection using controled radiofrequency to
‘‘seal’’ blood vessels and bile ducts, making liver resection easier and safer
compared with classical resectional techniques.
Objective. In the present study, the authors compared significant intraopera-
tive parameters and postoperative results on the 102 liver resections performed
at University Surgical Clinic, with the aim to determine real value of the LRFD
compared with the standard kellyclasia technique.
Methods. The patients are divided in two groups: control group (75 patients)
with the kellyclasia resection technique and group with resection preformed
using LRFD -Tissue Link/Dissection Sealer (DS-3.0) (27 patients). The
following parameters were analysed: duration of the liver ischaemia, liver
parenchyma transection time, intraoperative blood loss, significant intraopera-
tive and postoperative complication rate, duration of the hospitalisation and
mortality.
Results. LRFD was used in 26.47% liver resection. Average duration of the
liver ischaemia in the control group was 46 minutes. In the LRFD group, liver
was resected without ischaemia. Transection of the liver parenchyma was
significantly slower in the LRFD group (2.9 versus 1.5 cm2/min.). Intraopera-
tive bleeding was lower using LRFD (200 ml compared with 420 ml in the
control group). After use of the LRFD two biliary leaks were registered,
compared with 4 major complication in the control group.
Conclusion. LRFD is simple device for safe liver transection without
ischaemia and singificant reducing of the intraoperative blood loss. High price
for disposable device and slow parenchyma transection are negative caracter-
istics of this device.
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LIPIODOL I131 AFTER SURGERY FOR HEPATOCELLULAR CAR-
CINOMA: EARLY ADMINISTRATION IMPROVES SURVIVAL
Chu, Francis; Gunasegaram, Aravin; Morris, David
St George Hospital Campus, University of New South Wales, Dept. of Surgery,
Sydney, Australia
Introduction. The usage of lipiodol I131 in an adjuvant setting was first
published in a small randomized controlled trial in 1999. Lau and co-authors
showed a doubling of disease free and overall survival in the treatment arm and
after an interim analysis at 2 years the trial was halted. We have previously used
lipiodol I131 in the treatment setting, with patients given radioactive iodine
when tumours recurred within the remnant liver after curative resection that
were not amenable to re-section or ablation.
Methods. Thirty four patients (19 in the adjuvant group and 15 in the
treatment group) were identified to have had lipiodol I131 after potentially
curative surgical resection. There were eleven (58%) recurrences in the
adjuvant group and as expected all patients had recurrence in the treatment
group.
Results. The overall median survival was 41.1 months with a 5-year survival
of 38%. The median disease free survival was 12 months, with a 5-year
disease free survival of 25%. The median survival for the adjuvant group was
71.8 months and for the treatment group was 27.3 months (p/0.04). The 1-
, 3-, and 5-year survival was 90%, 69% and 59% in the adjuvant group. The
1-, 3-, and 5-year survival in the treatment group was 71%, 36% and 21%.
The median disease free survival for the adjuvant group was 40.7 months and
for the treatment group was 7.1 months (p/0.007). The 1-, 3-, and 5-year
recurrence free survival was 74%, 56% and 48% in the adjuvant group. The
1-, 3-, and 5-year recurrence free survival in the treatment group was 20%,
20% and 7%.
Conclusion. Lipiodol I131 has been shown to be relatively safe with no
significant toxic side effects. Our phase II data confirms the benefitical effects
of Lipiodol I131.
P24.47
LIVER HANGING MANEUVER FOR CAUDATE LOBECTOMY
Peng, Shu Y1; Li, Jiang T1; Liu, Ying B1; Wang, Jian W1; Xu, Bin2; Qian,
Hao R2; Xue, Jian F1; Liu, Fu B1; Hong, De F2; Mou, Yi P2; Cai, Xiu J2
1Second Affiliated Hospital, Zhejiang University, Dept. of Surgery, Hang-
zhou, China; 2Sir Run Run Shaw Hospital, Zhejiang University, Dept. of
Surgery, Hangzhou, China
Introduction. Being becoming a milestone in the history of hepatic surgery,
Belghiti’s Liver hanging maneuver(BLHM) has been verified as a safe and
useful procedure for right or left hepatectomy as well as piggy-back liver
transplantation when indicated, Is it also useful and safe for caudate
lobectomy? Herewith we report our experiences.
Methods. From July 2003 to Jan. 2006, we performed caudate lobectomy for
45 cases, among them BLHM were used for 12 cases. Including 2 isolated
caudate lobectemy and 10 combined caudate lobectomy. The essential idea
of BLHM is to pass a tape through the retrohepatic tunnel between the
anterior surface of the inferior vena cava and the liver parenchyma before
lifting the tape and suspend away the liver from the IVC. The prerequisite for
successful placement of the tape is to develop the retrohepatic tunnel by
finger dissection in this group. The operator’s right index finger is inserted
between the caudate process and the IVC. The alveolar tissue is dissected
with the finger tip carefully and slowly moving forward cranially, keeping on
the midline along the IVC, until the finger tip appears at the upper edge of
the liver between the right hepatic vein and the middle hepatic vein where
dissection has already been dissected previously.
Results. BLHM was feasible in all the 12 cases (12/12), 1 case of gallbladder
carcinoma, 4 cases of hilar cholangiocarcinoma, 1 case of metastatic liver
cancer, 2 cases of hemangioma, 1 case of left and caudate lobe intrahepatic
stones,3 cases of HCC. 2 isolated complete caudate lobectomy with
hemangioma, 6 left hepatectomy and 4 right hepatectomy combined caudate
lobectomy were carried out. No substantial bleeding or no other complication
related to BLHM was encountered in any of the cases.
Conclusions. BLHM is also useful for caudate lobectomy provided retro-
hepatic tunnel can be established safely. Finger dissection is safe for
developing the retrohepatic tunnel.
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LIVER RESECTION FOR BENIGN TUMOUR: MULTI-INSTITU-
TIONAL ANALYSIS
Chu, Francis1; Nguyen, Linh1; Thomas, Mark2; Gunasegaram, Aravin1;
Morris, David1; Buell, Joseph2
1St George Hospital Campus, University of New South Wales, Dept. of
Surgery, Sydney, Australia; 2University of Cincinatti Medical Centre,
University of Cincinatti, Dept. of Surgery, Ohio, USA
Introduction. This study evaluates the indications and outcomes of hepatic
resection for benign lesions of the liver.
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Method. Retrospective analysis of a prospectively collected multi-institu-
tional database. Patient demographics, indications, tumour size, pathology,
complications and outcomes were analysed.
Results. There were 266 resections for benign tumours were examined.
There were 62 males and 204 females. 79% had solid lesions. The mean age
of the patients was 45 years of age. The indications for surgery included
abdominal pain (n/146), incidental (n/34), palpable mass (n/29),
inability to exclude malignancy (n/29), worsening liver function tests (n/
7), rupture (n/6) and related to pregnancy (n/5). 198 had open liver
resections whilst 68 had laparoscopic liver resections. The median tumour
size was 6 cm. 179 patients underwent liver resection of B//3 Couinaud’s
segments, 64 underwent liver resection of //4 Couinaud’s segments and
20 underwent deroofing or local excisions. The diagnoses included haeman-
gioma (n/86), focal nodular hyerplasia (FNH) (n/65), adenoma (n/40),
simple cysts (n/32), biliary cystadenoma (n/20) and other (/22). There
were two post operative deaths (0.75%). These were secondary to HELP
syndrome after ruptured adenoma and the other from necrotizing pancrea-
tits. The morbidity rate was 17%, with 14 patients (5%) developed post-
operative bile leaks and 32 patients developed general surgical complications.
Conclusion. Benign hepatic tumours can be safely resected with acceptable
post operative morbidity and mortality.
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LIVER RESECTION UTILIZING BIPOLAR SCISSORS (BS) AND
LIVER HANGING TECHNIQUE (LHT): AN EXPERIENCE OF 271
CASES
Hoshino, Takanobu; Ishida, Takashi; Hashimoto, Daijo
Saitama Medical University, Medical Center, Surgery, Kawagoe-City, Japan
Objective. The usefulness of BS in combination with LHT for liver resection
was evaluated in this study.
Methods. Liver resection in our technique is as follows. 1) Intra-
operative ultrasonography for identification of tumors and vessels. 2) Control
of vascular pedicles of the segment (or lobe) to be resected. 3) Placement of a
tape between IVC and caudate lobe for consequent LHT (when applicable).
4) Division of liver parenchyma by combined Forceps Fracture Method,
CUSA, and BS. 5) Ligation is applied only for large vessels and bile ducts
while BS is applied for smaller ones (less than 2 mm in diameter). 6) LHT is
utilized to maintain proper resection line and to reduce blood loss during
division of liver parenchyma.
Results. We have performed 271 cases (HCC 108, CCC 14, Metastatic
Liver Cancer 69, Biliary Cancer 65, Benign Diseases 15) of liver resection by
this method (2000.52005.12). Blood transfusion was required only in 18%
(48 out of 271 cases) altogether (segmentectomy or less: 7.9%, lobectomy:
23%, extended lobectomy: 53%). Right hepatectomy with BS, when
compared to right hepatectomy without using BS, was associated with 1)
smaller amount of blood loss (8049/334 ml vs 15369/782 ml: pB/0.01), 2)
shorter operating time (3959/89 min vs 4699/133 min), and 3) reduced
frequency of ligation during liver transection (36.5 vs 87.5 times).
Conclusions. Liver resection utilizing BS could well contribute to short-
ening of operating time, reduction of blood loss, and relief of surgeons from
fatigue. LHTappears to be extremely useful for maintaining proper resection
line as well as reduction of intraoperative blood loss.
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LIVER VOLUMETRY PLUG AND PLAY: DO IT YOURSELF WITH
IMAGEJ!
Dello, Simon1; Slangen, Jules2; van Dam, Ronald2; van de Poll, Marcel2;
Bemelmans, Marc2; Greve, Jan W2; Beets-Tan, Regina3; Wigmore, Stephen4;
Dejong, Cornelis2
1University Hospital Maastricht, Nutrition and Toxicology Research Institute
(NUTRIM), Maastricht University, Dept. of Surgery, Maastricht, Nether-
lands; 2University Hospital Maastricht, Nutrition and Toxicology Research
Institute Maastricht (NUTRIM), Maastricht University, Dept. of Surgery,
Maastricht, Netherlands; 3University Hospital Maastricht, Dept. of Radi-
ology, Maastricht, Netherlands; 4Queen Elisabeth Hospital, Liver Unit,
Birmingham, UK
Introduction. The remnant liver volume after hepatectomy can be predicted
accurately by CT-volumetry using radiological image analysis software. This
software is difficultly accessible for surgeons. ImageJ is a free image analysis
software package developed by the NIH, which may bring liver volumetry to
the surgeon’s desktop.
Aim. To study the accuracy of ImageJ for hepatic CT-volumetry.
Methods. ImageJ was downloaded from http://rsb.info.nih.gov/ij/. Preopera-
tive CT scans of 9 patients who underwent hepatectomy were retrospectively
analyzed. Scans were opened in ImageJ and the liver and tumor were
manually outlined on every slice. The resection specimen was outlined
according to transection planes described in the operation notes. The area of
each selected region was multiplied by slice thickness to calculate liver
volume. Volumes of resection specimens measured with ImageJ were
compared with specimen weights, obtained during pathology examination.
Correlation between weight and volume was determined with Pearson’s test
for correlations.
Results. There was an excellent correlation between the volumes calculated
with ImageJ and actual the measured weights of the resection specimens (r2/
0.99, pB/0.0001). The mean (SEM) ratio between weight and volume (0.86
(0.03) g/ml) was in agreement with our earlier findings using CT-linked
radiological software. Mean total liver volume was 1878 (215) mls, mean
functional liver volume (total volume minus tumor volume) was 1701 (161)
mls. Functional liver volume was significantly correlated with body weight
(r2/0.73, p/0.004) while total liver volume was not (r2/0.36, p/0.09).
Maximum slice thickness that allowed accurate measurement was 1.0 cm.
Conclusion. ImageJ can be used for hepatic CT-volumetry on a Personal
Computer. This application brings CT-volumetry to the surgeon’s desktop
and could be particularly useful in cases of tertiary referred patients, who
already have a proper CT-scan on CD-rom from the referring institution.
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LONG TERM OUTCOMES AND SURVIVABILITY OF PATIENTS
UNDERGOING SIDE-TO-SIDE PORTACAVAL SHUNTING
Beale, Evan W; Bingener, Juliane; Sirinek, Kenneth R
UT Health Science Center at San Antonio, Dept. of Surgery, San Antonio,
USA
Background. The current literature on portal hypertension is lacking with
regards to long term follow up for large diameter portacaval shunting. In
contrast, a great deal of data has been published concerning long term
outcomes for TIPS patients, with recent reports of one and five year survival
rates of approximately 55% and 27% respectively, making us question our
long term outcomes for side-to-side portacaval shunting(SSPCS).
Objective. To report long-term outcomes and survivability of a group of
patients who underwent SSPCS.
Methods. A retrospective chart review was conducted of 310 patients who
had undergone SSPCS between 1978 and 2005 at two institutions. 261
patients met the inclusion criteria and/or had confirmed follow-up or death.
Statistical analysis was used to compute interval and overall survival rates, as
well as mean survival rates based on Childs Class.
Results. Mean survival for all patients was 61.1 mos. Mean survival time was
71 mos for Childs A patients(24), 61 mos for Childs B patients(75) and 33
mos for Childs C patients(51). Mean survival for Childs A and Childs B
patients(99) was 63 mos. Overall survival was 80% at 6 mos, 77% at 1 yr,
64% at 2 yrs, 40% at 5 yrs and 19% at 10 yrs. 31 patients were found to be
living with a mean since sugery of 149 mos and range of 10 mos to over 20
years.
Discussion. Having had a lengthy operative experience with SSPCS at our
institution, we have observed overall survival rates that are higher than those
of recently published TIPS patients. We find that SSPCS is a good and
durable operative choice in Childs A and B patients with portal hypertension
and bleeding varices. Similarly, we have found SSPCS suitable in higher risk
patients who have failed TIPS placement. Alternatively, TIPS placement is
useful for high operative risk patients, patients with refractory bleeding or as a
bridge to transplantation. We conclude that our long term data establishes a
continued use of SSPCS for symptomatic portal hypertension in the good
surgical risk patient.
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MAJOR AND MINOR HEPATECTOMIES CAN BE PERFORMED
WITH RADIOFREQUENCY ASSISTED TECHNIQUE WITH MINI-
MAL BLOOD LOSS
Ayav, Ahmet; Bachellier, Philippe; Healey, Andy; Habib, Nagy; Jiao, Long
Hammersmith Hospital, London, UK
Background. Liver resection remains a major surgical procedure associated
with significant intraoperative blood loss and blood transfusion requirement,
which can affect both postoperative morbidity and mortality rates as well as
long-term survival. A novel technique assisted with radiofrequency energy
can minimise blood loss in liver resection.
Objective. To evaluate the outcome of liver resection using heat coagulative
necrosis induced by radiofrequency energy.
Methods. Between January 2000 and October 2004, 156 consecutive
patients underwent liver resection with the radiofrequency-assisted techni-
que. Data were collected prospectively to assess the outcome including,
intraoperative blood loss, blood transfusion requirement, morbidity and
mortality rates.
Results. There were 30 major hepatectomies and 126 minor resections.
While total operative time was 2419/89 min, the actual resection time was
759/51 min. Intraoperative blood loss was 1399/222 ml. Nine patients (5%)
received blood transfusion, predominantly those receiving major hepatect-
omy (p/0.006). The need for transfusion was directly related to the size of
tumour (p/0.002) and intraoperative blood loss (p/0.02). Overall morbid-
ity rate (23%) was affected directly by the type of hepatectomy (p/0.009),
and the mortality rate (3.2%) by intraoperative blood loss (p/0.001). Mean
hospital stay was 129/12 days.
Conclusion. The radiofrequency-assisted technique to perform liver resec-
tion is associated with minimal blood loss, a low blood transfusion
requirement and reduced mortality and morbidity rates and can be used
for both minor and major liver resections.
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MANAGEMENT OF POLYCYSTIC LIVER DISEASE IN 53 CASES:
A 30-YEAR EXPERIENCE AT A SINGLE INSTITUTION
Azoulay, Daniel; Pascal, Gerard; Adam, Rene; Castaing, Denis
Paul Brousse Hospital, Hepato-Biliary Center, Villejuif, France
Objectives. The management of Polycystic Liver Disease ranging from
observation to Liver Transplantation is still debated. The aim of the present
study was to evaluate the respective indications of Deroofing, Liver Resection
and Liver Transplantation for the treatment of Polycystic Liver Disease.
Patients and methods. Beetween 1975 and 2004, 53 consecutive patients
with Polycystic Liver Disease were managed at a single institution: 45
Females (85%), mean age: 52 years. Twenty seven patients (51%) had an
associated Polycystic Kidney Disease. Operative Mortality, Morbidity and
long-term Results were analysed.
Results. Surgery was performed in 48 patients (91%) with highly sympto-
matic Polycystic Liver Disease: laparoscopic Deroofing in 18 patients (38%),
open Deroofing in 17 (35%), Liver Resection in 3 (6%), Liver Transplanta-
tion in 10 (21%), combined with Kidney Transplantation in 7 patients. There
was no Mortality. After laparoscopic Deroofing, there was no Conversion and
no Morbidity. After open Deroofing, a complication occured in 10/17
patients (59%), mainly Ascites (6 cases). After Liver Resection, there was
no Complications. After Liver Transplantation, Morbidity was 70%: 4
patients (40%) had a surgical complication, requiring a reintervention for 3
of them. After deroofing, long-term results (215 years) were good in all
patients with large cysts (75%) and poor in the remaining patients with small
cysts. After tranplantation all patients recovered an excellent quality of life
(29 years).
Conclusion. Laparoscopic Deroofing must be the gold standard of Poly-
cystic Liver Disease with large symptomatic cysts. Liver transplantation
should be considered as a safe option when Cyts are highly symptomatic,
small and extensive.
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MINIMUM INVASIVE TECHNOLOGIES IN TREATMENT OF
NONPARASITIC HEPATIC CYSTS
Zarivchatskiy, Michail F.1; Pirozhnikov, Oleg Yu.1; Mugatarov, Ildar N.1;
Gavrilov, Oleg V.2
1Academy of Medicine, Perm, Russia; 2Center of Surgical Hepatology, Perm,
Russia
Introduction. Development of methods of diagnosis and treatment of
nonparasitic hepatic cysts is an actual problem connected with prevalence of
the diseases and its possible complications. The present study was aimed at
working out indices and estimation of results of nonparasitic hepatic cyst
treatment with minimum invasive technologies.
Methods. Fifty four patients with nonparasitic hepatic cysts aged 3974
were examined. Localization of cysts by segments was the following: 1- 0, 2-
10, 3- 11, 44, 510, 68, 79 and 87. In 29 cases, cysts originated from
the right lobe, in 20-from the left one, 5 had bilateral localization. Diameter
of cysts ranged from 6 to 15 cm. Methods of study were the following:
clinical, biochemical, ultrasonography, computer tomography, selective
angiography, laparoscopy.
Results. Laparoscopic interventions carried out among 29 patients included
cyst fenestration, deepithelization of remaining internal membrane with
96% ethanol solution, diathermocoagulation or cryodestruction as well as
abdominal drainage: Remote results were followed up during the period
from 2 months till 4 years. Two cyst relapses were noted. They were
successfully cured using puncture and administration of sclerosant. Sono-
graphically controlled paracentetic-aspiration method was applied among 25
patients with 610 diameter cysts. After performing of 2- 3 punctures and
administration of 96% ethanol solution positive clinical and visual effects
(full obliteration of cavity in 22 patients or decrease in its volume to small
sizes- in 3 patients) were revealed.
Conclusions. Thus, while choosing method of treatment of nonparasitic
hepatic cysts, preference should be given to miniinvasive technologies
characterized by good immediate and remote results.
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MORBIDITY AND MORTALITY AFTER PARTIAL LIVER RESEC-
TION FOR BENIGN HEPATOBILIARY INDICATIONS
Erdogan, Deha; Busch, Olivier RC; Gouma, Dirk J; van Gulik, Thomas M
Academic Medical Center, Dept. of Surgery, Amsterdam, Netherlands
Background. Morbidity and mortality after liver resections have markedly
decreased. An increasing contingent of patients with benign indications is
also considered for liver resection.
Aim. To assess postoperative mortality and morbidity after liver resection for
benign liver tumors as compared to liver resection for malignant tumors (with
normal liver parenchyma).
Methods. A total of 205 partial liver resections performed between January
1992 and December 2004, were analysed (resection for biliary tumors or
HCC excluded). Major resection was defined as removal of three or more
liver segments. Postoperative morbidity was graded minor or major.
Mortality was defined as in-hospital death.
Results. Patients with benign tumours comprised 34% (70/205). Benign
indications mainly consisted of FNH (n/12; 17%), liver hemangioma
(n/11, 15.7%) and hepatocellular adenoma (n/9, 13%). The malignant
group mainly consisted of colo-rectal tumour metastases (89%, 121/135).
Patients resected for benign tumors were younger (43 vs.61 years; PB/
0.0001). Patients with malignant tumours underwent more major resections
(53 vs. 34%; P/0.013). Total morbidity rate was 31% (64/205). Major
complications occurred in 16% (22/135) in the malignant and 9% (6/70) in
the benign group (P/0.099). On univariate analysis, male gender (P/
0.029), comorbidity (P/0.020), major liver resection (P/0.004), blood
loss/500 ml (P/0.05), peroperative blood transfusion (P/0.025), surgical
irradicality (P/0.006) and prolonged operation time (PB/0.0001) were risk
factors associated with major postoperative morbidity. On multivariate
analysis, comorbidity (P/0.017, OR/3.95), prolonged operation time
(P/0.021, OR/1.009) and surgical irradicality (P/0.039) were significant.
Mortality was 3%, all after resection for malignant tumors.
Conclusion. Partial liver resection is a safe procedure for benign hepato-
biliary indications with low morbidity and no mortality. Comorbidity,
prolonged operation time and surgical irradicality were associated with major
complications.
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N-ACETYLCYSTEINE REDUCES LIVER ISCHEMIA-REPERFU-
SION INJURY BY MODULATION OF NITRIC OXIDE METABO-
LISM AND MAINTENANCE OF MITOCHONDRIAL ACTIVITY
Glantzounis, George K1; Hafez, Tarik S1; Sheth, Hemant1; Rocks, Sophie
A2; Winyard, Paul G3; Seifalian, Alexander M1; Davidson, Brian R1
1University Dept. of Surgery, Royal Free Hampstead NHS Trust, HPB and
Liver Transplant Unit, London, UK; 2Barts and the London, Queen Mary’s
School of Medicine, Bone and Joint Research Unit, London, UK; 3Peninsula
Medical School, Universities of Exeter and Plymouth, Institute of Biomedical
and Clinical Sciences, London, UK
Background. There is experimental evidence that N-acetylcysteine
(NAC) reduces warm liver ischemia-reperfusion (I/R) injury but the
mechanism of action is not completely clear. In vitro evidence suggests
that thiols are implicated in nitric oxide (NO) metabolism and that
reactive nitrogen species inhibit mitochondrial enzymes such as cytochrome
oxidase.
Aim(s)/Objective(s). The aim of the present study was to look at the effect
of NAC in NO metabolism and mitochondrial function.
Methods. Lobar liver ischemia was induced for 60 min, followed by 7 h of
reperfusion. Three groups of animals were studied (n/6 each): NAC, I/R
and sham laparotomy group. Mitochondrial activity was assessed through the
measurement of redox state of liver cytochrome oxidase (Cyt Ox) by
near-infrared spectroscopy. Nitric oxide metabolism was assessed through
measurement of plasma nitrite/nitrate levels by capillary electrophoresis and
plasma S-nitrosothiol levels by electron paramagnetic resonance spectro-
metry. Reactive nitrogen species formation was assessed by the oxidation of
the fluorescent dye dihydrorhodamine (DHR) 123 to rhodamine and
measurement of liver nitrotyrosine by mass spectrometry.
Results. In the I/R group Cyt Ox reduced significantly during reperfusion,
plasma nitrites and S-nitrosothiols were significantly increased at 5 and 7 hrs
post reperfusion, oxidation of DHR to RH increased and liver nitrotyrosine
decreased (7 hrs post reperfusion). NAC administration ameliorated the
reduction in tissue Cyt Ox, and attenuated the increase in plasma nitrites and
plasma S-nitrosothiol levels (all pB/0.05 at 5 h post reperfusion, NAC vs I/R).
Furthermore NAC reduced the oxidation of DHR 123 (pB/0.05, NAC vs I/
R,) and maintained nitrotyrosine levels.
Conclusion. The protective effect displayed by NAC in warm liver I/R is
associated with significant modulation of NO metabolism and mediated by
allowing the continuous maintenance of mitochondrial activity.
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NATURAL HISTORY OF RIGHT HEPATECTOMY EXTENDED TO
SEGMENT IV AFTER PORTAL VEIN EMBOLISATION
Muscari, Fabrice1; Suc, Bertrand1; Frezza, Anna1; Pey, Francois2; Sharaan,
Mohamed1; Otal, Philippe2; Fourtanier, Gilles1
1University Hospital of Rangueil, Digestive Surgery, Toulouse, France;
2University Hospital of Rangueil, Radiology, Toulouse, France
Background. To analyse biological changes after right hepatectomy ex-
tended to segment IV that was subjected to portal vein embolization and in
patients with uneventful postoperative course
Materials and methods. From August 2004 to July 2005. fifteen patients
underwent right hepatectomy extended to segment IV after portal vein
embolization. The procedure of embolization was done by the same
radiologist using a percutaneous way and histoacryl particles. A volumetric
CT scan was done before and 4 weeks after the embolization.
Results. The delay from embolization to surgery was 1 month. The median
duration of intraoperative clamping of the hepatic pedicle was 45 minutes.
The mean percentage of remaining liver calculated before embolization and
its ratio in relation with the patient’s weight was of 21%///6 and 0.5%///
0.1. One month after the embolization it was 31%///7 and 0.8%///0.2
and the remaining hepatic volume was increased by more than 56.5%
(median). The peak of cytolysis was reached in the first postoperative day
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(260 for ALAT and 250 for ASAT), with a most important elevation of the
ALAT, and a return to normal values after the first postoperative week. The
factor V decreased during the first 48 postoperative hours (minimum of 58%)
and returned to normal on the forth postoperative day. The pick of
hyperbilirubinemia occured in the third postoperative day (37 umol/l) and
returned to normal after the first postoperative week. Increase in GGT
started from the forth postoperative day due to hepatic regeneration.
Conclusion. This work allows to know the ‘‘physiological’’ changes after
extended hepatectomy preceded by portal vein embolization in a homo-
genous group of patients without postoperative complications. The knowl-
edge of this biological changes may help to early detection of complications.
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NO-DRAIN POLICY FOLLOWING HEPATECTOMIES
Ho, Choon-Kiat; Liau, kui-Hin; Chew, Soo-Ping; Chan, Chung-Yip
Tan Tock Seng Hospital, Section of Hepatobiliary Surgery, General Surgery,
Singapore
Background. The routine placement of drains following intra-abdominal
operations has been questioned recently. Following hepatectomies, the basis
for drains is perhaps to prevent significant intra-abdominal collections and
hence reduce the incidence of abscess. Drains can also alert the surgeons to
ongoing bile leak or hemorrhage.
Aim. Having adopted a no-drain policy, we aim to assess if this strategy has
an impact on the morbidity and mortality rates.
Methods. All data of patients with hepatectomies done for a hepatic tumour
are entered into a prospective database.
Results. Between January 2003 and November 2005, there were 28 patients
who had hepatectomies performed for a hepatic tumour, of which 25 had no
intra-abdominal drains placed. 16 patients had hepatocellular carcinoma
while the rest had metastatic adenocarcinoma. 8 patients had chronic viral
hepatic infection. The livers of 9 patients were cirrhotic. The average tumour
size is 59 mm. 16 patients had a major hepatic resection of more than 3
segments. There was 1 surgical mortality from massive pulmonary embolism.
3 had pulmonary complications, one had angina, and one had prolonged
ileus. No patients were found to have any intra-abdominal collections or
abscess.
Conclusion. A no-drain policy had no adverse impact on the post-operative
morbidity or mortality rates.
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OXALIPLATIN-BASED CHEMOTHERAPY AND SEVERE HEPA-
TIC SINUSOIDAL OBSTRUCTION DOES NOT INCREASE POST-
OPERATIVE MORBIDTY AFTER HEPATIC RESECTION FOR
COLORECTAL LIVER METASTASES
Nakano, Hiroshi1; Bachellier, Philippe1; Rosso, Edoardo1; Ooussoultzoglou,
Elie1; Oshita, Akihiko1; Scurtu, Radu1; Casnedi, Selenia2; Chenard, Marie-
Pierrett2; Jaeck, Daniel1
1CHU de Hautepierre, Centre de Chirurgie Visce´rale et de Transplantatio,
Strasbourg, France; 2CHU de Hautepierre, Laboratoire d’Anatomie Patho-
logique, Strasbourg, France
Background. Recently, it has been reported that oxaliplatin-based che-
motherapy may induce morphological injuries of the hepatic sinusoids and
may contribute to the development of SOS. However, no study has yet
investigated if this pathological findings affect the outcome of patients
undergoing liver resection for colorectal liver metastases.
Aim. To evaluate whether oxaliplatin-based chemotherapy and severe
hepatic sinusoidal obstruction syndrome (SOS) were associated with an
increased morbidity or to a worse postoperative hepatic function after
hepatectomy for colorectal liver metastases.
Methods. Between July 2004 and July 2005, 91 patients underwent 93 liver
resections for colorectal liver metastases in our institution. Pathological liver
specimens were evaluated for SOS* and steatosis by two pathologists. Thirty-
three patients underwent major liver resection (35.4%). Different chemother-
apy regimens were administered: Fufol n/20, Folfox n/32, Folfox/folfiri
n/16, Folfiri n/4. The mean number of session of oxaliplatin-based
chemotherapy was 8. The surgical outcome and postoperative liver blood
tests during the first five postoperative days were analyzed.
Results. Postoperative mortality was nil. Postoperative morbidity occurred in
24 patients (26.3%) including 5 specific complications. Pathological liver
specimens showed steatosis in 47 patients (50.5%) and SOS in 33 (35.4%).
SOS was significantly associated with oxaliplatin-based chemotherapy
(52.0% versus 12.5%, p/0.01, table). However, SOS and oxaliplatin-based
chemotherapy did not affect postoperative morbidity and liver function blood
tests after liver resection. No chemotherapy Fufol Folfiri Folfox Folfox/
Folfiri SOS (/) 16 (76%) 18 (90%) 3 (75%) 15 (47%) 8 (50%) SOS(/) 5
(24%) 2 (10%) 1 (25%) 17 (53%) 8 (50%)
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OXIDATIVE STRESS OCCURS DURING THE ISCHEMIC PHASE
OF INTERMITTENT HEPATIC INFLOW OCCLUSION IN MAN
AND MAY RESULT IN ANTIOXIDANT DEPLETION
van de Poll, Marcel1; Dejong, Cornelis1; Bast, Aalt2; Koek, Ger3
1University Hospital Maastricht, Nutrition and Toxicology Research Institute
Maastricht (NUTRIM), Maastricth University, Dept. of Surgery, Maas-
tricht, Netherlands; 2Nutrition and Toxicology Research Institute (NU-
TRIM), Maastricht University, Farmacology and Toxicology, Maastricht,
Netherlands; 3University Hospital Maastricht, Gastroenterology and Hepa-
tology, Maastricht, Netherlands
Introduction. Hepatic inflow occlusion reduces blood loss during liver
resection but may induce ischemia-reperfusion injury. Oxidative stress is
thought to become particularly important upon reperfusion but recent
studies indicate that oxidative stress may arise already during ischemia.
Aim. To study the effect of both ischemia and reperfusion of the liver on
oxidative stress.
Methods. We studied 10 patients undergoing hepatectomy with intermittent
inflow occlusion (15? clamping, 5? reperfusion). Arterial and hepatic venous
blood was sampled before and after each ischemia and each reperfusion
period to measure markers of lipid peroxidation (MDA) and antioxidant
activity (total endogenous antioxidant capacity (TEAC) and uric acid).
Results are expressed as mean9/SE difference between hepatic venous and
arterial concentration ([HV-A]).
Results. Before the first Pringle manoeuvre, [HV-A] of MDA, TEAC and
uric acid were not different from zero (p/0.4). After 15? ischemia, lipid
peroxidation and antioxidant release were significantly increased (MDA
1179/46 nM, pB/0.01; TEAC 559/209/M, p/0.08; uric acid 1069/22 mM,
pB/0.01). Within 5? of reperfusion [HV-A] of all parameters returned to
baseline values. During the 2nd ischemia period, lipid peroxidation and
antioxidant release increased similar to the first period (MDA 2059/63 nM;
TEAC 559/239/M; uric acid 589/15 mM; p/0.05 vs. 1st ischemia). During
the 2nd reperfusion, antioxidant release disappeared (TEAC p/0.4, uric
acid p/0.1 vs. zero) whereas lipid peroxidation still occurred (MDA 1229/
32, pB/0.01 vs. zero).
Conclusion. Oxidative stress and lipid peroxidation occur during short-term
ischemia of the liver and disappear upon reperfusion. After a cumulative
ischemia time of 30 minutes there appears to be a dysbalance between
oxidative stress (MDA release) and antioxidative capacity (uric acid release).
Administration of lipophilic antioxidants before induction of hepatic ischemia
may be a way to reduce oxidative stress.
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PARAMETERS OF CHANGES IN LIVER VOLUME AND EVALUA-
TION OF FUNCTIONAL LIVER VOLUME IN PATIENTS
UNDERGOING PORTAL EMBOLIZATION BEFORE MAJOR
HEPATECTOMY
Nanashima, Atsushi; Sumida, Yorihisa; Abo, Takafumi; Sawai, Terumitsu;
Yasutake, Toru; Nagayasu, Takeshi
Nagasaki University Graduate School of Biomedical Sciences, Division of
Surgical Oncology, Nagasaki, Japan
Background and aim. Portal vein embolization (PVE) is useful for
preventing hepatic failure after major hepatectomy. However, PVE-induced
changes in liver volume are not always uniform, thus prediction of such
changes is necessary. It is also useful to examine functional liver volume as
well as morphological volume when evaluating PVE. We examined these
issues based on clinicopathologic data and image analysis.
Methods. PVE followed by hepatectomy was conducted in 26 patients.
Morphological volume was measured by CT in all patients and functional
volume was measured by 99mTc-GSA liver scintigraphy in 9.
Results. Change in volume of embolized and non-embolized liver after PVE
was /75 and 128 cm3, respectively, and rate of change was 9.5%. Volume
change was not significantly influenced by background liver disease. ALP
level correlated negatively with reduced volume in embolized liver (r//
0.433). Platelet count correlated positively with increased volume of non-
embolized liver (r/0.412, p less than 0.05). Most patients showed a better
outcome after PVE. Reduced volume of embolized lobe of patients with
posthepatectomy hyperbilirubinemia was significantly less than other patients
(/17 vs. /105 cm3, p less than 0.05). Although functional liver volume in
both lobes correlated with morphological volume (r/0.93 and 0.89),
functional volume of embolized lobe after PVE (459 cm3) was significantly
smaller than morphological volume (577 cm3, p less than 0.01) and
correlation was weaker (r/0.83, p/0.03). For non-embolized lobe, func-
tional and morphological volumes were similar (497 and 485 cm3, respec-
tively, r/0.91).
Conclusion. ALP and platelet count are useful markers of PVE-induced
liver volume changes. Differences in functional and morphological volumes
in embolized lobe after PVE indicate the usefulness of PVE.
P24.62
SURGERY FOR LIVER HEMANGIOMAS
Baimakhanov, Bolatbek1; Aliyev, Mukhtar1; Akhmetov, Yermek2; Samratov,
Timur1; Chormanov, Almat1; Sahipov, Musa1
1National Scientific Center of Surgery, Abdominal Surgery, Almaty, Kazakh-
stan; 2National Scientific Center of Surgery, Almaty, Kazakhstan
Aim. To study the surgical results of surgical treatment of hepatic
hemangioma.
Methods. From 1985 to 2005 in our centre 43 patients were admitted for
treatment of hepatic hemangioma aged from 28 to 80 years, male: 9 (20,9%),
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female-34 (79,1%). The ratio between male and female was 1:3,7. All the
patients underwent ultrasound investigation, computer tomography, mag-
netic resonance imaging, and angiography. Indication for surgical treatment
was hepatic hepatomas measuring from 56 cm, presence of pain syndromes,
solitary and multiple hepatic hepatomas of any location. During the surgical
intervention, radical operation was performed in 37 patients (86%), palliative
(suturing the tumor, tying up the branch of the artery supply the tumor with
blood)-6 (14%). In 43 patients the following surgical procedures were
performed: atypical liver resection was done in 10 patients, left sided caval
lobectomy-7, hepatic segmentectomy -4-m, 9-m patients’ right hemihepa-
tectomy and to two patient’s right side lateral lobectomy. Left side
hemihepatectomy was done in 5 patients. In multiple hepatic hemangiomas,
as a result of inability to perform a radical operation, to two patients the right
hepatic artery was tied up at bifurcation. In 4 patients during the surgical
proceduresdue to hemangioma measuring from 3, 5 to 5 cm, they were
sutured, and additionally cryo-destruction was done in two cases and in two
patients using plasmic blade.
Results. In all, the surgical manipulation in hepatic hemagiomas gives
positive clinical effects in most patients with hepatic heamgiomas (good-81,
4%), satisfactory-13,9%), unsatisfactory-4, 7%).
Conclusions. therefore, from the results obtained, we can value the
possibility of radical surgical treatment of patients with hepatic hemangioma.
Anatomical and atypical lever resection, in which the lesion could be totally
removed, is radical method for treating hepatic hemangioma.
P24.63
PERIOPERATIVE FACTORS PREDICT MORBIDITY BUT NOT
MORTALITY FOLLOWING EXTENDED HEPATIC RESECTION
Neal, Christopher P; Pattenden, Claire J; Mann, Christopher D; Metcalfe,
Matthew S; Garcea, Giuseppe; Dennison, Ashley R; Berry, David P
Leicester General Hospital, Dept. of Hepatobiliary and Pancreatic Surgery,
Leicester, UK
Introduction and aims. Advances in surgical and anaesthetic technique
have improved outcomes following hepatectomy, but mortality rates of /5%
and morbidity rates of /50% are reported following extended resections.
Identifying patients at high risk of poor outcome would enable their
consideration for alternative treatments. The aim of this study was to
determine whether preoperative and operative variables could predict poor
outcome following extended hepatectomy.
Patients and methods. Data on consecutive patients undergoing extended
hepatectomy between 1993 and 2005 were identified from an established
database. Pre-operative variables (patient demographics, underlying pathol-
ogy, haematology/biochemistry results) and intra-operative variables (opera-
tion type, synchronous procedures, resection of additional hepatic tissue,
operative duration, blood loss, blood transfusion) were correlated with
patient outcome using the Chi-squared and Mann-Whitney tests.
Results. Over the study period 103 extended right hepatectomies and 6
extended left hepatectomies were performed. Eighteen patients had resection
of additional hepatic tissue and 25 patients had synchronous intra-abdominal
procedures. Median operation time was 300 minutes (range 130 600), with a
median blood loss of 600 ml (range 1007000) and a 46.7% perioperative
transfusion rate. 30-day mortality was 2.8%, in-hospital mortality 5.5% and
in-patient morbidity 36.7%. No factor was significantly associated with in-
hospital mortality, though elevated pre-operative alkaline phosphatase and
alanine transaminase demonstrated associations that approached significance
(P/0.09 and P/0.08). Low serum albumin and increasing length of
operation correlated with increased morbidity (PB/0.02), with perioperative
blood transfusion showing a borderline significant association with morbidity
(P/0.057).
Conclusion. Perioperative variables predict morbidity following extended
hepatectomy, but not mortality.
P24.64
PORCINE LIVER: EXPERIMENTAL MODEL FOR INTRA-HEPA-
TIC GLISSSONIAN APPROACH
Cavalcanti de A.Martins, Antonio1; Ferraz, Alvaro Antonio1; Machado,
Marcel Autran2; Ferraz, Edmundo1
1Hospital das Clı´nicas, Federal University of Pernambuco, Surgery, Recife,
Brazil; 2Hospital das Clı´nicas, USP- Sa˜o Paulo, Liver Surgery, Sa˜o Paulo,
Brazil
Background. Pigs are commonly used in experimental surgery because of
anatomical and physiological similarities. In surgical setting, they have been
used as experimental models for training several techniques, including
transplants, visceral arteriography, laparoscopic cholecystectomy, etc. The
intra-hepatic glissonian approach has been considered an advance in the
modern hepatic surgery by allowing a safe resection, with minor bleeding and
maximum preservation of hepatic tissue. Training for this complex technique
has been limited to observing its clinical use in the few surgical departments
where it is routinely applied. The porcine liver has been shown to display an
arrangement that resembles the segmental aspects described by Couinaud in
the human liver. Nevertheless, the presence of glissonian pedicles for each
segment has never been demonstrated in the porcine liver.
Objective. Evaluate the porcine liver as a teaching and training model for
performing intra-hepatic glissonian resections.
Methods. Eight livers were removed from domestic white pigs weighting 35 to
45 kg. Based on anatomical landmarks, the glissonian pedicles of each pig liver
segments were dissected and biopsies were taken for histological examination
(Hematoxilin-Eosin and Masson), to analyze the presence of the glissonian
sheath.
Results. An envelope of conjunctive tissue was observed wrapping each
segmental pedicle in the porcine livers.
Conclusion. The anatomical and histological arrangement of glissonian
pedicles in porcine liver makes this experimental model a useful tool for
learning and training the intra-hepatic glissonian approach in liver segmen-
tectomies.
P24.65
POST-RADIOFREQUENCY TRANS-METASTASIS HEPATECT-
OMY: RESULTS OF A 21-CASE STUDY
Elias, D1; Manganas, D1; Goe´re´, D1; Benizri, E1; de Baere, T2
1Institut Gustave Roussy, Surgical Oncology, Villejuif, France; 2Institut
Gustave Roussy, Interventionnal Radiology, Villejuif, France
Background. The post-radiofrequency (RF) trans-metastasis hepatectomy
(PRFTMH) consists in using RF to first ablate an ill-located liver metastasis
(LM) along the planned hepatectomy resection line, the only one possible for
volumetric reasons, and then to perform the hepatectomy passing via this
initially ablated LM. The aim of this study was to report the feasibility and
efficiency of this new approach.
Patients and methods. Twenty-one patients were treated with PRFTMH
between January 2000 and May 2004. Thirteen of them had a primary
colorectal tumour, four had a primary endocrine tumour and four had
miscellaneous primaries. The mean number of LMs per patient was 13.8
(10.7 for primary colorectal tumours and 22.2 for primary endocrine
tumours). Pre-operative hypertrophy of the future remaining liver was
obtained by selective portal vein embolisation in 11 patients.
Results. One patient died post-operatively (4.7%) and five developed
complications (24%). No local recurrence has occurred at the site of
PRFTMH after a median follow-up of 19.4 months (range: 747), demon-
strating the efficacy of this technique. All patients, except the patient who died
post-operatively, are currently alive, and the median survival rate has not yet
been attained, after a median follow-up of 19.4 months.
Conclusion. Post-radiofrequency trans-metastasis hepatectomy combining
RF ablation and trans-metastasis hepatectomy is a new and safe technique,
allowing a curative approach to be proposed to some patients with unresectable
bilateral LMs.
P24.66
PREOPERATIVE PLANNING AND SIMULATION OF PROCE-
DURES IN LIVER SURGERY BASED ON STANDARD CT IM-
AGESFIRST RESULTS FROM CLINICAL PRACTICE
Sojar, Valentin1; Hribernik, M2; Glusic, M3; Popovic, P3; Brencic, E3; Kreuh,
D4; Fius, T4; Velkavrh, U4; Stanisavljevic, D1
1University Medical Centre, Dept. of Abdominal Surgery, Ljubljana, Slove-
nia; 2Medical Faculty, Institute of Anatomy, Ljubljana, Slovenia; 3University
Medical Centre, Institute of Radiology, Ljubljana, Slovenia; 4Sekvenca Inc.,
Ljubljana, Slovenia
Purpose. New technologies, more frequently used in planning in complex
surgeries, include 3D reconstruction of diagnostic images (CT, NMR) and
virtual reality (VR). Two years ago our group developed the software for liver
surgery planning and simulation in VR based on 3D reconstruction from CT
images.
Methods. In the last two years the software was used in clinical practice in over
80 patients in different hospitals in Europe, USA and Australia. Retrospective
study in 24 patients was carried out in our institution (22 liver mets., 2 HCC).
The definitive surgical procedure was compared to the procedure planned on
the base of CT images and to the procedure planned on the base of 3D
reconstruction with preoperative surgery simulation. Subjective evaluation of
software use was performed as well.
Results. In 8 patients four or more liver segments were resected. In 9 pts.
the performed surgical procedure matched the preoperative virtual surgery
based on 3D reconstruction, or was superior to the preoperative planning
based on CT scans. Conversely, in 3 pts. preoperative evaluation of CT
scans successfully predicted the executed surgical procedure while 3D
reconstruction did not. In the remaining cases, either all three procedures
agreed (7 pts), or were in agreement but disagreed with the executed
surgical procedure (3 pts), or all three procedures disagreed (2 pts). Two
experienced surgeons found the computer program/software for liver surgery
simulation user friendly, helpful and would not have operated 8 patients
without it.
Conclusions. There are only a few systems available in clinical practice
which allow not only the visualization, but also the manipulation and
simulation of the surgical procedures. Our group successfully developed
and put into routine use a software application for liver surgery. The first
clinical results showed reliable presentation of the data and simple use for the
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surgeon. Our goal is now to further bring the method in clinical practice and
development in other surgical fields.
P24.67
PREVENTION OF BILE LEAKS AFTER HEPATECTOMY USING
A BIPOLAR VESSEL SEALER (BVS)
Evrard, Serge1; Leblanc, Fabien1; Lalet, Caroline2; Mathoulin-Pe´lissier,
Simone2
1Institut Bergonie´, Digestive Tumours Unit, Bordeaux, France; 2Institut
Bergonie´, Clinical Research Unit, Bordeaux, France
Background. A technique using a bipolar low thermal acting system
inducing not protein coagulation but collagenic sealing is available to control
vessels in general surgery. The aim of this work was to assess whether such a
device could be useful to secure hepatic parenchyma cutting.
Methods. Thirty consecutive hepatectomies were carried out using kellyclasy
plus ligatures and clips (controls); the following 50 using kellyclasy plus
bipolar vessels sealer (BVS). Blood loss, duration of hepatic pedicle
clamping, length of hospital stay and complications were recorded.
Results. There was no statistically significant difference in blood loss and
duration of clamping between controls and BVS. Specific complications (9/
21, a sub-phrenic abscess, 2 hemorrhages, 2 bile collections, 2 bile effusion
treated medically, 2 pleural effusions in the control group vs 1/49, a
reoperation for homeostasis for the BVS group: pB/0.00045) and length of
hospital stay (14 days for controls vs 11 days in the BVS group: pB/0.014)
were statistically lower in BVS group.
Discussion. Blood loss was not brought down by using BVS probably due to
temporal vascular inflow occlusion. Despite a strong trend, we failed to
demonstrate statistically that BVS reduces the time taken to perform
hepatotomy. The complications due to bile duct leakage such as bile effusion,
bile collection and subphrenic abscess were absent in the group operated on
using BVS, the very opposite of what has been reported for the harmonic
scalpel. This hypothesis that BVS allows a real prevention of bile leaks should
know be compared with classical options of hepatotomies; For this study, the
gold standard would be a randomized trial. What should BVS be compared
to, surgical clips, classical electrocautery, ligatures or a mixture of all three?
Another option might be prospective data collection with continuous
performance evaluation, a recommended approach for the analysis of
technical innovations (Lilford RJ et al. BMJ 2000;320:43 6.).
P24.68
PROGNOSTIC ANALYSIS OF HEPATIC RESECTION FOR COL-
ORECTAL LIVER METASTASIS
Aoki, Taku1; Tanaka, Soichi2; Okubo, Takao2; Umekita, Nobutaka2
1University of Tokyo, Dept. of Surgery, Tokyo, Japan; 2Tokyo Metropolitan
Bokutoh Hospital, Dept. of Surgery, Tokyo, Japan
Background. Surgical resection is the treatment of choice for colorectal liver
metastasis; however, the limitations of surgery remain unclear.
Aim/Objective. The aim of the present study is to clarify the limitations of
surgical treatment by investigating the prognostic factors after aggressive
resections for colorectal liver metastases including hilar lymph node
metastases and a minor peritoneal seeding if present.
Methods. All patients who underwent surgery for colorectal liver metastases
at Tokyo Metropolitan Bokutoh Hospital between September 1988 and
December 2004 were identified from a prospective database.
Results. A total of 229 curative hepatectomies were performed during
the study period. Liver metastases were synchronous in 122 patients.
Peritoneal seeding and hilar lymph node metastasis were present in 17 and
9 patients, respectively. The median tumor number was 3, and median
tumor size was 4.0 cm. Tumor recurrence occurred in 130 patients (69.9%),
of whom 38 patients underwent 43 repeat hepatectomies. Overall survival
rate at 1, 3, and 5 year was 83, 46, and 26%, respectively; the median survival
period was 25.0 months. After multivariate analyses, Dukes C grade,
peritoneal seeding, and hilar lymph node metastasis were identified as
significant prognostic factors; their hazard ratios were 1.85, 2.32, and 2.96,
respectively. However, 2 of 9 patients with hilar lymph node metastasis
survived over 40 months.
Conclusion. Aggressive surgical resection for colorectal liver metastases
yielded median survival time of 25.0 months and 46% overall survival rate at
3 years. Concomitant peritoneal seeding seemed contraindication for liver
resection; however, other indications/contraindications are still to be esti-
mated.
P24.69
PROGNOSTIC VALUE OF THE REMNANT LIVER VOLUME FOR
POSTOPERATIVE LIVER INSUFFICIENCY AFTER MAJOR LI-
VER SURGERY
Thelen, Armin1; Jonas, Sven2; Benckert, Christoph2; Lopez-Ha¨nninen,
Enrico3; Neuhaus, Peter2
1Charite Campus Virchow-Clinic, General, Visceral and Transplant Surgery,
Berlin, Germany; 2Campus Virchow-Clinic, General, Visceral and Trans-
plant Surgery, Berlin, Germany; 3Charite Campus Virchow-Clinic, Radiol-
ogy, Berlin, Germany
Background. Liver insufficiency remains the main reason for postoperative
mortality after major liver resections.
Aim/Objective. This study is conducted to investigate the value of
preoperative markers as predictors for postoperative liver insufficiency in
patients receiving a major liver resection, with special focus on the remnant
liver volume.
Methods. Between January 1988 and December 2005 222 patients under-
went a right trisectionectomy. To date, in 39 patients, operated between
January 2004 and December 2005, the preoperative liver volume was
measured and the postoperative results were retrospectively analysed.
Results. In 9 of the 39 patients the remnant liver volume represented less
than 15% of the whole liver. In this group of patients, 89% (8 of 9 patients)
suffered from postoperative liver insufficiency and 4 patients (44%) died
postoperatively from liver insufficiency. In patients with a remnant liver
volume exceeding 15% of the whole liver, only 6 patients (20%) suffered
from postoperative liver insufficiency and 2 (6,7%) patients died from by
postoperative liver failure. The rate of postoperative liver insufficiency was
statistically significant different between the two groups (pB/0,001). Also the
rate of postoperatively by liver insufficiency deceased patients was statistically
significant different between both groups (pB/0,05).
Conclusion. A remnant liver volume of less than 15% of the whole liver is
associated with increased postoperative liver insufficiency and postoperative
mortality after major liver resections. Further investigation is needed to
establish markers which help to calculate the postoperative risk for liver
insufficiency in patients with small remnant liver volumes.
P24.70
IRON METABOLISM IN PATIENTS WITH LIVER METASTASES
FROM COLORETAL CANCER. PRELIMINARY DATA
Serrablo, Alejandro1; Borque, Angel2; Garcia-Erce, Jose´ Antonio3; Esarte, J1
1Miguel Servet University Hospital, General Surgery, Zaragoza, Spain;
2Miguel Servet University Hospital, Urology Dept., Zaragoza, Spain;
3Miguel Servet University Hospital, Blood Bank, Zaragoza, Spain
Introduction. The preoperative anaemia is the fundamental but the main
reason of blood transfusion in the surgical patient. For this, its correction is
more important in the programmed surgery with the purpose to reduce or to
avoid the allogenic transfusion (ABT). The oral iron administration, alone or
together with erythropoietin (EPO), so much in patients included in
programs autodonation as in preoperative protocols, is useful for the per-
operative anaemia correction, especially in oncologic patient or with a chronic
illness. Nevertheless, there is some circumstances in those that the oral
ferrotherapy is inadequate, not well tolerated or it is contraindicated.
Aims. To analyze the preoperative iron metabolism in the patients with liver
metastases from colorectal cancer.
Materials and Methods. The patients with liver metastases from colorectal
cancer that are sent to predeposit self-donation program are analyzed. It is
determined the metabolism of iron preoperative parameters.
Results. The mean age was 61.92 years. The median of reticulocytes was 57,
reticulocytes% was 1.35, the sideremia mean 88, transferring mean level
245.6, the median of ferritin 57 and transferring saturation 21.5. The mean
of sTFR and CRP was 2 and 3.45, respectively. 25% of analyzed patients
had Hb 124 g/L, ferritin 38, transferring saturation 14, sTFR 2.5 what
indicates a ferropenic anaemia and, CRP 8 what produce a functional
iron deficiency. The analysis with Contingency showed that: 25% of all
patients had sideremia low levels, .54,5% of the patients with ferritin B/100
had PCR/2.
Conclusions. The patients with liver metastases from colorectal cancer
suffer from a ferropenic status in 25% Futhermore, the ‘‘ inflammation ’’
component would cause a functional iron deficit. In conclusion, the use of
intravenous iron therapy in metastatic illness should be kept in mind for the
preoperative preparation and the postoperative correction being able to
diminish the rate of per-operative ABT.
P24.71
PROSPECTIVE EVALUATION OF COMBINED USE OF HARMO-
NIC SCALPEL AND ULTRASONIC DISSECTOR VERSUS CLAMP
CRUSHING TECHNIQUE FOR HEPATIC PARENCHYMAL
TRANSECTION
Arru, Marcella; Pulitano`, Carlo; Aldrighetti, Luca; Catena, Marco; Finazzi,
Renato; Ferla, Gianfranco
San Raffaele Scientific Institute, Vita-Salute San Raffaele, Dept. of Surgery
Liver Unit, Milan, Italy
Background. The optimal method of transecting liver parenchyma has not
been yet established.
Aim. To evaluate the feasibility and effectiveness of combining two different
electronic devices, the ultrasonic dissector and the harmonic scalpel, during
hepatic resection.
Methods. One hundred consecutive patients underwent liver resection using
ultrasonic dissector (UD) plus harmonic scalpel (HS), between January and
December 2004 (UD/HS group). Patients with concomitant colonic
resection or biliary-enteric anastomosis were excluded from the study. The
ultrasonic dissector was used to fracture liver parenchyma and the uncovered
vessel were sealed using the HS. Surgical outcomes were compared with 100
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consecutive patients who underwent liver resection using the clamp crushing
method (CC group). Operative variables, postoperative liver function,
hospital stay, and type and number of complications were compared.
Results. The two groups were equivalent in term of demographic and
pathologic variables. The UD/HS group had a decreased blood loss (500
mL versus 700 mL, P/0.005), number of patients transfused (22 versus 39,
P/0.009), tumour exposure at the transection surface (4 versus 12, P/
0.012), hospital stay (7 versus 8.5 days, P/0.020). Postoperative major
complications, in particular fluid collection and biliary fistula, were sig-
nificantly less frequent in the UD/HS group (2 versus 9, P/0.030). A
longer operative time was recorded in the UD/HS group (385 versus 330
minutes, P/0.001).
Conclusions. The combined use of UD with HS allows liver resection to be
safely performed, with the advantage of reducing blood losses and surgical
related complications. The only major disadvantage may be a longer
transection time.
P24.72
REMOTE ISCHEMIC PRECONDITIONING MODULATES HEPA-
TIC MICROCIRCULATION TO AMELIORATE HEPATIC ISCHE-
MIA REPERFUSION INJURY IN A RAT MODEL
Tapuria, Niteen1; Junnarkar, Sameer P2; Yang, Wenxuan3; Seifalian, Alex-
ander M3; Davidson, Brian R2
1Royal Free Hospital, Hepatobiliary Surgery, London, UK; 2Royal Free
Hosp, Hepatobiliary Surgery and Transplant, London, UK; 3Royal Free
Hospital, Surgery, London, UK
Introduction. Liver resection and transplantation surgery involve a period of
ischemia reperfusion injury (IRI) which initiates an inflammatory cascade
resulting in hepatic and remote organ injury. It has been established that
remote ischemic preconditioning (RIPC) protects the liver. RIPC entails
brief periods of limb ischemia followed by reperfusion. The effect of RIPC on
the hepatic microcirculation has not been studied previously.
Hypothesis. RIPC would protect the liver from ischemia reperfusion injury
by modulation of the hepatic microcirculation.
Aim. To use a well described model of ischemia reperfusion injury to study
the effect of RIPC on the hepatic microcirculation under intravital micro-
scopy.
Methods. The effect of RIPC was studied in a rat model of ischemia
reperfusion injury with partial liver ischemia (70)% followed by 3 hours of
reperfusion. Three groups of animals namely Sham, IRI and RIPC/IRI were
studied with six animals in each group. Hepatic microcirculation was assessed
by measuring velocity of blood flow and sinusoidal perfusion and apoptosis
was assessed by propidium iodide staining under intravital microscopy.
Results. The velocity of blood flow was significantly better in the RIPC
group as compared to the IRI group at the end of three hours of reperfusion
(PB/0.05)but no statistical difference was found between Sham and RIPC
groups. Sinusoidal perfusion was better in RIPC group compared to the IRI
group. The number of apoptotic cells were significantly less in the RIPC
group compared to IRI (PB/0.05).
Conclusion. RIPC protects the liver from IRI by modulation of the hepatic
microcirculation.
P24.73
REPEATED LIVER PROCEDURES FOR COLORECTAL METAS-
TASES
Treska, Vladislav; Skalicky, Tomas; Sutnar, Alan; Liska, Vaclav
University Hospital, Alej Svoe´body 80, Dept. of Surgery, Plzen, Czech
Republic
Background. Recurrence of colorectal liver metastases (CRLM) developes
in 6080% of patients in the various time interval after primary liver
procedure for CRLM. It is believed that only chance for patients survival are
repeated liver procedures. Without possibility of such treatment the majority
of patients die within one year.
Aim. The aim of this study was to evaluate the long-term results of repeated
liver procedures for recurrent CRLM.
Methods. The authors operated on a total of 156 patients with CRLM from
January 1, 2000 to December 1, 2005. Repeated procedures (liver resection,
and/or RFA) were performed on 25 patients in the interval 637 months
after primary liver surgery. A total of 53 procedures were performed. Long-
term results were compared with the group of patients (N/131) where only
one type of liver procedure was performed. Statistical analysis was performed
using S.A.S. software (Statistical Analysis Software) release 8.02.
Results. 30 day post-operative mortality (N/25) was zero. 83.4%, 65.0%
and 34.7% of patients survived 1.2 and 3 years after the repeated
procedures. Disease free interval (DFI) was 32.2%, 5.4% and 0% for 1, 2
and 3 years. 30 day post-operative mortality (N/131) was 0.8%. 76.6%,
51.8%, 31.8% survived 1, 2 and 3 years after the liver procedures (pB/0.08).
DFI in this group of patients for 1, 2 and 3 years was 57.9%, 35.1% and
17.5% (pB/0.0001).
Discussion. Although in our group of patients a 3-year DFI was zero, and
11.6% of patients survived in average 1.9 years without relapse, it is very
important to note that the 3-year survival rate of our patients after repeated
liver procedures was 34.7%. Repeated resections or RFA give the patient the
highest chance of long-term survival.
Conclusion. Repeated liver procedures are fully indicated. They signifi-
cantly prolong the life of patients with CRLM recurrence. (Sponsored by
Grant NR83013/2005).
P24.74
RESECTABILITY OF LIVER METASTASES FROM COLO-
RECTAL CARCINOMA FOLLOWING IRINOTECAN-BASED
CHEMOTHERAPY
Polkowski, Wojciech P; Lewicka, Monika E; Budny, Witold M; Wierzbicki,
Ryszard L; Mielko, Jerzy; Kurylcio, Andrzej M; Stanis3 awek, Andrzej J
Medical University of Lublin, Dept. of Surgical Oncology, Lublin, Poland
Background. In patients with liver metastases (LM) from colorectal
carcinoma, liver resection offers the chance of long-term survival. However,
resectability rate in patients untreated with chemotherapy is only 10 25%.
Modern neoadjuvant chemotherapy has the potential ability to render
formerly unresectable patients resectable. Aim of the present study is to
assess influence of chemotherapy with irinotecan-based regimen on resect-
ability rate of LM in patients with colorectal carcinoma.
Patients and methods. Between January 2004 and March 2005, 66
patients with metastatic colorectal carcinoma were treated with the CLF1
regimen (Irinotecan 180 mg/m2 day 1; 5-FU 400 mg/m2 day 1 followed by 5-
FU 600 mg/m2 days 1 and 2; Leucovorin 200 mg/m2 days 1 and 2) every two
weeks. In 35 out of the 66 patients (53%), liver was the only metastatic site of
the disease.
Results. Seventeen patients were scheduled for primary surgical exploration.
In 5 patients understaging of the disease in the preoperative work-up was
found and further resection was postponed. In 12 patients following resection
procedures were performed (12/17; resectability: 71%): hemihepatectomy-7,
bisegmentectomy-4, (mono)segmentectomy-1. None of the 5 initially ex-
plored patients did have a response justifying re-exploration and resection,
after subsequent chemotherapy with CLF1. Whereas out of 18 patients with
primary non-resectable LM, three patients were subsequently explored due
to partial response to the chemotherapy. Resection of LM was done in 1 out
of the 3 patients. Altogether, resectability rate of primary non-resectable
tumours following CLF1 chemotherapy was 4.4% (1/23). Moreover, in 1
patient following initial bisegmentectomy and on further CLF1 treatment,
repeat hemihepatectomy was necessary for recurrent LM.
Conclusion. Irinotecan-based chemotherapy in patients with initially non-
resectable LM from colorectal carcinoma renders limited resectability.
P24.75
RESULTS OF MAJOR HEPATECTOMY WITHOUT VASCULAR
CLAMPING USING RADIOFREQUENCY-ASSISTED TECHNI-
QUE COMPARED WITH TOTAL VASCULAR EXCLUSION
Ayav, Ahmet; Navarra, Guiseppe; Basaglia, Ernesto; Tierris, John; Spalding,
Duncan; Canelo, Ruben; Tracey, Jackie; Habib, Nagy; Jiao, Long
Hammersmith Hospital, HPB Surgery, London, UK
Background. Various techniques with or without vascular clamping have
been developed to improve the outcome of major hepatic resections (more
than 3 segments according to Couinaud’s classification).
Objective. To compare the results of major hepatectomies performed with
two different techniques: radiofrequency-assisted technique (RF) without
vascular clamping and total vascular exclusion (TVE).
Methods. All patients who underwent a major hepatectomy between 1994
and 2004 were identified. Outcome of liver resection with these two
techniques was compared. Data including blood transfusion requirement,
intensive care unit admission, postoperative liver function, morbidity and
mortality were collected.
Results. Seventy-eight patients underwent a major hepatectomy including
resection using TVE (n/51) and RF (n/27). Blood transfusion rate was
lower in RF group (26% vs 53%, P/0.04). Postoperative morbidity rate was
similar in both groups, but there was a reduction in postoperative liver failure
in RF group (0 vs 9, p/0.05). One patient developed biliary leak
postoperatively in the RF group. None of the patients has been reoperated
on either for postoperative haemorrhage or biliary leak. In RF group, there
was a reduction in both ICU admission (6% vs 92%, PB/0.0001) and
postoperative stay (10 vs 17 days, PB/0.004).
Conclusion. Major hepatectomy using RF is feasible and decreases the rates
of blood transfusion, postoperative liver failure, ICU admission and post-
operative stay, when compared to TVE.
P24.76
RISK FACTORS FOR INTRAHEPATIC RECURRENCE IN PA-
TIENTS WHO HAD HEPATECTOMY FOR HEPATOCELLULAR
CARCINOMA
Ibrahim, Salleh; Tay, Khoon H
Changi General Hospital, Dept. of General Surgery, Singapore
The perioperative outcome of hepatectomy for HCC has improved sig-
nificantly in recent years because of better surgical techniques and perio-
perative care. However, the long term survival is still poor due to tumor
recurrence especially in the liver remnant. These risk factors are a combina-
tion of clinical, surgical and pathological in nature. In this study, we aim to
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study these risk factors for intra-hepatic recurrence after liver resection for
HCC.
Method. There were 76 consecutive successful hepatectomy for hepatocel-
lular carcinoma from Jan 1998 to May 2003 in Department of General
Surgery, Changi General Hospital.
Results. There were 22 patients who had intra-hepatic recurrence. There
were no significant difference between this group of patients and those
without recurrence in terms of age, sex and race. The patients with
recurrence had a siginificantly higher serum aspartate aminotransferase while
the rest of pre-operative parameters were similar. There were 54.5% hepatitis
C infected patients in the group of patients with intra-hepatic recurrence
while there were 22.2% hepatitis C infected patients in those without intra-
hepatic recurrence (pB/0.013). There was no difference between the two
groups in terms of number of segments resected or mean operating time. But,
patients with recurrence had a higher blood loss as compared to those who
did not have recurrence (387///521 vs 170///183 mLs, pB/0.010).
There were significantly higher proportion of patients in the recurrence group
who had microvascular tumor thrombi (95.5% vs 18.5, pB/0.0001). There
was significantly higher number of patients who had more than one HCC in
patients who had intra-hepatic recurrence. Using multivariate analysis, serum
AST level, operative blood loss, hepatitis C infection, more than one HCC
nodule and presence of microvascular tumor thrombi were significant risk
factors.
Conclusion. This risk factors allows us to manage our patient post-operative
and some risk factors like operative blood loss can be corrected.
P24.77
SAFETY OF SIMULTANEOUS COLON AND LIVER RESECTION
FOR COLORECTAL LIVER METASTASES
Stojanovic, Miroslav1; Stanojevic, Goran1; Radojkovic, Milan1; Zlatic,
Aleksandar1; Jeremic, Ljiljana1; Mihajlovic, Dragan1; Brankovic, Branko1;
Gmijovic, Dragojlo1; Zdravkovic, Miodrag2; Kostov, Milos3
1Surgical Clinic, HPB Unit, Nis, Serbia and Montenegro; 2Forensic
Medicine Institute, Nis, Serbia and Montenegro; 3Military Hospital,
Pathology Unit, Nis, Serbia and Montenegro
Background. The surgical strategy for the treatment of resectable synchro-
nous hepatic metastases of colorectal cancer remains controversial.
Objective. The aim of this study is to asses the safety of simultaneous and
delayed liver resections and relations of morbidity to the extensiveness of
hepatectomy and perioperative factors.
Methods. Analyzed were 64 patients with liver metastases from colorectal
cancer operated between 2001 and 2005 at the University Surgical Clinic.
Results. In this period, 102 hepatic resections were performed, of which 64
procedures were done for metastatic colorectal carcinoma. Thirty (46,8%)
had synchronous hepatic metastases and all were operated by one-time
simultaneous hepatic and colon resection and were compared to 34 (53,2%)
patients with metachronous metastases who underwent colon and hepatic
resection in the staging setting. In the group of the patients operated
simultaneously 4 hepatectomies, 6 sectionectomies, 2 bisegmentectomy, 12
segmentectomies, and 6 metastasectomies were combined with colon
resection. Operation time (280 vs. 330 minutes) and intraoperative blood
loss (380 vs. 520 ml) was lower compared with. the parameters cumulated in
two staged operation. Postoperative morbidity was 22 and 35%, respectively.
There was no hospital mortality in the both groups. Patients having
simultaneous resection required fewer days in the hospital (median 10 days
versus 18 days).
Conclusion. By avoiding a second laparotomy, overall operation time, blood
loss, hospital stay and complication rate are reduced with no change in hospital
mortality. Simultaneous colon and hepatic resection is a safe and efficient
procedure for the treatment of synchronous colorectal liver metastases.
P24.78
SEGMENTAL RESECTION OF THE LIVER ALONG THE ANTE-
RIOR FISSURE
Cho, Akihiro; Asano, Takehide; Yamamoto, Hiroshi; Nagata, Matsuo;
Takiguchi, Nobuaki; Kainuma, Osamu; Soda, Hiroaki; Narumoto, Souichi;
Yokomizo, Jissei; Ryu, Munemasa
Chiba Cancer Center Hospital, Gastroenterological Surgery, Chiba, Japan
Background. The classification proposed by Couinaud, which divides the
liver into eight surgical relevant segments, both longitudinally along the
hepatic veins and transversely through the right and left portal pedicles are
widely accepted. Thus, it is believed that the right anterior portal vein
bifurcates into P8 and P5. However, portal branching patterns which differ
from those previously described are occasionally encountered during liver
surgery.
Aims. To clarify portal branching patterns in the right liver, three
dimensional portograms reconstructed from multidetector row computed
tomography (MDCT) data were evaluated.
Results. The right anterior portal vein bifurcated into the ventral and dorsal
branches, and the conventional anterior segment (right paramedian sector)
could be divided into the anterior and middle segments by the anterior fissure.
The anterior fissure vein was running along the anterior fissure as if the
umbilical fissure vein laid along the umbilical fissure. Therefore, we propose a
reclassification of the right liver that divides the right liver into three segments,
which are designated as the anterior, middle, and posterior segments. The
portal and hepatic venous ramifications are symmetrical under our reclassifica-
tion. Dissection of the liver parenchyma along the anterior fissure from
the porta hepatis made it possible to expose all Glissonian pedicles of the right
liver.
Conclusions. This new anatomical classification based on MDCT may
contribute to the development of new and safer surgical procedures including
of more limited resection to preserve the remnant hepatic function.
P24.79
SHORT TIME TO RECURRENCE AFTER HEPATIC RESECTION
CORRELATES WITH POOR PROGNOSIS IN COLORECTAL HE-
PATIC METASTASIS
Takahashi, Shinichiro; Konishi, Masaru; Nakagohri, Toshio; Gotohda, Naoto;
Saito, Norio
National Cancer Center Hospital East, Surgical Oncology, Kashiwa, Japan
Background. Early recurrence is a major problem after hepatic resection
of colorectal hepatic metastasis (CHM). Our aim was to investigate the
relationship between time to recurrence after CHM resection and overall
survival.
Methods. A retrospective analysis was performed for 101 consecutive patients
who underwent hepatic resection for CHM and have been followed more than
5 years.
Results. Among 101 patients, 82 (81%) had a recurrence. Overall survival of
patients with recurrence within 6 months after CHM resection was signifi-
cantly worse than that of patients with recurrence after more than 6 months
(PB/0.01). Overall survival was poorer when time to recurrence was shorter.
One of the reasons for poor prognosis of patients with recurrence within 6
months was that few patients could undergo a second resection for recurrence
after CHM resection. Histological type, including poorly differentiated, signet
ring cell, or mucinous adenocarcinoma in the primary tumor, bilobar
metastases, microscopic positive surgical margin and carcinoembryonic
antigen (CEA) above 15 ng/ml had predictive value for decreased recur-
rence-free survival after CHM resection.
Conclusion. Short time to recurrence after CHM resection correlates with a
poor prognosis. Histological type of poorly differentiated, signet ring cell, or
mucinous adenocarcinoma in the primary tumor might be a predictor for early
recurrence after CHM resection.
P24.80
SURGERY FOR GIANT CAVERNOUS LIVER HEMANGIOMAS
Artis, Tarik; Yilmaz, Zeki; Sozuer, Erdogan; Ok, Engin; Kucuk, Can; Akyildiz,
Hizir; Karahan, Ibrahim; Akalin, Bilsay
Erciyes University Medical School, Kayseri, Turkey
Background & aim. Approach to liver hemangiomas still remains contro-
versial. There has been an increasing enthusiasm with surgical therapy in recent
years. We aimed to report our experience with giant liver hemangiomas which
diameter of the lesions greater than 4 cm comparing enucleation with hepatic
resection.
Methods. We studied retrospectively the outcomes of surgical therapy of the
patients with giant liver hemangioma at our department between January 2001
and February 2006. Patients demographics, chief complaints, characterization
of the lesions, diagnostic tools, operative data comparing enucleation with liver
resection were analyzed.
Results. During this period 28 patients underwent surgeryfor liver heaman-
gioma. Of those 6 were male and 22 female. Mean age was 46.59/10.6 (r, 32
57). Main indications for the surgery were abdominal pain and discomfort (n/
24) and uncertainty of the diagnosis(n/4). For the diagnosis, abdominal
ultrasound was used in 10 patients and 18 patients had also CT scan for
comfirmation. Enucelation was performed on 18 patients whereas liver
resection was 10. Mean diameter of the lesions in enucleation and liver
resection were 10.59/5.4 cm (r, 525 cm) and 11 .39/4.5 cm (r, 513 cm)
respectively. Mean operation times were shorter in enucleation group (1299/72
min vs. 1929/59 min) (pB/0.05). Three patients required blood transfusion in
enucleation group whereas 9 in resection group. Hospital length of stay in
enucleation and resection group was similar which are 6.29/2.4 days and 9.39/
4.1 days, respectively. Major complications were postoperative bleeding (n/
2)1 for each group and bile leak (n/2) all in resection group. There was no
postoperative mortality.
Conclusion. For giant cavernous liver hemangiomas surgery should be
considered for the symptomatic or equivocal diagnostic situations. Enucleation
is a safe and feasible technique which preserves liver parenchyma with minimal
complication.
P24.81
SURGICAL ANATOMY OF PONS HEPATIS
Cavalcanti de A. Martins, Antonio; Dias Martins Filho, Euclides; Kreimer,
Flavio; Correia de Arau´jo Jr, Guido; Guerra, Luciano; Souza Lea˜o, Cristiano
Oscar Coutinho-IMIP Hospital, Surgery, Recife, Brazil
Introduction/Background. The pons hepatis is a prolongation of the hepatic
tissue over the umbilical fissure, between the quadrate lobe (S4) and the left
lobe of the liver (S2/3). The anatomical aspects of this structure have seldom
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being presented, despite its importance during surgical procedures as tumors
involving the pons hepatis, left lateral segmentectomies, segment IV resections,
right trisegmentectomies and split liver for transplantation. Couinaud have
described the presence of pons hepatis in 46 out of 109 liver casts. According to
Couinaud, 56,5% had a long parenchymal bridge over Rex recessus. In 2003,
Onitsuka et al proposed a morphological classification of Rex’s recessus,
according to the amount of tissue in this area (Types I to III). These authors
recognized a pons hepatis in only 25% of cases.
Objective. To observe and describe the external anatomy of pons hepatis and
Rex recessus.
Results. In 22 cases (36.5%) there were no hepatic or fibrous tissue over Rex’s
recessus (Type I), 16 patients (26.5%) had a Type II (fibrous tissue connecting
S2/S3 to S4), 20 cases (33.5%) had a pons hepatis (Type III). Two patients had
a combination of fibrous and hepatic tissue that could not be classified
according to Onitsuka’s classification (3,5%).
Conclusion. The absence of pons hepatis (Type I) is the most common aspect
observed on Rex’s recessus in this population. The pons hepatis (Type III) was
observed in 33.5% of the cases.
P24.82
SURGICAL RESECTION OF HILAR BILE DUCT CANCER NAVI-
GATED BY 3D INTEGRATED IMAGES OF BILE DUCT, PORTAL
VEIN AND HEPATIC ARTERY
Yoshida, Atsushi; Okuda, Koji; Sakai, Hisamune; Morinaga, Akio; Ogata,
Toshiro; Yasunaga, Masafumi; Kinoshita, Hisafumi; Aoyagi, Shigeaki
Kurume University School of Medicine, Surgery, Kurume, Japan
Introduction. Intrahepatic and extrahepatic vasculatures have a lot of
anatomical variations. Preoperative understanding of individual variation of
these vasculatures is essential to achieve safe and curative resection. MD-CT
offers vast and reliable data of anatomical information. In this paper surgical
resection of bile duct cancer at hepatic hilum navigated by 3D integrated
images of bile duct, portal vein and hepatic artery, which is reconstructed by
Dynamic CT and PTCD-CT, is presented. 3D integrated images: MD-CT
with 16 detectors was used. Dynamic CTwith 100 ml of Iopamidol 370, 4.0 ml/
sec and PTCD-CT with 3% concentration of contrast media was performed
metachronously. FOV was corresponded between both. The hepatic arterial
3D images and the portal venous 3D images were reconstructed from
respective time phase data. Bile duct 3D image was reconstructed from
PTCD data. Each data was integrated in the work station with 3D revision of
positioning. Advantage of 3D navigation: Preoperative understanding of intra-
and extra hepatic vasculartures. 1. Determination of accurate cutting line of the
bile duct for curative resection, which had been determined inaccurately by
conventional images. 2. Rational hepatic resection corresponding to bile duct
cutting line can be planed.
Case presentation. 72 years old female with hilar bile duct cancer. Even
cancerous lesion mainly invaded to the left hepatic duct, 3D integrated image
indicated right lobectomy was rational to achieve curative resection. The left
hepatic duct bifurcated to B2 and B3/4, and A4 accompanied along the right
side of U-point of the portal vein. The bile duct cut at the U-point preventing
injury of A4 with right hepatic lobectomy and caudate lobectomy. The
hepatico-jejunostomies of B2 and B3/4 were performed.
Conclusion. 3D integrated image is useful modality to navigate safe and
curative resection of hilar bile duct cancer.
P24.83
SURGICAL TREATMENT FOR PRIMARY AND METASTATIC
LIVER LESIONS. EXPERIENCE FROM A SINGLE CENTER
Delis, Spyros1; Bakoyiannis, Andreas1; Avgerinos, Costas1; Athanasiou,
Kostas1; Manes, Kostantinos1; Exidavelonis, Theodoros1; Giannakou, Niki2;
Kostis, Vassilios2; Papaeliou, Jiannis3; Dervenis, Christos1
1Liver Surgical Unit, 1st Surgical Dept., Athens, Greece; 2‘‘Agia Olga’’
Hospital, Athens, Greece; 3Computed Tomography Dept., Athens, Greece
Background. Surgical treatment of liver tumors is the first option nowadays.
Objective. We report our experience in surgical treatment of primary and
metastatic liver lesions.
Methods. Between 2002 and 2006,105 liver surgical procedures were
performed in our department.57 were men and 48 women with median age
of 65 yrs (3880).48 pts diagnosed with HCC,40 presented with metastatic
liver lesions,12 with hilar or intrahepatic cholangiocarcinoma and 5 with
benign lesions:focal nodal hyperplasia, or epithelioid haemangioendothelioma.
The preop staging included spiral CTor MRI. Surgical procedures include 45
major hepatectomies, 2 extended and 40 segmental with 19 intraoperative RF
ablations. Laparoscopic resection was decided in three patients.2 pts under-
went a combined liver and lung resection for CRM in one stage through an
exclusive transthoracic approach or two incisions. Two stage hepatectomy for
bilateral metastatic lessions was performed in 2 pts. Chemotherapy related
steatosis was documented in 30% of the CRM group but only 3% developed
steatohepatitis. Cholangiocarcinomas were treated with excision,lymph node
dissection and hepaticojejunostomy, with or without hepatectomy.
Results. Average time of hospitalization was 8 days (412 days). Morbidity
included 2 biliary fistulas, 5 ascites collections, 10 pleural effusion,2
intrahospital pneumonias and 5 wound infections. Postoperative mortality
was 0, 9% (one patient died due sepsis from lung aspiration). Blood transfusion
was required in 10% of our pts. The complication rate was slightly increased in
the group with steatosis but not the mortality rate. In a 3year follow up the
hepatectomy group had a 3,44% mortality due to lung metastasis, a 65%
disease free survival is also documented.
Conclusion. Surgical excision remain the treatment of choice and provides
both quality of life and prolong survival. Morbidirty and mortality are low in
specialized centers. Neoadjuvant treatment, PVE and two stage hepatectomy
increase the resectability rate with few complications
P24.84
SURGICAL TREATMENT OF HEPATIC METASTASES OF NON
COLORECTAL ORIGIN
Ryska, Miroslav; Belina, Frantisˇek; Pantoflicek, Tomas; Langer, Daniel;
Strnad, Robin; Pantoflicek, Jaroslav
Central Military Hospital, Dept. of Surgery, Prague, Czech Republic
Introduction. Surgical resection is the only potentially curative treatment for
metastatic cancer to the liver Therapeutic guidelines for treatment of colorectal
liver metastases are well defined, but it remains difficult to establish therapeutic
guidelines for heterogeneous group of noncolorectal liver metastases.
Method. 33 patients with liver metastases of different origin were preopera-
tively indicated for multimodal therapy and were operated between 1998
2005 at our department. Assesment of tumor doubling time (TDT) allows
estimation of biological activity. All patients could be then divided in 4
homogenous groups according to origin of primary tumour. Group of
metastatic Grawitz tumour, breast carcinoma, digestive tumours and a group
of different tumours. Peroperative assessing of metastatic extent allowed
application of multimodal strategy to each patient.
Results. 40 multimodal procedures (7 implantation of port catheter, 10
nonanatomical resections, 9 hemihepatectomies, 4 segmentectomies and
bisegmentectomies, 10 cytodestructive procedures) were performed. simulta-
neously at 33 patients. There were no perioperative death Postoperative
complication was seen in 18% of patients. Actuarial survival rates were 66%,
33% and 12% at 1, 2 and 3 years,. With median survival 15,9 months.
Conclusion. Low morbidity and satisfactory survival rates justify a multi-
modal approach to the surgical management of noncolorectal liver metastases.
Assesment of TDT and biological activity of primary tumour is usefull for
indication of method of treatment.
P24.85
SURVIVAL AND TUMOUR RECURRENCE IN PATIENTS WITH
COLORECTAL CANCER LIVER METASTASES UNDERGOING
RADICAL LIVER RESECTION: HAS ANYTHING CHANGED?
Schindl, Martin J; Herberger, Beata; Puhalla, Harald; Laengle, Friedrich;
Gruenberger, Thomas
Medical University of Vienna-General Hospital, Dept. of Surgery, Hepato-
biliary service, Vienna, Austria
Background. Liver surgery has become the treatment of choice in patients
with CRCLM. Resection technique and perioperative care have remarkably
improved and recent strategies focus on the prevention of tumour recurrence
by the combination of surgery and chemotherapy.
Aim(s)/Objective(s). To evaluate whether recent advancements of multi-
modal treatment improve crude and disease free survival in patients with
CRCLM undergoing radical liver resection.
Methods. Retrospective analysis of patients undergoing radical liver resection
for CRCLM at a university hospital with a specialized, multidisciplinary
hepato-biliary team. Three different groups of patients based on consecutive
periods of time (A:1992 1995, B:1996 1999, C:20002004) were defined,
reflecting improvements of surgical technique, perioperative care and the
invention of multimodal treatment. Crude survival and disease free survival
were compared between the three groups by Kaplan Meier survival curve
analysis with Log rank test statistic. In hospital mortality rates were compared
by chi-square test.
Results. 300 patients with CRCLM undergoing radical liver resection were
included in the analysis. The groups A, B and C consisted of 39, 62 and 199
patients. The clinical risk scoring was comparable between the groups. No
patient in group A, 3% of patients in B and 11% in C underwent re-resection for
hepatic recurrence. Combined neo-/adjuvant chemotherapy was given in 8%,
23% and 45% of patients in group A, B and C. The in-hospital mortality rate
was 5% in group A and B, but 0% in C (p/0.007). The mean 5-year crude
survival was 15.49/5.8% in group A, 36.69/6.2% in B and 49.89/5.7% in C (A
vs. B, p/0.025; A vs. C, p/0.0001 and B vs. C, p/0.194). The mean 5-year
disease-free survival was 17.99/7.8% in group A, 25.49/6.2% in B and 18.09/
6.0% in C (p/ns).
Discussion. Despite frequent disease recurrence, the overall prognosis of
patients with CRCLM undergoing radical liver resection has significantly
improved. Multiple factors may contribute to such achievements.
P24.86
SYSTEMATIZED SEGMENTECTOMY IS SUITABLE FOR PA-
TIENTS WITH T2 HEPATOCELLULAR CARCINOMA ACCORD-
ING TO THE MODIFIED UICC TNM CLASSIFICATION
Ariizumi, Shun-ichi; Takasaki, Ken; Yamamoto, Masakazu; Katagiri, Satoshi;
Yoshitoshi, Kenji; Hamano, Mie
Tokyo Women’s Medical University, Tokyo, Japan
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Background. Outcomes after anatomically systematized hepatectomy with
transection of Glisson’s pedicle at the hepatic hilus within each modified
International Union Against Cancer (UICC) tumor (T) category were
examined.
Objective. The effectiveness of systematized hepatectomy in the modified
UICC staging classification for hepatocellular carcinoma (HCC) has not been
clarified in detail.
Methods. We retrospectively studied 829 patients with HCC who underwent
initial hepatectomy from 1990 through 2002. We separated the liver into three
segments on the basis of the Glissonean pedicles at the hepatic hilus (Takasaki’s
liver segments). Systematized hepatectomy was classified into segmentectomy
or larger resection, and partial segmentectomy. Segmentectomy refers to
resection of one of Takasaki’s segments.
Results. The cumulative recurrence-free survival rates of segmentectomy
or larger resection and partial segmentectomy at five years were, respectively,
47% and 44% in patients with T1, 23% and 0% in patients with T3, and 27%
and 17% in patients with T4. Outcomes after segmentectomy or larger
resection did not significantly differ from those after partial segmentectomy
in patients with T1, T3 or T4. However, in patients with T2, the 5-year
recurrence-free survival rates after systematized segmentectomy or larger
resection (36%) were significantly different from those after partial segmen-
tectomy (14%; p/0.0013). Multivariate analysis showed systematized seg-
mentectomy to be a significant independent prognostic factor for recurrence in
patients with T2.
Conclusion. Systematized segmentectomy or larger resection prevents
intrahepatic recurrence in patients with T2 HCC. Therefore, segmentectomy
is suitable for patients with T2 HCC according to the modified UICC TNM
classification.
P24.87
TAPE-GUIDING TECHNIQUE FOR VARIOUS TYPES OF LIVER
RESECTION
Tanaka, Hiromu; Takemura, Shigekazu; Hai, Seikan; Yamamoto, Satoshi;
Ichikawa, Tsuyoshi; Kodai, Shintaro; Shinkawa, Hiroji; Shuto, Taichi;
Hirohashi, Kazuhiro
Osaka City University Graduate School of Medicine, Hepato-Biliary-Pan-
creatic Surgery, Osaka, Japan
Background. During parenchymal resection, operator’s left hand often
plays important roles such as guidance of the direction and control of the
bleeding. Belghiti et al. reported hanging maneuver in deeper parenchymal
resection without left-hand guidance in right hepatectomy. We applied this
technique as the tape-guiding technique (TGT) in various types of liver
resection.
Objective. To know the significance of this technique.
Patients and methods. Between April 2003 and February 2006, 26 patients
underwent liver resection using TGT. The surgical indications were primary or
metastatic liver carcinoma in 19 and living-donor for transplantation in 7.
Types of liver resection were right heatectomy with or without middle hepatic
vein in 13, extended left hepatectomy with caudate lobe in 6, lateral
segmentectomy in 2, posterior segmentectomy with right hepatic vein in 1,
central bi-segmentectomy in 1, and other non-anatomical resections in 3. A
tape was placed between liver and inferior vena cava for right hepatectomy and
extended left hepatectomy with caudate lobe. For other hepatic resections, a
tape was passed just behind the cutting plane. The tape-passing procedure was
carried out after mobilization of the liver in most of the cases, while it was done
before mobilization in some cases in whom the tumor was too large or invaded
to diaphragm. Parenchymal resection was conducted from anterior surface
down to the posterior plane and the tape.
Results. Operating time was 3.5 12.0 (median 7.5) hr. The amount of
bleeding was 505100 (median 1360) g, and allogenic blood transfusion was
needed in 6 patients (23%). Postoperative bile leakage was complicated in 4
patients (15%) and mortality was nil.
Discussion and conclusion. There seems to be some advantages in this
technique: 1) the left hand of the operator can be used freely, 2) a goal of the
transection is easily to be understood by all surgeons, 3) the section plane
becomes minimal and flat, keeping the large vessels near the plane safely.
P24.88
‘‘BLOODLESS’’ SURGERY OF THE LIVER
Chzhao, Alexey; Kobzeva, Elena; Chugunov, Andrey; Kuznetsova, Nataliya;
Zhuravel, Sergey
Institute of Emergency Medicine n.a. Sklifosovsky, Liver Transplantation,
Moscow, Russia
Background. Integral approach to the therapy of patients with liver tumors,
precision surgical technique, apparatus reinfusion of the blood, and also
rational transfusion policy make it possible to limit indications to using of the
components of the donor blood during and after operation.
Aim. To study the intra-operating blood loss and the need of using of the
components of the donor blood in liver surgery.
Methods. The results of 55 resections of the liver are presented.
Results. Since 2003 we performed 55 resections of the liver, of them major
resections there were 30 (54,5%), the resection of the 3 segments(sg.) -4 (7,
3%), the resection of the 2 sg. -10 (18, 2%), mono-segmental resection -8 (14,
5%), subsegmentectomy -3 (5, 5%). Average blood loss during the operation
was 722/-578 ml (M/-standard deviation). The volume of blood loss varied
from 100 ml with the minor resection to 3000 with extended left hemihepa-
tectomy. The Pringle maneuver was applied only in 3 (5, 5%) cases(during 7,
15 and 20 min.) The need for Cells saver arose only in 8 (14, 5%) cases, in this
case it was washed clean from 100 to 1070 ml of erythrocytes with Ht 70%. The
need of donor erythrocytes arose only in 4 (7, 3%) resections of the liver, donor
plasma-in 13 (23, 6%). The average Hb before operations was 122/-20 g/l,
Ht- 36/-4%, after operation Hb was at the level 97/-22 g/l, Ht-30/-6. 41
(74,5%). Of the liver resections were performed without the donor compo-
nents of the blood in 22 cases these were major liver resections. Operative
mortality was 2 (3, 6%). Postoperative wound infection was observed in 3 (5,
5%) cases, right pleural effusion- in 2 (3, 6%), pneumonia-in 3 (5, 5%).
Conclusion. In the most cases of liver resection there are no needs for allogenic
blood components transfusion. The requirements for donors erythrocytes
arose only in 7,3% of liver resections, donor plasma-in 23,6%.
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THE ASSOCIATION BETWEEN CENTRAL VENOUS PRESSURE,
PNEUMOPERITONEUM, AND VENOUS AIR EMBOLISM IN LA-
PAROSCOPIC HEPATECTOMY
Jayaraman, Shiva1; Quan, Douglas1; Khakar, Anand1; Yang, Hong-Ji1; Bain-
bridge, Daniel2
1University of Western Ontario, Dept. of Surgery, London, Canada; 2Uni-
versity of Western Ontario, Dept. of Anesthesia, London, Canada
Laparoscopic hepatectomy (LH) is increasingly used, however, the safety and
outcomes following LH have yet to be elucidated. The risk of venous gas
embolism is increased during liver parenchymal transection. This risk may be
increased with positive pressure carbon dioxide pneumoperitoneum (PP). This
may be further exacerbated when using low CVP anesthesia used to minimize
hemorrhage during liver resection. To determine the risk of carbon dioxide
(CO2) venous air embolism, we performed hand-assisted laparoscopic left
hepatic lobectomy in 20 domestic pigs. They were divided into three groups:
Positive Gradient (normal pressure PP (1214 mmHg) and low CVP (57
mmHg), Negative Gradient (low pressure PP (78 mmHg) and normal CVP
(1012 mmHg), and Neutral Gradient (normal pressure PP and normal CVP
or low pressure PP and low CVP. Trans-esophageal echocardiography (TEE)
was used intra-operatively to assess for the presence of air embolism in the
suprahepatic vena cava and the right side of the heart. The TEE was recorded
and analyzed postoperatively by blinded observers. CO2 embolism was also
monitored using end-tidal CO2 measurements and compared to the TEE.
CO2 embolism was demonstrated in 14 of the 20 cases. The majority of gas
emboli were small gas bubbles associated with dissection of the major hepatic
veins. There was no statistically significant difference in the occurrence of gas
emboli between the groups. Thirteen of the 14 animals experienced no
significant hemodynamic changes. One pig in the Positive Gradient group
experienced hypotension in relation to gas embolism; the effects were only
transient and did not preclude safe completion of the operation. In conclusion,
we demonstrate that CO2 embolism during LH does frequently occur. The
clinical significance of this finding appears to be nominal, however, care must
be taken when dissecting around large veins and awareness of potential venous
air embolism by the surgical and anesthesiology teams is essential. Further
evaluation of this phenomenon is required.
P24.90
THE E-PASS (ESTIMATION OF PHYSIOLOGICAL ABILITY AND
SURGICAL STRESS) SCORING SYSTEM PREDICTS MORBIDITY
AND MORTALITY FOLLOWING HEPATIC RESECTION
Neal, Christopher P; Mann, Christopher D; Pattenden, Claire J; Thomasset,
Sarah C; Dennison, Ashley R; Berry, David P
Leicester General Hospital, Dept. of Hepatobiliary and Pancreatic Surgery,
Leicester, UK
Background and aim. The E-PASS scoring system, which predicts post-
surgical risk by estimating patients’ physiological reserves and the surgical
stress that they have undergone, has been proposed as an audit tool for elective
gastrointestinal surgery. We report on the value of this system in predicting
outcome in patients undergoing hepatectomy for benign and malignant
hepatobiliary disease.
Methods. The comprehensive risk score (CRS) of E-PASS, derived from six
pre-operative variables (age, heart disease, pulmonary disease, diabetes
mellitus, performance index, ASA grade) and four operative variables (blood
loss, body weight, operation time, extent of skin incision), was compared with
the clinical outcome of patients undergoing hepatic resection between January
2001 and December 2005 using data from an established database. The
observed mortality rates were then compared with the outcomes predicted by
the E-PASS equations.
Results. Over the study period, 191 hepatectomies were performed for benign
(n/18) and malignant disease (n/173). Seventy percent of patients had
major resections (removal of more than three segments), including 58
extended hepatectomies and 59 hemi-hepatectomies. Ten percent of patients
underwent synchronous intra-abdominal procedures. 30-day mortality was
0.9%, in-hospital mortality 3.7% and in-hospital morbidity 24.6%. Increasing
CRS correlated significantly with increasing in-patient morbidity (PB/0.05)
and length of hospitalization (PB/0.05), and showed a borderline significant
association with in-hospital mortality (P/0.07). Using linear analyses, E-
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PASS-predicted 30-day and in-hospital mortality rates were 0.9% and 1.9%,
which were not significantly different from the observed outcomes (0.5% and
3.7%).
Conclusion. The E-PASS scoring system may represent a simple means
for predicting complications and mortality following hepatectomy. In
addition, it may serve as a novel tool for auditing outcomes following hepatic
resection.
P24.91
THE FALCIFORM LIGAMENT PATCH USED AS A VASCULAR-
IZED GRAFT IN HEPATOBILIARY SURGERY
Schaeffer, David F; Buczkowski, Andrew K; Chung, Stephen W; Scudamore,
Charles H
University of British Columbia, Hepatobiliary and Pancreatic Surgery,
Vancouver, Canada
The falciform ligament (FL), the remnant of the peritoneal fold, has always
been considered to be an important landmark in hepatobiliary surgery, either
open or laparoscopic. For the sake of mobilization in open hepatic resections
or to increase the operative field in laparoscopic surgery it has traditionally
been postulated to divide the falciform ligament up toward the hepatic veins
and to remove any excessive fat tissue attached to this ligament. We postulate
to use the properitoneal fat patch associated with the falciform ligament as an
autologous circumferential biological graft to seal anastomotic sites within the
bowl or the bile duct, to cover the resected area of the liver or to fill any
defects within its reach. Due to its adequate blood supply and its relative
length the falciform ligament serves as a perfect graft. This technique has
been employed extensively in our institution with good success.
P24.92
THE INFLUENCE OF HIGH SERUM TESTOSTERONE LEVEL
ON THE LONG-TERM PROGNOSIS IN MALE PATIENTS UN-
DERGOING HEPATECTOMY FOR HEPATOCELLULAR CARCI-
NOMA (HCC) OF EARLY STAGE WITHOUT VASCULAR
INVASION
Lin, Min-Che; Wu, Cheng-Chung
Taichung Veterans General Hospital, Dept. of Surgery, Taichung, Taiwan
Introduction. The influence of high serum testosterone level on the long-
term prognosis in male patients undergoing hepatectomy for HCC remains to
be elucidated. The aim of this study is to retrospectively investigate the
impact of high serum testosterone level on the risk of tumor recurrence and
long-term prognosis in male patients undergoing hepatectomy for HCC of
early stage without vascular invasion.
Methods. Between August 1995 and March 1999 forty-two male patients
undergoing curative hepatectomy for HCC of tumor-node-metastasis
(TNM) stage I & II without vascular invasion were enrolled in the study.
Preoperative serum testosterone concentration was measured. The clinico-
pathological features, tumor recurrent rates, five-year disease-free and
actuarial survival after hepatectomy were compared between the patients
with serum testosterone level in the upper half (group I, n/21) and the other
patients in the lower half (group II, n/21).
Results. The background and clinicopathological features did not differ
significantly between the group I and group II. All survivors were followed up
more than five years. Until March 2004 the patients of group I with serum
testosterone in the upper half had significantly higher percentage of 5-year
tumor recurrent rate than group II with low testosterone level (71.4% versus
28.6%, pB/0.01). The patients of group I also had significant inferior five-
year disease-free (p/0.008) and actuarial (p/0.02) survival than patients of
group II.
Conclusion. The male patients with high serum testosterone undergoing
hepatectomy for HCC of early TNM stage without vascular invasion have
significant higher 5-year tumor recurrent rates and inferior long-term
prognosis than the patients with low testosterone, signaling the strategy of
adjuvant anti-androgen treatment selectively targeted for the male patients
with high serum testosterone who had HCC of early TNM stage without
vascular invasion to achieve better long-term outcome after hepatectomy.
P24.93
THE INFLUENCE OF SIMULTANEOUS HEPATIC AND COLONIC
RESECTION ON THE CLINICAL COURSE IN RATS
Sasanuma, Hideki1; Viborg Mortensen, Frank2; Hyodo, Masanobu1; Okada,
Masaki1; Yasuda, Yoshikazu1; Funch-Jensen, Peter2; Nagai, Hideo1
1Jichi Medical School, Surgery, Shimotsuke, Japan; 2Aarhus University
Hospital, Surgical Gastroenterology, Aarhus, Denmark
Background. The surgical strategy for the treatment of colorectal cancer
and synchronous liver metastases remains controversial. A one-step proce-
dure is considered too risky by many surgeons because of postoperative septic
complications. The aim of the present study was to investigate the effects of a
colonic resection on the clinical course in rats undergoing simultaneous
hepatic resection.
Methods. In total 108 Sprague-Dawley rats were block-randomized into 6
groups. In Group I, only a laparotomy was performed. In Group II, 1 cm of
the left side of the colon was resected. In Group III, 40% of the liver was
resected. In Group IV, 1 cm of the left side of the colon was resected, and
simultaneously 40% of the liver was resected. In Group V, 70% of the liver
resected. In Group VI, 1 cm of the left side of the colon was resected, and
simultaneously 70% of the liver was resected. Rats were killed on post-
operative day (POD) 7 and evaluated. The abdominal cavity was inspected
for the presence of anastomotic leakage and abscesses. Body weight was
recorded on POD 0,3,5 and 7. Remnant liver function was evaluated on the
basis of branched amino acids to tyrosine ratio (BTR). The change in liver
weights following 40% or 70% hepatic resection was evaluated as hepatic
regeneration rate. Plasma endotoxin levels were measured in blood taken
from the caval vein.
Results. The total number of complications were significantly higher in
Group VI. A greater extent of hepatic resection was associated with a lower
body weight and BTR. Colonic resection was also associated with a lower
body weight and BTR. Hepatic regeneration rate was suppressed by
simultaneous colonic resection. Plasma endotoxin levels were increased in
groups who had simultaneous colonic and hepatic resection.
Conclusions. Simultaneous colonic and excessive hepatic resection resulted
in increased septic complications in a rat model.
P24.94
THE ROLE OF RADICAL SURGICAL TREATMENT IN THE
PREVENTION OF EARLY LOCAL RECURRENCE OF LIVER
HYDATID CYST
Yu¨ksel, Osman; Salman, Bu¨lent; Akyu¨rek, Nusret; Azy´ly´, Cem; Yy´lmaz,
Utku; Tatly´cy´oðlu, Ertan
Gazi University Medical School, General Surgery, Ankara, Turkey
Background. The main aim of the cyst hydatid (CH) is the elimination of
parasites with minimum mortality and morbidity without recurrence. Unless
the treatment reaches a success after the primary liver CH treatment, new
formed cysts are accepted as local recurrence (LR). Especially the reason for
the LR in the patients who were treated with conservative surgery (CS) is
thought to be the satellite cysts which were remained around the pericysts.
Aim. For this reason, we aimed to investigate the role of radical surgical
procedures on LR in selected cases.
Patients and methods. Between January 2001February 2005, 35 patients
with liver CH were assigned. The patients were divided into two groups
according to surgical procedures. First group was composed of 16 patients
who were undergone radical surgery whereas second group was composed of
19 patients who were undergone CS. Patients were investigated with
laboratory results and radiological findings. Preoperative abdominal ultra-
sonography, computerised tomography and intraoperative ultrasonography
were performed in all patients. The patients with the cysts which were in close
relation with the major vessels and ducts, located deep in paranchyma or
located centrally were excluded in the study. Both groups were compared
according to the length of hospital stay, cost of treatment, early LR,
intraoperative complications, postoperative morbidity, biliary fistulas and
cavity abscess.
Results. Cavity abscesses, early LR and postoperative biliary fistulas were
seen in 4 (p/0,047), 4 (p/0,041) and 5 patients (p/0,046) respectively in
CS group.
Discussion. Unless complete surgical treatment is performed, remaining of
satellite cysts which are not determined preoperatively and intraoperatively
around pericyst, may lead early local recurrences, cavity abscesses and biliary
fistulas.
Conclusion. For this reason in order to prevent the local recurrence; it must
be kept in mind that complete surgical procedures should be performed in
selected cases.
P24.95
THE SHORT-TERM RESULTS OF HEPATIC RESECTIONS,
USING SELECTIVE VASCULAR EXCLUSION (SVE) METHOD
Shirabe, Ken1; Wakiyama, Shigeki2; Gion, Tomonobu2; Nagaie, Takashi2
1Aso Iizuka Hospital, Dept. of Hepatogastroenterological Surgery, Iizuka
city, Japan; 2Aso Iizuka Hospital, Dept. of Surgery, Iizuka, Japan
Background. The reduction of blood loss during hepatic resection is very
crutial to prevent the postoperative complication. We performed hepatic
resection, using selective vascular exclusion (SVE) method in 100 patients.
Aim. The aim of this study is to clarify the sort-term results of hepatic
resection, using SVE.
Patients and methods. Between April 2004 and November 2005, one
hundred and forteen patients underwent hepatic resection in department of
hepato-gastoroenterology, Aso Iizuka Hospital. Among them, we performed
100 hepatic resections, using SVE. The performed operative procedures
were: wedge resection in 39 patients, subsegmentectomy in 18, segmentect-
omy in 25, lobectomy in 18.
Results. The median blood loss was 500 ml, and mean blood loss was 792
ml in 100 patients (10 ml/4635 ml). The blood transfusion was performed
in 15 patients (15%). No operative mortality and in-hospital death was seen
in one patient, because of cancer recurrence.
Conclusion. SVE is important technique to reduce blood loss during hepatic
resection and make hepatic resction safer.
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LIMITATIONS OF HEPATIC PARENCHYMAL TRANSECTION
USING RADIOFREQUENCY ENERGY
Park, Il Y
Holy Family Hospital, Catholic University of Korea, Surgery, Bucheon,
Korea
Introduction. Radiofrequency (RF) ablation has been widely accepted as an
effective modality for the treatment of liver tumors. Recently, the role of
radiofrequency energy in liver surgery was expended in some reports. We
made a plane of coagulation necrosis for the parenchymal transection by
using the RF energy.
Methods. Between February 2003 and July 2005, 11 patients underwent
liver resection with RF energy.
Results. There were 7 men and 4 women of median age 57 year (range 39
71). There were 9 hepatocellular carcinoma, 1 intrahepatic stones and 1
hemangioma. In all patient, hepatic resection were performed successfully
using RF energy; partial resection 7 cases, left lateral sectionectomy 2 cases
and right heptectomy 2 cases. Pringle maneuver was applied in one case.
Median blood loss was 500 ml. One patient received blood transfusion.
Median hospital stay was 14 days. Major morbidities were seen in six patients
(ascite; 4, varix bleeding; 2, recurrence; 2, hepatic failure; 1). Two patients
died of hepatoreneal syndrome. Two patients died of esophageal varix
bleeding. One patient died of hepatic failure. Although hepatic arterial and
portal branches around hilum and hepatic vein were ligated and divided
without using RF energy, the patients of right hepatectomy were dead due to
hepatic failure and hepatorenal syndrome. Two patients of Child B cirrhosis
died.
Conclusion. Liver resection using RF energy is an effective method to avoid
intra-operative hemorrhage during parenchymal resection of the liver. But
major hepatic resection in cirrhotic patients and partial resection in Child B
cirrhotic patients are not recommended.
P24.97
TISSUELINK LIVER RESECTIONA ‘TWO-SURGEON TECHNI-
QUE’
Lee, Kit F; Wong, John; Ng, Wilson; Ling, Eva; Lai, Paul B
The Prince of Wales Hospital, Chinese University of Hong Kong, Dept. of
Surgery, Hong Kong, China
Background. We report our technique of performing major liver resections
using TissueLink device to replace diathermy for haemostasis.
Aim. To assess the feasibility of this technique for major liver resections
without the need of hilar inflow occlusion.
Patients & Method. We evaluated 43 consecutive patients undergoing
major liver resections (right hepatectomy [seg 5, 6 7, 8] or left hepatectomy
[seg 2, 3, 4]) between 2003 and 2005 at our institute. Preoperative,
intraoperative and postoperative data were collected prospectively.
Results. The indications for surgery included: hepatocellular carcinoma
(58%), colorectal metastasis (28%) and other pathologies (14%). 56% of
patients had liver fibrosis or cirrhosis. Parenchymal transection was performed
by a two-surgeon technique: surgeon standing on the right side of patient
would use CUSA to dissect along the transection plane, while haemostasis
performed by the surgeon standing on the left side of the patient using
TissueLink device. Vessels or ducts /5 mm were controlled by ligatures; main
trunks of hilar structures or hepatic veins were stapled. Mean operative time
was 294 min (SD 63 mins). Mean transection time was 90 mins. Mean blood
loss was 704 ml. Five patients required blood transfusion (12%). Median
hospital stay was 13 days. There were no re-operation but one patient
developed bile leakage requiring drainage and internal stenting. Five patients
(12%) required radiological-guided drainage of abdominal collection or
pleural effusion. One patient died of post-operative liver failure and MRSA
infection on post-op day 28. All the other patients had satisfactory recovery of
liver function.
Conclusion. Our ‘two-surgeon technique’ allows meticulous haemostasis to
be carried out throughout the transection of liver parenchyma without the
need of inflow occlusion. There was no excessive blood loss. Although the
transection time takes significantly longer, perfusion to the remnant liver is
maintained throughout the procedure where ischaemia is avoided.
P24.98
TO ASSESS THE SAFETY AND EARLY IMPACT OF THE INTRO-
DUCTION OF RADIOFREQUENCY ASSISTED LIVER RESEC-
TION IN A HEPATOBILIARY UNIT
Reid, Richard1; Spalding, Duncan2; Hutchins, Robert1
1St Bartholomew’s and the Royal London Hospital, Hepatobiliary and
Pancreatic Surgery, London, UK; 2Hammersmith Hospital, Hepatobiliary
and Pancreatic Surgery, London, UK
Background. Historically, liver surgery was associated with high mortality
due to blood loss and excessive transfusion requirements. Several techniques
are associated with reduced blood loss and thus better outcome of surgery.
The aim of this study was to assess the results of a single surgeon’s (RH)
experience with tissuelinkTM, a radiofrequency-assisted (RFA) method of
resection.
Methods. Between June 2003 and December 2005 data was collated on all
patients undergoing liver resection by the senior author on an intention to
treat basis.
Results. 120 patients were laparotomised with a view to liver resection. Eight
cases (6.6%) were deemed inoperable. Ten cases (8.3%) were openly ablated.
Liver resection was performed in 102 cases. 16 cases were resected using other
resection methods electively or because of conversion from RFA. 15.6% of
resections were performed with other techniques with a failure (conversion)
rate of 8.5%. 86 tissuelinkTM resections were analysed. 39 resections
comprised three or more Couinaud segments (45%). Mean operating time
was 3.9 hours. 66% of patients required no in-hospital transfusion with a
further 10% only having one unit transfused. 73% of patients had no inflow
occlusion (with a mean inflow time of 5.8 (///1.2)mins in the others). No
CVP control was employed. Mean blood loss was 520 mls (///74 mls) with
a median blood loss of 300 mls. Transfusion requirements were 0.9///0.2
units per patient (mean) and 0 units per patient (median). Post operative
complications occurred in 20.9% with biliary leaks secondary to the technique
in 4.6%. Mortality was 1%. Mean resection margin was 5.2 mm CRC mets,
6.3 mm HCC, 15 mm biliary malignancy and 5.2 mm other tumours. There
was no significant difference in pre-operative and discharge haemoglobin
(12.9 versus 10.9).
Conclusion. Radiofrequency-assisted resection using the tissuelinkTM device
is safe and oncologically-sound. It is associated with acceptable mortality and
morbidity and (as it is not a blind technique) can be used to perform major
resections safely.
P24.99
TWO-STAGE LIVER RESECTION FOLLOWING CHEMOTHER-
APY AND PORTAL VEIN EMBOLISATION: EXPERIENCE AT A
SINGLE CENTRE
Healey, Andrew; Pai, Madhava; Ayav, Ahmet; Abulkhir, Adel; Damrah,
Osama; Tait, Paul; Laudall, C; Phillips, Rob; Wasan, Harpreet; Habib, Nagy;
Jiao, Long
Hammersmith Hospital, Imperial College, Dept. of Surgery, London, UK
Background. In colorectal liver metastases, (CLMs) only 20% of patients are
suitable for curative surgical treatment. With downstaging chemotherapy, a
further 10% of patients can be made resectable. This study reports the
outcome of staged liver resection (SLR) performed in our centre with a
combination of chemotherapy and portal vein embolisation.
Patients and methods. From February 2000, 221 patients underwent
hepatectomies, 29 of these were deemed unresectable CLMs at presentation
due to a multiple bilobar involvement. All patients underwent preoperative
chemotherapy and were reviewed at 6-cycle intervals of chemotherapy. Those
who responded to chemotherapy or had stable disease were considered for
staged liver resection with intermediary portal vein embolisation (PVE).
Those who had progressive disease were excluded. All complications and
mortality rate were recorded. All patients were followed up closely with a 3
monthly CT scan for a year, then yearly thereafter.
Results. Sixteen patients successfully completed a two-stage resection
and 6 patients are currently awaiting stage two of their resection. Seven
patients were deemed either medically unfit for anaesthetic or unsuitable
for resection due to progression of disease whilst on chemotherapy. At the
1st stage, tumourectomy or segmentectomy was the type of liver resection
with, whenever possible, a small upper midline incision and without
mobilisation of the right lobe of liver. There was no postoperative complica-
tion for stage one resection except one patient, who developed intestinal
fistula, managed conservatively. The second resection was completed in
all patients. The overall operative mortality was zero. No patient developed
post resection liver failure. At follow up, a mean 3-year survival rate was
45%.
Conclusions. Patients who have unresectable CLMs should be considered
for a multidisciplinary approach with a combination of chemotherapy, PVE
and SLR which can result in a 3 yr survival rate comparable to those with
resectable disease.
P24.100
ULTRASOUND-CONTROLLED ASPIRATION ECHINOCOC-
CECTOMY OF THE LIVER
Belekov, Janek; Osumbekov, Baish; Ismailov, Kurmanbek
Osh Regional Hospital, Surgery, Osh, Kyrgyzstan
Surgical treatment of liver echinococcosis in recent years has been superceded
by a less invasive method: ultrasound-controlled aspiration echinococcect-
omy. In the period of 20002005 34 patients underwent this procedure. 11
patients were suffering from concurrent diseases: cardiorespiratory (8),
liver (2), and blood (1). 1 patient was 31 weeks pregnant. The size of hydatid
cysts varied from 2.5 to 20 cm. Single cysts were diagnosed in 31 patients,
and in the other 3, multiple cysts were localized in both liver lobes. In
14 patients, the echinococcosis was recurrent. 10 patients had deeply
intraparenchimatous cysts. 24 patients had secondarily infected cysts contain-
ing pus. Technique for the procedure involved puncture under ultrasound
control, repeated aspiration, drainage and irrigation. In all patients puncture
was performed under local anaesthesia. For puncture used a stylet catheter.
The chitin layer was evacuated during the procedure in 13 patients. 3 patients
with multiple cysts in both lobes underwent manipulation using 2 stylet
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catheters at the same time. Irrigation of the cavity was then performed
using 30% NaCl solution. There were no complications during or after
procedure, including allergic reactions. The size of cavities during the
postoperative period was monitored by ultrasound. Time to complete
liquidation of cysts in uncomplicated cases was 13.29/3.5 days after operation,
and in complicated cases (those with multiple cysts and secondarily
infected cysts) were 24.69/4.4 days after operation. 26 patients were followed
up post-operatively, for a length of time from 6 months to 3 years. Of
those patients, there was no clinical or laboratory evidence of recurrent cysts
in 25. 1 patient developed a recurrent cyst in the right lobe of liver. During
the follow up period, there was one death, which was unrelated to the
procedure.
P24.101
UTILITY OF SALINE-LINKED RF ABLATION IN LIVER
SURGERY: EFFECT OF POWER, SURFACE DIAMETER AND
INFLOW OCCLUSION ON DEPTH OF LIVER DESTRUCTION IN
HUMANS
Strasberg, Steven M; Linehan, David C; Hawkins, William G
Washington University in Saint Louis, HPB Surgery, Saint Louis, USA
Background. Saline-linked surface radiofrequency ablation is a new techni-
que for application of RF energy to surfaces. A potential application is to
extend surgical margins. Using swine we previously studied factors determin-
ing depth of liver ablation. (Ann. Surg. 239:51827, 2004). Power, surface
area of ablation, and inflow occlusion affected depth of tissue ablation and
ability to avoid steam popping (tissue disruption). The purpose of this study
was to extend these observations to humans.
Methods. 16 patients having liver surgery were studied. Ablations were
performed in a portion of non-tumor bearing liver to be resected. A
TissueLink 3.0 saline-linked surface coagulation device was used. Ablations
were performed over nine minutes at different power/surface area combina-
tions and with and without inflow occlusion (I/O). The power/surface area
combinations were 10W/ 0.8 cm2, 15W/3.1 cm2 and 45W/12.6 cm2. After
completion of resection, the liver was sectioned and depth of tissue ablation
determined.
Results. There were no instances of steam popping. Ablation depths (mm)
with and without inflow occlusion are shown.
10W-0.8
cm2
10W-0.8
cm2
15W-3.1
cm2
15W-3.1
cm2
45W-12.6
cm2
45W-12.6
cm2
No I/O I/O No I/O I/O No I/O I/O
7 12 10 12 9 20
3 12 5 9 14 19
3 11 6 12 12 15
3 16 10 10 4 16
mean 4
mm
mean 12.8
mm
mean 7.8
mm
mean 10.8
mm
mean 9.8
mm
mean 17.5
mm
Conclusions. The 3.0 saline-linked coagulation device can safely and
consistently ablate tissue to /1 cm in depth at low powers and at various
diameters when I/O is used. Without I/O the device is also safe but results are
less consistent. A minimum of 3 mm of tissue destruction can be obtained,
which would be sufficient tissue destruction for many oncologic purposes.
The device should be very efficient at creating a residual margin left in the
patient when transecting liver close to a tumor, or in extending a resection
margin when tumor is found to be near the plane of resection.
P24.102
VALIDATION OF THE POSSUM AND P-POSSUM SCORING
SYSTEMS FOR AUDIT OF MORTALITY FOLLOWING HEPA-
TECTOMY FOR BENIGN AND MALIGNANT DISEASE
Neal, Christopher P; Pattenden, Claire J; Mann, Christopher D; Metcalfe,
Matthew S; Dennison, Ashley R; Berry, David P
Leicester General Hospital, Dept. of Hepatobiliary and Pancreatic Surgery,
Leicester, UK
Background. The POSSUM (Physiological and Operative Severity Score
for the Enumeration of Mortality and Morbidity) and its modification, the
Portsmouth (P)-POSSUM, were designed to enable audit of surgical
practice. These systems have recently been evaluated in an Eastern popula-
tion undergoing hepatectomy for hepatocellular carcinoma (HCC), but have
yet to be validated for hepatectomy for all indications.
Aim. The aim of this study was to validate the use of the POSSUM and P-
POSSUM systems, as well as an adapted POSSUM equation developed for
hepatectomy for HCC, in a Western population undergoing hepatectomy for
benign and malignant disease.
Methods. Data on patients undergoing hepatic resection between January
2001 and December 2005 were identified from our Hepatobiliary database
and analysed using the established POSSUM/P-POSSUM equations. Pre-
dicted mortality rates were compared to the observed value.
Results. Over the study period, 191 patients underwent hepatectomy.
Underling pathology included colorectal metastases (n/123; 64%), cho-
langiocarcinoma (n/22; 11.5%), HCC (n/9, 8%), neuroendocrine
malignancy (n/10, 5%), gallbladder carcinoma (n/6; 3%) and benign
disease (n/18, 9.5%). 70% of patients had major resections (3 or more
Couinaud segments), including 85 extended hepatectomies. Synchronous
intra-abdominal procedures were performed in 20 patients (10%). In-
hospital mortality was 3.7% (n/7). Using linear analysis the P-POSSUM
equation overpredicted mortality (6.1%), but the difference between
observed and predicted mortality was not statistically significant (P/
0.347). Using exponential analysis, POSSUM significantly overestimated
mortality (28%, PB/0.05), as did the recently developed adapted logistic
regression model for hepatectomy in patients with HCC using linear analysis
(22%, PB/0.05).
Conclusion. P-POSSUM significantly predicted outcome in a UK popula-
tion undergoing hepatectomy, supporting its use as a tool to audit surgical
practice in this context.
P24.103
VARIOUS INTRAOPERATIVE TRANSFUSIONS AND SURVIVAL
AFTER HEPATECTOMY FOR HEPATOCELLULAR CARCINOMA
Nakayama, Hisashi; Takayama, Tadatoshi; Inoue, Kazuto; Higaki, Tokio;
Moriguchi, Masamichi; Oikawa, Takuichi; Kanamoto, Akira; Aramaki,
Osamu; Yamazaki, Shintarou
Nihon University School of Medicine, Dept. of Digestive Surgery, Itabashiku,
Tokyo, Japan
Background. The association between intraoperative transfusion and
survival after hepatectomy for hepatocellular carcinoma (HCC) is still
controversial. This retrospective study was performed to evaluate influence
of various transfusions on survival after curative hepatic resection for HCC.
Methods. We examined 396 patients who underwent hepatectomy. The
Patients were classified into 3 groups according to the types of blood
transfusion: without intraoperative blood transfusion (None-group), with
only fresh frozen plasma (FFP-group), with fresh frozen plasma and red
blood cells (RBC-group). Postoperative complications and survival were
evaluated among the 3 groups.
Results. ostoperative morbidity and mortality of the 3 groups were 39.3% and
0.7%; None-group, 44.9% and 2.9%; FFP-group, and 65.6% and 14.6%;
RBC-group, respectively (pB/0.001). The 3- and 5-year overall survival rates
were 86.0% and 64.3%; None-group, 68.9% and 54.8%; FFP-group, and
49.5% and 39.2%; RBC-group, respectively (pB/0.001). Transfusion of red
blood cells, elder (/65 years-old), and total serum albumin levels were
independently associated with postoperative mortality. But the risk factors for
survival were total serum bilirubin levels, number of tumor, and size of tumor.
Conclusions. In the treatment of HCC, hepatectomy remains a safe and
legitimate treatment. In transfused patients, establishment of strategy for
recurrence based on TNM staging, and tumor size may be required to
improve survival.
P24.104
VASCULAR OCCLUSION DURING LIVER RESECTION-INTER-
MITTENT OR CONTINUOUS?
Radojkovic, Milan; Jeremic, Miroslav; Filipovic, Nenad; Bogicevic, Aleksan-
dar; Stojanovic, Miroslav; Zlatic, Aleksandar; Jeremic, Ljiljana
Clinical Center, Surgery Clinic, HPB Dept., Nish, Serbia and Montenegro
Background. Major concern during liver resections is reducing blood loss
from transected liver parenchyma. This could be achieved by intermittent
(IPC) or continuous (CPC) hepatic blood inflow occlusion-pedicle clamping.
There is still some controversy about the benefits of IPC and CPC in terms of
critical hepatocellular injury.
Objective. To compare the benefits of IPC and CPC by biochemical and
histopathological assesment of the degree of liver injury in rats.
Methods. 40 male Wistar rats underwent 45 minutes continuous pedicular
clamping (CPC group) and another 40 rats underwent 45 minutes
intermittent hepatic blood inflow occlusion-three 15 minutes periods of
ischaemia separated by 5 minutes periods of reperfusion (IPC group). Sham
control group consisted of 10 rats. Parameters of hepatocyte damage and
recovery including serum ALT, AST, LDH, gGT and aldolase activity and
fibrinogen concentrations were measured and specimens of the liver were
histopathologically examined on postoperative days 1, 2, 3 and 7 in 10 rats
respectively for each day in both groups.
Results. Hepatocellular damage assesed by postoperative serum concentra-
tions and activities of liver products and enzymes was significantly higher in
CPC group then in IPC group. Also, histopathological changes were more
pronounced in animals undergoing continuous ischaemia.
Conclusions. Our experimental study clearly demonstrated better parench-
ymal tolerance and lesser necrotic response to ischaemia when hepatic blood
inflow occlusion (pedicle clamping) is applied intermittently rather than
continuously.
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COST ANALYSIS OF LAPAROSCOPIC VERSUS OPEN HEPATIC
RESECTION
Buell, Joseph1; Chu, Francis2; Hess, Karen3; Thomas, Mark3; Tevar, Amit3;
Volek, Paul3; Kemmer, Nyingi4; Neff, Guy4
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1University of Cincinnati, Transplant, Cincinnati, USA; 2St. George Hospi-
tal, Carlton, Australia; 3University of Cincinnati, Cincinnati, USA; 4Uni-
versity of Cincinnati, Internal Medicine-Digestive Disease, Cincinnati, USA
Background. Laparoscopic hepatic resection has become a viable option for
benign and malignant lesions of the liver. Despite multiple studies examining
the clinical efficacy of Lap resection have been reported, to date no cost
analysis comparing lap to open hepatic resection has been performed.
Objective. This study seeks to provide a cost analysis of lap to open hepatice
resection.
Methods. A retrospective analysis of all laparoscopic and open hepatic
resections performed during 1/?05- 4/?06 at our institution was performed. All
financial cost data were identified and compared using student’s t-test.
Results. During this period 53 laparoscopic and 36 open hepatic resections
were performed. Below is the comparison of total charges and their individual
component charges.
Therapy LOS (d)
Total
Charges
Lab
Charges
OR
Charges
Rad
Charges
Pharmacy
Charges
Room
Charges
RFA 3.89/3.7 $43,902 $4,871 $31,348 $668 $1,985 $3,570
RESECT 10.59/1.9 $101,639 $16,394 $44,596 $5.544 $9,835 $15,588
P-value 0.001 .0001 .0001 NS .0001 0.001 0.01
Conclusions. Despite the considerable increase in technology related charges
(ie. EndoStaplers and re-loads, TissueLink and hemostatic agents) the operat-
ive charges were not statistically different. However the benefit of a laparo-
scopic approach clearly led to a cost benefit in length of stay and associated
services. It appears that the laparoscopic approach provides considerable cost
benefit in addition to clinical improvements over the open procedure.
P24.106
COST ANALYSIS OF PRE-TRANSPLANT ABLATION OF HEPA-
TOCELLULAR CANCER
Thomas, Mark1; Buell, Joseph2; Hess, Karen2; Tevar, Amit2; Weber, Fred2;
Rudich, Steven2; Zuckerman, Darryl2; Volek, Paul2; Kemmer, Nyingi2; Neff,
Guy2
1University of Cincinnati, Transplant, Cincinnati, USA; 2University of
Cincinnati, Cincinnati, USA
Due to the rising waiting times for liver transplantation, multiple programs
have adopted the strategy of ablating hepatocellular cancers (HCC) in
recipients awaiting transplantation. Currently two methods of ablation are
favored in the United States. The first is transarterial chemoembolization
(TACE) and the other radiofrequency ablation (RFA).
Objective. This study seeks to examine the cost effectiveness of TACE
versus RFA.
Methods. The financial data was reviewed to identify cost data associated
with both procedures including total cost and seven specific subcatagories:
Operative, Lab, Radiology, Pharmacy, Supplies, statistical analysis was
performed using a student’s t-test.
Results. 55 transplant candidates were diagnosed with HCC patients during
a one-year period 4/?054/?06; 37 were treated by RFA while 18 by TACE.
Therapy LOS (d)
Total
Charges
Lab
Charges
OR
Charges
Radiology
Charges
Pharmacy
Charges
Room
Charges
RFA 3.99/3.7 $48,124 $5,626 $32,073 $1,169 $2,960 $4,289
TACE 1.59/1.9 $13,897 $617 $246 $10,103 $1,622 $1,213
P-value 0.01 .0001 .0001 .0001 .0001 0.2 0.07
During this time no RFA mortality was incurred however in the TACE group
one mortality occurred due to a gastric perforation. In critically ill end stage
liver failure patients the use of pre-transplant tumor ablation whether TACE
or RFA appears relatively safe. This analysis does demonstrate a cost benefit
to TACE in the preoperative treatment of hepatocellular. Unfortunately
TACE does not afford an intraoperative evaluation of the patient.
Conclusions. To determine the true cost benefit of TACE a further analysis
is required. Surgical evaluation may exclude candidates from transplantation
providing considerable cost savings while TACE does not provide such a
benefit. Surgical exploration and aborted liver transplant often conveys a
significant programmatic expense.
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COST ANALYSIS OF RADIOFREQUENCY ABLATION VERSUS
HEPATIC RESECTION
Tevar, MD, Amit; Buell, MD, Joseph; Hess, NP, Karen; Thomas, MD,
Mark; Weber, MD, Fred; Rudich, MD, PhD, Steven; Volek, Paul; Kemmer,
MD, Nyingi; Neff, MD, Guy
University of Cincinnati, Cincinnati, USA
Objective. Perform a cost analysis between RFA open hepatic resection.
Methods. A retrospective analysis of all radiofrequency ablations (RFA) and
open hepatic resections was performed at our institution between 4/?05 and 4/
?06. Financial cost records were examined and compared using student’s t-
test.
Results. The two comparison groups were comprised of 28 RFA and 29
open hepatic resections. All procedures were performed in the operating
room under general anesthesia. Below are the comparison of total charges
and individual components. There were no deaths reported in either group.
Therapy LOS (d)
Total
Charges
Lab
Charges
OR
Charges
Rad
Charges
Pharmacy
Charges
Room
Charges
RFA 3.89/3.7 $43,902 $4,871 $31,348 $668 $1,985 $3,570
RESECT 10.59/1.9 $101,639 $16,394 $44,596 $5.544 $9,835 $15,588
P-value 0.001 .0001 .0001 NS .0001 0.001 0.01
Conclusions. The financial cost of RFA compared to open resection was
similar. However total costs were significantly less due to shorter hospital
stays and fewer associated charges.
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LAPAROSCOPIC CAUDATE RESECTION-SAFETY AND FEASI-
BILITY
Thomas, Mark; Tevar, Amit; Buell, Joseph
University of Cincinnati, Surgery, Cincinnati, USA
Results
PT Path Specimen Size Age WT OR EBL PRBC LOS
1 Hamartoma 4.5/2/1.4 cm 25 77 kg 485" 250cc 0 2 dys
2 FNH 3.5/3/2.8 25 59 235 100 0 2
3 FNH 9.5/9.4/7.2 25 86 120 100 0 1
4 Adenoma 3/2/2 38 71 300 50 0 2
5 Hemagioma 10/8/10 55 85 280 200 0 2
Complications. One patient developed a fever 5 days post-op from an upper
respiratory infection.
Conclusions. Laparoscopic isolated caudate resection is a technically
challenging operation, but is safe and efficacious. The mean operative times,
EBL, LOS and complications are similar to reported non-laparoscopic
cases.
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LAPAROSCOPIC LIVER RESECTION FOR SOLID TUMORS
Buell, Joseph; Thomas, Mark; Rudich, Steven; Tevar, Amit
University of Cincinnati, Surgery, Cincinnati, USA
Lobe/
Seg OR time EBL Comps LOS Cost
Laparo-
scopic
21/75 2.39/0.8 2439/265 16.8% 2.79/1.4 $23,000
Open 27/79 4.59/1.2 4859/320 21.0% 6.59/2.1 $45,000
P-value NS B/0.001 B/0.001 NS B/0.001 B/0.001
There were 3 deaths (1 hepatic failure/ETOH withdrawal, 2 mesenteric
ischemias). The mean tumor size was 4.49/3.4 cm. Mean margin was 0.9
cm9/0.9 cm. Interval follow-up was performed at 6 wks, 3, 6, 12, 18 and 24
mos. At a median follow-up of fourteen months no resection bed recurrences
were observed. Six patients (5.8%) did have either systemic or regional
recurrence (liver n/3; lung n/3).
Conclusions. Laparoscopic resection is feasible for solid hepatic tumors with
acceptable morbidity and mortality rates. Significant advantages in operative
time, EBL, length of stay and cost were observed with no compromise in
oncologic integrity.
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RADIOFREQUENCY ABLATION IN LIVER TUMORS
Thomas, Mark; Tevar, Amit; Weber, Fred; Kemmer, Nyingi; Rudich, Steven;
Neff, Guy; Buell, Joseph
University of Cincinnati, Dept. of Surgery, Cincinnati, USA
Background. Radiofrequency ablation has become an alternative therapy to
hepatic resection for both primary and metastatic tumors of the liver.
Objective. This study seeks to identify the efficacy of radiofrequency
ablation with regard to local recurrence rates and patient survival.
Methods. A retrospective analysis of all radiofrequency ablations (RFA)
performed at our institution examined charts for patient demographics,
tumor characteristics, RFA technique, tumor recurrence and patient survival.
Results. 155 ablations were performed in 115 patients. 69 patients were
male and 46 female. 63 patients were cirrhotic (35 Hepatitis C, 9 Hepatitis B,
4 Hepatitis B & C, 5 other). Mean preoperative AFP was 28399/1243. 73
Abstracts 175
were performed laparoscopically while 39 open. There was one conversion to
open. Average OR time was 3.69/1.9 hrs. Mean number of tumors was 1.89/
1.2 with a mean diameter of 3.39/2.3 cm. An average of 1.4 ablations was
performed per patient. 85 were single lesions, 20 dual, and 10 with 3 or more.
Percutaneous biopsy was attempted in all patients. Final pathology confirmed
68 hepatomas, 17 colorectal metastases, 13 non-malignant tumors, 12 non-
colorectal metastases and 5 cholangiocarcinomas. The mean hospital stay
was 2 days. Post-ablation biphasic CT studies identified 9 (5.8%) recurrent
hypervascular lesions in or peripheral to ablation beds. All recurrences
occurred at the base of an adjacent blood vessel. Overall complication rate
was 14.7% and included: visceral tissue burns (n/3;stomach, duodenum
and lung), non-fatal pulmonary embolism (n/1), bile leak (n/1), hemor-
rhage (n/1), wound infection (n/3) and leaking ascites (n/6). There were
2 deaths (1 ETOH withdrawal, 1 liver failure).
Conclusion. This current series identified a 5.8% recurrence rate and
mortality rate of 1.7%. The complication rate was equivalent to modern
resection series. The laparoscopic approach did result in several unique
complications including thermal burns to the viscera. The laparoscopic
approach continues to evolve.
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RADIOFREQUENCY ABLATION-ASSISTED LIVER SURGERY:
MINIMAL BLOOD LOSS AND NEGATIVE RESECTION MAR-
GINS
Vishnevski, Vladimir; Sergeeva, Olga
A.V.Vishnevski Surgery Institute, HPB Surgery Dept., Moscow, Russia
Background. Radiofrequency ablation (RFA)-assisted technique of liver
resections has been proposed recently for reducing the blood loss during
parenchymal dissection.
Aim/Objective. To evaluate the safety and effectiveness of the newly
proposed procedure.
Methods. Twelve RFA-assisted liver resections were performed, including
three major (2 right and 1 left hepatectomies), seven bisegmentectomies (six-
2, 3 and one -6, 7) and two wedge liver resections. Eight out of them were
combined with additional simultaneous procedures: colon reconstruction
(after Hartmann procedure)-2 (16.6%), open RFA of the liver remnant
metastases-2 (16.6%), total abdominal hysterectomy with bilateral salpingo-
oophorectomy-1 (8.3%), lung resection -1 (8.3%), partial gastrectomy -1
(8.3%) and bile duct resection-1 (8.3%). The total blood loss and the blood
loss at the hepatic stage were estimated. Four patients were followed up by
magnetic resonance (MR) imaging from 1 to 32 months.
Results. The total average blood loss was 570.89/297.3 ml, including the
245.89/149.9 ml average blood loss at the hepatic stage. No significant
difference between hepatic and non-hepatic stages was revealed (p/0.3). The
average parenchymal dissection time was 49.59/19.0 min (range 20 -90 min).
At the end of the procedure, a 1.0 thick layer of grossly ‘‘roasted’’ parenchyma
had been leaved at the liver raw surface. Nevertheless, no parenchymal
sequestration was observed. The bile leakage complicated a single procedure.
Early post-operative MR STIR T2 weighted images revealed thick (up to 20
mm) linear zones of coagulative necrosis along the resection margins. MR
follow-up demonstrated their involution both in length and thickness, which
was mostly pronounced during first 6 months after the procedure. No local
recurrences were observed at the resection margins from 6 to 32 months.
Conclusion. RFA-assisted liver surgery effectively minimizes the blood loss
and provides the safe resection margin.
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OPERATIVE CONSIDERATIONS IN THE TREATMENT OF
LIVER METASTASES IN PATIENTS WITH GASTRIC CANCER
Otto, Wlodzimierz; Komorzycki, Krzysztof; Krawczyk, Marek
Medical University of Warsaw, General, Transplantation & Liver Surgery,
Warsaw, Poland
There can be no cure for the advanced gastric carcinoma with the metastases
to the liver but maybe it is possible to improve palliation in the resectable
cases. Aim of study: to evaluate the results of palliative gastrectomy and the
resection of liver metastases combined with adjuvant chemiotherapy in
advanced gastric cancer.
Material & method. 14 patients (m.9, f.5, m.a.64) with advanced gastric
cancer localized in the prepyloric part of the stomach and with the metastases
to the liver treated since 2000. The diagnosis and staging were established
and confirmed by endoscopy and histopathology and by USG/CT evaluation
in every case. There were 8 patients in Group I: 3 with the single metastasis to
segment VI, 3 with two metastases to segment III and VI, 2 with three
metastases to segment II and III. Patients underwent gastrectomy and liver
resection/metastasectomy completed with EAP adjuvant chemiotherapy.
There were 6 patients in Group II: 2 patients with the single metastasis to
segment VI, 3 with two metastases to segment III and VI, 1 with three
metastases to segment II, III and VI. Patients underwent palliative gastro-
jejunal anastomosis completed with EAP adjuvant chemiotherapy. The
interest of the study was the time of patients survival.
Results. There were not postoperative deaths among the patients from
Group I and from Group II. The mean time of survival was established at 13
(///3) months in the patients from Group I and at 10 (/// 2) months in
the patients from Group II.
Conclusion. Resection of the liver metastases in addition to gastrectomy and
EAP chemiotherapy should be considered as the beneficial for palliative
treatment of the advanced gastric carcinoma in resectable cases.
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THE EFFECTS OF SURGICAL MARGIN AND EDGE CRYOTHER-
APY AFTER LIVER RESECTION FOR COLORECTAL CANCER
METASTASES
Zhu, Jacqui; Chu, Francis; Gunasegaram, Aravin; Morris, David
St George Hospital Campus, University of New South Wales, Dept. of
Surgery, Sydney, Australia
Background. Surgical dogma dictates that a 1 cm margin is the minimally
acceptable margin for liver resections. Involved surgical marginal has been
stated as an adverse prognostic factor after resection of hepatic colorectal
metastases. A recent paper has shown that the width of a negative surgical
margin has no influence on survival or recurrence risk. We also believe that
liver parenchymal transection technique is important as the ultrasonic
surgical aspirator (CUSA) leads to a 1 cm destruction along the transection
plane.
Aim. We would like to assess the benefit of edge ablation on survival in
patients with macroscopically involved surgical margins.
Patients/Method. Between Jan 1990 to Dec 2005, 605 patients underwent
liver resections and or ablations for colorectal cancer liver metastases. All liver
resection were performed using the CUSA transection method. Marginal
status data was available for 394 patients. Patient demographics, pathological
margins, number of lesions recurrence and survival data were collected and
analysed.
Results. 174 patients had clear margins (/1 mm R0), 100 patients had
micrcoscopically involved (B/1 mm R1) margins but were macroscopically
clear, 120 had involved margins diagnosed at time of surgery (R2) and had the
resection edge ablated with cryotherapy. After a median follow-up of 60
months, the 5-year survival rates were 40% for R0, 30% for R1and 30% for R2.
Conclusion. Even in the presence of a macroscopically involved margin, edge
ablation can results in the same 5-year survival as a microscopically involved
margin. However, a negative surgical margin, whatever the width, should be
aimed for.
P24.114
TWO HUNDRED LIVER HANGING MANEUVER FOR MAJOR
HEPATECTOMY: A SINGLE CENTER EXPERIENCES
Ogata, Satoshi; Varma, Deepak; Sommacale, Daniele; Maeda, Atsuyuki;
Dondero, Federica; Sauvanet, Alain; Belghiti, Jacques
Hospital Beaujon, Clichy, France
Objective. To establish the indications of the liver hanging maneuver for
major hepatectomy. Summary Background Data The liver hanging maneuver,
which is a technique of passing a tape along the retrohepatic avascular space
and suspending the liver during parenchymal transection, facilitates anterior
approach of major hepatectomy. However, the feasibility and limits of this
maneuver have never been established in patients with different clinical
backgrounds.
Methods. From 2000 we reviewed the medical records of 242 consecutive
patients considered for major hepatectomy using the hanging maneuver.
Results. Among 242 patients, 14 (6%) were considered to have
contraindication for this maneuver preoperatively because of tumor
infiltration to anterior surface of retrohepatic IVC. It was successful in 201
patients with overall feasibility of 88%. The feasibility increased significantly
in the recent years as compared to the initial years (94% in 20032005 vs. 76%
in 20002002, PB/0.0001). Bleeding during the retrohepatic dissection
occurred in 5 patients (2%), which was minor due to injury of hepatic capsule
in 3 (1%) and major due to injury of short hepatic vein in 2 (1%). In all cases,
bleeding stopped spontaneously. The maneuver was abandoned in 27 patients
including 15 related to severe adhesion between liver and IVC. Univariate
analysis showed adhesion between IVC and liver was the only significant
negative predictor affecting the feasibility. Cirrhosis, large tumor, preoperative
radiological treatments did not influence on the feasibility.
Conclusion. The liver hanging maneuver has 94% feasibility in recent years.
Absolute contraindication is tumor infiltration to the retrohepatic avascular
space. Adhesion between IVC and liver has a negative impact of the feasibility.
According to this indication, the hanging maneuver is easily achievable without
risk of the major bleeding during the retrohepatic dissection.
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LARGE-VOLUME MICROWAVE ABLATION: A STUDYOF IN VIVO
PORCINE LIVER
Awad, Michael1; Devgan, Lara1; Kamel, Ihab2; Choti, Michael A1
1Johns Hopkins University School of Medicine, Surgery, Baltimore, Mary-
land, USA; 2Johns Hopkins University School of Medicine, Radiology,
Baltimore, Maryland, USA
Background. In recent years, there has been an increasing interest in
interstitial ablative approaches for the treatment of unresectable liver tumors.
Thermal ablation using radiofrequency (RF) is currently the most frequently
used modality but is limited by high local recurrence rates and potential heat-
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sink effects. Microwave ablation offers many theoretical advantages when
compared to RF including a wider zone of active heating, faster ablation times,
and more consistent thermal burns.
Objective. To evaluate the performance of a novel ceramic microwave
ablation device (Microsulis Medical Ltd.) in an in vivo porcine model.
Methods. Ten 25 kg pigs underwent laparotomy. Six pigs were used for non-
survival studies in which each received multiple 100-watt ablations to the liver
for 2, 4, or 8 min, with and without inflow occlusion. Livers were then
harvested, ablation lesions excised, measured, photographed, and fixed for
histologic (H&E) and vital tetrazolium staining. Four survival pigs underwent
identical ablative protocols, but were euthanized at day 7, 14, 21, or 28 days
and liver lesions analyzed as above.
Results. In non-survival pigs, 2, 4, and 8 min ablations resulted in lesions of
3.7/4.5 cm, 3.8/4.9 cm, and 5.3/6.4 cm, respectively. Inflow occlusion
generated lesions that were 0.6 cm wider and 1.2 cm longer, on average.
Lesions contained a well-defined area of killing with smaller than 2 mm
transition zone between necrotic tissue and live cells.
Conclusions. Microwave ablation offers many of the advantages of RF
ablation and has several other theoretical advantages that may increase its
efficacy. In this study, the use of a novel ceramic-based probe resulted in rapid,
large ablative diameters of up to 7 cm in live porcine liver. In summary, the use
of a novel microwave ablation probe may result in significant improvements
over conventional RF ablation including faster ablation times, the use of
multiple simultaneous probes, more consistent ablation sizes and shapes, and
less dependence on heat sinks.
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PERICYSTECTOMY: SURGICAL MANAGEMENT FOR HEPATIC
HYDATID CYST
Lendoire, Javier1; Duek, Fernando1; Barros Schelotto, Pablo1; Alvarez
Rodrı´guez, Juan2; Garay, Vero´nica1; Quarin, Carlos1; Raffin, Gabriel1;
Imventarza, Oscar1
1Hospital Dr Cosme Argerich, Liver Transplantation, Buenos Aires, Argen-
tina; 2Hospital Dr Cosme Argerich, Surgery, Buenos Aires, Argentina
Background. The echinococcosis is a common cystic parasitic disease in our
country. The most usual localization is the liver (70%). Different surgical
strategies were described (radical resection, partial and total pericystectomy,
unroofing and fenestration)
Aim. To analyze a consecutive series of pericystectomies as a treatment of
hepatic hydatid disease.
Patients and methods. In a 10 years period (19962005) 50 patients
underwent surgical treatment for hepatic hydatid cystic disease in our unit. 42
pericystectomies and 8 liver resections were performed. Standart pericystect-
omy technique with excision, total or partial of the fibrous capsule, total or
partial (/75%) were made. Diagnosis was performed by US, CTand serology.
Follow up: US every six month during the first year and then annually.
Results. 64.3% of the patients were female with a mean age of 44.2 (2368)
SD 14.2. Symptoms were presented in 93% and pain was the most common
(83%). Right lobe was the most frecuent localization (66.7%), mean size 9.2
cm and 43% were greater than 10 cm. Only in 5 patients (12%), lesions were
multiple and intrabiliary rupture was verified in 3 (7.1%) Total pericystec-
tomies were performed in 23 (54.8). Surgical approach was conventional in
97.6% and laparoscopic in (2.4%). Morbidity rate was 28.6%, (Clavien’s
classiffication) grade I/10 (23%), grade II/1 (2,5%) and grade IIIb/1
(2,5%). There were no statistical differences between incidence of complica-
tions and cystic size or surgical technique (partial/75% or total pericystect-
omy). No mortality was reported in this series.
Conclusion. Standard pericystectomy technique is a safe procedure for
hepatic hydatid cyst with low incidence of morbidity. Should be the first option
for the treatment of echinococcosis of the liver.
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THE SAFETY AND EFFICACY OF RADIOFREQUENCY AND
ELECTROLYTIC ABLATIVE LESIONS CREATED ADJACENT TO
LARGE HEPATIC VEINS
Metcalfe, Matthew S1; Mullin, Emma J2; Texler, M2; Berry, David P1;
Dennison, Ashley R1; Maddern, Guy J2
1Leicester General Hospital, Dept. of Surgery, Leicester, UK; 2The Queen
Elizabeth Hospital, Dept. of Surgery, Adelaide, Australia
Introduction. Immediately adjacent to large hepatic veins, ablation of
tumours by radiofrequency or electrolysis may be impaired by heat or current
sink effects. Ablation adjacent to major hepatic veins may cause vessel injury
and thrombosis, with potentially serious or life-threatening thrombo-embolic
complications.
Aim. The aim of this study was to evaluate the safety and efficacy of
radiofrequency and electrolytic ablative techniques immediately adjacent to
large hepatic veins in a porcine model.
Methods. Electrolytic and radiofrequency lesions were created immediately
adjacent to large hepatic veins under ultrasound guidance in 10 large white
pigs under general anaesthesia. After 72 hours the pigs were sacrificed, and the
lesions examined histologically. The histological features sought were: (a) the
presence and uniformity of tissue necrosis up to the vessel wall (b) the presence
of intimal damage and mural thrombus adjacent to the lesions.
Results. An unexpected complication of electrolysis near large veins was
sudden death from cardiac tamponade. This was a current related phenom-
enon, and could easily be avoided. In only 7 of 9 analysable electrolysis lesions
was necrosis complete adjacent to the vessel wall, and in only 4 of 7 analysable
radiofrequency lesions.
Conclusion. Ablation of hepatic tumours by radiofrequency and electrolysis
is unreliable immediately adjacent to large hepatic veins, with tissue necrosis
often incomplete. The risks of electrolysis include death from cardiac
tamponade. Both techniques are associated with hepatic vein thombus
formation, and so may cause Budd Chiairi or pulmonary embolism. For these
reasons the use of these ablative modalities is not recommended for lesions
adjacent to hepatic veins.
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LIVER RESECTION FOR COLORECTAL CANCER LIVER
METASTASES. IS A MORE AGGRESSIVE APPROACH JUSTI-
FIED?
Bollars, Peter N; Van Dam, Ronald M.; Coolsen, Marie¨lle M; Van de Poll,
Marcel C; Bemelmans, Marc H; Greve, Jan W; Olde Damink, Steven W;
Soeters, Peter B; Dejong, Cornelis H
University Hospital Maastricht, Departement of Surgery, Maastricht, Nether-
lands
Background. Surgical treatment options for patients with colorectal cancer
liver metastases (CRCLM), have been vastly improved. In resectional liver
surgery former contraindications have been abandoned. The only limitation is
a residual volume of the liver remnant of 30%. The aim of the study was to
assess the influence of intensified patient recruitment and a more aggressive
approach on numbers of resected livers, morbidity, mortality and survival after
liver resection (LR) for CRCLM at our hospital.
Methods. A consecutive series of patients undergoing liver resection
for CRCLM after January 1st 2000 (group I, n/102), when a more aggressive
treatment strategy was introduced, was studied. Data on number of liver
resections, mortality, morbidity and survival were collected prospectively and
compared (chi-square) with historical data derived from a retrospectively
collected database from 19901999 (group II, n/32). Survival rates were
calculated and compared according to the Kaplan-Meier Method.
Results. Mean (range) follow-up for the entire study population was 6,4 years
(0,113,7). Folluw-up for the sub-groups was 1,6 years (0,15,4) and 4,6
years (0,113,7) for group I and II respectively. The median annual number of
LR for CRCLM increased from 4 (17) before 2000 to 18 (728) (p/0.003)
thereafter. Complication rate decreased from 40,6% in group II to 30,8% in
group I. Mortality dropped from 6.3% in group II to 1,0% in group I (p/
0.07). Three-year survival was 71% for group I and 53% for group II (NS)
with presently 32 patients surviving for over two years in group I. Overall 5-
year survival following LR for colorectal metastases was 44%. Long term
survival 27%.
Conclusion. Liver resection for CRCLM is safe with a mortality of 1%, an
acceptable morbidity and a 5 year survival of over 40%. Intensified patient
recruitment and a more aggressive treatment strategy can increase the number
of patients undergoing liver resection for colorectal cancer liver metastases
without decreasing long-term outcome.
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MILD STEATOSIS IMPAIRS FUNCTIONAL RECOVERY AFTER
PARTIAL HEPATECTOMY IN A RAT MODEL
Vetelainen, Reeta1; Bennink, Roelof2; van Vliet, Arlene1; van Gulik, Thomas1
1Academic Medical Center, Surgery, Surgical Laboratory, Amsterdam,
Netherlands; 2Academic Medical Center, Nuclear Medicine, Amsterdam,
Netherlands
Background. Mild steatosis has been considered as a benign condition
without impact on posthepatectomy recovery. However, recent studies report
impaired recovery in patients with even with mild steatosis (5/30% hepato-
cytes affected).
Aim. To evaluate the recovery of hepatic functional reserve during regenera-
tion in a rat model of mild steatosis.
Methods. Male Wistar rats were fed a standard methione and choline
deficient (MCD) diet for 1 week to induce mild steatosis, or standard
chow. Non-operated groups served as baseline controls. 70% hepatectomy
(PH) was performed and animals were sacrificed after 1, 2, 3 and
7 days. 99mTc-mebrofenin pinhole scintigraphy was used to evaluate
hepatobiliary uptake and excretory function. Mebrofenin uptake rate, the
time of maximum hepatic uptake of mebrofenin (T peak) and the time
required for peak activity to decrease by 50% (T 1/2 peak) were calculated.
Parameters for hepatocellular, biliary and sinusoidal cell damage, hepatic
synthesis function and energy balance (ATP) were assessed together with liver
regeneration.
Results. After 1 week of MCD diet, mild steatosis (5/30% of hepatocytes
affected) without inflammatory changes was observed by histopathology. In
the mild steatotic rats, liver regeneration and proliferative response were
similar compared to controls. However, in the mild steatotic rats, mebrofenin
uptake rate was decreased and T peak and T 1/2 peak were prolonged up to 7
days posthepatectomy. Also, the recovery of hepatic ATP balance and
synthesis capacity were significantly impaired and prolonged. Furthermore,
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after PH, hepatocellular and biliary damage was increased while sinusoidal
endothelial cell function not.
Conclusion. Mild steatosis did not impair the hepatic regenerative capacity
but impaired and prolonged posthepatectomy functional recovery. Further,
hepatocellular and biliary damage was increased in mild steatotic rats after
PH.
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LIVER TISSUE DISSECTION: ULTRASONIC OR RFA ENERGY?
Papaconstantinou, Ioannis; Prassas, Evangelos; Kontos, Michalis; Karavo-
kyros, John; Chasiotis, Dimitrios; Georgopoulos, Sotirios; Bakoyiannis, Chris;
Pikoulis, Emmanouil; Diamantis, Theodoros; Tsigris, Christos; Papalambros,
Efstathios; Felekouras, Evangelos
Laikon Hospital, 1st Dept. of Surgery, University of Athens, Athens, Greece
Background. Hepatic resection remains the only potential curative
treatment for a wide variety of conditions. Still, liver surgery is technically
demanding and closely associated with a number of serious complications.
New devices and techniques are currently being used in order to improve
surgical outcome.
Methods. This retrospective study compares two methods of liver parench-
yma division: ultrasound energy, a modern but already widely used technique
versus Radio-frequency ablation (RFA) a completely novel method. Blood loss
and concomitant need for transfusions, the necessity of Pringle maneuver,
length of time needed for parenchymal division and postoperative complica-
tions and mortality are investigated. Fifteen patients underwent 17 ultrasound
assisted liver resections (group A). Ten metastatic tumors, 6 hepatomas and 1
cholangiocarcinoma were resected. On the other hand, 21 patients underwent
22 RFA assisted hepatectomies (group B). Eleven metastatic tumors, 10
hepatomas and 2 cholangiocarcinomas were removed.
Results. Thirteen patients (87%) in group A versus 11 (52%) in group B were
transfused. Average transfused RBC units were 3.5 and 1.6 respectively.
Pringle maneuver was necessary twice in group A and never in group B. Length
of time for parenchymal dissection was 124 minutes in group A and 93.18 in B.
One (6.7%) and four (19%) complications were observed respectively (NS).
Mortality remained zero in both groups.
Conclusion. RFA energy provides a novel reliable and safe alternative that can
be used exclusively or additionally to the older techniques.
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COMBINING PARTIAL LIVER RESECTION WITH LOCAL ABLA-
TION OF LIVER TUMOURS DOES NOT INCREASE SURGICAL
COMPLICATION RATE
Fioole, Bram1; Jansen, Maarten C2; van Duijnhoven, Frederieke H3; van
Hillegersberg, Richard1; van Gulik, Thomas M2; Borel R, Inne HM1
1University Medical Centre Utrecht, Surgery, Utrecht, Netherlands; 2Aca-
demic Medical Centre, Surgery, Amsterdam, Netherlands; 3Leiden University
Medical Centre, Surgery, Leiden, Netherlands
Background. The combination of partial liver resection and radiofrequency
ablation (RFA) is a novel concept in the treatment of unresectable liver
malignancies.
Aim. The aim of this study is to evaluate the results of this combined strategy
in the Netherlands.
Methods. Thirty-five patients were identified who had been treated with a
combination of partial liver resection and RFA. All patients were operated
between June 1999 and November 2003 in 8 medical centres in the Nether-
lands. Main outcome parameters were local success rate, morbidity, mortality
and survival.
Results. Thirty-seven operations were performed in 35 patients. The
group consisted of 20 male and 15 female patients with a median age
of 59 years (range 4176). Seventy-six lesions were resected and RFA
was performed to ablate 82 unresectable liver tumours. Twelve patients
developed a total of 24 complications, resulting in an overall perio-
perative morbidity rate of 32%. In two patients major complications
resulted in postoperative death (postoperative mortality rate 5.4%).
The median follow up was 13 months (range 146). The estimated
1-, 2- and 3-year survival rates were 84%, 70% and 43%, respectively.
Estimated disease-free 1-, 2- and 3-year survival rates were 57%, 38% and
20%, respectively.
Conclusions. Combining partial liver resection with RFA does not increases
the complication rate, when compared to resection alone. Because of
significant risk, caution is called for combining partial liver resection with
RFA, especially when combining major hepatectomy with contralateral RFA
or in patients with ]/4 tumours or extrahepatic disease.
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COMPARISON OF CLINICAL OUTCOMES BETWEEN HEPATIC
RESECTION AND OTHER TREATMENT MODALITIES OF COL-
ORECTAL CANCER LIVER METASTASIS
Won, Yong Sung1; Park, Il Young2; Kim, Jun Gi1
1St. Vincent’s Hospital/ The Catholic University of Korea, Surgery, Suwon,
Korea; 2Holy Family Hospital/ The Catholic University of Korea, Surgery,
Bucheon, Korea
Background. Despite of development of various treatment modalities, the
prognosis of colorectal cancer liver metastasis is still poor.
Aim. Of our study is to compare clinical outcomes between hepatic resection
of colorectal cancer liver metastasis and other less aggressive treatment
modalities.
Methods. We reviewed 30 patients who underwent treatment of colorectal
cancer liver metastasis from January 1987 to July 2004, Dept. of Surgery, St.
Vincent’s† Hospital, the Catholic University of Korea retrospectively. 16
patients who underwent hepatic resection with negative margin compromised
resection group and 14 patients who underwent percutaneous ethanol
injection or transarterial chemoembolization therapy compromised non-
resection group. Disease free survival and overall survival rates were estimated
according to the Kaplan-Meier method and survival curves were compared
using the log-rank test.
Results. There were no significant differences in age, sex, stages, differentiation
of primary tumor, the number and size of metastatic nodules, serum CEA level
at detection of metastasis between two groups (p/0.05). All hepatic resection in
resection group were achieved with more than 1 cm margin. Operative mortality
was not observed in resection group. Disease free survival in resection gruop was
28.959/7.69 months. Overall survival rate in resection group was 98.659/16.03
months and in non-resection group 31.669/7.49 months (p/0.69). Consider-
ing the time from diagnosis of primary tumor to detection of metastatic lesion in
resection group, patients who had metachronous lesions survived longer than
patients who had synchronous lesions (p/0.036).
Conclusion. We observed better survival in resection group than in non-
resection group. Also, patients who had metachronous lesion had better survival
in resection group. Our study suggests that hepatic resection of colorectal cancer
liver metastasis has a relative survival benefit and would be considered
preferentially in metachronous lesion.
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COMPUTER ASSISTANCE FOR SUPPORTING COMPLEX LIVER
RESECTIONS
Weber, Stefan1; Markert, Mathias1; Kleemann, Markus2; Bruch, Hans Peter2;
Lueth, Tim C1
1Micro Technology & Medical Device Engineering, CMIMED, TU
Munchen, Germany; 2University Hospital Luebeck, Surgical Dept., Luebeck,
Germany
Background. To preoperatively and precisely analyse scenarios for surgical
resections, computer based planning tools exist that visualize 3D models of the
liver, its vascular structure and existing tumours. No assistance system exist, that
support by displaying such models, ultrasound imaging and other information
directly within the surgical situs.
Aim. The goal of the research is the development of a device to provide surgeons
with planning information together with ultrasound imaging within one
computer based device. The system serves as a base for the later integration
of navigation technology in soft tissue surgery.
Methods. The system is attached to the OR table and connects to a navigation
camera (NDI Vicra), to an ultrasound transducer (Terason) and to a six-
dimensional computer mouse (Spaceball). During the intervention the planning
model is depicted on the screen together with the ultrasound images. Using the
Spaceball the surgeon rotates and zooms into the 3D liver model to understand
the anatomical situation. He benefits from a precise understanding of the
anatomical situation and direct comparison between the planning and ultra-
sound imaging.
Results. Integration and ergonomic aspects of novel computer assisted support
systems are essential for their later clinical success. The integration of the device
in the OR will help to identify the requirements for the application of navigation
technology in the area of soft tissue navigation. A set of requirements and
functionalities was identified prior to serve as a specification for the develop-
ment.
Conclusion. The system presented bases for further developments towards new
concepts and approaches for computer aided soft tissue surgery. It is necessary to
examine how useful and intuitive such an assistance systems can be integrated.
Therefore, the described system has been implemented and prepared for clinical
application. This work and its ongoing efforts are a base for novel, clinically
suitable systems and concepts for navigation in soft tissue surgery.
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DETERMINATION OF ACTUAL LIVER FUNCTION BY THE NEW
INTRAVENOUS LIMAX-TEST (MAXIMAL ENZYMATIC LIVER
FUNCTION CAPACITY BASED ON 13C-METHACETIN KI-
NETICS)
Stockmann, Martin1; Riecke, Bjo¨rn1; Fricke, Michael1; Niehues, Stefan2;
Lemke, Arne-Jo¨rn2; Neuhaus, Peter1
1Charite´-Campus Virchow Klinikum, Dep. of Visceral and Transplantation
Surgery, Berlin, Germany; 2Charite´-Campus Virchow Klinikum, Dept. of
Radiology, Berlin, Germany
Introduction. Determination of actual liver function capacity would be
important in many clinical situations. So far there is no test system providing
clinically valid and useful results. We developed a new method which easily
allows the valid measurement of actual quantitative liver function capacity and
evaluated the method in liver resection.
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Methods. Enzyme kinetic analysis when providing saturation kinetics (at least
for a short time) allows calculation of maximal liver function capacity. After
intravenous application of a special solution of 13C-methacetin (2 mg/kg BW)
13CO2 will be determined in breath at certain time points over 60 min by
nondispersive isotope-selective infrared spectroscopy (NDIRS, FANci2-
db16, Fischer Analysen Instrumente, Leipzig). The only rate-limiting step in
this setup is the demethylation of 13C-methacetin by CYP1A2. Evaluation of
the test was done on 18 patients without cirrhosis directly before and on
postoperative day (POD) 1 after liver resection of different extent. In parallel
CT-volumetry of the whole liver before operation and direct volumetry of the
resected liver was done. Remnant liver volume was calculated. In addition
patients were followed for 10 days at POD 1, 2, 3, 5, 10.
Results. In all cases valid LiMAx-measurements were possible, no side effects
were observed. Calculated remnant liver volume and appropriate remnant
liver function in the LiMAx-test after liver resection showed a highly significant
linear correlation (r/0.931, pB/0.0001). Liver regeneration after resection
could be followed by the LiMAx-test with high accuracy.
Discussion. The new LiMAx-test showed a high validity when compared to
remnant liver volume after liver resection and allowed immediate measure-
ment of actual maximal enzymatic liver function capacity in every clinical
situation.
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STUDY ON BLEEDING FEATURES OF PATIENTS UNDERGOING
LIVER TRANSPLANTATION AND EVALUATION ON EFFICACY
OF CLINICAL APPLICATION OF RFVIIA
Chen, Tao1; Liu, Jiang-ping1; Wang, Jie1; Peng, Shu-ling2; Li, Yu2; Ou, Qing-
jia2
1The Second Affiliated Hospital, Sun Yat-sen University, Dept. of General
Surgery, Guangzhou P.R., China; 2The Second Affiliated Hospital, Sun Yat-
sen University, Dept. of Anesthesiology, Guangzhou P.R., China
Background. Bleeding is still one of main causes of death in procedure of liver
transplantation (LT). Features of bleeding of Liver transplantation is not well
known. The effective of using of Factor VII (rFVIIa) in LT is rarely reported.
Objective. To investigate features of bleeding of LT and to investigate the
efficacy of application of Factor VII (rFVIIa) in LT.
Methods. Retrospectively investigated features of bleeding of LTon 15 cases.
Prospectively investigated the efficacy of using rFVIIa in study group (10
cases) and controls (6 cases).
Results. Oozing in resection stage is the main feature of bleeding type in liver
transplantation, which results in 59% of whole blood loss; PTand APTT could
be greatly improved by applying of rFVIIa and data recorded by Thromboe-
lastography (TEG) showed that parameters of r, k, alpha and MA were greatly
improved in patients in experimental group.
Conclusion. Control oozing of operating site should be main work of
hemostasis. rFVIIa could be successfully applied in controlling oozing which
is the main bleeding type of liver transplantation. which means that rFVIIa
could restore the impaired coagulopathy in liver transplant patients.
Keywords: Factor VII (rFVIIa); Liver transplantation; Thromboelastography
(TEG)
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RESECTED RESULTS OF PORTAL VEIN INVASIVE POSITIVITY
(VP3,4) HEPATOCELLULAR CARCINOMA WITH TUMOR
THROMBUS
Yoshitoshi, Kenji; Takasaki, Ken; Yamamoto, Masakazu
Tokyo Women’s Medical University, Tokyo, Japan
Background. Prognosis of patients with Hepatocellular carcinoma(HCC)
with tumor thrombus portal vein invasive positivity (Vp3,4) classified by Liver
cancer group of JAPAN is poor generally. Then so far recurrence preventive
measure it enforced on resection combining pre and post operative adjuvant
therapy. It examines record the so far this time, it reports concerning the
adjustment of the resection, the device of the resection and the effect of the
adjuvant therapy.
Aim(s)/Objective(s). This study enrolled 75 cases of resected HCC from
1990 to 2005. (in our hospital, first resection; 69 cases and second resection; 6
cases)
Results. 3 year and 5 year survival ratio(YSR) were 26.7%,19.4%, respec-
tively in all cases. 3 year and 5 year survival non recurrence ratio(YSNRR) were
25.1%, 20.9%. Residual resection were 22 cases (intra hepatic multiple
metastasis, remnant of portal vein tumor thrombosis, rupture of tumor). 5
YSR was non residual resection cases(NRR)(n/51):30.4%, residual resec-
tion cases(RR)(n/51):5.1% (P/0.0001). 5 YSNRR was 21.5%. On
adjuvant therapy 5 YSR was pre and post operative adjuvant
therapy(PROAT)(n/23):59.8%, non PROAT(n/28):6%(P/0.0001). In
our hospital, when we performed resection of the tumor thrombus of main
duct of portal vein, blocking of the portal vein and wash out of the portal vein.
We perfume preservation of remnant tumor thrombosis in the remnant liver
after hepatic resection.
Conclusion. Prognosis of patients with Vp HCC is poor, but it have a favorite
outcome in NRR and PROAT. It was thought the importance of improvement
in prognosis was to controls the recurrence of remnant liver. Pre and post
operative adjuvant therapy was effective. We suggested importance of the
trance catheter arterial infusion chemotherapy-centered the adjuvant therapy.
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PORTAL VEIN LIGATION AND PARTIAL HEPATECTOMY
DIFFERENTIALLY INFLUENCE GROWTH OF INTRAHEPATIC
METASTASIS AND LIVER REGENERATION IN MICE
Heinrich, Stefan1; Jochum, Wolfram2; Graf, Rolf3; Clavien, Pierre-Alain3
1University Hospital of Zurich, Swiss HPB Center, Zurich, Switzerland;
2University Hospital of Zurich, Dept. of Pathology, Zurich, Switzerland;
3University Hospital of Zurich, Dept. of Visceral and Transplantation Surgery,
Zurich, Switzerland
Background. Since modern treatment of liver metastases includes serial
hepatectomies and portal vein obstruction, we investigated the effects of portal
vein ligation (PVL) and partial hepatectomy (PH) on tumor growth in a mouse
model.
Methods. The effects of 70% PH and PVL on liver and lung metastases were
evaluated in a syngeneic mouse model. Tumor growth and liver regeneration
were assessed by morphometry and immunohistochemistry for PCNA and
BrdU. The effect of growth factors of liver regeneration on CT-26 cells was
tested in-vitro, and TGF-b secretion of CT-26 cells was measured by ELISA.
RNA synthesis of TGF-b and activin A by subcutaneous tumors was measured
by RT-PCR.
Results. Liver regeneration after PH and PVL was similar in tumor-free mice.
However, liver regeneration was dramatically delayed after PH in metastatic
livers (p/0.001) in contrast to PVL. While the intrahepatic tumor growth was
lower after PH than after PVL (p/0.016), the extrahepatic tumor growth was
not different between these groups. Tested growth factors of liver regeneration
stimulated CT-26 cells in-vitro, and CT-26 secreted significant amounts of
TGF-b in-vitro and in-vivo. Conclusions: Although similar in tumor-free
mice, liver regeneration significantly differed between PVL and PH in
metastatic livers. In addition, PH and PVL differently affected intrahepatic
tumor growth.
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IMPACT OF PREOPERATIVE PORTALVEIN EMBOLISATION ON
LIVER RESECTION A METAANALYSIS
Abulkhir, Adel M1; Limongelli, Paolo1; Healey, Andrew J1; Damrah, Osama1;
Tait, Paul2; Habib, Nagy3; Jiao, Long3
1Hammersmith Campus, Imperial College, Division of Surgery, Oncology,
Reproductive Biolog, London, UK; 2Hammersmith NHS Trust, Dept. of
Interventional Radiology, London, UK; 3Division of Surgery, Oncology,
Reproductive Biology and Anaesthetics, HPB Surgery, London, UK
Background. Preoperative portal vein embolisation (PVE) has been used
clinically to induce hypertrophy of the contralateral lobe of liver prior to major
resection to prevent possible postoperative liver failure.
Aim. The aim of this article is to review all published articles on PVE to assess
the impact of PVE on major liver resection.
Method. Comprehensive Medline search to identify all registered articles
published in English language. Based on the published data, meta-analysis was
performed to assess the result of PVE.
Results. Seventy publications met the search criteria. However, only 37
provided data sufficiently enough for analysis. The mean of future liver
remnant (FLR) and future liver remnant/total estimated liver volume (FLR/
TELV) ratio 26 weeks after PVE were respectively 41.39/9.5 and 11.49/3.8.
86.5% patients underwent hepatectomy one month after PVE. No patients
died after PVE, morbidity rate and mortality rates were 2.4% and 0%
respectively.
Conclusion. PVE is safe and effective procedure in inducing liver hypertrophy
to prevent post resection liver failure due to insufficient liver remnant.
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HIGH INCIDENCE OF UNSUSPECTED INTRA AND EXTRA
HEPATIC METASTASES DURING LAPAROTOMY FOR RESEC-
TION OF COLORECTAL LIVER METASTASES
Goe´re´, D1; Rouquie´, D1; de Baere, T2; Dromain, C3; Lassau, N3; Elias, D1
1Institut Gustave Roussy, Surgical Oncology, Villejuif, France; 2Institut
Gustave Roussy, Interventionnal Radiology, Villejuif, France; 3Institut Gus-
tave Roussy, Radiology, Villejuif, France
Background. When patients with resectable colorectal liver metastases (LM)
are treated with percutaneous radiofrequency (RF), some unsuspected
intrahepatic and extrahepatic metastases, detectable only at laparotomy, might
be ignored and left untreated. This would result in a reduced cure rate. Our
purpose was to analyze the incidence of unsuspected and surgically treatable
intrahepatic and extrahepatic metastases discovered at laparotomy.
Methods. From 1985 to 2003, the data of 506 patients who underwent a
laparotomy and then a hepatectomy for colorectal LM were prospectively
collected and retrospectively analyzed. All patients had undergone at least two
types of preoperative liver imaging including ultrasonography and/or CT-scan
and/or RMI (but no fluorodeoxyglucose-positron emission tomography).
Results. Unsuspected metastases were discovered at laparotomy in 209
patients (41.3%). There were extrahepatic metastases in 82 patients (16.2%),
additional LM in 152 patients (30%), and both in 25 patients (4.9%). Liver
palpation and intraoperative ultrasound allowed for detecting additional LM
in 125 (24.7%) and 48 (9.4%) patients, respectively. All of them were
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resected. When only the 124 patients who presented with 1 to 3 LM
measuring B/3 cm in diameter (candidates for percutaneous RF) were
considered, the results were similar. Moreover, the incidence of unsuspected
metastases was similar when the periods of surgery and imaging (before and
after January 1996) were considered.
Conclusion. Laparotomy permits discovery and treatment with a curative
intent of unsuspected intrahepatic or extrahepatic metastases in at least one
third of patients with classically resectable colorectal LM. This does not
support the use of percutaneous RF ablation instead of hepatic resection for
this population, because it will result in an important survival decrease.
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POSTOPERATIVE SERUM TRANSAMINASE LEVELS (TRL) IS
MORE RELATED TO THE WEIGHT OF RESECTED LIVER
RATHER THAN THE INJURY OF THE REMNANT LIVER
Dondero, Federica; Tonini, Valeria; Sommacale, Daniele; Sauvanet, Alain;
Corona, Francesco; Belghiti, Jacques
Beaujon, Hepatobiliary Surgery, Clichy, France
Background. Post-operative increase of transaminase levels (TRL) is
usually used as the main marker of hepatocyte injury of remnant liver after
hepatectomy with vascular clamping.
Aims. In this prospective study we evaluated the level of transaminase during
the peri-operative period of liver resection procedure in patients with and
without vascular clamping according to the resected liver volume.
Methods. Between June and November 2005, fifty patients, aged 539/13
years, who underwent hepatectomy on normal liver were included in a
prospective study. Major resection (/3 segments) was realised in 40 (80%)
patients. Liver transection was performed in 25 (50%) patients under
intermittent clamping for a mean duration of 38 min (range 1564 min).
All patients underwent serial blood samples assessing transaminase levels
(ALT) during surgical procedure, respectively before incision, before liver
transection and before abdominal closure and post-operatively, respectively
on days 1, 2, 5 and 7.
Results. As shows in the table TRL which increase early, at the end of
resection, remain stable on postoperative day (POD) 1, decrease thereafter
and was not affected by the presence of clamping. Major hepatectomy had
significant higher TRL than minor hepatectomy at the end (3429/216 vs
2199/102) and on day 1 (3649/204 vs 2319/160). TRL at the end of surgery
and on POD 1 has a significant correlation with the weight of resected liver
according to Sperman/rho.
Conclusions. Our results suggest that the early TRL should be considered
as reflect of the damaged resected liver rather than the damage of remnant
liver.
TRL abdom-
inal incision
(UI/l)
TRL before
resection
(UI/l)
TRL end
resection
(UI/l)
TRL
POD1
(UI/l)
TRL
POD5
(UI/l)
Total 279/11 1449/51 3189/171 3379/161 1499/83
Pringle 269/10 1459/58 2979/108 3209/103 1399/69
Non
Pringle
289/11 1429/44 3399/216 3539/204 1589/95
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RADIOFREQUENCY ABLATION (RFA) OR SURGERY IN THE
TREATMENT OF SMALL UNIFOCAL HEPATOCELLULAR CAR-
CINOMA (HCC)
Abu Hilal, Moha’d1; Pearce, Neil W1; Nicoli, Nicola2; Casaril, Andrea3;
George, Steve1; Mc Phail, Mark1; Primrose, John1
1Southampton General Hospital, Southampton, UK; 2Cervello, General
Surgery, Palermo, Italy; 3Borgo Roma, General Surgery, Verona, Italy
Background. The treatment of hepatocellular carcinoma (HCC) represents
a major challenge and the optimal treatment option is still debatable,
especially in the presence of chronic liver disease. Traditionally surgical
resection (SR) is the ‘‘standard of care’’ when feasible, but radiofrequency
ablation (RFA) has become popular recently, demonstrating superiority to
other percutaneous techniques.
Aims. To compare RFA and Surgery in the treatment of small (B/5 cm),
unifocal HCC; in terms of procedural mortality, morbidity, hospital stay,
overall and disease free survival.
Patients and methods. We retrospectively reviewed 109 patients with
unifocal small HCC; 52 patients were treated with surgical resection between
1990 and 2002 (Group SR) and 57 patients treated with percutaneous RFA
between 1997 and 2002 (Group RF). Patients characteristic were similar but
those having RFA were more likely to have cirrhosis and small tumors.
Results. One procedure related death occurred in each group. Four major
complications were observed; three in group SR and one in group RF. The
median hospital stay was 15.5 days in group SR and 3 days in group RF. The
global median follow-up was 27 months (IQR 15.550); 36.5 months in
group SR (IQR 18.25 89.75) and 24 months in group RF (IQR 12.539.5).
Recurrence occurred in 32/52 patients (61.5%) group SR; (3.9% local and
57.7% new) and in 34/57 (59,6%) in group RF (29.8% local and 29.8%
new). The median disease free survival was 43 months (I.C. 95% 27.858.1)
in group SR and 13 months (I.C. 95% 6.219.8) in group RF (pB/0.03). On
multivariate analysis the Child stage, the tumor size, recurrence of disease
and the treatment with RFA were found to be negatively associated with
survival.
Conclusion. When feasible, surgical resection is the treatment of choice for
HCC. However RFA is a safe, reproducible, easily repeatable and cost
effective technique and should considered when surgery is considered
inadvisable.
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IS PRINGLE MANOEUVRE OR PRECONDITIONING ROUTI-
NELY NECESSARY IN LIVER SURGERY?
Richter, Sven; Kollmar, Otto; Igna, Dorian; Schilling, Martin
Univ. Saarland, Dept. of Surgery, Homburg/Saar, Germany
Introduction. Since the first description, Pringle Manoeuvre has been used
to reduce blood loss in hepatic surgery and ischemic preconditioning has
been used as an extension of that technique to reduce ischemia reperfusion
injury in liver resection and transplantation. However advanced surgical
techniques like selective hilar vascular ligation (SVL) or vascular clamping
(SVC) and modern dissection techniques reduced the significance of Pringle
Manoeuvre. We therefore analysed our outcome data in patients undergoing
liver resection for various pathologies. Patients Between 01/2001 to 12/2004,
415 patients underwent liver resections. Parenchymal sparing resections were
planned whenever possible. Dissection planes were defined with the use of
SVL/SVC and parenchymal dissection was routinely performed along those
anatomical planes with either ultrasound or hydrojet dissection. In a selcted
series patients were randomised for various dissection techniques.
Results. Parenchymal sparing resection (sectorectomies/segmentectomies
and atypical resections) were performed in 88%, only 32 Patients required a
right or left hepatectomies. SVL/SVC was used in 63.6% and Pringle
Manoeuvre in 10.6%. There was no difference in terms of blood loss in
terms of blood loss with or without Pringle Manoeuvre, but biliary leakage
was less frequent after anatomical resections. Net prices were comparable for
the different dissection techniques.
Conclusion. SVL/SVC facilitates anatomical, parenchymal sparing liver
resection and obliviates the need for Pringle manoeuvre or ischemic
preconditioning in modern liver surgery.
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LIVER RESECTION FOR BREAST CANCER LIVER METASTASIS
Lubrano, Jean; Roman, Horace; Tarrab, Sophie; Resch, Benoit; Marpeau,
Loı¨c; Scotte´, Michel
CHU, Rouen, France
Brest cancer liver metastasis (BCLM) are usually associated with a poor
survival. The results of liver surgery for colorectal metastases have made it
possible to apply the principles of liver resection in patients presenting with
BCLM. The aim of our study was to analyse the outcome and prognosis
factors of liver surgery for metastatic breast cancer. Over a period of 5 years,
19 patients with BCLM were referred to our institution for surgical
treatment. None of them had extrahepatic disease, as assessed by preopera-
tive radiological examinations. Indications for surgery were non evolutive or
isolated BCLM in patients previously treated using chemotherapy. The
median age was 53 years (3868) and the median disease-free interval (time
between treatment of the primary and diagnosis of liver metastases) was 56
months (7120). The mean tumor size was 40 mm (10100). Because of
extrahepatic disease found in 4 women during laparotomy, only 15 patients
underwent liver resection (8 major and 7 minor hepatectomies). There was
no postoperative death. The overall survival at 1, 3, and 5 years was 100%,
65.6% and 35.3%, respectively. The median survival rate was 48 months.
The univariate analysis showed that type of hepatectomy, number of
metastasis and age of patients strongly influence survival rate. On the
contrary the survival rate was not influenced by disease free interval,
hormone receptor status, stage of breast cancer, size of tumor, and
perioperative blood transfusions. In multivariate analysis, no independent
prognostic factor was identified in the Cox’s proportional hazard model.
These results suggest that long term survival can be achieved in highly
selected patients by performing liver resection for BCLM.
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TECHNICAL ASPECTS RELATED THE RETRO HEPATIC VENA
CAVA RESECTION AND RECONSTRUCTION
Resende, Alexandre1; Nascimento, Sı´lvia1; Franc¸a, Marcelo1; Lima, Agnal-
do1; Savassi-Rocha, Paulo2
1Hospital das Clı´nicas UFMG and Hosptial Vera Cruz, Alfa Institute of
Gastroenterology, Belo Horizonte, Brazil; 2Hospital das Clı´nicas UFMG,
Alfa Institute of Gastroenterology, Belo Horizonte, Brazil
Background. The resection of the retro-hepatic vena cava is a challeng-
ing procedure, wich can turn irressecable lesions into potential curative
lesions.
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Objective. To study the technical aspects of the resection of the retro-hepatic
vena cava and it?s replacement for a Dacron vascular graft in a serie of 6
patients, with special attention to renal and hepatic veins reconstruction.
Methods and results. This serie was retrospectively studied The patients
age ranged from 29 to 62 years old, and their diagnostic was from a primary
sarcoma of the vena cava (3) and HCC, adrenal carcinoma and retro-
peritoneal ganglioneuroblastoma in one case each. All the procedures were
performed without using by-pass. The associated procedures were neprect-
omy (3), hepatectomy (2), adrenalectomy (2) and duodenopancreatectomy
(1). It was necessary to re-implant the renal vein in 4 cases, the middle and
left hepatic vein in one case and the right hepatic vein in one case. The time of
vena cava clamping ranged from 50 to 65 minutes (mean 56 minutes). When
necessary (3 patients), the hepatic pedicle clamping was from 35 to 72
minutes (mean 49 minutes) and the clamping time of the renal vein (4 cases)
ranged from 52 to 85 minutes (mean 75 minutes). There was one post
operative death, secondary to a multiple organs failure. On follow up, one
patient presented with the trombosis of the graft 9 months after surgery,
treated by anticoagulation, one patient died 13 months after the procedure by
lung metastases, one presented with hepatic mestastases 2 years after the
procedure and one with local recurrence, treated by local excision.
Discussion. The retro-hepatic vena cava resection can be performed,
leading pacients previously considered irressecable into patients that can be
treated with curative intent. The Dacron vascular graft has proved to be
effective in replacing the ressected vein, and has the advantage of its
maleability, wich is specially usefull in cases where hepatic or renal vein
reconstruction will be necessary.
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PRE-OPERATIVE NEUTROPHIL-LYMPHOCYTE RATIO (NLR)
PREDICTS LONG-TERM SURVIVAL IN PATIENTS UNDER-
GOING RESECTION OF COLORECTAL LIVER METASTASES
Neal, Christopher P; Mann, Christopher D; Pattenden, Claire J; Metcalfe,
Matthew S; Garcea, Giuseppe; Dennison, Ashley R; Berry, David P
Leicester General Hospital, Dept. of Hepatobiliary and Pancreatic Surgery,
Leicester, UK
Background. Hepatic resection offers the only hope of cure for colorectal
liver metastases (CLM), yet over half of patients will develop recurrence.
Novel methods are required to more accurately guide treatment according to
individual recurrence risk. Studies have shown that the presence of a systemic
inflammatory response predicts recurrence and survival in patients with
primary colorectal cancer (CRC). The neutrophil-lymphocyte ratio (NLR)
was recently shown to act as a simple index of the systemic inflammatory
response and predicted outcome following resection of primary CRC.
Aim. The aim of this study was to assess the prognostic value of the NLR in
the context of resectable CLM.
Methods. Data on patients undergoing resection of CLM between January
1995 and December 2004 was obtained from our Hepatobiliary Cancer
Database. Pre-operative neutrophil and lymphocyte counts (x109/L) were
recorded and the ratio between them calculated for each patient. Neutrophil-
lymphocyte ratios were then compared to overall survival by entry into a
Kaplan-Meier model and application of the log rank test.
Results. One hundred and eight-six patients underwent hepatic resection for
CLM over the study period. The median pre-operative NLR was 2.26 (range
0.57 to 18.33). Of the 186 patients, 46 had an NLR of 02, 99 had an NLR
of 24 and 41 had an NLR of/4. Comparison of overall survival for these
three groups demonstrated that increasing NLR was associated with
significantly poorer overall survival. Four year overall-survival was 61%
(NLR 02), 55% (NLR 24) and 37% (NLR /4) (P/0.0384).
Conclusion. The NLR can be calculated pre-operatively from data that
are routinely available and, together with established clinicopathological
factors, may be of use in refining individual recurrence risk following
metastasectomy.
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PORTAL VEIN EMBOLIZATION SIGNIFICANTLY INCREASES
GALACTOSYL SERUM ALBUMIN RECEPTOR SIZE IN NON-
TREATED LOBE AND IMPROVES POSTOPERATIVE COURSE
AFTER MAJOR HEPATECTOMY
Tsuchiya, Takao; Saito, Takuro; Kenjo, Akira; Kimura, Takashi; Tsukada,
Manabu; Abe, Tsuyoshi; Gotoh, Mitsukazu
Fukushima Medical University, Dept. of Surgery 1, Fukushima, Japan
Background. Portal vein embolization(PVE) has been reported to reduce
postoperative complications after major hepatectomy. In this study, we
estimated the effect of PVE on functional liver volume by GSA receptor size
which is measured by liver scintigram using SPECT.
Methods. Between 1994 and 2005, we performed PVE 54 times in 53
patients with hepatobiliary malignancies, and 32 cases underwent major
hepatectomies from 15 to 56 days after PVE (PVE group). Post operative
total bilirubin levels and complications of these patients were compared with
patients who were performed right extended hepatic lobectomy without PVE
at the same period (non PVE group). The volume ratio of the embolized and
nonembolized lobe of the liver were measured by serial CT scans before and
2 weeks after PVE. GSA receptor sizes were analyzed for 21 cases at the same
time with CT scans.
Results. PVE induced a significant increase of liver volume of non-
embolized lobe up to 121///12% and a significant decrease of embolized
lobe to 95///11/%. For functional liver volume, GSA receptor size
increased up to 168///21% in non embolized lobe and decreased to
80///23% in embolized lobe giving 129///21%, and 92///11% for
GSA receptor size per cubic volume, respectively. Although no hepatic failure
occurred between the groups. post-operative peak total bilirubin levels were
significantly low in PVE group compared with PVE group (7.5///2.5,
6.1///2.7, pB/0.05).
Conclusion. PVE can markedly increase not only pure volume but also
‘‘functional’’ liver volume in non-treated lobe offering safety for the patients
undergoing major hepatectomy.
P24.137
EARLY POSTOPERATIVE RESULTS AFTER LIVER RESECTION
OF COLORECTAL METASTASES FOLLOWING NEO-ADJUVANT
CHEMOTHERAPY
Zapletal, Christina; Gog, Christiane; Bechstein, Wolf O; Wullstein, Chris-
toph
Johann Wolfgang Goethe-University Frankfurt, Dept. of General and
Vascular Surgery, Frankfurt, Germany
Introduction. Liver resection of colorectal metastases is the only potentially
curative therapy available. Neoadjuvant chemotherapy is used for downsizing
irresectable metastases and is supposed to decrease recurrence. The aim of
the following study was to examine the early postoperative results after liver
resection of colorectal metastases following neo-adjuvant chemotherapy
focusing on postoperative liver function.
Patients and methods. A retrospective analysis was done on 90 patients
after hepatic resection of colorectal metastases from 08/0212/04. Patients
were divided into three groups: 1) Patients who received neoadjuvant
treatment before liver resection (n/34). 2) Patients, who had been treated
with adjuvant chemotherapy more than 6 months ago (n/20). 3) Patients,
who were chemo-naive (n/36). Statistical analysis was done with One-way
ANOVA. P-values B/.5 were considered significantly.
Results. The 3 groups did not differ significantly concerning age, gender and
number of rectal cancer. Tumour stage was UICC I/II-Stadium in 1014%
of the cases, in the neoadjuvant group 76.4% were UICC IV patients. The
adjuvant group included 40% of patients in UICC IV stage suffering from
recurrent liver metastases. The extent of hepatic resection was comparable
between the groups. R0-resection could be achieved in 80%. There were no
significant differences concerning hospital stay (p/.63), use of packed cells
(p/.27), complication rate (p/.80) and 30-day-mortality (p/.89). Con-
cerning postoperative liver function the maximum bilirubin level [mg/dl]
differed significantly between the groups (p/.043) being highest in the
neoadjuvant group (3.39/4.0) compared to the adjuvant (2.49/2.0) and the
chemo-naive patients (1.69/1.0). AST-peak showed no significant differences
(p/.8).
Conclusion. Hepatic resection after neoadjuvant chemotherapy can be done
with good results but postoperative liver function is significantly impaired in
the group of patients with neoadjuvant treatment.
P24.138
LIVER RESECTION FOR HEPATOCELLULAR CANCER (HCC):
DOES CIRRHOSIS INCREASE MORBIDITY?
Wullstein, Christoph; Rako, Ivan; Golling, Markus; Bechstein, Wolf
Johann Wolfgang Goethe-University, Dept. of General and Vascular Surgery,
Frankfurt am Main, Germany
Background. Curative treatment of HCC can only be achieved by liver
resection or transplantation. Liver cirrhosis limits the extent of resection and
may also increase morbidity.
Methods. Between August 2002 and July 2005 112 patients with HCC were
treated. 31 underwent liver resection (27.7%). In a retrospective analysis we
compare the results of resection in cirrhosis (RIC, n/15) with resections in
normal livers (RNL, n/16) in view of extend of resection, mortality,
morbidity and liver function.
Results. Liver cirrhosis was CHILD A in 13 pts and CHILD B in 2 pts.
CLIP-score was zero in 19, one in 11 and two in 1 patient. Clip-Score was
higher in RIC than in RNL (p/0.003). Operative time was 175 min. without
differences between RIC and RNL (p/0.62). No intra-operative blood
transfusions were necessary. The mean weight of the resected specimen was
753 g (/1540 g) in RIC and 463 g (/339 g) in RNL (p/0.48). There was
no difference in mean size of the HCC (7,3 cm RIC vs. 6,6 cm RNL, p/
0.71). The rate of R-0 resections was 11/15 in RIC and 16/16 in RNL (p/
0.04). There was no in-hospital-mortality. Morbidity was 67% in RIC and
50% in RNL (p/0.47). Re-interventions were necessary in 1/15 RIC and 2/
16 RNL patients. Post-operatively the minimum Quick was 52.5% in RIC
and 63.1% in RNL (p/0.03). Length of hospital stay was 17.2 days in RIC
and 12.3 days in RNL (p/0.054). During a mean follow-up of 13 months 7/
15 RIC patients and 3/16 RNL patients died (p/0.25).
Conclusion. With careful patient selection morbidity and mortality after
liver resection for HCC is not increased in patients with cirrhosis, contrary to
other reports. However, the impaired post-operative liver function and the
prolonged length of hospital stay may reflect the impaired convalescence of
patients with ciorrhosis.
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THE PRESENT CONDITIONS AND UTILITY OF LAPARO-
SCOPIC SURGERY FOR HEPATIC DISEASE
Sakoda, Masashiko; Ueno, Shinichi; Kubo, Fumitake; Hiwatashi, Kiyokazu;
Shinchi, Hiroyuki; Maemura, Kousei; Noma, Hidetoshi; Aikou, Takashi
Kagoshima University Graduate School of Medical and Dental Sciences,
Dept. of Surgical Oncology and Digestive Surg, Kagoshima city, Japan
Aim. Hepatectomy and ablation therapy are nominated for laparoscopic
operation for hepatic disease and we introduced laparoscopic surgery for
hepatic disease since 1996. On the basis of experience of laparoscopic
hepatectomy and ablation therapy for neoplastic disease, I want to report
about the present conditions and utility this time.
Methods. 1) Hepatectomy: Eleven patients underwent laparoscopic
partial resection and 5 patients underwent laparoscopic lateral segmentect-
omy between 1996 and 2005 were compared to 19 patients underwent
open partial resection and 5 pateints underwent open lateral segmentectomy
during same time period with respect to operation time, blood loss
and postoperative hospitalization. 2) Ablation therapy: 42 patients
underwent surgical ablation, laparoscopic approach in 5, thoracoscopic
approach in 5, laparotomy in 28 and thoracotomy in 4 formed the basis of
this study.
Results. 1) Of the 16 patients underwent laparoscopic hepatectomy,
conversion to laparotomy was necessary in one patient because of periopera-
tive bleeding. Blood loss and postoperative hospitalization have significantly
decreased in laparoscopic partial resection compared with open partial
resection. In laparoscopic segmentectomy, operation time is longer than
laparotomy. There was no difference in blood loss and postoperative
hospitalization. 2) For subcapsular tumor, surgical ablation is more effective
than percutaneous ablation in incidence of local recurrence. Local
recurrences were seen in 7 patients in laparotomic or thoracotomic
ablation. As a cause of recurrence, 1 case is location of proximity to hepatic
capsule, and others were proximity to intrahepatic vessels and deficiency of
ablation. There was no recurrence in laparoscopic and thoracoscopic
ablation.
Conclusion. Still the adaptive case is limited from tumor occupation locus,
tumor size and number, but more wide adaptation and good results are
expected by improvement of operation maneuver in future.
P24.140
INDICATIONS FOR ANATOMICAL RESECTION OF LIVER
METASTASES FROM COLORECTAL CARCINOMA
Vyhnanek, Frantisek; Denemark, Ladislav; Duchac, Vitezslav; Skala, Petr
3. Faculty of Medicine/Faculty Hospital, of Surgery, Prague, Czech Republic
Background. There is an ongoing contraversy regarding the optimal mode of
liver resection for metastases from colorectal carcinoma. Most authors failed
to detect any significant difference between anatomical and nonanatomical
procedures, while others report superior results from minor resection
performed in a nonanatomic manner. On the other hand anatomical approach
reduced the incidence of histologically nonradical/R 1/liver resection.
Aims. The study was aimed at evaluating criteria for anatomical resection of
the liver metastases from colorectal carcinoma.
Methods. Retrospectively was analysed group of 111 patients subjected to
liver resection for metastases from colorectal carcinoma, having operated from
1999 to 2005. More extensive anatomical resection/up to 2 segments/were
performed in 32 patients, segmentectomy in 22 and limited wedge resection in
57 individuals. More extensive anatomical resection was performed for lesions
up to 4 cm in diameter or for multiple lesions in one lobe, segmentectomy for
lesions affecting segments. Wedge resection was performed for smaller lesions/
to 4 cm/at the edge of the liver, at the border between segments or lobes and for
multiple peripheral lesions affecting both lobes.
Results. In group of limited liver wedge resection were histologically
positive margin in 5 patients. There were no 30 days mortality in group of
all patients.
Discussion. Anatomical resection for liver metastases of colorectal carcinoma
with application of new operative technique to be safely performed. Other
reason fro this approach in resection was that anatomical resection greatly
reduced the chance of positive margin when compared with wedge resection,
which has a reported positive margin rate of up 30%. Even within the RO-
group, however, survival with anatomical resection was significantly better.
Conclusion. Anatomical approach reduced the incidence of histologically
nonradical/R 1/resection.
P24.141
LAPAROSCOPIC LIVER RESECTION USING RADIOFRE-
QUENCY COAGULATION
Hompes, Daphne; Aerts, Raymond; Penninckx, Freddy; Topal, Baki
University Hospital Gasthuisberg KUL, Abdominal Surgery, Leuven,
Belgium
Background. The use of RF energy has been described to perform open liver
resection safely and with minimal blood loss. Yet, no data are available on the
potential contribution of RF energy to the limitation of intra-operative blood
loss during laparoscopic liver resection.
Aim. The aim of this prospective, non-randomized study was to investigate
the potential contribution of radiofrequency (RF) energy to the limitation of
intra-operative blood loss in patients undergoing laparoscopic liver resection
(LLR).
Methods. Fifty-six patients (male/female ratio 26/30, age 57 years (2680))
underwent LLR. Fifteen benign and 58 malignant lesions (mostly colorectal
metastases) were resected. Median number (1 (15)) and max. diameter
(40mm (8170)) of tumors as well as tumor free margins (10mm (130))
were comparable in patients undergoing LLR with (20 patients) or without
(36 patients) RF-assistance. Thirty-five minor and 22 major resections
were performed. Twenty-five patients simultaneously underwent additional
surgery.
Results. No mortality occurred. Median intra-operative blood loss was 100
(54000) ml and similar in patients undergoing LLR with or without RF-
assistance. Median operation time was 113 (45360) minutes. The type of
surgical procedure was the main determinant for the amount of intra-operative
blood loss (p=0.0002). Significant bleeding occurred from large hepatic
vessels at major resections. RF-assistance didn’t seem to reduce peri-operative
morbidity.
Conclusion. LLR can be performed with minimal intra-operative blood loss,
which is determined by the type of hepatectomy. Significant intra-operative
bleeding occurs from large hepatic vessels during major resections. In this
small patient series RF-assisted parenchymal transection in LLR doesn’t seem
to reduce blood loss, operation time or peri-operative morbidity.
P25.01
LAPAROSCOPIC LIVER BIOPSY
Grondona, Jorge P1; Bracco, Ricardo A2
1Centro Me´dico Martı´n y Omar de San Isidro, HPB Unit, San Isidro-Buenos
Aires, Argentina; 2Clı´nica Pueyrredo´n de Mar del Plata, HPB Unit, Mar del
Plata- Buenos Aires, Argentina
Background. Liver biopsy remains as the conclusive procedure to elucidate
the etiology, staging and outcome of a diffuse hepatic disease. Blind or
ultrasonography guided biopsies are efficient but not absolutely safe because
they may lead to morbidity and in some cases to mortality.
Aim. To asses the technique and results of laparoscopic liver biopsy during a
ten year period.
Methods. Between 1995 and 2005, 220 laparoscopic liver biopsies were
performed on 222 patients with the assumption and/or the diagnosis of diffuse
liver disease, excluding decompensates cirrhotic patients. Fifteen different
pathologies were diagnosed and according to frequency the 5 more common
were: Hepatitis C, Steatosis, Fibrosis, Hepatitis B and Alcoholism. Under
general anesthesia a-two-trocar approach was employed placing one on the
navel and another one on the epigastrium. The possibility of visualizing the
liver surface to evaluate the macroscopic findings and of taking several samples
of both lobes are two strong advantages with this procedure. According to the
case, the biopsy was incisional and /or by a Trucut-Type needle punction. In all
cases, by observing the exact site of the biopsy, the hemostasis and bilistasis
were certainly controlled by cautery.
Results. All patients were discharged within 4 hours after finishing the
procedure. One dose of Ketorolac in average was required and neither
complications nor mortality were observed in this period.
Conclusions. The laparoscopic liver biopsy allows an initial macroscopic
evaluation by the visualization of the liver at the beginning of the procedure
and, at the end a reliable control of hemostasis and bilistasis. The laparoscopic
approach is effective and safe, both for the absence of complications and
mortality and also to obtain enough material for the histological study in all
cases.
P25.02
A STUDY ON ANATOMICAL HOMOLOGY OF TWO PARAME-
DIAN SECTORS OF THE LIVER
Yu, Hee Chul; Jin, Guangyu; Yang, Jae Do; Cho, Baik Hwan
Chonbuk National University Medical School, Surgery, Jeonju, South Korea
Backgrounds. The interior structure of a liver form bisymmetry with middle
hepatic vein (MHV) placed in the center. To explain on homogeneity and
symmetry of left and right paramedian sectors(LPS and RPS) of a liver by local
dissection in Glisson’s(G) area.
Methods. We illustrated G area by dissecting of 36 cadaveric livers. Compared
both sides observed the 1st, 2nd, and 3rd-order G branches and measured
external diameter and number. Also observed existence and roots of anterior
fissural vein(AFV) which divides ventral and dorsal sides of RPS, and
umbilical fissural vein(UFV) which divides G3 and G4 in LPS. To observe
symmetry of both paramedian portions, subdivided the right into G8-v,d and
G5 versus the left into G4-a,b and G3.
Results. 1st-order G branch had 35 cases of bifurcation type, 1 case
of trifurcation type. 2nd-order G branch on right had 56% of Y type, 39%
of single-tip type, and on left mostly had multiple type. External diameter
of a branch in RPS was 1347 mm(G8v/G8d/1018, G5/308), and ones in
LPS were 1338 mm(G4a/G3/1022, G4b/316). There were total 332 3rd-
order G branches in RPS, and total 312 branches in LPS, which shows that
both sides were closely symmetry. AFV was found in 31 cases and when we
classify it according to locations of openings, A: MVH were 56%, B: between
MVH and right HV(RHV) were 17%, C: RHV were 6%, D: less than 3 cm of
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opening of MVH horizontally were 8%. UFV was found in 26 cases and when
we classify it according to locations of openings, A: left HV(LHV) were 22%,
B: 1 cm lower than LHV were 39%, C: MVH were 6%, D: between LHV and
MHV were 3%.
Conclusion. The main axis of 2nd-order G branches of both PS was twisted
each other by 90 degree. The 3rd-order G branches of RPS could be divided
into ventral and dorsal portions whereas LPS could be divided into left and
right portions. Each portion shows bisymmetry to each counter portion of the
liver. Two paramedian sectors show point symmetry to each other(G8v-d, G5
vs G4a-G3, G4b).
P25.03
ALPHA-LIPOIC ACID PROTECTS AGAINST REPERFUSION IN-
JURY FOLLOWING HEPATIC ISCHEMIA IN RATS
Dulundu, Ender1; Ozel, Yahya1; Topaloglu, Umit1; Sehirli, Ozer2; Gedik,
Nursal3; Sener, Goksel2
1Haydarpasa Numune Education and Research Hospital, 5th Dept. of
Surgery, Istanbul, Turkey; 2Marmara University, School of Pharmacy, Dept.
of Pharmacology, Istanbul, Turkey; 3Marmara University, Dept. of Biochem-
istry, Istanbul, Turkey
Background. Liver ischemia followed by reperfusion is an important and
common clinical event which causes oxidative damage. The aim of this study
was to investigate the role of lipoic acid against hepatic ischemia/reperfusion (I/
R) injury in the rat.
Methods. Wistar albino rats of both sexes were subjected to a model of hepatic
ischemia that was produced by occluding the portal vein and hepatic artery for
60 min and where the clamps were removed allowing reperfusion for 60 min.
Lipoic acid (LA, 100 mg/kg; i.p.) was administered 30 min prior to ischemia
and immediately before the reperfusion period. At the end of the reperfusion
period, the rats were killed by decapitation. Trunk blood samples were
collected to determine aspartate aminotransferase (AST) and alanine amino-
transferase (ALT) levels as indicators of liver function. Lactate dehydrogenase
(LDH) and TNF-a levels were also assayed in serum samples. Malondialde-
hyde (MDA) content -an index of lipid peroxidation, glutathione (GSH) levels
-a key antioxidant and myeloperoxidase (MPO) activity an index of neutrophil
infiltration were determined in the liver tissue samples.
Results. Plasma ALTand ASTactivities which were elevated in the I/R group
as compared to control group were significantly decreased by LA treatment. In
the I/R group, increased serum TNF-a and LDH levels, indicating cytokine
release and generalized tissue damage, respectively were also significantly
reduced by LA treatment. Similarly, the decrease in hepatic GSH levels in the
I/R group was elevated back to control levels in the LA-treated I/R group.
Increases in tissue MDA levels and MPO activity due to I/R injury were also
attenuated by LA treatment.
Conclusions. In the view of our present data, lipoic acid extract, with its
potent free radical scavenging and antioxidant properties, seems to be a highly
promising agent in protecting hepatic tissue against oxidative damage and in
preventing hepatic dysfunction due to I/R.
P25.04
BLOOD TRANSFUSION EFFECT ON PERIOPERATIVE AND
LONG-TERM OUTCOME AFTER HEPATIC RESECTION OF
COLORECTAL METASTASES
Garancini, Mattia1; Romano, Fabrizio1; Caprotti, Roberto1; Uggeri, Fabio1;
Visintini, Giorgio1; Crippa, Stefano2; Uggeri, Franco1
1San Gerardo Hospital, Dept. of Surgery, Monza, Italy; 2University of Verona,
Dept. of Surgery, Verona, Italy
Background. Blood transfusions are recognized to induce host immunosup-
pression and it is has been postulated to result in increasing postoperative
complication rates and in adverse long-term outcome in patients undergoing
surgery for cancer. Despite of surgical procedures improvements to limit blood
loss during hepatic transection and transfusion, these are often needed in
hepatic surgery.
Aim. Aim of this work was to analyze the influence of blood transfusion on the
clinical outcomeafter liver resection for colorectal metastases.
Methods. 170 consecutive patients (105 males and 65 females, mean age 63
years, range 4382) underwent liver resection for metastases from colorectal
cancer in a ten years period at a single institution. Surgical procedures,
intraoperative blood loss, postoperative complications, need and number of
transfusions, in-hospital mortality and long-term overall and disease free
survival were analyzed. Median follow up was 48 months.
Results. 120 (70%) minor and 50 major hepatectomies (35%) were
performed. The mean blood loss was 850 cc (range 1002800), the mean
hospital stay was 13 days (range 832). 79 patients (46%) received some blood
product transfusion (red blood cells, fresh-forzen plasma, platelets). High
grade postoperative complication were noted in 32 patients (19%). Transfused
patients had significantly higher complication rates than nontransfused,
especially local and systemic infectious complications (pB/0.005). The overall
postoperative mortality was 3.5% (6/170), and all these patients underwent
major surgery with 3 or more blood transfusion. 3- and 5 years overall and
disease fre survival rates were 42%47% and 26%31%. Patients receiving
any transfusion had decreased suvival compared with non trasfused (median
survival 48 versus 36 months).
Discussion. Blood product trasfusions predict minor and major complication
after liver resection. Moreover is associated with higher risk of perioperative
death and lower long-term survival.
P25.05
CLINICAL APPLICATION OF SPLENIC AUTOTRANSPLANTA-
TION IN ADDITION TO SURGUIRA PROCEDURE IN LIVER
CIRRHOSIS & PORTAL HYPERTENSION: A 26 YEARS EXPEIR-
ENCE
Chen, Tao; Chen, Ji-sheng; Huo, Jing-shan; Chen, Ru-fu; Zhang, Jie; Obetien,
Mapudengo; Zhang, Hong-wie; Fang, Tian-lingm; Chen, Ya-jin; Ou, Oing-jia
The Second Affiliated Hospital, Sun Yat-sen University, Dept. of General
Surgery, Guangzhou, China
Background. Many modalities for the treatment of liver cirrhosis and portal
hypertension (LCPTH) mainly focus on variceal hemorrhage. Splenic
function preservation was rarely considered. Splenic Autotransplantation
addition to Surgiura Procedure (SASP), was designed to preserve partial
splenic function. Clinical outcome of this procedure is not well known.
Objectives. To evaluate the clinical outcome of SASP.
Methods. 274 patient suffered from LCPTH were admitted in Department of
Surgery, Sun Yat-sen University Memorial Hospital from 1979 through 2005.
SASP includes modified Surguira procedure, partial Splenic Autotransplanta-
tion (5/3/1 cm3 residual spleen was implanted into retroperitoneal space)
were applied in all patients. Clinical parameters were prospectively investi-
gated; In 20 cases study, residual splenic function were evaluated by detection
of serum tuftsin, IgM level. Study further evaluated hemodynamic change of
portal vein on 28 patients, 3D MRA were applied in the study.
Results. In clinical prospective study on the 274 cases: surgical complica-
tion of morbidity was 17.9%, mortality was 4.4% in emergency cases and was
2.2% in routine cases. Splenism and esophagus varices recurrence were not
found; Liver coma incidence is 0.72%; postoperative portal hypertensive
gastrophathy bleeding (PHG bleeding) is 10%. The incidence of liver cancer
was 8.0%, which was the same as other procedures reported. In immunity
status assessment study, in control group serum tuftsin, IgM level had
remarkably decreased (p 0.001) in 2 months after surgery. The volume of
PV bloodstains were significantly decreased (p 0.001) in SASP patients.
Branches vein formed around autotransplantated spleen were clearly seen in
MRA.
Conclusion. SASP is a safe procedure for LCPTH which could provide well
effecicy of stanch and preserve the residual splenic immune function
successfully as well.
P25.06
ELECTRONIC-MICROSCOPIC ASSESSMENT OF ANTI-HY-
POXIC EFFECT OF FDP IN CASES OF EXTENDED HEMYHEPA-
TECTOMIES
Baimakhanov, Bolatbek; Aliyev, Mukhtar; Fedotovskikh, Galina; Akhmetov,
Yermek; Mirzhakypov, Arman; Sahipov, Musa
National Scientific Center of Surgery, Abdominal Surgery, Almaty, Kazakh-
stan
The aim of the work is the assessment of the anti-hypoxic efficiency of
intraoperative appliance of fructozo-1,6-diphosphate (FDP) by means of
electronic- microscopic investigation of the liver tissue.
The Patients and methods. Intraoperationally in cases of the hemyhepa-
tectomies bioptic material was received in quantity of 42 tissue samples before,
and in 5, 10, 15, 20, 25 minutes after the forcipressure and afterwards in 5
minutes after eliminating the Pringle-maneuver.
The Results. In 5 minutes after the forcipressure of the hepatoduodenal
chord in the individual mitochondrion’s the quantity of the granular materials
in the matrix decreased. After 15 minutes of hypoxia massive swelling of
mitochondrion’s with sharp lightening of the matrix was observed electro-
nically-microscopically that implied the decrease of the endogenous level of the
adenosine triphosphate. In 5 minutes after recovering of the afferent liver
bloodstream, the mosaicism of the liver structure was observed, which
reflected hepatocytes both in the condition of developed dystrophy and partial
necrosis as well as with the signs of beginning intracellular regenerative
processes. In cases of injecting the FDP prior to the Pringle-maneuver,
swelling signs of a number of mitochondrion’s appeared only in 20 minutes
from the beginning of the hypoxia period. At the same time, granular smooth
endoplasmic reticulum (SER) changes were not identified. SER’a expansion
and vacuolization were observed in 5 minutes after removal of tourniquet from
the hepatoduodenal chord.
Conclusion. Received electronic-microscopic results highlight anti-hypoxic
effect of FDP at inevitable hypoxia of liver during the period of Pringle-
maneuver’s application in cases of expanded hemyhepatectomies.
P25.07
EXPERIMENTAL RESEARCH ON BIOARTIFICIAL LIVER SUP-
PORT SYSTEM IN MINIPIGS WITH FULMINANT HEPATIC FAIL-
URE-PILOT STUDY
Pantoflicek, Tomas; Ryska, Miroslav; Ryska, Ondrej
Central Military Hospital, Dept. of Surgery, Prague, Czech Republic
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Aim. To evaluate the efficacy of a bioartificial liver support system in treating
minipigs with fulminant hepatic failure.
Methods. Ten minipigs with fulminant hepatic failure (FHF) induced by
portocaval anastomosis and hepatic artery ligation received bioartificial liver
system treatment (BAL group). Blood was perfused through a hollow fiber
tube containing hepatocytes. Ten minipigs with fulminant hepatic failure have
received no BAL treatment (control group).
Results. In a control group the main survival time was 13.45 (9/1,75). In the
3th hour of the experiment there was a decrease of glycaemia followed by
increase of ammonia, bilirubin, ALT, AST, PT and intracranial pressure
(ICP), In a BAL group there were no changes in survival time, amonia,
bilirubin, ALT, AST, PTand ICP. Statisticaly significant changes were only in
bilirubin levels.
Conclusion. There were no significant changes in a BAL treatment of
fulminant hepatic failure in minipigs in a pilot study.
P25.08
EXPRESSION AND SIGNIFICANCE OF TOLL LIKE RECEPTOR 2,
4 ON SPLENIC MACROPHAGE IN HYPERSPLENISM DUE TO
PORTAL HYPERTENSION
Li, Zongfang; Zhang, Shu; Su, Qinghua; Zhang, Yu; Xia, Xianming
The Second Affiliated Hospital, School of Medicine, Xi’an Jiaotong Uni-
versity, General Surgery, Xi’an, China
Background. The pathogenesis of hypersplenism due to portal hyperten-
sion(PH) is still not clear, it is generally accepted that the cytopenias result
predominantly from the increased phagocytosis and destruction of hemocytes
in splenic macrophage(Mphi). Toll-like receptor(TLR) 2, 4 mainly locate on
the surface of Mphi, they can activate Mphi by recognizing the microbial
products. Because of the general existence of endotoxemia in patients with
hypersplenism due to PH, we supposed that ‘‘Endotoxemia-Activation of
TLRs-Increase of phagocytosis of splenic Mphi-Hypersplenism’’.
Objective. To explore the role of splenic Mphi and TLRs in hypersplenism
due to PH.
Methods. 20 patients with hypersplenism due to PH and 6 patients with
traumatic rupture of spleen were regarded as hypersplenia and control group.
The level of serum endotoxin were all tested before operations. The Mphi were
isolated by adherent culture after splenectomy, and then the expressions of
TLR2, 4 were detected by immunohistochemistry and qRT-PCR, and the
phagocytosis of Mphi was measured by chicken red blood cell phagocytosis
assay.
Results. The expressions of TLR2, 4; the rate and the index of phagocytosis of
Mphi and the level of serum endotoxin observed in hypersplenia group were
126.159/24.20, 109.309/31.58(depth of dyeing), 2.299/0.55, 2.329/
0.41(qRT-PCR); 12.65%9/2.97%, 0.1469/0.035 and 0.289/0.21 EU/ml.
They were all significantly higher than that of the control group (75.849/
25.82, 61.819/4.51, 1.079/0.53, 1.019/0.14; 6.92%9/0.54%, 0.0769/0.008;
0.0549/0.014 EU/ml)(PB/0.05). The rate and index of phagocytosis of Mphi
were respectively in notable positive correlation with the expressions of TLR2,
4 and the level of serum endotoxin. The expressions of TLR4 were in positive
correlation with the level of serum endotoxin.
Conclusion. The activation of Mphi stimulated by the endotoxin and
other unidentified factors via TLR2, 4 could lead to the increased phagocytosis
of splenic Mphi. This may be one of the mechanism of hypersplenism due
to PH.
P25.09
FIRST IN VITRO COMPARISON OF TWO BIOARTIFICIAL LIVER
SUPPORT SYSTEMS: MELS CELLMODULE AND AMC-BAL
Poyck, Paul P1; Gesine, Pless2; Hoekstra, Ruurdtje3; Roth, Stephan2; van
Wijk, Albert A1; Schwartla¨nder, Ruth2; Chamuleau, Robert A4; Igor, Sauer
M2; van Gulik, Thomas M1
1Academic Medical Center, Dept. of Surgery (Surgical Laboratory), Am-
sterdam, Netherlands; 2Charite´-Universita¨tsmedizin, General, Visceral, and
Transplantation Surgery, Berlin, Germany; 3Academic Medical Center, AMC
Liver Center, Amsterdam, Netherlands; 4Academic Medical Center, Dept. of
Gastroenterology and Hepatology, Amsterdam, Netherlands
Background. Clinically applied bioartificial liver support (BLS) systems are
difficult to compare in terms of overall hepatocyte-specific function and their
effect on clinical outcome. Particularly, the large variability in cell type and
isolate, test set-up, patient population, outcome parameters and differences in
data presentation hamper simple device comparison.
Objective. In this study, two clinically applied BLS systems, the Modular
Extracorporeal Liver Support (MELS) CellModule and the AMC-bioartificial
liver (AMC-BAL), have been compared in an in vitro set-up.
Methods. Ten billion of freshly isolated porcine hepatocytes were loaded in
the MELS and the AMC-BAL (n/5) and cultured for seven days at 37oC in
the same culture medium. The overall in vitro functionality of both bioreactors
was assessed at day 1, 2, 4, and 7. Hepatocyte-specific functions (ammonia and
lidocaine elimination, urea and albumin production), hepatocellular cell
damage (LDH and AST release) and general metabolic activity (oxygen and
glucose consumption, and lactate production) were determined during a four
hour test period.
Results. In general, both bioreactors functioned well with an average decrease
of 9.7% in the hepatocyte-specific functions over 7 days. Lidocaine elimination
at day 1 and 2 was significantly higher in the AMC-BAL. In addition, ammonia
elimination showed an significant higher trend for the AMC-BAL over a
period of 7 days. All other parameters at all days did not differ significantly
between both bioreactors. Despite this observation, some trends were
observed. Glucose consumption and lactate production was lower in the
MELS at day 4 and 7. ASTand LDH release showed a tendency to be higher at
day 1 in the AMC-BAL.
Conclusion. This first in vitro comparison of two clinically applied BLS
systems (MELS CellModule and AMC-BAL) shows comparable functional
capacity over a period of seven days.
P25.10
FOLLISTATIN ATTENUATES APOPTOSIS AND LIVER FIBRO-
SIS: ACTIVIN SECRETED FROM HEPATOCYTES ACTIVATES
HSCS AND PLAYS A KEY ROLE IN FIBROGENESIS
Kitamura, Naoto; Azuma, Toshifumi; Tomita, Kengo; Inokuchi, Sayaka;
Nishimura, Takeshi; Ishii, Hiromasa; Shigematsu, Naoyuki; Kayoko, Naka-
mura; Kubo, Atsushi; Hibi, Toshifumi
Keio University, Tokyo, Japan
Background and aims. Activated hepatic stellate cells (HSCs) have been
considered as the major producers of extracellular matrix proteins in liver
injury and fibrosis. Here we show that follistatin, activin inhibitory protein,
could reduce apoptosis and prevent liver fibrosis and that activin could play a
key role in liver fibrogenesis.
Methods. Wistar male rats were injected intraperitoneally with dimethylni-
trosamine (DMN) three times a week for three weeks. Either follistatin or
saline were injected intravenously three times a week. Liver tissue sections were
either stained with Masson-trichrome or subjected to immunohistostaining.
The mRNA expressions of activin, TGF-beta were measured by RT-PCR.
Apoptosis of hepatocytes was analyzed by TUNEL.
Methods. Then, Wistar male rats were injected with DMN once. Liver
tissues were obtained 0, 12, 24, 36, 48, 60, 72 hours and 7 days after
injection. Hepatocytes and HSCs were isolated by collagenase-pronase
perfusion method and analyzed activin and TGF-beta mRNA expression by
RT-PCR.
Results. 50% of control rats died whereas none of follistatin-treated rats died.
The serum level of hyaluronic acid, AST and ALP levels were decreased and
apoptosis was reduced by follistatin dose-dependently. The expressions of
TGF-beta and alpha-SMA were also decreased. Activin expression was
observed at maximum level in hepatocytes 12 hours after DMN treatment.
TGF-beta expression was not detectable 12 hours after DMN administration.
TGF-beta expression was strikingly increased in stellate cells 48 hours after
DMN administration but not detectable in hepatocytes. Activin appeared in
HSCs as well as in hepatocytes 72 hours after DMN administration.
Conclusions. These results indicate that follistatin treatment blocks
activin secreted from hepatocytes and that inhibition of activin reduces
TGF-beta expression in HSCs. Follistatin could reduce apoptosis and
improve liver damage induced by DMN through blocking activin- TGF-beta
signaling.
P25.11
GLOBAL GENE EXPRESSION PROFILE ANALYSIS IN CRYPTO-
GENIC CIRRHOSIS
Kubrusly, Marcia S1; Sa´, Sandra V2; Correa-Giannella, Maria L2; Giannella-
Neto, Daniel2; Bacchella, Telesforo1; Machado, Marcel1
1University of Sao Paulo, Surgery, Sao Paulo, Brazil; 2University of Sao Paulo,
Endocrinology, Sao Paulo, Brazil
Background. Cryptogenic cirrhosis (CC) represents idiopathic end-stage
liver disease. This term is usually accepted only after an extensive evaluation
has excluded recognizable etiologies. It is emerging as an important indication
for orthotopic liver transplantation. However, little is understood about the
molecular mechanisms underlying its features. The high-throughput gene
expression technology provides simultaneous investigation of thousands of
genes, showing a snapshot of the transcription state of diseased tissue. With a
complete coverage of the liver transcriptome by microarray using normal liver
tissue as controls, we searched for similarities and differences in mRNA
abundances between normal and CC.
Aim. To evaluate differences in gene expression patterns between normal liver
and CC tissues.
Methods. We obtained liver specimens from two patients with confirmed CC
diagnosis and three control liver tissue samples from donor liver during
transplantation procedure. Samples were evaluated for differentially expressed
mRNAs by using CodeLink Uniset Human Whole Genome Bioarrays (GE
Healthcare, USA).
Results. Transcriptional levels of 444 annotated genes were changed in at least
2-fold with statistically significant ratio: 229 up-regulated in CC and 215 up-
regulated in non-diseased liver. Gene ontology (GO) analysis by GenMAPP
software identified 778 statistically significant clusters containing genes
assigned to biological processes (92%), molecular function (5%), and cellular
components (3%). Two major biological processes were strongly affected in
CC, namely development and cell adhesion, GO ID 7275 and 7155,
respectively.
Conclusion. This study reveals significant gene expression alterations in key
biological pathways and provides potential insights into understanding the
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molecular mechanisms involved in CC pathogenesis. These findings allow the
identification of new candidate genes likely to be early markers in CC.
P25.12
GRAPE SEED EXTRACT ALLEVIATES ISCHEMIA-REPERFU-
SION-INDUCED OXIDATIVE HEPATIC INJURY IN RATS
Ozel, Yahya1; Dulundu, Ender1; Topaloglu, Umit1; Sehirli, Ozel2; Sener,
Goksel2; Gedik, Nursal2
1Haydarpasa Numune Education and Research Hospital, 5th Dept. of
Surgery, Istanbul, Turkey; 2Marmara University, School of Pharmacy, Dept.
of Pharmacology, Istanbul, Turkey
Background & aim. The mechanisms underlying ischemia/reperfusion (I/R)
damage to the liver are most likely multifactorial and interdependent, involving
hypoxia, inflammatory responses, and free radical damage. The present study
was designed to evaluate the possible therapeutic effects of grape seed extract
(GSE) on hepatic (I/R) injury in rats.
Methods. Wistar albino rats were subjected to 60 min of hepatic ischemia,
followed by 60 min reperfusion period. Grape seed extract (GSE, 50 mg/kg,
orally) was administered either as a pretreatment for 7 days before the surgical
procedure and 30 min prior to ischemia and immediately before the
reperfusion period. At the end of the reperfusion period, liver tissues were
taken for the determination of malondialdehyde (MDA) levels, glutathione
(GSH) levels and myeloperoxidase (MPO) activity. Serum aspartate amino-
transferase (AST) and alanine aminotransferase (ALT) levels were determined
to assess liver functions. Plasma tumor necrosis factor-aand lactate dehydro-
genase (LDH) levels were also assayed as an indicator of cytokine release and
generalized tissue damage, respectively.
Results. Plasma ALTand AST levels were higher in I/R group than in control.
They showed significant reductions in GSE-treated groups. Similarly in-
creased TNF-a and LDH levels in the I/R group were reduced to control levels
with GSE treatment. Hepatic GSH levels which significantly depressed by I/R,
were elevated to control levels in the GSE-treated groups, being pre-treatment
more effective. Hepatic MDA levels and MPO activity were significantly
increased by I/R challenge. The increases in these parameters were partially
reduced by GSE when given as a single dose, whereas pre-treatment with the
GSE reduced these values back to control levels.
Conclusions. Our findings show that GSE has protective effects against
hepatic I/R injury and these effects were observed to be more pronounced
when given as a pretreatment in reversing the oxidative damage induced by I/R.
P25.13
HIGH FREQUENCY ULTRASOUND MONITORING OF A NEW
MICROWAVE ABLATION (MWA) DEVICE IN PORCINE LIVER:
LESSIONS LEARNED AND PHENOMENON OBSERVED
Helton, W Scott1; Espat, N Joseph2
1University of Illinois at Chicago, General Surgery, Chicago, USA; 2University
of Illinois at Chicago, Surgery, Chicago, USA
Background. MWA is presumed to be less susceptible than radiofrequency
ablation to convective heat loss from blood flow and will result in more effective
tissue ablation though this has yet to be studied.
Objectives. To evaluate the effects of hepatic blood flow (HBF) on MWA by
ultrasound (US) and to correlate US findings with gross inspection and
histology of the liver.
Methods. 4, 100 kg pigs underwent laparotomy. A 5.7 mm diameter MWA
probe was inserted into the liver using US guidance so that the tip was B/2 cm
to major hepatic blood vessels. A 2.45 GHz generator was used to deliver 70
100 watts for 4 minutes in 4 separate areas of the liver. US was performed with
3, 5 and 12 MHz transducers. HBF was interrupted by Pringle during some
ablations. Livers were explanted and the ablated zones sectioned for gross and
histologic inspection.
Results. Ablation zones were uniform in their shape and size (34 cm) and
related to power delivery despite being in proximity to large blood vessels. An
explosion with acoustical white-out occurred around the probe at 25/// 1
second in every ablation independent of HBF. 3 distinct zones of injury
(edema, hemorrhage and necrosis) were observed with the 12 MHz but not the
3 or 5 MHz transducers and correlated with gross and histologic injury. Pringle
increased ablation diameter by 70%. Thermal-induced coagulation could be
observed with US along hepatic veins remote from the central zone of ablation
and was associated with the formation of venous thrombus.
Conclusions. 12 MHz US is superior to 3 and 5 MHz US for monitoring liver
MWA and can identify zones of injury and convective heat spread. The zone of
ablation extends directly to the margin of major hepatic blood vessels and
sometimes extends beyond the intended target through convection. MWA-
induced explosion around the applicator could have adverse consequences in
patients. Further study is warranted to define the physics, benefits, limits, and
safety of this new MWA technology.
P25.14
IDENTIFICATION OF DIFFERENTIALLY EXPRESSED GENES IN
HYPERSPLENISM DUE TO PORTAL HYPERTENSION WITH
CDNA MICROARRAYS
Li, Zongfang1; Zhang, Shu1; Yan, Feng1; Huang, Chen2; Li, Aimin1
1The Second Affiliated Hospital, School of Medicine, Xi’an Jiaotong
University, General Surgery, Xi’an, China; 2Key Laboratory of Environment
and Gene Related to Disease (Xi’an Jiaotong University), Ministry of
Education of China, Xi’an, China
Background. It is believed that the destruction of hemocytes by macrophages
(Mphi) of spleen plays an important role in the development of hypersplenism
due to portal hypertension(PH). Our prior studies had proved that phagocy-
tosis of Mphi was augmented in hypersplenism due to PH, however, the reason
for increased phagocytosis and the gene regulation about phagocytosis are not
clear yet.
Objective. To screen the genes associated with hypersplenism due to PH
through the difference analysis of gene expression in macrophages between
normal and PH spleen by cDNA microarray and provide some evidence for the
research of spleen and Mphi from gene level.
Methods. The total RNA extracted from Mphi isolated from normal spleen
and PH spleen. The Biostar-H140s chips containing 14112 spots of cDNAs
were used to screen differently expressed genes associated with hypersplenism
due to PH.
Results. 896, 1330 and 898 genes were identified to be differently expressed in
three chips respectively. 121 genes (0.86%) were identified to be differently
expressed in all three chips, including 21 up-regulated and 73 down- regulated
known genes. The differently expressed genes were related with ionic channel
and transport protein, cyclin, cytoskeleton, cell receptor, cell signal conduct,
metabolism, immune, and so on. These genes might be related with the
hypersplenism due to PH.
Conclusion. Using cDNA microarray can screen the differently
expressed gene in Mphi from PH spleen successfully. It can provide some
new ideas about studying the hypersplenism due to PH. It suggests that the
different expressed genes might play key role in the pathogenesis of
hypersplenism due to PH, which code for the proteins in cell signal pathway,
DNA synthesis and repair, and cell cycle, such as upregulated ASK,
PI3KR1and downregulated PRKCD, IL1RN. But it is still to be determined
whether the different expressed genes could be used as target genes in gene
therapy of hypersplenism.
P25.15
IMATINIB INDUCED SUBCLINICAL LIVER INJURY
Nivatvongs, Supanit; Sirichindakul, Boonchoo; Sriuranpong, Virote; Wise-
dopas, Naruemon; Nonthasoot, Bunthoon; Suphapol, Jade
King Chulalongkorn Memorial Hospital, Bangkok, Thailand
Background. Severe clinical hepatitis after imatinib treatment has been
reported anecdotedly. During liver resection in case of gastrointestinal stromal
tumor (GIST) with liver metastases, we observed that hepatic tissue of patients
who received imatinib were very fragile and difficult to handle during
operation. We further characterized detailed histopathology of these patients.
Material and method. From July 2004 to November 2005 we operated 6
GIST patients with liver metastases. Four patients were naive for imatinib
where as two patients had received imatinib for 4 and 8 months before liver
resection. Preoperative hepatic biochemistry profiles of all patients were
unremarkable. Histopathology of hepatic parenchyma of these patients were
reviewed. Additional immunohistochemistry (IHC) for vascular endothelial
growth factor (VEGF) and epidermal growth factor receptor (EGFR) were
also studied.
Results. In all patients, common normal liver parenchymal histological
changes were swelling of hepatocytes, diffuse parenchymal congestion,
dilatation of central vein and infiltration of portal tract by mononuclear cell.
Interestingly, we found significant zone 3 hepatocytolysis in patients who
received imatinib treatment. Additionally, moderate degree of hepatic steatosis
was observed in correlation to imatinib exposure. However, immunohisto-
chemical study could not demonstrate any difference between these two
groups.
Conclusion. We described two cases of subclinical hepatotoxicity from ex-
posure to imatinib. Histopathology was consisted with drug induced liver injury.
Imatinib induced liver injury may be more common than obvious clinical
hepatitis which may implicate in future hepatic surgery in these patients.
P25.16
MANAGEMENT OF LIVER INJURIES
Frena, Antonio; La Guardia, Giuseppe; Martin, Federico
Regional Hospital of Bolzano, Dept. of General Surgery, Bolzano, Italy
Background. Liver injuries are the most frequent cause of death in the field of
abdominal traumas. The increase in road accidents and sports injuries makes
discussion of the treatment modalities increasingly relevant in this area.
Aim. In recent years we have witnessed an evolution in the therapeutic
management of such injuries with the increasingly frequent use of non-
operative procedures for the management of non-complex lesions.
Methods. A retrospective study was conducted in 111 cases of liver injuries
observed in our department over a 20-year period (19852005). The mean
age of the patients was 31 years. The most frequent causes were road accidents
(48%), followed by sports injuries (23%) and occupational accidents (11%).
Results. 82 patients (74%) were treated surgically and 29 conservatively. In
58 cases (35 of which treated surgically), the liver injury was isolated, while in
the other 53 cases lesions were also present in other abdominal organs. The
liver injuries, classified according to the AAST, were grade I in 47 cases, grade
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II in 30 cases, grade III in 19 cases, grade IV in 5 cases, and grade V in 10 cases.
Thirty-five percent of grade I-II lesions were treated conservatively, while 94%
of grade III-IV-V lesions received surgical treatment. The overall operative
mortality was 12.5%.
Conclusion. The evolution of the management of liver injuries has witnessed
an increase in conservative treatment, particularly for grade I and II lesions.
There is no alternative to surgical treatment when the injury involves the major
hepatic vessels or substantial amounts of parenchyma. The mortality rate is
high compared to that of elective liver surgery, but this is due to the frequent
associated lesions in other organs and apparatuses.
P25.17
PLATELET-DERIVATED SEROTONIN MEDIATES LIVER RE-
GENERATION
Lesurtel, Mickael1; Graf, Rolf1; Aleil, Boris2; Walther, Diego, J3; Tian,
Yinghua1; Jochum, Wolfram4; Gachet, Christian2; Bader, Michael3; Clavien,
Pierre-Alain1
1University Hospital Zurich, Dept. of Visceral and Transplantation Surgery,
Zurich, Switzerland; 2Etablissement Franc¸ais du Sang-Alsace, INSERM 311,
Strasbourg, France; 3Max Delbru¨ck Center for Molecular Medecine, Berlin,
Germany; 4University Hospital Zurich, Dept. of Pathology, Zurich, Switzer-
land
Background. Platelets play an important role in liver regeneration and they
are carriers of almost all the serotonin (5HT) in blood. In vitro, serotonin has a
very potent proliferatory activity and stimulates hepatocyte mitosis.
Aim/Objective. To test whether serotonin is part of the signal cascade
inducing hepatocyte proliferation in vivo after hepatectomy.
Methods. To assess liver regeneration, proliferating cell nuclear antigen
(PCNA), bromodeoxyuridine (BrdU) incorporation and Ki67 expression
were determined in male C57BL6 mice 48 hours after 70% hepatectomy. In a
first set of experiments, liver regeneration was compared among control mice,
immune thrombocytopenic mice (IT) and immune thrombocytopenic mice
treated with the serotonin agonist 2,5-dimethoxy-4-iodoamphetamine-hydro-
chlorid (DOI). In a second set of experiments, liver regeneration was
compared among control mice, tryptophan-hydroxylase 1 knock-out mice
(TPH-/-) and TPH-/- mice supplemented by the serotonin precursor 5-
hydroxytryptophan (5HTP) (TPH-/-5HTP). In TPH-/- mice, platelets lack
peripheral serotonin, while 5HTP supplementation reloads the platelets with
serotonin in TPH-/- mice. Next, liver regeneration was challenged using
specific serotonin receptor antagonists.
Results. In IT and DOI groups, platelet counts decreased below 10% of
controls. All indicators of cellular proliferation were significantly reduced in IT
group compared to controls, while they were restored in the DOI group (pB/
0.001). In TPH-/- mice, serotonin level in platelets was 9% of controls. 5HTP
treatment allowed reloading of platelets with serotonin in TPH-/- mice. Liver
regeneration was significantly impaired in TPH-/- mice compared to controls,
while it was rescued in TPH-/-5HTP mice (pB/0.01). The 5HT2A and
5HT2B receptor antagonists caused a significant reduction of liver regenera-
tion compared to controls.
Conclusion. We conclude that platelet-derived serotonin is a key molecule for
the initiation of liver regeneration after major hepatectomy.
P25.18
PREDICTING PERIOPERATIVE BLOOD TRANSFUSION IN LI-
VER SURGERY: A RISK SCORE SYSTEM
Pulitano`, Carlo1; Arru, Marcella1; Bellio, Laura2; Catena, Marco1; Finazzi,
Renato1; Ferla, Gianfranco1; Rossini, Silvano2; Aldrighetti, Luca1
1San Raffaele Scientific Institute, Vita-Salute San Raffaele University, Dept. of
Surgery Liver Unit, Milan, Italy; 2San Raffaele Scientific Institute, Vita-Salute
San Raffaele University, Transfusion Medicine Service, Milan, Italy
Background. Despite recent improvements in liver surgery, the risk for major
intraoperative blood loss and transfusions remain. The high cost of autologous
blood donation encourages the necessity to identify those patients most likely
to benefits from the procedure.
Aims. This study was designed to develop a point score system for predicting
the risk of blood transfusion in liver surgery, in order to identify patients who
may benefit from preoperative blood conservation strategies.
Methods. Data from 320 patients undergoing liver resection were retro-
spectively evaluated. Twenty-five preoperative variables were analyzed to
determine their univariate association with perioperative blood transfusion.
Significant variables were entered into a multiple logistic regression model,
and a transfusion risk score (TRS) was developed. The predictive utility of this
score system was validated by examining the area under the receiver operating
characteristic (ROC).
Results. Factors independently associated with blood transfusion included:
preoperative haemoglobin B/12.5 mg/dL, tumour size /4 cm, necessity of
vena cava exposure, additional surgical procedures, cirrhosis. Each significant
variable was assigned one point and the total score was compared with the
transfusion rate for each patient: 2% for score 0, 4% for score 1, 44% for score
2, 76% for score 3, 94% for score 4, and 100% for score 5. The calculate area
under the ROC curve was 0.88. The number of units transfused was
significantly correlated with the TRS (P 0.0009).
Conclusions. Patients with TRS greater than 2 should be encouraged to
utilize the autologous blood donation. Patients with TRS 5/1 could be
informed of the low risk for transfusion and not be encouraged to autologous
donation. These results suggest the possibility to predict which patients
undergoing elective hepatic resection may receive a perioperative blood
transfusion. The use of TRS could lead to substantial saving by improving
the cost-effectiveness of the autologous blood donation program.
P25.19
RECOVERY PATTERN OF LIVER FUNCTION TESTS FOLLOW-
ING SURGICAL BILIARY DECOMPRESSION
Singh, Shivendra; Agarwal, Anil K; Chaudhary, A; Sachdev, AK
GB Pant Hospital & MAM College, Dept. of GI Surgery, Delhi, India
Background. Liver functional recovery after biliary decompression has been
studied in experimental animal models, but the pattern and time frame of liver
function recovery after surgical biliary decompression and the importance of
biochemical parameters to determine liver function recovery has not been
studied well. This study was undertaken to evaluate the pattern of recovery of
liver function, especially biochemical parameters following surgical biliary
decompression.
Method. A prospective study of liver function using biochemical post-
operatively on day 1,4,7,15,and at 1 month parameters was done in 154
patients of obstructive jaundice undergoing surgical biliary decompression in
our department between June 2001Dec 2002. Serum bilirubin, transami-
nases and alkaline phosphatase levels were estimated pre-operatively (1 day
prior to surgery) and, 3 month and 6 month. Data was analysed to study the
effect of various factors like duration of jaundice, pre-op serum bilirubin,
cholangitis, benign vs. malignant etiology, type of surgery, pre-op stenting,
complete vs.partial biliary decompression, on recovery of biochemical para-
meters of liver function.
Results. The study comprised of 154 patients (60 Males & 94 Females) with
a mean age of 43 yrs (range1272 yrs). Mean serum bilirubin declined
by 46.46% from pre-operative level by day 7 and the levels almost normalized
by day 30. Decline in serum bilirubin is slower in patients undergoing
partial biliary decompression. Serum alkailine phosphatase level starts to
decline immediately and progressively after surgical decompression
however continue to remain high even after bilirubin has normalized. Analysis
of various factors using ANOVA for normalization of LFT parameters
following surgical decompression showed that for serum bilirubin, preopera-
tive stenting (pB/.017), benign/malignant etiology (pB/.003) and complete/
partial decompression (pB/.000) were the significant factors. On multiple
stepwise regression analysis only preoperative level of jaundice and complete/
partial decompression were found to be significant affecting normalization of
serum bilirubin.
Conclusion. In our study preoperative bilirubin level and nature of biliary
decompression were found to be significant factors affecting the recovery
of biochemical parameters of liver function.following surgical biliary decom-
pression.
P25.20
REGENERATION OF CHRONICALLY DAMAGED LIVER BY
STEM CELL THERAPY
Pai, Madhava1; Levicar, Natasa1; Al- Allaf, Faisal1; Dimarakis, Ioannis1;
Welsh, Jonathan2; Dazzi, Francesco3; Nicholls, Joanna1; Gordon, Myrtle2;
Jiao, Long R1; Habib, Nagy A1
1Faculty of Medicine, Imperial College, Hammersmith Campus, Dept. of
Surgical Technology & Oncology, London, UK; 2Faculty of Medicine,
Imperial College, Hammersmith Campus, Dept. of Haematology, London,
UK; 3Faculty of Medicine, Imperial College, Hammersmith Campus, Dept. of
Immunology, London, UK
Background & aim. Liver transplantation remains the definitive
therapeutic option for patients with chronic end-stage liver disease. A major
shortage of available organs restricts its use, highlighting the need to find
suitable alternatives. Advances in stem cell biology and the discovery of
pluripotent stem cells have made the prospect of cell therapy and tissue
regeneration a possible clinical reality. The aim of our study was to elicit the
potential clinical applications for these recent advances in patients with
chronic liver disease.
Methods. We isolated, from mobilised and leukapheresed blood, a morpho-
logically and phenotypically homogeneous subpopulation of CD34/ cells (5/
1%). We demonstrated that these cells and/or their progeny generated within 2
weeks in culture express genes corresponding to stem cells, hematopoietic and
hepatic cell differentiation. We also performed a phase I safety, toxicity and
feasibility clinical study in patients with liver insufficiency. The study involved
the collection of bone marrow cells by leukapheresis and subsequent infusion
of stem cells into the portal vein or hepatic artery of five patients with chronic
liver disease. All patients were followed-up for two months and studies were
performed for assessment of subjective criteria as well as objective clinical and
laboratory criteria.
Results. All the patients who were included in the study tolerated the
treatment protocol well. We have demonstrated the feasibility and safety of G-
CSF administration and mobilization, leukapheresis and intrahepatic transfer
of CD34/ stem cells in patients with chronic liver disease. Three patients
demonstrated improvement in liver function; one of these also had marked
decrease in the ascites while the remaining two patients did not show
improvement in liver function.
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Conclusion. Our study documents the existence of stem cells that can be
directly and reproducibly isolated from an accessible in vivo source and have
considerable promise for the clinical application of liver cell therapy.
P25.21
RELATION BETWEEN THE CAUDATE LOBE AND THE INFER-
IOR VENA CAVA LIGAMENT AND THEIR SURGICAL IMPOR-
TANCE
Kogure, Kimitaka1; Ishizaki, Masatoshi1; Nemoto, Masaaki1; Kuwano,
Hiroyuki1; Yorifuji, Hiroshi2; Takata, Kuniaki3; Makuuchi, Masatoshi4
1Gunma University, Graduate School of Medicine, Dept. of General Surgical
Science (Surgery I), Maebashi, Japan; 2Gunma University, Graduate School
of Medicine, Dept. of Neuromuscular and Developmental Anat, Maebashi,
Japan; 3Gunma University, Graduate School of Medicine, Dept. of Anatomy
and Cell Biology, Maebashi, Japan; 4Graduate School of Medicine,
University of Tokyo, Hepato-Biliary-Pancreatic Surgery Division, Depart,
Tokyo, Japan
Background. Resection of malignant liver tumors should encompass the
anatomical segment that includes the tumor-bearing region. Combined
resection of the tumor-bearing segment and the caudate lobe is conventionally
performed for hilar cholangiocarcinoma. However, there is no consensus on
the manipulation of the inferior vena cava ligament (IVC ligament) covering
the inferior vena cava (IVC) at the site of the caudate lobe.
Objective. This study was conducted to clarify the real relation between the
IVC ligament and the caudate lobe in human liver and to elucidate its surgical
importance in liver surgery.
Material and methods. The anatomical relation among the inferior vena
cava, the IVC ligament and the caudate lobe was macroscopically and
microscopically investigated in fifty-four human cadaveric livers.
Results. The IVC ligament was a membranous broad connective tissue
connecting both edges of the caval groove in which the IVC was deeply grasped.
The liver tissue of the caudate lobe became gradually thin at the end of the caval
groove and was transformed into the IVC ligament without any disconnection.
Terminal branches of the hepatic portal vein and of the hepatic artery, small bile
ductules and lymphatics were invariably observed in the IVC ligament and a
small nest of hepatocytes was observed in three cases of IVC ligament.
Conclusion. The study revealed that there is a close relation between the
IVC ligament and the caudate lobe and confirmed that the IVC ligament
invariably includes liver tissues in it. Since cancer may invade the IVC
ligament via its liver tissues, it is preferable to dissect the IVC ligament in a
case of hilar cholangiocarcinoma.
P25.22
SIGNIFICANCE OF BIOELECTRICAL IMPEDANCE DURING
ISCHEMIA-REPERFUSION INJURY IN THE RABBIT’S LIVER
Yun, Sung S; Lee, Dong S; Kim, Hong J; Ahn, Hyun S; Shin, Hyoun J
Yeungnam University Hospital, Dept. of Surgery, Taegu, South Korea
Background. During liver resection and liver transplantation, liver is
damaged by ischemia-reperfusion injury. Until now, there is no approved
method to measure or predict the extent of liver injury during the operation.
Aim/Objective. This is the preliminary study to make the real time
monitoring system by quantification of bioelectrical impedance and ische-
mia-reperfusion injury in liver.
Methods. Male Newzealand white rabbits (body weight 3.54.0 kg) were
used. Changes of bioelectrical impedance were observed during 30 and 120
minutes ischemia and reperfusion at various frequency (120 Hz-100 KHz).
Bioelectrical impedance of liver tissue were measured every 5 minutes
interval with two mono-polar needle coated with platinum using LCR meter
(GS-4311B, ANDO, Japan). Cell viability was assessed by metabolic capacity
of fatty acid (palmitic acid metabolic rate) and histologic examination (H&E
stain) at every 30 minutes interval during 120 minutes ischemia.
Results. Liver bioelectrical impedance was changed significantly (pB/0.05)
during ischemia in lower frequency compared to those of higher frequency.
The level of bioelectrical impedance(120 Hz) at preischemia, 5, 10, 15, 20,
25 and 30 minutes after ischemia are 4.799/0.23, 5.669/0.28, 6.819/0.44,
7.719/0.99, 8.539/1.40, 9.569/1.50, 10.079/1.46 ko (Mean9/SD), respec-
tively. The level of bioelectrical impedance returned to base line level after
reperfusion. The level of bioelectrical impedance(120 Hz) increased gradu-
ally after ischemia for 1 hour. After 1 hour, the level of bioelectrical
impedance had tendency to maintain plateau. Palmitic acid oxidation rate
were not changed significantly during 120 minutes ischemia and there were
no significant difference in histologic examination.
Conclusion. We found the possible role of bioelectrical impedance to
measure and predict the extent of ischemia-reperfusion injury. But we need
further study to clarify the relationship between bioelectrical impedance and
ischemia-reperfusion injury.
P25.23
SPONTANEOUS HAEMORRHAGE OF HEPATOCELLULAR
ADENOMAS: SELECTIVE ARTERIAL EMBOLISATION (SAE)
AS INITIAL OR ELECTIVE TREATMENT
Erdogan, Deha1; van Delden, Otto M2; Busch, Olivier RC1; Gouma, Dirk J1;
van Gulik, Thomas M1
1Academic Medical Center, Dept. of Surgery, Amsterdam, Netherlands;
2Academic Medical Center, Dept. of Radiology, Amsterdam, Netherlands
Background. Hepatocellular adenomas (HCA) are benign liver lesions
which may present with spontaneous haemorrhage. In case of haemorrhage
and rupture, laparotomy and resection or packing is required to control
bleeding. Recent advances in interventional radiology now offer selective
arterial embolisation (SAE) as a treatment option.
Aim. We describe our experience with SAE in 5 patients who presented with
haemorrhage of HCA.
Results. All patients presented with acute onset of abdominal pain. In the
first patient, an inhomogenic mass with rupture to peritoneal cavity was seen
arising from the left liver segments. Angiography of the left hepatic artery
with SAE of the feeding artery was performed using platinum coils. The
patient was discharged without complications. In the second patient, two
lesions and a subcapsular haematoma in right liver were seen at presentation.
Patient was observed. One year later SAE of left hepatic artery branch was
performed using Ivalon coiling particles in an attempt to reduce size of the
HCA. Follow-up CT showed regression of HCA from 4.6 to 3.7 cm. In the
third patient, imaging studies showed haemorrhage associated with a mass in
segment 4. Angiography showed two blushes from a peripheral branch of
right hepatic artery which was subsequently embolised. Follow-up CT
showed regression of the lesion. In the fourth patient, a large subcapsular
haematoma with rupture to peritoneal cavity, probably due to a HCA in
segment 2 was seen. Angiography showed no active bleeding site. The lesion
was observed and eventually resected after 16 months. In the fifth patient,
imaging showed a subcapsular haematoma in the right liver lobes. Angio-
graphy showed an abnormal cluster of blood vessels cranially in the right liver
lobes. One artery ended in a spherical structure showing contrast extravasa-
tion. SAE was performed although a specific bleeding focus was not revealed.
Conclusion. SAE is a viable option as initial or elective treatment in case of
spontaneous haemorrhage of HCA.
P25.24
SURGICAL MANAGEMENT OF HYDATID DISEASE OF THE
LIVER: A SINGLE CENTER EXPERIENCE
Saribeyoglu, Kaya; Kilic, Ilknur; Kapan, Metin; Pekmezci, Salih; Durgun,
Vedat; Kalafat, Hasan; Tasci, Hasan; Go¨ksoy, Ertugrul; Perek, Sadik; Sariyar,
Muzaffer
Istanbul University, Cerrahpasa Medical Faculty, Dept. of General Surgery,
Istanbul, Turkey
Background. Search for the optimal treatment hydatid disease of the liver.
Aim. To present our institution experience on hydatid disease surgery of the
liver.
Patients and methods. Between May 2002 December 2005, the patients
who were admitted to our clinic and underwent surgery for hydatid
disease of the liver were taken into the study and patients with extrahepatic
cysts were excluded. Patients’ records were retrospectively collected and
analyzed.
Results. During the study period 57 patients underwent surgery for hydatid
disease of the liver. There were 31 female and 26 male patients and mean age
was 43.4 (1576). 37 and 22 cysts were localized at right and left lobe
respectively; in two patients there were two cysts. Nine cases (%15.7) were
recurrences. Simple evacuation procedures (including partial cyst wall
excision, introflexion or omentoplasty) and excisional procedures (pericys-
tectomy, segment resection etc.) were performed in 52 (91.2%) and 5 (8.8%)
respectively. Six procedures (10%) were carried out laparoscopically and
there was no conversion to laparotomy. One patient who had a cyst at central
localization which was associated with destruction of the biliary tract and
reoperated for the revision of hepaticojejunostomy. There was no mortality
and early perioperative morbidity.
Conclusion. Hydatid disease of the liver can be managed successfully with
simple drainage procedures. Laparoscopic procedures are also safe and
efficient in selected cases.
P25.25
SURGICAL MANAGEMENT OF PORTAL BILIOPATHY-A PRO-
SPECTIVE ANALYSIS
Girish, SP; Singh, S; Agarwal, S; Mishra, PK; Puri, S; Sakhuja, P; Gondal, R;
Agarwal, Anil K
GB Pant Hospital & MAM College, Dept. of GI Surgery, Delhi, India
Background. Portal biliopathy denotes intrahepatic and extra hepatic biliary
ductal abnormalities in portal hypertension. It is usually associated with extra
hepatic portal vein obstruction (EHPVO).
Study. We performed a prospective study of the patients of EHPVO with
portal biliopathy presenting to the surgical clinic of this tertiary referral center
between September 2003 and December 2005. The data was analyzed for
presentation, clinical features, imaging and results of surgical management.
Results. During the study period, total of 44 patients of EHPVO were
referred for surgical management. Of these 14 patients were diagnosed to
have portal biliopathy. There were 9 males and 5 females. Mean age was
34.6years. 10 patients had prior history of variceal bleed which was managed
endoscopically. All patients had history of jaundice and 12 patients were
jaundiced at the time of presentation (85.6%). Recurrent cholangitis and
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right upper quadrant pain seen in 4 patients (28.6%) each. Physical
examination revealed jaundice in 12 patients (85.6%), splenomegaly in all
and mild ascites in 2 (15.3%). Upper GI endoscopy revealed esophageal
varices in all (grade 13), gastro esophageal varices in 7 and PGP in 7
patients. Two patients had ectopic gastric varices. Doppler evaluation of the
spleno portal axis revealed portal cavernoma and portal vein thrombosis with
collaterals in 13 and 1 patients respectively. ERCP/MRCP was used for
delineation of the biliary tree, which showed irregularity (14 patients),
dominant strictures (8 patients), filling defects (5 patients), and intrahepatic
biliary dilatation (7 patients). Proximal splenorenal shunt (PSRS) was
performed in 13 patients. While in 1 patient in whom peroperatively gross
nodular liver was found, gastro-esophageal devascularization with simulta-
neous biliary drainage was done. Of the 13 patients who underwent PSRS, all
patients were intensively followed for 46 weeks with history and liver
function tests. After 6 weeks, 5 patients showed clinical as well as biochemical
improvement and they are being followed up regularly. 8 patients had
persistent symptoms and abnormal liver function tests. Those with persistent
symptoms underwent Doppler and MRCP examination. 8 patients had
persistent dominant stricture. Of these 6 patients underwent Roux-en-Y
hepatico-jejunostomy while 1 patient refused surgery and were lost to follow
up and one patient is waiting for second surgery (RYHJ). The average blood
transfusion requirement at second surgery was 1 unit. Postop complications
were minimal with no mortality. Over a follow up of 328 months the
patients are asymptomatic and well.
Conclusion. Portal biliopathy with symptomatic biliary obstruction needs
intervention. Surgical decompressive shunt followed by biliary drainage is the
best possible treatment. While for most of the early biliary changes shunt
alone is effective, patients with dominant stricture will need a second stage
hepatico-jejunostomy following Porto systemic shunt.
P25.26
THE EFFECT OF PORTAL VENOUS PRESSURE CONTROL
THROUGH SELECTIVE MESENTERIC VESSEL LIGATION
(MVL) ON LIVER REGENERATION IN 70% HEPATECTOMIZED
RATS
Cho, Jai Y; Suh, Kyung-Suk; Lee, Hae W; Cho, Eung-Ho; Yang, Sung H;
Cho, Yong B; Yi, Nam-Joon; Lee, Kuhn U
Seoul National University College of Medicine, Seoul, Korea
Background. Partial liver regeneration is crucial after adult-to-adult living
donor liver transplantation. One of the mechanisms that inhibit regeneration
of partial liver is portal hypertension caused by excessive portal flow to the
small graft.
Aims. We investigated the effect of selective mesenteric vessel ligation
(MVL) on the control of portal pressure in 70% hepatectomized rats and its
impact on liver regeneration.
Methods. A total of 48 male Sprague-Dowley (about 250 gm) rats were
studied. The rats were divided into three groups; Group N (Sham operation;
n/16), Group C (70% hepatectomy; n/16), and Group M (MVL after
70% hepatectomy; n/16). MVL was performed by selective ligation of
proximal mesentery, supplying to about 8/10 cm of distal ileum. Portal
pressure was monitored and blood and remnant liver tissue were collected 0,
1, 24, and 48 hours after operation.
Results. After MVL, all animals survived and no complication was observed
after relaparatomy. The portal pressures immediately after operation were
11.5¡342.0 mmHg in Group N, 16.3¡
3
42.2 mmHg in Group C and 14.1¡
3
41.1
mmHg in Group M (pB/0.05). In Group M, MVL induced a significant
reduction of portal pressure (/15.6%, pB/0.05). The effect of MVL on
portal pressure lasted more than 48 hours. The portal pressure control
through MVL reduced the levels of serum total bilirubin and alanine
aminotransferase. Volume regeneration of the remnant liver was 5.3¡342.6%,
61.5¡348.8%, and 104.5¡
3
45.2% at 1, 24, and 48 hours postoperatively in Group
M and 7.8¡341.5%, 54.1¡
3
46.1%, and 81.3¡
3
46.8% in Group C, respectively.
Statistical difference was observed at 48 hours postoperatively. Proliferation
cell nuclear antigen indices were higher in Group M than those in Group N
or C at 24 hours postoperatively (pB/0.05). Serum tumor necrosis factor-
alpha levels were significantly higher in Group M than in Group N or C.
Conclusion. MVL effectively lowered portal pressure after 70% hepatect-
omy and safely accelerated liver regeneration.
P25.27
TIPS FOR REFRACTORY VARICEAL BLEEDING: AN ANALYSIS
OF REINTERVENTION TO MAINTAIN DECOMPRESSION FROM
A RANDOMZED TRIAL
Henderson, J. Michael1; Rikkers, Layton2; Livingstone, Alan3; Abu-Elmagd,
Kareem4; Galloway, John5
1Cleveland Clinic, Division of Surgery, Cleveland, Ohio, USA; 2University of
Wisconsin, Madison, WI, USA; 3University of Miami School of Medicine,
Center for Liver Disease, Miami, FL, USA; 4University of Pittsburg Medical
Center, Thomas E. Starzl Transplantation Institute, Pittsburgh, PA, USA;
5Emory University, Digestive Diseases, Atlanta, GA, USA
Objective(s). A randomized trial comparing distal splenorenal shunt
(DSRS) and transjugular intrahepatic portal systemic shunt (TIPS) for
management of refractory variceal bleeding showed no significant (p/0.29)
difference in rebleeding rates (DSRS 5.5%; TIPS 10.5%). The present
analysis evaluates factors that lead to this lowest reported rebleeding rate for
TIPS.
Methods. 67 patients at 5 centers received TIPS. Protocol monitoring for
TIPS patency was with Doppler ultrasound, plus TIPS catheterization and
pressure measurements every 12 months. Reintervention was TIPS dilation
or further stenting only when TIPS gradient ]/12 mm Hg or/50% stenosis.
Inpatient costs were based on DRG and outpatient costs on CPT coding.
Results. Mean follow-up was 469/26 months. There were 15 TIPS
thromboses-8 in the first month and 7 thereafter: 14 were salvaged with
reintervention. Overall patient reintervention rate was 83%, frequently with
multiple reinterventions: Table. Mean cost of an inpatient reintervention was
$12,830 per event, for outpatient redilation $1,880 (n/72) and outpatient
restenting $3,860 (n/33).
Conclusions. The low TIPS rebleeding rate was a consequence of intensive
monitoring and aggressive reintervention. Timely reintervention, including
routine catheterization of TIPS at 1- and 2-years, can achieve the low
rebleeding rate found in this trial. Cost of reintervention is high, but probably
not as high as the cost of managing rebleeding.
P25.28
ULTRASOUND ASSISTED LIVER BIOPSY IN A DISTRICT GEN-
ERAL HOSPITAL
Damodaran, Dinesh P; Salam, Imroz; Ananthasayanam, Ashok
West Wales General Hospital, Dept. of Gastro-enterology, Carmarthen, UK
Introduction. Liver biopsy is the central investigation of Hepatic disease.
The low Mortality (0.01%-0.17%) and the low Morbidity of this procedure
has made it very popular and has been widely used.
Aim. To evaluate the practice of liver biopsy in a District general
hospital(DGH) and compare with the British Society of gastro-enterology
(BSG) Guidelines.
Method. Retrospective study conducted between January 2000 and Sep-
tember 2004 on 65 patients. Details pertaining to age, sex, indication, biopsy
type, complication, transfusion, Hospital stay were analysed.
Results. There were 55% males and 45% females who had liver biopsy of
which most of them where in the 6th and 7th decade. Deranged LFT was
most common indication (45%) followed by suspected metastasis. ultrasound
assisted liver biopsy is being done more often in the trust (35%) than
ultrasound guided (31%) followed by laparoscopy (15%). Complication was
minimal, mostly related to pain (15%). No mortality was reported as
compared to the BSG Guidelines which shows 0.13% to 0.33% in District
general hospitals in the UK.
Discussion. Deranged LFT holds the maximum number of patients in our
trust. Ultra sound assisted Liver Biopsy is being done more than Ultra Sound
Guided liver biopsy. The maximum hospital stay is 1 day. Complications are
minimal and no mortality reported.
Conclusion. From the data Ultra sound assisted Liver Biopsy is the safest
and most effective method of liver biopsy if not contraindicated.
P25.29
YTTRIUM-90 SELECTIVE INTERNAL RADIATION THERAPY
(SIRT) IN THE TREATMENT OF NON-RESECTABLE HEPATIC
GI CANCER HEPATIC METASTASES
Helton, Scott W1; Bui, James2; Garrean, Sean3; Blend, Michael4; Espat,
Joseph N3
1University of Illinois at Chicago, Hepatobiliary Surgery, Chicago, USA;
2University of Illinois at Chicago, Radiology, Chicago, USA; 3University of
Illinois at Chicago, Surgery MC 958, Chicago, USA; 4University of Illinois at
Chicago, Nuclear Medicine, Chicago, USA
Background. Only limited data support surgical resection for hepatic
metastases from GI-origin malignancies other than CRC. However, selected
patients with minimal extra-hepatic disease or with significant symptoms with
an anticipated survival of /3 months whom are not resection candidates may
be the optimal candidates for SIRT Y-90 therapy as a means to stabilize
hepatic disease or to attenuate symptoms.
Purpose. To prospectively analyse a group of patients with hepatic
metastatic disease whom were not resection candidates treated with SIRT
Y-90 therapy and followed radiographically post treatment.
Methods. Under institutional protocol and with the IRB approved HPB-
maintained database, patients undergoing SIRT in 2005 meeting the above
criteria were evaluated subsequent to SIRT therapy by CT and PET at 3
months. Karnofsky peformance score(KPS) was assiged. 2 colorectal cancer
patients (1(patient A) metastatic post resection, HAI and RFA; 1 single
Table. Pattern of Reintervention and Rebleed
N (Pts) New Stents Redilation No Intervention Rebleed
Year 1 62 53% 20% 20% 4 pts
Year 27 51 47% 61% 25% 3 pts
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central lesion (patient B), 1 gallblader cancer (stage IV), 1 HCC (7.7 cm,
childs B, seg VII/VIII and 1 pancreatic adenoca were included in this analysis.
Results. All patients were treated as 23 hour admits. No radiation side-
effects were noted. KPS was maintained in all treated patients. All patients
had either stabilized tumor, or tumor regression radiographically. Symptoms
were controlled.
Conclusion. Hepatic failure is the common cause of symptoms and death
for patients with metastatic GI-cancers. While anecdotal at present, these
observations support the need to establish a SIRT disease treatment database
to analyze treatment outcome for SIRT in patients with otherwise refractory-
to-treatment tumors AND to compare the survival outcome as a function of
quality of life/ performance score to cost of treatment; in achieving the
suggested equivalent or potentially improved outcome.
P25.30
LIVER TRAUMA-A 10-YEAR EXPERIENCE OF 110 CASES
Bhatnagar, Ashok; Parmar, Chetan; Sharma, Praveen
Medical College & SSG Hospital, Dept. of Surgery, Vadodara, India
Background. Liver is one of the most commonly injured organs following
abdominal trauma which needs specialist approach and center for the
management. Management of liver trauma continues to evolve. Emphasis
is laid on selective nonoperative approach and perihepatic packing to control
hemorrhage.
Aims and objectives. To know the: 1. Incidence of minor and complex liver
trauma with associated injuries 2. Usefulness of different diagnostic
modalities 3. Role of non operative management and its associated problems
4. The usefulness of the different surgical techniques and perihepatic
packing.
Methods. This is a study of 10 years comprising 110 patients of Liver
trauma, divided into 2 groups- survivor and death groups. Survivors were
further classified into 3 groups based on the type of injury and the treatment
offered.
Results. The majority (75%) patients were of blunt trauma and 78% of
patients were stable and 22% were unstable. 53.6% patients had Associated
injuries. Ultrasonography and CT were used for the diagnosis. Survivor
group 1(39 patients) were offered non-operative treatment. 2 patients
developed complications but one was operated. No deaths in this group.
Survivor group 2: (53 patients) were offered surgery. Perihepatic packing
done in 4 patients. 8 developed complications and 3 died. Survivors group 3:
(18 patients) suffered severe injuries and were treated with aggressive
surgery.10 patients were unstable and 10 (56%) had associated injuries. All
were offered surgery, resection was done in 2 patients and perihepatic
packing in 9 patients. 7 developed complications and died. Death
group:(10patients) 2 were stable and 8 were unstable. All patients had
associated injuries. 2 died intraoperatively and 8 postoperatively.
Conclusion. Early recognition of severe liver trauma and associated injures.
Nonoperative management in stable minor liver injuries practiced. Judicious
use of perihepatic packing and portal occlusion in uncontrolled hemorrhage.
P25.31
MANAGEMENT OF LEAKING UMBILICAL HERNIA IN ASCITIC
PATIENTS DUE TO HEPATIC DISEASES; OUTCOME OF A NEW
TECHNIQUE OF UMBILICAL HERNIORRHAPHY
Anwer, Sammah1; Hassanen, Motaz2; Kishta, Sobhy3
1TBRI, Bacteriology, Cairo, Egypt; 2TBRI, Medical HPB & Gastroineriology
Unit, Cairo, Egypt; 3TBRI, General and HPB Surgery, Cairo, Egypt
Aim. Evaluation of leaking umbilical hernia [UH] in ascetic patients due to
decompensated liver disease, its complications, its management by Modified
Stone’s Herniorrhaphy [MSH] and outcome of the repair.
Methods. We have been studied 112 patients with leaking UH in ascetic
hepatic patients. Perioperative evaluation has been done. All cases have been
prepared by antibiotics, albumin, FFP and repeated sterile dressing. Hernior-
rhaphy have been done by our new technique of MSH as an emergency by
Local anesthesia (LA) in most of the cases.
Results. The patients with the leaking UH were 80 males, 32 females and
their ages were 26 to 72 years. They were Child C, in 96 cases Child B in 16 of
them & diuretic resistant ascites in 80 patients. Unhealthy skin with
pigmentation and discoloration has been found in 106 cases & irreducible
UH in 82 cases. Leaking was due to skin ulceration and infection in 106 cases
and sudden increase intra-abdominal or pressure/ external trauma in 6. The
mean operative time was 36/-2 minute and small hernial defect in 102 with
Caput medusa 60 cases were found causing irreducibility. Staphylococcus
epidermidis [SE] organisms have been isolated also from the turbid ascetic
fluid in 48 cases with portal bacteraemia in 28 cases. There was neither
operative mortality nor postoperative leaking in all cases. There was a
postoperative wound infection with long hospital stay in 42 cases. During
follow up to 4 years, recurrence was found in 18 and late postoperative
mortality in 28 cases mainly due to hepatic causes.
Conclusion. Management of leaking umbilical hernia in ascites due to liver
diseases is an emergency life saving procedure. Our new technique of
Modified Stone’s Herniorrhaphy can be done safely as an emergency away
from infected area by LA with minimal complications.
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CYSTIC LESIONS OF THE HPB SYSTEM: A SURGEON’S CON-
UNDRUM
Shetty, Tilakdas; Joshi, Rajeev; Adhikari, Devbrata; Khithani, Amit
TNMC and Nair Hospital, Surgery, Mumbai, India
Background. Cystic lesions of the HPB system are common and sometimes
pose a diagnostic and therapeutic dilemma.
Aim. Rare cystic lesions of the liver, pancreas and biliary tree may mimic
common clinical conditions. The aim is to clear the ambiguity and to reiterate
an open minded approach to these problems.
Patients and methods. 295 patients with cystic lesions of the HPB system
were analysed over a 7 year period (Feb’99 to Jan’06). Diagnosis was based on
clinical assessment, USG and CT scan along with biochemical markers,
MRCP and EUS in select cases.
Results. Cystic SOL’s of the liver (n/228) included 183 cases of amoebic
liver abscess. One non responder was eventually diagnosed as cystic
cholangiocarcinoma. Conversely, a diagnosed angiosarcoma was an amoebic
liver abscess. Multiple amoebic abscesses were rare (n/5) and needed to be
differentiated from pyogenic abscesses (n/15). Parasitic (n/21) and non-
parasitic hepatic cysts (n/9) were the other cystic SOL’s. 3 patients with
hepaticolithiasis and 1 patient each of biliary cystadenoma and hydatid cyst
underwent hepatic resection. A cysto-pericystectomy was performed in 14
and conservative surgery in 6 patients of hydatid cyst. A case misdiagnosed as
hydatid on CT was a cystic variant of embryonal sarcoma as also a hydatid
cyst which mimicked a simple hepatic cyst. A type I choledochal cyst
diagnosed on MRI was a simple liver cyst. In 45 pseudocysts and 11 true
cysts, treatment included cystoenterostomy in 26 cases of pseudocysts and
resection in 10 patients of true cysts. True cysts of the pancreas may
masquerade as pseudocysts and this was exemplified by one case of mucinous
cystadenoma.
Conclusion. Better imaging modalities do not necessarily translate into more
accurate diagnosis. Conventional medical teaching lays emphasis on common
conditions but uncommon lesions may mimic certain common ones.
Therapeutic dilemma always exists, whether to be radical or conservative? It
may be prudent to adopt a resectional policy in equivocal cases.
P25.33
CO-CULTURE OF ADULT HUMAN HEPATOCYTES WITH AUTO-
LOGOUS LYMPHOCYTES
Kataki, Agapi1; Doumba, Polyxeni1; Nikolopoulou, Marilena1; Gomatos,
Ilias1; Galani, Erietta1; Koskinas, Ioannis2; Konstandoulakis, Manousos1;
Bramis, John1
1University of Athens, Medical School, A? Propaedeutic Dept. of Surgery,
Lab. Surgical, Athens, Greece; 2University of Athens, Medical School, 2nd
Dept. of Internal Medicine, Athens, Greece
Introduction/Background. The liver has a distinctive immunological role
and characteristic vascular supply. There is continuous lymphocytic entrance
to the liver through the sinusoids, there is cross-talk among the different cell
populations, with hepatocytes and lymphocytes being the foremost. These
interactions may play a role in the pathophysiology of various inflammatory
liver diseases.
Aim/Objective. Study of apoptosis after direct contact between adult human
hepatocytes and autologous mononuclear cells in standardized in vitro
environment.
Patients/Methods. Liver tissue was resected from 4 patients undergoing
elective laparoscopic cholecystectomy. Hepatocytes were isolated by enzy-
matic disaggregation and purified by Percoll gradient centrifugation. Hepa-
tocytes viability was estimated by Trypan blue and cells were plated in 24-well
collagen-coated dishes. Autologous mononuclear were isolated from periph-
eral blood prior to surgery by gradient centrifugation. Two days after initial
plating adhesive hepatocytes were co-cultured with mononuclear in a ratio of
1:1 or 5:1 respectively. Apoptosis (7AAD staining) of co-cultured hepatocytes
and activated lymphocytes (HLA-DR-PE) were measured at 24 hour interval
for three days by flow cytometry.
Results. After purification the average value of hepatocyte and lymphocyte
viability was 88,95% (std.5,25) and 96,5% (std.5,03) respectively. Lympho-
cytes co-cultured with hepatocytes in a ratio of 1:5 stay concurrently activated
and viable for the first two days of co-culture in comparison to control
samples-lymphocytes only (21,63vs15,32 and 21,04vs12,69 respectively).
Conclusions. Adult human hepatocytes can be preserved in vitro for more
than two weeks maintaining their phenotypic differentiated characteristics.
When placed in co-culture with autologous lymphocytes they modulate their
degree of activation. This in vitro model can be used for the study of various
inflammatory diseases.
P25.34
THE EFFECT OF ISCHAEMIC PRECONDITIONING ON BILE
FLOW IN LEAN AND OBESE ZUCKER RATS
van Baal, Mark1; Nieuwenhuijs, Vincent1; de Bruijn, Menno1; Schiesser,
Marc1; Morphett, Arthur2; Padbury, Robert1; Barritt, Greg3
1Flinders Medical Centre, HPB and Liver Transplant Unit, Adelaide,
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laide, Australia; 3Flinders University School of Medicine, Dept. of Medical
Biochemistry, Adelaide, Australia
Background. Ischaemic reperfusion injury (IR) is a major risk factor for liver
failure in steatotic livers.Bile flow is an early, functional marker for liverdamage.
Ischaemic preconditioning (IPC) protects normal livers from IR-injury.
Aim. This study aimed to investigate whether IPC reduces IR-injury and
restores bile flow in steatotic livers in rats.
Methods. A model of partial (70%) hepatic ischaemia and reperfusion was
used in heterozygous lean (350480 g) and homozygous obese Zucker rats
(500830 g). Three protocols were studied: Controls, no ischaemia (125 min
perfusion), continuous clamping (CC) (20 min perfusion, 45 min ischaemia,
60 min reperfusion) and IPC (20 min perfusion, 10 min ischaemia, 10 min
reperfusion, 45 min ischaemia, 60 min reperfusion). Bile was collected from
the ischaemic lobes in 5 minute samples. Bile flow recovery at the end of 60
min reperfusion was calculated. Serum liver enzymes were analysed.
Results. Both CC and IPC resulted in a significant reduction in bile flow in
comparison to controls (pB/0.001). However, IPC did not result in improved
bile flow when compared to CC in both lean and obese animals (p/0.37 resp
p/0.06). Postoperative liver enzymes were increased compared with pre-
operative levels in all groups. IPC did not lower liver enzymes after 1 hour of
reperfusion compared with CC in both lean and obese rats.
Conclusion. In Zucker Lean and Obese rats, IPC does not improve post-
ischaemic bile flow and liver enzymes. The absence of an IPC effect in lean
Zucker rats may be due to the genetic background of these rats.
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CONTRAST ENHANCED INTRAOPERATIVE ULTRASOUND
HAS NO ADDITIVE DIAGNOSTIC VALUE ABOVE COMPUTED
TOMOGRAPHY AND INTRAOPERATIVE ULTRASOUND IN PA-
TIENTS WITH COLORECTAL LIVER METASTASES
Fioole, Bram1; de Haas, Robbert J1; Wicherts, Dennis A1; van Hillegersberg,
Richard1; Elias, Sjoerd G2; van Leeuwen, Maarten S3; Borel Rinkes, Inne
HM1
1University Medical Centre Utrecht, Surgery, Utrecht, Netherlands; 2Uni-
versity Medical Centre Utrecht, Julius Centre for Health Sciences and
Primary Care, Utrecht, Netherlands; 3University Medical Centre Utrecht,
Radiology, Utrecht, Netherlands
Background. Due to substantial recurrence rates after partial liver resection
for colorectal metastases, it is supposed that small metastases may not be
detected using intraoperative ultrasound (IOUS). In recent years the addition
of contrast has been used to improve the results of conventional ultrasound.
Aim. The aim of this study was to evaluate the added diagnostic value of
contrast enhanced intraoperative ultrasound (CE-IOUS) above computed
tomography (CT) and IOUS in hepatic lesions visible on CT in patients
scheduled for hepatic surgery for colorectal metastases (CRM).
Methods. A total of 39 patients with CRM were imaged with contrast-
enhanced CT, IOUS and CE-IOUS. The group consisted of 26 male and 13
female patients with a median (range) age of 62 (4983) years. A lesion-per-
lesion analysis was performed with histopathological examination and follow
up as the standard of reference. The added value of CE-IOUS above CT and
IOUS in correctly diagnosing malignant lesions was statistically evaluated
within the group of lesions visible on CT. Area under receiver operating
characteristic curves (AUC) were calculated per imaging strategy by making
use of logistic regression analysis. AUCs were compared by the method of
Hanley and McNeil.
Results. After a median (range) follow up of 329 (120748) days following
surgery a total of 199 lesions were identified. A total of 140 lesions were
identified on CT (of which 85 were malignant according to the reference
standard), 147 on IOUS and 151 on CE-IOUS. This results in a detection rate
of 140/199 for CT, 147/199 for IOUS and 151/199 for CE-IOUS. The AUCs
of CTalone, CT & IOUS and CT, IOUS & CE-IOUS were 0.980, 0.994 and
0.996 respectively. IOUS significantly improved the diagnostic performance
of CT alone (difference in AUC: 0.014 (95%/CI: 0.002 to 0.028); P/
0.029). CE-IOUS had no added value above CT & IOUS (difference in AUC:
0.002 (95%CI: /0.005 to 0.009); P/0.62).
Conclusion. CE-IOUS has no additive diagnostic value above CTand IOUS
in patients with CRM.
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CRYOABLATION INDUCES INFLAMMATION AND COAGULA-
TION RESPONSE MORE PROFOUNDLY THAN RFA OR INTER-
STITIAL LASER THERAPY IN RATS
Jansen, Maarten1; van Hillegersberg, Richard2; Levi, Marcel3; Schoots, Ivo4;
Beek, Johan5; Crezee, Hans6; Van Gulik, Thomas1
1Academic Medical Centre, Surgery, Amsterdam, Netherlands; 2Utrecht
Medical Centre, Surgery, Utrecht, Netherlands; 3Academic Medical Centre,
Internal Medicine, Amsterdam, Netherlands; 4Twee Steden Hospital, Sur-
gery, Tilburg, Netherlands; 5Academic Medical Centre, Dept. of Laser
Physics, Amsterdam, Netherlands; 6Academic Medical Centre, Radiotherapy,
Amsterdam, Netherlands
Background. Local ablative techniques, such as Cryoablation (CA), Radio-
frequency Ablation (RFA) and Interstitial Laser Coagulation (ILC), have
emerged as alternative therapies for irresectable liver tumors. Major compli-
cations have been noted predominantly after cryoablation, such as dissemi-
nated intravascular coagulation, renal and pulmonary failure. The systemic
response of inflammation and coagulation has been announced as the (lethal)
‘‘cryoshock phenomenon’’.
Aim(s)/Objective(s). The aim of this study was to illuminate the underlying
pathophysiological process of inflammation and coagulation following CA,
RFA and ILC.
Methods. In total 48 rats were allocated to CA, RFA, ILC or sham operation
(n/12). Blood was withdrawn before, and 1, 3, 6 and 24 hours after ablation.
Liver enzymes (AST, ALT), inflammatory (IL-6, IL-10) and coagulation
parameters (ATIII, TAT, PAA, PAI and FDP), were determined. Liver
biopsies from the coagulated area were stained for quantification and
morphological examination.
Results. Histological examination demonstrated similar volume of complete
morphological destruction of liver parenchyma in rats undergoing CA, RFA,
and ILC. ALT levels following CA were significantly higher than ALT levels
following RFA or ILC, and maintained high after 24 hours. The inflammatory
response following CA, as reflected by WBCs, IL-6 and IL-10 levels, was
significantly higher than following RFA or ILC. The systemic intravascular
procoagulation state following CA, as reflected by platelets, and levels of
ATIII, TAT, PAA, PAI and FDP, was significantly more profound than
following RFA or ILC.
Conclusion. This study demonstrated that CA induces the inflammatory and
coagulation response more profoundly than RFA or ILC therapy in rats.
Conjoined pathways in the cascade of inflammation and coagulation activa-
tion following cryoablation may result in the ‘‘cryoshock phenomenon’’
leading to substantial morbidity and mortality.
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RETROSPECTIVE STUDY ON NON OPERATIVE MANAGEMENT
OF LIVER TRAUMA
Subramaniam, Manisekar; Vasudevan, Vimal
Hospital Alor Star, Dept. of Surgery, Alor Star, Malaysia
Background. Blunt injury to abdomen is a common cause of liver trauma.
Previously diagnostic peritoneal lavage has let to unnecessary laparatomy.
With the availability of CT scan in most general hospitals, it is posible to
manage haemodynamic stable liver trauma patient non operatively.
Aim. To review our success and shortfalls in managing liver trauma patients
non operatively.
Method. It is a single centre, retrospective study following a strict criterias.
There was data available for 52 patients of the total of 76 patients with liver
trauma managed non operatively from 1.7.1996 to 30.6.1999.
Results. Liver trauma involved mainly males (80.8%), Malays (78.8%),
mean age was 33 years. Motorcylist was the commonest victims and 90.4%
had associated injuries which involves spleen (32.7%), kidney (30.8%) and
thorax (26.9%). Liver injury was graded using American Association for
Surgery of Trauma revised Organ Injury Scale. Grade I to Grade III was
98.1%. Non operative management success rate was 96.15% with failures due
to non liver related. There was no mortality during this study. Delayed
haemorrage occurred in 9 patients which was successfully treated. Blood
transfussion requirement was 1.88 units (S.D/2.14). Mean length of stay was
7.4 days (S.D/4.4). Length of stay was not significantly affected wheter
patient was managed in ICU or in acute surgical ward.
Conclusion. We conclude that non operative management of liver trauma
can be conducted safely if strict criteria followed and with the availability of
prompt CT scan facility
P25.38
USE OF RADIOFREQUENCY HEPATIC PARENCHYMAL TRANS-
ECTION DEVICE IN HEPATIC HEMANGIOMA RESECTION:
EARLY EXPERIENCE AND LESSONS LEARNED
Espat, Joseph N1; Helton, Scott W2
1University of Illinois at Chicago, Hepatobiliary Surgery, Chicago, USA;
2University of Illinois at Chicago, Hepatobiliary Surgery MC 958, Chicago,
USA
Background. With the advent of improved anesthetic techniques a sig-
nificant reduction in blodd loss during liver resection for hepatic tumors
has been accomplished. Most recently, the focus has shifted towards
instrumentation designed to reduce hepatic resection complications such as
post operative bleeding, bile leak and to reduce the time of liver parenchymal
transection.
Purpose. To present our early experience with hepatic resection for
hemangioma and evaluate Habib (TM) Sealer as an adjunct to parenchymal
transection.
Methods. Prospectively maintained database of hepatic surgery was used to
obtain diagnosis, demographic data; operative reports and surgeon recorded
observations were also utilized for evaluation.
Results. 4 patients were treated for symptomatic hepatic hemangioma; 2 were
atypical sub-lobar resections, 1 lobe and 1 trisegmentectomy. No bile leaks
occured, no post-operative bleeding requiring transfusion was observed. EBL
and operative time in comparison to historical controls did not differ.
Observations recorded: the RFA resection device as used does NOT seal
hepatic veins which require independent ligation for control, similarly biliary
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structures /2 mm require independent suture ligation; ‘‘superheating’’ of
parenchyma with resultant parenchymal fracture does occur and is associated
with high (100W) power setting; parenchymal ablation is most efficiently
achieved with a setting of 70W; liver must be mobilized in the same manner as
for standard hepatic resection given the risk of adjacent structure injury.
Conclusions. The use of an RFA parenchymal ablation device for resection
of hepatic hemagioma in this early experience did not result in bile leak or
post-operative bleeding. There is a learning curve associated with the
technical aspects of device utilization.
P25.39
THE USE OF FRUCTOZO-1,6-DIPHOSPHATE TO IMPROVE THE
RESULTS OF LIVER CANCER SURGERY
Baimakhanov, Bolatbek; Aliyev, Mukhtar; Akhmetov, Yermek; Samratov,
Timur; Mirzhakypov, Arman; Sahipov, Musa
National Scientific Center of Surgery, Abdominal Surgery, Almaty, Kazakh-
stan
The aim is the efficiency’s assessment of application of the tissue anti-hypoxic
substance fruktozo-1,6-diphosphate (FDP) in cases of the extensive anatomic
resection of liver in patients with nodular form of the initial cancer of liver.
Methods. 26 patients with the diagnosis of the initial cancer of liver have been
operated. All the patients underwent the hemihepatectomy operation (HHE)
and expanded hemihepatectomy (EHHE) were carried out. The main group
(I) was 11 patients, who underwent intravenous injection of FDP intraoper-
ationally. The application of FDP during 5 days to all these patients in
postoperative period was included in a set of infusion activities. 15 patients
were included in the comparative group (II), whose extensive resections of the
organs were accompanied without injection of FDP.
Results. In the postoperative period, 7 patients (63.3%) of the group I and 12
patients (80%) of the group II experienced various complications. It has been
verified a considerably decreased frequency of the development of post-
operative acute liver inefficiency, ascites in patients with application of FDP.
The frequency of these complications was observed in 45.5% and 66.7% of
the cases accordingly. Evidently, this observation is explained by anti-hypoxic,
positive metabolic effect of FDP on functional condition of hepatocytes in
cases of its introduction both before the Pringle-maneuver and in the earliest
and early postoperative periods. Sub acute myocardial ischemia (3 patients)
and thromboembolism of small branches of the pulmonary artery (1 case) had
a case in the comparative group. Whereas in the researching group one of the
abovementioned complications were found only in one patient.
Conclusion. Application of tissue substrate anti-hypoxic substance FDP in
the intra-and postoperative periods allows to highlight the efficiency of the
medication in terms of the enhancing of HHE and EHHE results.
P25.40
CURRENT RADIOFREQUENCY TECHNOLOGIES IN LIVER AB-
LATIONS; WHICH IS THE BEST?
Buczkowski, Andrew K1; Schaeffer, David F1; Owen, David A2; Chung,
Stephen W1; Scudamore, Charles W1; Ho, Stephen G3
1University of British Columbia, Hepatobiliary and Pancreatic Surgery,
Vancouver, Canada; 2University of British Columbia, Pathology, Vancouver,
Canada; 3University of British Columbia, Radiology, Vancouver, Canada
Introduction. Surgical removal of hepatic malignancy has been the treatment
of choice for liver malignancies. With advent of interstitial therapies the
indications for tumor treatment have been extended. The most recent
advances in radiofrequency technology improved short- and long-term
outcomes in patients with liver malignancy previously considered unresect-
able. RF is considered to be reliable, reproducible and relatively safe method
of ablation. Direct comparison has been attempted to improve indications
regarding the choice of RF technology.
Methods. Six adult pigs (mean weight 220 lbs) were used in this study. Three
currently available RF: Tyco Healthcare Group, Boston Scientific, and RITA
Medical probes were used in the study. Each of the probes was used in three
different positions in the liver on the rotation base. Each of the ablations was
repeated in the same place twice. The probes were used according to the user
manual at all times. The efficacy of the ablation was evaluated by contrast
enhanced biphasic liver CTwith 3-D reconstruction and volume rendering for
each of the ablations. Volumetric results were compared to gross pathology
findings. Each ablation area was identified, removed from the surrounding
tissue and then volumetric measurements utilizing Archimedes principles
were conducted.
Results. In total 18 ablations were performed. Each technology was used six
times. All CTand pathology findings are currently being calculated and will be
available in November 2004.
Summary. This is first North American study focusing on direct evaluation
and comparison of available RF technologies and their efficacy in any
model.
P25.41
CARVEDILOL APPLICATION FOR PREVENTION OF BLEEDING
FROM VARICES IN LIVER CIRRHOSIS
Chooklin, Serge; Perejaslov, Andre
Medical University, Lviv, Ukraine
Most frequently for primary preventive varices bleedings in patients with liver
cirrhosis of a liver appoint beta-blocker propranolol and nitrates. Hemody-
namic researches show, that the combination beta-blockers with nitrates
reduces portal pressure more effectively. However, long application of
propranolol in dozes, sufficient to cause proof portal pressure reduction,
frequently entails deterioration of a functional condition of a liver and kidneys
and development heavy portosystemic encephalopathy that demands the
termination of treatment. Nitrates application can provoke deterioration of
function of kidneys in patients with ascites, cause a system hypotension. These
by-effects can be avoided carvedilol assignment. 19 patients with liver cirrhosis
(Child-Pugh A-4, B-12, C-3) are surveyed. In all patients diagnosed varices,
in 6-ascites. Three patients in the anamnesis has varices bleedings were
marked. We are measures defined arterial pressure, heart rate, index portal
stagnation, portal perfusion index, daily diuresis before and after 4 weeks
application of 12,5 mg carvedilol. One patient (class C) had development a
system hypotension. The volume daily diuresis after four weeks in other
patients did not change. Frequency of heart rate reductions has authentically
decreased at insignificant reduction of arterial pressure. The increase of
portal perfusion index on the average from 24% up to 40% and reduction of
portal stagnation index was observed. It promoted decrease in portal
pressure, a gradient of hepatic venous pressure without deterioration of a
hepatic blood-groove. After 6 months bleedings in patients was not observed.
Carvedilol is effective for preventive varices bleedings in patients with liver
cirrhosis. Carvedilol does not worsen function of kidneys and hepatic blood-
groove.
P25.42
ASYMPTOMATIC COLORECTAL CANCER WITH UN-RESECT-
ABLE LIVER METASTASES: IMMEDIATE COLORECTAL RE-
SECTION OR UPFRONT SYSTEMIC CHEMOTHERAPY?
Muratore, Andrea1; Zorzi, Daria1; Bouzari, Hedayat1; Sperti, Elisa2; Leone,
Francesco2; Capussotti, Lorenzo1
1IRCC, Surgical Oncology, Candiolo, Italy; 2IRCC, Oncological Division,
Candiolo, Italy
Background. About 20% of patients with colorectal cancer have synchro-
nous un-resectable liver metastases at the diagnosis: resection of the colorectal
cancer in patients with moderate-severe symptoms is mandatory before
starting chemotherapy. Surgical treatment of relatively asymptomatic color-
ectal cancers is still a matter of discussion.
Aims. To evaluate the rate of complications related to the un-resected
colorectal tumour requiring surgical treatment.
Methods. From January 2000 to December 2004 we have prospectively
collected data on 35 consecutive cases who were treated straight away by
chemotherapy without primary tumour resection. All the patients underwent
FOLFOX6 as first-line chemotherapy.
Results. The median follow up was 18.5 months (range from 8.1 to 59.4).
The mean interval between diagnosis and start of chemotherapy was 33.1 days
(95% CI: 27.338.8). Fifteen of the 35 patients (42.9%) were down-staged to
surgery; the mean interval between chemotherapy start and colon-rectum
cancer resection was 6.5 months (95% CI: 5.57.5 months). No patients
developed clinical signs of intestinal complications due to the tumour during
chemotherapy. Of the other 20 patients, who did not underwent any curative
surgery, 16 received a second line chemotherapy and 10 a third line of
treatment. The mean interval between chemotherapy start and the end of the
follow-up was 17.7 months (95% CI: 1421.5 months). By the end of follow
up, six patients were alive. Only one patient (2.8%) developed clinical signs of
intestinal occlusion 5.6 months from the start of chemotherapy. Conclusions:
The rate of complications related to the non-resected colorectal tumour is very
low using oxaliplatin as first line chemotherapy. Non-operative management
of asymptomatic colorectal cancers with un-resectable liver metastases is a safe
approach.
OG Posters
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IMPACT OF BARIATRIC SURGERY ON COMORBIDITY ASSO-
CIATED WITH MORBID OBESITY
Mezghani, Julien; Gancel, Antoine; Teniere, Paul; Scotte´, Michel
Chu, Rouen, France
Background. Morbid obesity is a major public health problem, leading to
increased mortality or morbidity. Bariatric surgery is increasingly taking part
in the management of obese patients. The aim of this study was to analyse the
outcome of gastric banding (GB) and vertical calibrated gastroplasty (VCG)
in terms of weight loss and associated comorbidity for patients presenting
with morbid obesity.
Methods. 332 women and 54 men with a mean age of 41, were operated on
for morbid obesity. The mean BMI was 48 5 (41.5 to 54.5) and the mean
excess of weight was 73.6 (53.5 to 93.7). GB was used on 219 patient and
166 patients underwent VCG. Among these patients, 73 were diabetic
(18.91%), 111 had hypertension (28.76%), 122 had sleep apnea (31.61%),
208 had osteoarthritis (53.89%) and 271 were dyspneic (70.21%).
Results. In GB group, post operative complications were incidents with the
GB case box and tubes in 19.1%, dilatation and slip in 10.5%. Complications
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for VCG were ventral hernia in 2.3% and stenosis in 2.3%. Weight loss was
significantly more important with the VCG than with GB. Relative weight
loss were respectively at 1, 2, 3 and 5 years for VCG 51.42%///4.01%,
58.14%///4.63%, 58.71%///6.91% and 46.77%///16.87% versus
34.32%///2.15%, 39.09%///3.08%, 41.07%///4.32%, and
31.84%///7.85% for GB. The probability of improvement or disappear-
ance of comorbidity was 33.3% at 12 months and 34.7% at 24 months for
diabetes, 36.7% at 12 months and 41.9% at 24 months for hypertension,
34.7% and 39.4% for sleep apnea, 31.8% and 37.4% for joints pathologies,
and finally 30.3% and 36.3% for dyspnea.
Conclusions. GB is far less effective than VCG in terms of weight loss.
Surgery also positively acts on comorbidity since one third of patients
experienced an improvement or disappearance of their diabetes, hyperten-
sion, sleep apnea, joints pathology or dyspnea. These results call into
question the interest of GB in the treatment of morbid obesity.
P31.02
A COMPARISON OF CO-MORBIDITY VERSUS SUCCESSFUL
SURGICAL OUTCOME IN GASTRIC BAND AND GASTRIC BY-
PASS PATIENTS
Lee, Ronan1; Ackroyd, Roger2
1Royal Hallamshire Hospital, Sheffield Medical School, Sheffield, UK;
2Royal Hallamshire Hospital, General Surgery, Sheffield, UK
Introduction. The prevalence of obesity is increasing in most industrialised
countries and is now considered a major health problem. Purely medical
treatment for obesity has been of only limited benefit, and for severe obesity,
more aggressive types of treatment are required. With respect to surgery,
careful consideration is required in choosing the appropriate procedure, given
the patients individual condition.
Aim. This study explores the relationship between existing co-morbidities
and surgical outcome, in order to search for factors that may help determine
the appropriate patient choice for gastric band and gastric bypass patients.
Surgical outcome was examined with respect to successful weight loss but
also post-operative complications.
Method. One hundred and twenty nine patients were examined, all operated
on by the same surgeon over seven years.
Results. Banding patients had more co-morbidity on average than bypass
patients. However, a greater correlation between bypass patient’s co-
morbidities and post-operative complications was found. It was also shown
that bypass patients with low co-morbidity values lost weight more quickly.
Bypass patients lost weight on average twice as fast as band patients.
Individually, some of the commonest co-morbidities showed a good correla-
tion with increased post-operative complications. In particular, bypass
patients with diabetes mellitus had an increased risk of complications, with
incidence rising from 17% to 36% in-hospital (pB/0.2), and from 10% to
36% post-discharge (pB/0.05). Similar increased risks were observed with
hypertension, osteo-arthritis and asthma for in-hospital complications.
Interestingly, after bypass surgery, dyspnoeic patients were much less likely
to have post-operative complications in hospital than those without dyspnoea,
the risk being reduced from 26% without, to 9% with (pB/0.2). A similar
pattern was observed after banding operations post-discharge.
Conclusion. The above findings may have implications for patient treatment
pre and post operatively.
P32.01
QUALITY OF LIFE AND GASTROINTESTINAL SYMPTOMS
BEFORE AND AFTER LAPAROSCOPIC NISSEN FUNDOPLICA-
TION  A 6 YEAR FOLLOW UP STUDY
Sanders, Grant; Van Steenberghe, M; Pianta, E; Millat, Bertrand; Borie,
Frederic
St Eloi, University Hospital of Montpellier, Visceral Surgery, Montpellier,
France
Background. Evaluation of quality of life is a global measure of the efficacy
of anti-reflux surgery.
Aim/Objective. The prospective evaluation of quality of life and gastro-
intestinal symptoms, preoperatively and for 6 years following laparoscopic
Nissen’s fundoplication.
Methods. In a 15 month period, 35 consecutive patients underwent
operations for failure of, or dependence on, medical treatment for reflux.
Quality of life and gastrointestinal symptoms were evaluated before surgery
and again at 3, 6, 12, 24, 48, and 72 months after the surgical intervention,
using the Gastrointestinal Quality of Life Index (GIQLI).
Results. The preoperative GIQLI was below normal in global analysis and
for each of the domains studied: social, physical, emotional, and symptoms
(all pB/0.001). The augmentation of the global GIQLI at 3, 6, 12, 24, 48 and
72 months stayed inferior to the normal (all pB/0.01). From the 3rd month,
there was a normalisation in the domains social, physical, and emotional but
this subsided at six years. The symptom score always stayed below that of the
normal population (at 6 years pB/0.001). The percentage of patients with
abdominal pain, dysphagia, dietary modifications and belching decreased
non-significantly between the preoperative period and the 6th year. The
percentage of patients with symptoms of reflux decreased significantly
between the preoperative period and the 6th year (51% versus 4% p/
0.01), however 20% of patients had restarted proton pump inhibitors.
Functional intestinal problems were aggravated by surgery (30% preopera-
tively versus 53% at 3 months p/0.03), but this improved with time (28% at
6 years).
Conclusion. Laparoscopic Nissen’s fundoplication, for failure of, or
dependence on, medical treatment for reflux, improves but does not
normalise the quality of life of patients in the long term, as measured by
the GIQLI. A precise evaluation of preoperative symptoms is necessary in
order to better inform patients of the anticipated results.
P33.01
MEASURES OF BODY IRON STORES AND IRON DEFICIENCY
ANAEMIA IN PATIENTS WITH OESOPHAGOGASTRIC CAN-
CERS A PILOT STUDY
Ayantunde, Abraham; Welch, Neil; Parsons, Simon
Nottingham City Hospital, Oesophagogastric Unit, Dept. of Surgery,
Nottingham, UK
Introduction. Anaemia is the most frequently observed haematological
abnormality in cancer patients and it occurs in 2030% of patients with
oesophagogastric cancers (OGC). A significant number of patients with
OGC (approximately 50%) receive peri-operative blood transfusion even
though there have been reports of unfavourable outcome relating to blood
transfusion and cancer. Anaemia in OGC is multifactorial and iron deficiency
(ID) is proposed to be one of the main causes. Serum ferritin levels and
percentage transferrin saturation (PTSAT) are by far the most powerful tests
for iron deficiency anaemia (IDA).
Aims. To determine the incidence of IDA in OGC and advance reason for
the use of parenteral iron to reduce peri-operative blood transfusion
requirements in OGC.
Patients and methods. Some 46 consecutive patients recently diagnosed
with OGC were included into this pilot study. Serum iron, ferritin,
transferrin, haemoglobin (Hb), haematocrit (Hct), total iron binding capacity
and PTSAT were measured at diagnosis.
Results. There were a total of 46 patients. Mean age was 76 (5390) years
and male/female ratio of 1.4:1. The mean Hb was 11.5 g/dL in males and
10.5 g/dL in females. 68% (13/19) and 77% (21/27) of females and males
were anaemic at presentation respectively. All 13 females and 13/21 males
had low serum iron levels. 92% (12/13) of females and 81% (17/21) of males
who were anaemic had either combined low serum ferritin/TSAT (69%
versus 52%) and/or single low ferritin/TSAT (23% versus 29%). 4 females
and no male without anaemia had low ferritin and/or TSAT.
Conclusion. IDA occurs in significant numbers of patients with OGC.
Parenteral iron is more efficacious than oral iron supplements on account of
problems with dysphagia, intolerance to oral iron and poor absorption in
patients with OGC. The use of preoperative parenteral iron may increase
haemoglobin and reduce peri-operative transfusion requirements. We plan to
test this hypothesis in a randomized controlled trial.
P33.02
REDUCTION IN ADVERSE EVENTS OVER A DECADE IN 1209
PATIENTS DYING WITH OESOPHAGEAL CANCER UNDER
SURGICAL CARE
Young, Jamie1; Thompson, Alistair1; Kerr, Lynsey2; Burton, Helen2; Stone-
bridge, Peter3
1Ninewells Hospital and Medical School, Surgery and Molecular Oncology,
Dundee, UK; 2Scottish Audit Of Surgical Mortality, Paisley, UK; 3Ninewells
Hospital and Medical School, Dept. of Cardiovascular Research, Dundee,
UK
Background. Scotland has a high incidence of oesophageal cancer with a
poor prognosis for which surgery offers the best chance of survival. However,
perioperative mortality is higher in the UK than elsewhere. The aim of this
analysis was to identify adverse events associated with the death under
surgical care for patients with oesophageal cancer.
Method. Since 1994, the Scottish Audit of Surgical Mortality (SASM) has
sought peer review of all deaths under surgical care in Scotland. Areas of
CONcern or for CONsideration (ACONs) are identified and fed back to the
originating surgical team. Data for patients dying between 19942003 with a
diagnosis of oesophageal or junctional cancer were extracted from the SASM
database and analysed for trends over the decade.
Results. A total of 1209 deaths were audited from a total of 44,947 patients
who died under surgical care and an estimated 8,000 patients diagnosed with
oesophageal or oesophagogastric junction cancer over the decade. The
median age was 71 (range 29101), 61% were male and emergency
presentions rose from 55 to 72%. 500 (41%) had an operation and this fell
from 1 in 2 to 1 in 3 of oesophageal cancer deaths under surgical care over
time. 247 separate ACONs were recorded: 95 (38%) related to the operation
(most commonly anastomotic leak, perforation, bleeding or operation should
have not been done), 49 (20%) to medical care, 11 (4%) critical care, 9 (4%)
anaesthetic and 17 (7%) staff or communication problems. Over time the
largest reduction in ACONs was in the operative and medical care groups
(83% and 73% fall respectively since 1997. Of the 709 (59%) who did not
have an operation only 13 ACONs were recorded with 3 related to
perforation during attempted palliation.
Conclusion. A minority of patients dying with oesophageal cancer do so
following surgery. Concerns about practice in the operating room and of
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suboptimal medical care have declined over the decade and may reflect
enhanced high dependency care provision, multidisciplinary working and
increasingly specialisation.
P33.03
GASTRIC CARCINOMA AUDIT IN A DISTRICT GENERAL HOS-
PITAL
Satyadas, Thomas; Smith, Janette; Hariraj, Radhakrishnan; Warren, Huw
Queen Elizabeth Hospital, Upper GI Surgery, Kings Lynn, UK
Introduction. Retrospective audit of gastric carcinoma over a six year period
in a district general hospital in the United Kingdom.
Aims. To study several clinical, treatment and demographic data of gastric
cancers in our district general hospital.
Methods. Case records of 114 patients were analyzed. They were under the
clinical coding for gastric carcinoma. Histologically proven gastric adeno-
carcinomas were considered for the study.
Results. There were 84 males and 30 females. Age range was 30 to 95 years.
Due to the presence of more than one alarm symptom in many patients, the
alarm symptom distribution was as follows-persistent dyspepsia occurred 61
times, dysphagia 18 times, vomiting 24 times, weight loss 46 times and
anemia 46 times. There were no alarm symptoms in 19 patients. Curative
surgery was carried in 29 patients. 10 patients underwent total gastrectomy,
12 had subtotal gastrectomy and 7 had distal gastrectomy. Palliation was in
the form of resection in 12 patients, stenting in 17, Neodymium Yttrium
Aluminium Garnet laser treatment in 18 and chemotherapy in 5 patients.
The rest had symptomatic therapy. Among the 29 who underwent curative
resection, the survival figures are as follows- 9 are alive after one year, 3 after
two years, 3 after three years, 4 after four years, and 6 are alive after five years
or more.
Conclusion. Gastric carcinoma remains a disease of poor prognosis. The
reasons for poor outlook are its greater prevalence in the elderly, relative
paucity of symptoms in the early stages and lack of a precursor lesion like
polyps, as in colorectal carcinoma. However survival figures can be good if
surgery is carried out in appropriate patients. Waiting for alarm symptoms
makes it too late for curative treatment. Persistent dyspepsia, other than
reflux dyspepsia, occurred sixty one times among our patients. Should we
offer endoscopy to all those over fifty years who have dyspepsia longer than
four weeks not responding to a proton pump inhibitor drug but without other
alarm symptoms?
P33.04
IS HARMONIC SCALPEL AN EFFECTIVE TOOL FOR OESO-
PHAGECTOMY?
Waraich, Naseem; Javad, Ahmad; Farhan, Rashid; David, Mulvey; Leeder,
Paul; Iftikhar, Syed Y
Derbyshire Royal Infirmary, Dept. of Oesophago-Gastric Surgery, Derby,
UK
Background. Use of electrocautery in oesophagectomy is standard; how-
ever, the introduction of the harmonic scalpel (HS) and its use has changed
the methodology of oesophagectomy in recent years.
Aim(s)/Objective(s). We have assessed the efficiency of HS in oesophageal
cancer surgery. The parameters studied were blood loss, transfusion rates,
and post-operative complications.
Methods. Our cohort included 142 patients who underwent elective
oesophagectomy from January 1999 to December 2004. The control group
was the patients undergoing electrocautery oesophagectomy (n/98) be-
tween 1999 and 2002. Furthermore, 44 patients who were operated with the
HS were included in the study group.
Results. The numbers of units transfused were significantly less in HS group
(median 0) in comparison with controls (median 2), p/0.003. Median blood
loss in HS and the controls was 500 and 700 mls respectively, although not
significant (p/0.123). Mortality in HS group was 2.27% compared to
3.06% in controls. The complication (principally respiratory) rate was only
13.6% of patients in HS group compared to 17.3% in the controls.
Conclusion. Our study shows that HS reduces transfusion rates and post
operative complications, highlighting it as a safe and cost effective alternative
to traditional electrocautery.
P33.05
NATIONAL VARIATION IN EARLY OUTCOME AFTER RESEC-
TION FOR GASTRIC CANCER
Al-Sarira, Ali A1; David, Gerald G1; Al-Sarireh, Bilal A2; Hanchanale,
Vishwanath3; Slavin, John P1; Deakin, Mark4; Corless, David J1
1Leighton Hospital. Keele University, Dept. of Surgery. Leighton Research
Unit, Crewe, UK; 2Southport Hospital, Dept. of Surgery, Southport, UK;
3Leighton Research Unit, Keele University, Dept. of Urology, Crewe, UK;
4University Hospital North Staffordshire. Keele University, University Dept.
of Surgery, Stoke on Trent, UK
Background. Expertise in gastric surgery is difficult to maintain because of
the decreasing incidence of gastric cancer and the fall in surgery for peptic
ulcer.
Aim. To evaluate the prognostic impact of hospital volume and patient
characteristics on in-hospital morality rate (IMR) and length of stay (LOS)
after gastric resection.
Method. Data for all patients who underwent gastrectomy for gastric cancer
in England between 1997 and 2003 were retrieved from Hospital Episode
Statistics database. The relationship between hospital volume and outcome
was determined by dividing the patients into five approximately equal sized
groups based on annual hospital volume quintiles [very low (B/8), low (9
11), medium (1215), high (1621), very high (/21)].
Results. In total 12025 gastric resections were performed over the study
period. Overall IMR was 10.1% and it did not vary between hospital volume
groups (P/0.331). In case mix-adjusted multivariate analysis, hospital
volume had no prognostic influence when the very low volume group was
compared to the very high volume group (odd ratio (OR), 0.74; 95%
confidence interval (CI), 0.74 1.18; P/0.564). Prognostic factors for
higher IMR were male gender (OR, 1.5; 95% CI, 1.121.86; P/0.004)
compared to female, and age (/64 years) (OR, 2.89; 95% CI, 2.313.62;
PB/0.001). Median LOS was similar over the five hospital volume groups (15
days; (inter quartile range, 1224 days).
Conclusion. Hospital volume has no impact on outcomes after gastric
resection in England. Contributing factors to outcome were male gender and
age greater than 64 years.
P33.06
OESOPHAGOGASTRIC CANCERS SECONDARY TO A BREAST
PRIMARY DO NOT REQUIRE RESECTION
Ayantunde, Abraham; Agrawal, Amit; Parsons, Simon; Welch, Neil
Nottingham City Hospital, Oesophagogastric Unit, Dept. of Surgery,
Nottingham, UK
Introduction. Breast cancer metastasis to the gastrointestinal tract (GIT) is
rare but is more common in lobular than ductal carcinoma.
Aim. To review the clinicopathological features of oesophagogastric second-
aries from breast cancer.
Patients and methods. Patients with breast cancer metastases to the upper
GIT referred to us as either oesophageal or gastric cancers between
November 1997 and November 2004 were identified from our database.
The medical records of these patients were then reviewed for clinicopatho-
logical data and outcome.
Results. Nine patients with mean age of 71 (5790) years had mean
duration of 11 years (2.8332.75) between primary breast cancer diagnosis
and upper GI metastasis. All but one biopsy specimen from the oesophago-
gastric metastases were oestrogen receptor and CK7 positive. The median
survival following treatment of these metastases was 20 (2.07 93.63)
months.
Metastatic
site
Patients’
number
Histological
type
Treatment
Lower
oesophagus
1,2 D, L H/S, Dilatation & stent
GOJ 3 L H/S
Gastric body 4,5,6 L, D, L H, C, Palliation only
Pylorus 7,8,9 L, L, L Palliation only, C/GJ, H/S
GOJ, Gastroesophageal junction; D, Ductal; L, Lobular; H/S, Hormonal
therapy and stent; H, Hormonal therapy; C/GJ, Chemotherapy and
gastrojejunostomy.
Conclusion. The onset of non-specific GIT symptoms in patients with a
history of breast carcinoma should prompt the clinician to rule out the
possibility of upper GIT metastasis even many years after the original breast
cancer. Surgical resection is not advised and systemic therapy for breast
cancer may result in longer survival.
P33.07
THE EFFECT OF PRE-OPERATIVE WEIGHT (WT) LOSS AND
BODY MASS INDEX (BMI) ON POST-OPERATIVE OUTCOME IN
PATIENTS WITH OESOPHAGOGASTRIC (O-G) CARCINOMA
Skipworth, James; Hughes, Frances
Royal London Hospital, Dept. of Surgery, London, UK
Introduction. Studies have demonstrated that wt loss leads to adverse
outcome in all treatment modalities for O-G Carcinoma. Some have
suggested that excessive wt loss should be a contraindication to radical
surgery. We aimed to compare relationship of wt loss, BMI and outcome of
surgery for O-G cancer.
Methods. Data was collected prospectively between January 2001 and
March 2004 for all patients diagnosed with operable O-G Cancer. At initial
surgical consultation, pre morbid wt and height and current wt and height
were recorded, and BMI calculated. All patients underwent surgical resection
by a single surgeon and perioperative jejunal feeding. Hospital stay,
complications, pathological stage and survival were recorded. Patients were
allocated into four groups: no wt loss and BMI/25 (Grp A), no wt loss with
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BMIB/25 (Grp B), wt loss with BMI/25 (Grp C) and wt loss with BMIB/25
(Grp D).
Results. Of the 93 patients (57 male) that underwent resection, 48 had no
pre-operative wt loss, 34 in Grp A and 14 in Grp B. 45 patients had lost
weight, 20 in Grp C and 25 in Grp D. There was no difference in mean age
between the four groups (Analysis of Variance p/0.05). There were
4 perioperative deaths, 3 in Grp A (2 MI, 1 PE, 1 SMA thrombosis) and
1 in Grp C (PE). Surgical (n/7) and medical complications (n/7)
were distributed evenly among the four groups. There was no difference
in median hospital stay (Kruschall Wallis-p/0.05). There were a signifi-
cantly higher number of patients in Grps C and D with stage III disease
(pB/0.05 Chi-Squared), but difference in survival up to 3 years did not reach
statistical significance (59.3% in Grps A & B, 44% Grp C&D p/0.05 chi
squared).
Conclusion. Wt loss and low BMI did not influence the complication rate,
hospital stay or short-term prognosis. Therefore pre-operative wt loss and low
BMI cannot reliably be used as an independent predictor of poor outcome in
patients undergoing Oesophagogastric surgery. Perioperative feeding may be
responsible for this unexpected finding.
P33.08
PALLIATIVE GASTRECTOMY IN LOCALLY ADVANCED GAS-
TRIC CANCER
Khandelwal, Manish1; Khandelwal, Chiranjiva2; Goel, Ashish2
1Aberdeen Royal Infirmary, Aberdeen, UK; 2Mahavir Cancer Sansthan,
Patna, India
Background. Gastric cancer often presents with locally advanced disease.
Most of these patients have gastric outlet obstruction or upper GI bleed at
presentation, which requires surgical intervention.
Objective. We wanted to compare the outcome of surgical resection versus
bypass procedure for advanced gastric cancer, it’s effect on symptom control
& quality of life post operatively.
Methods. Retrospective analysis was doe for 313 consecutive cases operated
between 1989 and 2005, for stage at presentation, treatment, quality of life
and survival.
Results. The average age at presentation was 47.8 years (range 17 80 years)
with male predominance (M: F ratio 2:1.1). According to the Japanese
Staging, 6%, 15%, 21% & 58% patients presented in Stage I, II, III & IV
respectively. Overall 79% patients presented with advanced disease (Stage III
& IV). Sixty six percent cases were found to be resectable. Palliative resection
was done in 47% while curative resection was possible in 19% cases. The
most commonly performed operation was subtotal gastrectomy or distal
gastrectomy. Unresectable patients underwent gastrojejunostomy or feeding
jejunostomy according to the operative findings. Over the last 15 years, the
resectability rate had increased from 48% in first 100 cases, 72% in next 100
cases to 77% in last 113 cases (p/0.0002) without significant increase in peri
operative mortality. Patients who underwent resection had better palliation of
symptoms & better QOL. Survival rate was significantly better with palliative
gastrectomy (8.1 months) compared to bypass operation (3.4 months) with
no significant increase in mortality rate (p/0.5).
Conclusion. Palliative gastrectomy was attempted in all cases unless
unsuitable for major surgery due to comorbid conditions or advanced
disease. Resection if feasible is always a better option than a bypass procedure
as it offers better symptom control & quality of life.
P33.09
A FAST TRACK PATHWAY FOR UPPER GASTROINTESTINAL
CANCER
Krishna, Krishna1; Barham, CP1; Callaway, Mark2; Witherstone, Jo1;
Nicklin, Jo1; Norton, Sally1; Blazeby, Jane M3
1United Bristol Healthcare Trust, Surgery, Bristol, UK; 2United Bristol
Healthcare Trust, Radiology, Bristol, UK; 3University of Bristol, Surgery,
Clinical Sciences at South Bristol, Bristol, UK
Background. The NHS cancer plan has led to changes in the delivery of UK
cancer services, the most recent of which is the treatment targets. Achieving
31 and 62 day targets from decision to treat and urgent GP referral to start of
treatment for upper gastrointestinal (UGI) cancer is complex because of the
need for timely co-ordination of investigations between cancer units and
centers.
Aim. The aim of this study was to implement and monitor a fast tract
pathway for patients with UGI cancer within a cancer network in the United
Kingdom.
Methods. The cancer centre UGI team developed and audited a fast track
pathway including urgent out patient appointment, CT scan, EUS and
laparoscopy in August and September 2005.
Results. 27 patients with oesophageal and gastric cancer were studied. Local
cancer centre patients were older than patients referred from the network
(median ages 74 and 63 years). 10/16 patients breached the 62 day target (1
local patient and 9 from the network) and 2/11 breached the 31 day target (1
local, 1 network). Breaches occurred mostly because of delays in referral to
the cancer centre MDTor where treatment decisions changed after the MDT
meeting.
Conclusion. A fast track UGI pathway acheives cancer targets for local
patients, but earlier referral from network hospitals is required. Reducing
changes in MDT treatment decisions will decrease delays in treatment
implementation.
P33.10
PREDICTORS OF BIOLOGICAL BEHAVIOUR IN GASTRIC GAS-
TROINTESTINAL STROMAL TUMOURS (GIST)
Moorthy, Krishna; Balaji, NS; Joesph, Immanuel; Smith, Victoria; Crisp,
William J; Cheruvu, Chandra V
University Hospital of North Staffordshire, Stoke on Trent, UK
Background. Recent advances in the understanding of GISTs have resulted
in the ability to predict their biological behaviour.
Aim. This study reviews our experience in the management of gastric GISTs
and aims to identify predictors of biological behaviour.
Methods. The study cohort consists of patients with spindle cell tumours.
All were pathologically assessed and stained for different molecular markers.
Only those positive for CD 117 (c-kit positive) and CD 34 were included in
the analysis.
Results. In the period between 2000 and 2005, there were 30 patients
diagnosed with gastric and small bowel GISTs of which 18 were gastric. Of
these 8 underwent emergency surgery for active bleeding while 10 had
elective intervention. Patients were managed by local excision (n/10),
gastric resections (n/6), endoscopic excision (n/1) and alcohol injection
(n/1). Median size was 48 (Range 11140) mm. There was no correlation
between the size of the tumour and the choice of the surgical approach (local
excision vs resection). Tumours were classified as benign, low and inter-
mediate malignant potential and malignant on the basis of size, mitotic index,
presence of necrosis and invasion. Median follow up was 27 months. 3 of 4
patients diagnosed as malignant had died while 1 was alive with recurrent
disease. On univariate analysis mitotic index (p/0.006) and invasion (p/
0.04) and not size (p/0.43) were predictive of an adverse outcome. On
multivariate analysis only mitotic index was predictive.
Conclusion. In our study mitotic index was the only significant predictor
while site and size had no impact on biological behaviour.
P34.01
ADDITION OF AN ANTIREFLUX PROCEDURE IN LAPARO-
SCOPIC REPAIR OF LARGE HIATAL HERNIA: A PILOT STUDY
TO DECIDE UPON THE NEED FOR A RANDOMIZED TRIAL
Draaisma, Werner A; Gooszen, Hein G; Broeders, Ivo
University Medical Centre, Surgery, Utrecht, Netherlands
Background. There is an ongoing discussion about the indication and status
of an antireflux procedure for patients with large type II-IV HH repair.
Objective. The purpose of this pilot study was to decide upon whether a
randomized trial regarding this subject is necessary.
Methods. Patients with a demonstrated symptomatic type II-IV HH were
included in this pilot study. All patients underwent symptomatic and
objective assessment for co-existing gastro-oesophageal reflux disease
(GORD) before and after surgery. A robot-assisted laparoscopic HH repair
was undertaken in all patients and the addition of a Nissen fundoplication
was only performed in those patients with documented GORD.
Results. Twenty patients with a large type II (n/1), III (n/12) or IV (n/
7) hiatal hernia enrolled the study protocol. GORD was demonstrated in
eight patients (40%) after preoperative assessment. One procedure was
converted to open surgery (5%). Oesophageal perforation occurred in
another patient. After surgery, reflux symptoms were present in one patient
after HH repair without and in two with fundoplication. Troublesome
dysphagia was encountered in one patient without fundoplication. Satisfac-
tion with postoperative results was achieved in 85% of patients. Total median
oesophageal acid exposure decreased after HH repair with Nissen fundopli-
cation (p/0.01) and was not affected in those without fundoplication.
Asymptomatic GORD was seen in one patient after large HH repair without
fundoplication (8%).
Conclusion. Laparoscopic large HH repair with selective addition of Nissen
fundoplication in case of documented GORD seems a reasonable approach
in terms of safety and effectiveness. This pilot study has shown that, to really
answer the question about routine or tailored antireflux procedures after HH
repair in patients with and without GORD, a very large and unrealistic
randomized controlled trial should be performed.
P34.02
CERVICAL VERSUS INTRATHORACIC ANASTOMOSIS IN RA-
DICAL ESOPHAGECTOMY AND ABDOMINO-THORACIC GAS-
TRIC TRANSPOSITION
Helfritz, Fabian A1; Schrem, Harald H1; Kaudel, C Phillipp1; Schreiber,
Thomas C2; Schiller, Jo¨rn1; Klempnauer, Juergen1; Winkler, Michael1
1Hanover Medical School, General, Visceral and Transplantation Surgery,
Hanover, Germany; 2Hanover Medical School, Trauma Surgery, Hanover,
Germany
Introduction. In case of esophageal tumor surgical therapy of choice is the
radical esophagectomy and reconstruction through abdominothoracic gastric
tube transposition. Many authors describe a higher risk for leakage in cervical
anastomosis due to longer gastric tube and consecutive perfusion deficit of
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the anastomosis region. Thus many centres favor intrathoracic anastomosis.
The aim of this retrospective single centre study was to evaluate the risk of
surgical complications, in particular leakage, regarding the type of anasto-
mosis.
Patients and methods. 53 patients (42 m/11 f) underwent surgery between
apr 04 and dec 05. The median age was 62 years (3279). 26 cervical and 27
intrathoracic anastomosis were performed. Histologic tumortype was adeno-
carcinoma in 29, squamous cell carcinoma in 18 and other differentiated
tumors in 6 patients.
Results. Hospital mortality was 3.7% (2 patients died from other than
surgical reasons). The median duration of surgery was 320 min (139500).
The median length of hospital stay was 20 days (11160). The incidence of
anastomotic leakage was 7.7% (2/26) in the cervical and 22.2% (6/27) in the
intrathoracic anastomosis group. Leakage incidence was 17.2% (5/29) in the
group of patients with adenocarcinoma, 11.1% (2/18) in the squamous cell
carcinoma and 16.6% (1/6) in the other differentiated tumor group. 15
patients had received pre-treatment with radiation and chemotherapy, 3 of
them (20%) developed leakage (2/intrathoracic and 1/cervical). 7 of 8
cases of leakage occurred in patients /60 years of age (pB/0.05). The
median age in case of leakage was 68.63 years versus 60.16 years in patients
without leakage.
Discussion. There was no increased incidence for anastomotic leakage in
patients with cervical compared to intrathoracic anastomosis. Significant
influence of patient age for developing a leakage was registered (pB/0.05).
Histological tumortype as well as pretreatment did not influence the
incidence of anastomotic leakage.
P34.03
IS FAST TRACKING WITH EARLY FEEDING AFTER GASTRECT-
OMY FOR GASTRIC CANCER FEASIBLE?
Balaji, NS; Moorthy, Krishna; Durkin, Damien; Cheruvu, CVN
University Hospital of North Staffordshire, Upper GI Surgery, Stoke on
Trent, UK
Background. Fast tracking of patients by multimodal perioperative optimi-
sation in colorectal surgery is of proven benefit but the feasibility of this
concept in gastric cancer surgery remains unexplored.
Aims. To evaluate the benefits of early reintroduction of feeding and
multimodal optimisation after gastrectomy for cancer.
Methods. The study comprised of a prospective group of patients under-
going gastrectomy for cancer, who were self caring and motivated with an
ECOG performance status of 01. All patients were counselled preopera-
tively, had peri-operative fluid optimisation, early mobilisation, and post-
operative analgesia as per our protocol. The early feeding protocol
constituted-intake of 30 mls of water hourly on day1, clear fluids on day 2,
Free fluids built up to sloppy diet on day 3 and introduction of a normal diet
on day 4. The time taken to tolerate graded increments of feed served as the
primary end point for this study.
Results. There were 12 patients (M; F -8:4), with a median age of 69 (IQR
6477), ASA-1-3, ECOG status 01 who underwent Subtotal (10) or Total
(2) gastrectomy for gastric cancer with D1/D2 lymphadenectomy. The results
of the early feed reintroduction protocol and mobilisation are as follows:
HDU
Stay
clear
fluid
intake
Free
fluid
intake
Solid
intake
Sitting
out of
bed
Walking
few steps
Fitness for
discharge
Median
(days)
2 2 2.5 4 2 3.5 7
75%, 91% and 100% of patients tolerated free fluids by day 3, 4 and 5
respectively. Solid diet was tolerated by 75%, 83% and 100% of patients by
day 4, 5 and 6 respectively. The median hospital stay was 10 days (IQR 7
13). We had no mortality in the study; however morbidity occurred in 3
patients. One developed pulmonary oedema, one had wound infection and
the third developed chest and wound infections.
Conclusions. Our study concludes that fast tracking of post operative care
by multimodal optimisation and early feeding after gastrectomy for cancer is
safe and feasible.
P34.04
LAPAROCOPIC GASTRECTOMY: THE NEW STANDARD IN THE
TREATMENT OF BENIGN GASTRIC TUMOURS AND EARLY
GASTRIC CARCINOMA?
Morris-Stiff, Gareth; Davies, Iestyn; Jones, Rhidian; Barton, Karen; Hassn,
Ahmed
Princess of Wales Hospital, Surgery, Bridgend, UK
Background. Despite the proliferation in benign foregut surgery, there has
been a reluctance to develop laparoscopic resectional surgery for intermediate
and malignant lesions such as GIST tumours and early gastric cancer.
Aims. To report our early experience with laparoscopic gastrectomy and
examine its place in the armamentarium of the upper gastrointestinal
surgeon.
Patients & Methods. In the 20-month period ending December 2005, 6
patients with GIST tumours or early gastric cancers underwent laparoscopic
gastrectomy. A further patient underwent laparoscopic resection for benign
disease.
Results. There were 3 males and 4 females with a median age of 74 years.
Three patients had mucosal gastric cancer (T1), 3 had GISTs and 1 pyloric
obstruction due to peptic ulceration. Patients with GISTs underwent subtotal
gastrectomy with retrocolic loop gastrojejunostomy. Patients were eating at a
median of 5 days and home at a median of 8 days. The only complication was
prolonged nausea (n/1). Two of the patients with early carcinomas
underwent subtotal gastrectomy, D1 lymphadenectomy, and retrocolic
gastrojejunostomy. Intraoperative OGD in the 3rd patient, after full
mobilisation, demonstrated the tumour to be located more proximally than
anticipated, and so the operation was converted to allow total gastrectomy as
the desired instrumentation was not available. One patient developed a port-
site hernia that lead to afferent loop obstruction and blowing of the duodenal
stump. This patient required re-operation at which the stump was drained
leading to a controlled fistula that closed allowing discharge at 38 days. The
other 2 patients were discharged at 8 and 10 days. The final patient
underwent a distal gastrectomy and truncal vagotomy and was eating at 4
days and went home at 7 days.
Conclusion. This small experience with a selected approach to laparoscopic
resection has demonstrated that the procedure is feasible allowing an
adequate cancer operation with comparable complication rates and superior
early recovery.
P34.05
LAPAROSCOPIC PARAOESOPHAGEAL HERNIA REPAIR: FUN-
DOPLICATION IS NOT USUALLY INDICATED
Morris-Stiff, Gareth; Hassn, Ahmed
Princess of Wales Hospital, Surgery, Bridgend, UK
Background. Paraoesophageal hernias are an uncommon but important
diaphragmatic defect due to a high prevalence of associated complications.
The advent of laparoscopic surgery has popularised the surgical management
of this condition although the optimal technique has yet to be defined. The
aim of this cohort study was to assess the necessity of an antireflux procedure
in addition to the crural repair.
Methods. Details of all patients undergoing laparoscopic paraoesophageal
hernia repair were collected prospectively paying particular attention to the
details of the operative procedure, and outcome including the development of
early complications. All patients were followed for 6 months and symptoms
related to hernia recurrence or technical failure including dysphagia and
reflux were noted.
Results. 23 consecutive patients underwent laparoscopic paraoesophageal
hernia repair. The first 11 patients (Group1) routinely underwent an
additional antireflux procedure whereas the later cohort (Group2) did not
(Chi-squared pB/0.05). At 6 months, 9 of 11 patients in Group 1 reported
dysphagia, in 2 cases requiring dilatation, but this complication was not seen
in those in Group 2. No patient reported reflux at 6 month follow-up.
Conclusions. Laparoscopic repair of paraoesophageal hernias is an effective
treatment with excellent short-term results and no recurrences. Our
experience would suggest that an antireflux procedure is not indicated and
may indeed be detrimental to symptomatic outcome.
P34.06
OESOPHAGEAL RESECTION  A PATHOLOGICAL STUDY OF
CHANGE IN TECHNIQUE FROM IVOR LEWIS TO TRANSHIA-
TAL RESECTION
Tan, Tira1; Sahni, Mohit1; Pradhan, Jyotsna1; Karunanantham, Jay1; Amo-
Takyi, Baffour2; Cohen, Patricia2; Isla, Alberto1; Theodorou, Nikitas1
1Charing Cross Hospital, GI Surgery, London, UK; 2Charing Cross
Hospital, Histopathology, London, UK
Introduction. In our unit a policy decision was made to change form Ivor
Lewis oesophagectomy (ILO) to transhiatal oesophagectomy (THO) for
tumors of distal 1/3 of the oesophagus and gastro-oesophageal junction. A
retrospective pathological audit was performed to compare the surgical
clearance obtained with each of the procedures.
Patients & Methods. A retrospective analysis of the last consecutive 25
patients undergoing ILO and first 25 patients undergoing THO was
undertaken. Pathological clearance in respect of proximal & distal resection
margins, circumferential resection margin & nodal clearance was recorded in
accordance with the minimum data set recommended by the Royal College of
Pathologists. Patients in whom the minimum data set was incomplete were
excluded from the study.
Results. Complete data was available in 23 patients who had undergone ILO
and 20 patients who had undergone THO. There was a significant difference
in proximal clearance obtained in patients undergoing THO vs ILO (7.99/
4.1 cms mean9/Standard Deviation (SD), p/0.009, independent sample T-
test). There was a trend towards less involvement of circumferential resection
margin in patients undergoing THO vs ILO but this did not achieve statistical
significance (9/20 vs 17/23, p/0.053, x2 test) There was no significant
difference in the 2 techniques in distal resection margins (59/3 cms THO vs
4.69/2.7 cms ILO, p/0.597) or in the number of nodes resected (19.49/8.7
THO vs 14.59/8.8 ILO, p/0.074).
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Conclusion. The transition from one technique to the other was achieved
with improved pathological proximal margin, a trend towards less involve-
ment of circumferential resection margin and an equal distal clearance and
nodal clearance between Ivor Lewis and transhiatal oesophagectomy. Both
techniques achieve equal clearance of distal 1/3 oesophageal & oesophageo-
gastric junction tumors.
P34.07
MINIMALLY INVASIVE TRANSHIATAL OESOPHAGECTOMY-
THE FRENCH EXPERIENCE
Sanders, Grant; Blanc, Pierre; Husson, Emanuel; Claus, Christiano; Borie,
Frederic; Millat, Bertrand
St Eloi, Gastrointestinal Surgery, Montpellier, France
Background. Oesophagectomy is associated with considerable morbidity.
Minimally invasive oesophagectomy has potential advantages, and is parti-
cularly suited to the transhiatal approach.
Aim/Objective. To assess the feasibility of minimally invasive transhiatal
oesophagectomy.
Methods. A retrospective analysis of patients who underwent minimally
invasive transhiatal oesophagectomy was performed. Parameters assessed
included patient demographics, duration of operation, blood loss, morbidity,
mortality, histological stage, number of nodes harvested, length of stay and
follow up.
Results. 18 patients underwent minimally invasive transhiatal oesophagect-
omy, median age 69 years (range 3679). 17 were operated on for cancer
(median histological stage 2, range 13) and 1 for high grade dysplasia. 1
patient had neoadjuvant chemotherapy. 2 patients underwent non-emergent
conversion to open surgery. The median duration of operation was 300
minutes (range 180450). All anastamosis were hand sewn. No patients were
transfused. 30 day mortality was 0. Complications developed in 15 patients,
including 7 respiratory and 10 recurrent laryngeal nerve injuries. There was 1
anastamotic leak. 6 patients developed stenosis requiring dilatation. The
median length of stay was 15 days (range 1039). The median number of
nodes harvested were 10 (range 226). At a median follow up of 13 months
(range 442), 13 patients were alive.
Conclusion. Minimally invasive transhiatal oesophagectomy is feasible, with
acceptable mortality and morbidity.
P34.08
QUALITY OF LIFE AND PERSISTING SYMPTOMS AFTER OE-
SOPHAGEAL CANCER SURGERY
Viklund, Pernilla; Wengstro¨m, Yvonne; Rouvelas, Ioannis; Lindblad, Mats;
Lagergren, Jesper
Karolinska Institutet, Stockholm, Sweden
Background. Since oesophageal cancer surgery is extensive and the long-
term prognosis is poor, quality of life is a relevant outcome.
Aim. To assess quality of life and persisting symptoms in patients six months
after oesophagectomy for cancer.
Methods. A prospective nationwide population-based study was conducted
in Sweden from April, 2001 to June, 2005. Data from the Swedish
Esophageal and Cardia Cancer register, which includes most surgically
treated patients in Sweden, were used. Six months postoperatively patients
responded to a quality of life core questionnaire (EORTC QLQ-C30) and an
oesophageal-specific module (QLQ-OES18), from each of which scores were
calculated. Mann-Whitney test was used to compare groups.
Results. Among 282 included patients, the global quality of life was
considerably reduced (mean score 59) compared to that of a reference general
Swedish population (mean score 75 or more; pB/0.001). Similarly, function-
ing scales were negatively affected among the operated patients compared to
the reference population; particularly role (63 versus 87; pB/0.001) and social
(71 versus 90; pB/0.001) function. Younger patients scored worse than older,
while no clear gender differences were found. Common general symptoms
postoperatively included fatigue, appetite loss, diarrhoea, and dyspnoea, each
significantly more pronounced than those reported by the general population
(pB/0.001). Eating problems, cough, reflux, oesophageal pain, and dry mouth
were the most frequently reported oesophageal-specific symptoms.
Conclusions. Oesophageal cancer patients who undergo oesophageal
resection suffer greatly from reduced quality of life and several general and
oesophageal-specific symptoms still six months postoperatively. Informed
consent, careful patient selection and preventative actions are warranted.
P34.09
SURGICAL MANAGEMENT OF PERFORATION OF THE OESO-
PHAGUS: AUDIT OF OUR EXPERIENCE WITH 15 CASES
Decadt, Bart1; Ward, Jeremy1; Mughal, Muntzer2
1Stockport NHS Foundation Trust, Stockport, UK; 2Lancashire Teaching
Hospitals NHS Trust, Chorley, UK
Background. Oesophageal perforation is a rare emergency with a dismal
prognosis. Treatment of oesophageal perforation is challenging and con-
troversial.
Objective. We present our experience and treatment strategy with this
intriguing emergency.
Methods. We reviewed a prospective database on upper gastro-intestinal
emergency referrals to our unit during the period June 2002-Nov 2005. Leaks
following elective resections were excluded.
Results. Fifteen patients were treated (7 males) with a mean age of 60 (range
2180). Therapeutic endoscopy caused a perforation in six patients: during
dilatation for achalasia (1 patient), dilatation of a stricture (2 patients) and
removal of food bolus (3 patients). Other causes included diagnostic
endoscopy (3 patients), spontaneous perforation (5 patients) and perforation
following laparoscopic Heller’s myotomy (one patient). Eight patients
underwent repair of the perforation over a T-tube with a gastrostomy, feeding
jejunostomy and multiple drains in the thoracic, abdominal and mediastinal
cavity. Three patients with pre-existing pathology underwent emergency
oesophagectomy. Three patients underwent thoracoscopy and drainage. One
patient was stented. Median hospital and intensive care stay were respectively
80 (range 11170) and 44 (range 484) days. There was no mortality
following resection or repair over T-tube. Two patients died (mortality 13%),
one from a bronchopneumonia and another patient from a late complication
of the oesophageal stent.
Conclusions. This series accounts the favourable outcome in a cohort of
patients with a potentially dismal prognosis. Patients with existing oesopha-
geal pathology may benefit from emergency cardio-oesophagectomy. Repair
of the oesophageal perforation over a T-tube with a distal gastrostomy,
feeding jejunostomy and multiple drains appears a safe policy.
P34.10
VOLUME-OUTCOME RELATIONSHIP FOR OESOPHAGEAL
RESECTION IN ENGLAND
Al-Sarira, Ali A1; David, Gerald G2; Hanchanale, Vish2; Slavin, John P2;
Deakin, Mark3; Corless, David J2
1Leighton Hospital, Keele University, Leighton Research Unit, Dept. of
Surgery, Crewe, UK; 2Leighton Hospital, Leighton Research Unit, Dept. of
Surgery, Crewe, UK; 3University Hospital North Staffordshire. Keele
University, University Dept. of Surgery, Crewe, UK
Background. Oesophageal resection has been shown to have improved
outcomes when performed at high volume centres and a strong inverse
volume-outcome relationship in a number of studies worldwide.
Aims. We analysed nationwide data between 1997 and 2003 to
investigate this relationship for England and to examine variations between
hospitals.
Method. We have included all patients who underwent oesophageal resection
in England from 1997 through 2003 using Hospital Episode Statistics data.
In-hospital mortality was determined for hospital volume quintiles (very
low,B/10; low, 1014; medium, 1525; high, 2641; very high, /41).
Results. In total 11838 oesophageal resections were performed between
1997 and 2003. The overall in-hospital mortality rate was 10.1% and varied
2-fold from 5.7% to 12.7% across hospital volume groups (PB/0.001). In a
case-mix-adjusted multivariate analysis, the risk of death was higher, while
having surgery at a very low volume hospital (odd ratio (OR), 2.8; 95%
confidence interval (CI), 2.2 3.6; PB/0.001) or a low volume hospital (OR,
2.5; 95% CI, 1.93.2; PB/0.001) compared to the very high volume
hospitals. Overall median length of hospital stay (LOS) was 16 days which
decreased by 3 days from 18 to 15 days (PB/0.001) and the proportion of
patients who experienced prolonged LOS (LOS/75th percentile, 25 days)
decreased by 9.5% from 29.2% to 19.7% across hospital volume groups (PB/
0.001) with higher volume hospital performing better.
Conclusion. Outcome of oesophageal resections vary across hospitals in
England. It is better at higher volume hospitals. To improve quality of care
and outcome for patients in need for oesophageal surgery, patients should be
managed in higher volume hospitals. These data justify the reorganising and
centralising of oesophageal cancer service in UK.
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OUR EXPERIENCE IN APPLYING HYPERBARIC OXYGEN
THERAPY IN THE TREATMENT OF SEVERE ACUTE PANCREA-
TITIS
Pavars, Maris1; Lisagors, Ilans2; Sondore, Antonina2; Oshs, Peteris2;
Krutskiha, Vija2; Zamerovska, Andra2; Ribenieks, Roberts3; Stucka, Raimo3;
Eklona, Anete4; Porina, Ieva4; Bushujeva, Marina4
1Paula Stradins University Hospital, Dept. N23, Riga, Latvia; 2Paula
Stradins University Hospital, Anesthesiology and Intensive Care, Riga,
Latvia; 3Paula Stradins University Hospital, Dept. N28, Riga, Latvia; 4Riga
Stradins University, Riga, Latvia
Background. Severe acute pancreatitis (SAP) induces the fatal destructive
local and systemic inflammatory responses. Despite the progress in the
management of the SAP the death rate remains high and research in the field
of new treatment modalities is a pending matter. Blood dyscirculation is
important in the pathogenesis of the disease. Hyperbaric Oxygen Therapy
(HBO) results in hyperoxygenation of the perfused tissues and may have a
beneficial role in treating SAP.
Aim. The aim of this study was to evaluate the role of HBO in the treatment
of SAP.
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Methods. During the time period (June 2005 to January 2006) we
prospectively assessed 4 patients, who were admitted to the P.Stradins
University Hospital with SAP. The standard therapy was supplemented by
HBO treatment. We used the monoplace chamber ‘‘OKA’’ (Russia). In order
to establish control group, we retrospectively (20032005) reviewed 4 case-
records of patients with SAP. The inclusion criteria of SAP were organ failure
and/or local complications according to the Atlanta classification system.
Results. Age, gender distribution, disease severity were comparable in both
groups. In HBO group, local complications were met more frequently (6 vs
4). 3 patients acknowledged improvement in their state of health after HBO.
Systemic Inflammatory Response Syndrome (15 days (d.) vs 33 d.) and
Sepsis (11 d. vs.22 d.) persisted longer in non HBO group. In this group pain
(12 d. vs 5 d.), hyperglycemia (30 d. vs 20 d.) were more extended, than in
HBO group. Length of stay in the hospital (50 d. vs 54 d.), in the ICU (33 d.
vs 42 d.) were shorter in HBO group. 1 patient (25%) died in non HBO
group, no one in HBO group. For all patients HBO course consisted of 9
HBO sessions, under pressures 1, 51, 7 ATA. No complications were
encountered.
Conclusion. There were too few patients, to reliably confirm the clinical
efficacy of HBO in the treatment of SAP, although there was some evidence,
that further careful studies should be conducted.
P41.02
ACUTE PANCREATITIS AFFECTS KUPPFER CELL FUNCTION
BY A MECHANISM DEPENDENT ON PAF
Souza, Lourenilson J; Shio, Marina T; Molan, Nilza AT; Cunha, Jose EM;
Jancar, Sonia; Machado, Marcel CC
University of Sa˜o Paulo, Surgery, Sa˜o Paulo, Brazil
Introduction. The major complication of acute pancreatitis (AP) is
secondary infection. We have previously observed in experimental AP, that
the translocation of intestinal bacteria to several organs is reduced by
administration of PAF antagonists and that this phenomenon is accompanied
by Kupffer cells (KC) hyperplasia. In the present study we compared some
functions of hepatic cells and isolated KC from rats with AP to those from
healthy animals, treated or not with a PAF antagonist.
Methods. AP was induced in Wistar rats by sodium taurocholate (0.5 ml of
2.5% solution) injection into the main pancreatic duct. The animals were
killed 24 h later, the liver perfused with Krebs solution, non-parenchymal
hepatic cells were obtained by Percoll separation and KC by removal of the
non-adherent cells. The cells were stimulated or not with LPS (1 mg/mL).
Nitrite levels were measured in the supernantants 48 h later by Griess
reaction and TNF after 6 h by bioassay in L929 cells. Microbicidal activity
was evaluated by the capacity to kill Candida albicans. The PAF-antagonist
WEB2170 (10 mg/kg) was administered iv 30 min before induction of AP.
Results. We observed that the non-parenchymal hepatic cells from rats
with AP produced higher levels of NO and TNF than those from healthy rats.
Stimulation of these cells with LPS increased NO and TNF levels in cells
from both, healthy and AP rats. Treatment of the animals with the PAF-
antagonist WEB 2170 before induction of pancreatitis, significantly reduced
NO but had no effect on TNF production by KC and total hepatic cells. This
treatment increased the capacity of KC to kill Candida albicans.
Conclusions. These results suggest that PAF released during AP inhibits
KC microbicidal activity and this could explain the increased bacterial
circulatory dissemination that occurs in AP and the reduction of bacterial
translocation observed by using PAF antagonists.
P41.03
AGGRESSIVE NECROSECTOMY FOLLOWING EARLY FNA,
LEADS TO LOW MORTALITY IN PATIENTS WITH INFECTIVE
NECROTIZING PANCREATITIS
Satyadas, Thomas; Cheong, Edward; Mui-Liu, York; Groot-Wassink,
Thomas; Sinclair, Martin T; Rae, David M
Ipswich Hospital, Eastern Pancreatobiliary Unit, Ipswich, UK
Background. Mortality and morbidity in pancreatic necrosectomy for
infective pancreatic necrosis is fairly high.
Aim. To assess whether early FNA for bacteriology followed by a policy of
aggressive necrosectomy results in a low mortality in patients with necrotising
pancreatitis.
Methods. Prospective data were collected on 102 consecutive patients with
proven severe acute pancreatitis managed on our intensive care unit from
February 1997 to March 2006. A policy of early CT scanning with FNA for
bacteriology (FNAB) was adopted if pancreatic necrosis was evident. If
FNAB was positive, or if the CT showed retoperitoneal gas, pancreatic
necrosectomy was carried out and retroperitoneal irrigation established. We
collected data on severity scores, APACHE-11, CRP, morbidity and
mortality. The main outcome measure was mortality.
Results. Of the 102 patients managed in ITU, 25 underwent necrosectomy.
Only three deaths were recorded in the group undergoing surgery translating
to a mortality rate of 12%.
Conclusions. Early FNAB combined with a policy of aggressive necrosect-
omy in FNAB positive cases results in low mortality in patients with
necrotising pancreatitis
P41.04
ARE ALCOHOL INDUCED ACUTE PANCREATITIS (AAP) AND
BILIARY ACUTE PANCREATITIS (BAP) TWO DIFFERENT DIS-
EASES?
Ganguly, Narendra N
Gauhati Medical College, Dept. of Surgery, Guwahati, India
Aim. A substantial number of Indian people don’t drink alcohol for varied
reasons. The causes of acute pancreatitis in India can broadly be divided in to
two major types. The present study tried to evaluate the effect of alcohol on
the severity of the disease. The aim of this study was to produce evidence to
suggest that the behavioral patterns of these two different etiologies vary
widely. So much so, that they behave like two different disease altogether.
Methodology. 70 patients of acute pancreatitis were managed during the
period of 19952005. Patients were broadly divided on history of alcohol
consumption irrespective of USG finding. 14 patients having APACHE II
score/7 were having history of moderate to heavy alcohol consumption. 3
patient; two males and a female, were infact BAP patient. Amongst these
alcoholic cases 2 were also having billiary lithiasis.
Results. there were significant differences between the alcoholic and non
alcoholic groups. Barring one All the seriously ill patients were having history
of moderate to heavy alcohol consumption. Eleven patients (6 BAP and 7
AAP) having CT features suggesting similar pathologies behaved differently
All the patients with billiary acute pancreatitis excepting two behaved
predictably. All the patients who underwent emergency (17 in number)
open cholecystectomies behaved predictably.
Conclusion. A big percentage of Indian people don’t consume alcohol.
These people have less serious disease. The observations showed beyond
doubt that biliary acute pancreatitis behaves quite benignly and even in
seriously necrotized pancreatic state these patients tolerate surgery better
than the alcoholic acute pancreatitis. Considering there behaviors it can be
suggested that these two diseases should be considered as two different
diseases in line of Carcinoma stomach.
P41.05
CHANGES IN THE SYSTEMIC INNATE IMMUNE RESPONSE IN
TWO EXPERIMENTAL MODELS OF ACUTE PANCREATITIS
Yip, Vincent SK1; Powell, James J1; Bellamy, Christopher O2; Ansell, Ian F1;
Wigmore, Stephen J3; Ross, James A1; Garden, O J1
1University of Edinburgh, Dept. of Clinical and Surgical Sciences,
Edinburgh, UK; 2University of Edinburgh, Dept. of Pathology, Edinburgh,
UK; 3University of Birmingham, Liver Unit, Dept. of Surgery, Birmingham,
UK
Background. Nosocomial infections are common complications of severe
acute pancreatitis (AP) suggesting that the innate immune response is
impaired during the disease process.
Aim. To characterize aspects of the systemic innate immune response in two
models of AP by determining the rates of peripheral blood leukocyte cell
death (apoptosis and necrosis) and phagocytic capacity.
Methods. AP was induced in rats using either intraperitoneal arginine (Ar)
or cerulein (Ce). Fischer/Lewis rats (n/90) were divided into 3 groups (Ar,
Ce, control). AP was confirmed by biochemistry and histology. Peripheral
blood leukocyte function was determined at fixed time points between day 1
and 14 post induction. Leukocyte apoptosis and necrosis was quantified
using YOPRO/7AAD and AnnexinV/PI. The ability of leukocytes to
phagocytose E.coli was quantified using flow cytometry. Appropriate
statistical analyses were performed.
Result. Following AP induction with Ce, the rates of apoptosis and necrosis
of peripheral blood granulocytes demonstrated a biphasic pattern with a
significant increase on day1 (vs control p/0.011), followed by a fall on day 3
(pB/0.05). This pattern was not observed in the Ar group; in contrast a
significant reduction in granulocyte cell death occurred at day1 (vs. control,
p/0.005). The rate of lymphocyte apoptosis and necrosis was significantly
increased on day 1 in both Ar (p/0.001) and Ce (p/0.01) groups vs
control. The rate of lymphocyte cell death was sustained in the Ar group (p/
0.009) until day 3. An overall trend of reduced granulocyte phagocytic
capacity was noticed in both models throughout AP. However, it was
significantly reduced only at day 7 in Ar & Ce groups (vs. control pB/
0.005), but not at any other time points.
Conclusion. There is a combination of an increased leukocyte cell death at
early stages and a reduction of granulocyte phagocytosis at later stages in
experimental AP. These changes of systemic innate immunity may predispose
patients to the susceptibility of infectious complications during severe AP.
P41.06
CONTEMPORARY ANALYSIS IN TREATING 126 CASES OF
NECROTISING PANCREATITIS
Sileikis, Audrius; Jurevicius, Saulius; Zdanyte, Elena; Strupas, Kestutis
Vilnius University Hospital, Santariskiu klinikos, Vilnius, Lithuania
Background. Treatment of necrotising pancreatitis has shifted away from
early surgical debridment to aggressive intensive medical care. Some authors
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supposed that in future necrotising pancreatitis will be treated only
conservatively without any surgical intervention.
Aim(s)/Objective(s). The aim is to reveal the accumulated experience in
changed treatment of necrotising pancreatitis.
Methods. It was reviewed of 126 patients, have undergone treatment against
the necrotising pancreatitis within the years 2002 2005. Atlanta clinical
classification was applied, seeking to ascertain the degree of severity acute
pancreatitis. Pancreatic necrosis was proved by contrast-enhanced computed
tomography. Antibiotic therapy was used for pancreatic necrosis infection
prophylactic. The indications for operation were: proved pancreas necrosis
infection, persistent pancreatitis, intra-abdominal complication, incurable
intra-abdominal hypertension.
Results. The pancreas necrosis of the most patients 87 (69%) did not exceed
30% of the size of the pancreas. Most the patients were operated 72
(57,14%). Infection of the pancreas necrosis was the main indication for the
operation 37(51,4%). Other indications for surgery were: persistent pan-
creatitis-17(23,6%), bowel perforation and bleeding-12(16,7%), incurable
intraabdominal hypertension-6(8,3%). It was ascertained that the larger the
size of pancreatic necrosis is, the more often its infection occurs. After having
compared the methods of operation, it was ascertained that there were less
intestinal fistulas and duration of the post-operational treatment was shorter
among the patients, who have undergone the debridment and afterwards the
closed packing than open packing.
Conclusion. Although aggressive intensive medical care significant reduced
the number of surgical interventions, but it seems that surgery will be still
necessary for majority patients to treat complications associated with
necrotizing pancreatitis.
P41.07
DEVELOPMENT OF A TRANSGENIC MOUSE MODEL OF HER-
EDITARY PANCREATITIS
Athwal, Tejinderjit S; Merriman, Catherine; Vlatkovic, Nikolina; Neoptole-
mos, John P
University of Liverpool, Division Of Surgery & Oncology, Liverpool, UK
Background. Pancreatitis is a common disease of the pancreas which can be
acute (AP) or chronic (CP). The incidence of AP is 50 per 100,000 with a
mortality of 610%. CP often results in long term disability and is associated
with a 219 fold increased risk of pancreatic cancer. Insights into the
pathogenesis of pancreatitis followed the discovery of mutations in the
cationic trypsinogen gene (PRSS1) associated with Hereditary Pancreatitis
(HP). Two common mutations in PRSS1 are R122H and N29I, which are
thought to result in increased autoactivation or resistance to autolysis of
trypsin. This initiates an intracellular digestive enzyme cascade leading to
pancreatic autodigestion and pancreatitis.
Aims. To create a transgenic mouse model of HP which allow further study
of these mutations and the role of trypsin in pancreatitis.
Methods. The human PRSS1 cDNA was initially cloned by RT-PCR from
normal pancreatic RNA using specific primers. Mutants of the PRSS1 gene
were generated by PCR mutagenesis and confirmed by sequencing. The
cDNAs were sub-cloned downstream of the TRE (Tet responsive element) in
vector pBI-G, thus producing an inducible transgene construct. To achieve
expression solely in the acinar cells of the pancreas, rtTA (reversed Tet
transcriptional activator) was sub-cloned into the pBEG vector so that its
expression would be under the control of an acinar cell-specific elastase
promoter. Transgene constructs were microinjected into the pronucleus of
fertilized mouse eggs, to generate transgenic strains pBEG-Elastase: Opt
rtTA, pBI-G: PRSS1, pBI-G: R122H, and pBI-G: N29I. Candidate founder
animals were then identified using Southern screening.
Results. Founder animals have been identified for the PRSS1, R122H and
N29I strains with screening of potential candidates for the Opt rtTA strain in
progress.
Conclusion. Ultimately, studies of these transgenic animals will give us a
better understanding of the molecular events involved in pancreatitis,
resulting in improvements in prevention and treatment for this disease.
P41.08
INCREASED EXPRESSION OF SMAD6 WORSENS MURINE
ACUTE EDEMATOUS PANCREATITIS
Nakamura, Hayato; Miyamoto, Tamao; Tashiro, Mitsuo; Asaumi, Hiroshi;
Nomiyama, Yoko; Otsuki, Makoto
University of Occupational and Environmental Health, Japan, School of
Medicine, Third Dept. of Internal Medicine, Kitakyushu, Japan
Background. Smad6 is implicated in the inhibition of bone morphogenetic
protein signaling. However, the function of Smad6 in the pancreas remains
obscure.
Aim/Objective. To elucidate the unknown function of Smad6, we developed
transgenic mice selectively expressing Smad6 in pancreatic acinar cells using
a plasmid construct coding rat elastase 1 enhancer/promoter.
Methods. Acute pancreatitis was induced by intraperitoneal cerulein injec-
tions in male C57Bl/6NCrj mice or transgenic mice expressing Smad6
selectively in pancreatic acinar cells using a plasmid construct coding the rat
elastase 1 enhancer/promoter that directs high expression in exocrine pancreas.
The severity of pancreatitis was evaluated by serum amylase, pancreatic edema,
acinar cell necrosis, and myeloperoxidase activity in the pancreas.
Results. Smad6 transgenic mice had no specific distinguishing phenotype
such as body weight, pancreatic wet weight and concentrations of pancreatic
protein. Smad6 transgenic mice revealed a marked increase in parameters of
the severity such as serum amylase, necrosis score and myeloperoxidase
activity in the pancreas after induction of pancreatitis. There were no
differences in pancreatic protein levels of Smad6-related intracellular signal
molecules such as Smad2, Smad4 and p-Smad5 after acute edematous
pancreatitis between wild-type and transgenic mice.
Conclusions. These results suggest that the elevated expression of Smad6
in the pancreas results in an increased susceptibility to induction of
pancreatitis although increased expression of Smad6 does not affect the
Smad6-related intracellular signal molecules after induction of cerulein-
induced pancreatitis.
P41.09
LAPAROSCOPIC PANCREATIC NECROSECTOMY
Vidyasankar, Varadarajan; Sigurdsson, Audun
Princess Royal Hospital, Upper Gi Surgery, Telford, UK
Introduction. Necrotizing pancreatitis is a severe complication of acute
pancreatitis. Open necrosectomy is associated with substantial morbidity.
We present successful, minimally invasive management of pancreatic
necrosis.
Patients & Methods. Five patients (4 female, median age 42). The cause of
pancreatitis was alcohol in one and gallstones in the others. Patients had
severe pancreatitis on admission. Failed to settle on conservative manage-
ment. Mean time from admission to operation was 6 weeks. All patients
underwent contrast C.T. Patients required High Dependency support and
TPN pre-operatively. Surgery involved, Open pneumo-peritoneum, lesser sac
approached by dividing the gastro colic omentum, debridement using an
atraumatic grasper and combination of suction- irrigation, cavity inspection
with 30 degree scope and placement of tube drains (for lavage and irrigation).
For patients with gallstones, cholecystectomy was done.
Results. One patient had duodenal necrosis this was identified at operation
and treated as a controlled fistula. Mean HDU stay was 10 days and hospital
stay 2 weeks. No morbidity. No deaths.
Discussion. Open necrosectomy is associated with high morbidity (hae-
morrhage, fistulas, incisional hernias). Percutaneous methods do not allow
adequate drainage, septic recurrences are frequent. In comparison Laparo-
scopic necrosectomy provides adequate debridement and establish a lavage
and drainage system. Potential complications following open surgery are
avoided. Definitive procedures like cholecystectomy and internal drainage are
feasible.
Conclusion. Laparoscopic Necrosectomy is feasible. The procedure appears
safe and effective. The minimally invasive alternative offers shorter ICU
stays, less post-operative pain, early mobilisation, early oral intake with less
associated morbidity and mortality.
P41.10
MANAGEMENT OF ACUTE SEVERE PANCREATITIS WITHOUT
NECROSECTOMY AND LONG TERM FOLLOW UP
Khorsandi, Shirin; Aggarwal, Raj; Amin, Zahir; Lees, William; Pereira,
Steve; Hatfield, Adrian; Kurzawinski, Thomas; Russell, Christopher; Shan-
kar, Arj
University College Hospital, London, UK
Background. The standard approach to severe acute pancreatitis with
necrosis is necrosectomy. Recently only those with infected necrosis were
operated upon. An alternative is drainage under radiological control.
Objectives. To assess the in patient and long term outcome when acute
severe pancreatitis is managed conservatively.
Patients and methods. A retrospective review of patients admitted with
acute pancreatitis between January 1996 and December 2002. February
2006 a telephone survey was undertaken using the short form 36 survey with
additional questions to assess pancreas dysfunction.
Results. 105 patients (M46,F59), mean age 48 years (range 1779 years);
67 were tertiary referrals (64%). Aetiology gallstones 41 (40%), alcohol
36 (34%), idiopathic 16 (15%) and other 11 (11%); 36 had oedematous
pancreatitis (34%) and 69 had necrosis (66%), 26B/30% (38%),
29 3050% (42%), 14/50% (20%). Organ failure occurred in 50 (one
organ 29, two 11, three 3, four 5, five 2). Radiologically guided percutaneous
drains were placed in 51 with necrosis (74%), 30 of whom were infected
(59%). Three patients underwent therapeutic angiography (3%) and 28 had
an ERCP (27%). 42 patients received antibiotics (40%) based on blood and/
or drain cultures. Mean length of stay was 41 days, (range 1164). Sixteen
patients were admitted to ITU (15%). There were five deaths (5%) all in the
necrosis group, 4 of whom were infected. As a result of the disease process 26
patients (25%) were left with endocrine and 3 (3%) with exocrine
insufficiency. 56 (56%) of the 100 survivors were contacted by telephone.
The quality of life for patients after an episode of severe acute pancreatitis was
good. Only 2 patients were admitted with recurrent pancreatitis (ethanolic)
and no new cases of pancreas exocrine/endocrine failure developed after
discharge.
Conclusion. A non operative approach to acute severe pancreatitis
gives results similar to those series in which selective necrosectomy is
undertaken.
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FRAGMENT DNA IN SEVERE ACUTE PANCREATITIS: INDIF-
FERENT CORRELATION WITH DISEASE OUTCOME
Bagul, Anil
Manchester Royal Infirmary, Manchester, UK
Background. Release of genomic DNA into plasma as a result of necrotic
and apoptotic pathways is a feature of a range of human tumours. Severe
acute pancreatitis (AP) is characterized by inflammation but may also be
associated with accelerated apoptotic and necrotic pathways. This study uses
quantitative real-time PCR to measure free circulating DNA in patients with
severe Acute Pancreatitis.
Methods. DNA was purified and quantified using the RNAseP transcription
assay and quantitative PCR in 43 patients with severe acute pancreatitis and
compared to plasma DNA from 12 patients with pancreatic cancer and 28
Controls subjects undergoing laparoscopic cholecystectomy. In acute pan-
creatitis patients, baseline samples were taken on admission and further
samples taken at a median of 5 days into the disease course. Data are
presented as medians(range) Statistics: where statistical comparisions are
made, non- parametric analyses are used and significance is accepted at the
PB/0.05 level.(stats Direct Ltd).
Results. Plasma DNA levels on admission in patients with acute pancreatitis
were lower than in non-cancer controls 0.40 (0.050.79) compared to
1.60(0.459.10) [PB/0.001;95% CI 0.67 to 1.2; Mann-Whitney U test]. In
patients with acute pancreatitis, DNA levels fell during the disease course
0.40(0.050.79) compared to 0.08(0.00 0.53) [B/0.0001; 95% CI 0.05 to
0.12; Wilcoxon’s signed ranks test]. When entered into a logistic regression
model for prediction of mortality, DNA levels were non-significant and only
admission logistic organ dysfunction score was positively correlated with
adverse outcome.
Conclusion. This is the first study to use quantitative PCR to measure free
plasma DNA in SAP (severe acute pancreatitis). The results show that
plasma DNA is lower in patients with acute pancreatitis compared to control
and that values fall further during the disease course.
P41.12
NONALCOHOLIC FATTY PANCREAS DISEASE
Mathur, Abhishek1; Marine, Megan1; Debao, Lu1; Al-azzawi, Hayder1;
Swartz-Basile, Deborah1; Saxena, Romil2; Nakeeb, Attila1; Pitt, Henry A1
1Indiana University School of Medicine, Dept. of Surgery, Indianapolis,
USA; 2Indiana University School of Medicine, Dept. of Pathology, Indiana-
polis, USA
Background. Obesity has become epidemic in the United States with
more than 50,000,000 Americans having a Body Mass Index of more
than 30. Obesity leads to fat infiltration of multiple organs including the
heart, kidneys, liver and gallbladder. Under conditions of oxidative stress, fat-
derived cytokines are released locally and result in an inflammatory process
and organ dysfunction. In the liver, fat infiltration has been termed nonalco-
holic fatty liver disease which may lead to nonalcoholic steatohepatitis. No data
are available, however, on the influence of obesity on pancreatic fat and
cytokines, and nonalcoholic fatty pancreas disease (NAFPD) has not been
described.
Aim. To determine whether obesity would be associated with increased
pancreatic fat and cytokines (NAFPD).
Methods. Twenty-nine C57BL/6J lean control and 29 leptin-deficient obese
female mice were fed a low-fat diet for 4 weeks. At 12 weeks of age all animals
underwent total pancreatectomy. Pancreata from each strain were pooled for
measurement of a) wet and dry weight, b) histologic presence of fat, c)
triglycerides, free fatty acids, cholesterol, phospholipids, and total fat, and d)
interleukin (IL)-1b and tumor necrosis factor-alpha (TNF-a). Data were
analyzed by Student’s t and Fisher Exact tests.
Results. Results for pancreas dry weight, percent mice with pancreatic fat,
total pancreatic fat, and pancreatic cytokines are presented in the table.
Pancreas
weight (mg)
Pancreas
fat (%)
Pancreas fat
(mg/mg)
IL-1b (pg/
ml)
TNF-a
(pg/ml)
Lean 25.59/1.9 25% 25.79/1.3 23.99/2.7 1.89/1.8
Obese 77.99/17.1* 88%* 93.59/11.9* 58.99/12.0$ 27.99/4.6*
*pB/0.01, $p B/0.02 vs Lean Pancreata from obese mice had significantly
(pB/0.05) more triglycerides, free fatty acids, and cholesterol. Triglycerides
represented 11% of pancreatic fat in lean compared to 67% of pancreatic fat
in obese mice (pB/0.01).
Conclusions. These data suggest that obese mice have 1) heavier pancreata,
2) more pancreatic fat, especially triglycerides, and 3) increased cytokines.
We conclude that obesity leads to nonalcoholic fatty pancreatic disease.
P41.13
PARACENTETIC-ASPIRATION METHOD OF TREATMENT
OF PANCREATIC PSEUDOCYSTS UNDER SONOGRAPHIC
CONTROL
Zarivchatskiy, Mikhail F.1; Mugatarov, Ildar N.1; Bogatireva, Galina M.2
1Academy of Medicine, Perm, Russia; 2Center of Surgical Hepatology, Perm,
Russia
Introduction. Diagnosis and treatment of pancreatic pseudocysts is an
actual problem connected with growing of its frequency and occurrence of
complications.
Methods. From 1998 till 2005 thirteen patients with pancreatic pseudocysts
(PP) aged 2452 were treated with paracentetic-aspiration method (PAM)
under sonographic control. Cysts were formed in the period from 2 weeks to
5 years after acute pancreatitis. Diagnosis included ultrasonography, com-
puter tomography, fibrogastroduodenoscopy, clinical, biochemical analyses,
cytologic examination and bacteriological test of pseudocystic punctate.
Ultrasound scanner ‘‘TOSHIBA 220’’ with linear paracentetic data unit of
3,5 M Hz, Chiba and Lunderquist needles, Pictayl drainages were used to
perform an operation. The cyst was punctured, its content was evacuated,
one or two drainages were placed into cystic cavity.
Results. Cytologic examinations have shown presence of hemosiderin
granules, isolated macrophages, eosinophiles in aspirated brown fluid and
leukocytes and fibrin filaments-in purulent one. The volume of cystic content
varied from 50 to 2000 ml. Drainage terms were from 3 days till 2 months.
Sonographic monitoring was carried out. Recovery was observed in 20 cases,
cyst diameter was reduced in 10 patients, inflammatory process was cupped;
subsequently, these patients were subjected to cytojejunostomy. Five years
follow-up was fulfilled. Relapse was revealed in 1 patient.
Conclusion. Paracentetic-aspiration method is non-traumatic and effective
method of pancreatic pseudocysts treatment.
P41.14
PENTRAXIN 3 (PTX3) PLAYS A KEY ROLE IN THE AMPLIFICA-
TION OF THE INFLAMMATORY RESPONSE IN CERULEIN-
INDUCED PANCREATITIS
Montagnini, Andre L1; Souza, Danielle G2; Patzina, Roseli3; Teixeira, Mauro
M2; Matzuk, Martin4; Reis, Luiz F5; Dias, Adriana AM5
1Hospital do Cancer-FAP, Abdominal Surgery Dept., Sao Paulo, Brazil;
2Universidade de Minas Gerais, Minas Gerais, Brazil; 3Hospital das Clinicas,
Dept. of Pathology, Sao Paulo, Brazil; 4Bayllor College of Medicine,
Houston, USA; 5Institue Ludwig for Cancer Research, Sao Paulo, Brazil
Background. Acute pancreatitis (AP) is a common disease that has
numerous causes and which pathophysiology is only now being elucidated.
Significant evidence has accumulated that synthesis and release of chemo-
kines and proinflammatory cytokines (specially IL-1b and TNF) by acinar
cells are responsible for the local injury and the systemic dispersion.
Pentraxin 3 (PTX3) is a TNF and IL1b-stimulated gene that encodes a
long pentraxin with pro-inflammatory activity. Recently, we demonstrated
that PTX3 transgenic mice (PTX3Tg) showed an impaired survival rate after
intestinal ischemia and reperfusion injury, presenting a markedly increased
local and remote inflammatory response and higher tissue concentrations of
TNF-, IL-1b, KC, and MCP-1 as compared to Wild type (Wt) mice.
Aim. In the present study our aim is to contribute for the elucidation of the
mechanism of action of IL-1b and TNF in AP by evaluating the impact of a
PTX3 over-expression in this disease.
Methods. To address this issue PTX3Tg and Wild type (Wt) mice were
injected intraperitoneally with saline (control) or cerulein (7 times 50 mg/kg at
1 h interval) and 5 hours later, pancreas, lungs and sera were collected.
Results. All cerulein injected mice developed AP assessed by the elevation of
a-amylase in sera. Higher tissue concentrations of TNFa, IL-1b, KC, MCP-1
and MIP-2 were observed in the lungs and pancreas of PTX3Tg as compared
to Wt mice following cerulein injection. Also, PTX3Tg mice presented a
much more pronounced intra and inter-acinar edema while edema is almost
undetectable in the pancreas of cerulein injected-PTX3 null mice.
Conclusion. Our results point out PTX3 as one of the possible mediators
involved in the amplification of the inflammatory response that determine the
pancreatitis severity and its outcome.
P41.15
PROPHYLACTIC PROBIOTICS REDUCE BACTERIAL TRANS-
LOCATION AND IMPROVE OUTCOME IN EXPERIMENTAL
ACUTE PANCREATITIS
Van Minnen, L Paul1; Timmerman, Harro M1; Lutgendorff, Femke1;
Konstantinov, Sergey R2; Smidt, Hauke2; Visser, Maarten R3; Rijkers, Ger
T4; Gooszen, Hein G1; Akkermans, Louis MA1
1University Medical Center, Dept. of Surgery, Utrecht, Netherlands;
2Agrotechnology and Food Sciences Group, Wageningen University, La-
boratory of Microbiology, Wageningen, Netherlands; 3University Medical
Center, Dept. of Medical Microbiology, Utrecht, Netherlands; 4University
Medical Center, Dept. of Pediatric Immunology, Utrecht, Netherlands
Background. Infection of pancreatic necrosis by gut bacteria is a major
cause of morbidity and mortality during severe acute pancreatitis. Prophy-
lactic use of antibiotics to prevent infectious complications remains a topic of
debate.
Aims/Objectives. Aim of this study was to determine if prophylactic
multispecies probiotics (Ecologic 641) reduce bacterial translocation or
improve outcome in a rat model of acute pancreatitis.
Methods. Male Sprague-Dawley rats (n/48) were allocated into three
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groups: 1) controls (sham operated, no treatment), 2) pancreatitis, probiotics
treated or 3) pancreatitis, placebo treated. Acute pancreatitis was induced by
intraductal glycodeoxycholate (0.5 ml, 15 mM) and intravenous cerulein (5
mg/kg/hr, for 6 hours). Probiotics or placebo were administered intragas-
trically from five days prior to until seven days after induction of pancreatitis.
On day seven, tissue samples were taken for microbiological and real-time
PCR analysis of bacterial translocation.
Results. Probiotic treatment significantly reduced bacterial overgrowth of
potential pathogens in the duodenum (3.5///0.3 Log10 colony forming
units (CFU)/gram vs. 5.0///0.7, for probiotics vs. placebo, respectively,
PB/0.05), resulting in significantly reduced bacterial translocation to extra-
intestinal tissue (Spleen: 2.4///0.3 CFU/g vs. 3.7///0.5, PB/0.05. Liver:
2.8///0.5 vs. 4.6///0.8, PB/0.05. Pancreas: 3.1///0.5 vs. 5.4///
1.0,PB/0.05). Real-time PCR demonstrated reduced bacterial loads in
mesenteric lymph nodes (5.9///0.4 cells/g vs. 7.0///0.14, PB/0.05)
and pancreas (6.7///0.3 vs. 7.7///0.3, PB/0.05) of rats treated with
probiotics. Probiotics did not reduce overall mortality (4/17 vs. 10/21, P/
0.16), but significantly reduced late phase mortality (]/48 hrs, 0/13 vs. 4/15,
PB/0.05).
Conclusion. In this rat model of severe acute pancreatitis, prophylactic
multispecies probiotics reduce bacterial translocation and late phase mortality.
P41.16
RAISED AMYLASE IS NOT ALWAYS PANCREATITIS
Yeluri, Sashidhar1; Sarela, AI1; Naik, Katherine2; Rotimi, O3
1The General Infirmary at Leeds, General Surgery, Leeds, UK; 2The
General Infirmary at Leeds, Radiology, Leeds, UK; 3The General Infirmary
at Leeds, Pathology, Leeds, UK
Background. Serum amylase is a widely used marker for pancreatitis.
Though a majority of patients with non-specific abdominal pain and serum
amylase levels less than three times the upper limit of normal do not have
pancreatic disease, the same cannot be said with certainty for patients with a
classical history and borderline amylase. In addition abdominal pain in
pregnancy presents unique radiological difficulties.
Objective. After HIV, tuberculosis (TB) is the world’s second commonest
cause of death from infectious diseases. TB in England increased by 25 per
cent over the last ten years and is still rising. The aim of this paper is to report
a patient with abdominal TB who was incorrectly diagnosed with pancreatitis
on the basis of positive amylase results alone. The diagnostic importance of
magnetic resonance imaging (MRI) in pregnancy is highlighted. We also
evaluate the role of polymerase chain reaction (PCR) and culture in the
diagnosis of TB.
Patient and method. This is a case report of a young Asian immigrant
in the UK who presented with repeated episodes of epigastric pain
radiating to back. In view of her pregnancy, she was subjected to a limited
scan MRI.
Results. MRI revealed mechanical distal small bowel obstruction. Lapar-
otomy revealed 2 strictures in the terminal ileum with an interloop abscess.
Small bowel resection and anastomosis was performed. Histopathology
showed chronic active inflammation, panmucosal granulomatous reaction
and Langhans giant cells. Ziehl-Neelson stain and PCR were negative for
tuberculosis. However, culture confirmed TB after 5 weeks.
Conclusion. 1. Every patient presenting with a ‘typical’ abdominal pain and
raised amylase does not have pancreatitis. 2. MRI is safe and effective in the
2nd and 3rd trimester of pregnancy. 3. Though PCR provides a tool for rapid
diagnosis of TB, culture remains the gold standard. In cases with a strong
clinical suspicion, it is important to initiate early treatment even if PCR is
negative.
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ROUTINE SINGLE-STAGE LAPAROSCOPIC APPROACH FOR
THE TREATMENT OF MILD ACUTE BILIARY PANCREATITIS
Ha, Joe P; Tsui, K; Tang, CN; Yang, GP; Li, MK
Dept. of Surgery, Pamela Youde Nethersole Eastern Hospital, Hong Kong,
China
Background. In patients presented with mild acute biliary pancreatitis, the
timing of laparoscopic cholecystectomy and the approach to diagnose and
treat concomitant common bile duct (CBD) stones is controversial.
Aim. To evaluate the safety and feasibility of routine application of single-
stage laparoscopic treatment for mild acute biliary pancreatitis.
Methods. Between January 2000 and December 2005, 45 patients that
presented with mild acute biliary pancreatitis (epigastric pain, serum
amylase/three times the normal, presence of gallstones andB/3 Ranson’s
criteria) underwent laparoscopic cholecystectomy and intraoperative cholan-
giography (IOC) after resolvement of acute symptoms within the same
hospital admission. Laparoscopic exploration of CBD was attempted in case
of positive IOC. Preoperative ERCP was not performed.
Results. There were 20 males and 25 females and their mean age was 57//
/14 years (range 2682). The median operating time was 65 minutes (range
25150). Thirty eight operations (84%) were done in emergency list whereas
7 (16%) in elective list. IOC was successful in 44 patients (98%). Thirty five
patients (80%) had negative IOC and 9 were positive (20%). Laparoscopic
exploration of CBD for CBD stones was successful in 8 patients (3
transcyctic duct and 5 choledochotomy). The median preoperative, post-
operative and total hospital stay was 3 days (range 17), 2 days (range 17)
and 5 days (range 313) respectively. There was no open conversion and
mortality in this series. One patient suffered gallbladder fossa collection that
was treated conservatively. Two patients required postoperatve ERCP (one
failed intraoperative cholangiogram and one failed transcystic duct explora-
tion. With a median follow up of 30 months (range 375), there was no
recurrent attack of pancreatitis.
Conclusion. In patients with mild acute biliary pancreatitis, single-stage
laparoscopic management is safe and feasible. Postoperative ERCP should be
reserved as an adjunct in case of failed laparoscopic approach.
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SECONDARY INFECTION-THE INEVITABLE COMPLICATION
OF NECROTIZING PANCREATITIS IN POSTOPERATIVE PA-
TIENTS
Otto, Wlodzimierz; Komorzycki, Krzysztof; Krawczyk, Marek
Medical University of Warsaw, General, Transplantation & Liver Surgery,
Warsaw, Poland
Secondary infection in patients laparatomized for pancreatic necrosis baffles
very often the previous therapeutic efforts.
Aim of study. To evaluate indications for surgery, the patients outcome, the
routes of infection and responsible bacteria. Material & method: 30 patients
(m.19, f.11, m.a.49, RansonB/4, APACHEIIB/10) treated since 2000,
receiving prevention with Piperacillin/Tazobactam 4.5 g/3/24 h to the day
of surgical necrosectomy and peritoneal drainage. Infection of the necrosis
was determined at the stage of operation by the bacteriologic examination of
the samples of the necrosis. Secondary infections were determined post-
operatively in abdominal cavity, wounds, drains, blood, respiratory tract and
urine.
Results. Increasing intraabdominal pressure, toxemia and retroperitoneal
liquidation of the necrosis were the indications for surgical intervention.
There were 28 (93.3%) aseptic and 2 (6.7%) infected patients at the stage of
the operation. The secondary infections developed postoperatively in 29
(96.6%) due to Staphylococci (19), Escherichia coli (21), Enterobacteriacae
(14), Clebsiella (10), Pseudomonas (8), Proteus (6), Candida (6). Twenty
one patients (70%) required at least one additional operation due to
intraabdominal abscess (16) and bleeding (9). The infection was present
in: drains (23), wound (9), blood (7), respiratory tract (4), urine (11). Nine
patients (30%) developed sepsis, 7 patients (23%) died due to multiple organ
failure.
Conclusions. This is not possible to desist from the surgical intervention in
patients with toxemia and the retroperitoneal liquidation of the necrosis.
Secondary infection shoud be considered as the cosequence and the main
cause of treatment failure in such cases.
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SERUM AMINO ACID PATTERN IN PATIENTS WITH ACUTE
PANCREATITIS
Sandstro¨m, Per1; Trulsson, Lena1; Gasslander, Thomas1; von Do¨beln,
Ulrika2; Sundqvist, Tommy3; Svanvik, Joar1
1University Hospital, Dept. of Biomedicine and Surgery, Linko¨ping, Sweden;
2Karolinska University Hospital, Centrum for Metabolic Diseases, Hud-
dinge, Sweden; 3University Hospital, Dept. of Microbiology, Linko¨ping,
Sweden
Background. We have earlier noticed reduced levels of S-arginine and S-
citrulline in patients with acute pancreatitis (AP). This may be of importance
for the patho-biology of this condition with a defect formation of nitric oxide
(Pancreas, 2003, 27, 261266). In this study we have analysed the full serum
amino acid pattern in patients with AP during and six weeks after the acute
condition.
Methods. In 19 patients with acute pancreatitis serum samples were taken
the first 5 days after admittance to the hospital. The serum amino acid
spectrum was analysed with HPLC and the arginase activity in serum was
determined by an enzymatic method. The patients were followed by ordinar
clinical tests.
Results.
Day 1 Day 5 At recovery
after 6 weeks
(SD) (SD) (SD)
CRP (mg/l) 38(48) 136(92)*** 14(19)
Arginase activity
(nmol/min)
1.22(0.75) 0.92(0.29)*
Arginine (mmol/l) 88(29)** 100(31)* 115(18)
Citrulline (mmol/l) 22(7)*** 19(8)*** 39(14)
Ornithine (mmol/l) 59(29)** 60(16)*** 83(20)
Glutamine (mmol/l) 355(138)*** 319(160)*** 531(79)
Glutamate (mmol/l) 198(131)** 191(152)** 106(48)
* and ** and *** are compared to resp. ‘recovery’ *pB/0.05, **pB/0.001,and
pB/0.0001 S-arginine, citrulline, ornithine and glutamine are all reduced and
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glutamate raised during the acute condition. At admittance to the hospital
there is an increased serum arginase activity compared to day 5.
Discussion. In the early process of AP raised arginase activitity and low S-
citrulline may explain the low levels of S-arginine. The initially raised
glutamate and reduced glutamine levels may be explained by reduced
reformation of glutamine.
Conclusion. Reduced serum levels of arginine, citrulline and glutamine may
cause an impaired formation of nitric oxide with a general negative effect on
organ function.
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SURGICAL MANAGEMENT OF PANCREATITIS WITH NECRO-
SIS
Buczkowski, Andrzej K1; Kim, Peter T1; Ghag, Arvindera2; Chittock, Dean3;
Schaeffer, David F1; Romanowski, Andrew2; Chung, Stephen W1; Scuda-
more, Charles H1
1University of British Columbia, Surgery, Vancouver, Canada; 2University of
British Columbia, Vancouver, Canada; 3University of British Columbia,
Critical Care Medicine, Vancouver, Canada
Background. Severe acute pancreatitis with necrosis is a challenging clinical
condition requiring multi-discplinary management. Role of surgical manage-
ment is still controversial but accepted management is selective debridement
of infected necrosis. The approach to management is still evolving and calls
for a better understanding of the disease.
Aims/Objectives. To evaluate the characteristics of patients with severe
pancreatitis with necrosis and their outcome when managed with repeated
abdominal decontamination and staged debridement.
Methods. Nine patients with severe pancreatitis with necrosis admitted to
the intensive care unit (ICU) for septic shock were managed at a tertiary care
center. Interval open abdominal lavage and necrosectomy were followed by
closed continuous irrigation with temporary abdominal closure. The data
were collected prospectively and retrospectively and analyzed according to
the demographics, disease severity by imaging (Balthazar score), clinical
score (APACHE II) and sequential organ failure score (SOFA). Patient
outcomes were measured by survival, complications and length of stay.
Results. The mean patient age was 469/19 years. Alcohol (44%) was the
most common etiology followed by gallstones (11%), iatrogenic (22%) and
drugs (11%). Mean Balthazar score was 89/2 and the mean APACHE II
score was 269/5. Mean number of operations performed per patient was
129/8. Other surgical modalities such as retroperitoneal laparoscopic
debridement (30%) and ERCP (30%) were also used. Infected necrosis
was present in all patients and multiple organisms were present in 90%.
Mean number of organisms present was 49/2. Enterococcus species was the
most common organism (88%). Mean length of stay was 1509/67 days with
the mean ICU stay of 689/31 days. After median follow up of 9 months,
survival was 90%.
Conclusions. Multi-modality surgical treatment may improve outcome
and survival of patients in septic shock due to severe pancreatitis with
necrosis
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SURGICAL MANAGEMENT OF SEVERE ACUTE PANCREATITIS
Vyas, Frederick; Joseph, Philip; Sanghi, Ravish; Jehangir, Susan; Sitaram,
Venkatramani; Govil, Sanjay
Christian Medical College & Hospital, Dept. of General Surgery Unit 4,
Vellore, India
Background. About 20% of patients with acute pancreatitis develop severe
acute pancreatitis (SAP). Mortality rises sharply with the introduction of
infection into necrotic pancreatic tissue.
Aims. To evaluate objectively the management of patients undergoing
surgery for presumed infected pancreatic necrosis in a surgical unit over a
period of 5 years.
Methods. Charts of all patients with Severe Acute Pancreatitis who under-
went pancreatic necrosectomy between 1st January 2000 and 31st December
2005 were reviewed.
Results. Fifty one patients underwent pancreatic necrosectomy over the
study period. There were 45 males and 6 females with a mean age of 41 years.
Thirty seven patients were ill with organ failure at the beginning of their
illness but stabilized with organ support for variable periods until they
developed fever once again. Fourteen patients remained ill requiring intensive
care support till the point of surgical intervention. The overall mean organ
failure score preoperatively was 2.1. The mean score for those who died was 4
compared to 1.4 of those who lived. (p of 0.002, Mann-Whitney test). 46
patients were operated for suspected infected necrosis, 5 patients with sterile
necrosis underwent operation. Infection was diagnosed by CT scan and on
clinical grounds in all these patients. Only 2 patients with infected necrosis
were not picked up by above criteria. Bacterial isolates from 5 patients did not
grow any organism. 14 patients required re-operation. Six patients developed
pancreatic fistula, 7 enteric fistula, 3 retroperitoneal abscess, 2 splenic artery
aneurysm, and one patient each developed deep vein thrombosis, splenic
flexure stricture and left colon gangrene. There were 8 deaths with a
mortality of 15.68%.
Conclusion. Surgery is indicated in patients with proved infected pancreatic
necrosis. Patients with sterile necrosis may require surgical intervention in
view of deteriorating clinical condition. Infection in patients with SAP can be
diagnosed by careful monitoring of vital signs and CT scan.
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SURGICAL MANAGEMENT OF SEVERE ACUTE PANCREATI-
TIS: OUR EXPERIENCE IN TEN YEARS
Ovejero-Go´mez, Vı´ctor J1; Gutie´rrez-Ruiz, Amado1; Ansorena-Pool, Luis1;
Revuelta-Alvarez, Santiago1; Cobo-Castro, Toma´s2; Ingelmo-Setien, Al-
fredo1
1Hospital Sierrallana, Dept. of Surgery, Torrelavega, Spain; 2Hospital
Sierrallana, Dept. of Anaesthesia, Torrelavega, Spain
Background. Acute pancreatitis is a glandular inflammation caused by
enzymic autodigestion. The assessment of the severity of pancreatitis is
critical to predict prognosis. The aim of this study was to evaluate the results
of our district-general hospital in patients with severe acute pancreatitis
(SAP) for ten years.
Methods. We admitted 459 patients (mean age: 70?4 years and male/female
ratio: 0?9) with acute pancreatitis at our hospital between 1995 and 2005. A
retrospective study included 68 patients (mean age: 68?1 years) admitted in
our intensive care unit (ICU) suffering from SAP. Male/female ratio was 1’4.
The diagnosis of the disease was based on clinical data, Ranson?s criteria,
contrast-enhanced CT scan and/or percutaneous sample. All cases started
with antibiotherapy. One third was gallstone-associated pancreatitis. Surgical
treatment was indicated for infected necrotising pancreatitis, suppurative
complications and sterile necrosis with deterioriation despite ICU manage-
ment. Operative technique was debridement, necrosectomy, cholecystect-
omy, postoperative daily lavage and on-demand re-laparotomy.
Results. A conservative treatment could be successfully managed in 10
patients. Rest of cases required an operation at an average of 12?8 days from
the outset of pancreatitis. Postoperative morbidity was 77?6% (fistula: 42?2%,
peripancreatic abscesses: 15?6%, intrabdominal bleeding: 11?1%) and 55?2%
required at least a second-look surgery. Overall mortality was 56?9% due to
surgical complications or incomplete debridement of necrotic tissues and
sepsis. Surviving patients were discharge in 46?8 days.
Conclusions. A male-patient, alcohol-related pancreatitis and septic com-
plications of necrosis could be surgical prognostic predictors at our hospital.
An initial antibiotic regimen didn?t always provide against infective complica-
tions. We had a high postoperative morbidity and mortalility. We think this
could be related to delayed surgery after diagnosis of illness. A review of our
surgical protocol is now in process.
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SURGICAL TACTICS IN ACUTE DESTRUCTIVE PANCREATITIS
Baimakhanov, Bolatbek1; Aliyev, Mukhtar1; Ramazanov, Manas1; Akhmetov,
Yermek2; Betirova, Dagmara1
1National Scientific Center of Surgery, Abdominal Surgery, Almaty, Kazakh-
stan; 2National Scientific Center of Surgery, Dept. of Radiology, Almaty,
Kazakhstan
Aim. To improve the results of surgical intervention in patients with acute
destructive pancreatitis.
Methods. Within the period from 1993 to 2005 243 patients with acute
pancreatitis were admitted in our clinic. Conservative treatment using an
analogue of somatostatin and methods of extracorporal detoxication was
effective in 185 patients. 58 patients had the diagnosis of complicated acute
destructive pancreatitis. These patients were operated after an appropriate
pre-surgical preparation of 35 days from the time of admission. The
indications for operation included absence of effect from conservative
treatments and clinical progression of panreatogenic peritonitis.
Results. Laparotomy, necrosequestrectomy, cholecystectomy with common
bile duct drainage and omentobursotomy was performed in 32 patients. 13
patients had laparotomy, cholecystectomy with greater omentum drainage.
Laparotomy with direct pancreatoscopy and defining the diagnose was done
to 13 patients. Among them in 8 patients laparotomy, cholecystectomy with
marsupitaion of the greater omentum was performed after laparoscopic
diagnostics. Post surgical mortality within the first 30 days was 51,7% (30
patients). The causes of the death included septic complications: abscess of
the omentum, perotinitis, phlegmon of the retro-peritoneal space, bacterial-
septic shock.
Conclusions. The availability of detailed laboratory and instrumental
control of patients with destructive forms of acute pancreatitis allows us to
change the surgical treatment tactics and to define more accurately the
surgical indications. The indications to surgical treatments we considered to
be the following: none response to adequate conservative treatments within
710 days, the presence of clinical signs of abscess, if instrumentally septic-
necrotic lesions were seen.
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THE EFFECT OF ION SHIFTS ON DIGESTIVE ENZYME ACTI-
VATION WITHIN ZYMOGEN GRANULES IN MOUSE PANCREA-
TIC ACINAR CELLS
McLaughlin, Euan1; Smith, Duncan2; Raraty, Mike1; Criddle, David2;
Gerasimenko, Oleg2; Tepikin, Alexei2; Neoptolemos, John1; Petersen, Ole2;
Sutton, Robert1
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1Royal Liverpool University Hospital, Division of Surgery and Oncology,
Liverpool, UK; 2University of Liverpool, Physiology, Liverpool, UK
Background. Premature digestive enzyme activation is central to the
pathogenesis of acute pancreatitis. Zymogen granules store digestive enzymes
in a condensed, acidic, inactive state with high concentrations of calcium,
replaced by potassium in preparation for exocytosis. Premature digestive
enzyme activation may be caused by excessive granular calcium release and
potassium entry, as a result of acinar cell dysfunction induced by bile, ethanol
metabolites or other toxins implicated in acute pancreatitis.
Objective. To determine the effects of changes in calcium, potassium or
hydrogen ions in isolated murine zymogen granules on digestive enzyme
activation and granular morphology.
Methods. Zymogen granules were isolated from CD1 murine pancreatic
acinar cells. Granular calcium was depleted with 1 mM EGTA (calcium
chelator) and 20 mM ionomycin (calcium ionophore). Potassium and
hydrogen ion entry was induced with 10 mM valinomycin (potassium
ionophore) and 10 mM nigericin (protonophore) respectively. Granular
calcium was measured with the fluorescent probe Rhod 5N, while trypsino-
gen or cathepsin B activation was measured with IPR-CMAC or (FR)2
R110 respectively, using confocal microscopy. Morphological changes were
assessed using electron microscopy.
Results. Marked granular calcium depletion was induced by EGTA and
ionomycin (mean drop 57/4%). Progressive trypsinogen and cathepsin B
activation were observed in calcium-depleted granules, not untreated
controls. The combination of valinomycin and nigericin at pH 7.5 induced
activation of both enzymes. Electron microscopy demonstrated that calcium
depletion induced granular decondensation similar to that observed in early
acute pancreatitis.
Conclusion. Abnormal digestive enzyme activation is induced in zymogen
granules by excessive calcium loss and potassium entry, with an appearance
typical of early acute pancreatitis. This mechanism may be critical to the
pathogenesis of acute pancreatitis.
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THE ROLE OF SELECTIVE MESENTERIC ANGIOGRAPHY IN
THE INITIAL MANAGEMENT OF THE VASCULAR COMPLICA-
TIONS OF ACUTE PANCREATITIS
Logue, Jennifer A1; McCarter, Douglas H2; Imrie, Clem W1; McKay, Colin
J1; Carter, Ross1
1Glasgow Royal Infirmary, Dept. of Surgery, Glasgow, UK; 2Glasgow Royal
Infirmary, Dept. of Radiology, Glasgow, UK
Background. Optimal management of the vascular complications of acute
pancreatitis remains uncertain.
Aim. To evaluate selective mesenteric angiography in the management of
such complications.
Methods. A retrospective review of patients with acute pancreatitis who had
undergone mesenteric angiography from 19982005.
Results. Records for 32 patients were available for analysis. The median age
was 54 years (range 3373) and 62% were male. The aetiology of the acute
pancreatitis was gallstones (n/12), alcohol (n/12), idiopathic (n/7) and
post-ERCP (n/1). Twenty-one patients had intervention prior to angio-
graphy, most commonly percutaneous or open necrosectomy. Mesenteric
angiography was performed in 29 (91%) patients because of acute bleeding.
Four patients required emergency laparotomy for hypovolaemic shock at
presentation and following re-bleed underwent angiography///embolisa-
tion. Twenty-five patients underwent angiography as their initial intervention.
Bleeding was localised in 15 with control in 11. Five of these patients
required repeat embolisation for re-bleeds and one of these also required
surgery. Surgical intervention was necessary to control haemorrhage in 4
patients who were unsuitable for embolisation. Angiography did not localise
bleeding in 10 patients (observation n/5, laparatomy n/4, embolisation
n/1). The remaining 3 (9%) cases had pseudoaneurysms of the splenic
artery detected on radiological imaging and they underwent successful
embolisation. The vessels predominantly involved were splenic and gastro-
duodenal arteries. Overall, there were no complications of ischaemia related
to embolisation and in-patient mortality was 15.6%.
Conclusions. Selective mesenteric angiography is effective in localising the
bleeding site but also allows definitive treatment by major vessel embolisation
and is not associated with increased ischaemic complications. Angiography
should be first line therapy for mesenteric bleeding secondary to acute
pancreatitis.
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TIMING OF CHOLECYSTECTOMY AFTER ACUTE GALLSTONE
PANCREATITIS
Amonkar, Sunil J; Cain, Henry; Khout, Hazem; Farrell, Rory J
Queen Elizabeth Hospital, General Surgery, Gateshead, UK
Background. Current UK guidelines (Gut;54;Suppl 3:iii19) on acute
gallstone pancreatitis (AGP) recommend definitive treatment of gallstones
during the initial admission or within the next 2 weeks. The guidelines do not
cite any published evidence.
Aim. To review our practice and assess factors that may influence read-
mission.
Methods. Case notes of patients undergoing laparoscopic cholecystectomy
(LC) for AGP between April 2004 and April 2005 were reviewed.
Demographics, severity score, radiological findings, length of initial stay,
time from discharge to LC and unplanned readmissions were recorded.
Results. 20 patients (16 female, 4 male: ages 2281, median 57 yrs) were
studied. Initial hospital stay was 113 days, median 5 days. No patient
underwent LC on initial admission. Time from discharge to LC was 6143,
median 48 days. One patient was readmitted after 7 days with cholecystitis; 3
patients had recurrent pancreatitis at 13, 15 and 67 days after discharge. The
intervals between initial admission and readmission in these patients were 13,
20, 26 and 69 days respectively. There was no apparent association between
severity of the initial AGP attack and risk of recurrence. No factors were
identified that influenced readmission.
Conclusion. This retrospective study supports the UK guidelines. The ‘‘two
week interval’’ should furthermore, be measured from the time of admission
with, rather than discharge after, AGP. Larger multi centre studies would add
more support to this.
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TREATMENT OF INFECTED PANCREATIC NECROSIS BY COM-
PLETE DEBRIDEMENT, AND CLOSED CONVENTIONAL DRAI-
NAGE
Abu Hilal, Moh’d; Johnson, Colin D; Zidan, Bashar; Goussous, Galeb;
Mirnezami, Alex M; Pearce, Neil W
Southampton General Hospital, General Surgery, Southampton, UK
Background. After necrosectomy, conventional drainage, continuous lavage
or open drainage may be used. In reviews (D’Egidio 1991, Isaji 2000) it is
stated that mortality with conventional drainage is higher than after closed
lavage or open packing. Published data report different indications for
operation and different goals of therapy.
Aim. this study aims to report the results of closed drainage after
necrosectomy for infected necrosis.
Methods. 32 consecutive patients (median age 55 years, 25 men and 7
women) with infected necrosis were treated by extensive necrosectomy
and closed drainage preferably after the third week of illness. Complete
debridement was obtained in one procedure if possible. The aetiology
of pancreatitis was biliary in 19 patients, alcoholic in 9 and ERCP in 4.
CT was performed in all patients with a median Balthazaar CT severity index
of 7.
Results. Mean time between the acute attack and the necrosectomy was
34.5 days (range 1960). The mean operative time was 155 minutes;
median number of drains used was 4. In 29 patients debridement was
obtained after one procedure, in 3 patients the pancreatic bed was packed
due to diffuse ooze and reviewed after 48 hrs, one of these patient needed
one additional laparotomy and 2 patients needed a further 2 laparotomies
for completion of debridement. Three patients died (9%); 8 major
complications (25%) occurred, of which 3 needed surgical treatment (re-
operation rate after abdominal closure 10%). The mean hospital stay was
53.6 (range 25120) days, with a mean postoperative ITU stay of 4 days
(range 122).
Conclusions. Our results are similar to reported mortality of 8.3% with this
technique (Fernandez del Castillo, 1998). Conventional drainage following
aggressive necrosectomy is a valid option in the treatment of pancreatic
necrosis and can offer excellent results.
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WIDE BORE CATHETER DRAINAGE FACILITATES DELAYED
PANCREATIC NECROSECTOMY WITH IMPROVED OUTCOME
Rowan, Fiachra1; Conneely, John1; Doyle, Majella1; Ryan, Donal2; Fenlon,
Helen3; MacNicholas, Michelle3; Phelan, Dermot2; Colreavy, Francis2;
McEntee, Gerry1
1Mater Misericordiae Hospital, Surgery, Dublin, Ireland; 2Mater Misericor-
diae Hospital, Anaesthesia, Dublin, Ireland; 3Mater Misericordiae Hospital,
Radiology, Dublin, Ireland
Background. Mortality from infected pancreatic necrosis is as high as 25
35% in most series. Timing of necrosectomy is controversial with reoperation
common after early surgical intervention. Facilitated by aggressive radiolo-
gical drainage, targeted antimicrobial therapy and critical care support, we
have adopted a policy of delayed surgery in such patients.
Aim. To determine the benefit of radiological drainage and sub-
sequent delayed pancreatic necrosectomy in patients with necrotising
pancreatitis.
Methods. Patients with severe pancreatitis were referred to critical care
services. Illness severity was assessed by serial Acute Physiology And Chronic
Health Evaluation II (APACHE II) score. Patients with pancreatic necrosis
and suspected sepsis underwent fine-needle aspiration and wide-bore
radiological drainage if infection was confirmed. Antimicrobial therapy was
guided by microbiological culture. Necrosectomy was performed when
resolution of the pancreatitic process was confirmed radiologically and the
patient’s clinical status had improved.
Results. From January 1999 until December 2005, 35 patients
were admitted with necrotising pancreatitis and 34 underwent elective
delayed necrosectomy. Mean peak APACHE II was 12.6 (628). Critical
care and radiological protocols reduced the immediate preoperative score to
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6.9 (117). Median interval to necrosectomy was 69 days (26112). There
were 3 mortalities, one at 24 hours and another at 198 days post
necrosectomy with a third who developed a fatal colonic bleed prior to
necrosectomy.
Conclusion. By controlling sepsis, wide bore catheter drainage minimises
organ impairment in patients with infected necrosis rendering necrosectomy
a safer, elective procedure.
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DIAGNOSTIC VALUE OF DIFFUSION-WEIGHTED MAGNETIC
RESONANCE IMAGING (MRI) IN CYSTIC LESIONS OF THE
PANCREAS
Lobo, E; Schraibman, V; Goldman, SM; Abdala, N; Melo, H; Demarchi,
GTS; Francisco, VV; Rosas, G; Abud, T; Goldenberg, A; Trivino, T;
Szejnfeld, J
Federal University of Sao Paulo, Pancreas and Biliary Surgery, Sao Paulo,
Brazil
Purpose. To determine whether diffusion-weighted MRI can help differ-
entiate intraductal papillary mucinous tumors (IPMT) and mucinous
cystoadenomas/carcinomas from other pancreatic lesions.
Methods. Diffusion-weighted 1.5T MRI was performed in 17 patients with
mucin-producing tumors (n/4), pseudocysts (n/3), serous cystoadenomas
(n/2), polycystic disease (n/1), pancreatic abscess (n/1), simple cysts and
small (i.e. B/2 cm) cystic lesions (n/6). Images were obtained with
diffusion-weighted EPI with b-values of 0, 500, 700 and 1000 sec/mm2.
The apparent diffusion coefficient (ADC) was calculated. Surgical and
histopathologic correlation was obtained for 7 patients (4 mucin-producing
tumors, 1 abscess, and 2 pseudocyst) while size stability was determined for
10 patients after a follow-up of more than 6 months. Ten patients are still
under investigation.
Results. All cystic lesions were associated with very high signal intensity at
T2 images. IPMTs and mucinous cystoadenomas/carcinomas had high signal
intensity at 500, 700 and 1000 sec/mm2 and a decreased ADC, potentially
representing diffusion restriction indicative of the presence of mucinous
products. Simple cysts, pseudocysts and abscesses did not show signs of
restriction for all values of b.
Conclusion. Diffusion-weighted MRI can help characterize cystic
lesions of the pancreas differentiating mucin-producing tumors from others
lesions.
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ENDOSCOPIC PANCREATIC DUCT DECOMPRESSION FOR
TREATING PANCREATIC LEAKAGE: A SUCCESSFUL AND
SAFE METHOD IN SELECTED PATIENTS
Heisterkamp, Joos1; Poley, Jan Werner2; Dees, Jan2; Kazemier, Geert1;
Kuiper, Ernst2; van Eijck, Casper1
1Erasmus MC, Surgery, Rotterdam, Netherlands; 2Erasmus MC, Gastro-
enterology, Rotterdam, Netherlands
Background. Pancreatic duct leakage can occur as a consequence of
abdominal trauma, acute pancreatitis or pancreatic surgery. In any case, it
is a devastating complication associated with considerable morbidity and
even mortality. xternal drainage is most often performed resulting in
pancreatic fistulas with increased morbidity. Transpapillary stentplacement
or sphincterotomy may achieve resolution of leakage.
Aim. We therefore studied the effect of treatment of patients with persistent
pancreatic leakage after surgery, trauma or pancreatitis with ERCP to achieve
pancreatic ductal decompression.
Methods. Patients were identified from a database containing all endoscopic
procedures in our institution between 2003 and 2005. Follow-up ranged
from 3 months to 2 years.
Results. ERCP was attempted in 25 patients (14 male; median age 51 yrs,
range 873). Pancreatic injury was related to surgery (n/10), trauma (n/5)
or pancreatitis (n/10). Pancreatic duct decompression with either stentpla-
cement (n/19), or PD sphincterotomy (n/3) was technical successful in 22
patients (88%). Successful long term outcome, defined as recovery without
additional surgical or radiological procedures, was achieved in 76% (n/19)
and failed in 24% (n/6). Three of six patients were in the pancreatitis group
and three in the postoperative group (p/0.16 vs. trauma). In 10 patients one
or two repeat procedures were necessary after clogging of the stent. Long
term outcome was significantly different for patients with leakage in either
head or body area (6/11 successful; 55%) versus patients with leakage in the
tail area (13/13 successful; p/0.006). Three (12%) patients died; one in the
postoperative group and two in the pancreatitis group. Stentplacement was
successful in these patients and their deaths were unrelated to the procedure.
Conclusion. Pancreatic ductal decompression is a highly effective method to
treat pancreatic leakage in postoperative, trauma and pancreatitis patient-
sFurther research should focus on the indications an.
P42.01
86 CASES OF SURGICAL TREATMENT FOR CHRONIC PAN-
CREATITIS
Jurevicius, Saulius; Sileikis, Audrius; Zdanyte, Elena; Strupas, Kestutis
Vilnius University Hospital, Santariskiu Klinikos, Vilnius, Lithuania
Background. Chronic abdominal pain, and other complications of chronic
pancreatitis, such as obstruction of biliary and pancreatic ducts, duodenal
obstruction, stenosis and thrombosis of retropancreatic blood vesels,
pseudocysts and pseudoaneurysms, is an indication of surgical treatment.
Aim(s)/Objective(s). The aim is to reveal the accumulated experience in
our clinic of chronic pancreatitis.
Methods. It was reviewed of 86 patients, who have undergone pancreatic
head resection for chronic pancreatitis against the chronic pancreatitis within
the years 20032005. In all cases preoperative diagnostic included ultra-
sound, endoscopic ultrasound and enhanced computer tomography. A
median follow-up of time was 8 month.
Results. Duodenum-preserving pancreatic head resection was performed in
74 (86%) cases: 52 (60,5%) cases by Frey and 22(25,5%) by Bern
modification. In cases with common bile duct obstruction intrapancreatic
choledochotomy was preferred. For 12 (14%) patients we performed pylorus-
preserving pancreatoduodenectomy-the main indicaition-bleeding pseudoa-
neurysms. The incidence of leakage from the pancreatic anastomosis was
6,8% of patients after duodenum-preserving pancreatic head resection and
8,3% after pylorus-preserving pancreatoduodenectomy. 98,8% of patients
after operation have long-lasting pain relief. No recurrence of jaundice was
found after operation in follow-up time.
Conclusion. Duodenum -preserving resection of the pancreatic head is
effective and safe operation in the treatment of complicated chronic
pancreatitis.
P42.02
COMPARISON OF OUTCOME AND PANCREATIC FUNCTION
BETWEEN PD AND FREY PROCEDURE FOR CHRONIC PAN-
CREATITIS
Chen, Huang-Yang; Yeh, Chun-Nan; Hwang, Tsann-Long; Jan, Yi-Yin;
Chen, Miin-Fu
Chang Gung Memorial Hospital/Chang Gung University, Surgery, Taoyuan,
Taiwan
Background. Several surgical treatments have been proposed for treating
chronic pancreatitis (CP), including standard pancreaticoduodenectomy
(PD), pylorus-preserving PD, Beger procedure (duodenum-preserving pan-
creas head resection), and Frey procedure (local resection of the pancreatic
head combined with longitudinal pancreaticojejunostomy). However, few
studies have compared the pre- and postoperative functions of the pancreas in
CP patients who have received surgery. This study prospectively assessed the
outcome and pancreatic functional results in CP patients who underwent the
PD or Frey procedure.
Method. From 1996 to 2003, 42 patients with CP received pancreatic head
resection; with 17 undergoing PD and 25 undergoing the Frey procedure.
Clinicopathologic features, surgical morbidity, mortality, hospital stay were
compared between the PD and Frey groups. Pain intensity was evaluated
using the pain score. Furthermore, pre- and post-operative pancreatic
exocrine and endocrine functions were assessed using fecal elastase I and
Bentiromide testing and the need to treat diabetes mellitus with oral
hypoglycemic agents, or insulin, C-peptide and glycohemoglobin.
Result and conclusion. Both the PD and Frey group patients displayed
similar demographic features, surgical morbidity, and mortality. Improved
pancreatic exocrine function and significant pain relief following surgery were
observed in all patients. Complications of adjacent organs were definitively
resolved in both groups. Moreover, similar postoperative endocrine and
exocrine function results were observed in both the PD and Frey group
patients. The mean hospital stay was 15.4 days (15.49/2.1) in the PD group
and 10.6 days (10.69/2.0) in the Frey group (pB/0.0001).
P42.03
CONCOMITANT ALCOHOLIC LIVER DISEASE AND CHRONIC
ALCOHOLIC PANCREATITIS
Girish, SP; Singh, S; Sakhuja, P; Gondal, R; Agarwal, Anil K
GB Pant Hospital & MAM College, Dept. of GI Surgery, Delhi, India
Background. Alcohol is a common etiological factor in the pathogenesis of
both pancreatic and liver disease. The present study was conducted to study
the frequency of associated liver histological change in patients with alcoholic
chronic pancreatitis (AICP).
Methods. We studied liver-biopsy specimens from 23 patients with chronic
alcoholic pancreatitis subjected to operation for pain, from January 2004 to
April 2005; all the patients had undergone liver biopsy at the time of surgery
for AICP. The patients were followed as part of a prospective study of 33
patients who had been treated for chronic pancreatitis. The pathologists were
requested to report on alcohol related histological changes in the specimen.
Results. There were 23 patients and all were men. Chronic pancreatitis was
due to alcohol abuse in all patients. The median age at surgery was 39.8
years. The mean duration of alcohol abuse was 20.5 years (range 629
years). The average alcohol intake was 72 gm///36 gms/day. Three patients
had jaundice for 36 months duration. None of the patients had any other
risk factor for liver disease and none of them had clinical or biochemical
evidence of liver disease. The histological reports were, 4 patients had
alcoholic hepatitis, 2 severe steatohepatitis,1 granulomatous hepatitis, 3
cholestasitc changes, one fatty liver and 12 had no significant pathology.
None of the patients had cirrhosis. Thus significant alcoholic liver disease was
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present in 30.4% (7/23) of the patients. There was no increased incidence of
post operative mortality and morbidity in patients with liver pathology.
Conclusions. Significant Alcoholic Liver disease was found to be present in
30% of Patients undergoing surgery for Alcohlic Chronic pancreatitis.
However its clinical significance and prognosis of these patients are unknown.
P42.04
ENDOSCOPIC ULTRASOUND RELIABLY IDENTIFIES CHRO-
NIC PANCREATITIS WHEN OTHER IMAGING MODALITIES
HAVE BEEN NON-DIAGNOSTIC
Morris-Stiff, Gareth1; Webster, Phillip1; Frost, Ben2; Lewis, Wyn2; Puntis,
Malcolm1; Roberts, Ashley1
1University Hospital of Wales, Cardiff, UK; 2Royal Gwent Hospital, New-
port, UK
Background. There are classical radiological features for the diagnosis of
chronic pancreatitis (CP) on endoscopic retrograde cholangiopancreatogra-
phy (ERCP), magnetic resonance cholangiopancreatography (MRCP) and
computed tomography (CT), however, not all patients exhibit these features
despite convincing clinical histories, which may result in diagnostic delay.
Aims. to assess the use of endoscopic ultrasound (EUS) in the diagnosis of
CP when other imaging modalities had not yielded a diagnosis.
Methods. All patients undergoing pancreatic EUS between January 1996
and December 2004 were identified from the radiology computerised
database. Sixteen patients with a clinical diagnosis of CP (10 male, mean
age 53///4 years) underwent EUS after normal conventional imaging.
Results. Thirteen patients exhibited features of CP unidentified by other
modalities, which included duct dilatation (n/8), calcification (n/7);
parenchymal change (n/6), irregular undilated ducts (n/2), and pancreatic
ductal calculi (n/1) and fine calcification. Of the remaining 3 patients, a
diagnosis of sclerosing pancreatitis was made in one, in another, there was a
pancreatic duct stricture of uncertain origin which was stented, and in only 1
case was no diagnosis established.
Conclusions. EUS provided additional diagnostic information in 94% of
patients in the above series, in particular early CP, when cross-sectional
imaging or ERCP had failed to support a diagnosis of CP. EUS should be
used as a second line investigation in the face of patients with negative CT
and MRCP with convincing clinical diagnoses of CP.
P42.05
LONG TERM FOLLOW-UP ON QUALITY OF LIFE MEASURE-
MENT AFTER FREY PROCEDURE VERSUS PYLORUS-
PRESERVING PANCREATODUODENECTOMY FOR CHRONIC
PANCREATITIS
Issekutz, A´kos; Makay, Roland; Bela´gyi, Tibor; Ola´h, Attila
Petz Alada´r County Hospital, Dept. of Surgery, Gyo˜r, Hungary
Background. The aim of this retrospective non-randomized study was to
compare two surgical procedures in the treatment for chronic pancreatitis.
Comparison of long term effects of limited pancreatic head resection
according to Frey and complete pancreatic head resection as pylorus-
preserving pancreatoduodenectomy (PPPD) by measuring Quality of life
(QoL) is presented.
Material and method. During the last 8 years 56 consecutive patients were
included into this retrospective study. As individual surgical indication PPPD
was chosen when major complicated pancreatic head mass was present or
pancreatic cancer could not be ruled out (18 patients); otherwise Frey
procedure (FP) was performed (38 patients). Quality of life was measured
during follow-up using our simplified ESPAC Quality-of-Life Questionnaire.
Results. Median follow-up was 82 months (62106). The response rate was
84 percent. Although the QoL improved in all parameters at both groups
after surgery, we found statistically significant difference (pB/0.05) regarding
pain relief in favour of PPPD in contrast to FP. The complete pain relief was
78% in the PPPD group vs. 42% in the FP group, as occasional pain was
detected in 17% and 53%, respectively. The rate of patients with regular pain
was similar (5%).
Conclusions. Our retrospective study suggests that in advanced cases of
chronic pancreatitis PPPD gives better result in the aspect of pain after long-
term follow-up. Based of our data, inspite of extended intervention PPPD
may be the preferred solution in advanced cases.
P42.06
MICRONUTRIENT INTAKE AND EXOCRINE INSUFFICIENCY IN
ALCOHOL-RELATED PANCREATITIS: IS THERE EVIDENCE
FOR A PROTECTIVE EFFECT IN CLINICAL PRACTICE?
Turner, Richard Clive1; Carroll, Ann2; McDermott, Robyn3
1James Cook University School of Medicine, Cairns Base Hospital, Surgery,
Cairns, Australia; 2Cairns Base Hospital, Cairns, Australia; 3University of
South Australia, Faculty of Health Sciences, Adelaide, Australia
Background. Animal models suggest that antioxidants have a protective
role in the stellate cell-mediated fibrosis of chronic pancreatitis. Clinical
studies have also shown chronic pancreatitics to have lower levels or intake
of various antioxidants compared to controls. Faecal elastase-1 concen-
tration [FE-1] has good positive predictive value for pancreatic
exocrine insufficiency, including in mild acute presentations. The accepted
threshold for insufficiency is 200 mg/g. Red cell folate concentration [RCF] is
a suitable proxy measure for long-term overall micronutrient intake. It is not
affected by acute oxidative stress, but absorption may be reduced in
alcoholics.
Aim. This study aimed to examine the dietary micronutrient intake of those
diagnosed with pancreatic exocrine insufficiency in an acute setting.
Methods. Incident cases of mild acute pancreatitis were recruited prospec-
tively from a single surgical unit. [FE-1] was measured on the first available
stool specimen. Blood was collected for measurement of [RCF]. Non-
parametric data were evaluated by the Mann-Whitney test.
Results. Of 46 cases, 28 were alcohol-related based on standard criteria.
Median [RCF] was calculated for those with [FE-1] ]/200 mg/g and B/200
mg/g. Subgroup analysis was performed on alcohol-related cases to exclude a
confounding effect on the whole sample. See Table.
Discussion. [RCF] is significantly lower in patients with pancreatic exocrine
insufficiency. This difference is more pronounced in alcohol-related cases,
adding to evidence that dietary micronutrients may have a protective effect on
toxin-induced pancreatic fibrosis. Potential confounders, such as level of
alcohol intake and malabsorption, merit further discussion.
[FE-1]]/
200 mg/g
[FE-1]B/
200 mg/g Significance
median[RCF]: whole sample
(nmol/L) (n/46)
994.5 884.5 pB/0.01
median[RCF]: alcohol-related
(nmol/L) (n/28)
1044.5 740 pB/0.01
P42.07
NEW METHODS OF PANCREATODUODENAL RESECTION IN
CHRONIC PANCREATITIS
Baimakhanov, Bolatbek; Aliyev, Mukhtar; Ramazanov, Manas; Akhmetov,
Yermek; Betirova, Dagmara
National Scientific Center of Surgery, Abdominal Surgery, Almaty, Kazakh-
stan
Aim. The aim of this study was to improve the results of surgical treatment in
pseudotumour in the head of pancreas.
Patients and methods. The objects of investigation were 8 patients with
chronic primary pancreatitis, in which radical surgery was performed-
modified pancreatoduodenal resection. The main differences of our method
is that, after the pancreatoduodenal complex removal, we perform re-
constructive surgical stage with formation of pancreatojujenal and biliodi-
gestive anastomosis, using a single uninterrupted intestinal loop, ‘‘cutout’’ by
side inter-intestinal passage (as modified by Brown).
Results. In these, additionally, we perform a ‘‘closing’’ from the afferent
section of the isolated intestine prior to the gastroenteroanastomosis is done.
In 4 cases when the main pancreatic duct was not dilated (up to 5 mm)
pancreatoenteroanastomosis was done in termino-lateral ways, as ‘‘end to
end’’, but in the cases when the duct of Wirsung was dilated (more than
5 mm), this anastomosis was done in vertical position, as ‘‘side to side’’, in
this the duct of Wirsung was maximally opened along its extension (4 cases).
Conclusions. We consider, this form of operation is more physiologic, less
labour- and time-consuming during the mobilization and re-constructive
stages, easier to perform because of the all anastomosis is done on one
segment. The short-term postsurgical period within 30 days showed that,
there was no cases of anastomosis inconsistency. The patients were
discharged home in satisfactory conditions.
P42.08
PANCREATICOPLEURAL FISTULA AS A COMPLICATION OF
CHRONIC PANCREATITIS. REPORT OF 6 CASES
Straka, Martin1; Sabol, Martin2; Mrae`na, Peter2; Kra´lik, Robert2; Straka,
Vladimı´r2
1Hepetopancreatobiliary Dept. Martin Faculty Hospital, Martin, Slovak
Republic; 2St. Elisabeth Oncological Institute, Dept. of Oncological Surgery,
Bratislava, Slovak Republic
Background. Pancreaticopleural fistulas are rare, typical internal pancreatic
fistulas arising most of all during an acute exacerbation of underlying chronic
alcohol-associated pancreatitis. In posterior disruption of pancreatic ducts
leaking pancreatic juice may track through the esophageal and aortic hiatus to
the mediastinum.
Methods. Between 19972005 we treated 6 male patients with chronic
alcohol-associated pancreatitis in whom pancreaticopleural fistula arised
always with right-sided pleural cavity. Median age was 45 (range 36 57)
years. Abdominal symptomatology was insignificant. Dyspnea and chest pain
were dominant. Paracentesis revealed sanguinolent or brownish fluid that
refilled rapidly.
Results. In all patients we confirmed pancreaticopleural fistula with disruption
of panreatic duct by means of ERCPand/or CTand perioperative fistulography.
Visualisation of anatomy and location of ductus pancreaticus obstruction is
important. In one patient with proximal ductus pancreaticus obstruction
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successful duodenopancreatic drainage was performed by endoscopic stent
placement. Five patients were operated on after initial conservative treatment
failure. In 2 patients we created latero-lateral fistulopancreaticojejunostomy
Roux-en-Y. In one patient we made segmental(central) resection of the
proximal part of pancreas body and termino-terminal pancreaticojejunostomy
Roux-en-Y. Two patients with communicating pancreatic pseudocyst were
solved by pseudocysto-gastrostomy. Postoperative course in all patients was
complications free. Postoperative mortality was 0.0%. During the follow-up
after 5, 6, 7 and 9 years there was no exacerbation of pancreatitis.
Conclusion. Initial way of treatment is short-term conservative practice. In
the case of its failure invasive approach on the basis of imaged ductus
pancreaticus anatomy should proceed. Fistula is caused by obstructed ductus
pancreaticus followed by its disruption.
P42.09
PITFALL OF ENDOSCOPIC ULTRASONOGRAPHY-GUIDED
DRAINAGE FOR PANCREATIC PSEUDOCYSTS
Fujisawa, Toshio; Kubota, Kensuke; Yoneda, Masato; Takahashi, Hirokazu;
Inamori, Masahiko; Abe, Yasunobu; Kirikoshi, Hiroyuki; Saitou, Satoru;
Nakajima, Atsushi
Yokohama City University School of Medicine, Gastroenterology, Yokohama,
Japan
Background. Endoscopic Ultrasonography-guided (EUS-guided) cystdrai-
nage has been recognized as a nonsurgical treatment for pancreatic pseudo-
cysts.
Aim. We reviewed failure cases to treat pancreatic pseudocysts by using this
method.
Methods. Five cases of pancreatic pseudocysts (four alcohol-induced chronic
pancreatitis, one postoperative chronic pancreatitis) were treated in our
hospital between April 2004 and December 2005. The mean size of the
pseudocysts was 80 mm. After the absence of blood flow was observed at the
puncture site, 19G needle was passed into the cyst under EUS guidance.
Following dilation of the fistula with dilation catherter, 6Fr nasocystic tube
was inserted. Cystoenterostomy was performed a week after confirmation of
decreasing pseudocyst by CT.
Results. We performed EUS-guided cystoenterostomy in four of 5 patients. A
drainage tube was inserted through the duodenal bulb (n/1) and the body of
the stomach (n/3). Three of four patients were treated successfully without
complication. One of four cases was performed with open cystectomy because
the cystoenterostomy was not effective for the pseudocyst due to the
hematoma. The other one was not done for this method because of the
aneurysm in the pseudocyst. In this case, the pseudocyst was resected by distal
pancratectomy after coiling the aneurysm as an aneurysm in the pseudocyst
happened to be seen before the procedure on EUS. The successful cases by
EUS-guided cystdrainage have been doing well with no recurrence of
pancreatic pseudocyst for 522 months since discharge. Two failure cases
had a long history after pseudocyst formation over three months. It was useful
to detect an aneurysm but hematoma in psedocyst on EUS and CT.
Conclusion. Although EUS-guided drainage is safe and effective procedure
for the treatment of pancreatic pseudocyst, this method should be avoided in
these patients having a long history after pseudocyst formation, who are likely
to be complicated with aneurysm and/or hematoma in the pancreatic
pseudocyst.
P42.10
PANCREATICOJEJUNODUODENOSTOMY WITH AN ISOLATED
BOWEL SEGMENT IN SURGICAL TREATMENT OF CHRONIC
PANCREATITIS (CP)
Kopchak, Volodymir; Todurov, Ivan; Khomyak, Igor; Kopchak, Kostyantyn;
Khanenko, Vasyliy
Institute of Surgery and Transplantology, Pancreatic Surgery, Kiev, Ukraine
Background. Indications for different methods of surgical treatment of CP
are still controversial.
Methods. We investigated the results of surgical treatment of 26 male
patients with CP. The control group comprised 12 patients that underwent
standard Frey procedure. In these patients pancreatic juice was drained to the
bowel by Roux-en-Y pancreaticojejunostomy. In the main group (14
patients) pancreaticojejunoduodenostomy was performed. In these patients
we performed pancreaticojejunostomy with the isolated bowel segment.
Jejunoduodenoanastomosis was performed with the distal part of the isolated
segment. We compared clinical results in both groups, as well as the activity
of pancreatic enzymes in the duodenal contains before and after stimulation
and the results of 131J-3-oleate glycerine test.
Results. The results of clinical investigation were similar in both groups. In
the early postoperative period significant changes were not observed in
pancreatic excretion and enzymes presence in the control group. In patients
of main group pancreatic excretion was significantly increased. The presence
of enzymes was as low as in the control group. No significant changes in time
of half-absorbtion of 131J-3-oleate glycerine were observed. In terms of 812
months in the control group the insignificant decrease of time of half-absorb-
tion of 131J-3-oleate glycerine (7,8/0,21 hours) was observed. Pancreatic
excretion and enzyme presence were stable. In patients of main group we
observed that pancreatic excretion remained and there was a significant
increase of presence of trypsin, amylase and lipase in the pancreatic juice in
compare with the preoperative tests. Time of half-absorbtion of 131J-3-oleate
glycerine decreased to normal (from 9,4/0,33 to 5,2/0,22 hours).
Conclusion. Pancreaticojejunoduodenostomy is preferable than the stan-
dard pancreaticojejunostomy in surgical treatment of CP.
P42.11
QUANTITATIVE ANALYSIS OF COLLAGEN SUBTYPES I, III,
AND V IN CHRONIC PANCREATITIS
Paklina, Oxana; Bogautdinova, Galiya; Tsvircun, Victor
Hospital 119 of FMBA, Moscow, Russia
Background. The study deals in the pancreatic fibrosis which is the key
pathological feature of chronic pancreatitis. The aim of this research was to
demonstrate and evaluate some differences in the composition of extra-
cellular matrix in chronic pancreatitis.
Methods. Histologic findings and extracellular matrix proteins (collagen
types I, III and V, desmin and vimentin) were evaluated in 12 patients with
surgically treated chronic pancreatitis in 2005. Quantitative analysis was
performed using image analyzer WCIF ImageJ after taking photographs. The
significance of differences in expressions was tested using t- and r-test (P
values of less than 0.05). Fibrosis was only classified into 2 categories:
moderate changes (8 cases) and marked changes (4 cases). We estimated
moderate changes when the area of fibrosis was less than 5% of light field.
Results. Moderate and marked change cases showed interlobular and
intralobular fibrosis with a more marked anti-vimentin immunoreactivity
than anti-desmin immunoreactivity and lobular atrophy. Collagen III was
steadily positive along inter- and intralobular fibrosis septum and its expression
was the similar to the picture of expression of collagen V, but the latter was
more intensive especially in the marked changes. The expression of collagen I
was only identified in the centre of the inralobular fibrosis septum and looked
like a thin line. We found that the expression of collagen III was directly
correlated with collagen V (r/0,92); but indirect correlation was found
between the expression of collagen I and III (r//0,83), between the
expression of collagen I and V (r//0,7). No significant correlation was
found between the expression vimentin, desmin and the collagens.
Conclusion. Collagen synthesis imbalance in favor of collagen III at early
stages of the disease brings about intensification of collagen I and Vexpression
by fibroblasts. It also leads to the substitution of other types of collagen for
collagen III and formation of rough pancreatic fibrosis.
P42.12
FIRST EXPERIENCE OF LASER TUNNELING OF PANCREAS
FOR TREATMENT OF CHRONIC PANCREATITIS
Sovtsov, Sergey A1; Kozel, Arnold I2; Revel-Muroz, Jan A2
1Ural State Academy of Additional Education, Chelyabinsk, Russia; 2Chelya-
binsk State Institute of Laser Surgery, Chelyabinsk, Russia
Background. Chronic pancreatitis is an inflammatory disease of pancreas
with progressive degenerative and destructive changes of parenchyma, with
development of fibrosis, exocrine and endocrine dysfunction.
Purpose. Stimulation of pancreas regeneration process with laser tunneling.
Methods. Videolaparoscopic laser tunneling was performed in two patients
(43 and 27 years old) on account of chronic pancreatitis.
Results. The experiments had shown the dynamic processes of expressed
hyperplasia and hypertrophy of acinous cells, increase of blood vessels and
excretory ducts number; reduction of fibrous tissue volume fraction after laser
tunneling of fibrous pancreas. Clinical observations revealed gradual decrease
of pain intensity and malabsorption syndrome; ultrasonic Doppler showed the
blood flow improvement in the zone of laser exposure. Laser tunneling of
pancreas is accompanied by insignificant trauma of tissues, a reliable
hemostasis and absence of pancreatic juice discharge in the zone of operation
due to blood coagulation in vessels and obturation of excretory ducts with
eschar that prevents the development of acute pancreatitis and peritonitis and
does not demand additional management of laser wound.
Conclusion. Results of research testify for the opportunity of stimulation of
regeneration processes and reversion of sclerotic changes in pancreas with the
help of laser tunneling.
P42.13
SIX-YEAR FOLLOW-UP WITH ORGAN-PRESERVING RESEC-
TION OF THE PANCREATIC HEAD IN PATIENTS WITH
CHRONIC PANCREATITIS
Farkas, Gyula; Leindler, La´szlo´; Farkas, Jr., Gyula; Daro´czi, Ma´ria
University of Szeged, Faculty of Medicine, Dept. of Surgery, Szeged, Hungary
Introduction. In chronic pancreatitis (CP), enlargement of the pancreatic
head develops in consequence of inflammatory alterations. An organ-preser-
ving pancreatic head resection (OPPHR) technique has been developed. This
report is concerned with the results attained with this operation in a 6-year
period.
Methods. In 120 patients (m: 90, f: 30; mean age: 49.2 yr.), an organ-
preserving procedure was performed. The preoperative morbidity comprised
frequent abdominal pain, weight loss in all patients, jaundice in 10 patients,
and latent and insulin-dependent diabetes mellitus (IDDM) in 12 and 19
patients, respectively. The surgical procedure consists in a wide excision of the
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pancreatic head, without division and cutting of the pancreas over the portal
vein. Reconstruction, with drainage of the secretion from the remaining
pancreas into the intestinal tract, takes place through a jejunal Roux-en-Y loop.
In 10 icteric cases and in 14 patients with stenosis of the common bile duct,
prepapillary bile duct anastomosis was also performed with the jejunal loop.
Results. Only one reoperation was required in consequence of anastomosis
bleeding, but no mortality was noted in the postoperative period. The duration
of hospitalisation ranged between 7 and 12 days. The mean follow-up period
was 3.5 years (range 0.5 to 6.0). The late mortality rate was 3.3% (4 patients
died after a cardiovascular attack). 104 patients became complaint-free, 12
patients had moderate symptoms and the weight increased by a median of 11.6
kg (range 428). One or two years after the operation, bilio-digestive
anastomosis was performed in 5 patients in consequence of bile duct stenosis.
No change was noted in the preoperative endocrine function of 108 patients,
but 8 patients with latent diabetes mellitus became IDDM.
Conclusion. The 6-year experience clearly reveals that this OPPHR is a safe
and effective procedure for definitive control of the complications following the
inflammatory alterations of CP.
P42.14
CYSTIC LESIONS OF THE PANCREAS ASSOCIATED WITH
CHRONIC PANCREATITIS: AN ONGOING CHALLENGE
Gomez, Dhanwat1; Rahman, Sakhawat H1; Wong, LF1; Verbeke, Caroline2;
McMahon, Michael J1; Guillou, J Pierre1; Menon, KV1
1Leeds Teaching Hospitals NHS Trust, Division of Surgery, Leeds, UK;
2Leeds Teaching Hospitals NHS Trust, Dept. of Pathology, Leeds, UK
Background. Cystic lesion of the pancreas (CLP) associated with chronic
pancreatitis (CP) are increasingly being detected, yet prove to be a therapeutic
challenge. We sought to review the management of these lesions in order to
identify patients likely to benefit from surgical intervention.
Methods. Retrospective case note study of patients with CP & diagnosis of
CLP stated in radiology reports between 1998 & 2005.
Results. Of 121 patients with CLP, 31 patients with coexistent CP were
included (26%), with a median age of 53 yrs (Range: 27 82) & follow-up of 27
months (Range: 884). Presenting symptoms were abdominal pain (100%),
weight loss (32%), pancreatic insufficiency (29%) & jaundice (3%). The
distribution of CLP was head (52%), neck (6%), body (23%), tail (13%) &
multi-site (6%). Cysts were single in 87%, and multi-cystic in 13% of cases.
The median size of CLP on imaging was 3 cm (Range: 0.810). Seven (23%)
patients underwent surgical resection due to presumed malignancy on imaging
& 18 (58%) patients were managed with radiological follow-up over a median
period of 9 (148) months. Four patients (13%) were managed conservatively
due to co-morbidity (ASA/3). Five of 18 patients under radiological follow-
up (28%) underwent surgery after a median period of 3 months (range: 26),
due to clinical deterioration coupled with a persistent CLP (n/3), & an
increase in cyst size alone (n/2: histology was benign). Overall morbidity was
67% (pancreatic insufficiency) with 1 early death. Final diagnosis was benign
disease in 91% & malignancy in 9% of cases [IPMT (6%), adenocarcinoma
(3%)]. There was no significant association between final pathology, cyst size,
age and gender.
Conclusion. Surgical intervention is recommended in CLP in patients with a
background of CP due to the high risk of malignancy & for symptomatic
benefit. Identification of an at-risk population due to the associated morbidity
is extremely difficult based on diagnostic imaging or demographics alone.
P43.01
3D PANCREATIC ARTERIOGRAPHY WITH MDCT DURING IN-
TRAARTERIAL INFUSION OF CONTRAST MATERIAL IN THE
DETECTION OF INSLINOMAS: PRELIMINARY RESULTS
Takada, Koichi1; Takeshita, Koji1; Furui, Shigeru1; Nagashima, Ikuo2;
Amano, Hodaka2; Takada, Tadahiro2
1Dept. of Radiology, Teikyo University School of Medicine, Tokyo, Japan;
2Dept. of Surgery, Teikyo University School of Medicine, Tokyo, Japan
Purpose. To evaluate the efficacy in the detection and localization of
insulinomas using MDCT with intraarterial contrast infusion (MDCT-IA).
Materials and methods. 5 cases with 7 histological proven insulinomas
underwent MDCT-IA. For MDCT-IA, 2 catheters were placed in the superior
mesenteric artery and celiac artery, respectively. Then 60 mL of nonionic
contrast material (iodine, 150 mg/mL) was injected at a rate of 6 ml/sec with a
power injector. Scanning delay time was 3 seconds after the initiation of
intraarterial contrast administration. MDCT-IA images were reconstructed
with volume-rendering (VR) technique. DSA and three-phase enhanced study
with IV contrast material administration by MDCT (MDCT-IV) were also
performed. Detection and localization of the lesions were evaluated, and these
findings were compared to those of DSA and MDCT-IV. Maximum attenua-
tion differences (MAD) between the lesion to pancreatic parenchyma on the
axial images obtained by MDCT-IA technique and MDCT-IV were compared.
Result. In 5 cases, all of 7 insulinomas were depicted on MDCT-IA and 3D
images obtained by MDCT-IA. They were also seen on MDCT-IV. The
appearance of the tumors was more conspicuous on MDCT-IA with the higher
MADs between the lesions to pancreatic parenchyma. In 1 case with 3
inslinomas, 3 lesions in the pancreatic tail were located close to each other, and
were superimposed against the spleen, and therefore the shape and number of
the lesions were not well-defined by DSA. MDCT-IA technique clearly
showed the 3D structure of the tumors, peripancreatic vasculature and feeding
arteries.
Discussion. Results of our study suggest a potential application of MDCT-IA
for the detection of inslinomas, which are radiographically occult or equivocal
on DSA or MDCT-IV. MDCT-IA may also be useful for evaluating multi-
plicity of islet cell tumors in cases where one or more lesions have been found
on other diagnostic studies.
P43.02
PANCREATIC METASTASIS OF RENAL CELL CARCINOMA: A
SINGLE-INSTITUTIONS SERIES WITH SURGICAL MANAGE-
MENT
Simpfendorfer, Conrad H.1; Walsh, R. Matthew1; Vogt, David1; Henderson, J.
Michael1; Brody, Fred2
1Cleveland Clinic, Cleveland, USA; 2George Washington University, Wa-
shington, USA
Background. Renal cell carcinoma (RCC) to the pancreas is uncommon,
accounting for approximately 2% of resected pancreatic specimens in sizable
series. Metastasis to the pancreas, when it occurs is usually years after the
primary resection.
Aim. The aim of the study was to review the presentation, treatment, and
survival of a series of patients who underwent pancreatic resection for
metastatic RCC at a single institution.
Methods. An IRB approved retrospective chart review of 13 patients who
had undergone pancreatic resection for metastatic RCC at a single institu-
tion between January 1987 and October 2005. The records were analyzed
for patient demographics, primary nephrectomy, time to pancreatic metas-
tasis, type of resection, morbidity, time to recurrence, and survival. These
patients were compared to a group of 17 patients with RCC metastasis to the
pancreas who did not undergo pancreatectomy, and were receiving medical
therapy.
Results. Thirteen patients (10 men) with a median age of 65 (34 to 81)
underwent pancreatic resection. The median interval between nephrectomy to
pancreatic metastasis was 110 months (0 to 279 months). The majority of
resections were distal pancreatectomy///splenectomy (n/8), while the
remainder were pancreaticoduodenectomy (n/5). Median length of stay was
11 days (642). There were 6 (46%) post-operative complications and no
deaths. The median follow-up was 59.5 months (2 to 120). Median survival for
patients with more than one year follow-up was 62 months (14120). Three
patients died (23%) at 21, 75 and 120 months. In the group receiving medical
therapy only, the median time between nephrectomy and pancreatic metastasis
was 52 months (0 to 276). All these patients had additional organ metastasis.
Median survival was 25 months. 6 patients died (35%) at 1,10,16,23,34, and
36 months.
Conclusion. Surgical resection of metastatic RCC to the pancreas prolongs
survival for select patients with isolated pancreatic metastasis and longer
disease-free interval from the primary nephrectomy.
P43.03
A COMPARISON OF ENDOSCOPIC, IMAGE-GUIDED AND OPEN
PANCREATIC BIOPSY
Smith, Giles1; Chin Aleong, Joanne2; Mears, Lisa2; Hutchins, Robert1
1St Bartholomew’s and the Royal London Hospital, Surgery, London, UK; 2St
Bartholomew’s and the Royal London Hospital, Histopathology, London, UK
Background. Endoscopic ultrasound has not only increased the diagnostic
pathway of pancreatic malignancy but affords a new approach to pancreatic
tissue diagnosis.
Aims/Objectives. We compared the diagnostic accuracy of endoscopic
ultrasound-guided fine needle aspiration cytology (FNAC) with open and
cross-sectional image-guided pancreatic biopsy.
Methods. Biopsies were only carried out in patients who had been assessed as
inoperable on image or clinical grounds. Open biopsies were obtained
(assuming no previous tissue diagnosis) during exploratory laparotomy with
a view to resection, once a decision to abandon resection had been made. In
cases of diagnostic dilemma (but potential curative resection) endoscopic
biopsy was the method of choice. 110 biopsies were obtained; 37 open, 37
endoscopic and 36 image-guided. Results given are for first attempt biopsy.
Results. Overall pancreatic biopsy had a sensitivity of 67.5%, specificity of
100%, positive predictive value of 100% and negative predictive value of
57.6% for a diagnosis of carcinoma. Diagnostic accuracy overall was 78%.
Comparative data for a diagnosis of carcinoma and overall diagnostic accuracy
for each modality are tabulated below;
Endoscopic Open Image-guided
sensitivity (%) 50 90 58
specificity (%) 100 100 100
positive predictive value (%) 100 100 100
negative predictive value (%) 52 73 52
accuracy (%) 68 92 75
Conclusion. Endoscopic FNAC is comparable to image-guided biopsy.
Increased accuracy may be afforded by endoscopic ultrasound-guided trucut
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biopsy. Cystic lesions of the pancreas remain the most difficult diagnostic
dilemma for cytology or biopsy alone. These results should be borne in mind
when offering patients a tissue diagnosis and when designing studies
requiring pancreatic primary biopsy as a validation for entry.
P43.04
BOTH LOCATION AND RATIO OF METASTATIC/RESECTED
LYMPH NODES ARE IMPORTANT PROGNOSTIC FACTORS IN
PANCREATIC HEAD CANCER
Sierzega, Marek; Popiela, Tadeusz; Kulig, Jan
Jagiellonian University Medical College, 1st Dept. of Surgery, Krakow,
Poland
Background. The number of involved nodes or the metastatic/resected
lymph node ratio (LNR) is a potential prognostic factor in human
malignancies.
Aim. To evaluate the prognostic value of nodal involvement in individual
lymph node (LN) stations and LNR in resected adenocarcinoma of the
pancreatic head (PC).
Methods. Between 1980 and 2002, 96 patients underwent pancreatic head
resection for PC. Lymph nodes were numbered according to the Japan
Pancreatic Society rules. The best cut-off value for LNR (0, 020%, /20%)
was estimated with reverse Helmert contrasts.
Results. The median number of resected nodes was 17.0 (95% confidence
interval (CI) 15.021.0, range 592) and was significantly higher in patients
with lymph node involvement (median 21, 95% CI 16.024.6 vs median 13,
95% CI 9.421.0; P/0.011). The median number of metastatic nodes was
2 (95% CI 1.03.0, range 036) and the median LNR was 9.7% (95% CI
7.114.4%). The overall median survival was 14.2 months (95% CI 10.7 to
17.7) and was significantly higher for node-negative than node-positive
patients (median 34.0, 95% CI 15.552.4 vs median 10.6, 95% CI 8.7
12.5; PB/0.001). The median survival was significantly shorter if a metastatic
node was found in any of the evaluated LN stations. However, limiting the
analysis to node-positive patients, only group 8 and 12 were associated with a
significantly poorer outcome. Categorization of patients using the three
subgroups of LNR (0, 020%, /20%) significantly correlated with their
survival. The Cox proportional hazards model including all patients demon-
strated that LN involvement (HR 1.461, 95% CI 1.177 12.024), moderate
or poor tumor differentiation (HR 2.330, 95% CI 1.1816.949), and a
positive resection margin (HR 3.838, 95% CI 1.390 10.597) were asso-
ciated with poorer survival. If the analysis was limited to node-positive
patients, LNR /20% (HR 1.364, 95% CI 1.116 2.599) was an indepen-
dent negative prognostic factor.
Conclusion. LNR seems to be a new promising prognostic factor in patients
with resectable PC.
P43.06
CLINICAL ANALYSIS OF SOLID-PSEUDOPAPILLARY TUMORS
Matsuura, Hiroshi1; Hatori, Takashi1; Fukuda, Akira1; Onizawa, Shunsuke1;
Oohara, Toshiya1; Furukawa, Kenji1; Imaizumi, Toshihide2; Takasaki, Ken1
1Tokyo Women’s Medical University, Gastroenterological Surgery, Tokyo,
Japan; 2Tokai University, Surgery, Isehara, Japan
Background. Solid-pseudopapillary tumor (SPT) is regarded as a low grade
malignancy with potential of the metastasis or recurrence. SPT typically
consists of solid and cystic components on the imaging examinations.
However, some SPT have no cystic component and it is necessary to
distinguish SPT from other pancreatic tumors.
Objective. The aim of this study is to evaluate the clinicopathological
features of SPT, retrospectively.
Methods. A total of twenty-three patients who underwent pancreatectomy
for SPT between 1980 and 2005 at Tokyo Women’s Medical University
Hospital were chosen in this study. The average age was 39 years-old (1570
yr) and all patients were women.
Results. Thirteen patients (57%) had symptoms such as abdominal pain,
back pain, etc. The average size of the tumor was 4.5 cm (1.911.0 cm). The
tumors were located in the pancreatic head in 12 patients, in the body in 4
patients and in the tail in 9 patients including the multiple cases. CT revealed
a hypervascular tumor in 15 patients (65%), a capsule in 20 patients (87%), a
cystic component in 12 patients (52%), a calcification in 11 patients (48%).
Abnormal findings of the pancreatic duct were seen in 12 patients (52%) on
ERP. Correct diagnosis could be made in 15 patients (65%), preoperatively.
However, misdiagnosis such as MCN or endocrine tumor was made in other
patients. Obvious malignant findings were seen in two patients (tumor
invasion to the duodenum, liver metastasis). Observation period was 125
years and there was no death caused by tumor recurrence.
Conclusion. A half of SPTs did not show typical findings on imaging
diagnosis. It is suggested that the differential diagnosis between SPT and
other pancreatic tumors should be done very carefully before surgery.
P43.07
COMPARISON OF RESECTED AND NON-RESECTED INTRA-
DUCTAL PAPILLARY MUCINOUS NEOPLASMS OF PANCREAS
Shyr, Yi-Ming
Taipei Veterans General Hospital, Surgery, Taipei, Taiwan
Background. Intraductal Papillary Mucinous Neoplasm (IPMN) of the
Pancreas has been regarded as a relatively less aggressive tumor, and often
presents good prognosis after resection. However, the natural history of the
IPMN has not been well investigated. The purpose of this study is to clarify
the natural history of the IPMN by comparing resected and non-resected
IPMNs.
Methods. Seventeen resected and 8 non-resected IPMNs were included in
this study. Resection procedures included 13 pancreaticoduodenectomy, and
2 central, 1 distal and 1 total pancreatectomy. Clinical pictures, tumor
characteristics, and survivals were evaluated and compared.
Results. The most common clinical presentation was abdominal pain,
followed by weight loss and jaundice. There was no statistical difference in
survival between the resected and non-resected groups, p/0.320. The 5-
year survival rate was 70.6% for resected group, and 60% for non-resected
group. The median survival was 84 months (with a range of 4117 months)
for resected group, and 70 months (with a range of 270 months) for non-
resected group. IPMNs of main pancreatic duct type had better progosis than
other types (vs. branch duct and mixed types, p/0.002). Otherwise, no other
significant prognostic factor could be identified to predict survival.
Conclusions. Long-term survival could be occasionally expected in patients
with non-resected IPMNs. Therefore, resection of IPMN is not the only
recommended treatment of choice for patients of high surgical risk or old age.
P43.08
CONTRIBUTION OF POSITRON EMISSION TOMOGRAPHY
FOR DECIDING THE TREATMENT FOR PANCREATIC CANCER
Funasako, Yawara1; Maemura, Kosei1; Shinchi, Hiroyuki1; Noma, Hide-
toshi1; Kubo, Fumitake1; Sakoda, Masahiko1; Ueno, Shinichi1; Jinnouchi,
Seishi2; Takao, Sonshin3; Aikou, Takashi1
1Kagoshima University Graduate School of Medical and Dental Sciences,
Surgical Oncology and Digestive Surgery, Kagohima, Japan; 2Atsuchi
Memorial Clinic PET Center, Kagoshima, Japan; 3Kagoshima University,
Frontier Science Research Center, Kagoshima, Japan
Purpose. FThe purpose of this study was to estimate the usefulness of
positron emission tomography (PET) in deciding the strategy for treatment
of pancreatic cancer. The following two parameters were evaluated: The
ability of PET to provide an estimation of the progression of pancreatic
cancer, and the ability of PET to predict survival and effect of chemor-
adiotherapy.
Methods. Forty two patients underwent PET as part of the procedure for
making a diagnosis of pancreatic tumors. SUVmax were compared with
clinicopathological factors and analyzed.
Results. PET provided a sensitivity of 87%, a specificity of 67% and an
overall accuracy of 85% for diagnosis of pancreatic malignancy. Tumors with
distant metastases showed significantly higher levels of SUV than tumors
without metastasis. In the patients treated with chemoradiotherapy the
overall survival of the group in which SUVmax was less than 7.0 was better
than that of the group in which SUVmax was more than 7.0.
Conclusions. We conclude that PET is a useful tool for determining the
pathological state and distant metastasis in pancreatic cancer, and for
predicting the prognosis of patients treated with chemoradiotherapy.
P43.09
CXCL16-A NEW PLAYER IN REGULATION AND PROGRESSION
OF PANCREATIC CANCER?
Wente, Moritz N1; Gaida, Matthias M1; Bergmann, Frank2; Mayer,
Christine1; Giese, Nathalia A1; Buchler, Markus W1; Friess, Helmut1
1University of Heidelberg, Dept. of Surgery, Heidelberg, Germany; 2Uni-
versity of Heidelberg, Institute of Pathology, Heidelberg, Germany
Background. CXC chemokines and their receptors influence angiogenesis,
growth, and metastatic potential of pancreatic cancer (PaCa).
Aim. To evaluate the expression and functional role of CXCL16, a recently
identified membrane-bound and soluble CXC chemokine, in human PaCa.
Methods. Human PaCa cell lines (BxPC-3, Capan-1, Colo-357, T3M4)
were used for in vitro studies. Expression of CXCL16 was determined by
quantitative RT-PCR (qRT-PCR) and ELISA in non-stimulated, TNFa- and
IFNg-treated cells. Effects of CXCL16 on tumor cell viability and growth
were tested using MTT and crystal violet (CV) assays. In clinical specimens,
CXCL16 expression was assessed by qRT-PCR and immunohistochemistry
in pancreatic tissues and by ELISA in serum of PaCa patients and healthy
donors.
Results. CXCL16 was expressed on mRNA and protein level in all cell lines.
TNFa, IFNg, or the combination, increased the expression of soluble
CXCL16 by 1.21.7, 1.12.0, and 1.33.1, respectively. According to
MTT assay, CXCL16 doses below 25 ng/ml did not affect, whereas higher
doses decreased cell expansion. In contrast, CV revealed a dose-dependent
promotion of cell viability by CXCL16. Tissue qRT-PCR showed a 6.4 fold
increase of CXCL16 expression in PaCa compared to normal specimens.
Localized faint CXCL16 immunostaining was observed in malignant cells of
PaCa specimens, whereas tubular complexes were strongly stained in most
probes. In non-neoplastic structures of cancer and normal sections, CXCL16
expression was frequently observed in ducts, inflammatory and exocrine cells.
Serum analysis showed a 1.7 fold increase of circulating CXCL16 in PaCa
patients.
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Conclusion. CXCL16 is overexpressed in pancreatic cancer and may
influence activity of tumor cells either in autocrine fashion through regulation
of mitochondrial activity and/or proliferation or in paracrine fashion by
interfering with immune-cancer cell interaction. The impact of increased
CXCL16 serum levels on inflammatory status and metastatic pattern in PaCa
remains to be determined.
P43.10
DIAGNOSTIC PREDICTORS OF PANCREATIC CYSTIC MUCI-
NOUS TUMOURS
Ovejero-Go´mez, Vı´ctor J1; Nieto-Garcı´a, Luis2; Matute-Cuartero, Marı´a A3;
Bueno-Lo´pez, Jesu´s3; Gallego-Bellido, Toribio1; Ingelmo-Setien, Alfredo1
1Hospital Sierrallana, Dept. of Surgery, Torrelavega, Spain; 2Hospital
Sierrallana, Dept. of Internal Medicine, Torrelavega, Spain; 3Hospital
Sierrallana, Dept. of Radiology, Torrelavega, Spain
Background. They represent less than 2% of pancreatic exocrine tumours
and arises in middle-aged females. Most of them affect distal pancreas and
main symptoms are abdominal pain and palpable mass. They are clinically
divided into mucinous cystadenoma, border-line cystic tumour, invasive
cystadenocarcinoma and intraductal papillary tumour (IPT). The aim of this
study is to present current diagnostic predictors of these tumours.
Methods. Case 1 A 61-year-old man had past medical history of mellitus
diabetes and was admitted with dyspepsia, fever, jaundice and chills. Imaging
procedures demonstrated a great septal cystic mass and wall calcification on
pancreatic head. A laparotomy and cytology showed irresecable mucinous
tumour. We performed a palliative intervention Case 2 A 80-year-old man
with past medical history of heart attack, coronary by-pass and chronic
pancreatitis presented general symptoms for last year. He underwent imaging
studies which showed an atrofic pancreas with dilated Wirsung’s duct and a
cystic formation infiltrating portal vein. Fine-needle aspiration (FNA)
demonstrated mucoid material and epithelial cells with mucinous cytoplasm.
He was diagnosed with IPT. We decided not to operate him.
Results. High-resolution CT offers information about cyst structure and
signs from secretion. Magnetic resonance imaging can determine its com-
munication with pancreatic duct. Neither of them is conclusive in distin-
guishing malignancy of cyst. Endosonography seems neither sufficiently
accurate unless lesion infiltrate other organs or mural ductal nodules can be a
target for FNA in IPT. Cytological analysis and determination of CEA and
amylase level may provide information of diagnostic and prognostic value.
Conclusions. Diagnosis begins with a detailed history and its main concern
is to know if cyst is neoplastic and risk of its becoming malignant. A
combination of several imaging procedures and diagnostic tests can offer a
better accuracy to make a therapeutic decision.
P43.11
DOES COELIAC AXIS STENOSIS IDENTIFIED ON PREOPERA-
TIVE MDCT ANGIOGRAPHY PREDICT AN INCREASED RISK OF
COMPLICATIONS AFTER PANCREATODUODENECTOMY?
Satyadas, Thomas1; Cheong, Edward1; Mui-Liu, York1; Groot_Wassink,
Thomas1; Sinclair, Martin T1; Smith, Simon2; Rae, David M1
1Ipswich Hospital, Eastern Pancreatobiliary Unit, Ipswich, UK; 2Ipswich
Hospital, Radiology, Ipswich, UK
Background. Pancreatoduodenectomy has a high morbidity rate
Aim. To identify any correlation between coeliac artery compromise found
on CT angiography and the incidence of post and peri-operative complica-
tions.
Methods. The CT angiogram of 36 patients who underwent Whipples
procedure for pancreatic adenocarcinoma were examined retrospectively.
The results were correlated with the surgical course.
Results. 12 (33%) patients had significant post-operative complications. 10
(28%) patients had evidence of coeliac artery stenosis. Stenosis ranges from
2060%. There was no correlation between the two groups.
Conclusion. There appears to be no increase in risk of post or peri-operative
complications in patients undergoing Whipples procedure with a coeliac
artery stenosis of upto 60%.
P43.12
EFFECTIVE MANAGEMENT OF PANCREATIC CANCER IS DE-
PENDENT ON THE FIRST SYMPTOMS
Benes, Marek; Spicak, Julius
IKEM, Dept. of Gastroenterology and Hepatology, Prague, Czech Republic
Introduction. The prognosis of pancreatic cancer (PC) is dismal, and it’s
effective treatment is dependent on early diagnosis.
Aims and methods. The aim was to analyze the diagnostic process reflected
in adequate treatment. We analyzed the initial symptoms and length of the
diagnostic process with consequent application of adequate therapy.
Results. A total of 110 patients with PC were enrolled. The most frequent
first symptom was dyspepsia, followed by pain and jaundice. While
hyperglycemia was documented at the beginning of the diagnostic period in
30 patients, it was present in 23 of those with dyspepsia. Resection was
performed in 26 patients, exploratory laparotomy in 16, palliative surgery in
38, and chemotherapy in 21 patients. Mean time from the onset of the first
symptoms to presentation (time I) was 389/30 days. Mean time of the
diagnostic process to specific treatment (time II) was 3.59/3.4 months. Mean
time I in patients presenting with dyspepsia was 44.89/25.1 days, in patients
presenting with jaundice or pain 30.29/28.9, and in those who underwent
resection 26.19/24.3 days. Mean time II in these groups was 3.99/4.5, 2.79/
2.1, and 2.19/1.4 months, respectively. US was the most frequently used
imaging method followed by CT, ERCP, endosonography, and MR. The
mean number of imaging methods used per patient was 4.69/1.5. FNAB was
performed in 18 patients. The most frequent algorithm of use of imaging
methods was US followed by CT and ERCP.
Conclusion. The length of the process of diagnosis is dependent on the first
symptoms, which can influence resectability. The diagnostic process was
significantly shorter in resected patients. Dyspepsia with hyperglycemia have
been shown to serve as a warning sign, and when this combination appears at
an adequate age, intensive search for pancreatic cancer should be initiated.
P43.13
ENDOSCOPIC ULTRASOUND REMAINS IMPORTANT IN THE
STAGING OF PANCREATIC CARCINOMA
Webster, Phillip1; Morris-Stiff, Gareth1; Frost, Ben2; Lewis, Wyn2; Puntis,
Malcolm1; Roberts, Ashley1
1University Hospital of Wales, Cardiff, UK; 2Royal Gwent Hospital, New-
port, UK
Background. The traditional radiological staging of pancreatic carcinoma
by pancreatography allied to cross-sectional imaging may not always be
accurate or confirm the diagnosis.
Aims. To assess the role of endoscopic ultrasound (EUS) in the preoperative
staging of suspicious or confirmed pancreatic carcinoma.
Methods. All patients undergoing staging pancreatic EUS between January
1996 and December 2004 were identified from the radiology computerised
database. Fifty-eight patients (36 male, mean age of 619/1.6 years) were
identified all of whom had undergone prior US and CT and 35 prior ERCP,
and 28 of whom underwent EUS guided biopsy. Thirty-seven patients had a
mass believed to be a carcinoma and 21 had a suspicious lesion in the
pancreatic head.
Results. Thirty-two of the 37 patients with a mass on prior imaging had a
diagnosis of carcinoma confirmed (mean diameter 3.1///0.3 cm). Fifteen
tumours were deemed irresectable on EUS criteria: portal vein (n/4) or
superior mesenteric vein invasion (n/8); unrecognised liver metastases
(n/4), ascites (n/1); lymph nodes metastases outside the resection limits
(n/1). Only 1 patients underwent an open and close laparotomy due to a
discrepancy between operative and EUS findings (small right liver lobar
metastasis). The EUS diagnosis of the remaining 5 masses were: pancreatitis
(n/2); peripancreatic lymph node (n/1); pancreatic cystic tumour (n/1)
and IPMT (n/1). Eleven of the 21 patients with suspicious pancreatic
lesions were confirmed as carcinomas (3 irresectable), 3 patients had chronic
pancreatitis, 1 patient IPMT, 1 patient gallbladder carcinoma, and in 5
patients no mass was evident on EUS.
Conclusions. EUS was effective in assessing resectability of pancreatic
adenocarcinomas in cases in which there was CT suspicion of mesenteric or
portal vessel invasion and also facilitated targeted biopsies in order to confirm
a diagnosis of carcinoma.
P43.14
EXPRESSION ANALYSIS OF HEPATOCYTE GROWTH FACTOR
(HGF) AND ITS RECEPTOR (MET) IN INSULINOMAS
Rosa, Paula1; Sa, Sandra V1; Correa-Giannella, Maria L2; Pereira, Maria A3;
Patzina, Rosely A4; Siqueira, Sheila A4; Machado, Marcel C5; Giannella-
Neto, Daniel2
1University of Sao Paulo Medical School, Laboratory of Cellular and
Molecular Endocrinology, Sao Paulo-SP, Brazil; 2Laboratory of Cellular
and Molecular Endocrinology, Division of Endocrinology, University of Sao
Paulo Medical School, Sao Paulo, Brazil; 3University of Sao Paulo Medical
School, Division of Endocrinology, Sao Paulo-SP, Brazil; 4University of Sao
Paulo Medical School, Dept. of Pathology, Sao Paulo-SP, Brazil; 5University
of Sao Paulo Medical School, Dept. of Surgery, Sao Paulo-SP, Brazil
Background. To investigate novel pathways involved in carcinogenesis
process of insulinomas, we previously surveyed expression patterns among
20,469 genes in malignant (n/6) and non-malignant tumors (n/5) using an
oligonucleotide microarray. Hepatocyte growth factor (HGF) receptor
(MET) was among the genes that were up-regulated in malignant insulino-
mas. HGF, acting through MET receptor, plays an important role in most
human cancers, and inappropriate expression of this ligand-receptor pair is
often associated with poor prognosis and metastases secondary to its
mitogenic, angiogenic and invasive properties.
Aim. To assess MET and HGF mRNA expression in insulinomas with
benign and malignant behavior.
Method. Thirty-seven tumor samples were classified accordingly to WHO
Classification of Endocrine Tumors as well-differentiated endocrine tumors
of benign behavior (WDET-BB, n/17), well-differentiated endocrine
tumors of uncertain behavior (WDET-UB, n/13), well-differentiated
endocrine carcinoma (WDEC, n/2) and metastasis of endocrine carcinoma
(MEC, n/5). Samples were tested with primers for MET, HGF and
GAPDH by RT-qPCR.
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Results. Mean MET expression in malignant insulinomas group (WDEC/
MEC) was significantly higher compared to non-malignant tumors group
(WDET-BB/UB), confirming the data obtained in microarray analysis.
Although HGF mRNA was not up-regulated in array, its expression was
higher in malignant in comparison to non-malignant insulinomas (pB/0.05).
No correlation was found among MET and HGF expression and histopatho-
logical findings related to cell proliferation and tumour aggressiveness (tumor
size, mitotic index, nuclear atypia and immunoreactivity for Ki-67 antigen).
There were no statistically significant differences in MET and HGF mRNA
expression between WDET-BB and WDET-UB.
Conclusion. This approach suggest that METand HGF genes participate in
late events of insulinoma carcinogenesis, probably in metastatization, but
further studies are necessary to define their role in such tumors.
P43.15
EXPRESSION PROFILE OF GENES BELONGING TO TRYPSIN/
CHYMOTRYSIN AND SERINE-TYPE ENDOPEPTIDASE INHIBI-
TOR ACTIVITY PATHWAYS IN INSULINOMAS
Sa, Sandra Valeria1; Correa-Giannella, Maria L1; Machado, Marcio C2;
Krogh, Karin3; Almeida, Madson Q2; Pereira, Maria A2; Patzina, Rosely A4;
Siqueira, Sheila A4; Ibuki, Felicia S1; Toledo, Rodrigo de A5; Sogayar, Mari
C3; Machado, Marcel C6; Giannella-Neto, Daniel1
1University of Sao Paulo Medical School, Lab. Cellular and Molecular
Endocrinology-LIM/25, Sao Paulo-SP, Brazil; 2University of Sao Paulo
Medical School, Division of Endocrinology, Sao Paulo-SP, Brazil; 3Univer-
isty of Sao Paulo Chemistry Institute, Dept. of Biochemistry, Sao Paulo-SP,
Brazil; 4University of Sao Paulo Medical School, Dept. of Pathology, Sao
Paulo-SP, Brazil; 5University of Sao Paulo Medical School, Endocrine
Genetic Unit-LIM/25, Sao Paulo-SP, Brazil; 6University of Sao Paulo
Medical School, Dept. of Surgery, Sao Paulo-SP, Brazil
Background. Biological behavior prediction of insulinomas, based on
histological examination, is often difficult.
Aim. To identify gene expression patterns that can distinguish non-
malignant from malignant insulinomas.
Methods. Gene expression profiles by microarray analysis were performed in
6 insulinomas classified as well-differentiated endocrine tumor (WDET) of
benign behavior (BB) compared to one well-differentiated endocrine
carcinoma (WDEC) and 3 metastases of endocrine carcinoma (MEC). RT-
qPCR was employed to validate the differential expression of 5 genes in 37
tissue samples from sporadic insulinomas, comprising 30 WDET (17 BB, 13
uncertain behavior [UB]) and 7 malignant insulinomas (2 WDEC and 5
MEC).
Results. Comparison of microarray data from WDET-BB and WDEC/MEC
resulted in 315 differentially expressed genes with /2-fold: 188 up-regulated
in WDET-BB and 127 up-regulated in WDEC/MEC. Supervised hierarch-
ical clustering algorithm identified 16 gene clusters with similar expression
rates. Protease serine 2 (PRSS2) and chymotrypsin B1 (CTRB1), belonging
to trypsin/chymotripsin pathway were grouped in the second most up-
regulated gene cluster in WDET-BB. Messenger RNA quantifications by RT-
qPCR of PRSS2, properdin factor B (BF) (trypsin/chymotrypsin pathway),
serpin peptidase inhibitor clade A member 1 (SERPINA1) and angiotensino-
gen (AGT) (both from serine-type endopeptidase inhibitor activity pathway)
corresponded to the microarray findings. PRSS2 was shown to be up-
regulated in WDET-BB/UB, while SERPINA1, AGT and BF were up-
regulated in WDEC/MEC, pB/0.05.
Conclusion. This approach identified genes potentially implicated in
insulinoma progression. Further studies are necessary to confirm the clinical
utility of some of these genes to select patients that are more likely to develop
aggressive disease.
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FROM CARCINOMA TO LIPOMATOSIS: FAT REPLACEMENT
OF MALIGNANT PANCREATIC TISSUE AFTER NEOADJUVANT
THERAPY
Makay, Ozer1; Kazimi, Mircelal1; Aydin, Unal1; Karaca, Burcak2; Nart,
Deniz3; Yilmaz, Funda3; Zeytunlu, Murat1; Goker, Erdem2; Coker, Ahmet1
1Ege University Hospital, General Surgery, HPB workgroup, Izmir, Turkey;
2Ege University Hospital, Medy´cal Oncology, Izmir, Turkey; 3Ege University
Hospital, Pathology, Izmir, Turkey
Introduction. Pancreatic lipomatosis is characterized as massive lipid
infiltration of the pancreatic tissue. Although its etiology is ill defined;
obesity, diabetes mellitus, chronic panceatitis, hereditary pancreatitis and
factors like tumors and stones that cause pancreatic ductal obstruction are
conditions related to its pathogenesis. Recently, with the increased use of
computerized tomography and magnetic resonance imaging it is possible to
observe the fat replacement of the pancreas. Herein, we report a case,
previously diagnosed as pancreatic adenocarcinoma, where multimodal
treatment was carried out 100% with complete response and tissue pathology
revealed lipomatosis after surgery.
Case. A 60 year-old diabetic man was admitted to our hospital with a history of
abdominal pain and weight loss. Physical examination and laboratory studies
(incl. liver enzymes, tumor markers and lipid profile) revealed no pathology.
Abdominal ultrasonography and computerized tomography showed a pan-
creatic head tumor invading adjacent structures. Endoscopic retrograde
pancreatography approved the tumor. Histopathological examination of a
fine-needle biopsy specimen from the pancreatic head indicated an adeno-
carcinoma. The patient was commenced on a chemoradiotherapy regimen
consisting of Gemcitabine and 50,4 Gy radiotherapy given in 33 fractions.
After neoadjuvant therapy, pancreaticoduodenectomy was carried out with
success. Postoperative course was uneventful. Pathology of the specimen
revealed pancreatic lipomatosis with no malignant tumor infiltration.
Conclusion. It is difficult to decide whether lipomatosis is involved
with pancreatic duct obstruction due to a malignant lesion, since its
etiology is vague. In this report we discuss this relationship. To our knowledge,
this is the first report in the world literature of pancreatic head carcinoma
with total fat replacement of the pancreas after neoadjuvant chemoradio-
therapy.
P43.17
GENETIC SCREENING OF TWO INDIAN FAMILIES WITH THE
MEN1 SYNDROME: REPORTING A NEW MUTATION
Shah, Sudeep; Raghavan, Rani; Lala, Murad; Chauhan, Phulrenu; Desai,
Devendra; Abraham, Philip; Ashavaid, Tester
PD Hinduja Hospital, Mumbai, India
Background. The MEN1 syndrome is an autosomal dominant condition
presenting with pancreatic, pituitary and parathyroid tumours. Genetic
sequencing of patients of Indian origin has not been reported previously. We
report 2 such families including one with a unique mutation.
Methods. Genetic sequencing was carried out from blood samples of the two
families, where the probands presented with the MEN1 syndrome. Both
probands had multiple duodenal ulcers secondary to multiple pancreatic and
duodenal wall gastrinomas as well as parathyroid adenoma and pituitary
microadenoma. The first had two affected siblings while the second was the
index case with no other symptomatic family member. Sequencing was carried
out for the entire menin gene.
Results. For the first family, in exon 4, there was a Y227X mutation leading to
substitution of a stop codon for tyrosine. The second family shows a novel
mutation-G to C at nucleotide position 5297 which is a splice mutation in
intron 5.
Conclusion. This is the first report of MEN1 gene mutation from India which
includes a mutation [IVS5-1 GtoC], not previously reported.
P43.18
GLUCAGONOMA ASSOCIATED WITH MULTIPLE ENDOCRINE
NEOPLASIA SYNDROME TYPE I
Andraus, Wellington; Haddad, Luciana B; Jukemura, Jose´; Machado, Marcel
A; Bacchella, Telesforo; Machado, Marcel
Clinical Hospital of Sa˜o Paulo University, Surgery, Sa˜o Paulo, Brazil
Background. Glucagonoma is a rare pancreatic endocrine tumor. It may
present different clinical manifestation, such as necrolytic migratory erythema,
cheilitis, diabetis mellitus, anemia, weight loss, venous thrombosis, and
neuropsychiatric symptoms. It is rarely associated with the multiple endocrine
neoplasia syndrome type I (MEN I).
Methods. We related three cases of MEN I, presenting malignant glucago-
noma, treated at the Clinical Hospital of Sao Paulo University between January
2002 and April 2005.
Results. A 56-year-old woman, diagnosed primary hyperparathyroidism 6
months before, underwent total pancreatectomy because of multiple solid
tumors in pancreas, the biggest with 1,2 cm, showing lymphatic metastasis. A
49-year-old man was also submitted to total parathyroidectomy and 5 years
later was diagnosed cystic caudal pancreas tumor with 6,5 cm. Two years later
he was operated again because of adrenocortical adenoma. A 38-year-old
woman underwent distal pancreatectomy and adrenalectomy, with pancreas
tumor of 0,8 cm. None of them presented cutaneous eruption. They are still
alive after 45, 30 and 11 months respectively.
Conclusion. Glucagonoma may have different features associated with MEN
I. Despite the presence of metastasis the prognosis is good with prolonged
survival after resection.
P43.19
IMMUNOHISTOCHEMICAL STAINING FOR P53, BCL-2, BAX,
BAK, AND BCL-X PROTEINS ADDS LITTLE TO ROUTINE
PROGNOSTIC FACTORS IN PANCREATIC DUCT CELL CARCI-
NOMA
Sierzega, Marek; Popiela, Tadeusz; Kulig, Jan
Jagiellonian University Medical College, 1st Dept. of Surgery, Krakow, Poland
Background. Molecular alterations related to p53 and bcl-2 family proteins
have been reported to influence prognosis of patients with gastrointestinal
malignancies.
Objectives. To analyse the prognostic value of p53, Bcl-2, Bax, Bak and Bcl-X
proteins in pancreatic cancer (PC).
Methods. Tumour specimens of 101 patients who underwent pancreatic
resections for PC were reviewed. Protein expression was examined by
immunohistochemistry in formalin-fixed, paraffin-embedded sections. Stain-
ing was arbitrary categorized as none (B/5% cells), weak (520% of cells),
moderate (2150% of cells), or strong (/50% of cells).
Abstracts 209
Results. The percentage of tumours positive for p53, Bcl-2, Bcl-X, Bax and
Bak was 71%, 31%, 79%, 91% and 25%, respectively. The presence of p53 was
associated with poorer differentiation and a higher stage of the primary
tumour. Bcl-2 protein was related to lower staging, absence of lymph node
metastases, and a higher proportion of tumours limited to the pancreas. No
statistically significant correlations could be identified for Bcl-X, Bax and Bak.
The median survival was 14.8 months (95%CI 11.5 16.9 months) and the 5-
year survival was 14.3%. In p53-positive cases the median survival (13.6 vs
15.9 months) was significantly lower than for other patients. Bcl-X was the
next protein significantly affecting prognosis with the median survival (20.7 vs
13 months) higher in patients with negative immunoreactivity. No significant
differences could be identified for Bcl-2, Bak, and Bax proteins. The following
independent negative prognostic factors were identified with the Cox propor-
tional hazards model: moderate or poor tumour differentiation (HR 1.54,
95%CI 1.11 1.98), metastases to regional lymph nodes (HR 2.11, 95%CI
1.482.75), blood vessels involvement (HR 2.45, 95%CI 1.633.26), and a
positive resection margin (HR 4.84, 95%CI 2.544.35).
Conclusions. Although immunohistochemical staining for individual pro-
teins is associated with some tumour variables, its prognostic value is minimal.
P43.20
IMMUNOHISTOCHEMICAL STAINING IN AMPULLA OF VATER
ADENOCARCINOMA AND ITS RELATIONSHIP TO PROGNOSIS
Cho, Yong Kwon; Chung, Jun Chul; Jo, Sung Ho; Heo, Jin Seok; Choi, Seong
Ho; Choi, Dong Wook; Kim, Yong Il
Samsung Medical Center, Sungkyunkwan University School of Medicine,
Surgery, Seoul, Korea
Background. Ampulla of Vater adenocarcinomas are difficult to diagnose
because they lack specific immunohistochemical markers. Using immunohis-
tochemistiry, we analyse their clinical significance and relatioship of prognosis.
Methods. We studied the expression of cytokeratins(CK7, CK20), apomu-
cins(MUC1, MUC2, MUC5AC), CDX2 and Ki67 in 116 cases of ampulla of
Vater adenocarcinoma.
Results. Tumor recurrence was noticed in 42 cases (36%) among 116
operated patients. The median follow-up was 19 months (range 1 month to
100 months). The overall 5-year survival rate was 38.2%. Of all immunohis-
tochemical markers(MUC1, MUC2, MUC5AC, CK7, CK20, CDX2 and
Ki67), Ki67 was significantly related with recurrence (p/0.047).
Conclusions. The expression of Ki67 is a useful indicator for the recurrence
of the ampulla of Vater adenocarcinoma.
P43.21
IMMUNOMONITORING OF THE CAPRI TRIAL: FIRST RESULTS
Ma¨rten, Angela; Bu¨chler, Markus W; Schmidt, Jan
University of Heidelberg, Dept. of Surgery, Heidelberg, Germany
Background. In August 2004 we have started a phase III trial, where we
compare combined chemoradiotherapy plus IFN-a (arm A) with 5-FU bolus
infusion (arm B) in patients with pancreatic adenocarcinoma in the adjuvant
setting.
Aim. We hypothesize that IFN-a is the agent that turns a slightly effective
treatment (radiochemotherapy) into a potent therapy. Hypothesizing that the
main mechanism of IFN-a is via immuno-modulation, we perform a broad
immunomonitoring.
Methods. Blood samples from patients of both arms are drawn at several time-
points for immunological studies. Currently, we have analyzed samples from
44 patients for cellular cytotoxicity, granzyme B secretion, cytokine levels and
by FACS.
Results. Interestingly, we observed with regard to NK cell mediated
cytotoxicity an increase in cytotoxicity for patients in arm A during treatment.
Cytotoxicity increased from 13% before first administration of IFN-a to 45%
after 24 hrs and remained increased during treatment. The mean cytotoxicity
of about 20% in arm B did not change. Specific granzyme B secretion was
analyzed in ELISpot. Again, there was no change in arm B patient’s PBL and
no specific secretion (compared with medium control). Arm A patients showed
an increase in specific granzyme B secretion after the second IFN-a dosage.
Furthermore, we analyzed serum levels of cytokines. Only with regard to IL-12
we observed elevated serum levels in group with peaks one day after IFN-a
injection. FACS analysis of peripheral blood showed a significant increase in
monocytes, peripheral dendritic cells, CD80, CD40 and IFN-a R expression
on monocytes and effector memory T cells in arm A patients. Percentage of
naive lymphocytes decreased.
Conclusion. To summarize, we observed so far an increase in NK and T cell
cytotoxicity, IL-12 secretion and an activation of monocytes in group A
patients with a peak one day after the first administration of IFN-alpha.
P43.22
IMPACT OF GEMCITABINE AFTER RESECTION OF PANCREA-
TIC DUCTAL CARCINOMA
Niguma, Takefumi; Mimura, Tetusige; Tutui, Nobumasa
Okayama Saiseikai General Hospital, Surgery, Okayama, Japan
Background. From Sep. 2001, gemcitabine was available for pancreas cancer
in Japan, since then gemcitabine has been the main anti-cancer agent for
pancreatic ductal carcinoma. The aim of this study is to evaluate the impact of
gemcitabine after resection of pancreatic ductal carcinoma.
Methods. A retrospective analysis of 152 patients who underwent pancreatic
resections between Jan. 1990 and Dec. 2005 and histopathologically verified
pancreatic ductal carcinoma was carried out to evaluate the effectiveness of
gemcitabine after pancreatic resection. Clinical staging and histopathological
examination were performed according to the Japan Pancreas Society 5th
Ed.(and UICC 6th Ed.). The definition of radicality (R) was applied the UICC
guidelines.
Results. Among all patients undergoing surgical resection, there were 96
(63.2%) males and 56 (36.8%) females at the mean age of 67 years (range 36
86). The overall 3-year and 5-year survival were 28.9% and 23.7%, respectively.
The 5-year survival for Stage 3 was 30.3%, Stage 4a 24.5%, Stage 4b 4.9%,
respectively. (UICC: Stage2a 27.0%, Stage2b 34.3%, Stage3 15.0%, Stage4
NA) Before gemcitabine being available, the patients were treated with 5-FU and
CDDP via hepatic artery to prevent and to manage hepatic metastasis. Between
Sep. 2001 to Dec. 2005, 61 patients underwent surgical resections. In that
period, the patients who had recurrence were treated mainly with gemcitabine,
and some patients were associated with external radiation and hepatic artery
infusion. 35 patients received adjuvant chemotherapy with gemcitabine. The 3-
year survival for latter period was 39.3%, in contrast 23.9% for earlier period.
The clinical stage and R0 rate were not different in both periods. The improved
survival was observed in Stage 3 and 4a, but not in Stage 4b.
Conclusion. The survival after resection of pancreatic ductal carcinoma has
improved after the use of gemcitabine. The adjuvant chemotherapy with
gemcitabine might enhance the survival.
P43.23
IMPACT OF INTERFERON-ALPHA IN COMBINED CHEMORA-
DIOIMMUNO-THERAPY FOR PANCREATIC ADENOCARCI-
NOMA (CAPRI): FIRST DATA FROM IMMUNOMONITORING
Schmidt, Jan1; Ja¨ger, Dirk1; Bu¨chler, Markus2; Ma¨rten, Angela2
1University of Heidelberg, Heidelberg, Germany; 2University Hospital Hei-
delberg, Heidelberg, Germany
Data from a phase II trial combining chemoradiotherapy with IFN-a (CapRI
scheme) for adjuvant treatment of pancreatic carcinoma are very encouraging.
Therefore, a phase III trial comparing chemotherapy with the CapRI scheme
has been initiated in August 2004. Translational research with a focus on
immunomodulation is performed in parallel to the study. Blood and serum
samples are taken at various time-points. Patients in arm A (chemoradioim-
munotherapy) receive a single low-dose-Interferon (LDI) injection prior to
therapy to investigate the direct effect of IFN-a. Samples from so far 44
patients have been investigated for surface molecule expression, cytokine
levels, Natural Killer cell cytotoxicity and antigen-specific Granzyme B release.
Patients in arm A showed one day after IFN-a injection a significant increase in
spontaneous cytotoxicity; this effect was fading after repeated injections.
Furthermore, cells releasing Granzyme B after stimulation with CA 19.9 and
MUC-1 protein increased under therapy. Five days after the first IFN-a
injection IL-12 and TNF-a serum levels peak. We observed significant
increases of monocytes, peripheral dendritic cells (pDC), CD40/ cells,
central and effector memory T cells and CD8 cells, CD4 cells decreased during
therapy. All these effects were only observed in arm A patients none of them in
arm B patients. In conclusion, in a translational research project accompanying
a challenging multimodality treatment trial including IFN-a, we observed an
immediate activation of antigen-presenting cells and NK cells followed later on
by antigen-specific activation. It will be most interesting if the immunological
data will show a correlation with the clinical course of the patients.
P43.24
INFLUENCE OF STROMAL MATRIX PROTEINS ON MIGRATORY
ACTIVITY OF PANCREATIC CANCER CELLS
Ryschich, Eduard; Khamidschanov, Akmal; Bu¨chler, Markus W; Schmidt, Jan
University of Heidelberg, Dept. of Surgery, Heidelberg, Germany
Background. The ability to migrate is a prerequisite of pancreatic tumor cells
for invasion and metastases. Several previous investigations as well as our own
studies showed the high expression of extracellular matrix proteins in stromal
tissue of pancreatic cancer. The relevance of tumor stroma for tumor invasion
and metastases of pancreatic cancer was poorly investigated.
Aim. The aim of the present study was to study the influence of different
stromal proteins on migratory activity of pancreatic tumor cells.
Methods. The influence of stromal proteins (collagen I, III, IV, fibronectin,
vitronectin, vimentin, laminin) on migratory activity of 10 different tumor cell
lines was investigated by 3D-time-lapse microscopy and by 96 wells migration
assay in collagen I gel.
Results. Collagen I matrix induced a spontaneous migration in eight of ten
tumor cell lines (FAMPAC, Patu8988t, Patu890t, Capan-1, Panc-1, DANG,
PaCa44, MiaPaCa2). The percentage of migrating tumor cells was dependent
on the appropriate cell line and varied from 15% (MiaPaCa2) to 87%
(FAMPAC). The mean velocity of tumor cell migration varied from 5.69/2.5
mm/h (Panc-1) to 17.89/4.2 mm/h (FAMPAC) depending on the appropriate
cell line. The addition of collagen III/IV, fibronectin, vitronectin, vimentin did
not significantly change the migration of single tumor cells. However, the
migration of all cell lines in collagen matrix was significantly increased after
addition of laminin.
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Conclusions. Extracellular matrix proteins such as collagen I and laminin
promote the migratory activity of single tumor cells of pancreatic cancer which
could increase the high metastatic potential of this tumor type.
P43.25
MANAGEMENT STRATEGIES OF POSTOPERATIVE HAEMOR-
RHAGE AFTER PANCREATICODUODENECTOMY
Mullerpatan, PM1; Shah, RC2; Jagannath, P2
1Grantham and District Hospital, Dept. of Surgery, Grantham, UK; 2Lilavati
Hospital and Research Centre, Mumbai, India
Background. Haemorrhage is a common post operative complication seen in
520% of patients undergoing a Pancreaticoduodenectomy (PD) and can
account for between 1438% of the mortality. Early post operative haemor-
rhage (within 5 days) usually due to a improper hemostasis can usually be dealt
with by an early relaparotomy and does not need a Total Panctreatectomy. But
delayed haemorrhage is more common and is more difficult to manage as it is
commonly associated with pancreatic fistulae secondary to anastamotic
leakage, intra abdominal sepsis leading to bleeding from visceral arterial
pseudoaneurysms.
Aim. To study our experience in the management of delayed haemorrhage after
PD.
Methods & results. Retrospective study of 184 PDs between 19922003. Of
the 21 who had post operative hemorrhage 9 had delayed haemorrhage. 5
underwent trans arterial embolization (TAE). 2 who had upper GI bleeding
were found to have stress oesophageal ulcers and were managed conservatively.
Of the two who had intra abdominal bleeding one died before any intervention
and the other underwent relaparotomy.
Discussion. TAE was successful in controlling the haemorrhage in 3 of 5,
success rate of 60%. Though relaparotomy was successful in controlling
haemorrhage in the remaining 2 who had failed TAE; they eventually died
because of DIC.
Conclusion. We emphasize the shift in management of delayed haemorrhage
after PD from total pancreatectomy to more conservative measures like TAE.
P43.26
KL-6 MUCIN EXPRESSION IN CARCINOMA OF THE HEAD OF
THE PANCREAS
Seyama, Yasuji; Tang, Wei; Kokudo, Norihiro; Hashimoto, Masao; Sano,Keiji;
Imamura, Hiroshi; Makuuchi, Masatoshi
University of Tokyo, Hepato-Biliary-Pancreatic Surgery Division, Tokyo,
Japan
Background. KL-6 mucin is MUC1 bearing sialylated carbohydrate epitopes
recognized by KL-6 antibody. Sialylation of glycoconjugates is considered to be
important in tumor malignant behavior. However, little is known about the
expression of KL-6 in pancreatic carcinoma.
Aims and objectives. To assess subcellular localization of KL-6 mucin and its
clinicopathological significance in carcinoma of the head of the pancreas.
Patients and methods. Pancreas head carcinoma tissues were collected from
66 patients who underwent pancreatoduodenectomy between 1994 and 2005.
Tissues were subjected to immunohistochemical analysis using KL-6 antibody
(Eisai, Tokyo, Japan). Five-micrometer-thick sections were incubated at room
temperature for one hour with KL-6 antibody diluted to 1:200. Each section of
subcellular staining patterns was recorded by judging the apical membrane,
circumferential membrane, and cytoplasm.
Results. Positive staining of pancreatic carcinoma cells was observed in all the
examined cases. The staining was localized in the tumor-cell cytoplasm and cell
membrane in cancer regions. Positive staining was scarcely observed in the
region of the concomitant pancreatitis. On the other, weak staining was
sporadically detected along the inner surface of the pancreatic duct in the
surrounding non-tumorous pancreatic parenchyma. The staining of
the pancreatic duct cells surface became strong in the region adjacent to the
pancreatic carcinoma.
Discussion and conclusion. In our previous study, KL-6 was positive in 26 of
38 ampullary carcinoma, and positive expression of KL-6 was related to a
poorer prognosis. The aberrant KL-6 mucin was expressed all the carcinoma
tissues of the head of the pancreas, which suggested malignant behavior of
pancreatic carcinoma. Histochemical analysis of biopsy tissues using KL-6
antibody might be useful for the preoperative diagnosis of pancreatic
carcinoma.
P43.27
LAPAROSCOPIC VERSUS OPEN APPROACH FOR SOLITARY
INSULINOMA
Sa Cunha, Antonio; Beau, Cedric; Rault, Alexandre; Collet, Denis; Masson,
Bernard
Hoˆpital Haut Le´veˆque CHU Bordeaux, Pessac, France
Background. During the past years, advances in laparoscopic techniques have
allowed surgeons to treat pancreatic lesions laparoscopically. Insulinoma is the
most prevalent pancreatic endocrine tumor and is mostly benign and curable
with surgical resection.
Aim. The aim of this study was to assess the results of laparoscopic resection
(LG) of insulinomas and to compare to the results of open surgery (OG).
Methods. From September 1999 to December 2005, 56 laparoscopic
pancreatic resections were performed in selected patients including 12
laparoscopic resections of insulinomas. Results were compared with those of
patients who underwent open resection of insulinomas selected from our
pancreatic database.
Results. Three conversions to open approach were required because of an
inability to identify the tumor. There were no deaths in both group, and the
morbidity rates were 25% (3/12) in the LG and 55% (5/9) in the OG (NS). The
pancreatic fistula rate after laparoscopic enucleation was statistically lower than
after open enucleation (14% vs. 100%, p/0.015). Mean postoperative
hospital stay was 139/5.9 days for LG and 17.69/7.5 days for OG (NS).
Excluding patients with conversion to laparotomy, the mean postoperative
hospital stay for LG was 11.59/5.8 days and 17.69/7.5 days for OG (p/0.04).
Conclusion. This study demonstrates the feasibility and safety of laparoscopic
resection of insulinomas. The laparoscopic approach was associated with a
decrease of hospital stay and pancreatic fistula after enucleation. Preoperative
localization tests and laparoscopic ultrasonography seems to be required to
prevent conversion.
P43.28
SURGERY FOR SECUNDARY PANCREATIC TUMORS: AN AP-
PROACH FOR DECISION MAKING AND PATIENT SELECTION
Montagnini, Andre L; Diniz, Alessandro L; Coim, Felipe J; Mendes, Gabriella
O; Costa Jr, Wilson L; Herman, Paulo; Salum, Rubens A; Machado, Marcel A
Hospital do Caˆncer-FAP, Dept. of Abdominal Surgery, Sa˜o Paulo, Brazil
Background. Though pancreatic metastases may occur in up to 10% of cancer
patients. It hardly hits 2% of the total of pancreatic resections for tumors. The
reason for this is that pancreatic metastasis usually is associated with wide-
spread cancer disease and a poor prognosis.
Aim. This presentation will show our experience in the treatment of selected
patients with secondary pancreatic tumors and define clinical criteria for
patient selection.
Patients and methods. Retrospective analysis of six patients operated in our
service due to secondary pancreatic tumors, not considering tumor with direct
invasion to the organ. We evaluated primary tumor location, survival, disease
free period and surgery performed. Literature review and definition of clinical
criteria for patient selection.
Results. During January 1999 and march 2005 we had the opportunity to
perform six pancreatic resections for metastasis. Median age was 54 years old
(4469). The primary tumors in decreasing incidence were: Renal Cell
Carcinoma in 3 patients; Ovarian Carcinoma in 2 patients and Cutaneous
Melanoma in 1 patient. Surgical procedures performed were: Gastroduode-
nopancreatectomy (GDP) in 2 patients; Total pancretectomy in 2 patients and
distal pancreatectomy in 2 patients. And in one patient submitted to GDP due
to ovarian carcinoma a right colectomy was also associated to the procedure.
Only 1 patient had a sincronous metastasis from ovarian carcinoma and the
other 5 had metacronic lesions, with a median interval between primary tumor
treatment and pancreatic ressection of 78 months. Overall survival was 42
months. There was no per-operative mortality.
Conclusion. We strongly recommend resection for patients with long disease
free period; good performance status; primary tumor controlled; complete
clinical e radiological work up showing disease limited to the pancreas; surgical
team with low morbidity rates, and more over when tumors are metastasis from
renal cell carcinoma, ovarian and colon.
P43.29
LENGTH AND QUALITY SURVIVAL FOLLOWING CHEMO-RA-
DIATION THERAPY FOR LOCALLY ADVANCED UNRESECT-
ABLE PANCREATIC CANCER
Noma, Hidetoshi1; Shinchi, Hiroyuki1; Maemura, Kousei1; Kubo, Fumitake1;
Sasaki, Ken1; Hiwatashi, Kiyokazu1; Ueno, Shinichi1; Takao, Sonshin2; Aikou,
Takashi1
1Dept. of Surgical Oncology and Digestive Surgery, Kagoshima University
Graduate School of Medicine and Dental Science, Kagoshima, Japan;
2Frontier Science Research Center, Kagoshima university Graduate School
of Medicine and Dental Science, Kagoshima, Japan
Background & purpose. Pancreatic cancer is a morbid disease with a dismal
prognosis particularly in cases of unresectable tumor. The purpose of this study
was to evaluate whether external-beam radiotherapy (EBRT) with concurrent
chemotherapy affects the length and quality of survival in patients with locally
unresectable pancreatic cancer.
Methods. Fifty-eight patients with histologically proven locally advanced and
unresectable pancreatic cancer without distant metastases were evaluated in
this retrospective study. Twenty-seven patients received EBRT (50.4 Gy/28/
fractions) with concurrent twice-weekly gemcitabine (40 mg/m2/day) (GEM/
RT group), 16 patients received EBRTwith concurrent continuous infusion 5-
FU (200 mg/m2/day) (5-FU/RT group), and 15 patients received best
supportive care only without chemoradiation therapy (BSC group), respec-
tively. The length and quality of survival were analyzed and compared among
the three groups.
Results. The median survival and 1-year survival rate of 13.2 months and 56%
in the 5-FU/RT group and 12.8 months and 53% in the GEM/RT group was
significantly better than the respective 6.4 months and 0% in the BSC group. 2-
year and 3-year survival rate of 35% and 13% in the GEM/
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RT group was insignificant but better than that of 6% and 0% in the
5-FU/RT group (p/0.1). The average monthly Karnofsky score of 77 in
the 5-FU/RT group and 75 in the GEM/RT group, a quality of life indicator,
was significantly higher than the 65.5 in the BSC group. The number of hospital
days per month of survival was significantly smaller in the chemoradiation
group than in the BSC group.
Conclusions. External-beam radiotherapy with concurrent chemotherapy
increased the length and quality of survival as compared to no chemoradiother-
apy and provided a definite palliative benefit for patients with unresectable
pancreatic cancer. Gemcitabine-based chemoradiation appears to show a
further longer survival than 5-FU-based chemoradiation and provides a first-
line treatment.
P43.30
DENDRITIC CELL (DC) GENERATION FROM PERIPHERAL
BLOOD MONONUCLEAR CELLS OBTAINED FROM JAUNDICED
PATIENTS WITH PANCREATIC ADENOCARCINOMA
Treglia, Mariza1; Jukemura, Jose´2; Matheus, Andre´ S.2; da Cunha, Jose´
Eduardo M.2; Machado, Marcel C. C.3; Barbuto, Jose´ Alexandre M.1
1University of Sa˜o Paulo, Dept. of Immunology, Sa˜o Paulo, Brazil; 2University
of Sa˜o Paulo, Dept. of Gastroenterology, Sa˜o Paulo, Brazil; 3University of Sa˜o
Paulo, Dept. of Surgery, Sa˜o Paulo, Brazil
Pancreatic adenocarcinoma (PAde) is an aggressive malignancy with poor
prognosis, urging for improved or new therapeutic strategies. DC-based
vaccination is one of such promising approaches. DC are the most potent
antigen-presenting cells and central to the induction and maintenance of an
immune response. However, in cancer patients DC generation and function
may be deficient, imposing an obstacle to the success of their use. Here, we
describe the in vitro generation of DC from peripheral blood mononuclear
cells (PBMC) obtained from jaundiced patients with PAde and, also, the effect
of jaundiced plasma (JP) in the phenomenon. PBMC were separated from
blood obtained from 10 patients and 10 healthy controls over a density
gradient. Adherent cells were cultured with GM-CSF and IL-4 (50 ng/mL)
for 7 days. On the 5th day, TNF-Alpha (50 ng/mL) was added for DC
activation. Cultures were performed in 10% JP or normal plasma (NP). Non-
adherent cells were harvested at day 7, labeled with FITC- or PE-conjugated
monoclonal antibodies against CD86, CD80, CD1a, CD11c, CD14, HLA-
DR and analyzed by flow cytometry. Patient cells, cultured in 10% JP,
compared to healthy donor cells, cultured in 10% NP, had a significantly (pB/
0.05) lower expression of CD11c, CD80, CD86 and HLA-DR. It is
noteworthy that cells generated from patients PBMC did not express
CD11c, while 60% of those derived from healthy donor cells did so. The
presence of JP in healthy donor cells cultures caused a significant decrease in
the percentage of HLA-DR/ (66%/89%), CD11c/ (43%/60%) and
CD86/ cells (43%/66%). Finally, when patients PBMC were cultured in
NP, a significant increase in HLA-DR (87%/75%) and a tendency (p/0.06)
to increase in CD86 (43%/30%) expression occurred. These data indicate a
significant alteration in the patients PBMC ability to differentiate into DC in
vitro, a phenomenon that seems to depend both on soluble factors present in
plasma and on the cells, themselves.
P43.31
LOCALIZATION AND SURGICAL TREATMENT FOR PANCREA-
TIC INSULINOMAS: A TEN YEAR EXPERIENCE
Chung, Jun Ch; Cho, Yong K; Choi, Seong H; Jo, Sung H; Heo, Jin S; Choi,
Dong W; Kim, Yong I
Samsung Medical Center, Sungkyunkwan University School of Medicine,
Seoul, Korea
Objectives. Insulinomas are rare tumors that originate from islet cells of the
pancreas. The purpose of this study was to improve the understanding of the
clinical features of insulinomas and to establish diagnostic and therapeutic
strategies.
Methods. A review was performed in 20 patients with insulinoma surgically
treated at our institution over the last 10 years. Presenting symptoms,
biochemical studies, pre and intraoperative localization, operative manage-
ment and complications were analyzed.
Results. The male to female ratio was 8:12, with a mean age of 46.4 years.
Each patient suffered from significant neuroglycopenic symptoms, character-
ized by dizziness, sweating, headache, and confusion. The preoperative
median serum levels of glucose, insulin, and C-peptide after fasting were 37.5
mg/dl, 23.5 mU/ml and 5.6 ng/ml respectively. Preoperative tumor localiza-
tion was performed with ultrasonography, computed tomography, selective
angiography, or intra-arterial calcium injection with hepatic venous sampling;
the sensitivities of the examinations were 81.8%, 73.7%, 94.1% and 100%,
respectively. Intraoperative localization was performed by a combination of
manual palpation and intraoperative ultrasonography with retrospective
sensitivities of 80% and 100%. Enucleation was performed in 16 patients
and distal pancreatectomy in 4. The mortality and morbidity rates were 0%
and 10%. One patient developed late insulin dependent diabetes after distal
pancreatectomy.
Conclusions. Our findings suggest that the diagnosis of insulinoma can be
made after a supervised fast; intra-arterial calcium injection with hepatic
venous sampling is the single best preoperative study for localization of the
tumor. Careful palpation with intraoperative ultrasonography is essential for
intraoperative detection of insulinomas, and enucleation is the best approach
for treatment of benign insulinomas.
Key words. Insulinoma, Pancreas, Localization, Treatment
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LONG-TERM SURVIVAL AFTER PANCREATECTOMY FOR EXO-
CRINE DUCTAL ADENOCARCINOMA OF THE PANCREAS
(EDAP)
Partensky, Christian1; Jaeck, Daniel2; Le Borgne, Joel3; Oussoultzouglou,
Elie2; Adham, Mustapha1; Chenard-Neu, Marie-Pierre4; Mosnier, Jean
Franc¸ois5; Scoazec, Jean-Yves6; Mornex, Franc¸oise7
1Edouard Herriot Hospital, Dept. of Digestive Surgery, Lyon, France;
2Hautepierre Hospital, Dept. of General Surgery, Strasbourg, France;
3Edouard Herriot Hospital, Lyon, France; 4Hautepierre, Dept. of Pathology,
Strasbourg, France; 5Hotel-Dieu Hospital, Dept. of Pathology, Nantes,
France; 6Edouard Herriot Hospital, Dept. of Pathology, Lyon, France;
7Lyon Sud Hospital, Dept. of Radiotherapy, Lyon, France
The aim of the study was to collect a significant number of long-term
survivors (LTS) after pancreatectomy for EDAP and to describe the
pathological status, postoperative course and management of these patients.
Medical charts of patients who survived more than 5 years after pancrea-
tectomy for EDAP in 3 French surgical centers (02/1983 to 01/2000) were
analysed. Pathological slides from operative specimen were reviewed by 2
experienced pathologists. Patients with intraductal papillary mucinous
neoplasia, cystadenocarcinoma, acinous adenocarcinoma, endocrine or
mixed tumours were excluded. 30 patients (20 men, 10 women), median
age 619/9.8 years (3378) were identified as LTS. One patient had
neoadjuvant chemoradiation. Operations were: pancreaticoduodenectomy
(n/25) without (n/19) and with (n/6), pylorus preservation, -total
pancreaticoduodenectomy (n/3), and -splenopancreatectomy (n/2). Ad-
ditional procedures were portal vein resection (n/3), resection of the hepatic
artery (n/1), liver segmentectomy (n/1). All operative specimens were R0.
Median tumour size was 30 mm (1090). Tumors were classified pT2 (n/
1), pT3 (n/24), and pT4 (n/5). 12 patients were N/. One patient had
synchronous liver metastasis. 20 patients had adjuvant radiotherapy at
median dose of 46 Gy (4055), with concomitant chemotherapy in 18
patients (5FU in 6, 5FU-Cisplatin in 12). Mean additional chance of survival
after the initial 5 years was 3.99/4.2 years (2.7 m-16 y). 8 patients developed
recurrence. At the end of the follow-up, 19 patients were alive, one with
recurrence and 18 with no evidence of disease (among them, 2 were treated
successfully for a second unrelated cancer and 2 had more than 20 years
follow-up), 11 patients died, 6 from recurrence.
Conclusion. Pancreatic cancer can be cured, and long-term survival has
become a reality. Late recurrences and second primary cancers can occur
after the first 5 years and patients require a systematic follow-up during the
additional survival time.
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MALIGNANT INSULINOMA: TREATMENT AND FOLLOW-UP
Andraus, Wellington; Haddad, Luciana B; Jukemura, Jose´; Machado,
Marcel; Bacchella, Telesforo; Machado, Marcel
Clinical Hospital of Sa˜o Paulo University, Sa˜o Paulo, Brazil
Background. Malignant insulinomas are very rare endocrine tumours with a
variable clinical course.
Patients and methods. From January 1988 through December 2005, 9
patients were treated with malignant insulinoma at the Clinical Hospital of
Sao Paulo University.
Results. There were 6 women and 3 men with a mean age of 59,4 (2783)
years. The most common presenting symptom was hypoglycemia. Five
patients presented lymph node metastasis and five with hepatic metastasis.
The pancreas resection was three pancreatoduodenectomy, two distal
pancreatectomy and two total pancreatectomy. Most of tumors was bigger
than 5 cm or multiples. Two pantients was not submitted to pancreatic
resection because of intraoperative advanced disease, three patients under-
went additional hepatic surgery and two underwent hepatic chemoemboliza-
tion. Three patients died in one year, three patients had five-year survival,
and two patients are still alive with short surveillance.
Conclusion. The malignant insulinoma may have a variable natural history.
The tumor number and size may suggest malignancy. Hepatic resection can
control symptoms and may prolong survival time. After the initial surgical
resection, the biology of the tumor, rather than any treatment modality, was
most likely the major determinant of long-term survival.
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OUTCOMES OF CHEMORADIATION FOR LOCALLY AD-
VANCED PANCREATIC CARCINOMA IN THE EASTERN PAN-
CREATOBILIARY UNIT 20022005
Satyadas, Thomas; Cheong, Edward; Mui-Liu, York; Tippen, Karen; Groot-
Wassink, Thomas; Sinclair, Martin T; Soomal, Rubinder; Rae, David M
Ipswich Hospital, Eastern Pancreatobiliary Unit, Ipswich, UK
Background. 3040% of all pancreatic cancers are locally advanced at
diagnosis and median survival is 812 months.
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Aim. Our aim was to assess overall survival and toxicity in patients at Ipswich
Hospital who received external beam radiotherapy at a radical dose with
concurrent chemotherapy between 20022005. We also compared survival
in this cohort to survival data from the period 19992001.
Methods. A retrospective review was performed of the patients who received
external beam radiotherapy with chemotherapy for locally advanced pan-
creatic adenocarcinoma, diagnosed by histology and/or CT criteria.
Results. There were 20 patients, 11 men and 9 women, performance status
was 02, with a mean age 62 (range 5573). 80% had histological
confirmation of adenocarcinoma. Mean radiotherapy dose was 43.8 Gy
(range 4050.4 Gy). 2 patients were simulated and treated with parallel
opposed fields in 2002. The rest were CT planned using a co-planar 3 field
technique and 3-D conformal radiotherapy. 1 patient was treated with IMRT
with a co-planar 7 field technique. 55% of patients received concurrent
capecitabine at a dose of 800 mg/m2 twice daily and the rest infusional 5-FU
at a dose of 200 mg/m2/day. 55% had chemotherapy on progression with
gemcitabine. Three patients had second line chemotherapy (FEM, capeci-
tabine or capecitabine/oxaliplatin). The overall median survival and prob-
abilities of surviving to specific time-points were estimated using the Kaplan-
Meier method. The overall median survival was 10.4 months (95% CI 7
13.8 months). The three longest survivors were alive until 20, 37 and 39
months post diagnosis. For the 19992001 cohort, the median survival was
11.5 months. There was no significant difference in survival between the two
cohorts.
Conclusion. Chemoradiation for locally advanced pancreatic cancer is
generally well tolerated with acceptable toxicity. There has been no significant
change in survival comparing the two time periods 1999 2001 and 2002
2005 and is comparable to national and trial data.
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FOXP3 EXPRESSION IN PANCREATIC CANCER CELLS AS A
NOVEL MECHANISM OF IMMUNE EVASION IN CANCER
Hinz, Sebastian1; Pagerols-Raluy, Laia1; Oberg, Hans-Heinrich2; Sipos,
Bence3; Wesch, Daniela2; Fa¨ndrich, Fred1; Kabelitz, Dieter2; Kalthoff,
Holger1
1University Hospital Schleswig-Holstein, Clinic for General and Thoracic
Surgery, Kiel, Germany; 2University Hospital Schleswig-Holstein, Institute
of Immunology, Kiel, Germany; 3University Hospital Schleswig-Holstein,
Institute of Pathology, Kiel, Germany
Background. FoxP3 is a key marker of regulatory T cells. We describe the
novel expression of FoxP3 in pancreatic cancer tissue and pancreatic cancer
cell lines. We show that the expression of FoxP3 in pancreatic cancer cell lines
results in an inhibition of the proliferation of naive T cells in a co-culture
system with pancreatic cancer cells.
Methods. Expression of FoxP in pancreatic tumour specimen an cell lines
was determined using immunohistochemistry and qRT-PCR, respectively. In
Panc89 cells FoxP3 expression was downregulated with specific siRNA.
Expression of IL-6 and IL-8 after suppression of FoxP3 in Panc89 cells was
determined with qRT-PCR. To study the effects of FoxP3 expression in
Panc89 tumor cells on naive T-cells we used a co-culture system of naive
CD4/CD25- T-cells and Panc89 cells together with anti-CD3 and anti-
CD28. Subsequently, T-cell proliferation was measured using CFSE-label-
ling.
Results. The majority of the pancreatic tumour specimen show positive
FoxP3 immunhistochemistry. All pancreatic cancer cell lines express FoxP3.
After downregulation of FoxP3 with siRNA IL-6 expression in Panc89 cells
was upregulated. Treatment of Panc89 cells with TGF-b1/2 resulted in
upregulation of FoxP3. In a co-culture system a strong anti-proliferative
effect on T-cells was observed. This effect could be partially reverted after
inhibition of FoxP3 expression in Panc89 cells.
Conclusion. We show that the Treg marker FoxP3 is expressed in
pancreatic tumours and cell lines. FoxP3 can be induced by treatment with
TGF-b. Most importantly, the anti-proliferative effect on T-cells of FoxP3
expressing Panc89 cells could be partially reverted after inhibition of FoxP3
expression in Panc89 cells, indicating that this suppressive effect is dependent
on FoxP3 expression. We suggest that pancreatic cancer cells might mimic
functions of Treg through FoxP3-dependent suppression of T-cell prolifera-
tion. These findings reveal a new mechanism of immune evasion in
pancreatic cancer.
P43.36
MRI FINDINGS OF SOLID AND PSEUDOPAPILLARY TUMORS
OF THE PANCREAS
Yu, Chi-Chang; Yeh, Chun-Nan; Hwang, Tsann-Long; Jan, Yi-Yin; Chen,
Miin-Fu
Chang Gung Memorial Hospital/Chang Gung University, Surgery, Taoyuan,
Taiwan
Background. Solid and pseudopapillary tumor (SPT) of pancreas, a rare
tumor with indolent features, occurs mainly in young female patients. SPT,
although not a novel finding, has been recognized with variable clinical features
and even malignant potential. Here we did an intensive clinicopathological
analysis with emphasis on MRI findings to fully clarify this rare disease entity.
Methods. From 1981 to 2004, the clinical features of 26 surgically treated
cases of SPT were retrospectively reviewed, including demographics, labora-
tory data, imaging features, operative findings, pathological features, and
follow-up results. The imaging features of the latest 11 consecutive SPT cases
underwent MRI (Magnetom Vision; Siemens Erlangen, Germany; projection
technique and multislice plus maximum intensity projection) were studied.
Results. Twenty five patients are female and one is male. The median age is
23 years (range, 1357). The most common clinical sign is abdominal pain.
The median size of the lesions is 7.5 cm (range 3.815 cm). Pancreatic head
is the most frequent location of tumor. Nine patients were classified as solid
pseudopapillary carcinoma. During the follow-up period of from 10237
months, two patients had died of causes unrelated to the tumor or surgical
procedure. MRI was used in eleven SPT patients with three specific features
correlating well with pathological features. Type 1 image means SPT with
completely solid part and all the patients with type 1 image were detected
SPT incidentally. Type 2 image means SPT with solid mass with hemorrhage.
Type 3 image means SPT with massive hemorrhage and all three patients had
type 3 image suffering abdominal pain.
Conclusions. We present the clinical features and outcomes of 26 surgically
treated SPT with emphasis on MRI findings. SPT had favorable survival
irrespective of malignancy. MRI could reliably differentiate its pathological
features with specific imaging features and correlate well with clinical
features.
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CLINICOPATHOLOGIC ANALYSIS OF SURGICALLY PROVEN
INTRADUCTAL PAPILLARY MUCINOUS NEOPLASM (IPMN)
Han, Sung-Sik; Jang, Jin-Young; Lee, Seung-Eun; Yang, Sung-Hoon; Lee,
Kuhn-Uk; Kim, Sun-Whe
Seoul National University College of Medicine, Surgery, Seoul, Korea
Background. Despite increasing frequency of IPMN, knowledge of its
natural history and clinical course have not been well defined.
Objectives. To identify the clinicopathologic features of surgically proven
IPMN.
Patients and methods. A retrospective review of all patients (n/82) with
surgically proven IPMN from January 1994 to December 2004 was
performed. The age of the subjects ranged from 48 to 82 years (mean 62.2
years), with a male to female ratio of 1.56:1(50:32).
Results. Thirty-six patients underwent pancreatoduodenectomy including
pylorus-preserving procedure, 36 distal pancreatectomy, 7 organ preserving
pancreatectomy. Fifteen patients (18.3%) had adenomas, 49 (59.8%)
borderline tumors, 7 (8.5%) carcinoma in situ (CIS), and 11 (13.4%)
invasive carcinoma. Lymph node metastasis was found in two cases. Twenty-
two patients (26.8%) were main duct type, 49(59.8%) were branch duct type,
and 11 (13.4%) were combined type. Mural nodule was found in 17 patients
(20.7%) and eleven (64.7%) of them were invasive carcinoma. Four (2
invasive carcinoma and 2 CIS) patients (4.9%) had recurrence. Tumor
involvement in the resection margin were found in 10 patients (12.2%) and 2
developed tumor recurrence during 40.8 months mean follow-up. Thirty-
seven patients (44.0%) had combined extrapancreatic neoplasms. Stomach
(n/13) and colon (n/7) were frequently involved organs of the extra-
pancreatic neoplasm. Five-year survival rate of benign tumor (adenoma,
borderline tumor) was 88.5% which was significantly better than that of
carcinoma (CIS, invasive carcinoma; 71.3%)(p/0.01).
Conclusion. IPMN was frequent in the seventh decade with male
predominance. It distributed evenly to the whole pancreas. Borderline tumor
and branch duct type were frequently found. Fifty-seven percent of the
patients had combined pancreatic or extrapancreatic neoplasms. Overall
recurrence rate was 4.9%, whereas 20% when the residual tumor involved the
resection margin.
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NONFUNCTIONING ISLET CELL CARCINOMA OF THE
PANCREAS: PREDICTIVE FACTORS OF SURVIVAL AFTER
SURGICAL TREATMENT
Chung, Jun C; Cho, Yong K; Choi, Seong H; Jo, Sung H; Heo, Jin S; Choi,
Dong W; Kim, Yong I
Samsung Medical Center, Sungkyunkwan University School of Medicine,
Surgery, Seoul, Korea
Background. Studies that analyze prognostic factors in nonfunctioning
pancreatic islet cell carcinoma are rare. We identified predictive factors that
are associated with long term survival after surgical resection for nonfunc-
tioning islet cell carcinoma.
Methods. Among the 25 patients with a diagnosis of nonfunctioning islet cell
carcinoma, a review was performed in 22 patients surgically treated in our
institution over the last 10 years. The following factors were evaluated for
disease specific mortality: age, sex, tumor location, tumor size, histological
differentiation, status of resection margin, and status of lymph node
involvement.
Results. Tumor recurrence was noticed in nine cases (40.9%) among 22
operated patients. Of the nine recurred cases, seven patients (77.8%) had
liver metastases. The median follow-up time was 24.8 months (range 3.7 to
121.4 months). The overall 1-, 2-, and 5-year actuarial survival were 84.1%,
72.5%, and 52.8%. Factors shown to have favorable independent prognostic
significance was negative resection margin (odds ratio/19.44, 95% con-
fidence interval/1.22 to 310.54, p/0.045).
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Conclusions. Definitive surgical resection of the primary tumor was
predictor of long term survival after surgical resection for nonfunctioning
islet cell carcinoma. Key Words: Nonfunctioning islet cell carcinoma,
Pancreas, Predictive factors.
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NON-RESECTED PANCREATIC CANCER. A MANAGEMENT
OPTION NOT A FAILING IN CERTAIN CASES
Kontoyannis, Angeliki; Gilmour, Jeff; Jardine, Nicki; Puntis, Malcolm CA
University Hospital of Wales, Dept. of General Surgery, Cardiff, UK
Introduction. Pancreatic cancer is a condition with poor survival despite
treatment. Surgical resection is currently the gold standard. However
improvements in interventional radiology and chemotherapy have been
invaluable for the palliation of advanced disease.
Aim. To review survival of patients with pancreatic cancer comparing those
resected with those palliated in order to guide our decision-making of patients
with borderline disease.
Methods. All patients admitted to the surgical department with a diagnosis
of pancreatic cancer between June 1999 and June 2005 were identified. Data
was collected via computer records as well as the England and Wales death
register on-line.
Results. There were 170 patients in total. 34(20%) underwent resection. Of
those 28 had a pylorus preserving pancreaticoduodenectomy (PPPD), 3 had
a Whipple’s, 3 had a total pancreatectomy. 136 were palliated. Of those 22
underwent surgical bypass. The mean survival of resected patients was 18.2
months. Palliated patients were sub-divided into those with local disease and
those with disseminated disease at presentation. Their survival was 10 and
8.6 months respectively.
Conclusion. Resection is clearly indicated for certain patients with
pancreatic cancer. Others present a management dilemma when deciding
whether surgery offers a worthwhile survival advantage. Our results indicate
that resection adds an average of eight months to life expectancy. When this is
compared to the survival of non-resected patients we feel it is a valuable aid
for more informed patient choice and decision making in cases where the
indications for surgery are less clear.
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NOTCH3 OVEREXPRESSION IN PANCREATIC DUCTAL ADE-
NOCARCINOMAS IS ASSOCIATED WITH EXPRESSION OF
OTHER ONCOGENIC SIGNALLING MOLECULES
Doucas, Helena1; Sutton, Christopher D1; Garcea, Guiseppe1; Neal,
Christopher P1; Manson, Margaret M2; Dennison, Ashley R1; Berry, David1
1Leicester General Hospital, Hepatobiliary and Pancreatic Surgery, Leice-
ster, UK; 2University of Leicester, Leicester, UK
Background and aims. Previous research has shown Notch3 to be
expressed in pancreatic adenocarcinomas. In other tissues, Notch signalling
has been shown to affect STAT3 activation, levels of Cyclin D1, and
phosphorylation of Akt. Each of these signalling molecules has been linked to
pancreatic carcinogenesis, but their potential interaction with Notch has not
been explored in this tumour type.
Methods. An immunohistochemical study was performed on 23 samples of
human pancreatic ductal adenocarcinoma and 12 samples of normal pancreas,
to assess the expression of Notch3, cyclin D1, pAkt, STAT3, and pSTAT3.
The degree of staining, and cellular location of the proteins were assessed.
Results. Notch3 was significantly overexpressed in the cytoplasm of 73.9%
of tumours. Nuclear expression was noted in 43.5% of cases. There was a
significant correlation between expression and intracellular location of
Notch3 and STAT3 and pSTAT3. pAkt staining also correlated with Notch3
staining, with a particularly strong relationship between nuclear expression of
Notch3 and nuclear expression of pAkt (p/0.008). No significant correla-
tion with cyclin D1 expression was found.
Conclusion. The correlation of Notch3 expression with STAT3, pSTAT3,
and pAkt expression has not previously been described in pancreatic cancer.
The fact that the intracellular location of these proteins correspond is
particularly striking, as the presence of Notch3 in tumour nuclei is likely to
represent functional activation of the protein. These data further demonstrate
the importance of Notch signalling in pancreatic carcinogenesis.
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SYNCHRONIZED ADENOCARCINOMA OF THE MAJOR AND
MINOR DUODENAL PAPILLAE
Jukemura, Jose1; Matheus, Andre S1; Montagnini, Andre L1; Jurendini,
Ricardo1; Haddad, Luciana B1; Perini, Marcos1; Yamanari, Mauricio2;
Patzina, Rosely A3; Kunitake, Tiago2; da Cunha, Jose E2
1University of Sao Paulo, Dept. of Surgery, Sao Paulo, Brazil; 2University of
Sao Paulo, Dept. of Gastroenterology, Sao Paulo, Brazil; 3University of Sao
Paulo, Dept. of Pathology, Sao Paulo, Brazil
Introduction. Carcinoma of the ampulla of Vater is the second most
common periampullary cancer and has the best prognosis with high
respectability rate. Synchronized carcinoids of the ampulla of Vater and
minor papilla are rare; however there is only one case of adenocarcinoma
derived from the minor papilla and no case of synchronized adenocarcinoma
of the ampulla of Vater and minor papilla. We describe a case of synchronous
adenocarcinomas of the minor and major papilla.
Case report. A 50 year-old woman presented with pancreatitis,
fluctuant jaundice, weight loss and abdominal pain. Contrast-enhanced
computed tomography and abdominal ultrasound showed slight dilatation
of the biliary tree and gallbladder without calculi. Endoscope demonstrated
tumor protruding from the papilla of Vater. Endoscopically biopsy
diagnosed papillary adenocarcinoma. The patient underwent duodenopan-
createctomy. The specimen taken according to Whipple’s procedure
was fixed in formalin (10%). The tissue was processed routinely, and paraffin
sections were stained with hematoxylin-eosin and periodic acid Schiff
(PAS). Gross examination showed two tumors seen as prolapsed nodules
growing isolated from the minor and major duodenal papillae measuring
1.5 and 1.0 cm respectively, both covered by duodenal mucosa. The bile
and pancreatic ducts of Vater’s papilla and pancreatic duct of Santorini’s
papilla were both constricted by white-grey mass, which extended separated
into the muscularis propria of the duodenum. Microscopically both
tumors consisted of simple or branching glands and papillary formations
surrounded by a desmoplastic stroma. Per neural invasion was extensively
present but vascular or lymphatic invasion was not detected. There were not
lymph node metastases. After surgery, she performed a colonoscopy without
evidence of poliposis, and she is alive 18 months without evidence of
recurrence.
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OILY CHEMOEMBOLIZATION (OCE) FOR THE TREATMENT
OF UNRESECTABLE PANCREATIC CANCER: FURTHER EX-
PERIENCE
Granov, Dmitry; Pavlovskij, Alexander; Tarazov, Pavel
St.Petersburg Research Institute of Roentgenology, Surgery, St.Petersburg,
Russia
Purpose. To study the results of OCE for locally advanced unresectable
pancreatic cancer.
Material and methods. Between 1999 and 2005, we treated 78 pts (33
male, 45 female, ages 3275 years) with morphologically proven ductal
adenocarcinoma of the pancreatic head of stages T3 (n/37) or T4 (n/41),
N0-X, M0. The 41 pts received OCE that was performed as follows. The
angiographic catheter was placed in the tumor-feeding artery and bolus
injection of 200600 mg/sq.m. gemcitabine emulsified in 35 ml Lipiodol
was performed. OCE was repeated with 1- to 2-mo interval. The remaining
pts received celiac artery infusion (CAI) of gemcitabine, 400 600 mg/sq.m
every 2 wks (n/22) or diagnostic angiography only (n/15).
Results. Totally, 41 pts received 125 courses of OCE, 1 to 11 per pt. There
were no treatment-related complications. Clinical improvement was noticed
in 33 (80%) pts. There were 8 partial and 12 minor tumor responses (49%),
10 (24%) stable diseases and 11 (27%) tumor progression. At present,
10 pts are alive including 6 who live more than 1 yr, the longest survival is 67
mo. The 22 pts died from tumor progression within 6 and 24 (mean, 12.9/
5.9) mo. For pts treated with /3 courses the mean survival is 19.4/8.5 mo.
The 1- and 2-year survival is 38.1% and 14.3%. After CAI, clinical
improvement was achieved in 7 (32%) pts with no objective responses.
Stabilization and tumor progression were seen in 6 (27%) and 16 (73%)
patients, respectively. Eight pts are alive for 10 to 19 mo. The 14 pts died in
210 (mean, 5.7/3.9) mo. For pts treated with /3 courses the mean
survival is 12.0/4.5 mo.
Conclusion. OCE is safe and potentially effective treatment for locally
advanced unresectable carcinoma of the pancreas.
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PALLIATIVE SURGICAL MANAGEMENT OF UNRESECTABLE
PANCREATIC CANCER BY HIGH HEPATICODUODENOSTOMY
PLUS GASTROJEJUNOSTOMY
Papapolychroniadis, Costas1; Kaimakis, Dimitrios1; Karagiannopoulou,
Georgia2; Giannoulis, Eleftherios3; Harlaftis, Nikollaos1
1Aristotle University of Thessaloniki, 1st Propedeutical Surgical Departm,
Thessaloniki, Greece; 2Aristotle University of Thessaloniki, Pathology Dept.,
Thessaloniki, Greece; 3Aristotle University of Thessaloniki, 1st Medical
Dept., Thessaloniki, Greece
Background. Pancreatic cancer patients are about 80% with advanced
disease during the first presentation and diagnosis. Curative surgical manage-
ment is unable in this major cohort of patients.
Aim. Hepaticoduodenostomy plus gastrojejunostomy in advanced pancreatic
cancer patients with obstructive jaundice and dysphagia is a satisfactory
palliative surgical procedure to relief the patient from the obstructive
symptoms and signs.
Material and methods. At 1st Propedeutical Surgical Department of
Aristotle University of Thessaloniki, Greece, from September 2003 till
November 2004 were admitted 12 patients with unresectable head pancreatic
cancer. There were 8 men and 4 women with an age range between 50 and 80
years old. All these patients suffered from abdominal pain, anorexia with
body weight loss and jaundice. A preoperative staging research of malignant
disease was carried out with abdominal ECHO, C.T., MRCP, Octreoscan
and total body scan. The patients underwent a preoperative fine needle
biopsy guided by C.T. tomogram. There were no serious postoperative
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complications and gradual relief of the jaundice, about 2 weeks later, was
succeeded. Dysphagia also was disappeared. Follow-up study involved tumor
markers control (CEA, CA 199, CA 50), MRCP and a hepaticoduodeno-
scopy with stoma’s biopsy.
Results. There was a postoperative death from tumoral recurrent hemor-
rhage. A patient died from heart infract 6 months later. The mean survival
was 12 months with a range of 6 to 17. There was satisfactory performance
status of patients and no signs of jaundice or gastric outlet obstruction during
the follow-up period.
Discussion-conclusion. High hepaticoduodenestomy with simultaneous
gastrojejunostomy in advanced unresectable head pancreatic cancer is a
procedure which offers jaundice relief, long-term stoma’s patency without
sings of cancer infiltration and satisfactory total survival results.
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PANCREATIC CARCINOID TUMOR
Lee, Hwa-Soo; Kang, Gil-Ho; Kim, Sung-Yong; Baek, Moo-Jun; Lee,
Moon-Soo; Cho, Moo-Sik; Kim, Chang-Ho
Soonchunhyang University. Cheonan Hospital, Dept. of Surgery, Cheonan,
Korea
Background. Pancreatic localizations of carcinoid tumors are very rare and
can cause obstructive pancreatitis by compression of the pancreatic duct.
Late diagnosis and consequent poor prognosis are usual patterns of
pancreatic carcinoid.
Aim/Objective. The aim is to find the result of surgical resection in one
case of carcinoid tumor which is located in the head of pancreas with
pancreatitis.
Patient and method. One case of pancreatic carcinoid in a 50 year-old-male
presenting as pancreatitis with obstruction of the main pancreatic duct, was
diagnosed by radiologic findings and serologic tests. Abdominal computed
tomography showed the 10-mm sized hyperattenuating tumor and the dilated
pancreatic duct in the body and tail portion with peripancreatic fluid
collection, indicating pancreatitis.
Results. At laparotomy, a 1-cm hard mass was found in the neck of the
pancreas with upstream main pancreatic duct dilatation. Pancreaticoduode-
nectomy was performed with relieved pancreatitis. Immunohistochemical
examination showed tumor cells strongly positive for serotonin, which was
consistent with carcinoid tumor.
Conclusion. A very rare case of pancreatic carcinoid tumor with obstruction
of the main pancreatic duct, presenting as pancreatitis, was treated success-
fully by the surgical resection
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PANCREATIC DUCTAL CARCINOMA: ADJUVANT CHE-
MOTHERAPY AFTER ETENDED PANCREATICODUODENECT-
OMY IS ASSOCIATED TO BETTER SURVIVAL VERSUS
SURGERY ALONE
Iacono, Calogero1; Cantore, Maurizio2; Ruzzenente, Andrea1; Verlato,
Giuseppe3; Facci, Enrico1; Zugni, Chiara1; Campagnaro, Tommaso1;
Fontana, Monica1; Pachera, Silvia1; Guglielmi, Alfredo1
1University of Verona, Dept. of Surgery and Gastroenterology, Verona, Italy;
2Massa Carrara City Hospital, Dept. of Oncology, Massa Carrara, Italy;
3University of Verona, Dept. of Medicine and Public Health-Unit of, Verona,
Italy
Background and aims. The present observational study aims at evaluating
whether survival is increased in patients undergoing also adjuvant chemother-
apy(ACT) with respect to patients undergoing surgery alone. The rational for
this treatment is to combine local control of the disease, achieved by
Extended Pancreaticoduodenectomy (EPD), with control of distant metas-
tases, achieved by adjuvant treatment.
Patients and methods. From January 1994 to October 2005, 84 patients
underwent EPD for periampullary cancer. Fifty-four patients suffering from
ductal pancreatic carcinoma were included in this study. From July 1998, 20
of this patients received ACT and long-term outcome in these patients was
compared with that of 34 who did not receive ACT. Fifteen of 20 patients
received intra-arterial chemotherapy employng FLEC regimen (5-fluoruracil
750 mg sqm-1, leucovorin 75 mg sqm-1, epirubicin 45 mg sqm-1,
carboplatin 225 mg sqm-1 administered every three weeks in to coeliac
axis for three cycles), in 7 cases followed by systemic gemcitabine (at the
dosage of 1 mg sqm-1 on days 1, 8, 15 every 4 weeks for three months); five
of 20 patients received others type of adjuvant treatments.
Results. The two group were comparable for gender, age, grading, tumor size,
stage, N status, R0 or R1 resection. Median follow up time was 16, 5 months.
The overall mean and median survival was 40, 9 months and 18 months (range
4136), respectively, with actuarial 1, 3 and 5-year survival rates of 70, 4, 36, 9
and 18, 9%, respectively. Significant difference in mean survival (47 vs 30
months, pB/0.05) and actuarial 5-year survival rates (52 vs 10%, pB/0.05) was
seen between those who received and those who did not receive ACT. The
ACT significantly influenced distant recurrence rate (45% vs 85%, pB/0.05)
but did not reduced local recurrence rate (20% vs 35%, p/0, 2)
Conclusion. ACT is associated with long-term survival and decreased
distant recurrence rates in patients with pancreatic cancers who have
undergone EPD.
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PANCREATIC SEROUS OLIGOCYSTIC ADENOMAS: CLINICO-
PATHOLOGICAL FEATURES AND A COMPARISON WITH SER-
OUS MICROCYSTIC ADENOMAS AND MUCINOUS CYSTIC
NEOPLASMS
Goh, Brian KP1; Tan, Yu-Meng2; Yap, Wai-Ming3; Cheow, Peng-Chung1;
Chow, Pierce KH1; Chung, Yaw-Fui A1; Wong, Wai-Keong1; Ooi, London
LPJ2
1Singapore General Hospital, General Surgery, Singapore; 2National Cancer
Centre, Surgical Oncology, Singapore; 3Singapore General Hospital, Pathol-
ogy, Singapore
Background. The preoperative distinction between serous cystic neoplasms
(SCN) and mucinous cystic neoplasms (MCN) is essential as all MCN are
considered malignant or potentially malignant and should be surgically
resected whereas SCN are almost always benign. However, the radiological
distinction between SCN and MCN is frequently difficult especially with
serous oligocystic adenoma (SOA), a morphological variant of SCN.
Aim. We reviewed all SOA managed at our institution to determine any
clinicopathological features which might prove useful in establishing a
preoperative diagnosis.
Methods. Over a 15-year period, 64 patients with a pathologically con-
firmed diagnosis of a pancreatic cystadenoma or cystadenocarcinoma treated
were retrospectively reviewed. There were 27 MCN and 37 SCN including 12
SOA. In addition, 40 cases of SOA previously reported in the literature were
reviewed and analyzed together with the 12 patients; making a series of 52
SOA.
Results. SOA comprised 32% of SCN and females predominated (7/12). The
median age of patients was 43 (range, 2274) years and only 4 of 12 patients
were symptomatic. The majority of cysts were located in the body or tail of the
pancreas (9/12) and the median cyst size was 53 (range, 10190) mm. There
was no difference between patients with SOA and SMA in terms of age, sex,
presence of symptoms, cyst size and site of lesion. However, SOA occurred in
females less frequently (67% vs 96%, p/0.004), were smaller [40 (range, 10
190) mm vs 95 (range, 25180) mm, pB/0.001] and occurred more
commonly in the head of pancreas [25(48%) vs 2(7%)] compared too
MCN. None of the SOA compared to 30% of MCN were frankly malignant.
Conclusion. SOA and SMA have similar clinicopathological features. On the
other hand, SOA differs from MCN by its relatively higher male to female ratio,
higher frequency of tumors occurring in the head of pancreas and smaller cyst
size.
P43.47
PANCREATICODUODENECTOMY FOR AMPULLARY ADENO-
CARCINOMA: T-STAGE, CHROMOSOME 17P ALLELIC LOSS
AND EXTENDED RESECTION ARE RELEVANT PROGNOSTIC
FACTORS
Iacono, Calogero1; Verlato, Giuseppe2; Zamboni, Giuseppe3; Scarpa, Aldo3;
Montresor, Ettore1; Capelli, Paola3; Bortolasi, Luca1; Serio, Giovanni1
1University of Verona, Departement Of Surgery and Gastroenterology,
Verona, Italy; 2University of Verona, Dept. of Medicine and Public Health,
Verona, Italy; 3University of Verona, Departement of Pathology, Verona,
Italy
Background and aim. There are discordant data on factors affecting
prognosis in AAV. To evaluate the prognostic significance of different clinico-
pathological and molecular factors, and to compare survival after standard and
extended pancreaticoduodenectomy (PD) in adenocarcinoma of the ampulla
of Vater (AAV).
Patients and methods. Clinical-pathological factors were evaluated in fifty-
nine patients, subjected to PD for AAV; in 42 subjects information on
chromosome 17p and 18q allelic losses (LOH) and microsatellite instability
(MSI) was also available. The association between survival and type of PD was
investigated in the twenty-five patients operated between 19902001 (16
standard and 9 extended).
Results. The overall 5 and 10-year tumor-related survival rates were 46%
and 33%, respectively. Sixteen patients had T-stage 12, 14 T-stage 3, and
29 T-stage 4 cancers. Chromosome 17p and 18q LOH were detected in 23
(55%) and 15 cases (36%) respectively, and in 12 cases (29%) coexisted.
Five cases were MSI-positive (12%). At univariate analysis, poor survival
was associated with cancer ulceration (P/0.051), poor differentiation (P/
0.008), T-stage 4 (PB/0.001), nodal metastases (P/0.004), chromosome
17p (PB/0.001) and 18q LOH (P/0.002) and absence of MSI (P/0.009).
At multivariate analysis, only T-stage (P/0.002) and 17p LOH (P/0.001)
were independent predictors of survival. All patients with MSI-positive
cancers were long-survivors (/12 yrs), while only 30% of MSI-negative
cancer patients survived at 5 years. Extended PD was associated with a 3-
year disease-related survival longer than standard resection (83% vs 31%;
P/0.018).
Conclusion. MSI and chromosome 17p status allow to better define
prognosis within ampullary cancers at the same stage. Surgery alone resulted
curative in MSI-positive cancer patients, while it was inadequate in patients
showing allelic losses, who might benefit from adjuvant therapy. In this
observational study extended PD was associated with increased survival
compared to standard procedures.
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PANCREATICODUODENECTOMY: THE INCIDENCE OF BE-
NIGN DISEASE IN CASES OF SUSPECTED BUT UNPROVEN
MALIGNANCY
Hammond, John; Mitchell, James; Doran, John; Lobo, Dileep; Rowlands,
Brian; Beckingham, Ian
University Hospital Nottingham, Dept. of Surgery, Nottingham, UK
Background. Pre-operative confirmation of peri-ampullary and pancreatic
malignancy remains challenging. As a result some patients may undergo
pancreaticoduodenectomy for suspected malignant lesions that turn out to be
benign.
Aim. To establish the incidence of benign disease in patients undergoing
pancreaticoduodenectomy for suspected but unproven malignancy.
Methods. A retrospective analysis of patients that underwent pancreatico-
duodenectomy for suspected malignancy between January 2000 and August
2005 was performed.
Results. Of the 57 patients that underwent pancreaticoduodenectomy for
malignancy, 9 (15.8%) turned out to have benign disease (6/chronic
pancreatitis, 2/Brunner’s gland hyperplasia, 1/pancreatic serous cystade-
noma). Pre-operative confirmation of malignancy was not obtained in 22
patients (38.6%). The false-positive rate for these suspected but unproven
malignancies was 9 out of 22 (40.9%). One of the 9 patients (11.1%) died;
there were no other serious post-operative complications.
Conclusion. Pancreaticoduodenectomy offers a cure for pancreatic and peri-
ampullary tumours. However, the difficulty in confirming diagnosis pre-
operatively results in a number of patients with benign disease being
subjected to major surgery. If this treatment is undertaken at a specialist
centre this approach is justified.
P43.49
PERIOSTIN CREATES A TUMOR SUPPORTIVE MICROENVIR-
ONMENT IN THE PANCREAS BY SUSTAINING FIBROGENIC
STELLATE CELL ACTIVITY
Erkan, Mert1; Kleeff, Jorg1; Gorbachevski, Andre´1; Reiser, Carolin1; Mitkus,
Tomas1; Esposito, Irene2; Giese, Thomas3; Buchler, Markus W1; Giese,
Nathalia A1; Friess, Helmut1
1University of Heidelberg, General Surgery, Heidelberg, Germany; 2Uni-
versity of Heidelberg, Pathology, Heidelberg, Germany; 3University of
Heidelberg, Immunology, Heidelberg, Germany
Background. Pancreatic cancer creates an excessive desmoplasia by
stimulating stellate-cells, thereby influence tumor aggressiveness.
Aim. To analyze the impact of the pancreatic stellate-cell specific matrix
protein, periostin, on tumor responses to radio-chemotherapy.
Methods. Stellate-cancer cell interactions in primary and metastatic lesions
of patients treated with and without neoadjuvant radio-chemotherapy were
evaluated by immunohistochemistry and immunoblotting. Periostin mRNA
levels determined by quantitative RT-PCR were correlated to patient survival.
In vitro, interactions of stellate-cancer cells and the effects of periostin in
modulation of cellular responses under hypoxia, starvation and radio- and
chemotherapy were assessed by immunoblotting, growth, clonogenitiy and
invasion-assays.
Results. Stellate-cells are the only source of periostin in the pancreas and its
mRNA levels are 42-fold elevated in cancer. Patients with periostin mRNA
expression above the normal range had tendency for a shorter survival
(19mo vs. 12mo, p/0.14). In primary and metastatic sites, tumor cells
ostensibly trigger periostin secretion by stimulating local a-smooth muscle
actin-positive cells. In vitro, cancer-cell supernatants, hypoxia and g-radiation
upregulated periostin expression in cultured primary human stellate-cells.
Moreover, periostin increased collagen-1, TGF-b1 and its own mRNA
expression, significantly reduced stellate-cell invasivity (p/0.02), and
sustained their active state, which was otherwise suppressed by radiotherapy.
In cancer cells, collagen-1 increased chemoresistance significantly (p/0.03)
and periostin stimulated growth, conferred resistance to starvation and
hypoxia.
Conclusion. Once stimulated by cancer cells, stellate-cells remain active via
an autocrine periostin-loop even under radiotherapy and produce excessive
collagen-1, creating a tumor supportive microenvironment. Increased peri-
ostin expression may therefore reflect a more aggressive tumor phenotype.
P43.50
PHASE I/II TRIAL ASSESSING THE SAFETY AND EFFICACY OF
RADIO LABELLED ANTI-CARCINOEMBRYONIC ANTIGEN
ANTIBODIES IN UNRESECTABLE PANCREATIC CANCER
Sultana, A1; Shore, S1; Vinjamuri, S2; Evans, JC3; Tudur Smith, C4;
Chauhan, S1; Bosonnet, L1; Garvey, C3; Neoptolemos, JP1; Ghaneh, P1
1Royal Liverpool University Hospital, Division of Surgery and Oncology,
Liverpool, UK; 2Royal Liverpool University Hospital, Dept. of Nuclear
Medicine, Liverpool, UK; 3Royal Liverpool University Hospital, Dept. of
Radiology, Liverpool, UK; 4University of Liverpool, Centre for Medical
Statistics, Liverpool, UK
Background. Advanced pancreatic cancer has a very poor prognosis and
novel treatments may improve the outlook.
Aims. This study aimed to evaluate the safety and tolerability of KAb 201, an
iodine 131 (I131) labelled anti-carcinoembryonic antigen (CEA) monoclonal
antibody. Pharmacokinetics, antigenicity and efficacy of KAb 201 were also
assessed.
Methods. Patients with histologically/cytologically proven, advanced adeno-
carcinoma of the head of pancreas were randomised to either the intra-
arterial (i.a.) or intravenous (i.v.) arms. Following a positive dosimetry scan, a
therapeutic dose of Kab 201 was given. Patients were assessed for safety and
efficacy and followed up until death.
Results. Between February 2003 and July 2005, 24 patients were enrolled.
Nineteen patients (median age 60 years, range 4767 years; median
Karnofsky Performance Status [KPS] 80, range 70100; stage IVa/8; stage
IV b/11) were randomised, 9 to the i.v and 10 to the i.a. arm. Eighteen
patients received the treatment dose (one patient had a negative dosimetry
scan). In the i.a. arm, dose limiting toxicity (DLT) was seen at in 2/6 (33%)
patients at 50 mCi whereas in the i.v. arm, DLT was noted in 1/6 (17%)
patients at 50mCi, but did not occur at 75 mCi (0/3). Median overall survival
was 5.6 months (inter quartile range/3.311.1 months; range/2 to 15
months) from study entry, with no significant difference between the i.v and
i.a arms on Kaplan Meier analysis (log rank p/0.65). Two patients were
alive at the time of this analysis, at 9 and 13 months respectively. Patients with
KPS scores of 90/100 survived significantly longer than those with KPS of
70/80 (log rank p/0.048) {provisional results}.
Conclusions. Dose limiting toxicity for KAb 201 by the i.a. route was 50
mCi, while DLT was not reached in the i.v. arm. A good performance status
was associated with a survival advantage. Acknowledgement: Xenova
Biomedix sponsored this study.
P43.51
PIN1 IS NOT OVEREXPRESSED IN HUMAN PANCREATIC
DUCTAL ADENOCARCINOMAS
Doucas, Helena1; Sutton, Christopher D1; Garcea, Guiseppe1; Neal,
Christopher P1; Manson, Margaret M2; Dennison, Ashley R1; Berry,
David P1
1Leicester General Hospital, Hepatobiliary and Pancreatic Surgery, Leice-
ster, UK; 2University of Leicester, Leicester, UK
Background and aims. Pin1 is responsible for catalysing the change
between cis and trans isomers in proteins containing the Ser/Thr-Pro motif,
and can therefore affect the activity of a variety of proteins. Recently it has
been recognised that Pin1 is overexpressed in many human malignancies,
including breast and prostate cancers. Pin1 has been shown to increase
expression of oncogenic proteins, including b-catenin and cyclin D1. The
expression of Pin1 in pancreatic adenocarcinomas has not previously been
described.
Methods. An immunohistochemical study was performed on prospectively
collected samples of pancreatic tissue. Twenty three cases of human
pancreatic ductal adenocarcinoma and 12 samples of normal pancreas were
assessed for the expression of Pin1, b-catenin, and cyclin D1.
Results. Pin1 staining was rarely observed in benign pancreatic ductal tissue.
However, pancreatic islets were noted to stain very strongly in all specimens.
Most tumour samples did not stain for Pin1, but some staining was observed
in 30.4% of cases. The stain was cytoplasmic in location, and tended to affect
only a small percentage of the tumour specimen. This level of overexpression
was not statistically significant. Cyclin D1 overexpression was demonstrated
in tumour specimens, but there was no correlation between its expression and
Pin1 expression, nor between Pin1 and b-catenin expression. There was no
correlation between Pin1 staining and clinical features such as tumour size,
presence of metastases, or survival.
Conclusions. Despite the fact that Pin1 is overexpressed in several human
malignancies, these data do not provide any evidence for its role in pancreatic
carcinogenesis.
P43.52
PORTAL VENOUS RESECTION FOR DUCTAL ADENOCARCI-
NOMA OF THE HEAD OF THE PANCREAS
Spalding, Duncan1; Hutchins, Robert2
1Hammersmith Hospital, London, UK; 2Royal London Hospital, London,
UK
Background. Although surgical resection remains the only potentially
curative treatment for pancreatic ductal adenocarcinoma (PDA), only 10
20% of patients are resectable. This low resectability rate reflects the
advanced stage of the disease at the time of presentation, with approximately
50% of patients having distant spread and one-third locally advanced disease.
Although most agree that distant metastases is an absolute contraindication
to resection, the clinical benefit of resection of the portal vein (PV) when
isolated local invasion is present remains controversial. The aim of this study
was to assess the outcomes of proximal pylorus preserving pancreatoduode-
nectomy (PPPP) with PV resection for PDA based on the experience of two
pancreatic units in affiliated university hospitals
Methods. PPPP with PV resection was performed on 8 patients when
isolated local invasion was found at operation between 20022005.
Histology and the clinical outcome were reviewed.
Results. There were 3 men and 5 women of median age 56 (range 4772)
years. Histology revealed PDA in all (1 well, 4 moderately and 3 poorly
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differentiated), invasion of the PV (n/6), positive lymph nodes (n/4) and
positive resection margins (n/2). There was no operative mortality and
morbidity was 37.5% (late re-exploration for bleeding secondary to pancrea-
tic leak 1, abdominal collection 1, gastric stasis 1). Six patients had adjuvant
chemotherapy (gemcitabine 3, gemcitabine and local radiotherapy 2, 5-FU
1). At a median follow-up of 11 (range 442) months, 3 patients had died of
recurrent disease (all had PV invasion and positive lymph nodes, 2 were
poorly differentiated and 1 moderately differentiated with positive margins).
The patient with well-differentiated PDA had evidence of recurrence at 32
months but was alive and well.
Conclusions. Resection of the PV to ensure free margins is appropriate if
vein involvement is discovered during operation. This extension of the
procedure does not increase operative mortality or morbidity.
P43.53
POSSUM DOES NOT PREDICT MORBIDITY BUT DOES PRE-
DICT SURVIVAL IN PATIENTS WHO UNDERGO PANCREATIC
SURGERY
de Castro, Steve; Houwert, Taco; Lagarde, Sjoerd; Busch, Olivier; van Gulik,
Thomas; Gouma, Dirk-Jan
Academic Medical Center, Surgery, Amsterdam, Netherlands
Background. Comparison of operative morbidity rates after bypass surgery
for unresectable pancreatic cancer between units may be misleading because
it does not account for the physiological variation of the condition of the
patient.
Aim(s)/Objective(s). The aim of this study was to evaluate the Physiolo-
gical and Operative Severity Score for the enUration of Mortality and
Morbidity (POSSUM) for these patients and to analyse whether POSSUM
can predict long-term outcome in these patients.
Methods. Between January 1993 and December 2003, 241 patients had
unresectable pancreatic cancer at exploratory laparotomy and underwent a
double bypass procedure consisting of a gastrojejunostomy and a hepatico-
jejunostomy. The performance of POSSUM was evaluated by assessing the
‘‘goodness-of-fit’’ using the linear analysis method. The outcome prediction
of POSSUM was also compared with long-term survival using the Kaplain-
Meyer method. The median POSSUM score was used as cut-off to create
two groups. These two groups consisted of patients with high postoperative
morbidity (HPM) and low morbidity (LPM) score.
Results. Overall, 64 of 241 patients (26.6%) had one or more complication
after bypass surgery and 4 patients (2%) died. POSSUM predicted morbidity
in 114 patients (47.3%). The O:P (observed: predicted) ratio for morbidity
was 0.56 and the model had a significant lack of fit (pB/0.001) using
‘‘goodness-of-fit’’ analysis. The overall median survival was 7 months. The
median survival was significantly higher in patients with a low postoperative
morbidity score (HPM 6 months versus LPM 9 months, P/0.02).
Conclusion. Overall, POSSUM overpredicted morbidity and had a lack of
calibration of in patients who underwent bypass surgery for unresectable
pancreatic cancer. However, POSSUM could be useful in determining long-
term outcome and aid in the decision to perform a prophylactic gastro-
jejunostomy.
P43.54
PREOPERATIVE ENDOSCOPIC BILIARY STENTING FOR DIS-
TAL MALIGNANT BILIARY OBSTRUCTION
Vladov, Nikola1; Sergeev, Sergei1; Takorov, Ivelin1; Katzarov, Krum2;
Dimov, Petko1; Belev, Nikolai1; Odiseeva, Evelina3
1Military Medical Academy, Clinic of Hepato-Biliary and Pancreatic
Surgery, Sofia, Bulgaria; 2Military Medical Academy, Clinic of Gastroenter-
ology and Hepatology, Sofia, Bulgaria; 3Military Medical Academy, Clinic of
Critical and Intensive Care, Sofia, Bulgaria
Background. Obstruction of common bile duct is one of the most common
signs of pancreatic head cancer. It leads to increased values of holostatic
enzymes, followed by increase of serum bilirubin levels. Obstructive jaundice
is associated with postoperative complications related to increased endotox-
aemia and the inflammatory response.
Aim. To evaluate the effects of preoperative endoscopic biliary decompression.
Methods. From January 2005 to January 2006, endoscopic stent placement
was done in 41 patients with pancreatic head cancer. 7 of them had only
malignant obstruction detected with endoscopic retrograde cholangiopancrea-
tography (ERCP) and increased holostatic enzymes. The rest 34 had developed
obstructive jaundice. Average bilirubine level was 196 mmol/l (from 22 to 569
mmol/l).For the sameperiod44patientswithpancreatic cancerwereoperated in
our Dept.. 38 (86.4 per cent) of them had pancreatic head cancer. 25 radical
resections and 19 drainagee procedures were done. 22 of stented patients
underwent operation, while the remaining 19 patients were with advanced
disease unsuitable for surgical treatment. Preoperative endoscopic stenting was
performed in 14 of radically operated patients, 2 of them underwent surgical
biliary bypass, and the rest 9did not undergo any form of biliary decompression.
Results. The bilirubine level decreased with 35% for the week after stenting.
All stented patients received infusions, antibiotics and hepatoprotectors for
prophylaxis of cholangitis. Endoscopic stent insertion was followed by
operation approximately 9 days later. The group of stented patients had a
similar mortality and morbidity compared with the pancreatoduodenec-
tomies and drainage operations made in non-stented patients.
Conclusions. The preoperative biliary stenting is an effective method for
overcoming the malignant obstruction of common bile duct and does not
increase operative mortality and morbidity rates.
P43.55
PREOPERATIVE STAGING OF PANCREATIC, PERIAMPULLARY
AND AMPULLARY TUMOURS: A TWO YEAR RETROSPECTIVE
COMPARISON OF IMAGING WITH OPERATIVE CORRELATION
Robinson, Mark1; Richards, Dafydd2; Brown, Tim3; Griffiths, Paul4
1University Hospital Wales, Radiology, Cardiff, UK; 2Swansea NHS Trust,
Radiology, Swansea, UK; 3Swansea NHS Trust, Surgery, Swansea, UK;
4Swansea NHS Trust, Pathology, Swansea, UK
Background. Recent guidelines recommend the selective use of imaging in
the preoperative staging of patients with pancreatic, periampullary or
ampullary tumours.
Aims. To review the accuracy of multidetector computed tomography
(MDCT) and endoscopic ultrasound (EUS) in detecting and determining
tumour resectability in patients with suspected pancreatico-biliary malig-
nancy by comparison with surgical findings.
Methods. The imaging and surgical records of patients who underwent
pancreatic resection or bypass in 2004/5 were reviewed and correlated.
Standard staging performed using MDCT, with EUS in patients fit for
surgery without metastatic disease. EUS was used to assess local resectability
but also to identify tumour poorly seen on MDCT or obtain histology.
Imaging signs of invasion of portal vein, superior mesenteric vein or superior
mesenteric artery were considered predictive of irresectability. Cystic
pancreatic tumours were excluded.
Results. 27 patients underwent resection or bypass surgery (17 pancreatic
adenocarcinoma, 5 ampullary tumours, 2 cholangiocarcinomas, 2 neuroen-
docrine tumours and 1 benign disease). All had MDCT which showed a
sensitivity of 0.87, specificity of 0.75, /ve predictive value of 0.95 and /ve
predictive value of 0.5 for indicating a successful surgical resection. For the
15 patients having successful EUS, the values were 1.0, 0.75, 0.92 and 1.0
respectively. There were 4 technically unsatisfactory studies, 4 patients with
ampullary tumours in whom EUS was not performed and 4 patients for
whom the scope was not available.
Conclusion. MDCT has a tendency to over-call vascular invasion but this is
not the case with EUS. In patients being considered for surgical resection,
staging with MDCT is mandatory with EUS being reserved for those patients
in whom CT suggests vascular invasion.
P43.56
PROGNOSTIC FACTORS DETERMINING LONG-TERM SURVI-
VAL FOLLOWING DISTAL PANCREATECTOMY FOR PANCREA-
TIC CANCER
Nishioka, Ryohei; Tani, Masaji; Kawai, Manabu; Shimamoto, Tetsuya;
Miyazawa, Motoki; Uchiyama, Kazuhisa; Yamaue, Hiroki
Wakayama Medical University Hospital, Surgery, Wakayama, Japan
Background. Prognosis of pancreatic cancer is dismal. Five-year survival
rate especially following distal pancreatectomy (DP) for pancreatic cancer
have been reported to be approximately 10%.
Objectives. We examined factors influencing long-term survival after DP for
pancreatic cancer.
Methods. Between January 1990 and December 2005, 46 patients under-
went DP for pancreatic cancer at our institute. We retrospectively examined
clinicopathological factors determining long-term survival in these patients.
Results. Overall median survival time (MST) was 275 days. Several tumor
characteristics proved to be important prognostic predictors. Factors shown
to have favorable prognostic significance were well tumor differentiation (pB/
.0001), absence of invasion to retropancreatic tissue (p/.0381), less
remarkable venous infiltration (p/.0276), absence of distant lymph node
metastasis (p/.0079). Negative resection margin tended to be a significant
prognostic factor (p/.0527), and complete surgical resection with no
residual tumor proved to be a significant factor for long-term survival (p/
.0006). Tumor infiltration into lymphoid vessels or invasion to extrapancrea-
tic neural plexus (superior mesenteric plexus or celiac plexus) has been shown
to be less significant predictive factors for postoperative survival.
Conclusion. Complete resection is important for long-term survival. In DP
for pancreatic cancer, surgical procedure ensuring negative resection margin
is considered to be crucial for better outcome.
P43.57
PROTEOMIC ANALYSIS AND CLINICAL CORRELATION OF
PHOSPHOGLYCERATE KINASE-1 (PGK-1) IN PANCREATIC
ADENOCARCINOMA
Hwang, Tsann-Long; Liang, Ying; Lo, Chih-Hong; Jan, Yi-Yin; Chen, Miin-
Fu
Chang Gung Memorial, Chang Gung University, Dept. of Surgery, Taipei,
Taiwan
Background. For novel molecular diagnosis of pancreatic cancer, proteomic
analysis of proteins expressed in clinical samples should provide as an
alternative.
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Aim. New biomarker of pancreatic cancer may be detected with genomic
and proteomic methods, which can be further proven its function with
SiRNA. The possible new biomarker may be used for novel diagnosis and
therapy for pancreatic cancer.
Methods. Pancreatic tumors and adjacent normal tissues from pancreatic
cancer patients (43 males and 20 females), as well as 21 serum samples were
collected from 1993 to 2005. The protein profiles between pancreatic cancer
specimens and the adjacent non-tumor tissues by 2-DE and MALDI-TOF
MS. The significant protein was further proven by immunohistochemical
staining and Western blotting. Its function was also confirmed by SiRNA
using nude mice. The new biomarker in each patient’s serum or tumor tissue
was compared with his clinical outcome.
Results. Twenty-one proteins are overexpressed in pancreatic cancer. One of
them, phosphoglycerate kinase (PGK-1), was chosen for further examination
by immunohistochemistry and SiRNA. We demonstrated that more than
70% of pancreatic cancer samples showed moderate to high level of PGK-1
expression as compared to the normal counterparts. Significantly higher
levels of PGK-1 were detected by ELISA in serum samples as compared to
those from the control group. The patient with higher level of PGK-1 had
longer survival time.
Discussion. PGK-1 is known as the seventh enzyme of glycolytic pathway,
which could be secreted by several tumor cell lines and participates in the
angiogenic process as a disulphide reductase. The possible application of
serum PGK-1 level as a serological diagnostic marker and the biological
significance of elevated PGK1 expression in pancreatic cancer are currently
further investigated.
Conclusion. PGK-1 as we found has its potential use for new biomarker of
pancreatic cnacer, which may be due to its angiogeneicity.
P43.58
ROLE OF TP AND OPRT GENE EXPRESSION AND ITS RATIO
TO DPD ON PROGNOSIS AND CLINICOPATHOLOGICAL FEA-
TURES IN PANCREATIC CANCER PATIENTS
Miyake, Kotaro; Imura, Satoru; Ikemoto, Tetsuya; Morine, Yuji; Fujii,
Masahiko; Soejima, Yuji; Shimada, Mitsuo
Institute of Health Biosciences, The University of Tokushima Graduate
School, Digestive and Pediatric Surgery, Tokushima, Japan
Background and aims. Thymidine Phosphorylase (TP), orotate phosphor-
ibosyltransferase (OPRT) and dihydropyrimidine dehydrogenase (DPD) are
important enzymes of DNA de novo synthesis and the salvage pathway in
cancer cells. In this study, we investigated the intratumoral TP, OPRT, DPD
expressions to determine the correlation between the gene expression of the 3
enzymes and clinicopathological features in pancreatic cancer.
Methods. Gene expressions in pancreatic cancer were analysed by a real-
time reverse transcriptional-polymerase chain reaction method in 25 patients.
Results. The median values of TP and OPRT mRNA expressions were 5.10
and 0.83. Apart from infiltrating patterns and differentiation, TP and OPRT
showed no correlation with clinicopathologic factors. TP gene expression was
lower in infiltrating patterns of alpha cases than other cases (pB/0.05). OPRT
gene expression was higher in poorly differentiated type cases than
differentiated type cases (pB/0.05). When the median value of the TP/
DPD ratio in our institute was selected as the cutoff value, patients with a low
TP/DPD ratio survived statistically longer than those with a high ratio (PB/
0.05).
Conclusion. Both the expression of TP and OPRT gene and its ratio to
DPD might be useful as prognostic and clinicopathological parameter in
pancreatic cancer patients.
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SHOULD DISTANT METASTATIC LYMPH-NODES MODIFY
SURGICAL TREATMENT OF PERIAMPULLARY CARCINOMA?
Lesurtel, Mickael; Schwarz, Lilian; Parc, Rolland; Tiret, Emmanuel; Paye,
Francois
Saint Antoine Hospital, Dept. of Digestive Surgery, Paris, France
Introduction. In periampullary carcinoma, it remains unclear whether
pancreatic resection should be performed in patients with distant metastatic
lymph-nodes.
Aim/Objective. We compared the outcome of patients with a palliative
bypass indicated because of interaortocaval metastatic lymph-nodes found at
laparotomy with patients whose carcinoma appeared intra-operatively non
respectable for other causes.
Methods. Between 1995 and 2005, 120 patients underwent a palliative
biliary and gastric bypass for periampullary carcinoma that appeared
unresectable at laparotomy. Forty-six patients had systematic interaorticoca-
val picking with frozen sections (group P). In the other 74 patients, no picking
was performed and contraindications to resection were metastases, non-
resectable vascular involvement or peritoneal implants (group NP). Among
group P, 23 patients had metastatic interaorticocaval lymph-nodes which
were the only contraindication to pancreatic resection (group P/). In 23
other patients, the interaorticocaval picking was negative and the contra-
indication to resection was vascular invasion (group P/).
Results. Post-operative morbidity and mortality rates were non different in
group P compared to group NP. Median survival was not different among
group P/ (14 months), patients with peritoneal implants (10 months), and
patients with vascular involvement (9 months). Only patients with liver
metastases had a significant worse median survival than group P/ (6 vs 14
months, p/0.02). Main causes of death were liver metastases in group P/
(60% vs 29% in group P/) and local involvement in group P/ (71% vs 26%
in group P/) (p/0.03).
Conclusion. In periampullary carcinoma, interaorticocaval picking with
frozen sections is not associated with an increased morbidity. Following
palliative surgery, metastatic interaorticocaval lymph-nodes are associated
with a survival as poor as other consensual contraindications to resection.
These results prompt us to perform a systematic interaorticocaval picking
before pancreaticoduodenectomy.
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FIXED DOSE RATE INFUSION OF GEMCITABINE VIA ARTER-
IAL CATHETER IN UNRESECTABLE PANCREATIC CARCI-
NOMA
Okada, Yuji; Matsuo, Youichi; Funahashi, Hitoshi; Sawai, Hirozumi;
Manabe, Tadao
Nagoya City University, Graduate School of Medical Sciences, Dept. of
Gastroenterological Surgery, Nagoya, Japan
Background. Pancreatic carcinoma is an extremely lethal disease, 5 years
survival rate after the curative resection is still around 10%. The new strategy
for this disease should be established immediately. Recently, Gemcitabine
(2?-2? difluorocytidine monohydrochloride) has been used as a therapeutic
agent for pancreatic cancer, and the response rate was increased, compared
to the conventional 5-fluorouracil protocol. However, the result is far away
from our satisfaction. A few article revealed that the fixed dose-rate
gemcitabine infusion (FDR-GEM) had the pharmacokinetic advantage and
might result in improved therapeutic efficacy. Moreover, intra-arterial
chemotherapy with GEM was done widely to improve the response of
chemotherapy.
Aim. The aim of this study was to clarify the benefit of the combination
therapy of radiation and FDR-GEM via arterial catheter in unresectable
pancreatic carcinoma.
Methods. Between January 2004 and December 2004, 3 patients with
advanced-stage unresectable pancreatic carcinoma were treated with both 56
Gy full dose radiation and FDR-GEM. Gemcitabine was administered at a
dose of 600 mg/m2 once weekly for consecutive weeks of every 4 weeks using
an arterial catheter, and was infused at the FDR of 10 mg/m2 per minute
(100 minutes of total infusion time).
Results. All 3 cases showed partial response rate (100%, 3 of 3), although
there was no cases of complete response. The most common toxicities were
hematological events. No patients died of adverse effects using this
chemoradiation therapy. All 3 cases survived over 1 year. The anti cancer
effect could continue only 68 months, and after this period, the
chemotherapy protocol was required to be changed.
Conclusion. Although the number of cases using the FDR-GEM was a very
few, this combination therapy was well tolerated and might be the hopeful
therapy for unresectable pancreatic carcinoma.
P43.61
SPONTANEOUS RUPTURE OF MUCINOUS CYSTADENOMA OF
PANCREAS
Biswas, Atindriya1; Carp, Lauren2; Bhattacharya, Satyajit1
1St Bartholomew’s and Royal London Hospitals, HPB Surgery Unit,
London, UK; 2St Batholomew’s and Royal London Hospitals, Dept. of
Histopathology, London, UK
Background. Mucinous cystic neoplasms (MCN) of pancreas, which have
varying potential for malignancy, comprise about 1045% of all cystic
neoplasms of the pancreas (CNP). Spontaneous rupture of these tumours is
very rare.
Aims. We report here a patient with mucinous cystadenoma (MCA), who
presented with spontaneous rupture and intra-peritoneal haemorrhage.
Methods and results. A 59-year old lady was admitted with sudden severe
abdominal pain and loss of consciousness. She had suffered a blunt injury to
her abdomen 3 years ago, a year after which she presented to her local
hospital with a pancreatic cyst. There was a suggestion that it might be a post-
traumatic pseudocyst. It was aspirated on one occasion before, but filled up
again. On her arrival at our hospital, she was in hypovolaemic shock. CT scan
revealed haemoperitoneum and a large cystic lesion involving the body and
tail of the pancreas. An intraperitoneal drain was inserted and drained frank
blood. She was initially treated conservatively with fluid resuscitation and
blood transfusion, and was operated on after an initial 12-hour period of
stabilisation. On laparotomy, a large ruptured cyst was found in the body and
tail of the pancreas and it difficult to tell if this lesion was neoplastic or
inflammatory. Distal pancreatectomy with splenectomy was performed.
Subsequent examination of the specimen proved it to be a mucinous
cystadenoma. She made a good recovery and remains well. This is an
exceedingly rare mode of presentation of a cystic neoplasm. Our review of the
literature has revealed only 2 other reports of spontaneous rupture of MCA.
Discussion and conclusion. Pancreatic cysts developing after an abdom-
inal trauma and cysts that rupture spontaneously should not be assumed to
be pseudocysts. Neoplasms should always be considered in the differential
diagnosis, and if there is doubt, the lesion should treated as a tumour until
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proved otherwise. This is particularly important because of the malignant
potential of MCNs.
P43.62
INVESTIGATION AND MANAGEMENT OF PANCREATIC
NEUROENDOCRINE TUMOURS
Bhattacharya, Satyajit1; Coyle, Frances2; Monson, John3; Hutchins, Robert
Raynor1
1St Bartholomew’s and Royal London Hospitals, HPB Surgery Unit,
London, UK; 2St Bartholomew’s and Newham University Hospitals,
Endocrinology, London, UK; 3St Bartholomew’s Hospital, Endocrinology,
London, UK
Background. Diagnosis of pancreatic neuroendocrine tumours (NETs) is
often a challenge and involves biochemical characterisation and anatomic
localisation of the tumour. Wherever feasible, curative surgical excision is the
treatment of choice.
Aims. We retrospectively analysed the surgical management of all patients
with pancreatic NETs at our HPB Unit.
Methods. All consecutive patients with pancreatic NETs referred for
consideration of surgery over a six-year period (19992005) were analysed.
Following use of multi imaging modalities to localise, all were operated on by
the same surgical team.
Results. Twenty-four patients underwent surgical resection (11 women, 13
men; age 2177 years, median 53). Sixteen tumours secreted known
hormones (11 insulinomas, 1 somatostatinoma, 1 gastrinoma, 1 glucago-
noma, and 2 multiple islet cell tumours) and 8 were non-functioning. Three
were part of the MEN 1 Syndrome. All 24 tumours were successfully
localised prior to resection. Operations performed included 7 pylorus
preserving pancreatoduodenectomies, 7 tumour enucleations, 7 distal
pancreatectomies, 1 duodenum-preserving resection of pancreatic head, 1
excision of retropancreatic gastrinoma, and 1 liver segment resection were
performed. There were no fatalities. Six patients (25%) had perioperative
complications. Complete excision with symptomatic cure was documented in
20 patients. Of the remaining 4, two had MEN 1 with multiple islet cell
tumours. One patient with neuroendocrine carcinoma (positive resection
margins) received adjuvant chemotherapy. One patient had MIBG avid liver
metastases and received targeted radiotherapy for these.
Conclusion. Accurate pre-operative localisation can be achieved in pan-
creatic NETs and facilitates pancreas sparing surgery. Surgical resection can
be performed in high-volume centres with a very low mortality and
acceptable morbidity, and carries a high likelihood of cure.
P43.63
STAT3 AND PHOSPHO STAT3 ARE OVEREXPRESSED IN
PANCREATIC ADENOCARCINOMAS
Doucas, Helena1; Sutton, Christopher D1; Garcea, Guiseppe1; Neal, Chris-
topher P1; Manson, Margaret M2; Dennison, Ashley R1; Berry, David P1
1Leicester General Hospital, Hepatobiliary and Pancreatic Surgery, Leice-
ster, UK; 2University of Leicester, Leicester, UK
Background and aims. Signal transducers and activators of trans-
cription (STATs) are known to upregulate oncogenes and prevent apoptosis.
In vitro studies have shown that STAT3 is active in malignant pancreatic cell
lines, and that its inhibition results in growth arrest, but its expression in
human tumours, and correlation with clinical features, has not previously been
investigated.
Methods. An immunohistochemical study was performed on 23 samples of
human pancreatic ductal adenocarcinoma and 12 samples of normal
pancreas, to assess the expression of total STAT3, as well as expression of
its phosphorylated (and therefore activated) form, pSTAT3. The degree of
staining and cellular location of the proteins were assessed.
Results. Very little STAT3 or pSTAT3 staining was observed in normal
pancreatic ducts. Both total STAT3 and pSTAT3 were significantly over-
expressed in tumour tissue. STAT3 was present in the cytoplasm of 73.9% of
tumours, and 30.4% also exhibited nuclear staining. pSTAT3 was present in
the cytoplasm and nuclei of 69.6% and 56.5% of cases respectively. Tumours
expressing nuclear STAT3 were significantly larger, and were more likely to
be non resectable. There was a tendency for patients expressing nuclear
STAT3 or pSTAT3 to have a shorter survival time, although this did not
reach statistical significance.
Conclusion. This study reports, for the first time, that pancreatic adeno-
carcinomas significantly overexpress STAT3. This finding is associated with
adverse clinical features, suggesting that further research into the role of
STAT3 signalling in this tumour type would be valuable.
P43.64
PANCREAS CANCER TREATMENT WITH VITAMIN K3 IN-
DUCED GROWTH INHIBITORY EFFECT
Osada, Shinji; Sakashita, Fumio; Nonaka, kennichi; Imai, Hisashi; Tomita,
Hiroyuki; Sugiyama, Yasuyuki
Gifu University School of Medicine, Surgical Oncology, Gifu, Japan
Background. The molecular mechanism of Vitamin K3 (VK3)-induced
cellular growth inhibitory effect was characterized to evaluate its efficacy by
local injection for application against unresectable pancreatic cancer.
Methods. Cell viability was determined by test method with MTT.
Expressions of cellular proteins were evaluated by Western blott analysis.
Results. The IC50 of VK3 for pancreas cancer cells was calculated to be
42.19/3.5 mM. By Western blot analysis, VK3 was shown to induce
phosphorylation of extracellular signal-regulated kinase (ERK) and c-Jun
NH2-terminal kinase (JNK) for 30 minutes. Expression of apoptosis by VK3,
as shown by caspase-3 activation, and poly ADP-ribose polymerase cleavage
is found. Treatment with the thiol-antioxidant (/0.2 mM) completely
abrogated VK3-induced ERK but not JNK phosphorylation or inhibition
of proliferation. A caspase-3 inhibitor had no inhibitory effect on the
proliferative activity of VK3. As a comparison with agent to mediate cellular
molecular phosphorylation, oxidative stress (H2O2) at concentrations/5.0
mM was found to inhibit cell proliferation at 24 hours. H2O2 also induced
phosphorylation of JNK or ERK, and activation of Caspase-3. And H2O2-
induced these activations were completely abrogated by non-thiol-antiox-
idant, but not thiol-antioxidant. Because H2O2 mediated growth inhibitory
effect was quite hasty, high toxicity was anxious for in vivo study. By contrast,
VK3 was found to induce extensive tumor tissue necrosis. By Western blot,
ERK phosphorylation, but not JNK, was clearly detected only in response to
VK3 injection into tumor tissue.
Conclusion. The local injection with VK3 may be useful in the curative
treatment of unresectable tumors, and the detection of ERK phosphorylation
in tissue is important to predict the effect.
P43.65
SURGERY FOR CYSTIC NEOPLASMS OF THE PANCREAS: A
SAFE AND EFFECTIVE TREATMENT
Biswas, Atindriya; Hutchins, Robert; Abraham, Ajit; Bhattacharya, Satyajit
St Bartholomew’s and Royal London Hospitals, HPB Surgery Unit, London,
UK
Background. Cystic neoplasms of the pancreas (CNP) are being
identified more frequently due to the use of modern imaging methods.
Currently these tumours are said to constitute 1015% of all pancreatic
neoplasms.
Aims. To review the presentation, management and outcomes of patients
with CNP, at a tertiary referral unit, over a 6-year period.
Methods. Between 2000 and 2005, 338 patients with potentially treatable
pancreatic neoplasms were seen by our team. We performed a retrospective
analysis of the demographics, presentation, management and outcomes of all
patients with CNP.
Results. Twenty-nine patients had CNP (age 2783 years, median 60).
Twenty patients presented with abdominal pain, 3 with jaundice, 4 with
palpable abdominal masses, 4 with incidentally detected tumours and 1 with
spontaneous rupture of the tumour. Twenty-seven patients received opera-
tions and 2 refused surgery. Of the 27, 10 had intraductal papillary mucinous
tumour (IPMT) of which 2 were malignant, 6 had mucinous cystic neoplasm
(MCN), 2 had MCN with moderate dysplasia and 1 had mucinous
cystadenocarcinoma. Serous cystadenoma (SCA) and PSEN (pseudopapil-
lary and solid epithelial neoplasm) were detected in 5 and 3 patients
respectively. The most commonly performed operation was distal pancrea-
tectomy. There was no peri-operative death. Only one patient had recurrence,
which was later treated with completion pancreatectomy. Three patients
received adjuvant chemotherapy. All of the patients are still alive (survival 1
66 months).
Discussion and conclusions. The majority of patients with CNP present
with symptoms, and a proportion of these tumours are malignant. Surgical
treatment is safe and effective and should be considered unless there are
strong contraindications or one is absolutely sure of the benign nature of the
tumour.
P43.66
SURGERY FOR SECONDARY TUMOURS OF THE PANCREAS
Dar, Faisal; Mukherjee, Samrat; Bhattacharya, Satyajit
St Bartholomew’s and Royal London Hospitals, HPB Surgery Unit, London,
UK
Background. The vast majority of pancreatic tumours are primary. The
pancreas can however be the site of metastasis from renal cell cancer, non-
small cell lung cancer, colon cancer and sarcoma. The value of surgical
treatment is unclear in such situations.
Aims. To evaluate the outcome of surgical therapy in patients with isolated
metastases to the pancreas.
Methods. All patients who underwent operative treatment for pancreatic
surgery for malignant disease from 1999 to 2005(n/338) were evaluated
from a database. Surgical outcome and survival were examined in patients
with metastatic pancreatic tumours.
Results. Five patients were studied. Two had metastatic renal cell carcinoma
and presented 8 and 14 years from the primary surgery. Both underwent
distal pancreatectomy and are alive 6 and 14 months later. One had
metastatic breast cancer and underwent a palliative bypass following which
she died at 6 months. One patient with ovarian cancer presented with
unresectable metastases 8 years later and received a bypass and then cisplatin
chemotherapy, and is alive at 65 months. One patient presented with direct
infiltration of the pancreas by a colon cancer and underwent synchronous
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resection in the form of Whipple’s procedure and colectomy. he is alive at 38
months.
Conclusions. The pancreas is a uncommon site for metastasis. Patients can
present years after the primary lesion. Long-term survival can be achieved
with pancreatic resection in a highly selected subset of patients, and patients
with primary renal cell carcinoma seem to have a favourable prognosis.
P43.67
THE DEVELOPMENT OF PANCREATIC CARCINOMA 29 YEARS
AFTER PANCREATICOJEJUNOSTOMY FOR CHRONIC CALCI-
FYING PANCREATITIS
Isa, Tsutomu1; Yamamoto, Hirofumi1; Furugen, Tomonori1; Kaneshiro,
Takao1; Higa, Takao1; Teruya, Tsuyoshi1; Shiroma, Hiroshi1; Arakaki,
Kyoko2; Saginoya, Toshiyuki3
1Tomishiro Chuo Hospital, Surgery, Tomishiro City, Japan; 2Tomishiro
Chuo Hospital, Pathology, Tomishiro City, Japan; 3Okinawa PET Imaging
and Diagnostic Center, Surgery, Toyosaki, Tomishiro City, Japan
We herein present a case of pancreatic carcinoma that developed in a patient
29 years after undergoing a pancreaticojejunostomy for chronic calcifying
pancreatitis, and in which patient FDG-PET proved to be very useful for the
diagnosis of carcinoma. Our patient was a 65-year old male, and had
undergone a pancreaticojejunostomy for chronic calcifying pancreatitis 29
years previously. He had no history of heavy alcohol intake and had been
undergoing treatment with insulin to control diabetes mellitus since the
operation. At 29 years after the operation, he began to suffer from discomfort
in his left back region and therefore was referred to our department due to
tumorous enlargement of the pancreatic head containing intratumoral
calcification based on abdominal CT findings and a high CA19-9 level(102.6,
t/ml). FDG-PET revealed a focally increased accumulation of FDG in the area
of the pancreatic tail. A distal pancreatectomy with a left adrenal gland and
partial colon resection was performed. The histopa-thological findings
revealed invasive ductal carcinoma. He is presently doing well without the
sign of recurrence 1 year and 2 months after the operation. A careful long-
term follow-up of patients with chronic calcifying pancreatitis is thus called for
in order to not overlook any coexisting pancreatic carcinoma, and FDG-PET
may also be useful for differentiating between pancreatic carcinoma and
inflammatory masses in patients with chronic calcifying pancreatitis.
P43.68
THE OUTCOME OF SURGICAL MANAGEMENT OF PERIAM-
PULLARY TUMOURS
Pai, Madhava1; Limongelli, Paolo1; Healy, Andrew1; Stamp, Gordon2;
Habib, Nagy A1; Williamson, Robin C1; Jiao, Long R1
1Hammersmith Hospital, Imperial College, Hepatobiliary Surgery, London,
UK; 2Hammersmith Hospital, Imperial College, Pathology, London, UK
Background & aims. Surgery remains the curative option for patients with
periampullary tumours. The outcome of patients with periampullary tumours
including survival and recurrence data is reported here.
Methods. The current study examines the outcome of surgical therapy
either with curative or palliative intention in patients with periampullary
tumours. One hundred and forty patients who presented with periampullary
tumours underwent surgery between January 1990 to December 2004.
Survival and disease-free survival were evaluated. Univariate and multivariate
analyses were performed to determine factors affecting survival and recur-
rence.
Results. The overall median survival time was 6 months after by-pass
operations and 20 months after resection. After resection the 5 year actuarial
survival rates was 14.2% whereas the 5 year disease-free survival rates after
resection was 9.8%. In patients with pancreatic adenocarcinoma, multivariate
analysis identified an advanced UICC status (p/.01) as a significant
predictor of shorter disease-free survival. In-patients with periampullary
tumours of non-pancreatic origin, postoperative sepsis (p/.008) and the
presence of four or more lymph nodes were found to be associated with worse
survival rates (p/.009) whereas a poor tumour differentiation (p/.03) was
found to be significantly related to shorter disease-free survival.
Conclusions. Patients who had non-pancreatic periampullary tumours had a
better prognosis and survival than those with pancreatic periampullary
tumour. Factors influencing survival and recurrence included stage of
disease, number of lymph nodes, postoperative sepsis, and tumour grading.
P43.69
THE UNCHANGED MELODY OF CARCINOMA OF THE BODY
OF PANCREAS
Dickinson, Karen J1; Gomez, Dhanwant2; Rahman, Sakhawat H2; Gokhale, J
A1; Ausobsky, Jon A1; Guillou, J Pierre2
1Bradford Royal Infirmary, Dept. of Surgery, Bradford, UK; 2Leeds
Teaching Hospitals NHS Trust, Division of Surgery, Leeds, UK
Introduction. Carcinoma of the body of pancreas has a very poor prognosis
due to advanced stage of disease at presentation. Recent experience suggests
that the disease is becoming more prevalent, and our aim was to determine if
a more aggressive approach to diagnosis has impacted on the natural history
of these tumours.
Methods. Patients diagnosed with pancreatic body cancers from 19952005
& managed at two large teaching Hospitals were included. Groups were
divided into pre- and post 2003 based on the introduction of the Yorkshire
Cancer Network Pancreas Cancer MDT. Collected data included patient
demographics, presentation, imaging, treatment and outcome.
Results. In total 24 patients were included with a male to female ratio of
0.85. The pre-2003 group included 8 patients (33.3%) with a median age of
72.5 yrs (Range: 6087), and 16 patients (66.6%) in the post 2003 group
with a median age of 70.5 yrs (Range: 4385). Overall staging for the
tumours in the pre-2003 group was; Stage IIB (n/1), Stage III (n/5), and
stage IV (n/2), and in the post-2003 group; Stage III (n/8), and stage IV
(n/8). Best supportive care was provided for 61% of patients, with 26%
suitable for chemotherapy and 2 patients undergoing exploratory laparotomy
(all irresectable). All patients diagnosed prior to 2003 are deceased (median
survival by stage; Stage III: 4.8 months (range 112), stage IV: 4 months
(range 26). Seven of 16 patients in the post-2003 group are still alive (One
patient diagnosed in 2004 stage III post-chemotherapy, the remainder
diagnosed after 2005. Median survival for post-2003 by stage; Stage III:
4.5 months (range: 118), stage IV: 3 months (range 0.57).
Conclusion. There is a trend towards an increased prevalence of pancreatic
body cancer and this may in part be due to the introduction of the MDT.
Over the last decade patients with pancreatic body cancer consistently
present late in the disease process. Therefore the natural history of the disease
appears to remain unchanged.
P43.70
THERAPEUTIC PERSPECTIVES IN LOCALLY ADVANCED PAN-
CREATIC CANCER
Balzano, Gianpaolo1; Reni, Michele2; Zerbi, Alessandro1; Beneduce, Aldo
A1; Cereda, Stefano2; Nicoletti, Roberto3; Scaltrini, Francesca1; Di Carlo,
Valerio1
1San Raffaele Scientific Institute, Surgery, Milan, Italy; 2San Raffaele
Scientific Institute, Radiochemotherapy, Milan, Italy; 3San Raffaele Scientific
Institute, Radiology, Milan, Italy
Background. 30% of pancreatic cancer are not resectable due to vessels
invasion, in absence of distant metastases.
Aim. To evaluate the effect of a chemotherapy regimen (PEFG) in this
setting.
Methods. Retrospective evaluation of prospectively collected data. The
study group included chemotherapy-naive pts B/75 years, Karnofsky PS/
50, with cito- histologically proven locally advanced pancreatic cancer. Before
treatment, a senior surgeon judged the cancer not resectable (at laparotomy
or by CT scan). Scheduled chemotherapy consisted of PEFG regimen
(Lancet Oncol 2005; 6:36976); cycles were repeated every 28 days for a
maximum of 6 cycles. Pts were restaged by CT scan every 2 cycles. As a
control group, we used pts who underwent surgery with curative intent, but
resulting in R1-R2 resections (micro- and macroscopic local residue) in the
same period.
Results. From 1997 to 2004, 55 pts with locally advanced pancreatic cancer
were treated with PEFG. According to WHO criteria, 5 pts (9%) had
progression of disease and had median survival (MS) of 6 m; 23 pts had
stable disease (42%, MS 11 m.); 27 pts (49%) had partial response, and were
stratified in two subgroups: 18 pts (33%) had persistency of vessel invasion
(MS: 16/ m); 9 pts (16%) were eligible for surgery: 8 of them were resected.
There was 1 operative death. Further 3 pts died of recurrence at 14, 17 and
31 m. The remaining 6 pts are alive (range 1596 m) (MS not reached). MS
of overall study group (55 pts) was 15 m. Despite the possible bias due to less
advanced cancer in the control group, survival of 55 pts treated by PEFG was
similar to survival of 133 pts undergoing R1-2 resections in the same period
(15 m vs 16 m; p/0.8).
Conclusions. PEFG is an adequate treatment for locally advanced pancrea-
tic cancer. When regression of vessel invasion is observed (16%), laparotomy
with curative intent is indicated. PEFG should also be tested as neoadjuvant
approach, when a non-radical resection can be predicted.
P43.71
TREATMENT STRATEGY FOR PANCRATIC CANCER: SINGLE
CENTER EXPERIENCE
Shimoda, Mitsugi; Katoh, Masato; Sawada, Tokihiko; Kubota, Keiichi
Dokkyo Medical University School of Medicine, Dept. of Sugery, Mibu,
Tochigi, Japan
Introduction and aim. This study was conducted to clarify the efficacy of
chemotherapy and surgical resection for the treatment of pancreatic cancer
during the past five years.
Patients and methods. From April 2001 to October 2005, 87patients with
pancreatic cancer were treated at our department and classified into 3 groups,
Anticancer theraphy group(ACT G: n/31; Gemcitabine only: n/25,
Gemcitabine with Radiation therapy n/6), Surgical group (SR G: n/35;
pancreatic resection n/26, pancretic resection with Gemcitabine n/9) and
Best supportive care group (BSC G: n/21) groups. Twenty six cases for
pancreato-duodenectomy and 9 cases for distal-pancreatectomy. Gemcita-
bine 800 mg/m2 was administered once per week for 3 weeks followed by one
week off. This procedure was repeated. Radiation dose was 50 Gy and
Gemcitabine dose was 400 mg/m2. However, if patients had treatment related
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toxicity or poor performance status, Gemcitabine dose was reduced. Retro-
spectively, 3-year survival rates were compared between the three groups.
Data were expressed as a mean. Student’s t test, Kaplan-Meier and Mantel
Cox methods were used for comparisons. Statistical significance was defined
as a p-value of less than 0.05.
Results. One and three year survival rate were 33.4% and 0% for the
ACT G, 50.4% and 11.5% for the SR G, 0% and 0% for the BSC G,
respectively. SR G showed significantly better survival rate than ACT G and
BSC (P/0.047, 0.017). In SR G, no lymph node metastasis, low level of
CA19-9 and early stage were significantly good impact factors for patients
survival (p/0.046, p/0.02, p/0.005). Decrease of the tumor marker by
20% and good performance status were good prognostic factor for ACT G
(p/0.0002).
Conclusion. Surgical resection and Gemcitabine treatment were feasible
with acceptable adverse effects and improved the survival rate of patients
with pancreatic cancer. As for treatment of Gemcitabine, decrease of the
tumor marker is a good prognositc factor for unresected pancreatic cancer
patients.
P43.72
SURGERY FOR BENIGN TUMORS OF THE BODY AND NECK
OF THE PANCREAS: THE ROLE OF THE INTRAOPERATIVE
ULTRASOUND (IOUS)
Fedorov, Vladimir; Kubyshkin, Valery; Vishnevsky, Vladimir; Shevchenko,
Tatyana; Grishankov, Sergey
Vishnevsky Institute of Surgery, Moscow, Russia
Background. Surgery of the benign tumors of the body and neck of the
pancreas remains controversial. The use of enucleation (En), central
pancreatectomy (CP) and distal pancreatectomy (DP) is well justified,
however, the selection criteria are unclear.
Aim. To study the role of IOUS and establish selection criteria between En,
CP and DP.
Methods. Between 1991 and 2004 we treated 26 patients with benign
pancreatic tumors including 5 men (19.2%), and 21 women (80.8%);
median age 53 years. Tumor localization: neck -5 (19.2%), body-21(80,
8%). CP performed in 7 (26.9%) cases (cystic neoplasm (CN)5,
neuroendocrine tumor-1, lymphangioma-1). En was used in 9 (34.6%)
cases-all CN, and DP performed in 10 (38.5%) patients-all CN. The
following parameters were determined by IOUS: tumor size, localization,
proximity to pancreatic duct (PD), distance between tumor and the border of
tail of the pancreas.
Results. Patients undergoing En had smaller tumors than CP and DP (3.2
cm vs. 5.4 cm, pB/0.05). Close proximity of the tumor to PD (less than
5 mm) was found in 17 patients, in 9 patients the distance was more than 5
mm. Intraoperative PD injuries were detected during the En in 6 patients
with distance between tumor and PD less than 5 mm by IOUS. It was
indication for conversion to CP in 2 cases and to DP in 4. The distance from
the left tumor margin to pancreatic tail was less than 5 cm by IOUS in 10
cases. It was indication for DP. If the distance more than 5 mm we performed
CP. Pancreatic fistula developed in 4 cases (1-after En, 1-after CP and 2-after
DP). No other complications developed.
Conclusion. IOUS is extremely useful in determining the surgical approach
towards benign tumor of the body and neck of the pancreas. En was
performed when the distance between the tumor and PD was at least 5 mm.
CP was used in cases with deep parenchymal involvement and closed
proximity of the tumor to PD provided that the length of the pancreatic
stump was at least 5 cm.
P43.73
USEFULNESS OF MULTISLICE COMPUTED TOMOGRAPHY
FOR DIAGNOSIS OF BILIARY AND PANCREATIC TUMORS
Horiguchi, Akihiko; Isihara, Shin; Ito, Masahiro; Miyakawa, Shuichi
Fujita Health University, Gastroenterological Surgery, Toyoake, Japan
With the advent of multi slice CT, progress in the detection of microlesions of
the biliary truct and pancreas has been rapid. In particular, progress has been
made in the preoperative assessment of the extent of small pancreatic cancer
and in distinguishing between neoplastic and non-neoplastic lesion. In the
present study, to assess the value of this imaging modality, we compared the
feaures of biliary pancreatic disease detected by multislice CT with the
histologic findings.. Multislice CTallowed us to assess the tumor vasculature.
Contrast-enhanced images showed satisfactory details of the tumor. Multi
slice CT allows sequential scanning of the entire pancreas during one breath
hold, and provides detailed diagniosis through high-speed dynamic studies,
multiplanar reconstruction, and three dimensional images. Rapid scanning
demonstrates the tumor vasculature. Its discriminate evev relatively small
tumors from the surrounding pancreatic parenchyma, and clarify the
intracystic structures. Three-dimensional images allow us to estimate the
volume and assess the location of the tumor, and were compared to the
postoperative histologic findings in terms of visualization of intracystic septa,
intracystic papillary protrusions, clacification. In conclusion, multi slice CT
enables us to assess tumor vasculature, and to obtain satisfactory details of
the morphology of the biliary pancreatic tumors.
P43.74
CLINICAL AND PATHOLOGICAL PROGNOSTIC FACTORS
AFTER RESECTION FOR PANCREATIC CANCER: SHORT
AND LONG TERM RESULTS OF TWO LIMB RECONS-
TRUCTION
Perini, Marcos V; Montagnini, Andre L; Jukemura, Jose; Penteado, Sonia;
Abdo, Emilio; Jureidini, Ricardo; Bacchela, Telesforo; Machado, Marcel C;
Cecconello, Ivan; Cunha, Jose Eduardo
Sao Paulo Medical School, Sao Paulo, Brazil
Introduction. Pancreatic cancer is one of the main cancer related
deaths in the world and its incidence is similar to its mortality. The aim of
the present study is to correlate clinical and pathological findings with
survival in patients with pancreatic adenocarcinoma treated with surgical
resection.
Matherial and methods. Fifty six patients resected between 1990 and 2003
at the Biliopancreatic Surgical Service of Dept. of Gastroenterology of Sao
Paulo Medical School, Brazil were retrospectively studied.
Results. There were 32 females (57.1%) and 24 males (42.8%) with
mean age of 58.1 years. Pylorus preserving duodenopancreatectomy was
performed in 51, 8%, classical duodenopancreatectomy (41.1%), distal
pancreatectomy (3., 6%) and total pancreatectomy (3., 6%). Portal vein
resection was performed in 10 patients (17.9%). There was no intra-
operative mortality. Postoperative complications occurred in 24 patients
(44.4%), and pancreatic fistula was the most common complication (22.6%),
followed by delayed gastric emptying (20.4%), bleeding (12, 9%) and
infection (11.1%). Three patients were re-operated because of bleeding
(5.4%) and two of them died because of systemic complications. Mean tumor
size was 3, 3 cm and most of them had moderate differentiation. (66%).
Vascular and neural invasion were present in 41.1% and 80, 4%, respectively.
Positive margin was present in 18 patients (32.1%). Four patients were stage
IA, seven stage IB, 12 stage IIA, 29 stage IIB and two stage III. Mean follow
up and survival times were 21, 17 and 24, 9 months, respectively. Male
patients had lower survival time (p/0.009), as had patients with portal vein
resection (0.025). Undifferentiated tumors (p/0.025) with neural invasion
(0.041) and with positive margin status (p/0.012) also had lower survival
rates.
Conclusion. It was concluded that gender, portal vein resection, tumor
differentiation and peri-neural invasion are statistically associated with long
term survival.
P43.75
WHAT IS THE BEST METHOD FOR ESTABLISHING TISSUE
DIAGNOSIS IN PATIENTS WITH SUSPECTED PANCREATIC
TUMOURS?
Sultana, A1; Ahmad, H1; Grabham, JM1; Halloran, CM1; Bosonnet, L1;
Evans, JC2; Lombard, M3; Smart, HL3; Gilmore, IT3; Raraty, M1; Hartley,
M1; Sutton, R1; Neoptolemos, JP1; Ghaneh, P1
1Royal Liverpool University Hospital, Division of Surgery and Oncology,
Liverpool, UK; 2Royal Liverpool University Hospital, Dept. of Radiology,
Liverpool, UK; 3Royal Liverpool University Hospital, Dept. of Gastroenter-
ology, Liverpool, UK
Background. Tissue diagnosis in patients with surgically unresectable
pancreatic malignancy is critical in decision making for chemotherapy/clinical
trials. Currently there is no consensus on which is the best diagnostic
approach.
Aim. The aim of this study was to assess the diagnostic yield of different
methods in patients with suspected pancreatic tumours at a single tertiary
referral centre.
Methods. Patient demographics, diagnostic approaches and histology details
of patients with pancreatic tumours were obtained from a prospectively
maintained database (Jan 1997 to Dec 2005). The yields of the diagnostic
approaches were evaluated.
Results. A total of 763 patients were identified. Of the 387 patients
who had histology/cytology, 203 underwent endoscopic retrograde cholan-
giopancreatogram (ERCP), 36 endoscopic ultrasound (EUS), 46 CT guided
biopsies, 33 ultrasound guided biopsies (USG) 46 laparoscopic ultrasound
(LUS), and 23 operative biopsies. CT guided biopsy sensitivity was 84%,
accuracy 84% and negative predictive value 12.5%. The figures for USG
biopsy were 86.4%, 84.8% and 17% respectively. Similar rates were
noted for EUS (78.8%, 80.6%, 30%) and operative biopsy (73%, 74%,
14%). However, the diagnostic yield with ERCP overall was lower
(57.5%, 58.9%, 6%) as was LUS (55%, 57%, 9%). The figures for a revised
method (cytosol) for processing ERCP specimens (after January 2001)
revealed 61.8% sensitivity, 59.3% accuracy and 1.8% negative predictive
value. All modalities were 100% specific with a 100% positive predictive
value.
Conclusions. The diagnostic yield for CT, USG and EUS guided biopsies
were similar. The diagnostic yield of ERCP is slightly lower than the other
methods. However, it is still the most relevant as it is both diagnostic and
therapeutic. Considerable effort must be made to obtain specimens during
ERCP. The other approaches should be used to complement it, on a case-by-
case basis.
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P43.76
X-LINKED INHIBITOR OF APOPTOSIS (XIAP) SILENCING
DECREASES GEMCITABINE RESISTANCE OF PANCREATIC
CANCER CELLS
Shrikhande, Shailesh1; Kleeff, Jorg1; Kayed, Hany1; Keleg, Shereen1; Reiser,
Carolin1; Giese, Thomas2; Buchler, Markus1; Esposito, Irene3; Friess,
Helmut1
1University of Heidelberg, Dept. of General Surgery, Heidelberg, Germany;
2University of Heidelberg, Institute of Immunology, Heidelberg, Germany;
3University of Heidelberg, Dept. of Pathology, Heidelberg, Germany
Background. XIAP belongs to a family of proteins that suppress apoptosis
by inhibition of caspases in some cancers. It confers resistance to apoptosis
induction by chemotherapeutic agents. To evaluate the influence of X-linked
inhibitor of apoptosis (XIAP) in pancreatic cancer.
Methods. Tissue samples from 43 patients with pancreatic adenocarcinoma
(median age of 67 years (range: 3981 years) were analyzed. Pancreatic
samples from healthy organ donors (10) and chronic pancreatitis patients
(10) served as controls. XIAP expression and localization analysis was carried
out by quantitative RT-PCR and immunohistochemistry (IHC). XIAP
silencing was achieved by transfection of specifically designed siRNA
oligonucleotides. Proliferation and chemotherapy experiments were per-
formed by MTT cell growth assays.
Results. There was a 2.1-fold increase of median XIAP mRNA levels in
pancreatic cancer compared to controls. Kaplan Meier analysis indicated a
tendency for reduced patient survival with increasing levels of XIAP mRNA
(higher levels: 13.4 months; lower levels: 16.1 months). IHC revealed strong
XIAP staining in tubular complexes and pancreatic cancer cells. XIAP
silencing resulted in a slight reduction of the proliferation of Capan-1 and
T3M4 pancreatic cancer cells. In addition, XIAP silencing resulted in
increased sensitivity of both cell lines to gemcitabine.
Conclusion. XIAP is overexpressed in pancreatic cancer and contributes to
chemoresistance. Interfering with this pathway may have potential therapeu-
tic role in the treatment of this disease.
P43.77
ZOLEDRONIC ACID ACTS WITH ANTI-PROLIFERATIVE AND
ANTI-METASTATIC ON PANCREATIC CARCINOMA CELLS
AND IS AN ANTIGEN FOR D2 gD T CELLS
Ma¨rten, Angela1; von Lilienfeld-Toal, Marie1; Ja¨ger, Dirk2; Bu¨chler, Mar-
kus1; Schmidt, Jan1
1University of Heidelberg, Dept. of Surgery, Heidelberg, Germany; 2Uni-
versity of Heidelberg, National Centre for Tumor Diseases, Heidelberg,
Germany
Background. Beside their use as anti-resorptive drug, bisphosphonates are
well known to stimulate gD T cells and to have direct effects on tumor growth.
Methods. We determined the direct cytotoxic effect of pamidronate and
zoledronic acid, the induction of apoptosis and their anti-metastatic poten-
tials. Next, we analyzed how bisphosphonates acts on gD T cells propagated
with our recently published protocol. The susceptibility of pancreatic
carcinoma cells pretreated with bisphosphonates against gD T cells was tested
in cytotoxicity assays and the subgroup involved in killing was investigated
Results. Zoledronic acid but not pamidronate has a cytotoxic potential even
at physiological dosage. Zoledronic acid does not only induce apoptosis by
inhibiting the Ras-pathway but has also an anti-metastatic effect. Fresh
prepared gD T cells consisting mainly out of VD2 cells showed increased
cytotoxicity against bisphosphonate-treated pancreatic carcinoma cells. gD T
cells could be expanded four-fold by use of anti-CD3 and IL-2. However,
these gD T cells do not respond to bisphosphonates and kill mainly in a VD1
dependent manner.
Conclusion. Our results demonstrate that zoledronic acid has a direct
apoptotic effect on pancreatic carcinoma cells and has anti-metastatic
properties. Tumor cells treated with zoledronic acid are more susceptible
against Vg9VD2 T cells, the most abundant population of gD T cells in the
peripheral blood. Treatment with zoledronic acid for patients with pancreatic
carcinoma might be an option.
P43.78
ZOLLINGER-ELLISON SYNDROME-THE REALITY OF SURGI-
CAL EXPERIENCE
Sabol, Martin; Straka, V; Straka, M; Chvalny´, P; Beseda, O
St. Elisabeth Oncological Institute, Dept. of Oncological Surgery, Bratislava,
Slovak Republic
Background. Precise localisation of gastrinomas by means of combination
of various examination methods preoperatively is possible in about 50 per
cent of cases. Therapeutical approach should be focused on the early
diagnostics of Zollinger-Ellison syndrome(ZES), antisecretory and surgical
therapy of the tumor. Undiagnosed ZES, failure of conservative treatment
and unjustified delay of the operation leads to serious complications of
resistant, recurrent ulcer and increases the risk of lymphnode and liver
metastases. The aim was to evaluate our own experiences.
Methods. Between 1995 and 2005, 20 patients with sporadic ZES under-
went surgical treatment. The median age was 53.7(range 3468)years.
Duration of symptoms of the disease up to establishment of the diagnosis of
ZES was 228 years(median 7.4). Interval from establishment of the
diagnosis to operation was 18 years(median 3.5). Prior to the gastrinoma
operation only 6 patients had no gastric operation, 4 patients underwent
operation for gastrojejunocolic fistula.
Results. In 20 patients we removed 22 gastrinomas that were histopatho-
logically confirmed. In 10 patients tumors were in duodenum from which in 8
cases there were malignant gastrinomas(80 per cent). In the group of
pancreatic gastrinomas 4 patients had malignant tumors from which 1 female
had right liver lobe metastases. We performed 2 proximal pancreatoduode-
nectomies, 7 distal pancreatectomies, 1 right hepatectomy, 10 local resec-
tions(1 from pancreatic head, 9 duodenal) and 1 lymphadenectomy only.
During the operation of gastrinoma we performed in 9 patients simulta-
neously gastric operation due to complications of recurrent ulcer(bleeding)
and gastrojejunocolic fistula(4 patients).
Conclusion. Tumor resection is the principle of modern treatment.
Operation is indicated even if preoperative localisation has failed because it
permits experienced surgeon to identify and remove the tumor in consider-
able number of patients.
P43.79
ADRENOMEDULLIN (ADM) IS INDUCED BY HYPOXIA AND
ENHANCES PANCREATIC CANCER CELL INVASION
Kayed, Hany1; Keleg, Shereen1; Giese, Thomas2; Buchler, Markus W1;
Friess, Helmut1; Kleeff, Joerg1
1University of Heidelberg, Dept. of General Surgery, Heidelberg, Germany;
2University of Heidelberg, Institute of Immunology, Heidelberg, Germany
Background. Adrenomedullin (ADM) is a peptide synthesized by different
cells that act by binding calcitonin receptor-like receptor (CRLR) and members
of the receptor activity-modifying protein (RAMP) family. It plays an important
role in various functions, such as blood pressure regulation and angiogenesis.
Aim. The expression and functional role of ADM and its signalling
components were investigated in pancreatic adenocarcinoma.
Methods. QRT-PCR, immunohistochemistry, ELISA, ADM silencing, cell
growth and invasion assays, induction of and hypoxia were utilized.
Results. Median ADM and CRLR mRNA levels were 1.5-fold and 2.5-fold
higher, respectively, but a decrease in RAMP-1, 2 and 3 mRNA expression
levels was observed in PDAC tissues compared to normal pancreatic tissues.
ADM, CRLR, RAMP1 and RAMP2, but not RAMP3, were localized in
pancreatic cancer cells. ADM serum levels were significantly increased in
pancreatic cancer patients compared to controls, with a sensitivity of 80%
and specificity of 85% at a cut-off ADM level of 30.6 ng/ml. 8 pancreatic
cancer cells lines expressed ADM and CRLR, whereas RAMP1, 2 and 3 were
present only in some of the cell lines. ADM was strongly induced by hypoxia
and significantly increased invasiveness of 4/5 human pancreatic cancer cells.
Blocking of CRLR decreased invasiveness in all tested cell lines, but ADM
silencing by siRNA oligonucleotides decreased invasiveness of 1/3 human
pancreatic cancer cell line tested. In addition, recombinant ADM up-
regulated VEGF in 3/5 cultured pancreatic cell lines, with no significant
VEGF changes in response to CRLR antagonist or ADM silencing.
Conclusion. ADM is induced by hypoxia, over-expressed in pancreatic
cancer, and released into the blood, suggesting that it might serve as a
potential tumour marker. ADM increases invasiveness of some pancreatic
cancer cells and might influence angiogenesis via VEGF induction, suggest-
ing that blocking this pathway might have therapeutic potential.
P43.80
ANGIOGENESIS INDUCED BY THE NOTCH SIGNALLING
PATHWAY: DETERMINATION OF NEUROVASCULAR PRO-
GRESSION OF PANCREATIC CANCER
Buchler, P; Gazdhar, A; Schubert, M; Ceyhan, G; Buchler, MW;
Friess, H
University of Heidelberg, Dept. of General Surgery, Heidelberg, Germany
Introduction. Angiogenesis and pain are clinical features of neurovascular
development. Early metastasis via nerves and blood vessels are hallmarks of
pancreatic cancer (PaCa) progression. Since nerves and blood vessels
developmentally use common routes through the organism they most likely
develop together and importantly use similar signalling pathways. The Notch
pathway (Notch-1/4, Jagged-1/2, Delta-1/2) has recently been identified as
the most crucial pathway in this process. By a phenomenon called lateral
inhibition Notch signalling can led to the development of nerval tissue or
blood vessels dependent on ligands and environment. The current study
analyzed this pathway in pancreatic cancer and characterized the angiogenic
and invasive effects of Jagged-1.
Material and methods. Five PaCa cell lines were used in vitro. Real time
quantitative PCR was used to quantify mRNA expression in 31 human PaCa
specimens. Immunohistochemistry and Immunoflourescence were used to
localize protein expression within tumour specimens. Recombinant activation
of the Notch signalling was done by transfection of PaCa cells with a
constitutive active Notch-1 mutant (Notch-IC). Overexpression of Jagged
and Delta was achieved by retroviral transfection of full length cDNA.
ELISAs were used to measure VEGF, bFGF and Angiopoetin expression.
Spheroid assays were utilized to study angiogenesis. Matrigel Invasion Assays
were used to characterize invasive growth.
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Results. Notch-3 and Notch-4 mRNA were significantly overexpressed in
human tumour specimens. Immunohistochemistry revealed protein accumu-
lation of Notch-1 as well. Among the ligands Jagged-1, Jagged -2 and Delta-2
were significantly overexpressed. Immunopositivity of Jagged-1, Notch-1 and
Notch-4 were seen in nerves, blood vessels and ductal tumour cells.
Transfection of PaCa cells with the constitutive active Notch-IC mutant
and with Jagged-1 revealed that activation of Notch signalling caused
upregulation of VEGF and bFGF. Similarly recombinant Jagged-1 resulted
in increased sprouting of endothelial cells in the spheroid assay. Furthermore,
recombinant Jagged-1 increased invasive growth of PaCa cells dose depen-
dently in Matrigel assays.
Conclusion. The Notch pathway most likely regulates neurovascular
development in pancreatic cancer. Activation of this signalling pathway by
constitutive Nocht-1 mutants and by Jagged-1 causes an angiogenic and
invasive tumour phenotype. Specific blockade of Notch signalling may
therefore result in synergistic antiangiogeic and antineuronal effects to better
treat patients with pancreatic cancer.
P43.81
APC FOR AMPULLARY CARCINOMA
Wysocki, A Peter; Carter, C Ross
Glasgow Royal Infirmary, West of Scotland Pancreatic Unit, Glasgow, UK
Background. Pancreaticoduodencetomy is the mainstay for managing most
patients with ampullary adenocarcinoma with an actuarial 5 year survival of
at least 50% in most modern series. Literature regarding the management of
non-operable patients is sparse with most reporting median survival of less
than 10 months with stenting alone.
Aim(s)/Objective(s). Assess outcome following Argon Plasma Coagulation and
stenting for ampullary carcinoma in patients who are unsuitable for resection.
Methods. Retrospective analysis of a prospectively kept endoscopy database
was performed to identify patients managed with endoscopic stenting and
argon plasma coagulation for histologically proven ampullary carcinoma.
Results. The 17 patients with ampullary adenocarcinoma who were treated
with Argon Plasma Coagulation have at least a comparable outcome to
historical series of stenting alone.
Conclusion. There is insufficient published data regarding non-operative
outcome of patients with ampullary carcinoma to determine whether Argon
Plasma Coagulation has a beneficial role.
Key words. Ampullary carcinoma-Argon Plasma Coagulation-Palliation
P44.01
THE USE OF A LINEAR CUTTING STAPLER IN PANCREAS
TRANSPLANTATION: A NEW TECHNIQUE
Wong, Kit; Hawthorne, Wayne; Robertson, Paul; Nankivell, Brian; O’Con-
nell, Philip; Chapman, Jeremy; Ryan, Brendan; Lau, Howard; Pleass, Henry;
Allen, Richard
Westmead Hospital, NSW, Australia
Aim. The drainage of pancreatic exocrine secretions following pancreas
transplantation is an evolving area of surgical practice. Our aim was to
compare hand sutured enteric and bladder drained transplants with a new
stapled technique.
Methods. 205 combined kidney/pancreas transplants performed between
July 1987 and March 2006 were reviewed. Using a prospective database and
chart review, complications and outcome related to the technique of exocrine
drainage were compared.
Results. Of the 205 combined kidney/pancreas transplants, 143 were
bladder drained (BD) using a 2 layered 3/0 PDS suture technique. 43 were
enterically drained (ED), again using a 2 layered suture technique. Between
April 2005 and March 2006, 19 of the last 20 kidney/pancreas procedures
have been performed using a stapled side to side graft duodeno-jejunostomy.
The defect was closed using interrupted 3/0 PDS sutures. In this latest group,
one patient has returned to theatre 16 days postop for a graft pancreatectomy,
secondary to venous thrombosis. One patient was readmitted 6 weeks postop
with melaena, managed conservatively, thought secondary to a bleed from the
staple line. One patient with severe graft pancreatitis has developed a
pancreatic fistula 4 weeks post transplantation. This has not required surgical
intervention and did not involve the enteric anastamosis. No other
complications have been encountered. In the BD group, 15.5% required a
relaparotomy at some point to convert to enteric drainage. Of the hand
sutured ED group, 4.7% required a relaparotomy for either leak or bowel
obstruction and one pancreatic graft was lost as a result.
Conclusions. The stapled technique of ED appears safe in this recent cohort
and is simple and quick to perform. This new technique produces less
narrowing of the recipient’s jejunum and will remain the technique of choice
within our unit with continued prospective audit.
P44.02
N-ACETYL CYSTEINE ATTENUATES HYPERAMYLASEMIA
AND INCREASES EXPRESSION LEVEL OF GST-a GENE IN A
PANCREATIC ISCHEMIA-REPERFUSION MODEL IN RATS
Meirelles, Roberto; Kubrusly, Ma´rcia; Sa´, Sandra; Correa-Gianella, Maria L;
Gianella-Neto, Daniel; Bacchella, Tele´sforo; Machado, Marcel
University of Sao Paulo, Surgery, Sao Paulo, Brazil
Background. Graft acute pancreatitis (AP) remains a frequent complication
(35%) on pancreas transplantation (PTx). Ischemia-reperfusion (IR) injury
may be involved in graft AP pathogenesis. Glutathione-S-transferases (GST)
enzymes provide protection against oxidative stress products. N-acetyl
cysteine (NAC) has been shown to improve pancreatic microcirculation
alterations in experimental PTx.
Aim. Evaluate pancreatic injury and expression level of isoform GST-a after
pancreatic IR induction.
Methods. Twenty-four Wistar rats were divided equally in Group 1-sham;
Group 2-ischemia-reperfusion; Group 3-ischemia-reperfusion plus NAC iv;
Group 4-ischemia-reperfusion plus NAC po. Splenic pancreatic portion
underwent to 1 h ischemia followed by 4 h of reperfusion. Group 3 received
intravenously 150 mg/kg body weight 15 min before reperfusion followed by
50 mg/kg body weight during the remaining time. Group 4 received NAC
(4800 mg/L) ad libitum 48 h before the experiment. Blood and splenic
pancreatic tissue samples were collected after 4 h of reperfusion. Serum
amylase was determined and expression level of isoform GST-a was evaluated
by quantitative real-time polymerase chain reaction (qRT-PCR). Normalized
qRT-PCR data were determined from the ratio of GST-a/b-actin values for
each sample.
Results. Serum amylase levels were 6.11 (sd/0.55) mg/mL/min, 10.30
(sd/0.50) mg/mL/min, 9.77 (sd/1.24) mg/mL/min and 7.82 (sd/0.38) in
Groups 1, 2, 3 and 4, respectively. There was an increase in serum amylase
when compared group 1 with group 2 (p/0.0002) and a decrease when
compared group 2 with group 4 (p/0.003). An increase in GST-a expression
was observed in groups 3 and 4 when compared to group 2 (p/0.016).
Conclusion. NAC given 48 h before experimental IR injury induction
normalizes hyperamilasemia. This protective effect in pancreatic tissue injury
may be due to an increase in expression level of GST-a gene. NAC may have
a potential benefit in graft AP related to IR injury.
P45.01
A NEW TECHNIQUE FOR PANCREATICOGASTROSTOMY: THE
TRANSFIXING SUTURE METHOD
Shinchi, Hiroyuki; Takao, Sonshin; Maemura, Kosei; Noma, Hidetoshi;
Ueno, Shinchi; Sakoda, Masahiko; Kubo, Fumitake; Aikou, Takashi
Kagoshima University School of Medicine, Kagoshima, Japan
Background. Pancreatic anastomotic leak remains a persistent problem
after pancreaticoduodenectomy (PD). The presence of soft, nonfibrotic
pancreatic tissue is one of the most important risk factors for pancreatic
leak. Accordingly, we devised a pancreas-transfixing suture method for
pancreaticogastrostomies in patients with a soft, nonfibrotic pancreatic
remnant.
Methods. The pancreas-transfixing method was applied to 103 consecutive
patients after either standard PD (49 patients) or pylorus-preserving
pancreaticoduodenectomy (PPPD) (54 patients) for malignant or benign
disease. Of these 103 patients, 65 patients had a soft, nonfibrotic pancreatic
remnant. As for the pancreaticogastrostomy technique, an ultrasonically
activated scalpel was used for transecting the pancreas. The inner layer
involves a duct-to-mucosa anastomosis with an internal stent and the outer
layer involves a single row pancreas-transfixing sutures between the pancrea-
tic remnant and the posterior gastric wall.
Results. Operative mortality was zero, and morbidity was 22%. Only 2
patients (2%) developed pancreatic leaks; both resolved nonoperatively with
the continuation of closed drainage.
Conclusions. This technique is simple and appears to reduce the risk of
pancreatic leakage possibly by decreasing the risk of suture injury of the
pancreas and by embedding the transected stump into the wall of the
stomach. This novel pancreaticogastrostomy is an effective reconstructive
procedure, especially for patients with a soft, nonfibrotic pancreas.
P45.02
COMPARISON BETWEEN PANCREATECTOMY METHODS AND
PANCREATOGASTOROINTESTINAL ANASTOMOTIC LEAKAGE
FOLLOWING PANCREATICODUODENECTOMY
Sumiyama, Yoshinobu1; Watanabe, Manabu2; Tanaka, Hidenori2; Enomoto,
Toshiyuki2; Osawa, Akihiro2; Kanai, Ryota2; Matsukiyo, Hiroshi2; Saida,
Yoshihisa2; Kusachi, Shinya2; Nagao, Jiro2; Koji, Asai1
1Toho University School of Medicine, Third Dept. of Surgery, Tokyo, Japan;
2Toho University School of Medicine, Tokyo, Japan
Background/Purpose. This study investigated correlations between meth-
ods of pancreatectomy methods and occurrence of pancreatogastrointestinal
anastomotic leakage following pancreaticoduodenectomy (PD).
Method. A total of 114 PD cases were performed at our hospital from April
1985 to April 2005. From April 1995, we attempted to maintain consistent
surgical methodologies. The pancreatic resection, electric cautery was
applied for the excision before 1995. The surgical instrument was initially
changed to a scalpel since 1995, then to a Cavitron ultrasonic surgical
aspirator (CUSA) after 2000. So, PD cases performed before March 1995
were categorized as first group (n/51), and after April 1995 were
categorized as latter group (n/63).
Results. Pancreatogastrointestinal anastomotic leakage occurred in 14 cases
(27.4%) for first group, and 10 cases (15.8%) for latter group. Significantly
better results were achieved using a CUSA for normal pancreas (6.2%).
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Histopathological study of pancreatic stump showed almost identical findings
and insignificant differences in level of tissue damage between scalpel and
CUSA methods.
Conclusions. CUSA can be considered as a prospective precision device
that can reduce the risk of pancreatogastrointestinal anastomotic leakage.
P45.03
PERI-OPERATIVE TRANSFUSION AND ITS INFLUENCE AS A
PROGNOSTIC FACTOR IN RESECTED PANCREATIC DUCTAL
ADENOCARCINOMA
Clark, EJ; Connor, S; Taylor, MA; Hendry, CL; Madhavan, KK; Garden,
OJ; Parks, RW
Royal Infirmary of Edinburgh, Clinical and Surgical Sciences (Surgery),
Edinburgh, UK
Background. Pancreaticoduodenectomy (PDD) is a major operative
intervention most commonly performed for malignancy in the head of
pancreas.
Aim. To evaluate utilisation of red cell concentrate (RCC) transfusion in
PDD and whether this has prognostic significance in a subset of patients with
pancreatic ductal adenocarcinoma (PDAC).
Methods. RCC transfusion requirement was collected for patients under-
going PDD between 19982005. Standard prognostic factors and survival
data were also collected in patients with PDAC. Continuous data are
presented as median (inter-quartile range).
Results. One hundred and seventy patients underwent PDD between 1998
2005. Seventy-six (45%) patients required transfusion. The median number
of units of RCC transfused peri-operatively (intra-operatively and within 24
hours of surgery) was 0 (01) units, range 022 units. The median pre-
operative haemoglobin (Hb) was 126 g/dl. The median number of units of
RCC transfused peri-operatively for Hb B/126 g/dl was 2 (13) units and for
Hb ]/126 g/dl it was 0 (01) units, p/0.004. Forty-six patients with PDAC
were subjected to survival analysis. Univariate and multivariate analysis
showed that only posterior margin invasion was associated with an adverse
outcome (margin positive 214 [156455] days versus (vs.) margin negative
386 [300848] days, p/0.024). Peri-operative RCC transfusion require-
ment was not a significant predictor of survival (Transfusion given 408
[214769] days vs. no transfusion given 314 [196398] days, P/0.14).
Furthermore RCC transfusion within 30 days of operation was not a
significant predictor of survival (Transfusion given 314 [196398] days vs.
no transfusion given 353 [214690] days, P/0.30).
Conclusion. PDD can be performed with a low requirement for RCC
transfusion. Pre- operative haemoglobin is a predictor for peri-operative
requirement of RCC transfusion. Administration of RCC transfusion does
not appear to be a significant adverse prognostic factor in patients with
PDAC.
P45.04
NUTRITIONAL AND ANTHROPOMETRIC ASSESSMENT OF
THE SCOPE FOR DIETARY OPTIMIZATION PRIOR TO PAN-
CREATICODUODENECTOMY: A DETAILED PROSPECTIVE PI-
LOT STUDY
Siriwardena, Ajith1; Goonetilleke, Kolitha1; Burden, Sorrel2
1Manchester Royal Infirmary, Hepatobiliary Unit, Dept. of Surgery, Man-
chester, UK; 2Manchester Royal Infirmary, Dept of Nutrition and Dietetics,
Manchester, UK
Introduction. Although several studies have examined peri-operative
nutritional supplementation in patients undergoing pancreaticoduodenect-
omy (PD) all provided support at various timepoints. In theory, the pre-
operative period offers a therapeutic window for nutritional support. This
study undertakes a detailed nutritional assessment in the pre-operative work-
up period to identify whether there is a window for nutritional supplementa-
tion.
Methods. Data were collected prospectively on 14 patients undergoing
PD under the care of an individual hepatobiliary surgeon in a regional
HPB service during the calendar year 2005. Data were collected from
index admission to discharge on: demography, clinical course, tumour-
related data, anthropometric measurements, calorie intake, operative detail
and outcome.
Results. The median age was 58 (range 3275) yrs and 8 were female. 10
were in-patients at admitting hospitals prior to referral with a-pre HPB unit
median hospital stay of 10 (131) days. Eight (57%) were jaundiced. Median
delay from admission to surgery was 36 (960 days). Median pre-operative
daily calorie and protein intake was 1945 (11342942) Kcal and 85 (47
134) g protein respectively. One patient received regular pre-operative
nutritional supplementation. Median body mass index (BMI) on admission
was 24 and unchanged prior to surgery. Mean percentage change in mid arm
circumference (MAC) from index admission to immediate pre-op was /
0.46%, and the mean percentage change in triceps skin fold thickness
(TSFT) from index admission to immediate pre-op was /3.09%. The mean
nutritional risk index was 102 prior to surgery.
Conclusions. The nutrition risk index and percentage changes of anthro-
pometric data do not show a significant pre-operative nutritional impairment
in the preoperative staging period prior to undergoing PD to warrant s
upplemental nutritional intervention during this ‘‘window’’ period.
P45.05
PANCREATIC METASTASIS OF RENAL CELL CARCINOMA:
RESULTS OF SURGICAL TREATMENT OF FOUR PATIENTS
Lipska, Ludmila; Visokai, Vladimir; Levy, Miroslav; Zaruba, Pavel
Teaching Thomayer Hospital and the 1st Faculty of Medicine Charles
University, Dept. of Surgery, Prague, Czech Republic
Background. Four cases of patients with solitary or multiple pancreatic
metastases from renal cell carcinoma treated by different types of pancreatic
resection.
Method. A report of four patients (one female and three males), mean age 59
years, operated for pancreatic metastasis from renal cell carcinoma between
the years 1994 and 2005.
Results. In the reported cases three of the patients underwent radical
nephrectomy for renal cell carcinoma six, nine and 14 years ago. The fourth
patient presented with asymptomatic jaundice due to metastasis of renal cell
carcinoma into the pancreatic head, which was the first sign of the primary
tumor. Two of the patients were admitted to the surgical department for
jaundice and pruritus and underwent endoscopic cholangiopancreatography,
which confirmed a double duct obstruction sign due to the metastasis. The
third patient was asymptomatic, and the metastasis was diagnosed on the
follow-up CT scan. The fourth patient underwent abdominal ultrasound due
to epigastric pain, which showed tumor infiltration of pancreas. As a result,
further analysis by CT scan was indicated. One Whipple operation was
performed, one simultaneous Whipple with nephrectomy, one total pancrea-
tectomy and one atypical resection combining resection of the pancreatic
head and tail with splenectomy was performed. The patient after the atypical
pancreatic resection died nine months later, the other three patients are alive
and disease free (126, 17 and one months after the surgery).
Discussion and conclusion. Pancreatic resection due to pancretic second-
aries of renal cell carcinoma may be possible in exceptional cases and can
provide long term survival. Metastases are solitary in fewer than 10% of
patients with metastatic renal cell cancer. Resection of isolated metastases
may contribute to prolonged survival in a small subgroup of these patients.
Three types of resection are used in the treatment of pancreatic metastases:
Whipple resection, distal pancreatectomy and total pancreatectomy.
P45.06
A COMPARISON OF PANCREATICODUODENECTOMY WITH
PYLORIC PRESERVING PANCREATICODUODENECTOMY:
META-ANALYSIS OF 2, 600 PATIENTS
Lovegrove, Richard1; Tilney, Henry S1; Iqbal, Naureen2; Abraham, Ajit T2;
Bhattacharya, Satya2; Tekkis, Paris P1; Kocher, Hemant M2
1Imperial College London, Dept. of Biosurgery and Surgical Technology,
London, UK; 2St Bartholomew’s and The Royal London Hospital, Dept. of
Hepatobiliary and Pancreatic Surgery, London, UK
Background. The gold-standard for surgical excision of peri-ampullary
tumours has not been established despite numerous studies, due to
conflicting outcomes.
Aim. To consolidate the published evidence and compare outcomes between
pancreaticoduodenectomy (PD) and pyloric preserving pancreaticoduode-
nectomy (PPPD) across all published comparative studies.
Methods. Using meta-analytical techniques the study compared: operative
details, post-operative adverse events and survival following PD and PPPD.
Comparative studies published between 1986 and 2005 of PD versus PPPD
were included. End points were classified into peri-operative details, post-
operative complications including 30 day mortality, and survival as measured
during follow up. A random effect model was employed, with significance
reported at the 5% level.
Results. 29 studies comprising 2, 600 patients (1, 217 PD and 1, 383
PPPD), including 4 randomized controlled trials with 381 patients (192 PD
and 189 PPPD), were included. Patients undergoing PPPD were found to
have smaller tumours (weighted mean difference (WMD) /0.54 cm, p/
0.030), although no significant difference in the number of patients with stage
III or IV disease existed between the groups (OR 1.01, p/0.980). Decreased
operating times (WMD /35.9 mins, p/0.050) and fewer blood transfusions
(WMD /0.9 units, pB/0.001) were observed in the PPPD group. There was
no difference in post-operative complications, including pancreatic and
biliary leaks or fistulae, between the two groups. It was suggested that peri-
operative mortality was decreased in the PPPD group (odds ratio 0.57, p/
0.040), and overall survival was better (hazard ratio (HR) 0.68, p/0.040),
although this did not remain significant on subgroup analysis.
Conclusions. Both PD and PPPD had similar peri-operative adverse events,
however, it is suggested that PPPD has lower mortality and improved long-
term patient survival, although this may be a reflection of the smaller tumour
size in this group.
P45.07
A SYSTEMATIC REVIEW AND META-ANALYSIS OF PYLORUS-
PRESERVING VERSUS CLASSICAL PANCREATICODUODE-
NECTOMY FOR SURGICAL TREATMENT OF PANCREATIC
CANCER
Knaebel, Hanns-Peter1; Diener, Markus K.1; Heukaufer, Christina1; Antes,
Gerd2; Bu¨chler, Markus W.1; Seiler, Christoph M.1
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1University of Heidelberg, Dept. of General-, Visceral- and Trauma Surgery,
Heidelberg, Germany; 2Institute for Medical Biometrics and Medical
Informatics, University of Freiburg, German Cochrane Centre, Freiburg,
Germany
Introduction. Comparison of effectiveness between the pylorus-preserving
pancreaticoduodenectomy (pylorus-preserving Whipple-PPW) and the
classical Whipple (CW) procedure for pancreatic and peri-ampullary
carcinoma.
Methods. A systematic literature search (Medline, Embase, The Cochrane
Library, Biosis, Science Citation Index, Ovid Journals) was performed to
identify all eligible articles. Randomized controlled trials (RCTs) comparing
PPW versus CW for periampullary and pancreatic carcinoma were eligible for
inclusion. The methodological quality of included studies was evaluated
independently by two authors. Quantitative data on peri-operative para-
meters (blood loss, transfusion, operation time and length of hospital stay),
mortality, morbidity and survival were extracted from included studies for
meta-analysis. Pooled estimates of overall treatment effect were calculated
using a random effects model.
Results. 1235 abstracts were retrieved and checked for eligibility and
seven RCTs finally included. The critical appraisal revealed varying
heterogeneity with respect to methodological quality and outcome para-
meters. The comparison of overall in-hospital mortality (OR 0.82; 95% CI
0.36 to 1.90; P/0.65), morbidity (OR 0.72; 95% CI 0.45 to 1.13; P/0.15)
and survival (HR 0.83; 95% CI 0.62 to 1.11; P/0.21) showed no significant
difference. However, operating time (WMD /56.43 min; 95% CI /92.04
to /20.81; P/0.002), length of hospital stay (WMD /2.93 days; 95% CI -
4.71 to /1.14; P/0.001) and frequency of pancreatic fistula (OR 0.56; 95%
CI 0.32 to 0.95; P/0.03) were significantly reduced in the PPW group.
Conclusions. Hence, in the absence of relevant differences in mortality,
morbidity and survival, the advantages in reduced operating time, hospital
stay as well as a reduced rate of postoperative pancreatic fistula qualify the
PPW to be the reference surgical treatment of periampullary and pancreatic
carcinoma.
P45.08
CLINICAL EXPERIENCE OF PANCREATIC END-TO-END
ANASTOMOSIS FOR RECONSTRUCTION AFTER MIDDLE
SEGMENT PANCREATECTOMY
Oida, Yasuhisa; Imaizumi, Toshihide; Okada, Kenji; Matsuyama, Masahiro;
Yazawa, Naoki; Ishii, Masanori; Sugio, Yoshinori; Tobita, Kosuke; Ohtani,
Yasuo; Makuuchi, Hiroyasu
Tokai University Hospital, Surgery, Kanagawa, Japan
Background. Middle segment pancreatectomy can be adopted for benign
and borderline tumors located in the pancreatic neck and body. This limited
resection of the pancreas has the potential advantage of preserving pancreatic
endocrine and exocrine function. With the recent development of radiologic
studies, the prevalence of this procedure has been increasing. Reconstruction
by pancreaticoenterostomy has generally been employed after this limited
resection. However, this procedure does carry a risk of pancreatic fistula at
the proximal and distal pancreatic stumps, and requires the surgical
manipulation of digestive tract.
Aim. Here we report three patients who successfully underwent pancreatic
end-to-end anastomosis after middle segment pancreatectomy.
Methods. The subjects consisted of 2 patients with serous cystadenomas and
1 patient with an intraductal papillary mucinous tumor. These tumors were
detected in the pancreatic neck or body, and the maximal tumor diameters
ranged from 10 to 33 mm. The pancreatic duct diameters were 2 mm in 2
patients and 4 mm in 1 patient. This reconstructive procedure was carried
out by ductal anastomosis with interrupted absorbable sutures and parench-
ymal anastomosis with interrupted nonabsorbable sutures. A pancreatic tube
was inserted for decompression at the anastomotic site in all patients.
Results. The mean operative time was 3 hours and 31 minutes (range, 2:52
to 4:00), and the intraoperative blood loss was 428 ml (range, 255 to 625 ml).
Although pancreatic fistula was observed in 2 patients with the normal
pancreas, conservative therapy relieved this comlication. Postoperative
hospitalization ranged from 31 to 55 days. Neither tumor relapse nor
stenosis of the pancreatic duct at the anastomotic site was detected in any
patient, with a follow-up of 4 to 27 months.
Conclusion. Our experience confirmed that in selected cases, this recon-
structive procedure is feasible and safe for physiological reconstruction
without involvement of the digestive tract.
P45.09
CRITICAL REVIEW OF CENTRAL PANCREATECTOMY-
SHOULD WE DO IT?
Montagnini, Andre L; Diniz, Alessandro L; Coimbra, Felipe J; Costa Jr,
Wilson L; Mendes, Gabriella O; Herman, Paulo; Machado, Marcel A
Hospital do Caˆncer-FAP, Dept. of Abdominal Surgery, Sa˜o Paulo, Brazil
Background. Segmentar pancreatic resections have been performed in
selected patients with an aim of provide endocrine and exocrine function
preservation. It is usually indicated in the treatment of benign pancreatic
tumors or low malignancy tumors. However, this approach remains not
widely accept.
Aim. This presentation looks forward to show an initial experience within
this surgical technique in a brazilian cancer hospital, and to demonstrate a
critical review about this subject.
Patients and methods. Retrospective analysis of 4 patients submitted to
central pancreatectomy in our service. Data from pathologic diagnosis, age,
pancreatic insufficiency, surgical complications and mortality were collected.
Review of literature.
Results. Four patients were operated between January 2004 and January
2006. Mean age was 49 years old (ranging from 26 to 72). Diagnosis were: one
carcinoid tumor, one solid- cystic tumor of pancreas (Frantz), one mucinous
cystic neoplasm and one serous microcistic tumor. Only one patient had a
serious complication, which was a acute pancreatitis with adjacent infection.
In three patients which were previously health there were neither development
of diabetes or signs of malabsortion. One patient, which was already diabetic
kept the same medication levels, with good control. There was no mortality.
Discussion. Literature shows about 107 patients submitted to central
pancreatic resection. Most indications were due to benign or indolent
tumors. Although there is no randomized study comparing this technique
with standard treatment (distal pancreatectomy), it reveals very encouraging
results in function preservation and morbidity.
Conclusion. Central pancreatectomy is a safe procedure with acceptable
morbidity rates, when performed in reference centers. It should be consider-
ing specially, in benign or intermediate pancreatic tumors.
P45.10
CURRENT STATUS OF PANCREATICOGASTROSTOMY AND
PANCREATICOJEJUNOSTOMY AS RECONSTRUCTION METH-
ODS AFTER PANCREATICODUODENECTOMY-A META-
ANALYSIS
Wente, Moritz N; Shrikhande, Shailesh V; Seiler, Christoph M; Muller,
Michael W; Diener, Markus K; Koninger, Jorg; Friess, Helmut; Buchler,
Markus W
University of Heidelberg, Dept. of Surgery, Heidelberg, Germany
Background. The ideal pancreatic anastomosis after pancreaticoduodenect-
omy (PD) remains a matter of debate.
Aim. To perform a systematic review and meta-analysis to determine the
benefits of the two reconstruction methods, pancreaticojejunostomy (PJ) and
pancreaticogastrostomy (PG).
Methods. A systematic literature search and exploration of given references
revealed original articles published until January 2006 comparing PJ and PG
after PD, grouped into randomized controlled trials (RCT) and observational
studies (OS). Two reviewers independently assessed quality and eligibility of
the studies and performed data extraction for analysis using a random effects
model with weighted odds ratios.
Results. Three RCT consisting of 445 patients were included; the meta-
analysis failed to show an advantage of a particular technique on mortality
(OR 1.10 (0.42, 2.93) or postoperative complications (OR 0.93 (0.63, 1.38)).
In addition, the occurrence of pancreas specific complications such as
pancreatic fistula, delayed gastric emptying, and haemorrhage was not
significantly different in PJ or PG. The analysis of overall 1687 patients
reported in the included twelve OS comparing PJ and PG showed an influence
on mortality in favour of PG (OR 0.35 (0.21, 0.58)). In addition, the rate of
overall complications (OR 0.53 (0.34, 0.82)) and pancreatic fistula (OR 0.22
(0.12, 0.40)) was in favour of PG following pancreaticoduodenectomy.
Conclusion. The meta-analysis of RCT failed to show an advantage of any
technique, with PG and PJ providing equally good results as reconstruction
methods following PD. Contrastingly, all OS invariably noted superiority of
one method; the reports of the OS should be considered as influenced by
several types of bias (selection, publication) and surgical preferences and
experience. In conclusion, the present study also highlights the singular
importance of well designed RCT in guiding modern surgical practice. So
far, there is no evidence for the superiority of a specific reconstruction
method following PD.
P45.11
DEFINITION AND INCIDENCE OF PANCREATIC ANASTOMOS-
TIC FISTULA AFTER A WHIPPLE PROCEDURE: A SYSTEMA-
TIC REVIEW OF THE LITERATURE
Wada, Keita1; Takada, Tadahiro1; Nagashima, Ikuo1; Yoshida, Masahiro1;
Miura, Fumihiko1; Isaka, Takahiro1; Toyota, Naoyuki1; Kato, Kenichiro1;
Traverso, L. William2
1Teikyo University School of Medicine, Surgery, Tokyo, Japan; 2Virginia
Mason Medical Center, General Surgery, Seattle, USA
Background/Aim. Pancreatic anastomotic fistula (PF) is commonly
occurred after a Whipple procedure. None of the anastomotic techniques
seems perfect. It is difficult to compare different series or techniques because
of the lack of a universal definition of PF. The purpose of this study was to
clarify the followings from the review of recent articles. (1) What were the
definitions used in recent publications? (Is there more commonly used
definition?) (2) What is the current incidence by using more common
definition?
Methods. A systematic review was performed mainly focusing on the
definition and incidence of PF. Definitions found in literature were evaluated
by adopting to the actual Whipple data.
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Results. One hundred two articles were reviewed. Of the 102 articles 9
studies (8%) did not mention a specific definition, 8 studies (9%) used
radiographic demonstration only (fistulogram etc.) for the definition,
the remaining 82 studies (83%) used drain data such as amylase-rich
fluid, volume etc. . . Of the 82 studies of which the definition was based on
drain data, most commonly used item was drain amylase value in 92%,
following timing to diagnose in 62%, drainage volume in 60% and duration
of PF in 25%. PF rate was clearly stratified from 8% to 28% according to the
strictness of definitions formulated by most commonly used items of drain
amylase value and timing to diagnose. By using similarly strict definition the
incidence of PF was around 11% with the mortality rate of 1.2% in high-
volume centers.
Conclusion. Current definitions of PF in recent literature are ‘‘broad’’
definition but the cut-off value of each variable was so arbitrary. In addition
to a universal ‘‘broad’’ definition, severity grading of PF based on clinical
impact is necessary. PF rate of around 11% with low mortality rate by
using a ‘‘broad’’ definition is current acceptable numbers for pancreatic
surgeons.
P45.12
DELAYED PRESENTATION OF PANCREATIC INFECTED
NECROSIS FOLLOWING GALLSTONE PANCREATITIS
Jacobs, Michael J1; Kuruba, Rajesh1; Saidi, Reza1; Stawick, Lawrence2
1Providence Hospital, Surgery, Southfield, USA; 2Providence Hospital,
Gastroenterology, Southfield, USA
Background. Infected pancreatic necrosis uncommonly presents several
months after gallstone pancreatitis. The appropriate surgical treatment is
similar to the management of acute onset of pancreatic necrosis.
Aim. To discuss and review the treatment of delayed-onset of pancreatic
necrosis.
Methods. An 83-year old gentleman was admitted several months prior
for gallstone pancreatitis and underwent a same admission cholecystectomy
that revealed chronic calculous cholecystitis. Cholangiogram was unremark-
able. The patient was noted to have a persistant low-grade fever and malaise
that developed several months after the index admission. He underwent
a CT scan that demonstrated a pancreatic phlegmon without evidence
of biliary obstruction. Oral antibiotics were instituted after persistance
of his symtoms and a CT-guided fine needle aspirate was steriley performed
and confirmed non-infectious pancreatic necrosis. The patient underwent
an exploratory laparotomy, intraoperative ultrasound, and transgastric
pancreatic necrosectomy with completion pancreatico-gastric anasta-
mosis. Cultures demonstrated the presence of an infectious process and
necrosis. The patient did very well postoperatively and his symptoms rapidy
resolved.
Conclusion. The delayed onset of pancreatic infectious necrosis is un-
common. Sound management is based upon standard surgical principles and
warrants aggressive and early debridement when recognized.
P45.13
DIAGNOSIS, TREATMENT AND OUTCOME OF ABDOMINAL
HAEMORRHAGE (AH) IN PATIENTS WITH PANCREATOBILI-
ARY (PB) DISEASES
Krupa, Jaroslaw1; Wagensveld, Bart A1; Desigan, Sharmini2; Hyare, Har-
preet2; Brookes, Jocelyn A2; Shankar, Arjun1; Kurzawinski, Tom R1
1University College London Hospital, Dept. of Hepato-Pancreato-Biliary &
Endocrine Surgery, London, UK; 2University College London Hospital,
Dept. of Radiology, London, UK
Objective. This study reviews our experience with managing abdo-
minal haemorrhage in patients with PB diseases referred to us between
19902005.
Methods. Patients with PB diseases who had AH were identified retro-
spectively from radiological and surgical databases.
Results. 64 patients with AH were identified (45 male, 19 female). 25 (39%)
patients had acute pancreatitis, 12 (18.7%)-chronic pancreatitis, 24 (37.5%)-
PB cancers, 2 (3.1%)-gallstones and 1 (1.6%)-trauma.38 (59.4%) bled
primarily as a result of their disease and 26 (40.6%) after surgery (Whipple-
19, cholecystectomy-2, Puestow-1, cystgastrostomy-1, distal pancreatect-
omy-1, other-2). Contrast-enhanced CT was performed in 36 (56.2%)
patients and showed evidence of bleeding in 26 (72.2%). Visceral angio-
graphy was performed in 60 patients and bleeding source was identified in 43
(71.6%). The source of bleeding was: gastroduodenal artery (GDA)-23
(30.3%), splenic-10 (13.1%), SMA-5 (6.6%), right hepatic-5 (6.6%),
common hepatic-3 (3.9%), other-4 (5.3%). Radiological therapeutic inter-
ventions were carried out in 52 patients (47 (61.8%) coil and gelfoam
embolizations, 5 (6.6%) covered stent occlusions). Technical success was
achieved in 48 (87.3%) cases, partial success in 2 (3.6%) and failed in 6
(10.9%) patients. Re-bleeding occurred in 11 (21.1%) patients. 1 patient
died instantly. 10 had 2nd embolization, which stopped bleeding in 6 patients
and failed in 4, all of whom died. 4 patients (6.25%) had surgery for massive
haemorrhage; 3 of these died and 1 survived. Mortality in the radiological
intervention group was 5/52 (9.6%) and 3/4 (75%) in the surgical group.
Overall mortality rate was 18.7%.
Conclusions. CT scan and visceral angiography have similar ability to
diagnose haemorrhage in patients with PB diseases. Commonest site of
bleeding was GDA. AH in these patients is a life threatening complication
with a mortality of 18.7%. Radiological intervention is a treatment of choice
in these patients.
P45.14
DIFFERENT LAPAROSCOPIC APPROACHES FOR THE SURGI-
CAL MANAGEMENT OF PANCREATIC PSEUDOCYSTS
Pekmezci, Salih; Saribeyoglu, Kaya; Kilic, Ilknur; Kapan, Metin; Tasci,
Hasan; Kalafat, Hasan
Istanbul University, Cerrahpasa Medical Faculty, Dept. of General Surgery,
Istanbul, Turkey
Background. The search for the ideal treatment of pancreatic pseudocysts
Aim. To report our experience in the laparoscopic treatment of pancreatic
pseudocysts.
Patients and methods. Between February 2001September 2005, the
patients who were admitted to our clinic and underwent laparoscopic surgery
for pancreatic pseudocysts were included in the study.
Results. Five patients underwent laparoscopic surgery of pancreatic pseu-
docysts. There were four female and one male patients and mean age was
60 (5269). Pseudocysts were related to acute hyperlipidemic in one and
acute biliary pancreatitis in four cases. The mean diameter was 15 cm
(720). Laparoscopic ultrasound was used in order to define anatomical
localization of the cysts. In two patients cystogastrostomy was performed
through a gastrotomy by endo-GIA stapler; in another two patients
anastomosis was done between two holes created on gastric and pseudocyst
walls at lesser sac. In one patient posterior transcystic cystogastrostomy was
performed using Ligasure. There was no mortality or procedure related
complication.
Conclusion. Laparoscopy is safe and efficient in the surgical management of
pancreatic pseudocysts. Anatomical localization of the cyst and adherence
between posterior gastric wall and anterior cystic wall determine the ideal
laparoscopic approach
P45.15
DOES CLOSED DRAINAGE CONTRIBUTE TO PREVENTING
INFECTION AFTER PANCREATODUODENECTOMY?
Hatori, Takashi1; Onizawa, Shunsuke1; Ohara, Toshiya1; Furukawa, Kenji1;
Matsuura, Hiroshi1; Imaizumi, Toshihide2; Takasaki, Ken1
1Tokyo Women’s Medical University, Dept. of Gastroenterological Surgery,
Tokyo, Japan; 2Tokai University, Dept. of Surgery, Isehara, Japan
Background. Pancreatoenterostomy leakage and intraabdominal abscess
sometimes occur in the patients who undergo pancreatoduodenectomy. In
case of pancreatoenterostomy leakag the patient will be critical if the drainage
is not performed effectively. We adopted the open-type drainage until 1993,
however we have changed to the closed drainage with connection to the
water-sealed bag since 1994.
Aim. We analysed to make clear whether the closed drainage contributs to
prevent the postoperative infection.
Methods. A retrospective review of 796 patients who underwent pancrea-
toduodenectomy performed in our institute between 1985 and 2004 was
carried out. We studied the incidence of postoperative infectious complica-
tion (intraabdominal abscess, surgical site infection(SSI)), duration of the
drainage, positive rate of the bacteria in the discharge taken from the drains
isolated species of the bacteria.
Results. Open drainage was performed in 289 cases until 1993 (open
group), and closed drainage has been performed in 507 cases since 1994
(closed group). The mean number of drainage tube was 4.5 in the open type
group, 2.2 in the closed type group. Mean duration of the drainage was
sinificanlty shorter in the closed group (10.5 days) than in the open group
(23.1 days). Most of the intraabdominal abscess was caused by pancrea-
toenterostomy leakage. There is no difference of the incidence of the
intraabdominal abscess and SSI in between the open group and the closed
group. As for the positive rate of bacterial culture, open group was
significantly high (33 cases; 11%) than closed group (17 cases; 3%). Most
of the isolated bacterial spieces were enterobacterium, but positive rate of
Staphlylococcus spieces suggesting retrograde infection is significantly higher
in the open group (42%) than in the closed group (11%).
Conclusion. Closed type drainage was useful in reducing the number of
drainage tube and preventing the retrograde infection after pancreatoduode-
nectomy.
P45.16
POSSUM FOR PATIENTS UNDERGOING PANCREATODUODE-
NECTOMY
de Castro, Steve; Houwert, Taco; Kuhlmann, Koert; Reitsma, Hans; Busch,
Olivier; van Gulik, Thomas; Gouma, Dirk-Jan
Academic Medical Center, Surgery, Amsterdam, Netherlands
Background. Comparison of operative morbidity rates after pancreatoduo-
denectomy between units may be misleading because it does not account for
the physiological variation of the condition of the patient.
Aim(s)/Objective(s). The aim of this study was to evaluate the Physiolo-
gical and Operative Severity Score for the enUration of Mortality and
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Morbidity (POSSUM) for these patients and to look for risk factors
associated with morbidity in a high-volume centre.
Methods. Between January 1993 and December 2003, 511 patients under-
went a pancreatoduodenectomy of which 425 for malignant disease.
POSSUM performance was evaluated by assessing the ‘‘goodness-of-fit’’
using the linear analysis method.
Results. Overall, 260 of 511 patients (50.9%) had one or more complication
after pancreatoduodenectomy and 8 patients (2%) died. POSSUM had a
significant lack of fit using ‘‘goodness-of-fit’’ analysis. In Multivariate
analysis, one statistically significant factor associated with morbidity and
not incorporated in POSSUM (pB/0.05) was identified: ampulla of Vater
adenocarcinoma (OR/1.73, 95% CI: 1.072.80).
Conclusion. Overall, there is a lack of calibration of POSSUM in patiets
who undergo pancreatoduodenectomy.
P45.17
EFFECT OF PREOPERATIVE ENDOSCOPIC BILIARY DRAI-
NAGE ON INFECTIOUS MORBIDITY AFTER PANCREATODUO-
DENECTOMY: A CASE-CONTROL STUDY
Pessaux, Patrick1; Etienne, Sandrine2; Lermite, Emilie2; Teyssedou, Carlos2;
Mucci, Stephanie2; Arnaud, Jean-Pierre2
1University Hospital, Digestive Surgery Dept., Angers, France; 2University
Hospital, Angers, France
Background. The utility of preoperative endoscopic biliary drainage
(PEBD) in jaundiced patients before pancreatoduodenectomy (PD) is still
debated, because of the heterogeneity of the studied population including
different tumor, drainage techniques and surgical procedures. The aim of this
study was to report the influence of PEBD on postoperative outcome after
PD.
Patients and methods. Between January 1996 to December 2004, 124
patients underwent a PD, and 28 patients (22.6%) had PEBD. This group of
patients was matched for age, sex, indication of surgery, serum bilirubine
levels, to 28 control patients who underwent PD without PEBD during the
same period.
Results. The specific morbidity of the PEBD was 10.7% (pancreatitis: n/2;
cholangitis: n/1) with a mean hospital stay of 4.59/3 days. Overall morbidity
(57% vs 64%), surgical morbidity (43% vs 46%), medical morbidity (29% vs
36%), and mortality (3.5% vs. 3.5%) were not significantly different between
the two groups. The infectious morbidity was significantly higher in the
PEBD group (50% vs 21%; p/0.05). Total hospital stay (including stenting
hospital stay) was significantly longer in the PEBD group (34.29/13.8 vs
25.19/9.8 days; p/0.006). The bacteriological analysis of infected collec-
tions in PEBD group revealed a strong correlation with the bacteria present in
the bile (collected during PD).
Conclusions. These data demonstrate that PEBD increases the risk of
postoperative infectious complications after PD and prolongs the overall
hospital stay. We suggest to do not perform routine PEBD for resectable
cancers, unless presence of cholangitis, the need for preoperative assessment
or neoadjuvant treatments.
P45.18
EVALUATION OF THE P-POSSUM SCORING SYSTEM FOR
PANCREATODUODENECTOMY
Bhati, Chandra S; Tamijmarane, Appou; Mirza, Darius; Bramhall, Simon;
Mayer, David; Wigmore, Stephen; Buckels, John A
Queen Elizabeth Hospital, HPB and Liver Transplant Surgery, Birmingham,
UK
Background. Pancreatoduodenectomy (PD) is associated with significant
morbidity and mortality. Various scoring systems are in place to assess and
predict risks involved for patients.
Aims. Evaluation of P-POSSUM (Portsmouth modification of Physiological
and Operative Severity Scoring System for Enumeration of Morbidity and
Mortality) score on the post operative morbidity and mortality rates in
patients who had PD in a tertiary referral centre.
Method. P-POSSUM score was calculated for 241 consecutive patients who
had PD from January 2002 to September 2005 and correlated with observed
morbidity and mortality.
Result. Median age was 64 (Range 21.7 84.5). There was no difference in
the physiological scores (PS) and operative scores (OS) between different
aetiological groups. Overall 30 days mortality was 7.8% and morbidity was
44.8%. Mean PS was 16.079/3.30 and the mean OS was 13.679/3.42.
However, the mean OS rose to 20.289/2.52 for the complex major
operation (pB/0.001) with 2 fold increase in morbidity and 3.5 fold
increase in mortality, in comparison to those who had PD without any
venous or additional visceral resection. The observed to predicted ratio (O:P)
in terms of overall morbidity was 1:4 for groups with PS5/15. However this
ratio seems to be closer to 1 as the PS increases to above 18.00. The average
O:P ratio for the postoperative mortality was 3:4. Univariate analysis
identified factors such as haemoglobin (p/0.013), white cell count
(WCC) (p/0.059), albumin (p/0.04), extent of PD (p/0.033) and P-
POSSUM physiological score (p/0.001) as important in predicting severe
complications and death whereas logistic regression revealed that only
physiological score (p/0.005) and WCC (p/0.010) were significant
predictors.
Conclusion. Whilst P-POSSUM underestimated the actual mortality rate,
the predicted morbidity risk score closely matched the observed risks
especially for those with high PS. Physiological score and WCC were the
independent risk factors. Physiological score is a useful tool for predicting
risks for PD
P45.19
EXAMINATION OF COMPLICATIONS AFTER PANCREATO-
DUODENECTOMY (PD)
Kinoshita, Hisafumi; Sakai, Takenori; Furukawa, Satoshi; Kawahara, Ryui-
chi; Maruyama, Yuichiro; Ishikawa, Hiroto; Uchida, Shinji; Yasunaga,
Masafumi; Koji, Okuda; Kazuo, Shirouzu
Kurume University School of Medicine, Surgery, Kurume, Japan
Aim. We investigated complications after PD to establish prevention and
strategies.
Subjects and methods. The subjects were 460 patients who underwent PD
in Kurume University Hospital between January 1965 and December 2004.
We investigated early postoperative complications such as leak, hemorrhage,
and abscess in these patients.
Results. The incidence of postoperative complications was 42.2%, and the
hospital mortality rate was 5.9%. Leak was observed in 68 patients (14.8%). In
41 of these patients, leake of pancreatojejunostomy was observed, and drainage
by additional laparotomy was performed in 5 patients, and preservative
treatment in 36 patients. Eleven of the 41 patients died during admission.
Hemorrhage occurred in 38 patients (8.3%); intraperitoneal hemorrhage,
biliary hemorrhage, and digestive tract hemorrhage were observed in 19, 2, and
17 patients, respectively. In 11 of the 19 patients, intraperitoneal hemorrhage
was related to leak. To treat intraperitoneal or biliary hemorrhage, hemostasis
by additional laparotomy was performed in 9 patients, transcatheter arterial
embolization in 8 patients, and preservative treatment in 4 patients. Nine of
these patients died during admission. Abscess was detected in 47 patients
(10.2%); they consisted of 29 patients with intraperitoneal abscess, 12 patients
with abdominal wall abscess, and 6 patients with liver abscess. In 14 of the 29
patients, intraperitoneal abscess was related to leak. To treat intraperitoneal or
liver abscess, drainage by additional laparotomy was performed in 4 patients,
ultrasonography -guided drainage in 7 patients, and preservative treatment in
24 patients. Six of these patients died during admission.
Conclusion. In patients with leak, drainage should be performed to prevent
secondary complications. Transcatheter arterial emboization should be
selected as a first-choice treatment in patients with hemorrhage, and
ultrasonography-guided drainage in patients with abscess.
P45.20
FACTORS INFLUENCING OUTCOMES OF ENDOSCOPIC AND
SURGICAL TREATMENT OF PANCREATIC PSEUDOCYSTS
Zdanyte, Elena; Sileikis, Audrius; Jurevicius, Saulius; Strupas, Kestutis
Vilnius University Hospital ‘‘Santariskiu Klinikos’’, Centre of Abdominal
Surgery, Vilnius, Lithuania
Background. Endoscopic drainage provides a good alternative or supplement
to the surgical treatment of pancreatic pseudocysts. Few data exist concerning
the evaluation of specific risk factors influencing treatment outcomes. AIM of
our study was to evaluate factors influencing outcomes of endoscopic and
surgical approaches in the treatment of pancreatic pseudocysts.
Methods. Prospective study of 106 patients (mean age 44, 9) with
symptomatic and/or bigger than 5 cm pseudocysts treated from 2000 to
2004 was conducted. 39 (36, 8%) patients underwent endoscopic drainage
procedures, 67 (63, 2%)patients had surgical procedures. The impact of
endoscopic versus surgical management, gender, age, surgical risk according
to ASA, nutritional status, etiological and morphological peculiarities of
pseudocysts on the treatment outcomes was investigated.
Results. No significant difference between the effectiveness of endoscopic
and open operations was found. A lesser experience of surgeon (p/0.008),
female gender (p/0.008) and incision (versus transmural drainage) (p/
0.0055) reduced operative effectiveness, pancreatic necroses increased the
number of postoperative complications (p/0.04) in endoscopic group. In the
open surgery group advanced age (p/0.04), male gender (p/0.03), ASA
grade III (p/0.04), localization of pseudocysts in the pancreatic body/tail
(p/0.04) increased number of intraoperative complications. An average
patient age (p/0.03) and pseudocyst volume (p/0.04) was greater and
localization of pseudocyst in the the pancreatic body/tail more frequent (p/
0.003) in patients with postoperative complications.
Conclusion. Endoscopic transmural drainage present an effective alternative
to open operations in the cases of pseudocysts with close opposition of
gastroduodenal wall, without disorders of pancreatic juice leakage and
pseudotumorouschangesof thepancreaticparenchyma,butpancreaticnecrosis
considerably influenced a development of postoperative complications.
P45.21
GASTROINTESTINAL ENDOSCOPY AFTER FAILED TREAT-
MENT OF DELAYED GATRIC EMPTYING BY ERYTHROMYCIN
FOLLOWING PANCREATICODUODENECTOMY
Coron, Emmanuel1; Frampas, Eric2; Metairie, Sylvie3; Meurette, Guil-
laume3; Miraillie, Eric3; Leborgne, Joel3; Regenet, Nicolas3
Abstracts 227
1University Hospital, Gastroenterology, Nantes, France; 2University Hospi-
tal, Radiology, Nantes, France; 3University Hospital, Digestive and Endo-
crine Surgery, Nantes, France
Background. Delayed gastric emptying (DGE) occured in 30% after
pancreaticoduodenectomy. Different risks factors have been identified such
as pylorus preservation, enteral nutrition and surgical complications.
Definitive treatment of DGE has not been established.
Aim. This study was undertaken to determinate the role of gastric endoscopy
in the management of DGE.
Methods. Of 182 patients who underwent pancreaticoduodenectomy
(Whipple procedure) from 1991 to 2005, 64 patients (34.4%) suffering
DGE were analysed (33 female and 31 male; mean age 60 years9/13.6).
DGE was defined as the inability to tolerate a regular diet after 10 days
postoperatively.
Results. The pancreaticoduodenectomy was realised for a cancer in 38 cases
(59%). Surgical complications were associated with DGE in 23 patients
(36%) of which 11 pancreatic fistula. Sixteen patients were managed
medically without erythromycin or endoscopy. Forty five patients (70%)
have been managed by erythromycin and healed in 24 cases (53.3%). An
endoscopy was done in 19 cases including 17 patients who didn’t responded
after erythromycin treatment. Endoscopy was made to check the permeability
of the gastrojejunal anastomosis and emptyed the stomac. It was done at
mean 19.99/6 days postoperatively. Two patients had an anastomotic
stenosis, two patients had an anastomotic ulcer and one patient had both.
DGE healed after endoscopy in 14 cases (73.7%).
Conclusion. After failed treatment of DGE by erythromycin a gastrojejunal
endoscopy could be done to check the gastrojejunal anastomosis. The
endoscopy improved the DGE in 73.7%.
P45.22
THE USE OF ENFORCEMENT MATERIALS FOR PANCREATIC-
JEJUNAL ANASTOMOSIS DURING THE WHIPPLE PROCEDURE
Severtsev, Alexey; Tchudaev, Dmitry; Ovtchinnikov, Vladimir
Non-governmental Medical Institution, HPB-Surgical Dept., Moscow,
Russia
Background. The pancreatic-jejunal anastomosis is the weakest milestone of
the Whipple procedure. There are many different techniques and materials
used to do this anastomosis safer and warranted. One of the prospective
methods is to use intraoperative adhesive materials like fibrin sealant and
Tachocomb.
Aim. The purpose of this study was to assess the use of these two very close
materials for the enforcement of pancreatic-jejunal anastomosis during the
Whipple procedure.
Methods. During the period from December 1998 till December 2005,
35 patients had the Whipple procedure with the use of fibrin glue or
Tachocomb at site of pancreatic-jejunal anastomosis (15 and 20 patients
respectively). All patients had the cancer of pancreatic head. The mean age,
sex ratio, disease history and concomitant diseases, and the technique of
pancreatic-jejunal anastomosis (end-to side, two layers) in both groups were
similar. During the surgery there were used 5 ml of sealant or 1 large fleece of
Tachocomb.
Results. The intraoperative time for additional manipulation was high for
sealant group (1, 5 times as compared with Tachocomb). The intraoperative
adhesion and sealing were better for sealant group (in 9 cases of Tachocomb
the material was not fixed to the line of anastomosis; no such cases in the
sealant group). There were 2 cases of pancreatic-jejunal anastomosis leakage
in Tachocomb group, and the absence in the fibrin glue group. The first
postoperative day of mean amylase level from the area of surgery (drainage
fluid from the abdominal cavity) was 3 times higher for Tachocomb (66000
IU for Tachocomb and 21500 IU for fibrin glue).
Conclusions. These results show that if the surgeon had decided to use any
adhesive materials (as Tachocomb or fibrin sealant) for the enforcement of
pancreatic-jejunal anastomosis during the Whipple procedure, the use of
sealant is more preferable because of its plasticity and temporary-time liquid
condition, which help this material to penetrate to any deep layers of
anastomosis.
P45.23
LAPAROSCOPIC DISTAL PANCREATECTOMY. A GOOD TECH-
NIQUE EVEN IN COMPLICATED CASES
Rotellar, Fernando1; Pardo, Fernando1; Casanova, Daniel2; Regueira,
Fernando1; Pastor, Carlos1; Valentı´, Victor1; A-Cienfuegos, Javier1
1University Clinic. University of Navarra, Digestive and General Surgery,
Pamplona, Spain; 2Marques de Valdecilla Hospital, Digestive and General
Surgery, Santander, Spain
Introduction. In december 2003 we began our program of laparoscopic
pancreatic surgery. In this time we have improve our knowledge of this
technique in a way that has allow us to apply it in difficult cases such as big or
complicated tumors or in patients with previous laparotomies or retro-
peritoneal surgery. We show our surgical technique and results.
Surgical technique. The patient is placed in a modified lithotomy position
and reverse Trendelenburg. A five-port technique is used. The approach to
the pancreas is initiated by dividing some vessels of the greater curve. The
mobilization of the tail of the pancreas is iniciated along the inferior border of
the gland. Afterwards the posterior face is dissected from the retroperito-
neum. This allows the visualization of the splenic vessels. If the vessels are
free, a spleen-preserving distal pancreatectomy with conservation of the
splenic artery and vein is performed. In case that the splenic vessels are
affected by the tumor in the proximity of the splenic hilum, the vessels are
sectioned between clips and a distal pancreatectomy with splenectomy is
performed. If the vessels are affected distal to the spleen we resect the splenic
vessels and preserve the pancreas vascularized with the short vessels
(Warshaw’s technique).
Results.
Case 5 was a young woman with a BMI of 40. The tumor was abscessed after
a endoUS-guided biopsy. The inflammatory mass affected spleen and greater
gastric curvature. The operation was a distal pancreatectomy with splenect-
omy and parcial gastrectomy. Case 9 was a woman who had underwent an
open left nefrectomy due to a hypernefroma. A pancreatic metastases
appeared in the tail of the pancreas and in the right adrenal gland. The
operation was a Warshaw’s technique and simultaneous right adrenalectomy.
Conclusion. Laparoscopic distal pancreatectomy is possible and safe even in
complicated tumors or difficult cases.
P45.24
LAPAROSCOPIC MEDIAL PANCREATECTOMY FOR TUMORS
OF THE NECK OF THE PANCREAS
Rault, Alexandre; Sa Cunha, Antonio; Beau, Ce´dric; Collet, Denis; Masson,
Bernard
Hopital Haut Le´ve´que, Pessac, France
Background. Medial pancreatectomy is an alternative technique for benign
or low grade malignant neoplasms located to the left of gastro-duodenal
artery and close to the spleno mesenteric confluence. The aim of medial
pancreatectomy is to preserve part of the distal pancreatic parenchyma.
Aim. The aim of this study is to report the results of the first laparoscopic
medial pancreatectomy series.
Methods. Since 1999, we conducted a prospective evaluation of laparoscopic
pancreatic resections. From 1999 to February 2006, 60 patients were
enrolled, from whom 6 patients underwent laparoscopic medial pancreatect-
omy. The entire procedure was performed laparoscopically. A four ports
procedure was realised (10 mm umbilical:308 optical, 5 mm at the xyphoid,
10 mm left sub-costal, and 5 mm on the right). The gastrocolic ligament was
opened; the pancreatic was freed from the portal vein. The proximal pancreas
was stapled while the distal pancreas was transacted with bipolar coagulation
device. The proximal end of the distal pancreatic remnant was anastomosed
to the posterior gastric wall.
Results. One patient required conversion to open laparotomy due to
specimen lost. Five patients (83%) underwent a full laparoscopic medial
pancreatectomy. Indications for resection was cystic tumors (n/3), neu-
roendocrine tumor (n/1), adenocarcinoma (n/1), focal pancreatitis (n/
1). The median duration was 225 minutes (range, 180365 min). No death
occurred. Post operative complication was observed in 5 patients (83%). All
Results table for P45.23
AGE SEX ETIOLOGY AND PROCEDURE TIME(MIN) BLOOD LOSS (CC) TRANSFUSION STAY
1 31 F Neuroendocrine- SPDP 240 B/50 NO 3
2 58 F Neuroendocrine -DP/S 372 150 NO 4
3 72 F Insulinoma-SPDP 183 B/50 NO 3
4 48 F Insulinoma-SPDP 337 100 NO 3
5 28 F Solid-pseudopapilary-DP/S/G 401 250 NO 7
6 42 F Insulinoma-SPDP 240 100 NO 4
7 45 F Insulinoma-SPDP 105 B/50 NO 5
8 59 F Serous cystic-SPDP 208 B/50 NO 6
9 63 F Metastases -Warshaw 413 350 NO 6
10 26 F Mucinous cystic-SPDP 331 B/50 NO 6
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of these were pancreatic fistulas, only one was clinically symptomatic (17%).
Median hospital stay was 18 days (range, 1525 days).
Conclusion. Laparoscopic medial pancreatectomy is a feasible and safe
procedure, with morbidity rate similar to open surgery.
P45.25
LONG TERM RESULTS OF FREY’S PROCEDURE IN PATIENTS
WITH CHRONIC PANCREATITIS
Chamlou, Reza; Balladur, Pierre; Tiret, Emmanuel; Parc, Roland; Paye,
Franc¸ois
Hoˆpital Saint-Antoine, Digestive Surgery, Paris, France
Background. With the development of alternative endoscopic procedures,
the benefits of surgical treatment for painful obstructive chronic pancreatitis
(OCP) remain under debate. The Frey’s procedure, combining local
resection of pancreatic head with longitudinal pancreatico-jejeunostomy
(LR-LPJ), is rarely performed. This study assessed the long-term results of
the Frey’s procedure.
Methods. 19 patients underwent LR-LPJ. The median interval between the
first symptoms of pancreatitis and surgery was 48 months. Indications for
surgery were intractable pain in 84% of patients and other complications of
OCP in 16%. The mean diameter of the pancreatic duct was 11.19/3.6 mm.
Nine patients (47%) had a common bile duct stricture and underwent
associated hepaticojejunostomy. Quality of life (QOL) was assessed by using
the QLQ-C30 questionnaire of the EORTC. Median follow-up was 47
months.
Results. There were no deaths. Postoperative complications occurred in
4 patients (21%). Complete pain relief was achieved in 76% of patients
(p/0.01). Desobstruction of the cephalic portion of the main pancreatic
duct was complete in 16 patients (84%); all the three patients with residual
cephalic pancreatic obstruction reported continuing pain post-operatively
(p/0.04). The average weight gain in patients with no pain was 4.6 Kg.
Four patients (21%) had pre-operative steatorrhoea versus 10 post-opera-
tively (58%). The number of patient with insulin-dependent diabetes
increased from 16% pre-operatively to 41% post-operatively. One unresect-
able pancreatic ductal adenocarcinoma occurred during follow-up. The
results of QOL questionnaire was similar to those reported in the
literature.
Conclusion. Frey’s procedure provides effective pain relief with low
procedure-related morbidity. A complete desobstruction of the cephalic
portion of the main pancreatic duct is mandatory for an optimal result. The
observed increase in endocrine and exocrine pancreatic insufficiencies could
be related to the natural course of the disease.
P45.26
LONGITUDINAL PANCREATOJEJUNOSTOMY WITH DISTAL
PANCREATECTOMY FOR A PANCREATIC TAIL CANCER ON
CHRONIC PANCREATITIS
Nozawa, Satoshi; Shimizu, Hiroaki; Yoshidome, Hiroyuki; Ohtuka, Ma-
sayuki; Kato, Atsushi; Yoshitomi, Hideyuki; Furukawa, Katsunori; Mitsuha-
shi, Noboru; Sawada, Shigeaki; Takeuchi, Dan; Kimura, Fumio; Miyazaki,
Masaru
Graduate School of Medicine, Chiba University, Dept. of General Surgery,
Chiba, Japan
Background. Chronic pancreatitis could be a risk factor for pancreatic
cancer. It is sometimes difficult to distinguish from a pancreatic cancer, too.
If a pancreatic cancer is found in a patient with symptomatic chronic
pancreatitis, the operative procedure might be difficult. We experienced a
case of pancreatic tail cancer developed on the chronic pancreatitis that
required main duct decompression for pain reduction.
Case report. A 64 years old man visited our hospital because of his
back pain and recent body weight loss. He did not drink alcohol but had
been treated for diabetes for 26 years. A computed tomography revealed
significant dilatation of the main pancreatic duct from the head to the tail of
the pancreas. In the pancreatic head, there was a pancreatic stone, 10 mm
in diameter. There were some small calcifications in the atrophic
parenchyma of the pancreas. A poorly enhanced mass lesion, 2 cm in
diameter, was exhibited in the tail of the pancreas close to the splenic hilus.
An angiogram showed encasement of the splenic artery and vein at the site of
the mass lesion. Endoscopic ultrasound-guided fine-needle aspiration cytol-
ogy performed for the lesion revealed class V. Based on a preoperative
diagnosis of a pancreatic tail cancer occurred on chronic pancreatitis, a
surgical operation was performed. A local resection of the head of the
pancreas combined with longitudinal pancreatojejunostomy (Frey procedure)
was performed after a distal pancreatectomy. Histological findings showed
moderately differentiated tubular adenocarcinoma with atrophic change and
fibrosis of the pancreas parenchyma in the proximal side of the tumor. His
post-operative course was not eventful and his back pain disappeared
completely.
Conclusion. Frey procedure is a useful method to decompress the
pancreatic main duct in chronic pancreatitis with the pancreatic head lesion,
especially. It can also be useful and safe procedure when it is combined with a
distal pancreatectomy for a pancreatic tail cancer.
P45.27
MANAGEMENT OF DELAYED ARTERIAL HAEMORRHAGE
AFTER PANCREATICODUODENECTOMY
Pai, Madhava1; Limongelli, Paolo1; Whitelaw, Douglas1; Jackson, James2;
Williamson, Robin CN1; Jiao, Long R1
1Hammersmith Hospital, Imperial College, Hepatobiliary Surgery, London,
UK; 2Hammersmith Hospital, Imperial College, Radiology, London, UK
Background & aims. Controversy exists regarding the best management of
delayed haemorrhage after pancreaticoduodenectomy. We reviewed exten-
sively the published articles describing this complication and reported our
own series among 180 pancreaticoduodenectomy to examine both the role of
diagnostic and interventional radiology and laparotomy in management of
this serious condition.
Methods. A literature search of all reported cases in the last 15 years on
delayed haemorrhage after pancreaticoduodenectomy together with identifi-
cation and review of cases among 180 pancreaticoduodenectomy from our
unit between 1993 and 2003. For metaanalysis, the end points evaluated
were of operative and functional outcomes and adverse events. A random-
effect model was used for analysis and sensitivity analysis was performed to
examine the bias in patient selection.
Results. One hundred cases of delayed arterial haemorrhage were described
among a total of 2503 pancreaticoduodenectomy (3.9%). Analysis revealed
that recurrent bleeding occurred in 42.2%of patients undergoing laparotomy
in comparison with 23.6% of embolised patients. The mortality rate was
28.8% in laparotomised patients (as compared to 14.6% in radiologically
embolised patients) Four cases of delayed arterial haemorrhage were
identified among 180 pancreaticoduodenectomy performed in our unit
(2.2%). All cases had urgent diagnostic visceral angiography. Two patients
were successfully managed with transcatheter arterial embolisation of
bleeding vessels. But two patients who were operated on died in the
postoperative period from multiorgan failure.
Conclusions. Delayed arterial haemorrhage after pancreaticoduodenectomy
carries significant mortality. Radiological management with transarterial
embolisation would seem to be a better treatment option than laparotomy.
P45.28
MEDIAL SEGMENT PRESERVING PANCREATECTOMY
Miura, Fumihiko; Takada, Tadahiro; Nagashima, Ikuo; Amano, Hodaka;
Yoshida, Masahiro; Isaka, Takahiro; Toyota, Naoyuki; Wada, Keita; Takagi,
Kenji; Kato, Kenichiro
Teikyo University School of Medicine, Surgery, Itabashi-ku, Tokyo, Japan
Background. When patients have two major foci, pancreatic head and tail,
total pancreatectomy (TP) might be generally applied although sequelae of
pancreatic insufficiency make patients‘ quality of life (QOL) worse. On the
other hand medial segment preserving pancreatectomy (MSPP) that pre-
serves middle pancreas maintains pancreatic exocrine and endocrine func-
tion.
Objective. We describe the feasibility of medial segment preserving
pancreatectomy (MSPP) for patients with double tumors as an alternative
for TP.
Metohds. Three patients underwent MSPP. Patient 1 underwent pancreatic
tail resection with splenectomy for invasive ductal carcinoma 45 months after
pylorus preserving pancreatoduodenectomy (PPPD) for intraductal papillary
mucinous neoplasm (IPMN). About 4 cm of pancreatic body was preserved.
Patients 2 underwent PPPD for ampullay carcinoma 55 months after
pancreatic tail resection for IPMN. About 5 cm of pancreatic body was
preserved. Patient 3 underwent PPPD, pancreas tail resection, and splenect-
omy simultaneously for ampullary carcinoma and IPMN, with the pancreatic
body measuring 6 cm being preserved.
Results. The surgical margins of the resected specimen were free of atypical
cells in all cases. Patient 3 encountered pancreatic fistula and was successfully
treated by conservative therapy. Post operative course of other 2 patients was
uneventful. All three patients are alive without recurrence 20, 10, and 6
months after surgery for carcinoma at this writing. Diabetes mellitus has not
been identified except in patient 3 who had diabetes mellitus before surgery.
Conclusions. MSPP may be performed for patients with double pancreatic
tumors since it keep curability and postoperative QOL.
P45.29
OPTIMAL SURGERY FOR CYSTIC TUMORS OF THE PANCREAS
Nakamura, Akiko1; Ohhigashi, Seiji1; Matsufuji, Hiroshi2; Suzuki, Akihiro1;
Shimada, Gen1; Onodera, Hisashi1
1St. Luke’s International Hospital, Surgery, Tokyo, Japan; 2St. Luke’s
International Hospital, Pediatric Surgery, Tokyo, Japan
Introduction. Most of cystic tumors of the pancreas were benign and long
time prognosis is expected. The purpose of this study is to know the optimal
surgical management for such lesions.
Methods. Eighteen patients who underwent surgery for cystic tumors of the
pancreas were retrospectively reviewed. Data include clinical features of the
tumors, operative procedure, early and late postoperative complications and
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outcome. Early complications include wound infection, abdominal abscess,
pancreatitis or fistula. Late complications were exocline dysfunction of the
pancreas, and post-splenectomy related immuno deficiency.
Results. Fourteen patients were females and 4 were males with a mean age
of 58.4 (range, 1078). The average size of the tumor was 6.1 cm (range,
123). Eight patients underwent distal pancreatectomy with splenectomy
(DP/S), 5 required pancreatoduodenectomy (PD) or pylorus preserving
pancreatoduodenectomy (PPPD). Excision (Ex) was performed in 2 patients
who had a tumor in the head of the pancreas. Enucleation (En) was
performed in one patient with 18 cm-sized tumor located in the tail, and one
with a huge lesion (23 cm) in the tail underwent enuculation with
splenectomy (En/S). Frozen section pathological evaluation showed all
cases were benign and curatively removed. Pathologic analysis revealed 6
cases with serous cystadenoma, 4 intraductal mucinous neoplasms, 4
mucinous cystic tumors, 3 solid cystic tumors, and 1 lymphoepithelial cyst.
The incidence of early complications was low in the patients who underwent
Ex, En, and En/S. Recurrence was not occurred in any patients, but the
patients who underwent PD, PPPD, and DP/S have been suffered from late
postoperative complications.
Conclusions. Pancreas preserving operation is feasible to prevent both early
and late postoperative complications. Enucleation or excision should be
attempt for the benign tumor of the pancreas regardless of its size and
location. To improve accuracy of preoperative diagnosis for the cystic lesion
of the pancreas is crucial.
P45.30
OUTCOME OF PANCREATICODUODENAL RESECTION ON
PERIAMPULLARY TUMOR
Lalisang, Toar; Philippy, Benny; Liza, Nasrul
Cipto Mangunkusumo Hospital, Dept. of Surgery, Jakarta, Indonesia
Forty pancreatic duodenal resections were performed for periampullary
tumor cases during six years period on 21 males with age averages 3165
years. Jaundice was the most common symptom beside melena and
abdominal pain. 26 biliary decompression were performed preoperative
(bilirubine average15- 27 mg/dl). The albumin level was less than 3, 5 mg/dl
in 21 cases. Twenty four classic Whipple, 13 PPPD and 3 total pancrea-
tectomy and duodenectomy were performed on carcinoma of 21 pancreatic
head, 9 ampula vater, 7 duodenum and 3 benign tumors. Only 5 out of the 37
were in stage I/II. The operative time was 300570 minute, with averages
blood lost 4001500cc. Pancreatic leakage was occurred in 15 patients who
heal spontaneously by adequate drainage and only one needed for relapar-
otomy. Delayed gastric emptying occur on 3 cases which treated by prolong
intubations and diet modification. There were 16 site wound infection.
Operative mortality occurred on 7 cases mostly due to sepsis between the
second po and 42 po days. Among the 33 survivors, 9 alive without disease
until present (the longest was 53 months), 13 patients die due to recurrent
tumor between 246 months. 6 patients die out of the hospital related to the
surgery procedure between 1, 515 months, mostly due to hypoglycemia. 2
patients died to other diseases after 24 months. Lost of contact in 2 patients
after 12 months, and one patient refused for further care.
Conclusion, Pancreatic duodenal resections were frequently performed,
considered decreased operative mortality, but the recurrent time was short.
Most survivors live within 1 year after operations.
P45.31
PALLIATIVE SURGICAL BYPASS FOR PANCREATIC CANCER:
OUTCOMES IN A SPECIALIST UK CENTRE
Mukherjee, Samrat; Kocher, Hemant; Hutchins, Robert; Bhattacharya,
Satya; Abraham, Ajit
St Bartholomew’s & the Royal London Hospital, Hepatobiliary & Pancreatic
Surgery, London, UK
Background. The optimal method of palliation for patients with unresectable
pancreatic cancer is controversial. Historically, bypass procedures for pan-
creatic cancer were associated with poor outcomes, leading to a shift towards
palliative stenting. Long term patency is a problem with palliative stenting and
the associated morbidity is not insignificant. Recently, favourable outcomes for
palliative surgical bypass have been reported by specialist pancreatic centres.
Aims. We analysed short and long term outcomes of all surgical palliative
bypass procedures for unresectable pancreatic cancer at a specialist UK centre.
Patients and methods. All patients undergoing palliative surgical bypass for
unresectable pancreatic cancer from Aug 1999 to Feb 2006 were identified
from our pancreatic cancer database. Outcomes were analysed for morbidity,
mortality and overall survival.
Results. 87 patients (median age 65.2 yrs, range 37 86 yrs; M:F 1.4:1) had
palliative surgical bypass procedures for unresectable cancer. Patients under-
went combined biliary and gastric bypass (n/65, 74.7%), gastric bypass
(n/20, 23%) or biliary bypass (n/2, 2.3%) alone. 39 procedures (44.8%)
were planned palliative bypasses and 48 patients (55.2%) underwent
palliative bypass for vascular involvement or metastases after exploration
for pancreaticoduodenectomy. Overall morbidity was 6.9% and in hospital
mortality was 8%. Median hospital stay was 10 days (range 454 days).
Median survival was 6.4 mths (range 8 days-31 mths). For patients
undergoing palliative bypass following exploration (n/48) morbidity/
10.4%, mortality/6.2%; median survival/7.4 mths, range 1.6 mths- 31.5
mths. For planned palliative bypass: morbidity/2.6%, mortality/10.3%;
median survival/6 mths, range 8 days -13.7 mths. No re-interventions for
recurrent biliary or gastric obstruction were required.
Conclusion. Surgical bypass performed in a specialist pancreatic centre can
offer effective palliation for unresectable pancreatic cancer with satisfactory
outcomes.
P45.32
PANCREATIC FISTULA AFTER PANCREATICODUODENECT-
OMY: A COMPARISON BETWEEN TWO PANCREATICOJEJU-
NOSTOMY METHODS. INTERRUPTED VS. CONTINUOUS
STITCHES
Jang, Jin-Young; Lee, Seung Eun; Han, Sung-Sik; Yang, Sung Hoon; Kim,
Sun-Whe
Seoul National University College of Medicine, Surgery, Seoul, South Korea
Background. Leakage of the pancreaticojejunal anastomosis has been a
major complication after pancreaticoduodenectomy. Over the past decades,
various methods for prevention of pancreatic leakage have been studied.
Aim. The purpose of this study is to find better operative technique
comparing the interrupted stitches with the continuous stitches for the outer
layer in a duct to mucosa pancreaticojejunostomy. And risk factors for the
pancreatic leakage were also explored.
Method. From 1997 to 2004, 138 patients underwent the end-to-side, duct-
to-mucosa pancreaticojejunostomy after pancreaticoduodenectomy with the
interrupted suture for outer layer of pancreaticojejunostomy and 173 patients
with the continuous suture by one surgeon. A pancreatic fistula was defined
as drainage of more than 30 ml of fluid with an amylase level higher than 600
U/dl on or after postoperative week 1. Major pancreatic leakage was defined
as drainage of more than 200 ml of fluid or development of the intra-
abdominal abscess or the pseudoaneurysm due to pancreatic fistula.
Results. There were no differences between two groups in the diagnosis,
texture of pancreas, using of sandostatin and staging. For the interrupted
suture group, operative time was 35.4¡344.8 minutes, and for the continuous
group, 29.1¡343.9(pB/0.001). Pancreatic fistula occurred in fourteen inter-
rupted suture cases(10.14%) and in ten continuous suture cases(5.75%)(p/
0.126). Major pancreatic leakage developed in three interrupted suture
patients(2.17%) and two continuous suture patients (1.15%)(p/0.168).
Conclusion. The two methods for approximating the pancreatic parench-
yma to the jejunal seromuscular layer in duct to mucosa pancreaticojeju-
nostomy revealed no significant difference in the development of pancreatic
fistula. However, for the continuous suture group, operative time was
significantly reduced and pancreatic fistula rate was decreased without
increasing morbidity. In conclusion, the continuous suture is more feasible
and safe in performing pancreaticojejunostomy.
P45.33
PANCREATIC FISTULA FOLLOWING DISTAL PANCREATECT-
OMY: COMPARISON OF HAND-SEWN VS. STAPLE CLOSURE
FOR REMNANT OF THE PANCREAS
Wada, Keita; Takada, Tadahiro; Nagashima, Ikuo; Amano, Hodaka; Yoshida,
Masahiro; Miura, Fumihiko; Isaka, Takahiro; Toyota, Naoyuki; Kato,
Kenichiro
Teikyo University School of Medicine, Surgery, Tokyo, Japan
Background and aim. Pancreatic fistula (PF) is a most common
complication after a distal pancreatectomy (DP). According to the increase
of laparoscopic surgery staple closure technique for the pancreatic remnant
become more common, however its efficacy is not clear. The purpose of this
study is to compare two techniques, hand-sawn vs. staple closure for the
pancreatic remnant during DP.
Methods. A retrospective analysis of 50 patients who underwent DP during
20002005 was performed. The incidence of complication was compared
between the two groups. Risk analysis for having a PF was also performed.
Definition of PF used in this study was defined as any measurable amylase-
rich (/1000 IU/L) drainage obtained from surgically-placed drain or
percutaneous aspiration on or after POD 5.
Results. There was no mortality. PF rate was 32% for entire cohort. There
was no difference in the incidence of PF (28% vs. 37%), as well as the
incidence of intraabdominal abscess, duration of drainage and length of
hospital stay (pB/0.05) between the two groups. The thickness of remnant of
the pancreas greater than 10 mm is an only risk factor for having a PF by
univariate analysis, but eliminated by multivariate analysis. None of PF was
seen in patients with the width of pancreas less than 10 mm.
Conclusion. PF is commonly occurred for the patients with a thick pancreas
greater than 10 mm without relationship to the technique. More promised
technique should be prepared for this high-risk group and it is need to be
evaluated by a randomized controlled trial.
P45.34
PANCREATIC FISTULA RATE FOLLOWING DISTAL PANCREA-
TECTOMY WITH STANDARDIZED CLOSURING TECHNIQUE
Timm, Stephan; Maier, Markus; To¨pfer, Claudia; Steger, Ulrich; Thiede,
Arnulf
University Hospital of Wuerzburg, Surgery, Wuerzburg, Germany
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Background. The optimal closuring-technique of the pancreatic remnant
after distal pancreatectomy is still a matter of intensive discussion. While
most centers prefer handsewed stidges of pancreatic duct and parenchyma,
occlusiontechniques and stapler-procedures have been described. The rate of
postoperative pancreatic fistulas after distal pancreatectomy varies between 0
and 50%.
Aim. We report our results with a standardized closuring-technique over a 4-
year-period.
Methods. Between 5/2001 and 5/2005 a total of 60 consecutive patients (35
men and 25 women) underwent distal pancreatectomy (line of resection on or
left of the portal plane). The pancreatic duct was always separately closed by
6.0 PDS-stidges followed by handsewed closure of the parenchyma and
application of hemostyptica. In 30 patients octreotid (Sandostatin†) was
given for 7 postoperative days. Pancreatic fistula was defined as persisting
secretion of amylase/lipase-rich fluid (/ three times of serological value) after
postoperative day 4 and ongoing. The rate of postoperative pancreatic fistula
and the influence of octreotid were calculated.
Results. In 23 patients a spleen-preserving panceasresection was performed,
while 37 patients underwent an oncological left resection including spleen and
lymphadenectomy. Indications were endocrine tumors (13), cystadenoma (8),
adenocarcinoma (21), chronic pancreatitis (10) and others (8). 4 of 60
patients (6, 7%) developed a pancreatic fistula one of which recieved octreotid.
29 out of 56 patients without fistula recieved octreotid postoperatively.
Conclusion. The retrospective analysis of our patients after distal pancrea-
tectomy revealed a fistula rate of 6, 7%. The influence of octreotid-
application did not show statistical significance. At present a prospective
randomised evaluation is performed to evaluate the value of the stapler-
resection in distal pancreatectomy.
P45.35
PANCREATIC FISTULAE:IS THERE MORE TO LEARN?
Joshi, Rajeev; Khithani, Amit; Shetty, Tilakdas; Adhikari, Devbrata
T.N.Medical College and B.Y.L.Nair Hospital, Dept. of Surgery, Mumbai,
India
Background. Disease free and overall survival in patients undergoing
curative resections is dependent upon well documented prognostic factors
but what has not been investigated is the association between pancreatic leaks
and local recurrence.
Aim. Establish the relationship between occurrence of a fistula following
curative pancreatic surgery and disease free survival (DFS).
Patients and methods. Records of 106 patients, 103 pancreaticoduode-
nectomies and 3 distal resections, over a 7 year period (Feb’ 99 to Jan’ 06)
reviewed.
Results. Of 103 pancreaticoduodenectomies, 32 developed a pancreatic
fistula (31.06%). 19 had a clinically significant leak, 6 succumbed, 2 were re-
explored and survived, while the remaining 11 were managed conservatively.
The overall postoperative mortality rate following pancreaticoduo-
denectomy was 10.67% (11/103) and the procedure related mortality rate
was 7.76% (8/103). Clinically significant leaks were responsible for 6 out of 8
procedure related deaths (75%). Of the 26 patients who survived following a
pancreatic fistula, it was found that in 20 patients the DFS was 1 year or less
(77%). On imaging they had predominantly local recurrence. In the
remaining 66 patients only 4 patients had a DFS of 1 year or less (6.06%).
Subsequent DFS rates at 2, 3, and 4 years were 48% (44/92), 18% (17/92)
and 9% (8/92) respectively. Only in 2 patients with ampullary carcinoma was
a 5 year DFS seen (2.17%).
Discussion. A high fistula rate of 31.06% following curative pancreatic
resection may be attributed to unfavourable morphological features of the
pancreas. Clinically significant leaks were responsible for 75% of procedure
related deaths. 77% of patients with pancreatic fistulae had a DFS of 1 year or
less whereas only 6% with no fistulae had a similar DFS. It is likely that a
pancreatic fistula is an independent predictor of diminished DFS after
curative resection. Based on this small cohort a trend is definitely emerging
and needs to be validated by larger study groups.
P45.36
PANCREATIC STUMP MANAGEMENT DURING PANCREATICO-
DUODENECTOMY
Del Chiaro, Marco; Gremmo, Fiorenza; Croce, Chiara; Mosca, Irene; De
Lio, Nelide; Signori, Stefano; Sgambelluri, Francesco A; Vistoli, Fabio;
Boggi, Ugo; Mosca, Franco
University of Pisa, Division of General and Transplant Surgery, Pisa, Italy
Background. The history of pancreatoduodenectomy (PD) has been shaped
by complications related to the management of the pancreatic stump (PS).
Aim. To retrospectively compare the outcomes of pancreaticojejunal
anastomosis (PJA) vs duct occlusion (DO) after PD.
Methods. Between November 1987 and August 2005 we performed 426
PD. PS was managed by PJA in 230 (54%) and by DO in 196 (46%) cases.
The 2 groups were comparable regarding all baseline characteristics,
although there were more cases of chronic pancreatitis in the PJA group.
Results. Overall morbidity and mortality rates were 42, 5% and 6, 1%,
respectively (41, 3% and 7% in PJA vs 43, 8% and 5, 1% in DO; p/ns). PS
related complications occurred more frequently with DO (27, 5%) than with
PJA (14, 3%) (p/0.0008). PS related complications occurred more often
after DO vs PJA when hystological type was ductal adenocarcinoma (22, 4%
vs 9.2%, p/0.01) or in case of other malignancies (36% vs 21.9%, p/
0.003); when pancreatic gland was normal (33% vs 20.9%, p/0.03) or soft
(20.3% vs 5.6%, p/0.002) and when main duct was large (23.3% vs 4.1%,
pB/0.0001); in case of chronic pancreatitis, soft gland or small duct
morbidity was not significantly different between the two groups. However,
most complications of DO had a benign course, since there was no difference
in PS related mortality between the two groups (DO: 1.5% vs. PJA: 3.5%;
p/NS). At hospital discharge enzyme replacement therapy was required
more often after DO (100%) than after PJA (48, 3%) (pB/0,0001). A sub-
group analysis in patients without pre-operative diabetes showed that, one
year after surgery, significantly more DO patients (15%) required insulin
therapy as compared with PJA individuals (8, 1%) (p/0, 02).
Conclusions. PS related complications occur more frequently after DO than
after PJA, although they usually pursue a benign course and do not increase
post-operative mortality. Exocrine and endocrine functions are better
preserved by PJA as compared with DO.
P45.37
PANCREATIC TUBE GUIDED INFERIOR PANCREATIC HEAD
RESECTION FOR INTRADUCTAL MUCINOUS TUMOR
Horiguchi, Akihiko; Ishihara, Shin; Ito, Masahiro; Miyakawa, Shuichi
Fujita Health University, Gastroenterological Surgery, Toyoake, Japan
Patients with intraductal papillary mucinous tumor (IPMT) have a good
prognosis after surgical treatments. One of the recent advances in pancreatic
surgery is organ preserving operation. Although local resection can preserved
pancreatic function, morbidity still occurs frequently, especialy pancreatic
fistula for the main pancreatic duct injury. We performed pancreatic tube
guided inferior pancreatic head resection for brunch typed IPMT. A 69-year-
old man who visited our hospital because of epigastric pain. MRCP showed
cystic tumor about 3.5 cn in diameter in the pancreatic head. Multi plannar
reconstruction CT revealed cystic tumor in the pancreatic uncus. Endoscopic
retrograde pancreatography demonstrated cystic tumor in the inferior
pancreatic duct region. Endoscopic naso-pancreatic drainage tube was
inserted in the main pancreatic duct preoperative day one. The resection
line near the main pancreatic duct decided by touching the ENPD tube. The
patient was good course without postoperative complication. This procedure
is considered to be appropriate for treating benign tumor and non-invasive
malignanttumor involving the uncinate process.
P45.38
PANCREATICODUODENECTOMY (PD) IN PRESENCE OF
ABERRANT RIGHT HEPATIC ARTERY
Jah, A; Huguet, E; Jamieson, NV; Praseedom, RK
Addenbrooke’s Hospital, Hepato-Biliary Unit, Cambridge, UK
Background. Aberrant Right Hepatic Artery (ARHA) is present in 1322%
individuals and arises from the superior mesenteric artery. It runs in close
relationship with the head of the pancreas. During PD there is a potential for
damaging the artery or an attempt to preserve it may compromise the
adequacy of cancer resection.
Aim. To study the operative and oncological implications of presence of
ARHA in patients undergoing pancreaticoduodenectomy.
Methods. All patients undergoing either PD between 01-06-2002 to 30-06-
2005 were studied from a prospectively held database. The intra-operative
variables (blood loss and operative time), cancer clearance (lymph node
retrieval and lateral resection margins) and relevant post-operative complica-
tions were compared between patients with ARHA and those without.
Results. A total of 72 patients underwent PD of which 20 (27.7%) patients
were found to be having either accessory or replaced right hepatic arteries
(ARHA group). Remaining 52 (72.3%) patients had normal right hepatic
arterial anatomy(non-ARHA group). The mean blood loss in ARHA group
was 1464 mls as opposed to 1066 mls in patients without ARHA (p/0.27).
The operative time in ARHA and non-ARHA group was 400 and 382
minutes respectively (p/0.37). The mean lymph node retrieval was identical
in both groups at 11 (p/0.86). There was no significant difference between
the incidence of positive posterior resection margin in both groups [5 (25%)
in ARHA versus 19 (36.3%) in non-ARHA] The incidence of post-operative
complications such as pancreatic leak [ARHA 3(15%); nonARHA 5(9.6%)]
and delayed gastric emptying [ARHA 3(15%); nonARHA 4(7.6%)] was also
similar in both the groups.
Conclusions. Presence of ARHA in patients undergoing pancreaticoduode-
nectomy does not significantly influence the operative variables or post-
operative complication rate. Although there was a trend toward higher blood
loss in patients with ARHA, it was statistically insignificant. There does not
seem to be any impact on oncological clearance.
P45.39
PANCREATICODUODENECTOMY IN ELDERLY PATIENTS IS IT
WORTHWHILE?
Regenet, Nicolas1; Pessaux, Patrick1; Frampas, Eric1; Lermite, Emilie1;
Meurette, Guillame1; Teyssedou, Carlos1; Arnaud, Jean-Pierre2; Leborgne,
Joel1
1University Hospital, Nantes, France; 2University Hospital, Angers, France
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Background. The risk to develop pancreatic or ampullary cancer increases
with age. As the population in France, there were an increasing number of
elderly patients who were presented for surgical evaluation. These population
had several comorbidities and the benefit of major surgery such as
pancreaticoduodenetomy was not defined. The aim of this study was to
evaluate the outcomes of pancreaticoduodenectomy in elderly.
Methods. We analysed retrospectively data of 317 patients who underwent
pancreaticoduodenectomy from 1991 to 2005. The study population was a
consecutive sample of patients from Nantes university hospital (n/185) and
Angers university hospital (n/131). Data collected include surgical indica-
tions, mortality, complications and survival.
Results. Eighty four patients 70 years of age or older were compared to those
of patients younger. Indication for surgery was more often for malignancy in
elderly (89.3% vs 62.2%; p/0.0001). The two groups were statistically
similar with respect to sex, body mass index, type of pancreaticoduodenect-
omy, operative time (337.1 minutes vs 350.4 minutes;p/0.08) and mean
blood tranfusion rate. Elderly patient have a higher ASA score (p/0.0009)
and postoperative length of stay (29 days vs 15.3 days) but the difference was
not statistically significant (p/0.38). Patients 70years of age or older had
statistically similar complication rate (75% vs 62.6% p/0.55) including
delayed gastric emptying (39.7% vs 34.5%;p/0.47) and pancreatic fistulae
(14.6% vs 11.2%; p/0.56). Pancreaticoduodenectomy in the older group
resulted in a 5.9% mortality rate compared to 3% in the younger (p/0.38).
The mean survival was not statistically different between older and younger
patients who underwent pancreaticoduodenectomy for malignancy (21
months vs 27.9;p/0.13).
Conclusion. These data demonstrate that pancreaticoduodenectomy can be
performed safely in selected elderly patients. The morbidity, the mortality
rates and the survival approached those observed in younger patients.
P45.40
PANCREATICODUODENECTOMY WITHOUT PREOPERATIVE
RADIOLOGICAL AND HISTOLOGICAL DIAGNOSIS
Van der Gaag, Niels1; Nio, Yung2; Van Berge Henegouwen, Marc1; Van
Gulik, Thomas1; Bruno, Marco3; Busch, Olivier1; Rauws, E.J.3; Fockens,
Paul3; Gouma, Dirk1
1Academic Medical Center, Surgery, Amsterdam, Netherlands; 2Academic
Medical Center, Radiology, Amsterdam, Netherlands; 3Academic Medical
Center, Gastroenterology, Amsterdam, Netherlands
Introduction. Controversy still exits about the diagnostic strategy/manage-
ment of patients with clinical suspicion of a periampullary tumour but without
a ‘visible mass’ noticed on US/CT/MRCP. In these patients EUS and/or brush/
biopsy might be helpful in deciding whether or not surgery is indicated.
Objective. The present study evaluated the additional value of EUS/brush/
biopsy in the diagnostic workup of patients with inconclusive radiological
imaging. Pathology after resection was correlated with preoperative diag-
nostics.
Methods. A consecutive cohort of 303 patients, suspected to have a
periampullary malignancy, underwent pancreaticoduodenectomy from Jan-
uary 2000 to October 2005. Patients were classified by results of preoperative
diagnostic workup: (A) visible mass on US/CT/MRCP, (B) no visible mass
but conclusive additional diagnostic workup, (C) no mass and inconclusive
results of additional diagnostic procedures or without further diagnostics
performed. Final pathological findings after resection were correlated with
preoperative diagnostic results.
Results. A visible mass was found in 231 patients (group A: 76%). Of the 72
patients without a visible mass in 62 (86%) EUS/brush/biopsy had led to a
preoperative diagnosis (group B: 21%). The remaining 10 patients had
inconclusive results of additional diagnostic workup or no further diagnostics
performed (group C: 3%). Pathological findings after resection were, overall
& each group separately (A/B/C): (pre)malignancy 85% (85/87/60), benign
cystic 5% (7/0/0), focal pancreatitis 10% (8/11/30), no tumour 1% (-/2/10).
Conclusions. In patients clinically suspected to have a periampullary
tumour, 76% has a visible mass of which 85% had a (pre)malignancy at
pathology. In the remaining 24% additional diagnostic workup through EUS/
brush/biopsy leads in 86% of the cases to a preoperative diagnosis. In the
small subgroup without conclusive preoperative diagnostics, 60% appears to
have a malignancy after resection.
P45.41
PANCREATICODUODENECTOMY: SUPRACOLIC DIVISION OF
JEJUNUM HELPS IN UNCINATE RESECTION
Shukla, Parul; Pandey, Durgatosh; Kanitkar, Gajanan; Nadkarni, Mandar
Tata Memorial Hospital, GI Surgical Oncology, Mumbai, India
Background. Pancreaticoduodenectomy is a standard procedure for peri-
ampullary and pancreatic head tumours. The dissection of the uncinate
process from the superior mesenteric vessels is a key step in the procedure.
Aims & objectives. To modify the technique of jejunal division in order to
facilitate the complete removal of the uncinate process.
Methods. We describe a modification in which jejunum is divided in the
supracolic instead of the infracolic compartment and traction on the proximal
jejunal mesentery in the supracolic compartment is used to facilitate exposure
of the uncinate process of pancreas. This modification is based on a sound
understanding of the embryological development of pancreatic anatomy.
Results. This method has been used in 30 patients undergoing pancreati-
coduodenectomy from February 2004 to February 2006. It has resulted in an
easier exposure of the uncinate process and simplifies the dissection along the
superior mesenteric vessels.
Conclusions. The jejunal mesentery and uncinate process of pancreas are
anatomically and embryologically contiguous. Thus, when the jejunum is
divided in supracolic compartment, the traction on the jejunal mesentery
aligns the uncinate process and assists in its complete removal.
P45.42
PANCREATODUODENECTOMY-AN AUDIT OF EIGHTY CASES
Khandelwal, Chiranjiva1; Goel, Ashish1; Khandelwal, Manish2
1Mahavir Cancer Sansthan, Dept. of Surgical Oncology, Patna, India;
2Aberdeen Royal Infirmary, Aberdeen, UK
Introduction. Once the diagnosis of an operable periampullary or pancreatic
head carcinoma is made, the dilemma remains between curative resection v/s
palliative bypass. Pancreatoduodenectomy is the operation of choice for
majority of these patients. Today its operative mortality is below 5% and most
of the series report a 5-year survival rate of 510%.
Methods. We present a retrospective aanlysis of 80 cases of pancreatoduo-
denectomy performed over a span of ten years till December 2005.
Results. The Male: Female ratio was 4:1 with age ranging from 2075 years.
68 (85%) patients underwent pylorus preserving Pancreatoduodenectomy
(PPPD) while classic Whipples’; Pancreatoduodenectomy (WP) was done in
11(14%) cases & wide local excision in 1 case. Distribution of primary site of
disease was ampullary carcinoma in 32 (40%) cases, distal CBD growth in 23
(29%), Ca head of pancreas in 13 (16%), duodenal growth in 8 (10%) cases
& chronic pancreatitis and ca gall bladder in 2 patients each. Pancreatoje-
junostomy was done in 65 (81%) cases and pancreatogastrostomy in 14
cases. Five (6%) patients required re exploration. Significant morbidity was
seen in 15% cases with overall perioperative mortality of 8.7%. The mean
disease free survival was 15 months with 40% patients surviving for more
than one year.
Discussion. PPPD minimizes complications related to gastric resection,
such as early satiety, marginal ulceration, and bile reflux gastritis. Average
operating time in PPPD was less than WP, so later on PPPD became the
procedure of choice unless indicated otherwise. Since surgical resection is the
only chance of cure; it should always be attempted in resectable tumours.
Considering the poor nutritional status & if required unable to sustain post
operative management due to poor economical background; a mortality of
8.7% is quite acceptable. With experience, the mortality and morbidity will
further come down and help achieve better quality of life.
P45.43
PROLONGED TH1/TH2 IMBALANCE IN PATIENTS WITH
PANCREATIC AND BILIARY ADENOCARCINOMA AFTER
PYLORUS-PRESERVING PANCREATODUODENECTOMY
Enoki, Tadahiko; Kitada, Kouji; Yagi, Takeshi; Harada, Eijirou; Noshima,
Shinji; Hamano, Kimikazu
Yamaguchi University School of Medicine, Dept. of Surgery and Clinical
Science, Ube, Japan
Background. Helper T cell is mainly divided into the type 1 and 2 CD4/ T
cell (Th1 and Th2) according to their profile of cytokine synthesis. Surgical
insult induces the shifts toward Th2 predominance in the Th1/Th2 balance,
which may cause an infectious complication and promote a tumor growth.
Aim. The aim of this study was to clarify whether and how long
pancreatodudenectomy for pancreatic and biliary malignancy induces Th1/
Th2 imbalance.
Patients and methods. Ten Japanese patients were prospectively enrolled in
this study. Six patients (PpPD group) underwent pylorus-preserving pan-
creatoduodenectomy (PpPD) for adenocarcinoma of bile duct or pancreas
head, and other 4 patients underwent total gastrectomy (gastrectomy group)
for adenocarcinoma of stomach. Blood sampling was performed before
surgery, and 1, 3, 7 and 14 days postoperatively (POD). The proportion of
CD4/ T cells and their intracellular cytokines (interferon-gamma and
interleukin-4) were measured by flow cytometry.
Results. There was no significant difference in operation time and blood loss
between 2 groups. Lymphocytes were significantly decreased at 3 and 7 POD
in both groups, which restored to preoperative level at 14 POD. Th1/Th2
ratio of gastrectomy group was not decreased postoperatively (989/22% of
preoperative value at 3POD, 1349/29% at 14POD), however, that of PpPD
group was decreased to 589/6% at 3 POD. Furthermore, Th1/Th2 ratio
remained lower level even at 14 POD (539/4%, p/0.018 vs gastrectomy).
Conclusion. PpPD induces prolonged Th2 predominant state in Th1/Th2
balance, which might imply that patients undergoing PpPD are more
susceptible to infectious complication as long as 2 weeks after surgery.
P45.44
POSSUM ACCURATELY PREDICTS MORBIDITY FOR PAN-
CREATIC RESECTIVE SURGERY
Joseph, Saju; Pratt, Wande; Maithel, Shishir; Vanounou, Tsafrir; Callery,
Mark; Vollmer, Charles
Beth Israel Deaconess Medical Center, Dept. of Surgery, Boston, USA
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Background. The Physiologic and Operative Severity Score for the
enUmeration of Mortality and Morbidity (POSSUM) is a predictive scoring
system for postoperative morbidity. While numerous studies demonstrate its
validity following major abdominal surgery, few exclusively consider resective
pancreatic surgery, whose unique complications are costly and uncompro-
mising.
Aim. We examined whether POSSUM could reflect clinical and economic
outcomes in pancreatic resection.
Methods. 250 consecutive pancreatic resections were performed from 10/01
to 1/06. POSSUM Score was calculated for each case, and patients were
stratified by 3 categories of risk (Minor to Major). Morbidity risk was
correlated with actual clinical and economic outcomes. Furthermore, the
Physiologic and Operative components of POSSUM were independently
evaluated for their contributions to overall risk assessment.
Results. Observed and Expected morbidity rates were equivalent (63.6% vs.
62.7%) with an O/E ratio of 1.01. Clinical and economic outcomes worsened
with increasing overall POSSUM Score. When Physiologic Score alone was
separately evaluated, the impact of increasing morbidity risk was accentuated
(Table). Major Risk patients had significantly longer hospital stays, higher
rates of major complications, and regularly required blood transfusions,
supplemental nutrition, and ICU management. This resulted in a substantial
cost increase per patient ($6, 840). Operative Score lacked any significant
predictive value for pancreatic resections.
Conclusion. POSSUM accurately predicts postoperative morbidity follow-
ing pancreatic resection. Increasing POSSUM Score reflects worsening
clinical and economic outcomes. Preoperative risk assessment, according to
Physiologic Score, can be employed to guide management decisions that
impact postoperative outcomes, and is useful in evaluating variance in
pancreatic surgical methods and outcomes.
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POSTOPERATIVE OCTREOTIDE TO PREVENT GENERAL AND
ANASTOMOTIC COMPLICATIONS FOLLOWING PERIAMPUL-
LARY SURGERY
Uguz, Alper1; Gurcu, Baris2; Aydin, Unal2; Ersoz, Galip3; Tekesin, Oktay3;
Ozutemiz, Omer3; Zeytunlu, Murat2; Coker, Ahmet2
1Ege University Hospital Med School Hospital, Dept. of General Surgery
HPB Unit, Izmir, Turkey; 2Ege University, General Surgery, Izmir, Turkey;
3Ege University, Gastroenterology, Izmir, Turkey
Background. The aim of the study was to evaluate the influence of
postoperative Octreotide on the prevention of general complications an/or
pancreatico- and/or hepaticojejunostomy leakgae and/or fistula in patients
undergoing pancreatic tumor surgery.
Methods. 66 patients were randomized to receive either Octreotide 3 mg
intravenously /day for a total of 7 days or no Octreotide. The primary
endpoints were the occurrence of a biliary and pancreatic fistula. There were
36 duodeno-pancreatectomies with or without preservation of the pylorus
and 30 other procedures like palliative drainage and distal pancreatectomy.
All patients with pancreaticoduodenectomy underwent duct-to-mucosa
pancreatico-jejunostomy and hepaticojejunostomy.
Results. 28 patients received Octreotide and 38 did not. The incidence of
fistula formation in the Octreotide group was zero and in the control group 5,
2% (n/2). There was two deaths in the Octreotide group and none in the
control group for an overall mortality of 3%. The morbidity, except fistulas,
was 9% in the Octreotide group and 8, 8b% in the control group. The length
of hospital stay in postoperative period was 9.1 //3.1 days in the group
receiving Octreotide vs 8.4 //2.1 days in the control group (p/ns).
Stratifying the data for curative intend surgery and for draining procedures
there was no difference between the groups either.
Conclusion. In patients undergoing periampullary surgery, the postopera-
tive use of 3 mg Octreotide for 7 days does not reduce general complications
nor fistula formation.
P45.46
PREOPERATIVE STENTING IS ASSOCIATED WITH A HIGHER
PREVALENCE OF POSTOPERATIVE COMPLICATIONS FOL-
LOWING PANCREATICODUODENECTOMY
Morris-Stiff, Gareth; Tamijmarane, Appou; Koukoutsis, Ilias; Tan, Yu-
Meng; Shapely, Iestyn; Mayer, David; Buckels, John; Bramhall, Simon;
Mirza, Darius
Queen Elizabeth Hospital, HPB Unit, Birmingham, UK
Background. Whilst there are theoretical benefits from preoperatively
draining the bilary tree prior to pancreaticoduodenectomy (PD), the current
literature does not support this intervention, and at best suggests that it is not
a detrimental procedure.
Aims. The aim of this study was to report the relationship between
preoperative stenting and outcome in a large United Kingdom practice
where patients are referred following investigation and are frequently stented
at presentation.
Methods. All patients undergoing PD between January 1998 and December
2004 were identified from a prospectively maintained database. Data was
reviewed to identify those stented or not prior to PD and the results of bile
cultures taken at PD. The subsequent postoperative courses and the
development of complications were related to the presence or absence of
stents and identification of infected bile.
Results. 280 patients underwent PD for malignancies obstructing the distal
bile duct all of which presented with jaundice including: pancreatic head (n/
148); ampullary (n/77); cholangiocarcinoma (n/25); duodenal (n/21);
other (n/9). There were 128 females and 152 males and the median age was
65.6 years. 119 patients were stented prior to referral of which 98 were placed
at ERCP and 20 at PTC. Positive bile cultures were significantly more
common in the stent group at 98/118 (83%) compared with the no stent
group 91/162 (56%). Despite stenting, the percentage of patients with a
normal bilirubin level or alkaline phosphatase at the time of PD were
comparable for stented and non-stented groups at (38.1% vs. 42%) and
(1.7% vs. 3.4%) respectively.
Complication
Stent
(n/118)
No Stent
(n/162)
Infection
(n/189)
No
Infection
(n/91)
Pancreatic leak 26 (22%) 18 (11.1%) 31 (16.4%) 13 (14.3%)
Bile leak 4 (3.4%) 4 (2.5%) 6 (3.2%) 2 (2.2%)
Septicaemia 16 (13.6%) 15 (9.3%) 22 (11.6%) 9 (9.9%)
Intra-abdominal
abscess
10 (8.5%) 10 (6.2%) 12 (6.3%) 8 (8.8%)
Gastrointestinal/
Intra-abdominal
haemorrhage
15 (12.7%) 9 (5.6%) 16 (8.5%) 8 (8.8%)
Wound infection/
Dehiscence
22 (18.6%) 20 (12.3%) 35 (18.3%) 7 (7.7%)
Cardiac arrhythmia/
Acute coronary
syndrome
9 (7.6%) 18 (11.1%) 22 (11.6%) 5 (5.5%)
Pneumonia/
Respiratory failure
15 (12.7%) 14 (8.6%) 19 (10.1%) 10 (11%)
Renal failure 11 (9.3%) 7 (4.3%) 11 (5.8%) 7 (7.7%)
Death 10 (8.5%) 11 (6.8%) 16 (8.5%) 5 (5.5%)
The overall prevalence of complications was 54% in the stented and 41% in
the non stented group.
Conclusions. Preoperative stenting of the biliary tree pior to PD confirs no
significant benefirt to the patient and should be avoided in place of prompt
referral and resection.
P45.47
PREVENTION AND MANAGEMENT OF SURGICAL SITE INFEC-
TION AFTER PANCREATODUODENECTOMY
Maemura, Kosei1; Shinchi, Hiroyuki1; Noma, Hidetoshi1; Kubo, Fumitake1;
Sakoda, Masahiko1; Ueno, Shinichi1; Takao, Sonshin2; Aikou, Takashi1
1Kagoshima University Graduate School of Medical and Dental Sciences,
Table. Preoperative Risk and Outcomes for Pancreatic Resection.
Outcome Minor Risk Moderate Risk Major Risk
Criteria Physiologic
POSSUM
Score5/15
Physiologic
POSSUM
Score 1624
Physiologic
POSSUM Score
]/25
N (%) 80 (32%) 106 (42%) 64 (26%)
Predicted Morbidity 33% 61% 85%
Overall
Complications
54% 59% 81%
Minor
Complications
50% 51% 65%
Major
Complications
4% 8% 16%
Postoperative Blood
Transfusions
9% 17% 25%
Supplemental
Nutrition
10% 9% 23%
ICU Transfer 8% 11% 22%
ICU Duration
(mean, days)
0.2 1.0 2.1
Re-Operation 2% 7% 9%
Discharge to
Rehabilitation Fa-
cilities
1% 14% 31%
Length of Stay
(mean, days)
8.2 9.6 10.6
Total Costs (mean) $21, 479 $25, 789 $28, 319
Cost Increase
Above Minor Risk
 $4, 310 $6, 840
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Surgical Oncology and Digestive Surgery, Kagoshima, Japan; 2Kagoshima
University, Frontier Science Research Center, Kagoshima, Japan
Purpose. Despite a low death rate and improvements in perioperative care
and operative management, there is still a relatively high complication rate
after pancreatoduodenectomy (PD). The aim of this study was to analyze the
surgical site infection after PD.
Methods. We have introduced the duct-to-gastric mucosa anastomosis with
gastric seromuscular-to-pancreas-piercing suture for reconstruction after PD
since 1999. We analyzed the prospectively collected database of 93
consecutive patients underwent PD using these methods of reconstruction
at Kagoshima University Hospital between 1999 and 2005.
Results. Mortality and pancreaticogastric anastomotic leakage were all 0%.
Overall complication and surgical site infection (SSI) were occurred in 35%
(n/33) and 23% (n/22), respectively. Univariate analysis of factors
predicting the occurrence of SSI showed that the high volume of%IBW
and soft pancreatic texture were significantly associated. Organ/space SSI was
found in 18% (n/17) and showed significant high rate of infected bile juice
preoperatively compared to non-SSI group. Pancreatic fistula occurred in
eight patients (8.6%) who were belongs to organ/space SSI group. Average
level in the drainage fluid of non-SSI group was less than 300 IU/L, on the
other hand that of pancreatic fistula patients were more than 3000 IU/L on
post operative day three.
Conclusion. Our data suggest that careful attention should be paid to the
patients with obesity and normal consistency of pancreas. Prevention
of infected bile juice spreading during operation is the important periopera-
tive management. Monitoring of amylase level in the drainage fluid
and culture may provide a clue of prevention of serious postoperative
complication.
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QUALITY OF LIFE AND FUNCTIONAL LONG-TERM OUTCOME
AFTER PANCREATICODUODENECTOMY
Lepage, Sebastien1; Caputo, Sergio1; Kwiatkowski, Fabrice2; Gouillat,
Christian1
1Hotel Dieu, Dept. of Surgery, Lyon, France; 2Centre Jean Perrin, Service de
Statistique, Clermont Ferrand, France
Background. The pancreaticoduodenectomy (PD) is a major surgical
procedure, whose physiological effects regarding gastrointestinal functions,
nutrition and metabolism, are potentially noxious on Quality of life (QoL).
Aim. The goal of this retrospective unicentric pilot study was to assess the
effects of the long-term sequelae of PD on patient’s QoL.
Patients and method. Thirty patients without recurrence more than one
year after PD were asked to answer to the GIQLI (Gastro Intestinal Quality
of Life Index) questionnaire and a self-developped one assessing the long-
term morbidity of PD in more details.
Results. The acceptability rate was 100%. The internal coherence of the
GIQLI questionnaire was good (Cronbach’s alpha coefficient: 0.85). The
average total score of the GIQLI was 94 (IC95%/[86101]), compared to
144 and 126 for ideal result and national normative population, respectively.
When compared to the base for normal population, 8 patients (27%) had
normal QoL. The QoL was significantly related to the need of treatment for
diarrhea and the need of pancreatic enzyme supplements. Steatorrhea was
associated to a significant decrease of the symptom scale score. Other
symptoms related to exocrine and endocrine insufficiency did not demon-
strate a significant impact on Qol.
Conclusions. Compared to the base for the normal population, the PD is
associated to an average 25% decrease of the long-term QoL, although
numerous patients experience normal QoL. The impairement of Qol after
PD could be related to the gastro-intestinal postoperative changes. The
GIQLI score could be used to assess the various surgical procedures of
PD.
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RESCUE PANCREATECTOMIES
Croce, Chiara; Del Chiaro, Marco; Boggi, Ugo; Signori, Stefano; Vistoli,
Fabio; Mosca, Irene; Gremmo, Fiorenza; Perrone, Vittorio; Sgambelluri,
Francesco A.; Mosca, Franco
University of Pisa, Division of General and Transplant Surgery, Pisa, Italy
Introduction. Optimal management of pancreatic diseases requires dedica-
tion and experience.
Aim. To retrospectively define the outcomes of ‘‘rescue’’ pancreatectomies
(RP).
Methods. A RP was defined as a pancreatectomy performed after a previous
palliative procedure (RP-PPP) or an erroneous treatment strategy (RP-ETS)
due to a faulty diagnosis. From November 1987 to August 2005 out of 1742
patients evaluated for pancreatectomy we identified 117 (6.7%) possible RP:
of them 104 underwent surgical (re)exploration (88.9%) and 80 (62 RP-PPP
and 18 RP-ETS) RP(68.4%). Previous procedures included 5(8%) explora-
tory laparotomies, 15(24.2%) biliary and 11(17.7%) digestive by-passes,
23(37.2%) endoscopic/percutaneous biliary drainages, 7(11.3%) ‘‘cyst’’
drainages and 1(1.6%) ampullectomy. RP included 55(68.7%) pancreatico-
duodenectomies, 13(16.3%) left sided pancreatectomies, and 12(15%) total
pancreatectomies.
Results. Mean delay of RP by the initial evaluation was 6 months (range 1
84). Overall, 10 patients (12.5%) (4 RP-ETS, 6 RP-PPP) non resected due
to supposed locally advanced or metastatic malignant diseases were even-
tually diagnosed with benign or low grade diseases; 22 patients (27.5%) (9
RP-ETS, 13 RP-PPP) thought to have benign diseases were diagnosed with
high grade malignancies after RP; 7 cases (8.7%) (1 RP-ETS, 6 RP-PPP)
treated for a pseudocyst had actually a cystic tumor; 37 patients (46, 25%) (3
RP-ETS, 34 RP-PPP) deemed technically unresectable underwent a
successful RP. When compared with standard pancreatectomy (SP) RP
didn’t show increased morbidity (47.5% vs 40.7%), mortality (4.8% vs
4.3%), or worsened survival. For patients finally diagnosed with ductal
adenocarcinoma a treatment delay/vsB/3 months was associated with
shorter survival expectancy.
Conclusions. Carefully selected patients can safely undergo RP. Timely
referral to high volume centers optimizes clinical outcomes and economic
and s
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RESECTION OF THE SUPERIOR MESENTERIC AND PORTAL
VEIN FOR PANCREATIC ADENOCARCINOMA DOES NOT IN-
CREASE MORBIDITY OR MORTALITY
Fischer, Craig
Weill Medical College of Cornell University, Surgery, Houston, USA
Background. Vascular Resection at the time of pancreaticoduodenectomy
(PD) is controversial. 40% of patients with periampullary carcincinoma
present with locally advanced disease, and if deemed unresectable, have a
median survival of 810 months. Recent data indicates that an aggressive
surgical approach involving resection of the superior mesenteric and portal
venous confluence (SMPV confluence) have equivalent 5-year survival to
those who undergo standard PD for adenocarcinoma of the pancreas. We
present a contemporary series of patients undergoing PD for locally advanced
periampllary malignancy and present in-hospital outcomes.
Aims/Objectives. To compare in-hospital surgical outcomes between
patients undergoing standard PD for periampullary malignancy, to patients
undergoing vascular resection at the time of PD.
Methods. Between January 2001 and January 2006, 218 patients underwent
pancreaticoduodenectomy for periampullary disease. A total number of 41
PD operations with resection of SMPV confluence were identified. All
patients fulfilled criteria of resectability: (1) absence of extra-pancreatic
metastatic disease, (2) absence of tumor extension to the superior mesenteric
artery or celiac axis, (3) patency of the SMPV confluence with a suitable
segment of superior mesenteric vein (SMV) and portal vein (PV) to allow
venous resection and reconstruction if necessary. We analyzed the hospital
and 30-day mortality and morbidity rates.
Results. See Table.
Discussion. No statistical differences were found between standard peri-
operative outcomes for pancreatic surgery, between patients who underwent
PD and PD/Vascular Resection. This data further validates an aggressive
surgical approach to locally advanced periampullary malignancy
Conclusions. PD/vascular resection may help selected patients, previously
thought to be inoperable, to undergo surgical treatment for periampullary
malignancy, without increased risk, compared to standard PD, in centers with
appropriate surgical expertise.
Variable
Gender (men%) 48.6% 53.6%
Average Age 62.7 59.5
Mortality (%) 4.5% 7.3%
OR time, minutes (range) 489 431
EBL cc (range) 1174 1683
Length of Stay (days) 12.5 17.7
Pancreatic Fistula (%) 6.7% 9.7%
Delayed Gastric Emptying 24.8% 12.2%
Reoperation 3.4% 4.9%
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RESECTION WITHOUT BILIARY DRAINAGE IN PATIENTS
UNDERGOING PROXIMAL PANCREATIC RESECTION
Jaques, Brian; Jaques, Kathleen; O’Sullivan, Chris; Charnley, Richard;
French, Jeremy; Mansfield, Stephen; Manas, Derek
Freeman Hospital, HPB Surgery, Newcastle upon Tyne, UK
Introduction. Biliary stenting prior to resection is standard management of
patients with proximal pancreatic/periampullary malignancy. Resection
before biliary drainage however is offered to few patients mainly for logistical
reasons.
Aim. To identify patients suitable for resection without drainage and
compare outcomes with those undergoing drainage before resection.
Methods. Between 1-4-4 and 30-9-5, based on their presenting bilirubin
levels and other logistical factors, jaundiced patients who might be suitable
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for resection without drainage were identified. Data on complications and
hospital stay were compared with those patients in whom a conventional
pathway (with biliary drainage) was used during the same time period. Data
was also compared with a group of patients from the preceding 6-months (1-
10-3 to 30-9-4).
Results. 9 patients underwent resection without drainage and 49 patients
were treated by the conventional pathway. In resection-without-drainage
patients, median(range) serum bilirubin level (mmol/l) was 265(162391) at
time of the operation compared to 43(4194)(p//0.0001) in conventional
patients. Median(range) of time from referral to operation, 14 days(633) vs
59(6201), was significantly shorter in resection-without-drainage patients
vs conventional patients (p/B/0.0001). Median(range) of total hospital stays
at 21 days(1236) vs 32(14144)(p/0.014), was significantly shorter in
resection-without-drainage patients. There was no difference in rates of
surgical complications and mortality. Prior to surgery the 49 conventional
patients underwent a total of 73 biliary drainage procedures resulting in 7
major complications. Comparison with the group of patients from the
previous time period indicated that the conventional group were not
disadvantaged.
Conclusions. Management of patients with distal biliary strictures by
resection without drainage is safe and gives clear benefit in terms of reducing
the waiting time to surgery, the number of biliary drainage procedures per
patient and the total hospital stay.
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RISK FACTORS FOR PANCREATIC FISTULA AND DELAYED
GASTRIC EMPTYING AFTER PANCREATICODUODENECTOMY
WITH PANCREATICOGASTROSTOMY
Pessaux, Patrick; Etienne, Sandrina; Teyssedou, Carlos; Arnaud, Jean-Pierre;
Mucci, Stephanie; Brachet, Dorothee
University Hospital, Angers, France
Background. Complications after pancreaticoduodenectomy (PD) remain
frequent despite a decreasing mortality. Delayed gastric emptying (DGE)
remains the most common complications (about 30%) and pancreatic fistula
(PF) the most serious. The aim of this study was to identify the risk factors of
PF and DGE after PD with pancreaticogastrostomy.
Patients and methods. Between January 1996 and December 2004, 124
consecutive patients who underwent PD with pancreaticogastrostomy were
prospectively evaluated. PF was defined as amylase level in surgical drainage
fluid more than 5 fold the serum level after day 5, or amylase-rich fluid
collection. CT scan was only done for suspicion of abdominal collection.
DGE was defined as the requirement of keeping the nasogastric after day 10
or of reinsertion the nasogastric tube.
Results. PF occurred in 8.8% (n/11) and DGE in 30% (n/38) of patients.
After univariate analysis, soft pancreatic texture, coronary disease, no
preoperative jaundice, and no artery hypertension were significantly asso-
ciated PF. Multivariate analysis identified 2 predictive risk factors for PF:
coronary disease [OR/2.5; IC95%(1.114)] and absence of artery hyper-
tension [OR/2.2; IC95%(1.210)]. Soft pancreatic texture was a marginal
factor (OR/1.5; IC95%(0.99 8.2);p/0.07]. After univariate analysis, age,
postoperative infectious complications, and PF were significantly associated
DGE. There was no independent factor of DGE after multivariate analysis.
Conclusions. PF was strongly predicted by preoperative comorbidities
(coronary disease and artery hypertension). Choice of surgical technique
did not correlate with PF. The occurrence of DGE must fear the presence of
intraabdominal infectious complications or PF, and CT scan must be
performed.
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RISK FACTORS FOR POST-OPERATIVE COMPLICATIONS IN
PATIENTS UNDERGOING PANCREATICODUODENECTOMY
WITH A DUCT-TO-MUCOSA PANCREATICOJEJUNOSTOMY
Tay, Khoon Hean; Ibrahim, Salleh
Changi General Hospital, Dept. of General Surgery, Singapore
Pancreatico-duodenectomy (PD) has been associated with high morbidity
and mortality. The identification of risk factors helps surgeons in patient
selection as well as to formulate a better pre-operative management plan for
his patients in order to minimize complications.
Method. There were 51 consecutive PD with a duct-to-mucosa pancreatico-
jejunostomy performed in Changi General Hospital from May 1999 to May
2004.
Results. There were 12 patients (23.5%) who had surgically related
complications in the whole series. There were no differences in terms of
patients’ age, pre-operative liver enzymes and hemoglobin between this group
of patients and those without complications. The serum creatinine was
significantly higher in the complicated group at 125.4///9.5 U/L as
compare to 45.5///10.5 U/L in the group of patients without complications
(Odds ratio/4.51, 95%CI, 1.8632.6). Male sex was also found to be an
independent risk factor (Odds ratio/8.7, 95%CI, pB/0.003). Patients with
pre-operative biliary stenting had high risk of developing complications as
compared to those without (Odds ratio/7.652, 95%CI, pB/0.034). Patients
who had no complications and biliary stenting were operated on a minimum
three weeks after the stenting procedure. There was no difference in terms of
operating time, blood loss, type of resection, pancreatic duct size or pancreas
remnant texture between the two groups. The need for blood transfusions,
however was found to be a significant independent risk factor (Odds ratio/
5.425, 95%CI, pB/0.018). There were no 30-day mortality in the series.
Conclusion. Male sex, pre-operative biliary stenting, high serum creatinine
levels and peri-operative blood transfusions were associated with increase risk
of complications after pancreatico-duodenectomy with a pancreaticojeju-
nostomy.
Keywords. Pancreaticoduodenectomy, risk factors, morbidity
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RISK FACTORS FOR POST-PANCREATICODUODENECTOMY
(PD) HEMORRHAGE
Morris-Stiff, Gareth; Wickremseekera, Kusal; Koukoutsis, Ilias; Bellagamba,
Ricardo; Silva, Michael; Mayer, David; Buckels, John; Mirza, Darius;
Bramhall, Simon
Queen Elizabeth Hospital, HPB Surgery, Birmingham, UK
Background. Post-PD hemorrhage is an often lethal complication, which
commonly requires multimodality treatment.
Aims. To document the prevalence and to evaluate the management
strategies of hemorrhagic complications following PD.
Patients and methods. A total of 362 patients had PD between January
2000 and October 2005. The indication for surgery was: pancreatic
adenocarcinoma (59%); ampullary adenocarcinoma (21%); and cholangio-
carcinoma of the distal bile duct (12%). 199 patients were male and 163 were
female with a median age of 66 years (range 22 to 90 years). Data on
pancreatic leak and fistula, bile leak, presence of sentinel bleed, sepsis, intra-
abdominal abscess, etiology of hemorrhage, treatment strategy and mortality
rate were analyzed. Statistical analysis was performed using Spearman’s test
and Fischer’s two-tailed test in SPSS.
Results. 32 patients (8.83%) experienced at least one episode of bleeding,
during the first 30 postoperative days. Primary intra-luminal bleeding was
recorded in 13 patients (40.6%), primary intra-abdominal haemorrhage in 5
(15.6%), and secondary hemorrhage in 14 (43.8%). The mortality rate was
47% (15 deaths), mainly due to sepsis and/or multiorgan failure syndrome.
Two patients with primary intra-luminal bleeding, all patients with primary
intra-abdominal haemorrhage and nine patients with secondary hemorrhage
were treated by laparotomy. Successful trans-arterial embolization (TAE) was
performed in two out of seven patients. Statistical analysis revealed sepsis and
sentinel bleed as risk factors for post-PD hemorrhage and pancreatic leak and
sentinel bleed as risk factors for secondary hemorrhage (pB/0.05).
Conclusions. Sepsis, pancreatic leak and sentinel bleed are statistical
significant factors for post-PD hemorrhage. The effectiveness of therapeutic
TAE was not demonstrated in our study.
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SPLENIC PRESERVATION AFTER DISTAL PANCREATECTOMY
INCLUDING SPLENIC ARTERY AND VEIN
Schaeffer, David F; Buczkowski, Andrew K; Chung, Stephen W; Scudamore,
Charles H
University of British Columbia, Vancouver, Canada
Distal pancreatectomy with splenectomy has been the accepted surgical
procedure for malignant, premalignant and symptomatic benign lesions of
the body and tail of the pancreas. Concomitant splenectomy has traditionally
been considered to be a necessity, due to the intimate and complex
relationship of the splenic vein and artery to the pancreas and for adequate
excision of malignant pancreatic lesions. Splenectomy in conjunction with
other major upper abdominal organ resection, however, has shown an
increased postoperative morbidity, especially infectious complications. Sple-
nic preservation has therefore been considered desirable in patients under-
going gastric or colon resection. The concept of distal pancreatectomy with
splenic preservation has been described in the literature, however, mainly in
patients undergoing surgery for trauma, inflammatory or benign lesions and
was the usual technique for splenic preservation requiring preservation of the
splenic artery and vein, a tedious technique. Because of the dual splenic
supply to the short gastric, splenic artery and vein can be sacrificed, if the
short gastric are preserved to the spleen, therefore simplyfing the procedure.
In this study we report about our experience in twenty patients, who
underwent a distal pancreatectomy with preservation of spleen, splenic vein
and artery. All patients in this study did not shown any immediate
postoperative morbidity. Long term follow up showed patent splenic artery
and no surgical related morbidities. The intraoperative blood loss was
negligible and no infective complications were observed.
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STENTING OF THE MAIN PANCREATIC DUCT AND COMMON
HEPATIC DUCT IS USEFUL AND SAFE FOR RADICAL ENU-
CLEATION OF SOLID-PSEUDOPAPILLARY TUMOR OF THE
HEAD OF THE PANCREAS
Sawada, Shigeaki; Kimura, Fumio; Shimizu, Hiroaki; Yoshidome, Hiroyuki;
Ohtsuka, Masayuki; Kato, Atsuo; Yoshitomi, Hideyuki; Nozawa, Satoshi;
Furukawa, Katsuki; Mitsuhashi, Noboru; Takeuchi, Dan; Miyazaki, Masaru
Graduate School of Medicine, Chiba University, General Surgery, Chiba-
city, Japan
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Background. Solid-pseudopapillary tumors (SPT) of pancreas are rare
neoplasm of low malignant potential that predominantly affects young
women. Radical resection is the most effective treatment and the operative
types in radical resection depend on the tumor position of the pancreas. SPT
is existed more frequently at the head and tail of pancreas. In case of pancreas
head tumor, the pancreaticoduodenectomy is often performed for radical
reseciton. Here we report a case of a SPT closed to main pancreatic duct
(MPD) and common hepatic duct (CBD). The tumor was enucleated
radically without injury of MPD and CBD inserting stent tube to MPD and
CBD in each.
Case. A 16-year-old woman had admitted in our hospital with pancreas head
tumor detected by abdominal ultrasound. In dynamic-CT examination, the
tumor was located at pancreas head closed to MPD and CBD (the distance
between tumor edge and MPD was 5 mm). The tumor was solid and was not
enhanced in any phase. Under endoscopic ultrasound, fine needle aspiration
was performed and tumor was diagnosed as SPT.
Operative findings. After cholecystectomy, a tube was inserted into CBD
from the cystic duct to the second portion of duodenum through the Papilla
Vater. Mobilization of the duodenum was performed and then 3 cm incision
was made at second portion of the duodenum opposite side of Papilla Vater.
We inserted a tube into main pancreatic duct from Papilla Vater. Then we
enucleated the tumor from pancreas head paying attention for the tubes to
avoid injury of CBD and MPD. The surgical margin was free of tumor in
fresh frozen section. Bleeding volume was 26 g and operation time was 2 hour
50 mins. The stent tubes for CBD and MPD were removed on postoperative
day 22 and 23 respectively. The patient was discharged on postoperative day
38 and her hospital course was relatively uneventful.
Conclusion. Stenting to MPD and CBD is useful and safe method for
radical enucleation of SPT at pancreas head.
P45.57
SUCCESSFUL CONSERVATIVE TREATMENT OF 50 CONSECU-
TIVE POSTOPERATIVE PANCREATIC FISTULAS
Pedrazzoli, Sergio1; Pasquali, Claudio1; Sperti, Cosimo1; Scappin, Sabrina1;
Liessi, Guido2
1University of Padova, Clinica Chirurgica 4/Istituto Oncologico Veneto,
Padova, Italy; 2Castelfranco Veneto Hospital, Radiology, Castelfranco
Veneto, Italy
Background. Pancreatic fistula is a feared complication after pancreatic
surgery, with a mortality rate up to 28% due to retroperitoneal sepsis and
hemorrhage. We performed a retrospective study of the incidence of
pancreatic fistula, and of the results of treatment, of patients who underwent
pancreatic surgery.
Methods. From January 1994 and January 2006, 335 patients underwent
pancreatic surgery. Twelve total pancreatectomies were excluded living 323
patients. Drains were removed within 8 days whenever possible. A pancreatic
fistula was diagnosed on the basis of drainage of more than 50 ml of amylase-
rich fluid (/5000 IU)/day. A conservative treatment, based on interventional
radiology, aimed to create a straight external fistula was applied to all
patients.
Results. Out of 323 patients: 135 underwent surgery for a pancreatic or
periampullary cancer, 67 for endocrine pancreatic tumors, 45 for a cystic
tumor of the pancreas, 16 for IPMN, 40 for chronic pancreatitis, 15 for
pseudocyst post SAP, 16 for several different diseases. A pancreatic fistula
was diagnosed in 50 patients (15.5%). The fistula rate was 8.8% (11/124)
after pancreaticoduodenectomy, 11.9% (11/92) after left pancreatectomy, 53,
8% (14/26) after central pancreatectomy, 41.1% (7/17) after DPPHR, 20.7%
(6/29) after enucleation, 5.5% (1/18) after pancreatico-jejunostomy, 20% (1/
5) after subtotal pancreatectomy, 0% after cystojejunostomy (0/9). All
underwent conservative treatment. A patient in dialysis for renal insufficiency
developed abrupt generalized peritonitis 8 days after PD. She underwent
surgical treatment aimed to recreate the condition of a guided external fistula
as for the other patients. All fistulas closed spontaneously after a mean of 28.4
days (range 1077). No patient died of pancreatic fistula.
Conclusion. An early and intensive interventional radiology treatment of
external pancreatic fistulas can prevent severe complications that usually
need surgical treatment, completion pancreatectomy included.
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SUPERIOR MESENTERIC ARTERY ORIENTED PANCREATICO-
DUODENECTOMY
Horiguchi, Akihiko; Ishihara, Shin; Ito, Masahiro; Miyakawa, Shuichi
Fujita Health University, Gastroenterological Surgery, Toyoake, Japan
We have encounter the bleeding and congestion of the head of the pancreas by
the ligation and cutting of some small branches from the SMV in the middle
of pancreatoduodenectomy. We report superior mesenteric artery (SMA)
oriented pancreatoduodenectomy that ligated feeding artery at the first. After
cholecystectomy, common hepatic artery and common hepatic duct were
exposed and developed by blunt and sharp dissection in the hepatoduodenal
ligament. After a Kocher maneuver was performed to mobilize the duodenum
and head of the pancreas. Left renal vein were exposed, vessel tape was then
passed around the origin of the SMA. The gastroduodenal artery were
double-ligated and severed at this origin. Treitz ligament was divided from
retroperitoneum. The dissection is directed toward the root of the SMA. The
middle colic artery were exposed, vessel tape were passed around. The
inferior pancreatoduodenal artery were exposed and ligated. After exposure
of the superior mesenteric vein (SMV), the pancreas was freed from the portal
vein. The pancreas parenchyma was cut using a scalpel giving at least a 2 cm
margin from the tumor. The jejunum was transected 3 cm distal to the Treitz
ligament. After these procedures, the departure of the posterior inferior
pancreaticoduodenal vein, the anterior inferior pancreaticoduodenal vein,
and the posterior superior pancreaticoduodenal vein from the portal trunk
and SMV was reveals. These vein were ligated and cut, followed by the
ligation and cutting of some small branches from the SMV. This procedure is
considered to be appropriate for safety pancreaticoduodenectomy.
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SURGICAL TREATMENT OF LOCALLY ADVANCED PANCREA-
TIC CANCER
Gurcu, Baris1; Uguz, Alper1; Aydin, Unal1; Karaka, Burcak2; Nart, Deniz3;
Ersoz, Galip4; Tekesin, Oktay4; Ozutemiz, Omer4; Zeytunlu, Murat1;
Yilmaz, Funda3; Goker, Erdem2; Coker, Ahmet1
1Ege University Hospital, General Surgery, HPB workgroup, Izmir, Turkey;
2Ege University Hospital, Medy´cal Oncology, Izmir, Turkey; 3Ege University
Hospital, Pathology, Izmir, Turkey; 4Ege University Hospital, Gastroenter-
ology, Izmir, Turkey
Background. Except some Far-Eastern studies, the outcome of surgery for
locally advanced pancreatic cancer is still quite poor. Since the advantages of
surgery over other treatment modalities like radio and/or chemotherapy have
not yet been confirmed by evidence based data, and it has long been
discussed whether surgical resection could be indicated for locally advanced
pancreatic cancer.
Methods. We reviewed our pancreatic cancer cases in terms of surgical
resection and adjuvant radiochemotherapy for locally advanced pancreatic
cancer.
Results. Sixty two patients were treated for locally advanced pancreatic
cancer. Although there was 2 perioperative death, surgery offered significantly
acceptable results, as measured by 1-year survival (62%), mean survival time
(/14 months). Patients were evaluated also in terms of quality of life score
and gastric emptying for pancreaticoduodenectomy patients after surgery.
Thirty patients (48, 4%) were found eligible for adjuvant chemo and/or
radiotherapy. Infectious complications were quite high (n/19 and 30, 6%)
and early postoperative complications were comperable with historical results.
Conclusion. The results of our series are reviewed in brief, and surgical
treatment of locally advanced pancreatic cancer is advisable procedure.
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THE ADEQUATE DEFINITION OF OPERATIVE MORTALITY
AFTER PANCREATICODUODENECTOMY
Balzano, Gianpaolo; Zerbi, Alessandro; Gilardini, Cristina; Capitanio,
Vanessa; Gavazzi, Francesca; Polese, Marco; Di Carlo, Valerio
San Raffaele Scientific Institute, Surgery, Milan, Italy
Background. An operative death after pancreaticoduodenenctomy (PD)
may occur late in the postoperative period, due to persistent intrabdominal
complications and prolonged intensive care unit treatment. An incorrect
definition of the postoperative follow-up may underestimate the actual
mortality after PD.
Aim. To assess the variability of the operative death rate after PD in a large
patients’ group by applying different definitions of postoperative follow-up.
Methods. English literature since 1990 was reviewed, considering articles
reporting the operative outcome of at least 100 PD, looking for definitions of
operative mortality. Five definitions of the postoperative follow-up period to
consider operative mortality were identified in 75 articles: 30-day mortality
(22 articles), 60-day mortality (2 articles), in-hospital mortality (25 articles),
30-day or in-hospital mortality (22 articles), and in-hospital/30-day after
discharge (4 articles).
Results. The study group was made of 592 patients undergoing PD from
1995 to 2005. There were 20 in-hospital deaths occurring at 1110
postoperative days. Two further patients died after being readmitted (decease
at 24 and 41 days after PD). By applying the five definitions to the study
group, the following death rates were recorded: 2.53% (15 pts), 3.38% (20
pts), 3.38% (20 pts), 3.54% (21 pts) and 3.72% (22 pts), respectively. The
relative increase of mortality rate between the most limited and the most
extensive definitions of postoperative follow-up was 32%.
Conclusion. Most articles reporting death rate after PD have inadequate
definitions, that may underestimate the actual mortality up to 32%. An
adequate definition should include in-hospital mortality (irrespective of the
duration) and 30 days after discharge.
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THE PREVENTION OF IN-DEHISCENCE OF PANCREATOJEJU-
NO ANASTOMOSIS AFTER GASTROPANCREATODUODENAL
RESECTION
Baimakhanov, Bolatbek1; Aliyev, Mukhtar1; Akhmetov, Yermek2; Nusratdi-
nov, Rasul1
1National Scientific Center of Surgery, Abdominal Surgery, Almaty, Kazakh-
stan; 2National Scientific Center of Surgery, Almaty, Kazakhstan
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Aim. To study the method of prevention of indehiscence of pancreatojeju-
noanastomosis after gastropancreatoduodenal resection
Methods. During 20002005 years 120 pancreatoduodenal resections
were performed. Out of the gastropancreatoduodenal resections using the
adopted method of prophylaxis or prevention of indehiscence of the
pancreatojujeanastomosis in 25 operated patients. The method includes
formation and invagination of the pancreatojejunoanastamosis ‘‘end to end’’
with internal and external drainage of the anastomosed areas using draining
tube through microjejunostoma. The drainage of the hepaticoenteroanasto-
mosis using Felker’s method is performed externally, formation or creation of
gastroenteroanastomosis. All the anastomoses are formed using a single
intestinal loop.
Results. Out of the 100 operated patients without applying our adopted
method, pancreatojejunoanstomosis indehiscence was seen in 24% cases.
Complications associated with indehiscence of the pancreatojejunoanasto-
mosis in patients with external and internal drainage of the pancreatojuje-
noanastomotic zones are not seen.
Conclusions. Therefore, the method allows us to perform decompression
of the pancreatojujenoanastomotic zones, minimizes contacts with the
resected edges of the pancrease and its stump and ducts that have aggressive
substances of intestinal contents, especially in long post operational intestinal
paresis.
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THE RELATION BETWEEN RECONSTRUCTION AND DELAYED
GASTRIC EMPTYING AFTER PYLORUS-PRESERVING PAN-
CREATICODUODENECTOMY
Asakura, Takeshi; Jinnouchi, Yuji; Koijumi, Satoshi; Asano, Takayuki;
Nakano, Hiroshi; Otsubo, Takehito
St. Marianna University School of Medicine, Dept. of Gastrointestinal and
General Surgery, Kawasaki, Japan
Background/Aims. Delayed gastric emptying (DGE) is the most common
early complication after pylorus-preserving pancreaticoduodenectomy
‘‘PPPD’’. We examined the relation between reconstruction and DGE after
PPPD.
Methods. This study evaluated the influence of the reconstruction type of
surgery after PPPD. Twenty-five patients with PPPD were divided into three
groups according to their surgical years and surgical reconstruction. Group A
is Billroth I type (Pancreaticogastrrectomy) with retrocolic duodenojujunost-
omy (n/7, February 1998 through November 2000). Group B is Billroth II
type (Pancreaticojejunostomy) with retrocolic duodenojejunostomy (n/12,
December 2000 through September 2003). Group C is Billroth II type
(Pancreaticojejunostomy) with antecolic duodenojejunostomy combined
with Braun anastomosis (n/6, October 2003 through December 2003).
We defined that if they can’t take anything orally even 15 days after operation
classified as DRG. This study compared with occurrence of DGE, duration
of nasogastric tube insertion, duration of gastric aspiration less than 500 ml,
timing of solid food intake, and length of hospital stay.
Results. DRG occurrence rate in Group A is 86%, Group B is 42%, and
Group C is 0%. Duration of nasogastric tube insertion in Group A is 15.39/
8.2 days, Group B is 11.89/11.0 days, and Group C is 2.39/0.8 days. Gastric
aspiration less than 500 ml is 10.79/6.5 days in Group A, 6.79/11.2 days in
Group B, 0.39/0.8 days in Group C. Solid diet is started in 39.39/12.8 in
Group A, 29.79/11.0 days in Group B, and 17.59/4.8 days in Group C.
Group C is the best results from above data. We guess that Group C was
much better to pass the food from stomach to protect DGE.
Conclusion. We conclude that Billroth II type (Pancreaticojejunostomy)
with antecolic duodenojejunostomy combined with Braun anastomosis is
able to shorten the hospital stay and this will be the best choice of
reconstruction to decrease DGE after pylorus preserving pancreaticoduode-
nectomy.
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TOWARD SAFER PANCREATODUODENECTOMY (PD)-REDU-
CING THE RISK OF PANCREATIC LEAK WITH A ‘‘P-LOOP’’
RECONSTRUCTION TECHNIQUE
Quyn, Aaron; Polignano, Francesco M; Tait, Iain S
Ninewells Hospital & Medical School, Surgery & Molecular Oncology,
Dundee, UK
Background. Life-threatening complications (abscess, fistula, bleeding)
after PD are associated with leakage at the pancreatic anastomosis. As mixed
bilio-pancreatic juices result in rapid activation of pancreatic enzymes, a
reconstruction technique that separates the biliary & pancreatic systems may
reduce the risks associated with pancreatic leak.
Aims. This study investigates outcome after PD using a standard roux-loop
reconstruction, and a modified P-Loop configuration to avoid mixed bilio-
pancreatic secretions at the pancreatic anastomosis.
Methods. Cancer patients undergoing PD between Jan 2000-Dec 2005 had
2 layer duct-to-mucosa pancreato-jejunostomy. Group 1-Separated pancrea-
tic & biliary anastomoses with modified P-loop configuration. Group 2-
Pancreatic & biliary anastomoses on single roux-loop. Pancreatic leak/Drain
amylase/x3 serum amylase/day 10, or radiological confirmation. End
points-pancreatic leak & re-intervention rates, length of hospital stay, and in-
hospital mortality.
Results. PD in 53 patients mean age 65 yrs [range 4485]-for peri-ampullary
cancer 45% (n/24) & pancreatic cancer 55% (n/29). Group 117 pts;
Group 236 pts. Pancreatic leak rate 35% (n/6/17) in Group 1 & 36% (n/
13/36) in Group 2. In pancreatic leak: (i) spontaneous resolution with no
intervention-86% Group 1 (n/6/7) vs. 62% Group 2 (n/8/13) [p/0.02]; (ii)
duration of leak and hospital stay significantly shorter in Group 1 [28 (11) vs. 39
(12) days; p/0.03]. Re-intervention in Group 2: completion pancreatectomy-
2, percutaneous drainage-3. Leak related mortality significantly greater than
overall mortality [10.5% (n/2/19)] versus 5.6% (n/3/53) p/0.003].
Discussion. P-loop reconstruction converts a mixed bilio-pancreatic leak
into an isolated pancreatic leak which has a more benign clinical course. In
this study leak rates were similar after PD, but those with P-loop
reconstruction had lower leak related mortality, quicker leak resolution, less
re-intervention, and shorter hospital stay.
P45.64
TREATMENT OF NECROTIZING PANCREATITIS AND PAN-
CREATIC WOUNDS
Rakhimov B.M, Bahtiyar1; Romanov VE, Vladislav2; Kolesnikov VV,
Vladimir3
1City Hospital 5, Togliatti, Russia; 2Samara Medical University, Samara,
Russia; 3City Hospital 5 ‘‘MedVAZ’’, Togliatti, Russia
Bacgrounds. Acute diseases and injuries of pancreas account for a
considerable place in the urgent surgery of the organs of abdominal cavity.
Aim. Development of adequate surgical methods and optimization of
surgical treatment of necrotizing pancreatitis and pancreatic wounds and
injuries.
Materials. Studied are the results of treatment of 174 patients subjected to
surgery for pancreanecrosis and pancreatic injuries. Out of the 174 patients
110 were men aged from 17 to 68 and 64 women aged from 32 to 74.
Results. The patients can be divided in two basic groups, i.e. 144 patients
with acute necrotizing pancreatitis of alcoholic and biliary etiology. All of
these patients were operated and the surgery consisted of subtotal resection of
pancreas-14/9, varying degrees of sequestroectomy-130/32. 41 patients died
during the postoperative period. Out of 121 patients operated at the stage of
toxemia and infiltrate 40 patients died, whereas out of 23 patients operated at
the stage of purulent complications only one patient died. The second group
included 30 patients with traumatic lesions of pancreas where 7 were knife
slash wounds, 3-gunshot wounds and 20-internal abdominal pancreatic
injuries. 6 patients had isolated lesions while 24 patients suffered concomi-
tant and multiple injuries. Performed were the following operations:
pancreatoduodenal resection-1/1, pancreatic resection-6, suture of pan-
creas-20/6 and drainage of wound-affected region-3. Out of 30 patients 11
patients developed various complications and 7 patients died.
Conclusion. Optimization of results of therapy of pancreatic wounds and
diseases requires a differentiated approach with regard to the selection of
adequate amount and time factors, as well as methods of operative intervention.
P45.65
TREATMENT STRATEGY FOR ADVANCED PANCEATIC CAN-
CER- LYMPH NODE DISSECTION, PORTAL VEIN RESECTION,
AND EARLY ADJUVANT CHEMOTHERAPY
Amano, Hodaka; Tadahiro, Takada; Nagashima, Ikuo; Yoshida, Masahiro;
Miura, Fumihiko; Isaka, Takahiro; Toyota, Naoyuki; Wada, Keita; Takagi,
Kennji
Teikyo University School of Medicine, Dept. of Surgery, Tokyo, Japan
Background. Majority of pancreatic cancer is still found in advanced stage,
and no remarkable improvement of outcome is obtained. Analysis of extended
operation of the past, result of RCTabout extended versus standard operation,
and an appearance of Gemcitabine (GEM), recent pancreatic cancer treatment
strategy is changing.
Aim/Objective. We experienced 146 PPPD/PD of pancreas head cancer with
72 portal vein resection (PVR) in Teikyo university hospital. Extended
operation (D3) was performed in 63 cases and standard operation (D2) in 83
cases. We performed adjuvant chemotherapy with Gemcitabine (GEM) in 64
cases, and started chemotherapy from 0 POD (postoperative day) in 36 cases.
Recently, we aimed for three times of GEM administration within a month after
operation as early adjuvant chemotherapy. We analyze about pancreatic head
cancer cases in our department, and report recent treatment strategy of rational
lymph node dissection, portal vein resection, and adjuvant chemotherapy.
Results. We recognized no significant difference of outcome in extended
operation and standard operation. We did not recognize significant difference
in PVR (/) with R0 and PVR (/) with R0. We recognized significant
improvement in adjuvant chemotherapy with GEM. The adverse event by
chemotherapy of 0 POD showed leucopenia to grade2 and thrombocytopenia
to grade2 in about 15%, but did not show serious complications. The successful
execution case of three times of GEM within a month after operation was about
60%. The interruption reason was caused mainly by postoperative complica-
tions such as pancreatic fistula.
Conclusion. Our treatment strategy for advanced pancreatic cancer is as
follows. We perform minimum lymph node dissection enabling R0, and
perform portal vein resection in potentially R0 possible case. Adjuvant
chemotherapy by GEM seemed to have some role to improve outcome, and
early chemotherapy was possible by an operation without complications.
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RISK FACTORS FOR PANCREATIC FISTULA: IS THERE A
CLINICAL APPLICATION FOR EARLY IDENTIFICATION OF
PATIENTS WITH A HIGH RISK OF DEVELOPING A PANCREATIC
FISTULA AFTER PANCREATICODUODENECTOMY?
Matheus, Andre S; Montagnini, Andre L; Jukemura, Jose; Jurendini, Ricardo;
Perini, Marcos; Penteado, Sonia; Haddad, Luciana B; Abdo, Emilio E; da
Cunha, Jose E
University of Sao Paulo, Dept. of Gastroenterology, Sao Paulo, Brazil
Operative mortality rates after pancreaticoduodenectomy (PD) have decreased
dramatically over the past 3 decades. Nevertheless pancreatic fistula remains
the major cause of morbidity. To analyze the clinical application of risk factors
for pancreatic leakage after PD, we conducted a retrospective review.
Methods. Thirty-seven patients who underwent PD at our hospital between
January 2004 and July 2005 were reviewed retrospectively. Standard PD was
performed for 3 cases and pylorus-preserving PD for 34 cases. Four
preoperative, two intraoperative, and five postoperative risk factors with
potential to affect the incidence of pancreatic fistula were analyzed. The recent
established definition of pancreatic fistula was used to make the fistula
diagnostic-a drain output of any measurable volume of fluid on or after
postoperative day 3 with an amylase content greater than 3 times the serum
amylase.
Results. Of the 37 patients, 11 (29.7%) were identified as having pancreatic
leakage after operation. The hospital mortality in this series was 5.4% (2/37),
and the mortality associated with pancreatic fistula was 0% (0/37). General risk
factors including patient age, gender, history of jaundice, preoperative
nutrition, and pathological diagnosis didn’t have any relation with pancreatic
fistula. Intraoperative risk factor, texture of the remnant pancreas, was not
found to be associated with pancreatic leakage. Blood loss, type of resection,
and serum amylase level did not have relation with pancreatic fistula. The
incidence of pancreatic leakage was 81.9% (9/11) in those patients with
abdominal drain amylase level/1000UI/dL on postoperative day 1, with
significantly relation with pancreatic fistula (pB/0.05).
Conclusion. Amylase level/1000UI/dL in the abdominal drain on post-
operative day 1 shows a significant relation with the occurrence of pancreatic
fistula and seems to be an important factor for early identification of pancreatic
fistula development after PD.
P45.67
DISTAL PANCREATECTOMY-A RANDOMIZED CONTROLLED
TRIAL TO COMPARE TWO DIFFERENT SURGICAL TECHNI-
QUES ON THE BASIS OF A SYSTEMATIC REVIEW
Diener, Markus K; Knaebel, Hanns-Peter; Wente, Moritz N; Kienle, Peter;
Bu¨chler, Markus W; Seiler, Christoph M
University of Heidelberg, Dept. of General-, Visceral- and Trauma Surgery,
Heidelberg, Germany
Introduction. Appropriate closure of the pancreatic remnant after distal
pancreatectomy is still debated. A variety of procedures have been recom-
mended to reduce the frequency of pancreatic fistula. A systematic review and
meta-analysis of the existing literature was performed to compare the available
techniques regarding postoperative mortality and morbidity respectively.
Subsequently, a study protocol was developed in order to generate high-level
evidence in a multicenter randomized-controlled trial.
Methods. Systematic literature search of all relevant databases (Cochrane
Controlled Trials Register, Medline and Embase). Three reviewers indepen-
dently assessed each study’s eligibility, quality and extracted the data. A random
effects model was performed using weighted odds ratios. A study protocol was
developed on the basis of the pooled and quantified data.
Results. Only ten of 262 articles were eligible for the systematic review.
Reported postoperative morbidity varied from 13.3 to 64 per cent. The primary
outcome measure, pancreatic fistula, occurred within a range of 064.3 per
cent. Meta-analysis of the six studies comparing stapler versus hand-sutured
closure showed a non significant combined odds ratio for occurrence of a
pancreatic fistula of 0.66 (95% confidence interval 0.35 to 1.26, P/0.21) in
favour of stapler-closure.
Conclusions. On the basis of these data the Study Centre of the German
Surgical Society plans to conduct a RCT comparing stapler-closure versus
hand-sewn closure of the pancreatic stump following distal pancreatectomy.
DISPACT-TRIAL is planned as a multi-centred, intra-operatively rando-
mized, patient and assessor-blinded RCT performed in a two-group
paralleled adaptive superiority design. 151 patients in each group will be
recruited in up to 20 centres of excellence in order to assess the primary
endpoint: pancreatic fistula and death. A standardized surgical technique
and follow-up will provide a valid predication of a potential superiority of one
technique
P45.68
HAEMORRHAGE IS THE PREDOMINANT COMPLICATION
OF DUODENOPANCREATECTOMY FOR BILIOPANCREATIC
CANCER
Topal, Baki; Aerts, Raymond; Penninckx, Freddy
University Hospital Gasthuisberg KUL, Abdominal Surgery, Hepato-Pan-
creato-Biliary Unit, Leuven, Belgium
Background. Pancreatoduodenectomy (PD) is associated with high morbid-
ity.
Aim. The aim of the present study was to analyze morbidity and mortality in
PD for primary cancer of the ampulla, distal bile duct and pancreas.
Methods. Between 1998 and 2005 PD (classical Whipple 121; pylorus
preserving 126) was performed in 247 consecutive patients with cancer of the
ampulla (84), distal bile duct (31) and pancreas (132). The male/female ratio
was 135/112 and the median (range) age 66 years (3285). Mean (SEM)
duration of surgery and intra-operative blood loss was 267 (6.06) minutes and
1402 (111.5) ml, respectively. A portal vein resection was performed in 27
(11%) patients (pancreas 25, ampulla 1, bile duct 1) for oncological reason.
Results. The overall morbidity and mortality rate was 51.4% and 2.4%,
respectively. Pancreatic leakage was observed in 11.7%, i.e. ampulla 14/84
(16.6%), bile duct 6/31 (19.3%) and pancreas 9/132 6.8%) (p/0.002). In 11
(38%) patients pancreatic leakage was associated with post-operative bleed-
ing. Haemorrhage was the most frequent complication observed: intra-
operative 18, post-operative 22 and both intra- and post-operative in 4
patients. Relaparotomy was performed for acute haemorrage in 14/20 (70%)
patients, whereas bleeding was fatal in 3/6 patients who died post-operatively.
Conclusion. Haemorrhage is the predominant complication in PD for
biliopancreatic cancer. It is often associated with pancreatic leakage and is
responsible for urgent relaparotomy and mortality, indicating the necessity for
intensive peri-operative care in a specialized surgical unit.
P45.69
CASE REPORT OF INFECTED PANCREATIC NECROSIS IN A
POST-ERCP PATIENT WHO UNDERWENT SURGERY FOR CHO-
LANGIOCARCINOMA
Yamada, Takuya; Kimura, Masaki
Graduate School of Medicine, Gifu University, Gifu, Japan
A 40-year-old man was admitted to our hospital due to liver dysfunction and
dilated intrahepatic bile ducts by abdominal ultrasound. Abdominal CT
indicated a 24/40 mm tumor in the S2/3 liver segments, and a biopsy
obtained during ERCP confirmed intrahepatic cholangiocarcinoma, for
which left hepatic lobectomy was scheduled. Following ERCP, the patient
developed grade IV acute pancreatitis and pancreatic pseudocyst. This
improved after percutaneous drainage of the pseudocyst and administration
of antibiotics, and left lobectomy was performed on normalization of CRP and
leukocyte. On the 3rd postoperative day the patient developed fever and
cloudy fluid draining from the resected area of the liver, abdominal CT
demonstrated a small fluid collection around the operated area. Culture of the
drainage fluid identified MRSA and the patient was started on vancomycin
hydrochloride. The fluid collection around the operated area was drained
percutaneously but turned out to be serous and culture-negative. On the 34th
day, the patient developed a fever of 408C accompanied by elevated CRP and
leukocyte. Abdominal CT demonstrated a low density area with internal air in
the pancreas head, and infected pancreatic necrosis was diagnosed. His fever
improved following administration of vancomycin hydrochloride and clin-
damycin, and the patient was discharged on the 64th day. 0n the 69th day, the
patient developed fever. With no improvement following three endoscopic
transgastric drainages of the abscess, we decided to treat the infected
pancreatitis and duodenal stricture surgically. Then necrosectomy, drainage,
and gastrojejunostomy was performed. No recurrence has occurred for about
2 years. It is thus important to note that, in surgical operations following post-
ERCP pancreatitis, the necrotic pancreas may become infected and potent
antimicrobial therapy might be necessary, which, if unsuccessful, would
warrant aggressive surgical resection of the necrotic pancreatic tissue.
P46.01
A NOVEL APPROACH TO THE INTRAOPERATIVE ASSESSMENT
OF THE UNCINATE MARGIN OF THE PANCREATICODUODE-
NECTOMY SPECIMEN
Khalifa, Mahmoud1; Maksymov, Vlad1; Hanna, Sherif2
1Sunnybrook and Women’s College, Pathology, Toronto, Canada; 2Sunny-
brook and Women’s College, Surgical Oncology, Toronto, Canada
Introduction and aim. Assessment of the surgical margins is a common
indication for intraoperative consultation during pancreaticoduodenectomy
(PD). However, there is no consensus regarding the margins examined
intraoperatively or the technical protocol for frozen section examination. We
find the intraoperative assessment of the uncinate margin extremely important
in cases of adenocarcinomas involving the head or uncinate process of the
pancreas. The aim of this work is to summarize our experience in this area and
compare it with the published literature.
Materials and methods. Our local protocol for the intraoperative assessment
of the PD specimens with carcinomas in the head or the uncinate process of
pancreas requires inking of the posterior surface of the pancreas including the
uncinate process. The tip of the uncinate process, including its distal 1 cm is
then cut off from the rest of the specimen and is serially sectioned at 3 mm
intervals perpendicularly. This produces 68 pieces of tissue that are submitted
for frozen section examination. A PubMed search using the terms pancreati-
coduodenectomy and margin was performed. Retrieved articles were categor-
ized according to whether they discussed frozen section margin examination.
Results. Ten articles published between 1984 and 2005 were retrieved which
discussed the intraoperative examination of PD specimens. Of the 10 articles,
238 Abstracts
4 discussed the intraoperative consultation for diagnostic purposes only, one
discussed the consultation for both diagnostic purposes and assessment of
margins, and 6 discussed intraoperative assessment of margins only. Of the
total of 7 articles, which discussed the intraoperative assessment of margins
none went in the technical details of submitting the uncinate margin for frozen
section assessment.
Conclusion. Our proposed protocol for the intraoperative assessment of the
uncinate margin of PD specimens allows for its accurate evaluation and has
not been previously described.
P46.02
AGENESIS OF THE DORSAL PANCREAS
Cho, Chol-Kyoon1; Kim, Hyun-Jong1; Jeong, Soon-ju1; Koh, Yang-Seok1;
Kim, Jung-Chul1; Joo, Young-Eun2; Park, Chang -Hwan2; Lee, Wan-Sik2;
Choi, Sung-Kyu2; Rew, Jong-Sun2; Kim, Sei-Jong2; Jang, Nam-Kyoo3; Jeong,
Yong-Yeon3; Lee, Jae-Hyuk4
1Chonnam National University Medical School, Surgery, Gwang-ju, Korea;
2Chonnam National University Medical School, Internal Medicine, Gwang-
ju, Korea; 3Chonnam National University Medical School, Radiology,
Gwang-ju, Korea; 4Chonnam National University Medical School, Pathol-
ogy, Gwang-ju, Korea
Background. Agenesis of the dorsal pancreas is a very rare congenital
anomaly that results from the embryological failure of the dorsal pancreatic
bud to form the body and tail of the pancreas. To date, four cases have been
recorded in Korea.
Patients. We report an additional case of a 25-year-old woman presented
with diabetes mellitus and abdominal pain. Abdominal computed tomogra-
phy (CT) revealed a normal-appearing pancreatic head, but the body and tail
were not visualized. Endoscopic cholangiopancreatogram (ERCP) revealed a
short pancreatic duct and normal biliary tree. Abdominal magnetic resonance
imaging (MRI) findings are similar to those of CTand ERCP. The patient was
shown to have agenesis of the dorsal pancreas by CT, ERCP and MRI.
Discussion. In Korea, agenesis of dorsal pancreas is a very rare congenital
anomaly that may be associated with diabetes mellitus and abdominal pain.
However, hereditary mechanism in this anomaly remains still unclear. If
agenesis of the dorsal pancreas is suspected, the combined use of CT and
ERCP or MRI is useful for the confirmation of this anomaly.
P46.03
ASSESSMENT OF THE TREATMENT OF PANCREATIC AND
BILIARY PAIN WITH ENDOSCOPIC STENTING AND/OR SUR-
GERY
Khorsandi, Shirin1; Ainley, Colin2; Bhattacharya, Satya1; Hutchins, Robert1
1St Bartholomew’s and the Royal London Hospital, Hepatobiliary and
pancreatic surgery, London, UK; 2St Bartholomew’s and the Royal London
Hospital, Gastroenterology, London, UK
Background. Type I Sphincter of Oddi dysfunction (SODD) or pancreatic
pain with a dilated pancreatic duct (on secretin stimulation) and hyperamy-
lasaemia is thought to respond best to endoscopic or surgical treatment.
However many patients present with atypical or equivocal findings. We
assessed our experience of pancreas divisum (PD) and SODD over a four year
period.
Methods. 23 endoscopic cases and six surgical cases were assessed retro-
spectively with respect to sphincter pressures, symptoms, treatment modality
and complications.
Results. There were six cases of PD and 17 SODD. All cases of divisum were
diagnosed endoscopically. Atypical presentation was seen in five. The one case
of biliary type pain remains pain-free after accessory pancreatic sphincter-
otomy and stent insertion at 12 months. Of the 4 with constant pancreatic
pain, all were relieved of symptoms by accessory pancreatic sphincterotomy
and stenting. One remains free of pain 5 months after stent removal and one
has developed recurrent pain after 8 months. Two were referred for
surgical intervention when their symptoms returned rapidly. Both these
patients have undergone accessory sphincteroplasty with resolution of
symptoms at 4 and 9 months. SODD All patients suffered from biliary-type
pain (type III).
Endoscopic treatment was associated with a morbidity of 18%, all seen in
SODD and not related to sphincter pressure. Surgery was associated with a
morbidity of 33% (one minor duodenal leak from an accessory papilla in a
diverticulum and one duodenotomy bleed). Median follow-up of the divisum
patients was 8 months (412) and of the SODD patients 6 months (048).
80% of the divisum patients remain asymptomatic and 64% of the SODD are
pain-free.
Conclusion. Type III sphincter of Oddi dysfunction does not necessarily
preclude successful outcome with endoscopic or surgical sphincterotomy/
sphincteroplasty. Prediction of success is not dictated by endoscopic
manometry.
P46.04
COLONIC COMPLICATIONS IN SEVERE ACUTE PANCREATI-
TIS
Perejaslov, Andre; Chooklin, Serge; Usach, Orest
Medical University, Lviv, Ukraine
Background. Colonic involvement in patients with severe acute pancreatitis
(SAP) often diagnosed when perforation and hemorrhage occurred. These
complications aggravated the clinical course of SAP, determined high
morbidity and mortality and required the adequate prophylaxis and treatment.
Methods. The goal of this study was to evaluate the changes in the colon in
patients with SAP. Colonoscopy was performed in 46 patients with SAP.
Levels of interleukins (IL) 1b, 18, and adhesion molecules (ICAM-1) were
also studied in these patients. The study protocol was approved by the
University Committee on Research Ethics and writing agreement was
obtained from all patients before study inclusion.
Results. The increased levels of all proinflammatory mediators were noted in
all patients already at the time of admission. The ischemic changes of the
colon mucosa were observed in 19 (45.2%) patients at the same time, which
correlated with the mediators’ levels. By the subsequent colonoscopy the
development of acute ulcer was noted in 8 (42.1%) of them that accompanied
by the hemorrhage in one patient. Among patients with initial colonic
changes, 9 (47.4%) of them were operated. Extensive transmural necrosis
was present in 2 patients that required subtotal colectomy. These patients had
stabile high levels of proinflammatory mediators. The decrease levels of Il-1b,
IL-18, and ICAM-1 were observed in the rest patients with simultaneous
normalization of colonoscopic picture.
Conclusion. Thus, colonic involvement occur in 45% of patients with SAP
that accompanied by the increased levels of IL-1b, IL-18, and ICAM-1. The
corticosteroids and probiotics should be included in the complex management
of SAP.
P46.05
HETEROTOPIC PANCREAS: AN UNUSUAL CAUSE OF BILIARY
OBSTRUCTION
Biswas, Atindriya1; Husain, Ehab2; Reid, Richard1; Feakins, Roger2; Abra-
ham, Ajit1
1Royal London Hospital, HPB Surgery Unit, London, UK; 2Royal London
Hospital, Pathology, London, UK
Introduction. Heterotopic pancreas (HP) is an unusual clinical entity, which
is found in approximately 1 in 500 upper abdominal operations. It may be
present throughout the gastrointestinal tract. However, presence of HP at the
ampulla or lower end of the common bile duct (CBD) causing biliary
obstruction is uncommon.
Manometry endoscopy complication surgery outcome follow-up/time till pain
(months)
hypertensive (3)
sphincterotomy and stent
bleed (1) nil pain-free 3, 7, 22
hypertensive sphincterotomy and stent bleed nil pain 5
hypertensive (3) sphincterotomy and stent nil sphincteroplasty pain 6, 6, 6
hypertensive sphincterotomy and stent nil sphincteroplasty pain-free 25
equivocal (2) sphincterotomy and stent pancreatitis (1) nil pain-free 3, 10
equivocal botox then sphincterot-
omy and stent
nil sphincteroplasty pain-free 8
equivocal botox and stent nil nil pain 0
normal sphincterotomy and bo-
tox
nil nil pain 0
stenosis sphincterotomy and stent nil nil pain-free 6
not assessed botox recurrent pancreatitis nil pain-free 48
not assessed nil nil sphincteroplasty pain-free 5
not assessed sphincterotomy and stent nil sphincteroplasty pain-free 24
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Aim. We report a case of HP at the duodenal ampulla presenting with
obstructive jaundice like a distal cholangiocarcinoma and review the literature
in this context.
Patient & methods. A 47-year-old man presented with abdominal pain and
obstructive jaundice. CT did not reveal a pancreatic mass, but ERCP
suggested a malignant distal CBD stricture. He underwent a pylorus
preserving pancreatico-duodenectomy (PPPD) and made an uncomplicated
recovery. Histology confirmed a well circumscribed submucosal nodule of
heterotopic pancreas at the ampulla associated with distal CBD inflammation
and fibrosis. There was no evidence of malignancy.
Results. Review of the literature revealed only 21 previous reports of cases of
HP presenting with biliary obstruction. The average age of presentation was
57 years (range: 4277 years). HP was present at the ampulla in 15 cases, and
within the CBD in the remainder. Whipple’s procedure or PPPD were done in
14 patients, and in 12 out of the 13 jaundiced patients. Local resection was
carried out in the form of ampullectomy (3 cases) or CBD resection (2 cases).
The diagnosis was made on post-mortem examination in 1 case. All 3 post-
operative deaths occurred prior to 1950. The remaining patients were cured
after Whipples/ PPPD or local resection. Endoscopic ultrasound (EUS)
suggested benign pathology in 1 case.
Discussion. Accurate pre-operative diagnosis of HP remains difficult in these
cases. EUS may be useful in identifying benign pathology causing obstructive
jaundice. The satisfactory outcomes reported after surgical treatment suggest
PPPD to be an acceptable treatment option for HP presenting as biliary
obstruction, when there is clinical or radiological suspicion of malignancy.
P46.06
IMMUNOTHERAPY APPROACH AFTER PANCREATIC RESEC-
TION FOR METASTASES FROM RENAL CANCER
Gardini, Andrea; Gunelli, Roberta; Ridolfi, Ruggero; Fiammengi, Laura;
Ridolfi, Laura; Morgagni, Paolo; Zaccaroni, Alberto; Garcea, Domenico
G.B. Morgagni-L. Pierantoni Hospital, Forli, Italy
Background and aims. Natural history of renal cell carcinoma includes
metastases to the pancreas. The literature reports that selected patients may
have benefits by pancreatic resection in terms of long term survival. We report
patients outcome from a single centre and considerations on immunotherapy
approach in selected patients.
Methods. From February 1999 to march 2005 eight patients underwent
pancreatic resection for metastases from renal cancer. We reviewed surgical
outcome and subsequent adjuvant treatment (conventional chemotherapy:
5FU-Vindesine; Immunotherapy: Interleukin 2 [IL2]- Interferon [IFN]
Dendritic cells [DC: prepared from peripheral blood monocytes pulsed with
autologous tumor lysate]) of these patients.
Results. All patients underwent radical pancreatic resection (7 spleno-
pancreasectomy; 1 segmental pancreatic resection) and were disease free after
surgery. No postoperative mortality is reported. Morbidity was 37% (2 distal
leakage; 1 pneumonitis). Two patients did not received any treatment; 2
patients conventional chemotherapy; 2 patients: immunotherapy (inter-
leukin2/interferon); 2 patients: Dendritic Cells (DC) interleukin-2 infusion.
Two years overall survival rate was 70%, disease free survival rate after 2 years
was 29%. Lung was site of recurrence in all cases.
Conclusions. Our data confirm that pancreatic resection should be offered to
selected patients; Long term survival is achievable, but recurrence rate after
surgery is high. Conventional chemotherapy should be administered but
immunotherapy seems to be more effective to control tumour progression
especially in selected cases where pulsed DC may be used.
P46.07
IS THERE A VARIABLE RELATION BETWEEN CA 19/9, CRP AND
BILIRUBIN IN MALIGNANT OR BENIGNE CHOLOSTATIC JAUN-
DICE?  A PRELIMINARY STUDY
La Greca, Gaetano; Lombardo, Rosario; Rapisarda, Domenico; Barbagallo,
Francesco; Grasso, Emanuele; Castello, Giorgio; Sofia, Maria; Gagliardo,
Salvina; Latteri, Saverio; Puleo, Stefano
University of Catania-Cannizzaro Hospital, Surgical Sciences Transplanata-
tion Advanced Tech., Catania, Italy
Background. CA 19/9 is often abnormal in patients with cholostatic jaundice
beeing increased not only in patients with pancreatic or biliary cancers but also
in benigne diseases resulting often missleading. Some AA suggested empiri-
cally to correct the value of CA 19/9 dividing it by the value of bilirubin.
Difficult interpretation of pathologic CA 19/9 levels is more frequent in
diseases associated with relevant inflammation due to jaundice.
Aim. The AA tried to analyze a possibile relation between inflammation and
CA 19/9 to find a better corrective factor to increase predictivity and reduce
false positive.
Method. 40 patients with cholostatic jaundice were recorded concerning all
routine laboratory tests including PCR, bilirubin, CA 19/9. These parameters
were anlyzed, calculated and combined differently and related to the
diagnosis.
Results. All the patients had abnormal bilirubin levels, 71, 7% had pathologic
CA 19/9 levels, 32, 7% were affected by malignancy of the pancreas or biliary
tract and the other by benigne disease. 100% of the patient with malignancy
had pathologic CA 19/9. CRP levels were pathologic in 69% of the patients
with benigne jaundice and in only 23% with jaundice due to malignancy.
Dividing CA19/9 levels by bilirubin level 52.1 of the patients with pathologic
CA 19/9 turned in the normal range. The remaining 47, 9% with calculated
pathologic CA 19/9 bilirubin ratio included 45, 4% patients with benigne
disease. In these patients the calculated CA 19/9 bilirubin ratio was divided by
the level of CRP. After this correction the 85% of the false positive CA 19/9
resulted normal for benigne diseases and on the other hand 95% of the true
positive CA 19/9 for malignancy remained true positive.
Conclusion. This preliminary study shows that CPR value could be useful as
a correction factor to improve the diagnostic value of the CA 19/9 level in
jaundiced patients due to uncertain benigne or maligne disease also convin-
cing us to continue the research in this particolar field of tumor markers.
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ISOLATED PANCREATIC TUBERCULOSIS  A CASE REPORT
Iype, Satheesh; Sylesh, A; Subhalal, N
Medical College Hospital, Surgical Gastroenterology, Trivandrum, India
Introduction. Tuberculosis of the pancreas usually occurs as a complication
of miliary tuberculosis. However, isolated involvement of the pancreas is
exceedingly rare.
Case report. A 55 year old male patient presented with complaints of upper
abdominal pain, loss of appetite and loss of weight of 3 months duration, and
low grade fever of 1 month duration. Abdominal examination revealed
tenderness and a vague mass in left hypochondrium. Ultrasound scan of the
abdomen showed a 5/5 cm heterogenous lesion in the tail of pancreas. CT
scan revealed an abscess in the pancreatic body and tail. A provisional
diagnosis of pancreatic abscess was made and an exploratory laparotomy was
performed. At laparotomy, there was a multiloculated abscess in relation to
the body and tail of the pancreas close to the hilum of the spleen. The abscess
was drained and culture of pus was sterile. Patient symptomatically improved
after the surgery. But he was readmitted 50 days after the surgery with
complaints of tenderness of the left upper abdomen and persistent discharge
through the drain site of 1 month duration. Ultrasound of abdomen showed
an ill defined hypoechoic mass in the tail of pancreas and moderate ascites.
ERCP and duct stenting was performed. A drain was placed into the abscess
cavity percutaneously. As the patient continued to have pus discharge through
the drain he was taken for exploratory laparotomy 3 weeks after the ERCP.
Distal pancreatectomy was done along with removal of adherent abscess.
Patient had an uneventful postoperative period. Histopathology of the
specimen revealed the diagnosis of pancreatic tuberculosis. The patient was
started on anti tuberculous therapy and within one month, his general
condition improved and he started gaining weight. On follow up at 1 year the
patient is healthy and asymptomatic.
Conclusion. Erroneous diagnosis of pancreatic malignancy or abscess often
leads to unnecessary laparotomy in pancreatic tuberculosis. Surgery should be
reserved for dealing with associated complications.
P46.09
MULTI-MODALITY TREATMENT OF PANCREATIC PSEUDO-
CYSTS
Khorsandi, Shirin1; Hutchins, Robert1; Fotheringham, Tim2; Fairclough,
Peter3; Bhattacharya, Satyajit1
1St Bartholomew’s and Royal London Hospitals, HPB Surgery Unit, London,
UK; 2St Bartholomew’s and Royal London Hospitals, Radiology, London,
UK; 3St Bartholomew’s and Royal London Hospitals, Gastroenterology,
London, UK
Background. Surgical internal drainage is the standard treatment for
symptomatic, large or complicated pancreatic psuedocysts. However, EUS-
guided cyst-gastrostomy and percutaneous cyst-gastrostomy under imaging
guidance are two alternative treatment options now available to us.
Aims. To assess the outcomes of patients with pancreatic pseudocysts, and
compare the three treatment modalities.
Methods. Over 6 years, 36 interventions were performed on patients with
large, symptomatic, or complicated pseudocysts. Every patient was discussed
amongst surgeons, endoscopists and radiologists, and the treatment was
determined by cyst size/location, equipment/anaesthetic logistics, and the
patient’s preference. Nine patients underwent attempted EUS-guided drai-
nage-they were the first 9 patients to undergo such therapy at our institution.
Three had pigtail stents placed, draining their cysts into the stomach-but one
patient suffered a bleed necessitating surgery, another experienced stent
migration and one got long-term resolution. One had the cyst aspirated but it
refilled. In 5 patients, the procedure failed because of problems with sedation
or difficulty in puncturing a thick cyst wall. Seven underwent percutaneous
transgastric placement of a stent extending from the gastric lumen into the
cyst cavity. All treatments were completed successfully, with no immediate
complication. One patient went on to receive surgery due to infection in the
cyst cavity. The other six experienced good resolution. Twenty patients
received surgery (5 cyst-jejunostomy, 15 cyst-gastrostomy). Four had under-
gone previous attempts at drainage by other means. There were no deaths, and
one wound infection. None of the cysts recurred on follow-up.
Conclusions. In our initial experience with EUS-guided drainage we noted a
high incidence of failure and complications. Percutanous cyst-gastrostomy
and surgical internal drainage yielded a high technical success rate and long-
term resolution, with surgery being the treatment of choice in complicated
situations.
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P46.10
PANCREATIC FLUID COLLECTIONS: TOWARDS A CLASSIFI-
CATION TO FACILITATE TREATMENT SELECTION
Apostolou, Christos; Krige, Jake EJ; Bornman, Philip C
Groote Schuur Hospital, Surgery & Surgical Gastroenterology, Cape Town,
South Africa
Background. Several treatment options are available for the therapeutic
drainage of pancreatic fluid collections (PFC), but their efficacy remains
difficult to determine due to the heterogeneity of these collections.
Aim. To review the outcome of different treatment modalities of pancreatic
fluid collections according to a classification derived from clinical features and
morphological characteristics.
Methods. Patients with symptomatic and unresolved PFC treated during a
nine-year period were reviewed. In addition to the clinical presentation, the
anatomical location was determined using CT and ERCP and the following
classification system was applied:
Type Post-Acute Chronic
Description Fluid collection persisting
/4weeks following acute
pancreatitis
Intra Pancreatic
(Atlanta Symposium 1992) Extra Pancreatic
Results. 73 patients were reviewed, of whom 62 were males; mean age: 42
years (1378).
Aetiology was alcohol (63), gallstones (6) and other (4).
Type, distribution and intended treatment success:
Post Acute Chronic
Intrapancreatic
Chronic
Extrapancreatic
Treatment Modality 28 patients 20 patients 25 patients
Surgical 2 of 2 1 of 1 9 of 9
Percutaneous 4 of 9 2 of 2 1 of 5
Endoscopic 5 of 13 13 of 16 5 of 9
Conservative 4 of 4 1 of 1 2 of 2
Mean stay was 17.6 days (186). There was one death. Median follow up
was 3 months (052).
Conclusion. The proposed classification provides a useful guide in treat-
ment selection of pancreatic fluid collections. Where feasible endoscopic
treatment can be recommended as first line treatment for PFC in chronic
pancreatitis
P46.11
PANCREATIC TUBERCULOSIS MIMICKING METASTATIC PAN-
CREATIC CARCER: CASE REPORT
Sassatani, Alexandre S; Azevedo, Inah CC; Pereira, Fernando L; Vasques,
fernando T; Moricz, Andre; Silva, Rodrigo A; Pacheco Jr, Adhemar M
Santa Casa School of Medicine, Surgery, Sa˜o Paulo, Brazil
Introduction. Tuberculosis (TB) is an important problem of public health
in developing countries, this incidence has increased in immunosuppressed
individuals in developed countries. Approximately 5% of the patients with
tuberculosis can present abdominal manifestations, however pancreatic
involvement is extremely rare. We present case of pancreatic tuberculosis
that initially presented radiological diagnosis of pancreatic carcinoma with
hepatic metastasis.
Case report. A 41 years-old Brazilian male was admitted to the emergency
department for upper gastrointestinal bleeding. It was made a CT scan and
showed up a solid lesion in the body and tail of the pancreas adjacent to the
splenic hilum, multiples lesions on the liver, and no plane between the lesion
and the stomach. The appearances were consist with a carcinoma of pancreas
and hepatic metastasis. An ultrasound guided percutaneous needle aspiration
was performed, but was not diagnostic. A surgery was performed and
confirmed through biopsies granulomatous inflammatory. Patient responded
well to antituberculosis regimens.
Discussion. Gastrointestinal TB is commonly seen in the form of
tuberculous peritonitis or involvement of mesenteric lymph nodes. Involve-
ment of the liver, spleen, intestine, and bone marrow is usually seen in
association with miliary tuberculosis. Pancreatic involvement is extremely
rare worldwide. The usual clinical forms of pancreatic TB. Pancreatic TB
usually presents with anorexia, weight loss, fever, obstructive jaundice,
gastrointestinal bleeding and epigastric tumors. Abdominal USG and CT
findings suggested pancreatic carcinoma. The diagnostic of pancreatic TB is
important to treatment and prevent unnecessary laparotomy or pancreatic
resection.
P46.12
PANCREATIC TUBERCULOSIS MIMICKING PANCREATIC CYS-
TIC NEOPLASIA: A CASE-REPORT AND REVIEW OF THE
LITERATURE
Montagnini, Andre L; Costa Jr, Wilson L; Mendes, Gabriella O; Diniz,
Alessandro L; Coimbra, Felipe; Herman, Paulo; Machado, Marcel AC
Hospital do Caˆncer-FAP, Dept. of Abdominal Surgery, Sa˜o Paulo, Brazil
Background. Tuberculosis (TB) of the pancreas is an extremely rare
condition that has been increasingly reported in the recent literature. Most
of the times diagnosis is made after pancreatic tissue has been obtained via
biopsy or laparotomy.
Aim. The aim of this study is to discuss a rare condition through a case
report and to review the related literature.
Patients and methods. We report the case of a 38-year-old woman who had
a one-year history of upper abdominal and back pain, more intense in recent
days. She had a history of lymph node tuberculosis, treated two years before
with a six-month course of isoniazid, rifampin and pyrazinamida. Abdominal
CT: hypodense cystic lesion of 1, 6 cm in the body of the pancreas. Based on
a presumed diagnosis of a cystic neoplasia an exploratory laparotomy was
performed. We found a hard 2 cm body pancreatic mass, with retraction of
the corresponding mesocolon and enlarged peripancreatic lymph nodes. A
distal pancreatectomy with splenectomy was performed. The post operative
period was uneventfully. Pathologic findings were granulomatous inflamma-
tion and caseous necrosis.
Discussion. This case illustrates an example of pancreatic TB. A recent
review in the literature showed 38 previous cases of the disease mimicking a
pancreatic mass, which is its most common presentation. A previous history
of TB can be observed in about 20% of the patients. Symptoms include
abdominal pain, weight loss, weakness, fever and obstructive jaundice.
Abdominal ultrasound, CT or MRI are the initial tests. When feasible, an
endoscopic ultrasound-guided biopsy or CT/ultrasound-guided percuta-
neous biopsy should be performed. However, in most cases, the diagnosis
is only obtained after surgery. The management of the pancreatic TB include
the medical treatment of the patient and the prevention of infectious spread.
Conclusion. Pancreatic TB is a very rare condition and it should be
suspected in young patients with a pancreatic cystic lesion, especially in the
ones with a previous history of tuberculosis.
P46.13
PANCREATIC TUBERCULOSIS: REPORT OF THREE CASES
Sozbilen, Murat1; Ozsan, Ismail1; Aydin, Unal1; Akyildiz, Murat2; Karaca,
Burcak3; Nart, Deniz4; Yilmaz, Funda4; Zeytunlu, Murat1; Goker, Erdem3;
Coker, Ahmet1
1Ege University Hospital, General Surgery, HPB workgroup, Izmir, Turkey;
2Ege University Hospital, Gastroenterology, Izmir, Turkey; 3Ege University
Hospital, Medy´cal Oncology, Izmir, Turkey; 4Ege University Hospital,
Pathology, Izmir, Turkey
Introduction. Tuberculosis may involve any part of Gastrointestinal Tract.
Pancreatic tuberculosis quite rare entity (04, 7%).
Methods. Three patients treated for pancreatic tubercuosis have been
evaluated retrospectively.
Results. Two patients were misdiagnosed first as a tumor and a third one
has associated with ampullary adenocarcinoma. All three pateints revealed
similar symptoms and findings, and abdominal CT scan showed pancreatic
solid mass. All cases diagnosed perioperatively by frozen section examination,
the last one associated with ampullary tumor. No further surgery has been
applied first two cases, but pylorus preserving pancreaticodudoenectomy
has been applied the last one. Anti-tuberculosis treatment has been
introduced. In cancer associated case not any anti-cancer treatment has
been applied
Conclusion. Pancreatic tuberculosis a rare lesion and should be mentioned
in especially endemic areas. Caseification necrosis during frozen section
examination is a pathognomonic finding.
P46.14
THE EFFICACY OF THE AORTIC OCCLUSION BALLOON
CATHETER DURING SURGICAL HEMOSTASIS
Narumoto, Soichi; Cho, Akihiro; Asano, Takehide; Yamamoto, Hiroshi;
Kainuma, Osamu; Mori, Mikito; Nagata, Matsuo; Ryu, Munemasa
Chiba Cancer Centre Hospital, Chiba, Japan
Background. In a haemodynamically unstable patient, uncontrolled intra-
abdominal hemorrhage is closely associated with high mortality. Although
immediate and accurate haemostasis is essential to save such patients, it is
often difficult to control the bleeding points during surgical haemostasis
because massive bleeding prevents a good surgical field. At Chiba cancer
center hospital, Aortic occlusion balloon catheter(AOBC) has been used to
control the massive bleeding.
Aim. The purpose of this study was to evaluate the efficacy and safety of the
AOBC during surgical hemostasis.
Methods. Between 1993 to 2005, AOBC was used in 7 patients (3 males and
4 females, mean age 67.1 years; range 60  C 77 years) for perioperative
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management only if the blood pressure (BP) responded insufficiently despite
rapid resuscitation due to massive intra-abdominal hemorrhage. Postopera-
tive hemorrhage occurred in 4 patients after pancreaticoduodenectomy and
in 2 after extrahepatic bile duct resection. Intraoperative hemorrhage
occurred in one case during laparoscopic left adrenectomy. A 8Fr balloon
catheter was introduced via right femoral artery into the supraceliac
descending aorta under fluoroscopy. The balloon was inflated for 20 minutes
with 5 minutes interval repeatedly until the hemostasis was obtained.
Results. The mean period of supraceliac aortic occlusion time was 30
minutes, range 20  C 40 minutes, except for one unknown case. One patient
suffered from renal insufficiency temporarily after operation. One could not
obtain haemostat and had dysuria. All patients became at least temporarily
stable hemodynamically with the blood pressure rising above 100 mmHg. In
6 of 7 patients, AOBC provided a better surgical field and bleeding was
successfully controlled. The remaining one patient died of uncontrolled
bleeding.
Conclusion. AOBC provides fast and effective bleeding control and is useful
for the management of massive intra-abdominal bleeding.
P46.15
PANCREATIC/PERIPANCREATIC TUBERCULOSIS MIMICKING
PANCREATIC MALIGNANCY
Polat, Yucel1; Ozden, Ilgin1; Bilge, Orhan1; Tekant, Yaman1; Acarli, Koray1;
Alper, Aydin1; Emre, Ali1; Demir, Kadir2; Poyanli, Arzu3; Ariogul, Orhan1
1Istanbul University, Istanbul Faculty of Medicine, General Surgery Hepa-
topancreatobiliary Surgery Unit, Istanbul, Turkey; 2Istanbul University,
Istanbul Faculty of Medicine, Gastroenterohepatology, Istanbul, Turkey;
3Istanbul University, Istanbul Faculty of Medicine, Radiology, Istanbul,
Turkey
Background. Pancreatic/peripancreatic tuberculosis is a very rare entity that
may mimic pancreatic malignancy.
Objective. To review our experience of pancreatic/peripancreatic tubercu-
losis in order to formulate a diagnostic and therapeutic approach.
Patients and methods. The charts of 11 patients treated for pancreatic/
peripancreatic tuberculosis between 1994 and 2005 were reviewed.
Results. Five patients were women and six were men; median (range) age
was 31 (1854). Ten patients had no history of tuberculosis and their chest
radiographs were unremarkable; one patient had received treatment for
pulmonary tuberculosis. The symptoms were abdominal pain (7/11),
jaundice (5/11), weight loss (3/11) and itching (2/11). Typically, a large
pancreatic head mass and multiple enlarged lymph nodes were demonstrated
by ultrasonography, computed tomography or magnetic resonance imaging.
The diagnosis was made by open biopsy in 10 patients and percutaneous
biopsy in one patient; caseous necrotizing granulomatous inflammation was
observed. Two patients were lost to follow up. Antituberculosis treatment
achieved complete resolution of the masses in 8 patients, one patient is still
receiving treatment. There has been no recurrence during a median (range) 6
(211) years of follow up.
Conclusions. Tuberculosis should be considered in the differential diagnosis
of pancreatic and peripancreatic masses, particularly in endemic regions. It
may occur in immunocompetent patients with no other site of involvement.
Performing a biopsy of inoperable lesions and exercising a reasonable
skepticism in the evaluation of operable lesions (attention to nonexclusive
but helpful clues, such as young patient age, history of tuberculosis, absence
of jaundice) will lead to the diagnosis. Close association with vascular
structures may mandate a diagnostic laparotomy in some patients. The
response to antituberculosis treatment is very satisfactory.
P46.16
PHOSPHATIDYLINOSITOL 3-KINASE FACILITATES BILE
ACID-INDUCED CA2 RESPONSES IN PANCREATIC ACINAR
CELLS
Fischer, Lars1; Gukovskaya, Anna2; Penninger, Josef3; Buechler, Markus
W.1; Friess, Helmut1; Gukovsky, Ilya2; Pandol, Stephen J.2
1University of Heidelberg, Dept. of Surgery, Heidelberg, Germany; 2UCLA,
Los Angeles, USA; 3Institute for Molecular Biotechnology, Vienna, Austria
Background. Bile acids induce Ca2/ responses in pancreatic acinar cells;
however, the underlying mechanisms are poorly understood. We recently
showed that phosphatidylinositol 3-kinase (PI3K), in particular its gamma
isoform, regulates changes in free cytosolic Ca2/ ([Ca2/]i) elicited in
pancreatic acinar cells by inhibition of the sarco/endoplasmic reticulum
Ca2/-ATPase (SERCA). Other investigators demonstrates that bile acids as
well are able to inhibit SERCA activity in pancreatic acinar cells.
Aims. The present study sought to determine whether PI3K regulates bile
acid-induced [Ca2/]i responses in pancreatic acinar cells.
Results. In isolated pancreatic acini, pharmacologic inhibition of PI3K with
LY294002 or wortmannin markedly inhibited [Ca2/]i responses induced by
taurolithocholic acid 3-sulfate (TLC-S) and taurochenodeoxycholate
(TCDC). Furthermore, genetic deletion of PI3K gamma isoform also
decreased [Ca2/]i responses to bile acids. Depletion of CCK-sensitive
intracellular Ca2/ pools or application of caffeine, a blocker of inositol 1, 4,
5-trisphosphate (IP3) receptor, inhibited bile acid-induced [Ca2/]i signals,
indicating that bile acids release Ca2/ from agonist-sensitive ER stores via
IP3-dependent mechanism. The PI3K inhibitors increased the amount of
Ca2/ releasable from the intracellular stores during exposure of acinar cells
to bile acids. This suggests that PI3K negatively regulates the SERCA-
dependent Ca2/ reloading into ER during bile acid stimulation. Further, in
permeabilized acinar cells bile acids inhibited Ca2/ reloading into the ER,
and this effect was augmented by phosphatidylinositol 3, 4, 5-trisphosphate
(PIP3), a major product of PI3K.
Conclusions. Our results indicate that both bile acids and PI3K act
synergistically to inhibit the SERCA-dependent Ca2/ reloading into the
ER. The findings have important implications for the mechanism of acute
pancreatitis since [Ca2/]i increases mediate key pathologic processes in this
disorder.
P46.17
SMALL CELL CANCER IN PANCREASE
Ha Guen, Kwang Soo, Hwon Kyum, LL; Ha Guen, Lee
Hanyang University Hospital, Surgical Dept., Seoul, South Korea
Background and aim. Small cell cancer commonly occurs in the lungs, but
rarely in other organs. Small cell cancer that occurs in the pancrease is rare
and progress is so fast, and most have spread by metastasis when discovered.
Although this cancer has poor prognosis, combing curative resection and
chemotherapy shows good prognosis, therefore reporting as index case.
Methods. A 62 year-old female patient with indigestion, jaundice, and
epigastric pain as her chief complaints since 20 days prior to her hospital visit,
showed no signs of symptom improvements as she was being treated for acute
pancreatitis and gastric ulcer at another hospital, therefore made a visit to our
hospital. Computed tomogram carried out and revealed mass like lesion at
the pancrease head portion, and the next bipsy carried out in ERCP
(endoscopic retrogradecholangiopancreatogram) showed suspicious of small
cell cancer, therefore PPPD (pylorus preserving pancreatoduodenectomy)
was performed.
Discussion. Although small cell cancer that occurs in the pancrease does not
show good prognosis, combining curative resection and chemotherapy allows
for improvement in the rate of survival.
P46.18
A NATURAL CYSTODUODENOSTOMY: SPONTANEOUS DUO-
DENOPANCREATIC FISTULA IN THE COURSE OF NECROTIZ-
ING PANCREATITIS
Emek, Ertan1; Ozden, Ilgin1; Emre, Ali1; Poyanli, Arzu2
1Istanbul Faculty of Medicine, General Surgery, Hepatopancreatobiliary
Surgery, Istanbul, Turkey; 2Istanbul Faculty of Medicine, Radiology Dept.,
Istanbul, Turkey
Background. A direct communication between the pancreatic lumen and
the duodenum is a very rare complication of necrotizing pancreatitis.
Objective. To discuss the results of treatment in duodenopancreatic fistula
in the course of necrotizing pancreatitis.
Patients and methods. The first patient, a 52-year-old man, underwent
cholecystectomy and necrosectomy on the 25th day after an attack of
necrotizing pancreatitis. An irrigation system was established. A direct
communication between the pancreatic lumen and the duodenum was
demonstrated by computed tomography (CT) on the 30thpostoperative
day, however, there was no oral contrast agent in the pancreas. The second
patient, a 78 year-old-woman, was referred with the diagnosis of sepsis of
unknown origin. CT showed dilation of the entire biliary tree and hepatic
abscesses; the pancreas was filled with necrotic material that contained gas
bubbles and oral contrast agent. A pancreatomy and necrosectomy were
performed. Drains were placed into the pancreas as well as in front of the
pancreatomy site. Hepatic abscesses in the right lobe were drained. Post-
operatively, duodenal fluid drained from the pancreatic drains. Both patients
were successfully treated by total parenteral nutrition (TPN), octreotide and
gradually removal of the drains. The first patient has been asymptomatic with
no findings of recurrent fistula during 18 months of follow up. The second
patient died of a myocardial infarction two days after discharge.
Conclusion. This initially alarming complication is actually a natural
cystoduodenostomy that can be managed conservatively by TPN, octreotide
and gradual removal of the intrapancreatic drains.
P46.19
MONOCYTE DERIVED ‘‘NEO-ISLETS’’ FROM NON HUMAN
PRIMATES PRODUCE AND SECRET INSULIN IN A GLUCOSE
DEPENDANT FASHION
Schulze, Maren1; Faendrich, Fred2
1Groote Schuur, UCT Capetown, General Surgery, Capetown, South Africa;
2University of Kiel, Kiel, Germany
Background. We previously showed that human peripheral blood mono-
cytes can be differentiated into insulin-producing neo-islets in vitro and
normalize blood glucose levels of diabetic mice.
Aims and objectives. For future clnical studies large animal models in an
autologous setting would be of greta interest to estimate required cell number,
apllication site and long trem in vivo function of neo-islets. We now produced
neo-islets with comparable in vitro function from non-human primates
(baboon) opening the pathway for preclinical large animal in vivo studies.
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Methods and results. Peripheral blood and spleen monocytes from baboons
were treated with human MCSF and IL-3 for six days in vitro to produce
programmable cells of monocytic origin (PCMO). Treatment was continued
with EGF, HGF, Nicotinamid and glucose to produce Neo-islet cells. In vitro
staining and glucose dependant insulin secretion as well as quantitative PCR
analzzsis showed comparable in vitro insulin production and secretion as in
human monocyte drived neo-islet cells. Non human primate cells responded
correctly to human growth factors.
Discussion and conclusion. These findings enable us to now proceed into
preclinical autologous non human primate in vivo studies in diabetic baboons
in order to estimate appropriate cell number, optimal injection site and long
term function of monocyte derived neo-islets for future clinical application.
Case Report Poster
CR1.01
AMPULLARY CARCINOID TUMOR: A CASE REPORT
Song, In-Sang; Shin, Dong-Sun
Chungnam Natiotnal University Hospital, Dept. of Surgery, Daejeon, South
Korea
Introduction. Ampullary carcinoid tumor is a rare lesion accounting for less
than 0.3% of all carcinoid tumors of the gasrointestinal tract. We experienced
a case of ampullary carcinoid tumor.
Method. A 70-year-old man was admitted to our hospital on January 2006
for RUQ pain with jaundice. He had recently presented the diabetes mellitus.
He underwent PPPD for ampullary carcinoid tumor.
Result: Liver function tests were abnormal with TB, 6.9 mg/dl; AST, 75U/L;
ALT, 50 U/L; Alkaline phosphatase, 536 U/L. Abdominal CT showed oval
shaped mass at ampulla of Vater with abrupt obstruction of distal end of
CBD and marked dilation of both intra- and extrahepatic duct. He under-
went a PTBD for a cholangiogram, which noted a filling defect with smooth
margin at the ampullary portion. At operation, a firm, greyish-pink, and fairly
well circumscribed tumor measuring 2.5 cm was found in the ampulla of
Vater. Histopathologically, the tumor with invasion to the muscular layers
consisted of cells with an eosinophillic cytoplasm and uniform, oval
hyperchromatic nuclei. Immunohistochemical stainging of the tumor was
positive for chromgranin, synaptophysin and NSE. He had an unremarkable
hospital course.
Conclusion. Carcinoids of the ampulla of Vater are very rare. Only 105 cases
are reported in the literature, most as single case reports. So, we report a case
of ampullary carcinoid tumor with a discussion based on the literature.
CR1.02
A CASE OF INTRALUMINAL CARCINOMA OF GALLBLADDER
WITHOUT INVASION OF THE GALLBLADDER WALL
Lee, Daesung
Sunlin, Pohang, South Korea
Background. Early gallbladder carcinomas are especially difficult to
diagnosis preopertively and to differentiate grossly from chronic cholecystitis,
and are often found incidentally on only pathologic section.
Objective. In general, the most common form is the infiltrative or combined
nodular-infiltrative form in gallbladder carcinoma. Because gallbladder
cancer tends to spread by direct extension into other organs through the
gallbladder wall.
Methods. We experienced a rare case of early gallbladder carcinoma which
fulfills the lumen with none invasion of the gallbladder wall and is completely
detached from the mucosa of gallbladder.
Results. A 66-year-old female was admitted to our hospital with a history of
dyspepsia and intermittent right upper quadrant pain from 7 days ago.
Ultrasound showed diffuse gallbladder wall-thickening, a intraluminal
gallbladder mass with an echogenic ball-like lesion. An intraluminal mass,
symmetric gallbladder wall thickening was seen in the computed tomography.
Tumor marker, such as carcinoembryonic antigen and CA19-9, were within
the normal limits. Liver function laboratory values included AST 18 IU/L,
ALT 16 IU/L, total bilirubin 0.6 mg/dL, and indirect bilirubin 0.1 mg/dL.
Discussion. We decided to do laparoscopic cholecystectomy not only for
diagnosis but also for treatment. We needed pathologic specimen for
diagnostic confirmation, because preoperatively our radiologic imagings
were ambiguous or indeterminated. In addition, if the diagnosis was early
gallbladder cancer or benign disease, there was a chance of the curative
treatment. We did laparoscopic cholecystectomy. Only diffuse thickening of
the gallbladder was seen during the operation.
Conclusion. A round shaped mass measuring about 4.5/3/2.2 cm and
almost filling the gallbladder lumen was seen. The mass was completely
detached from the gallbladder wall. Tumor cells were not detected in the
gallbladder wall, but in the intraluminal mass.
CR1.03
TRAUMATIC NEUROMA OF THE BILE DUCT-CASE REPORTS
HIGHLIGHTING A RARE CAUSE OF BILIARY OBSTRUCTION
Navina, Sarah1; Sielaff, Timothy2; Batts, Kenneth3
1University of Minnesota, Pathology, Minneapolis, USA; 2Virginia Piper
Cancer Institute, Dept. of Surgery, Minneapolis, USA; 3Virginia Piper
Cancer Institute, Pathology, Minneapolis, USA
Background. Benign post cholecystectomy strictures commonly result from
ischemia and are amenable to endoscopic therapy. Refractory strictures may
have other benign or malignant causes.
Aim. To describe the presentation and histopathology of post cholecystect-
omy strictures caused by traumatic neuroma.
Methods. Two elderly patients, 10 and 12 years post cholecystectomy
presented with jaundice. Focal malignant appearing common hepatic duct
strictures were found, both cytologically negative for malignancy. Treatment
included multiple stents and balloon dilations for 12 and 5 months. Because
of the refractory nature of the lesions, and concern for malignancy, resection
was undertaken.
Results. At operation sclerotic masses were identified. Radical bile duct
resections were performed. Histopathologic examinations each revealed a
traumatic neuroma as the stricture etiology.
Discussion. Traumatic neuromas are non-neoplastic, reactive neural pro-
liferations that can occur at any site in the body in response to prior injury. In
the biliary system, traumatic neuromas occur most commonly after chole-
cystectomy or liver transplantation, arising at the site of the prior bile duct
manipulation. While subclinical neuromas have been identified in 2530% of
explanted liver allografts and post-cholecystectomy stumps at autopsy,
symptomatic traumatic neuromas are rare. Symptomatic biliary traumatic
neuromas present with obstructive jaundice. The time to presentation is
variable. Preoperative diagnosis is not possible as the neural proliferation will
be inaccessible to endoscopic biopsy. Failure of dilation and stenting
protocols warrant surgical management and should raise the possibility of
traumatic neuroma
Conclusion. Traumatic neuroma is part of the differential diagnosis of
refractory post-operative bile duct strictures. If the lesion cannot be
differentiated from a neoplasm or is refractory to stenting, radical resection
of the extrahepatic bile duct is appropriate therapy.
CR1.04
NEOADJUVANT CHEMORADIOTHERAPY USING GEMCITA-
BINE PLUS SURGERY FOR LOCALLY ADVANCED GALLBLAD-
DER CANCER: REPORT OF 2 CASES IN STAGE III
Hyodo, Masanobu; Koizumi, Masaru; Sata, Naohiro; Yasuda, Yoshikazu;
Nagai, Hideo
Jichi Medical University, Surgery, Tochigi, Japan
Background. Advanced gallbladder cancer has been recognized as a
malignant disease with poor prognosis even after resection. Multidisciplinary
approaches are urgently needed.
Aim. Aiming at downstaging to augment the possibility of radical resection,
we introduced chemoradiotherapy(CRT) using gemcitabine followed by
surgery to 2 cases of locally advanced gallbladder cancer in Stage III.
Profiles. Patient 1, a 50 year-old male presented with obstructive jaundice.
Diagnostic imaging confirmed advanced gallbladder cancer associated with
anomalous arrangement of the pancreaticobiliary ducts as well as lymph node
swelling suggestive of metastasis (T2 N2 M0, Stage III). Patient 2, a 57 year-
old female had her gallbladder removed for gallstones. Histopathology proved
advanced cancer of the gallbladder involving the surgical margin of the cystic
duct. Diagnostic imaging did not reveal any findings of metastasis (T3 N0
Mo, Stage III).
Regimens. Gemcitabine (200 mg/m2) was administrated intravenously on
days 1, 8 and 15, while the gallbladder and its surrounding tissues were
irradiated concurrently with a total dose of 40 for 3 weeks. We performed
radical resection 4 weeks after the completion.
Results. Patient 1 responded to CRT with size reduction of 67% (PR). He
underwent extended cholecystectomy plus lymph node dissection (D2/a).
Histopathology showed invasive tubular carcinoma in the gallbladder with
very few effects of CRT. Adjacent lymph nodes had metastatic cancer nests,
viable in some parts and degenerative in others. He is alive without
recurrence for 1 year. Patient 2 underwent resection of the extrahepatic
bile duct plus lymph node dissection (D2). Pathological findings revealed no
cancer cells remaining in the specimen. She is alive without recurrence 6
months after relaparotomy.
Conclusion. Neoadjuvant CRT using gemcitabine plus surgery might be
worth a randomized investigation as promising strategy for locally advanced
gallbladder cancer.
CR1.05
MID BILE DUCT CANCER WITH PORTAL VEIN TUMOR
THROMBUS: A CASE REPORT
Shimoda, Mitsugi; Iso, Yukihiro; Furihata, Makoto; Kubota, Keiichi
Dokkyo medical University school of Medicine, Dept. of Surgery, Mibu,
Tochigi, Japan
A 78-year-old woman was suffering from jundice. Laboratory data showed
sever liver dysfunction with high serum levels of total bilirubine and high
CA19-9. Computed tomography showed a mass in the middle bile duct and
main portal vein. FDG PET scan and 3D imaging showed a hot spot in the
same position of CT. Under a diagnosis of middle bile duct cancer with portal
vein thrombus, the patient underwent surgery, on lapalotomy, the main tumor
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was located in the middle of common bile duct and tumor thrombus, 2 cm in
diameter, was presented in the main portal vein. The patient underwent
pancreato-duodenectomy with thrombectomy. Histological examination
showed that this thrombus had same histological findngs with those of the
main bile duct cancer (poorly differentiated adenocarcer). Here we report a
first resected case of middle bile duct cancer with portal vein tumor thrombus.
CR1.06
A CASE OF 10-YEAR SURVIVAL AFTER HPD FOR HILAR BILE
DUCT CANCER WITH AORTOCAVAL LYMPH NODE INVASION
Jung, Dong-Hwan; Lee, Sung-Gyu; Lee, Young-Ju; Park, Kwang-Min; Park,
Kwang-Min; Hwang, Shin; Kim, Ki-Hun
Asan Medical Center, Seoul, Korea
Case: A 39-year-old female presented with complete obstruction of common
and right hepatic duct considered as Bismuth type IIIA, and tumor
encasement at right hepatic artery on angiography. With planning extended
right hepatectomy, right PV embolization was done. Preoperative ICG 15
minutes retention rate was 2.659 and total bilirubin level was 1.6 mg/dl prior
to operation. The para-aortic LN metastasis was suspected macroscopically
and was confirmed by frozen biopsy. LN dissection was performed from
hepatoduodenal ligament to the bifurcation level of common iliac artery. The
common hepatic and gastroduodenal artery was sacrificed due to tumor
involvement. Fortunately, left lobe was supplied by left hepatic artery
originating from left gastric artery. Suspicious of tumor encasement of the
main PV, we performed main PV resection and end-to-end anastomosis
between the main PV and left PV. Based on the preoperative imaging, the left
hepatic duct was divided at the point where segment 4 duct branches joined
the left hepatic duct. Segment 5, 6, 7, 8, 4a and caudate lobe were resected.
Pancreatoduodenectomy was done because of distal common bile duct and
duodenal involvement. The patient suffered from large amounts of ascites for
postoperative 2 weeks and subsided with conservative management. She is
presently healthy at 10 years 6 months after surgery, without recurrence.
Conclusion. Although there is aortocaval LN involvement, vascular encase-
ment, and duodenal invasion in HBDC, it may be possible to improve patient
survival via aggressive surgical resection.
CR1.07
A CASE OF EOSINOPHILIC PSEUDOTUMOR OF BILE DUCT
MIMIKING BILE DUCT CANCER
Lee, Min Ku; Choi, Yoo Shin
Eulji University Hospital, Dept. of Surgery, Daejeon, South Korea
Inflammatory pseudotumor is infrequent lesion characterized by localized
mass composed of benign proliferation of inflammatory cells with varying
amount of fibrosis. As a type of inflammatory pseudotumor, eosinophilic
cholangitis or eosinophilic psuedotumor is extremely rare and characterized
by eosinophilic cholecystitis and associated extrahepatic biliary obstruction.
We report a case of eosinophilic pseudotumor of bile duct. A 37-year old
man referred for evaluation of jaundice. In cholangiography and CT
scan, intrahepatic duct dilatation and common hepatic duct obstruction
were detected, so common hepatic duct cancer was suspected. After
percutaneous bililary drainage, he underwent operation of bile duct resection
and hepaticojejunostomy. Final pathologic finding was cholecystitis with
eosinophil and wall thickening of bile duct with eosionphil infiltration and
fibrosis, compatible with eosinophilic pseudotumor. The patient subsequently
had unremarkable postoperative course and was discharged with normal liver
function.
CR1.08
TWO CASES OF RECURRENT BILIARY TRACT CANCERS,
USING GEMCITABINE FOLLOWING POST OPERATIVE PRO-
CEDURE
Nakadaira, Keiko1; Kurosaki, Isao2; Ueki, Hidenori1
1Kameda Daiiti Hospital, Dept. of Surgery, Niigata, Japan; 2Niigata
University, Dept. of Surgery, Niigata, Japan
Background. It is difficult to manage the cancer recurrence, particularly in
biliary tract cancers. Patients with progressive metastatic diseases have
shorter survival periods.
Objectives. Two cases of recurrent biliary cancers are reported, who were
treated with gemcitabine after surgical methods for the recurrent lesions.
Results. The first patient was a 67-years-old woman who had a radical
operation for a cancer of the papilla of Vater with multiple lymph nodes
metastasis in October 2003. She had another operation, left hepatectomy, for
a solitary metastatic liver tumor in March 2004. She received chemotherapy
with gemcitabine biweekly for 14 months postoperatively. Her recurrence-
free survival period is now about two years after hepatectomy. The second
case is a 67-years-old woman who was operated for an advanced gallbladder
cancer in February 2001. Because of the elevation of CEA, she was examined
with the thoracic CT to reveal multiple metastatic tumors of the bilateral lung
in April 2004. Palliative resections of the tumors were performed. She started
chemotherapy using gemcitabine with S-1 postoperatively. She has continued
to receive the therapy for 20 months after the second operation with a good
result.
Conclusion. Gemcitabine is considered to be effective to cope with the
recurrence of biliary cancers after surgical treatments.
CR2.01
A CASE OF EXTENDED SURGERY FOR ADVANCED GALL-
BLADDER CANCER
Kaneko, Tetsuya; Tokoro, Takamasa; Okada, Nao; Kagawa, Tadashi
Tokai Central Hospital, Surgery, Kagamigahara, Japan
Patient was 56-year-old woman. She admitted our hospital for abdominal
pain. On CT scan, a large gallbladder tumor which infiltrated to the liver was
found. The size was 10 cm. The tumor invaded to segment 4, 5, 6, 8 of the
liver. Lymph nodes along the hepatoduodenal ligament were swollen. The
tumor invaded to the duodenum and transverse colon. But, the common bile
duct and common hepatic duct was not invaded. Percutaneous transhepatic
portal vein embolization was performed and the right portal vein was
embolized 4 weeks before operation. Preoperative serum CA 19-9 was
70718 IU/ml. She underwent right hepatic trisectionectomy/
pancreaticoduodenectomy/transeverse colectomy. The pancreatic duct was
not anastomosed and external drainage was done. Postoperative complication
was right subphrenic abscess and treated by percutaneous drainage. The
pancreatic duct was anastomosed to the jejunum 3 months after resection.
Serum CA 19-9 decreased to 100 IU/ml after resection. Pathological findings
were moderately differentiated adenocarcinoma of the gallbladder. Lymph
node metastasis was negative. She has been doing well without recurrence 6
months after surgery. We reported here the advanced gallbladder cancer,
which was resected by extended surgery.
CR2.02
A CASE OF PRIMARY SURGICAL RECONSTRUCTION OF DOU-
BLE IATROGENIC INJURY OF THE COMMON BILE DUCT
Pejovic, Tomislav
Z.C. Gornji Milanovac, General Surgery, Gornji Milanovac, Serbia and
Montenegro
The aim of this study was to perform successful early repair iatrogenic
injuries (double lesion) on the common bile duct in the young women while
undergoing a routine open cholecystectomy. Cholecystectomy is most
frequently performed abdominal operation and the most serious complica-
tion associated with this procedure is accidental injury to the common bile
duct (0.160.4%). Common bile duct injury has potential catastrophic
implications if unrecognized or inadecvately managed at the time of initial
surgical intervention. N.Z., 36 year old women, admitted in our hospital with
symptomatic cholelithiasis. Injury of the biliary tree diagnosed at the time of
cholecystectomy. This bile duct injury is due to misidentification of the
biliary tract anatomy. The levels of the injury was Bismuth Type I (a complete
transection) and Bismuth Type II (lateral injury-partial laceration) referral to
Bismuth classification. In this case we decided to do primary reconstruction
the common bile duct injury. We did end-to-end anastomosis over a T-tube
on the transection place and choledochorrhaphy on the place with lateral
common bile duct lesion, the use of a single layer of interrupted sutures. The
patient remains symptom free with normal clinical, laboratory data and NMR
CP more then 5 years.
Conclusion. We suggested that intraoperative injures of extrahepatic bile
duct should be reconstructed immediately including repair of end to end
anastomosis of the injuries of bile duct.
CR2.03
A CASE OF RARE EXTRAHEPATIC BILE DUCT ANOMALY
Kim, Kee-Hwan1; An, Chang-Hyeok1; Kim, Jeong-Soo1; Lim, Keun-Woo1;
Lee, Keun-Ho2; Park, Il-Young3; You, Young-kyung4
1Uijeongbu St. Mary’s Hospital, College of Medicine, The Catholic
University of Korea, Surgery, Uijeongbu, South Korea; 2Our Lady of Mercy
Hospital, Surgery, Bupyeng, South Korea; 3Holy Family Hospital, Surgery,
Bucheon, South Korea; 4Daejeon St. Mary’s Hospital, Surgery, Daejeon,
South Korea
The frequency of anatomical variation of the bile duct system is relatively
common. The constitution of a normal biliary confluence by union of the
right and left hepatic duct is reported only 57percent(Couinaud 1957) to
72percent(Healy and Shroy 1953) of cases. Although an aberrant hepatic
duct entering the cystic duct is not especially rare, the main right hepatic duct
entering the cystic duct is extremely rare. A 69-year-old woman developed
moderate intermittent right upper quadrant pain for five months. A diagnosis
of multiple left intrahepatic duct stones was made by radiographic examina-
tions. Abdominal CT scan demonstrated dilatation of the left hepatic duct,
but could not identify the junction of the right hepatic duct and the cystic
duct. We find out the extrahepatic bile duct anomaly during the operation.
Intraoperative table cholangiography established that the right side hepatic
duct forms a confluence with the cystic duct, subsequently draining into the
common bile duct through a narrow segment. As the right hepatic duct
entering the cystic duct can lead to ductal injury, this anomaly should be kept
in mind when performing cholecystectomy. Especially, in laparoscopic
cholecystectomy. Pre- and intraoperative cholangiography contribute to the
avoidance of iatrogenic bile duct injury. When the right hepatic duct drains
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into the cystic duct, the gallbladder should be removed distal to the junction
of the hepatic and cystic ducts.
CR2.04
CASE REPORT: SUCCESSFUL THROMBOLYSIS FOR PORTAL
VENOUS THROMBOSIS OF THE POST-HEPATECTOMY PA-
TIENT
Nakamura, Takayuki1; Kitamura, Tosuke1; Nakajima, Masanobu1; Hoka-
mura, Nobukazu1; Haga, Norihiro1; Kawano, Noriaki1; Horikoshi, Hir-
oyuki2; Okayama, Aya2; Sawada, Toshio1
1Gunma Prefectural Cancer Center, Surgical Oncology, Ota, Japan; 2Gunma
Prefectural Cancer Center, Radiology, Ota, Japan
Introduction. Post-operative portal venous thrombosis is one of the serious
complications in the hepato-biliary surgery. It causes hepatic failure and high
mortality without appropriate treatment. We report one successful case of
thrombolytic therapy for the post-operative portal venous thrombosis in the
major hepatectomy patient.
Report of a case. 62-year old male was referred to Gunma Prefectural
Cancer Center because of obstructive jaundice. Imaging studies revealed the
hilar cancer (Klatzskin tumor) that involved left portal vein from the portal
bifurcation. He had the left hepatectomy with segmental resection of portal
vein that was reconstructed end-to-end anastomosis. On the next day (the
post-operative day 1st), routine bedside ultrasonography detected poor portal
blood flow. CT scan showed portal venous thrombosis. Emergency lapar-
otomy was done. The intravascular catheter was inserted through the
peripheral ileal vein to portal vein. Urokinase 200,000 units was administered
through the catheter to thrombus, which was dissolved. Urokinase was
continued with that indwelling catheter to the portal vein and systemic
heparinization was done. The thrombolytic therapy was discontinued on the
post-operative day 6th of the initial thrombolysis because of the catheter
related infection. Unfractionated heparin was also tapered. He was dis-
charged home on the post-operative day 28th of his hepatectomy without any
recurrence of the vascular problem.
Comment. Routine bedside ultrasonography is essential for early detection
of vascular problem after major hepato-biliary surgery. Early thrombolysis
with urokinase by portal vein catheterization is effective remedy for post-
operative portal venous thrombosis.
CR2.05
INTRALUMINAL GALLBLADDER HEMATOMA MIMICKING
GALLBLADDER TUMOR. A CASE REPORT
Papapolychroniadis, Costas; Kaimakis, Dimitrios; Harlaftis, Nikolaos
Aristotle Universtiy of Thessaloniki, 1st Propedeutical Surgical Dept.,
Thessaloniki, Greece
Background. Intraluminal or intramural gallbladder hematoma are rare
clinical conditions which mimicking neoplasms. We report this case because
the preoperative investigations and imaging radiological tests it is difficult to
reveal the correct diagnosis.
Materials and methods. A 72-year-old male was presented with sudden
onset of right upper quadrant pain, with no history of abdominal trauma. The
abdomen was soft with mild tenderness of the right upper quadrant and a
positive murphy’s sing. Abdominal sonography, computed tomography and
endoscopic retrograde cholangiopancreatography, all revealed the presence of
a mass lesion in the gallbladder. The several tumor markers tests were normal
but a gallbladder tumor was the most possible diagnosis. After the preoperative
respiratory and cardiovascular investigation and preparation an open chole-
cystectomy was performed and intraluminal old hematoma was found.
Results. Postoperatively the patient was transferred to the Intensive Care
Unit for the first 24 hours. He was discharged on 7th postoperative day
without any complications. Hiistological findings were negative for gallblad-
der carcinoma.
Discussion-conclusion. Intraluminal gallbladder hematoma is an uncom-
mon entity with very few reports in the literature. In most cases the cause of
hematoma is unknown. In our patient possibly the anti-coagulation therapy
by warfarin, because of a previous cardiac valvular surgical procedure,
contributed to this rare condition. In most cases the diagnosis is intraopera-
tive as in our patient.
CR2.06
DELAYED REPAIR OF A BILE DUCT INJURY AFTER LAPARO-
SCOPIC CHOLECYSTECTOMY. A CASE REPORT
Papadopoulos, Vasileios1; Apostolidis, Stylianos2; Michalopoulos, Antonios2;
Paramythiotis, Daniel2; Papavramidis, Theodosis2; Netta, Smaro2; Harlaftis,
Nikolaos2
1Aristotle’s University of Thessaloniki, Surgical Dept., Thessaloniki, Greece;
2AHEPA Hospital, Aristotle’s University of Thessaloniki, Thessaloniki,
Greece
Background. Over the last decade, laparoscopic cholecystectomy has gained
worldwide acceptance and is considered as ‘‘gold standard’’ in the surgical
management of symptomatic cholecystolithiasis. However, the incidence of
bile duct injury in laparoscopic cholecystectomy is still two times greater
compared to classic open surgery.
Case. In March 2003, a 43-year-old female presented in a rural hospital with
signs and symptoms of cholelithiasis. The patient underwent laparoscopic
cholecystectomy. Ten days postoperatively she complained for abdominal
pain at the right upper quantrum and she was investigated by E.R.C.P. which
revealed an injury of common bile duct and choleperitoneum. A rhinocho-
ledochal tube was placed. The catheter gave 600 to 1000 ml of bile the first
two days and after that the patient was transferred to our institution for
further treatment. A deficit of common bile duct was revealed at the
operation and the tube was found to drain the bile from the peritoneal
cavity. The deficit was 2 to 3 cm long and the patient underwent a
choledocho-jejunal anastomosis (Roux en Y). The patient was released
from the hospital 8 days later with an uneventful postoperative course and
follow up.
Conclusion. Although relatively infrequent, there are major complications of
laparoscopic cholecystectomy because of the serious resulting morbidity and
mortality. Surgery provides the mainstay of treatment, with proximal
hepaticojejunostomy Roux en Y being the operation of choice; a selective
role for endoscopic or radiological treatment exists but it must be
individualised.
CR3.01
LONG-TERM PROGNOSIS OF TWO CASES WITH POST-TRAU-
MATIC BILIARY STENOSIS TREATED WITH EXPANDABLE
METALLIC STENT (EMS)
Soga, Yukihiro; Nakagawa, Takao
Tokyo Women’s Medical University Medical Center East, Emergency
Medicine, Tokyo, Japan
Introduction. Two patients that have presented good long-term prognosis
after the treatment of posttraumatic extrahepatic biliary stenosis with
expandable metallic stent (EMS) are reported.
Case report. Case 1. Case 1 is a 52-year-old male who received
transpapillary biliary stenting (TBS) 10 months after operation for multiple
traumas (bilateral hemopneumothorax, flail chest, severe hepatic injury
treated with right hepatic lobe resection, and bilateral humeral open
fractures). After TBS, the patient has followed a good clinical course for 5
years and 8 months.
Case 2. Case 2 is a 55-year-old male who received percutaneous trans-
hepatic biliary stenting (PBS) 4 months after operation for blunt trauma to
abdomen (traumatic gastric rupture and pancreatic damage treated with
subtotal gastric resection with B-II reconstruction and pancreatic head
suture). After PBS, the patient has followed a good clinical course for 5
years and 4 months.
Discussion and conclusion. The safety of long-term implantation of EMS
has not been established, and reports on the results of benign diseases treated
with EMS have been limited. However, EMS was a low-invasive, safe
procedure without complication for approximately six years in our two cases.
These results suggest that EMS may be useful for treating posttraumatic
biliary stenosis.
CR3.02
SUCCESSFUL ENDOSCOPIC MANAGEMENT OF A BRONCHO-
BILIARY FISTULA: A CASE REPORT
Johnson, Nick A; Mann, Christopher D; Neal, Chris P; Pattenden, Clare J;
Metcalfe, Matthew S; Berry, David P; Dennison, Ashley R
Leicester General Hospital, Dept. of Surgery, Leicester, UK
A 79-year-old man was admitted with a 5-week history of cough productive of
copious amounts of foul smelling green/brown sputum. He complained of no
other symptoms. This had failed to improve with oral antibiotic treatment.
Past medical history was unremarkable except for an attack of acute
pancreatitis 2 years previously. He was a non-smoker and consumed only
small amounts of alcohol. On examination the patient was pyrexial at 38.58C,
tachycardic at 110 bpm with oxygen saturations of 95%. Examination of his
respiratory system demonstrated reduced air entry and dullness to percussion
of the right lung base. Abdominal examination was unremarkable. Blood tests
on admission revealed a leucocytosis, but were otherwise normal. Chest x-ray
showed a right-sided pleural effusion with an area of consolidation above.
Initial impression was pneumonia and the patient was treated with appro-
priate antibiotics. His condition failed to improve and the colour of the
sputum raised concerns about its origin. Analysis of sputum demonstrated
the presence of bilirubin. Upon this finding a bronchobiliary fistula
was suspected. An MRCP showed a 10/5 cm multi-loculated right sub-
phrenic collection and a small right-sided pleural effusion. It also revealed
gallbladder calculi, but did not demonstrate any dilated ducts or fistula.
ERCP showed no hepatic duct dilation or obstruction. Leakage of contrast
was noted from ducts in segment 8 superiorly towards the sub-phrenic
collection. A biliary stent was inserted to improve biliary drainage. The
bilioptysis did not settle, therefore a laparoscopy was performed which
confirmed the sub-phrenic collection and this was drained laparoscopically.
Microbiological analysis of the fluid obtained demonstrated no growth. Over
the subsequent weeks, the bilioptysis significantly reduced and the patient
was discharged after 8 weeks.
Conclusion Bronchobiliary fistulae are rare. We present a case highlighting
successful endoscopic management of this condition by drainage of the
abscess cavity.
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CR3.03
PORTAL BILIOPATHY IN A CIRRHOTIC PATIENT: SUCCESS-
FUL SURGERY WITHOUT PORTAL DECOMPRESSION
Shah, Sudeep; Desai, Chirag; Desai, Devendra
PD Hinduja Hospital, Mumbai, India
Background. Portal biliopathy is a rare cause of obstructive jaundice in
patients with portal hypertension. This usually occurs in patients with non-
cirrhotic livers and portal vein thrombosis. Usually shunt surgery preceeds
biliary decompression to avoid excessive bleeding. We report a case with
cirrhosis and biliopathy who was successfully treated with a biliary bypass
without shunt surgery.
Case report. A 21 year old presented with obstructive jaundice with a past
history of variceal bleeding controlled with endoscopic sclerotherapy.
Hepatitis B antigen was positive. MRCP confirmed a mid CBD biliary
stricture that was treated initially with biliary stenting. Cytology was negative.
Doppler USG showed multiple collaterals around the CBD with hepatopetal
flow, but a patent portal vein. Liver biopsy confirmed cirrhois. His liver
function normalised with the stent. He had 3 stent changes over a year
following which he was referred for surgery due to good synthetic liver
function and development of small stones above the stent. A hepatichodo-
chojejunostomy was constructed. Cholangioscopy showed no intrabiliary
tumour. A Pringle manouvre was used to reduce bleeding from the duct. He
is well over a follow up of 2 years.
Conclusions. Portal biliopathy, though rare, may occur in the cirrhotic
patient and can be safely treated surgically without prior portal decompres-
sion.
CR3.04
A RARE COMPLICATION OF A MIGRATED BILIARY METALLIC
STENT: VERTICAL ROTATION AND IMPACTION WITHIN THE
COMMON BILE DUCT
Archontovasilis, Fotis1; Lagoudiannakis, Emmanuel1; Romanos, Andreas2;
Albanopoulos, Konstantinos1; Leandros, Emmanuel1; Bramis, John1
1Hipokration General Hospital, First Dept. of Propedeutic Surgery, Athens,
Greece; 2Hipokration General Hospital, Surgical Endoscopy Dept., Athens,
Greece
Background. Biliary stent placement is an established procedure for the
treatment of biliary obstruction due to malignant disease.
Case report. We report a case of a 56 year old man presenting to our
department due to recurrence of a previously treated obstructive jaundice.
He had been subjected to endoscopic stenting of the common bile duct one
month ago for palliation of a metastatic pancreatic tumor. At that session, a
self expandable metallic stent was placed for the treatment of the stricture of
the intrapancreatic portion of the choledochal duct. Repetition of endoscopic
retrograde cholangiography showed distal migration of the stent. Surpris-
ingly, the stent had been impacted in a vertical position to the choledochal
duct axis. No attempt was carried out for removal of the stent. Instead, a
plastic stent was placed through the metallic stent’s openings for biliary
drainage. The patient returned to the ward, discharged the same day and died
four months later from the metastatic disease. During this time no
complications were noted from the presence of the malpositioned metallic
stent.
Discussion. Metallic stents are not designed to be extracted. However, their
removal has been reported in selected cases. In our case the vertical
impaction of the stent to the choledocal duct axis precluded any attempt to
reposition or remove the stent. Consequently, we felt that the placement of
the plastic stent was an effective intervention for the treatment of this unusual
complication.
CR3.05
ADENOCARCINOMA OF THE AMPULLA OF VATER WITH
CONCURRENT PANCREATIC INTRADUCTAL NEOPLASIA
AND ISLE CELL TUMOR
Park, Eun H; Kwak, Jin H; Choi, Kun M; Han, Myoung S; Jang, Hyuk J
Gangneung Asan Hospital/ University of Ulsan, Surgery, Gangneung, Korea
We reported a case of ampullary adenocarcinoma with concurrent pancreatic
intraductal neoplasia (PanIN) and islet tumor. A 51-year old female was
admitted to our hospital with jaundice and RUQ pain. Abdominal computed
tomography and ERCP revealed the mass in the ampulla of Vater and
dilatation of the pancreatic duct. The preoperative diagnosis was the tumor of
the ampulla of Vater. The tumor, which was measured about 2.5/2 cm,
arouse from the Ampulla of Vater and distal CBD. Pancreatoduodenectomy
was performed. The examination of the surgical specimen resulted in
papillary adenocarcinoma in the ampulla of Vater and distal CBD, intraductal
papillary neoplasia of the pancreas (high grade) in the main & secondary
pancreatic ducts, and incidental discovery of the endocrine tumor, mesuring
5 mm in diameter and located immediately at the pancreatic duct. The tumor
was well differentiated and lymphatic invasion was not present. Immunohis-
tochemical studies showed that endocrine tumor cells expressed chromo-
granin and synaptohysin. Adenoma and adenocarcinoma of the ampulla of
Vater, and are uncommon neoplasms of the GI tract. PanIN is a recently
proposed nomenclature for precursor lesions of pancreatic cancer. Only two
reports has analyzed the relationship between ampullary adenocarcinoma and
pancreatic intraductal neoplasia (PanIN), the precursor lesion of pancreatic
adenocarcinoma. We reported a case of ampullary adenocarcinoma with
concurrent PanIN.
CR4.01
A RARE CASE OF ADULT LEFT SIDED DIAPHRAGMATIC
EVENTRATION WITH RECURRENT COLONIC VOLVULUS
O’ Connell, Claire; Sheth, Hemant; Patel, Bijen
Royal London Hospitals NHS Trust, Dept. of Surgery, London, UK
Extreme elevation of whole or part of the diaphragm, which is usually
atrophic and abnormally thin is defined as eventration of the diaphragm.
Diaphragmmatic eventration usually presents in childhood and is associated
with gastric volvulus.
Patients & methods. We present a case of a 52 year-old lady who presented
with recurrent episodes of bowel obstruction secondary to volvulus of the
colon and a large incisional hernia. Preoperative Chest X-ray & CT scan
suggested a large diaphragmatic hernia with possible large bowel in the left
hemithorax and complete collapse of the left lung. At laparotomy she was
found to have eventration of the left hemidiaphragm with the stomach and
spleen in normal anatomical position. The splenic flexure and left hemicolon
were in the left hemithorax with evidence of dilatation and incomplete
volvulus. She underwent a left hemicolectomy, a extraperitoneal ProceedTM
mesh reconstruction of the left hemidiaphragm and repair of the incisional
ventral hernia.
Results. Post operatively there was normalization of the position of the left
hemidiaphragm on chest xray and uneventful postoperative recovery.
Complete eventration of left hemidiaphragm is rare and adult presentation
with stomach and spleen in normal anatomical position with recurrent
colonic volvulus and obstruction has not been reported before.
Conclusion. Surgical correction should be performed promptly for sympto-
matic patients and is associated with a good postoperative outcome.
CR4.02
GASTRIC BODY PARTITION TO AVOID ULCEROGENIC RISK
AND HYPERGASTRINEMIA
Shyr, Yi-Ming
Taipei Veterans General Hospital, Surgery, Taipei, Taiwan
Background. We hypothesized that partitioning of the gastric body instead
of antrum would prevent hypergastrinemia and minimize ulcerogenic risk.
Aims. This study would to testify if partitioning of the gastric body instead of
antrum would prevent hypergastrinemia and minimize ulcerogenic risk.
Methods. We studied (a) gastric body partition in six critically-ill patients,
with giant perforated peptic ulcers, and (b) the influence of gastric partition
on serum gastrin in 18 dogs with gastric body partition/gastrojejunosotmy
(study), or antral partition/gastrojejunosotmy, or gastrotomy.
Results. No patient had major postoperative complications. Only one patient
developed recurrent peptic ulcer. Serum gastrin levels were normal in all
patients 1 month after gastric body partition. Two of the patients even did not
show any abnormal elevation of serum gastrin during each postoperative
follow-up for 2 year. In animal study, both the serum gastrin levels and the
numbers of gastrin-secreting cells (G-cells) in the excluded antrum and acid-
secreting parietal cells in the gastric body increased on the day 60 or death
after antral partition, as compared with preoperative data in the same group.
These observations did not occur in the gastric body partition group and
gastrotomy group. The postoperative serum gastrin levels, numbers of G-
cells, and parietal cells were also significantly higher in the antral partition
group than other two groups. No ulcer was found in any dog of gastric body
partition and gastrostomy groups, but 4 dogs in antral partition group died of
ulcer perforation.
Conclusion. The gastric body partition and gastrojejunostomy is a simple,
dependable procedure which does not require expertise and can be performed
in a very short time even by a trainee general surgeon in emergency.
CR4.03
HETEROTOPIC GREATER OMENTUM OSSIFICATION FOL-
LOWING TOTAL GASTRECTOMY FOR A WATERMELON STO-
MACH VARIANT. REPORT OF A RARE CASE
Archontovasilis, Fotis1; Vlachos, Konstantinos2; Tsekouras, Dimitrios1;
Karameris, Andreas3; Vilias, Konstantinos2; Zaravinos, Spyros2
1Hipokration General Hospital, First Dept. of Propedeutic Surgery, Athens,
Greece; 2401 Army Hospital, First Surgical Dept., Athens, Greece; 3NI-
MITS Army Hospital, Histopathology Dept., Athens, Greece
Background. Intraabdominal heterotopic ossification is a very uncommon
disorder. In addition, watermelon stomach or gastric antral vascular ectasia
(Gave disease) with its variants is a very rare source of upper GI bleeding.
Case report. We report on a case of a unique finding of an extraskeletal
osseous lesion of the greater omentum on a 42-yr-old man with comorbid
heart disease, following two laparotomies for severe upper GI bleeding. The
final operation was a total gastrectomy and the pathology examination
revealed a variant of watermelon stomach or GAVE disease with ectatic
lesions occurred in all regions of the stomach.
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CR4.04
SUPERIOR MESENTRIC ARTERY SYNDROME-MANAGEMENT
OF 2 CASES
Rajasekar, Arthanari
Sri Gokulam Hospital, Surgical Gastroenterology, Salem, India
Background. Superior mesenteric artery syndrome (SMAS) is an uncom-
mon cause of high intestinal obstruction most frequently occurring in
patients who have had rapid weight loss. Identification of this syndrome
can be a diagnostic dilemma and is often made by exclusion. We present here
the management of the two cases, we have encountered.
Case 1. A 23 years old female weighting 30 kg presented with 5 days history
of progressive abdominal distension, vomiting and fever. She gave a history of
significant weight loss following delivery of a healthy baby seven months
back. On admission she was pyrexial, tachycardic and had a grossly distended
stomach. The stomach was decompressed by aspirating 3 litres of bile stained
fluid. A thin barium meal examination revealed grossly distended stomach
and duodenal loops. Delayed film showed hold up at the third part of the
duodenum. Laparotomy, side-to-side duodenojejunostomy and a feeding
jejunostomy were performed. The stoma started functioning only after 6
weeks.
Case 2. A 48 years old female weighting 32 kg presented with 5 months
history of vomiting and weight loss. Ultrasonography and contrast study were
suggestive of obstruction at the third part of the duodenum. Laparotomy
side-to-side duodenojejunostomy and a feeding jejunostomy were performed.
As she was having high gastric aspirate for more than 2 weeks, Percutaneous
Endoscopic Gastrostomy was done. Initially the PEG aspirate was mixed
with jejunostomy feeding. Gradually after 6 months the PEG output
decreased and she was started on oral feeding. After 7 months PEG and
the jejunostomy were removed.
Discussion. Duodenojejunostomy or lysis of ligament of Treitz is the
surgical treatement of choice. Due to the gross distension of the atonic
stomach, the duodenojejunostomy may take a long time to function, until
then the patient had to be maintained on enteral feeding.
CR5.01
CYSTIC LIVER METASTASES FROM SQUAMOUS CELL CARCI-
NOMA OF OESOPHAGUS
Rajasekar, Arthanari1; Rasapan, Rajasekaran2
1Sri Gokulam Hospital, Surgical Gastroenterology, Salem, India; 2Sri
Gokulam Hospital, Dept. of Ultrasonography, Salem, India
Background. Cystic neoplasms of the liver may represent a diagnostic
challenge in every day practice. Cystic liver metastases are rarely reported. We
describe what we believe to be the first case of cystic metastases to the liver
from a squamous cell carcinoma of the oesophagus.
Case report. A 58 year old male patient presented with 5 weeks history of
progressive dysphagia for both solids and liquids. An upper Gastrointestinal
endoscopy revealed an eccentric stricture at the lower third of the
oesophagus. The endoscope could not be negotiated through the stricture.
After dilating the stricture using both balloon and rigid bougie the scope was
passed beyond the stricture. There was an oesophageal tumour occupying the
lower third of the oesophagus extending into the oesophagogastric junction.
Biopsy from the tumour confirmed poorly differentiated squamous cell
carcinoma. An ultrasound examination revealed Oesophagogastric mass and
two cystic lesions in segment III and IV of liver. Ultrasound guided aspiration
cytology of the liver cyst was done. The cytology revealed malignant cells with
features in favor of secondary deposit from squamous cell carcinoma. Self
exapanding oesophageal metal stent was inserted. On discharge patient was
able to swallow both liquids and solids.
Discussion. Cystic liver metastases are fortunately uncommon and may
exhibit Ultrasonography features like mural nodules, thick walls, fluid-fluid
levels and internal septations that will distinguish them from the
ubiquitous benign hapatic cyst. The patient report had a thick walled
liver cyst, which raised the possibility of cystic liver secondaries. We
conclude that incidental finding of a liver cyst in patients with primary
neoplasm arising from any organ, should be viewed with suspicion.
Aspiration cytology would be of great help in deciding the treatment
modality to be administered.
CR5.02
MULTIVISCERAL RESECTION FOR LOCALLY ADVANCED GAS-
TRIC LYMPHOMA WITH HEMATEMESIS & OBSTRUCTION
Bhalerao, Suryabhan; Rege, Aparna
K.E.M. Hospital & Research Centre, Dept. of Surgery, Pune, India
Background. Surgery is a necessary treatment independant of stage & grade
of lymphoma in bleeding & outlet obstruction of stomach.
Aims & objectives. To study the feasibility of multivisceral resection in
locally advanced gastric lymphoma.
Methods. A 60 yr male presented with hematemesis, severe anaemia &total
gastric obstruction. USG &CT revealed a large lobulated soft tissue mass in
distal stomach & involving left lobe liver & mesocolon without abdominal
lymphadenopathy. UGIscopy revealed polypoidal ulcerated mass in distal
stomach, biopsy was inconclusive. Diagnostic laparoscopy &later laparotomy
confirmed near total involvement of stomach with incontinuity spread to liver
& transverse mesocolon. Total gastrectomy, left hepatic & caudate lobe
resection with transverse colectomy was done. Reconstruction was done with
Roux-en y esophagojejunostomy. 5Fr tube was used as endobiliary stent in
CBD to minimise bile leak.
Result. Patient had uneventful postop recovery & was discharged on 10th
postop day. Histopathology revealed high grade NHL. Bone marrow did not
show involvement. HRCT did not reveal mediastinal lymphadenopathy. 6
cycles of CHOP chemotherapy were given 1 month later. At 1 yr postresec-
tion patient is disease free & has gained 7 kg weight.
Discussion. In evolution of treatment of gastrointestinal lymphoma, surgery
has a defenitive role in bleeding & obstruction. In high grade advanced stage
lymphoma surgery plays a role as an adjuvant therapy with chemotherapy for
better results.
Conclusion. In selected cases of locally advanced tumors multivisceral
resection is a viable option. Surgery ensures accurate pathologic diagnosis
through examination of resected specimen & chemotherapy related bleeding
& perforation.
CR5.03
A GASTROINTESTINAL STROMAL TUMOUR PRESENTING AS
ACUTE PANCREATITIS AND MASSIVE UPPER GI BLEED
Elwell, Vivian1; Sheth, Hemant2; Patel, Bijen2; Glazer, Geoffery2
1St, Mary’s hospital, Dept. of Surgery, London, UK; 2Royal London
Hospitals NHS Trust, Dept.. of Surgery, London, UK
Background. Acute abdomen with hyperamylasaemia secondary to acute
pancreatitis must be differentiated from other causes of severe abdominal
pain and hyperamylasaemia, i.e acute cholecystitis, perforated peptic ulcer,
ruptured abdominal aneurysm, and mesenteric infarction. We report a novel
case of infarction of a gastrointestinal stromal tumour (GIST) which
mimicked acute pancreatitis.
Patient & methods. A previously healthy 53 year old egyptian woman was
treated conservatively at her local hospital for acute pancreatitis when she
presented with severe abdominal pain and hyperamylasaemia(1300 somogyi
units). Three days later, she had a major gastrointestinal haemorrhage
requiring multiple blood transfusions (15 units in total). Upper gastrointest-
inal endoscopy showed ulceration and a possible lesion in the stomach and an
initial CT scan showed no evidence of pancreatitis. On referral to our hospital
her symptoms had improved. Ultrasound showed no evidence of acute or
chronic cholecystitis and no gallstones were present. (There was no history of
excess alcohol consumption). A repeat endoscopy at our hospital showed a
large tumour in the distal stomach. A CT scan revealed a large circular lesion
with rim enhancement and central attenuation suggestive of necrosis. The
pancreas was normal.
Result. At laparotomy, she was found to have a large tumour arising from the
posterior wall of the stomach occupying 50% of the circumference of the
stomach. There was no evidence of acute pancreatitis. She underwent a
partial gastrectomy with a Roux-en-Y gastrojejunostomy. Her postoperative
recovery was uneventful. Histological examination revealed a non malignant
GIST with areas of coagulative necrosis. In this case, infarction of a GIST
mimicked acute pancreatitis which has not been previously described.
Conclusion. This case illustrates that, while acute pancreatits is a serious
and frequently encountered clinical scenario, it still remains a diagnostic
challenge.
CR5.04
VIDEOSCOPIC ASSISTED RETROPERITONEAL DEBRIDE-
MENT (VARD) IN INFECTED NECROTISING PANCREATITIS.
DUTCH ACUTE PANCREATITIS STUDY GROUP
van Santvoort, Hjalmar C1; Besselink, Marc G1; Schijven, Marlies P1; van
Leeuwen, Maarten S2; Gooszen, Hein G1
1University Medical Center Utrecht, Surgery, Utrecht, Netherlands; 2Uni-
versity Medical Center Utrecht, Radiology, Utrecht, Netherlands
Background. Surgical intervention is warranted in case of secondary
infection of (peri-)pancreatic necrosis. The 20-centres of the Dutch Acute
Pancreatitis Study Group recently embarked on a randomised controlled trial
in which patients with (suspected) infected necrotising pancreatitis are
randomly allocated to A) maximal necrosectomy by laparotomy or B) CT-
guided percutaneous catheter drainage, if necessary, followed by videoscopic
assisted retroperitoneal debridement (VARD). In this presentation we
describe the technical aspects of VARD by means of a series of photographs
and a video.
Case. A 48 year old woman with acute necrotising pancreatitis was operated
upon 28 days after onset of symptoms. Indication for surgical intervention
was based on positive fine needle aspiration and progressive clinical
deterioration whilst admitted on the intensive care unit. A retroperitoneal
percutaneous catheter drain was positioned in the (peri-)pancreatic collec-
tion. A 5 cm incision was made in the left flank below the exit point of the
percutaneous drain. By using the percutaneous drain as a guidewire, the
collection was opened and the first necrosis encountered was carefully
removed with a long grasping forceps. A videoscope was inserted and the
cavity was cleaned of loosely adherent necrotic material under irrigation and
consequent suction. A total of 40 grams of (peri-)pancreatic necrosis was
removed.
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CR6.01
SURGICAL TREATMENT OF PANCREATIC PSEUDOCYSTS AND
PERIPANCREATIC FLUID COLLECTION: TWO CASE REPORTS
Eiji, Hayashi; Fumihiko, Yoneyama; Masahiko, Hasegawa; Ochiai, Hideto;
Nakazawa, Hideo; Ito, Yasushi; Watanabe, Tetsuya; Kitamura, Hiroshi
Iwata City General Hospital, Dept. of Surgery, Iwata, Japan
Pancreatic pseudocysts occur as a consequence of acute pancreatitis.
Pseudocysts that are symptomatic complicated, or enlarging with time can
be treated surgically, via percutaneous drainage, or by endoscopic methods.
We report two cases of large pseudocyst treated by surgical internal
drainage. First case was a 45-year-old woman with severe acute pancreatitis.
On admission, computed tomography (CT) revealed extensive necrosis of
the body and tail of pancreas. CT revealed a large post-necrotic fluid
collection of 15 cm 4 weeks after admission. Because the fluid collection
was complicated with infection 7weeks after admission, we performed
percutaneous drainage through the retroperitoneal space. Although the size
of the lesion gradually decreased, pancreatic fistulae persisted owing to
damage in the main pancreatic duct in the body of the pancreas. Therefore,
pancreatic fistula-jejunostomy by Roux was performed 6 months after
percutaneous drainage. Second case was a 49-year-old man with repeatedly
acute pancreatitis. CT revealed a large pseudocyst of 8 cm in the retro
pancreatic head. Elevation of serum amylase level persisted. It was
impossible to perform percutaneous drainage, because the pseudocyst was
surrounded the head of pancreas, portal vein, abdominal aorta, inferior
vena cava, duodenum, right kidney, liver and hepatoduodenal ligament.
Also, because we could not insert the endoscope cause of the cervical
diverticulum, it was impossible to carry out endoscopic transduodenal
drainage. Therefore, we performed surgical pseudocystjejunostomy by Roux
8 months after initial diagnosis. In both cases, post-operative course was
uneventful. Percutaneous drainage is best applied to pseudocysts compli-
cated with secondary infection and in critically ill patients. External
drainage, however, risks the formation of an external pancreatic fistula. If
Patient’s condition is stable, endoscopical or surgical internal drainage
should be selected as much as possible.
CR6.02
A RARE CASE OF PANCREATIC PSEUDOCYST PRESENTING
AS HYDROCELE
Apostolidis, Stylianos; Papadopoulos, Vasileios; Michalopoulos, Antonios;
Papavramidis, Theodosis; Paramythiotis, Daniel; Harlaftis, Nikolaos
AHEPA Hospital, Aristotle’s University of Thessaloniki, Thessaloniki,
Greece
Pancreatic pseudocysts typically present as palpable masses. In rare cases, the
psedocysts masquerade as hernias. The present case concerns a pseudocyst
masquerading as hydrocele. To our knowledge this is the 2nd case in the
English literature of a pancreatic pseudocyst presenting as hydrocele. A 34
years-old man presented with a soft swelling of his scrotum. On physical
examination, the lesion was found to be mobile but was not reducible. The
patient recently had an acute episode of pancreatitis. Computed Tomography
revealed a low density mass, in the scrotum, which no obvious communica-
tion with the pancreas. A suspicion for the existence of a pancreatic
pseudocyst appeared. Our suspicion was confirmed when the cyst was
evacuated by needle aspiration through the scrotum. The biochemical
analysis of the fluid indicated high level of amylase (17000IU/ml). The
conservative treatment of the patient appeared very effective since the
swelling mass disappeared after 6 weeks.
CR6.03
CASE REPORT: ACUTE PANCREATITIS SECONDARY TO BILI-
ARY ASCARIASIS
Subramaniam, Manisekar; Sharma, Amit
Hospital Alor Star, Dept. of Surgery, Alor Star, Malaysia
A lady who presented with a history of epigastric pain with associated
vomiting and loss of weight was subjected to an ERCP after an ultrasound
was supported a diagnosis of ascaris induced pancreatitis. The worm was
removed endoscopically and the patient was immediately reliefed of her
symptoms. The case is presented here as to highlight one of the rarer causes
of pancreatitis which seems to be not uncommon in this parts of the country
and the use of ERCP as a diagnostic and therapeutic tool.
CR6.04
MINIMALLY INVASIVE PANCREATIC NECROSECTOMY BY AN
ANTERIOR APPROACH: REPORT OF 2 CASES
Kulkarni, Varsha1; Raut, Abhijit2; Deshmukh, Ninad1; Joshi, Shalaka1
1K.E.M. Hospital, Seth G.S. Medical College, General Surgery, Mumbai,
India; 2K.E.M Hospital, Seth G.S. Medical College, Radiology, Mumbai,
India
Background. Necrotising pancreatitis is known for its high mortality in spite
of the best critical and surgical care. It is due to multi-organ failure rather
than the operative complications. This demands an approach that will have
access for complete necrosectomy with less ‘‘second-hit’’TM phenomenon post
operatively. Since minimal invasive retroperitoneal approach is not suitable
for all patients and has problem of higher morbidity, we describe an
alternative minimal invasive approach.
Aim. The aim was to have a complete necrosectomy with as minimal tissue
trauma, local complication, blood loss and reduced anaesthesia time, as
possible.
Method. Two patients of severe acute necrotizing pancreatitis were treated
prospectively. After initial conservative management, computer tomography
(CT) guided insertion of pigtail catheters in the lesser sac was done from
anterior approach. On maturation, the tract was surgically dilated along the
pigtail catheter, tube drain was inserted and the cavity was packed. This was
done under local anesthesia in one patient. The pack was removed after 48
hrs, and a zero degree laparoscope was introduced along the tract. The
separated necrotic tissue was removed under vision. The procedure was
repeated as required. The completeness of the necrosectomy was assessed by
the clinical improvement, CT scan, and direct visual information.
Result. No patient required blood transfusion for the procedure or
ventilatory support during or after the procedure. The mean ICU stay
post-procedure was 4 days. Both patients had pancreatic fistulae that healed
with conservative management.
Conclusion. Minimal invasive necrosectomy by anterior approach is an
effective method in selected patients, for infected pancreatic necrosectomy.
It can avoid need for ventilator, blood transfusion and be done under
local anesthesia. Its main advantage is complete vision of the cavity, easy
access for control of bleed. Simpler anatomy from front gives less technical
challenges.
CR7.01
CANCER ON CHRONIC PANCREATITIS, A DIFFICULT DIAG-
NOSIS
Herjean, Marion1; Gamblin, Claudine2; Alhamar, Elias3; Marks, Anne4
1Centre Hospitalier de Valenciennes, Digestive Surgery, Valenciennes,
France; 2Centre Hospitalier de Valenciennes, Gastro Enterologie, Valen-
ciennes, France; 3Centre Hospitalier de Valenciennes, Chirurgie Digestive,
Valenciennes, France; 4Centre Hospitalier de Valenciennes, Gatroenterolo-
gie, Valenciennes, France
Mr BER, 45, presented in Oct. 2004 with epigastric pain and nausea. He had
history of acute pancreatitis (AP), and alcoholism. Biological tests confirmed
AP, with Ranson score at 0, but CRP at 232. CT scan diagnosed chronic
pancreatitis (CP), with multiple calcifications in the head and enlarged
pancreatic duct (PD); and AP, with pancreatic edema and fluid collections in
left anterior pararenal space. It also showed a necrotic adrenal nodula of 3
cm. AP relapsed uneventfully. Adrenal secretions were checked normal.
Control CT was made, focused on adrenal nodula, that was stationary. CP
evolved with appearance of 3 small intrapancreatic pseudocysts(PC).
Peripancreatic edema and fluid collections disappeared. He came back to
hospital with acute pain after meals in April 2005. Seric pancreatic tests were
normal and CRP reached 90. CT scan showed larger PD, and PC had grown
too. Left adrenal gland kept a necrotic aspect, same size. Pain occured at
every oral intake, and patient lost weight. Surgery was scheduled on May, for
internal drainage of PD via an enterostomy. Opening PD and PC, we had the
surprise to find a puriform liquid, sent to bacteriological and cytological
study: tumoral cells were seen, of poorly differenciated adenocarcinoma,
CK7 positive and CK20 negative. Seric CA19.9 and immunochemical study
on tumoral cells was negative. Adrenal origin was not compatible. Final
diagnosis was pancreatic poorly differenciated adenocarcinoma with adrenal
metastasis. Chemotherapy was performed, with Gemcitabine, first improving
patient’s status. But he developped liver metastases, and died in nov. 2005.
This case shows traps in diagnosing cancerization on CP. The first clinical
presentation of the patient, and images of CT scan, were typical of AP on CP,
but we know now that he already had adrenal metastasis from pancreatic
adenocarcinoma! Then he had pains characteristic of PD obstruction. We
also thought of underlying intraductal papillary mucinous neoplasm of the
pancreas mimicking CP: calcifications seldom occur.
CR8.01
A CASE OF SCLEROSING EPITHELIOID FIBROSARCOMA OF
THE PANCREAS
Jinnouchi, Yuji1; Asakura, Takeshi1; Koizumi, Tetu1; Asano, Takayuki1;
Nakano, Hiroshi1; Ootubo, Takehito1; Narahashi, Kiyoshi2; Takagi, Ma-
sayuki2
1St. Marianna University School of Medicine, Gastroenterological Surgery,
Kawasaki, Japan; 2St. Marianna University School of Medicine, Diagnostic
Pathology, Kawasaki, Japan
We report a rare case of sclerosing epithelioid fibrosarcoma of the pancreas. A
20-year-old woman visited a local clinic because of systemic itching.
Hematology and biochemistry data revealed hyperbilirubinemia and liver
damage. She was admitted to our hospital for careful study. Radiological
examination revealed a dumbbell shaped, solid tumor, measuring 7.0 cm in
diameter, located in the pancreas head. Pylorus-preserving pancreatoduode-
nectomy was carried out under the pre-operative diagnosis of solid-
pseudopapillary tumor of the pancreas. Grossly, the tumor, measuring
7.0/3.5/6.5 cm, was well-demarcated, lobulated, and had a whitish cut-
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surface. No definite cystic appearance or necrotic change was observed. The
common bile was compressed by the tumor. Histological examination
revealed proliferation of trabecular arrangement of small round cells with
dense collagenous matrix. Foci of spindle shaped cells with dense myxoid
matrix, pseudoepithelial arrangement, pseudopapillary arrangement, and
ossification were also identified. Tumor cells infiltrated into the pancreas
matrix and common bile duct wall. We finally diagnosed this tumor as
sclerosing epithelioid fibrosarcoma of the pancreas. Although the recurrence
of bone metastases was detected 6 months after surgery.
CR8.02
INTRADUCTAL PAPILLARY MUCINOUS NEOPLASM WITH
NON-INVASIVE CARCINOMA AFTER DISTAL PANCREATECT-
OMY FOR THE PANCREATIC BODY CARCINOMA; A CASE
REPORT
Hatori, Takashi; Fukuda, Akira; Onizawa, Shunsuke; Oohara, Toshiya;
Furukawa, Kenji; Matsuura, Hiroshi; Takasaki, Ken
Tokyo Women’s Medical University, Gastroenterological Surgery, Tokyo,
Japan
Background. Pancreatic cancer has usually a poor prognosis and the 5-year
survival rate after surgical resection is around 10%. We experienced an
interesting case of intraductal papillary mucinous neoplasm (IPMN) with
non-invasive carcinoma in the remaining pancreas after distal pancreatect-
omy for the invasive ductal adenocarcinoma of the pancreatic body.
Case. The patient was a 58-year-old man who underwent distal pancrea-
tectomy with resection of celiac artery and left adrenal gland for the invasive
ductal adenocarcinoma of the pancreatic body in August 2003. The tumor
infiltrated to the extrapancreatic nerve plexuses, splenic artery and vein, and
there were lymph node metastases, histopathologically (T4, N2, Stage IVb,
R0 by JPS classification). He has been alive without tumor recurrence and he
has undergone medical follow-up every three months. Two years and four
months later, the branch duct IPMNs were revealed in remaining pancreas on
MRCP and ERP. Moderate atypia was detected in cytology of the pancreatic
juice. And upper GI endoscopy revealed a gastric carcinoma in the middle of
the stomach. After informed consent about the possibility of the pancreatic
carcinoma in the present or in the future, he underwent duodenum-
preserving pancreatic head resection (duodenum-preserving resection of
the remaining pancreas) and total gastrectomy in February 2006. Histo-
pathological examination revealed IPMN with non-invasive carcinoma in the
remaining pancreas and adenocarcinoma in the stomach.
Discussion. This is a very interesting case from the viewpoint of the carcino-
genesis of the pancreatic cancer and the follow-up after pancreatectomy.
CR8.03
LARGE PANCREATIC HEAD MASS RESECTION: SECOND
THOUGHT
Bhalerao, Suryabhan; Rege, Aparna
K.E.M. Hospital & Research Centre, Dept.. of Surgery, Pune, India
Background. Solid cystic papillary epithelial tumors(SCPET) of pancreas
are rare neoplasms of uncertain pathogenesis that rarely metastasize &com-
monly found in young women. Aggressive resection to achieve Ro status is
necessary for good long term benefit.
Aims & objectives. To achieve Ro status despite severe portal hypertension
in view of good prognosis.
Methods. A 23 yrs woman with 2 months amenorrhoea was diagnosed to have
large tumor apparently arising from left lobe liver on USG. CT guided FNAC
revealed a hepatic adenoma. On laparotomy she was found to have a large
pancreatic head tumor(20*15 cm)with severe portal hypertension & SMV
coursing through the tumor. In view of these findings & lack of tissue diagnosis
surgery was terminated after trucut needle biopsy of the tumor. Histopathol-
ogy showed a low grade SCPET. Reexploration was planned 1week later.
Extended pancreaticoduodenectomy with resection of anterior wall of portal
vein & splenoportomesentric vein junction with splenectomy was done.
Result. R0 resection was achieved. Histopathology showed low grade
SCPET Postoperatively she needed ventilatory support for 1week with 27
units of blood. She was discharged after 3weeks. She developed right 7th
costochondral junction metastasis of adenocarcinoma. She responded
completely to radiotherapy. At 2 yrs she is disease free & in good health.
Discussion. SCPET are often large asymtomatic tumors & tend to
metastasize rarely to liver & omentum. This patient had developed mets in
bones which is suggestive of aggressive disease but aggressive treatment has
resulted in a good quality & reasonable survival. This is a reward of margin
negative resection.
Conclusion. Aggressive approach of extended pancreatic head resection can
palliate patient better than non surgical treatment. Patients with radiologi-
cally locally advanced disease will not be denied of long term benefits.
CR8.04
MIXED DUCTAL-ENDOCRINE CARCINOMA OF THE PAN-
CREAS: CASE REPORT
Sassatani, Alexandre S; Pereira, Fernando L; Vasques, Fernando T; Azevedo,
Inah CC; Moricz, Andre; Silva, Rodrigo A; Pacheco Jr, Adhemar M
Santa Casa School of Medicine, Surgery, Sa˜o Paulo, Brazil
Introduction. The majorities of pancreatic tumors are composed of single
cell type, but exist a few reported cases of pancreatic tumors with two or more
cellular components. Mixed ductal-endocrine carcinoma is a tumor of
epithelial origin, extremely rare, in which the ductal and endocrine
components are admixed as well as in its metastasis.
Case report. Patient of 46 years-old, masculine, caucasian, was admitted in
our service with 3 years of abdominal pain, episodes of jaundice and 20-Kg
weight loss. Laboratory data showed the following values: glucose 300 mg/
dL, AST (SGOT) 79 IU/L, ALT (SGPT) 105 IU/L, total bilirubin 0.9 mg/
dL, direct bilirubin 0.5 mg/dL, alkaline phosphatase 3.122 IU/L, GGT 1.328
IU/L. Tumor marker CA19-9 was normal. Abdominal computed tomogra-
phy displayed a 3 cm irregularly mass located in the head of the pancreas.
Duodenoscopy displayed an tumor protruding from the papilla, endoscopy
biopsy of the tumor showed adenocarcinoma. The patient underwent a
pancreatoduodenectomy with pyloric preservation, microscopy confirm the
presence of two components as well as one metastatic lymphonode with same
components.
Discussion. The mixed ductal-endocrine tumors are characterized by the
presence of the ductal and endocrine components. Criteria of mixed tumor as
defined in the WHO classification. The tumor need a presence of exocrine
and endocrine components comprised at least one-half of the tumor tissue as
well as in its metastases. The prognosis of mixed carcinoma is unclear.
Although it is generally accepted that this tumor behaves like usual ductal
adenocarcinoma.
CR8.05
MUCINOUS CYSTIC NEOPLASM OF THE PANCREAS IN AN
ELDERLY WOMAN; A CASE REPORT
Hatori, Takashi1; Fukuda, Akira1; Onizawa, Shunsuke1; Oohara, Toshiya1;
Furukawa, Kenji1; Matsuura, Hiroshi1; Kameoka, Shingo2; Takasaki, Ken1
1Tokyo Women’s Medical University, Gastroenterological Surgery, Tokyo,
Japan; 2Tokyo Women’s Medical University, Surgery 2, Tokyo, Japan
Background. It is thought that mucinous cystic neoplasm (MCN) may
progress to malignancy and all MCNs should be removed surgically. We
experienced an interesting case of MCN with adenoma in aged woman who
has been observed for ten years as a pancreatic cyst.
Case. The patient was a 70-year-old woman who underwent sigmoid colon
resection for the sigmoid colon cancer in January 1994. At that time, abdominal
ultrasonography revealed a unilocular cystic lesion 2 cm in diameter in the
pancreatic tail, and the tumor was diagnosed as a pseudocyst. She has been
alive without tumor recurrence and she has undergone medical follow-up every
six months. However, the cystic lesion of the pancreas has progressed to 5 cm in
diameter in October 2005. EUS detected cyst in cyst appearance, and the
lesion was diagnosed as a MCN finally. She underwent distal pancreatectomy
with spleen in February 2006. Histopathological examination revealed
adenoma in the epithelium and ovarian-type stroma was seen below the
epithelium sporadically among inflammatory cell infiltration.
Discussion. It is considered that sporadic ovarian-type stroma is due to the
aged woman after menopause. It should be treated cystic lesion of the
pancreas in aged women carefully, and it should be considered that it may be
possible to fail to demonstrate the ovarian-type stroma when the pathological
examination is performed in the aged women.
CR8.06
SOLID CYSTIC PSEUDOPAPILLARY TUMOR OF THE PAN-
CREAS
Grondona, Jorge P1; Bracco, Ricardo A2; Calafiore, Dario2
1Centro Me´dico Martı´n y Omar de San Isidro, HPB Unit, SAn Isidro-
Buenos Aires, Argentina; 2Clı´nica Pueyrredo´n de Mar del Plata, HPB Unit,
Mar del Plata-Buenos Aires, Argentina
Background. The solid cystic pseudopapillary tumor (SCPT) is a rare but
characteristic neoplasm of the pancreas described by Franz in 1959. The
most common localization is in the body and tail of this organ but sometimes
it has been localized in the head. In spite of its low potential malignancy the
tumor can be severely invasive locally. However, if it is completely resected
the local recurrence is exceptional.
Aim. A-30-year old female patient bearing a SCPT in the head of the
pancreas is presented.
Methods. The patient suffered dyspepsia during 6 months before admission.
Blood insulin was found slightly elevated twice. Ultrasonography and
Magnetic Resonance Imaging showed a solid tumor of 3.8 cm in diameter
located in the head of the pancreas, without compression of the bile duct. A
surgical approach was decided due to a doubt in diagnosis between an
endocrine tumor and a non-invasive ductal adenocarcinoma. Intra-operative
ultrasonography and a frozen biopsy were not conclusive. A complete
enucleation of the tumor employing an ultrasonic dissector was carried out.
An Argon beam coagulator to complete the hemostasis was employed.
Results. Even though the subcutaneous treatment with Octreotide had been
started intra-operatively, a high output of pancreatic leak was observed as
from the 3rd day of the postoperative period. A relaparotomy and several
percutaneous drainages were required to control the collections of pancreatic
juice in the upper abdominal cavity. Ninety days after the operation a final
control of the fistula with nutritional and metabolic improvement was
achieved. Histopathology examination revealed a SCPT of the head of the
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pancreas. Three years later, the patient is symptom free and without evidence
of recurrence.
Conclusions. SCPT is an infrequent tumor of the pancreas with a non-
aggressive biological behaviour. When it is localized in the head of the
pancreas the management is controversial. An enucleation or a pancreato-
duodenectomy are to be decided upon based on the size of the tumor.
CR8.07
STROMAL TUMOR OF THE PANCREAS WITH EXPRESSION OF
THE C-KIT PROTEIN: REPORT OF A CASE
Kim, Seon T; Jung, Jun C; Choi, Dong W
Samsung Medical Center, Sungkyunkwan University School of Medicine,
Surgery, Seoul, Korea
Mesenchymal tumors of the pancreas are a very rare disease entity, which
account for less than 1% of all pancreas tumors. Reports of such pathologies
are mostly in the form of case reports or small series. These cases include
leomyosarcoma, malignant peripheral nerve sheath tumor, malignant fibrous
histiocytoma, liposarcoma, rhabdomyosarcoma, hemangiopericytoma,
schwannoma and solitary fibrous tumor. Mesenchymal tumors are more
commonly found in the gastrointestinal tract, and they are mostly gastro-
intestinal stromal tumors (GISTs). GISTs are defined as KIT-positive
mesenchymal spindle cell or epithelioid neoplasms showing differentiation
toward the interstitial cell of Cajal. GISTs occur most commonly in the
stomach(6070%), small intestine (2025%), colorectum (5%) and eso-
phagus (B/5%). Rare findings of GISTs in the bladder, gallbladder,
omentum, mesentery have been reported. We report a case of GIST of the
pancreas head. A 55 year old female is referred to Samsung Medical Center
for evaluation of a pancreas head mass. She had been admitted in an outside
hospital for fever and during work-up for the origin of the fever, an abdominal
CT was done and the pancreas mass detected. Pancreas CT at our institute
revealed a large mass in the pancreatic head. Ultrasound guided biopsy
yielded no significant diagnostic results. Surgical exploration was done and
whipple’s procedure was carried out. The mass was located in the pancreas
head and measured 5.5/4.4 cm in size. The mass had distinct margins and
no gross involvement of the pancreatic duct. Microscopic evaluation showed
GIST withB/5/50 HPF mitosis count, and was positive for C-KIT immuno-
histochemistry. C-KIT gene analysis results revealed mutation in exon 9. The
expression of c-kit protein suggests that this pancreatic stromal tumor may
originate from primitive mesenchymal cells which can be a logical candidate
for the origin of gastrointestinal stromal tumors and extra-gastrointestinal
stromal tumors.
CR8.08
VIPOMA OF THE HEAD OF THE PANCREAS
Kim, Chang-Ho; Lee, Hwa-Soo; Kang, Gil-Ho; Kim, Sung-Yong; Baek,
Moo-Jun; Lee, Moon-Soo; Cho, Moo-Sik
Soonchunhyang University, Cheonan Hospital, Dept. of Surgery, Cheonan,
Korea
Background. VIPomas are rare neuroendocrine tumors secreting excessive
vasoactive intestinal peptide(VIP) and cause a syndrome of profound watery
diarrhea, hypokalemia, and achlorhydria. VIPomas are more commonly
located in the distal pancreas. About 50% of patients have metastatic spread
by the time of diagnosis.
Aim/Objective. The aim is to find the result of surgical resection in one case
of VIPoma of the pancreatic head.
Patient and method. A VIPoma of the pancreatic head in a 76-year-old
patient was diagnosed by typical symptoms(profound watery diarrhea for ten
years, hypokalemia), high serum level of VIP, and radiologic findings.
Abdominal ultrasonography and computed tomography revealed a 4-cm to
5-cm mass in the head of the pancreas. In endoscopic ultrasound guided fine
needle biopsy, neuroendocrine tumor was strongly suspected.
Results. Panreaticoduodenectomy was performed with immediate resolving
of symptoms, and normalization of VIP level. The immunohistochemical
examination was compatible with the VIPoma of the pancreas.
Conclusion. A case of VIPoma of the pancreatic head was treated
successfully by surgical resection.
CR8.09
NESIDIOBLASTOSIS ACCOMPANIED WITH CHRONIC ALCO-
HOL-INDUCED PANCREATITIS
Park, Eun Hwa; Kwak, Jin Ho; Choi, Kun Moo; Han, Myoung Sik;
Jang, Hyuk Jai
Gangneung Asan Hospital/University of Ulsan, Surgery, Gangneung, Korea
Nesidioblastosis is a primary neonatal disease and reported rarely in the
adult. Nesidioblastosis has been defined as a diffuse islet cell hyperplasia
accompanied with a differentiation of islets arising from the pancreatic ductal
epithelium. The diagnosis of nesidioblastosis with radiologic methods is
difficult, because a distinct tumor lesion is seldom found in the pancreas. The
best diagnostic procedures are venous blood sampling of the portal,
mesenteric, and splenic veins, with results indicative of pancreatic beta-cell
hyperfunction. Chronic pancreatitis is the result of fibroinflammatory
changes in the pancreas from varies causes. Chronic pancreatitis is the
most common cause of splenic vein thrombosis. Diabetes mellitus, a common
complication of chronic pancreatitis is characterized by a progressive
destruction of the pancreas, including loss of the islet cells. However, In
our case, he has a chronic pancreatitis with hyperinsulinemic hypoglycemia,
and splenic vein thrombosis. Patients concurrently having a chronic
pancreatitis with nesidioblastosis have not been described in the literature.
We report a case of nesidioblastosis in a 60-year-old man with chronic
alcohol-induced pancreatitis and splenic vein thrombosis manifested by
attacks of hypoglycemia. The state of the patient improved after Whipple
procedure (80% resection)
CR8.10
ENDOCRINE TUMOR OF THE PANCREAS ACCOMPANIED BY A
CYSTIC LESION
Jang, Hyuk J; Park, Eun H; Han, Myoung S
Gangneung Asan Hospital/University of Ulsan, Surgery, Gangneung, Korea
Background. We have reported a case of pancreatic endocrine tumor with
dilated distal pancreatic duct and the cyst formation.
Case. A 47-year old man without previous history of the pancreatitis was
admitted to our hospital with upper abdominal cystic mass, which was
formed in the pancreatic tail by ultrasonogram and computed tomography.
The preoperative diagnosis was a pancreatic cystic lesion or pseudocyst. The
tumor, which was measured about 13 cm in length and 6 cm in diameter,
arouse from the pancreatic body and was well capsulated. The examination of
the surgical specimen resulted in the incidental discovery of an obstructive
nodule of endocrine tumor, mesuring 7 mm in diameter and located
immediately at the contact of the cyst. The tumor was ill limited and neural
invasion are present. Immunohistochemical studies showed that the tumor
cells expressed chromogranin and synaptohysin.
Conclusion. Pseudocysts accompanying pancreatic ductal carcinoma were
sometimes reported but endocrine tumors accompanied by cyst were very
rare. This case report underlines that the diagnosis of a cystic lesion of the
pancreas must be done much cautiously in the patient without a clinical
history of the pancreatitis.
CR8.11
A CASE OF MUCINOUS CYSTIC TUMOR OF THE PANCREAS
Morigaki, Satoko; Horiguchi, Akihiko; Ishihara, Shin; Ito, Masahiro; Nagata,
Hideo; Shimizu, Tomohiro; Ito, Ryoutaro; Tuda, Kazuki; Kamiya, Hiroki;
Miyakawa, Shuichi
FUjita Health University, Pancreatico-Biliary Surgery, Toyoake, Japan
We report here a case of mucinous cystic tumor of the pancreas (MCT). A
36-year -old female was admitted to our hospital for pancreas mass. The
ultrasonographic and CT scanexaminations revealed a well defined mass of
32 mm in diameter. This patient did not have specific symptom, but only
tumor size was increased. MRCP was performed, the pancreatic duct was not
connect to tumor. The result of laboratory data and imaging studies indicated
that the patient had Mucinous cystic Tumor (MCT) or SPT of the pancreas.
Distal pancreatectomy without splenectomy were performed. Histological
findings established ovarian-type stroma (OLS) and thick fibrous capsule,
Mucinous Cystic Tumor of the pancreas. The recovery was uneventful. The
patient was symptom free, with normal findings. One of the topics among
pancreatologists is classification of cystic ors of pancreas. There is still
confusion between MCT and Intraductal Papillary Mucinous Tumor
(IPMT). This report shows a typical MCT.
CR8.12
INFECTED INTRADUCTAL PAPILLARY MUCINOUS NEO-
PLASM (IPMN)
Nagamachi, Yukiko1; Takikawa, Hajime1; Takada, Tadahiro2; Yoshida,
Masahiro2; Toyota, Masayuki2; Takada, Koichi3; Nagamachi, Masao4
1Teikyo University School of Medicine, Dept. of Internal Medicine, Tokyo,
Japan; 2Teikyo University School of Medicine, Dept. of Surgery, Tokyo,
Japan; 3Teikyo University School of Medicine, Dept. of Radiology, Tokyo,
Japan; 4Sano Citizens Heartful Hospital, Dept. of Surgery, Tochigi, Japan
Background. Intraductal papillary mucinous neoplasm of the pancreas
(IPMN) products a large amount of mucus in enlarged pancreatic duct.
Aims. Although it is not unusual causing the acute pancreatitis by the
outflow of mucus, we experienced a rare case which caused infection in the
cystic lesion of IPMN, and it progressed to septicemia.
Patients/Methods.Aseventy-nineyear-old femalepatientwasadmitted toour
departmentof internal medicine inorder to controldiabetes in June, 2002.After
admission, she showed chills and fever, an elevation of CRP level. Antimicrobial
drugs were administered under the suspected diagnosis of urinary tract
infection, however, methicillin resistant Staphylococcus aureus (MRSA) was
identified from bacterial culture in this patient. In addition, Klebsiella
pneumoniae was identified from the blood culture. And then, this bacterium
was also identified from stool and phlegmon of left antebrachium. In spite of
appropriate antimicrobial drugs were administered, general condition was
getting worse and spike fever had been continued. During these clinical course,
CTand ERCP were performed and they revealed branched type IPMN. From
these images, the infection to a cystic lesion of IPMN was strongly suspected.
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Results. Patient was transferred to surgical department to receive pancrea-
toduodenectomy (on August 26, 2002). Patient’s postoperative course was
well with improvement of inflammatory reaction.
Conclusion. A report of infected IPMN is the first, then we consider this
case report to be a significance.
CR9.01
PALIATIVE PANCREATICODUODENECTOMY FOR ADVANCED
CARCINOMA OF THE AMPULLA OF VATER
Jureidini, Ricardo; Haddad, Luciana B; Andraus, Wellington; Jukemura,
Jose´; Abe, Emerson S; Siqueira, Andre´ M; Perini, Marcos; Montagnini,
Andre´; da Cunha, Jose´ E
Clinical Hospital of Sa˜o Paulo University, Departament of Gastroenterology,
Sa˜o Paulo, Brazil
Background. Pancreaticoduodenectomy is the choice surgical procedure for
periampullary tumors. How the morbimortality became lower, this surgery is
been used to palliation of symptoms related with biliar obstruction, duodenal
obstruction and bleeding.
Case report. A healthy forty-two-year-old woman with hemorrhagic
ampullary adenocarcinoma started to present high decreasing of red blood
cells level since two months. Endoscopy showed extensive ulcerate lesion
surrounding Vater’s papilla. Abdominal CT scan showed pancreas invasion
and no distant lesions. Liver metastasis (0, 3 cm in the segments III, IV and
VII) was found during the surgery. Palliative pancreaticoduodenectomy was
performed with good postoperative evolution. The patient is alive after 6
months without any adjuvant therapy.
Discussion. Some authors have demonstrated better survival in periampul-
lary patients after palliative pancreaticoduodenectomy than biliar bypass and
gastroenteroanastomosis. Pancreaticoduodenectomy mortality is lower than
5% in specialized centers. These confirm the possibility of use that surgery as
palliation in selected cases when symptoms are difficult to control.
Conclusion. Palliative resection is a good option in patients with periam-
pullary tumors that presenting difficult control bleeding, even though liver
metastasis are present.
CR9.02
CANCER OF THE AMPULLA OF VATER’S COMPLICATED WITH
GOODPASTURE SYNDROME: A CASE REPORT
Tokoro, Takamasa
Tokai Cantral Hospital, Surgery, Kakamigahara, Japan
Background and aim. It’s very rare to perform pancteticoduodenectomy
for a patient complicated with a collagen disease. We should consider the
risks such as leakage and infection when to perform an operation for an
immunocomprompromised host.
Patient and method. A 69-years-old man had been admitted in our hospital
for chronic renal failure due to Goodpasture syndrome. He was administered
high doses of steroid hormone, so peroral-endoscopy was conducted for
screening of peptic ulcer. Peptic lesion was found at the Vater’s papilla and
the result of the biopsy was adenocarcinoma. Later on it had caused life-
threatening blood poisoning repeatedly. Though we considered it carried
risk of postoperative complication, pancreaticoduodenectomy was conducted
after obtaining informed consent. All drainage tubes were removed until
the postoperative day 6th after confirmation of the level of ascitic amylase. On
the postoperative day 8th, major leakage of pancreatojejunostomy
was suspected from the high level of ascitic amylase, so suction drainage
was performed through operative wound. After that, his recovery was
progressing nicely. He was released from the hospital on the postoperative
day 35th.
Conclusion. Only few reports are recorded in the literature with the
pancreatoduodenectomy for a compromised host. It’s important in the
postoperative management to deal with complications as soon as possible.
CR10.01
A CASE OF COLON CANCER LIVER METASTASIS WITH IN-
TRAHEPATIC BILE DUCT TUMOR EMBOLISM
Fujishita, Manami; Uchida, Shinji; Hisaka, Toru; Ishikawa, Hiroto; Ki-
noshita, Hisafumi; Shirouzu, Kazuo
Kurume University School of Medicine, Surgery, Kurume, Japan
A vascular infiltration is often found in hepatic metastasis of colorectal
cancer. But the example which metastatic tumor infiltrates into bile duct,
and tumor embolism is rare. We report a case of colon cancer liver
metastasis with intrahepatic bile duct tumor embolism. Patient was 56 years
old man, he resected a sigmoid colon cancer(stage3) in 2001. We could find
rise of CEA from November, 2004. Abdominal CT scan and FDG-PET
showed metastatic liver cancer and he was admitted our hospital on January,
2005. We did not find him anemia, icterus, and did not palpate the mass in
abdomen. We did not show his abnormal laboratory data on admission. We
could find low attenuate area of tumor in segment 3, and dilatation of
intrahepatic bile duct on abdominal CT scan. FDG-PET showed accumu-
lation to tumor in segment 3. Endoscopic retrograde cholangiography
showed tumor block up left branch of intrahepatic bile duct. We performed
left lateral segmentectomy of the liver January, 2005. In pathological
diagnosis, tumor infiltrated and proliferated in hepatic lobule through
Glisson’s capsule with necrosis and tumor embolism.
CR10.02
AN EXTREMELY RARE CASE OF GASTRIC CARCINOMAS WITH
LIVER METASTASES
Matsumoto, Tomio; Toshiyuki, Itamoto; Momisako, Hiroyuki; Hashizume,
Junji; Masumoto, Norio; Asahara, Toshimasa; Usitora, Yuichirou; Yahata,
Hiroshi; Fukuda, Saburou
Divison of Frontier Medical Science, Hiroshima University Hospital, Surgery,
Hirohima, Japan
A 62-year-old man was referred to our hospital due to gastric cancers
consisting of two separate tumors. One was 7 cm in diameter and located on
the stomach body and the other was 5 cm in diameter and located on the
stomach antrum. Total gastrectomy combined with splenectomy and resec-
tion of the pancreatic tail was performed. Histological examination revealed
that the larger tumor was small cell carcinoma and that the small tumor was
poorly differentiated adenocarcinoma. Thus, there was no connection
between the two tumors. The patient was treated with adjuvant chemotherapy
after surgery. However, computed tomography (CT) performed 4 months
after the first operation showed a liver metastasis, 3.0 cm in diameter, in
segment 6 of the liver. Resection of segment 6 of the liver was performed.
Pathological examination revealed that the resected liver tumor was small cell
carcinoma. After the second operation, the patient was treated with adjuvant
chemotherapy again. CT performed 20 months after the first operation
showed two tumors in segments 7 and 8 of the liver, which were 3.4 cm and
1.6 cm in diameter, respectively, and resection of segments 7 and 8 of the liver
was performed. Pathological examination revealed that the resected tumors
were poorly differentiated carcinomas. The patient is alive without cancer
recurrence 1 year and 2 months after the second hepatectomy.
Discussion & conclusion. We reviewed 120 reported cases of primary
gastric small cell carcinoma, a rare disease first reported in 1976. Small cell
carcinoma of the stomach is an aggressive malignant tumor and has an
extremely poor prognosis similar to the prognosis of small cell carcinoma of
the lung. The clinical course of the present case was different from previously
reported cases. The liver metastases were treated successfully by two
hepatectomies. We herein report a case of small cell carcinoma of the stomach
that had an unprecedented clinical course and a favorable prognosis.
CR10.03
A CASE OF PRIMARY LIVER NEUROENDOCRINE TUMOR
WHICH WAS DIFFICULT TO DISCRIMINATE FROM CHOLAN-
GIOLOCELLULAR CARCINOMA
Edamoto, Yoshihiro; Terashima, Hiroo; Noji, Shuuichi; Shimizu, Sayaka;
Saito, Yukio; Masaki, Naohiko; Mochizuki, Makoto; Saito, Kiyoshi
International Medical Center of Japan, Surgery, Tokyo, Japan
A 24-year-old woman was admitted to our hospital because of the notice of
right lateral abdominal lump. Laboratory data were within a normal range
except CA 19-9 and PIVKA-II. Ultrasonography revealed a mass measuring
10 cm in diameter localized at the right lobe of the liver. Computed
tomography scan, magnetic resonance image, and angiography showed a
hypervascular tumor. Aspiration needle biopsy was performed before opera-
tion. Biopsy specimen included cancer tissue that was composed of markedly
atypical large cancer cells showing trabecular and medullary growth with
microglandular formation. Immunihistochemical studies revealed that the
tumor cells were positive for cytokeratin(CAM5.2) and CK7 in cytoplasm,
positive for CA19-9 and CD10 at glandular border. Right hepatectomy was
carried out. A 10 cm sized nodular tumor was found in the resected liver. On
the cut surface, the tumor was well-demarcated simple nodule with partially
extranodular growth. Microscopically a large part of the tumor was showed
same histological feature with biopsy specimen. Immunihistochemical analy-
sis showed that CK7 and CK19 were positive, but AFP and hepatocyte
were negative. The tumor cells were diffusely positive for CD56 and slightly
positive for glimerius, synaptophysin and chromogranin A. These induced
weak neuroendocrine differentiated of this tumor. A minor part of the tumor
was carcinoid-like area that showed mild nuclear atypism and distinct
neuroendocrine differentiation. We diagnosed this tumor as neuroendocrine
carcinoma.
CR10.04
HUGE LIVER TUMOR WITH CUSHING SYNDROME IN A YOUNG
FEMALE: A NEW ENTITY
Rod, Julien1; Rouleau, Vincent2; Plard, Laurent3; Dao, Thong4; Reznick,
Yves5; Chiche, Laurence3
1University Hospital of Caen, Caen, France; 2University Hospital of Caen,
Dept. of Pathology, Caen, France; 3University Hospital of Caen, Hepatobili-
ary and Transplantation Dept., Caen, France; 4University Hospital of Caen,
Hepatogastroenterology, Caen, France; 5University Hospital of Caen, En-
docrinology, Caen, France
Background. Liver tumors with endocrine symptoms are rare, usually
metastatic. But endocrine features can also be in relation to paraneoplastic
syndrom associated with primary liver neoplasm.
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Objective. To describe a case of a rare epithelial and stromal primary tumor
recently described in children, and responsable for a cushing syndrom.
Methods. A 17-year-old girl presented with face oedema and a palpable
abdominal mass. Computed tomography and MRI showed a solitary huge,
hypervascularized, calcified solid tumor occupying the left liver and invading
segment 8. Face oedema and slight hirsutism were reported to a Cushing
syndrom, confirmed by laboratory studies: urinary free cortisol/1600 mg/24
hours (N 30100), serum cortisol 290 ng/mL at 0:00 (NB/250), ACTH 136
pg/mL at 0:00 (NB/75). Serum AFP, ACE, CA 19-9, chromogranin A level
was normal, only serum Ca 125 was slightly elevated (NB/35). There were no
extrahepatic spread according to PET-scan. Octreoscanner was negative. The
patient underwent a left hepatectomy extended to segment 5 and 8. Post
operative course was uneventful. Two months later, cushing syndrom has
disappeared and biology returned to normal. Histological diagnosis was a
nested stromal epithelial tumor: on macroscopy, it was a 25 cm well-
circumscribed but non encapsulated mass which was lobulated, myxoid and
gray with small spicules of calcification, without satellite nodules nor vascular
invasion. On microscopy, the tumor displayed an organoid arrangement of
well demarcated nests of bland spindle cells arranged in short fascicles. Cystic
degeneration was seen within some of the nests as well as psammomatous
calcification and regions of ossification, within the nests or the stroma.
Discussion. Clinical, radiological and histological differential diagnosis are
discussed, pointing out this new entity, initially and until this case, only
described in children less than 12 years old. Treatment is surgery, no
chemotherapy is recommended, and prognosis seems quite favourable if R.
CR10.05
A UNIQUE HYPERVASCULAR FOCAL NODULAR HYPERPLA-
SIA-LIKE NODULE RESECTED BY LAPAROSCOPIC LATERAL
SEGMENTECTOMY, REPORT OF A CASE
Sasaki, Ken; Ueno, Sinichi; Kubo, Fumitake; Sakoda, Masahiko; Hiwatashi,
Kiyokazu; Shinchi, Hiroyuki; Maemura, Kousei; Noma, Hidetoshi; Takao,
Sonshin; Aikou, Takashi
Digestive Surgery and Dept. of Pathology, Kagoshima University School of
Medicine., Dept. of Surgical Oncology, Kagoshima, Japan
A 41-year-old man was incidentally pointed out a liver nodule in the lateral
segment at a detection survey. He had no history of hepatitis and no alchol
abuse. The nodule was demonstrated as a homogeneous hyperechoic lesion
with peripheral wide lowechoic zone on ultrasnographic examination. Plain
computed tomography failed to detect the nodule. Dynamic CT showed that a
part of the nodule was slightly high-attenuated in early phase and low-
attenuated in delayed and plateau phase. Angiography showed that the nodule
had slight hypervascularity but not spoke-wheel appearance. In addition, the
nodule was visualized as a portal flow defect by CT during portal flow and iso-
attenuated nodule in early phase and slightly high in delayed phase by CTwith
hepatic arteriography (CTA). Magnetic resonance image (MRI) suggested
that the nodule have Kupffer cells and fat tissues. We could not make suitable
diagnosis for these findings and the possibility of malignancy like early
hepatocellular carcinoma was remained, so we performed laparoscopic
assisted lateral segmentectomy. The cut surface of resected specimen showed
heterogeneous dark green with bleeding inside. Capsular formation and
central scar-like stellate fibrosis were not observed. Histologically, portal tracts
were not present in the nodule and a lot of small vessels were found in the
border area. The hyperplasty of cholangion commonly detected in focal
nodular hyperplasia (FNH) were not present. In the some parts of surround-
ing liver tissue, mild portal deformity and wall thickness of portal veins were
noticed. So it was thought that the intrahepatic blood flow aberration rather
than the neoplastic progression caused this unique nodule. Representative
hyperplastic nodule based on blood flow aberration is FNH, but the nodule
did not have typical findings with FNH macroscopically and histologically.
Finally the diagnosis of FNH like lesion was made.
CR10.06
AORTO-CAVAL FISTULA DUE TO NEUROENDOCRINE MALIG-
ANCY: REPORT OF THE FIRST DOCUMENTED CASE AND ITS
DIAGNOSIS BY INTRA-OPERATIVE ULTRASONOGRAPHY
Neal, Christopher P; Peterson, M; Mann, Christopher D; Pattenden, Claire J;
Berry, David P; Dennison, Ashley R
Leicester General Hospital, Dept. of Hepatobiliary and Pancreatic Surgery,
Leicester, UK
Background and aim. Aorto-caval fistula (ACF) is a rare condition, most
commonly seen as a complication of abdominal aortic aneurysm, penetrating
trauma or iatrogenic injury. The aim of this paper is to present the first
reported case of ACF secondary to neuroendocrine malignancy. In addition,
we present images from intraoperative ultrasonography that diagnosed the
anomaly.
Patient and methods. A previously well 48-year old female presented with a
3-month history of epigastric pain and a left upper quadrant mass. Magnetic
resonance imaging of the liver demonstrated a mass involving the left lobe of
the liver, centred on segments 2 and 3 with an exophytic posterior extension
compressing the inferior vena cava. Following laparoscopy, the patient was
listed for formal exploration with the intention of performing a left
hepatectomy, with splenectomy and partial gastrectomy depending on
operative findings. Twelve hours prior to surgery the patient deteriorated
dramatically, complaining of abdominal pain and becoming hypotensive,
tachycardic and oliguric. Fluid resuscitation restored normotension, yet led to
minimal improvement in urine output, despite a high central venous pressure.
Emergency laparotomy was performed for a suspected intra-abdominal
catastrophe, but was negative save for the presence of the known liver mass.
At this point intraoperative ultrasonography was performed, which demon-
strated an ACF at the level of the renal arteries at the posterior border of the
tumour mass. Frozen sections confirmed malignancy and the abdomen was
therefore closed. The patient deteriorated and died several hours later.
Histology of the tumour confirmed a poorly differentiated carcinoma with
immunohistochemical features of a high grade neuroendocrine malignancy
(strong positive staining for synaptophysin, chromogranin and CD56).
Discussion. The ACF reported in this case is unusual in its aetiology,
anatomical location (at the level of the renal arteries) and means of diagnosis.
CR10.07
REPORT OF A CASE WHICH WAS POSSIBLE TO RESECT BY
EXTENDED HEPATECTOMY AFTER IMPROVEMENT OF LIVER
FUNCTION BY ADMINISTRATION OF LAMIVUDINE
Ueno, Shinchi; Sakoda, Masahiko; Kubo, Fumitake; Aikou, Takashi; Hiwa-
tashi, Kiyokazu
Kagoshima University Hospital, Kagoshima City, Japan
Background. Recently, it has been reported that HCC patients with
viral chronic hepatitis undergone local therapy such as liver resection and
ablation should be followed by anti-viral therapy using Lamivudine for HBV
positive patients and IFN/Ribavirin for HCV positive patients. The adjuvant
therapy could have not only anti-virul effect but also anti-carcinogeneic
effect.
Case. We have experienced a patient with primary HCC who was undergone
limited liver resection because of his poor liver function. (ICG test 27%,
histlogical inflammation activity index score 12 point)Pathological findings
was pT1, N0, M0 stage1. He was given adjuvant anti-viral therapy using
Lamivudine for 3years. The patient’s liver function has been recovered (ICG
test 10%, histlogical inflammation activity index score 5 point) and his
recurrent HCC with portal thrombus 3 years after 1st surgery was treated by
extended liver resection. Pathological findings was pT3, N0, M0 stage3.
Conclusion. In case of HCC patients with chronic viral hepatitis, post-
operative anti-virus therapy might be useful not only for remission of hepatitis
and carcinogenesis of residual liver but also for extension of the operation
adaptation by liver function improvement.
CR10.08
LIVER METASTASES FROM SALIVARY GLAND ADENOID CYS-
TIC CARCINOMA
Reid, Richard; Long, Melanie; Hutchins, Robert; Bhattacharya, Satya
Barts and The Royal London Hospital, Hepatobiliary and Pancreatic Surgery,
London, UK
Background. Adenoid cystic carcinoma (ACC) is a rare tumour arising from
the epithelial and basement membrane components of glandular tissue. They
are commonly reported in salivary glands, but also from breast, lung and
female genital tract. Treatment is surgical excision. Microscopic clearance is
often not achieved and post op radiotherapy may be required. Distant
metastases are reported; most commonly to the lungs, but also brain and
bone. Metastases may present late and despite a slow doubling time of this
tumour are associated with a poor prognosis. Liver metastases from ACC are
rarely reported in the literature. We report two such patients who presented
late and with bulky tumours despite non specific symptoms.
Method/Cases. A 59 yr old lady presented with lung and liver metastases 8
years after resection of a right submandibular ACC. A 2.3 Kg solitary liver
metastasis was resected with extended right hepatectomy and a solitary lung
nodule excised at thoracotomy. Histology confirmed metastatic ACC. She
remains in follow-up 10 months later. A 31 year old lady presented with a large
liver tumour 11 yrs following superficial parotidectomy for ACC followed by
radiotherapy. A subsequent left quadriceps metastasis was excised 2 years
later. 2 liver metastases were resected with clear margins and histology
confirmed ACC (largest 0.8 Kg) The patient died two years later from
metastatic disease despite adjuvant chemotherapy.
Conclusion. Liver metastases do occur with ACC. Surgery may be an
appropriate treatment modality in a few selected patients. Only a larger series
will indicate whether surgery offers survival advantage.
CR10.09
A RARE CASE OF PRIMARY HEPATIC NEUROENDOCRINE
TUMOR
Brozzetti, Stefania; De Angelis, Monica; Drumo, Andrea; Cassini, Diletta;
Nicolanti, Virgilio; Cavallaro, Antonino
Policlinico Umberto I, Pietro Valdoni, Rome, Italy
Primary neuroendocrine tumors of the liver are extremely uncommon. The
liver is usually the site of metastases from neuroendocrine neoplasm of various
organs. Prognosis of these tumors is more favourable when compared with
metastatic disease. A case of a 29 year-old man with primary carcinoid,
submitted to right hepatectomy, is described. At presentation patient’s
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complaints were acute pain, discomfort at upper abdomen, weakness and
fatigue lasting since 3 weeks. At physical examination a mass was palpable in
the right liver which was confirmed at ultrasonography and computerized
tomography (CT). The mass of 8 centimetres had a central area of necrosis
and without infiltration displaced the right portal vein. Histology on a fine CT
needle biopsy was consistent with an hepatocellular carcinoma. Any other
different primary tumor sites were excluded by a careful clinical research, by
chest radiography and endoscopy. Plasma levels of carcinoembrionic antigen
and alpha-pheto protein were normal. The surgical procedure was radical. At
hematoxylin-eosin staining a typical trabecular arrangement was seen. The
tumor cells were small, round with hypercromatic uniform nuclei and sparse
mitotic figures. Immunohistochemically a broad positivity to chromogranin A
and neuron-specific enolase was observed. Two years after, because of an
octreotide scintigraphy demonstrating somatostatin receptors in liver and
intestinal tract, a surgical second look was required. At that time, upper
gastrointestinal roentgenology, colonoscopy, levels of bio-active amines and
peptides syntetized by cacinoids were normal. At surgical recognition neither
primaries nor recurrences were detected. The patient is well doing and disease
free at 10 year follow-up. To our knowledge this is one of few fully documented
cases of primary hepatic carcinoid. Present report deals with a complete
clinical laboratory and imaging workup, careful surgical explorations and a
long follow-up all excluding a different site of a primary and thus confirming
hepatic origin of neuroendocrine tumor.
CR10.10
AN EXAMPLE OF COMBINED TYPE HEPATOCELLULAR CAR-
CINOMA WITH SUPRACLAVICULAR LYMPH NODE METASTA-
SIS AND PARAAORTIC LYMPH NODE METASTASIS
Uchida, Shinji; Hisakaya, Toru; Ishikawa, Hiroto; Kinoshita, Hisafumi;
Shirouzu, Kazuo; Kawashima, Yuji
Kurume University School of Medicine, Surgery, Kurume, Japan
It is rare that small hepatocellular carcinoma metastasize paraaortic lymph
node and supraclavicular lymph node. We report an example of combined
type hepatocellular carcinoma with supraclavicular lymph node metastasis
and paraaortic lymph node metastasis in five months after operation of
hepatocellular carcinoma. The patient was 72 years old woman with hepatitis
C from four years ago. She was detected 2 cm hepatocellular carcinoma on
dynamic CT scan in May, 2004 and she admitted in our hospital on August 9,
2004. In familial history, her mother died of hepatic carcinoma. We were not
palpable her liver on admission. On admission laboratory data was the
following. Blood platelet 115000, AST/ALT is 152/149 U/l, Ch-E 78U/l, Alb
3.93 g/dl, T.Bil 0.88 mg/dl, PT 95%, HPT94%, HA 182 ng/ml, ICG15
29.5%, CEA 2.2 ng/ml, CA19-9 70.2U/ml, AFP 69.5 ng/ml, AFP-L3 0.5,
PIVKA 17 mAU/ml. We could find the 20 mm tumor in segment 5 on
dynamic study early phase, and it’s tumor showed washed out in delayed
phase. We performed segmentectomy of No. 5 on August 26, 2004.
Pathological diagnosis was hepatocellular carcinoma of combined type. Five
months after operation, she had pains from left upper quadrant to back
increased from about January, 2005. And we could find paraaortic lymph
node swelling on abdominal CT scan in February. FDGPET scan showed
abnormal accumulation in paraaortic lymph node and the left supraclavicular
lymph node. We performed intra-operative radiation therapy (30 Gy) on
March, 2005. Pathological diagnosis of paraaortic lymph node was poorly-
differentiated hepatocellular carcinoma cells. She died at September, 2005.
CR10.11
A RARE CASE OF PRIMARY HEPATIC NEUROENDOCRINE
TUMOR
Brozzetti, S; De Angelis, M; Drumo, A; Cassini, D; Nicolanti, V; Cavallaro, A
University of Rome, Dept. of Surgery, Rome, Italy
Primary neuroendocrine tumors of the liver are extremely uncommon and
reported cases in literature anecdotic. The liver is usually the site of
metastases from neuroendocrine neoplasm of the pancreas, gastrointestinal
tract, bronchus and various other organs. Prognosis of these tumors is more
favourable when compared with metastatic disease. A case of a 29 year-old
man with primary carcinoid, submitted to right hepatectomy, is described.
At presentation patient’s complaints were acute pain, discomfort at upper
abdomen, weakness and fatigue lasting since 3 weeks, no flushing and
diarrohea. At physical examination a mass was palpable in the right liver
which was confirmed at ultrasonography and computerized tomography
(CT). The mass of 8 centimetres in diameter had a central area of necrosis
and without infiltration displaced the right portal vein. Histology on a fine
CT needle biopsy was consistent with an hepatocellular carcinoma. Any
other different primary tumor sites were excluded by a careful clinical
research by chest radiography, endoscopy, with specific attention paid to
gastrointestinal tract. Plasma levels of carcinoembrionic antigen and alpha-
pheto protein were normal. The surgical procedure was radical. Macro-
scopically the tumor appeared as a white soft mass. At hematoxylineosin
staining, a typical trabecular arrangement was seen. The tumor cells were
small, round with hypercromatic uniform nuclei and sparse mitotic figures.
Immunohistochemically a broad positivity to chromogranin A and neuron-
specific enolase was observed. Two years after, because of an octreotide
scintigraphy demonstrating somatostatin receptors in liver and intestinal
tract a surgical second look was required. At that time, upper gastro-
intestinal roentgenology, colonoscopy and levels of bio-active amines and
peptides syntetized by cacinoids were normal. At surgical recognition
neither primaries nor recurrences were detected. The patient is well doing
and disease free at 10 year follow-up. To our knowledge this is one of the
very few fully documented cases of primary hepatic carcinoid. Present
report deals with a complete clinical laboratory and imaging workup,
careful surgical explorations and a long follow-up all excluding a different
site of a primary and thus confirming hepatic origin of neuroendocrine
tumor.
CR10.12
EFFICACY OF INTRAARTERIAL INFUSION OF PROSTAGLAN-
DIN E1 FOR HEPATOMA PATIENTS WITH TYPE C CIRRHOSIS
Uchida, Shinji; Hisaka, Toru; Ishikawa, Hiroto; Kawashima, Yuji; Kinoshita,
Hisafumi; Shirouzu, Kazuo
Kurume University School of Medicine, Surgery, Kurume, Japan
A therapy for the hepatoma patient with jaundice is difficult and we can’t find
an effective therapy for them now. Any way, we know prostaglandin E1
(following PGE1) as multifunctional drug, e.g. hepatocyte protection,
increase of hepatic blood flow, improvement of microcirculation and
promotion of liver regeneration. We injected PGE1 from hepatic arterial
infusion catheter for two patients with jaundice and hepatoma. 1st patient
was 69 years old man with cirrhosis of HCV. He was admitted to our hospital
cause of jaundice in March, 2004. Abdominal echo and CT showed tumor
embolism in bile duct cause of HCC (segment8), so we performed PTBD. At
first we gave PGE1 from hepatic arterial infusion catheter. One week later, we
held hepatic arterial infusion chemotherapy for four weeks. We found
improvement in termination of hepatic arterial injection. Abdominal CT
showed reduction of HCC remarkably. 2nd patient was 61 years old man. We
procedured transarterial chemoembolization (following TACE) for HCC
patient (segment3) with alcoholic cirrhosis in July, 2005. After TACE, we
injected of PGE1 from hepatic arterial infusion catheter. However, his T.Bil
was not change and he had distension of his abdomen, so we stopped
intraarterial infusion of PGE1 from hepatic arterial infusion catheter. He died
three months later. We did not recommend intraarterial infusion of PGE1 for
the severe cirrhosis patient.
CR10.13
MULTIPLE NECROTIC NODULES OF THE LIVER SIMULATING
HEPATIC METASTASIS
Osawa, Akihiro1; Sumiyama, Yoshinobu2; Watanabe, Manabu2; Tanaka,
Hidenori2; Asai, Koji2; Enomoto, Toshiyuki2; Kanai, Ryota2; Matsukiyo,
Hiroshi2; Saida, Yoshihisa2; Kusachi, Shinya2; Nagao, Jiro2
1Toho University School of Medicine, Third Dept. of Surgery, Tokyo, Japan;
2Toho University School of Medicine, Tokyo, Japan
Necrotic nodule of the liver is an uncommon non-malignant lesion. Features
on preoperative CT angiograpy (CTAP, CTHA) examinations have never
been reported. We report a case of multiple necrotic nodule of the liver and
describe the preoperative features on CT angiograpy examination.
Case. In July 2005, a 74-year-old man was referred to our hospital for
anemia and elevated serum carcinoembryonic antigen (CEA) and carbohy-
drate antigen (CA)19-9 levels. He was detected advance colon cancer by
colonoscopy and hepatic lesions incidentally detected on Ultrasonogra-
py(US) and CT examinations. US, CT and Superparamagnetic iron oxide
(SPIO)-enhanced magnetic resonance (MR) imaging revealed maximum
measuring 20 mm in diameter wide lesions located in Couinaud’s segment 3,
5, 6, 7, 8 of the liver); suggesting a metastatic liver tumors. Angiographic
findings showed no tumor stains in the hepatic artery. At the same time, we
underwent multi-phasic CTAP and CTHA. On early- and late-phasic
CTHA, all lesions were demonstrated as rim enhancement. All lesions
were shown as oval, wedge or irregular perfusion defect nodules on early-
phasic CTAP. And All lesions became gradually isodense compared with the
surrounding liver tissue on early-phasic CTAP, and the shape and size of
lesions were changed on late-phasic CTAP. Surgical resection was performed
in August, 2005. Laparotomy revealed a small nodule, which was relatively
hard, whitish, and had well-defined margin, and was lacalized on the anterior
surface and deep part of the liver (hepatic subsegment 3, 5, 6, 7, 8. Partial
resection of the liver (the tumor in the hepatic subsegment 5 and 8) was
performed with an adequate margin. The resected specimen revealed the
presence of a rounded, non-encapsulated nodule, with well-defined margins
and elastic consistency. Histological examination revealed that the lesions was
necrotic nodules.
CR10.14
NEW ATTEMPT AT PREOPERATIVE DIAGNOSIS OF HEPATO-
CELLULAR CARCINOMA USING MDCT
Koizumi, Satoshi; Asano, Takayuki; Asakura, Takeshi; Nakano, Hiroshi;
Otsubo, Takehito
St. Marianna University, Kanagawa Pref., Japan
Background. In treatment to the hepatocellular carcinoma(HCC), the
operation and RFA/TAE are mainly performed. It is needless to say that the
operation is the best method, but it is also true that the adjustment of RFA is
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being expanded along with the tool and the advance in technology. It hears of
the report that RFA comes to be done frequently, and the state deteriorated
rapidly after it treats. It is thought as the reason because the tumor had the
progress factor. There is something that has the progress factor even if it is a
small tumor. So, it is dangerous to judge the adjustment of RFA only from
the tumor size. But there is no method of the diagnosis about the presence of
the progress factor of HCC before it operates surely. A more detailed image
analysis has become possible by the advancement of the CT equipment
recently. Then the examination whether preoperative diagnosis of HCC using
MDCT is useful or not, begins our facilities.
Objective and method. The patient who is scheduling the operation by
diagnosing HCC, has no allergy to the contrast medium, to whom the
excision of a range that was bigger than the segmental excision was scheduled
is targeted. CT scan is done by injecting the contrast medium from the vein
as done so far. Thin slice scan is done by using Multidetector-row
CT(MDCT) made by Toshiba Acquilion64, the multiple planner recon-
struction(MPR) image of Coronal Saggital was made with Zio workstation.
Results(case presentation). A 71 years-old man was introduced to our
hospital for the liver tumor to be pointed out in another hospital. It was
diagnosed as HCC that had the progress factor since the thorough
examination was done in our facilities. CT(saggital scan) shows the liver
tumor, 15 mm in diameter, in segment8. We performed systemic liver
excision of segment8. In the excised specimen, the progress factor was
confirmed to the part as preoperative diagnosis.
Conclusion. Preoperative diagnosis of HCC using MDCT might be useful.
CR10.15
SURGICAL APPROACH OF INTRAHEPATIC CHOLANGIOCAR-
CINOMA
Ovejero-Go´mez, Vı´ctor J1; Matute-Cuartero, Marı´a A2; Bueno-Lo´pez,
Jesu´s2; Villa-Pen˜a, Pablo J3; Gutie´rrez-Ruiz, Amado1; Berrio-Obrego´n,
Ignacio1; Ingelmo-Setien, Alfredo1
1Hospital Sierrallana, Dept. of Surgery, Torrelavega, Spain; 2Hospital
Sierrallana, Dept. of Radiology, Torrelavega, Spain; 3Hospital Sierrallana,
Dept. of Histopathology, Torrelavega, Spain
Background. This is an epitelial tumour that may arise anywhere along
intrahepatic and extrahepatic bile ducts. It represents 5 10% of primary
hepatic cancers and usually presents a high grade of malignancy, multifocal
implantations and lymphatic affection. Its prognosis is predicted by infiltra-
tion of resection ledges and lymphatic or perineural invasion. We report an
asymptomatic intrahepatic cholangiocarcinoma and the importance of
surgical treatment on diagnosis of this disease.
Methods. A 76-year-old female was attended as out patient due to problems
of intestinal motility and weight loss. She had a past medical history of
hypertensive cardiopathy and dyslipaemia. A computed tomography scan
showed an heterogeneous focal tumour on hepatic segment IVb, another with
cystic aspect and cholelithiasis. We continued by magnetic resonance
cholangiography which detected both lesions with a doubtful diagnosis of
focal nodular hyperplasia. The result of a percutaneous biopsy had a
suspicion of malignancy.
Results. She underwent left hepatectomy and cholecystectomy. An intrao-
perative sonography was performed to detect other hepatic lesions. A seroma
of surgical wound ocurred. She was discharged in 8 days. Histological
diagnosis was moderate differentiated cholangiocarcinoma which infiltrated
perineural fatty tissue of ligamentum teres hepaticus.
Discussion. Its early diagnosis is difficult because they are asymptomatic
patients and their physical examination may not usually reveal anything.
Main differential diagnosis should be made with hepatocarcinoma and
metastasic digestive cancer. The treatment of choice probably remains
surgical resection which provides longest survival when it is possible. A 5-
year survival rate is less than 25% after resection and most recurrences are on
hepatic bed or lymph nodes between 2448 months after surgical operation.
An hepatic mass with unclear diagnosis by imaging procedures could justify a
surgical aggressive approach on asymptomatic patients.
CR11.01
PORTOSYSTEMIC GRAFT SHUNTING IN EXTRAHEPATIC POR-
TAL ANEURYSM
Florez, Carlos W1; Ferrer, Joana1; Calatayud, David1; Hessheimer, Amelia
J2; Fuster, Josep1
1Barcelona Clinic Hospital, Liver Surgery and Transplantation, Barcelona,
Spain; 2Barcelona Clinic Hospital, Liver Unit, Barcelona, Spain
Background. Portal aneurysms are very rare and typically associated with
portal hypertension (PH) and hepatic disease, though some occur in the
absence of known risk factors. There is no consensus regarding treatment.
Though a conservative approach is usually favored, surgical portosystemic
shunting has been described.
Objective. To report an unusual case of extensive portal aneurysm
presenting with portal hypertension and gastrointestinal bleeding who was
succesfully managed by aneurysm graft shunting.
Patient. A 30-year-old female presented with a sporadic high gastrointestinal
(GI) bleed. She had a 3-year history of PH; extensive thrombosis of the
portal, splenic, and superior mesenteric veins; and a 12-cm aneurysm of the
portosplenic axis. Coagulopathy tests and hepatitis serologies were negative,
and she was on low molecular-weight heparin therapy. The patient was
transfused monthly over 3 months with 34 units of packed cells.
Angiography demonstrated pancreaticoduodenal and jejunal arteriovenous
fistulas, which were embolized with partial response. After the last GI bleed,
treated by sclerosis of the lesser gastric curvature, her hematocrit fell to 18%,
and she was surgically intervened. Surgical exploration revealed a tension
aneurysm extending from the portosplenic confluence to the hepatic hilum,
which was decompressed by devascularization of the greater gastric curvature
and fundus. A 12-mm Goretex shunt was also placed between the aneurysm
and the vena cava.
Results. The postoperative evolution was satisfactory, and the patient was
sent home on day 11. According to imaging at day 7, the aneurysm measured
8.8/6.5, and the shunt was permeable. At month 2, pressures in the
aneurysm and vena cava were 8 and 6 mmHg respectively, the aneurysm
measured 5.8/3.7 cm, and the shunt was permeable.
Discussion and conclusion. Portosystemic shunting in which the graft
arises from the aneurysm itself is a potential treatment for portal aneurysm
when other portosystemic derivations cannot be realized.
CR11.02
RESECTED HEPATOCELLULAR CARCINOMA FOLLOWING
RADIO-FREQUENCY ABLATION THERAPY: REPORT OF TWO
CASES
Takasaki, Ken; Katagiri, Satoshi; Yamamoto, Masakazu; Yoshitoshi, Kenji;
Hamano, Mie; Ariizumi, Shunichi; Kotera, Yoshihito
Tokyo Women’s Medical University, Tokyo, Japan
We describe our experience with two resected cases of local recurrence after
radio-frequency ablation therapy (RFA) for hepatocellular carcinoma
(HCC).
Case 1. The patient was a 72-year-old man with chronic hepatitis C. On
1999, percutaneous ethanol injection therapy (PEIT) was performed for
HCC in segment 8 at the local hospital. On 2001, RFA was performed for
new HCC in segment 5. On 2001, local recurrence after RFA for HCC in
segment 5 was detected. Transarterial embolization (TAE) was performed.
Therapiatic effect was no change. On February 2002, we performed segment
2 and 5 resection of the liver. Histopathologically, the hepatic lesion showed
moderately differentiated HCC with multiple intrahepatic metastasis.
Case 2. The patient was a 60-year-old man with chronic hepatitis C. On
1998, transarterial chemotherapy was performed for HCC in segment 3.
Three months later, therapiatic effect was complete response. On 1999,
PEIT was performed for local recurrence HCC in segment 3. On May 2000
and October 2001, RFA was performed the local recurrence HCC after
transarterial chemotherapy and PEIT. On February 2002, gastric bleeding
was detected for local recurrence HCC with stomach invasion. We performed
left lobectomy of the liver and distal gastorectomy. Histopathologically, the
hepatic lesion showed moderately and poorly differentiated HCC with
multiple intrahepatic metastasis. These cases represents a warning of RFA
for HCC.
CR11.03
RUPTURE OF FOCAL NODULAR HYPERPLASIA (FNH) OF THE
LIVER IN A YOUNG WOMAN AFTER CAR ACCIDENT. A CASE
REPORT
Daskalakis, Kritolaos; Paraskaki, Stefano; Daskalaki, Despina; Anastasiou,
Anastasios
General Hospital of Rethymnon, Dept. of Surgery, Rethymnon, Greece
Background. Most of the FNH tumors are small and found incidentally at
laparotomy for another reason. Spontaneous rupture and haemorrhage of
FNH is very uncommon.
Aim. The aim of this paper is to present the possibility of rupture of FNH
after abdomen injury.
Material. We describe a case of an 18 years old woman who had rupture of
FNH caused by car accident. She had serious brain injury, bilateral
haemothorax and intraperitoneal haemorrhage. Urgent exploratory lapar-
otomy revealed rupture of the spleen and right hepatic lobe and rupture of
FNH in the left hepatic lobe. The main bleeding was from the rupture of
FNH. Suture of the spleen and liver was done. Atypical left hepatic
lobectomy was performed for the rupture of FNH. The patient was admitted
to intensive care unit.
Results. Unfortunately, the patient died after three days because of serious
brain injury.
Conclusions. Spontaneous rupture of FNH is very seldom. We must keep
in mind that rupture of FNH and bleeding can occur due to abdominal
injury.
CR12.01
INFLAMMATORY LESIONS OF LIVER AND INTESTINE SIMU-
LATING TUMORS: REPORT OF 2 RARE CASES
Papapolychroniadis, Costas1; Kaimakis, Dimitrios1; Karagiannopoulou,
Georgia2; Harlaftis, Nikolaos1
1Aristotle Universtiy of Thessaloniki, 1st Propedeutical Surgical Dept.,
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Thessaloniki, Greece; 2Aristotle Universtiy of Thessaloniki, Pathology Dept.,
Thessaloniki, Greece
Background. Inflammatory pseudotumors are infrequent non-neoplastic
mass lesions of lung, mesentery, liver, spleen, billiary tract and more rarely of
intestine. We present these 2 rare cases of pseudotumors of liver and intestine
because they can mimic malignant lesions which are difficult to diagnose
them preoperatively.
Materials and Methods. Our report describes 2 cases of 53 and 55 years
old house-wives originally admitted with diagnosis of upper abdominal sepsis
and occlusive ileus respectively in our surgical department. After further
preparation, resuscitation, laboratory and radiological investigations an
exploratory laparotomy was performed. In the first case segmental hepatect-
omy from the right lobe and in the second one a small bowel resection were
performed.
Results. The postoperative period was uneventful. The pathology reports
revealed inflammatory pseudotumors of the liver and jejunal loop. Patients
presentation during the follow-up period till now is without any signs of
pseudotumor recurrence.
Discussion-conclusion. Pseudotumor lesions should not be assumed to be
neoplastic without histological proof and certainly a presumed diagnosis of
primary neoplasia should not be managed de rigeur conservatively and
deprive the patient of effective and possibly curative surgery.
CR12.02
HEPATOCELLULAR CARCINOMA WITH UNUSUAL METASTA-
SIS TO THE PHARYNX
Cho, Akihiro; Nagata, Matsuo; Yamamoto, Hiroshi; Takiguchi, Nobuhiro;
Kainuma, Osamu; Souda, Hiroaki; Mori, Mikito; Narumoto, Souichi; Onai,
Yasuhide; Yokomizo, Jissei
Chiba Cancer Center Hospital, Chiba, Japan
Background. We present here a rare case of premortem-diagnosed
pharyngeal metastasis from hepatocellular carcinoma (HCC), in whom the
pharyngeal metastasis was successfully resected.
Patient. A 72 year-old man was referred to our hospital with passage
disturbance. The patient underwent twice hepatectomy for the treatment of
HCC 5 years and 2 years previously. In addition, he repeatedly underwent
transarterial chemoembolization (TACE) for HCC. Endoscopic examination
showed an oozing semipedunculated polypoid mass in the pharynx. The
patient underwent resection of the pharyngeal tumor. Pathological and
immunohistorical findings showed the metastasis from HCC. Although he
had no metastases to the lung, bone, and adrenal gland, remnant liver
recurrence was detected. The patient had an uneventful postoperative course.
Discussion. Metastasis to the esophagus is rare, being present in less than
0.4% of patients with HCC. Oral metastasis from HCC is extremely rare.
These metastases are presumed to be caused by tumor thrombi infiltrating via
the portal system, at which point they are disseminated by hepatofugal portal
blood flow to the gastrointestinal tract. We reviewed the literatures relating to
esophageal and oral metastases from HCC.
CR13.01
A DISEMINATED STOMACH ECHINOCCOCOSIS
Stanisic, Veselin; Bakic, Milorad; Stijovic, Blazo; Vlaovic, Darko
General Hospital Berane, Surgical Dept., Berane, Serbia and Montenegro
Introduction. Echinoccocosis with its complications (rupture, compression,
infection, allergy) endangers the life of a patient. Rupture in the free
peritoneal cavity-less than 5%, manifested by allergic manifestations or by
the purulent peritonitis, causes the echinoccocus dissemination-the second-
ary echinoccocosis. The treatment-surgical and medicamentous.
Aim. A case report with stomach cavity echinoccocus dissemination,
threatening cyst rupture in the VI, VII liver segment, a positive family
echinoccocus anamnesis.
Material and methods. A.S., 1947, admitted on 14.12.2005, powerful
pains in the right hypocohondrium, suboclusive problems, cachexy. The
ECHO e. cyst in the liver (4, 5/14, 0 cm.) occupying the right liver lobus,
numerous cystic formations in the stomach cavity, the small pelvis(5, 4/4, 4
cm to 12, 0/9, 0 cm), operated because of the threatening cyst rupture in
the right liver lobus. Intraoperatively disseminated e. cysts into the stomach
cavity-VI, VII, III, IVa liver segment, the radix of the mesocolone
transversum, omentum majus et minus, the left uterine tube, Douglassi
cavum compressing the sigmoid colon, rectum, vesica urinaria, atypical liver
resection/VI-VII segment/, a closed total cystopericistectomy in the Douglassi
cavum and uterine tube, the lavage, stomach cavity drainage (subhepatic,
perisplenic, subfrenic loge). During the early postoperative period signs of
cardio-respiratory insufficiency. A lethal outcome 20.12.2005.
Conclusion. Numerous e. cyst lead to cachexy, the death of the patient,
rarely, the immune system kills the scolex depositing the calcium-hydatide
pseudotuberculosis. The e.cyst evacuation into the blood vessel can cause
the lungs embolism, metastatic echinoccocus dissemination into other
organs, anaphylaxis. A cyst rupture can cause a rapid death of a patient
due to embolism, anaphylaxis, bleeding or sepsis. Mortality of sick,
operated-25%.
CR13.02
2 CASES OF PNEUMATOSIS INTESTINALIS AND HEPATIC
PORTAL VENOUS GAS
Ito, Masahiro; Horiguchi, Akihiko; Ishihara, Shin; Miyakawa, Shuichi
FUjita Health University, Toyoake, Japan
A 67-year-old woman was performed PD operation with PV resection.
Complaining was right lower abdominal pain and high fever after 12
operation days. Abdominal X-ray and computed tomography showed
hepatic portal venous gas, as well as pneumatosis intesinalis. An emergency
laparotomy was performed. At laparotomy, extensive necrosis of the bowel
from the jejunum to ascending colon was disclosed. All necrotic bowels
were resected and a jejunostomy was performed. The length of the intact
small intestine was only 30 cm. The postoperative course was compara-
tively uneventful. This type of complication was a rear case after PD
operation, but cannot be saved by any treatments other than surgery.
Second case was 45-year-old women complaining of abdominal pain and
constipation was admitted to our hospital. Abdominal X-ray and and
computed tomography showed free air and hepatic portal venous gas, as
well as pneumatosis intesinalis. Her past history was chronic toluene
inhalation. However, her physical findings, including laboratory data, did
not support the presence of bowel necrosis. Hyperbaric oxygen therapy was
performed for this patient. This therapy was effective to care it. Thus, we
reported that these are 2 cases with hepatic portal venous gas.
CR13.03
LAPAROSCOPIC DRAINAGE OF PYOGENIC LIVER ABSCESS
Chang, Stephen KY
National University Hospital Singapore, Surgery, Singapore
Traditionally pyogenic liver abscesses have been managed by antibiotics
alone or together with drainage, open surgical or percutaneous depending
on the number, size, and accessibility from percutaneous route. Although
percutaneous drainage offers minimally invasiveness, it is limited by certain
abscess location or where it is near the major vessels. Multiple procedure
may also be required due to blockage of tube. Recently, laparoscopic
drainage has been introduced. This offers the benefit of minimally
invasiveness and also allows large bore drainage into abscess cavity which
does not block easily. At the same time, a diagnostic laparoscopy can be
performed. I present here my early experience with laparoscopic liver
abscess drainage including 2 interesting cases; one involving a ruptured
abscess presenting with severe sepsis and acute abdomen;and the other, an
abscess in caudate lobe with the cause of the abscess being acute gangrenous
cholecystitis not diagnosed on pre-operative imaging.
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